Batch	Target	Species	refseq_id	UniProt	integr8_id	embl_acc	genome_project_id	Annotation	Target Role	RNA Seq	aa seq	RNA len	aa	kDa	MaxCode	Status	LigandCode	Ligand Screen Status	BEI Repository
Batch01a	BrabA.00002.a	Brucella melitensis	YP_419127	Q2YJQ7				"Bacterial transferase hexapeptide repeat:2,3,4,5-tetrahydropyridine-2-carboxylate N-succinyltransferase "	Potential drug target		MTKPDLASLEKTIEKAFDERDGINTATRGEVREAVEQSLILLDRGEVRVAEKQADGNWHVNQWLKKAVLLSFRLNPMEVIKGGPGQSSWWDKVPSKFDGWTANEFEKAGFRAVPNCIVRHSAYIAPNAILMPSFVNLGAYVDKGAMIDTWATVGSCAQIGKNVHLSGGVGIGGVLEPMQAGPTIIEDNCFIGARSEVVEGCIVREGSVLGMGVFIGKSTKIVDRATGEVFYGEVPPYSVVVAGTMPGKNVPGENWGPSLYCAVIVKRADEKTRSKTSINELLRD*		285	31	17	In PDB	-1	 	NR-13705
Batch01a	BrabA.00003.a	Brucella melitensis	YP_415201	Q2YLL8				"Regulator of chromosome condensation, RCC1:Ribosomal protein L27 "	Potential drug target		MAHKKAGGSSRNGRDSESKRLGVKKFGGEAVLAGNIIVRQRGTKWHPGANVGLGKDHTIFATVNGSVSFRTKANGRTYVSVNPIAEAAE*		90	9	-2	Work Stopped	-2	Work Stopped	
Batch01a	BrabA.00005.a	Brucella melitensis	YP_415266	Q2YLR9				Lactate/malate dehydrogenase:L-lactate dehydrogenase:TrkA potassium uptake protein 	Potential drug target		MARNKIALIGSGMIGGTLAHLAGLKELGDVVLFDIAEGTPQGKGLDIAESSPVDGFDAKFTGANDYAAIEGADVVIVTAGVPRKPGMSRDDLLGINLKVMEQVGAGIKKYAPEAFVICITNPLDAMVWALQKFSGLPAHKVVGMAGVLDSARFRYFLSEEFNVSVEDVTVFVLGGHGDSMVPLARYSTVAGIPLPDLVKMGWTSQDKLDKIIQRTRDGGAEIVGLLKTGSAFYAPAASAIQMAESYLKDKKRVLPVAAQLSGQYGVKDMYVGVPTVIGANGVERIIEIDLDKDEKAQFDKSVASVAGLCEACIGIAPSLK*		321	34	17	In PDB	17	Ligand-bound structure submitted to PDB	NR-13706
Batch01a	BrabA.00006.a	Brucella melitensis	YP_414688	Q2YRF5				Precorrin-8X methylmutase CbiC/CobH 	Potential drug target		MTDYIRDGQAIYDRSFAIIRAEADLRHIPADLEKLAVRVIHACGMVDVANDLAFSEGAGKAGRNALLAGAPILCDARMVAEGITRSRLPADNRVIYTLSDPSVPELAKKIGNTRSAAALDLWLPHIEGSIVAIGNAPTALFRLFELLDAGAPKPALIIGMPVGFVGAAESKDELAANSRGVPYVIVRGRRGGSAMTAAAVNALASERE*		209	22	17	In PDB	-1	 	
Batch01a	BrabA.00007.a	Brucella melitensis	YP_413859	Q2YMA4				"Conserved hypothetical protein, ArsC related:Arsenate reductase and related "	Potential drug target		MSVTIYGIKNCDTMKKARIWLEDHGIDYTFHDYKKEGLDAETLDRFLKTVPWEQLLNRAGTTFRKLPEDVRSNVDAASARELMLAQPSMVKRPVLERDGKLMVGFKPAQYEAYFKL*		117	13	17	In PDB	-1	 	
Batch01a	BrabA.00008.a	Brucella melitensis	YP_414220	Q2YN95				Glycine hydroxymethyltransferase 	Potential drug target		MSQANAATKAYSDVFFNASLEDIDPEIFGAIRNELGRQRHEIELIASENIVSRAVLEAQGSILTNKYAEGYPGKRYYGGCQYVDVVEELAIERAKKLFGAEFANVQPNSGSQMNQAVFLALLQPGDTFMGLDLNSGGHLTHGSPVNMSGKWFNVVSYGVRKDDHLLDMDEVARLARENKPKLILAGGTAYSRIWDWKRFREIADEVGAYLMVDMAHIAGLVAGGQHPSPVPHAHVCTTTTHKSLRGPRGGMILTNDADIAKKINSAVFPGLQGGPLMHVIAGKAVAFAEALKPEFKLYAKNVVDNARALAEELKSHGLDIVSGGTDNHLMLVDLRPKNATGKRAEAALGRANITCNKNGIPFDPEKPFVTSGVRLGTPAGTTRGFGVAEFKEIGSLIAEVLDGLKVANSDEGNAAVEQAVKEKVIALTGRFPMYGYQG*		439	47	10	Diffraction	-1	 	NR-13707
Batch01a	BrabA.00010.a	Brucella melitensis	YP_413907	Q2YMC8				Short-chain dehydrogenase/reductase SDR:Glucose/ribitol dehydrogenase 	Potential drug target		MTAQSGLLQGKRGLILGVANNRSIAWGIAKAAREAGAELAFTYQGDALKKRVEPLAEELGAFVAGHCDVADAASIDAVFETLEKKWGKLDFLVHAIGFSDKDELTGRYIDTSEANFTNTMLISVYSLTAVSRRAEKLMADGGSILTLTYYGAEKVMPNYNVMGVAKAALEASVKYLAVDLGPQNIRVNAISAGPIKTLAASGIGDFRYILKWNEYNAPLRRTVTIDEVGDVGLYFLSDLSRSVTGEVHHADSGYHVIGMKAVDAPDISVVKD*		273	29	17	In PDB	-1	 	NR-13708
Batch01a	BrabA.00010.b	Brucella melitensis	YP_413943	Q2YMG6				Short-chain dehydrogenase/reductase SDR:Glucose/ribitol dehydrogenase 	Potential drug target		MFDLTGRKALVTGATGGLGEAIARALHAQGAIVGLHGTREEKLKELAAELGERIFVFPANLSDREAVKALGQKAEEEMGGVDILVNNAGITRDGLFVRMSDEDWDAVLTVNLTSVFNLTRELTHPMMRRRNGRIINITSIVGVTGNPGQANYCASKAGLIGFSKSLAQEIASRNVTVNCIAPGFIESAMTGKLNEKQKDAIMGNIPMKRMGVGADIAAAVVYLASDEAAYVTGQTLHVNGGMAMI*		246	26	17	In PDB	5	Target selected for ligand screening 	NR-13709
Batch01a	BrabA.00010.c	Brucella melitensis	YP_415492	Q2YQR0				possible enoyl-(acyl-carrier-protein) reductase 	Potential drug target		MEGLMQGKRGLIMGVANNHSLAWGIAKQLAAQGAELAFTYQGDALGKRVKPLAEQVGSDFVLPCDVEDIATVDAVFEEIEKKWGGLDFLVHAIGFSDKTELKGRYADVTTRENFSRTMVISAYSFTEVAQRAEKLMKDGGSILTLTYGGSTRTIPNYNVMGVAKAALEAMVRYLAADYGPQGIRVNAISAGPVRTLAGAGIGDARAIFSYQRRNSPLRRTVDIDDVGKSAVYLLSDLSSGVTGEIHFVDSGYNIVSMPTLEELKSSDSERGE*		273	29	10	Diffraction	-1	 	
Batch01a	BrabA.00012.a	Brucella melitensis	YP_413577	Q2YNV0				Transcriptional coactivator/pterin dehydratase 	Potential drug target		MARNRLTESEMNEALRALDGWQKVDGREAITRSFKFKDFSTAFGFMAQAALYAEKLDHHPEWFNAYNRVDVTLATHSENGVTELDIKMARKMNAIAG*		98	11	17	In PDB	-1	 	"NR-16675, NR-16676, NR-16677, NR-16678, NR-16679"
Batch01a	BrabA.00013.a	Brucella melitensis	YP_415064	Q2YRD2				"CbxX/CfqX superfamily:Disease resistance protein:ATP/GTP-binding site motif A (P-loop):AAA ATPase:AAA ATPase, central region:... "	Potential drug target		MSDRNPLIDADRRADEDNTLRPQTLDDFVGQAAARANLKVFIEAAKVRGEALDHVLFVGPPGLGKTTLAQIMAKELGVNFRSTSGPVIAKAGDLAALLTNLEERDVLFIDEIHRLSPAVEEILYPAMEDFQLDLIIGEGPAARSVKIDLAKFTLVAATTRLGLLTTPLRDRFGIPVRLNFYTVEELEYIVRRGARIMQMGISSDGAREVARRSRGTPRIAGRLLRRVRDFALVAGADIIDRRIADEALSRLEVDNRGLDQLDRRYLNIIARNFGGGPVGIETIAAGLSEPRDAIEDIIEPYLIQQGFLQRTPRGRVLTAVAWQHLGLPAPAEIIQQSQYGLFMEDE*		347	38	4	Soluble	-1	 	
Batch01a	BrabA.00014.a	Brucella melitensis	YP_414989	Q2YQA0				Isocitrate lyase and phosphorylmutase:Isocitrate lyase 	Potential drug target		MTDFYSLIPSAPKGRFDGIERAHTAEDVKRLRGSVEIKYSLAEMGANRLWKLIHEEDFVNALGALSGNQAMQMVRAGLKAIYLSGWQVAADANTASAMYPDQSLYPANAGPELAKRINRTLQRADQIETAEGKGLSVDTWFAPIVADAEAGFGGPLDAFEIMKAYIEAGAAGVHFEDQLASEKKCGHLGGKVLIPTAAHIRNLNAARLAADVMGTPTLIVARTDAEAAKLLTSDIDERDQPFVDYEAGRTAEGFYQVKNGIEPCIARAIAYAPYCDLIWMETSKPDLAQARRFAEAVHKAHPGKLLAYNCSPSFNWKKNLDDATIAKFQRELGAMGYKFQFITLAGFHQLNYGMFELARGYKDRQMAAYSELQQAEFAAEADGYTATKHQREVGTGYFDAVSLAITGGQSSTTAMKESTETAQFKPAAE*		430	47	17	In PDB	5	Target selected for ligand screening 	
Batch01a	BrabA.00015.a	Brucella melitensis	YP_414642	Q2YM02				"Ribosomal protein S10:Ribosomal protein S10, bacterial form "	Potential drug target		MNGQNIRIRLKAFDHRILDASTREIVSTAKRTGANVRGPIPLPTRIEKFTVNRSPHIDKKSREQFEMRTHKRLLDIVDPTPQTVDALMKLDLSAGVDVEIKL*		103	12	-2	Work Stopped	-2	Work Stopped	
Batch01a	BrabA.00016.a	Brucella melitensis	YP_419065	Q2YJW9				Blue (type 1) copper domain:Blue (type 1) copper protein:Amicyanin:Plastocyanin 	Potential drug target		MRNTAIKFAAAGLFALLAAPALAENIEVHMLNKGAEGAMVFEPSYIKANAGGTITFIPMDKGHNVETVKDMIPDGAEKFKSKINEHYTVTVNQPGAYLIKCTPHYAMGMVALIAVGDKPENLEKIVSAKKPKVVQERLDKILAEVK*		147	16	4	Soluble	-1	 	
Batch01a	BrabA.00019.a	Brucella melitensis	YP_418407	Q2YII2				Aldo/keto reductase 	Potential drug target		MWWPAPRKTAQKISGKGYIMTVPTVKLNDGNHIPQLGYGVWQISNDEAVSAVSEALKAGYRHIDTATIYGNEEGVGKAINGSGIARADIFLTTKLWNSDQGYESTLKAFDTSLKKLGTDYVDLYLIHWPMPSKDLFMETWRAFIKLKEEGRVKSIGVSNFRTADLERLIKESGVTPVLNQIELHPQFQQDELRLFHGKHDIATEAWSPLGQGKLLEDPTLKSIAEKHAKSVAQIILRWHIETGNIVIPKSITPARIKENFDIFDFTLNGTDHDAITKLDMADGRIGPNPSVFSA*		295	33	17	In PDB	-1	 	NR-13713
Batch01a	BrabA.00020.a	Brucella melitensis	YP_415006	Q2YRI3				Aldehyde dehydrogenase 	Potential drug target		MLALKDPSLLKSQCLVNGRWIDAADGTTIKVTNPADGSVIGTVPSLSVATIKEAIDASAKALSGWAAKTAKERAGILRKWFDLIIANADDIALIMTSEQGKPLAEARGEVLYAASFIEWFAEEAKRVYGDTIPAPQNGQRLTVIRQPVGVTAAITPWNFPAAMITRKAAPALAAGCTMIVRPADLTPLTALALGVLAEKAGIPAGVLQIVTGKAREIGAELTSNDTVRKLSFTGSTEVGRLLMAQCAPTIKRISLELGGNAPFIVFDDADLDAAVDGAMVSKYRNAGQTCVCANRIYVQRGVYDKFAEKLAAKVKELKVGNGTEPGVVIGPMIEEKAITKVKAHIEDAVSKGAKLITGGKELGGLFFEPGILTGVTSDMLVAKEETFGPLAPLFAFDTEEEVIAQANDTIFGLAAYFYTENFSRAIRVSEALEYGMVGHNTGLISNEVAPFGGVKQSGLGREGSKYGIEEYLETKYICSAYKR*		484	51	17	In PDB	9	Experimental evidence of bound ligand(s)	NR-13714
Batch01a	BrabA.00021.a	Brucella melitensis	YP_418952	Q2YK82				"Amino acid-binding ACT:D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain:D-isomer specific 2-hydroxyacid dehydr... "	Potential drug target		MTERLSLSRDRINVLLLEGISQTAVEYFKSSGYTNVTHLPKALDKADLIKAISSAHIIGIRSRTQLTEEIFAAANRLIAVGCFSVGTNQVELKAARKRGIPVFNAPFSNTRSVAELVIGEIIMLMRRIFPRSVSAHAGGWEKTAIGSREVRGKTLGIVGYGNIGSQVGNLAESLGMTVRYYDTSDKLQYGNVKPAASLDELLKTSDVVSLHVPSSKSTSKLITEAKLRKMKKGAFLINNARGSVVDLEALAKVLQEGHLAGAAIDVFPVEPASNGERFSTPLQGLENVILTPHIGGSTEEAQERIGTEVTRKLVEYSDVGSTVGAVNFPQVQLPPRPTGTRFMHVHENRPGILNSLMNVFSHHHINIASQFLQTDGEVGYLVMEADGVGEASDAVLQEIREIPGTIRARLLY*		413	45	17	In PDB	-1	 	NR-13715
Batch01a	BrabA.00023.a	Brucella melitensis	YP_415326	Q2YR76				Inorganic pyrophosphatase:Bacterial/Archaeal inorganic pyrophosphatase 	Potential drug target		MNIDAISIGSNPPEDVNVIIEVPVGGQPIKYEMDKKAGALIVDRFLYTPMTYPGNYGFVPHTLSEDGDPIDVLVCNTRPLIPGCVINVRPIGVLVMEDNSGKDEKIIAVPSPHLTRRYEKIHDYTDMPEITLKQIAHFFEHYKDLEPGKWVKIGDWGDEDYARKFIVEAIERAKGK*		177	20	17	In PDB	9	Experimental evidence of bound ligand(s)	NR-13716
Batch01a	BrabA.00026.a	Brucella melitensis	YP_413944	Q2YMG5				Acyl carrier protein (ACP):Phosphopantetheine attachment site:Phosphopantetheine-binding domain 	Potential drug target		MSDTAERVKKIVVEHLGVDADKVTEGASFIDDLGADSLDTVELVMAFEEEFGVEIPDDAAETILTVGDAVKFIDKASA*		79	8	8	HSQC	-1	 	NR-13717
Batch01a	BrabA.00027.a	Brucella melitensis	YP_414502	Q2YPZ4				"Acyl-CoA dehydrogenase:Acyl-CoA dehydrogenase, C-terminal:Acyl-CoA dehydrogenase, central domain:Acyl-CoA dehydrogenase, N-te... "	Potential drug target		MSRAAFAWEDPFLLEEQLTEDERMIRDSAKAFASDVLLPRVEKAYLEETTDPELFHLMGQAGLLGVTLPEDYGAANASYVAYGLVAREVERIDSGYRSMMSVQSSLVMYPIYAYGSDEQRKKYLPGLVSGELIGCFGLTEPDAGSDPAGMKTRAEKIDGGYRLSGSKMWISNSPIADVFVVWAKSAAHDNAIRGFILEKGMKGLSAPKIGGKLSLRASITGEIVMDGVEVSEDAILPNVSGLKGPFGCLNRARYGISWGVLGAAEDCWFRARQYGLDRKQFNKPLAGTQLYQKKLADMQTEIALGIQASLRVGRLFDEGKMAPEMISIVKRNNCGKALDIARQARDMHGGNGIQIEYHVMRHAQNLETVNTYEGTHDVHALILGRAQTGIQAFF*		395	43	10	Diffraction	9	Experimental evidence of bound ligand(s)	NR-13718
Batch01a	BrabA.00028.a	Brucella melitensis	YP_418850	Q2YKI4				Ferritin:Bacterioferritin 	Potential drug target		MKGEPKVIERLNEALFLELGAVNQYWLHYRLLNDWGYTRLAKKEREESIEEMHHADKLIDRIIFLEGFPNLQTVSPLRIGQNVKEVLEADLKGEYDARASYKESREICDKLGDYVSKQLFDELLADEEGHIDFLETQLDLLAKIGGERYGQLNAAPADEAE*		162	19	17	In PDB	-1	 	
Batch01a	BrabA.00029.a	Brucella melitensis	YP_415432	Q2YQX0				thioredoxin:Thioredoxin type domain:Thioredoxin domain 2 	Potential drug target		MATVKVDNSNFQSDVLQSSEPVVVDFWAEWCGPCKTIAPALDEIAAEMAGQVKIAKVNIDENPELAAQFGVRSIPTLLMFKDGELAANMVGAAPKSRLADWIKASAA*		108	11	7	Crystallized	-1	 	
Batch01a	BrabA.00030.a	Brucella melitensis	YP_414524	Q2YPX2				"CbxX/CfqX superfamily:ATP/GTP-binding site motif A (P-loop):Bacterial chromosomal replication initiator protein, DnaA:AAA ATP... "	Potential drug target		MSKVSNGGGDSKNTLYCSFCGKSQHEVRKLIAGPTVFICDECVELCMDIIREENKSSMVKSREGVPTPQEIMAVLDDYVIGQKDAKRVLSVAVHNHYKRLAHQSKNSDIELAKSNILLVGPTGCGKTYLAQTLARIIDVPFIMADATTLTEAGYVGEDVENIILKLLQAADYNVERAQRGIVYIDEVDKISRKSDNPSITRDVSGEGVQQALLKIMEGTVASVPPQGGRKHPQQEFLQVDTTNILFICGGAFAGLDRIISARGEKTSIGFGATVKSVDERRIGEVFKELEPEDLLKFGLIPEFVGRLPVIATLEDLDVDALVQILTEPKNALVKQYQRLFDMENVELVFHDDALRAIANKAVERKTGARGLRSIMEKILLDTMFELPTLEGVREVVISGDVVDGSARPLYIYAERQDEKGNVSA*		425	47	10	Diffraction	-1	 	NR-13719
Batch01a	BrabA.00032.a	Brucella melitensis	YP_415424	Q2YQX8				S-adenosyl-L-homocysteine hydrolase:ATP/GTP-binding site motif A (P-loop) 	Potential drug target		MTASQDFVVKDISLADWGRKELDIAETEMPGLMAAREEFGKSQPLKGARISGSLHMTIQTAVLIETLKVLGAEVRWASCNIFSTQDHAAAAIAATGTPVFAVKGETLEEYWTYTDQIFQWPDGEPSNMILDDGGDATMYILIGARAEAGEDVLSNPQSEEEEVLFAQIKKRMAATPGFFTKQRAAIKGVTEETTTGVNRLYQLQKKGLLPFPAINVNDSVTKSKFDNKYGCKESLVDGIRRGTDVMMAGKVAVVCGYGDVGKGSAQSLAGAGARVKVTEVDPICALQAAMDGFEVVTLDDAASTADIVVTTTGNKDVITIDHMRKMKDMCIVGNIGHFDNEIQVAALRNLKWTNVKPQVDLIEFPDGKRLILLSEGRLLNLGNATGHPSFVMSASFTNQVLGQIELFTRTDAYKNEVYVLPKHLDEKVARLHLDKLGAKLTVLSEEQAAYIGVTPQGPFKSEHYRY*		467	51	17	In PDB	-1	 	
Batch01a	BrabA.00033.a	Brucella melitensis	YP_418957	Q2YK77				Protein of unknown function DUF25 	Potential drug target		MKYQKSAEAIAKLSAEQYRVTQENGTERLGTGEYLYNKEPGIYVDIVSGEPLFASSDKYESHCGWPSFTKPIERANVTELTDMSHGMVRTEVRSAHGDSHLGHVFPDGPVDRGGLRYCINSASLRFVPKDRMEAEGYGDYLDQVEG*		147	16	5	Purified	-1	 	
Batch01a	BrabA.00034.a	Brucella melitensis	YP_413812	Q2YPG0				"Alpha/beta hydrolase fold:Esterase/lipase/thioesterase, active site:Epoxide hydrolase:Prolyl aminopeptidase S33:Alpha/beta hy... "	Potential drug target		MTRNTLYPEIEPFKEEMLQVSSLHRIHVEQCGNPDGKPVIMIHGGPGGGITPTMRRLHDPKRYRIILFDQRGCGRSTPHAELRENTTWDLVADMEHIRAHLGIDKWQVFGGSWGSTLGLAYAETHPERVSELVLRGIFMVRRFEVDWMYSNGASIIFPDHFEAYQEHIPEAERGDMIAAYYKRLTDRDPRVQLEAARRWARWEGSVISLLPDPARVDAFGEDQYAIAFARIECHYFQNRGFLESDDQLLRNVERIRHIPGVIVHGRYDICTPFINAWQLKKMWPEADLKIVEDSGHAVTEPGIMHELIEATKRFCE*		317	37	3	Expressed	-1	 	
Batch01a	BrabA.00036.a	Brucella melitensis	YP_414349	Q2YNP3				"Acetyl-CoA carboxylase, biotin carboxylase:Carbamoyl-phosphate synthase L chain, ATP-binding:Carbamoyl-phosphate synthetase l... "	Potential drug target		MFQKILIANRGEIALRVLRACKELGIKTVAVHSTADADAMHVRLADESVCIGPPPSRDSYLNIHQIVAACEITGADAIHPGYGFLSENAKFAEILEAHDITFIGPTASHIRIMGDKIEAKRTAKRLGIPVVPGSDGGVTDEVEAARIAKEIGYPVIIKASAGGGGRGMKVARSAEELPIALATARSEAGAAFGDDAVYIEKYLEKPRHIEVQVMGDGAGNAVHLGERDCSLQRRHQKVWEEGNSPALNAEAREKIGMICANACAELGYRGAGTIEFLYEDGEFYFIEMNTRLQVEHPVTEAITGIDLVHEQIRVAAGLGLSVKQKDIRFSGHAIECRINAEDPLTFAPSPGLITHYHTPGGLGVRVDSGVYSGYRIPPYYDSLIGKLIVHGRNRVECMMRLRRALDEFVVDGVKTTLPLFQDLISNQDIANGDYDIHWLEKYLANKSKNESA*		453	49	7	Crystallized	-1	 	
Batch01a	BrabA.00037.a	Brucella melitensis	YP_414261	Q2YNF5				"7Fe ferredoxin:3Fe-4S ferredoxin:4Fe-4S ferredoxin, iron-sulfur binding domain "	Potential drug target		MASIAQAAKSLLLKEFASAFALSMRQFFAPKATLNYPHEKGPVSPRFRGEHALRRYPNGEERCIACKLCEAICPAQAITIEAGPRRNDGTRRTVRYDIDMVKCIYCGFCQEACPVDAIVEGPNFEFATETREELYYDKDKLLANGDRWEREIARNIAMDAPYR*		164	19	4	Soluble	-1	 	
Batch01a	BrabA.00038.a	Brucella melitensis	YP_414256	Q2YNG0				"Pectinesterase:NADH-ubiquinone oxidoreductase, chain 49kDa "	Potential drug target		MAETQVRNFNINFGPQHPAAHGVLRLVLELDGEVVERVDPHIGLLHRGTEKLMEAKTYLQAVPYLDRLDYVAPMNQEHAYALAVERLLDIEVPKRGQLIRVLYSEIGRILNHLLNVTTQAMDVGALTPPLWGFEEREKLMVFYERACGARMHAAYFRPGGVHQDLPDQLIEDIGKWIDPFFTTLKNLDDLITPNRIFKQRNVDIGVVKLEDAWAWGFSGVMVRGSGAAWDLRKSQPYECYSEMEFDIPVGKNGDCYDRYLIRMEEMRQSARIMRQCVDLLLGKERVGPVSNTDHKIVPPKRGEMKRSMEALIHHFKLYTEGYHVPAGEVYAAVEAPKGEFGVYLVSDGSNKPYRFKLRAPGFAHLQAMDFLCRGHMLADVSAILGSLDIVFGEVDR*		397	45	3	Expressed	-1	 	
Batch01a	BrabA.00039.a	Brucella melitensis	YP_414683	Q2YRG0				"Metallopeptidase family M24:Methionine aminopeptidase:Methionine aminopeptidase, subfamily 1 "	Potential drug target		MVTYIEATSAPVKYTGQIRLYGPEAFEAMRKVCNLTARCLDALNDIVKPGVTTNEIDRFVFEFGMDHDAFPATLNYRGYTKSTCTSINHVVCHGIPNDKPLREGDIVNIDVTYLLDGWHGDSSRMYAVGEIKRASERLLEVTYESLLRGIAAVKPGAKTGAIGAAIQTYAESERCSVVRDFCGHGVGRLFHDAPNILHYGTPNEGVEIKEGMIFTIEPMINLGKPHVKVLADGWTAVTRDRSLTAQYEHTVGVTRDGCEIFTLSPANIFGPPSMR*		276	30	7	Crystallized	-1	 	NR-13720
Batch01a	BrabA.00041.a	Brucella melitensis	YP_419020	Q2YK14				glutamate decarboxylase alpha 	Potential drug target		MTGSNYPARDLIASVFGTEALQEIAASRGFREKEMQANAVYQIIHDELFLDGNARQNLATFCQTWDDDYVHKLMDLSINKNWIDKEEYPQSAAIDLRCVNMVADLWNAPKFADNATGTNTIGSSEACMLGGMAMKWRWRKKMQEMGKPTDKPNFV*		156	18	4	Soluble	-1	 	
Batch01a	BrabA.00042.a	Brucella melitensis	YP_414643	Q2YM08				"Elongation factor, GTP-binding:ATP/GTP-binding site motif A (P-loop):Elongation factor Tu, C-terminal:Elongation factor Tu, d... "	Potential drug target		MAKSKFERTKPHVNIGTIGHVDHGKTSLTAAITKFFGEFKAYDQIDAAPEERARGITISTAHVEYETANRHYAHVDCPGHADYVKNMITGAAQMDGAILVVSAADGPMPQTREHILLARQVGVPAIVVFLNKCDQVDDAELLELVELEVRELLSKYEFPGDEIPIIKGSALAALEDSSKELGEDAIRNLMDAVDSYIPTPERPIDQPFLMPIEDVFSISGRGTVVTGRVERGIVKVGEEVEIVGIKATTKTTVTGVEMFRKLLDQGQAGDNIGALIRGVGREDVERGQVLCKPGSVKPHTKFKAEAYILTKDEGGRHTPFFTNYRPQFYFRTTDVTGVVTLPAGTEMVMPGDNVAMDVTLIVPIAMEEKLRFAIREGGRTVGAGIVSSIIE*		392	43	7	Crystallized	-1	 	NR-13721
Batch01a	BrabA.00044.a	Brucella melitensis	YP_413690	Q2YP66				Zinc-containing alcohol dehydrogenase superfamily:Zinc-containing alcohol dehydrogenase 	Potential drug target		MAKTMKAAVVRAFGKPLTIDEVPIPQPGPGQIQVAIQASGVCHTDLHAAEGDWPVKPNPPFIPGHEGVGFVSAVGSGVKHVKEGDRVGIPWLYTACGHCRHCLGGWETLCEEQLNTGYSVNGGFAEYVVADPNFVGHLPKNIDFNEIAPVLCAGVTVYKGLKVTDTKPGDWVVISGIGGLGHMAVQYARAMGLNVAAVDIDDRKLDLARRLGATVTVNAKTVADPAAYIRKETDGGAQGVLVTAVSPKAFEQALGMVARGGTVSLNGLPPGDFPLSIFNMVLNGVTVRGSIVGTRLDLQESLDFAADGKVKATIQTGKLEDINAIFDDMRQGNIEGRIVMDLTQ*		345	36	17	In PDB	-1	 	
Batch01a	BrabA.00047.a	Brucella melitensis	YP_415293	Q2YLW1				Fumarate lyase:Delta crystallin 	Potential drug target		MTTLENIHPLTRREQDSLGERDIPMDAYFGIQTLRAVENFSLSDVALNHIPALVRALAMVKKAAATANYKLRQLPEPKYAAIVAACDDIIDGLLMEQFVVDVFQGGAGTSSNMNANEVIANRALEHLGRPRGDYQTIHPNDDVNMSQSTNDVYPTAVRLALLLSQNQVQTALHRLIAAFEAKGREFATVIKIGRTQLQDAVPITLGQEFEAFAATLREDTARLEEVAALFREVNLGGTAIGTRINASHAYAEQAIVELSQISGIELKATGNLVEASWDTGAFVTFSGILRRIAVKLSKIANDLRLLSSGPRSGLGEIRLPAVQPGSSIMPGKVNPVIPESVNQVCYQVIGNDLTVTMAAESGQLQLNAFEPLIVYNILSSMRLLGRAMTNLAERCVDGIEANVERCRAGAEESISLATALVPVVGYARAAEIAKQALASGQTVMEVAISKGLDASALTIMLDPLRMAFPPETHDKEAHHASVG*		484	52	10	Diffraction	-1	 	NR-13722
Batch01a	BrabA.00049.a	Brucella melitensis	YP_419002	Q2YK32				Catalase 	Potential drug target		MTDRPIMTTSAGAPIPDNQNSLTAGERGPILMQDYQLIEKLSHQNRERIPERAVHAKGWGAYGTLTITGDISRYTKAKVLQPGAQTPMLARFSTVAGELGAADAERDVRGFALKFYTQEGNWDLVGNNTPVFFVRDPLKFPDFIHTQKRHPRTHLRSATAMWDFWSLSPESLHQVTILMSDRGLPTDVRHINGYGSHTYSFWNDAGERYWVKFHFKTMQGHKHWTNAEAEQVIGRTRESTQEDLFSAIENGEFPKWKVQVQIMPELDADKTPYNPFDLTKVWPHADYPPIDIGVMELNRNPENYFTEVENAAFSPSNIVPGIGFSPDKMLQARIFSYADAHRHRLGTHYESIPVNQPKCPVHHYHRDGQMNVYGGIKTGNPDAYYEPNSFNGPVEQPSAKEPPLCISGNADRYNHRIGNDDYSQPRALFNLFDAAQKQRLFSNIAAAMKGVPGFIVERQLGHFKLIHPEYEAGVRKALKDAHGYDANTIALNEKITAAE*		500	56	4	Soluble	-1	 	
Batch01a	BrabA.00052.a	Brucella melitensis	YP_415091	Q2YRE0				"Glyceraldehyde 3-phosphate dehydrogenase:TrkA potassium uptake protein:Glyceraldehyde-3-phosphate dehydrogenase, type I "	Potential drug target		MAVRVAINGFGRIGRNILRAIVESGRTDIQVVAINDLGPVETNAHLLRYDSVHGRFPKEVEVAGDTIDVGYGPIKVHAVRNPAELPWKEENVDIALECTGIFTSRDKAALHLEAGAKRVIVSAPADGADLTVVYGVNNDKLTKDHLVISNASCTTNCLAPVAQVLNDTIGIEKGFMTTIHSYTGDQPTLDTMHKDLYRARAAALSMIPTSTGAAKAVGLVLPELKGKLDGVAIRVPTPNVSVVDLTFIAKRETTVEEVNNAIREAANGRLKGILGYTDEKLVSHDFNHDSHSSVFHTDQTKVMDGTMVRILSWYDNEWGFSSRMSDTAVALGKLI*		336	36	17	In PDB	9	Experimental evidence of bound ligand(s)	NR-13723
Batch01a	BrabA.00053.a	Brucella melitensis	YP_415408	Q2YQZ4				CbxX/CfqX superfamily:ATP/GTP-binding site motif A (P-loop):AAA ATPase:Heat shock protein HslVU 	Potential drug target		MSNFSPREIVSELDRFIIGQKDAKRAVAIALRNRWRRQQLEGQMREEVMPKNILMIGPTGVGKTEISRRLAKLAGAPFVKVEATKFTEVGYVGRDVEQIIRDLVEIAITLVREKRREDVKAKAHLNAEERVLDALVGKTASPATRDSFRKKLRNGEMDDKEIEIEVSDSGASPNFEIPGMPGANIGVLNISDMLGKAMGGRTKTRKTTVKDSYPILINDESDKLLDQDQIVQEALRVSEDEGIVFIDEIDKIAAREGGSGAGVSREGVQRDLLPLVEGTTVATKYGPVKTDHILFITSGAFHVSKPSDLLPELQGRLPIRVELSALTREDFRRILTETEASLIKQYIALMETEEVKLEFSDDAIDALADIAVDLNATVENIGARRLQTVIEKVLDEISFTAPDKAGATFIIDAAYVKEKIGGLAKNTDLSRFIL*		435	48	10	Diffraction	-1	 	NR-13724
Batch01a	BrabA.00057.a	Brucella melitensis	YP_419049	Q2YJY5				ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase:TOBE domain 	Potential drug target		MAELQLRDVRKSFGSFEVIKGVDMDIRPGEFMVFVGPSGCGKSTLLRLIAGLEEITSGTLSIDGTVVNSFNPSRRGIAMVFQSYALYPHMTVYENMAFGMQLAGKSRQECKARIHAAAEMLQLTPYLERLSRQLSGGQRQRVAIGRAIVRDPKVFLFDEPLSNLDAALRVATRLEIARLHQSMEDTTMIYVTHDQVEAMTLADRICVLRDGRVEQIGTPLELYEKPNSLFVAGFIGSPKMNFLTGPHAEPFGAHTVGLRSEHLAIVPERGHWSGQVVHTEILGSDTYVYIDLGLEEPLVVRESGVSARKPGETLSISPTGDHVHRFDEKGRAV*		334	37	7	Crystallized	-1	 	
Batch01a	BrabA.00059.a	Brucella melitensis	YP_414608	Q2YRU9				Alkaline phosphatase 	Potential drug target		MPRKFTRPLLASAAIIVTFCAPASTVMAQSETAAPLFQRSAKGDLSAAGGARRLDGDITAAFRDQIRKGPARNVILLIGDGMGDSEITVARNYAVGAGNHFKGIDALPVTGQYTHYSLDKESGKPNYVTDSAASGTAWTTGVKTYNGAIGVDIHGKPHKTLIELAKEKGLGTGNVSTAELQDATPAVQVAHVTHRKCYDPTSTAEKCKDNALENGGPGSISEQLLNTRPDVTLGGGAKYFEDKARAGTWKGQTLSAQAEARGYQLVRNADALSKVETANQDKPVLGLFSPGNMPVRWKGPQAAHHGNLDREPVKCKVNEKRTADIPTLAQMTEKAIDLLKTNEKGFFLQVEGASIDKQDHAANPCGQIGETVDLDEAVQAALDFARKDGNTLVIVTADHAHASQIIDPDAKAPGLSQALKTEDGAIMGVTYGNSDEADDQGHTGAQLRIAAFGPGAANFTGLTDQTDMFYTIRDALQLQAE*		482	51	5	Purified	-1	 	
Batch01a	BrabA.00060.a	Brucella melitensis	YP_413662	Q2YP33				3' exoribonuclease:Ribonuclease PH 	Potential drug target		MRPSKRAADEMRAISFERGVSKHAEGSCLVKFGDTHVLCTASLEEKVPGWMRNTGKGWVTAEYGMLPRSTGERMRREAAAGKQGGRTQEIQRLIGRSLRAVVDMQALGEMQITVDCDVIQADGGTRTAAITGGWVALHECLRWMEARQMVRVEKVLKDHVAAISCGIYEGVPVLDLDYAEDSVAETDSNFVMTGKGGIVEIQGTAEGVPFSEEEFGALMKLARSGIDRLVSLQKMAVA*		239	26	7	Crystallized	-1	 	NR-13725
Batch01a	BrabA.00066.a	Brucella melitensis	YP_414617	Q2YRU0				"RNA polymerase, alpha chain, bacterial and organelle "	Potential drug target		MIQKNWQELIKPNKVDFITHGSRTHATVVAEPLERGFGLTLGNALRRVLLSSLRGAAVTAVQIDGVLHEFSSIPGVREDVTDIVLNIKEIAIRMEGEGPKRMVVRKEGPGVVTAGDIQTVGDVEILNPEHVICTLDEGAEIRMEFTVNTGKGYVPADRNRAEDAPIGLIPVDSLYSPVRKVSYKIENTREGQVLDYDKLTLNIETNGSVTGEDAVAYAARILQDQLSIFVNFEEPQKEAPQEQVAELAFNPALLKKVDELELSVRSANCLKNDNIVYIGDLIQKTEAEMLRTPNFGRKSLNEIKEVLASMGLHLGMEIPAWPPENIEDLAKRYEDQY*		338	37	7	Crystallized	-1	 	
Batch01a	BrabA.00067.a	Brucella melitensis	YP_414667	Q2YQG6				WW/Rsp5/WWP domain:Bacterial transferase hexapeptide repeat:Serine O-acetyltransferase 	Potential drug target		MNAGLDQVDPIWHSIRAEAEEATRNDPVLGAFLYATILNQPSLEEAVMHRIAERLGHPDVSADILRQTFDTMLEANPEWSHVLRVDIQAVYDRDPAYSRFMDPVLYLKGFHAIQTHRLAHWLYKQGRKDFAYYLQSRSSSIFQTDIHPAARLGSGLFLDHATGLVVGETAVVEDNVSILHGVTLGGTGKSSGDRHPKIRQGVLIGAGAKILGNIQVGQCSKIAAGSVVLKSVPHNVTVAGVPARIIGETGCTEPSRVMDQMLGDGI*		267	29	17	In PDB	-1	 	
Batch01a	BrabA.00069.a	Brucella melitensis	YP_414610	Q2YRU7				RecA bacterial DNA recombination protein:ATP/GTP-binding site motif A (P-loop):AAA ATPase 	Potential drug target		MSQNSLRLVEDNSVDKTKALDAALSQIERAFGKGSIMRLGQNDQVVEIETVSTGSLSLDIALGVGGLPKGRIVEIYGPESSGKTTLALHTIAEAQKKGGICAFVDAEHALDPVYARKLGVDLENLLISQPDTGEQALEITDTLVRSGAIDVLVVDSVAALTPRAEIEGEMGDSLPGLQARLMSQALRKLTGSISRSNCMVIFINQIRMKIGVMFGSPETTTGGNALKFYASVRLDIRRIGSIKERDEVVGNQTRVKVVKNKLAPPFKQVEFDIMYGAGVSKVGELVDLGVKAGVVEKSGAWFSYNSQRLGQGRENAKQYLKDNPEVAREIETTLRQNAGLIAEQFLDDGGPEEDAAGAAEM*		362	39	7	Crystallized	-1	 	
Batch01a	BrabA.00070.a	Brucella melitensis	YP_418380	Q2YLA2				"AP endonuclease, family 2 "	Potential drug target		MPRFAANLSTMFNEVPFLERFRLAAEAGFGGVEFLFPYDFDADVIARELKQHNLTQVLFNMPPGDWAAGERGMAAISGREQEFRDNVDIALHYALALDCRTLHAMSGITEGLDRKACEETFIENFRYAADKLAPHGITVLVEPLNTRNMPGYFIVHQLEAVGLVKRVNRPNVAVQLDLYHAQIMDGDLTRLIEKMNGAFSHVQIASVPDRHEPDEGELNYPYLFSVLESVGYRGWVGCEYNPRGKTESGLAWFAPYRDQSA*		262	29	17	In PDB	-1	 	
Batch01a	BrabA.00071.a	Brucella melitensis	YP_414840	Q2YM35				"Methylenetetrahydrofolate reductase:5,10-methylenetetrahydrofolate reductase "	Potential drug target		MGFYGLSRRPDVGQTTRVSFEFFPPKTEEMEQRLWETVTRLAPLQPDFVSVTYGAGGSTRERTVRTVARILKETDIKPAAHLTCVDATREDVDRVAREFAALGVNRFVALRGDPANGIGEKYVPTPGGYQNGAELVGGLRNIADFDISVSAYPEKHPESPDFATDIDMLKRKVDNGATRAITQFFFENDLYERYVERVRRAGIYIPIVPGVLPVHNFKQVRNFCARSATHIPAWLAERFDGLDNDPQTHQLVAAAIAAEQVMDLIERGVQDFHFYTMNRADLPFAICHMIGIRPKTQAALEVA*		304	34	3	Expressed	-1	 	
Batch01a	BrabA.00073.a	Brucella melitensis	YP_414414	Q2YQ82				Arsenate reductase:Arsenate reductase and related 	Potential drug target		MDVTIYHNPVCGTSRKVLGMIREAGIEPHVIEYMKTPLPRDMLVELLRQMAISPRALLRAKEARYAELGLDDPALSDEVLIDAMISNPVLMNRPVVVTPKGVRLCRPAETVQELL*		116	13	8	HSQC	-1	 	
Batch01a	BrabA.00076.a	Brucella melitensis	YP_419161	Q2YJM3				Phosphoribosyltransferase:Uracil phosphoribosyl transferase 	Potential drug target		MRKKETSTASFRRLLKEISLLLCYEVTRNLELTTMSIETPLMPMEAPVLEGKKLVFASILRAGNGLLEGMLDLVPAARVAHIGLYRDHDTLQPIEYYFKAPEDIVNRLVIVVDPMLATANSAIAAIDKLKERGATNIRFLCLLAAPEGIERFTKAHPDVEVFTASIDECLDEKGYIVPGLGDAGDRMYGTK*		192	23	4	Soluble	-1	 	
Batch01a	BrabA.00079.a	Brucella melitensis	YP_415222	Q2YLN2				Glutaredoxin:Thioredoxin type domain 	Potential drug target		MVDVIIYTRPGCPYCARAKALLARKGAEFNEIDASATPELRAEMQERSGRNTFPQIFIGSVHVGGCDDLYALEDEGKLDSLLKTGKLI*		89	10	17	In PDB	-1	 	NR-13726
Batch01a	BrabA.00080.a	Brucella melitensis	YP_414646	Q2YLZ8				"Ribosomal protein S12, bacterial and chloroplast forms:Ribosomal protein S12/S23 "	Potential drug target		MPTVNQLIRKPRTAPVKRNKVPALQANPQKRGVCTRVYTTTPKKPNSALRKVAKVRLTNGFEVIGYIPGEGHNLQEHSVVMIRGGRVKDLPGVRYHIIRGVLDTQGVKNRKQRRSKYGAKRPK*		124	14	-2	Work Stopped	-2	Work Stopped	
Batch01a	BrabA.00083.a	Brucella melitensis	YP_418399	Q2YIS2				"Cytochrome c heme-binding site:Cytochrome c, class IA/ IB:Cytochrome c, class I "	Potential drug target		MRAAMTAISAIAASLLISTVAQGADIESGKKIFNACKACHQIGEGAKNMVGPELNGLFGRHSGSVEGYKYSDANKNSGIVWDEEIFRKYIKKPREVIPKTKMVYAGLKDEGKIDDLIAFLKQYDLGGKIKE*		132	14	3	Expressed	-1	 	
Batch01a	BrabA.00085.a	Brucella melitensis	YP_413999	Q2YMP3				"Short-chain dehydrogenase/reductase SDR:GDP-mannose 4,6-dehydratase "	Potential drug target		MKKVALITGITGQDGAYLAELLLQKGYAVHGIKRRTSQFNTARIDHLYHDPHEQGVDLTLHHGDLTDTSSLVRIMQLVRPDEVYNLGAQSHVAVSFEEPEYTANSDALGALRLLEAIRILGMEKQTRYYQASTSELYGLVQEIPQKETTPFYPRSPYAAAKLYAYWITVNYREAYGIYACNGILFNHESPLRGETFVTRKITRALARIKIGNQNRLYLGNLDSLRDWGHARDYVEMQWLMLQQDQPEDFVIATGKQYSVREFVTLAAKDIGIEMRWEGSGEAEKGYDAKTGACIVEVDPRYFRPAEVETLLGDATKAHQKLGWKPKISFETLVSEMIAEDLAAAARENLLREHGHQFFAPKE*		363	41	5	Purified	-1	 	NR-13727
Batch01a	BrabA.00085.b	Brucella melitensis	YP_414484	Q2YQ12				NAD binding site:NAD-dependent epimerase/dehydratase:UDP-glucose 4-epimerase 	Potential drug target		MTILVTGGAGYIGSHTCVQLIEAGHEVVVVDNFDNSHPEALHRIEKITGRAPRREPGDIRDRALMEQVIKRHKCTAVIHFAGLKAVGESSEKPLLYYDCNVLGTLRLLQAMEATGVKKLVFSSSATVYGDPDKLPITEDQPLSATNPYGRTKLVIEDMLRDLYNSDNSWAIAILRYFNPVGAHESGLIGEDPKGIPNNLMPIIAQVATGRREKLNIWGNDYPTPDGTGVRDYIHVNDLAAGHLKALKKLDKPKCFAVNLGTGQGYSVLDVIKAFEHVSNREIKYEIAPRRPGDVAECYADPGFAKKFLGWSAEKNLREMCQDMWNWQSKNPNGYE*		336	37	7	Crystallized	-1	 	NR-13728
Batch01a	BrabA.00086.a	Brucella melitensis	YP_414351	Q2YNP1				"Dehydroquinase, class II "	Potential drug target		MTKTVFVLNGPNLNLLGKREPGIYGVATLDDIEASCKREAGQLELQIDFRQSNHEGDLVSWIQEAGEKNAYVLINPAAYSHTSVAIHDAIRSARVTVVEVHLSNIHAREAFRHHSHVSAVAKGVICGFGAEGYLLGLRALAAIAKEEEKNGQSIKGA*		158	17	10	Diffraction	-1	 	NR-13729
Batch01a	BrabA.00087.a	Brucella melitensis	YP_418419	Q2YIJ2				Chaperonin Cpn10 	Potential drug target		MADIKFRPLHDRVVVRRVESEAKTAGGIIIPDTAKEKPQEGEVVAAGAGARDEAGKLVPLDVKAGDRVLFGKWSGTEVKIGGEDLLIMKESDILGIVG*		99	10	7	Crystallized	-1	 	NR-13730
Batch01a	BrabA.00089.a	Brucella melitensis	YP_414988	Q2YQA1				"Bacterial periplasmic spermidine/putrescine-binding protein:Bacterial extracellular solute-binding protein, family 1 "	Potential drug target		MGIKSFLLATTVATGFVAAATFSAGAQERVVNIYNWSDYIDDSILKDFTKETGIKVVYDVYDSNEILETKLLAGGNGYDLVVPSGEFLGRQIPAGVFLKLDKDKLPNLKNMWDEISTRAATYDPGNEYSVNYMWGTTGIGYNKAKIKEALGTDTIDSWDVLFDPEKTAKLKDCGIYLLDSASEMLRPALNYLGLDPNSPSPDDLQKAQDLYLKIRPNIRKFHSSEYINALANGDICMAVGYSGDIFQARDRAEKAKQGVEIGYSIPKEGALIWFDQMAIPADAKHVPEALEFMNYMMRPEVAAKASNYVFYANGNKASQKFIDKEILDDPEIYPSDEVMKKLFVPTPYDTKTQRVVTRAWTKIVTGQ*		368	41	7	Crystallized	-1	 	
Batch01a	BrabA.00091.a	Brucella melitensis	YP_414493	Q2YQ03				GTP cyclohydrolase I 	Potential drug target		MDARILQDNDDTSLPVNQASVTRIHKKPGKAEAEAAVRTLLLWAGEDPDREGLLETPKRVAKAYQELFGGYSESPEEVLGTTFEEVAGYDDMVLVKDISFFSHCEHHMVPIIGKAHVAYLPEGRVVGLSKIARVVDIFARRLQTQESITAQIADSIQRILKPRGVAVMIEAEHMCMAMRSIRKQGSSTITTTFTGDFKEKADQQVRFMTLIRT*		214	24	7	Crystallized	-1	 	
Batch01a	BrabA.00097.a	Brucella melitensis	YP_413826	Q2YPI2				Pantoate-beta-alanine ligase:Cytidyltransferase-related domain 	Potential drug target		MQIIHTIEELRQALAPARQQGKKIGFVPTMGYLHKGHLELVRRARVENDVTLVSIFVNPLQFGANEDLGRYPRDLERDAGLLHDAQVDYLFAPTVSDMYPRPMQTVVDVPPLGNQIEGEARPGHFAGVATVVSKLFNIVGPDAAYFGEKDFQQLVIIRRMVDDMAIPVRIVGVETVREDDGLACSSRNVYLTPEQRRAAIIVPQALDEADRLYRSGMDDPDALEAAIRTFIGRQPLAVPEVIAIRDPETLERLPALQGRPILVALFVRVGATRLLDNRVIGHAAPQITQERAA*		294	33	17	In PDB	-1	 	NR-13731
Batch01a	BrabA.00102.a	Brucella melitensis	YP_414547	Q2YPU9				DAHP synthetase I/KDSA superfamily:2-dehydro-3-deoxyphosphooctonate aldolase 	Potential drug target		MVTANSTVKVGNVTFSNSAPLALIAGPCQMETRDHAFEMAGRLKEMTDKLGIGLVYKSSFDKANRTSLKAARGIGLEKALEVFSDLKKEYGFPVLTDIHTEEQCAAVAPVVDVLQIPAFLCRQTDLLIAAARTGRVVNVKKGQFLAPWDMKNVLAKITESGNPNVLATERGVSFGYNTLVSDMRALPIMAGLGAPVIFDATHSVQQPGGQGGSTGGQREFVETLARAAVAVGVAGFFIETHEDPDNAPSDGPNMVPIDKMPALLEKLMAFDRIAKAL*		278	30	17	In PDB	-1	 	NR-13732
Batch01a	BrabA.00106.a	Brucella melitensis	YP_418408	Q2YII1				Methyladenine glycosylase 	Potential drug target		MSDMAEARAGLVVGADGRTRCFWPGELPDYLAYHDNEWGVPVADDFRLFEKICLEGFQSGLSWLTILRKRENFRAAFDGFNFHRIATYDESDVERLLADKGIVRHRGKIVSVINNAGRAIELIEEKGSLAAYFWSFEPGAENRPAVVDYPTLVANPITATSTRISKDLKKRGWSFVGPTTVYAFMQAMGLVNDHIEGCHCRATIEKLRQNFKRPGKKL*		219	25	5	Purified	-1	 	"NR-16680, NR-16681, NR-16682, NR-16683"
Batch01a	BrabA.00111.a	Brucella melitensis	YP_414429	Q2YQ67				"Glutamine synthetase class-I, adenylation site:Glutamine synthetase type I:Glutamine synthetase, catalytic domain:Glutamine s... "	Potential drug target		MTTANDILKQIKDNDVKFVDLRFTDPKGKLHHVTMDIGLVDEDMFVDGVMFDGSSIAGWKAINESDMVLMPDPETAHIDPFFAQSTLVILCDILEPLSGESYSRDPRTTAKKAEAYLKSLGIGDTVYVGPEAEFFVFDDVKFKADPFNTGFKLDSAELPSNDDTDYETGNLGHRPRVKGGYFPVPPIDSLQDMRSEMLTVLSEMGVTVEKHHHEVASAQHELGTKFDTLVRNADKMQIQKYVVHQVANAYGKTATFMPKPVFGDNGSGMHVHFSIWKDGKPTFAGNEYAGLSENCLYFIGGVIKHAKAVNAFTNPSTNSYKRLVPGYEAPVLLAYSARNRSASCRIPFGSSPKSKRLEVRFPDPSANPYLCFSALLMAGLDGIKNKIHPGQAMDKDLYDLPPKELKQIPTVCGSLREALQSLNKDREFLKAGGVFSDDQIDSFIELKMAEVMRFEMTPHPVEFDMYYSV*		470	52	5	Purified	-1	 	
Batch01a	BrabA.00113.a	Brucella melitensis	YP_415493	Q2YQQ9				Beta-ketoacyl synthase 	Potential drug target		MRRVVVTGMGIVSSIGSNTEEVTASLREAKSGISRAEEYAELGFRCQVHGAPDIDIESLVDRRAMRFHGRGTAWNHIAMDQAIADAGLTEEEVSNERTGIIMGSGGPSTRTIVDSADITREKGPKRVGPFAVPKAMSSTASATLATFFKIKGINYSISSACATSNHCIGNAYEMIQYGKQDRMFAGGCEDLDWTLSVLFDAMGAMSSKYNDTPSTASRAYDKNRDGFVIAGGAGVLVLEDLETALARGAKIYGEIVGYGATSDGYDMVAPSGEGAIRCMKMALSTVTSKIDYINPHATSTPAGDAPEIEAIRQIFGAGDVCPPIAATKSLTGHSLGATGVQEAIYSLLMMQNNFICESAHIEELDPAFADMPIVRKRIDNVQLNTVLSNSFGFGGTNATLVFQRYQG*		408	43	17	In PDB	17	Ligand-bound structure submitted to PDB	
Batch01a	BrabA.00121.a	Brucella melitensis	YP_418916	Q2YKB8				Biotin synthase:Elongator protein 3/MiaB/NifB:Radical SAM 	Potential drug target		MPDRGGENGASCSVGRWSAEEARAIYNLPFNDLLFRAHGLHRENFDPNRIQLSKLLNIKTGGCPEDCGYCSQSASAENGLKASKLMEIETVLEEARKAKAAGATRYCMGAAWRSPKDRDMPALTHMIESVKAMGLETCMTLGMLDSDKAEKLADAGLDYYNHNIDTSERFYPAVITTRSFEDRLDTLANVRNAGIKVCSGGILGLGEEAEDRIDMLVTLANLPEPPESVPINMLIPMPGTRLAKAAPVDPLEFVRVVALARILMPKSHVRLTAGRTAMSDEMQALCFFAGANSLFMGDTLLTAANPGDDRDSSLLRRLGIQAETEQPA*		329	36	5	Purified	-1	 	
Batch01a	BrabA.00123.a	Brucella melitensis	YP_419203	Q2YJI1				Immunoglobulin/major histocompatibility complex 	Potential drug target		MKRAAIWPNAFQPHMEIISSAPTKKARRLSSIGLLSVVRYRAVHAKTVEDIVALDIALPRNTLDWFERLPAEIEKKIDVTMYCGHFFCHVLHQEYLVKKGEDCEALKKAILALLEERGAKYPAEHNVGHLYEAEESLKKFYRDLDPTNAFNPGLGQTSYLLNWQTPGYHSDQ*		173	20	4	Soluble	-1	 	"NR-16684, NR-16685, NR-16686, NR-16687, NR-16688, NR-16689"
Batch01a	BrabA.00128.a	Brucella melitensis	YP_419019	Q2YK15				"Bacterial extracellular solute-binding protein, family 3:Pyridoxal-dependent decarboxylase "	Potential drug target		MCWHKFARYWDVEIREIPMEPGRLFMGPEQMLEAVDENTIGVVPTFGVTYTGNYEFPEPLQDALDKLQKTKGLDIDIHVDAASGGFLAPFCAPDIPWDFRLPRVKSISASGHKYGLAPLGCGWVVWRDKEALPEELIFNVDYLGGQVGTFAINFSRPAGQVISQYYEFMRLGREGYTKVQQAAYRVAQYIAREIEPLGPYEFICAGEEKGGIPAVCFRIREGEDPGYSLYDLSERLRLTGWQVPAFALSGKASDITVMRVMCRCGFEMDLAALFIRDFKAGIEFFKSHPSPKITPSMGTGFHHT*		305	34	3	Expressed	-1	 	
Batch01a	BrabA.00136.a	Brucella melitensis	YP_415470	Q2YQT2				Ferritin:DNA-binding protein Dps 	Potential drug target		MPKKSMHATRNDLPSNTKTTMIALLNENLAATIDLALITKQAHWNLKGPQFIAVHEMLDGFRAELDDHVDTIAERAVQIGGTAYGTTQVVVKESRLKPYPTDIYAVHDHLVALIERYGDVANLVRKSIKDADDAGDDDTADIFTAASRSLDKALWFLEAHVQESN*		166	18	17	In PDB	-1	 	
Batch01a	BupsA.00001.a	Burkholderia pseudomallei	YP_336223	Q3JJN0				cytidine deaminase 	Potential drug target		MTHHALIEAAKAAREKAYAPYSNFKVGAALVTNDGKVFHGCNVENASYGLCNCAERTALFSALAAGYRPGEFAAIAVVGETHGPIAPCGACRQVMIELGKPTLEVVLTNMQGDVRVTSAGDLLPDAFYLA*		131	14	17	In PDB	5	Target selected for ligand screening 	NR-13733
Batch01a	BupsA.00002.a	Burkholderia pseudomallei	YP_333986	Q3JR17				"2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase "	Potential drug target		MRRRRAAHRRFLPRPRPLNARRNAPIHSSSTSSIATNMSQQLQQIIDNAWENRAELSPKAASAEIREAVAHAIEQLDRGALRVAEKIDGAWTVHQWLKKAVLLSFRLEDNAPMPAGGYSQFYDKVPSKFANYTAEDFAAGGFRVVPPAIARRGSFIAKNVVLMPSYTNIGAYVDEGTMVDTWATVGSCAQIGKNVHLSGGVGIGGVLEPLQANPVIIEDNCFIGARSEVVEGVIVEENSVISMGVYLGQSTKIYDRETGEVTYGRIPAGSVVVAGNLPAKDGTHSLYCAVIVKKVDAKTRAKVGLNELLRGD*		313	30	7	Crystallized	-1	 	NR-13735
Batch01a	BupsA.00003.a	Burkholderia pseudomallei	YP_334894	Q3JNF9				50S ribosomal protein L27 	Potential drug target		MAHKKAGGSSRNGRDSESKRLGVKVYGGQAINAGGIIVRQRGTRMHAGENVGMGKDHTLFALVDGHVKFTTKGAAKKHTVVVVPAAA*		88	9	-2	Work Stopped	-2	Work Stopped	NR-13736
Batch01a	BupsA.00004.a	Burkholderia pseudomallei	YP_334791	Q3JNR2				30S ribosomal protein S9 	Potential drug target		MIGNWNYGTGRRKSAVARVFIKAGKGDIVVNGKPISDYFSRETSLMIVRQPLELTNHAQTFDIKVNVSGGGETGQAGAVRHGITRALIDYDATLKPALSNAGFVTRDAREVERKKVGLHKARRAKQFSKR*		131	14	-2	Work Stopped	-2	Work Stopped	
Batch01a	BupsA.00005.a	Burkholderia pseudomallei	YP_335954	Q3JKE9				malate dehydrogenase 	Potential drug target		MAKPAKRVAVTGAAGQIAYSLLFRIANGDLLGKDQPVILQLLDLPQAQAAVKGVVMELDDCAFPLLAGVVITDDPKVAFKDADVALLVGARPRSKGMERKDLLSANAEIFTVQGAALNEVASRDVKVLVVGNPANTNAYIAMKSAPDLPKKNFTAMLRLDHNRALSQLAAKSGKPVASIEKLAVWGNHSPTMYPDFRFATAEGESLLKLINDDVWNRDTFIPTVGKRGAAIIEARGLSSAASAANAAIDHVRDWVLGTNGKWVTMGIPSDGSYGIPEDIIYGVPVICENGEYKRVEGLEIDAFSREKMDGTLAELLEERDGVAHLLK*		328	35	17	In PDB	10	Experimental evidence of bound ligand(s)	NR-13737
Batch01a	BupsA.00008.a	Burkholderia pseudomallei	YP_337258	Q3JGP5				serine hydroxymethyltransferase 	Potential drug target		MSNANPFFSQSLAERDASVRGAILKELERQQSQVELIASENIVSRAVLDAQGSVLTNKYAEGYPGKRYYGGCEFADEVEALAIERVKRLFNAGHANVQPHSGAQANGAVMLALAKPGDTVLGMSLDAGGHLTHGAKPALSGKWFNALQYGVSRDTMLIDYDQVEALAQQHKPSLIIAGFSAYPRKLDFARFRAIADSVGAKLMVDMAHIAGVIAAGRHANPVEHAHVVTSTTHKTLRGPRGGFVLTNDEEIAKKINSAVFPGLQGGPLMHVIAGKAVAFGEALTDDFKTYIDRVLANAQALGDVLKAGGVDLVTGGTDNHLLLVDLRPKGLKGAQVEQALERAGITCNKNGIPFDPEKPTITSGIRLGTPAGTTRGFGAAEFREVGRLILEVFEALRTNPEGDHATEQRVRREIFALCERFPIY*		425	45	17	In PDB	5	Target selected for ligand screening 	
Batch01a	BupsA.00009.a	Burkholderia pseudomallei	YP_332466	Q3JVD7				kynureninase 	Potential drug target		MKTREEALALDRDDPLAPLREQFALPAGVIYLDGNSLGAQPRAAAARAQQVIGAEWGEGLIRSWNTAGWFALPRRLGDRLAPLIGAADGEVAITDTISINLFKLLAAMLRHQARHAPKRRVIVSERSNFPTDLYIAQGLIAQLDRDYELRLIDDPADLPDALDDETAVAMITHVNYRTGYMHDMPSVTQTVRQAGALMLWDLAHSAGAVPVDLNGALADGAVGCTYKYLNGGPGSPAFVWVPKRHQRAFEQPLSGWWGHRAPFAMQPAFEPDPGIARFLCGTQPIVSMSMVECGLDVFAQTDMHAIRRKSLALTDAFVALVESRCAGQPLKLVTPRAHHQRGSQASFEHPHGYEVMQALIARGVIGDYREPRILRFGFTPLYTRFVDVWDAVETLRDILDTEAWRAPEFATRAAVT*		417	46	1	Selected	-1	 	
Batch01a	BupsA.00010.a	Burkholderia pseudomallei	YP_334286	Q3JQ67				3-ketoacyl-(acyl-carrier-protein) reductase 	Potential drug target		MDKTLDKQVAIVTGASRGIGRAIALELARRGAMVIGTATTEAGAEGIGAAFKQAGLEGRGAVLNVNDATAVDALVESTLKEFGALNVLVNNAGITQDQLAMRMKDDEWDAVIDTNLKAVFRLSRAVLRPMMKARGGRIVNITSVVGSAGNPGQVNYAAAKAGVAGMTRALAREIGSRGITVNCVAPGFIDTDMTKGLPQEQQTALKTQIPLGRLGSPEDIAHAVAFLASPQAGYITGTTLHVNGGMFMS*		250	26	17	In PDB	5	Target selected for ligand screening 	NR-13738
Batch01a	BupsA.00010.b	Burkholderia pseudomallei	YP_334023	Q3JQY0				enoyl-(acyl carrier protein) reductase 	Potential drug target		MGFLDGKRILLTGLLSNRSIAYGIAKACKREGAELAFTYVGDRFKDRITEFAAEFGSELVFPCDVADDAQIDALFASLKTHWDSLDGLVHSIGFAPREAIAGDFLDGLTRENFRIAHDISAYSFPALAKAALPMLSDDASLLTLSYLGAERAIPNYNTMGLAKAALEASVRYLAVSLGAKGVRVNAISAGPIKTLAASGIKSFGKILDFVESNSPLKRNVTIEQVGNAGAFLLSDLASGVTAEVMHVDSGFNAVVGGMAGLEE*		264	28	17	In PDB	1	Target selected for ligand screening 	
Batch01a	BupsA.00011.a	Burkholderia pseudomallei	YP_334909	Q3JNE4				cell division protein FtsZ	Potential drug target		MEFEMLETETNGTIIKVIGVGGAGGNAVQHMINKGVQGVDFVVMNTDAQALSRSRAPSVIQLGNTGLGAGAKPEMGRAAAEEARERIADALRGAHMVFITAGMGGGTGTGAAPVVAQIAKEMGILTVGVVSKPFEFEGGKRMRVAEAGSQQLEDHVDSLIVVLNDKLFEVMGDDAEMDKCFQCADDVLNNAVAGIAEIINVDGLVNVDFEDVKTVMGEQGKAMMGTATVAGVDRARLAAEQAVASPLLEGVDLSGARGVLVNITSSRSLRLSETREVMNTIKSYAADDATVIFGAVYDDAMGDALRVTVVATGLGRAAKKQQSAPMTLLRTGTDNQPISAAPQGYAASHHVSTGDYGAFDTPAVWRNSRETAASHVQALQEKGVDTYDIPAFLRKQAD*		399	42	10	Diffraction	-1	 	
Batch01a	BupsA.00013.a	Burkholderia pseudomallei	YP_334778	Q3JNS5				Holliday junction DNA helicase RuvB 	Potential drug target		MIETDKLAAERIIAATPASSHEEAFERALRPRQLDEYVGQEKVRDQLEIFIEAAKRRSEALDHVLLFGPPGLGKTTLAHIIAREMGVNLRQTSGPVLERAGDLAALLTNLEANDVLFIDEIHRLSPVVEEILYPALEDYQIDIMIGEGPAARSVKLDLQPFTLVGATTRAGMLTNPLRDRFGIVARLEFYDAEQLSRIVRRSAALLNAQIDPAGALEIAKRSRGTPRIANRLLRRVRDYAEVKADGNITAAVADAALAMLDVDPVGFDLMDRKLLEAILHKFDGGPVGVDNLAAAIGEERDTIEDVLEPYLIQQGFLQRTPRGRVATLLTYRHFGLSAPDAANPVRNLWDTPDAEC*		357	39	5	Purified	-1	 	"NR-16690, NR-16691, NR-16692"
Batch01a	BupsA.00014.a	Burkholderia pseudomallei	YP_334005	Q3JQZ8				isocitrate lyase 	Potential drug target		MSRQQQAQELQKQWETDPRWKGIKRAFTAEDVVRLRGSIQQEHTLAKRGAEKLWTLINNEPFVNALGALTGNQAMQQVKAGLKAIYLSGWQVAGDANVAGEMYPDQSLYPANSVPLVVKRINNTLTRADQIQWSEGKNPGDEGYVDFFAPIVADAEAGFGGVLNAFELMKAMIEAGASGVHFEDQLASVKKCGHMGGKVLVPTREAVAKLTAARLAADVMGTPTVLVARTDAEAADLITSDIDDNDKPYLTGERTVEGFFRTKPGLEQAISRGLAYAPYADLIWCETGKPDLEYAKKFAEAIHKQFPGKLLSYNCSPSFNWKKNLDDATIAKFQKELGAMGYKFQFITLAGFHALNYSMFNLAHGYARTQMSAFVELQQAEFAAADKGFTAVKHQREVGTGYFDAVTQTVEREASTTALHGSTEDEQFFDGQKVA*		436	48	17	In PDB	7	Target selected for ligand screening 	NR-13739
Batch01a	BupsA.00014.b	Burkholderia pseudomallei	YP_336893	Q3JHR0				methylisocitrate lyase 	Potential drug target		MGNPQLISAGAKFRAAVAAEQPLQVVGAITAYAAKMAEAVGFKAVYLSGGGVAANSLGIPDLGISTMDDVLVDANRITNATNLPLLVDIDTGWGGAFNIARTIRSFIKAGVGAVHLEDQVGQKRCGHRPGKECVPAGEMVDRIKAAVDARTDETFVIMARTDAAAAEGIDAAIERAIAYVEAGADMIFPEAMKTLDDYRRFKEAVKVPILANLTEFGSTPLFTLDELKGANVDIALYCCGAYRAMNKAALNFYETVRRDGTQKAAVPTMQTRAQLYDYLGYYAYEEKLDQLFNQGRN*		298	32	17	In PDB	5	Target selected for ligand screening 	NR-13740
Batch01a	BupsA.00015.a	Burkholderia pseudomallei	YP_335141	Q3JMR2				30S ribosomal protein S10 	Potential drug target		MQQQKIRIRLKAFDYRLIDQSAAEIVDTAKRTGAIVRGPVPLPTRIQRFDILRSPHVNKTSRDQLEIRTHQRLMDIVDPTDKTVDALMKLDLPAGVDVEIKLQ*		104	12	-2	Work Stopped	-2	Work Stopped	NR-13741
Batch01a	BupsA.00017.a	Burkholderia pseudomallei	YP_332590	Q3JV13				cytochrome C552 precursor 	Potential drug target		MREQKAQAACSHAPASRHCGRAAMALTRGDKKRQDEEGGATYSRPLSFYNARTAKPDTVPAETSMKRTTLRLTAFALVAAAANTQAQQADGLALAQRKNCMACHAIDKTLMGPSFHAIADKYAARGDAAGYLAQTIVKGSVGVWGNVPMPANTQLTSAEAGTLAHWILSSK*		172	18	3	Expressed	-1	 	
Batch01a	BupsA.00018.a	Burkholderia pseudomallei	YP_333972	Q3JR31				ribosome releasing factor 	Potential drug target		MSVADIKKSVEQKMQRSIEAFKNDLAKIRTGRAHTGLLDHVQVDYYGSMVPISQVANLTLVDARTIGVQPWEKTMVAKVEKAIREADLGLNPATSGDLIRVPMPPLTEERRRELTKVVKSEGETAKVAVRNLRRDANEQLKKLVKDKEISEDDERRASDDVQKLTDKHVAEIDKLVQAKDAEIMTV*		187	21	12	NMR assigned	-1	 	NR-13742
Batch01a	BupsA.00020.a	Burkholderia pseudomallei	YP_333602	Q3JS51				succinate-semialdehyde dehydrogenase (NADP+) 	Potential drug target		MKDPSLLRHQAYIGGEWQAADSDATFEVFDPATGESLGTVPKMGAAETARAIEAAQAAWAGWRMKTAKERAAILRRWFDLVIANSDDLALILTTEQGKPLAEAKGEIAYAASFIEWFAEEGKRVAGDTLPTPDANKRIVVVKEPIGVCAAITPWNFPAAMIARKVGPALAAGCPIVVKPAESTPFSALAMAFLAERAGVPKGVLSVVIGDPKAIGTEITSNPIVRKLSFTGSTAVGRLLMAQSAPTVKKLTLELGGNAPFIVFDDADLDAAVEGAIASKYRNNGQTCVCTNRFFVHERVYDAFADKLAAAVSKLKVGRGTESGATLGPLINEAAVKKVESHIADALAKGASLMTGGKRHALGHGFFEPTVLTGVKPDMDVAKEETFGPLAPLFRFASEEELVRLANDTEFGLAAYLYSRDIGRVWRVAEALEYGMVGINTGLISNEVAPFGGVKQSGLGREGSHYGIDDYVVIKYLCVAV*		481	51	17	In PDB	-1	 	NR-13743
Batch01a	BupsA.00020.b	Burkholderia pseudomallei	YP_335535	Q3JLL8				betaine aldehyde dehydrogenase 	Potential drug target		MSVYGLQRLYIAGAHADATSGKTFDTFDPATGELLARVQQASADDVDRAVASAREGQREWAAMTAMQRSRILRRAVELLRERNDALAELEMRDTGKPIAETRAVDIVTGADVIEYYAGLATAIEGLQVPLRPESFVYTRREPLGVCAGIGAWNYPIQIACWKSAPALAAGNAMIFKPSEVTPLSALKLAEIYTEAGVPAGVFNVVQGDGSVGALLSAHPGIAKVSFTGGVETGKKVMSLAGASSLKEVTMELGGKSPLIVFDDADLDRAADIAVTANFFSAGQVCTNGTRVFVQQAVKDAFVERVLARVARIRVGKPSDSDTNFGPLASAAQLDKVLGYIDSGKAEGAKLLAGGARLVNDHFASGQYVAPTVFGDCRDDMRIVREEIFGPVMSILSFETEDEAIARANATDYGLAAGVVTENLSRAHRAIHRLEAGICWINTWGESPAEMPVGGYKQSGVGRENGITTLEHYTRIKSVQVELGRYQPVF*		490	52	7	Crystallized	-1	 	
Batch01a	BupsA.00022.a	Burkholderia pseudomallei	YP_335153	Q3JMQ0				50S ribosomal protein L1 	Potential drug target		MAKISKRRQAFAAKVDRQKLYPIDDALALVKECASAKFDESIDVAVQLGIDAKKSDQVVRGSVVLPAGTGKSVRVAVFAQGEKAEQARAAGAEVVGMEDLAEQIKAGQMDFDIVIASPDTMRIVGTLGQILGPRGLMPNPKVGTVTPDVATAVKNAKAGQVQFRVDKAGIIHATIGRASFEPTALRTNLSALIEALQKAKPATSKGVYLRKIALSSTMGVGVRVDQGSLAAQ*		233	24	-2	Work Stopped	-2	Work Stopped	
Batch01a	BupsA.00023.a	Burkholderia pseudomallei	YP_332648	Q3JUV5				inorganic pyrophosphatase 	Potential drug target		MSFSNVPAGKDLPQDFNVIIEIPAQSEPVKYEADKALGLLVVDRFIGTGMRYPVNYGFIPQTLSGDGDPVDVLVITPFPLLAGSVVRARALGMLKMTDESGVDAKLVAVPHDKVCPMTANLKSIDDVPAYLKDQIKHFFEQYKALEKGKWVKVEGWDGIDAAHKEITDGVANFKK*		176	19	17	In PDB	17	Ligand-bound structure submitted to PDB	NR-13744
Batch01a	BupsA.00024.a	Burkholderia pseudomallei	YP_335782	Q3JKX1				alpha-ketoglutarate-dependent taurine dioxygenase 	Potential drug target		MTRLTLTRLTPALGAIVDDVDLSNATDALRDDIRAALAHHQVLFFRGQRLSAARHRDFAAGFGDLHVHPIYPSHPDAREIMVLDNAVFDLQDNAIWHTDVTFTETPPRASILAAHTLPETGGDTLWGSGFAAYDALSGRVKAQLDGLTAQHDFTKSFPLKRFGVTAEDRARWEKTRATHPSVAHPVVRTHPETGRKTLFVNEGFTTEIDELPEEEGAALLRFLFAHQSRPEFTLRWRWQPGDVAFWDNRSTIHYAVNDYGKAHRVMHRATIVGDRPY*		278	31	5	Purified	-1	 	NR-13745
Batch01a	BupsA.00025.a	Burkholderia pseudomallei	YP_335674	Q3JL79				NAD(+) synthetase 	Potential drug target		MSRPDQAARRRAIAAELHVSPTFDARDEAERRIGFVADYLRTAGLRACVLGISGGIDSSTAGRLAQLAVERLRASGYDARFVAMRLPYGAQHDEADARRALAFVRADETLTVDVKPAADAMLAALAAGGLAYLDHAQQDFVLGNIKARERMIAQYAVAGARNGVVIGTDHAAESVMGFFTKFGDGGADVLPLAGLTKRRVRALARMLGADEPLVLKTPTADLETLRPQRPDEHAYGITYEQIDDFLEGKPMDDAVAETVLRFYDATRHKRALPYTMFDWPGHPA*		285	31	17	In PDB	-1	 	
Batch01a	BupsA.00026.a	Burkholderia pseudomallei	YP_334285	Q3JQ68				acyl carrier protein 	Potential drug target		MDNIEQRVKKIVAEQLGVAEAEIKNEASFVNDLGADSLDTVELVMALEDEFGMEIPDEEAEKITTVQQAIDYARANVKA*		80	9	4	Soluble	-1	 	
Batch01a	BupsA.00027.a	Burkholderia pseudomallei	YP_334609	Q3JP94				glutaryl-CoA dehydrogenase 	Potential drug target		MAAATFHWDDPLLLDQQLADDERMVRDAAHAYAQGKLAPRVTEAFRHETTDAAIFREMGEIGLLGPTIPEQYGGPGLDYVSYGLIAREVERVDSGYRSMMSVQSSLVMVPIFEFGSDAQKEKYLPKLATGEWIGCFGLTEPNHGSDPGSMVTRARKVPGGYSLSGSKMWITNSPIADVFVVWAKLDEDGRDEIRGFILEKGCKGLSAPAIHGKVGLRASITGEIVLDEAFVPEENILPHVKGLRGPFTCLNSARYGIAWGALGAAESCWHIARQYVLDRKQFGRPLAANQLIQKKLADMQTEITLGLQGVLRLGRMKDEGTAAVEITSIMKRNSCGKALDIARLARDMLGGNGISDEFGVARHLVNLEVVNTYEGTHDIHALILGRAQTGIQAFF*		396	43	17	In PDB	17	Ligand-bound structure submitted to PDB	NR-13747
Batch01a	BupsA.00028.a	Burkholderia pseudomallei	YP_337087	Q3JH66				bacterioferritin 	Potential drug target		MQGDKKVIEYLNAQLKNELTAINQYFLHARMYKHWGLEKLGKHEYDESIGEMKHADWLIERVFMLDGLPNLQDLHKLLVGEETEEILKCDLKLEQVSQATCKEAIAYCESVRDYVSREIFEKILDDTEEHIDWLETQIDLIGKVGIQNYQQSMMGSPE*		159	19	4	Soluble	-1	 	
Batch01a	BupsA.00029.a	Burkholderia pseudomallei	YP_333769	Q3JRN4				thioredoxin 1 	Potential drug target		MQRSRPSFRKSGASCPGDRHGPRAAGAGSPRTERGIDPMSEQIKHISDASFEQDVVKSDKPVLLDFWAEWCGPCKMIAPILDEVAKDYGDKLQIAKINVDENQATPAKFGVRGIPTLILFKNGAVAAQKVGALSKSQLTAFLDSHL*		147	16	7	Crystallized	-1	 	NR-13748
Batch01a	BupsA.00030.a	Burkholderia pseudomallei	YP_333873	Q3JRD0				ATP-dependent protease ATP-binding subunit 	Potential drug target		MPATRPEHLRQKNIAAVSRVFTRSWCRGQTAYYVTHVSGGSTFMADKKGSNSEKLLYCSFCGKSQHEVKKLIAGPSVFICDECIDLCNEIIRDEAAAAGVEASLSKSDLPSPQEIRDILDQYVIGQERAKKILAVAVYNHYKRLKHLDKKDDVELSKSNILLIGPTGSGKTLLAQTLARLLNVPFVIADATTLTEAGYVGEDVENIIQKLLQNCNYEVEKAQRGIVYIDEIDKISRKSDNPSITRDVSGEGVQQALLKLVEGTMASVPPQGGRKHPNQDFIQVDTTNILFICGGAFDGLEKVITDRTEKTGIGFGATVKSKQERDAGEVLREVEPEDLIKFGLIPELIGRLPVVATLGKLDEAALMKILVEPKNALVKQYQKLFAMERVELEIRPDALQAVARKAIRRKTGARGLRSIIEQALLDVMYELPTLKGVSKVIIDDNVIEGDGKPLLIYEDTPKVAGSN*		467	46	10	Diffraction	-1	 	
Batch01a	BupsA.00031.a	Burkholderia pseudomallei	YP_334834	Q3JNL9				cyanate hydratase 	Potential drug target		MLRSSALAIDHGAHDAGHHRRVSEVPARRIRAAHGVVQAPRREPAATRPLHLVLGQPSRARARHAARAGRAVRDPQRGQHRAFVRPRARRRIGVRRIRGGGARSGRRRRVRALGLRRDACDRVVRVPRSSARRAQLAALRGRRETCERSARACGRAGARRFDGARKRRRATRESQYTSVGAARARARAPHAARLGVRHRDRLDRRARRRDGPLRRARRASAGARDAAARPARGVTHDTTRAAPGAARSTPRGPLPDPSPQGVRMTQSQHSQSAREALAERIVEAKTRKNLTFEQINEGTGLSVAFTTAALLGQHPLPADAARVVAAKLDLDDDAQRLLQTIPVRGSIPGGVPTDPTIYRFYEIVQVYGSTLKALIHEQFGDGIVSAINFKLDIKKVDDPEGGSRAVITLDGKYLPTKPF*		420	17	3	Expressed	-1	 	
Batch01a	BupsA.00032.a	Burkholderia pseudomallei	YP_331474	Q3JY79				S-adenosyl-L-homocysteine hydrolase 	Potential drug target		MNAAVIDSHSAQDYVVADIALAGWGRKELNIAETEMPGLVQIRDEYKAQQPLKGARIAGSLHMTIQTGVLIETLKALGADVRWASCNIFSTQDHAAAAIVEAGTPVFAFKGESLDEYWEFSHRIFEWPNGEFANMILDDGGDATLLLILGSKAEKDRSVIARPTNEEEVALFKSIERHLEIDGSWYSKRLAHIKGVTEETTTGVHRLYQMEKDGRLPFPAFNVNDSVTKSKFDNLYGCRESLVDGIKRATDVMIAGKIAVVAGYGDVGKGCAQSLRGLGATVWVTEIDPICALQAAMEGYRVVTMEYAADKADIFVTATGNYHVINHDHMKAMRHNAIVCNIGHFDSEIDVASTRQYQWENIKPQVDHIIFPDGKRVILLAEGRLVNLGCATGHPSFVMSNSFTNQTLAQIELFTRGGEYANKVYVLPKHLDEKVARLHLARIGAQLSELSDDQAAYIGVSKAGPFKPDHYRY*		474	52	17	In PDB	17	Ligand-bound structure submitted to PDB	NR-13749
Batch01a	BupsA.00033.a	Burkholderia pseudomallei	YP_333853	Q3JRF0				methionine-R-sulfoxide reductase 	Potential drug target		MSGDRDDPRYPYPKDDAELRRRLTPMQYEVTQHAATEPPFTGEYTDTEDAGIYHCVVCGTALFESGAKYHSGCGWPSYFKPIDGEVIDEKMDYTHGMTRVEVRCNQCGAHLGHVFEDGPRDKTGLRYCINSAALNFEAKPERK*		144	16	17	In PDB	10	Experimental evidence of bound ligand(s)	NR-13750
Batch01a	BupsA.00035.a	Burkholderia pseudomallei	YP_332167	Q3JW86				ribose-phosphate pyrophosphokinase 	Potential drug target		MSSHDGLMVFTGNANPALAQEVVKILGIPLGKAMVSRFSDGEIQVEIQENVRGKDVFVLQSTCAPTNDNLMELMIMVDALKRASAGRITAAIPYFGYARQDRRPRSARVAISAKVVANMLEIAGVERIITMDLHADQIQGFFDIPVDNIYATPILLGDLRKQNYPDLLVVSPDVGGVVRARALAKQLNCDLAIIDKRRPKANVAEVMNIIGEVEGRTCVIMDDMVDTAGTLCKAAQVLKERGAKQVFAYATHPVLSGGAADRIAASALDELVVTDTIPLSAESLACPKIRALSSAGLLAETFSRIRRGDSVMSLFAES*		319	34	17	In PDB	10	Experimental evidence of bound ligand(s)	NR-13751
Batch01a	BupsA.00036.a	Burkholderia pseudomallei	YP_332759	Q3JUJ4				5'-phosphoribosylglycinamide transformylase 	Potential drug target		MRAGGFESRRDAEIAWRSCRRRRLAPCRARRRAPNRPAARGPCVLASQVVFAIHHPAGNLMQIGQRLGTPLSPSATRVMLLGAGELGKEVIIALQRLGVEVIAVDRYPNAPGHQVAHRAHVIDMTDPDALRALVDAERPHLVVPEIEAIATDALAAIEAAGVCEVIPTARATQLTMNREGIRRLAAEELGLPTSPYAFAQSFDEFAAAVARIGFPCVVKPVMSSSGKGQSVVRSEADIEPAWRYAMAGGRVNHGRVIVEGFIRFDYEITQLTVRAIDPASGQTRTSFCAPIGHLQVAGDYVESWQPQPMSAKALERSRDIAHRVTSALGGRGIFGVELFVRGDDVWFSEVSPRPHDTGLVTLASQRQSEFELHARAILGLPVEPALATPAASAVIYGGLDEAGIAFEGVRDALAVPGADLRLFGKPESFAKRRMGVALATGANVDEARERAKRAAAAVRPVSAR*		465	50	3	Expressed	-1	 	
Batch01a	BupsA.00037.a	Burkholderia pseudomallei	YP_332852	Q3JUA1				NADH dehydrogenase subunit I 	Potential drug target		MTAIQQFFKTFFLTELLKGLALTGRYTFKRKFTVQFPEEKTPISPRFRGLHALRRYENGEERCIACKLCEAVCPALAITIESETRADNTRRTTRYDIDLTKCIFCGFCEESCPVDSIVETQILEYHGEKRGDLYFTKDMLLAVGDRYEKEIAAAKAADARYR*		163	19	5	Purified	-1	 	
Batch01a	BupsA.00039.a	Burkholderia pseudomallei	YP_334031	Q3JQX2				"methionine aminopeptidase, type I "	Potential drug target		MARSRQVPIRSKAEIAMARRAGTMAAQVLSMIAPHVKAGVTTNALDRLCREYIVDVLRARPANIGYHGYPKTICASVNHVVCHGIPSDHALQDGDIVNIDVALDHDGWYGDTSRMYCVGEPAAPARRLVDATYEAMMAGIAAVRPGATLGDVGHAIQSVAHREGFSIVREYCGHGIGRIYHDEPQVLHYGRPGAGLRLAPGMIFTIEPMLNAGRAETRQLADGWTVVTQDRSWSAQWEHMVVVTEDGFDILTPWPDGEPARSSAATGAAGAA*		273	29	7	Crystallized	-1	 	
Batch01a	BupsA.00039.b	Burkholderia pseudomallei	YP_333976	Q3JR27				methionine aminopeptidase 	Potential drug target		MRNSPHFRHRLMAITLKNEHDIAQMRIACRLASEVLDYITPFVVAGVTTGELDRLCHEYMTHVQGTVPAPLNYQPPGYPPFPKAICTSVNDVICHGIPGEKTLKNGDALNIDITVIKNGYFGDTSRMFIIGEGSILAKRLVQTTYECMWLGIDQVRPGAHLGDIGHAIQKHAEAQGYSVVREYCGHGIGTVFHEDPQVVHYGRPGTGLELKPGMIFTIEPMINAGKRDIRTMPDQWTVKTRDRSLSAQWEHTILVTDTGHEVLTVSAGTPARPTFAAPATAA*		283	30	5	Purified	-1	 	NR-13752
Batch01a	BupsA.00040.a	Burkholderia pseudomallei	YP_331809	Q3JX94				S-adenosylmethionine synthetase 	Potential drug target		MANDYLFTSESVSEGHPDKVADQISDAILDAILAQDKYSRVAAETLCNTGLVVLAGEITTTANIDYIQIARDTIKRIGYDNTDYGIDYRGCAVLVAYDKQSPDIAQGVDRAHDNNLDQGAGDQGLMFGYACDETPELMPLPIHLSHRLVERQANLRRDGRLPWLRPDAKSQVTVRYVDGKPHSIDTVVLSTQHAPEIDLPALREAVIEEVIKPTLPADLIKGDIKFLVNPTGRFVIGGPQGDCGLTGRKIIVDTYGGAAPHGGGAFSGKDPSKVDRSAAYAGRYVAKNIVAAGLASRALIQVSYAIGVAEPTSVMVNTFGTGRVSDETITKLVREHFDLRPKGIIQMLDLLRPIYEKTAAYGHFGREEPEFSWEAADKALALAEAAGVEPAVQVA*		396	43	17	In PDB	-1	 	NR-13753
Batch01a	BupsA.00043.a	Burkholderia pseudomallei	YP_334796	Q3JNQ7				dihydroorotase 	Potential drug target		MPSVGRRRARPARRASRLAARHSHDTMNASVPASLTLARPDDWHLHVRDGAMLAAVLPHTARQFGRAIIMPNLKPPVTTTAQAQAYRERILAAVPAGMTFEPLMTLYLTDNTPADEIRRARESGCVHGVKLYPAGATTNSDAGVTDLLGKCAKTLEAMQEVGMPLLVHGEVTDPSIDLFDREKVFIDRVMEPLRRALPGLKVVFEHITTKDAADYVRDADAASGRIGATITAHHLLYNRNAMFFGGIRPHYYCLPVLKRETHRIALVEAATSGNPRFFLGTDSAPHAKGAKEAACGCAGCYTALHALELYAEAFDQAGALDKLEGFASFFGADFYGLPRSAETVTLRRETWELPREIDAGAGPVVPLRGGEAIGWRLV*		379	41	3	Expressed	-1	 	
Batch01a	BupsA.00046.a	Burkholderia pseudomallei	YP_332674	Q3JUS9				"alpha,alpha-trehalose-phosphate synthase (UDP-forming) "	Potential drug target		MSRLIVVSNRVAAGQDARPTAGGLAVGVLDALKETGGVWFGWNGEIAGAPEEPVIERDGNVTYATVGLTRRDYDQYYRGFSNATLWPVFHYRGDLARFDRQEYAGYLRVNCALAKQLCALVQPDDIIWVHDYHLLPFAHCLRELGVKNPIGFFLHIPFPSPEVLRTVPPHEELMKFMCAYDVIGLQTESDKQAFVDYIERRGLGTSSEDGILHAHGRVVKVAAYPIGIYPDAIGKAAIEYGSRKAVKALRDTMRERKLVISVDRLDYSKGLVERFQAFERMLANAPGWQGRVSLVQIAPPTRSDVQTYQRIRQTLEGEAGRINGRFAQLDWTPIQYLNRKYERNLLMALFRLSQVGYVTPLRDGMNLVAKEYVASQDPNDPGVLVLSEFAGAAAELPGALLVNPFDLSQMAESLERALAMPLEERQARHAENIARLRKNDLSVWRDSFLTDLRSVATAASVTQRAGRRVANA*		473	53	3	Expressed	-1	 	
Batch01a	BupsA.00046.b	Burkholderia pseudomallei	YP_334256	Q3JQ97				"alpha,alpha-trehalose-phosphate synthase (UDP-forming) "	Potential drug target		MSRLIIVSNRVAPISEGEPAAGGLAIGVYDALKETGGMWFGWSGEVIASGVPQIRIEEHGPVTFATIGLSRRDYDQYYRGFSNATLWPAFHYRADLIQFDRHEFEGYSRVNVWLAQQLVPLLRDDDVIWVHDYHLIPFARALRTAGVKNRIGFFLHIPFPAAQVLVNVPPHRELVEALCSFDLLGFQTDTDLRAFFEYVEYEAGGTVDRAAHPARVDAFGRTLRAAAYPIGVYPDEIAALAMAGENGRAVKSLAASLRGRQLVMSVDRLDYSKGLVERFRAFEKLLEHETSFRNHVSFLQIAPSTRADLRAYQDIRRQLEGESGRINGRFAELDWAPILYIHRQYERPVLAALYRLARVGYVTPLRDGMNLVAKEYVSAQDPDDPGVLVLSRFAGAACELTGALIVNPIDIGGMADALSRALSMPLAERRARHADMLARLRENNVSVWRDHFLRDLGR*		459	51	2	Cloned	-1	 	
Batch01a	BupsA.00047.a	Burkholderia pseudomallei	YP_334319	Q3JQ34				fumarate hydratase 	Potential drug target		MTTVDSPRDANGPPRFAASGFATPRRPDDTDDTGDADETAATVPHRTRALTTPPRRKTIAAPCIDARTRRDRPARRATHARRALADFRAPAPPVARGTTRNRARRYACPSVDAVARTAPSPHAHRAAPARRPPSSEGAIMSEAVRMERDTFGEIAVPAARLWGAQTQRSLQNFKISTEKQSPELIHALALIKRAAAAVNLELGVLAQDKANAIVAAADEIIAGRHADEFPLAVWQTGSGTQTNMNLNEVIANRASELLGGERGESRAVHPNDDVNRGQSSNDVFPTAMHIAAARAIVDHLLPALRTLRATLDAKAAAFADIVKIGRTHLQDATPLTLGQEFSGYVAQLDQGIRHVEAALPHLYELAQGGTAVGTGLNAHPKFAAGVAAEIGRLTGLPFVSAPNKFEVMAAADALVFAHGALKTVAASLMKIANDIRWLASGPRCGLGELSIPENEPGSSIMPGKVNPTQSEAVTMLCCQVFGNDVAVNFGGASGNFELNVFRPMIAHNVLQSVRLLADGAQGFNDHCAVGIEPNRARIDALLNESLMLVTALNPHIGYDKAAQIAKKAHKEGTTLKAAALALGYVTDAQFDEWVRPEHMVGNR*		604	49	1	Selected	-1	 	"NR-16693, NR-16694"
Batch01a	BupsA.00048.a	Burkholderia pseudomallei	YP_334263	Q3JQ90				hypothetical protein BURPS1710b_2879 	Potential drug target		MRRRRARRRIPVDCTSHGRARPPLNLHVNRSLMFALSEALPSSKPALYETLAAQARALVETETDIVANAANFASLVYHSLDGLNWAGFYFFDGRELVVGPFQGKPACVRIPLGKGVCGTAAQTRGTQVVHDVHAFAGHIACDSASQSEIVVPLVARDGALIGVWDVDSPLVGRFDAEDATGMEALCRVFVEVAWENATRRGE*		203	22	3	Expressed	-1	 	
Batch01a	BupsA.00050.a	Burkholderia pseudomallei	YP_335917	Q3JKI6				"GDP-mannose 4,6-dehydratase "	Potential drug target		MTQARKAIITGITGQDGAYLAKLLLDKGYEVVGTYRRTSSVNFWRIAELGVDKHPCLTLVEHDLTDLGSSLRLVERTQPHELYNLAAQSFVGVSFDQPATTAEVTGLGALHLLEAIRVVNPKIRYYQASTSEMFGKVQAIPQIESTPFYPRSPYGVAKLFAHWTTLNYRESYGIFGSSGILFNHESPLRGREFVTRKITDTVAKIKLGKASRLELGNLGAKRDWGFALEYVEGMWRMLQADEPDTYVLATNRTETVRDFVRMAFAAAGYQLEWSGKGEDERGIDTATGNVLVSVNPKFYRPAEVDLLIGCADKARDKLGWVPKTTLEALCRMMVEADLTRNRHHETF*		348	39	7	Crystallized	-1	 	
Batch01a	BupsA.00051.a	Burkholderia pseudomallei	YP_331487	Q3JY66				chemotaxis protein CheY 	Potential drug target		MRRPAGTRAGRRASPVWLGQTARLARCTTAGIARSRARDREPGLATVTEHESGKEQTMDKSMKILVVDDFPTMRRIVRNLLKELGYSNVDEAEDGLAGLARLRGGGYDFVISDWNMPNLDGLAMLKEIRADASLTHLPVLMVTAESKKENIIAAAQAGASGYVVKPFTAATLDEKLNKILEKMAKAGS*		189	20	5	Purified	-1	 	NR-13754
Batch01a	BupsA.00051.b	Burkholderia pseudomallei	YP_335540	Q3JLL3				response regulator 	Potential drug target		MIADERGNFVEILLVEDSPTDVMMTKEALEYYKVLNPLNVVEDGVAAMAYLRREGPYAGARRPGLIILDLNLPRKSGREVLQELKLDPELSTIPVVILTTSKSEEDVARSYGLHANCYITKPVDFAKFTDVVHSINEFWLSVVTLPPAKS*		151	17	10	Diffraction	-1	 	NR-13755
Batch01a	BupsA.00052.a	Burkholderia pseudomallei	YP_334837	Q3JNL6				"glyceraldehyde-3-phosphate dehydrogenase, type I "	Potential drug target		MTIRVAINGYGRIGRNTLRAFYENGKKHDLEIVAINDLGDAKTNAHLTQYDTAHGKFPGEVSVDGDYLVVNGDRIRVLANRNPAELPWGELGVDVVMECTGFFTSKEKASAHLKGGAKKVIISAPGGKDVDATIVYGVNHDVLKAEHTVISNASCTTNCLAPLVKPLNDKIGLETGLMTTIHAYTNDQVLTDVYHEDLRRARSATHSQIPTKTGAAAAVGLVLPELNGKLDGYAIRVPTINVSIVDLSFIAKRDTTAAEVNAIMKEASEGALKGILGYNEAPLVSIDFNHNPASSTFDATLTKVSGRLVKVSSWYDNEWGFSNRMLDTAIALANAK*		337	36	17	In PDB	-1	 	NR-13756
Batch01a	BupsA.00053.a	Burkholderia pseudomallei	YP_331799	Q3JXA4				ATP-dependent protease ATP-binding subunit 	Potential drug target		MSTMTPAEIVSELDKHIIGQAKAKKAVAVALRNRWRRQQVAEPLRQEITPKNILMIGPTGVGKTEIARRLAKLADAPFIKIEATKFTEVGYVGRDVDSIVRDLIEISVKQTRETEMRKVRSKATDLAEDRILDVLLPQPRAVGFGASAEHANDDNNATRQTFRKRLREGQLDDKEIELDIEQPAVGMDIMAPPGMEEMTEQIRSMFSNLGSGKKQRRKVKIKEALKLLTDEEAAKMLNDEEVKTKAVQNVEQNGIVFLDEIDKITSRNHEGGGGEVSRQGVQRDLLPLVEGTTINTKYGMVKTDHILFIASGAFHLAKPSDLIPELQGRFPIRVELDSLSVKDFEAILVATDASLVKQYQALLATEDVKLEFADDGIRRLAEIAYAVNEKTENIGARRLYTVIEKLLEEVSFAAGNHAGQSVTIDSAYVDHALGEVSKDEDLSRYVL*		448	50	10	Diffraction	-1	 	
Batch01a	BupsA.00054.a	Burkholderia pseudomallei	YP_334345	Q3JQ08				tRNA (guanine-N(1)-)-methyltransferase 	Potential drug target		MDEATQSAIQFDVVTLFPEMFRALTDWGITSRAVKQGRFGLRTWNPRDFTTDNYRTVDDRPYGGGPGMVMLAKPLEAAIGAAKAAQAAQGVATSRVVMMSPQGAPLTHERVARMAAEPGVVLLCGRYEAIDQRLIDRCVDEELSLGDFVLSGGELPAMALMDAVVRLLPGVLNDAQSAVQDSFADGLLDCPHYTRPEEYEGVRVPDVLLGGHHAEIERWRRQEALRNTIAKRPDLIARARREKLLSRADEAWLASLAKEAKQAS*		265	29	5	Purified	-1	 	
Batch01a	BupsA.00055.a	Burkholderia pseudomallei	YP_334875	Q3JNH8				thiol peroxidase 	Potential drug target		MSKVTLGGNPIDIAGTFPTVGSPAPDFKLVGKDLADVSLATFAGKRKVLNIVPSLDTPTCAASTRKFNEAASKLDNTVVVVVSADLPFAATRFCTTEGLANVITASTFRGGRAFADAYGVNVTSGPLDGLAARAVIVIDENDKVTYTELVGEIKNEPNYDAALAALK*		168	17	5	Purified	-1	 	
Batch01a	BupsA.00056.a	Burkholderia pseudomallei	YP_332544	Q3JV59				nicotinate-nucleotide pyrophosphorylase 	Potential drug target		MTIDAVSPLFADISREYGAAFDAAIARNVADALAEDVGSGDQTGRLVPDGAPRRARVIVREDAVLCGVPWFDAVVRAVDPSIEVDWRHREGDRMSADSTVCELRGPARALLTAERNALNFLQLLSGVASATRQYVDRIADTRARILDTRKTLPGLRLAQKYAVRVGGGANQRLALYAGILIKENHIAAAGGVGEALDAAFALNAEVPVQIEVETLDQLRTALAHGARSVLLDNFTLDMMRDAVRVTEGRAVLEVSGGVNFDTVRAIAETGVDRISIGALTKDVRATDYSMRIVE*		295	32	17	In PDB	-1	 	NR-13759
Batch01a	BupsA.00057.a	Burkholderia pseudomallei	YP_332452	Q3JVF1				"ABC sugar transporter, ATP-binding protein "	Potential drug target		MASVLLRNIGKRYDDNEVLRNVNLDIVDGEFVVFVGPSGCGKSTLMRMIAGLEEISGGELLIDGAKVNDVPSAKRGIAMVFQSYALYPHMTLYDNMAFGLKLAGAKKQEIDDAVKQAARILHIDHLLDRKPRQLSGGQRQRVAIGRAITRKPKVFLFDEPLSNLDAALRVKMRLEFARLHDELKTTMIYVTHDQVEAMTLADKIVVLSAGSVQQVGAPNALYHAPANQFVAGFIGSPKMNFLAGVVESASADGALVRFESGETQRAAVDASTLRAGERVTVGIRPEHLHVGVTGGDGIVARTMAVESLGDAAYLYAESAVAPDGLIARIPPLDTYRAGEMLRVGAQPEHCHLFDADGRAFKRKPRHALAA*		371	40	3	Expressed	-1	 	
Batch01a	BupsA.00058.a	Burkholderia pseudomallei	YP_334452	Q3JPQ1				thioredoxin-disulfide reductase 	Potential drug target		MSTPKHAKVLILGSGPAGYTAAVYAARANLSPLLITGIAQGGQLMTTTDVENWPADADGVQGPELMQRFLAHAQRFNTEIVFDHIHTAKLHEKPIRLIGDSGEYTCDSLIIATGASAQYLGLQSEEAFMGRGVSACATCDGFFYRGQNVAVVGGGNTAVEEALYLTGIAKKVTVIHRRDKFRAEPILVDRLLEKEKEGAVEIKWDHVLDEVTGDDSGVSGVRIKHVTTGATEDVAVQGLFIAIGHKPNTDIFKGQLEMKDGYIITNSGLSGNATGTSVPGVFAAGDVQDHIYRQAITSAGTGCMAALDAQRYLESLHDHK*		321	34	5	Purified	-1	 	NR-13760
Batch01a	BupsA.00061.a	Burkholderia pseudomallei	YP_336289	Q3JJG4				UDP-N-acetylglucosamine 2-epimerase 	Potential drug target		MKKILLAFGTRPEAIKMAPLVRMLQTRADVDARVCVTAQHRQMLDQVLALFDIAPAYDLNVMRQSQTLADVTTGILQTIGAVFDDFDPDIVLVHGDTTTTLAVSLAAFYRYLPIGHVEAGLRSGDIWSPWPEELNRRVTDAVSSWHFAPTERAQHNLFSEGVPTQGVVLTGNTVIDALQDVKRMLDADAPLAREIAAQFPFLGHDERVVLITGHRRESFGEPFAHFCDALRTLARRYPGVRFVYPLHLNPNVQGPAHALLDGLPNVHLIAPQEYLSFVFLMSRAHFIITDSGGIQEEGPALGKPVLVTRDTTERPEAIQAGTARLVGTDTERIVGEASRLLDDDDAYDEMSRATNPYGDGHASERIAHALLNMPHAADTARFPLAAIEAPCNALALGLRALRSA*		405	44	3	Expressed	-1	 	
Batch01a	BupsA.00062.a	Burkholderia pseudomallei	YP_333941	Q3JR62				inositol-5-monophosphate dehydrogenase 	Potential drug target		MRLIQKALTFDDVLLVPAFSDVLPRDTSLKTQLTRNISLNMPLVSAAMDTVTEGRLAIAMAQQGGVGIVHKNLTPVEQAREVAKVKRFESGVVRDPITVPPSMKVRDVIALSRQHGISGFPVVEGPKLVGIVTNRDLRFETRLDEPVKSIMTPRERLVTVAEGTPLAEAKALMHSHRLERVLVVNDAFELRGLMTVKDITKQTEHPEACKDEHGKLRVGAAVGVGADNEERVELLVQAGVDVIVVDTAHGHSKGVLERVRWVKQNFPKVEVIGGNIATAAAAKALVEYGADAVKVGIGPGSICTTRIVAGVGVPQISAIANVSDALRGTGVPCVADGGIRFSGDVSKALAAGANAVMMGSMFAGTEEAPGDVFLYQGRQYKSYRGMGSVGAMKDGAADRYFQDNSANIDKLVPEGIEGRVAYKGSVNAIIFQLIGGVRASMGYCGCKTIAELHEKAEFVQITAAGMRESHVHDVQITKEAPNYHVD*		487	52	5	Purified	-1	 	NR-13761
Batch01a	BupsA.00063.a	Burkholderia pseudomallei	YP_333748	Q3JRQ5				histidyl-tRNA synthetase 	Potential drug target		MTEQKRKLEKLTGVKGMNDILPQDAGLWEFFEATVKSLLRAYGYQNIRTPIVEHTQLFTRGIGEVTDIVEKEMYSFVDALNGENLTLRPENTAAVVRAAIEHNMLYDGPKRLWYLGPMFRHERPQRGRYRQFHQVGVEALGFAGPDADAEIIMMCQRLWDDLGLTGIKLEINSLGLAEERAAHRVELIKYLEQHVDKLDDDAQRRLYTNPLRVLDTKNPALQEIVRNAPQLIDFLGDVSRAHFDGLQQLLKANNLPFTINPRLVRGLDYYNLTVFEWVTDKLGAQGTVAAGGRYDPLIEQLGGKPTAACGWAMGVERILELLKEEHLVPEQEGVDVYVVHQGDAAREQAFIVAERLRDTGLDVILHCSADGAGASFKSQMKRADASGAAFAVIFGEDEVANGTVSVKPLRGTGAEGEKNVQQSVPVESLTEFLINAMVATAEDGDD*		447	50	5	Purified	-1	 	NR-13762
Batch01a	BupsA.00064.a	Burkholderia pseudomallei	YP_332492	Q3JVB1				adenylate kinase 	Potential drug target		MRLILLGAPGAGKGTQANFIKEKFGIPQISTGDMLRAAVKAGTPLGVEAKTYMDEGKLVPDSLIIGLVKERLKEADCANGYLFDGFPRTIAQADAMKEAGVAIDYVLEIDVPFSEIIERMSGRRTHPASGRTYHVKFNPPKVEGKDDVTGEPLVQRDDDKEETVKKRLDVYEAQTKPLITYYGDWARRGAENGLKAPAYRKISGLGAVEEIRARVFDALK*		221	24	17	In PDB	-1	 	
Batch01a	BupsA.00065.a	Burkholderia pseudomallei	YP_336708	Q3JI95				4-hydroxybenzoate 3-monooxygenase 	Potential drug target		MRTQVAIIGAGPSGLLLSHLLRLQGVDSVVLETRSREYCENRIRAGVLEQGTVDTLNDAGLGARMRREGLVHRGIELLFDGRRHRIDFGELTPGRAITVYSQHEVVRDLIAAALEHGQPIHFDVRDVALHDVATERPSVTFMHADGRPDRIDCDYVAGCDGFHGVARQAIPAERRRTFERVYPYAWLGILADAAPSLDELVYAHHARGFALFSMRSPTVTRLYLQCRPDENLAEWPDARIWEELGTRFENDGGWTPTPGRITQKSVTPMRSFVSETMQHGRLFLAGDAAHIVPPTGAKGMNLAVADVRALSRALVARYRHGRGDLLDAYSSTCLERIWRAEHFSYSMTNMLHPCADDSPFVNRLKLAELRYVTRSRAAAQSLAENYVGLPFDETAGDAPSFGEAAAA*		408	45	5	Purified	-1	 	"NR-16695, NR-16696, NR-16697, NR-16698, NR-16699"
Batch01a	BupsA.00066.a	Burkholderia pseudomallei	YP_335114	Q3JMT9				DNA-directed RNA polymerase alpha subunit 	Potential drug target		MQTSLLKPKIIAVESLGENHAKVVMEPFERGYGHTLGNALRRVLLSSMVGYAPTEVTIAGVVHEYSTLDGVQEDVVNLLLNLKGVVFKLHNRDEVTVTLRKEGEGVVTAGDIELAHDCEVINPNHVIAHLSKGGKLDVQIKVEKGRGYVPGNVRRYGDETAKIIGRIVLDASFSPVRRVSYTVESARVEQRTDLDKLVMNIETSGVITPEEAIRQSARILVDQLSVFAALEGTETAAEAPSRAPQIDPILLRPVDDLELTVRSANCLKAENIYYIGDLIQRTENELLKTPNLGRKSLNEIKEVLASRGLTLGMKLENWPPAGLDK*		326	36	5	Purified	-1	 	
Batch01a	BupsA.00068.a	Burkholderia pseudomallei	YP_331622	Q3JXT1				phenylalanine-4-hydroxylase 	Potential drug target		MMRNYRIYPYTIAHFAPKPREPRSTLACIPTTDAKQGYPMSTVVTAKLKEQFDAGLETRADFTIDQPLARYGDVDHAVWTQLYTRQAALLRGRACDAFIEGLARIGLAPDRVPSFADVNRRLEPATGWRIVAVPGLVPDAVFFEHLANRRFPVTWWMRRPDQLDYLQEPDCFHDLFGHVPLLIDPVFADYMHAYGRAALRVADDASALALLARLYWYTVEFGLIRDTRGENGLRIYGAGIVSSKGETLYSLESTSPNRIGFDLERVMRTRYRIDTFQKTYFVIDDFAQLFALADLDARALAARLAGAPEHAAGAVLDGDHVLTRGTGEGWAADADA*		337	38	3	Expressed	-1	 	
Batch01a	BupsA.00069.a	Burkholderia pseudomallei	YP_332384	Q3JVL9				recombinase A 	Potential drug target		MEESKKGSGLTAEKSKALAAALAQIEKQFGKGSIMRLGDGEAVEDIQVVSTGSLGLDIALGVGGLPRGRVVEIYGPESSGKTTLTLQVIAEMQKLGGTAAFIDAEHALDVQYASKLGVNVPELLISQPDTGEQALEIVDALVRSGSIDMIVIDSVAALVPKAEIEGEMGDALPGLQARLMSQALRKLTGTIKRTNCLVIFINQIRMKIGVMFGNPETTTGGNALKFYSSVRLDIRRIGSIKKNDEVIGNETRVKVVKNKVSPPFREAIFDILYGEGISRQGEIIDLGVQAKIVDKAGAWYSYSGEKIGQGKDNAREFLRENPEIAREIENRIRESLGVAAMPQGAGSEAEIMDEEE*		357	38	4	Soluble	-1	 	
Batch01a	BupsA.00072.a	Burkholderia pseudomallei	YP_332082	Q3JWH1				"RNA methyltransferase, TrmH family, group 2 "	Potential drug target		MFNVVLVEPEIPPNTGNVIRLCANTGARLHLIEPLGFPLDDAKMRRAGLDYHEYAQMRVHRDWDAFVAAEAPDPARMFAFTTRGSGRFHDRAFEPGDWFVFGAETRGLAPALVDRFAPEQRVRLPMRPGNRSLNLSNTVAVVVFEAWRQAGFEGGA*		157	17	17	In PDB	5	Target selected for ligand screening 	NR-13763
Batch01a	BupsA.00074.a	Burkholderia pseudomallei	YP_336021	Q3JK82				organic hydroperoxide resistance protein 	Potential drug target		MNILYKTAATSTGGRDGRATSHDQKLDVKLSAPRELGGAGAEGTNPEQLFAAGYSACFLSAMKFVAGQNKQTLPADTTVTAEVGIGPNEEGGFALDVELRVALPGLDAAAAKTLVDRAHHVCPYSNATRNNVAVRLVVA*		140	14	16	In BMRB	-1	 	NR-13764
Batch01a	BupsA.00075.a	Burkholderia pseudomallei	YP_335110	Q3JMU3				delta-aminolevulinic acid dehydratase 	Potential drug target		MSQKFTEGNCKVSSVTYPSHSAMSIHPLHRPRRMRRDDFSRRLMRENILTTNDLIYPVFVVEGTNVRQPVPSMPGVERVSIDLLMGVAEQCVELGVPVLSLFPAIEPSLKTPDGREAANPEGLIPRAVRELKRRFPELGVLTDVALDPYTSHGQDGVLDEAGHVLNDETLEILVEQARAQAEAGVDIVAPSDMMDGRIGAVREMLEREGHIYTRIMAYSAKYASAFYGPFRDAVGSASNLGKGNKMTYQMDPANSDEALREVRLDIDEGADMVMVKPGMPYLDIVRRVKDEFRYPTYVYQVSGEYAMLKAAAQNGWLDHDKVVLESLLAFKRAGADGILTYFALDAARLLRAQK*		355	39	10	Diffraction	-1	 	NR-13765
Batch01a	BupsA.00076.a	Burkholderia pseudomallei	YP_332797	Q3JUF6				uracil phosphoribosyltransferase 	Potential drug target		MKQDSRFPNLFILDHPLIQHKLTHMRDKDTSTRTFRELLREITLLMGYEITRNLPITTKRVETPLVEIDAPVIAGKKLAIVPVLRAGVGMSDGLLELIPSARVGHIGVYRADDHRPVEYLVRLPDLEDRIFILCDPMVATGYSAAHAIDVLKRRGVPGERLMFLALVAAPEGVQVFQDAHPDVKLYVASLDSHLDDHAYIVPGLGDAGDRLFGTKN*		217	24	17	In PDB	-1	 	NR-13766
Batch01a	BupsA.00077.a	Burkholderia pseudomallei	YP_334599	Q3JPA4				fumarylacetoacetase 	Potential drug target		MNGENDNHDIGFFETGRSRLSERLRERIRDRGAAGRVAARAQLAAARAVRALRGAVLRHRVHRAARPQPPLVAVPDPARRRASAVRARVGRAPDRRRVRRFGRRAADAAEPVALGSAADARAADRFRRRLGDDGGQRLGRRDERLRDPPVRGEPLDARALLLQRGRRAADRAAGRAPLHHDGARPARRRAVRDRGDPARRALRGRAAGRARARLCMRELRCAAQAAGPRADRLERPRESARLPHAARVVRGSRRRVRARREAEWPALARGHRSFAVRRRRVARQLRAVQVRPASLQHDRLDQLRSSGPVDLPRAAVAKRYAGRRRDRLRDLPPALARGRGYVPPALVPPQRRERIHGARARRLRREGRRLRAGRREPAQLHVRPRARRGHVREGFFDRHVEAEQGRRHDGVHVRDPHADPADALRARHRATAGELLRMLARPQETLQSGATMSAIPDTLRASLDPSRKSWLDTANAAACDFPIQNLPFGIFSDARDASRRAGVALGDQIIDLAALARAGLLTVDGGAAVFARPALNDFISLGRDAWRSVRAQLSALFERGDARLRDDAALRAKVLVAQRDAALHLPVDIPGYTDFYSSKEHATNVGSMFRDPKNALLPNWSEMPIGYNGRASSVVVSGTPVRRPNGQLKLPDSERPVFGACRKLDIELETGFIVGRGNALGEPIACEDAESHIFGMVLLNDWSARDIQQWEYVPLGPFNAKTFATSISPWIVTLDALEPFRTAQPRQEPEPLAYLRHGGAHAFDIELEVRLRPEGAADATTIARTNFRHMYWTMAQQLAHHTVSGCNTRVGDLMGSGTISGPAKQAFGSLLELTWNGKEPVSLAGGGTRAFIEDGDELTLAGWCQGDGYRVGFGTCVGKILPARGR*		887	98	1	Selected	-1	 	
Batch01a	BupsA.00078.a	Burkholderia pseudomallei	YP_331761	Q3JXE2				peptide deformylase 	Potential drug target		MARVVESILRPARASRQSAERPMRAGRSSPDTEIMALLNILHYPDKRLHKVAKPVAKVDDRIRKLVADMAETMYAAPGIGLAATQVDVHERVIVIDVSEDKNELRVFINPEIVWTGDGKQVYEEGCLSVPGVYDEVERPDRVRVRALDGQGEPFELDCEGLLAVCIQHEMDHLMGRVFVQYLSPLKQTRIKTKMKKLERAM*		202	19	5	Purified	-1	 	NR-13767
Batch01a	BupsA.00081.a	Burkholderia pseudomallei	YP_334119	Q3JQN4				cysteine desulfurase IscS 	Potential drug target		MNNDIPHLPIYMDYSATTPVDPRVVDKMVPYLREQFGNPASRSHAYGWDAERAVEEAREQVAALVNADPREIIWTSGATESDNLAIKGAAHFYQGKGKHIVTVKTEHKAVLDTCRELEREGFEVTYLDVKDDGLIDLDVFKAALRPDTILVSVMHVNNEIGVIQDIATIGEICREKGIIFHVDAAQATGKVEIDLAKLKVDLMSFSAHKTYGPKGIGALYVRRKPRVRIEAQMHGGGHERGMRSGTLPTHQIVGMGEAFRIAREEMATENERIRMLRDKLLRGLSEIDETYVNGDLEHRIPHNLNISFNFVEGESLIMAIKDVAVSSGSACTSASLEPSYVLRALGRNDELAHSSIRFTVGRFTTEQEVDYVIDLLKSKIAKLRDLSPLWEMHQEGIDLSTIEWAAH*		408	45	5	Purified	-1	 	NR-13768
Batch01a	BupsA.00082.a	Burkholderia pseudomallei	YP_332640	Q3JUW3				porphobilinogen deaminase 	Potential drug target		MNSETLPAELPATLTIASRESRLAMWQAEHVRDALRKLYPACDVKILGMTTRGDQILDRTLSKVGGKGLFVKELESALADGRADLAVHSLKDVPMALPEGFALAAVMSREDPRDAFVSNDYASLDALPAGAVVGTSSLRREAMLRARHPRLDVRPLRGNLDTRLAKLDRGDYAAIILAAAGLKRLGLAARIRALLDVDDSLPAAGQGALGIEIAARRADVAAWLAPLHDHASALAVEAERAVSRALGGSCEVPLAAHAVWRGGELHLTGSVSTTDGARVLAAHAHARAATAADALALGRRVSDALERQGARAIVDALVAASAQAQKGGA*		330	34	2	Cloned	-1	 	
Batch01a	BupsA.00084.a	Burkholderia pseudomallei	YP_334097	Q3JQQ6				phosphopyruvate hydratase 	Potential drug target		MSAIVDIIGREILDSRGNPTVECDVLLESGTMGRAAVPSGASTGSREAIELRDGEAGRYGGKGVLKAVEHINTEISEAIMGLDASEQAFLDKTLLELDGTDNKSRLGANAMLAVSMAVAKAAAEEAGLPLYRYFGGSGAMQLPVPMMNIVNGGAHANNSLDIQEFMIVPVSQPTFREALRCGAEVFHALKKILGDRGMSTAVGDEGGFAPNFGSNDECLSTILQAIEKAGYRAGEDVLLALDCAASEFYHDGKYQLAGEGLQLSSAEFTDYLATLADKFPIVSIEDGMHEGDWDGWKLLTERLGKKVQLVGDDLFVTNTRILKEGIEKGIANSILIKINQIGTLTETFAAIEMAKRARYTAVISHRSGETEDSTIADIAVGLNAGQIKTGSLSRSDRISKYNQLLRIEEDLGDIASYPGKSAFYNLR*		428	46	4	Soluble	-1	 	
Batch01a	BupsA.00085.a	Burkholderia pseudomallei	YP_334535	Q3JPG8				"dTDP-glucose 4,6-dehydratase "	Potential drug target		MGAWLRSSHAAATGRCHSSDQRHASERAGHAAHAGCLTDSQFQQRNPMILVTGGAGFIGANFVLDWLAQSDEAVLNVDKLTYAGNLGTLKSLQGNPKHVFARVDICDRAAIDALLAQHKPRAIVHFAAESHVDRSIHGPADFVQTNVVGTFTLLEAARQYWSALGTDAKAAFRFLHVSTDEVFGSLSPADPQFSETTPYAPNSPYSATKAGSDHLVRAYHHTYGLPVLTTNCSNNYGPYQFPEKLIPLMIANALGGKPLPVYGDGQNVRDWLYVGDHCSAIREVLARGVPGETYNVGGWNEKKNLDVVHTLCDLLDEARPKAGGSYRDQITYVTDRPGHDRRYAIDARKLERELGWKPAETFETGLAKTVRWYLDHQEWVDEVVSGDYRKWVETNYAQRA*		401	44	5	Purified	-1	 	NR-13769
Batch01a	BupsA.00085.b	Burkholderia pseudomallei	YP_334520	Q3JPI3				UDP-glucose 4-epimerase 	Potential drug target		MSTKGTILVTGGAGYIGSHTAVELLAHGYDVVIADNLVNSKREAIARIEKITGKTPAFHETDVSDERALARIFDAHPITAAIHFAALKAVGESVAKPIEYYRNNLDSLLSLLRVMRERAVKRIVFSSSATVYGVPERSPIDETFPLSATNPYGQTKLMAEQILRDVEAADPSWRVATLRYFNPVGAHESGLIGEDPAGIPNNLMPYVAQVAVGKLEKLRVFGSDYPTPDGTGVRDYIHVVDLARGHIAALDALERRDASLTVNLGTGRGYSVLEVVRAFEKASGRAVPYELVARRPGDVAECYANPAAAAETIGWKAERDLERMCADHWRWQENNPRGFV*		341	37	17	In PDB	5	Target selected for ligand screening 	NR-13770
Batch01a	BupsA.00085.c	Burkholderia pseudomallei	YP_334365	Q3JPY8				ADP-L-glycero-D-manno-heptose-6-epimerase 	Potential drug target		MTLIVTGAAGFIGANIVKALNERGETRIIAVDNLTRADKFKNLVDCEIDDYLDKTEFVERFARGDFGKVRAVFHEGACSDTMETDGRYMMDNNFRYSRAVLDACLAQGTQFLYASSAAIYGGSSRFVEAREFEAPLNVYGYSKFLFDQVIRRVMPSAKSQIAGFRYFNVYGPRESHKGRMASVAFHNFNQFRAEGKVKLFGEYNGYGPGEQTRDFVSVEDVAKVNLHFFDHPQKSGIFNLGTGRAQPFNDIATTVVNTLRALEGQPALTLAEQVEQGLVEYVPFPDALRGKYQCFTQADQTKLRAAGYDAPFLTVQEGVDRYVRWLFGQL*		331	37	2	Cloned	-1	 	
Batch01a	BupsA.00086.a	Burkholderia pseudomallei	YP_334870	Q3JNI3				3-dehydroquinate dehydratase 	Potential drug target		MAEFEISLAPICMKLTDSTQASGPPRARRRRRPFGKTRQISLIGDKVRAIPQKKKRPMTRLLVLHGPNLNLLGTREPEVYGRVTLEQIDQALAARAQEAGAELESFQSNHEGALVDRVQAAGSDGTAFILINPAAYTHTSVAIRDALAGVGIPFVEIHLSNVHRREPFRHHSYFSDQAEGVICGLGWKGYLYALEYALDKLQGASRG*		208	23	4	Soluble	-1	 	
Batch01a	BupsA.00088.a	Burkholderia pseudomallei	YP_333522	Q3JSD1				ornithine carbamoyltransferase 	Potential drug target		MSFNLHNRNLLSLIHHNARELRYLLDLARDLKRAKYSGTEQPRLLRKNIALIFEKTSTRTRCAFEVAAYDQGANVTYIDPASSQIGHKESMRDTARVLGRMYDAIEYRGFSQEIVEELAHHAGVPVFNGLTDEYHPTQMLADVMTMREHSDKPLHDIRYAYLGDARNNMGNSLLLIGAKLGMDVRIGAPKSLWPAADFIAQCEAFAAESGARLTLTEDPYEAVKGVDFIHTDVWVSMGEPVEAWDERINALLPYQVNRKLIESTGNPRTRFMHCLPSFHNCETKVGKQIAERYPHLKDGIEVTDEVFESPRCIAFEQAENRMHTIKAVLVSTLGGI*		337	38	10	Diffraction	-1	 	NR-13771
Batch01a	BupsA.00090.a	Burkholderia pseudomallei	YP_334707	Q3JNZ6				3-deoxy-7-phosphoheptulonate synthase 	Potential drug target		MAREAQPNSRKTAGEPGGFFSPRRFASRDDGPIHRFTESPICRIEPPAAPAHAGRRTEPENSSMPPHNTDDVRIRELKELTPPAHLIREFALGEAVSELIYNARQAMHRILHGMDDRLIVIIGPCSIHDTKAALEYAGRLVQERERFASELEIVMRVYFEKPRTTVGWKGLINDPHLDNSFKINDGLRTARELLLQINEMGLPAGTEYLDMISPQYIADLISWGAIGARTTESQVHRELASGLSCPVGFKNGTDGNVKIAVDAIKAASQPHHFLSVTKGGHSAIVSTAGNEDCHVILRGGKAPNYDADSVNAACADIGKAGLAARLMIDASHANSSKKHENQIPVCADIGRQIAAGDERIVGVMVESHLVEGRQDLKEGCPLTYGQSITDACINWDDSVKVLEGLAEAVKARRVARGSGN*		421	46	1	Selected	-1	 	
Batch01a	BupsA.00090.b	Burkholderia pseudomallei	YP_335471	Q3JLT2				3-deoxy-7-phosphoheptulonate synthase 	Potential drug target		MQNIDNPQRDRETGFADATQDTTRIDDVRIGAVRPLISPALLQDELPVPSAVQALVEASRDAIGDVLHGRDDRLLAIVGPCSIHDHDQALDYARRLKSAADALRDDLLIVMRVYFEKPRTTVGWKGYINDPRLDGSFRINEGLRAARRLLIDINALGLPAGTEFLDLLSPQYIADLIAWGAIGARTTESQSHRQLASGLSCPIGFKNGTDGGVQVAADAIVAARASHAFMGMTKMGMAAIFETRGNDAAHVILRGGKRGPNYDRASVDEACAVLRAAGQREQVMIDCSHANSNKSHLRQVDVAEDLARQLSDGERRITGVMVESNLEAGRQDLKPGVPLQYGVSITDACLSWAQTEPVLDTLAQAVRRRRAA*		373	40	1	Selected	-1	 	
Batch01a	BupsA.00092.a	Burkholderia pseudomallei	YP_332521	Q3JV82				isocitrate dehydrogenase 	Potential drug target		MPYQHIKVPEGGDKITVNKDFSLNVSDQPIIPYIEGDGTGFDITPVMIKVVDAAVEKAYGGKKKIHWMEIYAGEKATKVYGPDVWLPEETLQVLKEYVVSIKGPLTTPVGGGIRSLNVALRQELDLYVCLRPIQYFKGVPSPVREPEKTNMVIFRENSEDIYAGIEWAAESEQAKKVIKFLQEEMGVKKIRFPQTSGIGIKPVSKEGTERLVRKAIQYAIDNDRKSVTLVHKGNIMKFTEGAFRDAGYALAQKEFGAELIDGGPWMKFKNPKTGNEIVVKDSIADAFLQQILLRPAEYDVIATLNLNGDYISDALAAQVGGIGIAPGANLSDSVAMFEATHGTAPKYAGKDYVNPGSEILSAEMMLRHLGWTEAADVIISAMEKSIKQKRVTYDFARLMEGATQVSCSGFGQVLIENME*		420	46	17	In PDB	5	Target selected for ligand screening 	
Batch01a	BupsA.00093.a	Burkholderia pseudomallei	YP_337624	Q3JFM9				N-ethylmaleimide reductase 	Potential drug target		MPSLFDPLTIGDLTLANRIIMAPLTRARAGDTRTPNALMARYYAERASAGLIISEATSVTPQGVGYASTPGIWSPEQVDGWRLVTDAVHAAGGRIFLQLWHVGRVSDPVFLDGALPVAPSAIAPGGHVSLVRPQRPYVTPRALELDEIPGVVAAFRRGAENARAAGFDGVEVHGANGYLLDQFLQDSANRRTDAYGGSIENRARLLLEVVDAAIDVWSAARVGVHLAPRGDAHTMGDSDPAATFGHVARELGRRRIAFLFARESFGGDAIGQQLKAAFGGPFIVNENFTLDSAQAALDAGQADAVAWGKLFIANPDLPRRFKLNAPLNEPNAATFYAQGEVGYTDYPALESAA*		354	38	17	In PDB	-1	 	
Batch01a	BupsA.00094.a	Burkholderia pseudomallei	YP_331794	Q3JXA9				acetylglutamate kinase 	Potential drug target		MRIAQENLTFPAAAPDFDTPAAHRPNGQKPHAALRHSCTIPPVSTFRTRAAAMSEPIDLSQISPALKAEILAEALPYIRRYHGKTVVIKYGGNAMTEERLKQGFARDVILLKLVGINPVIVHGGGPQIDQALKKIGKQGTFIQGMRVTDEETMEVVEWVLGGEVQQDIVTLINHFGGHAVGLTGKDGGLIHARKLMMPDRDNPGEYVDIGQVGEVEAINPAVVKALQDDAFIPVISPIGFGEDGLSYNINADLVAGKLATVLNAEKLVMMTNIPGVMDKEGNLLTDLSAREIDALFEDGTISGGMLPKISSALDAAKSGVKSVHIVDGRIEHSVLLEILTEQPFGTMIRSH*		352	38	10	Diffraction	-1	 	NR-13773
Batch01a	BupsA.00095.a	Burkholderia pseudomallei	YP_337143	Q3JH10				non-heme chloroperoxidase 	Potential drug target		MDTITTKDGTRIFYKDWGAGRPVVFSHGWPLNADAWDAQMLFLAQRGYRAIAHDRRGHGRSGQPATGNDMDTYADDLAALLDALDLREATLVGHSTGGGEVARYIGRHGSKRVAKAVLIGAVPPIMLQTEANPGGLPMEAFDGIRRGVAGNRSQFYRDVALPFFGFNRPDAQVSQATIDAFWAQGMTGGILGQYACIREFSEVDYTADLKKIDVPTLILHGDDDQMVPIDASARLSAKLVAGATLKVYPGGSHGICVTHADEVNADLLAFLAS*		274	29	4	Soluble	-1	 	
Batch01a	BupsA.00096.a	Burkholderia pseudomallei	YP_336667	Q3JID6				2-amino-3-ketobutyrate coenzyme A ligase 	Potential drug target		MRDAYLAHLRGTLEQIRADGFYKTEREIASPQAADIRLAGGTHVLNFCANNYLGLADDSRLIAAAQAALEQDGFGMASVRFICGTQTVHKQLEAALSAFLKTDDCILYSSCFDANGGLFETLLDENDAIISDELNHASIIDGIRLSKARRFRYKNNDLADLEAKLREADAAGARFKLIATDGVFSMDGIIANLKGVCDLADRYGALVMVDDSHAVGFIGEHGRGTLEYCGVEGRVDIVTGTLGKALGGASGGYVAARREIVELLRQRSRPYLFSNTLTPSIAAASLKVLELLASDEGARLRERVRANGAHFREKMSAAGFALVPGEHPIIPVMLGDAQVASKMADALLAEGVYVIGFSFPVVPRGRARIRTQMSAAHTREQIDRAVDAFVRVGKTLGVI*		400	43	3	Expressed	-1	 	
Batch01a	BupsA.00098.a	Burkholderia pseudomallei	YP_333787	Q3JRL6				"molybdopterin converting factor, subunit 2 "	Potential drug target		MATVRVQADDFDVSAEIAALRARNPKVGAIACFVGTVRDLNEGEQIDALELEHYPGMTEKALAAIAEDAIARWPGIDVAIVHRVGKLYPLDQIVFVATVSAHRGDAFQSCEFVMDYLKTQAPFWKKEKTPAGERWVDARSADDAALARWGVESGNAREKRST*		163	18	6	Mass spec verified	-1	 	NR-13774
Batch01a	BupsA.00100.a	Burkholderia pseudomallei	YP_334856	Q3JNJ7				"L-arabinose ABC transporter, periplasmic L-arabinose-binding protein "	Potential drug target		MKRRTFITLAAAATVAAAGLPAQAAEPVKIGFLVKQPEEPWFQDEWKFAELAAKDKGFTLVKIGAPSGEKVMSAIDNLAAQKAQGFIICTPDVKLGPGIVAKAKSHGLKMMTVDDRLVDGAGKPIESVPHMGISAYDIGKQVGGGIAAEIKRRGWNMNEVGAIDITYEQLPTAHDRTTGATDALVAAGFPKANVIAAPQAKTDTENAFNAANIALTKNPKFKHWVAYGLNDEAVLGAVRAAEGRGFKAADMIGIGIGGSDSALSEFKKPQPTGFFGTVIISPKRHGEETSELMYAWITQGKAPPPLTLTTGMLATRENVAQVRETMGLAAK*		332	35	5	Purified	-1	 	NR-13775
Batch01a	BupsA.00101.a	Burkholderia pseudomallei	YP_334027	Q3JQX6				ferredoxin--NADP reductase 	Potential drug target		MSANAHETVLSVHHWNDTLFSFKTTRAPGLRFKTGQFVMIGLEIDGRPLMRAYSVVSAHYDDHLEFYSIKVPDGPLTSRLQHLRAGDKLLVAGKPTGSLIIDNLRPGKHLYLLSTGTGLAPFISVIRDPDYYGAFDKIVLMHGVRWKSELGYFDHITTELPENAYFGDLVRDKLIYYPSVTRETFERQGRLTELIESGKLFDDVGLPPLDPAVDRAMVCGGPSMLADLVEMLERRGFVEGTSHAPGDYVIERAFVEK*		258	29	4	Soluble	-1	 	
Batch01a	BupsA.00102.a	Burkholderia pseudomallei	YP_334635	Q3JP68				2-dehydro-3-deoxyphosphooctonate aldolase 	Potential drug target		MNVAISPGVTAGNSLPFVLFGGINVLESLDFTLDVCGEYVAVTRKLGIPFVFKASFDKANRSSIHSYRGVGLDEGLKIFAEVKARFGVPVITDVHEAEQAAPVAEIADVLQVPAFLARQTDLVVAIAKAGKPVNVKKPQFMSPTQLKHVVSKCGEVGNDRVMLCERGSSFGYDNLVVDMLGFRQMAETTGGCPVIFDVTHSLQCRDPLGDASGGRRRQVLDLARAGIAVGIAGLFLEAHPDPDRARCDGPSALPLHQLEGLLSQMKAIDDLVKRMPALEIR*		282	30	7	Crystallized	-1	 	
Batch01a	BupsA.00103.a	Burkholderia pseudomallei	YP_334945	Q3JNA8				uracil-DNA glycosylase 	Potential drug target		MTKPSSPRPMPQPSLFDDHTPPAPPAVQGGASALTLESQFDALPPDWRAIVEPFVASDAYAPLCRFVDGERAAGKAIYPADVFRALRLTHPDDVKVVILGQDPYHGEDRDIPQAHGLAFSVPPGVRPPPSLRNIFKEISADFGYETPRHGCLDTWARQGVLLLNTVLTVERAAAASHAKRGWEKCTDTLIHELATRHRHLVFMLWGAHAQAKRALFDAREHCVLEAPHPSPLSAHRGFLGCRHFALANDYLVQHGRAPIDWRLPDEAETLA*		272	30	1	Selected	-1	 	
Batch01a	BupsA.00104.a	Burkholderia pseudomallei	YP_337703	Q3JFF0				beta-lactamase 	Potential drug target		MPDSRPFNLPAIRLMNHSPLRRSLLVAAISTPLIGACAPLRGQAKNVAAAERQLRELESTFDGRLGFVALDTATGARIAHRGDERFPFCSTSKMMLCAAVLARSAGEPALLQRRIAYAKGDLIRYSPITEQHVGAGMSVAELCAATLQYSDNTAANLLMALLGGPQAVTAYARSIGDATFRLDRREPELNTALPGDERDTTTPAAMAASVHRLLVGDALGAAQRAQLNAWMLGNKTGDARIRAGVPADWRVADKTGTGDYGTANDIGVAYPPNRAPIVFIVYTTMRNPNAQARDDVIASATRIAARAFA*		310	33	5	Purified	-1	 	"NR-16700, NR-16701, NR-16702, NR-16703, NR-16704"
Batch01a	BupsA.00105.a	Burkholderia pseudomallei	YP_335488	Q3JLR5				beta-lactamase 	Potential drug target		MNSAFDAPASAAAAAFPPADDAALAARLDRVLGAALGERRIVGAVALAARHGRLVYRRAHGLAERETQRPMREDTLFRLSSITKPIVTVAVLRLVADGRMALDAPITRWLPDFAPALPDGRAPALSVHQLLTHTAGLSYWLLEAPGSAYHTLGVSDGIDLVDFDLAENLRRIAAAPLAFEPGSAWRYSLALDVLGAAIERETGRALPDAVARLVTTPLGMHDTGFVAADPARFAVAYANAAPEPARITDNLDVPLPEGHGVAVRFAPSRVFDATAFASGGAGMYGSADDVLRVLETIRTGGDGFLPAALVAAMRTDHTGPAAGTRGPGWGFGYGGAVLSDPALAQSPQSAGTLQWGGVYGHSWFVDAARGLTVLLMTNTAYEGMSGPLTLEVRDAVYGV*		400	42	4	Soluble	-1	 	
Batch01a	BupsA.00107.a	Burkholderia pseudomallei	YP_332430	Q3JVH3				"efflux transporter, RND family, MFP subunit subfamily "	Potential drug target		MRVERVPYRLITVATAAVFLAACGKKESAPPPQTPEVGVVTVQPQSVPVVSELPGRTSAYLVAQVRARVDGIVLRREFTEGSDVKAGQRLYKIDPAPYIAQLNSAKATLAKAQANLATQNALVARYKVLVAANAVSKQQYDDAVAAQGQAAADVGAGKAAVETAQINLGYTDVVSPITGRVGISQVTPGAYVQASQATLMSTVQQLDPVYVDLTQSSLDGLKLRQDIQSGRIKTEGPGAAKVTLILEDGKPYPERGKLQFSDVTVDQTTGSVTIRAIFPNKQRVLLPGMFVRARIEEGVNENAFLVPQIGVTHDPKGQAIAMIVDGKGKVEPRVLVTGGTQGQNWVVESGLQAGDRVIVQGIDKVRPGMTVKAAEAQLPAAAAGASGAAPAGGSPAQAAAASAAASGAAPSSAAAASSAQ*		421	43	0	Target Approved	-1	 	
Batch01a	BupsA.00108.a	Burkholderia pseudomallei	YP_332194	Q3JW59				single-strand DNA-binding protein 	Potential drug target		MASVNKVILVGNLGADPEVRYLPSGDAVANIRLATTDRYKDKASGEFKEMTEWHRVAFFGRLAEIVNEYLKKGSSVYIEGRIRTRKWQGQDGQDRYSTEIVADQMQMLGGRGGSGGGGGGGDDGGYGGGGGGYGGGRDMERGGGGGRASGGGGAGARSGGGGGGASRPSAPAGGGFDEMDDDIPF*		186	19	7	Crystallized	-1	 	
Batch01a	BupsA.00109.a	Burkholderia pseudomallei	YP_337486	Q3JG17				cytosine deaminase 	Potential drug target		MKLINATLRKRSGLFSIVLDGGAIASVTPQPARVDAPHAPRADVIDADGKLVIPPLVEPHIHLDAVLTAGEPEWNMSGTLFEGIERWAQRKATITHEDTKARAHAAIGMLRDHGIQHVRTHVDVTDPSLAALKAMLEVKDEARGLIDLQIVAFPQEGIESFDGGRALMERAIEVGADVVGGIPHFENTREQGVSSIRFLMDLAERSGCLVDVHCDETDDPNSRFLEVLAEEARVRGIGARVTASHTTAMGSYDNAYCSKLFRLLKRSQINFISCPTESIHLQGRFDTFPKRRGLTRVAELDRAGMNVCFGQDSIRDPWYPLGNGNILRALDAGLHICHMMGYQDLARSLDFVTEHSARAMHLGERYGIEPGRPANLVVLDASDDYEALRRQAKALLSIRGGEVIMRRVPERIAYPAAR*		419	46	11	Native diffraction-data	-1	 	
Batch01a	BupsA.00110.a	Burkholderia pseudomallei	YP_334545	Q3JPF8				Rubredoxin 	Potential drug target		MQRANATRGRLLGSAPPTRYHHGSQINGLSFTRLKMEYKSWMCLICGWIYDEEAGLPEEGIAPGTRWEDVPINWTCPECGARKEDFEMVQI*		92	10	5	Purified	-1	 	NR-13776
Batch01a	BupsA.00112.a	Burkholderia pseudomallei	YP_334688	Q3JP15				3-methyl-2-oxobutanoate hydroxymethyltransferase 	Potential drug target		MTVPKLQAMREAGEKIAMLTSYDASFAALLDRANVDVQLIGDSLGNVLQGQATTLPVTLDDIAYHTACVARAQPRGLVVADLPFGTYGTPADAFASAVKLMRAGAQMVKLEGGEWLAETVRFLVERAVPVCAHVGLTPQSVHAFGGFKVQGKTEAGAAQLLRDARAVEEAGAQLIVLEAVPTLVAAEVTRELSIPTIGIGAGAECSGQVLVLHDMLGVFPGKRPRFVKDFMQGQPSIFAAVEAYVRAVKDGSFPGPEHSF*		261	27	17	In PDB	5	Target selected for ligand screening 	
Batch01a	BupsA.00114.a	Burkholderia pseudomallei	YP_332076	Q3JWH7				phosphoglyceromutase 	Potential drug target		MYKLVLIRHGESTWNKENRFTGWVDVDLTEQGNREARQAGQLLKEAGYTFDIAYTSVLKRAIRTLWHVQDQMDLMYVPVVHSWRLNERHYGALSGLNKAETAAKYGDEQVLVWRRSYDTPPPALEPGDERAPYADPRYAKVPREQLPLTECLKDTVARVLPLWNESIAPAVKAGKQVLIAAHGNSLRALIKYLDGISDADIVGLNIPNGVPLVYELDESLTPIRHYYLGDQEAIAKAQAAVAQQGKSAA*		250	28	17	In PDB	17	Ligand-bound structure submitted to PDB	
Batch01a	BupsA.00115.a	Burkholderia pseudomallei	YP_332531	Q3JV72				deoxyuridine 5'-triphosphate nucleotidohydrolase 	Potential drug target		MKLDLKILDARMRDYLPKYATTGSAGLDLRACLDAPVTLKPGDTALVPTGLAIHLADPGYAALILPRSGLGHKHGIVLGNLVGLIDSDYQGELMISTWNRGQTEFALNPFERLAQLVIVPVVQARFNLVDDFAQSERGAGGFGSTGRG*		149	16	7	Crystallized	-1	 	
Batch01a	BupsA.00116.a	Burkholderia pseudomallei	YP_332286	Q3JVW7				4-hydroxythreonine-4-phosphate dehydrogenase 	Potential drug target		MSDRPQPLRIAITTGEPAGVGPELTARALADAATRWPDARFTVLGDASLIAARAAAVGLDWTRMTAAGGGAHVANAHVANAHVAVAHRALAAPAEAGKLNPANGRYVLDLLDAAIDGALAGEYDAIVTAPLQKSTINDAGVPFTGHTEYLAERTRTPHVVMMLAGTGERPLRVALATTHLPLRDVSAALTIDGLADTLSIIDRDLRGSFGLAAPRILVTGLNPHAGEHGYLGREEIDVIEPALERARAAGIDARGPYPADTLFQPRYLEHADCVLAMFHDQGLPVLKYATFGEGINVTLGLPIIRTSVDHGTALDLAGTGRADPGSLVAAIDTAVTMARHRRAG*		345	36	3	Expressed	-1	 	
Batch01a	BupsA.00117.a	Burkholderia pseudomallei	YP_336145	Q3JJV8				"catechol 1,2-dioxygenase "	Potential drug target		MNKEAIDALLKSFDDAATRPGNPRVRAIVNRIVKDLFYTIEDCDVQPSEFWTALNYLNDAGKEFGLIAAGLGFERFLDVRMDEAEAKAGLQGGTPRTIEGPLYVAGAPESVGHARLDDGTDPGETLVMRGRVLGGNGAPLANALVEVWHANHLGNYSYFDPSQPAFNLRRSIRTDAEGRYSFRSVLPVGYSVPPGSKTEQLLDQLGRHGHRPAHIHFFVSAPGHRKLTTQINIEGDPHIWDDFAFATREGLIPKIAQAEGAQGKPYGIDGRFALIDFDFTLTRERGDVPASEVERVRAQA*		301	33	3	Expressed	-1	 	"NR-16705, NR-16706, NR-16707, NR-16708"
Batch01a	BupsA.00118.a	Burkholderia pseudomallei	YP_334534	Q3JPG9				glucose-1-phosphate thymidylyltransferase 	Potential drug target		MGRNELRATRVKVEPMARKGIILAGGSGTRLYPITHAVSKQLLPVYDKPMIYYPLSTLMVADIRDVLIISTPQDTPRFEAMLGDGSQWGMNIRYAVQPSPDGLAQAFVIGREFVGRDPSTLILGDNIFYGHDLAKQLDRASARQAGATVFAYHVHDPERYGVVEFDGEFRALSIEEKPAKPRSNYAVTGLYFYDNQVCDIAADIKPSARGELEITDVNSRYLAAGLLDVEIMGRGYAWLDTGTHDSLIEAATFIATLQKRQGLVVACPEEIAYRRQWIDAEQLLKLAQPLSKNGYGQYLKNILTDQVAWPSK*		313	35	4	Soluble	-1	 	
Batch01a	BupsA.00119.a	Burkholderia pseudomallei	YP_334912	Q3JNE1				D-alanine--D-alanine ligase B 	Potential drug target		MSGIDPKRFGKVAVLLGGDSAEREVSLNSGRLVLQGLRDAGIDAHPFDPAQRPLAALKDEGFVRAFNALHGGYGENGQIQGALDFYGIRYTGSGVLGSALGLDKFRTKLVWQQTGIPTPPFETVMRGDDYAARAQDIVAKLGVPLFVKPASEGSSVAVEKVKSADALPAALEEAAKHDKIVIVEKSIEGGGEYTACIAADLDLPLIRIVPAGEFYDYHAKYIANDTQYLIPCGLDAAKEAEFKRIARRAFDVLGCTDWGRADFMLDAAGNPYFLEVNTAPGMTDHSLPPKAARAVGIGYSELVVKVLSLTLD*		313	33	11	Native diffraction-data	-1	 	NR-13778
Batch01a	BupsA.00120.a	Burkholderia pseudomallei	YP_334893	Q3JNG0				"GTP-binding protein, GTP1/OBG family "	Potential drug target		MKFIDEARIEVIAGDGGDGSASMRREKFVPFGGPDGGDGGRGGSVYVIADRNINTLIDYRYAKKHMARNGENGRGSDCYGKGGDDITLRMPVGTVINDMDTGELIADLTEHDQKVLVAKGGAGGLGNLHFKSSTNRAPRQKTDGKPGERRMLKLELKVLADVGLLGMPNAGKSTFISSVSNAKPKIADYPFTTLAPNLGVVRVGPGKSFVIADIPGLIEGAAEGAGLGHQFLRHLQRTGLLLHLVDLAPFDERVDPVAEARAIVGELRKYDESLYEKPRWLVLNKLDMVPEDERRARVADFIERFGWTGPVFEISALTGQGCEGLVYAIHDYLVEHSDAHRAELAEDLASDVRFRDAPGAGGEPHERDAGAH*		373	40	3	Expressed	-1	 	"NR-16709, NR-16710, NR-16711"
Batch01a	BupsA.00122.a	Burkholderia pseudomallei	YP_333903	Q3JRA0				"2C-methyl-D-erythritol 2,4-cyclodiphosphate synthase "	Potential drug target		MDFRIGQGYDVHQLVPGRPLIIGGVTIPYERGLLGHSDADVLLHAITDALFGAAALGDIGRHFSDTDPRFKGADSRALLRECASRVAQAGFAIRNVDSTIIAQAPKLAPHIDAMRANIAADLDLPLDRVNVKAKTNEKLGYLGRGEGIEAQAAALVVREAAA*		163	17	17	In PDB	17	Ligand-bound structure submitted to PDB	NR-13779
Batch01a	BupsA.00124.a	Burkholderia pseudomallei	YP_335055	Q3JMZ8				imidazoleglycerol-phosphate dehydratase 	Potential drug target		MRVAQVVRNTSETQISVKIDLDGTGRQKLATGVPFLDHMLDQIARHGLVDLDIEANGDTHIDDHHTVEDVGITLGQAVAKAVGDRKGIRRYGHSYVPLDEALSRVVIDFSGRPGLEFHVPFTRARIGTFDVDLSIEFFRGFVNHAGVTLHIDNLRGVNAHHQLETVFKAFGRALRMAVELDERAAGQIPSTKGSL*		196	21	7	Crystallized	-1	 	NR-13780
Batch01a	BupsA.00125.a	Burkholderia pseudomallei	YP_331490	Q3JY63				chemotaxis protein methyltransferase 	Potential drug target		MPARAASRLDAPEPQERSGDAARDFEFTSADFTKIRALIHRRAGISLSEHKRDMAYSRLARRLRARGLNRFCDYLELLERENDPSEWEAFTNSLTTNLTAFFRESHHFPILAEFVKRREQPVSVWCSAASTGEEPYSIAMTLVEALGESAARSASVIATDLDTQVLAKADAGVYAFEQVKHLSPERLKRFFLKGTGAQAGRVKVRPELRAMIRFAQLNLTDADYGLTKPFDAIFCRNVMIYFDKPTQSQVLARFEPLMKPGGLLFAGHSENFTYVTQAFRLRGQTVYELTRDGQSAAPRVRARIAAAAAEEELR*		315	35	2	Cloned	-1	 	
Batch01a	BupsA.00126.a	Burkholderia pseudomallei	YP_332614	Q3JUY9				aspartate 1-decarboxylase precursor 	Potential drug target		MQRHMLKSKIHRAAVTHCELHYEGSCAIDEDLLEAANIVENERIDIWNVNNGERFSTYAIKGERGSGMISLNGSAARRAQLGDLVIIAAFAMIDEQELKAGWKPDLVFVDEDNKIKGSRDHVPTQNWT*		129	14	2	Cloned	-1	 	
Batch01a	BupsA.00127.a	Burkholderia pseudomallei	YP_333607	Q3JS46				NIPSNAP superfamily 	Potential drug target		MFYEIRTYRVKTGAVLAYLKLVEEEGIELQKRYLGQLVGYFHSEIGPLNQIVHIWAYPSLDERERRRAALVEDPAWRVFAPKIQALMEEMESKIMRPAAFSPLK*		105	12	5	Purified	-1	 	
Batch01a	BupsA.00129.a	Burkholderia pseudomallei	YP_334247	Q3JQA6				pyridoxal kinase 	Potential drug target		MRESHVSFDVIRRARRAPAHSIMKNVLSIQSHVIYGHAGNSAAVFPMQRLGVNVWPLNTVQLSNHMQYGHWAGSAIDAAKMEQLVDGIAAIGALKRCDAVLSGFLGSPAQARAAVEIVRTVKATNPNAWYFCDPAMGQTGGIRPEPGVEEFIVAELPELADGMAPNHSELQKLAGQRIETVAEAVAACRLIIRRGPQVILVKHLHDRNSPADRFNMLVVTETEAWIGQRPLYAFPRHPVGVGDLTSAIFVARRLRGDSVRAAFEHTLAAVHAVVKATYDARRYELELVAAQDEIARPSEWFGAWVTGAD*		310	34	4	Soluble	-1	 	
Batch01a	BupsA.00130.a	Burkholderia pseudomallei	YP_336065	Q3JK38				peptidyl-prolyl cis-trans isomerase 	Potential drug target		MTVVTTESGLKYEDLTEGSGAEARAGQTVSVHYTGWLTDGQKFDSSKDRNDPFAFVLGGGMVIKGWDEGVQGMKVGGVRRLTIPPQLGYGARGAGGVIPPNATLVFEVELLDV*		114	12	17	In PDB	17	Ligand-bound structure submitted to PDB	NR-13781
Batch01a	BupsA.00131.a	Burkholderia pseudomallei	YP_334273	Q3JQ80				pyridoxal phosphate biosynthetic protein 	Potential drug target		MSFFLTTPAAIDLGVNIDHVATLRNARGTAYPDPVRAALAAEDAGADAITLHLREDRRHIVDADVRTLRPRVKTRMNLECAVTPEMLDIACEIRPHDACLVPEKRSELTTEGGLDVVGHFDAVRAACKQLADAGVRVSLFIDPDEAQIRAAHETGAPVIELHTGRYADAHDAAEQQREFERIATGVDAGIALGLKVNAGHGLHYTNVQAIAALPGIAELNIGHAIVAHAVFVGWDNAVREMKAIMVAARVAALHGGR*		258	28	17	In PDB	-1	 	NR-13782
Batch01a	BupsA.00133.a	Burkholderia pseudomallei	YP_334067	Q3JQT6				cysteinyl-tRNA synthetase 	Potential drug target		MESLRIYNTLARDKQDFVPRQPGEVRMYVCGITVYDYCHIGHARMVVVFDIVQRWLRARGYRVTYVRNITDIDDKIIRRAVENGETIQSLTRRFTDAMNADFDALGVERPDLEPRATEFIPQMLGMIEKLEANGYAYQAKDGDVNYSVRKFANYGRLSGKSLEDLRAGERVAANDAKEDPLDFVLWKRAKPQEPAGASWESKYGAGRPGWHIECSAMGCTLLGAHFDIHGGGQDLQFPHHENEIAQSEGATGQTFVNYWMHNGFVQVDSEKMSKSLGNFFTIREVLEKFDAEVVRFFIVRTHYRSPLNYSDVHLDDARASLTRLYTALKDATPDAQPLDWSEAHAQRFAAAMNDDFNTAVAVAVLFELATEVNRTREPALARQLRLLAGLLGLLGREPREFLQHAAGAARTGALEPHEIEARIAARVAAKQAKNYAEADRIRAELLEAGIALEDKPGGSTEWRRV*		466	52	5	Purified	-1	 	
Batch01a	BupsA.00134.a	Burkholderia pseudomallei	YP_331434	Q3JYB9				4-hydroxyphenylpyruvate dioxygenase 	Potential drug target		MQIPTWDNPVGTDGFEFIEYTAPDPKALGQLFERMGFTAVARHRHKDVTLYRQGDINFIINAEPDSFAQRFARLHGPSICAIAFRVQDAAKAYRHALELGAWGFDNKTGPMELNIPAIKGIGDSLIYFVDRWRGKNGAKPGAIGDISIYDVDFEPIPGADPNPAGHGLTYIDHLTHNVHRGRMQEWAEFYERLFNFREVRYFDIEGKVTGVKSKAMTSPCGKIRIPINEEGSDTAGQIQEYLDAYRGEGIQHIALGAADIYRAVDGLRAKGVTLLDTIDTYYELVDRRVPNHGEPLDELRKRKILIDGAHDDLLLQIFTENQIGPIFFEIIQRKGNQGFGEGNFKALFESIELDQIRRGVVQDKA*		366	41	7	Crystallized	-1	 	
Batch01a	BupsA.00137.a	Burkholderia pseudomallei	YP_335115	Q3JMT8				30S ribosomal protein S4 	Potential drug target		MARYIGPKAKLSRREGTDLFLKSARRSLADKCKLDSKPGQHGRISGARTSDYGTQLREKQKVKRIYGVLERQFRRYFAEADRRKGNTGETLLQLLESRLDNVVYRMGFGSTRAEARQLVSHKAITVNGIVANIPSQQVKAGDVVAIREKAKKQARIVEALSLAEQGGMPSWVAVDAKKFEGTFKQVPERADIAGDINESLIVELYSR*		208	23	-2	Work Stopped	-2	Work Stopped	
Batch01a	BupsB.00011.a	Burkholderia pseudomallei	EDO94351	A8KUM1  				cell division protein FtsZ	Potential drug target		MEFEMLETETNGTIIKVIGVGGAGGNAVQHMINKGVQGVDFVVMNTDAQALSRSRAPSVIQLGNTGLGAGAKPEMGRAAAEEARERIADALRGAHMVFITAGMGGGTGTGAAPVVAQIAKEMGILTVGVVSKPFEFEGGKRMRVAEAGSQQLEDHVDSLIVVLNDKLFEVMGDDAEMDKCFQCADDVLNNAVAGIAEIINVDGLVNVDFEDVKTVMGEQGKAMMGTATVAGVDRARLAAEQAVASPLLEGVDLSGARGVLVNITSSRSLRLSETREVMNTIKSYAADDATVIFGAVYDDAMGDALRVTVVATGLGRAAKKQQSAPMTLLRTGTDNQPISAAPQGYAASHHVSTGDYGAFDTPAVWRNSRETAASHVQALQEKGVDTYDIPAFLRKQAD*		399	42	5	Purified	-1	 	
Batch01a	RiprA.00002.a	Rickettsia prowazekii	NP_220583	Q9ZDX0				"2,3,4,5-tetrahydropyridine-2-carboxylate n-succinyltransferase (dapD) "	Potential drug target		MSYIIKEIEEAWQIKENILHDSSKLIKLKKILNESIASLNQGIIRVCEKQGNQWKVNEWVKKAILLYFITTESQLYNNNYNSWYDKVAPKFPADTDKNIFKEAAIRKVPGAIVRTGTYIAKNVVIMPSFINIGAYIDEGTMIDTWATIGSCAQIGKNCHISGGAGIGGVLEPLQAKPVIIEDNCFVGARSEIAEGVIVEEGSVISMGVFIGSSTKIVYRDTGEIIYGRIPAYSVVVPGILPPPEVGKPGLYCVVIVKQVDKTTRGKVSINDLLR*		275	30	7	Crystallized	-1	 	NR-13786
Batch01a	RiprA.00003.a	Rickettsia prowazekii	NP_221104	Q9ZCI8				50S ribosomal protein L27 	Potential drug target		MATKKAGGSSRNGRDSAGRRLGVKKSDGQYVIPGNIIVRQRGTKIHPGINVGLGKDHTIFSLIEGRVEFLTKQSHKIVNVKEIANV*		87	9	-2	Work Stopped	-2	Work Stopped	
Batch01a	RiprA.00004.a	Rickettsia prowazekii	NP_220620	Q9ZDU0				30S ribosomal protein S9 	Potential drug target		MTELKIKTEKVVKQLTKESLKSVLKIPKEKIDSVSKFYATGKRKNAIARVWLKVGKGKIVVNNKILNQYFPSETYVKTILQPFILTKTIDQYDVICTVKGGGISGQKGAILHGISKALDKSAPCFHAILRKGGLLTRDSRVVERKKYGQRKARKKTQFSKR*		162	18	-2	Work Stopped	-2	Work Stopped	
Batch01a	RiprA.00008.a	Rickettsia prowazekii	NP_221095	O08370				serine hydroxymethyltransferase 	Potential drug target		MNILNNNLYEMDKEIYEIIKNEKIRQNNVIELIASENFVSSAVLEAQGSILTNKYAEGYPSKRFYNGCDEVDKAEVLAIERIKKLFNCKYANVQPHSGSQANQTVYLALLQPCDTILGMSLDSGGHLTHGAAPNISGKWFNTVSYHVDQETYLIDYDEVERLAVLHNPKLLIAGFSAYPRKIDFAKFRKIADKVGAYLMADIAHIAGLVATGEHQSPIPYAHVVTSTTHKTLRGPRGGLILSDDEEIGKKINSALFPGLQGGPLMHIIAAKAVAFLENLQPEYKNYIKQVISNAKALAISLQERGYDILTGGTDNHIVLVDLRKDGITGKCAANSLDRAGITCNKNAIPFDTTSPFITSGIRFGTPACTTKGFKEKDFVLIGHMVAEILDGLKHNEDNSKTEQKVLSEVKKLMKLFPFYD*		421	46	7	Crystallized	-1	 	NR-13787
Batch01a	RiprA.00011.a	Rickettsia prowazekii	NP_221028	Q9ZCQ3				cell division protein FtsZ	Potential drug target		MVLNIKAPENIVLKPTITVFGVGGAGSNAVNNMIHANLQGANFVVANTDAQSLEHSLCINKIQLGVSTTRGLGAGASPEVGALAAQESENEIRSSLENSNMVFITAGMGGGTGTGSAPIIARIAKELGILTVGVVTKPFHFEGGHRMKTADKGLIELQQFVDTLIVIPNQNLFRIANEQTTFADAFKMADDVLHAGVRGVTDLMIMPGLINLDFADIKAVMSEMGKAMMGTGEDSGEDRAIKAAESAISNPLLDHSSMCGARGVLINITGGPDMTLFEVDNAANRIREEVDNIDANIIFGSTFNPELKGIIRVSVVATGIDADKVPKYKLAIDKNTNTLPEETYNESIIQHTQIETIPSFNSYSTENIEINESSIKQDYTGNEQELRLHVNAVNKPENNSQKSSFLGKIWESLRTSNNQTLERKNVIVNTVDQDNKESDIHDIPAFLRKKRD*		453	49	3	Expressed	-1	 	
Batch01a	RiprA.00013.a	Rickettsia prowazekii	NP_220767	Q9ZDE5				Holliday junction DNA helicase RuvB 	Potential drug target		MTNILSPEKSEHDQELPIRPSYLKEFVGQQQIKENLLVFIKAAKSRNEHLDHTLFYGPPGLGKTTLAKIISNEIGGNFKSTAGPAIIKAADLASILTNLEKNDVLFIDEIHRLNTLVEEVLYSAMEDFELDIIIGEGSAARPVKITLPKFTLIGATTRFGLISNPLRDRFGIPMRLNFYNTEELKQVLNRASKLLDIDLTDSGSEEIAKRSRGTPRIALRLLRRIRDFAVVDGKSRIDKEICDFGLKRLTVDSIGLDSNDYRYLKFIADNYHGGPVGIETIAAALSEQRDELEETIEPYLIKIGLVKRTPRGRVITIAAFEHLKMPIPNKSQNQLNILNENE*		343	38	5	Purified	-1	 	"NR-16712, NR-16713, NR-16714, NR-16715, NR-16716"
Batch01a	RiprA.00015.a	Rickettsia prowazekii	NP_221024	P48850				30S ribosomal protein S10 	Potential drug target		MKNKIKIRLKSFDHRSLDQATKEIVSAVKRTFATINGPIPLPRKIERFTVNRSPHVHKKSREQFEIRKHKRLLVIDDPNPAVVDALSKVDLAAGVDVVIELESGE*		106	12	-2	Work Stopped	-2	Work Stopped	
Batch01a	RiprA.00023.a	Rickettsia prowazekii	NP_220958	Q9ZCW5				inorganic pyrophosphatase 	Potential drug target		MFIKKIKAKANNNEINVIIEIPMNSGPIKYEFDKESGALFVDRFMQTTMSYPCNYGFIPDTLSNDGDPVDVLVVAHHPVVPGSVIKCRAIGVLMMEDESGLDEKIIAVPTSKLDITFDHIKELDDLCEMLKKRIVHFFEHYKDLEKGKWVKVTGWGDKVKAETLIKEGIDRN*		173	20	17	In PDB	10	Experimental evidence of bound ligand(s)	NR-13788
Batch01a	RiprA.00029.a	Rickettsia prowazekii	NP_220398	Q9ZEE0				thioredoxin (trxA) 	Potential drug target		MSCYNEITTLLEFDSNDINTTQRINMVNNVTDSSFKNEVLESDLPVMVDFWAEWCGPCKMLIPIIDEISKELQDKVKVLKMNIDENPKTPSEYGIRSIPTIMLFKNGEQKDTKIGLQQKNSLLDWINKSI*		131	15	8	HSQC	-1	 	NR-13789
Batch01a	RiprA.00030.a	Rickettsia prowazekii	NP_221053	Q9ZCN1				ATP-dependent protease ATP-binding subunit 	Potential drug target		MVVDADKKELICSFCSKKQHEVKKLIAGPAVFICDECIDLCTDIMKEESKVALKQITASIPTPQKICKILNDYVVGQDQAKKILAVAVYNHYKRLEYVQSGNNDVELNKSNILLIGPTGSGKTLLAQTLAKILDVPFTMADATSLTEAGYVGEDVENILLRLLISAEFNIAKAQKGIIYIDEVDKIARKSDNPSITRDVSGEGVQQALLKIMEGTVASVPPQGGRKHPQQDFVQLDTSNILFICGGAFMGIDRIIRSRTNHSSIGFAANINIDKEKSNNEILKSLEIEDLTKFGLIPEFIGRLPIITTLDELDKEALITILTKPKNAIVKQYQKQFELDDADLVIDYSALEAIAEKALVKKTGARGLRSILEHLLLDSMYKVAELKKQRVTITKEVVDGLIEPCMTSIISTKLNKKQPIIEDIPA*		426	47	5	Purified	-1	 	
Batch01a	RiprA.00037.a	Rickettsia prowazekii	NP_221145	Q9ZCF8				NADH dehydrogenase subunit I 	Potential drug target		MINYLKSFFLYEIIRGMTLTLKYFFKPKVTINYPYEKSPVSPRFKGEHALRRYENGEERCIACKLCEAICPAQAIVIESDERDDGSRRTTRYDIDMTKCIYCGLCQEACPVDAIVEGPNFEFASLTHTALIYDKERLLNNGDKWEQALANKLHKDYQYR*		160	19	3	Expressed	-1	 	"NR-16717, NR-16718, NR-16719, NR-16720, NR-16721, NR-16722"
Batch01a	RiprA.00039.a	Rickettsia prowazekii	NP_221173	Q9ZCD3				methionine aminopeptidase 	Potential drug target		MTIKIHTEKDFIKMRAAGKLAAETLDFITDHVKPNVTTNSLNDLCHNFITSHNAIPAPLNYKGFPKSICTSINHVVCHGIPNDKPLKNGDIVNIDVTVILDGWYGDTSRMYYVGDVAIKPKRLIQVTYDAMMKGIEVVRPGAKLGDIGYAIQSYAEKHNYSVVRDYTGHGIGRVFHDKPSILNYGRNGTGLTLKEGMFFTVEPMINAGNYDTILSKLDGWTVTTRDKSLSAQFEHTIGVTKDGFEIFTLSPKKLDYPPY*		260	29	17	In PDB	-1	 	NR-16345
Batch01a	RiprA.00045.a	Rickettsia prowazekii	NP_221085	Q9ZCJ9				DNA polymerase III subunit epsilon 	Potential drug target		MSSLREIILDTETTGLDPQQGHRIVEIGAIEMVNKVLTGKHFHFYINPERDMPFEAYKIHGISGEFLKDKPLFKTIANDFLKFIADSTLIIHNAPFDIKFLNHELSLLKRTEIKFLELTNTIDTLVMARNMFPGARYSLDALCKRFKVDNSGRQLHGALKDAALLAEVYVALTGGRQSTFKMINKPDEINNLAVKCVDVQQIKRGIVVKPTKEELQKHKEFIDKILIQA*		230	26	5	Purified	-1	 	
Batch01a	RiprA.00047.a	Rickettsia prowazekii	NP_221027	Q9ZCQ4				fumarate hydratase 	Potential drug target		MKNYRIESDSFGEIQIEEKFYWGAQTQRSLNNFKISKQKMPKILIRALAILKKCAAQVNYEFGDLEYKIATSIDKAIDRILAGEFEDNFPLVVWQTGSGTQTNMNMNEVIASIANEELTGKKGGKFPVHPNDHVNKGQSSNDSFPTAMHIATVLATKQQLIPALNNLLTYLQDKSKDWDKIIKIGRTHLQDATPLTLKQEFSGYITQIEYALERIEDALKKVYLLAQGGTAVGTGINSKIGFDIKFAQKVAEFTQQPFKTAPNKFESLAAHDALVEFSGTLNTIAVSLMKIANDIRLLGSGPRCGLGELHLPENEPGSSIMPGKVNPTQVEALTMVCTQVMGNHVTVTIAGSNGHLELNVFKPVIIYNILQSIELLSDSVNSFVTHCVKGLEPNIARINTLRDKSLMLVTVLNPHIGYDNAAKIAKEAHKYGITLKEAAKKLNFLSEEEFDKIVVPEKMIS*		462	51	17	In PDB	-1	 	
Batch01a	RiprA.00053.a	Rickettsia prowazekii	NP_220703	Q9ZDK8				ATP-dependent protease ATP-binding subunit 	Potential drug target		MKSTETTYKKDNMGLTPSQIVNELNRFIVGQDKAKKAVAIALRNRYRRKRVEGNLRNEIVPKNILMIGSTGVGKTEIARRLAKLTNSPFYKIEATKFTEVGYVGRDVESIIRDLVEIAVNTEKALAKIAVDINAREKAIERILDSLVGKTSSSETREKFKAKVLNGELDDTEIEISVADTTPVGGGGFEIPCIPGASMGVLNLGDMIGRALGNSKTKTKKMLIKDAMTVIIPEESEKLIDQEKIIQKAINLAENDGIVFIDEIDKIASTSNAGAKNAEISREGVQRDLLPLIEGTTVNTKYGPVKTDHILFIASGAFHIAKPSDLLPELQGRLPIRVELNLLTKDDMIKILLEPETSLIKQYSALIGTEEVHLEFTDAAIEKIADYAITVNLEVEDIGARRLHTILENLLEDISFEASEMKVKKIIIDDKFVENQLSKIITNLDLAKFVL*		451	50	10	Diffraction	-1	 	
Batch01a	RiprA.00069.a	Rickettsia prowazekii	NP_221113	P41079				recombinase A 	Potential drug target		MSNIDKERAIAAALAQIEKSYGKGSVMKLGQRPNVDIEAISTGSLGLDIALGIGGVPKGRIIEIFGPESSGKTTLTLHLIAESQKKGGTCAFIDAEHALDPAYAKKLGVNIDELIISQPDTGEQALEIADTLIRSGGIDMIIIDSVAALVPKSEIEGEMGDAQMASQARLMSQALRKLTASINRTNCITVFINQIRMKIGVMFGSPETTTGGNALKFYASVRIDIRRIGSIKDKEEVIGSQTKVKVVKNKVSPPFKTADFDIMYGSGISKEGEIIDLGVKLEIIEKSGSWFSYNKIRIGQGRENVKQYLKEHPQISNEIEKIIREKSSAITNINLDQTEE*		341	37	5	Purified	-1	 	
Batch01a	RiprA.00075.a	Rickettsia prowazekii	NP_220912	Q9ZD11				delta-aminolevulinic acid dehydratase 	Potential drug target		MYPLIRFRRNRKALWLRELIAESNLSISDLVLPLFVVEGHNEMQEIKTMPGIYRLSIDQIVETAKKAADFGINAIALFPSIDHSLKSDNADEAYNLDNLICRTIIKIKNANIDIGIICDVALDPYTISGHDGIVHHGEVDNDRSVKALCNQALVLAKAGVDIVAPSDMMDGRIAAIREYLDKEGFINVGILAYAAKYASSFYGPFRDAVQSNKKNYLDKSSYQIDVRNIKEAMLEIEHDIAEGADIVMVKPGMPFLDVIREAANNFNAKIFAYQVSGEYAMLKFAAETGAIDWERALIESLISFKRAGATGIFTYAALEVAEILKHNNIK*		331	37	10	Diffraction	-1	 	
Batch01a	RiprA.00080.a	Rickettsia prowazekii	NP_220522	P41082				30S ribosomal protein S12 	Potential drug target		MPTYNQLVRFGRKSKTRKTKSPALESNPFKSGVCLVVKTVTPKKPNSALRKIATVRLSNKRTVNAYIPGEKHSVKEHDRVLVRGGQVPDLPGVKYHIVLGAYDIAGVKGRKQGRSRYGAHRKQVAATKK*		130	14	-2	Work Stopped	-2	Work Stopped	
Batch01a	RiprA.00081.a	Rickettsia prowazekii	NP_220863	Q9ZD60				cysteine desulfurase 	Potential drug target		MNQQLKNLTLPIYMDYQSTTPIDPRVMEAMLPYFTTKFGNPHSRSHSFGWEAENAVENARSMVAKVIGADSKEIIFTSGATESNNLVIKGIAKFYGNKKKHIITLVSEHKCVLNACRHLEQEGIKITYLPIKSNGIIDLETLKNAITDQTLLVSVMAVNNEIGVIQPLKEIGKICRERNVFFHSDIAQGFGKIPINVNECNIDLASISGHKIYGPKGIGALYIRKKPRVRVTPLINGGGQERGMRSGTLPTPLIVGLGIASEIAYNEMEKDTQHVNYLFDRFLNNIHSKISEVYLNGDKDQRYKGNLNLSFAGVEGESIILAIKDLAVSSGSACTSASLEPSYVLRSIGISEELAHTSIRFGIGRFTTEQEIDYAVNLVCSKIDKLRRLSPLWEMMQEGVDLKKIRWTAH*		411	46	5	Purified	-1	 	
Batch01a	RiprA.00099.a	Rickettsia prowazekii	NP_220737	Q9ZDH5				ATP synthase subunit E 	Potential drug target		MNTKITNFTFAFDKKNLNLAETIIKKYPPEGKRSAILPLLDLAQRQNGGWLHVSAIEYVANMLEMPYMRAYEVATFYTMFNLNPIGKYHIQVCTTTPCWLRGSDNIMKICEKKLAIKHKETTKDQKFTLSEIECLGACVNAPVVQINDDYYEDLNEAKMEKLIEQYLNEFKSKMQNG*		178	20	4	Soluble	-1	 	
Batch01a	RiprA.00102.a	Rickettsia prowazekii	NP_220456	Q9ZE84				2-dehydro-3-deoxyphosphooctonate aldolase 	Potential drug target		MKKVVKLNNIKIGNDLQFVLIAGPCQIEGKDHALFMAEKLMKLTSKLSIPFIYKSSFDKANRTSINGIRGLGIEKGLEILSKVKSEFDCPIITDVHSESQCIETAKVVDILQIPAFLCRQTDLLKAAAKTGKIVKVKKGQFLAPWDMKNVQKKLEVFGAKDILFTERGSCFGYNNLVSDMRSLAIMSELNVPVVFDATHSVQQPGGRGGSSGGERKYVELLAKAAISVGIAGIYMEVHQDPDNAPSDGPCMIKLDNLESILIKLKKYDKITKEIV*		276	30	2	Cloned	-1	 	"NR-16723, NR-16724, NR-16725, NR-16726, NR-16727"
Batch01a	RiprA.00132.a	Rickettsia prowazekii	NP_220683	Q9ZDM8				ribose-5-phosphate isomerase B 	Potential drug target		MKTYNIVIASDHSGYELKSKIINYLEQKCLNIYDCGTQDTQTVDYPDYAKKVVDIIIEKAAPIGILISDTGIGMSIAANRSSEIRAALCNDILTAENAKAHNDANILILGAKSVDNKIVFNIIDKFLTTKFEGGRHSTRLSKIK*		145	16	5	Purified	-1	 	
Batch01a	RiprA.00135.a	Rickettsia prowazekii	NP_221076	Q9ZCK8				queuine tRNA-ribosyltransferase 	Potential drug target		MSKFSFTIHSHYKKARSGVITTAHGEIRTPAFMPVGTRGAVKAMLTEAVVETGADILLGNTYHLMLQPSAERIAYLGGLHKFMNWDKPILTDSGGFQVMSLSKLCKITEEGVSFRSHINGNKYMLTPEYSTEIQYLLGSTITMALDECTPYPSTFEKAKTSMHLTTRWANRSRDAFVKREGYAQFGIIQGSVYKELREQSVKDLVKCDFEGYAIGGLAVGEGQELMFRVLDYVPDFLPQNKPRYLMGVGKPSDIIGAVSRGIDMFDCVIPTRSGRNGQAFTKYGTVNIRNSKYADDKEPLEHDCKCPACTNYTKAYLHHLVRIREILGPMLMTWHNLTYFQNLMSRIRTYIKLGKDFDFVH*		362	41	4	Soluble	-1	 	
Batch01b	BrabA.00011.a	Brucella melitensis	YP_414816	Q2YLZ1				cell division protein FtsZ	Potential drug target		MTINLQKPDITELKPRITVFGVGGGGGNAVNNMINAGLRGVDFVVANTDAQALTMSKSDRIIQLGAAVTEGLGAGSQPEVGRAAAEECIDEIVDHLNGTHMCFVTAGMGGGTGTGAAPVVARAARERGILTVGVVTKPFHFEGARRMKTADLGIEELQKNVDTLIVIPNQNLFRIANDKTTFADAFAMADQVLYSGVACITDLMVKEGLINLDFADVRSVMREMGKAMMGTGEASGEGRAMAAAEAAIANPLLDETSMRGAKGLLISITGGRDMTLFEVDEAATRIREEVDPEANIILGATFDEGLEGVIRVSVVATGIDKQQGDAAPAPLEFRQPVKPTAAQAKPMAPHGALRPPVAEQPRQADPVAQVIQAAEAEMPVAPAAPAASAEPEFRPQSRIFQAPAPEAFERAPVARAPMQPAQAMHAPQPQQYQQPQMHEQPVREPRPAPRMPAVSDFPPVAQAEINARRAPQQPVQEEPRGPMGLLKRLTHGLSRREEEQPAARLEPAQHREPGMRPAEPRRPMQQDSSIYAPRRGQLDNQGRPQPRTASEEDQLEIPAFLRRQSN*		567	61	4	Soluble	-1	 	
Batch01b	BrabB.00011.a	Brucella abortus	YP_222111	Q57C84				cell division protein FtsZ	Potential drug target		MTINLQKPDITELKPRITVFGVGGGGGNAVNNMINAGLRGVDFVVANTDAQALTMSKSDRIIQLGAAVTEGLGAGSQPEVGRAAAEECIDEIVDHLNGTHMCFVTAGMGGGTGTGAAPVVARAARERGILTVGVVTKPFHFEGARRMKTADLGIEELQKNVDTLIVIPNQNLFRIANDKTTFADAFAMADQVLYSGVACITDLMVKEGLINLDFADVRSVMREMGKAMMGTGEASGEGRAMAAAEAAIANPLLDETSMRGAKGLLISITGGRDMTLFEVDEAATRIREEVDPEANIILGATFDEGLEGVIRVSVVATGIDKQQGDAAPAPLEFRQPVKPTAAQAKPMAPHGALRPPVAEQPRQADPVAQVIQAAEAEMPVAPAAPAASAEPEFRPQSRIFQAPAPEAFERAPVARAPMQPAQAMHAPQPQQYQQPQMHEQPVREPRPAPRMPAVSDFPPVAQAEINARRAPQQPVQEEPRGPMGLLKRLTHGLSRREEEQPAARLEPAQHREPGMRPAEPRRPMQQDSSIYAPRRGQLDNQGRPQPRTASEEDQLEIPAFLRRQSN*		567	61	4	Soluble	-1	 	
Batch01b	BrmeA.00011.a	Brucella melitensis	NP_539502	Q8YI60				cell division protein FtsZ	Potential drug target		MTINLQKPDITELKPRITVFGVGGGGGNAVNNMINAGLRGVDFVVANTDAQALTMSKSDRIIQLGAAVTEGLGAGSQPEVGRAAAEECIDEIVDHLNGTHMCFVTAGMGGGTGTGAAPVVARAARERGILTVGVVTKPFHFEGARRMKTADLGIEELQKNVDTLIVIPNQNLFRIANDKTTFADAFAMADQVLYSGVACITDLMVKEGLINLDFADVRSVMREMGKAMMGTGEASGEGRAMAAAEAAIANPLLDETSMRGAKGLLISITGGRDMTLFEVDEAATRIREEVDPEANIILGATFDEGLEGVIRVSVVATGIDKQQGDAAPAPLEFRQPVKPTAAQAKPMAPHGALRPPVAEQPRQADPVAQVIQAAEAEMPVAPAASAASAEPEFRPQSRIFQAPAPEAFERAPVARAPMQPAQAMHAPQPQQYQQPQMHEQPVREPRPAPRMPAVSDFPPVAQAEINARRAPQQPVQEEPRGPMGLLKRLTHGLSRREEEQPAARLEPAQHREPGYAPSRTAPPDAAGFVDLCTGPRSA*		539	57	5	Purified	-1	 	
Batch01b	BrsuA.00011.a	Brucella suis	NP_698423	Q8FZP8				cell division protein FtsZ	Potential drug target		MTINLQKPDITELKPRITVFGVGGGGGNAVNNMINAGLRGVDFVVANTDAQALTMSKSDRIIQLGAAVTEGLGAGSQPEVGRAAAEECIDEIVDHLNGTHMCFVTAGMGGGTGTGAAPVVARAARERGILTVGVVTKPFHFEGARRMKTADLGIEELQKNVDTLIVIPNQNLFRIANDKTTFADAFAMADQVLYSGVACITDLMVKEGLINLDFADVRSVMREMGKAMMGTGEASGEGRAMAAAEAAIANPLLDETSMRGAKGLLISITGGRDMTLFEVDEAATRIREEVDPEANIILGATFDEGLEGVIRVSVVATGIDKQQGDAAPAPLEFRQPVKPTAAQAKPMAPHGALRPPVAEQPRQADPVAQVIQAAEAEMPVSPAAPAASAEPEFRPQSRIFQAPAPEAFERAPVARAPMQPAQAMHAPQPQQYQQPQMHEQPVREPRPAPRMPAVSDFPPVAQAEINARRAPQQPVQEEPRGPMGLLKRLTHGLSRREEEQPAARLEPAQHREPGMRPAEPRRPMQQDSSIYAPRRGQLDDQGRPQPRTASEEDQLEIPAFLRRQSN*		567	61	4	Soluble	-1	 	
Batch01b	BumaA.00011.a	Burkholderia mallei	YP_104088	Q62GT3				cell division protein FtsZ	Potential drug target		MEFEMLETETNGTIIKVIGVGGAGGNAVQHMINKGVQGVDFVVMNTDAQALSRSRAPSVIQLGNTGLGAGAKPEMGRAAAEEARERIADALRGAHMVFITAGMGGGTGTGAAPVVAQIAKEMGILTVGVVSKPFEFEGGKRMRVAEAGSQQLEDHVDSLIVVLNDKLFEVMGDDAEMDKCFQCADDVLNNAVAGIAEIINVDGLVNVDFEDVKTVMGEQGKAMMGTATVAGVDRARLAAEQAVASPLLEGVDLSGARGVLVNITSSRSLRLSETREVMNTIKSYAADDATVIFGAVYDDAMGDALRVTVVATGLGRAAKKQQSAPMTLLRTGTDNQPISAAPQGYAASHHVSTGDYGAFDTPAVWRNSRETAASHVQALQEKGVDTYDIPAFLRKQAD*		399	42	5	Purified	-1	 	
Batch01b	ButhA.00011.a	Burkholderia thailandensis	YP_441671	Q2SZH8				cell division protein FtsZ	Potential drug target		MEFEMLETETNGTIIKVIGVGGAGGNAVQHMINKGVQGVDFVVMNTDAQALSRSRAPSVIQLGNTGLGAGAKPEMGRAAAEEARERIADALRGAHMVFITAGMGGGTGTGAAPVVAQIAKEMGILTVGVVSKPFEFEGGKRMRVAEAGSQQLEDHVDSLIVVLNDKLFEVMGDDAEMDKCFQCADDVLNNAVAGIAEIINVDGLVNVDFEDVKTVMGEQGKAMMGTATVAGVDRARLAAEQAVASPLLEGVDLSGARGVLVNITSSRSLRLSETREVMNTIKSYAADDATVIFGAVYDDAMGDALRVTVVATGLGRAAKKQQSAPMTLLRTGTDNQPISAAPQGYAASHHVSTGDYGAFDTPAVWRNSRETAASHVQALQEKGVDTYDIPAFLRKQAD*		399	42	10	Diffraction	-1	 	
Batch01b	RicoA.00011.a	Rickettsia conorii	NP_360652	Q92GV7				cell division protein FtsZ	Potential drug target		MVLNIKAPENIVLKPTITVFGVGGAGSNAVNNMISANLQGANFVVANTDAQSLEHSLCTNKIQLGVSTTRGLGAGASPEVGALAAQESESEIRNYLENSNMVFITAGMGGGTGTGSAPVIARIAKELGILTVGVVTKPFHFEGGHRMKTADKGLIELQQFVDTLIVIPNQNLFRIANEQTTFADAFKMADDVLHAGVRGVTDLMIMPGLINLDFADIKAVMSEMGKAMMGTGEASGEDRAIKAAESAISNPLLDHSSMCGARGVLINITGGSDMTLFEVDNAANRIREEVDNLDANIIFGSTFNPELKGMIRVSVVATGIDADKVPTYKPAIAETTNIVPEETYNKAIAQPTQIEEMPDFNSYSTENIEITDSPINQNFIGNEKELGLHANTFNKSEDDSPKPSFLGKIWGSLRASNNQTLERKNVVVSTLDQDNKESDIHDIPAFLRKKRD*		453	48	5	Purified	-1	 	
Batch01b	RifeA.00011.a	Rickettsia felis	YP_246286	Q4UMT7				cell division protein FtsZ	Potential drug target		MVLNIKAPENIVLKPTITVFGVGGAGSNAVNNMISANLQGANFVVANTDAQSLEHSLCTNKIQLGVSTTRGLGAGASPEVGALAAQESESEIRSYLENSNMVFITAGMGGGTGTGSAPVIARIAKELGILTVGVVTKPFHFEGGHRMKTADKGLIELQQFVDTLIVIPNQNLFRIANEQTTFADAFKMADDILHAGVRGVTDLMIMPGLINLDFADIKAVMSEMGKAMMGTGEASGEDRAIKAAESAISNPLLDHSSMCGARGVLINITGGSDMTLFEVDNAANRIREEVDNLDANIIFGSTFNPELKGIIRVSVVATGIDADKVPTYKPAIAETTNIVPEETYNEPIVQPTQIEEIPDFNSYSTENIEITDSPINQNFIGNEKELGLHANSFNKSEDDSPKPSFLGKIWGSLRASNNQTLERKNIVVNTLDQDNKESDIHDIPAFLRKKRD*		453	48	4	Soluble	-1	 	
Batch01b	RiriA.00011.a	Rickettsia rickettsii	YP_001495111	A8GT78				cell division protein FtsZ	Potential drug target		MVLNIKAPENIVLKPTITVFGVGGAGSNAVNNMISANLQGANFVVANTDAQSLEHSLCTNKIQLGVSTTRGLGAGASPEVGALAAQESESEIRNYLENSNMVFITAGMGGGTGTGSAPVIARIAKELGILTVGVVTKPFHFEGGHRMKTADKGLIELQQFVDTLIVIPNQNLFRIANEQTTFADAFKMADDVLHAGVRGVTDLMIMPGLINLDFADIKAVMSEMGKAMMGTGEASGEDRAIKAAESAISNPLLDHSSMCGARGVLINITGGSDMTLFEVDNAANRIREEVDNLDANIIFGSTFNPELKGMIRVSVVATGIDADKVPTYKPAIAETTNIVPEETYNKAIAQPTQIEEMPDFNSYSTKNIEITDSPINQNLIGNEKELGLHANTFNKSEDDSPKPSFLGKIWGSLRASNNQTLERKNVVVSTLDQDNKESDIHDIPAFLRKQRD*		453	48	5	Purified	-1	 	
Batch01b	RityA.00011.a	Rickettsia typhus	YP_067601	Q68W73				cell division protein FtsZ	Potential drug target		MILNIKAPENIVLKPTITVFGVGGAGSNAVNNMIHANLQGANFVVANTDAQSLEHSLCINKIQLGVSTTRGLGAGASPEVGALAAQESENEIRSSLENSNMVFITAGMGGGTGTGSAPIIARIAKELGILTVGVVTKPFHFEGGHRMKTADKGLIELQQFVDTLIVIPNQNLFRIANEQTTFADAFKMADDVLHAGVRGVTDLMIMPGLINLDFADIKAVMSEMGKAMMGTGEDSGEDRAIKAAESAISNPLLDHSSMCGARGVLINITGGPDMTLFEVDNAANRIREEVDNIDANIIFGSTFNPELKGIIRVSVVATGIDADKVPKYKLAIDENTNTVPKETYNESMIQHTQIEEIPAFNNYSTENIEITDSSIKQNYTENEQELRLHVNAVNKPENNSQKSSFLWKIWGSLRASNNQTLERKNVIVNTLDQDNKESDIHDIPAFLRKKRD*		453	49	5	Purified	-1	 	
Batch02	BaheA.00010.a	Bartonella henselae	YP_032986.1	Q6G517				enoyl-(acyl carrier protein) reductase	Potential drug target		MKGLMEGKRGLIMGVANDHSIAWGIACQLAKAGAELAFTYQGEAFGKRVQPLAEKIGCKLVLECDVEKIENVDRVFKRLEKEWKTIDFVVHAIGFSDKTQLKGRYVDVTTRENFKRTMVISAYSFTEIAQRAGKLMPNGGTLLTLTYGASQQVVPNYNIMGVAKAALEAMVRYLAADFGPQNIRVNAISAGPIRTLAGNGIAAARAIFSYQRRNAPLRRNVNINEIGKSALYLLSDLSSGVTGEIHYVDSGYNIMSMPTLEELKQSEEAQEE		272		10	Diffraction	-1	 	NR-13692
Batch02	BaheA.00010.b	Bartonella henselae	YP_033269.1	Q6G4D5				enoyl-(acyl carrier protein) reductase	Potential drug target		MAKGNGLLYGKRGLILGLANNRSIAWGIAKTASSAGAELAFTYQGEAMKKRVEPLAEEVKGFVCGHCDVSDSASIDAVFNTIEKKWGKLDFLVHAIGFSDKEELSGRYVDISESNFMMTMNISVYSLTALTKRAEKLMSDGGSILTLTYYGAEKVVPNYNVMGVAKAALEASVKYLAVDLGPKHIRVNAISAGPIKTLAASGIGDFRYILKWNEYNAPLRRTVTIEEVGDSALYLLSDLSRSVTGEVHHVDSGYNIIGMKAVDAPDISVVKE		272		11	Native diffraction-data	-1	 	NR-13693
Batch02	BaheA.00010.c	Bartonella henselae	YP_033370.1	Q6G443				3-ketoacyl-(acyl-carrier-protein) reductase	Potential drug target		MFKLTGRKALVTGATGGIGEAIARCFHAQGAIVGLHGTREDKLKEIAADLGKDVFVFSANLSDRKSIKQLAEVAEREMEGIDILVNNAGITRDGLFVRMQDQDWDDVLAVNLTAASTLTRELIHSMMRRRYGRIINITSIVGVVGNPGQTNYCAAKAGLIGFSKALAQEIASRNITVNCIAPGFIKSAMTDKLNEKQKEAIMAMIPMKRMGIGEEIAFATVYLASDEAAYLTGQTLHINGGMAMI		245		17	In PDB	5	Target selected for ligand screening 	"NR-13694, NR-13695"
Batch02	BaheA.00013.a	Bartonella henselae	YP_034187.1	Q6G5R1				Holliday junction DNA helicase B	Potential drug target		MHKDEDQRLLGAVPLPNDPDRSLRPQVLDDFIGQEAARANLKIFIEAAKARQEALDHVLFVGPPGLGKTTLSQIMAKELGVNFRSTSGPVIAKAGDLAALLTNLEERDVLFIDEIHRLSPAIEEILYPAMEDYQLDLIIGEGPAARSVKIDLAKFTLVAATTRLGLLTTPLRDRFGIPIRLNFYTIEELEYIVQRNARLFSVQISEDGAHEIARRARGTPRIAGRLLRRVCDFALVKRAKKIDRKIADEALSRLEVDHLGLDPLDRRYLLLIAQTFLGGPVGIETIAAALSEPRDAIEDIIEPYLLQQGFIQRTARGRILHQKAWSHLGLCAPASTQKHPQLFDMPDNASRQTVLWDEADD		361		4	Soluble	-1	 	
Batch02	BaheA.00057.a	Bartonella henselae	YP_032889.1	Q6G595				ABC transporter/ATP-binding protein	Potential drug target		MFGIKRKKQADGHNFASEALRKRLKGTLIASHLVKFYRGRQVINDVSFGIRTGEAVGILGPNGAGKTTCFYMVTGLIKSDGGSIKIDGFDITHLPMYRRARLGIGYLPQEASIFRGLSVEKNIKAVLEVVEKDRLKRREDLDALLHEFKIDHLRKMPALSLSGGERRRLEIARALASRPNFMLLDEPFAGIDPIAIFDIQQLIRYLTRRGIGVLITDHNVRETLGLVDRAYIIHAGQVLVHGCPNDIINDADVRRIYLGNQFSL		264		4	Soluble	-1	 	
Batch02	BaheA.00057.b	Bartonella henselae	YP_033632.1	Q6G3E7				"High-affinity branched-chain amino acid transport, ATP-binding protein"	Potential drug target		MNDTILLLNDIVMRFGGLVAVNNINMAIKRGKITGLIGPNGAGKTTIFNMISGFYAPTSGTILFDGKKVSGAPPYIICRYHIARTFQNIRLFSGLTVLQNVMVGAHVRQKHPWFSSALFFPKAMKEKREIHKNAMKLLEQLQLDHLANQSATTLPYGVQRRLEIARALATKPKLLLLDEPVAGMDPQESEDLRKFIAKVQKDFDLTILLIEHDMKVVMGLCQYILVMEHGCCIANGTPDEIRNNPKVIEAYLGGDVYGYS		260		5	Purified	-1	 	
Batch02	BaheA.00113.a	Bartonella henselae	YP_032987.1	Q6G516				3-oxoacyl-(acyl carrier protein) synthase I	Potential drug target		MRRVVVTGMGIVSAIGNNPGTVLTSLYEAKSGISYAPQYAKLGFRSRVYGKPDINIEELVDRRALRFHGRGTAWNHIAMDQAIADAGLEPHEVSNEHTGIIMGSGGASTQSIVEAADITRQKSPKRVGPFVVPKAMSSTASATLATFFKIKGVNYSISSACATSNHCIGNAYEMIQYGKQDRIFAGGCEDLDWTLSVLFDAMGAMSSKYNDVPEKASRAYDAHRDGFVIAGGAGVLVLEELECAKARGAKIYGEIVGYGATSDGHDMVAPSGEGAERCMRMALATVKNKIDYINPHATATPVGDPPEIEAIRRIFGAGDQCPPISATKSLTGHSLGAAGVQEAIYTLLMMNHNFICESAHIEELDPAFADMPIVRERRDHQQLNTVLSNTFGFGGTNATLVFQRYG		406		4	Soluble	-1	 	NR-13696
Batch02	BaheA.00113.b	Bartonella henselae	YP_033372.1	Q6G441				3-oxoacyl-(acyl carrier protein) synthase II	Potential drug target		MRRVVITGLGLVSPLAGDVEYSWKRLLEGKSGVRRITEFDVSDLSCQIAARIPVGDGTNGTYNADLHMESKEQRKVDAFIVYAIAAADQALADAEWFPKSDEDQICTGVLIGSGIGGIEGIVEAGYTLRDKGPRRISPFFIPGRLINLASGYVSIKYGLRGPNHSVVTACSTGAHAIGDAARLIALGDADVMLAGGTESPINRISLAGFSACRALSTCRNDDPERASRPYDVDRDGFVMGEGAAIVVLEELEHAKKRGARIYAEIIGYGLSGDAYHITAPSESGEGAQRSMMAALKRAQVNVSELDYINAHGTSTMADVIELAAVERVLGYYAPQVSMSSTKSSIGHLLGAAGAAEAIFCVLAIRDNIAPATLNLENPSIETKIDLVPHKPRERKIDTVLSNSFGFGGTNASLVMRRFSE		420		17	In PDB	5	Target selected for ligand screening 	NR-13697
Batch02	BaheA.00113.c	Bartonella henselae	YP_033556.1	Q6G3M3				3-oxoacyl-(acyl carrier protein) synthase II	Potential drug target		MQYNDHFGRPIVAITGAGIVTSLGKGKHENWQKLTSGVSGIHKITRFPVDELKTRIAGTVDFLKESTYGASALSEKLANLAAEEALEQADLGKTNFNGPLFLAAPPVELEWKARLTLDQEGELNSAPSYVHLLEICSHKLHETLFETTQFGAIAENLQKKFGTKGLPITLSTACASGATAIQLGVEAIRRGETNRALTIATDGSVSAESLIRFSLLSALSTQNDPAEKAAKPFSRDRDGFVMAEGSGALVLESLKSALDRNAIILGILAGCGETADDFHRTRSKPDASPAIEAVRKALEDANITINEIDYINAHGTSTPENEKMEYLALSTVFGDRLEHIPVSSNKSMIGHTLTAAGAIEAVFSLLTIQSGILPPTINYDDPDPAIPLDVVPNHSRKACVNAVLSNSFGFGGQNMSLVITAYKG		424		5	Purified	-1	 	
Batch02	BaheA.00133.a	Bartonella henselae	YP_033354.1	Q6G5G9				cysteinyl-tRNA synthetase	Potential drug target		MRELRFYNTLTRKKENFIPIDATRVRLYVCGPTVYDYAHIGNARPVIVFDILFRLLRHVYGNEHVIYARNITDVDDKINARAAYEYPELALNDAIRQLTQLTYTQFQQDTMALGCLPPTIEPRATDHLEEMRSLIERLLEKGHAYKAENHVLFSVSSIRNDPHYGSFAKRSLDEMRAGARVDVASYKREEMDFVLWKPSAEGEPGWTSPAGIPVLGRPGWHIECSAMSMAKLLAPYGGGLTCDDPTENVFDIHGGGLDLIFPHHENEIAQSCSAFGTERMANLWMHNGFLQVEGKKMSKSLSNFITIRSILESDFFEFNGVLTNEMKQNWAGLSARFSMLQTHYREPLNWTAQRLMQSSSELYRWYELLRCEKTEMEKKNEVIDDSLINALSDDLNTPKALTLLRKFYKRGNAVSLASGMNFFGLLRQEWVRDGKCPLFMRKTSLDEKFIDQRIAERLRLIHNKEWTAADTIRDKLAAEGIVLKDIKDPQTGERTTMWEIKRF		503		7	Crystallized	-1	 	NR-13698
Batch02	BaheA.00145.a	Bartonella henselae	YP_033770.1	Q6G330				aspartyl-tRNA synthetase	Potential drug target		MHRYRSHHCAALRKCDVGIKARLSGWVHRVRDHGGILFVDLRDHFGITQIVADPASPAFKIIEKVRSEWVIRVDGEVRARSDEVINTSLPTGEIEIFAKEVEILSKSDELPLPVFGEPDYPEDIRLKYRFLDLRRETMHRNIMRRTEIIAAIRRSMQENGFTEFTTPLLTASSPEGARDFLVPSRIHQGKFYALPQAPQQYKQLLMMSGFDRYFQIAPCFRDEDPRADRLPGEFYQLDVEMSFVEQEDVLVTMEPIMRSLFEEFADGKPVTQSFPRLSYEEAMRKYGSDKPDLRNPIIMEDVSQHFYDSGFKVFAQILANDENARVWAIPAKTGGSRAFCDRMNGWAQSEGQPGLGYIFWREEQGKFEGAGPIAKNIGEQRTEALRMQLGLENGDACFFVAGDPKKFLPFAGAARTRVGEELDLVDRDCFSLAWIVDFPFFEWNEEEKKLDFAHNPFSMPQGGKDALECQDPLTLKAFQYDLVCNGYEIASGGIRNHSPEMMLKVFNLAGLSKEVVEDRFGGLYRAFHYGAPPHGGMAAGVDRIIMLLQGVKNLREVALFPMNQQALDLLMSAPSDVSPVQLRDLGIRIAPAAKND		596		5	Purified	-1	 	
Batch02	BaheA.00148.a	Bartonella henselae	YP_034281.1	Q6G1R6				site-specific tyrosine recombinase XerC	Potential drug target		MLPKKDSRKDKNFSLIPAAPPVLAARKNWLDNLLGTRRMATYTAQAYERDTRQFLFFLCQHLGHTPTFKDLANLRVIDLRAYLAYRRKHDISARSLSRGMAGIRSFFNYLSREGIASIPAAKLVRTPKHPKSLPKPLNIKSALHLVKQENQQENEPWIIARNTAVLMLLYGCGMRISEALSLTPEQFSDPQKTSLFVTGKGGKTRLVPLIKVVYEAIQNYLKCCPYPLLDNQPMFRGARGGPLQPAIIQKTVRNLRAYLGLPETATPHTLRHSFATHLLSRGGDLRTIQELLGHACLSTTQVYTHVDTKHLLEIYQKAHPRSLKDF		326		4	Soluble	-1	 	
Batch02	BaheA.00148.b	Bartonella henselae	YP_034327.1	Q6G1P0				Integrase /recombinase xerD	Potential drug target		MKSNTVIDHFLEMMSAERGACEHTLAAYQRDLQWAQDELFSHSVSLFSAQREDLIGLLSLMHTLGFAASSQARRLSTLRQFYQFLYAEGLRADDPSHNIDAPRQGRPLPKVVSENVVTKLLDLAQLEVNQEDYGSKGHFRALRLQLLIEMLYATGLRISELVSLPVQAVRGKDYSILVRGKGKKERMVLLSKKACQVLSQWLSLRDQGKYAESLYLFPARSETGYIARQVVARDLKSLARRAGIKSGGFSPHVLRHAFASHLLQNGADLRAVQHLLGHSDIATTQIYTHVLEEGLYRLVNEHHPLADEQKAR		312		4	Soluble	-1	 	
Batch02	BaheA.00150.a	Bartonella henselae	YP_033779.1	Q6G321				UDP-N-acetylglucosamine pyrophosphorylase	Potential drug target		MRSCLSIVLAAGEGTRMKSSLPKVLHKIAGLPLICHVIKQIELAGVSQLAVVVGFGAKDVVHVVESFVKNAMIFEQKERLGTAHAVLSARLALQKGVDDVLIVFGDTPLIEQDSLLQLRAQLAGGADVVVAGFRAFNPTGYGRLLEKNGKLIAIIEEKDASDEEKKLSFCNGGILALNGKYALSLLEKIGNNNSKREYYLTDIVSIASQEGLDVRVVEVPFDNIIGVNNCFELFEADSLWQKRKARDLMLSGVTILKPETVYFSYDTQIKPGVMIEPNVYFGLGVKVHSGAVIHAFSYLEGAVVGTDARIGPYARLRPGTELAGSVKIGNFCEVKKAKIGKASKINHLSYIGDAEIGAQVNIGAGTITCNYDGFHKHKIMIGDHAFIGSNSALVSPLMIGDGSYIASGSVITEDVPMNSIALGRARQVTKKDYAMKLRARLSANQQKK		448		11	Native diffraction-data	-1	 	NR-13699
Batch02	BaheA.00154.a	Bartonella henselae	YP_033270.1	Q6G4D4				chorismate synthase	Potential drug target		MSHNTFGHLFRVTTWGESHGEALGCVIDGCPPGITFTLSDIQSYLNKRKPGQSKYTTQRRELDQVEILSGVIVQDDGITFVTTGTPISLLIRNMDQRSKDYSAIVHQYRPGHADYTYDVKYGIRDFRGGGRASARETAARVAAGAVARKIIPGVIVRGAVIAIGPHTINRNRWNWSEVDNNPFFTPDAEMVQVFSDYIDKVHKNGSSVGAVVEIVAENIPAGLGAPIYAKLDQDIASLLMSINAVKGVEIGDGFAAARLTGEENADEMRMGSDGKPLFLSNHAGGIVGGISSGQPIIARFAVKPTSSILIPRRSIDVDGNDVNVITKGRHDPCVGIRAVPVGEAMVACALADHYLRHRGQVGCFKR		366		10	Diffraction	-1	 	NR-13700
Batch02	BaheA.00157.a	Bartonella henselae	YP_033769.1	Q6G331				DNA topoisomerase IV subunit A	Potential drug target		MSDKMNLPFDKEHIESIELRSALQERYLAYALSTITHRALPDVRDGLKPVHRRIVHAMRLLKLNPGHSYAKCARIVGDVMGKFHPHGDASIYDALVRLAQNFAVRYPLVDGQGNFGNIDGDNAAAMRYTEARMTEVAALLLEGINENAIDFRLTYNEEDEEPIVLPGAFPNLLANGSSGIAVGMATSIPPHNVSELCDAALHLIAHPNARDEELNHFVLGPDFPTGGILVEPKKSIEESYRVGRGFFRLRSRWHQETGNRGSYVLVVTEIPYQVQKSRLIEKTAELLLARRLPMLEDIRDESAEDIRIVLIPKNRTVDPEILMESLFKLTDFEIRFPLNLNVLSFGKVPNVLSLRESLKQWLEHRQEVLIRRSRYQLDEIERRLEILHGYLITYLNLDEVIQIIREEDEPKKKLIDRFELTENQAEAILNMRLRSLRKLEEFEIRKEFETLRAEKEKLQNLLDSRTKQWKIISEEIIKVRKVFGPHTLLGKRRTTFEEAPRHDFDDIYQAMIEKEPVTIVISEKGWMRALKGHLSDYNALSFKEGDCLKLAFPAFTTDKIVVISTGGKFFAIAANSLPGGRGHGEPIRILVDMDDEHDLLTAFVHHTQEKLLLVSSHGNGFIVPATEVIANTRKGKQVMNVKFPDKVKLCVPVKGDHVAVVGENRKMLIFAIEQIPEMSRGKGVRLQRYKQGGVVDVKTFNLSEGLSWQDTAERCFNRQASDLIEWMGVRSGVGRVVPKGFPKSGKFTN		749		5	Purified	-1	 	NR-13701
Batch02	BaheA.00159.a	Bartonella henselae	YP_033777.1	Q6G323				ATP-dependent DNA helicase recG	Potential drug target		MLPDLIRPLFTSVRILPGMSPKIYGLLAKVLNINATQREPTIIDLLQLMPYSVIDRRMRPNIAFAQEGNTVTLEIIIDQHHSPPIGRNRLPYRVSAHDQTGKINLVFFHAQPPWLKKQLPEGKKVIVSGKVERFNGQLSMVHPDHIAPSKQSNQMPLIEPIYPSTAGLSAKTLRRTIQNALEYIPLLPEWIEESVKKQQNFSSFSVALRRIHAPIDPDDLALESTARKRLAYDELLACQLALGLMRLKTKSLVGTSRPPTGTYTEKLLKILPFQLTNGQKKAIQDIANDLASPEPMLRLLQGDVGAGKTVVALMAMAQIAENRGQSALMTPTEVLARQHFATIAPLAEKIGLQTVLLTGREKGKLRTNILNNISSSQASIIIGTHTLIQNNVTYNNLSLAIIDEQHRFGVNQRLALTAKGHKPDMLVMTATPIPRTLVLTAFGDMDVSKITEKPMGRQPITTAILSLKRIDELIERIAVALEKGEKLYWICPLVEESITLELTSIESRFAMLQERFGTSVGMIHGKMSTDKKEAAMASFKCGNIGILVATTVIEVGVDIPDASIIIIEHAEHFGLSQLHQLRGRVGRGEKKSSCILLYKDPLTKMAATRLNIIRSTEDGFKIAEEDWRLRGEGELLGTRQSGMPEFHIANLAVHGDLLLLARRDARLFLQRDPHLSSEQGQALRLLLYLFGRDDATRLLRAG		702		4	Soluble	-1	 	
Batch02	BaheA.00162.a	Bartonella henselae	YP_033595.1	Q6G3I4				DNA topoisomerase IV subunit B	Potential drug target		MSDKNKDLFSILNNAQFSINIKEKNLSPSLSSEAANSRKDTQENDYNALSIRVLEGLEPVRLRPGMYIGGTDSKALHHLFAEIIDNAMDEAVAGYADFIDVSLEKNGYLTVTDNGRGIPVENHPQMPGKSTLEVIMTQLHSGGKFDGKAYQTAGGLHGVGISVVNALSDYMEVEVARERKLYRQRFSRGIPQSGLEDLGDVYNRRGTRVRFHPDSKIFGEKAAFDPEKIYKMARSKAYLFGGVKIRWNCDPVLLENTKNIPEKAVFHFPDGLKDYLLSSLKDEYRVTSEIFSGKTKHSNGHGSVEWAIAWHGGDSHVQSYCNTIPTGEGGTHEMGLRQALLRGLKSYAELIGNKRAAIITSDDVMISTSAILSVFIKDPEFVGQTKDRLATIEAQRIVENAIRDPFDHWLTNSPQESTKLLDWVVERAEERVRRRQDREINRKTAVRKLRLPGKLADCSQNCAAGAELFIVEGDSAGGSAKQARNRANQAILPLRGKILNVASAAHEKMNSSQTIGDLILALGCGTRSKYREKDLRYERIIIMTDADVDGAHIASLLITFFFQEMPDLIRQGHLYLAVPPLYRISQGGKVAYARDDTHKDELLKTEFTGKAKIEIGRFKGLGEMRAEQLKETTMHPQKRTLLRVSINAEEVQETKNTVESLMGTKPEARFRFIQENSTFASNLDI		685		3	Expressed	-1	 	
Batch02	BaheA.00163.a	Bartonella henselae	YP_032947.1	Q6G5E3				Phenylalanyl-tRNA synthetase alpha chain	Potential drug target		MSDIERLEQEICLALEMAGDEQALEAVRIAALGKKGSISEKLKALGKMSASERQKVGPVLNGLKNRVLELWTQKRDFLRRQAMDACLTRETVDITLPVRSSPIERGRIHPISQVIEEIIAIYMKMGFSLAEGPDIETDYYNFTALNFPEGHPAREMHDTFFFDVNKTGERKLLRTHTSPVQIRTMEKQKAPIRIIIPGKTYRMDSDATHSPMFHQVEGLVIDKTSTIAHMMWLHETFCKAFFEVSSVKMRFRPSFFPFTEPSMEVDIQCDRSGSEVKFGEGQDWLEILGCGMVHPHVLKNVGLDPDEYQGFAWGMGIDRIAMLKYGMPDLRAFFDADLRWLDHYGFRCFDMHAFFPGLRNV		361		3	Expressed	-1	 	
Batch02	BaheA.00166.a	Bartonella henselae	YP_033889.1	Q6G2R2				UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase	Potential drug target		MIKLVQKYQSTLKKVVTFKGIGVHSGCLSVVKVCPADVGCGIVFKRFAVDGTEQIFQAHASQTGATELSTALGHGGFRVETIEHLMAAIAAYNLDNLIIEVSSHEIPILDGSSWQYCQAFDEVGVIRQNVLRSYFVIKKPLRVESTNGVAEFLPFDGRRFDITISFPSSAIGKQHLTFDLTPQSFRDDLSRARTFGFVKDVEKLWVSGKGIGASLENSLIIGLNDKIINPDGPYWKNEYVRHKTLDAIGDTALLGAPFIGLFRSYCSGHRMNSQLVKAVLADESCYEKSHL		291		7	Crystallized	-1	 	
Batch02	BaheA.00168.a	Bartonella henselae	YP_033416.1	Q6G3Z8				hypothetical protein	Potential drug target		MRCFCQNPAITTIILVIHPEDRQICEQAIADFKEQLIIVEGGNTRQKSTLRGLQALRKFKPKYVHIHDGARPFVENKLLEQIHTTVTPQEGVLPVLAVCDTLKRINSTHHVLETIPRTHLYSAQTPQCFPFERILAAHEKAIKTCKKEFTDDSAIAEWFGISMRTIPGSPHNIKITWHEDLNTAHLYLQKKMQMFPDIRTGNGYDVHSFEEGNSLILCGIKIPFHKKLNGHSDADVALHALTDALLATRGAGDIGTHFPPSDPQWQNVSSEIFLRHALDIVKQAGGRIANVDITLIAEEPKIGPYRHAMVGNLMNMLTILPDRISIKATTNEKLGFIGRGEGIAAFATANVLYPGEIPK		359		4	Soluble	-1	 	
Batch02	BaheA.00171.a	Bartonella henselae	YP_033575.1	Q6G3K4				3-oxoacyl-(acyl carrier protein) synthase III	Potential drug target		MIRSVVRGIGGALPKKSLSNDDIAKFVETSDSWIVQRTGIRQRYIANEKETTVSLGVEAAQAALINAGLTIKDIDCIILATSTPNHTFPASAVEIQHALGMSHGFAFDIQAVCSGFIFALTTGDAYLRCGTAKRILVIGSDTFSRILDWQDRTTCVLFGDGAGAAVLEAQEIERGVASDHGILSTKLRSNGAYMDKLYVDGGPSTTQKTGYLRMEGREVFKYAVGMITDVVDECFAAAGMDSSQLDWFVPHQANKRIIEASAKKLGISIDKVVITVDRHGNTSAASVPLALTMAICDGKIKKGDLVMLEAMGGGFTWGAILIRW		324		5	Purified	-1	 	NR-13702
Batch02	BobuA.00013.a	Borrelia burgdorferi 	NP_212156.1	P70828				Holliday junction DNA helicase B	Potential drug target		MKDENSISFLSSNENYLYDKSENELRPKVFEDFKGQVNVKETLSIFIRASKERDEALDHVFLSGPPGLGKTTLASIIAFEMNASIKITSAPAFDKPKDIIGILTGLDEKSVLFIDEIHRLRPIIEEMLCIAMEDYELDWVIGQGANARTVRMPLPKFTLIGATTKPGKVTSPLYARFGITARFELYSEIELVEIIKRNSLILNIEIEEDAAFLLARSSRGTPRIANRLLRRIRDIAQVTGSLVITSDIVSIGLEMLRIDGEGLDEQDRNILRSLILKFNGGPVGVDTLAISVGETADSLEDFYEPYLIMKGFISRTHRGRKATEFAYLHLNLEMKEDGLNENQRVSF		348		4	Soluble	-1	 	
Batch02	BobuA.00057.a	Borrelia burgdorferi 	NP_212600.1	O51422				"ABC transporter, ATP-binding protein"	Potential drug target		MREVLRENLLKLKMMLLKKKNKIKEIKESLNLDSVNNVVLKADNIIKKYGEKLAVNGITINIYKGEVVGLLGPNGAGKTTTFYTIVGFIKPNAGKVLINDYNISSLNMYERARIGIVYLPQDASIFRELTVEENIMVALERREDLSKAERKIELVNLLKEFEIKRIQSQKAYTLSGGERRRAEIARALAVNPYFLLLDEPFAGIDPIAIGDIKNIIKILKEKNIGVLITDHNVRDAFDIIDRAYIVYQGQVLDEGDVDYIISSEKAKKLYLGEEFRL		278		4	Soluble	-1	 	
Batch02	BobuA.00133.a	Borrelia burgdorferi 	NP_212733.1	O51545				cysteinyl-tRNA synthetase (cysS)	Potential drug target		MILKLYNTRTKDFSELTNFENVKVYACGPTVYNYAHIGNFRTYIFGDLLIKTLRFLGYKVNYAMNITDIGHLTGDLDDGEDKVAKTAREKGLTVYEISEFFTEAFFNDCRKLNIVYPDKVLVASKHIPIMIEVVKILEEKKITYFSNGNVYFDTSCFKSYGEMAGIDLIDKDMTLPRVDVDKFKRNKTDFVLWFTNSKFKDQEMKWDSPWGFGYPSWHLECAAMNLEYFKDALDIHLGGVDHIGVHHINEIAIAECFLNKKWCDVFVHGEFLIMDYNKMSKSRGNFITVKDLEDQNFSPLDFRYLCLTSHYRNQLKFSLDNLQASKIARENLINKLSYFYESLDPVDLNTLNKDLKNFGFSVEKEYYDSFVEKISFDLNVAQGLALLWEIIKSDNLSFVSKLRLAFIFDEIMSLNLREEILKNLQNHDVVIDENMKALIEERRIAKCEKNFKRADEIRDFFAKKGFVLVDTKEGTKVKRG		481		10	Diffraction	-1	 	
Batch02	BobuA.00137.a	Borrelia burgdorferi 	NP_212951.1	O51757				UDP-N-acetylmuramate--L-alanine ligase	Potential drug target		MKVDFDDLNNIFFVGIKGSGACSLACFLNSKGYCVEGVDVSDKFYTDEILSNNKISYYDNIYEFSLKQLDRSFDLIVYSSAYNKDGLQVLLEAKELNIPILSYPEALGELSRKYYSIGIAGSHGKTTTTAFLGVLFNKLGLNPNVIVGSSVKDFKDNSAIAGISNIFIVETCEYKKHFLNFSPNMLILTNVDYEHVDFFKNYEALEEAFLQYINNLKKNGILIINSDDNNLLKIKRQINRKDISIFSYGSGDLSDFQISNIAVRSEYFCFSFLGLLNVELKTVLFHNVLNFSAALLALNLFLESNGKSIFDFEEAIKRIAKNYSGIKRRVEVVKEENGVIYMDDYAHHPREIKNTLFGIKNFYKNKRIILDFMPHTFTRTKEFFADFVEVLSAADILILHNIYLSNRENFNPDELSVKLFLNIKKINKNTYFFKDVKDSINFIKSLLISGDLFITMGAGNNFILHDFL		469		3	Expressed	-1	 	
Batch02	BobuA.00145.a	Borrelia burgdorferi 	NP_212580.2	O51402				aspartyl-tRNA synthetase	Potential drug target		MFKVIKCNELNEKLIDKKVEINAWVKKIRHHGKFIFLNIRDRYEKAQVLVNEEKLLKIAEKIKLEYCIKIQGLLIKRPPNMINANMKTGHFEILAKNIEIISKCNELPFMIEDDNNASENSKLEYRYLDLRRDSLKNKIILRCQATHLIRNFLIKRKFLELETPTFVKSTPEGARDFVIPSRIHKGSFYALPQSPQLYKQLIMIAGFDKYFQIARCYRDEDSRGDRQPEFTQLDLEMSFVKKENIFKLIENMLFLIFKNCININLPKKFKKITYKKAMNKYGSDKPDTRFELELQDISRNLKNSEFNIFKDTLKNKGSIKILIVKDKADKFSRAKINNLEEIAKLYKTQGLYFTKIENNKFSGGIAKFLKTEEQELIKTYSLENNDIIFFTANNNWETACKAMGQIRIKIANDLGLIDENKFEFLWVYDFPLFEYDENTKTYSPAHHMFSLPKKQYIANLEKNPKKTIGEIYDLVLNGVELGSGSIRIHNKELQQRIFKIIGFQKEKSEDRFGFFLKALEYGAPNHGGIAIGIDRLIMLMTKSTSIKDVILFPKNSFAASPLDNSPSKISNEQLKELGINIVDGDN		587		7	Crystallized	-1	 	NR-13704
Batch02	BobuA.00153.a	Borrelia burgdorferi 	NP_212844.1	O51653				DNA primase (dnaG)	Potential drug target		MKYLQTVASMKSKFDIVAIVEQYIKLVKSGSAYKGLCPFHAEKTPSFFVNPLQGYFYCFGCKKGGDVIGFLMDMEKINYNDALKILCEKSGIHYDDLKISRGSENKNENKDMVSKIYSLNSRLINTIKFFLSKNKKALDYVLKSRAISKEIVDLFELGYLPFNFKNGLELHDFLVSKGYSSEVLRKSGLFSKTNPKVSILFQRLIFPIKDFKGNVVGFGGRDLDGKGSKYINLGETEVFKKRELLYGFYEGFEEIKSTKSVILVEGYIDVLAFFTSGIKRAVSTLGTAFSKEHLALIQRYADEIIFSFDGDDAGLSATLKAYQICLPFNINVSVVRMDFGTDPADVLKSEGVDSLQKILNNRCDAFEYLLDVYSNKYNLNKTVDLNAMINLFLNLINLSKVDTQKKIFLDKLSNKLGIGVTTLLKDYYRIKERFVVDNNKRNLYAHNDDSYERYLIVALLKNFSYFSIVRRNIIDSDLINVDARKVFMCFENLFENNKDFSLMDLKKNLKDTYKVSEFFLKKF		524		3	Expressed	-1	 	
Batch02	BobuA.00155.a	Borrelia burgdorferi 	NP_212478.1	O51319				DNA helicase (uvrD)	Potential drug target		MMDKIKKFFSSLNTSQEKIVFSKSKNPMLVLAGPGSGKTRVIIAKIVYLIKYMNIDPNEILALTFTNKAANEMNDRINDLLKFDKKLHIQTFHSFGSWLLRVYYKDFNENYDSNFTIWDTNDVVKFVKQIDLAPNLEMAKHIAALILKDKENFFLEKFIQFTEKEYEYIKIYEEEKAKNNAFDFSDLIIKPILMLRQSKSLKESIQSRFKVIFVDEYQDTNYSQFLFLKELYLDGMYFMVVGDEDQSIYSFRGARIENILEFEKTFDNVIKFYLVQNYRSNSNIVGIANEVISKNKNRYEKQITTQNSSNKRMKFLVFQSTSDEAEYFSNLLISNDIKTAILYRFNSQSFHFETSFLKKNIPYKVLGSIKFYDREEIKDIICLLRLFINKKDKISFLRMINKPSRGIGKTTLDKIISSLNDKDVNFNLFCASKKTLGLLKNRAKESLLLFLNVYEELGKKLFEDNYINLSAFIEDVVIRFGLLDYYRKFDKDEKLRNIDELINSGIEYSGTFEGLAIFLENSSLSPLISGDFKSNILLSSIHGVKGLEFDRVVISGLEKGLLPAEIEELTEDRLEEERRLFYVAITRAKSELIVTLNLRRAFRGSYKGTLPSVFFQDIDKNSYDIIFIPEYLKENFNNFFINNKRDIGFNIGDYIIYNGEKGIVVDSWYQSNLQFVKISLRNGKKAILSPEYIKKIVKV		700		3	Expressed	-1	 	
Batch02	BobuA.00155.b	Borrelia burgdorferi 	NP_212741.1	O51552				"rep helicase, single-stranded DNA-dependent ATPase (rep)"	Potential drug target		MSNDDFLKNSLNQFQYEAVTTIEGALLIIAGAGSGKTRVVTHRIAYLLLKGIAQREILALTFTNKAANEMKDRIKKILKSPLSNLMVSTFHAFGLYFLKENYKLLGYRKNFSIYDDNDRISLLKEILLDEGLFNKKVSLNSLSNVISLLKNGILTLNDLKEEDINIYRLYEERLRLYNSFDFDDLILKPKELLSNNSDIRNKYSKRYKYVLIDEFQDTSLIQYNFIRLLINHSNLCCVGDDDQSIYSWRGANYNNMLQFEKDYNVKEIKLEQNYRSAKNILDVANSVILNNKNRKEKTLWSSKMCSKVIDVFIFEDEIQESEFVANRIMQLSRLEDFKSKKIGVLMRTNALFKNVEMIFRRQGIKYKVSGGTSFFQRKEIKDIISYLNVIINPKSDYDLLRIINVPRRGIGKEYLKKIRDIADKKGCCIYDALCDITFSFTNISSYDKALNKQVIESIEDFVSFIEEYQYKFSITKNTYSNIIKEMIESIEYWGFLVSENPNSIKVAEYKYQNIEGFLSIIKNWESKQFGELRDLSSFLNYIVLQSNEVSEEAENININLMTVHSAKGLEFDYVFFIAVEDNIIPHHRIIEDSEVDLEEERRVFYVALTRAKDSLVITMANKRKKDRQIFDQLPSRFISEIPKEFLNFNYYADFVENKA		660		2	Cloned	-1	 	
Batch02	BobuA.00156.a	Borrelia burgdorferi 	NP_212854.1	O51662				threonyl-tRNA synthetase (thrZ)	Potential drug target		MSKDLDKEDILYKKRHSIAHVMAEAVLDLFPNTKIAIGPPIKDGFYYDFEFKKQITEDSLLDIENRMREILKTGSSFEKEIISVEQALEIFKDEPYKIDLIKNFDLQNEVSIYKSHNFVDLCRGPHVENMNKIDPKAFKLTSIAGAYWRGSEKNPMLTRIYGTLWNNEKELRSYLNLREEIKKRDHRKLGKELDLFSIHEEIGPGLVFFHPNGAKIRALIEDFWREEHSKNGYDILFTPHIGKSWLWQTSGHLDFYKDSMFEKIEMDKSDYYLKPMNCPFHIAIYNTGKHSYRDLPFRWAELGTVYRYEKIGALHGMMRARGFTQDDAHIICTHSQVLDEIKEVLRFAIYMWSKFGFSNPKAYLSTKPDKSVGNDSDWEMSLKVLEETLSDFEVPYEIDKGGGAFYGPKIDLKIVDSLEREWQMSTIQFDFNLPERFNMTYTAEDGKEKRPFMIHRALLGSIERFFGILVEHYGGAFPLWLSPVQVVIIPVNNIVEDYAIKVFNKFKNEGIRIKLDNSSSRMNAKIREYQAKKIPYMFIIGEREATEERISIRTRTNEQINGMKLDEALKFILFKIRDKEI		582		2	Cloned	-1	 	
Batch02	BobuA.00157.a	Borrelia burgdorferi 	NP_212169.1	O51066				DNA topoisomerase IV subunit A	Potential drug target		MDIRTVLKDNFLQYSSYVIKDRAIASVVDGFKPVQRRIIHSLFEMHDGNFHKVANVVGNTMKYHPHGDTSIYEALVNIANKDLFIEKQGNFGNLFTGDPASASRYIECRLTPLAFDVLYSKEITIYESSYDGRNNEPLLYPAKIPVILIQGSEGIAVGMAAKILPHNFNEILNAVKSELLGESYDIYPDFPTGGIVDVNEYADGNGKVLVRAKIETIDEKTIVIRELPFGETTESLISSIEKAIRKNYIKVSSINDFTAENVAIELSLPRGVYASEVIEKLYHYTNCQISISVNLLLLSERYPVVYTIKDLIKFHAAHLQKILKMELELQKSKILEKIFYKTLEQIFIEKKIYKLLETISKEENILSIILSEVLRHKESFSREVLKEDVENLLKIPIRKISLFDIDKNSKDIKILNKELKSINSNISSIRGYSINFIDLLLAKYSKEHQRKTKISLIKSKNVKEIATKNMKVYLNLAEGFAGTSLFDGEFIGNASYYDKILVFRENSYVLKNIEDKTFIDKKNVCALVYDINNSKEQIFSIIYFNRLDNFYYVKRFKIDKFITDKVYEFLGENDEFVDFSLNPEFVEFSTNKDIVKRIEIDNFMVKSRSSIGKRISSNNLKKVKFK		627		2	Cloned	-1	 	
Batch02	BobuA.00159.a	Borrelia burgdorferi 	NP_212715.1	O51528				DNA recombinase (recG)	Potential drug target		MFLHEFEYELKGIGGLGEKGVERLNNLQIFNVKDLIEFFPVKYEDRQNIQTFPDFSKVKSCDMMTVFTVLGHKKFGDSSKKNLKLTVKSINEEPFEILLFNRAFLENVFKIDKKFYIYSKFTYNDYSGLWSCSNFDSEVYSDKPERFKKILPVYSLTEGLTSKKISLYVKEALEYFFKFGQTDIPRFLIEKYSLLSLSDALKEIHFPSSLEMLEKAKKTLIYREIFLLQFFSRYRSSKILFREKKDLSKDLLEKVVSSLPFELTEDQKISIDEIFFDLNSSKPMNRLLQGDVGSGKTLVALLSGLPLIEAGYQVAFMAPTDLLARQHYDNLSNILAPFNISMTLLTGSLRKKDKEQALESIRNGTSGLIVGTHAIFYESTEFKRLAYVIIDEQHKFGVVQREELKNKGEGVDMLLMSATPIPRSFALTLFGDLEVSFIKTLPKGRLPITTYLARHGNEDKVYEFLRKELLKGHQVYFVYPLISSSEKFELKDVNNMCLKLKEVFGEYVVDMLHSKLPSDLKEEIMKNFYSKKVDILVATSVIEVGIDCPNATCMVVEHAERFGLSTLHQIRGRVGRSNLQSFFFLLYKEPLTSAGKFRLKTIKENLDGFKIAEEDLRLRGPGNLFGLEQAGYLKLKIANFVDDREIIVLVREELDLFFYDNSAYDKLDIDLLDNLFCSYLNAGRSI		687		2	Cloned	-1	 	
Batch02	BobuA.00162.a	Borrelia burgdorferi 	NP_212170.1	Q59189				DNA topoisomerase IV subunit B	Potential drug target		MKTQNYDESKIITLSSLEHIRLRSGMYIGRLGDGSNIDDGIYVLIKEIIDNSIDEFIMGYGNEIFIKKENNLISIRDYGRGIPLGKVIESVSVINTGAKYNDDVFQFSVGLNGVGTKAVNALSSKFLVRSTRNGKSFEALFSKGKLLESREIKSSDKDGTYVEFLADSEIFGKYSYSEDFLKRRFFHYACLNKGLIINYNDQIFESKNGLLDFLNSEIKSDDLLYDIVYYSSKTLEFAFSHTNNYGETYFSFVNGQYTNDGGTHQTGFREGFVRAINDFLKKTYSSTDIREGLVATLSVKIKDPIFESQTKNKLGNIETRGNVAKEVQKIISEILYKDKILAKLIEKKVVDNERLRKELSSVRKEARERAKKISFKIPKLKDCKFHFNDSSKQSEQTMIFLTEGDSATGSMVSCRDVYTQAIFSLRGKPQNMFEKNKSEIYKNEELYNMMVALGIEESIENLRYNKVVIATDADFDGFHIRNLLLTFFLTFFEDLILNGHMYILETPLFRVRNKKITTYCYSEEEKQKAILELKGGCEVTRFKGLGEISPNEFKGFIDINSIKLTKVDLFNIKEIKEKLGFYMGQNTPERRNFIMENLI		600		3	Expressed	-1	 	
Batch02	BobuA.00162.b	Borrelia burgdorferi 	NP_212570.1	P33769				"DNA gyrase, subunit B (gyrB)"	Potential drug target		MNGRFMNYVASNIQVLKGLEAVRKRPGMYIGSVSINGLHHLVYEVVDNSIDEALAGFCDRIDVIINLDNTITVIDNGRGIPTDIHEEEGISALELVLTKLHSGGKFNKGTYKVSGGLHGVGISVVNALSSFLEVYVNRDGKIFRQTFSKGIPTSKVEVVGESSVTGTKVTFLADSEIFETLDYNFDVLEKRLKELAFLNDKIYISIEDKRIGKEKSSKFYFEGGIKSFVDYLTNDSKAFQSEPYYIDGFINDVIVNVGLKWTESYSDNILSFVNNINTREGGTHVMGFRSGLTKAMNEAFKNSKISKKDIPNLTGDDFKEGLTAVISVKVPEPQFEGQTKSKLGNSEIRKIVEVVVYEHLLEIINLNPLEIDTILGKAIKAARAREAARKARESERKKNAFESLALPGKLADCTSKNPLEREIYIVEGDSAGGSAKMGRNRFFQAILPLWGKMLNVEKTREDKVITNDKLIPIIASLGAGVGKTFDITKLRYHKIIIMADADVDGSHIRTLLLAFFFRYMRDLIENGYIYIAMPPLYKIKYDNRIYYFYEEKEKEKFLDSIETKNRNSISLQRYKGLGEMNPTQLWETTMDPARRKMRLMNIDDAIEAEKIFVTLMGDLVEPRKEFIEQNALNVINLDV		640		3	Expressed	-1	 	
Batch02	BobuA.00169.a	Borrelia burgdorferi 	NP_212245.1	O51138				replicative DNA helicase (dnaB)	Potential drug target		MALAAFSNSALLFNDGAEKAVISSIFYNSDKIEQIAFHVRADDFYNETHKLIFKAMVSLYEKRENIDPITVFEEVSKHVSKTQLLIKKDLINLPDYLDSLSVYLPTDRTINVYAKIVKEQSVRRSILNVSKELNDYINDSTKSINEIVEESQQKILSIELDYSSKNLYHAKVIAERVHNEIYERSMKKKEANFGIPSGFRKVDSLIGGFRNSDFIIVGARPSIGKTAFALNIASYIALRKEEKKKVGFFSLEMTADALIKRIISSQSCIDSFKVQNSILSGQEIKSLNDIINEISDSELYIEDTPNISLLTLATQARKLKRFYGIDIIFVDYISLISFETKNLPRHEQVASISKSLKELARELEIPIVALSQLTRDTEGREPNLASLRESGALEQDADIVILLHRDKDFKFESSAEIEPIETKVIVAKHRNGPTGRADILFLPHITKFVNKDHQY		456		3	Expressed	-1	 	
Batch02	BrabA.00010.d	Brucella melitensis	YP_418276.1	Q2YL80				Short-chain dehydrogenase/reductase SDR:Glucose/ribitol dehydrogenase	Potential drug target		MKFEFENRTLVLTGANGGIGRAIAELFHASGANLVLTDLDREGLDAFAASLGSPERIATIKADASSADDAEKTVALAMERFGGIDFLVPSAGIYQAKPFAEMSDADWHRTISINLDGVFYLCKRALPALKEDSSIVTLASLAAYRGAYVNAHYGATKGAMVSMTRALSRELAPKTRVNGVSPGIIETPMTSELLKTRMDETMTQTPLKRLGKPSEIASVIAFLCSPAASFVTGETIQVNGGIYMA		245		10	Diffraction	-1	 	
Batch02	BrabA.00010.e	Brucella melitensis	YP_414992.1	Q2YQ97				7-alpha-hydroxysteroid dehydrogenase	Potential drug target		MSYESPFHLNDAVAIVTGAAAGIGRAIAGTFAKAGASVVVTDLKSEGAEAVAAAIRQAGGKAIGLECNVTDEQHREAVIKAALDQFGKITVLVNNAGGGGPKPFDMPMSDFEWAFKLNLFSLFRLSQLAAPHMQKAGGGAILNISSMAGENTNVRMASYGSSKAAVNHLTRNIAFDVGPMGIRVNAIAPGAIKTDALATVLTPEIERAMLKHTPLGRLGEAQDIANAALFLCSPAAAWISGQVLTVSGGGVQELD		255		17	In PDB	-1	 	
Batch02	BrabA.00010.f	Brucella melitensis	YP_415369.1	Q2YR33				Short-chain dehydrogenase/reductase SDR:Glucose/ribitol dehydrogenase	Potential drug target		MGEFAVVTGGSTGIGRHLVSAFADAGYAVAFSYRHDDDAAQSLVEAIEDAGGQALGLGCDVGRRAEVEAFFDEACDWFGDAPDVLVNNAGIQTWAPLLELSEEGWDDVICTNLKGCFLNTQAAAKRMVEADKGGAIVNIGSGCNKLAFPKLVSYTASKGGIEQLTKASAVELGPHGIRVNCVAPGAILNERTAQEQPDYAQSWAPITPLRRVGVPEDISGPVLFLVSDEARFVTGQTLWVDGGLFSQANWPYDG		254		5	Purified	-1	 	NR-16398
Batch02	BrabA.00010.g	Brucella melitensis	YP_419113.1	Q2YJS1				3-ketoacyl-(acyl-carrier-protein) reductase	Potential drug target		MSLEGKVALITGAGSGFGEGMAKRFAKGGAKVVIVDRDKAGAERVAGEIGDAALAVAADISKEADVDAAVEAALSKFGKVDILVNNAGIGHKPQNAELVEPEEFDRIVGVNVRGVYLMTRKLIPHFKENGAKGQECVILNVASTGAGRPRPNLAWYNATKGWVVSVTKALAIELAPAKIRVVALNPVAGETPLLTTFMGEDSEEIRKKFRDSIPMGRLLKPDDLAEAAAFLCSPQASMITGVALDVDGGRSI		252		17	In PDB	-1	 	
Batch02	BrabA.00057.b	Brucella melitensis	YP_413646.1	Q2YP14				ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase	Potential drug target		MGLFWNKKAGEVQSPSHDVAASGVDAISGQPNMASRLKGTLVARGLCKSYRGRQVVNGVSFGVRAGEAVGILGPNGAGKTTCFYMVTGLVPADSGSIEIDGFDVTSMPMYRRSRLGIGYLPQEASIFRGLSVENNIKAVLEVVEKDRARRASELDALLEEFHIAHLRKAPAISLSGGERRRLEIARALASRPNFMLLDEPFAGVDPIAVSDIQQLVRHLTSRGIGVLITDHNVRETLGLIDRAYIIHAGQVLTHGRPAEIVANPDVRRLYLGDQFTL		277		3	Expressed	-1	 	
Batch02	BrabA.00057.c	Brucella melitensis	YP_418273.1	Q2YL83				ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase	Potential drug target		MTKDILVLDQLNKSFGPAHIIRGVNLAVRDGERHAVIGPNGAGKSTLFHLISGNFTPSSGSIRFQGEEIGGLTPAAVNRKGLARSFQITNIFPGLTVFENIRLAVMRRYKVQFTFWRPVSSMRKVTAEVESLLEQVRLTARAYTLASQLSYSEQRSLEIGMTLASDPRLIILDEPMAGMSQEETDYTVGLIREITQNRTLMIVEHDMYVVFTLADRISVLVYGEIIATGTPKEIRENARVREAYLGEEAH		250		3	Expressed	-1	 	NR-16399
Batch02	BrabA.00057.d	Brucella melitensis	YP_418494.1	Q2YLC0				ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase	Potential drug target		MNTASGAIPVLHEAGPGTSQTASGIVLSARGLGKSFGGFHAVKNVDLDVEHARVHALIGPNGAGKTTVFNLLTKFLQPTSGEITLLGETITKTDPARVARKGLVRSFQISATFPHLTVLENVKVALQRPNGLATQFWRSLSALDRLDAQAVELLERVGLADARHALAADLSYGRKRALEIATTLALDPKVLLLDEPLAGMGHEDVHTIAALITDVAKDRAVLMVEHNLKVVADIAHHVTVLQRGEILASGDYATVSKDERVRTAYMGTEHE		271		2	Cloned	-1	 	
Batch02	BrabA.00057.e	Brucella melitensis	YP_418773.1	Q2YKR1				ATP/GTP-binding site motif A (P-loop):Ras GTPase superfamily:ABC transporter:AAA ATPase	Potential drug target		MSTVFEVSKLRKNFGGLAVTNDVSLSMAKGDRVALIGPNGAGKTTFVNLVTGNLAATSGTVTLGGENVSKLNAMQRVRRGLVRSFQVTRLFFDMTPEEHVALAILQREGKTGRILGNYRRMPQVMDEARDILHMLGLLPLAQLRVSEIAYGQQRLLEIALALALRPKVLLLDEPAAGVPQSDTGRIEEALDRLPPDLAVLMIEHDMDLVFRFAKRVVVLAAGTVIFDGLPQAVVQDARVREAYLGSYAQ		249		2	Cloned	-1	 	
Batch02	BrabA.00057.f	Brucella melitensis	YP_419030.1	Q2YK04				"Chaperonin clpA/B:Glycoside hydrolase, family 18/2:ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase:TOBE doma..."	Potential drug target		MTDYRIRFENISKSYGDFKVIDGLNLDIERGEFVSLLGPSGSGKTTLLMMLAGFENPSSGTIHVDGKSINSVPSYKRNMGVVFQNYALFPHMTVAENIAFPLQMRGVGKAQAAEKVARVLDMVQLSAMSERKPSQLSGGQQQRVALARALVFEPHVVLMDEPLGALDKQLREQMQLDIRALHNRLGLTIVFVTHDQSEALTMSDRIAVFNKGKIEQIGSPRAIYDEPQTRFVAEFIGETNLAEGTVESVEGSRILIRLKDGTAIAASSASRPISGQNVLLSIRPERIELGEADGAENRLAARVMDSVYQGDHLRIQLEAKAHNFVVRLDRKAREWQPGADVAASFKAADCWTILV		355		3	Expressed	-1	 	NR-16400
Batch02	BrabA.00057.g	Brucella melitensis	YP_419277.1	Q2YJA7				ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase	Potential drug target		MTALLEVRNLTKRFGGLTAVNNVSFTLNKGEILGFIGPNGAGKTTVVGLISGSIYPSSGEVYFKGARIDTVPMYRRAHMGIGRTFQIMKPFPGLSVLDNVAVGAMFGRKEAHHGLTAAREQARANLDFVGLGNAIDKRAEELGGSDRKRLELAKALAMQLELLLCDEVMAGLNLVELEEVIEVIRKVRDSGVTILVIEHVMKAIKSLSDRLMMLHHGEKIAEGSTDAVLSNAVVIEAYLGKKRA		244		3	Expressed	-1	 	NR-16401
Batch02	BrabA.00113.b	Brucella melitensis	YP_413946.1	Q2YMJ5				3-oxoacyl-(acyl carrier protein) synthase II	Potential drug target		MRRVVITGLGLVSPLASGVEETWKRLLAGESGARRVTEFEVDDLACQIACRIPVGDGTNGTFNPDLHMDPKEQRKVDPFIVYAVGAADQALDDAGWHPENDEDQVRTGVLIGSGIGGIEGIVEAGYTLRDKGPRRISPFFIPGRLINLASGHVSIKHKLRGPNHSVVTACATGTHAIGDAARLIAFGDADVMVAGGTESPVSRISLAGFAACKALSTERNDDPTAASRPYDEDRDGFVMGEGAGIVVLEELEHALARGAKIYAEVIGYGMSGDAFHITAPTESGEGAQRCMVAALKRAGIVPDEIDYINAHGTSTMADTIELGAVERVVGEAAAKISMSSTKSSIGHLLGAAGAAEAVFSTLAIRDNIAPATLNLDNPAAQTRIDLVPHKPRERKIDVALSNSFGFGGTNASLVLRRYTA		420		17	In PDB	-1	 	
Batch02	BrabA.00113.c	Brucella melitensis	YP_414300.1	Q2YNI5				3-oxoacyl-(acyl carrier protein) synthase II	Potential drug target		MTKYTDHLGRPIVAISGAGVVSSLGQGKDDNWAALTGGKSGIHTITRFPTENLNTRFSGTVDFLPESESGASALSEALARLAGEEALAQSGLSVTAFGGPLFLAAPPVELDWKSRFALDASVKDEGPASYQLLLEACRRARHDALFNTTQFGYIAERLSQAFGTRGLPITLSTACASGATAIQLGVEAIRRGESDRVLSIGTDGSVSAEALIRFSLLSALSTQNDKPEKASKPFSKDRDGFAMAEGSGALVMESLESAVARGAKVLGILAGCGEKADDFHRTRSKPDASPAIGTVRAALADAGLTEDQISYINAHGTSTPENDKMEYLALSTVFGDKLGSIPVSSNKSMIGHTLTAAGAIEAVFSLLTIQTGTLPPTINYDNPDPAIPLDVVPNVKREAKVAAVLSNSFGFGGQNTSLVLTPNPN		425		3	Expressed	-1	 	
Batch02	BrabA.00133.a	Brucella melitensis	YP_414139.1	Q2YN22				cysteinyl-tRNA synthetase	Potential drug target		MPDTTPQLRLYNTLTRTKEAFAPIDAKNVRMYVCGPTVYDFAHIGNARPVIVFDVLFRLLRHVYGAQHVTYARNITDVDDKINARAARDYPDLPFNEAIRKVTESTNAQFQADVTALGNLQPTVQPRATEHMDEMRAMIDRLVQRGVAYVAQDHVLFSPSAMNARKGPRYGALARRSLDEMLAGARVDVASYKRDEMDFVLWKPSKKGEPGWPSPAGIETLGRPGWHIECSAMSMAKLLEPFGGGLKCDDPERNQFDIHGGGIDLVFPHHENEIAQSCCALGTERMANIWMHNGFLQVEGQKMSKSLGNFITIRDVLNDGLPQLGEWGDNTVRDHWAGLAARLSMLQTHYREPINWTAQRLAESADELHRWYGLLRDEGFGAPEKLSHASAVAAALCDDLNSWAAITALRQAFKVRDVAALGEGMALMGLLDPYFVTASDVPIFARADVDASAIAARIAERLNFINAKNWAEADRIRDELLQEGVQLKDSKDPATGERITTWDVVG		506		5	Purified	-1	 	
Batch02	BrabA.00138.a	Brucella melitensis	YP_414477.1	Q2YQ19				Alanyl-transfer RNA synthetase	Potential drug target		MAYETEALFREDSYLSTAEGTVLAIAGNGGIILDRTNFYATSGGQPGDTGFFERADGSRIEIATTVTGETKNEIVHMPAQGQQMPDVGEKLVLHIDWQRRYKLMRMHTACHLLSVACPFPITGAAVGEDESRVDFDLPDQSYTKESVTEKLMELVQANAPVSIHWISDEEFLANPDIVKSKNVRPPVGLGRIRLVAIGENGSVDSQPCGGTHVSETQEVGEIHIGKIEKKGKENRRFRIRFGSLPQA		247		7	Crystallized	-1	 	
Batch02	BrabA.00140.a	Brucella melitensis	YP_418324.1	Q2YIP5				para-aminobenzoate synthase component I	Potential drug target		MTRPGNKPLILFRDDKAGRDVLFAAPSRIIRADTPDEFEPAWEAMQRAHEAGEWLAGYLSYEAGYLLEPKLRPLLPEGRKTPLLCFGVFDGPSDEQLHVRDSENATYLRNPVAQWSFEDYAPRFERLYRHLREGDCYQGNLTFPVTAQWGGDPLILFNMLAKRQPVRYATYCDLGGPVVLSRSPELFFKVDGDGWIETHPMKGTMPRGATPEEDERNRQFLLNDPKNQAENRMIVDLLRNDISLVSEVGSLDVPELFRVESYPTVHQMISRVRARLKSGLHLRAVFAALFPCGSITGAPKISAMKILRRLETGPRDIYCGSLGWIEPGGRMRFNVAIRTISLLGGNRAIFNVGGGVVFDSTAQAEYEECLLKARFATGQKPLPANRIIS		389		2	Cloned	-1	 	
Batch02	BrabA.00143.a	Brucella melitensis	YP_418655.1	Q2YL29				3-ketoacyl-(acyl-carrier-protein) reductase	Potential drug target		MNRLQDKVAIITGAGSGFGLGMARRFAAEGARVVLADVNVKRVEDGLADISSNGISIQADVSRKDDMERVARTAFEEFGRIDIMVNNAGFTHRNMPLTDVDEHNFDLIVAVNMKALYYSTQLVVPIMEHQGGGVIINTASATGLHPRKGLTWYCASKGWVVSATKAMALELAERNIRVNCLCPAESDGEGLKMFLAEDTPEARAALKSTIPLGRFSTPKDVAEAALWLASDDASMVTGVALGIDGGYSI		249		5	Purified	-1	 	
Batch02	BrabA.00145.a	Brucella melitensis	YP_414208.1	Q2YNA7				aspartyl-tRNA synthetase	Potential drug target		MHRYRSHTCAALRKTDVGSNVRLSGWVHRVRDHGGILFIDLRDHYGITQIVADPDSPAFKVAETVRGEWVIRVDGEVKARADDAVNTNLPTGEVEIFATEIEVLSPAKELPLPVFGEPDYPEDIRLKYRFLDLRRETLHKNIMSRTKIIAAMRRRMTEIGFNEFSTPILTASSPEGARDFLVPSRIHPGKFYALPQAPQQYKQLLMVAGFDRYFQIAPCFRDEDPRADRLPGEFYQLDLEMSFVTQEEVWETMEPVMRGIFEEFAEGKPVTKVFRRIAYDDAIRTYGSDKPDLRNPIEMQAVTDHFAGSGFKVFANMIANDAKVEVWAIPAKTGGSRAFCDRMNSWAQSEGQPGLGYIFWRKEGDKLEGAGPIAKNIGEERTEAIRKQMGLEDGDACFFVAGLPSKFYKFAGDARTRAGEELNLVDRDRFELAWIIDFPFYEWDEDNKKIDFAHNPFSLPQGGMDALENMDPLEIKAYQYDLVCNGFEIASGSIRNQLPEVMVKAFEKVGLSQQDVEERFGGLYRAFQYGAPPHGGMAAGIDRVIMLLVGAKNLREISLFPMNQQALDLLMGAPSEVSPAQLRDLHVRLAPVQKS		595		1	Selected	-1	 	
Batch02	BrabA.00146.a	Brucella melitensis	YP_413537.1	Q2YPM5				prephenate dehydratase	Potential drug target		MKTNRISFQGEAGANSDTACRNMFPDMEPLPCPTFEDAFNAVETGAADLAMIPIENTLAGRVADIHYLLPLADMHIVGEYFLPIHFQLMVLPGVRREEIKTVHSHIHALGQCRNVIRQNGWKGVIAGDTAGAARLVADVKDRSMAALAPRLAADLYGLDILEENVEDSENNVTRFVVLSKNKQWAARPENDERIVTTFVFRVRNVPAALYKALGGFATNGVNMTKLESYQLGGRFIATQFYADIEGHPEERSVQLALEELRFFTKEVRILGVYKGSDIRGTQLLAAE		287		5	Purified	-1	 	
Batch02	BrabA.00148.a	Brucella melitensis	YP_415256.1	Q2YLS9				site-specific tyrosine recombinase XerC	Potential drug target		MATNSEFLIPARADLAAAREEWLKSLKTMRRLSDNTLIAYERDTRQFLQFLTGHLGEPPSLKEIGNLRIADLRSFLANRRNDGAGARTLGRGLAGVRSLLRHLEKRGLVNAAGASAMRAPRQPKSLPKPLTADDARRVVSADGQMAEEPWIAARNAAVLTLLYGCGLRISEALGLSGDALSDPSARSMTITGKGSKTRLVPLLPAVHKAVAQYRALCPFDLSAGQPLFRGAKGGPLHAAIIQREMQKLRAGLGLPDSATPHALRHSFATHLLGRGGDLRTIQELLGHASLSTTQVYTGVDTQRLLEVYDKTHPRA		315		3	Expressed	-1	 	
Batch02	BrabA.00148.b	Brucella melitensis	YP_415362.1	Q2YR40				site-specific tyrosine recombinase XerD	Potential drug target		MRASLAIENFLEMMSAERGAAQNTLESYRRDLEAAAEELAAKGVNLAEAETGHIRMTLDTMAAQGFAPTSQARRLSALRQFFRFLYSEGFRQDDPTGILYAPKKQKPLPKIMSVENVGKLLDRAALEANEAAEPGERIKALRLHALLETLYATGLRVSELVGLPVTVARTDHRFLLVRGKGSKDRMVPLSRKARDALQKFLTLRDSLPGSDDNPWLFPAFSESGHLARQVFARELKGLAARAGLAASSASPHVLRHAFASHLLQNGADLRTVQQLLGHADISTTQIYTHVLEERLHKLVSEHHPLAD		307		3	Expressed	-1	 	
Batch02	BrabA.00149.a	Brucella melitensis	YP_413936.1	Q2YMH3				SAM (and some other nucleotide) binding motif:Generic methyltransferase:Cyclopropane-fatty-acyl-phospholipid synthase	Potential drug target		MYGMLRTVLTHMIKTGDLTVTDADGSKTRFGDRTGTPVHVHFKTAHAQRAVAFNPELKLAECFMDGEIDFLEGDIYTLLQVVFENTGPTAATEPWMKAAGKLRVLFRRFQQMNTISRSSSNIKSHYDLSGELYDLFLDPDKQYSCAYFDPPNATLAEAQLAKKRHIAAKMLVKEGDKVLDIGCGWGGMGLYLARHLKANVTGVTLSEEQHAIANQRARDEGLADRAKFELTDYRNINDKFDRLVSVGMFEHVGVGHFAEYFQHVARLMKPDGVFLLHAIGRSDGPGATNPFIRKYIFPGGYIPALSEVLPHIEKAGLYVTDIEILRLHYAETLKAWREAFLANRDKAKALYDERFCRMWEFYLAASESAFRWQNMMVFHIQITHRQEAVPLTRNYIEAEEKRLKRLDSAPKGANSETRSVKKSINA		426		3	Expressed	-1	 	
Batch02	BrabA.00150.a	Brucella melitensis	YP_418832.1	Q2YKK2				Bacterial transferase hexapeptide repeat:ATP/GTP-binding site motif A (P-loop):Nucleotidyl transferase	Potential drug target		MTDRTCLSIVLAAGEGTRMKSNLPKVLHRVAGLPLVCHVVNAVRGTGKSDVALVVGRGAEDVRSAVEKIAGPVSAFEQKERLGTAHAVLAAHEAIARGYDDLLIVFGDTPLIEAQSLLAARERLAQGADLVVIGFRPASPHGYGRLIEEGGQLVAIIEEKEATDEQKKIGFCNGGLMALRGQHALALLDAVGNDNAKGEYYLTDIVAIAHGKGLNVTAIEVPVDNVIGINNRAELAEAETIWQNRKRRELMLSGVTLIAPETVFFSYDTVIEPDVVIEPNVFFGPSVHVASGALIHSFSHLEGAQVGEKAEIGPFARLRPGADLAEKSKVGNFCEVKNAKVGKGAKINHLAYIGDAVIGASSNIGAGTITCNYDGYNKFKTIIGDNAFIGSNSSLVAPVEIGDNAYIASGSVITADVPADALALGRARQETKEGRAKILREKYAAIKAAKSVSK		454		7	Crystallized	-1	 	
Batch02	BrabA.00153.a	Brucella melitensis	YP_414867.1	Q2YM25				DNA primase	Potential drug target		MRFPPSFLDEIRDRVPISTLIGTRVSFDRKKSNPPKGDFWACCPFHGEKTPSFHCEDRKGRYHCFGCGVTGDHFKFLTDLEGLSFPEAVERVADMAGVPMPARAPEMEKREAQRATLYDVMELAAQFFESQLQSATGAKARAYLRDRGLSTATQQAFRMGYAPESRNALKEFLAGKGVSREQIEACGLVVHGEGIAVSYDRFRDRVMFPIEDLRGRIIAFGGRALSADAPAKYLNSPETELFHKGRVLYNGLRARKACQPQGGEPAKPIIAVEGYMDVIALAQAGIHHVVAPLGTALTEEQLELLWRISPEPILCFDGDGAGLRAAYRAADLGLPVLQPGKSLRFALLPEGQDPDDLVKAEGPSAFHAVLRDARPLVEMVWTRETAGGVFDTPERRAELEARLREITSRIANEDIRRHYSQDMRERAQAFFGQGRQGFQNGGQRSQSFTRRNEGARGRGGPAGSGRLAISDSLARSTLVKGGRQGGAAHAPLRETAIVLTLLNHPRLIEEDFETLAALDLGHDALKTLHLAMLDVLAAGRVDDGIAMRRALVDAGHGDLIKMLEQVVKGAKLWTATTLAAEDDAREALRQALHLHQRARTLHKELRAVEAALETDETGELFARLRDIQNQILKADATEALIDGFGLSSGRPHGGF		655		5	Purified	-1	 	NR-16322
Batch02	BrabA.00156.a	Brucella melitensis	YP_414489.1	Q2YQ07				threonyl-tRNA synthetase	Potential drug target		MSNTVSLQFPDGSVREYDASMTGAALAESISKSLAKKAVAYAVDGTVRDLSDPLGASGKLEIITREDPRALELIRHDTAHVLAEAVQELFPGTQVTIGPVIENGFYYDFARNEPFTLDDLPVIEKKMREIIQRNKPFTKEVWSREKAKQVFSDKGESYKVELVDAIPAGQDLKIYYQGDWFDLCRGPHMASTGQIGNSFKLMKVAGAYWRGDANNPMLTRIYGTAFANDNDLQAYLHMLEEAEKRDHRRLGREMDLFHFQEEGPGVVFWHAKGWKMFQNLVSYMRRRLDSHGYQEVNTPQVLDKSLWETSGHWGWYRDNMFKVTVAGDDTDDDRVFALKPMNCPGHVQIFKHGLKSYRDLPIKLAEFGNVHRYEPSGALHGLMRVRGFTQDDAHIFCTEEQMAAECLHINDLILSVYKDFGFEEITIKLSTRPEKRVGSDELWDRAESVMMTVLEQIRQQSNNIKTGILPGEGAFYGPKFEYTLKDAIGREWQCGTTQVDFNLPERFGAFYIGADSEKKQPVMIHRAICGSMERFLGILIENFAGHMPLWFAPVQVVVATITSDADEYAKEAAAKLKAAGLQVVTDLRNEKINYKVREHSLQKVPVILVCGKREAEEKTVNMRRLGSRDQESMTLDEAIARLCEEATPPDLLRLKNAG		658		7	Crystallized	-1	 	
Batch02	BrabA.00159.a	Brucella melitensis	YP_418834.1	Q2YKK0				"DEAD/DEAH box helicase:RecA bacterial DNA recombination protein:Helicase, C-terminal:ATP/GTP-binding site motif A (P-loop):Ha..."	Potential drug target		MFDPMRPSMLDPFFASVRSLSGIGPKVAVLLGKLLGTDVPGGEPKIGQLLFLPPHSIIDRRNRPGIAFAQEGAIVTLEVTVDQHQPAPKGRGNVPHRVFAHDDTGEIALTFFHAQLPWLQKMLPEGETVIVSGKVEWFNGRASMVHPDYIASMDDAASLPLVEPVYPLTAGLSPKTLGRAIKEALTRVPVLPEWIDAPLLAREGFPAFQQALNTLHQPEDPGDIALESITRRRLAYDEFLAGQLALALVRAKTRRLSGRPLEGTGNIVAEIMRHLPYRLTKAQEQAVREIITDLKSPQRMLRLLQGDVGSGKTVVGLLSMAHAAESGGQSALMAPTEVLARQHFATIAPLAEKAGLKAALLTGREKGRERNAVLEGLKSGEIDIVIGTHALFQEKVEYHDLVFVIIDEQHRFGVHQRLMLTAKGSAPDMLVMTATPIPRTLVLTAFGDMDVSKLTEKPVGRQPITTAIVPMERMGELVERIRKAVSEDQKIYWICPLVEESEVVELTSAEERFESLKSVFGERIGLIHGRMSGAEKDEAMRAFKQGETRLLVATTVIEVGVDVPDATIIVIEHAERFGLSQLHQLRGRVGRGDKPSTCLLLYKGPLGEIAQARLKVMRETEDGFRIAEEDLKLRGEGELLGTRQSGTPGFRLASIEAHGDLLEIARKDARYILASDPDLESERGQALRVLLYLFGRDEAIRLLRAG		706		2	Cloned	-1	 	
Batch02	BrabA.00162.a	Brucella melitensis	YP_418824.1	Q2YKL0				DNA topoisomerase IV subunit B	Potential drug target		MDDSNDLFSRVVNNARERQMERQTGENTVAQPVVQPAPSAPKPVPAAAKAPPAASGGDDYNASSIRVLEGLEPVRLRPGMYIGGTDEKALHHLFAEVIDNSMDEAVAGHANFIEVTVDKEGFVTVSDNGRGIPVDEHPQVPGKSTLEVIMTKLHAGGKFDGKAYETSGGLHGVGVSVVNALSDVLEVEVARNRRLYRQCFSRGIPQGGLEELGEVHNRRGTRVRFHPDPEIFGKNAHFDPHRLYRMARSKAYLFGGVEIRWNCDPSLLDPKKETPEKAVFHFPGGLKDYLEASLGKEHQVTREVFAGRTEKQGGHGAVEWAVAWFGGDGFVHSYCNTIPTGDGGTHEAGLRIALTRGLKAYAELTNNKRASIITTDDVMVSAAGMLSVFIREPEFVGQTKDKLATVEAQRLVENAIRDPFDHWLAASPQEASRLLEWVIDRADERLRRRQEKETVRKSATRKLRLPGKLADCTQNAAAGAELFIVEGDSAGGSAKQARNRANQAILPLRGKILNVASAGREKLTANQQIADLVQALGCGTRKNYREDDLRYDRVIVMTDADVDGAHIASLLITFFYQEMPELIRNGHLYLAVPPLYRLSQGGKTAYARDDAHKEELLRTVFTGRGKIEIGRFKGLGEMRADQLKETTMDPAKRTLLRVQVDEEYGDETRNTVDDLMGTKPEARFRFIQDRAAFVEELDI		699		2	Cloned	-1	 	
Batch02	BrabA.00163.a	Brucella melitensis	YP_415447.1	Q2YQV5				phenylalanyl-tRNA synthetase subunit alpha	Potential drug target		MSDLEQLERQILEDIAAAVDEQGIEAVRVAALGKKGTVSEKLKTLGGMSPEERQMQGPAINGLKNRVTEALSERRTELRKAAVAARLEREKVDVTLPVRESAASRGRIHPISQVIDEITAIFADMGFSIAEGPDIETDYYNFTALNFPEGHPAREMHDTFFFNPDEKGERKLLRTHTSPVQVHTMEKFAAMRDKEGRDEPIRIVIPGKTYRMDSDATHSPMFHQVEGLVVDKSANVANMKWVLEEFCKAFFEVPSVKMRMRPSFFPFTEPSVEVDIQCDRSGPHVKFGEGNDWLEILGCGMVHPNVLRMSGYDPEVYQGFAWGMGIDRIAMLKYGMPDLRAFFDADVRWIEHYGFRPLDIPTLFGGLSA		369		7	Crystallized	-1	 	
Batch02	BrabA.00164.a	Brucella melitensis	YP_414321.1	Q2YNJ9				arginyl-tRNA synthetase	Potential drug target		MNIFADFDARIKKTFQDIDLKPKDGGELDLSRIGVEPPRDASHGDIATNAAMVLSKAVGQNPRELAARIAEALKADEDVESVDVAGPGFINLRLKASYWQRELLVMLNEGTDFGRSRLGAGKKVNVEYVSANPTGPMHVGHCRGAVVGDVLANLLKFAGYDVVKEYYINDAGAQIDVLARSVMLRYREALGESIGEIPAGLYPGDYLVRVGQELAGEFGTKLLEMPEAEALAIVKDRTIDAMMAMIRADLDALNVHHDVFYSERKLHVDHARAIRNAINDLTLKGHVYKGKLPPPKGRLPEDWEDREQTLFRSTEVGDDIDRPLMKSDGSFTYFAGDVTYFKDKYDRGFNEMIYVLGADHGGYVKRLEAVARAVSDGKAKLTVLLCQLVKLFRNGEPVRMSKRAGEFITLRDVVDEVGRDPVRFMMLYRKNDAPLDFDFAKVTEQSKDNPVFYVQYASARCHSVFRQAADQLGLVDLDRVAMGSHFEKLTDESEIALVRKLAEYPRLIESAAIHQEPHRLAFYLYDLASSFHSQWNRGAENPDLRFIKVNDPDLSLARLGLVQVVSDVLTSGLTIIGADAPTEMR		585		5	Purified	-1	 	
Batch02	BrabA.00167.a	Brucella melitensis	YP_414950.1	Q2YRS8				"Glutamine amidotransferase class-I:Carbamoyl-phosphate synthase, GATase domain:Anthranilate synthase component I and chorisma..."	Potential drug target		MNAKTADSEIFQHETAGGIIVERVRHLTAYKGAIESYIDVLNEWRGAVFSSNYEYPGRYTRWDTAIVDPPVVITSRARTMRIEALNARGVILLRPILDTVKALSEVKIDQSGENRIDLTIVEPVGTFTEEERSRMPSVFTVLRAIVGLFFSEEDANLGLYGAFGYDLAFQFDPIQYKLKRPDDQRDLVLFIPDEIFVADHYAARAWVDRYEFRCGGSSTHGLDRATPVVPFKPSERKLARGDHNPGEYARLVERAKESFKRGDLFEVVPGQTFYERCHTAPSEIFRRLKSINPSPYSFFINLGESEYLVGASPEMFVRVNGRRIETCPISGTIKRGEDAISDSEQILKLLNSKKDESELTMCSDVDRNDKSRVCEPGSVRVIGRRQIEMYSRLIHTVDHIEGRLRDGMDAFDGFLSHAWAVTVTGAPKLWAMRFLEENERSPRAWYGGAIGMMHFNGDMNTGLTLRTIRIKDGVAEIRAGATLLFDSNPDEEEDETELKASAMIAAVRDAQKSNQIAEESVAAKVGEGVSILLVDHEDSFVHTLANYFRQTGAKVSTVRSPVAEEIFDRVNPDLVVLSPGPGSPQDFDCKATIDKARKRQLPIFGVCLGLQALAEAYGGALRQLRVPVHGKPSRIRVSKPERIFSGLPEEVTVGRYHSIFADPERLPDDFLVTAETEDGIIMAFEHKHEPVAAVQFHPESIMTLGHNAGMRMIENVVTHLAGKHKARRTNY		731		4	Soluble	-1	 	NR-16323
Batch02	BrabA.00168.a	Brucella melitensis	YP_414535.2	Q2YPW1				"bifunctional 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase/2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase protein"	Potential drug target		MQAQSLAEVTVISKAAAVIVAAGRGERAGQSAEGPKQYRLIGAEAVLARTLRAFTDCPLIGTIAVVIHPDDHALYRRAVPEKHENVILVTGGPTRQESTRLGLLALKDEAPQYVLIHDGVRPFIGQDLLERIIANLTPDNGVLPALAVSDTLKRAAADGMVETTISRTGLFAAQTPQAFPYAPILDAHEKAFAINRTDFTDDAAIAEWQEIAVRIIEGSADNTKLTWAKDIEMADKRLRQDHAVFPDIRTGNGYDVHSFEPGDHVTLCGVKIPHEAKLNGHSDADVALHALTDALLATRGAGDIGTHFPPSDPQWKGAASRIFIEHAAKIVREAGGRIANVDVTLISEAPKIGPHRAAMTQALCDMLGIAADRVSIKATTNEKLGFVGRREGIAAIATATVIYPGEVPE		409		5	Purified	-1	 	
Batch02	BrabA.00169.a	Brucella melitensis	YP_413935.1	Q2YMH4				replicative DNA helicase	Potential drug target		MAEAAVRKLDDARDQKDVRYREAPHNIEAEQALLGAILINNDAFYRVSDFLKPTHFLEPLHRRIYEIATDLIRVGKMANPVTMKTFLPTEGKVGDLSIFQYVTRLATEAVTIINAEDYGRAIYDLATRRALIGIGEDMVNIAYDAPVDMAPQEQIEDAERRLFELAETGRYDGGFLPFKDAVTTAVDMANAAFMRDGHLSGISTGIHALDSKMGGLQPSDLIILAGRPGMGKTSLATNIAFNIANAYEPDQQADGTIKAANGGVVGFFSLEMSAEQLATRIISEQTEVSSSKIRRGEITETDFEKLVACSQVMQKIPLYIDQTGGISIAQLAARARRLKRQRGLDVLVIDYVQLMTGSSKASAQNRVQEITEITTGLKALAKELNVPIIALSQLSRQVESRDDKRPQLSDLRESGSIEQDADVVLFVFREEYYVKNLEPRDKFDPKYEEWKQHFEKVRGTADVIIAKQRHGPTGTVKLAFQSEFTRFADLADGSYLPEQYE		501		2	Cloned	-1	 	
Batch02	BrabA.00171.a	Brucella melitensis	YP_414231.1	Q2YNB9				3-oxoacyl-(acyl carrier protein) synthase III	Potential drug target		MIRSVVRGIGSALPKRVMKNTDFEGIVETSDEWIVQRTGIRERHIAGEGETTVSLGAAAARAAIENAGLQPSDIDLVLLATSTPNNTFPASAVAIQRELGITRGFAFDLQAVCSGFIYAITTADLYIRGGMARRVLVIGAETFSRILDWTDRTTCVLFGDGAGAIVLEAAEGHGLTSDRGILAANLRSDGNHKEKLYVDGGPSTTQTVGHLRMEGREVFKHAVGMITDVIEASFEATGLTAEDIDWFVPHQANKRIIDASAKKLHIAEEKVVITVDRHGNTSAASVPLALATAVADGRIKKGDLVLLEAMGGGFTWGAVLVRW		323		5	Purified	-1	 	
Batch02	BrabA.00171.b	Brucella melitensis	YP_418920.1	Q2YKB4				3-oxoacyl-(acyl carrier protein) synthase II	Potential drug target		MTVCSSRLAGFGHAVPDRRVENAEIEAQLGLETGWIERRTGIRCRRWAMPDETLSHLAASAADMALSDAGIERSDIALTLLATSTPDHLLPPTAPLLTHWLNLQNSGAADLAGACTGFLYALVLADGFVRAQGKPVLVVAANLLSRRINMAERASAVLFGDAAGAVVLAPSAKANSFQSQFITNGSHYDLIKVPAGGSARAYAPERDASEFLMTMQDGRAVFTEAVRIMSGASQNVLASAAMLPQAIDRFFPHQANIRIVDKVCETIGVPRAKAASTLETYGNSSAATIPLSLSLANLEQPLREGERLLFAAAGAGMTGGAVLMQV		326		2	Cloned	-1	 	
Batch02	BupsA.00010.c	Burkholderia pseudomallei	YP_337448.1	Q3JG55				enoyl-(acyl carrier protein) reductase	Potential drug target		MRLQHKRGLIIGIANENSIAFGCARVMREQGAELALTYLNEKAEPYVRPLAQRLDSRLVVPCDVREPGRLEDVFARIAQEWGQLDFVLHSIAYAPKEDLHRRVTDCSQAGFAMAMDVSCHSFIRVARLAEPLMTNGGCLLTVTFYGAERAVEDYNLMGPVKAALEGSVRYLAAELGPRRIRVHALSPGPLKTRAASGIDRFDALLERVRERTPGHRLVDIDDVGHVAAFLASDDAAALTGNVEYIDGGYHVVG		253		10	Diffraction	-1	 	
Batch02	BupsA.00010.d	Burkholderia pseudomallei	YP_332645.1	Q3JUV8				3-ketoacyl-(acyl-carrier-protein) reductase	Potential drug target		MRLSGKTAVVTGAGSGFGEGIAKTFAREGACVVVNDLHAAAAERVASEIALAGGRALAVAGDVSRGEDWQALRDAALAAFGSVQVVVNNAGTTHRNKPVLDITEAEYDRVYAINMKSLFWSVQTFVPYFRGAGGGAFVNIASTAAVRPRPGLVWYNSTKGAMLTASKTLAAELGADRIRVNCVNPVLGETGLTSEFMGVPDTPENRARFVATIPLGRLSTPQDVANAALYLASDEAAFVTGACLEVDGGRCV		252		2	Cloned	-1	 	
Batch02	BupsA.00010.e	Burkholderia pseudomallei	YP_333724.1	Q3JRS9				acetyacetyl-CoA reductase	Potential drug target		MVMSQRIAYVTGGMGGIGTSICQRLHKDGFRVVAGCGPNSPRRVKWLEDQKALGFDFYASEGNVGDWDSTKQAFDKVKAEVGEIDVLVNNAGITRDVVFRKMTREDWQAVIDTNLTSLFNVTKQVIDGMVERGWGRIINISSVNGQKGQFGQTNYSTAKAGIHGFTMSLAQEVATKGVTVNTVSPGYIGTDMVKAIRPDVLEKIVATIPVRRLGSPDEIGSIVAWLASEESGFSTGADFSLNGGLHMG		248		17	In PDB	-1	 	
Batch02	BupsA.00010.f	Burkholderia pseudomallei	YP_334857.1	Q3JNJ6				short chain dehydrogenase	Potential drug target		MADRPPRSGTVNRLAGKVAIVTGAGRGIGAAIARAFVREGAAVAIAELDAALAEESADAIARDTAGARVLAVPTDVAQAESVAAALARTERAFGPLDVLVNNAGVNVFGDPLALTDEDWRRCFAIDLDGVWNGCRAALPGMVERGRGSIVNIASTHAFKIIPGCFPYPVAKHGVLGLTRALGIEYAPRNVRVNAIAPGYIETQLTHDWWSAQPDPQAARRETLALQPMKRIGRPDEVAMTAVFLASDEAPFINASCITIDGGRSVLYHD		269		4	Soluble	-1	 	
Batch02	BupsA.00010.g	Burkholderia pseudomallei	YP_336172.1	Q3JJT1				acetoacetyl-CoA reductase	Potential drug target		MQAKRVAFVTGGMGGLGAAISRRLHDAGMAVAVSHSERNDHVSTWLMHERDAGRDFKAYAVDVADFESCERCAEKVLADFGKVDVLINNAGITRDATFMKMTKGDWDAVMRTDLDAMFNVTKQFIAGMVERRFGRIVNIGSVNGSRGAFGQANYASAKAGIHGFTKTLALETAKRGITVNTVSPGYLATAMVEAVPQDVLEAKILPQIPVGRLGRPDEVAALIAFLCSDDAGFVTGADLAINGGMHMS		248		17	In PDB	-1	 	
Batch02	BupsA.00010.h	Burkholderia pseudomallei	YP_337614.1	Q3JFN9				3-ketoacyl-(acyl-carrier-protein) reductase	Potential drug target		MNGVDSRRAAPPRGGLAADFRGRTALVTGAAQGIGAAIADAFAAAGASVAIADVQGDAAAAFAARLAARGAADGQTVRAYRVDAARRDELFGLVAQAEADSGRLDIVVHNAAYFPLTPFGAIAPDVLERTLAVNLSALFWLTQAALPAFERVGRGRVLATSSVTGPRVAYPGLAHYAASKAGVNGFIRAAALELARRNVTVNGVEPGMIRTPAAGNLGDAAHGERIARGVPLGRLGEPEDIAAAMLFLASDAAGYITGQTIVVDGGATLPETAAALG		277		4	Soluble	-1	 	
Batch02	BupsA.00057.b	Burkholderia pseudomallei	YP_331616.1	Q3JXT7				"branched-chain amino acid ABC transporter, ATP-binding protein"	Potential drug target		MILGDTILETRGLTKEFKGFTAVNGVNLRVRRGSIHALIGPNGAGKTTCFNLLTKFLKPTSGQIVYNGIDITDERPSQIARRGVIRSFQISAVFPHLSALQNVRIGLQRSLGTAFHFWRSERLLKRLDDRAMDLLTQVGLTDFAHVPTVELAYGRKRALEIATTLAMEPELMLLDEPTQGMGHEDVDRVTALIKKVANGRTILMVEHNMNVIAGISDTITVLQRGEVLAQGTYAEVSKNPLVVEAYMGSADAALAGAHA		259		5	Purified	-1	 	
Batch02	BupsA.00057.c	Burkholderia pseudomallei	YP_331682.1	Q3JXM1				ABC transport system ATP-binding protein	Potential drug target		MIEISNLTVQFGGTRVLDALDAKLAAPICGLIGPNGAGKTTLLNVLSGFLRPRAGSVALDGRALLALSVAERVRAGVRRTFQTEQIVEDLSVHDNVLALAEHVMPALAARDDTRRALELVGLADVAHAQGAALNLYQRRMLELGKALVGAPRLLLLDEPGAGLNETEAARLADVIVRIPECVGAQVLLIDHDVDLIDAVCEATLVLDFGKRLALGPTRAVLDDPLVRSAYLGQAFDEHEA		240		3	Expressed	-1	 	
Batch02	BupsA.00057.d	Burkholderia pseudomallei	YP_332179.1	Q3JW74				"ABC transporter system, ATP-binding protein"	Potential drug target		MNALPNRQPAGTTSSLVVRNLKKRYGSRTVVKDVSLDVKSGEVVGLLGPNGAGKTTSFYMIVGLVPLDAGDISLNGSPISLMPIHKRASLGLSYLPQEASVFRKLTVEQNVRAVLELQHDENGKRLSKDAIGARTEALLEELQIAHLRENPALSLSGGERRRVEIARALASNPSFILLDEPFAGVDPIAVLEIQKIVKFLKQRNIGVLITDHNVRETLGICDHAYIISDGSVLASGAPKEIIENESVRRVYLGEHFRM		258		4	Soluble	-1	 	
Batch02	BupsA.00057.e	Burkholderia pseudomallei	YP_332557.1	Q3JV46				leucine/isoleucine/valine transport system ATP-binding protein	Potential drug target		MSEQIRLSVKGVNKRFGGLQALSDVGLEIREGQIYGLIGPNGAGKTTFFNVITGLYTPDSGEFKLDGTEYTPTAVHQVAKAGIARTFQNIRLFGGMTALENVMVGRHVRTKHGLLGAVFQTPAERREEREIKERAIELLDYVGVLQYADYTARNLSYGHQRRLEIARALATDPKLLALDEPAAGMNATEKVELTRLLDKIRSDGRTILLIEHDVKLVMGLCNRMTVLDYGKVIAEGLPQDVQKNPKVIEAYLGAGVH		257		4	Soluble	-1	 	
Batch02	BupsA.00057.f	Burkholderia pseudomallei	YP_332558.1	Q3JV45				"branched-chain amino acid ABC transporter, ATP-binding protein"	Potential drug target		MAAAMLKIKGLQVNYGGIQAVKGVDMEVRQGELVTLIGANGAGKTTTMKAITGLKPYSAGDIEYDGQSIKGVPPHELLKRGLAMVPEGRGIFARMSIIENMQMGAYLRNDNEQIKKDVERMFGFFPRLKERATQLAGTLSGGEQQMLAMSRAILSKPKLLLLDEPSMGLSPIMVEKIFEVVREISKEGITVLLVEQNARLALQAADRGYVMDSGTVTMEGDAKQMLDDPKVRAAYLGE		238		4	Soluble	-1	 	
Batch02	BupsA.00057.g	Burkholderia pseudomallei	YP_337292.1	Q3JGL1				leucine/isoleucine/valine transporter ATP-binding subunit	Potential drug target		MSATTEMLKVSALQMRFGGLLAVDGVDFDVRRDEVFAIIGPNGAGKTTVFNCIGGFYRPTGGRVVLDGHSIGGLTSHLVARKGLVRTFQNIRLFQSLTVVENLLVAQHRQVKSGLLHGLFATPAYRRAEREALERAAMWLERMNLTAVANRPAGTLSYGHQRRVEIARCMITNPRLLMLDEPAAGLNPQEKVELQHLIDRLRREFGISVLLIEHDMSLVMGVSDRILVMEHGRPITIGRPDEVRNDPRVIKAYLGEE		257		3	Expressed	-1	 	
Batch02	BupsA.00113.a	Burkholderia pseudomallei	YP_334284.1	Q3JQ69				3-oxoacyl-(acyl carrier protein) synthase II	Potential drug target		MSRRRVVVTGLGLISPVGNNVADGWANLVAGKSGIVNITKFDATNFSTRFAGEVKGFNVEEYIPAKEARHMDTFIHYGIAAGMQAMQDSGFQVTDENAERVGVVVGSGIGGLPMIEVTQTELLNRGPRRISPFFVPASIINMISGHLSIKFGIKGPNLAIVTACTTGLHCIGEAARLIEYGDADVMIAGGAEATVSPLGIGGFAAARALSQRNDDPATASRPWDKDRDGFVLGEGAGVMVLEEYEHAKARGAKIYAEVAGYGMSGDAYHMTAPLENGDGARRCMLAALRNAGVNADQVNYLNAHGTSTPLGDLAETVAIKRAFGDHSKDIVVNSTKSMTGHLLGGAGGLESVFTVLAVHNQVSPPTINIFNQDPECDLDYCANEAREMKIDVALKNSFGFGGTNGTLVFKRA		412		5	Purified	-1	 	
Batch02	BupsA.00137.b	Burkholderia pseudomallei	YP_334914.1	Q3JND9				UDP-N-acetylmuramate--L-alanine ligase	Potential drug target		MKHIVKHIHFVGIGGAGMSGIAEVLVNLGYQVSGSDLARNAVTERLEALGARVSIGHDAANIEGANAVVVSTAVRSDNPEVLAARRLRVPIVPRAVMLAELMRLKQGIAIAGTHGKTTTTSLVASVLAAGGLDPTFVIGGRLTSAGANARLGTGDFIVAEADESDASFLNLYPVIEVITNIDADHMDTYGHDFARLKQAFIEFTQRLPFYGSAVVCIDDANVRQIVPLISKPVVRYGFAADAQVRAENVEARDGRMHFTVRREGREPLPVVLNLPGLHNVQNALAAIAIATDLDVADAAIQQALAEFNGVGRRFQRYGEIAAAGGGAYTLIDDYGHHPVEMAATIAAARGAFPGRRLVLAFQPHRYTRTRDCFDDFVNVLSTVDALVLTEVYAAGEAPISTANGDALSRALRAAGKVEPVFVATVDEVPDALAKLARDGDVVITMGAGSIGGVPGKLAQDTQQKG		465		7	Crystallized	-1	 	
Batch02	BupsA.00138.a	Burkholderia pseudomallei	YP_332812.1	Q3JUE1				alanyl-tRNA synthetase	Potential drug target		MATQALFREDAYLTRCDALVTAVDAAGIHLDRTVFYPLGGGQAGDSGTLTLAGGAALAVADTRKAKFDGATPDDAVHVLAPGQAALAAGVKPGDALVAEIDWAPRHRRMRLHTASHLLCAVLPYPVDGCSVTADYVRIDFATVEPIDREHVQARLAELVGGAHPVTTEWITDDEMVARPELVRTMSVKPPMGLGRVRLLRIEGVDLQPCGGTHVRNTAEIGALRVAKLEKKSARTRRLVLELA		243		4	Soluble	-1	 	
Batch02	BupsA.00138.b	Burkholderia pseudomallei	YP_335495.1	Q3JLQ8				putative alanyl-tRNA synthetase related protein	Potential drug target		MNRLFCQDDPDTLLLSGTVVDTRPGAVRLSRHPFYPGGGGQLPDLGTVRWEGGVETVAGFSEDGGGLWIEFANGVEIVGDVQSSVDAAFRRAMRELHTDLHVLNALVYRDFDGALVTGVQMNADRTARIDFDLPDADNDRLRALEAEMNDVVRRDLPVRTRYVPLADAQQASGLLRSRSVAPPPTADGLVRIVEIDGLDSQACGGTHLASTGGSSPVRILKIENKGRSNRRVRIGLEPR		239		4	Soluble	-1	 	
Batch02	BupsA.00139.a	Burkholderia pseudomallei	YP_334900.1	Q3JNF3				dephospho-CoA kinase	Potential drug target		MFSVGLTGGIGSGKTTVADLFGKLGATIVDTDLIAHRITAPQGLAMPLIAREFGAEFVAADGSLDRAKMRALVFSDESARKRLEAITHPLIREETEREARTAQGAYVVFVVPLLVESGTWKTRVDRVLVVDCDVETQIARVTARNGFTRAQVEAIVARQASRDARLAAADDVIANDNASVAELAAEVAALHQRYLECAAAARN		203		5	Purified	-1	 	
Batch02	BupsA.00141.a	Burkholderia pseudomallei	YP_334287.1	Q3JQ66				acyl-carrier-protein S-malonyltransferase	Potential drug target		MKFAFVFPGQGSQSVGMLNAFADVAVVRETLDEASDALGQDIGKLIADGPADELNLTTNTQPVMLTAAYACYRAWQQAGGAQPSIVAGHSLGEYTALVAAGAIAFRDALPLVRFRAQAMQTAVPVGVGGMAAILGLDDDTVRAVCAEASATGVVEAVNFNAPAQVVIAGTKAGIEKACEIAKEKGAKRALPLPVSAPFHSSLLKPASDKLREYLAGVDVKAPKISVVNNIDVAVVSDPAAIKDALVRQAAGPVRWVECVQHIAREGVTHVIECGPGKVLAGLTKRIDGNLVGASVFDPASLDEALKLAAA		310		17	In PDB	5	Target selected for ligand screening 	
Batch02	BupsA.00141.b	Burkholderia pseudomallei	YP_337007.1	Q3JHE6				malonyl CoA-acyl carrier protein transacylase	Potential drug target		MKALIFPGQGAQAAGMGAGLFERFPEIVATANDVMGLSIERLCLDDPHGQLADTRYAQPAIFVVNALHLAAWRDAHDTGDGAPVWLAGHSLGEYSALLAAGVFDFRTGLEIVKRRGELFASAGGGAMAAVVGVTAAELGRRLRAAGFDDIDLANLNSAEQTVIAGPAASVDAAASMLDAGGDVTVHPLKVSGAFHSRRMTPLKPAFEAFVSRFALAEPARPVVSNVTARPYQPPGTPADYLVEQLDQPVRWRDSVRHMLRAGVDEWIELGPGRRILTRLVDAIRLEPPERHAAPQPALP		299		3	Expressed	-1	 	
Batch02	BupsA.00141.c	Burkholderia pseudomallei	YP_337765.1	Q3JF88				malonyl CoA-acyl carrier protein transacylase	Potential drug target		MLNTFMFPGQGSQAKGMGGALFDRFADLTAQADAVLGYSIRALCVDDPRDELGRTQFTQPALYVVNALTYYAKCEDSGETPDFLAGHSLGEFNALLAAGCFDFETGLKLVARRAELMSQARDGAMAAIVNASREQIERTLDEHGLVDTAIANDNTPSQLVISGPAHEIARAEALFQHDRVRYLRLNTSGAFHSKFMRPAQQAFAAHLQSFRLADPAIPVISNVSARPYENGRVSEGLAQQIASPVRWCESIRYLLALAAERGEAIEFTELGHGDVLTRLVHTIRRQTPAPAAAATSARARPTPPGEPERPAQQTAAAPRASDSASASLGAAERVAAWNRDYPVGTRVRSSLIHDDVLETRTPATVLFGHRAAVYMKGYNGYFDLAEVTPA		390		17	In PDB	-1	 	
Batch02	BupsA.00142.a	Burkholderia pseudomallei	YP_332162.1	Q3JW91				phosphopantetheine adenylyltransferase	Potential drug target		MVVAVYPGTFDPLTRGHEDLVRRASSIFDTLVVGVADSRAKKPFFSLEERLKIANEVLGHYPNVKVMGFTGLLKDFVRANDARVIVRGLRAVSDFEYEFQMAGMNRYLLPDVETMFMTPSDQYQFISGTIVREIAQLGGDVSKFVFPSVEKWLTEKVAAMAQGPSA		166		17	In PDB	17	Ligand-bound structure submitted to PDB	
Batch02	BupsA.00144.a	Burkholderia pseudomallei	YP_333297.1	Q3JT06				integration host factor subunit alpha	Potential drug target		MNDMNSSEFEALLTAQRSAMSRDVAASTPAGDTPTLTKAELAELLFDSVGLNKREAKDMVEAFFEVIRDALENGESVKLSGFGNFQLRDKPQRPGRNPKTGEAIPIAARRVVTFHASQKLKALVENGAEPDLAR		134		5	Purified	-1	 	
Batch02	BupsA.00144.b	Burkholderia pseudomallei	YP_334371.1	Q3JPY2				integration host factor subunit beta	Potential drug target		MTKSELVAQLASRFPQLVLKDADFAVKTMLDAMSDALSKGHRIEIRGFGSFGLNRRPARVGRNPKSGEKVQVPEKHVPHFKPGKELRERVDGRAGEPLKNDEPEDAQ		107		2	Cloned	-1	 	
Batch02	BupsA.00146.a	Burkholderia pseudomallei	YP_334376.1	Q3JPX7				chorismate mutase/prephenate dehydratase	Potential drug target		MDDELNSRLKPLRERIDAIDTQLIALLNQRAAVALEVGEVKKHFNAPVFRPEREQQVIARLQDMSAGPLASEHISAIWREIMAASRDLEQTIHVAFLGPVGTYSEQAMFDYFGQSIEGLPCPSIDEVFRSVEAGAATFGVVPVENSSEGAVSRTLDLLLHTQLLIGGELSLPIHHNLLTQTGKLDGVKRVCAHAQALAQCQQWLASNAPHLERQAVASNAEAARLAADDATVAAIAGDRAATHYGLQIAYALIQDDPHNRTRFAVIGQEPAGPSGHDQTSLIVSVKNEPGAVFKLLEPLARHGVSMTRFESRPARVGTWEYYFYIDIEGHRDDAAVQGALAELGRKAAFLKILGSYPRAR		360		5	Purified	-1	 	
Batch02	BupsA.00147.a	Burkholderia pseudomallei	YP_334940.1	Q3JNB3				anthranilate synthase component I	Potential drug target		MLRARAQRHAKPGAPRRSSRRQDRNMTELEFQSLANEGYNRIPLIAEALADLETPLSLYLKLAQPERGGANSFLLESVVGGERFGRYSFIGLPAHTLVRTKNGVSEVVTDGQVTETHDGDPFAFIATFQSRFKVAQRPGLPRFCGGLAGYFGYDAVRYIEKKLAHTAPRDDLGLPDIQLLLTEEVAVIDNLAGKLYLIVYADPTKPEAYTKAKQRLRELKQRLRASVVPPVTSASVRTEIYREFKKDDYLAAVRTAKEYIAAGELMQIQVGQRLTKPYRDNPLSLYRALRSLNPSPYMYYYNFGEFHVVGASPEILVRQEKRGDDQIVTIRPLAGTRPRGNTPERDAELATELLNDPKEIAEHVMLIDLARNDVGRIAEIGSVHVTDKMVIEKYSHVQHIVSSVEGKLKPGVTNYDVLRATFPAGTLSGAPKVRAMELIDELEPIKRGLYGGAVGYLSFSGEMDLAIAIRTGLIHNGNLYVQAAAGIVADSVPESEWQETENKARAVLRAAEQVQDGLDSDF		522		7	Crystallized	-1	 	
Batch02	BupsA.00148.a	Burkholderia pseudomallei	YP_331806.1	Q3JX97				site-specific tyrosine recombinase XerC	Potential drug target		MTAKPIADPIVDYLSNLRHVRKLSDHTLRAYAHELDELKKLANGRPLDSLTAVDMRSAVARAHAGGLSARSISHRLSAWRAFYRWFSQHVEMNANPVAAVRAPKRAKTLPKALSVDDTAALMDAPTAGTAESLRDHAILELFYSSGLRLAELIGLDIEYVKDGAYRSAGWLDLAEAEVTVRGKGDKERKVPVGRKALDALHAWLAVRGEFVKHDPRPLFLSVRGNRMSPGVVRERVKRAALAAGIPANVHPHVLRHSFATHVLQSSGDLRAVQELLGHASISATQVYTSLDFQHLAKIYDSAHPRAKKRD		310		5	Purified	-1	 	
Batch02	BupsA.00148.b	Burkholderia pseudomallei	YP_332479.2	Q3JVC4				site-specific tyrosine recombinase XerD	Potential drug target		MDALAASPAWLDSRASIDLFCDAMWLEHGLSRNTLDAYRRDLQLFAQWLAARHVASVDHASEPTLTEYIAARSDGKATSSNRRLSVFRRYYGWAVREHRAAVDPTLRIASAKQAPRFPSTLSEAQVEALLAAPDVDTPLGLRDRTMLELMYASGLRVSELVTLKTVEVGLNEGVVRVTGKGSKERLVPFGEVAHGWIERYLRDARPALLGARAADALFVTARGDGMTRQQFWNIIKRHAQQADVRVHLSPHTLRHAFATHLLNHGADLRVVQLLLGHSDISTTQIYTHVARERLKTLHAAHHPRG		305		0	Target Approved	-1	 	
Batch02	BupsA.00149.a	Burkholderia pseudomallei	YP_332472.1	Q3JVD1				cyclopropane fatty acid synthase family protein	Potential drug target		MFWEKKLAQWANEVREKADIPARLVLWNGQQLDFGTFAAPQVTLKVNSASALPLLLEPSLDNLGEAYVKGKIDIEGKLADIINIGYSLARSTVTSASKLARVKRYFNHSKHSDRKAIQYHYDVSNEFYQLWLDENMVYSCAYFENGDEDLGTAQIKKIDHILTKIGVQPGQRLLDIGCGWGALVLRAAGKFGARCVGVTLSQNQFDLATERVKRAGLENQIEIRLQDYREIDGQFDRITSVGMFEHVGRKNLPLYFSRIRELLADDGIAMNHGITSTDAESGETALGGGEFIDRYVFPDGELPHISLALEAAQRGGLEAVDVESLRRHYARTLDIWTENFEAKAEEARKLVDDEKFRIWRVYLAGCAYAFEHDDVSIFQIVCRKAGQSAKTLPWSRRYMYEHALPR		406		5	Purified	-1	 	
Batch02	BupsA.00150.a	Burkholderia pseudomallei	YP_331932.1	Q3JWX1				UDP-N-acetylglucosamine pyrophosphorylase	Potential drug target		MARIARRPAPPGHACSPARRTLSRPARHIRLASSPAPPDLARLPDRFGATRRRPRGRLALPAFVRLERTSRPRPPAAAAPGPPGCPAAPDGARMLEWPASNSPYETGAMNIVILAAGTGKRMRSALPKVLHPLAGRPLLSHVIDTARALAPSRLVVVIGHGAEQVRAAVAAPDVQFAVQEQQLGTGHAVRQALPLLDPSQPTLVLYGDVPLTRTATLKRLADAATDARYGVLTVTLDDPTGYGRIVRDQAGCVTRIVEQKDASPDELRIDEINTGIVVAPTAQLSMWLGALGNDNAQGEYYLTDVVEQAIEAGFEIVTTQPDDEWETLGVNSKAQLAELERIHQRNLADALLAAGVTLADPARIDVRGTLACGRDVSIDVNCVFEGDVTLADGVTIGANCVIRHAAIAAGARVDAFSHLDGATVGANAVVGPYARLRPGAVLAADAHVGNFVEVKNATLGQGSKANHLTYLGDADIGARVNVGAGTITCNYDGANKFRTVIEDDVFVGSDTQFVAPVRVGRGVTVAAGTTVWKDVAADMLVLNDKTQTAKSGYVRPVKKKS		561		3	Expressed	-1	 	
Batch02	BupsA.00152.a	Burkholderia pseudomallei	YP_334941.1	Q3JNB2				anthranilate synthase component II	Potential drug target		MLLMIDNYDSFTYNLVQYFGELGEAVRTYRNDEITLDEIARLNPDAICLSPGPSNPQHAGITLSVLREFAGKKPILGVCLGHQAIGEAFGGRVVRAKTIMHGKVSRIETDGRGVFADLPKHFDVTRYHSLAIERESLPDCLEISAWTDDGEIMGVRHKTLPIEGVQFHPESILSEHGHALLENFLKEARQAAAHSA		196		5	Purified	-1	 	
Batch02	BupsA.00153.a	Burkholderia pseudomallei	YP_335992.1	Q3JKB1				DNA primase	Potential drug target		MIPHSFLQDLLNRVDIVDVVGRYVQLKKGGANFMGLCPFHNEKSPSFTVSPTKQFYHCFGCGAHGTAIGFLMEHAGLTFPEAVQELAQSVGLTVPHEPSPMRGGGGSSDGHAPPAASKSVTTALSDVMQTACDYYRKQLRGAPNAIQYLKRRGLTGEIALRFGLGYAPDGWQNLEAAFDDYRHDSLVDAGLVIVSEKTDANGVARRYDRFRERIMFPIRNVKGQVIGFGGRVLDGGEPKYLNSPETPLFNKGSELYGLFEARLAIREHKYALVVEGYMDVVALAQLGFPNAVATLGTACTPIHVQKLLRQTDTVVFSFDGDAAGRRAARRALEACLPHAADNRTIRFLFLPPEHDPDSYVREFGTDAFSEQVKRAMPLSQFLLNEATAGKELDQPEGRAKALFDAKPLLQALPANALRAQIMHMFADRLQIPFDEVTALAEVDARIAAPARQAPARNERRRVTESEKRALRNLVMHPRIAAAIDDESVATLRALPRIGELFDEVIGHARALGDGAEFRLLSDVLRNSANAPTYDEIFREILVYDENVRDLMQQNPESDAAQEGLRERERIAGEELQAAVLKMRYDACCDRLNSLSKRSAPSSEELAEIKDLHQNLADMKRRLGL		624		5	Purified	-1	 	
Batch02	BupsA.00154.a	Burkholderia pseudomallei	YP_333268.2	Q3JT35				chorismate synthase	Potential drug target		MSGNTLGTLFTVTTFGESHGPAIGCVIDGCPPGMALTEADVQLELDRRKPGTSRHVTQRQEPDQVEILSGVFEGVTTGAPIALLIRNTDQRSKDYGNIAETFRPGHADYTYWQKYGVRDYRGGGRSSARLTAPVVGAGAIAKKWLRERFGVEVRGYMSALGEIEIPFVDWSHVRENPFFAPNADIVPQLEGYMDALRKDGDSIGARIDVVASGVPVGWGEPLFDRLDADIAHAMMGINAVKGVEIGAGFASVAQRGSVHGDELTPDGFVGNHAGGVLGGISTGQDITVSIAIKPTSSIRTPRRSITRAGEPAVVETFGRHDPCVGIRATPIAESMLALVLIDHALRHRAQCGDVSSATPRIAARAPDAQ		369		2	Cloned	-1	 	
Batch02	BupsA.00156.a	Burkholderia pseudomallei	YP_333290.1	Q3JT13				threonyl-tRNA synthetase	Potential drug target		MVSIRLPDGSVRQYEHPVTVAEVAASIGPGLAKAALGGKLDGELVDTSALIDRDASLAIVTDKDADGLDIIRHSTAHLLAYAVKELHPDAQVTIGPVIDNGFYYDFSYHRPFTPEDLEAIEKRMQELAKRDEPVTRRVVSRDEAVSYFRSIGEKYKAEIIESIPASDEIKLYSHGSFTDLCRGPHVPSTGKLKVFKLMKVAGAYWRGDSKNEQLQRIYGTAWTRKEDQDAYLHMLEEAEKRDHRKLGKQLDLFHIQEEAPGMVFWHPKGWTLWQQVEQYMRRRLDAAGYLEIKTPMIMDRSLWEASGHWQNYRENMFTTESEKRDYAIKPMNCPGHVQVFKHGLRSYRDLPLRYAEFGSCHRNEASGALHGLMRVRGFVQDDAHIFCTEDQINSEAIAFNKLAMSVYEDFGFDRIDIKLSLRPEQRMGSDETWDHAEEGLRNALKACGLEWEELPGEGAFYGPKIEYHIKDALGRSWQCGTLQLDMMLPERLGAEYVAEDNSRRRPVMLHRAIVGSMERFLGILIEHHAGAMPVWLAPAHAVVLNIAESQAEYARTVAQSLQKQGLRVSADLRNEKISYKIREHTLEKVPYLLVVGDKEREAQTVAVRARGGVDLGVMPVEAFVERLREDIQAFK		635		5	Purified	-1	 	
Batch02	BupsA.00158.a	Burkholderia pseudomallei	YP_337086.1	Q3JH67				glutamate racemase	Potential drug target		MTTPYAPDSPAPSARAPIGVFDSGLGGLSVLRAVRERLPDEALVYVADSRHAPYGPRDDVFIVERTLAIGEWLVAQGAKALVVACNTATAQSIAIVRERLPIPLVGVEPGIKPAALHSKTRVAGVLATQATLRSARFEALLARHAADCRFLCQPGHGLVEAIERGDTGSPALRALLASYLEPMLEAGADTLVLGCTHYPFLGAAIRDVTRNRLHLIDTGDAIARQLARVLDERGLRAPASPRPAPLPRFCSTSDGRQLQALAATLLGLDAPVESVTISSPSTAASAADPA		290		2	Cloned	-1	 	
Batch02	BupsA.00160.a	Burkholderia pseudomallei	YP_334416.1	Q3JPT7				chorismate mutase	Potential drug target		MPASPSFTMKQSLRASLAAAVLGCIVLSAPRIAAADGDDTALTNLVALASQRLALAEPVAHWKWLNGKPISDPPREAALLADVEQRATANGVDPAYARAFFDDQIAASKQVQNALFATWRATHGPEGPAPDLATSTRPQLDRLTQSLIAALARVAPLRDAPDCPSRLARSVSNWKTLTRYDSGRKDALGTALSHVCTAGSTSAVG		205		7	Crystallized	-1	 	
Batch02	BupsA.00161.a	Burkholderia pseudomallei	YP_334398.2	Q3JPV5				adenosine deaminase	Potential drug target		MTPTFKDKIARAPKAELHIHIEGSLEPELIFELAQRNGVKLAYESIDALRAAYAFTDLQSFLDIYYAGASVLLTEQDFYDMTAAYVERALADHVVHAEIFFDPQTHTERGVPIETVVAGIDRALADAEKRGFSSKLILCFLRHLSEESALATFDAALPLFDRYARRLIGVGLDSSERGNPPSKFARVFAKARERGLKLVAHAGEEGPPEYVTQALDVLKIDRVDHGVRSAEDAALVARLAGEKIALTVCPLSNLKLCVFDDLTKHTLKTLLDRGVAVTINSDDPAYFGGYVNENYFATVDALQLGEADVYTVIRNGFEASFVSADERAALIAKLDAHWHAA		341		5	Purified	-1	 	
Batch02	BupsA.00162.a	Burkholderia pseudomallei	YP_332710.1	Q3JUP3				DNA topoisomerase IV subunit B	Potential drug target		MSTKKPAAAYSEASIKVLKGLEPVKQRPGMYTRTENPLHIIQEVIDNASDEALGGFGKQITVTLHPDQSVSVEDDGRGIPFGLHPEEKVPVVEIVFTRLHAGGKFDKAKGGAYTFSGGLHGVGVSVTNALATRLDVTVWRDGRIAQLGFADGDVVKPLATQGAGRGEKKSGTRVTVWPNPKYFDSPNLPLGELQRLLRSKAVLLPGVEVVLVNEKTGERQSWKYDDGLRGYLLDEMNGSELLIPLFEGERFADSRSGDDTFAEGEGASWVVAWSEEGSLVRESYVNLIPTPAGGTHESGLRDGLYQAVKSFVELHNLQPKGVKLLAEDVFARVSFVLSAKVLDPQFQGQIKERLNSRDAVKLVSSFTRPALELWLNQHVEHGKKLAELVIKQAQARTRAGQKVEKKKSSGVAVLPGKLTDCETEDIARNELFLVEGDSAGGSAKMGRDKEYQAILPLRGKVLNTWETERDRLFANNEVHDISVAIGVDPHGPDDSVDVSNLRYGKICILSDADVDGAHIQVLLLTLFFKHFPQLIERGHVFVARPPLFRVDAPARGKKPAQKLYALDEGELEAILDKLRKDGVRESQWTISRFKGLGEMSAEQLWDTTMNPDTRRLMPVALGELDFEATVARMTMLMGKGEAAARRNWLEEKGNEVEADI		660		5	Purified	-1	 	
Batch02	BupsA.00163.a	Burkholderia pseudomallei	YP_333295.2	Q3JT08				phenylalanyl-tRNA synthetase subunit alpha	Potential drug target		MGSMDLDQIVADAQQSFEGAADITTLENEKARFLGKSGALTELLKGLGKLDPETRKTEGARINVAKQQVEAALNARRQALADALLNQRLAAEAIDVTLPGRGAGAGSLHPVMRTWERVEQIFRSIGFDVADGPEIETDWYNFTALNSPENHPARSMQDTFYVDGKDADGRPLLLRTHTSPMQVRYARMNRPPIKVIAPGRTYRVDSDATHSPMFNQVEGLWIDENVSFADLKGAYTDFLKKFFERDDILVRFRPSYFPFTEPSAEIDMMFEHGKNAGKWLEISGSGQVHPTVIRNMGLDPERYIGFAFGSGLERLTMLRYGVQDLRLFFENDLRFLRQFA		340		2	Cloned	-1	 	
Batch02	BupsA.00164.a	Burkholderia pseudomallei	YP_332006.1	Q3JWP7				arginyl-tRNA synthetase	Potential drug target		MLPAQKHTLETLLENSVKQVVQASKGDADAAFVLPAIALERPKVAAHGDVACNVALQLAKPLGANPRQLAEQIVAALTAQPEAAGLVDAAEIAGPGFINLRLTPASKQAVIGAVLAQGRAFGASERDHDKRVLLEFVSANPTGPLHVGHGRQAALGDALANVLASQGYAVHREFYYNDAGVQIGNLAISTQARARGLKPGDAGWPEAAYNGEYIADIARDYLNGETVAASDGEPVTGKRDVEDLEAIRKFAVTYLRREQDMDLKAFGVKFDQYYLESSLYTEGRVEKTVDALIAAGMTYEQEGALWLRTTDEGDDKDRVMRKTDGTYTYFVPDVAYHVTKWERGFTKVINIQGSDHHGTIARVRAGLQGLHIGIPKGYPDYVLHKMVTVMRDGQEVKISKRAGSYVTVRDLIEWSGGATPGSEGSPELLDEATITRGRDAVRFFLISRKADTEFVFDIDLALKQNDENPVYYVQYAHARICSVINEWKSRYGATDALLPGADLSPLDSKQAMALMQKLAEYPDVLAHAAGELAPHAVAFYLRELASEFHSFYNAERVLVDEQAPRTARVALLAATRQVLENGLAMLGVSAPSKM		594		2	Cloned	-1	 	
Batch02	BupsA.00165.a	Burkholderia pseudomallei	YP_332252.1	Q3JW01				7-cyano-7-deazaguanine reductase	Potential drug target		MNPEHSPLGKATVYANQYDASLLFPIPRAGAREQIGIGAPLPFFGTDIWNAYELSWLNARGKPQIAIATFYVPAESPNIVESKSFKLYLGSFAQTAFESADAVRDALKRDVSAACDASVTVRLATPAEFRKLQMDELDGLSLDRLDLDAHVYETDPSFLTASHGEAPVEETLVTDLLKSNCPVTGQPDWGSVQIHYVGAPIDHAGLLRYIISFRNHTGFHEQCVERIFVDILRACQPVKLAVYARYTRRGGLDINPFRTNYNQPMPDNARTARQ		274		3	Expressed	-1	 	
Batch02	BupsA.00166.a	Burkholderia pseudomallei	YP_334655.1	Q3JP48				UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase	Potential drug target		MSVPTGWATSQGTLARALTIDGHGLHTGRRVGVRILPARPEDGVTGIAFRRVEQGRTLATLPVDPALRRAQPLCTMLRNADGVGVRTVEHLLASLLACEIDHAIVELDAEEVPILDGSATPWVDAIRTCGRVALDAPKRFIRVLRTVVVTEGEGEQRREMRIEPAPRYELSVRNDLRGFGEMHWDGALTPAAFATEIAPSRSYGRVKWAVPAILAGYLRGVPILRGARPSCTASIVGKRVLGGMRLPDEFVRHRVLDLVGDLALAGAPLLARVSAVRPSHEMNFRLVDALLAEPGAWQWADFSEA		305		4	Soluble	-1	 	
Batch02	BupsA.00166.b	Burkholderia pseudomallei	YP_334907.1	Q3JNE6				UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase	Potential drug target		MISSIKKTVTMLKQRTIKSIVKTVGIGVHSGRKVELTLRPAAPDTGIVFSRVDLPTPVDIPASALSIGDTRLASVLQKDGVRVSTVEHLMSACAGLGIDNLYVDVTAEEIPIMDGSAATFVFLIQSAGIEEQNAAKKFIKVTKPVEIRDGDKFARLDPYFGFKLKFTIDFRHPAVDKTGQELEVDFANTSYVREIARARTFGFAHEVEMMRELGLARGGSMDNAIVLDEYRILNNDGLRYDDEFVKHKMLDAIGDLYVIGHPLLASYTAYKSGHGLNNALLRELLAHEQAYEIVTFDDPKTAPTGFGFDAQTAFA		315		5	Purified	-1	 	
Batch02	BupsA.00169.a	Burkholderia pseudomallei	YP_333807.1	Q3JRJ6				replicative DNA helicase	Potential drug target		MNAPKDPQIESLKVPPHSIEAEQSVLGGLLLDNGAWDRIADFLSQSDFYRYDHRIIFEHIGRLIAATRPADVVTVYEALTTSGKAEDVGGLAYLNALAQNTPSAANIRRYAEIVRDRAVLRRLVSVADEISADAFNPQGKEVRQLLDEAESKVFSIAEDGARGTQGFLEIGPLLTQVVERIDTLYHTANPSDVTGTPTGFVDLDRMTSGMHGGELIIVAGRPSMGKTAFSMNIGEYVAVEYGLPVAVFSMEMPGTQLVMRMLGSVGRLDQHRMRTGRLTDEDWPKLTHAVQKMSEAQLFIDETGGLNPMELRSRARRLARQCGKLGLIIVDYLQLMTGSSQGENRATEISEISRSLKSLAKELDVPVIALSQLNRGLEQRPNKRPVMSDLRESGAIEQDADVILFIYRDEVYNPDSPDKGTAEIIIGKQRNGPIGPVRLTFLGQYTKFDNFAGAQNFYGE		460		2	Cloned	-1	 	
Batch02	BupsA.00171.a	Burkholderia pseudomallei	YP_331513.1	Q3JY40				3-oxoacyl-(acyl-carrier-protein) synthase III	Potential drug target		MTPAAHPPRAAIADIAGHLPEQVLTNDVLAQLYPDWPAEKILAKTGIRERRIAAPRETAADLAYEAARKLFAQGAVGADQVDFVILCTQAPDYVLPTSACMLQHRLGIPTHAGALDVNLGCSGYVYGLSLAKGLVETGAARCVLLLTADTYSKYLHPLDKSVRTLFGDGASATAVIAEHGELERIGPFVFGTDGRGAPNLIVKAGLFREPKSADSAREHEDASGNVRTDEHLYMNGAEVMAFSLAEVPRAADRLLALAGEPRENIDCFVLHQANRFMLDALRKKMKIPEHKFPVLMEHCGNTVSSTLPLALETMRANGTLARGMRLMLLGFGVGYSWAGCLVNF		344		17	In PDB	11	Experimental evidence of bound ligand(s)	
Batch02	BupsA.00171.b	Burkholderia pseudomallei	YP_331516.1	Q3JY37				3-oxoacyl- synthase	Potential drug target		MSTPHAVAGREIRLGGARLAGIVSCLPSREIDNDAFVARFGEGPVRDVVKMIGVERRRWAAEHETTSDLCRAAGAHLLRELDWRPDSVDAVIFVSQTPDYRLPGTSFVLQAAWGLPQASIALDVNLGCSGYPQALWLGTNLIATGAARRVLLAVGDTISKLVDPNDRSTSLLFGDAGTVTALEADGAAGDAHFVIGADGRGARNLIVPSGACRPYDAQADARLAQRSPGHLFMDGGEIFNFTLQGIPPLVAHTLAFANTSVDQYDAFLFHQANLFMLKHLAKKAGLPAERVPINIGTYGNTSCASIPLLMTTALQAQLAARPMRLAMFGFGVGYSWASASLAVEPLSVIDNIEL		354		4	Soluble	-1	 	
Batch02	BupsA.00171.c	Burkholderia pseudomallei	YP_334288.1	Q3JQ65				3-oxoacyl-(acyl carrier protein) synthase III	Potential drug target		MAQSTLYSRVLGTGSYLPPDRVTNQELADRLAKDGIETSDEWIVARTGIRARHFAAPDVTTSDLALVAAQRAIEAADVDPQSIDLIIVATSTPDFVFPSTACLLQNKLGIKNGGAAFDVQAVCSGFAYALATADSFIRTGQHRTALVIGAETFSRILDFKDRTTCVLFGDGAGAVVLSASEEPGILGSALHADGSYSNILCTPGNVNRGVIAGSAFLHMDGQAVFKLAVNVLEKVAVEALSKAELASEQVDWLIPHQANIRIMTSTCRKLGLPQERMIVTVDEHGNTSAASIPLALDVAVRDGRIKRGQHVLIEGVGGGFTWGASVFRF		329		2	Cloned	-1	 	
Batch02	MytuD.00010.a	Mycobacterium tuberculosis	NP_214756.1	O53665				3-ketoacyl-(acyl-carrier-protein) reductase	Potential drug target		MAPKRSSDLFSQVVNSGPGSFLARQLGVPQPETLRRYRAGEPPLTGSLLIGGAGRVVEPLRAALEKDYDLVGNNLGGRWADSFGGLVFDATGITEPAGLKGLHEFFTPVLRNLGRCGRVVVVGGTPEAAASTNERIAQRALEGFTRSLGKELRRGATTALVYLSPDAKPAATGLESTMRFLLSAKSAYVDGQVFSVGADDSTPPADWEKPLDGKVAIVTGAARGIGATIAEVFARDGAHVVAIDVESAAENLAETASKVGGTALWLDVTADDAVDKISEHLRDHHGGKADILVNNAGITRDKLLANMDDARWDAVLAVNLLAPLRLTEGLVGNGSIGEGGRVIGLSSIAGIAGNRGQTNYATTKAGMIGITQALAPGLAAKGITINAVAPGFIETQMTAAIPLATREVGRRLNSLLQGGQPVDVAEAIAYFASPASNAVTGNVIRVCGQAMIGA		454		17	In PDB	-1	 	NR-13784
Batch02	MytuD.00113.a	Mycobacterium tuberculosis	NP_217463.1	P96284				PROBABLE POLYKETIDE SYNTHASE PKS15	Potential drug target		MIEEQRTMSVEGADQQSEKLFHYLKKVAVELDETRARLREYEQRATEPVAVVGIGCRFPGGVDGPDGLWDVVSAGRDVVSEFPTDRGWDVEGLYDPDPDAEGKTYTRWGAFLDDATGFDAGFFGIAPSEVLAMDPQQRLMLEVSWEALEHAGIDPLSLRGSATGVYTGIFAASYGNRDTGGLQGYGLTGTSISVASGRVSYVLGLQGPAVSVDTACSSSLVAIHWAMSSLRSGECDLALAGGVTVMGLPSIFVGFSRQRGLAADGRCKAFAAAADGTGWGEGAGVVVLERLSDARRLGHSVLAVVRGSAVNQDGASNGLTAPNGLAQQRVIQVALANAGLSAADVDVVEAHGTATTLGDPIEAQALLSTYGQGGPAEQPLWVGSIKSNMGHTQAAAGVAGVIKMVQAMRHGVMPATLHVDEPSPRVDWTSGAVSVLTEAREWSVDGRPRRAAVSSFGISGTNAHLILEEAPVPAPAEAPVEASESTGGRGRRWCRG		496		4	Soluble	-1	 	
Batch02	MytuD.00145.a	Mycobacterium tuberculosis	NP_217088.1	Q50649				aspartyl-tRNA synthetase	Potential drug target		MFVLRSHAAGLLREGDAGQQVTLAGWVARRRDHGGVIFIDLRDASGIAQVVFRDPQDTEVLAQAHRLRAEFCVSVAGVVEIRPEGNANPEIATGEIEVNATSLTVLGECAPLPFQLDEPAGEELRLKYRYLDLRRDDPAAAIRLRSRVNAAARAVLARHDFVEIETPTITRSTPEGARDFLVPARLHPGSFYALPQSPQLFKQLLMVAGMERYYQIARCYRDEDFRADRQPEFTQLDMEMSFVDAEDIIAISEEVLTELWALIGYRIPTPIPRIGYAEAMRRFGTDKPDLRFGLELVECTDFFSDTTFRVFQAPYVGAVVMPGGASQPRRTLDGWQDWAKQRGHRGLAYVLVAEDGTLGGPVAKNLTEAERTGLADHVGAKPGDCIFFSAGPVKSSRALLGAARVEIANRLGLIDPDAWAFVWVVDPPLFEPADEATAAGEVAVGSGAWTAVHHAFTAPKPEWEDRIESDTGSVLADAYDIVCNGHEIGGGSVRIHRRDIQERVFAVMGLDKAEAEEKFGFLLEAFMFGAPPHGGIAFGWDRTTALLAGMDSIREVIAFPKTGGGVDPLTDAPAPITAQQRKESGIDAQPKRVQQA		596		5	Purified	-1	 	NR-13785
Batch02	MytuD.00148.a	Mycobacterium tuberculosis	NP_216217.1	P67636				site-specific tyrosine recombinase XerD	Potential drug target		MKTLALQLQGYLDHLTIERGVAANTLSSYRRDLRRYSKHLEERGITDLAKVGEHDVSEFLVALRRGDPDSGTAALSAVSAARALIAVRGLHRFAAAEGLAELDVARAVRPPTPSRRLPKSLTIDEVLSLLEGAGGDKPSDGPLTLRNRAVLELLYSTGARISEAVGLDLDDIDTHARSVLLRGKGGKQRLVPVGRPAVHALDAYLVRGRPDLARRGRGTAAIFLNARGGRLSRQSAWQVLQDAAERAGITAGVSPHMLRHSFATHLLEGGADVRVVQELLGHASVTTTQIYTLVTVHALREVWAGAHPRAR		311		4	Soluble	-1	 	
Batch02	MytuD.00148.b	Mycobacterium tuberculosis	NP_217410.1	P67628				site-specific tyrosine recombinase XerC	Potential drug target		MQAILDEFDEYLALQCGRSVHTRRAYLGDLRSLFAFLADRGSSLDALTLSVLRSWLAATAGAGAARTTLARRTSAVKAFTAWAVRRGLLAGDPAARLQVPKARRTLPAVLRQDQALRAMAAAESGAEQGDPLALRDRLIVELLYATGIRVSELCGLDVDDIDTGHRLVRVLGKGNKQRTVPFGQPAADALHAWLVDGRRALVTAESGHALLLGARGRRLDVRQARTAVHQTVAAVDGAPDMGPHGLRHSAATHLLEGGADLRVVQELLGHSSLATTQLYTHVAVARLRAVHERAHPRA		298		4	Soluble	-1	 	
Batch02	MytuD.00151.a	Mycobacterium tuberculosis	NP_216179.1	O06585				Probable polyketide synthase pks17	Potential drug target		MEAGPQRIAQMLAELVELFKTEALHRLPVKSWDVRHAREAYRFLSQARHVGKVVLTMPDAWAAGTVLITGGTGMAGSAVARHLVSRYGVRQVVLASRAGEHTESVAALVDELGSAGARVQVVSCDVADRDAVAGLVASQPDLTAVFHAAGVLDDAVITGLTPERVDKVLRAKVDGAWNLHELTRHLDVSAFVLFSSMAGIVGAPGQANYAAANAFLDGLAAYRRSRGLAALSVAWGLWEQASAMTEHLGERDRVRMSRVGLAPLPTNQAMGFLDAALLADRPVVVAARLDRAALAGAELPALFSQLVAGPIRRIIDGADEVSGSGLASRLHGLTPEQRHRELTELVCSNAAIVLGHSGTEIDAHKAFQDLGFDSLTAVELRNRLKTATGLTLPPTLIFDYPTAAELAEHLDIQLANAPAVTVDQPNPSTRFNEVTRELQALLDQPNWNPDDKTRLIKRLQAILTDCTAPPASSGPSTTHDDEDITTATESQLFAILDDELGP		502		5	Purified	-1	 	
Batch02	MytuD.00155.a	Mycobacterium tuberculosis	NP_217714.1	P64320				PROBABLE ATP-DEPENDENT DNA HELICASE II UVRD2	Potential drug target		MSIASDPLIAGLDDQQREAVLAPRGPVCVLAGAGTGKTRTITHRIASLVASGHVAAGQVLAVTFTQRAAGEMRSRLRALDAAARTGSGVGAVQALTFHAAAYRQLRYFWSRVIADTGWQLLDSKFAVVARAASRTRLHASTDDVRDLAGEIEWAKASLIGPEEYVTAVAAARRDPPLDAAQIAAVYSEYEALKARGDGVTLLDFDDLLLHTAAAIENDAAVAEEFQDRYRCFVVDEYQDVTPLQQRVLSAWLGDRDDLTVVGDANQTIYSFTGASPRFLLDFSRRFPDAAVVRLERDYRSTPQVVSLANRVIAAARGRVAGSKLRLSGQREPGPVPSFHEHSDEPAEAATVAASIARLIASGTPPSEVAILYRVNAQSEVYEEALTQAGIAYQVRGGEGFFNRQEIKQALLALQRVSERDTDAALSDVVRAVLAPLGLTAQPPVGTRARERWEALTALAELVDDELAQRPALQLPGLLAELRRRAEARHPPVVQGVTLASLHAAKGLEWDAVFLVGLADGTLPISHALAHGPNSEPVEEERRLLYVGITRARVHLALSWALSRSPGGRQSRKPSRFLNGIAPQTRADPVPGTSRRNRGAAARCRICNNELNTSAAVMLRRCETCAADVDEELLLQLKSWRLSTAKEQNVPAYVVFTDNTLIAIAELLPTDDAALIAIPGIGARKLEQYGSDVLQLVRGRT		700		2	Cloned	-1	 	
Batch02	MytuD.00163.a	Mycobacterium tuberculosis	NP_216165.1	P94984				phenylalanyl-tRNA synthetase subunit alpha	Potential drug target		MLSPEALTTAVDAAQQAIALADTLDVLARVKTEHLGDRSPLALARQALAVLPKEQRAEAGKRVNAARNAAQRSYDERLATLRAERDAAVLVAEGIDVTLPSTRVPAGARHPIIMLAEHVADTFIAMGWELAEGPEVETEQFNFDALNFPADHPARGEQDTFYIAPEDSRQLLRTHTSPVQIRTLLARELPVYIISIGRTFRTDELDATHTPIFHQVEGLAVDRGLSMAHLRGTLDAFARAEFGPSARTRIRPHFFPFTEPSAEVDVWFANKIGGAAWVEWGGCGMVHPNVLRATGIDPDLYSGFAFGMGLERTLQFRNGIPDMRDMVEGDVRFSLPFGVGA		341		4	Soluble	-1	 	
Batch02	RiprA.00010.a	Rickettsia prowazekii	NP_220429.1	Q9ZEB0				acetoacetyl-CoA reductase	Potential drug target		MSEIAIVTGGTRGIGKATALELKNKDLTVIANFFSNYDAAKEMESKYGIRTKCWNVADLEECKKAVNEIEEEFKKSVSILVNNAGITKDKMLHRMSNQDWTDVINVNLHSCFNMSSSVMKQMRNQNYGRIVNISSINAQAGQIGQTNYSAAKAGIIGFTKALARETASKNITVNCIAPGYIATEMVNTVPKDILTKIVNSIPKKRLGQPEEIARAVAFLVDKNAGFITGETISINGGHNMI		241		5	Purified	-1	 	
Batch02	RiprA.00010.b	Rickettsia prowazekii	NP_221114.1	P50941				3-ketoacyl-(acyl-carrier-protein) reductase	Potential drug target		MIDLTGKTSLITGASSGIGSAIARLLHKLGSKVIISGSNEEKLKSLGNALKDNYTIEVCNLANKEECSNLISKTSNLDILVCNAGITSDTLAIRMKDQDFDKVIDINLKANFILNREAIKKMIQKRYGRIINISSIVGIAGNPGQANYCASKAGLIGMTKSLSYEVATRGITVNAVAPGFIKSDMTDKLNEKQREAIVQKIPLGTYGIPEDVAYAVAFLASNNASYITGQTLHVNGGMLMV		241		17	In PDB	-1	 	
Batch02	RiprA.00057.a	Rickettsia prowazekii	NP_220884.1	Q9ZD39				ABC TRANSPORTER ATP-BINDING PROTEIN (abcT2)	Potential drug target		MVKWRYYRKHINKKMDSLQIKNISKSYKKRNILTDISLHIKQGEIVGLFGPNGAGKTTCFNIIIGLMRPDSGQLLLNDINITNLPIYLRARLGIGYLLQEPSIFRGLSVADNIKAVVEISENDKEVIEQKTHNLLEKFSIVHLKDLSSASLSGGERRRLEIARSFVIEPKFIMLDEPLAGIDPLAISDIKKLITYLREFNIGILITDHNVRDTLDIVDRAYVIFEGKVLLEGSAQEIANSKKVKEVYLGESFNF		254		3	Expressed	-1	 	NR-16446
Batch02	RiprA.00113.a	Rickettsia prowazekii	NP_221116.1	Q9ZCH8				3-oxoacyl-(acyl carrier protein) synthase II	Potential drug target		MSNQNINKRVVITGLGLVTPVGLNVSSTWKNIVGGVSGIKTITEFDTSKLACKIAGVIDNSEQNGFKLENFTQADDINRLSKMDKFIHYGIAAATEAVEDSGWLPKDEKSRDRTGLILGSGIGGLKMIEDTSIKLYKENNGKVSPFFIPASLINLLSGLVSIKYGFSGPNQAAVTACSTGAHAIGDAMRMIKHGYADVMIAGGAEAPVTPVGIAGFVAARALCTKYNDNPEKASRPWDKDRSGFVMGEGAGIVVLEEYEHAINRGAKIYCEVIGYGSTGDAYHMTAPHPKGRGAYRAMSEALQDADITPSMIDYINAHGTSTPLGDMIELDATQKLFLESNPKILMSSTKSSIGHLLGAAGSVEFIFSVLTIRDQIAPPTLNLENPIDDVKIDLVKFKARETVIDYVLSNSFGFGGTNASLVIKKI		426		2	Cloned	-1	 	
Batch02	RiprA.00133.a	Rickettsia prowazekii	NP_220478.1	Q9ZE62				cysteinyl-tRNA synthetase	Potential drug target		MKLHLYNTLTRTKEVFNPQDPANIKMYVCGPTVYDNPHIGNSRSVVVYDLLYRIIIKIFGKKAVKYVRNITDVDDKIIDRAELLGITINDLTDKVTREFHINMEYLGCMLPTIEPKATEHIDVMIEIIERLIAKDHAYIADNHVYFDVLSAPNYTELSNRNLEAMFEGVRIENSKTKKNPQDFVLWKPAKKNEPENINFTSPWGLGRPGWHIECSAMSYKYLGQNFDIHGGGADLIFPHHTNEIAQSRCAFPSSTYAKYWIHNGFLTVNGSKMSKSLGNFITVRDLMDKQIQGEVVRLFLLSSHYRRPLDYNDKAIDDAKKTLDYWYRAIEHINVQKVDLPSNFMRSLFDDMNTPLAIKIINDYAKCVFISKTEAERKFNASAIITCANFIGLMRKTQYEWFNRDVDEFYINELINKRLKAKKQKNWLLADKIRNQLLEKKIILEDKSNYITIWRKE		457		7	Crystallized	-1	 	NR-16447
Batch02	RiprA.00137.a	Rickettsia prowazekii	NP_220632.1	Q9ZDS8				UDP-N-acetylmuramate--L-alanine ligase	Potential drug target		MLLLELKKTNQTLGTIHFIGIGGVGMSGIAEILHNLGYKVQGSDLVENYNTKRLESYGIKIFLGQAKQNIKNVSYVVISSAINQNNPEIKEALERKIPIIRRAEMLAELMRLKCSVAVSGSHGKTTTTSLIACLFEAAGLCPTVINGGIINNKSTNAYLGSSNYLIAEADESDATFIHIPSTIAIITNIDPEHLDYYQDFEILIGAFRSFITNLPFYGFAVCCIDHKIVRKLVDDITERKIITYGIDSEDAHIIAFNINTDIASSTFDVKISLPNVLGTTIIEKITIPTPGRHNILNSLAAIAVGIELDFGIKAIKNGFNNFKGVKRRFTKVAEYNKAVIIDDYAHHPEEIKATLATAKNIANQQNGKVIAIFQPHRYSRIKYLFDDFMLCFADADILYITNIYAAGETPIEGITGQSLVDKMTQNKHHDKANFLAELDDVVSIIIDNAASGDMIIMMGAGNISSFANELDRRLLSHEILENTDCDTKSNDKVMQ		495		3	Expressed	-1	 	NR-16448
Batch02	RiprA.00141.a	Rickettsia prowazekii	NP_221088.1	Q9ZCJ6				acyl-carrier-protein S-malonyltransferase	Potential drug target		MIINNMKTAFIFPGQGSQLIGMGKDFYDNLKPAKETFQIIDEVLNRKLTDIIFNGPSEALTLTTNAQPALMAVSMAIINIIKAETGKNLDSLCDYAAGHSLGEYSALCSAESINLETTAKLLHIRSTSMQEACPEGVGAMAACINIPLQTLVELLEDIKKINLCQIANDNIEGQIIISGKVEAINHAISIIKDLGYKAIRLKVSAPFHCSLMKPAEEKMSIALDKAVINKPIIPIIQNYTAKPTINPLEIKQNLILQICGRVRWRETLKLFNHLHVTHIVEIGAGNVLTNMLRKINYPYKLSNIRNLAELKNFLDNINK		319		2	Cloned	-1	 	
Batch02	RiprA.00145.a	Rickettsia prowazekii	NP_220536.1	Q9ZE17				aspartyl-tRNA synthetase	Potential drug target		MHKYRTHNCNELQLSNVGQEVKLSGWVHRRRDHGNLVFIDLRDHYGITQIVFTDQNQQLMYDASRLCYESVITVSGTVVARSLDTINNKLPTGYVEVLAMECIVESASSPLPFVINNEKEAPEESRLKHRFLDLRREKLHNNIILRSQVIAHIRHLMIARGFTELQTPILTSSSPEGARDFLVPSRIHPGKFYALPQAPQQFKQLLMVAGFDRYFQIAPCFRDEDARADRSPGEFYQLDLEMSFVTQEDIFNTIEPVLYDLFTKFTNKTVSNTPFVRIPYNESMLKYGSDKPDLRNPIIISDVTEVFRDSNFTIFRENIKKGSVVHAIPAPQAASLPRSFFDKMIEFAISKGARGLGYIQFSESGEAKGPLSKFLTGQQLEILKATANTSNGDAVFFVSDKKDEAVKLCGKVRIKLGEELNLLEKDCFKFCWITDFPFYELNEETGKIDFSHNPFSMPQGGIDALEQAKTTEELLALTAYQYDIVCNGIELSSGAIRNHKPEIMYKAFSIAGYSAEEVEQRFGAMIKAFRFGAPPHGGIAPGIDRIVMLLAEATNIREIIAFPLNQQAEDLLMNAPSYVEEKALKELSIMLSPSSRKIHKKNTNL		605		3	Expressed	-1	 	
Batch02	RiprA.00148.a	Rickettsia prowazekii	NP_220744.2	Q9ZDG8				site-specific tyrosine recombinase XerD	Potential drug target		MEFIAQFLEMLLAERALSKNSILSYKRDLLDFQHYLAAQKISELNITTGNIRKWIEYLASNNLHARSINRKISTIKSYYAFLISENHTKFNPVLNIDLPKYQNKLPIILSIDQIKLILEYCSKDNTPEGIRLNAMINLLYASGLRVSELVSLKLADILTNNTSKGTVRKIFSVLGKGNKERVIVINDQAVLSIIKYLEIRDFFINKAKSKNLIYLFPSSAVAGYMTRQNFAILLKSVALYTGLNPEHVSPHILRHSFASHLLEGGADLRVIQELLGHADISTTQIYTHLHTNHLKKALLHHPLNKNSFILS		311		3	Expressed	-1	 	
Batch02	RiprA.00148.b	Rickettsia prowazekii	NP_221166.1	Q9ZCE0				site-specific tyrosine recombinase XerC	Potential drug target		MLDISIQELIKQWQKYLILQKNYSNNTVIAYNNDLKHFLEFMNYYNSELVTLNHIKTADIRLIRSWLAKRKCENFTASSIARGLSTVKNFYKFLEKTLLLNNHIIFSIKSPKKAKLLPKGLSVDDVLISLEHIEEYGNVKWVELRNKALIVLIYAAGLRISEALSITKLHLQNLEFIKIIGKGSKERIIPWLPLTKNLITKYLEILPYKLDENEPIFRGRQGKKLQPSVFNRELIKLKRIYGLPEYLTAHSFRHSFASHLLEYGADLRSIQELLGHKSLSTTQKYTQTSIKHLEAVYNTAYPIKK		305		3	Expressed	-1	 	NR-16449
Batch02	RiprA.00155.a	Rickettsia prowazekii	NP_220828.1	Q9ZD95				DNA HELICASE II (uvrD)	Potential drug target		MKDKIQNQNFMHTLNAEQKKAALHTEGPLLLLAGAGTGKTKVLTSRIANIIHQNLALPHNILAVTFTNKAAKEMSERVHNLINCYGLNIGTFHSMAAKILRDQIENLNLGFNNRFTIISHDDQLTLVKDIVKLKKDIDAKKYTPKLIHIIISRWKDQGLLPNKLSTSDTNLPLQKIAKLVYEEYQKNLLISNVLDFGDLLLYNNELFIKNPAVLKYYQEKYRYILIDEYQDTNIAQYLWARMLASLYRNICCVGDDDQSIYGWRGAEVGNILRFEKDFAGATIIKLEQNYRSTLPILAAASNVINNNKNRHSKTLWTDSSSGEKIKIISCLSDKEEARYIACEIDKLVKEERYNAGNIAILVRAGFQTRSFEEAFINSAIPYKIIGGLRFYERMEIRDVLAYIRISLNQNDNLALERIINVPKRAIGAASLNKIRSYALERNISNFAAIKEILEIGNIKAKSYESLKDLLTKIDNWYEQFIIDTPINVVKAILDDSGYLAMLKEEKTEEAFGRIENINEMLRAIAEFNDIHDFIEYSSLVMENEVLETNYGGSVTIMTLHAAKGLEFDVVFLPGWEEGVFPSQRSLDEDGEKGLEEERRIAYVGITRAKKDLYITHAESRKIFYEIVRSCPSRFINEIPDEITIRTSSMKQYNSFYKF		658		4	Soluble	-1	 	
Batch02	RiprA.00157.a	Rickettsia prowazekii	NP_220461.1	Q9ZE79				DNA topoisomerase IV subunit A	Potential drug target		MKEAKIENIDFGNALSERYLAYALSTIMSRSLPDVRDGLKPVHRRLLYAMLQLRLEPNSGYKKCARVVGDVIGKYHPHGDVAVYDTLVRLAQHFSLRYPLIDGQGNFGSIDGDNAAAMRYTESRMTEICMLLMEDIDKDTVDFRSTYDDSDLEPVIMPASFPNLLANGSEGIAVGMATNIPPHNLHELCDALLYLIDNPQAGINDIMNFIKGPDFPTGGIIIDKAEVINAAYTTGRGSFRVRSRWEKEELSYGTYQIVVTEIPYQIQKSKLIEQIAILLKDKKIPLISSIRDESTDIIRVVIEPRDRSCDPQIVMESLFKLTNLESRIQLNMNVIGSNNVPRVMNILEILQEFLVHRKNIIIRRSTYLLNKIKQRLEILKVLRIVYLNLDEIIEIIREEDEPKTIIMERFKISAIQVEVILNTRLRSLQKLEEHAIIDEHSNLQKQQAILEKILKNHKELWQIVKKEIKAVQTKFGLNTIIGARRTSFEEVDLTNQVVDITAFITKEPITIICSKMGWVRSLKGHNTDLSTIKYKEGDTEKFIIEAYTTDKILIISSKGRFFTLLADNISKGKGTGGVSIKLLVDIGNNDITNILVYKPNQLLLLASSIGKGFLVNSNEVIAQTKTGKQIMNIPEGYSCIACLPVNGDSIACIGESRRLLVFNIDEIPEMKKGQGVVLQRFKNAKLLDIKIFNKQDGLSWNDGTKIQLEKNIVAFLGKRGGFGTFPPIGFPKNNRFSP		738		3	Expressed	-1	 	
Batch02	RiprA.00159.a	Rickettsia prowazekii	NP_220962.1	Q9ZCW1				ATP-DEPENDENT DNA HELICASE RECG (recG)	Potential drug target		MKGLYKVNYFIINFLSKVILKYMLTTLEQFLFAPVKAFINIREDTVSALKRLGIKNIRDLLFYLPVSYQNKILSPNLTKVRGGEIIQTEIIVNSINLQKRGNQPLKITASNNTGSLLLVFFHKPPQFILNKLKVGTKHIISGKVQFFDYQLQILHPEFITNPQLSKAIEPLYSMTYSLSNTQLYSYIIKAIEIFEEKCNGIEDKELKEYLDVILQNLKILHVFLSPHNLISCSRTTDIVVNPSYAIVAAKKQLAIKELIANQISLLNVRMQINRKHGNIYPKAASIQENILRELGFELTYYQKQVIEEIEFEQSDKVEMMRLLQGDVGSGKTLVALLTMVNVVTTGFQATLMAPTDLLANQHYDFFVKALKNTNIRVGLLTGKILGKARKNIIIQLVNGKIDILIGTHALFQEKVSFKKLGYIVIDEQHRFGVQQRLNLINKGVNPDVLIMTATPIPRSLALTMFGDMTVSKLIGKPKNRLSIVTKTMSVNKIGYIIKAINKRLIAGERVYWICPLITQREKETLQEDLLLMDVINRFNSIKNIYQGYTGIIHGKMKNDQKERIMKQFKEGEIKILVATNVIEVGIDVSEATLIVIENAEQFGLAQLHQLRGRVGRGRLQSYCILLYNPKRLGKVAQNRFKIMKHTNDGFYIAEQDLKLRGSGEILGIKQSGEIDFFFADLAEDYALLIKAHKIAEREISLKDNVNFVNFQIKLFAKSQVSYLI		724		1	Selected	-1	 	
Batch02	RiprA.00162.a	Rickettsia prowazekii	NP_220613.1	Q9ZDU7				DNA topoisomerase IV subunit B	Potential drug target		MSDLFSLNKEKKNKIVYTNYSAKDIEVLDGLEPVRKRPGMYIGGTDSNAMHHLVSEVLDNAMDEAVAGFASIIMIKMHQDHSITIFDNGRGIPIDNHPKFPDKSALEVILTTLHSGSKFSNNVYHTSGGLHGVGISVVNALSKHFKIKVYKQGKLYSQSYSKGAKLTDLISAEASKRLRGTSINFTPDPEIFSEKLHFNPKKIYEIARSKAYLYRGVSIEWECEVEVPSDIPKKALINFPNGLKDYLSSKISLDNLVIPEIFSGNIESTVDDIKLEWAICWQNNDTSAFMQSYCNTVPTPQGGTHEQGLKSAILRGLKAYSEMIGNKKAANLTIEDILETASIVLSIFIVEPSFQGQTKEKLVSNGVSKLVENIIKDHFDHFLSSDKVLATHLLEHVIAIAEFRRNKKNERNISRKSVTQKLRLPGKLADCTRTSAEGTELFIVEGDSAGGSAKQARNRETQAVLPLWGKVLNVASSTLEKIINNQAIQDLEIALACGSLKNYKKENLRYEKIIIMTDADVDGAHIASLLMTFFFLRMPKLVEEGHLYLAKPPLYRLTQSNKIYYACDEEEKIKLTYKLSKASKAKIEVGRFKGLGEMMPAQLKETTMHPEKRSLLKVTLEDVQNVDKIVDDLMGKKPEKRFQFIYEQALVKMDQIINKLDI		662		1	Selected	-1	 	
Batch02	RiprA.00163.a	Rickettsia prowazekii	NP_220798.1	Q9ZDB5				phenylalanyl-tRNA synthetase subunit alpha	Potential drug target		MKNIETILKLAEEKIVLVHNLKDLQEYKVEFLGRNGIVTSELKKLGSLINGQKRKEFGLKINTLKDKIHDIIKAKAQNLEAEELHLKLAADKIDLTIPARRYKQGSIHPITQCMDELIQVFSQFGFTIENGPNIENDFYNFTALNFEYDHPARQMHDTFYLKGHENDKPLLLRTHTSTVQIRAMKNGKPPFRFIAPGRTYRSDSDMTHTPMFHQIEGLVIDKNINMGHLKYVIITFIRSFFENSNIELRFRPSFFPFTEPSAEVDIRMNKNDKWLEVLGCGMVHPNVLKNIDINRSEYQGFAFGLGVERFAMLKYNIKDLRRFFEGDIRWLKHYNFESFDIPNLAGGLTK		350		3	Expressed	-1	 	NR-16450
Batch02	RiprA.00164.a	Rickettsia prowazekii	NP_220459.1	Q9ZE81				arginyl-tRNA synthetase	Potential drug target		MNIFNQLKQDIIAASQKLYNNKEIANTATIETPKDSFNGDLSSNIAMIIASKESIAPREVALKFKEVLVTLPYIASIEIAGPGFINFTIKAESWQAAIKDILQHEEKFFEIDIDKNSNINIEYVSANPTGPMHIGHARGAVYGDVLARILQKVGYSVTKEYYVNDAGSQINDLVSTVLLRYKEALGEPITIPVGLYPGEYLIPLGEILSKEYGNKLLTMNDVERFKIIKSFAVEKMLDLNRKDLADLGIKHDVFFSEQSLYDKGEIEKTVKLLERMGLIYEGTLPAPKGKVHEDWEYRVQKLFKSTNYGDSQDRPIEKADGSWSYFASDLAYAKDKIDRGANHLIYVLGADHSGYVKRIEAIVKALGQEKVKVDVKICQLVNFVENGVPIKMSKRLGSFASVQDVNKEVGKDIIRFMMLTRQNDKPLDFDLVKVKEQSRENPIFYVQYAHVRTKSILSKARELMPEAYNSFKEGKYNLSLLSSEEEIEIIKLLAAWTKTLEASVKYFEPHRIAFYLINLASKFHSMWNFGKENSDYRFIIENNKELTLARLALASVIQKIIASGLEVIGVEPMVTM		576		1	Selected	-1	 	
Batch02	RiprA.00165.a	Rickettsia prowazekii	NP_220466.1	Q9ZE74				7-cyano-7-deazaguanine reductase	Potential drug target		MPLSTSLLGKKNTYKDSYDATLLFKIPRINNRNVLGIDSNHLPFYGVDIWNTYEISCLNKNGKPLVGIGTFYIPADSENIVESKSFKLYLNSFNNFIIESIEELERIILQDLSNVTYAKVTGRIFPINTKIEFGIPSGKNIDNLDIVCNNYGPPDNSLIEYEDVLVEEEIYSNLFKSNCLVTGQPDWGTIVIKYKGKKLKYDSFLRYLISFRNFNEFAEQCAERIFIDIKNSINLDFLSIYIVYTRRGGIDICPYRSTDKSYTLPNDKRLIRQ		273		5	Purified	-1	 	
Batch02	RiprA.00166.a	Rickettsia prowazekii	NP_220639.1	Q9ZDS1				UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase	Potential drug target		MHQSTLLKPVSCYGIGVHTGKRTQLTIEPAKENTGIIFIRTDISSENNYIEASYCNVSDTLLSTTISNNHKIQISTIEHLMAALWGCSIDNAIIKIDGPEVPIMDGSSKPFVFMIECAGKKLQNAPKKYLKILKEVKVVNKDCELYCTPSEHMAVDLTIDFSSKAIGRQNLSFGMQESFTKNIADARTFGFIRDVEYLKSKGLAQGASFENAIGIDEHDKVLNPSGLRYADEFVRHKLLDLFGDLYTSGISVVSAIKGYKTSHAFNNELLHKIFSDTTSYKFVTSNEL		288		2	Cloned	-1	 	
Batch02	RiprA.00169.a	Rickettsia prowazekii	NP_220915.1	Q9ZD08				replicative DNA helicase	Potential drug target		MVRNKINNDDNLSIPRVLPSNIQAEQMLLGAIITNNALLSYVSEFLRNEHFFEPIHQKIYDAIEKIIEKGLIATPITLRSMLTQDALFKEIEGEGYLAKLITMSMMVINPIDYGKIIYDLAIKRNLINIGEEVVNNAYNSSLAVAAKEQIEYAEAKLYDLTKEGLNEKSFTKVGISISESLASINRAMKNNDHVIGISTGLLDLDNKLFGFHNSDLIILAGRPSMGKTAFAINLALNTCNNMRLKNIRDNQEIKSVGFFSLEMSSEQLTTRLLSLCAEIDSTALRTGMLSEDKYNRLRKEANTLSELQFFIDDTPALSISAIRTRARRMKRKHNLGILFIDYLQLIRGVSKSENRVNEISEITQGLKAIAKELNIPVIALSQLSRAVELREDKKPMLSDLRESGTIEQDADIVMFIYREEYYLTRKEPVAGDAKHAEWLDKLNKVYNIADIIIAKHRNGPVGNVSLYYDSQFSKFGNLEKRTFNSI		486		1	Selected	-1	 	
Batch02	RiprA.00170.a	Rickettsia prowazekii	NP_220748.1	Q9ZDG4				enoyl-(acyl carrier protein) reductase	Potential drug target		MTTGLLQGKKGLITGIANNMSISWAIAQLAKKHGAELWFTYQSEVLEKRVKPLAEEIGCNFISELDVTNQKSISNLFNDIKEKWNSFDFLLHGMAFANKNELKGRYVETSLENFHNSLHISCYSLLELSRSAETLMHNGGSIVTLTYYGAEKVIPNYNIMGVAKAALEASVKYLANDMGENNIRVNAISAGPIKTLASSAISDFSTMLKSHAATAPLKRNITQEDVGGAAVYLFSELSKGVTGEIHYVDCGYNIIGSSKLL		261		2	Cloned	-1	 	
Batch03	AnphA.00176.a	Anaplasma phagocytophilum	YP_505371.1	Q2GJT0				conserved hypothetical protein TIGR00046	Potential drug target		MVFKKKPVKIRLYYSDSALNKGEKVLLRSDQAHYIRDVMRVRISDAVVLFDGVTGDWFATISEISRKKVEVRVEHLVSEYVKSRDLMLCIALVKQDTMRSVVRQATEMGVTQIQPIRTEYSVVSDINVQKCRQWAIEAAEQCERQDIPEIASVMEFTHLNDLGKKLVLCDETGKGRMPAEVLRSKENLGIIIGPEGGFSERELVCAESFCEKMSLGHRILRVDTAVVAALAYVNEYYIS		239		7	Crystallized	-1	 	NR-16225
Batch03	AnphA.00180.a	Anaplasma phagocytophilum	YP_505233.1	Q2GK68				pantetheine-phosphate adenylyltransferase	Potential drug target		MTKRLGIYPGTFDPITFGHIDIIKRACTLVDELVIGVARSVQKSTIFSAELRAEMIQREMHVLECKSVVKVEVFDGLLTAFAKQKKALMIIRGLRAVTDFDYEFQMSWINYKLTPGIETVFLPAAEETQFISSSFVKEVARLGGDVSVFVPHNVHEHLRDFYNNSSAK		168		1	Selected	-1	 	
Batch03	AnphA.00202.a	Anaplasma phagocytophilum	YP_505830.1	Q2GIH1				phosphoglycerate kinase	Potential drug target		MGDIRDLPVIDAANISNSRVLLRVDLNVPISNGEVHDKTRIERIAPTVEFLVKAKAKVVMISHLGRPKAQEEEFSLKQVVDVVSKVLGVEITFIPDITREEVDSVIDSLPWGSVVLLENLRFFTGEVENDLGFAGQLASLADMYVNDAFSCSHRKHASVDAIMNLLPSFAGFNLQEELNYLDGIVSESPGAAIIGGAKTSVKIPMLRNFASRLDFLILGGSLSTTFLDAMGFKVGNSFFEKNVEEALAVIEAAKESGCKIILPVDHAVAQNLEGPVTVKDNNDVTMEDSIFDIGEKTSRIIEETIRKCKTIFWNGPLGVFEHESFKGGTERLTKALVSCHKENGAKTIIGGGDSIFAMRSFGYCEQDFSYVSTGGGALLHFLAL		384		5	Purified	-1	 	NR-16301
Batch03	AnphA.00205.a	Anaplasma phagocytophilum	YP_504746.1	Q2GLK5				phosphoribosylaminoimidazole-succinocarboxamide synthase	Potential drug target		MENTREVLYEGKAKIILRHPENERAVIQHFKDTLTAFNAQRKSEIQGKGALTNRISSLLMEHLEASGIRTHFLSFLNDKEQLVSKLNMIPLEVVVRNIAAGSMCKKFGIPKGKVLAEPIVEFYYKNDELSDPMIAEDHATCFGLASKSELARMREIALQANNILSALFSEVKILLVDFKLEFGKDSHSEQEIVLGDEISPDTCRLWDTSTLTVLDKDLYRFDIGNIEDGYKEVLQRLEQHFKNK		244		5	Purified	-1	 	
Batch03	AnphA.00258.a	Anaplasma phagocytophilum	YP_505030.1	Q2GKS1				seryl-tRNA synthetase	Potential drug target		MHDIEFIKNNPELFDKAMLSRGLESQAAKIIELDLQKRKLLTELYALREQRNAITKEVTVLKQSGADCSSHVETSKKLAHEISELEERIKRDTGLSYLLCSLPNIPDDAVPFGKSADDNVEVRSYGQKRSFSFEIKPHYVLGEMLNLMDFRRAAFLSGSRFSILSGQLAALERGLASFMLEMHTKEFGYTEVFHPSLVNDLAMFNVGQLPKFTHDSFQTTDAMRLVPTSEVVLTNLVANTNLHRNSLPLRFTAYSQCFRSEAGSAGQDTRGMIRQHQFSKVELVSITDASQSNVELERMLSVAEEVLKRLELPYRVVLLCTGDMGFSASISYDIEVWMPAQNKYREISSCSNCKDFQARRMGAKCFYLEKQNKRSSFVHTLNGSALALGRTIAAIMENYQNSDGTITIPDALRKFMSADYIRPGTALP		428		1	Selected	-1	 	
Batch03	AnphA.00270.a	Anaplasma phagocytophilum	YP_505551.1	Q2GJA0				recombination protein RecR	Potential drug target		MDISRLISLFSKLPGLGPASSRRIVLHLLRHRHDVMTPLANGIRELEESTKECEICFNLDVTSPCSICTDSRRDKSLLCIVEELGDLWAFEKGRIYQGMYHVLGGVLSALSGVGPEDLNMSSIPERVRLHGVKEVIVATGSDMDGQVTCHYIAQSIKSTGVKVTRLACGIPLGGEIDYLDEGTLRAALSSRYII		194		4	Soluble	-1	 	NR-16302
Batch03	AnphA.00279.a	Anaplasma phagocytophilum	YP_504915.1	Q2GL36				DNA-directed RNA polymerase subunit alpha	Potential drug target		MADHWNKLTRPSSIKVVGGKEPCVMELVIEPLESGFALTLGNALRRVMMSSLRGFAVYGIEIEGASHELTALSGVREDVADLVLNLSMLRVKLLNSNQRVLRLVARGPGEVTAASIVDSADHVVLNKDLHICTLGKDVDFCMKIYVNSGKGYVPATEYRAASRSGGASEVGSGFIATNALYSPVKKVALKIESSRIGQFTDYDRLMLTVETDGSVAPDDAVAVAAKILQDQLQSFISFDEVEETRKSVDKEEGVLPYDHNLLRKVDELELSVRSHNCLKNDNITYIGDLVQRTESDMLRTPNFGRKSLNEINEVLASMNLHLGMKVPNWPPESIENLSKQYSED		344		1	Selected	-1	 	
Batch03	AnphA.00302.a	Anaplasma phagocytophilum	YP_505147.1	Q2GKF4				cysteinyl-tRNA synthetase	Potential drug target		MKLYDTFSAAKRVFDPIDSACVKIYACGPTVYDLAHIGNARSAVVYDVLFRLLRELYPEVIYVRNITDVDDKIINAAAETGQNIGDFTERYIRYFHEDMDALNCLSPTVEPRATAEIDTMLQLISRLVESGHAYVKGGSVYFSISSHRHYGRLSGRKIDEMISGNRVSIDAEKLHPGDFVLWKPATEQDIKLGAAWESPWGGGRPGWHIECSAMSYRYLGESFDIHGGGADLMFPHHENELAQNMCAFSGSEYARYWVHNGFLTVNAGEKMSKSLGNVITVRGLRNSGIEGAVIRYVFLCTHYRKPLDWNEKAIFDAQSALSKMRRSCEEFTSEELNSDIEAVGVHNMLLEALKDDMNTPMAIAALHALVGEINKTTDFKERLKLARVLNRSAKLMGITDGFAGKSAEEAVDVDKIQELLERRREARNGGNYSLADEIRDQLHSMGIVIKDDKDGVTRWSRA		462		5	Purified	-1	 	NR-16226
Batch03	AnphA.00316.a	Anaplasma phagocytophilum	YP_505786.1	Q2GIL5				tRNA (guanine-N1)-methyltransferase	Potential drug target		MIFNVLTIFPQMFPGPLGVSNLGSALKKGLWTLNVFDIRAFANNKHNTVDDTPYGGGPGMLLRADVLGRCIDEVLSLHPNTKLMFTSPRGVSFTQDIARQTMNFDNITLLCGRFEGIDERVVDFYKLQEVSIGDYVLSGGELAAMVIIDTCVRMVPGVIGNAESLKQESMEGSLEYPQYTRPASWKGMEVPEVLLTGNHGEIEKWRRNASLSITAARRPDLLKDRYGENDVE		232		17	In PDB	-1	 	NR-16227
Batch03	AnphA.00321.a	Anaplasma phagocytophilum	YP_505051.1	Q2GKQ0				"translation elongation factor G, truncation"	Potential drug target		MQDYIYSVVLNSGKGYTESVGRILLMHENNREDIREIKAGDIAALAGLKKTTTQKIKQNLISCNSTVITYIKQQN		75		2	Cloned	-1	 	NR-16228
Batch03	AnphA.00332.a	Anaplasma phagocytophilum	YP_505586.1	Q2GJ65				50S ribosomal protein L1	Potential drug target		MLDKNIVYTPEEGIDQLLKSTTARFKESVDVAIKLSTGDSRSGDSIRGVAVLPKGLGREVRVAVLAKGEYAKQAKDAGADVVGDSDLIEEIKKGRKLDFDWCIATPDFMSQVSAIAKILGPRGLMPNPKFGTVTFDIAKMVGIVKSGQVRFRSDKYGIVHVKIGDVGFSREDLMENLRAVVSAVQGLKPATVKGAFFKAVFLNSTMGKSFRITGLG		216		-2	Work stopped	-2	Work stopped	NR-16229
Batch03	AnphA.00344.a	Anaplasma phagocytophilum	YP_504928.1	Q2GL23				fatty acid/phospholipid synthesis protein	Potential drug target		MTEIRDDSISIALDAMGGDSAPDVVIEGANLVLSGVVPCDGKVHFSIYGKKEEVLPVLAKYKLVEANSVFVDVSDAVSSSDRPSYALRHRRRSSMWHAVEDLKKGLVSAVVSAGNTGALMAISRHLLGTIHSIDRPAIAVAMPSQKSSFVVLDIGANIECSADALLQFAIMGVAFAKAILGRTDPKVGLLNVGSEEVKGTYAVQEAFSLMRAAKSKMDFYGYIEAEEVFKGEVDVVVADGFSGNIMLKTTEAVANLLMSLFKGVVKSSITAKIAACMLKPSVRKTMELVDPKLYNGAMLVGLNGVVVKSHGSADGKAYACAIKTAVHSARYAIVSKIASEISEMG		345		1	Selected	-1	 	
Batch03	AnphA.00354.a	Anaplasma phagocytophilum	YP_504888.1	Q2GL63				cytidylate monophosphate kinase	Potential drug target		MGATSLEGNSVRRIVIAIDGPSSSGKGAMASAIAAELGFVHMDTGMLYRIFAAEFAKNYIHSASAENYEICITAEDRCKMLSLLAENNSQYSSEAVGKAASIISRNGQVRAALLPIQQEFVRSSKRGVVLDGRDIATIVCPDADVKIFITAYASIRALRRYKQLRLRHGTRKVMYKNVFYSLLNRDIRDSCRSKGPLRRVKEAYYLNNSHINKEISLHQLMKKIKTFL		228		3	Expressed	-1	 	
Batch03	AnphA.00369.a	Anaplasma phagocytophilum	YP_505745.1	Q2GIQ6				D-alanyl-D-alanine carboxypeptidase family protein	Potential drug target		MRASLGLLLFKAFICALIFVLPAHPDASGLRTKAPHAIVFEWGSKTILFEHDVDAPTPTASMSKLMTLYIVLKNLKAGNIKLEDNLRVSEGAASAGAPTAFLKTGQLISVNDLIKGAAVASGNDACITLAEGLYTSQEKFVEEMNRVAKELDLKNSRFVNVTGWPDDNMMSVRDLLILSARILQDFPEYYYFFGEKQFTYNGITQKNYNALLNYNNIEVDGIKTGHTRTGGYGMVASALKDGRRVLVVINGLSTETERAYEAKKLILYALNHFSTKTIFPANGVVGEISVKHKKGTSLQVFLKEDAVVTYPKDLEHELHAFLLSQESLKAPIKKGQLVGSLLVKTKNSVQYSFPVYAATSVRAPCAVCDYIRSLYRTLYSHYTSDD		386		2	Cloned	-1	 	
Batch03	AnphA.00377.a	Anaplasma phagocytophilum	YP_504844.1	Q2GLA7				putative phosphoribosylformylglycinamidine synthase I	Potential drug target		MNVIVLSGYGLNCEEETLFAFQEAGRYLNTNISGKIVHIKELLSNPKQLASFNTMVIPGGFSYGDDTGAGNAYALRLIHGLNEHIRDFMARDTLLLGICNGCQILLRMLCPNVALVSNDVGMYQCRWVTVKASNNSVWLDGIDKMYIPVAHGEGKFYAAEDVLQNLETQGDIALRYVNSDGEYAEGEFPYNPNGSARDIAAITCNSGRALMMMPHPERAIFFTQRYDWTDIVHGHQNTKGAVEKYADGFQIFVNAVRYFS		260		4	Soluble	-1	 	NR-16230
Batch03	AnphA.00396.a	Anaplasma phagocytophilum	YP_504931.1	Q2GL20				cytidine and deoxycytidylate deaminase family protein	Potential drug target		MRASAYMKIAMEEANSSSGEIPVGALVVRNGVIIAKAHNLTIQNTDPTAHAEIVAIRMACKALSTHILDGCDIYVTLEPCAMCTQAISLARIRRIYFGACNEKLGGIENGAQVLKYCLHVPEVYGGFLEQENAELLKAFFKKMRLKK		147		2	Cloned	-1	 	
Batch03	AnphA.00421.a	Anaplasma phagocytophilum	YP_505870.1	Q2GID1				"uracil-DNA glycosylase, family 4"	Potential drug target		MTDEHNKPNVEDIKMFAEVLRFYHDSGVTHTLNDDLHPDDTLSPANFEKSPVVPDRAKTRESQEIVLNKTSNKKSSSNANMLQWVEEARKAAANCVDLAELRAAVCAFEGCEIKKAAVNTVFSDGNPKSKIMLIGEAPGSTEDREGIPFCGASGQLLDKMFAAINLNRSSNIYISNTVFWRPPGNRKPTDFELEVCRPFVEKHISLVDPDVVVMVGSTACYSLLQTPDNISRLRGKFYEYTNSFLSRSITAMVIFHPAYLLRQPQQKRLAWEDLKMLRAYIETHKIQVNT		290		7	Crystallized	-1	 	NR-16231
Batch03	AnphA.00427.a	Anaplasma phagocytophilum	YP_505847.1	Q2GIF4				conserved hypothetical protein TIGR00150	Potential drug target		MLSCRYEGLNLLSLRRVARELAGSLRGGMVVALRGNLGVGKTAFSREIIDCFSGEDFLGSPTFSLVHEYSTPAFSLYHVDLYRLSTLKEVQEVGFFDFCDNNLVLVEWPDILDGVVPFDVNVRITHSSDIEEMVRDVEIEWSKA		144		5	Purified	-1	 	NR-16232
Batch03	AnphA.00430.a	Anaplasma phagocytophilum	YP_504669.1	Q2GLT2				tryptophanyl-tRNA synthetase	Potential drug target		MIFSAVQPSGGSLHLGNYLGAVKKWVALQDAGKCVFCIVDMHALTSGSAETLSIRANTLSLLASYIACGIDPAKAVVFLQSSVPEHAELCWILGCLTPVGWLNRMTQFKDKSRSDSYRANLGLYSYPVLMAADILLYKADLVPVGNDQKQHLELAQSIARTFNTIYGVDFFCIPEAMPFDSAARIMSLKTGTKKMSKSDPSDFSRINLSDDNDVIALKIKKATTDSATGFCYGGLNQRPEVNNLVNIFAALSDSEPREVCVRFTNSSNKDFKDALTELLIERISPIRTKTRELLDDPGYLNSILSSGNEQARSIAGKNLREVKEIIGLYSV		331		5	Purified	-1	 	NR-16233
Batch03	AnphA.00435.a	Anaplasma phagocytophilum	YP_504816.1	Q2GLD5				glutathione synthetase	Potential drug target		MLKVAFQMDADVVVGKDLTVQFIQESKRRGHDVFFYQPRDLSFSRGEVVATAYSVDIGENSLHLRDRVRLSLEGLDILFIRQNPPFDMRYITNTYLLERLAGVLFVNDPKAIRDFPEKLLPLSFPEFIPPTLITESVQEACEFYREYGDVVIKPLYSFGGDGVIRICGNVDIAVIFDVMVARYGTQVVIQQIIPSVEDDKRVVLLNGEPIGAIKRRVISSGEIRTNLRVGAVPEMTELSERDREICRVVGDKLTAAGIIFAGIDILGGYLLEVNVTSPCGILEINQVYGTTLEKECWDQFEGMLA		305		3	Expressed	-1	 	"NR-16234, NR-16413"
Batch03	AnphA.00455.a	Anaplasma phagocytophilum	YP_505227.1	Q2GK74				ribose 5-phosphate isomerase B	Potential drug target		MVKRVFLSSDHAGVELRLFLSAYLRDLGCEVFDCGCDPKEHSVDYPDYVHDVVREVSDTSFGVLICGTGIGMSIAANRHKNIRAALCSSTMLAKLSREHNDANVLCFGSRYIDPDTAQSVLYTFMTTAFLGGRHAVRVQKLGE		143		3	Expressed	-1	 	
Batch03	AnphA.00462.a	Anaplasma phagocytophilum	YP_504734.1	Q2GLL7				riboflavin synthase subunit alpha	Potential drug target		MFNGIVTLIGRVEDIQHDGDTDVIARISVQSEEFLSQIVIGSSIACSGVCLSVVEKGATHFVTNISKATLDITNLRFWTLGTKVNLEPALRAGAPLDGHMVQGHVDCIGEIHSITQVAGSHVMEICCDSSTSKYIAKKSSIALDGVSLTVNSTTPGLFSVNLIPYTWNNTTFQYNTVGDFVNIETDLIARYLEALLAHRTYGL		203		5	Purified	-1	 	
Batch03	AnphA.00468.a	Anaplasma phagocytophilum	YP_505091.1	Q2GKL0				putative translaldolase	Potential drug target		MKIFLDTIDVDSIAVLYKTGAVDGITTNPALLSKSERPYRELLEEICSLVQGDISVEVVSVDADDMVAEGLKLAKIAKNVVVKLPLTFDGIRACNILARERDIKVNVTLCFSATQALMAAKAGATYVSPFMGRIDDLGGDGAALIRDIRCVYSNYGFKTQVLAASVRSPMHVLEAAKAGAEVATVPVSVFKQLFLHPLTDKGLADFLKSWEVSGRSIL		218		3	Expressed	-1	 	"NR-16235, NR-16414"
Batch03	AnphA.00473.a	Anaplasma phagocytophilum	YP_504897.1	Q2GL54				50S ribosomal protein L22	Potential drug target		MSIVIAAKGLGLRSTPAKLNLVADLIRGKDVAVAAMYLKFCKKKAALLIDKVLKSAIANARANYGVDADNLYVKEVLVGKAFTLRRVQPRARGRACRISKRYGSVVVKLLER		112		-2	Work stopped	-2	Work stopped	NR-16303
Batch03	AnphA.00481.a	Anaplasma phagocytophilum	YP_505732.1	Q2GIR9				methionine aminopeptidase	Potential drug target		MGRGTITIHSKEDFACMRRAGMLAAKVLDFITPHVVPGVTTNALNDLCHDFIISAGAIPAPLGYRGYPKSICTSKNFVVCHGIPDDIALKNGDIVNIDVTVILDGWHGDTSRMYWVGDNVSIKAKRICEASYKALMAAIGVIQPGKKLNSIGLAIEEEIRGYGYSIVRDYCGHGIGREFHAAPNIVHYYDEEDDVTIQEGMFFTVEPMINAGKYHTVLDKKDGWTVTTRDFSLSAQFEHTLGVTETGVEIFTMSPKNWHCPPYL		264		7	Crystallized	-1	 	NR-16236
Batch03	AnphA.00487.a	Anaplasma phagocytophilum	YP_505574.1	Q2GJ77				dihydroorotate dehydrogenase 2	Potential drug target		MSLFRFNNPLFLIPPKVAHSLTLFALQQGLYSSSVRKMPECLSAQPLNFKVRTPIGLAAGFDKNAEVIRPVLSLGFGFTEVGTVTKYPQSGNKGPRLFRMHKQKAVINRLGFNNKGLTRLLKKVDSKDLNNLVFGINVGMYKGCSDPPAEYAELVQKVYGLSSYITINLSSPNTAGLRELQKRNSLNEILASVRKARYAVDHAESVPILLKIDPDLSDEVLQDVVDEVLRHKINGIIVSNTTTNFKLLGTKAPISRGGLSGQPLFSLSTRVLADVYSQTRGRVVLVGCGGVSSGAQALEKIRAGASLVQLYTAIVYGGFGIIDKINMELADLLTRDGFNKVEQAVGIDVH		350		4	Soluble	-1	 	"NR-16237, NR-16415"
Batch03	AnphA.00493.a	Anaplasma phagocytophilum	YP_505212.1	Q2GK89				immunogenic protein	Potential drug target		MFFTNVALSADAPSRDFVLIGSGSMTGVYYSIGGGLCKFVVSGYRERHPGDALICSTASTSGSVYNLNAMRRGAMDIGAAQSDIGYYAYAGKNLYSGEHPMQNLRLLAQLHREYLTLIVRADSGIKTIDDIKGKRVNIGAPGTGIRTAMLGLMELKGWTTKDFLVTSDLRASEQVQALCDGKVDVISDFIGHPNASMQEVAATCGSVVLSLDADLIAQVIEKYPYYQAGMIPGNTYSNIPYDVHTISIRASIYGTAELSDEMAYITVKSIASNLVRFRELSGALRNLTLADLPGASTRGSAFEVPLHEGAEKFYRDFGLITG		322		3	Expressed	-1	 	NR-16238
Batch03	AnphA.00501.a	Anaplasma phagocytophilum	YP_505874.1	Q2GIC7				"peptide deformylase, truncation"	Potential drug target		MINSFDLVSMEEGCLSVPNQRELVVRPERVVMQYTDLHGKRKILKAQGLLSRCLQHEIDHLNGTVFIKHISKLKRDLVMQKMRKAASLMKN		91		2	Cloned	-1	 	NR-16239
Batch03	AnphA.00513.a	Anaplasma phagocytophilum	YP_505546.1	Q2GJA5				"putative cation ABC transporter, ATP-binding protein"	Potential drug target		MLVVDSITLFYGNRKVIDNVSFSIRPGEIITILGPNGGGKTSLVRVLVGINQDYIGTIHYTKRPIIAYMPQNFKVNSFMPMTVEYLLLSACWGRGISLDLRAVIQYVDISKLLTRQISELSAGEIQLVLLARCMVMKPDLIVLDEPVSCMDVEAKNNFYRLIGKLVSKYNISIIMTSHDLHCVMACSDRVICINRSIRCEGTPEEITESAKFMSVFPENV		220		3	Expressed	-1	 	NR-16240
Batch03	AnphA.00518.a	Anaplasma phagocytophilum	YP_505666.1	Q2GIY5				ApaG	Potential drug target		MTVLECGKEAGLIEVEVTPSYLEEHSIPHENCYIWLYSVRINNRSDSTVQLLKRSWKIIDSKGVVNEVSGSGVAGSQPVLKPGAFFEYTSGTCLSTPSGVMNGWYQFVDEDKAQVFYVDVPAFSLDSPYDSLRLN		135		5	Purified	-1	 	NR-16241
Batch03	AnphA.00520.a	Anaplasma phagocytophilum	YP_505555.1	Q2GJ96				phosphomethylpyrimidine kinase	Potential drug target		MYKGNVLSIAGSDSGGGAGIQADIKTITMLGCYAATCITAITAQNTQEVRGVWELAPEVVKGQLEAVLDDLKVDAIKIGMLPVGLIGVVAESLPCEIPVILDPVMVSTSGFELTDPMGYTESIRPLAQNAALVTPNIKETEALSGMKNIRTREEMVTAGNKIIQFLGIKAVLVKGCIWEEEEFVESVLIYDGKTVFFRNERAPGELHGTGCTLTSAIACFIARGLSLEESTRLAFDYVSCTIRNAPIVGQGLRPLFHNYFIVGDC		265		7	Crystallized	-1	 	
Batch03	AnphA.00532.a	Anaplasma phagocytophilum	YP_504787.1	Q2GLG4				FAD-dependent thymidylate synthase	Potential drug target		MVDEATEYTKRLVVPALENVLYQEHKVLDHGFVRVIDYMGSDASIVQAARVSYGKGTKQVSQDAALIGYLMRHAHTSPFEMCEIKFHIKLPIFVARQWVRHRTASINESSARYSVVENEFYIPEACDVAEQSSNNAQGRGNPLTSEVAQNVIGMFKDNSDSMYASYESMLSDGVARELARMTLPLNCYTHWYWKVDLHNLLRFVTLRLGSGAQYELRAYAGKILDIIALWVPMVYAAYMEYCFESKTLSKSALSVIRMLLKGEKVSREDVGMSKREWGELMATLYPDE		288		5	Purified	-1	 	"NR-16242, NR-16416"
Batch03	AnphA.00551.a	Anaplasma phagocytophilum	YP_504657.1	Q2GLU4				uroporphyrinogen decarboxylase	Potential drug target		MKIIIYNKKTITVLREILTTRRSTQRLPIWFMRQAGRYLPEYQKVMAHVQDFLEACYTPEIVEEVTLQPIQRFDLDAAIIFSDIMTVPDALGFEVVFKRGYGPQINAKTRREVTLEWSLEKVSPVLESIKRVRKSLSPNKSLIGFAGSPWTVATYILEQEKKITDIFALHRSGDNSVAKLIDEIVSFTTVYLKKQVEYGVDILQLFDSNASGLPVDLFETFIVEPTQRIVKELRKHHPSIPIIGFPKGAGVLYTHYALTTGISAVSVDYSIPSQWIKNNISGVVQGNLDPFLLAYDVEGALKCAGEIIADLRDKPLIFNLGHGIIPPTPVDNVYRLVDFVRSF		343		3	Expressed	-1	 	NR-16243
Batch03	AnphA.00555.a	Anaplasma phagocytophilum	YP_504890.1	Q2GJ61				elongation factor Tu	Potential drug target		MTEGRKPHINVGTIGHVDHGKTTLTAALTTVLARKLSGANKVVKYDEIDKAPEEKARGITISTAHVEYETEGRHYAHVDCPGHADYIKNMITGAAQMDVAILVVSATDGAMPQTREHILLAKQVGVKDIVVWINKCDVVEDEEMLSLVDMEIRELLSQYGYDGDSIDAVRGSAVKALEEDADGPWSDKIMELVGALEKIELPMREKDKPFLMSVEDVFSIPGRGTVVTGRIERGVVRVGDKIDIVGLRELQSTVCTGVEMFHKALEAGEAGDNAGILLRGIKKEDVERGQVLSAPGQMKSYKKFKAEVYVLKKEEGGRHTPFFANYQPQFYVRTTDVTGSISLPAGVEMVMPGDNLSIEVALDKPVAIDKGLRFAVREGGRTVGSGIITEILE		393		5	Purified	-1	 	NR-16244
Batch03	AnphA.00571.a	Anaplasma phagocytophilum	YP_504995.1	Q2GKV6				GTP-binding protein EngA	Potential drug target		MQKVAIVGLPNVGKSTLFNRLTRRKSAIVSDIAHVTRDRKEALVDFCGLRFIAIDTGGVADGGEIQSLVKTQVQLALENADVVLFVIDAQRATDSHSTSLGKWLSKITNKPIILVANKCESNKNNVHVDTMEYLGFLGPVYISAEHNLGMADLYEAIAPLIEQSERPKKDQDRPIAISIIGQPNVGKSTFVNSILGEERVITSGIAGTTRDSISAEYSYKGITLLLTDTAGIRKRTKVTENMEKLSVQSAIHALSKSHVVILIVDFTQGISQQDLSIASTAIKDGKGIVLALNKADLVNDKAAEDAILNAIRQYSRVDFDVPIMKMSALENIGCDKVLSKAVKIYESASTHISTSKLNKWLGTAIDYHPPHLQNKKKVRLKYISQVSTLPPTFVIATNSTEVESTYQTYLKNSFLKHFSMQGVPIRMIFKKGNNPYISKD		440		0	Target Approved	-1	 	
Batch03	AnphA.00588.a	Anaplasma phagocytophilum	YP_505757.1	Q2GIP4				signal recognition particle-docking protein FtsY	Potential drug target		MSSNESFWQSLKRGLSKTSARLSEGIRNIFGGKADVDQSTLKALRDLLISTDMGPDVADFFTQKISTLKFTDSVAEEVRLKLASEIENFLQPRSAPITITHTPHIILLCGVNGSGKTTTVAKLAHKFMKKNMSVIIGACDTFRAAAVEQLNVWAERISCPIVTGTIGADAASVAYKTVERAVKEPFDVVIIDTAGRLHNHKNLMEELAKICRVIRRHDEKAPHDIILVLDATIGQNTFTQVEMFSSFVDVGGLILTKLDGTAKGGVVLRVSQKYNLMIHAIGTGEGIEDLEDFSATNFAKSLLEI		305		3	Expressed	-1	 	
Batch03	AnphA.00602.a	Anaplasma phagocytophilum	YP_504891.1	Q2GL60				30S ribosomal protein S10	Potential drug target		MVTQKIYIELKAFDHGLLDRSARNIVLVAKRSGAKVNGPIFFPRRTAKFIVNRSTHVDKKSREQFEIRTHKRLISLPKANSAILQALMSLQLPAGVDVKVKVVGG		105		-2	Work stopped	-2	Work stopped	"NR-16245, NR-16417"
Batch03	AnphA.00603.a	Anaplasma phagocytophilum	YP_505532.1	Q2GJB9				collagen triple helix repeat protein	Potential drug target		MTSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGLSGSLKIF		165		1	Selected	-1	 	
Batch03	AnphA.00604.a	Anaplasma phagocytophilum	YP_504691.1	Q2GLR0				S-adenosylmethionine synthetase	Potential drug target		MPLSEAATIAGEVSGVIVEEEKVDGVVRKTLREIGYEKEGFHWREVKVRIMLQEQSHDIMLGVNRGRKKKGAGDQGVMYGYAINETESYMPSPIFYSHRVLKNLSDAVKQGSITGIGPDAKTEITLQYVDHKPVKVLRAVLSVQHDESRTQQDVRDLVYPYFVSSIPEGWMCKEENFLVNPTGRFVVGGPVGDTGITGRKIMVDTYGGHIPHGGGAFSGKDPSKVDRSAAYMARYIAKNVVHAGLASECLVQMSYAIGVPAPLTFAINTFGTSVVDVKEIERCIISNIDLSVSGICEKLSLYEQIYSPTSCYGHFGRTHENSFSWEKLDLSLILNREFSCN		341		1	Selected	-1	 	
Batch03	AnphA.00604.b	Anaplasma phagocytophilum	YP_504646.1	Q2GLV5				S-adenosylmethionine synthetase	Potential drug target		MFHLDRYYNSYFITSESVAHGHPDKVADRISDDILDYFMSINPEAHVAVEALVTRDNVIIAGEVSGVIVEEEKVDGVVRKTLREIGYEKEGFHWREVKVRIMLQEQSHDIMLGVNRGRKKKGAGDQGVMYGYAINETESYMPSPIFYSHRVLKNLSDAVKQGSITGIGPDAKTEITLQYVDHKPVKVLRAVLSVQHDESRTQQDVRDLVYPYFVSSIPEGWMCKEENFLVNPTGRFVVGGPVGDTGITGRKIMVDTYGGHIPHGGGAFSGKDPSKVDRSAAYMARYIAKNVVHAGLASECLVQMSYAIGVPAPLTFAINTFGTSVVDVKEIERCIISNIDLSVSGICEKLSLYEQIYSPTSCYGHFGRTHENSFSWEKLDLSLILNREFSCN		392		1	Selected	-1	 	
Batch03	AnphA.00614.a	Anaplasma phagocytophilum	YP_504944.1	Q2GL07				adenylosuccinate synthetase	Potential drug target		MPSIVVVGLQWGDEGKGKIVDWLSENADTVVRFQGGSNAGHTIVIEGKVYKLSLLPSSVLRPGKQSIIGNGVVLDPYALVREIEKLQESNIELTPENLSLSETCPLVLSVHRETEVILENLRGVHAIGTTCMGIGPCYEDKIGRRAIRLCDLLDEKSLREKVEFLLSYHNLLRKATNKDELQSEKVMEEILFIAPKVLPFMKHVGGMIYEQLAEGKTVLFEGAQGALLDIDHGTYPYVTSSNTLAGCVPIGCGVGSPGSIRVLGLAKAYTTRVGNGPFITELTGDLDDLMVERGREFGTVSKRRRRCGWFDAALVRHAALLSGATELALTKLDVLDTLSEIKICVGYKHGESFYNYLPPASHIQGALEPIYEVLPGWQSSTLGAVSKNDLPANALAYVQRIEELVQIPVSLVSTSPDRDHIVFLGDSSSIAKSY		434		5	Purified	-1	 	NR-16246
Batch03	AnphA.00626.a	Anaplasma phagocytophilum	YP_505116.1	Q2GKI5				"NADH dehydrogenase I, C subunit"	Potential drug target		MSLDIEPVASSHIQELLQTDIVLRQDGVLQCYLEAQSIRDNLITLRDDPKTKLRVLTDIFAVDYHNKKSRFEVVYMLLSLVYNIRVCCKVALTEGSIIPSVTSVFGSAGWFEREVYDMYGIEFSDHPDLRRILTDYGFRGHPMLKDFPLTGYEEIRYDFRKGKVAYQPVDLQQNFRLFNSMSPWKGYK		188		3	Expressed	-1	 	"NR-16247, NR-16418"
Batch03	AnphA.00630.a	Anaplasma phagocytophilum	YP_505349.1	Q2GJV2				rod shape-determining protein MreB	Potential drug target		MTRKNWWANDLAIDLGTANTLVYVKGKGIIINEPSVVALLKDNGGYVPYAFGVEAKMMLGKTPEGIEAVRPLKDGVIADFRSAEEMIKFFIKTANKGRTLNRPTAVICVPSGSTPVERRAIQDAALCAGAGTVYLIEEPMAAAIGADLPVSNPEGSMIVDIGGGTTEVAIISLGGIVYSRSLRSGGDLMDEAIIAYTRKNHNLLIGDATAEKVKKNIGAARIPEEGSGDSTVVKGRDLTTGVPREITLTEKEVAESLTELVDTIIAAIKLALECSPPEISADIVDQGITLTGGASMLKNLDVVIAEATGLQVTLAANPLYCVALGVGKVLENMSSLSRVLFRQN		344		1	Selected	-1	 	
Batch03	AnphA.00636.a	Anaplasma phagocytophilum	YP_505593.1	Q2GJ58				30S ribosomal protein S12	Potential drug target		MPTINQLVRRPRKPSVSANKAPALQHNPQKRAVCVKVYTTTPKKPNSALRKVARVRIAGYGSEVIAYIPGEGHNLQEHSVVLIRGGRVKDLPGVRYHIVRGALDTKGVQGRKKARSKYGVKRGS		124		-2	Work stopped	-2	Work stopped	NR-16248
Batch03	AnphA.00642.a	Anaplasma phagocytophilum	YP_505115.1	Q2GKI6				NADH dehydrogenase subunit B	Potential drug target		MGECDQILENDLWQGYKDQGFVVTQFSDLIERVLKWARSGSLWPMTFGLACCAVEMMHTAASRYDLDRYGIMFRASPRQADVMIVAGTLTNKMAPALRRVYDQMADPKYVISMGSCANGGGYYHYSYSVVRGCDRVVPVDIYVPGCPPTAEALLYGLLCLQQKILRNGQGTWRA		174		2	Cloned	-1	 	
Batch03	AnphA.00651.a	Anaplasma phagocytophilum	YP_504684.1	Q2GLR7				iron-binding protein	Potential drug target		MVLAICFGVIAYNKHSSIQEKVVNVYSSRKEELLRDLFKKFTADTGIQVRYINDEAAQLIARMESEGAYSEADVFLTADAVNLILAKKKGLLQPVRSEILEQVIPARYRDNDGYWFGLTKRARIVVYNKDLVDVSQLSTYEDLADSKWRNQILVRSSNSPYNQSLIAFMVANNGMEATREWVRGLVSNFARKPAGGDTDQIYAAAAGEGGIAIVNSYYWGRVCSSERRVDKEAAAKLAIFFPNQGSTGAMINISGGAVAKSAKNKDNALKLLEFLSGEEAQSIYANSNQEYPIVLGAARSKILQSWGEFQESELPLQELEKYLGESVQIADEEGWK		336		3	Expressed	-1	 	
Batch03	AnphA.00652.a	Anaplasma phagocytophilum	YP_505748.1	Q2GIQ3				nucleoside diphosphate kinase	Potential drug target		MQERTLSILKPDVVERGIIGNVISYIEAAGLKVVAQRMCRLTVSQAEEFYDVHRDRPFFPELVKFMTSGPVVVQVLEGESAIAVYRDVMGATNPKEAAKGTIRADFAESIDANCVHGSDNADNAKREIMFFFGECEIFKR		140		7	Crystallized	-1	 	
Batch03	AnphA.00666.a	Anaplasma phagocytophilum	YP_504912.1	Q2GL39				adenylate kinase	Potential drug target		MEKEQVNLLIFGAPGSGKGTQARLLGEYLKGLEVISMGDLLRAEVASKTVIGAEVEAIMQEGRLVGDPLVCEMIFRKLRGFSAGFLLDGFPRNLPQAEFLTAVMQLLNRKIDAVLKLEVDAAVVENRLQGRLVCKGCGAVSNAVFNHGACQACGCEEYVRRNDDSLNVIRRRLMDYDREVTVLEGYYQDKVIRINGDRTVEEIHGDVKHVLDRLNN		216		1	Selected	-1	 	
Batch03	AnphA.00668.a	Anaplasma phagocytophilum	YP_505627.1	Q2GJ24				ATP-dependent protease ATP-binding subunit	Potential drug target		MRDLSPKQITKELDRFIVGQTEAKRAVANALRSRWRRNRVPQPLRDEIIPKNILMIGHTGVGKTEIARRLAKLAQAPFIKVEATKFTEIGYVGRDVDSIMRDLVDRAVLLVKEKYRKVVRKQARKSAEDIILNCLVGADASEETKNAFRHKLRAGEYENSEISINVKDNRKSMPPSFDVPGMPGGQVGIMNINEIVQKVLGGNKLSRTISTTVKEAREILLDEETEKLIDEDKIVREALHIASNEGIVFLDEIDKIAARTEVRGEVNREGVQRDLLPLLEGTSVSTKYGTVTTDHVLFIASGAFHLAKPSDLLPELQGRLPIRVELQPLSRDDLVRILTEPEANLLKQYRALLETEGVTVEFTEDGIFAIAEIASTVNREVENIGARRLHTIMEKLMEDISYNASENSGQTFVIDEKHVRERLEDISKQLDLSKFIL		437		3	Expressed	-1	 	
Batch03	AnphA.00670.a	Anaplasma phagocytophilum	YP_505024.1	Q2GKS7				GTPase EngB	Potential drug target		MLGCRFVAGVQDRKSFPDFGVPEVAFAGRSNVGKSSLINAITNNKKNAKTSSNPGSTRQINFYLNKGIVALVDLPGYGYSKASKEATRGYLDVMEHYLMSREALQRLVLLIDSRIGLKEIDRDFLCWLEEHGIYYSIVLTKADKLSEQALGSMVSFVQNQAQGGNFLLQPIMWVSSKSGRGIRELAHEISRCI		193		4	Soluble	-1	 	
Batch03	AnphA.00677.a	Anaplasma phagocytophilum	YP_504847.1	Q2GLA4				phosphoribosylglycinamide formyltransferase	Potential drug target		MKKELRVGVLISGRGSNLEALAKAFSTEESSVVISCVISNNAEARGLLIAQSYGIPTFVVKRKPLDIEHISTVLREHDVDLVCLAGFMSILPEKFVTDWHHKIINIHPSLLPSFKGLNAQEQAYKAGVKIAGCTLHYVYQELDAGPIIMQAAVPVLREDTAESLASRILAAEHVCYPKGVKLIAQDKIKLCDDGTVQCTGEDELFLFQENF		211		17	In PDB	-1	 	NR-16249
Batch03	AnphA.00677.b	Anaplasma phagocytophilum	YP_504715.1	Q2GLN6				"putative phosphoribosylglycinamide formyltransferase, truncation"	Potential drug target		MTFVVRRKPLDIEHISTVLREHDVGLVCLAGFMSILPEKFVTDWHHKIINIHPSLLPSFKGLNAQEQAYKAGVKIAGCTLHYVYQELDAGPIIMQAAVPVLREDTAESLASRILAAEHVCYPKGVKLIAQDKIKLCDDGTVQCTGEDELFLFQENF		156		-2	Work stopped	-2	Work stopped	
Batch03	AnphA.00685.a	Anaplasma phagocytophilum	YP_505071.1	Q2GKN0				aspartyl/glutamyl-tRNA amidotransferase subunit B	Potential drug target		MSWIINGASHDWEVVIGLEVHAQIVSNSKLFSGASTEISVDPNSHVALLDVAMPGVLPVTNEYCIVQAVKTALALSCEVKKYSVFDRKNYFYPDLSFGYQITQFYHPIAKNGHIMLDESADNKKIGIARIHIEQDAGKSLHVGDKTCIDFNRAGVALMEIVTDPDLRSPEEAAEYLKKLRIILRYIGACSGDMENGALRCDANVSVRKVGESALGVRSEIKNLNSIKYVAQAIKYEAMRHVEVLESGGKVEQSTLLYDVDTGTTRTMRSKEDVCDYRYFPDPDLLPLEITDEFIASIRDTLPELPMAKMSRYMNDFSLSRYDAVILSSDRDVAEYYDEVMQRNLPGDLVAAWVTGELFGMLNKRGMCISDSPVRADALGDLLRLMVDGTISGKMAKQVFATMFETGKSASKIVEEEGLQQIADEGVLSAMVERVLEKNPDKVQQYKQGKEKLFGYFVGQIMQETKGRANPEVLNALIQSKLSQ		483		4	Soluble	-1	 	NR-16250
Batch03	AnphA.00715.a	Anaplasma phagocytophilum	YP_505166.1	Q2GKD5				putative tRNA-dihydrouridine synthase	Potential drug target		MRQFISENPVILAPMSGVTDLPFRTTVRKLGAGLLISEMVASRAMILKTRQSMQKSEVCPNTSVQLAGCTPEIMAEAAKINEDLGAKSIDLNFGCPAKKVVDGYAGSALMKDEVIATKIMESVVKAVKVPVTVKMRMGWDTTNLNAPTLAKVAEDVGIQMITIHGRTRSQMFSGSADWKFVKRVKECVKIPVIVNGDIRTLDDIVVALNESGADGVMIGRGAYGKPWLIKQALSFMKNSEILPEPTKSEKLAIILDHYDYALDYYGKDLGVKILRKHLSWYSSSYSGASYFRAQVNTMSDPVEVREKLTEFFQTS		315		3	Expressed	-1	 	NR-16304
Batch03	AnphA.00718.a	Anaplasma phagocytophilum	YP_504756.1	Q2GLJ5				"tubulin/FtsZ family, C-terminal domain"	Potential drug target		MLWCDANLTVRTLKNTVQYTGVRGITDLMVMPGLINLDFADVKVVMSEMGKAMMGTGEAEGEHRAVAAAEAAISNPLLDNISMKGARGILINITGGMDMTLFEVDAAANRIREEVDEEANIIFGSTFDENSAGRIRVSVLATGIDSTHTSNSKGRMTRGSESDLGVSDVGGDSARVGVSGYARAGQESSGAPAEADLFSRGSGNRNSSLNWNSKSFDVPAFLRKK		225		2	Cloned	-1	 	"NR-16251, NR-16419, NR-16252"
Batch03	AnphA.00718.b	Anaplasma phagocytophilum	YP_505806.1	Q2GIJ5				cell division protein FtsZ	Potential drug target		MSLHVYLPDQSVIRPRITVLGVGGAGGNAVNNMIQSCLQGVNFVVANTDAQALDCSLSEKKIQLGMNLTKGLGAGSLPEIGRGAAEESIEEIIAEISDSNMLFITAGMGGGTGTGAAPVIAKAAKDSKILTVGVVTRPFHFEGAHRMKTAEYGLEELQKHVDTLIVIPNQNLFRIANENTTFADAFKLADTVLHTGVRGITDLMVMPGLINLDFADVKVVMSEMGKAMMGTGEAEGEHRAVAAAEAAISNPLLDNISMKGARGILINITGGMDMTLFEVDAAANRIREEVDEEANIIFGSTFDENSAGRIRVSVLATGIDSTHTSNPKGRMTRGSESDLGVSDVGGDSARVGVSGYARAGQESSGAPAEADLFSRGSGNRNSSLNWNSKSFDVPAFLRKK		400		2	Cloned	-1	 	
Batch03	AnphA.00810.a	Anaplasma phagocytophilum	YP_505328.1	Q2GJX3				3-octaprenyl-4-hydroxybenzoate carboxy-lyase	Potential drug target		MRIVVGISGASGAIYGVRLLQHLKNTDVEVHLVISNAAKLTLMHECADIITLRELEEDLCYQCHNCENIGASIASGSFATAGMIVAPCSVRTMSEIASGAASNLLTRAADVTLKERRKLVLMLRETPFHFGHLRNMTALTEIGAIIAPPIPSFYHHPKSITDIVDHSVSRVLNIFGFWDKAKEWQGLKK		189		2	Cloned	-1	 	
Batch03	AnphA.00811.a	Anaplasma phagocytophilum	YP_504764.1	Q2GLI7				glutaredoxin-related protein	Potential drug target		MDNNLVNRIKHDIENNDVVLYMKGTATAPQCGFSSVVASVLVHLGIAFKDVDVLRDPELREGIKEFSNWPTIPQLYVKGEFIGGCDIVREMYQSGELQELLKKKGVITG		109		5	Purified	-1	 	
Batch03	AnphA.00817.a	Anaplasma phagocytophilum	YP_505073.1	Q2GKM8				enoyl-(acyl-carrier-protein) reductase	Potential drug target		MRTGMLMEGKKGVIIGVANDKSLAWGIAKAVCAQGAEVALTYLSETFKKRVDPLAESLGVKLTVPCDVSDAESVDNMFKVLAEEWGSLDFVVHAVAFSDKNELKGRYVDTSLGNFLTSMHISCYSFTYIASKAEPLMTNGGSILTLSYYGAEKVVPHYNVMGVCKAALEASVKYLAVDLGKQQIRVNAISAGPVRTLASSGISDFHYILTWNKYNSPLRRNTTLDDVGGAALYLLSDLGRGTTGETVHVDCGYHVVGMKSVDAPDISRVKGDHSV		275		17	In PDB	-1	 	NR-16253
Batch03	AnphA.00818.a	Anaplasma phagocytophilum	YP_504643.1	Q2GLV8				"ABC transporter, ATP-binding protein"	Potential drug target		MYAVSLSNLHVSFNNKEVLKGVDLDIAWGDSLVILGESGSGKSVLTKVVLGLIVPQEGSVTVDGTNILENRQGIKNFSVLFQNCALFDSLTIWENVVFNFRRRLRLDKDNAKALALRGLELVGLDASVMNVYPVELSGGMKKRVALARAIIGSPKILILDEPTSGLDPIMSSVVSDIIARCHRDFNLTIITITHDLSSAFHVANKIAVLRGGKIIACDGVENIKKSTDPYVAKFMKFGMHT		241		3	Expressed	-1	 	NR-16305
Batch03	AnphA.00826.a	Anaplasma phagocytophilum	YP_505066.1	Q2GKN5				single-strand binding protein	Potential drug target		MSSIGVNKVILIGYLGKDPDVRVMQNGKEMANFSLATSESWLDKASGSRTEKTEWHNIVVFSEGLVKVVKTCARKGSKVYLEGSLRTRKWVDQNNNDRYTTEVVLQGFNSTLCLLDPKGMSSGDAAASSIGAPPASSEEAGSFGGGVDFLDPDVDEIPF		159		3	Expressed	-1	 	
Batch03	AnphA.00837.a	Anaplasma phagocytophilum	YP_505569.1	Q2GJ82				pyridoxamine 5'-phosphate oxidase	Potential drug target		MTINKEGLRVDACSGDPMSIFGLWYEEVLRVKSVREPSAMVLATCDSENRPSARVVLLKRYSDAGFEFYTNLESRKAREIALNPCVSLVFDWRPIYKQVRVEGIAEFMDASESDAYFASRSRESQIGAWCSRQSMILEDRDVLLSKIELMEREYEGREIPRPKFWGGIRVVPNVIEFWMDGKHRLHDRRQYSKNIDGTWTSVYLYP		206		5	Purified	-1	 	NR-16306
Batch03	AnphA.00846.a	Anaplasma phagocytophilum	YP_504893.1	Q2GL58				50S ribosomal protein L4	Potential drug target		MEVNIVNIANEVVGSIDLNPQVFGLEPRRDVLKEVVNWQLAKRRAGTHKAKGISDISGTTAKPYRQKHTGRARQGSLRSPQFRGGAVIFGPVPRSHEYSLNKKVRRLGLKVALSMKVAANKLVVLDSLDVDLKKTADAKGVFGNFAGHSSYLVVSESCKEEVVRACRNLRGVDLLKCVGINVLDILKHDCVILTVDTVKSLEGRLSNE		208		-2	Work stopped	-2	Work stopped	NR-16254
Batch03	AnphA.00847.a	Anaplasma phagocytophilum	YP_505544.1	Q2GJA7				"8-amino-7-oxononanoate synthase, truncation"	Potential drug target		MVFSSGYTTNIGSISALVGRHDMILADKFIHASSLDGARLSGATIYRFTHNNVDHCMQLISKYRELHDNCLILLENIYGVDGDLAPVDEFIQLAKEWNAWVIVDTAHGFGMLSSLQADIYVGTLSKAMGALGGFVCSSKITIEYLLNKSRSFIYTTALPPAIIAAASASIDLFKSYAEVPMRLAKEFCKIMELPEPQSHIVPLIMEDVRSVILAEQALAERGILVSAIRPPTAPTPRLRLTFTAAHKLIDVHRLCNALKACVVLTEAGNWRVL		273		3	Expressed	-1	 	
Batch03	AnphA.00847.b	Anaplasma phagocytophilum	YP_505577.1	Q2GJ74				8-amino-7-oxononanoate synthase	Potential drug target		MLKDILRERLEVIESNGLLRKLKQSTIQSSIAGRKIQNDAGNELTSFSCNDYMGLSTHDVVKQAAIDAINLYGMGARASRLTTGNHPLYAEIEAKLASLYGTEAALVFSSGYTTNIGSISALVGRHDMILADKFIHASSLDGARLSGATIYRFTHNNVDHCMQLISKYRELHDNCLILLENIYGVDGDLAPVDEFIQLAKEWNAWVIVDTAHGFGMLSSLQADIYVGTLSKAMGALGGFVCSSKITIEYLLNKSRSFIYTTALPPAIIAAASASIDLFKSYAEVPMRLAKEFCKIMELPEPQSHIVPLIMEDVRSVILAEQALAERGILVSAIRPPTAPTPRLRLTFTAAHKLIDVHRLCNALKACVVLTEAGNWRVL		378		2	Cloned	-1	 	
Batch03	AnphA.00854.a	Anaplasma phagocytophilum	YP_505171.1	Q2GKD0				periplasmic divalent cation tolerance protein CutA	Potential drug target		MSSTLLLIYTTMPDHDSARNMSELLLREKLISCSNMINGITSMYIWNGDINTSTECIVIMKTTAGLYEEIAKKIKELHPYNTPAIFSIPTHNCDPEFLKWVNSSTYRDIDC		111		5	Purified	-1	 	NR-16307
Batch03	AnphA.00856.a	Anaplasma phagocytophilum	YP_504878.1	Q2GL73				ferrochelatase	Potential drug target		MSRKIAVVLFNLGGPASLREVESFLFNMFNDSHIVSAPRPFRYFLAKAISKLRARSSREIYTLMGGKSIVEQETAKQAIALEELLNKNAETGCSYKVFTCMRYSAPNALTVLGDIDEYKPCKVVLLPMYPQYSSATTQSSIEDWFSTSHKAGYSFWTDIIWDYHSDEHFIAAHCKLISEAYEKALALNARARILFSAHSLPVSFIEKGDPYKQQLRQTVLSILQNMGLQSIDNTLCYQSKLGPVRWLEPSTKSELLRACNDNVSVVLVPIAFVSENSETLVELDIEYKALVGEKKFIRVPTLGTDPKFIECLCNLVLAKQ		320		4	Soluble	-1	 	NR-16308
Batch03	AnphA.00869.a	Anaplasma phagocytophilum	YP_505106.1	Q2GKJ5				"NADH dehydrogenase I, C subunit, truncation"	Potential drug target		MPSVTSVFGSAGWFEREVYDMYGIEFSDHPDLRRILTDYGFRGHPMLKDFPLTGYEEIRYDFRKGKVAYQPVDLQQNFRLFNSMSPWKGYK		91		3	Expressed	-1	 	NR-16255
Batch03	AnphA.00882.a	Anaplasma phagocytophilum	YP_505871.1	Q2GID0				peptide deformylase	Potential drug target		MSVRPLVVLPDSRLFLCSEEVRETDFCEKFNSLVEDMFDTMYAEQGIGLAAVQVGVHKRIFVIDLGPKTEESSEIADDPDGYHSTCGPMVVINPEIVEKSVDLVSMEEGCLSVPDQRELVVRPERIVMQYTDLHGKRKILKAQGLLSRCLQHEIDHLNGTVFLKHISKLKRDLVMQKMRKAASLRKN		187		7	Crystallized	-1	 	NR-16256
Batch03	AnphA.00902.a	Anaplasma phagocytophilum	YP_505261.1	Q2GK40				iron-sulfur cluster-binding protein	Potential drug target		MPLVTFVSPDGTRKTYEALEGETLLTLAHRNKIDLEGACEGSMACSTCHLIVAPEWYSKVEQYNELTDEENDMLDLAFGLTETSRLGCQVVMTKELDGLCVILPGETRNVSFDHRE		116		5	Purified	-1	 	NR-16257
Batch03	AnphA.00916.a	Anaplasma phagocytophilum	YP_504711.1	Q2GLP0				thioredoxin	Potential drug target		MAHVTEIGDSDFADKVERKSGIVVVDFWAPWCGPCVAFAPQLDKIAERYSGKIDVYKLNVQDHQETPIKFGVSAVPTLIVFKNGVESARIVGVNLQQLLSAIDGAIGSQN		110		5	Purified	-1	 	NR-16309
Batch03	AnphA.00918.a	Anaplasma phagocytophilum	YP_504985.1	Q2GKW6				deoxyuridine 5'-triphosphate nucleotidohydrolase	Potential drug target		MKVGIIRMKGGEGLPLPSYATPQSAGLDLYAALSEEVVIRSGERCLIRTGVAIELPDGYEAQVRSRSGLAVKAGVVVLNSPGTIDADYRGEIAVILANFGASDYVVKHGDRIAQLVIAPVMRISWEESSNITETQRGAGGFGSTGV		146		5	Purified	-1	 	
Batch03	AnphA.00921.a	Anaplasma phagocytophilum	YP_504833.1	Q2GLB8				2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase	Potential drug target		MVKQIYQPNKSAMVVLALGSNIGDRMSALKEAIKLIPLHNRLYSSVYESCALLPDNAPFCWNMPFLNMVIAGYTHFSPEDLLQSIKQIESQLGRCSLGHWSPRSIDIDIILWEGVTVEDKALTIPHKEMHKRDFVLVPTCDICPRFPHPILKETVESILLNKQDINLVKKYQAIHL		176		3	Expressed	-1	 	NR-16347
Batch03	AnphA.00929.a	Anaplasma phagocytophilum	YP_504645.1	Q2GLV6				isoprenoid biosynthesis protein with amidotransferase-like domain	Potential drug target		MNCAVLLCGCGHMDGSEIREAVLALLALDSYGINVTCCAPNIKQVDVVDHLSGSTLEEERDIMSESARIARGNVVDPKDISPNDFDMLILPGGFGVAKNYSDILKGESPVSVLEEVKQTIVKFHKEKKAIGAICIAPAIVAASLSSVSKVKVTLGEDIDSIISRCGGEHVFCETDDYVADIDMGVFSTPAYMRKDSLHKIHVGIHKMVGAMVDFVKKKEQL		221		5	Purified	-1	 	NR-16348
Batch03	AnphA.00936.a	Anaplasma phagocytophilum	YP_505240.1	Q2GK61				thioredoxin-disulfide reductase	Potential drug target		MSEVHKDAVKVLILGSGAAGCTAAIYAGRANLNPVLVTGMQPGGQLTITTDVENYPGFSAIEGPKLMEYMQEQAVKSGATLLTDEISEIDASVYPFKCTSMFGETLQAYSIIVATGAQAKWLGLESEQNFKSKGVSACATCDGAFFKDEVVAVIGGGNTAVEEALYLTRSSKKVFLIHRRDKLRAEAVMQQRLFSNSKIEVIWNSVVKEILGDSEGKKVTSLLLQSTVDSTESLLDVGGVFVAIGHTPNTQVLKNMLGAKVNLDDEGYVITAPGTTITSCPGIFAAGDVCDKVYRQAVVAAGSGCMAALDAEKYLAEKGIE		321		4	Soluble	-1	 	NR-16349
Batch03	AnphA.00941.a	Anaplasma phagocytophilum	YP_505074.1	Q2GKM7				chromosomal replication initiation protein	Potential drug target		MDRDSTYDGHLSWQSVQKKLRDFYGSAAYDSWLSALVYSGYENGRVILLVPTRFIKEWILVHYLEKILEYWRGENSAVYCIDICVADGAESSVLQGNRGVSVRSTEAQEVSSVSTYEHLSSPLDPRFTFDNFVVGKPNELAFAAARRVAESSEPIPGSNPLFLYGGVGLGKTHLMHAIAWYALGSPRKRKIAYLSAEKFMYQYVTALRSKDIMLFKEQFRSVDVLMVDDVQFISGKDSTQEEFFHTFNALIDQSKQLVISADRSPSDLDGVEDRIKSRLGWGLVADINETTFELRLGILQLKVEKMGIHVPDEVLEFLAKNIKSNIRELEGALNKVVAHSSLVGSSVTVELASDILSDLLRANHRLVTIDAIQKKVAEFFGIRLEDMYSARRLRALARPRQVAMYLSKRLTQKSLPDIGKSFGGRDHATVIHAVKQVEKFIDTDSKLAGDISLLIRMLR		459		1	Selected	-1	 	
Batch03	AnphA.00943.a	Anaplasma phagocytophilum	YP_505367.1	Q2GJT4				pyridoxal phosphate biosynthetic protein PdxJ	Potential drug target		MQLGVNVDHVATLRNLRGTTYPSIVELANIAVEHGADFITVHLREDRRHVRDDDLYALKKHVNVPINLEMAATEEMLAIAKELSPEFVCLVPEKREEVTTESGLDTKLLYDTRLFIISELQRHGIKVTLFLDPSEEDIACAKRMNVDKIELHVGAYCISRAPQELEMITRAAQLVHEAGMICHAGHGIDYECAAAISKVKHITAINVGHFLVCEAITQGMGNAVRKMKDIITS		233		4	Soluble	-1	 	NR-16350
Batch03	AnphA.00945.a	Anaplasma phagocytophilum	YP_504987.1	Q2GKW4				carbamoyl phosphate synthase small subunit	Potential drug target		MTSEFHNAVIVLSDGRYFFGRSLGKRTDCVGEVCFTTGVTGYQYTITDPSFAGQIVTFTFPHIGNVGINSKDFECEQVLAKGIVVREISGASHVSSHIDLNSWIEQNNFTGISGVDTRALAIHLRENGTLGGVIHHFDDIGAVHIQELQNVARTHKKSLATELPHLMDHSHHVDGHSVCVIDFGAKHGIFSALTRIGCAVHVVAAQNDFAARALSLKPRGIVISNGPGDPADISDPVMDQLRVLIDSGIPVLGICLGHQLIAKALGAKTIKMHHGHRGSNHPVYSLETKSVEVTSQNHGYTVDASTLPDNIEVTHISLFDGTVEGIKMTNRPVLSVQYHPEGCPGPNDSHYIFRKFADLITSAHA		365		3	Expressed	-1	 	NR-16351
Batch03	AnphA.00971.a	Anaplasma phagocytophilum	YP_505549.1	Q2GJA2				"ABC transporter, ATP-binding protein"	Potential drug target		MEGLELKDISYRYRKSDFLLEVEELSAKRGEIICLLGPSGCGKSTILKLIAGLERPFAGVIRINGKTVNDARGGVYIPTESRNVGLIFQHPALFQHQTIVENVAFAVKAQSRDKRTKHALKVLKKLGISAHKDAYPHMLSGGQQQLATIARTMAQDPEIVLLDEPFSNLDTILRESIRAAVLSVIKAENITVLLVTHDPEEALEIADKIYVVREGKIVQCGTPYQIYNAPKDAHLARFFGRLNYFESLVRDGKVSLTIGSINADGFLDGSRVAVCIRPDAILLHDSSDTLAVVKLVRFFNNMIYISVGNSAYWMLFLGAVLPEVGDVIRVSLDSSKALLFRL		342		3	Expressed	-1	 	NR-16352
Batch03	AnphA.00973.a	Anaplasma phagocytophilum	YP_504757.1	Q2GLJ4				deoxycytidine triphosphate deaminase	Potential drug target		MSVMPDHWIKERALKDGMISPFVDHKEGTGVLSYGLSSYGYDARLDNKFKIFANTHSVVVDPKNFSQDSFVDREGDFCIIPPNSFMLAKTVEYFNIPRDVMVVCVGKSTYARCGIVVNVTPLEPGWSGYVTLEFSNTSPLPVKVYAFEGACQFLFFSGKERCSKSYDEAGGKYMGQSDVTLPIIS		185		17	In PDB	-1	 	NR-16353
Batch03	AnphA.00984.a	Anaplasma phagocytophilum	YP_505769.1	Q2GIN2				5-aminolevulinate synthase	Potential drug target		MIDYEEVFRERINGIKEEGRYREFTGFRRVPGRFPYAIECQTERVVTLWCSNDYLGMSQHESVLSAARNLNVNVGAGGTRNISGTTEEVIELERSLADLHNKPAALAFVCGYVANQTSISTILATIPDVVVFSDEKNHSSMIEGIRAGNRVKHIFRHNDVEHLESLLKAAGASPKIILFESVYSMDGDIAPIKEICDLASKYNAITYLDEVHAVGLYGARGGGISEMEGLADRISVIQGTLSKAFGVMGGYVAASKSLVDVIRSFAPGFIFTTAISPLIAASARASVEHLKNSNIEREKHREVIAKVKSALLQAGIEFLMTDTHIIPVIIGDATICKQVSQALLRDHGIYIQSINYPTVPLGTERLRITPTPYHTDEMIDHLVKGLQEVFSRFSVPAGRSYAYFEALGKLKESR		414		1	Selected	-1	 	
Batch03	AnphA.01004.a	Anaplasma phagocytophilum	YP_504819.1	Q2GLD2				nitrogen assimilation regulatory protein	Potential drug target		MSKVKRFYIPEVLIVDDEADLRAMIQDILRDDNYVTRVAADGLSAMKLAYEREPDVVLLDIWLKGSDIDGLSVLEKLKERYPSLPVIMISGHGNIATAVKSLHIGAYDYIEKPFTENRLKLVVKRAVESGRLRRENDELRSFFEDYELIGNSPQIKSLRSTVNKAASTFSRILITGAPGTGKEVVARLIHKKFRGGSTFVSFCPSILPENSYLENIFGSEGENSSLQHVVPHSVGIIEQANHGTLFIDEVTDLRYDAQLRLMRLLQEGRIYRESGKIPVIVDTRVIASSSKIMEDEVRLGKFCEDLYYRLNVFPIRVPSLSEYCADLPEICEYMMKSICKKMRLFPRAISEEAIVAMQSYCWPGNLRQLRNVLEWVMIMQTKHDVITVDDLPAEIVNGAPINSVFTHIVSAPLRKAREEFERQYLKTQLSRFGGSVSRTAEFIGMERSALHRKLKMLGLFTG		462		3	Expressed	-1	 	NR-16354
Batch03	AnphA.01008.a	Anaplasma phagocytophilum	YP_505655.1	Q2GIZ6				30S ribosomal protein S9	Potential drug target		MLEGEEVSAGSSKPVKARIDSLGRSYGTGSRKNAVAKVWLKVGSGVVTVNGMECAAYFGREALCKRVFNPFHVASSVGCYDVRAVVFGGGKSGQAGAVAHGISKALKDINPSLQPVLRQAGLLTRDSRVVERKKYGQHKARKKCQFSKR		149		-2	Work stopped	-2	Work stopped	NR-16355
Batch03	AnphA.01018.a	Anaplasma phagocytophilum	YP_505502.1	Q2GJE9				putative acyl carrier protein	Potential drug target		MSEEIKAQVMESVIGCLKLNDEQKQILSGTTNLAKDFNLDSLDFVDLIMSLEERFSLEISDEDAQKLETVDDICRYIASKSSDA		84		8	HSQC	-1	 	NR-16356
Batch03	AnphA.01019.a	Anaplasma phagocytophilum	YP_504869.1	Q2GL82				dihydropteroate synthase	Potential drug target		MQHSAVTTKIVGILNVTPNSFSDGGKFLEANAAIRHATDLIEHGADVIDVGAESTAPGVSPITQEEEWSRLKEVLPEIIRIAHNAHVEVSIDTRNAKTAELALKLGVDYINDQGGLLDPDMPAIAAASSAKIIIMHHFGLPVSQDRSYVGQPEQLLNEIIEWLCSRVDTLIAQGVVRERIILDPGLGFGKLPEYSWYIAKNIGKLKKLGFPVCVGHSRKSMFSLIPVELSERDVPTAMLSTFLAQQQVDFLRVHDVKLTGISIKIANLLV		270		4	Soluble	-1	 	NR-16357
Batch03	AnphA.01028.a	Anaplasma phagocytophilum	YP_505770.1	Q2GIN1				tyrosyl-tRNA synthetase	Potential drug target		MEFNSEFLATLCARGYLHQLTDATALDGIMSSGAVTAYIGFDCTANSLHIGSLMQIMLLRYLQRFGHKPIVLLGGATTKVGDPSGKEKTRAMLSEDNISANKEGILRVIKKFLSEDVVVVDNAEWLGNYGYLDFLREIGSKFSVNVMLGLESVKSRLSRDQQLSFLEFSYVLLQSYDFVELHKRYGCILQIGGSDQWGNIVSGIDLARKMGCPQLYGVTTPLLLNSSGAKMGKTADGAIWLDETLYSPYNYWQYFRNVPDQDVGRLLRLFTELPLSEIERLEALKGEELNEAKKILATAVTSICHGAEVALQVENQALKVFEHNDHDELRSITFSRKTLGQGIPISKLLHMWGLEESISAGRRLIRGGGCKINGGVVLDEEKLLNCGDFDDNGGYVAVFCGKKRRLKVVLED		412		5	Purified	-1	 	NR-16358
Batch03	AnphA.01030.a	Anaplasma phagocytophilum	YP_505310.1	Q2GJZ1				"DNA polymerase III, epsilon subunit"	Potential drug target		MKVREIVLDTETTGLDADGGDRIIEIGCVELVDYVMTGRVFHKYIDPERDISVAATRVHGITRESLIGMPKFAEVADELLDFLQDSALVIHNARFDMRFLEVEIERLSNKRAITNTIVDTLEMARKKFPGMPASLDALCKRFNISTQERKFHGALKDATLLARVYVELLEALQRRLVFSQEGDDSKQVSVIHDKAKRVVYPARTFTLSSEEKRLHRQTVSKMKNPIWLMCFDEKEFFCNENINS		244		3	Expressed	-1	 	NR-16359
Batch03	AnphA.01047.a	Anaplasma phagocytophilum	YP_504740.1	Q2GLL1				ribosome recycling factor	Potential drug target		MATGAIRQYAQERMDKTYAMFLNDISGIRTGRVSASLLDGISVSYYGNKVKLNTVSSISVNGRTLLVSLWDASILGEVKSAIEASNMGFGMTCESSTVRLVVPELTNDVRKNLVKMLNKLAEESKVSIRNIRRDAIERLKSLQDNKEISEDDMHGVSAEIQKITDSFIKKIADAYTSKESEILG		184		5	Purified	-1	 	NR-16360
Batch03	AnphA.01049.a	Anaplasma phagocytophilum	YP_505098.1	Q2GKK3				aspartate carbamoyltransferase catalytic subunit	Potential drug target		MKKLNKLLRIQSLSDVDIENIVALAHRYLQDSSANNVLQGRVIANLFFENSTRTLLAFEIAEKSLGAVSVTLNVETSSMKKGESVSDTLSTLSAMGVDLVVVRSGFSGFIDEVVERVGDCCVINAGDGNHEHPTQALTDYATIRYLKGKYIEGLNVTICGDIFHSRVARSNMRLLSRYGANINVVTPPCWSASVPSSNVTKITHSLEEGIKDADVIMLLRIQKERMSGASFISANEYSRHYMLDNAKLSIAKDDVIIMHPGPMNRGIEISDEVADASSSILLQVKMGVAVRKAILHYMLG		300		2	Cloned	-1	 	NR-16361
Batch03	AnphA.01070.a	Anaplasma phagocytophilum	YP_505779.1	Q2GIM2				fructose-bisphosphate aldolase	Potential drug target		MICSGIMGLSEPVESVLDFYDSENPGVKTNLVRMLTHGALAGTGRLLILPVDQGFEHGPVRSFGVNPSACDPHYHYRLARDCGFSAYAAPLGMLECGAAMYAGQIPTILKLNGSTALTPKSTPPTQVITASVKDALRLGCVAIGLTIYPGSESFFSMVREVKELIHEAKMCGLAVVVWSYPRGGDISKEGETSLDIISYAAHVAASLGAHIIKVKLPTARIERDNVEPDMLSSLAQRVAYVKRCCFAGRRMVVFSGGDTKDDESLFQEVAAVRAGGGDGSIIGRNTFQRSEKDAVSLISSIVKLYS		306		3	Expressed	-1	 	NR-16362
Batch03	AnphA.01075.a	Anaplasma phagocytophilum	YP_505854.1	Q2GIE7				recombinase A	Potential drug target		MKDSPSDKQRAVDAAIGQIERAFGRGSIMRLQNSPVEAVECVSTGSIALDAALGVGGLPRGRIIEIFGPESSGKTTLALHVIAEAQKNGGACAFIDAEHALDTLYARKLGVSVGDLIVSQPDTGEQALHIVEHLVNSGAVDVIVVDSVAALTPRAEIEGDMGDQHMGLQARLLSHALRKLTSIVSKANCLLVFINQIRMKIGVVYGNPEVTTGGSALKFYTSIRLDIRKVSALKEKENVTGHLARVKVVKNKVAPPFKQAEFDIMYSEGISKVGEILDMGVRFGFIEKAGSYYSHEGIKLGQGRETARSYLKNNADLSHKLEGLIRAKLLESMRSSDVFGSDGRAPSEEIEESF		354		3	Expressed	-1	 	NR-16363
Batch03	AnphA.01080.a	Anaplasma phagocytophilum	YP_505272.1	Q2GK29				S-adenosyl-methyltransferase MraW	Potential drug target		MDSHRPVLLNEMLELLSPKDGAVYVDATFGGGGYSRGILERAKCTVLAIDQDPIASEFYQSLHSQFPGRVHFFLSKFSRLREALQHFDHNQVDGVVFDVGVSSMQLSDPDRGFSFMKEGPLDMRMDMLRSQSKSAATFVNSLSEKDMADVIFYYGGERLSRRVTRAIISARESNNKIRNTSDLAKIIRSVVPRSKANPIDPATRTFQAIRIWVNDELEELKAGLEAASQIVGVGGKIIVTSFHSLEDRIVKHKFNALREKGFQLINKKAIKPTEKEISENTRSRSAKLRGIVKEE		295		3	Expressed	-1	 	NR-16364
Batch03	AnphA.01094.a	Anaplasma phagocytophilum	YP_504790.1	Q2GLG1				Holliday junction DNA helicase B	Potential drug target		MNELLHQHKAIPEDERNFALRPSLIEEFVGQSEIIENLKVFIKSAYERRATLDHVLLYGPPGLGKTTLAHIIAKELKVSLRSTSGPLLSKAGDLAAILTNLQPMDVLFIDEIHRLHRNIEEILYSAMEDCCLDIVVGEGCGARTLRIDLPAFTLVGATTRFGLISNPLRDRFGIPLHLEFYSVEELMLVIKRAAHVICTDIDDSGAYEIASRSRGTPRIALRLFRRVRDFMVVERQSIIDNHFADSALFNLGVDKSGLDKMDIKYLSFIYEAKNAVGIETIAAALSEDVGNIEETIEPYLLKIGFIQRTPRGRILTTKAIEHLMNYKYI		329		2	Cloned	-1	 	NR-16365
Batch03	AnphA.01103.a	Anaplasma phagocytophilum	YP_504858.1	Q2GL93				co-chaperonin GroES	Potential drug target		MNLAMLHDNVLVEALEDSNPNSPIQLPDSAKKKPTKGKVVSVGPGASNSDGKVTPMSVKVGDCVYYRQWAGNEIEFDGKKFIVMKESDIIAKEA		94		1	Selected	-1	 	
Batch03	AnphA.01106.a	Anaplasma phagocytophilum	YP_505730.1	Q2GIS1				hexapeptide transferase family protein	Potential drug target		MREVLVPYAGVSPSVDSTAFIAGNARIIGDVCIGKNASIWYGTVLRGDVDKIEVGEGTNIQDNTVVHTDSMHGDTVIGKFVTIGHSCILHACTLGNNAFVGMGSIVMDRAVMEEGSMLAAGSLLTRGKIVKSGELWAGRPAKFLRMMTEEEILYLQKSAENYIALSRGYL		170		17	In PDB	-1	 	NR-16366
Batch03	AnphA.01110.a	Anaplasma phagocytophilum	YP_505165.1	Q2GKD6				4-diphosphocytidyl-2C-methyl-D-erythritol kinase	Potential drug target		MSKYFISAPAKINLFLHIVGKAPCGYHLIESVFAFVELYDVLEFDIGSRNRGIRFLKPSCINRRDNTIQRAIGHLVRRCSPGTTDNVYVKVLKNIPVSSGLAGGSADAAAAINLLSKLWGINEKETERVAFRVGSDVPVCLESKTAFVAGMGDVVELLEDSFLPRHVILVGPKVELSTKSVFDMYNPKAFSPSIGKLPGNSEDWLSLLKEARNDLTEVSVELVPEIRIILDVLGSLDGCCFSRMSGSGAMSFAIFEDENSAELATRYLRRNYPDWFIFKTRIIRSSDQEDNNMGNL		296		4	Soluble	-1	 	NR-16367
Batch03	AnphA.01115.a	Anaplasma phagocytophilum	YP_505758.1	Q2GIP3				dethiobiotin synthetase	Potential drug target		MPAYFITSTGTDVGKTFVTTALCWHFRRIGHNVQAIKPVITGWNSATEGESDTVKIIQSLECTVSEQSISRVSPWRFEAPRAPNVAADMSGAHLDYEEILRFCRKSSQTLDSYTFIEGVGGVMSPITENKSCLELIHDLGIDVVLVIGSYLGSISHTLTAMKVLQGLRIHVILSEKEEENPCARDVVEYVNQYYNCTVYIQEHVSRNLRAPWTHTSPEIAHFLLR		225		4	Soluble	-1	 	NR-16368
Batch03	AnphA.01127.a	Anaplasma phagocytophilum	YP_505754.1	Q2GIP7				"recA protein, truncation"	Potential drug target		MKDSPSDKQRAVDAAIGQIERAFGRGSIMRLQNSPVEAVECVSTGSIALDAALGVGGLPRGRIIEIFGPESSGKTTLALHVIAE		84		2	Cloned	-1	 	NR-16369
Batch03	AnphA.01136.a	Anaplasma phagocytophilum	YP_505043.1	Q2GKQ8				1-deoxy-D-xylulose 5-phosphate reductoisomerase	Potential drug target		MKKVSVFGSTGFIGKTTVGILSGNTEDFKVIALVAGSNVSLLAQQAKLLNAEMAVIADDAQYEELKRSLHGSGIRVAAGKEAVLEAAALSVDTAVMAITGIVALSAVMRLIESGVGTIALASKESVVCGGVLLRDAACKSGTRIVPVDSEHNAVFRLLSQGDNPYKITITASGGPFLHWSHDQLKSVTIEDALVHPVWKMGKKISVDSATMMNKALEVLEASYLFELGYRKIDVVIHPESIVHALAFYQDGTSTALMSLPDMSIPILHALYWPHRKEVSVREVDLIAYGKLTFIRPDFERFPALKAAFDILQSSERDVASIVFNAANEVAVESFLNSEITFLEIVNIVLHVMNKVPYGKVSSLADIMEYDLLGRCIAREVISDAS		385		5	Purified	-1	 	NR-16370
Batch03	AnphA.01140.a	Anaplasma phagocytophilum	YP_505025.1	Q2GKS6				acetylglutamate kinase	Potential drug target		MKFQDVSKGSRKENGPWLEGGQLSEEDQWLNEARVLSESIKSIHQFSGETFVIKYDGTALQDKRLADSFASDIVLLKQVGIHPIIVHGGNYRVEEVLEKFGKKEGVFVNDFRVVDSEVLEITEMVLSGLVNKEIVQTINENGGYAVGISGKDACLVEAKKVCFTARNGQPNNVEKIMDIGFVGEPQSVNTELLFFLEESDFIPIVSPICRGPNGMTHVVNPDLVAGAIASSLSAAKLVILTDSAEDIKNMQHDDELLVGTVEQAEKLLNDGKVCETMVQRLQTCIKFARETCGTAHVVDGSIPHILLMELFTINGTGTSICGDFSKD		327		5	Purified	-1	 	NR-16371
Batch03	AnphA.01148.a	Anaplasma phagocytophilum	YP_505125.1	Q2GKH6				"hydrolase, TatD family, truncation"	Potential drug target		MPIKKIDGVETDSPYLCPEPHREKQNSPEMTRFVVESLAQIWEESVDVVSEITTKNFFTLFDKCARLYYASEESNNLRS		79		2	Cloned	-1	 	NR-16372
Batch03	AnphA.01160.a	Anaplasma phagocytophilum	YP_504771.1	Q2GLI0				"guanylate kinase, truncation"	Potential drug target		MREHVVSIFIMPPSMEELRRRLCGRRADDSEVVEARLKGAAFEISHCEAYDYVIVNEDIEETADRISNILRAEQMKTCRQVGLRELLESRFPIED		95		-2	Work stopped	-2	Work stopped	
Batch03	AnphA.01165.a	Anaplasma phagocytophilum	YP_505660.1	Q2GIZ1				ribose-phosphate pyrophosphokinase	Potential drug target		MVIIPGSTSLALAKSVSGMLDVPMVIPCVSRFADGEINLEVPTGVATGSGHIVLMQSLSAPASDNLIELTLLTDAVRRTLAPQRITAVIPYLCYSRQDRVMQRVDSQETFTSALSAKVIARILSTSGLDHIVTLDLHSQQAAGFFDVPFTNISAYDVFVDYLSSSNLLERLVIVSPDYGALGRVRAFVRMLSSRYNMNSIQVAVIDKYREGPGISEVMHVVGNVQDRHCFILDDIVDSGGTLCNAAAALKTRGAISVHSFITHGVLSGRAIDAIGTAELDSLVITDTIHNPDRVNLPEKIKVLSVDRLLSDYLLSHAVWRKS		322		4	Soluble	-1	 	
Batch03	AnphA.01168.a	Anaplasma phagocytophilum	YP_504892.1	Q2GL59				50S ribosomal protein L3	Potential drug target		MWMKKVGSTAMFDATTGSRVPVTLLLLEDTFVVGTKVSGIHGYDAVVLGTKRRGVVNKPQVQALRKLGIEEDYKLFESRVKAVGDLQPGSKVEVSHFFKGQFVDVTGYTIGRGFAGVMKRHNFRGLRASHGVSISHRSQGSTGQCQDPGRVFKGKKMAGHMGDSKVTMQNLQVMLVDEKESLLVVRGTGIPGAEGSYVFVRDAIKKPVPKGEALSESMAG		220		-2	Work stopped	-2	Work stopped	NR-16373
Batch03	AnphA.01172.a	Anaplasma phagocytophilum	YP_504778.1	Q2GLH3				serine hydroxymethyltransferase	Potential drug target		MVGYIGDIHISESDAEVAECLSAEYKRQNTSLQMIASENFVSRAVLQAQGSVLTNKYAEGYPGSRYYCGCSEVDVAETLAVERLCKLFGCKYANVQPHSGSQANQQVYMALLKPGDTVLGMSLDSGGHLTHGAGPNVSGKWFNAVPYNVRRDTNLLDMGEIEEIALRVKPNLIIAGASSYPRRIDFKAFRAIADKVGAYFLADIAHYSGLIAGGQYPTPFGYAHVVTSTTHKTLRGPRGGVIMTDDEEIHKKLRSAVFPGMQGGALMHVIAAKAVAFREAMSPDFKVYVSQILDNSRALAAVLATGGLDVVTGGTDSHMVVVDLRSKGLTGRDVSSSLERAGIVCNKNAVPFDTEKPWVTSGIRLGAAAETSRGLVVKDFEKIGQLVLKIVDSMRAGADMSVVESGVREEVATLVRVVPYDTLAC		425		4	Soluble	-1	 	NR-16374
Batch03	AnphA.01176.a	Anaplasma phagocytophilum	YP_505793.1	Q2GIK8				"2C-methyl-D-erythritol 2,4-cyclodiphosphate synthase"	Potential drug target		MGFDVHRFTESREEGQYIPICGIKVAHTQGIVAHSDGDVALHALTDALLGCMGEGSIGQHFPNSDPQWKNASSSYFLLEAQKKAAAKSYAILNFDVTIVCEQPKIMPHVPKMKEFLSKLLDVDVSQMNIKAVTTEKLGFLGRGEGIAAHAVLMCYRV		157		3	Expressed	-1	 	NR-16375
Batch03	AnphA.01178.a	Anaplasma phagocytophilum	YP_505610.1	Q2GJ41				"succinyl-CoA synthetase, alpha subunit"	Potential drug target		MSVLVDKNTKVICQGFTGSQGTFHSEQAIAYGTNMVGGVTPGKGGTEHLGLPVFDTVAQAKEATGANASVIYVPAAFAADAILEALEAEIELIVCITEGIPVLDMVRVKRALRGSRSRLIGPNCPGIITPEECKIGIMPGYIHGKGNVGVVSRSGTLTYEAVAQTTAVGLGQSTCIGIGGDPVHGLTFAECVELFMNDDDTHCIVMIGEIGGSEEEEAVEYMQSLEKKKPMIGFVAGQTAPAGRRMGHAGAITSGNSGTAKGKIEFMERAGVVVAATPAVIGKTVLEVMQSQGLV		295		3	Expressed	-1	 	NR-16376
Batch03	AnphA.01183.a	Anaplasma phagocytophilum	YP_505122.1	Q2GKH9				orotidine 5'-phosphate decarboxylase	Potential drug target		MHQKNPIICALDTADLERATTLAKAISGKVAMAKVGLEFFTAHGLSGVQKIVDLGFRIFLDLKLHDIPNTVRGALKSVVNLPAIDMLTIHVSGGKNMIMGAIDALKECDIEPVGVTVLTSMDDVDLRACGINSSVEAHVMNLVDLAVSSGLNAIVCSAKEVASIRKKYPSLKLVVPGIRMAQSATGDQKRVDTPKDTLAAGADYLVIGRVITQSSDPAGEIDKILKTL		228		5	Purified	-1	 	NR-16377
Batch03	AnphA.01192.a	Anaplasma phagocytophilum	YP_505277.1	Q2GK24				enolase	Potential drug target		MLYSRSVAKINGVSARQILDSRGRPTVEAVVSLSDGALGVVSVPSGASVGKNEALELRDKDMNKYGGHGVTKAVENVNSIIAPRLVNTDPFNQKALDDLLIELDGTDNKSRLGANATLAVSVATAKAAAASLKLPLYRYIGGVASREMPVPLVNVINGGLHADNGLDFQEFMIMPIGASTFSDALRMCAEVFLSLKEILKSNKLSTNTGDEGGFAPNLESNDRVFCILLEAIEKAGYKPSIDFALALDVAASTFYDGKIYKFSGSSMSSAEMVSYYEELVKKYPIISIEDGIAEDDLAGWKELTVRLGKKVQLVGDDLFVTNPRLIKDFSERGLANAVLIKPNQIGTLSETIEAIRLASMSNFNSIVSHRSGDTEDPFIAHIAVALNCGQIKTGSMSRSERMAKYNELLRIEEDLCGTAILRSVKIGRH		429		1	Selected	-1	 	
Batch03	AnphA.01196.a	Anaplasma phagocytophilum	YP_505636.1	Q2GJ15				phosphoribosylamine--glycine ligase	Potential drug target		MNVLVIGSGGREHALLSCLSRSPMLERLFVAPGREAMSDLATLVDVNVDNFVEVVQLCKQEKIDLIVVGPEQPLINGLADALSDEGIFVFGPSKAASRLEASKGFTKELCSRYHIPTARYGYFMDINAAKQYVKRSKLPLVVKADGPAKGKGVVVCRTHDEAYDALESMLVHGKFGKAGDAVVIEEFLEGKELSFLTLIDGTNPVVLGAVQDYKTLYDGNKGPNTGGMGSYSSPNIMTPEMEHLIVQKIVYPTIKAMYNMGIRYRGLLFAGIMIRKNEPYLLEYNVRFGDPETQAILPRLDSDLLRLMSLTAKGRLGSEVVELNRKSVVCVVAASKGYPDKCETGSVINGLDAVAKCPNVQVFHAGTKRVGNAWVADGGRVLNVVASADDLDAAKHQVYAALDLLDWPGGMYRYDIGS		418		3	Expressed	-1	 	NR-16378
Batch03	AnphA.01200.a	Anaplasma phagocytophilum	YP_504925.1	Q2GL26				"phosphate ABC transporter, ATP-binding protein"	Potential drug target		MQDVHAVVKDLNLWYEGKQILFDVNLNVCKREITTLIGPSGCGKSTFLRCFNRMNDFVPNCKVDGKIIVDGMDVFSDATDVVLLRAKVGMVFQKPNPFPKSIYDNIAYGPKLHGLARSKKKLDSIVEDSLRSVGLWEELGGRLRDNACKLSGGQQQRLCIARAIAVRPTMLLMDEPCSALDPVATGVVENLIRDLKKNFAIVVVTHSIKQVKKISDKVIFFSGGRVVEQGATQEVFQNPKSDVVKGYLEEHP		252		3	Expressed	-1	 	NR-16379
Batch03	AnphA.01202.a	Anaplasma phagocytophilum	YP_505813.1	Q2GII8				NADH-ubiquinone oxidoreductase family protein	Potential drug target		MKKVLVFGGSGFIGRYLVCELVARKYSVTVYTRNHEKAARLKLFGRLGQVDIVCGKLSDAALIQKLIADCDVIVNLVGTISDPRGAVLQYLHVTFPSNIAKLATKHGKMFVHFSAMGADIAKTSSYAQSKLEGEKRIRDVCEDAVILRPNLVFGDGDNFFNKFANLARVAPFMPLFGGGKNLLQPVHVDDVVNVAMDLIVNQASSGTYEVAGPTVYSLKDLIKFVLVATGRKKPMLSIPSKMAKFIAYICEIKIVSFILQPATGSSEPIVTRDQIELMKYDIILPDSNNVRKGKTTIEEIVPEYLKIYEKASN		313		4	Soluble	-1	 	NR-16380
Batch03	AnphA.01210.a	Anaplasma phagocytophilum	YP_505312.1	Q2GJY9				NADH dehydrogenase subunit D	Potential drug target		MSDSSDGYAKPMTINFGPQHPAAHGVMRLILEMSGEVIERIDPHIGLLHRGTEKLIEYKTYLQALPYFDRLDYVSPMSQEHAYSLCVERLLGCEVPIRAKYLRVIFCELTRLLNHLLNVACQALDSGATTPLLWIFEEREKILSFYERASGARFHSAYIRPGGLAADVPDGLLDDIHEFTNYFPKLLDSVDDLLTENSIWKQRNVEIGKVTKQQALDWGFSGPMLRACGIPWDLRKSQPYEIYDILDFKVPVGSNGDCYDRYLVRMAEIRESLYILEQCLRDIPSGPVKTDDRKIAPPKREELKYSMEALIHHFKLFSEGYKVPEGEAYAAVEAPKGEFGVYIVSDGTNKPYRCRIRSPGFAHLQAIDAMARGHMLADLPVIIGSLDIVFGEIDR		395		1	Selected	-1	 	
Batch03	AnphA.01211.a	Anaplasma phagocytophilum	YP_505761.1	Q2GIP0				citrate synthase I	Potential drug target		MVEKAVLECGDRRISLPVLRGTDGTPVVDITTLYRENNVLTYDPGFMSTAACRSEITFIDGNKGTLRYRGIDIENLIGTPNSFSSIVYLLLKGTLPSETEHEEFVRILGAEYDVPEQVMNVIRSFPRDSHPMAILIASFSALAANYHASRIDPLTGAIIAIAKVPGIVASIYRHTANLDFIQADANLEYTHHFIRMMFGDMDDAHRDIMHKALDAIFIMHADHEQNASTSTVRMTGSSGAGLFACLCAGVATLWGPAHGGANEAVIKMLAEIGSPENVSSFIDKVKNNKGKSRLMGFGHRVYKSYDPRARVLRTICKDVLDSLGRDENLLAVAEELESQALQDEYFIERKLYPNVDFYSGIVLRAMGVPVDMYTAFFALARTSGWASQWYEMIQSDEGKRISRPRQLYTGK		411		1	Selected	-1	 	
Batch03	AnphA.01217.a	Anaplasma phagocytophilum	YP_505325.1	Q2GJX6				porphobilinogen deaminase	Potential drug target		MGIVMVIRIGTRGSLLAMQQARIVKTAIETNYAELSTRIITIKTSGDMNTHVPLYDIGGKGLFIKEIEEALLDNIIDVAVHSAKDVPGIYSEDLDIPCILPRASALDAFLSSKYDSIASLPLNAKIGTSSVRRKVQLLTMRPDLEIIPMRGNVETRISKMQMGECDGIVLAEAGLYRVSKDNLISEVLQPEVMLGAVGQGAICVQCRRYDRRILEILKKLNCHKSYTTVSAERSFMRAVDGSCNTPLAAMAKYIDMDILTMKCMLADDARNMVFTERVFAEQNAESAGYEMGTLLKNELHLHRL		304		1	Selected	-1	 	
Batch03	AnphA.01224.a	Anaplasma phagocytophilum	YP_505552.1	Q2GJ99				30S ribosomal protein S4	Potential drug target		MVAVVNRKYRASRRLGVNLWGRSKDPFNTRNYPPGQHGAMGYKKLSSFGRQFVAHQKFKCYYVVSSRQLRNVFLKAYRKKGDTGDNLVGALESRLASVVYSAGLVPTMFSARQLVSHKHVTVNGRVVNIPSFSVKPGDIVEVRKRASQLPMVLAAIQSQERRVPDHLDVNTEKLSVKYLAVPKYSDVPYPANMEVNLVVEFYSG		204		-2	Work stopped	-2	Work stopped	
Batch03	AnphA.01225.a	Anaplasma phagocytophilum	YP_504675.1	Q2GLS6				"ABC transporter, ATP-binding protein"	Potential drug target		MSTVLKLCNVSKRYSEQQNCVFSDVNLEIFKGEFVALIGNSGAGKSTLLHIAGLLEVPSQGKVIINNVQCSPESDKVRTKMRRSFLGFVYQSPNLLHELTVLENVMLPLRIAGNSFSQAKHQAMVTLCEVGLEGKVNQHISTLSGGEKQRVAFARAMVNHPNLLLADEPTGSLDPQMSETIFSIMYQNVKSKNLAALVATHNLALAKKADAVIELRNGILSKVDL		225		3	Expressed	-1	 	NR-16381
Batch03	AnphA.01227.a	Anaplasma phagocytophilum	YP_505230.1	Q2GK71				holo-(acyl-carrier-protein) synthase	Potential drug target		MILGIGVDLVCTRRIQALIAKYGNKFTNRIFSEKEILDSLKYRDEYARARHFAKRFAAKEAYVKALGLGFGRGVEAKDISVHNDPYGQPMISLEGGALRNGHVKLSMSDDGDYAIAFVTLHT		122		4	Soluble	-1	 	NR-16382
Batch03	AnphA.01250.a	Anaplasma phagocytophilum	YP_504717.1	Q2GLN4				inorganic polyphosphate/ATP-NAD kinase	Potential drug target		MQDIASPRGCRFKTVGYVAAAGGEAKVACLRNFYGVVRMEEASCSDIDLLVVVGGDGLMLHSLHNYVISSAKSVPVYGVRYGTVGFLLNGCAEGSLPFKIENAVATELTLLRMEAVDVYGRSHSAIAVNEVSLFRGTHQAAKLKICLDGKTVMEELVSDGIIVASPAGSTAYNFSAGGPILPFNSNVIALTSVNSFRPRRWRGALLPNSVEVEIEVLSPELRTVSAVADYTEFRDIKSIKIRQDCNAKVTLMFDPEHRLEERTIAEQFLA		270		3	Expressed	-1	 	NR-16383
Batch03	AnphA.01268.a	Anaplasma phagocytophilum	YP_504824.1	Q2GLC0				phosphoribosylaminoimidazole synthetase	Potential drug target		MSKYLDSGVDIASADKLVGEIKQLSQETKSDNVVSEIGGFGAVFDLYATGHKYRSPLLVSSTDGVGTKLLIAQATVQHQHIGVDLVAMCVNDVLAQGAKPLFFLDYFATGALDPSVALEVLRGISHGCKLAGASLVGGETAEMPGMYSRGHYDLAGFTVGIVEREDILPKLDLIQAGDVILGLPSSGLHSNGFSLVRKILKDLDIDYSSPCPFSEKELTWADVLLEPTRIYVNSVLPTCHLLKAIAHITGGGLVHNVPRILPTHLAAEIRQDSWPKQNIFTWLEGAGNIPKEDMLETFNCGIGLVLVTARETSAELMAMLAELGETAYVIGAVIPRGEKPVVLR		344		5	Purified	-1	 	NR-16384
Batch03	AnphA.01278.a	Anaplasma phagocytophilum	YP_505231.1	Q2GK70				prolyl-tRNA synthetase	Potential drug target		MRLSEFYSPTVKNVSSDVVSASHKYSIRAGIVSQTASGIYTLLPLGLMVLRKVENIIREEINAVGFSEILMPTMQPADLWKESQRYDSYGQELIRIHDRGGREMVLGPTHEEVVTDLVRSSLKSYRDLPVNLYQIQWKFRDELRPRNGILRSREFLMMDAYSFDTDFEKAMKTYDAVFRAYRKAFKRMNLQTIALKADMGAIGGSVSHEFHVLTPTGESTVYYDERALELSEMNDYGIEELKEVYAATDDMHDEKSCGIAPEDLKTARGIEVGHIFYLDDRYSRTMNVKFCNTDGHSGTHVKMGCYGIGISRLIGALIEVFHDDAGIKWPLSVAPFKVGIVNLFSKNEECKRVSERIHSVLPNDSLYDDRDDTPGVKLSRMDLIGLPWQVIVGNSFIKDGVLELKNRATGDIELLSVDDVVSRISV		426		2	Cloned	-1	 	
Batch03	AnphA.01281.a	Anaplasma phagocytophilum	YP_505276.1	Q2GK25				GTPase ObgE	Potential drug target		MSFIDEAKVFVKGGNGGNGCVSFRREKYIEFGGPDGGNGGDGGSVILEASSAVNTLLFFRYHQHLRAENGKSGSGKKKSGASGRDLVIKVPIGTQVFDSPGGSLIADLSTVGQRYVVASGGKGGVGNAQYKSSTNRAPVYYTLGAVEEEFPIFMQLKVLSDIGIIGMPNAGKSSLLSRCTMSKTKVADYPFTTLEPHLGVARINEYDLILADIPGLIENANEGAGLGHKFLKHIERCSLLLHLIDGSTEDIVGAYKLVSRELAMYSKELSEKREVIVLNKCDMITEEEIVQKKHLLEDYSNKTVVTLSLDDPLNPLLVMLYEMLQKDDIEEESKKFDPFLHVGYNKKKTPKI		352		1	Selected	-1	 	
Batch03	AnphA.01284.a	Anaplasma phagocytophilum	YP_505242.1	Q2GK59				aspartate aminotransferase	Potential drug target		MLSERMNCIKPSPTLELSRLTLELRAQGLDIISLGAGEPDFDTPDHVKDAAIAAINAGKTKYTPVEGIPELKDSIIRSVRRDYGIDYVANQVLVGAGAKQCIYNLFMATINEGDEVIIPAPYWVSYPDMVKIAGGAPVIVNCGDYLKLTPELLRGAITPKTKWLIINSPSNPTGAVYSREELAAIAEVLKQHKHVLVITDDIYAKLVYDAEFCGILQVEPSLYDRVYIVNGVSKAYSMTGWRIGYILGNAEAIKAVSTIQSQSTTNANSIAQYAAIAALDGDQSFLDTRIKAFARRRDRVMDAVLSSGVLQADVPQGAFYVFISCGNAIGKHAPKVGVINDGSDMAKHLLNHRVAVVPGVAFGAPNFFRISYALSDDRLSEACERILEACSYLS		394		1	Selected	-1	 	
Batch03	AnphA.01298.a	Anaplasma phagocytophilum	YP_505437.1	Q2GJL4				HIT family protein	Potential drug target		MEPSLYDNDNVFAKILRGELPCTKVYEDDNVLAFHDIKPEAPVHVLVIPKGKFVSFDDFVESGYDVSEFFKTVGKIARQFNLHTGGYRLVTNHGKSAGQIVHHFHVHILGYPQREHDCTNNSGE		124		5	Purified	-1	 	NR-16385
Batch03	AnphA.01306.a	Anaplasma phagocytophilum	YP_504974.1	Q2GKX7				lipoyl synthase	Potential drug target		MNSKPSWLRVKMPGGEVFEEVRDLVKRQRLNTVCEEAACPNIGECWNKRHATIMVMGDVCTRACAFCNVKTGVPRALDLGEPERVGEAISKLGLKHVVITSVDRDDLPDGGASHFAKCIREIRKRDPNVTIEILTPDFQGKPGAVDVIASARPDVYNHNLETVPRLYARVRPRAKYFNSLQLLQQVKDKTQGVFTKSGLMLGLGEQKEEVYQVMDDLRCAGVDFLVLGQYLQPTKDNIDVDRYVTPEEFEQYKRMAYAKGFSMVASSPLARSSYHAEDDFLRLRALRTARMRVAT		295		1	Selected	-1	 	
Batch03	AnphA.01317.a	Anaplasma phagocytophilum	YP_505537.1	Q2GJB4				"ATP-dependent Clp protease, proteolytic subunit ClpP"	Potential drug target		MNLVPMVVEQTGRGERAYDIYSRLLKERIIFVTGPIEDEMASLIVAQLVFLEAEDPEKDISMYINSPGGVVTAGLSIYDTMQYIKPNVATLCLGQAASMGSLLLCAGAPGMRCALPNSRVMIHQPSGGFRGQATDIEIHAREILEIKRRLNEIFVRHTGKSLEEIESSMERDNFMIAEKARDFGIIDKVIEKRIEEK		197		1	Selected	-1	 	
Batch03	AnphA.01338.a	Anaplasma phagocytophilum	YP_505311.1	Q2GJZ0				NADH dehydrogenase subunit E	Potential drug target		MNSADQESFRFTDGNLEEAYKCISRYPEGRQASAVMPLLHLVQQQAGGFVPRSAIEYIAKLLSMRPVHVREVVEFYSMYNTAPVGKYLVQVCKTTPCWLRRSDDVLNACKRVLCVRVGETTKDNLFTLREVECLGACVNAPVVQINDDYYENLDAESMEKILLKLKEGNEG		171		3	Expressed	-1	 	NR-16386
Batch03	AnphA.01343.a	Anaplasma phagocytophilum	YP_505452.1	Q2GJJ9				biotin--acetyl-CoA-carboxylase ligase	Potential drug target		MKPFVIHRRSISQSTNLDAMELAEQGADSGTVIVADEQSSGVGRRGRQWYSPKGNLYFSIVLKEHLHVPTLSFACALSVGISLEQIFSQHIENSKIPTLKYKWPNDVFVDNKKISGVLLQSKVQGHSIPWIVCGVGVNILHHPEYATSISSYIPDLKLTNIELLDVVLENLAKLLDIYSASGFAPLRSLWLKKAHALNSHVCITTSDGITHEGTFTDIGLDGSIVLKSGEDTLKLDYGSML		241		5	Purified	-1	 	NR-16387
Batch03	AnphA.01360.a	Anaplasma phagocytophilum	YP_504977.1	Q2GKX4				Fe superoxide dismutase	Potential drug target		MFELSDLPYEGLEPYISSHLLDRHYNGHHKTYVDVLNKLVVGTEFEGLGNESLGDIVVKAHNSGSAGRAIFNNAAQIWNHDFYWQSMKPNGGGNPPEKLREMIEHSFGSVEGFNNAFTTSGLGQFGSGWVWLVYDEDAKALKVVSTANADSPLLTQGQLPLATMDVWEHAYYLDYLNLRKKYIDVFLEHLLNWDFVLGRLEDAGVL		206		17	In PDB	-1	 	NR-16388
Batch03	AnphA.01361.a	Anaplasma phagocytophilum	YP_505123.1	Q2GKH8				"hydrolase, TatD family"	Potential drug target		MIVDSHCHLNYFDSASLRDIIDHACAVGVSLMQTVCTTIEEFPVLLEIANGYAQVYASVGVHPCNSAKGEFSSVDDLVAFAQNNKVIGLGETGLDFYRSEEGIDKQEKSFLAHIDAARVTQLPVIIHSRNADTRMAEICASEMKNGAFKGVMHCFASSMELARHSLDAGLYISFSGILTFKNAGFLRDIAKFVPRDRVVVETDSPYLCPEPHRGKQNSPEMTRFVVESLAQIWEESVDVVSEVTTKNFFTLFDKCARLYYASEESNNLRS		270		4	Soluble	-1	 	NR-16389
Batch03	AnphA.01366.a	Anaplasma phagocytophilum	YP_505241.1	Q2GK60				"antioxidant, AhpC/Tsa family"	Potential drug target		MRRLMNLVTKPAIDFTARAVMSDGKMCDLTLSKHVAGKYAVLFFYPRDFTFVCPTEILSLHSRIPQFSEQNAEVIAISTDSEFAHSHWRNTPLEKGGIGMVSFPLVADDSHSISESYGMLFAGKVSLRGTIIIDENFVVRHQSINDLPIGRNVDEFLRIIDAIEHHKKHGEVCPAGWSKGKVAMEATQQGVEHYLQSHIDSLS		203		1	Selected	-1	 	
Batch03	AnphA.01377.a	Anaplasma phagocytophilum	YP_505796.1	Q2GIK5				"phosphoribosylaminoimidazole carboxylase, catalytic subunit"	Potential drug target		MNEPKLPPVPVAVIMGSKSDLPTMSAAISVLDELMIAHEALVVSAHRTPERLFNFAKSAHETGFKVIIAGAGGAAHLPGMVAALTHIPVIGVPVMSECLKGMDSLLSIVQMPKGTPVATMAIGPAGAFNAAVLAASIIGLWDENVSLRLQNWKQKITDSVSITPY		165		1	Selected	-1	 	
Batch03	AnphA.01382.a	Anaplasma phagocytophilum	YP_505649.1	Q2GJ02				inorganic pyrophosphatase	Potential drug target		MNLDDIGSGSNAPEEVNVVIEVSQDSHPVKYEFDEKNGALWVDRFLPTAMYYPCNYGFIPNTIAGDGDPVDVLVLARFPVMPGAVICVRPVGVLMMNDEKGEDAKVLAVPATKVDQYYGNIVNYSDLPSSFLDSISHFFSFYKKLEKDKFVSVGCWQDAASAKELIRSAIIAAKKGEN		178		17	In PDB	-1	 	NR-16390
Batch03	AnphA.01389.a	Anaplasma phagocytophilum	YP_505702.1	Q2GIU9				glutaredoxin 3	Potential drug target		MRDVVIYTKVPCPYCTRAKALFNKKSIPFKEIDITNDPAAQLEMVERSGRKTVPQIFIDGESIGGCDDLYELYESGKLEL		80		5	Purified	-1	 	NR-16391
Batch03	AnphA.01397.a	Anaplasma phagocytophilum	YP_505368.1	Q2GJT3				putative nicotinate (nicotinamide) nucleotide adenylyltransferase	Potential drug target		MIVGIFGGTFDPPHEGHVYIAQKLRKLLRLREVWWVVTSRNYLKSSSKYDLEKRKDLVQEVVLKLQGMRVITMDSPRGYEVVQYCKNKYPSFKFIWIAGSDNMASIHRWYRWRDFCEMVPIVFLERAVSTYKVLKRPFASVVPRVNFSADNVCNISRGWSIIRARACDMSSTKIRNKL		178		2	Cloned	-1	 	
Batch03	AnphA.01429.a	Anaplasma phagocytophilum	YP_504713.1	Q2GLN8				"pyruvate dehydrogenase complex, E1 component, pyruvate dehydrogenase alpha subunit"	Potential drug target		MRLKREALQSSIAGTKDIGRKEVLHVNLTNESVLSAYKHMLFMRRLEEKVGQLYGMGLIRGFCHLYIGQEAVAAGMYSVLQPSDSVITSYREHGFALSSGESPGKIIAELLGRSAGSSKGKGGSMHIFNVQKNFYGGHGIVGAQVPIGTGIAFANKYKANGGVVFTCLGDGAINQGQVYEAFNMAALWKLPVVYVVENNEYAMGTSVARSSYVSDLYKRGESCGVPGRRVDGMDLFEVIREVSQAAAHCREGNGPILLEMKTYRYRGHSMSDPAKYRTREEVEEIRNNRDPLCIVKSHILEHNMASEEVLTTWEKEIRDEIKKAVEFAEGCPEPSVEELYTDVYK		345		2	Cloned	-1	 	
Batch03	AnphA.01435.a	Anaplasma phagocytophilum	YP_505609.1	Q2GJ42				"succinyl-CoA synthetase, beta subunit"	Potential drug target		MNVHEFQAKGILSGFDVRVPKGVVVRSVEEVDSALGSLAAGIVAVKAQIHAGGRGKAGGVKIGKAREEVADLVKSMLGSVLVTHQTSAAGQKVHAVYLEEGVSIKKEYYLGAVVDRKAGMVSVIFSSEGGMDIEEVAHSRPEMVVVVNVDPVYGFLDFHGRKLCYGLGLKKEQVVQITAMARKVCRALMETDASQVEINPLVETTCGEFIALDAKMTFDDNGLFRRPEIVKLTDPHEYSEEELEAAKYGLSYIKLDGNIGCMVNGAGLAMATMDIVKYYGGEPANFLDVGGGASKDTVREAFKIILRSGVDGILVNIFGGIMRCDVIAAGIIESAKEIGVSVPMVVRLSGTNYKIGKEMLDASGLSIVTAENLDEAARFVVDLVGKRG		388		2	Cloned	-1	 	
Batch03	AnphA.01447.a	Anaplasma phagocytophilum	YP_505324.1	Q2GJX7				UDP-N-acetylenolpyruvoylglucosamine reductase	Potential drug target		MSYTFTGYKLPKVRGVYKRSVKMHSMTWVGVGGVAPLLFKPKDIDDLATFLKNTSLTASAIGAGSNVIVRDGVFNNVVVRLEREFSDMRCEDNAITVGCGASISELAAFARENSLSGFEFCVGMPGTVGGAIATNARCHGKDIASILHSVIAVNEYGEICTLYKDDMQYSRRSHGLEGRWVFVEARFVGNPAELNTIRNTMSELLIKRNATQPIYYGKSIGYIFQDAGNAEAKALIEEAGCRGLQVGCAVVSEKHCNFIENIGGASAAEIEDLGSEVKRLVKEKTGVNLEWSIEFLGARVVK		302		3	Expressed	-1	 	NR-16392
Batch03	AnphA.01448.a	Anaplasma phagocytophilum	YP_505536.1	Q2GJB5				ATP-dependent protease ATP-binding subunit	Potential drug target		MSETKKGAYSCSFCGKLHSEVKKLIAGPEAYICNECVELCGGILQEENLPAKQGRFDLKPREIKEVLDEYVIGQEHSKKVLSVAVYNHYKRLRNSGVISEVEISKSNVLLIGPTGSGKTLLARTLARVLQVPFAMADATTLTEAGYVGEDVENILLKLLQAANFNVEAAQRGIIYIDEVDKISRKSENASITRDVSGEGVQQALLKVIEGTVSSVPPQGGRKHPHQEFIQISTDNILFIFGGAFDGLEKIIEARNRGSSMGFEANVQSMVSPTKDVLSYAEPEDLVKFGLIPEFIGRIPVITSLGKLDENTLFRVLVEPKNSLVKQYAKLFEMDNLELKFDDDALMAIARKAVDRNTGARGLRAIMESLLLDFMFDPQGCAHEGKVSISKEMVENLVLGKNCFEDARKGNLYGRG		415		3	Expressed	-1	 	NR-16393
Batch03	AnphA.01463.a	Anaplasma phagocytophilum	YP_504794.1	Q2GLF7				guanylate kinase	Potential drug target		MLKSVGVILVLSSPSGCGKTTVANKLLEKQKNNIVKSVSVTTRAARKGEKEGKDYYFVDREEFLRLCSNGEIIEHAEVFGNFYGVPRKNLEDNVDKGVSTLLVIDWQGAFKFMEMMREHVVSIFIMPPSMEELRRRLCGRRADDSEVVEARLKGAAFEISHCEAYDYVIVNEDIEETADRISNILRAEQMKTCRQVGLRELLESRFPIED		210		17	In PDB	-1	 	NR-16394
Batch03	AnphA.01473.a	Anaplasma phagocytophilum	YP_505822.1	Q2GIH9				pyruvate dehydrogenase subunit beta	Potential drug target		MEVITVREALRLAMEEEMERDQSVFLMGEEVGEYQGAYKISQGLLERFGPQRVVDTPISEHGFTGLAVGAAFCGLKPIVEFMSFNFSMQAMDQIVNSAAKTNYMSGGQLGCPIVFRGPNGAAAGVAAQHSQCFASWYSHVPGIKVVAPYFAADCKGLLKSAIRDPNPVIFLENEIAYGHSHEVTEEQLSKDSLVELGKAAIVREGKDVTIITFSLQLKYALEAAEILLKDNISAEVIDLRTLRPLDTEAILKSVKKTNRVVTVEEGWPFCGVGAEITALIDECAFDDLDAPVTRVTAKDVPLPYAANLESLALPGVEDIVSAVHKVCNYSIA		332		3	Expressed	-1	 	NR-16395
Batch03	AnphA.01501.a	Anaplasma phagocytophilum	YP_504923.1	Q2GL28				flavin reductase family protein	Potential drug target		MQQLGSISAKRFKSCMGRFATGVTVVTTVDSSGAQHGVTVSSFNSVSLDPPLVLFSIQKSSSRFAAFSQCTEFVVNILSDAQKDVSQDFACNLVENWDSHDYIKLSGIPVICGSIAYFHCALYRLYDGGDHKIVVGRVLDCATLEDDDPLLHYRGSYCSINHEL		164		5	Purified	-1	 	NR-16396
Batch03	AnphA.01509.a	Anaplasma phagocytophilum	YP_505001.1	Q2GKV0				maf protein	Potential drug target		MDSLVLASSSEYRLRLLKQLMIVPGEVISPDLDESVHKGELPRLYAERVAREKALKVFSSRPDKFVLGADTVAYCGRRIMLKTDDEAQATEYLEMISGRRHRVCTAVCLCAPTGDVRVRSVVSVVKFKRLSKDEIDCYIRSGEWKGKAGGYSIQGWASALISWMQGSHSSIVGLPLHETYCLLSGYFKLTHIP		193		5	Purified	-1	 	NR-16538
Batch03	AnphA.01522.a	Anaplasma phagocytophilum	YP_504956.1	Q2GKZ5				signal recognition particle protein	Potential drug target		MFNSLTKGFSSALQRLSGKREISSKDFDLVIEDITQALLDADVNLGVVDEFIENVKSKIVGGDVVKGVLPEQMVIKRIEECLIEVLGNEKSALDLKGKIPAVIMMVGLQGVGKTTNTVKVALRLKKDSKNPLVASLDVYRPAAREQLKVLADGVGIDSLPIVEEQKPLDIAKRAMREARLKGHDVVLLDTAGRLHINQDMIDELKCVKKEVSPAEIVLVVDSLMGQDAVTMVRKFNEELGITGTIFTRADGDPRGGAILSMKLVAGCPIKFMSTGEKPEDLDDFYPDRIARRMLNMGDVASLVEKAVEAVGKDTINELQAKAKKGKFDLDDLVIQLKALNKMGGIANIMKFIPAFGNDIKRKVAGIADDSKVDMYIAIINSMTKQERANPEILNGARKARIAKGAGVKVDAVNALLKQYNQMNSMISKFSQMKMDKIADSDIMNLLKGK		449		2	Cloned	-1	 	
Batch03	AnphA.01539.a	Anaplasma phagocytophilum	YP_505811.1	Q2GIJ0				phosphopantothenoylcysteine decarboxylase	Potential drug target		MDILLLITGSVAAYKALEVIRELRRRKYNLRCVLSKAGEQFITPLSVSALSDANTYTESDSFSPQECMKHISLSRGTDLILVVPASADIMGKAAHGICDDLPTTILMAANVPVIMAPAMNTVMWQSPAMQRNLNTLKQDKVFIIEPETGILACGEEGPGKMAKVEDIVAFVEKFQKC		177		5	Purified	-1	 	NR-16539
Batch03	AnphA.01540.a	Anaplasma phagocytophilum	YP_505778.1	Q2GIM3				branched-chain alpha-keto acid dehydrogenase subunit E2	Potential drug target		MPVKVLMPALSPTMKSGTIAKWHKNAGDAVKPGDIVADIETDKAVIEFEYADEPGVMYKILKEEGSKNVAVNQSIAVIKVDGDEEAALLEMVHSAEGASGSVSNEAASAALQATPAKVAGDMVAPSSANKASETAHITSGSDRVKASPLAKKLAAQLSVDISKITGSGPYGRVVKADVLGASVPTSDTTIQEGSRVVEVSTMRKVISERLAESKRNIPHFYLAIDCMVGELLEVRSRINSNAEALGTKITVNDLVIKATALAAREFPEVNALWAGDKIVYHQNVDIAFAVALDDGLLTPVIAGADKMTLSELSKTAKSLVARAKDRKLLPHEFQGGCLTISNLGMFCIKEFYAIINPPQSCIMAVGQSEKRPVVVDNCVVAADVMSVTLSVDHRVIDGALAAKFLNRFKFYIENPLAMLA		420		5	Purified	-1	 	NR-16540
Batch03	AnphA.01547.a	Anaplasma phagocytophilum	YP_504709.1	Q2GLP2				putative oxidoreductase	Potential drug target		MNKNGSRALVHRPAKNAMQSGTFRGDLWYVEFEPSRSQYVEGLMGWTGSEETLQQVRMCFGSKEDAIAYVEAHGIPYILLQDATASRVPKSYATNFLRKRGL		102		2	Cloned	-1	 	NR-16541
Batch03	AnphA.01587.a	Anaplasma phagocytophilum	YP_504853.1	Q2GL98				"oxidoreductase, short chain dehydrogenase/reductase family"	Potential drug target		MDGLLRGRVALITGASGSIGSAVAKRYAAEGASVVLASRNVSKMKALYDSIQGLGGDVILAPIDLNDYESVGNLALSIENKYGLLDILVSAAAVLGNLAPVQECDPVKWKEVMGVNLNANWYLIKHFDALLKQSAAGRAIFVTSEATRTLLNYSYFAPYATSKVALEALVQVYAAETKHSKLCVNMVYPGQVDSGIHVAIFSTQEQSKFPSPEELTDKFVELASPECTVTGQVYELTVAEKVRQRSFL		248		1	Selected	-1	 	
Batch03	AnphA.01597.a	Anaplasma phagocytophilum	YP_504721.1	Q2GLN0				thymidylate kinase	Potential drug target		MFITFEGIDGCGKTTQSILLAKYMSDLYGEDNVVLTREPGGTSFNELLRSVFLSVSDYKVDKLTELFLFLAMRRESFVKVVESALRANKIVISDRCVDSTVAYQGYGCGIDLDLIYKLNSLVMGIVPDMTFIIDIDIEKALSRATRNGYESNSMDFYHKVRKGFQRIAEEEKHRCVLLRCDDYEENGICDVYSVHNKIVGLLQGVLHNKMDAASSSVKV		219		7	Crystallized	-1	 	NR-16542
Batch03	AnphA.01598.a	Anaplasma phagocytophilum	YP_505280.1	Q2GK21				50S ribosomal protein L27	Potential drug target		MATKKSGGSSCNGRDSRGRRLGVKKFGSELVIPGNIIIRQRGTKYHPGKNVGIGRDHTIFSKIAGVVSFRRKAEGRVFVDVLPESVSASLS		91		-2	Work stopped	-2	Work stopped	NR-16543
Batch03	AnphA.01601.a	Anaplasma phagocytophilum	YP_505528.1	Q2GJC3				thiamine-phosphate pyrophosphorylase	Potential drug target		MDDIGFYLIVPDAHWFEFAASCGVRTIQLRAKDKPVSEVENMVKRCSEIAVRYGVRFIVNDYWELALKYNAYGIHLGQEDIKTADLYRISSSGIRLGISTHCYHEFARASFYKPSYIALGPIYDTTSKSMQFHAQGLELLKQWVKSSSCPVVAIGGITLANIDDVVRCNAGGVAVISAVTEAADPKDAIRRFLDKCSVGV		200		3	Expressed	-1	 	NR-16544
Batch03	AnphA.01627.a	Anaplasma phagocytophilum	YP_505256.1	Q2GK45				cysteine desulfurase	Potential drug target		MKNNEDKGAKLPVFFDYQATTKLDDRVLEAMIPYFQQFSNPHSRSHCYGWRAESAVEIAREQVAQSIGADPKEVIFTSGATESNNLAIKGVARFYKNRGNHIVTVSTEHKCVLDSCRHLETEGFEVTYLGVKKDGLIDLEVLKKAIREDTILVSVMMVNNEIGVIQPIREIGEICKSEGRDVFFHTDAAQAFGKLLIDVNEMGIDLLSISGHKIYGPMGIGALYVRKRNPRVRLVPLLSGGGQERGMRSGTVPTPLAVGLGEAARIALEEMDSESERIKKLRDVLYERIMNGLPHVVLNGSYSSRIAGNLNLSFSYVEGESLIMSVSDLAVSSGSACTSASLESSYVLRALNVEQDLEHSSIRFGIGRFTTLEDVERAADLIISSVRRLRDISPLWEMVQEGTNLSTIKWDV		412		3	Expressed	-1	 	NR-16545
Batch03	AnphA.01639.a	Anaplasma phagocytophilum	YP_505250.1	Q2GK51				3-oxoacyl-(acyl-carrier-protein) reductase	Potential drug target		MFDLQGKKFLVTGASSGIGAAISLMLSKAGAQLCLSGTRIEALQEVAAACENGTHVLQCNLLNSDKVDTLVDKAVDCMSGMDGVICSAGITRDKLSLRITDDDWNQVIAVNLTAIFKINRNACKAMLKNKSGRIINLSSVVGISGNVGQANYTASKAGIIGMSKSLALEFASRGITVNCIAPGFIDTPMTSVLQDKQKGYILNSIPMGRMGTAEEIASVALFLASDASKYITGQTIHVNGGMLMY		245		2	Cloned	-1	 	NR-16546
Batch03	BaboA.00187.a	Babesia bovis	XP_001611752.1	A7ANQ0				uracil-DNA glycosylase family protein [Babesia bovis]	Potential drug target		MSKRLITDFFDIPRPNIKRRDVGSTLSRNSDPDKEDSDPVVCPTVPSLGECPGELQGQTATGDSEVVSLVSKLLGEEWSDKLNNEIKKPYFGNLWAKVNKDRKNKRVYPPEHLVFNAFQIVPLSKVKVVIVGQDPYHQPKQAMGLSFSVPRGVAIPPSLRNIYKEIGIERSHGDLTYWAQQGVFLLNTVLTVIDSQPFSHKDYGWTKFTDIVIDLINTHRENVVFLLWGKSAEQKCSKISTTRHCILKCGHPSPLSQKLFFGCDHFNKCNEYLRNTKQKPIDWMLPP		287		5	Purified	-1	 	NR-16310
Batch03	BaboA.00422.a	Babesia bovis	XP_001608645.1	A7AXF4				"EFTU_STAAS Elongation factor Tu, putative [Babesia bovis T2Bo]"	Potential drug target		MAKEQYIKNKPHINIGTIGHIDHGKTTLTSALTSVLKAKGLAKKAHSYEEIDSAPEEKSRGITINTKHVEYESNYRHYAHIDCPGHADYIKNMITGAVQMDGAVLVISLTDGPMPQTIEHLLLIKQIGIENVIVFLNKEDKITDIELSNFVEEEVRDILLKYNFKEEFVHFTSGSALEALNVVKQSSKLDFNNKWIKKILNLVDCIDKYIPTPTRDLLKPFLMPVEDSFSITGRGIVATGKVERGSANIGDKVELLGYDSSKIVSILNIEMFNKSLLKAESGDNVGILLRGVTKEDIKRGYVLTVPGSSKLYKQFKANLYVLSKLEGGRHTAFTVGYKPQFFIRTANITGTITNIYSSSNDLSLDLAIPGDNVIVTADIEKSMPLETELRFAIREGGKTIGAGIVIELLK		410		1	Selected	-1	 	
Batch03	BaboA.00436.a	Babesia bovis	XP_001609068.1	A7AWS2				cAMP-dependent protein kinase [Babesia bovis T2Bo]	Potential drug target		MGVTYSITNGIDTGMGAYENKNHVNKETSYSVVQSTRRLPQPQTAPRISRFMARCNNIAKHMICTNDSMASDVRYKAWTESDTISDGTMEIIPSLPEKLDISNFDIGPIVGTGSYATVCIATLNTGPKSQRATFALKILHKTKVIAERQVMHLRNERHILSTVRHPFIVNYVKSFQDDINVYILLEYVSGGELFSYIYKYGALGHTVARFYTAQAILAIDFLHFKGIVYRDLKPENMLLDQDGHIRLVDFGFAKEVKHKTYTVCGTHDYLAPEIFLRCGHGIEADWWSLGVLVYEILTGVPPFHASDPSATYDLALANHIRFPLSVRVEVKDFIRRLLVVNPRKRLGGSNSSELYSHRFFAGMDWMKLLSKQLKPPIVPRVSGLSDTTNYMQYPDDWRAHDARITRSQQDEYFSDF		416		3	Expressed	-1	 	NR-16311
Batch03	BaboA.00509.a	Babesia bovis	XP_001608710.1	A7AX69				tat-binding protein-like protein [Babesia bovis T2Bo]	Potential drug target		MMETETKAGTIQRSEPVNGLLTYYRYRIADYEALLNEKEQTRRRLVAQRNELNAKVRALKDELHALLESGSFVGEVVKQMCQDKVLVKISLEGKYVVDVSKDVDISKCTPSTRVALMSDSYKLHKILPTKVDPLVALMKVEKVPDSTYEMVGGLEQQVKEVKEVIELPIKHPEIFESLGISQPKGVLLYGPPGTGKTLLARAVAHHTDCTFIRVSGSELVQKYIGEGSRMVRELFVMARAHAPSIIFMDEIDSIGSQRTDSGHGDSEVQRTMLELLNQLDGFEPYQNIKVIMCTNRIDILDEALLRPGRIDRKIEFPNPNAEARAQILAIHSRKMNLVRGIDLEMIAREMTNVSGAEVKAVCTEAGMFALRERRVHVTQEDFLMAVAKVMKKDSDKNVSFTKLWK		405		3	Expressed	-1	 	
Batch03	BaboA.00576.a	Babesia bovis	XP_001609217.1	A7AV23				acyl CoA binding protein [Babesia bovis T2Bo]	Potential drug target		MSADDFDAAVKYVSNTTTMMASNDDKLCFYKYYKQATVGDCNKPKPGMLQLQEKYKWEAWNALRGMSTESAKEAYVKLLDTLAPSWRN		88		5	Purified	-1	 	NR-16312
Batch03	BaboA.00641.a	Babesia bovis	XP_001611422.1	A7AMS0				"casein kinase I, putative [Babesia bovis]"	Potential drug target		MISRSLEIRVGGKYRLGRKIGSGSFGDIFMGTQIQTGEDVAIKLESHRSRHPQLLYESKLYRLLAGGVGIPTIHWYGIEGEYNILIMDLLGPSLEDLFTICNRKLSLKSVLMLADQMLNRIEYCHSKNFIHRDIKPDNFLIGRGKKISIVYIIDFGLAKKYRDPKTGQHICYREGKNLTGTARYASINTHLGIEQSRRDDLEALGYVLLYFMRGSLPWQGLKANSKKDKYDKISEKKIAIPVDLLCKQLPFEFVTFINYARSLRFEDRPDYPYLRRILKDLFFRQGYQYDFIFDWTFLHTAQLMHTMVNEDIERFERMNRERDAEEPATRPALINN		336		3	Expressed	-1	 	NR-16179
Batch03	BaboA.00727.a	Babesia bovis	XP_001610134.1	A7AUF5				"guanylate kinase, putative [Babesia bovis]"	Potential drug target		MAQVPFLVIVGPSGVGKTTLYKMLLEEFQGFFELSVSCTTRKIRPHEIDGVNYYFITEEKFNQMKDEEAFLECATYVGNQYGTPCSEITRIQSKGKVPLLEIEVCGFQKIKSLGIPLYSVFVSTSDIDALRKRLVRRGSDEEQTVDKRIGRAVEEIAEAKHAGFSMILYNDVLEVAYKQLREQIIKWYGLKSEQ		194		2	Cloned	-1	 	
Batch03	BaboA.00728.a	Babesia bovis	XP_001608692.1	A7AX51				actin [Babesia bovis T2Bo]	Potential drug target		MSDEEATALVIDNGSGNVKAGVAGDDAPRCVFPSIVGRPKNPALMVGMDEKDTYVGDEAQAKRGILTLKYPIEHGIVTNWEDMEKIWHHTFYNELRIAPEEHPVLLTEAPMNPKANREKMTTIMFETHNVPAMYVAIQAVLSLYSSGRTTGIVLDSGDGVTHTVPIYEGYALPHAIMRIDLAGRDLTEFMQKILAERGFTFTTTAEKEIVRDIKEKLCYIALDFEEEMNSSASSSEIEKSYELPDGNIITVGNERFRCPEVLFQPSFIGQESAGIHTTTFNSIARCDVDIRKDLYANVVLSGGTTMYEGIGQRMTKELNALVPSTMKIKVVAPPERKYSVWIGGSILSSLSTFQQMWITKEEFDESGPNIVHRKCF		376		3	Expressed	-1	 	NR-16313
Batch03	BaboA.00748.a	Babesia bovis	XP_001611907.1	A7AP55				"casein kinase II, alpha chain (CK II) [Babesia bovis]"	Potential drug target		MKLTGGVWKLYLASNLLFAAFHSGVSLKPVSANEVGTAQSGAPRGQQRKPLAFRGSIRIFVNPEGYIEESENDEPSPTNMDVESEKRATSRGTYPNTNLPIILPKLYADVNTKRGPDYWDYENITLMWNVPNNYEIVRKLGRGKYSEVFEGTNLLTHERIVVKILKPLKKKKIKREIKILQNLSGGPNIIKLLDIVKDPQSRTPSLIFEYVNNTDFKILYPTFTIADIKYYMYQLLKAVDYAHSQGIMHRDVKPHNVMIDHEKRELKLIDWGLAEFYHPEQEYNVRVASRYYKGPELLVDMKYYDYSLDVWSIGCMLAGMVFKKEPFFYGHDNYDQLVKIAKVLGTEDLRAYFKKYGLKVAPVYEKILGNYPRKPWSSFIEDENKHLCVPEVIDLIDKMLVYDHTMRITPKDAMDHPFFKDVA		423		3	Expressed	-1	 	
Batch03	BaboA.00756.a	Babesia bovis	XP_001611807.1	A7ANV5				"small GTP-binding protein, putative [Babesia bovis]"	Potential drug target		MGSKRSYKTVLLGDASVGKSSFVLRLTRGEFADSTTSTIGAAFFMHTVRCSPPAAKAVTESAAPKDGSSTRGIQTPTSQDDASGAQVTVKFDIWDTAGQERFKSIAPIYYRGAACAIVILDVSSSSSLQHAISWVDQIRMTNSSNTLTILVANKIDLLGTKDEYEQTLSSARTYARENSLLLVETSAKTGQNISKVFELLAKEILRNPQRFDKPSATSSTRAINVDDSRSRMLRLKCCDSF		241		7	Crystallized	-1	 	NR-16180
Batch03	BaboA.00819.a	Babesia bovis	XP_001611660.1	A7ANF8				nucleoside diphosphate kinase family protein [Babesia bovis]	Potential drug target		MERTYIMVKPDGVQRGLIGEILKRFEMKGLKLIAAKFEHPTMDVVAQHYCEHKDKPFFKDLCDFISHGPVFCMIWEGPEAIKIGRNLVGLTSPVESAAGTIRGDFGVVKNFNIVHASSSAEDAARECALWFTPEQLVTWERSVGGWIY		148		17	In PDB	-1	 	NR-16314
Batch03	BaboA.00832.a	Babesia bovis	XP_001609099.1	A7AWV3				"antioxidant, AhpC/TSA family [Babesia bovis T2Bo]"	Potential drug target		MMNGVLRLPTASAYRAMRMLSNKTTGWLNNDSVRCFRPVYNQFVVRAFGTQAGSCHTNIGDLVGREFPDFKTSAVINGNITEFDASAYFRDSYALLVFYPLDFTFVCPSELLGFSARLPEFEQRGIKVVGISIDSVFSHLAWLQMDLKKGGVQGLKIPLVSDISRSISKSFGLLRSDGFAQRASVLIDKTGKVRHTAVFDLGIGRSVDETLRVFDAIKFNDESGQVCPVNWQKGGAGMSQTSSSTGDYLFKTFS		254		2	Cloned	-1	 	
Batch03	BaboA.00841.a	Babesia bovis	XP_001609356.1	A7AVG2				high mobility group protein-like protein NHP1 [Babesia bovis T2Bo]	Potential drug target		MAGASDRTGVRRPRKAKKDPNAPKRALSSYMFFAKEKRVEIIAENPEIAKDVAAIGKMIGAAWNALSDEEKKPYERMSDEDRVRYEREKAEYAQRKV		97		8	HSQC	-1	 	NR-16181
Batch03	BaboA.00914.a	Babesia bovis	XP_001609777.1	A7ATE8				glyceraldehyde-3-phosphate dehydrogenase protein [Babesia bovis]	Potential drug target		MVVKVGINGFGRIGRLVLRASLAYDNLEVVAINDPFMTADYMAYLLKYDSVHGTLGETVSVTADTLKIGSRSIKLFFEREPSQIPWGQNGVDFVAECTGVFTSSEKSQQHIAGGAKLVIISAPPSDSTPIYVYGVNHTKYEKSQRIVSNASCTTNCLAPLAKVIHEKFGIVEGLMTTVHATTANQLTVDGASRGGKDWRAGRCAGANIIPASTGAAKAVGKVIPELNGKLTGMAFRVPTPDVSVVDLTCKLAKPATYDEIVSAVKAASEGELKGILGWADDDLVSTDFVHDKRSSIFDVKAGIALTDTFVKLVSWYDNEWGFSNRLLDLGLYICSKQ		337		4	Soluble	-1	 	NR-16182
Batch03	BaboA.00974.a	Babesia bovis	XP_001609245.1	A7AV51				"fructose-1,6-bisphosphate aldolase [Babesia bovis T2Bo]"	Potential drug target		MQVKLSQERAKELAENASFIASPGKGILAADESTGTIQKRFDNVGVENTEKNRAEYRSILFTTKGLGKYISGCILFEETLFQQAPNGQNMVDLLRAEGILPGIKVDKGLVTIPNTDEEVSTTGLDGLAERCQKYYNAGARFAKWRAVLSIDVKKNKPSNLSILETAHTLARYAAICQENGLVPIVEPEILADGDHSIEVCAEVTERVLAAVFKALNDHKVLLEGALLKPNMVTQGVDCKDKPAPQTVGFLTSRALRRTVPPALPGVMFLSGGQSESMATRHLNEINKCNKHPWSLSFSYGRALQSSVLKTWNGSMSNAAAAQDVLMKLAQQNSEASLGSLKTDLSDDGESLFEAKYIY		358		17	In PDB	-1	 	NR-16183
Batch03	BaboA.01035.a	Babesia bovis	XP_001610970.1	A7AS83				"succinly CoA-ligase beta subunit, putative [Babesia bovis T2Bo]"	Potential drug target		MRAFVGFRKALARSIVNGKLSFKGDNASCNHARSTKRYLNVPEFGGMRILKEHGIPTPMNRLARSPSEAEAMTHEILESTKCGEVVLKALVLTGGRGKGKFVGTDISGVELAKSPERAKTLAEGMIGNVLVTKQTGASGLKCKEVLVAEKLNLAKERYISFMLDRSSCSIMAIATKHGGGNVEEVSEKDPSAVLTVKINPLKGITDDEVTKIATHLDFSKGLLEDTKSFVKNMYHAFVAKDALLLEINPLSETENSKLVACDSKVIIDDNADFRQKEIFESVPPAENELEARANEVGLNYISLGGNIACIVNGAGLAMATLDLLTHHGGSPSNFLDVGGNATGHMLNQALDIVASDAKAKALLVNIVGGIVQCDQFALSFVEAAKNSKMQIPVVLRLQGTNADAAKRILNEAQIPHIFCQDFDSAAKSVVEIANAS		436		5	Purified	-1	 	NR-16184
Batch03	BaboA.01044.a	Babesia bovis	XP_001612222.1	A7AQ20				histone deacetylase [Babesia bovis]	Potential drug target		MEKRVSYFYDPDVGSYYYGPGHPMKPQRIRMAHALVLSYDLYRHMEVFRPHKAVEPELLAFHDHEYLQFLSGVSPDNYRDFAYQLKRFNVGEATDCPVFDGLYVFQQSCSGASIDGAHRLNNQQADISINWSGGLHHAKRSEASGFCYLNDIVLAILELLKYHARVMYIDIDVHHGDGVEEAFYVTHRVMTVSFHKFGNFFPGTGDVTDVGVASGKYYSVNVPLNDGMDDESFVDMFRTVVGKCVEVYEPGAIVLQCGADSLTGDRLGRFNLTNKGHAGCVAFCRSLNIPLLVLGGGGYTIRNVARCWAYETGVVLDKHNEMAEQISLNEYYDYYAPDFNLHLQPTNMPNYNTSEHLDRIKMKIIENLRHVERAPGVQFAHVPNDFFQYDDDEDEAAQLEVFDEGGGVAPAIVPHRKTTPPIYVNHRLRRKDYKNDYYHLPDRDQHIPI		449		3	Expressed	-1	 	NR-16185
Batch03	BaboA.01078.a	Babesia bovis	XP_001610485.1	A7AQU8				"GMP reductase, putative [Babesia bovis T2Bo]"	Potential drug target		MEIFDFDDVMLVPRMCTLETRAHADVSAKLGNRTFKIPLMASNMPSVLDENIVIELAQNNYFYVMHRIDVDLVEFSRKMRDLQLFVSISIGVQEQSYKVVDSLVANDLIPDYVTIDVAHGHSLAMQRMISYIKKAFGPKTFIIAGNVATAEGVVDLENWGADAIKVGLGPGYVCSTSIRTGFGTRNWQLAAVRECARVAKKAVIIADGGCRLSGDIVKALYMGADWVMSGYFYAGFIKSPSETEIVDGVPMKVYYGNASARCKKSRSRVEGVSLMVPCEEGTLLEKLKGIEEDLQSAVSFAGGRCILDVRKCEYVIVRHSRGPKESG		327		5	Purified	-1	 	NR-16186
Batch03	BaboA.01375.a	Babesia bovis	XP_001610429.1	A7AQP2				"cyclophilin, putative [Babesia bovis T2Bo]"	Potential drug target		MLFRLLCCLALTVITSAEAYRIPRQTSSTGTGYTPGKSYPVYSEPMSKMSRSRVFFDIAIGGAPAGRIEFTLFDDITPKTAENFRSLCVGDKTVQGVKCHFKNSIFHRIIPQFMCQGGDITNHNGTGGMSIYGRRFNDEDFSVKHSVPGLLSMANSGPNTNGSQFFITTVPCPWLDGKHTVFGEVSEGMDVVKKMERYGSGSGATTKEVKIVDCGQL		217		3	Expressed	-1	 	NR-16187
Batch03	BaboA.01614.a	Babesia bovis	XP_001610309.1	A7AQC2				"ATP-dependent Clp protease proteolytic subunit , putative [Babesia bovis T2Bo]"	Potential drug target		MTPLGVPLVEYKIPGTQRSEFHDIHTRLYRERILFVSQSLDESYTNMIIGTLLCLDSDSNEKPITLYINSQGGPSTAGITLYDTIKHLKSKIATINVGFCSATASLLLASGTPGMRSALPHSRVVMHQPAGTLEGSAEQIRSQAQYMLNMKRILQKLYSQVTNQPLDNIAKDLEREQFMSAEESLQYGLVDRIIRTDHAK		200		7	Crystallized	-1	 	NR-16188
Batch03	BaboA.01620.a	Babesia bovis	XP_001609446.1	A7AVQ2				"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase, putative [Babesia bovis T2Bo]"	Potential drug target		MLAFSFRHYTVKTNVVNRNALGQTRHDASDNSMDKDAYRIGLGYDIHRLVGTGKGGKPFKLGGVLVDDSKIFVVGHSDGDTLLHALADALLGATGCGDIGDYFSELDSINKDMDSRIILESAIKEASLRGYRPTNIDINIILERVRLGRRLKDAIKKALYDMLGSDVMINVKAKTNEGLDAIGRGEAVSCQVIAHLKRI		199		4	Soluble	-1	 	NR-16315
Batch03	BaboA.01644.a	Babesia bovis	XP_001611013.1	A7ASC6				GTP-binding nuclear protein Ran [Babesia bovis T2Bo]	Potential drug target		MAEEMPQFKLLLVGDGGVGKTTLVKRHLTGEFEKKYIPTLGVEVHPLKFRTNCGGIQFNAWDTAGQEKYGGLRDGYYIKGECAIIMFDVTSRITYRNVPNWHRDIVRVCDNIPMVLCGNKADVKERQVKAGHIQFHRKRNLQYYDLSARSNFNFERPFLWLARRLLNQPQLVFVGECAKEPEFRIDPQLAQECERNLEAAANVAIDDDGDL		211		2	Cloned	-1	 	
Batch03	BaheA.00026.a	Bartonella henselae	YP_033371.1	Q6G442				acyl carrier protein	Potential drug target		MSDTVERVKKIIVEHLGVNADKVVEDASFIDDLGADSLDTVELVMAFEEEFGVEIPDEAAETIFTVGDAVKFIDKASA		78		3	Expressed	-1	 	
Batch03	BaheA.00181.a	Bartonella henselae	YP_033592.1	Q6G3I7				30S ribosomal protein S9	Potential drug target		MAEINSLTELSVVTNTAETHENIAPVHVQKLDSQGRAYATGKRKDAVARVWIKPGSGKITINNKEFDKYFARPVLRMILRQPIVATNRDTQFDIIATVAGGGLSGQAGAVRHGISKALTYYEPELRTILKKGGFLTRDSRVVERKKYGKAKARRSFQFSKR		161		-2	Work stopped	-2	Work stopped	
Batch03	BaheA.00183.a	Bartonella henselae	YP_033626.1	Q6G3F3				aspartate carbamoyltransferase catalytic subunit	Potential drug target		MTQNTFFSLFPHQHLLGIKDLSVQDLTILLDRANANVPFLKKSDKKQSILHGRTQINLFFEASTRTQSSFELAGKRLGADVMSMAIGNSSVKKGETLVDTATTLNAMKPDILVIRHSCAGAAALLAQKVDCCVINAGDGAHEHPTQALLDALTIQRTKGRIEGLTVAICGDILHSRVARSNILSLNALGACVRVIAPSTLLPASIADMSVEVYNTMKEGLKGADVIMMLRLQQERMTGSFIPSIREYFHYFGLHKENLAYAKSDCIILHPGPINRGVEIASDIADGPQSMIHTQVEMGIAVRMAVMEALLDSRLKASGEKK		321		3	Expressed	-1	 	
Batch03	BaheA.00189.a	Bartonella henselae	YP_033998.1	Q6G2G3				dihydrodipicolinate reductase	Potential drug target		MRLTVVGANGRMGRELITAIQRRKDVELCAVLVRKGSSFVDKDASILIGSDFLGVRITDDPESAFSNTEGILDFSQPQASVLYANYAAQKSLIHIIGTTGFSKTEEAQIADFAKYTTIVKSGNMSLGVNLLANLVKRAAKALDDDFDIEIYEMHHANKVDSPSGTALLLGQAAAEGRNIMLKNVSVNGRSGHTGKREKGTIGFACSRGGTVIGDHSITFAGENERIVLSHIAQERSIFANGALKAALWAKNHENGLYSMLDVLGLNE		267		17	In PDB	-1	 	
Batch03	BaheA.00197.a	Bartonella henselae	YP_033307.1	Q6G497				Two-component system regulatory protein	Potential drug target		MRILIVEDDRNLNRQLAEAVKNAGYVSDSAFNGEEAYFLGSTESYDAVILDIGLPRLDGICVVEKWRKEGHLMPVLMLTARDRWSDKVLGIDAGADDYVVKPFHLEELMARLRALIRRSTGHATSTLCCGKVLLDTKTSRVFFDGQLIKLTSYEFRLLSYLMHHGDRIVSRTELTEHLYDQDFDKDSNTVEVFVGRLRKKLGMDLIETIRGMGYRVRMPGDQ		222		5	Purified	-1	 	
Batch03	BaheA.00204.a	Bartonella henselae	YP_033925.1	Q6G5M0				carbamoyl phosphate synthase small subunit	Potential drug target		MTQTIPSPKPWSINKPTALLVLANGTVIEGKGAGATGFAEAEICFNTAMTGYEEILTDPSYKKQIVNFTFPHIGNVGTNSEDIEDLIPLNCHGAVGAIFKADITHPSNYRANENLNQWLKKRKIIALCGIDTRALTVLIREKGALNGIIAHDPNGNFDINTLKKRAQKWTGLVNLDLAQEVTSKQSMKWNEKPWVWNKGYKTNNDASNFHIVAIDYGIKRNILRLIAAHSAHITIVPANTNIEEILAMNPDGVFLSNGPGDPAATANYAVPTIQALIDSNIPLFGICLGHQLLALAVGAKTIKMHQGHHGANHPVKDFITGKVEIVSMNHGFTVDTTSLPQHVEETHISLFDNSNCGLRIIGKPVFSVQHHPEASPGPQDSHYLFQRFFNLIMDYKKTA		399		3	Expressed	-1	 	
Batch03	BaheA.00209.a	Bartonella henselae	YP_033924.1	Q6G5M1				chorismate pyruvate lyase	Potential drug target		MSDPKDSILPPLKWLSDQDPPVPTHIKDWLMELGSMTRRFENHCTYIHIKPQRECFITRDKLKEEAAHLPKSTRYWLREVILMGDNQPWLLGRTVIPQETLFEHNEALINLGDVPLGRYLFSIDKLTRDYIHIGRKDTLWARRSRLRLTGKPLLLTELFLAASPLYTTNPI		171		4	Soluble	-1	 	
Batch03	BaheA.00221.a	Bartonella henselae	YP_033323.1	Q6G481				thiamine-phosphate pyrophosphorylase	Potential drug target		MKLDPFYPIVDNADWVERLVPLGIKLIQLRMKNENLKTIREHIKRAKNICDKLGAQLIINDHWTIAIDEKCHFIHLGQEDLRNADLPAIRKNAIRFGLSTHDEHELDIARSVDPDYIALGPIYPTILKEMKWMPQGLEKIKQWRKQIGALPLIGIGGLTPERAIGVLKAGANSAAVVTDILLHKKPEKRVRQWIKVTQAWR		201		3	Expressed	-1	 	
Batch03	BaheA.00227.a	Bartonella henselae	YP_032874.1	Q6G5B0				Septum formation maf protein	Potential drug target		MLAETLILASLSSYRAQLLKKAGLNFFVKGASFDEREVEKTGKTKNPKELSCFLASAKAKNVSERFPEALVIGCDQILDLEGQVFHKVKSIEEAHQRLCILSGKIHSLHSAVALFQNGQEIWVEAFSAHMSVRPLSSEFIERYLARVETDILNSVGVYQIEGEGIHLFEKIEGDFFTIIGLPLLPLLIKLRHFEVIDG		198		4	Soluble	-1	 	
Batch03	BaheA.00239.a	Bartonella henselae	YP_033472.1	Q6G3V4				glutathione reductase	Potential drug target		MGSFDFDLFVIGSGSGGVRAARLAGALGKRVAIAEEYRIGGTCVIRGCVPKKLYFYASQYAQEFSKSIGFGWKYADPIFNWEKLVAAKNKEISRLEGLYREGLQNSNVHIYESRAVFVDEHTLELSVTGERISAEKILIATGAKIVSNSAIKGSDLCLTSNEIFDLEKLPKSIVIVGGGYIGVEFANIFHGLGVKTTLLHRGDLILRNFDYDLRQLLNDAMVAKGISIIYEATVSQVQSTENCYNVVLTNGQTICADRVMLATGRVPNTTGLGLERAGVKVNEFGAVVVDEKMTTNVSHIWAVGDVTGHIQLTPVAIHDAMCFVKNAFENTSTTPDYDLITTAVFSQPEIGTVGLSEEDALHRYKRVEIYRTVFRPMRNVLSGSPEKMFMKLVVDGESRIVVGAHVLGENAGEIAQLIGISLKGKLTKDIFDKTMAVHPTMSEELVTMYKPSYVYENGEKLDN		463		10	Diffraction	-1	 	
Batch03	BaheA.00241.a	Bartonella henselae	YP_034071.1	Q6G2A0				tryptophanyl-tRNA synthetase	Potential drug target		MDTFTPLVFSGVQPSGHLHLGNYLGAIKHWVELQTSYNCLYCVVDMHALTVNPDPLALRESTRAVTAAFLAAGIDPKKHIIFNQSQVFQHAELAWILNCIARIGWLQRMTQFKDKAGKDREKASLGLFAYPSLMAADILLYRATHVPVGEDQKQHVELTRDIAQKFNNDYAQRIVDLNFSVTMQMGEEKKQVFFPLPKALIGDTAMRVMSLRDGTKKMSKSDPSDFSRINLTDDADLIAKKIRKAKTDSAPLPDTLAALEERPEIDNLLGIYAAFAQISKEKALSEFSGQQFSLFKTTLADLAVEKLAPITQELRRLHQESSYIDSVLHDGAQRASALAEKNMKKVREIVGFLHNI		356		5	Purified	-1	 	
Batch03	BaheA.00252.a	Bartonella henselae	YP_033996.1	Q6G2G5				GTPase EngB	Potential drug target		MTEYSSLSGIFFHNWVFIRGVPTIRFLPPEGPPEIAFAGRSNVGKSSLINALVRQKSLARTSNMPGRTQELNYFVPDGFSGRPEDLPPIALVDMPGYGFAKAPKNLVDAWTDLIYSYLRGRTTLKRVYVLIDSRHGIKKNDAEILELLDKAAVSYQIVLTKSDKIKSSVLEQRIITTKTKLLKRPAAYPEILATSSEKAFGLEELRAAILQTIAV		215		3	Expressed	-1	 	
Batch03	BaheA.00261.a	Bartonella henselae	YP_032923.1	Q6G561				Phosphocarrier protein	Potential drug target		MHARASAKFVQIVDNFNAIVEVEKDGQTVGGSSIMGLMMLAASSGCNLTIRVWGPEASDALDALEKLINNKFGEEN		76		4	Soluble	-1	 	
Batch03	BaheA.00263.a	Bartonella henselae	YP_033751.1	Q6G5R9				phosphoribosylaminoimidazole synthetase	Potential drug target		MNNQDLINDKSKNGLTYAKAGVNIDMGNAMVEKIKPFIRATKRAGTDAEIGGFGGLFDLKAAGFTDPILVAANDGVGTKLKIAIEVGIHDTIGIDLVAMCVNDLLVQGAEPLFFLDYFATGKLDPEQGAAIVSGIAKGCQQAGAALIGGETAEMPDMYAKGDYDLAGFAVGAAERSALLPSKDLTEGDIILGLSSSGIHSNGFSLVRRIIQQSDLKWNDHAPFNPQMNLGTALLTPTRIYVKSLLPIIKSYKGIKALAHITGGGFLENIPRVLPSSLCAEINLSAIHVPSIFSWIAKQGKIEKIEMLRTFNCGVGMIIIVAQHEVEKVTQELKMQGETVTLLGKLTKRQNKGITFKGALHL		361		5	Purified	-1	 	
Batch03	BaheA.00264.a	Bartonella henselae	YP_033055.1	Q6G5F4				Mutator mutT protein	Potential drug target		MPIKSSLLIVVACALLDQDNRVLLTQRPEGKSLAGLWEFPGGKVEQGETPEASLIRELEEELGVHVQADNLFPLTFASHGYETFHLLMPLYFCSHYKGVAQGREGQNLKWIFINDLDKYPMPEADKPLVQVLKNFFI		137		17	In PDB	-1	 	
Batch03	BaheA.00265.a	Bartonella henselae	YP_033436.1	Q6G3X8				50S ribosomal protein L1	Potential drug target		MGKVAKRIKNIRKDINFNELYALKDAVSMVKERAIAKFDETIEISMNLGVDPRHADQMVRGVVHLPNGTGRNVRVAVFARGDKAEEAKTAGADIVGAEDLFESINGGAIDFDRCIATPDMMPLVGRLGKILGPRNLMPNPKVGTVTLDVANAVKASKGGAVEFRVEKAGIVHAGIGKASFGVEKIVENIKAFASAVIKAKPQGAKGEYIKRVAVSSTMGVGIKVDPATVRSE		232		-2	Work stopped	-2	Work stopped	
Batch03	BaheA.00266.a	Bartonella henselae	YP_033631.1	Q6G3E8				"High-affinity branched-chain amino acid transport, ATP-binding protein"	Potential drug target		MDILKIKNLHVHYGAIKAIQNLSMSIKKGSIVTLIGANGAGKSSIVRSITGLNRSVYGEINYKGESIIKKSPEKILRLGIALSPEGRRIMPHLTVLENLHLGAYIRHDKSGISRDIEWIFDLFPRLRERAKQLGGTMSGGEQQMLAVGRALMSNPDMVILDEPSLGLAPLLIREIFSIIRKINDMGKTVLLIEQNAFAALSIADYAYILEVGHVLFHGEGKAMLSDPRVKEAYLGG		236		3	Expressed	-1	 	
Batch03	BaheA.00283.a	Bartonella henselae	YP_033854.1	Q6G2U6				ATP-dependent RNA helicase	Potential drug target		MNVNRENIFTKLGLSALLVKNLTIAGMSKPKPIQEQAIPMMLKGHDILGIAQTGSGKTLAFSLPILSQILALGDKRFPKTARALILAPTRELAVQIDETIRAVAKGTHLSTCLIFGGVSRLKQIKRMEAGVDILIATPGRLRDLIREKYVDLSQSRFLILDEADRMLDMGFIHDIRHIVKLLHQVRQTALFSATMPKEITTLAKCLLNDPVKIEVSPQGTTAAEIAQKLYCVPTCEKKNVLGKLLTNPDFVSVIVFTRTKYCADAVTRNLASRGYSVATIHGNKSQSARQSALKAFRERSVRILVATDIAARGIDIPGISHVINYDLPDEAESYVHRIGRTGRNGASGEALTLFDEGVEQMRLRAVERLICMRLVRETIPEQFAAFPEKPLVIEGIEKENIKGPHFRKSKRQKWFKSHKDNAAQSEGRKSSSQSERHRKAKAIAKRAKSFHSRKSVNKVA		460		2	Cloned	-1	 	
Batch03	BaheA.00293.a	Bartonella henselae	YP_033321.1	Q6G483				"DNA polymerase, bacteriophage type"	Potential drug target		MLNHTPCSITYEELLSFYKESGVDTALTDLPIDRFSQSASLEKKSTQVVKISHNQQTSPSIKLDNHPLSNSTIIQGELSAIESAKNANTLDELKSALLAFNGCSLKLTAKNTCFSDGTAGSPLMLIGEAPGREEDIQGIPFVGKAGMLLNKILASIGLTRNSVYIANTIPWRPPGNRTPTPREVALCRPFIERQIYLANPRILIALGGVATQFLTGAQNGIIRTRGKWLTYKSENNIKIPVMPTFHPAYLLRTPSQKKLTWLDFLEVKNRLDSLL		275		3	Expressed	-1	 	NR-16420
Batch03	BaheA.00296.a	Bartonella henselae	YP_033591.1	Q6G3I8				Response regulator	Potential drug target		MSKKVMIVEDNELNMKLFRDLVEASGYETVETRNGLMALDLARSSMPSLILVDIQLPEVSGIDVIKQLKKDEELRAIPVVAVTAFAMKGDEERIRASGCEEYMSKPISVPHFITMVKNFLE		121		5	Purified	-1	 	
Batch03	BaheA.00311.a	Bartonella henselae	YP_033830.1	Q6G2X0				50S ribosomal protein L22	Potential drug target		MGKAKFPRQLKDNEAKAVARTIRVSPQKLNLVAAMIRGKKVGAALADLTFSRKRIAGTVKKTLESAVANAENNHDLDIDSLVVAEAYVGKSIVMKRFHVRGRGRASRIERPFSHLTIIVREVIEKVEVA		129		-2	Work stopped	-2	Work stopped	NR-16421
Batch03	BaheA.00313.a	Bartonella henselae	YP_033476.1	Q6G3V0				ATP-dependent RNA helicase	Potential drug target		MTPPLNNFDDLGLSAKVIKAVKSVGYTVPTPIQSGTIPHVLQRRDVLGIAQTGTGKTASFVLPMLTLLEKGRARARMPRTLILEPTRELAAQVEENFDKYGINHRLNVALLIGGVSFEQQDRKLERGVDVLIATPGRLLDHFERGKLLLMGVEILVIDEADRMLDMGFIPEIERICKLTPFTRQTLFFSATMAPEITKLTKQFLHSPVTVEVTKASSTASTITQRLVKSGNKAWDKRAVLRELIHNEGDKLKNAIIFCNRKRDISELLRSLIRHNFSVGALHGDMDQYSRMSTLADFKDNKITLLVASDVAARGLDIPAVSHVFNYDVPTHAEDYIHRIGRTGRANRSGKAFTIVTKTDQKYINAIEEISNEKIEWLTGDLSTLTTTDQKDDIILKRKSPTSSKKTAQKERSVHTQKSLKDDKVGYMKATNNKVNLLQKCHSRKNKNHTPSGFGDDIPAFMLIKIRT		467		5	Purified	-1	 	
Batch03	BaheA.00318.a	Bartonella henselae	YP_033654.1	Q6G3D3				hypothetical protein	Potential drug target		MLIDTHCHLDFEDFSQDLDDVIQRALDANVKRMITISTHVRKLDKLLTITQAYPQVFCSVGTHPNHAHEEQNITAKELIDLSKHPKIVAFGEVGLDYHYDYSSPEEQKKVFQEHIIASQETQLPLVIHSRNADGDMEKILRKQIKENTFPFVMHCYSSGMQLARAGIELGGYISFSGILTFKNAFEIREIAKIVPHKYLLIETDAPFLAPVPHRGKTNEPSFVRYTAAVLAETIGLTIEEITQITTQNAFRLFSKMK		257		2	Cloned	-1	 	
Batch03	BaheA.00323.a	Bartonella henselae	YP_033285.1	Q6G4B9				Processing protease protein	Potential drug target		MGVDISRLRNGLTIATHTMQQIDSVALGIWVKVGSRNETFTQHGIAHLLEHMAFKGTENRTAFQIASDIEDVGGEINATTSTETTAYFARVLKNDIPLAIDILADILMHSKFDEDELEREKQVVFQEIGAARDVPDDVVFDYFTETAFRHQSLGRSILGTPKTVQSFTSADLHSFMNKHYSADRMIVVAAGAVQHENFLQEVESRLSTFRPHSTEPLTNLANYVGGDFREYRDLMDTQVVLGFEGRPYHARDFYAAQILSIILGGGMSSRLFQEVREKRGLCYSIYAFHWGFSDIGLFGLHAATGQEKLKELLPVILDELSKVSKNIHTNELQRARAQYRATLTMAQENPSSQANFIARQILLYGREIPLSETIERLELITPARLTDLAGRLFINATPTLAAVGPVGSLMNFDNLTSTLSSNIKQV		426		2	Cloned	-1	 	
Batch03	BaheA.00334.a	Bartonella henselae	YP_033241.1	Q6G5J5				Glutaredoxin	Potential drug target		MKEIILYTRPNCPYCKRARDLLDKKGVKYTDIDASTSLRQEMVQRANGRNTFPQIFIGDYHVGGCDDLYALENKGKLDSLLQDVH		85		17	In PDB	-1	 	
Batch03	BaheA.00339.a	Bartonella henselae	YP_034019.1	Q6G2F2				Alanine racemase	Potential drug target		MNKSAKDTANPLFPATAIATIDVRAIVANYRTLAQHVAPTECSAVVKANAYGLGAHKIAPALYQAGCRTFFVAQIEEALQLKAVLPENVMIALLNGFPHKAEEFVAQSGIIPLLNSWSTIEDWQTLCQKKNKKFPAIIQVDTNMSRLGLDKKELQKLIKNPTIFEKAEIKYILSHLANGEDASHSSNNKQLAAFKRVLAQLPTCKVSFANSGGIFLGSDFYFDLVRPGIALYGVDPHGKHPTPLKAVVKVEAQVLQSRFIDAGIPVGYRESFMTRRPSTLATISIGYADGWPRILSNKGTVYFNGHKLPIVGHISMDSIIVDATDLDKKPQRGDWVELIGPHQPLEKVSTDTNTIPHEILTSLGKRYKRIYI		372		17	In PDB	-1	 	
Batch03	BaheA.00342.a	Bartonella henselae	YP_033454.1	Q6G5C6				ribosome recycling factor	Potential drug target		MSVTSIMDDLKRRMHGAISAFKHELGGLRTGRASASLLEPLTVEAYGSVVHINQVANISVPEPRMLSVSVWDKTMVGAVERAIRDSGLGLNPITDGMNLRIPLPELNEERRKELVKIAHQYAEQARVATRHVRRDGMDNLKKLEKEGEIGQDEAHGLSEKVQKLTDETIADIDKILAVKESEIMHV		186		5	Purified	-1	 	NR-16316
Batch03	BaheA.00347.a	Bartonella henselae	YP_033023.1	Q6G4Y0				inorganic pyrophosphatase	Potential drug target		MNIKEIAVGKNPPEDVNVIVEVSLGGQPIKYEMDKKSGALFVDRFLYTSMVYPGNYGFVPHTLSEDGDPIDVLICNTRPLLPGCVINVYPIGALIMEDDGGKDEKIIAIPTPKLTQRYNNIHDYTDLPEITLKQIEHFFEHYKDLEPGKWAKIEGWRDKSFAHELIKQAIERNKEL		176		10	Diffraction	-1	 	
Batch03	BaheA.00355.a	Bartonella henselae	YP_032985.1	Q6G518				NAD(P)H-dependent glycerol-3-phosphate dehydrogenase	Potential drug target		MHAVSMTIIGAGSYGTALAIVLARNGHHVLLWGYNPQHIRELQEYRCNQAFLPDVQFPDNLCPEDSLETAIKASRNILIAVPSHVFHQVLYNIRPYLDQHSRIIWATKGLEHGTGRLLQEVAREILGDKIPLAVFSGPTFAKELAIGLPTAITIAASDTEFSEELQQLFHFDKSFRVYKNSDMIGVQLGGAVKNVIAIGAGISDGMGFGANARIALITRGLAEISRLGIAMGAELSTFMGMTGLGDLVLTCTDNQSRNRRFGMLLGQGVDIEEAKKQIDQIVEGYLNTKEVHMLAQRIRVEMPITEQIYHVLYCGKSVSEAANALLSRQLKDEMYDTVRF		340		4	Soluble	-1	 	
Batch03	BaheA.00367.a	Bartonella henselae	YP_034217.1	Q6G1Y0				RNA polymerase factor sigma-32	Potential drug target		MGNLSNAVYKNSKNYSDADKSLGRNMMRSAMQAPYLERQKEHDLALRWKDKRDDEAMHQIAAAHMRLVIAIANRFKRFKMPLGDLVQEGYVGLLEAAARFEPDREVRFSTYATWWIRASIQDYILRNWSIVRGGTSSSQKALFFNLRRLRAKLVQDDSALSKQDIFRSIAEKLGVSVRDVETMDFRFSSSDNSLSVSVSENSDNPVAKMDALVDDSPLPDALIEQVIDGQRRTQWLYDALQILNERELEIIRFRRLNEEGATLEVLGEKLGISKERVRQIEARALQKLRSALLTVNPADAYDV		303		3	Expressed	-1	 	
Batch03	BaheA.00368.a	Bartonella henselae	YP_033406.1	Q8L202				Enolase	Potential drug target		MTIIVDIIGREVLDSRGNPTVEVEVHLENGALGRALVPSGASTGAHEAVELRDGGTRYQGKGVKKAIAAINGEILEELGGRDARNQIGIDQAMIALDGTPNKARLGANALLGVSLAVAKAAAESLSLPLYRYIGGTQAHILPTPMMNIINGGVHADNPIDFQEFMIIPVGASTLKEAIRYGAEIFHTLKKRLKDAGYNTNVGDEGGFAPQFKSAEQAIDFIMESIIACGYKPGEQIALGLDCAATEFYKNGSYFYEGEGKYRDVGEQVDYLAQLIKTYPIITIEDGMAEDDWEGWKLLTDSIGKKCQLVGDDLFVTNSARLRDGIKMGAANSILIKVNQIGTLSETLDAVETAHKAGYRAIISHRSGETEDSFIADLAVATNCGQIKTGSLARSDRLAKYNQLIRIEEMLGLQACYAGNWYC		422		1	Selected	-1	 	
Batch03	BaheA.00398.a	Bartonella henselae	YP_033421.1	Q6G3Z3				ATP-dependent Clp protease proteolytic subunit	Potential drug target		MSDPIKTALSLVPMVIEQTNRGERAYDIFSRLLKERIIFINGPVEDGMAMLVCAQLLFLEAENPKKEISLYINSPGGVVTSGMAIYDTMQFIRPPVSTLCMGQAASMGSLLLTAGAKGHRFTLPNARIMVHQPSGGFQGQASDIERHAQDIIKMKQRLNEIYVQHTGQNYDVIERTLDRDHFMTAEEAKQFGLVDDVIQYRAETEKEEKD		210		3	Expressed	-1	 	
Batch03	BaheA.00428.a	Bartonella henselae	YP_033460.1	Q8VQ21				UDP-N-acetylglucosamine acyltransferase	Potential drug target		MSGTKIHPTALVEKGAQLGENVFVGPFCHISSEAVIGDGCSLMSHVVIMGKTTLGADSKVFSHAILGAEPQDNKHKGGYTTLSIGKNCTIREGVTMHRGSDSSVGMTIVGDNCQFFCYAHIAHDCRVGNNVTFANNVMIAGHVTVGDYVIIGGGAAVHQFVRVGHHAFIGGVSALVGDLIPYGTAVGVQAKLAGLNIIGMKRAGLERKDIHALRHAVAMLFDHSKPFKERVSDVASFYPASQSVVDVVNFIKEKGKRFYCTPKFEGDRIKENKD		274		4	Soluble	-1	 	
Batch03	BaheA.00431.a	Bartonella henselae	YP_033445.1	Q6G3W9				Penicillin-binding protein	Potential drug target		MYIDCQKIVRCYKKIAIAFVVLALSYSWAFATPQEAYPDKYAAIVIDANTGKTLFQANATLKRYPASLTKMMTLYLLFEAMHMRRVTPNTPILVSRNAATRPPTKLGLKTGQTISAQEAAKALITRSANDVATAIAEYLGGNEKKFARMMTAKARKLGMINTHFANASGLPDVRNYSTARDMATLSLALRKHFPQQYKLFKIKSFIFHGHTVNTHNKLVKTMKGVDGIKTGYTQMSGSNLATSMRIEGRSIVAVVMGGKSSTARDKHMASLLSQYLPKASRMKNDGRLMASAHYNLPNGAQTPIPPVKADPTDSDDEISTLLTAFAEQSRNSNTAIAAVNQAIIPIPNPQKAISVKINEIVTASLSTNAGWAIQIGSLPSKKQAETLLLKAKNKAYSALKNASSHMQLFEKNKRRYYRARFVGFQSKKAAFNACSLLKKANFNCYTVAY		449		3	Expressed	-1	 	
Batch03	BaheA.00434.a	Bartonella henselae	YP_034322.1	Q6G1P5				Penicillin-binding protein	Potential drug target		MQRLLYKLFLSFVLSFTSSLALAQPFISVDVKTGRILEHNQAFERWYPASLTKLMTAYVIFRAMSRGEISSNKHITISEYAAKAPTYRSGYKAGSVLTLDTALSITMVKSTNDLAIAMSEAVAGSQKAFVKKMNAEAQRLGMFGTHFANASGLPDPNNYSTARDIALLAIQIRREFPQYAHYFSIPAIDFGNKRKIQPNSNNLIGRFDGIDGMKTGFICASGFNLVASATRNKRTIIAVILGSKNISEREKKAAKLLETGFSRQGSLQLTLETLEPYGTKMTHARDMRQQTCTPEAVKMNANSYDDQGNIILTSPFIAPPPSSVLPLPVRLISTPKKPKVKGKPLKKISIPSKKHTNHALKKAVHHTR		368		4	Soluble	-1	 	
Batch03	BaheA.00452.a	Bartonella henselae	YP_033850.1	Q6G2V0				Protein-L-isoaspartate(D-aspartate) O-methyltransferase	Potential drug target		MVADFAELRRKMVDNQIRTVDVTDLSVLEAFLMVPREDFVPENMKALSYLDTDILLYPAQEGVPACYLMGPAPLAKLLQLAAVKSSDIVLDIGANGGYCAALLSKLARSVIALEAHKALLERTASTLERNQCNNVVVVHGALEQGYAVEGPYDVIFIEGSVDFIPKIIFDQMKDGGRLVVVEGHGNAGVALIYVKEDGIISARRAFNLAVKRISGFLKTPDFIF		224		5	Purified	-1	 	
Batch03	BaheA.00476.a	Bartonella henselae	YP_033349.1	Q6G5H3				3-methyl-2-oxobutanoate hydroxymethyltransferase	Potential drug target		MTIHKAVKRITASEIRSRKGQEPIVSLTAYQAYSARIADPYCDLLLVGDSVGMVVHGFETTLPVSLDMMILHGQAVMRGSKRALVVVDMPFGSYEESPEQAFSNASRILAETGCSAVKLEGGVYIAETIDFLCKRGIPVMSHVGLTPQAVNRFGGFKTQGRNESNWQQIEADAAAIEKAGAFAVVVEGVVEPLAVKLTQMLSIPTIGIGASSQCDGQILVMEDMLGYGTWVPKFVRRYGVLEQEMEKAIKSYADDVKSRTFPSDEEIYKLKQKSG		275		5	Purified	-1	 	
Batch03	BaheA.00483.a	Bartonella henselae	YP_033012.1	Q6G4Z1				gamma-glutamyl kinase	Potential drug target		MAVGLQKLVHYKRIVIKIGSALLVDPQTGLRAEWLKSLISDVANLHQKGVEILLVSSGAIALGRTLLRLPKGALKLEESQACAALGQIELAKTYSDTLAQYGLKTGQILLTLFDTEERRRYLNARATINVLLRFGAVPVINENDTVATSEIRYGDNDRLAARVATMMGADLLILLSDIDGLYTKSPHRDPTAEFIPFIASITSDIEKMADVAHSELSRGGMKTKLDAGKIANSAGTAMIITSGKRMNPLAAIDRGERGSFFAAGEKPVNAWKTWISGHLDPSGILMIDQGAVKALESGKSLLAAGVVAIEGRFNRGDTVAIVDTNGVEIARGLVSYGKDESVRIMGRKSEEIESILGYEARSAMVHRNDMVLRCLTDSA		379		5	Purified	-1	 	
Batch03	BaheA.00490.a	Bartonella henselae	YP_034354.1	Q6G1L3				Hydroxyacylglutathione hydrolase	Potential drug target		MLIEQFICREDNFGVLIHDETSGYTAAIDAPESNAIQNALKRRNWTLQTIFLTHHHHDHVEALAELKQIYKAIVIGPEAEKEKISHIDQTLKPDESFLFGTHTILALSTPGHTLGALSYYFPQENLLFAGDTLFSLGCGRLFEGTPAQMLNSLKKLRQLPDETLLYCGHEYTKSNALFALTLDPYNQKLQQRAEDVFLLRAKNAMTLPVTLGQEKKNNPFLRWDNRTLRKTLRMEKETDEEVFAEIRKRKDNF		253		3	Expressed	-1	 	
Batch03	BaheA.00494.a	Bartonella henselae	YP_033410.1	Q6G404				pyruvate dehydrogenase subunit beta	Potential drug target		MSIDILMPALSPTMEEGKLSKWLKKEGDKVSSGDIIAEIETDKAMMEVEAVDEGTLGRICVLEGSEGVKVNTVIAVLLEEGETVEDISQSTNSLNTHQKNGGASSSFSSSVPQLPILDTLPDSDIPAGTKMVTMTVREALNQAMAEEMRRDEMVFLLGEEVAQYQGAYKVSQGLLEEFGTRRVIDTPITEHGFAGLAVGAAFGGLRPIVEFMTFNFAMQAMDQIINSAAKTRYMSGGQMTAPMVFRGPNGAAARVGAQHSQCYAAWYSHVPGLKVVMPYSAADAKGLLKAAIRDDNPIIFLENEILYGHQFDVPQIDDFVLPIGKARIHKSGQDVTVVACGIGMHYAVQALPEIEKLGVDVELIDLRTIRPMDLPTIVSSVKKTGRLITIEEGYPQSSVGTEIATRVMQQAFDYLDAPVATVAGKDVPMPYAANLEKLALPNTAEIVEAVKAVTYKA		457		3	Expressed	-1	 	
Batch03	BaheA.00498.a	Bartonella henselae	YP_033348.1	Q6G456				Pantoate-beta-alanine ligase	Potential drug target		MKMRVLKTIPEVRQSITEERRLGFSIGLVPTMGALHNGHIALVRRARAMCDRVLVSIFVNPKQFGPDEDFDKYPRDLKGDCALLEEAGVEYLFTPSVEEMWPPGNETIVNVEKLSRMLIGKLRPGHFCGVTSVVAKLFNIVQPDKAFFGEKDFQQILIVRRMVEDLAFPIEVVGVPVLREADGVASSSRNQFLTLEDRKAAKIIPESGKAAENLYRQGERSVDKLCKIVRDILQQESRAIIESIDLRDMETLSVVKGRLDKSAVLLLTVRFGEIRLIDQYILQEKG		286		4	Soluble	-1	 	
Batch03	BaheA.00502.a	Bartonella henselae	YP_034316.1	Q6G1Q1				"ABC transporter, ATP-binding protein"	Potential drug target		MIEFSHVGVTFKPQTPLEKQALIDINLKIDRGSFVTVIGSNGAGKSTLLSVLAGAILPTTGKVVINGQNVSRQSVSERAEKVACVFQDSLMGSCGSLTIEENLALAAFRGKRRGLRSALNHEKRQFFRDEIAQLGIGLEAYIHNPMDSLSGGQRQAVCLVMATLAYADVLLLDEHTSALDPGMADFVMRLTEKIVEEKKLTTIMVTHSMRQALDHGDRTLMLHDGKVILDVCQEERKGLNVNDLIGMFQKVRGEALDDDELLMD		264		3	Expressed	-1	 	
Batch03	BaheA.00506.a	Bartonella henselae	YP_033049.1	Q6G5T8				Protoporphyrinogen oxidase protein	Potential drug target		MNKHSLNNVIRQTQEKLRSQGVSEANLDAKILVEWITDTNISDRVLQPDLCLSFEQILQLEKAIQRRIAGEPVYRIIGKREFYGISFALSQETLEPRSDTETLVDLVLPPLKKYGEKSEKITLLDMGTGSGAIAIAILKQIPQSYAVAVDISENALKTATKNAKSAKVINRFTPLLSDWFDSVTGQFDLIISNPPYIPETDITKLAKEVHLHDPLRALIGGKDGLDFYRKLSDKAANYLKEKGSIAVEIGYSQEKEVCDLFEKNGFKCLEMRKDLNGIPRALLFVCNP		288		3	Expressed	-1	 	
Batch03	BaheA.00507.a	Bartonella henselae	YP_033864.1	Q6G2T6				ketol-acid reductoisomerase	Potential drug target		MRVYYDRDANVNLIKEKKVAIVGYGSQGRAHALNLRDFGVKNVKIALRSESATVKKAVADGFEVVCVAEAAKWADLIMMATPDELQADIYKEHIHDHLRDGAVIAFAHGLSIHFGLIEPKKTVDVVMIAPKGPGHTVRNEYQNGCGVPCLIAVAQDASGHAHNVALSYACGLGGGRAGVIETTFKEECETDLFGEQAVLCGGLVELIRAGYETLTEAGYAPEMAYFECLHEVKLIVDLMYEGGIANMNYSISNTAEWGEYMSGPRVITDETRAEMKRILKDIQTGKFTSNWIQEYKAGAAHFKGMRRLNDSHPIEEVGKKLRSMMPWIKANALVDKERN		339		5	Purified	-1	 	
Batch03	BaheA.00511.a	Bartonella henselae	YP_032957.1	Q6G546				cytidylate kinase	Potential drug target		MKPFVIAIDGPAASGKGTLARKIATHYHLHYLDTGLTYRGVAHALLQQKLALDDEKNALVYARELDFNTLNPALLSSHELGNAASKIAIIPTVRETLVAKQRNFAKILPGSVLDGRDIGTIVCPDADVKLYVLANVQIRAKRRYQEILKKGAQADYHEILVNLEQRDSRDITRKQSPLKQAKDAYLLDTSELSIEATFTVACALIDPIIKARIIG		215		5	Purified	-1	 	
Batch03	BaheA.00516.a	Bartonella henselae	YP_034356.1	Q6G1L1				Chromosome partitioning protein parA	Potential drug target		MSEMRIIAIANQKGGVGKTTTAINLATALAAIGENVLIMDIDPQGNASTGLGIDRNSRPLSSYDVMISGISVTKAALKTAVPNLSIVPSTLDLLGVEMEIASSQDRIQRLRKALYDDPKMAKKFSYILIDCPPSLNLLTLNAMGAADSVLVPMQCEFLALEGLSQLLETVKQVQSVLNPSLEIQGIVLTMYDGRNNLSNQVVEDVRSFMGDKVYRTVIPRNVRVSEAPSFGKPVLLYDLKCAGSQAYLRLASEVIQREKQAQAAA		265		4	Soluble	-1	 	
Batch03	BaheA.00539.a	Bartonella henselae	YP_032988.1	Q6G515				3-hydroxydecanoyl-(acyl carrier protein) dehydratase	Potential drug target		MAEQKSRYTYEELLSCARGEMFGKGNAQLPAPPMLMIHRITEINETGGEYNKGMLRAEFDITPDLWFFNCHFIGDPVMPGCLGLDGMWQLTGFFLGWLGEPGKGRAISTGEVKLSGMVTPQTQLLEYGIDFKRIRRGNLVLGIADGWVKADGESIYKASDLRVALFKED		169		2	Cloned	-1	 	
Batch03	BaheA.00545.a	Bartonella henselae	YP_033286.1	Q6G4B8				threonine synthase	Potential drug target		MQYISTRGEAPALGFIETIMTGLASDGGLYLPEKFPQLSFDALRALRGQSYMTIAKTILWPFVNNEIEYTSFENMISESYATFHHPATCPLLQTGPNEFILELFHGPTLAFKDVAMQFLSRLMDYVLIKKNKSATIIAATSGDTGGAAIQAFAGREYSDVFILFPKGRISPVQQRQMTTSQKTNVHAIAIEGSFDDCQALVKAMFNDHNFRQKKALSGVNSINWARIMAQIVYYFSSALSLGAPDRAVSFTVPTGNFGDIFAGYVAARMGLPIAQLVIATNDNDILVRTLTNGTYETQPTTHTTSPSMDIQVSSNFERLLFESGDRDPVWIRNAMENLKKSGYFNLNEKQLKNIRSLFSAGKSSIAETAKIIDSVYKESGYLVDPHTAVALKVARENRQPHIPMIVLSTAHPAKFPDAIKNACGLNAPWPSRLNDLIEREEHFIGLANDEKIVKDYISLKSRASY		465		7	Crystallized	-1	 	
Batch03	BaheA.00553.a	Bartonella henselae	YP_033083.1	Q6G4V2				recombination protein RecR	Potential drug target		MSKHIAGPEIERLIQLLARIPGLGPRSARRAALHLIKKKETLLEPLGAAIQAAVQKVCICSVCGNVDTIDPCSICTDPRRDDATIIVVEDIADLWALERAKTLAARYHVLGGKLSPLDGIGPDELNIAPLIQRVVQNPITEIILAVNATVEGQTTAHYITDQLSNFSVKVTRLAHGVPVGGELDYLDDGTLAAALQARTNL		201		2	Cloned	-1	 	
Batch03	BaheA.00557.a	Bartonella henselae	YP_033947.1	Q6G2L4				ribose-phosphate pyrophosphokinase	Potential drug target		MKLFCGNSNPRLAKEVTNYLSIPLGKATVKRFADQEIFVELHENVRGQDVFVLQSTSYPANDHLMELLIMIDALRRSSARRITAVIPYFGYARQDRKPGPRTPISAKLVANLITEAGAHRVLTLDLHAGQIQGFFDIPTDNLYAVPVIARDVKMHYSLENVIVVSPDVGGVVRARSLAKRLNSLLAIVDKRRERPGESEVMNIIGDVSGKNCLLLDDIVDSGGTLCNAASTLLKHGANSVTAYITHGVLSGNAIERITNSEMKELVITNSIMPTEEIEKAHNIRVLPITDLIGEAIARTAAEQSVSSLFG		310		4	Soluble	-1	 	
Batch03	BaheA.00573.a	Bartonella henselae	YP_033419.1	Q6G3Z5				Nitrogen regulation protein	Potential drug target		MVSDILIVDDEADIRELIAGILDDEGYETRVACNSDEALAQISERIPKLIFLDIWLQGSRLDGLALLDEIKTRYPNLPVVMISGHGTIETAVSAIKRGAYDFIEKPFKADRLVLVAERTLENSNLKRELLELRKRSNETLELLGTSTAIKHLRQIIEKVAPTNSRIMITGPSGAGKEMVARAIHALSTRSNGPFVTINAATITPERMEIELFGSEMEGRERKIGALEEAHGGILYLDEIADMPRETQGKILRVLTGQAFERVGGTKRVKVDVRIISSTAQNLENLISDGRFREDLFHRLSVVPIAVPPLSARREDIPELVRHFVKTISQQVGIKPREISDDVMAILQTHAWPGNVRQLRNNIERLLILVRDGDDPITTEFLPSEVSDSLPRLQMDTDESIMDLPLREARELFEKKYLEAQIGRLGGNISRTAEFIGMERSALHRKLKALGVS		452		7	Crystallized	-1	 	
Batch03	BaheA.00606.a	Bartonella henselae	YP_032935.1	Q6G549				"2,3,4,5-tetrahydropyridine-2-carboxylate N-succinyltransferase"	Potential drug target		MTDLTQLEMIIEKAFDDRNSINTTTKGEILESVEHALNLLDKGEVRVVKRQKNGKWHVHQWLKKAVLLSFRLNPMQIMTGGVNGTSWWDKVPSKFSHWQEADFKKADFRSVPGAIVRHSAYIAPNVILMPSFVNLGAFVDEGTMVDTWATVGSCAQIGKHVHLSGGVGIGGVLEPLQANPTIIEDHCFIGARSEVVEGCIIREGSVLGMGVFIGKSTKIIDRTTGEIFIGEVPPYSVVVPGSLPGKPLPNGEIGPNLYCAVIVKRVDQKTREKTSINDLLRD		282		10	Diffraction	-1	 	
Batch03	BaheA.00608.a	Bartonella henselae	YP_033939.1	Q6G2M2				Transcriptional regulator ompr	Potential drug target		MTDHVQVLCDDAPHLLVIDDDTRIRNLLFQFLIKNGFRVSVSANADEARRQLSNLDFDLLIVDVMMPGENGIDLTHSLRQTKDVPILMLTALSEIDNRINGLEAGADDYLAKPFDPRELLLRIHAILRRGFALNQSKIEQIVFGPYIFSISRRELKKGGEVIKLTDKEQKMMVIFAENPGDIIPRHKFATEDSNIGERAIDVQINRLRRKIEKNPSLPIWLQTVRGIGYKLSIE		234		5	Purified	-1	 	
Batch03	BaheA.00617.a	Bartonella henselae	YP_034206.1	Q8L201				glyceraldehyde-3-phosphate dehydrogenase	Potential drug target		MSVRVAINGFGRIGRNILRAIIESGRQDIEVVALNDLGSVETNAHLLRYDSVHGCFPGTVQVVGDAIDIGSSLIKVFAERDPAQLPWKALDIDIALECTGIFTARDKASAHLDAGAKRVLVSAPSEGADLTVVYGVNHQFLSKEHHVISNASCTTNCLAPVAQVLHNTVGIEKGFMTTIHSYTGDQPVLDTMHRDLYRARAAALSMIPTSTGAAKAVGLVLPELKGLLDGVSIRVPTPNVSVVDLTFTAKRSTTIEEINTAIRTAAQGSLKGILDYTDEKLVSCDFNHNPHSAIFHNDQTKVIDGQLCRVLVWYDNEWGFSNRMCDTAVAFAKTI		335		17	In PDB	-1	 	
Batch03	BaheA.00632.a	Bartonella henselae	YP_034346.1	Q6G1M1				succinyl-CoA synthetase subunit beta	Potential drug target		MNIHEYQAKRLLHEYGAPIANGVAVYSVEQAEKWAKKLPGPLYVVKSQIHAGGRGKGKFKELDPDAKGGVRLAKSVEEVVANVKEMLGKTLVTKQTGPEGKQVNRLYIEDGADIERELYLSLLVDRNVGRVAFVVSTEGGMDIETVAEETPEKILTLPINSTQGVTSSDCARLCDALDLHDSAREDGEKLFPILYKAFCEKDMSLLEINPLIVMTNGHLRVLDAKVSFDNNALFRHPDILELRDTSEEDPKEIEASKHDLAYVALEGTIGCMVNGAGLAMATMDIIKLYGAEPANFLDVGGGASKEKVTAAFKIITADPNVKGILVNIFGGIMRCDVIAEGVVAAVREVGLKVPLVVRLEGTNVEQGKAIISDSGLNVIPADDLDDAAQKIVAAVKGA		398		5	Purified	-1	 	
Batch03	BaheA.00633.a	Bartonella henselae	YP_033581.1	Q6G3J8				GTP cyclohydrolase I	Potential drug target		MHNIKVGTKNPFLSGRKRPPFEEVEAAIRTFLLWIGENPNREGLLDTPGRVAKAYRDLFTGYDESVEEILGTVFEEVSGYNEPVIMKDLSFYSHCEHHMIPIVGKAHIAYFPDEKIVGLSKIARVVNVFSRRLQTQEAMTAQIANALETHLKPRGVAVLIEAEHMCMTMRGVQKQGAKTITTSFHGSYEKDQVAQAHFMMIVRRSS		206		4	Soluble	-1	 	
Batch03	BaheA.00647.a	Bartonella henselae	YP_034307.1	Q6G1R0				Two-component response regulator	Potential drug target		MNFYTLLIVENDNDLRPILIEQLQTHKEFKIFQAKTAETGITIAQEENVDLAIFATELPDLDGHKAVKKLRTQGFRAPIIMITNYDTNCDTLLDPETGANDYVTKPFRFAVLLARIRAQLRQYEQNDDAVLYIGPYTFKPGQKLLIDQQNNKIRLTEKEAAILKYLSCTNEQIVNRETLLEQIWGYNENVVTHTLETHIYRLRQKIEKDPSNAQILITEQNGYRLNL		227		4	Soluble	-1	 	
Batch03	BaheA.00655.a	Bartonella henselae	YP_033683.1	Q6G3A4				prolyl-tRNA synthetase	Potential drug target		MRLSQYFLPLLKENPKEAEIISHRLMLRAGMIRQQTSGIYSWLPLGKKVLDKICKIIREEQERAGAIEILMPTIQSADLWRESDRYDDYGLEMLRIKDRQKRDLLYGPTNEEMVTDIFRSYIRSYKDLPLNLYHIQWKFRDEIRPRFGVMRSREFLMKDAYSFDLDYEGSKISYNRMFVAYLRTFSCLGLKAIPMRADTGPIGGKLSHEFIILAETGESAIFCDKHFLELTVPDSSIDFSDKAILANIVKQWTSFYAATEEMHDEEEWAKISDNNRLSARGIEVGHIFHFGTKYSAPMGAKVMGQDGKEHLVSMGSYGIGPSRLVAAVIEASHDENGIIWPKSIAPFDFGIINMKPDDEKCTHACETLYKGLRYAGFDPLLDDRNERPGSKFATMDLIGLPTQIIVGPKSVAQNEVEIKDRKTGIKKSLTVENVLNQFSVI		441		3	Expressed	-1	 	
Batch03	BaheA.00657.a	Bartonella henselae	YP_034022.1	Q6G2E9				Glycine cleavage system protein t	Potential drug target		MGTSQEFETSSLKTLPLYELHEKAGAKFGAFAGWRMPLTYPLGVLKEHLHTRAHAGLFDISHMKLIAVEGPKAVEFLSYALPVDAALLKIGQSRYSYLLNERAGILDDLILTRLAECRFMLVANAGNAQADFAELEKRAFGFECQVIALERVLLALQGPQAAAVLADAGLPGNELLFMQGFEPQQDWFITRSGYTGEDGFEIALPIGCARALAEKLLGDSRVEWVGLAARDSLRLEAGLCLHGNDITPDTTPIDAALTWAVPKNVREKAQFYGAKAFLESLQKGPSRCRVGLKPQTRQPIRAGAVLFDNEGNRIGVVTSGGFGPSFDGPVAMGYVPVAWKVEGTEVFTELRGKKIALSVHSLPFVEQRYFKG		372		17	In PDB	-1	 	
Batch03	BaheA.00672.a	Bartonella henselae	YP_033641.1	Q6G3D8				methionine aminopeptidase	Potential drug target		MTDYIEYYKIPLKFNGQIRIFDDYAFDKMRKVGRIAAECLDALTDIIKPGITTQEIDDFVFTFGAERGALPADLNYHGYGHSCCTSINHVVCHGIPNKRPLQEGDIVNVDVTFILDGWHGDSSRMYPVGKIRRAAERLLKITYESLMRGIAAVKPGATTGDIGAAIQRYAESERCSIVRDFCGHGIGQLFHDAPNILHYGNPGEGIELKQGMMFTIEPMINLGKPQVKILSDGWTAVTRDRSLTAQYEHTIGVTNEGCEIFTQSPKNIFYISNSYV		276		7	Crystallized	-1	 	
Batch03	BaheA.00674.a	Bartonella henselae	YP_033929.1	Q6G5L6				aspartate aminotransferase	Potential drug target		MAFIADKLSHIKPSATIAVSQKARNLKVLGRDVITLGAGEPDFDTPENIKNAAIEAIRRGETKYTPISGIPELRQAISAKFKRENNLTYQPEQIIVGTGGKQILFNALMATLNKGDEVIIPSPYWVSYPEMVTLNGGIPVFLETKAEFSYKLQPQELEAAITHKTKWFIFNSPSNPSGAAYTHEELKKLTDVLIKYPHVYILTDDIYEHLTYEGFTFVTPAQVEPNLYDRTLTMNGVSKAYAMTGWRIGYAGGPQELIKAMDTIQGQQTSGTSSISQWAAVEALNGPQDFIAKNKTVFQTRRDLVVSMLNQAPGIECPTPEGAFYVYPSCAKLIGKKTPEGKVIAHDEDFVTALLEAESIAVVHGSAFGLGPAFRISYATSEKFLEEACSRIKHFCESLL		400		3	Expressed	-1	 	NR-16422
Batch03	BaheA.00676.a	Bartonella henselae	YP_033574.1	Q6G3K5				fatty acid/phospholipid synthesis protein	Potential drug target		MIRISIDVMGGDYGPEATIAGAARVTEYLPNIYFLFYGLEETVKPVLKKYPCLASISCFCPTESYTRMDEKPSQALRNGRGKSSMWHAIEAVKNGEADVCISAGNTGALMAMSYFCLKMMAEAERPGIAGIWPTLRSESIVLDIGATIGASANQLVDFAVMGAGMFRALYHTEKPSVGLLNVGVEEVKGLYAIKKAGMILREVQLEGLEYKGFVEGNDIGKGTVDVVVTEGFSGNIALKTAEGTARQIGEILNSAMRSSFFSSLGYFLSRGAFRTLKHKMDPDRVNGGVLLGLNGIVIKSHGSANADGFASAIRIGYTMVHNGLLKKITADLRRFHQNKQTLFYKEDKATENEKII		356		4	Soluble	-1	 	NR-16423
Batch03	BaheA.00679.a	Bartonella henselae	YP_033314.1	Q6G490				Two-component response regulator	Potential drug target		MKILVIEDDHETGRYLEKAFEEAGHSVDVAYDGETGYALAETENYDVMVVDRMLLHRDGLSIIAELRAKGNETPALILSALGQVNDRVMGLRAGGDDYLTKPYAFSELLARVEVLQRRKNPKEAETVYCVGNLELDRLAHTVKRGDRNIILQPREFRLLEYLMRYAGQVVTRTMLLENVWDYHFDPQTNVIDVHISRLRAKIEKDFDVPLLYTIRGAGYMLKAPDNKI		228		7	Crystallized	-1	 	
Batch03	BaheA.00683.a	Bartonella henselae	YP_032980.1	Q6G523				3-dehydroquinate dehydratase	Potential drug target		MSMIITILNGPNLNFLGKREPEIYGTETLKDIEQFCKECATRLGVRIHFYQSNYEGQLVEWIQEAIGVSAGLIINPAAYSHTSVAILDALKMFTGTKVEVHLSHIYHREAFRHHSYTSAAVDAVIAGCGGDGYWLALEYIVKRFNRNK		148		3	Expressed	-1	 	
Batch03	BaheA.00711.a	Bartonella henselae	YP_034347.1	Q6G1M0				malate dehydrogenase	Potential drug target		MARKKIALIGSGMIGGTLAHIIGLKELGDVVLFDIAEGIPQGKALDIAESSPVDGFDVSLTGANSYDVIEGADVVIVTAGVARKPGMSRDDLLGINLKVMEQVGAGIKKYASSAFVICITNPLDAMVWALQKFSGLPTQKVVGMAGILDSARFRHFLSEEFKISVKDVTAFVLGGHGDSMVPLVRYSTVGGISLPDLVKMGWTTQEKIDQIIQRTRDGGAEIVSLLKTGSAFYAPAASAVSMAEAYLKDTKRVVPVAAYLSGQYGVKDTYVGVPVVIGAGGVERVIEIDLDKEEKAAFEKSVSAVQKLCEACIAVAPGLK		320		10	Diffraction	-1	 	
Batch03	BaheA.00713.a	Bartonella henselae	YP_033374.1	Q6G439				Guanylate kinase	Potential drug target		MVTFFENELSAKKRNQRRGFLFILSSPSGAGKSTLSRLLLKDGKLELSISMTTRQKRPSEVDGLHYHFISKKEFKRKRDGNEFIEWAEVHGNYYGTLRESVENVLSTGRDMLFDIDYQGTKQLQKKMPGDTVSVFILPPSMKELISRLYRRAEDSQDIINLRLKNARTEMQHWRSYDYVIINENLNQSVSLIKSIYLAETVKRERCFFLEPFINGLIAEKID		222		10	Diffraction	-1	 	
Batch03	BaheA.00720.a	Bartonella henselae	YP_034060.1	Q9RNC7				virB11 protein homolog	Potential drug target		MNQNLHTLSDETVAIVLTKLEPISTFLKDENLFEIVINRPYQVMTEGVEGWKTIETPALSFNELMGIAKVVASYSKQNISEKNPILSATLPGNERIQIVIPPAVEKNTISMTIRKPSSRSFSLEDLANKGLFSVCEQVSFTPLNNYLSHLSELKHIDHDLVRAYAKKDFVFFLNQAVQCQKNILIAGKTGSGKTTLSKALIAKIPDDERIITIEDTPELVVPQPNYVSMIYSKDGQGLASVGPKELLESALRMRPDRILLQELRDGTAFYYIRNVNSGHPGSITTVHASTALAAFEQMTLLVKESEGGGDLERDDIRGLLISMIDIIIQCKRIEGKFKVTEIYYDPFKQRNIFGGN		356		3	Expressed	-1	 	NR-16424
Batch03	BaheA.00729.a	Bartonella henselae	YP_033073.1	Q6G4W2				S-adenosylmethionine synthetase	Potential drug target		MSHQDYLFTSESVSEGHPDKICDRISDEIVDMIYKEAQKTGTDPWLVRIACETLVSINRVVIAGEVRVPDTLLKRDKNREFIYDETGLPRINPARFRAVARRAIRAIGYEQVGFHWKTVKIDVLLRPQSVDIARGVDNARDRHDEEGAGDQGIMFGYACRETPDLMPAPIYYAHKILKLLAEARHKGEGETGKLGPDAKSQITIRYKNGKPIEVTSIVLSTQHLDESWDSHKVRTVVEPYIHQALHDIPISDQCSWYINPTGKFVIGGPQCDAGLTGRKIIVDTYGGAAPHGGGAFSGKDTTKVDRSAAYAARYLAKNIVAADLAERCTIQLSYAIGVAQPLSIYINFHGTGKVDESIIEAVIRKIMDLSPTGIRKHLDLNKPIYTKTAAYGHFGRKPKRDGSFSWEKTDLIKTLQKMIKVP		422		5	Purified	-1	 	
Batch03	BaheA.00734.a	Bartonella henselae	YP_034186.1	Q6G5R2				hypothetical protein	Potential drug target		MLEKKTFKSSHTNAFHDFQARVYVADTDFSGVVYHARYLEFFERGRSEFLRDTGFNNTLLASGVEGEKLFFVVRHMEINFSRPAQIDNLLTIKTRISRLQGARFFMEQYILHGESMLVTAKVEIALINEEGKPRRLPKELFSTIVV		146		17	In PDB	-1	 	
Batch03	BaheA.00757.a	Bartonella henselae	YP_033359.1	Q6G454				Oxidoreductase	Potential drug target		MKKLDFSLFGRVALVTGASRGIGYHLALELAERGAHIIALARTMSGLTELDNQIQKKGARATLIPIDLHHMENIDALATSITQDWKKLDIMIANAGILGTLSPIAHIENKVFEDIFQINLISQWRLMKAVEPLLRKSDAGRVILLSSSVAHVARAFWGPYAASKAALEIISRCWAEELKQTPIKINCVDPGATRTAMRAQAMPGEDPQTLPPPQEVAEKIAHLLSPDLKETGKLFNVRKNRFMNYHAPN		249		7	Crystallized	-1	 	
Batch03	BaheA.00759.a	Bartonella henselae	YP_034201.1	Q6G1Z6				Extragenic suppressor protein suhB	Potential drug target		MPQSAVMNVMVQAAMKAGRSLVRDYGEVQNLQVSLKGPADYVSQADRKAEKIIFNELSKARPKFGFLMEESEEIIGEDSQHRFIVDPLDGTTNFLHGIPFFAVSIALESQGKIVAGVIYNPINDELFTAERGSGAFFNDRRCRVSARRRLEDCVIATGMPHLGRPGHGTYLIELRNVMAEVSGIRRFGTAALDLAYVAAGRTDGFWEDNLQIWDMAAGILMVREAGGFVTDKEGGNDIFRKKNIIAGNEHIRIKLERALKKGI		263		17	In PDB	-1	 	
Batch03	BaheA.00763.a	Bartonella henselae	YP_033569.1	Q9REF5				riboflavin synthase subunit alpha	Potential drug target		MFTGIVTDIGCVEDIQSLKQGMRFNISTRYSIENLEIGASIACSGVCLTIVERGSKQQAKINWFAVEAWEEALRLTNLTQWTKGTFINLERSLRLGDEMGGHLVSGHIDGLAEIIDQKSEGDAVRFFLQVPKRFIPFIVNKGSIALNGTSLTVNCVEEHIFDVLIIRHTLEMTTWRQAKIGDLVNLEIDQLARYVAKLSGFRIKDE		206		7	Crystallized	-1	 	
Batch03	BaheA.00770.a	Bartonella henselae	YP_034236.1	Q6G1W1				hypothetical protein	Potential drug target		MSTDTTPHDLCVEAWKNLQKDITKTCKDYHRLAEEIQFIAVSKTVSVENIRPLLQAGQSVFAENRVQEATEKWSVLRQQFKNIELHLIGPLQSNKTAQAVKIFDVIQTVDREKIAKNLSIEMQKQKKTLPCYIQVNLGLEPQKSGIAPQEVVPFVARCKNHYGLDIIGLMAIPPVEENPGPYFALLAKLAKQADLQKLSMGMSNDFKTALQFGSNVLRIGSALFGKRPV		229		2	Cloned	-1	 	
Batch03	BaheA.00771.a	Bartonella henselae	YP_034310.1	Q6G1Q7				Diaminopimelate decarboxylase	Potential drug target		MRFFSYNQGVLHAEGLSLSALAQDVGTPFYCYSASAVVTNFKDYQNAFLDMPSLIAYAVKANSNQAVLRLLAANGAGADVVSEGELRRALAAGIPAHRIVYSGVGKTVKEIDFALAHDIYCFNVESEPELEQLSVCAVALSKTARVSLRINPDVDARTHRKITTGKSENKFGIPLSLAWDVYKKAAQLPGIQVCGVDMHIGSQICDLKPFEDAFLIVADFVRQLRSHGYALTHIDIGGGLGIDYGNEHHSVPSLSDYAALVRKHIAPLGIHIILEPGRSIVGDAGVLVTSVLYLKRGNGRNFVIVDAAMNDLMRPTLYDAWQNVLLVEQASKDALLMKADIVGAVCETGDYLALDRRVPTLATGDLLAIMEAGAYGAVMASTYNSRLLVPEVLVQDTRYAVIRPRLDYAQLIGCDYVPDWI		421		3	Expressed	-1	 	NR-16425
Batch03	BaheA.00772.a	Bartonella henselae	YP_034238.1	Q6G1V9				Cell division protein ftsE	Potential drug target		MIHFENVGLRYGMGPEILRDISFHIPPGSFQFLTGASGAGKTSLMRLMFLALKPTRGHIDLFGNDTALLKRQELPALRQRIGVVFQDFRLLDHMTTYENVSLPLRIKGQEEATYRSEVEDLLCWVGLGNHIHVLPPVLSGGEKQRIAIARALIDQPEILLADEPTGNVDPPLAKRLLRLFIELNRFGTAVVIATHDIALMEQVAARRMLLHNGRMTIHE		219		3	Expressed	-1	 	
Batch03	BaheA.00779.a	Bartonella henselae	YP_034298.1	Q6G5B2				Carbonic anhydrase protein	Potential drug target		MTRLPERLLSGYRSFIKNHFFYKTAHYQQLAIEGQKPEILVIACCDSRAIPETIFDAKPGEIFTLRNVANLVPPFSPDNQYHATSAAIEYAVQLLEVKHIVVFGHAHCGGVNTALEGTCKSLSSNDFIGQWISLLIPAAQTIIENKSLTPSEQQTALEKLSIRHSLKNLETFPWIKARKDQGILTLHGVWFDISSGELWSMEQETGHFMRVEVGNFEE		218		5	Purified	-1	 	
Batch03	BaheA.00784.a	Bartonella henselae	YP_033931.1	Q6G2N0				Thioredoxin reductase	Potential drug target		MVQSHVRLLIIGSGPAGYTAAIYAARGMLKPVLITGLQQGGQLMITTDVENYPGFADPIQGPWLMEQMAKQAENMGTKIVYDNITKADLSKRPFILYGDSGAQYCCDALIIATGAQARWLGLESEQVFMGGGVSACATCDGFFYRDKDVIVVGGGNTAVEEALYLSHLAKRVSVVHRRDYFRAEKILQDRLFARDNVCVLWDHVVEEIIGLPARASIGAVVTGVRLKNVKTGQKVHVDTDGIFIAIGHDPAVSLFEGQLKQKSGGYLWTAPDSTATSIAGVFAAGDVVDDVFRQAITAAGRGCMAALEAERFLELQI		317		5	Purified	-1	 	
Batch03	BaheA.00805.a	Bartonella henselae	YP_033099.1	Q6G4T6				Phosphate transport system ATP-binding protein	Potential drug target		MKIKMRGQDVKVFYGSKEALHGITLDIPEHQVTALIGPSGCGKSTFLRCFNRMNDTIEGAKITGLITLDGENIYESRIDVVELRARVGMVFQKPSPFPKSIFENVAYGPRIHGLVKSRAELHDVVEKSLRQAGLFEEVKDRLHEAGTSLSGGQQQRLCIARAIAVSPEVILMDEPCSALDPIATARIEELIDALRKDYTIVIVTHSMQQAARVSQYTAMFHLGHLVEVGETEVMFTSPKEQRTQDYITGRFG		252		3	Expressed	-1	 	NR-16426
Batch03	BaheA.00806.a	Bartonella henselae	YP_032927.1	Q6G557				Transcriptional regulator	Potential drug target		MKDNPTITQTIVLVDDDRNILTSLSFALETEGYRVESYTDGASALKGLTLHPPHLAIFDIKMPRMDGMELLRRLRQKSDIPVIFLTSKDDEIDELFGLKMGADDFITKPFSQRLLIERVKAILRRASTRNQPLTTGASPTSSLKRGDLVMDQERHTCTWKDKPVILTVTEFLILQTLAQRPGVVKSRDALMDAAYSDQVYVDDRTIDSHIKRLRKKFKQVDDDFAMIETLYGVGYRFHEV		240		4	Soluble	-1	 	
Batch03	BaheA.00808.a	Bartonella henselae	YP_033059.1	Q6G5G2				L-asparaginase	Potential drug target		MKKIAIGTLGGTIAMAADNLGQMQPILTSDILIKSVPDLDSVADIHAQTLIQIPSGSLSFKSLFEIIEWATQQIKAGAEGIVLTQGTDTVEETAFFLSLYWNKAEPLIVTGAMRLPHEAGADGPANILAATRVAAHPQSRNRGVLVVINDTIHSPYWVQKSHTIKIETFQSSPVGVLGIILEGKLIYFTDRNFFPTTFDLPKNYDHQVAILYSSLSSDTQLMKFCFESGHYAGVVIAGFGSGHCSFEEADIVRQYTQKMPIIIASRTYTGPTTRKTYGYKGSEVDMIASGALMSGYLSALKARLLLWAFLAQGLSLEQINAHWDDWTIS		329		2	Cloned	-1	 	
Batch03	BaheA.00822.a	Bartonella henselae	YP_033814.1	Q6G2Y6				adenylate kinase	Potential drug target		MRIVLLGPPGAGKGTQAKMLCEEYHIPQLSTGDMLREVIRRETEIGKKAKAMINAGTLVSDSIVNQIVSDRIDESDCINGFVLDGYPRTVGQAEVLQQVLQSKNMQLDAVIELIVDEDALLERMKKRVQETIIAGGQVRSDDNPVAFAKRLVEYREKTAPLSEFYLQRRLLKLVDGMIGVTEVSRKIREVLK		192		11	Native diffraction-data	-1	 	
Batch03	BaheA.00824.a	Bartonella henselae	YP_033267.1	Q6G4D7				pyridoxamine 5'-phosphate oxidase	Potential drug target		MGNTVQTDNDFMQMQKPFALFAKWLEEATVSEINDPNAMALATVDKTGFPNVRMVLLKDFSPQGFVFYTNYESPKGQEILKSMKASLVFHWKSLRRQVRIRGIVEKVTPQEADAYFQSRPRDSRIGAWASKQSQPLESRFVLEKAIARYTTRYAVGNIPRPPYWSGFRVKPLSIEFWCDRPFRLHDRLLFTRDSVEHVDWKRQKLYP		207		4	Soluble	-1	 	
Batch03	BaheA.00852.a	Bartonella henselae	YP_033248.1	Q6G5J7				GTP-binding protein EngA	Potential drug target		MSLTIAIVGRPNVGKSTLFNRLVGQKLALVDDKPGVTRDRRVHAATLQDLRFDVIDTAGLEETGDHTLEGRMRAHTKAAIDEADLILFVFDAKSGITPSDLNFASLVRKSGKPIVLVANKSESKAAIGGEYEAWSLGLGEPCSISAEHGLGLSDLRDAIMKASGGERIFASKNQEEHIALQSASLDDYIDNLEEKGDVYDKSKPLRIAVAGRPNTGKSTLINRMLGQDRLLTGPEAGLTRDSISVDWEWRGRHIKLFDTAGLRRKSKIQEKLEKLSVADTLRAIRFAEVVVIVFDATTPFEKQDLQIADLVIREGRVPLIAFNKWDLIENSQATLVDLHEKCIRLLPQVRGLRAVPLSGQYGQGIDKLMENVMMMHRVWNRRISTGKLNRWLETIVAHHPPPAVLGRRLKVKYVTQVKTRPPGFVFSCSRPKLMPQSYLRYLSNELRNTFDMPGIPIRISLRASDNPFATRSKKK		475		5	Purified	-1	 	
Batch03	BaheA.00862.a	Bartonella henselae	YP_033971.1	Q6G2J0				"ABC transporter, ATP-binding protein"	Potential drug target		MTNCDNILDISNLSVTFGHKHKAVTVVKNVNFHIKRGEAYGLIGESGCGKSTILNTLVGLIPDYSGRLIFDGKEVAKKRDKGFLRRIQMVFQDPYASLHPRKMVHTVLSESLKIHGMDNPKERVCDALNSVGLNSSFLYRYPHELSGGQRQRIALARALIIEPEVLLLDEPTSALDVSVQAEILNLLKSLREERKLTYLMVSHDLAVVAHICERVGIMHKGIILEELSNDDLRNLHAENDYTKMFFEASIEPIAHREKRV		260		3	Expressed	-1	 	
Batch03	BaheA.00866.a	Bartonella henselae	YP_033011.1	Q6G4Z2				GTPase ObgE	Potential drug target		MKFLDQAKVYIRSGNGGAGAISFRREKFIEFGGPDGGDGGRGGDVWALVVDGLNTLIDYRYQQHFRAKTGGHGKGRNMTGQKGDDIILKVPVGTQIFEEDNTTLICDLTEVGQRYRLAKGGNGGFGNLHFTTSTNRAPRRANPGLSGEERTLWLRLKLIADAGIIGLPNAGKSTFLASVTAAKPKVADYPFTTLYPHLGVARIDAREFVLADIPGLIEGAHEGVGIGDRFLGHVERCRVLFHLISAQEEDVVKAYQIVRNELKAYGNNLNDKTEIIALSQIDTLTIEERKAKQEFLQKVTGKSVMMFSAVSREGLENLLRAGAHIIEMARKKDVVREEQD		340		5	Purified	-1	 	NR-16427
Batch03	BaheA.00867.a	Bartonella henselae	YP_033322.1	Q6G482				Phosphomethylpyrimidine kinase	Potential drug target		MALMPSILIVAGTDPTGGAGIVRDIETAAHFQIKANLAITCINVQDDNHVAEIVPMCEKLIAAQMRAALEANPISAIKIGMTGNQAIIAAICNVIEDYPHIPVILDPVLFASSGGKLTTEPIIEIMINKLLPYVDLLTPNREELALLSQTPLASCHKQAIQQAKKLLSFGPRSILIKGGHADGPLATDSFIDKTEIIDISTVRLTRTMRGTGCILSSAIAAHLALNESMIQAIKNAKEYIYRLLLNHNQKGD		252		3	Expressed	-1	 	NR-16428
Batch03	BaheA.00875.a	Bartonella henselae	YP_033801.1	Q6G2Z9				Glutamine synthetase I	Potential drug target		MTTASDILKQIADNDIRFVDLRFTDPRGKLHHITIDIAEISEDTFNDGVMFDGSSISGWKTIHESDMVLMPDPETAHIDPFFAQSTLVIFCDVLDPVSGEFYRRDPRSIAKRAEVYMKSLGIGDTINVGPEAEFFIFDDVRYKVAPYNTGFKLDSSELPSNDDTEYETGNLGHRPRMKGGYLPVPPIDPCQDMRSEMLTVLKDMGIRVEKHHHEVAAGQHELGIRFDTLVREADKMQIFKYVVHQIANSYGKTATFMPKPVFGDNGSGMHVHMSIWKDGKPIFAGNEYAGLSETCLFFIGGIIKHAKAINAFTNPSTNSYKRLVPGYEAPVLLAYSVRNRSASCRIPMTPSPNSKRVEVRFPDPTANPYLAFAALLMAGLDGIKNKIHPGHAMDKDLYDLPLKELKDIPTVSGSLREALEALDKDRSFLKAGDVFDDDQINSFIQVKMQEVLRYETTPHPIEFDMYYSV		469		4	Soluble	-1	 	
Batch03	BaheA.00880.a	Bartonella henselae	YP_033061.1	Q6G5G0				ATP-dependent protease ATP-binding subunit	Potential drug target		MCVVFSPRETVSELDRFIIGQSDAKRSVAIALRNRWRRQQLDGPMRDEVMPKNILMIGPTGVGKTGIARRLAKLAGAPFVKVEATKFTEVGYVGRDVEQIIRDLVEIAISLVREKKRDEVKVKAHINAEERVLDALVGKTASPATRESFRKKLRDGELDEKEIEIEVSDNNSNSTSTFDIPGMPGAQMGIMNLSEIFGKMGNRTKVRKTTVKDAFKPLIDDESEKLLDQDQIIQEALRVAENDGIVFIDEIDKIATRDGGASAAVSREGVQRDLLPLVEGTTIATKYGQIKTDHILFIASGAFHVSKPSDLLPELQGRLPIRVELNPLTREDLRRILTEPEASLIKQYIALMATEEVHLEITDDAIDALADIAVDLNARIENIGARRLQTVMERVLDEISFTAPDKAGTSFKVDAAYVKKSIGDLAADVDLSRFIL		436		5	Purified	-1	 	
Batch03	BaheA.00886.a	Bartonella henselae	YP_033224.1	Q6G4G1				Aldehyde dehydrogenase	Potential drug target		MLNKRKFYINGLWDDPSTPHDLYVIDPSTEEACAVISLGSTRDADKAINAAKKAFQTWKTTSPHERLGFVEKILEIYEKRSSDMAKTISMEMGAPIDMALNAQTATGSSHIRNFIKAYKEFSFQEALIEGNEQAILHYDAIGVVGLITPWNWPMNQVTLKVIPALLAGCTMVLKPSEIAPLSAMLFAEILDEAALPSGVFNLINGDGANVGSYLSAHPDLGMISFTGSTRAGKDISKNASNTLKRVCLELGGKGANIIFADADIDALQRGVRHCFYNSGQSCNAPTRMLVEQAIYDKAIKTAKDIAEKTQVGPGHQTGNHIGPVVSKEQYDKIQDLIQSGIDEGATLVTGGTGLPMGMERGYYVRPTVFADVKPHMRIFREEIFGPVLSLLPFNTEDEAVTLANDTEYGLTNYIQSQDRSKCRRIAAQVRSGMVEVNGHELPGGSYFGGVKFSGRAREGGLWGIKEFLDTKAISYW		476		17	In PDB	-1	 	
Batch03	BaheA.00888.a	Bartonella henselae	YP_033220.1	Q6G4G5				adenylosuccinate synthetase	Potential drug target		MANVVVVGTQWGDEGKGKIVDWLSERADIIVRYQGGHNAGHTLVVNGVNYKLSLLPSGLVRGKLSIIGNGVVVDPHHFVVELKKLRDQGVKIVPEILRIAENAPLILSLHRDLDAIRESGFSGLKIGTTKRGIGPAYEDKVGRRAIRVMDLAEANTLMAKIKRLLRHHNALRRGMGVAEIDSQALYDELMQVADEILPFMDCTWRLLDESYRMGKHVLFEGAQGALLDNDFGTYPYVTSSNTVAGQACTGSGMGPGAIHYVLGIAKAYTTRVGEGPFPTEQINDIGEFLGIRGHEFGVVTGRKRRCGWFDAVLVRQMVTICGVQGIALTKLDVLDGLDEIKVCVGYELDGKRIDYLPSSMGAQSRVKPIYETLEGWKQATAHALKWEDLPVQAIKYIRYIEELIGTQVALLSTSPEREDTILITDPFAN		429		3	Expressed	-1	 	NR-16429
Batch03	BaheA.00898.a	Bartonella henselae	YP_033681.1	Q6G3A6				Lipoprotein releasing system ATP-binding protein lolD	Potential drug target		MTAILELVEIERHFLGGNKPLIILDKANFILNRGELVALVAPSGAGKSTLLHIAGLLEKPTAGDVMLRGVSCAKRSDNERTAIRQNDIGFVYQFHHLLPEFTALENVMIPQMIAGFKKSIAEERALKLLTYLRVSHRANHRPSELSGGEQQRVAIARAVANGPSVLLADEPTGNLDPVTSAYVFQALSALVRQAGLSALIATHNYALAKQMHRRITLKEQKIVELP		226		3	Expressed	-1	 	
Batch03	BaheA.00900.a	Bartonella henselae	YP_033661.1	Q6G3C6				Superoxide dismutase [Cu-Zn ] precursor	Potential drug target		MNKLIFLFLAQVAFFNCISNVLADSTQVKIYELKENNLKNPIGTIEIEENIYGLIFAPNLSSLPEGFHGFHVHVNPSCDTKDGVIGGAAGGHYDPYQTNKHLGPYNINGHLGDLPALYVDEQGRATMSVIAPRLKKLSEVKGHSVIIHIGGDNQSDKPLPLGGGGARLACGIIEE		175		2	Cloned	-1	 	
Batch03	BaheA.00904.a	Bartonella henselae	YP_033672.1	Q6G3B5				Bacterioferritin comigratory protein	Potential drug target		MTKQMKGTPAPDFNLPRDGGDKLCLSDLQGKMVVLYFYPKDDTSGCTNEALDFTRLKTKFDEIGVVIIGISPDNVKKHEKFKIKHALDIILVSDEEKTTLEAYGVWVEKSMYGRKYMGVERSTFLIDPTGTIVEEWRKVSVSGHAENVLAAATFLYRKSLSI		162		5	Purified	-1	 	
Batch03	BaheA.00911.a	Bartonella henselae	YP_033790.1	Q6G310				isocitrate dehydrogenase	Potential drug target		MIKIKVENPIVEIDGDEMTRIIWKYIKDKLIHPYLDIELKYYDLSVENRDATNDQVTIDSANAIKKYGVGIKCATITPDESRVKEFNLKKMWKSPNGTIRNILGGVIFREPIICKNVPRLVPNWTKPIIIGRHAFGDQYKATDFKFPGKGKLSIKFVGDDNQVIEHDVFDAPSAGIAMAMYNLDESIRDFARASFNYGLQRNLPVYLSTKNTILKTYDGRFKDIFQEIFDAEFKAEFENRKLYYEHRLIDDMVASALKWSGGYVWACKNYDGDVQSDIVAQGFGSLGLMTSVLMTPDGKIVEAEAAHGTVTRHYRQYQKNEETSTNSIASIFAWTRGLTHRAKLDNNEKLKNFATTLESVCIKTVEEGFMTKDLALLIGSKQKWLSTTGFLDKIDENLKKAMGN		404		5	Purified	-1	 	
Batch03	BaheA.00912.a	Bartonella henselae	YP_033954.1	Q6G2K7				RNA methyltransferase	Potential drug target		MTLHIALFQPDIAGNTGTILRLSACFGLHVHIIEPAGFNLSDRNLKRAGMDYLEYASLERHIDWPHFIHTMKQFNRRLLLLSTKAETCYTQICYQENDVLLFGRESAGVPNYVYEAVNETLKIPMQPYARSLNLAMSVAITTGEALRQIGYYKKRKTL		158		3	Expressed	-1	 	
Batch03	BaheA.00926.a	Bartonella henselae	YP_034204.1	Q8L207				Fructose-bisphosphate aldolase	Potential drug target		MNERLEDIALTLVGAGKGILAADESTATIGKRFESIGVECTEDNRRAYREMLFTAKEAMESAISGVILFDETLRQKASTGQMLTDLIRDAGAVPGIKVDTGAKPLAAFPQETITEGLDGLRERLKDYYTLGARFAKWRAVIAIDAQTLPTRGAISQNAQALARYAALCQEAGLVPIVEPEVLMDGPSRQHSITRCFEVTKVVLHTVFKELFEARVLFEGMILKPNMVIDGKDARIASVEEVAEKTVHVLKQTVPAAVPGIAFLSGGQTDEEATAHLSAMNALGALPWKLTFSYGRALQAAALKAWAGKNENIVVAQKAFCHRARMNHLAALGQWTKDQEKSCA		343		17	In PDB	-1	 	
Batch03	BaheA.00934.a	Bartonella henselae	YP_033234.1	Q6G4F1				Methylenetetrahydrofolate dehydrogenase	Potential drug target		MNNIIDGKKLAEKIIMKVKAETTKLRNNYKIQPGIAVIIVGNDPASQVYVTSKSKKAEECGFFSIKHMISKETQEKELLHLIATLNSDPQIHGILVQLPLPDHINTNRITQAIAFQKDVDGFHYINIGKLAANALEDAIIPCTPAGAMMMIEQQCGQDLSGLDAVVVGRSNIVGKPMAALLTAANATVTIAHSRTRDLDDVCRSADILVTAIGRPQMIKKDWVKNGAIIIDVGINRIAAPEKGVGKTRLVGDVDFEEIKEKAAAITPVPGGVGPMTIAMLMVNTLKAAARLHNLPIPKF		299		2	Cloned	-1	 	
Batch03	BaheA.00944.a	Bartonella henselae	YP_033470.1	Q6G3V6				ribose-5-phosphate isomerase A	Potential drug target		MNVQQLKKMAALKALEFVEDDMRLGIGSGSTVNEFIPLLGERVANGLRVTCVATSQYSEQLCHKFGVPISTLEKIPELDLDIDGADEIGPEMTLIKGGGGALLHEKIVASASRAMFVIADETKMVKTLGAFALPIEVNPFGIHATRIAIEKAADNLGLSGEITLRMNGDDPFKTDGGHFIFDAFWGRILQPKLLSEALLAIPGVVEHGLFLGLASRAIVAMADSQIKVLEPFDF		234		17	In PDB	-1	 	
Batch03	BaheA.00946.a	Bartonella henselae	YP_033405.1	Q6G409				2-dehydro-3-deoxyphosphooctonate aldolase	Potential drug target		MSEPNAIVKVGNIIFSNEAPFSLIAGPCQIESRDHAFEMAGRIKTITDQVGIGFVYKSSYDKANRTSLSAVRGVGLENAMAIFSDLKKEFGCPILTDVHTEEQCTVVASTVDILQIPAFLCRQTDLLVAAAKTGRVINIKKGQFLAPWDMKNVLRKVTQSGNRNVMLCERGTSFGYNRLISDMRSLPILRSFGAPVIFDATHSVQEPGGQGDSSGGQRQFVEILARAAVSVGVAGIFLETHQDPDNAPSDGPNMIKIDHLQRLLETLMEFDYLSKKTIE		279		3	Expressed	-1	 	
Batch03	BaheA.00960.a	Bartonella henselae	YP_033796.1	Q6G304				phosphopantetheine adenylyltransferase	Potential drug target		MRIEMMKIALYAGSFDPLTNGHLDILKASFVLADKVIVAIGIQAKKESLFSFEERVDLITQAGKELLNMGSDRLQVISFETLLIDKAREIGASFLIRGLRDGTDLDYEMQMAGMNGLMAPELQTVFLPAGVLGRVITSTLVRQIASMGGDVAPFVPANVARALHLKFQSSRGSDCVS		177		3	Expressed	-1	 	
Batch03	BaheA.00963.a	Bartonella henselae	YP_034076.1	Q6H8L3				co-chaperonin GroES	Potential drug target		MANIQFRPLHDRVVVRRVESENKTAGGIIIPDTAKEKPQEGEVIAVGNGALDDNGKRVPLEVKTGDRILFGKWSGTEVKINGEDLLIMKESDIMGILG		98		5	Purified	-1	 	
Batch03	BaheA.00965.a	Bartonella henselae	YP_033645.1	Q6G5E2				30S ribosomal protein S4	Potential drug target		MSKRETTKYKIDRRMGENIWGRPKSPVNRRDYGPGQHGQRRKGKLSDYGVQLRAKQKLKGFYGDISEKQFRKTYEEAARRRGDTGENLIGLLESRLDAVIYRAKFVPTIFASRQFINHGHVNVNGRRTNIQSYRCKPGDVIEIREKSKQLVLVLESVQLVERDVPEYIEADHNQMKATFTRIPAFADVPYAVQMEPNLVVEFYSR		205		-2	Work stopped	-2	Work stopped	
Batch03	BaheA.00970.a	Bartonella henselae	YP_032877.1	Q6G5A7				DNA polymerase III epsilon chain	Potential drug target		MREIIFDTETTGLDKEKDRIIEIGCVEMVDRYLTGRRFHVYLNPQGVIIPDEVVAVHGLTNERLKNEKSFSDIADEFLEFINGATMIAHNASFDIGFLNAELARANKPLISVDNILDTLAMARRKFPMAPNSLDVLCKRFGIDNSHRVFHGALLDAEILADIYIELIGGKQGVLVFGNNGSVHEESENDKNAFSAVKIRPQNLSPRLSVQEKTMHADFVKKMGEKALWNSFKIPQ		235		2	Cloned	-1	 	
Batch03	BaheA.00975.a	Bartonella henselae	YP_033034.1	Q6G4W9				inositol-5-monophosphate dehydrogenase	Potential drug target		MAKIVETGTGALALTFDDVLLQPGHSLVMPSQVDLSTRIAADIKLNLPLLSAAMDTVTESRLAIAMAQAGGLGVIHRNMSPTEQAEEVRQVKKFESGMVVNPVTIGPDATLEEAKALMRSHGISGIPVVENGIKGETAGRLVGILTNRDVRFASDLKQKIYELMTHENLITVRENVQLNEAKYLLHHHRIEKLLVVDEHNRCVGLITVKDIEKAQLNPNAAKDSQGRLRVAAAMSVGNDGVERAERLIDAGVDVLVIDTAHGHSQRVLETVERVKKMAFSPALIAGNVATPQATQALIDSGADAVKVGIGPGSICTTRIVAGVGVPQLAAIMSAAEVADKAGIPVIADGGIKASGDFAKALAGGACSVMIGSLLAGTEESPGEVYLYQGRSFKAYRGMGSVGAMVGGSADRYFQDEVRDELKLVPEGVEGQVAYKGPIASVLHQLAGGLRASMGYVGAKNLAEFREKATFVRITNAGLHESHTHDVAITRESPNYRRPV		499		5	Purified	-1	 	
Batch03	BaheA.00977.a	Bartonella henselae	YP_033046.1	Q6G5I3				ribonucleotide reductase stimulatory protein	Potential drug target		MGLIVYYSSATGNTEYFVSQLDQRLFKIDKKKPSMLVDEPYVLVVPTYADGEGKMAVPKAVIRFLNEDENRKLIRGVIGGGNRNFGRYYSLASKIIAEKCFVPCLYRFELRGTEEDIICVKKGLERFWKQLV		132		4	Soluble	-1	 	NR-16317
Batch03	BaheA.00983.a	Bartonella henselae	YP_034352.1	Q6G1L5				Cell division protein ftsY	Potential drug target		MTKPFIKKIFSFNKSKEQKIEQVSTPYENDRVDENKDKSEITKNDLSSIDRKTKEQTENQNIASAKYDEKNQPFESYSSKEHHSSKVIITDIISEKKIEEILPVSSVEQEKRAWFGRLKKGLALSSQRLSKSIGEVFVKEKLDKDKLQELEDILIQADLGVETATHITDTLASSRYKKNLSPDDVHSIIANEIEKVLKPVAIPLELDLNHKPHVILLVGVNGTGKTTTIGKLAAKLTKGGLKVMLAAGDTFRAAAIEQLHIWGERIGAPVISTKLGADAASLAFDAYEKAKKANSDVLIIDTAGRLQNKTELMDELAKIIRVLGKHNPQAPHTILQTLDATTGQNALNQVDIFRDIAGVNGLVMTKLDGTARGGILVAIAAKYKLPVYFIGIGENIEDLQPFSASDFAKTIAGRHS		416		3	Expressed	-1	 	
Batch03	BaheA.00989.a	Bartonella henselae	YP_033057.1	Q6G5G4				Leucyl aminopeptidase	Potential drug target		MHLHHIHFTSTRIDNSCPIFLVNQRSLADLSLDASTTAWIKVNDFTGKAGQILFIPHETGHLKKVLFGLGNGDEPFITGLLAKNLPAGNWHLEGTASHEINNYLGLAFGSYQFNRYRQNSSSKSLSFYVNDTVDLNELKRIYETVFFVRDLINIPANDMNPDILEKETRHLGKTYGADVQSICGDELLTHNFPMIHAVGRASNTVPRLIELHWGQENHPKITLVGKGVTFDTGGLDIKSANNMLLMKKDMGGGAHVLGLAKLIMDAKLPFRLRVLIPAVENAISANAYRPGDILKSRKGLSVEIGNTDAEGRLVLADALAYGDEESPQFMLCMATLTGAAHIALGPELPAFYCNDSVWAQQISQSAHSVYDPLWQMPLWKPYEEMLSSPIADLNNITGNNFAGSIVAALFLNSFVEKTKHFAHFDLYGWVPKEKPGFPVGGSAQAIRALYNLFKN		455		5	Purified	-1	 	
Batch03	BaheA.00993.a	Bartonella henselae	YP_032932.1	Q6G552				acetylglutamate kinase	Potential drug target		MDDVENGVADVFEKQAAFLSSALPYMQKYENETVVVKYGGHAMGDPALGRAFARDIALLKQSGINPVVVHGGGPQIAEILMKMGIESRFENGLRVTDERIVEVVEMVLAGSINKEIVALINAEGEWAIGLCGKDGNMVFAEKAYKTVIDPDSHIERVLDLGFVGEPVEVDRTLLDLLACSEMIPVLAPVAPGRDGKTYNINADIFAGAIAGALEAKRLLFLTDVPGVLDKKGKLLKELTISEAENLIKNETISGGMIPKVETCMKALQNGVEAVVILNGRTPHSVLLELFTEQGAGTLIVS		301		7	Crystallized	-1	 	
Batch03	BaheA.00996.a	Bartonella henselae	YP_033058.1	Q6G5G3				pantothenate kinase	Potential drug target		MIDTILPKINQEDNLVKSISDRYSPYRVFTAQEWSQFRADTPLTLTFDEIKRLRSIDDPIDLEEVQRIYLSLSRLLSCHVEAVQELFHKRQQFLYQEGTRKTPFIIGIAGSVAVGKSTTARILQELLKRWTSSLKVDLITTDGFLYPNAVLQQKNRMNRKGFPDSYDIKKLLCFLSAIKAGIGNVRAPLYSHMIYDVLENQTVTIDRPDILIVEGINVLQVNDLPKDGKIIPFVSDFFDFSIYVDAETEVIRHWYLERFKRLRKTAFQNPKSYFHRYALMHEEESLKIAENIWQTINLKNLQENILPTRPRSNLILRKGKKHLVEYVALRRL		332		5	Purified	-1	 	NR-16318
Batch03	BaheA.00999.a	Bartonella henselae	YP_032875.1	Q6G5A9				Shikimate 5-dehydrogenase	Potential drug target		MVNLTIKREKKKIPRAFVVGTPIHHSKSPKIHNFWLKQYDLQGEYLAQEVTSEEFRDFLTSLKRRGFCGGNVTLPHKQEAFHLANYKDDVATMIGAVNTLWYEGDKLCGTNSDAYGFSANLDDSAPDWMGETALVFGAGGAARAILYALKKRGFERICLVNRTKQRAESLAEHFGKPVEVCDWYKAHEILYQADLIVNTTSVGMINSNEKESTSFFCDFHKTKTTALVTDIVYTPLVTPFLQRAKAHGLRTVDGLGMLLHQAVLGFERWFGIRPRVTKALRATILQDMGEKRG		293		2	Cloned	-1	 	
Batch03	BaheA.01005.a	Bartonella henselae	YP_033999.1	Q8L1Z7				phosphoglyceromutase	Potential drug target		MERTLVLIRHGQSEWNLKNLFTGWKDPGLTEKGRTEAIAAGKKLKETGLKFDIAYTSALQRAQKTAQNILEQMEQSDLELIKTPALNERNYGDLSGLNKDEVRQKWGEQQVQIWRRSYTIAPPNGESLRDTGARVWPYYLHHIQPHILRSQTVLIAAHGNSLRALIMALEGLNSEEIISQELATGIPIVYTFNSDSTISSKTIITP		206		5	Purified	-1	 	
Batch03	BaheA.01006.a	Bartonella henselae	YP_033894.1	Q6G2Q7				UDP-N-acetylenolpyruvoylglucosamine reductase	Potential drug target		MLFFLVLAISHNGLVLCLTNWRYLITMINFQLIDGEALLARLQPTLGGIKGKLTPNMDMQKVTWFRTGGLAELFYQPADEVDLAFFLQNLPESIPVTIVGIGSNLLVRDGGIPGVVIRLSAKGFGQVQQVSPTGFLVGAATADKHLAAAALEAEIAGFHFYHGIPGGLGGALKMNAGANGVETAARVVEVYALDRRGQCHTLSLADMHYSYRHCAVPEDFIFTAALLEGKPGNKGDIRAAMDEVALHRESVQPVREKTGGSTFRNPKDISAWRVIDEAGCRGLQIGGAQMSEMHCNFMINTGQATAYDLEALGETVRARVFAYSSHLLQWEIQRIGQFEQGRIVSSFDPFN		351		3	Expressed	-1	 	
Batch03	BaheA.01009.a	Bartonella henselae	YP_033800.1	Q6G300				Nitrogen regulatory protein p-II	Potential drug target		MKKIEAIIKPFKLDEVKEALQKIGLHSITVTEAKGFGCQKGHTELYRGAKYVIDFLPKVKIEIVIADEKLEQAIDTIRKAAQTKHIGDGKIFVSSIDHAIRIGTGKSGIDAL		112		4	Soluble	-1	 	
Batch03	BaheA.01015.a	Bartonella henselae	YP_034278.1	Q6G1R9				tRNA (guanine-n1)-methyltransferase	Potential drug target		MKFQARVLTLYPEMFPGFLGCSLAGQALKQGIWSLETVQIRDFALDKHHSVDDTPAGGGAGMVMRADVLAAALDSCPNDSPRLLMSPRGRLLNQAYARSLARSSGVTLVCGRFEGVDERIIEARELEEVSIGDYILSGGETAALVLLDAIVRLLPGVMGNEISAKCESFENGLLEHPQYTRPAVFEGRGIPPVLTSGHHKAIANWRQQQAESLTRQRRPDLYALYNKNRQKT		232		17	In PDB	-1	 	
Batch03	BaheA.01050.a	Bartonella henselae	YP_033271.1	Q6G4D3				GTP cyclohydrolase II	Potential drug target		MTYDQKKIVSALRAFERGEIVVVTDDDDRENEGDLIVAAVHCTEEKMAFIIRHTTGIVCAPMPKEEAQRFNLTPMVLDNNSVHRTQFTVTVDFKHGTTTGISAHDRTLAVRNLANSNAGANDFIRPGHIFPLIAHEGGVLMRSGHTEAAVDLCKLAGLPPVGVIGELVNDDGSVKHGDEVTRFAQENQFHIITVADLIAYRQRKEMLIQHVGEMHIETLVGPAVVQSYQLPWEAVQHVAIIFGDIRDGEDIPVRLHRENIVNDVFGQTSDILEIMRRMMKKEKRGVFVYLREGSVGVKSAVSIQALAMRGGESHTQAIEREEEWRQIGLGSQILKHLGISSVILYASKERHYVGLEGFGIRISRTDIL		368		7	Crystallized	-1	 	
Batch03	BaheA.01057.a	Bartonella henselae	YP_033549.1	Q6G3M7				Response regulator	Potential drug target		MKRILLAEDDNDMRRFLAKALERAGYEVADFDNGASAYERLQEEAFSLLLTDIVMPEMDGIELARRATEIDPDLRVMFITGFAAVALNSNSDAPPDAKVLSKPFHLRDLVNEVEKILIAA		120		5	Purified	-1	 	
Batch03	BaheA.01059.a	Bartonella henselae	YP_033752.1	Q6G5R8				Phosphoribosylglycinamide formyltransferase	Potential drug target		MKKQIVVFISGNGSNMVALVKASKQKEYPAEIIAVICDNPHAKGIEKARDNHLPIHIIDRKDYPTKEAYEESIFKVLAKYQPDLICFAGYMRLISSRFVKLYEGKILNIHPSLLPSFKGLKTHERVLQAGVKITGCTVHLVTEDMDSGKILAQAAVPICPNDTADSLAQRVLKAEHKLYPEALKAFIEGNNKITDAQQQLLSF		203		7	Crystallized	-1	 	
Batch03	BaheA.01062.a	Bartonella henselae	YP_033872.1	Q6G2S9				Dihydrofolate reductase	Potential drug target		MTFPICLIAAVAKNGVIGREGAMPWHLSTDLQRFKALTFGSPVIMGRKTWDSLRAPLPGRTNIVITRNCAFKAESAVITHSLSHACSIAKKVASQNGADAIFIIGGGEIFQQCFDIADKIFLTEVLDSIEGDSFFPVFDKEKWTIVQTQYIPEGDKDSHPTRFVVYERK		169		5	Purified	-1	 	
Batch03	BaheA.01064.a	Bartonella henselae	YP_033367.1	Q6G446				30S ribosomal protein S6	Potential drug target		MALYEHMFLARQDIAPQQVDELLNIYKGVIETYGGKVGRVENWGLRPLAYRIRKNRKAYYVLVNIDAPATAIAEVERQMRINEDILRYMTIRVEKHEKEKSAMFSRLDRNGHIGHDEKHPRSPSRQREDVIEGVE		135		-2	Work stopped	-2	Work stopped	
Batch03	BaheA.01066.a	Bartonella henselae	YP_034145.1	Q6G226				UDP-N-acetylglucosamine 1-carboxyvinyltransferase	Potential drug target		MDSIEIVGGKKLKGIIPISGAKNAALPLMIAALLTEETLSLDNIPHLADIELLIRILNNHGVGYAVDGQKNHTECVHSRTIHFTAQKITTTYAPYDLVRKMRASFWVIGPLLARCREAYVSLPGGCAIGTRPVDFILEGLKTLGARITIENGYVHAKVPKGLKGAHYRFPKVTVGGTHVMIMAAVTANGKTVLENAACEPEVTNLVQALNAMGAKITGEGTTILTIEGVQKLNGARISVIPDRIEAGTYAMAVAMTGGDVMLKNANPHHLTQVLEILQKTGLDIEIKPQGIHLKRNLRQTKIMPVDIKTGPYPAFPTDLQAQFMALMTRAQGISHITETIFENRFMHVQELNRLGAQIKLDGQTATVFGTEHLQGAPVMATDLRASVSLVIAALAAKGKTTVNRVYHLDRGFERLEEKLARCGATIQRITV		431		1	Selected	-1	 	
Batch03	BaheA.01067.a	Bartonella henselae	YP_033811.1	Q9FDC7				DNA-directed RNA polymerase subunit alpha	Potential drug target		MIQKNWQELIKPNKVEFSKHDNPNISSVIVEPLERGFGLTLGNALRRVLLSSLRGAAITAVQIDGVLHEFSSIPGVREDVTDIILNIKEIALRMREEGPKRIVVCKEGPGVLRAGDISTVGDMEILNPDHVICTLDEDAEIRMEFIVNTGKGYVPSDRNCIDDARIGLIPVDSLYSPIRKVSYKVENTREGQVLDYDKLTLTVETNGAVNGEDALAFAARILQDQLALFINFKEPEKPTVEESNSELAFNPALLKKVDELELSVRSANCLKNDNIVYIGDLIQKTESEMLRTPNFGRKSLNEIKEVLACMGLHLGMEVPTWPPENIDDLAKRYEDQY		337		2	Cloned	-1	 	
Batch03	BaheA.01071.a	Bartonella henselae	YP_032890.1	Q6G594				Nitrogen regulatory IIA	Potential drug target		MNLSELIAPEAIIPALKANSKKQVLQILAEKAAGLTGLNERVVFDIVLQREKLGSTGLGGGIAIPHGKLPNINRIIGIFARLESPVDFEALDDEPIDLVFLLLAPENAGADHLKALSQIARVLRCSDVVQKLRNTHDANALYALLIQNSTSNAA		154		5	Purified	-1	 	
Batch03	BaheA.01076.a	Bartonella henselae	YP_034328.1	Q6G1N9				Shikimate kinase	Potential drug target		MKSNRPKHIPITKIKNQLLSSLDNRALVLIGLMGVGKSVIGKRIATMLCLPFYDSDQEIEKAAQMTITELFKTYGESEFRALEQRVILNLMKNRPLVLATGGGAYINEDIRKAVHKNGISIWLKVDLDTLMQRVSKRPTRPLLQTENPKETMQKLMKQRYPIYAKANLTINSHKENRQTVAQNVIRSVQHYLDTEKNDRNNQHANQNCHC		210		5	Purified	-1	 	
Batch03	BaheA.01090.a	Bartonella henselae	YP_033095.1	Q6G4U0				glutathione synthetase	Potential drug target		MKIAIQMDHISTLQIQGDTTFALALAAQERGYSLFHYTPDRLSMRDGCVIVKLEALTVHDKEGNHYQLGKPIRTQLMDMDVVLLRQDPPFDLNYITTTHLLECIHPKTLVVNDPAWVRNSPEKIFVTEFPDLMPETLITKDIEEITAFRATFGEIIVKPLYGNGGAGVFHLKQDDRNLASLLEIFAQIYREPFIVQRYLDAVRKGDKRIILLDGKPVGAINRIAAETDVRSNMHVGGRAENVDLTKRDYEICQRIGPALKERGLLLVGIDVIGDYITEINVTSPTGIREIKRFSGTDIAHLFWDVIEFKRSN		312		2	Cloned	-1	 	
Batch03	BaheA.01095.a	Bartonella henselae	YP_034222.1	Q6G1X5				Geranyltranstransferase (farnesyl-diphosphate synthase)	Potential drug target		MHEFITLLAKHAHSVEKRLATLLSDQVQNGEIARPEILLKAMRYGVLNGGKRLRPFLVIQSCALFDIPIEYSLNVASALECIHCYSLIHDDLPAMDNDTLRRGQPTVHIAFDEATAILAGNALLTFAFEIIAHKTSELSFETRIRLITALAQASGLGGMIGGQMLDLEAEKKPQESKDITTLQHMKTATLISFACQAGAIIGNASQELTEKLAAFGTYLGLAFQLTDDLLDVTASTKVLGKTAGKDETAHKATFIRLYGIEETQKKRDELIAQAEALLLPFGAKATPLQQAARFSATRKN		300		4	Soluble	-1	 	
Batch03	BaheA.01099.a	Bartonella henselae	YP_033475.1	Q6G3V1				glutamyl-tRNA synthetase	Potential drug target		MIKVRFAPSPTGYIHIGNIRIALFNWLYAQAHNGTFILRYDNTDVERSKQEYIDAIAVDLEWLGIQPDEIYYQSKRFNRYDEVAEILKQRGLLYPCYETAEELDRRRKIQLSRKLPPVYDRAALKLTPEKKREFETQGRKPHWRFLLPNFENDPLQKKRTEVCWNDAVKGKQTIDLASLSDPVLIREDGSYLYTLPSVVDDIDMAITHIIRGDDHITNTGAQIALFEALNAKLPTFGHINLLTTLLGKGLSKRNNDLSIHSLRADGFESIAVQCLAVLIGTSQNVHPYPNQAVLLEHFNLQDTSRSVAKFDIADLLTLNSHFVHELTYEEVKKRLENLSINGEKVECFWNAIRSNINKVNDAVLWWKMLHDEQNFDTVALEDRAFVRQSLNLLPEGTLNEESWKVWTVALKEKTGRRGKALFMPLRQALTGMDHGPEMGKILQLLGREKVIERLIIQGE		459		1	Selected	-1	 	
Batch03	BaheA.01104.a	Bartonella henselae	YP_033669.1	Q6G3B8				Nitrogenase cofactor synthesis protein nifS	Potential drug target		MVVKRRYFDHNATTPLKKAAEVALLESLEIFGNPSSVHTEGRAAKALLQKARRQIAKSLNANPDHVVFTSGASEAAMTLLTPFYNMGSSKVQFSHLYIGATEHPSVAEGGRFPKEFISTIAVDQDGLIQQDKLLSLLSFHDKTKGLPLVAIQAANGETGVMQQIKEIAAIVRNCGGTLIVDLTQYIDKNFVDVHQMEGDFFILSAHKIGGPKGIGAFVSCGNLLMPYPLIVGGGQEKGLRGGTEALPLIAAFGAAMADCYNQEEIKQLLYLRHKLEDGIQKICHDVEIFGKKVQRLPNTTYFTVRNIKAETLQISFDLAGFSVSAGSACSSGKVKQSRVLEAMGYDVPNGAIRISTGRCTTSKDIDDFLLFFSQIINKKKAGTL		384		5	Purified	-1	 	
Batch03	BaheA.01109.a	Bartonella henselae	YP_033463.1	Q6G3W3				Amino-acid ABC transporter	Potential drug target		MNLKNNKLVHTTKSPVISIRNLNKWYGNFHVLHDINLDVEIGQRIVICGPSGSGKSTLIRCINQLEQTHKGSICIHNINIHTAPIHQQKTVLRKIGMVFQHFNLFPHMTVMQNCILAPMTVQGLSKQQAKKRAMHYLTQVGIEKHCEKYPLQLSGGQQQRVAIARALCMKPEVMLFDEPTSALDPESVGEVLEVMVQLANTGITMLCVTHEMGFARKVSERILFLENGKIIEDTASDEFFINPKSQRARDFLAKIKH		257		3	Expressed	-1	 	
Batch03	BaheA.01111.a	Bartonella henselae	YP_033477.1	Q6G3U9				inorganic polyphosphate/ATP-NAD kinase	Potential drug target		MTQLPSRFHFISAETENAIKATNKLISVYGHYSLEETDVVVAIGGDGTMLQTVHNVMNTGKPIYGMNQGAVGFLMNEFHEEKLPNRIAVAHKKEIHPLRMIAKAECQGTIEALAINEVSLFRQSYQAAKIRISIDNNVRMEQLSCDGILVATPAGSTAYNLSAQGPILPLMAPLMALTPVSPFRPRRWHGALLPNTAIVRFDMLESDKRPVNAAADNVEVKSVYSVTISTAKEVTVSILFDSNHSWDERILSEQFLY		257		4	Soluble	-1	 	
Batch03	BaheA.01112.a	Bartonella henselae	YP_033448.1	Q6G5D3				Hit-like protein involved in cell-cycle regulation	Potential drug target		MKQAYDNNNIFAKLIRNEIPSVRVYEDDDVIAFMDIMPQAPGHTLVIPKKGSRNLLDADTETLFPVIKAVQKIAKAVKKAFQADGITVMQFNEAASQQTVYHLHFHIIPRMEGIELTPHNNIITPTEILEENAKKIRAAL		140		17	In PDB	-1	 	
Batch03	BaheA.01120.a	Bartonella henselae	YP_033744.1	Q6G3Q0				Single-strand binding protein (ssb)	Potential drug target		MLNKVMLIGYLGDDPESKTMTSGAEVVNFRMATFESYMNKNTHQKVEKTEWHSVVVFNPHFAKIALQYLHKGSKVYIEGKLQTRKWQDKNGHDRYTTEIVLPQYKGELHLLDAKKEQSASSSSVTSQSYAIASGADDYGISAHDSMPF		148		5	Purified	-1	 	
Batch03	BaheA.01120.b	Bartonella henselae	YP_033526.1	Q6G3Q0				Single-strand binding protein (ssb)	Potential drug target		MLNKVMLIGYLGDDPESKTMTSGAEVVNFRMATFESYMNKNTHQKVEKTEWHSVVVFNPHFAKIALQYLHKGSKVYIEGKLQTRKWQDKNGHDRYTTEIVLPQYKGELHLLDAKKEQSASSSSVTSQSYAIASGADDYGISAHDSMPF		148		17	In PDB	-1	 	
Batch03	BaheA.01120.c	Bartonella henselae	YP_033197.1	Q6G4I8				Aingle-strand binding protein SSB	Potential drug target		MLNKVMLIGYLGDDPESKTITSGAEVVNFRMATSESYMNKNTYQKVEKTEWHSVVVFNPHFAKIALQYLHKGSKVYIEGKLQTRKWQDKNGHDRYTTEIVLPQYKGELHLLDAKKEQSEHPSPITSQNYAIASGAQDHSTALNDGVPF		148		5	Purified	-1	 	
Batch03	BaheA.01123.a	Bartonella henselae	YP_033352.1	Q6G5H1				dihydroorotase	Potential drug target		MFKTFDTIFKGATVVNHDGSGKRDIGITNGRIAEIGDLTRASAGEVVDCIGLHILPGIIDSQVHFREPGNEHKEDLESGSRSAVLGGVTAVFEMPNTDPLTISEETLIDKIKRGFHRMHCDFAFWVGGTRENAHELVELERLFGVAGIKVFMGSSTGDLLVDDDESVRLILKNIRRRAAFHSEDEARLRERKMLRIEEDASSHSVWRDEVAALKCTQRLVKIAHETKARIHILHLSTAEEIDFLKNHKDVATIEVTQHHLTLTADDYQRLGTLIQMNPPIRESRHREALWYGVQQGIIDILGSDHAPHTLEEKFQPYPASPSGMTGVQTTAAIMLTHVNAGKISLERFVDLTSHGPSRIFGISRKGRLAVGYDADLTIVDLKREEIITNVLIGSRAGWTPYDGKKVKGWPVGTIIRGMRVMWEGEIVTPSQGEPVKFTEVLV		442		2	Cloned	-1	 	
Batch03	BaheA.01128.a	Bartonella henselae	YP_034077.1	Q6G294				fumarate hydratase	Potential drug target		MVETRQETDSFGTISVRQDRYWGAQTERSLHNFNIGIEKQPLTIIYALSLIKKAAAVVNMEKGKLAKNIGKAIITAADEVLSGAFDTHFPLSVWQTGSGTQSNMNVNEVIANHANMLLGGKLGSKTPVHPNDHVNMSQSSNDSFPTALHIATTLQTRQHLFPILDALITTLKKKEEEFADIIKIGRTHTQDATPLTLAQEFSGYRTALEANRQRIENALCDVQMLAQGGTAVGTGLNAPQGFDIAFAQTISTFTGIPFKTASNKFEALAHHGALAHFHGSLNALAADLFKIANDIRFLGSGPRSGLGELSLPENEPGSSIMPGKVNPTQCEAMTMVACQVFGNHTSVTFAASQGHFELNVYKPVIGYNVLQSITLLGDCMRSFDLHCIQGLRANRVHIHSLMERSLMLVTALAPEIGYEKAAAIAKAAHKNDTTLRTEALKLGVSGEDYDRLVDPKKMIHPQ		462		5	Purified	-1	 	
Batch03	BaheA.01132.a	Bartonella henselae	YP_033807.1	Q6G2Z3				recombinase A	Potential drug target		MDKIKALDAALSQIERSFGKGSIMRLGQKEQVVEIETIPTGSLSLDIALGVGGLPKGRIVEIYGPESSGKTTLALHAIAEAQKNGGVCAFIDAEHALDPIYARKLGVDLENLFISQPDTGEQALEITETLVRSGAVDVLVVDSVAALTPRAEIDGEMGDALPGLQARLMSKALRKLTASIFRSNCMVIFINQIRMKIGVMFGSPETTTGGNALKFYASVRLDIRRIGSIKDRDMIVGNQTRVKVVKNKLAPPFKQVEFDIIYGEGISKLGELIDLGVKVGTVEKSGSWFSYNSQRLGQGRENAKQFLREHPEIATEIETALRQNAGLIAIELLENAGSENTESDEVI		347		5	Purified	-1	 	
Batch03	BaheA.01135.a	Bartonella henselae	YP_034345.1	Q6G1M2				succinyl-CoA synthetase subunit alpha	Potential drug target		MSILVNKDTKVLVQGLTGKTGTFHTEQALAYHGTQMVGGVNPKKGGETWEGSKGETLPIFASVAEGKEKTGADASVIYVPPAGAAAAIIEAVEAEIRLIICITEGIPVMDMVKVKARLEKSKSRLIGPNCPGILTPNECKIGIMPGSIFRKGSVGVVSRSGTLTYEAVFQTSHEGLGQTTAIGIGGDPVKGTEFIDVLEMFLADDETQSIVMIGEIGGSAEEEAAQFLQDEAKKGRKKPVVGFIAGRTAPPGRTMGHAGAVISGGKGGAEDKIAAMESAGIKVSPSPSQIGKTLMSVLKG		300		3	Expressed	-1	 	
Batch03	BaheA.01137.a	Bartonella henselae	YP_033787.1	Q6G313				branched-chain amino acid aminotransferase	Potential drug target		MKSPTSSIPFKIEKHPSPLSDEEREHILKNPGFGQFFTDHMVIIKWTKDKGWHNAVISQYKSLEINPASTVLHYGQEIFEGLKAYRAKDGRILLFRPDANAQRFIESARRLAMPELPKDIFLDAVHKLVRIDQNWISGNPNASLYIRPFMFGNENFLGVRPSEKYIFCIIASPVESYFKGEEKPVSVWLETDYSRAGPGGTGVAKCGGNYAASLLAQKNAEQNNCSQVLFLDMVEHKWIEELGGMNVCFIMENNTLVTPALNGTILAGITRHSILKLAQKMGLKIEERPYSFESLQEDARSNHLKEVFACGTAAVVTSIGRFKYKGGEFVIGNGMIGEVTKKLRTQLVDLQKGNREDKNGWVHSVQLS		368		1	Selected	-1	 	
Batch03	BaheA.01149.a	Bartonella henselae	YP_033112.1	Q6G4S3				Nitrogen fixation protein	Potential drug target		MTLTPMEIALLEAQWAAKKDEVPVGAVITRGQSIIVRAGNSIKAAYDPTGHAEIRVIRMACAAFQSERLPDCDLYVTLEPCAMCAAAISFARIRRLYYATSDPKGGAIEHGPRLYKQSTCHHSPEVYSGFKEKEAAQLLKDFFAQKRC		148		2	Cloned	-1	 	
Batch03	BaheA.01161.a	Bartonella henselae	YP_034210.1	Q8L200				pyruvate kinase	Potential drug target		MKRARKVKIIATLGPSSFSISMIEKLFMAGADVFRLNMSHTDRETMVDLVQRIRKVEKTVRRPIGILVDLQGPKLRVGCFDKGQEDLRIGQSFTLDDRDILGDAQRVFFPHGEVLAAIKPGDRLLIDDGKLELLAQVCDGHSVQCLVVAGNRISDRKGVSLPDTVLPFGPMTLKDKADLQAVLEQPVDWVALSFIQRPEDIIAVRALTKSKVSLMAKIEKPQALEHIEEIIDVADGIMIARGDLGVEMPLERVPAIQMELIKACRLAGKPVVVATQMLESMITSSVPTRAEVSDVATAVYTGTDAVMLSAESASGRYPEEAVLMMDRIAQQIEQDQTYAAQVGAQHPAPESTGTDAISLAARQIAETLQLTAIVAYTASGTTGVRTSRERPNRPIIALSPIVKTARRLALVWGLHCVVTEDARDLEDMVDRAAAIAFQEGFCQGGDRFLVTAGVPLGTPGATNLLRIASVSQDGTKGV		478		4	Soluble	-1	 	
Batch03	BaheA.01164.a	Bartonella henselae	YP_033650.1	Q6G5D7				Penicillin-binding protein	Potential drug target		MRTVLRIFFTLFWMLTLDGRGKAEDFQTSAQQLLLVDDDTDTVLFEKQSDIPFFPASLAKLMTAEVIFHQLKEGLLSNTQTFKVSENAWRKGGAPSGTTTMFAKVKTEISVSDLLRGLIIVNGNDAAITLAEGVSGSEADFAKLMNQRAKALGLEHSYFVNPTGLPEEEQFVTLRDMMTLTRHIARAYPNYYILYREPHFTWNKIFQRNKNPLISKEIGVEGFGFGYSEEEGFSMVVAAYKNHRHLFLAINGLQNGKGHTKEIERILQWGMTAFDLKTIFTKGETVGHASVYGGEQNSVPLIVKGPIRFMLSNEKKVDVKAKIKYRGPLKAPIILGQPVGVIQILQDKKVLLEKPVFAGNNVQEGSFFAKIKNAFYEITIGWLRKYL		387		2	Cloned	-1	 	
Batch03	BaheA.01166.a	Bartonella henselae	YP_033698.1	Q6G389				NADH dehydrogenase subunit B	Potential drug target		MGLISSNSTITAPKSKGIIDPNTGELIGSDDRFFCEVNAELSEKGFLVTSADALITWARTGSLMWMSFGLACCAIEMMQCSMPHYDNERFGYAPRASPRQSDVMVVAGTLTNKMAPALRKVYDQMPEPRYVISMGSCANGGGYYHYSYSVVRGCDRIVPVDIYVPGCPPTAEALLYGILLLQKKIRRTGSIER		193		2	Cloned	-1	 	
Batch03	BaheA.01187.a	Bartonella henselae	YP_033468.1	Q6G3V8				glutamyl-tRNA synthetase	Potential drug target		MPVITRFAPSPTGFLHIGGARTALFNWLYAKHTGGKMLLRIEDTDRERSTEAAVKAIIDGLHWMGLSYDGDPISQFERAERHRQVAEQLVKDGKAYYCYASPEELAEIRENARAEGRPPRYDGRWRERDISKAPKDIKPVIRIKAPQDGETIVHDRVQGDVRFPNKDLDDFIILRSDGSPTYMHAVVVDDHDMGVTHIIRGDDHLTNAARQTIIFNAMGWDIPVMAHIPLIHGENGAKLSKRHGALGVAAYRKMGYLPAALRNYLVRLGWSHGDDELMSIEDMISWFDIDDINKGAARFDLKKLDAINGHYIRMSNNQDLFDAALHILKEIEGGLQIMERLDEQRRAQFLKAIPNLKERSKTLCELIDNASFIFTKRPLQLDEKAQTLLDKNGLAILKVIYLALKACPSWDVKSLDETLRSYAQTQDLKFGSIAQPLRAALTGRLTSPGVFDVLVLLGRDESLNRINDQLVTTACSLHTNQCI		483		1	Selected	-1	 	
Batch03	BaheA.01213.a	Bartonella henselae	YP_033762.1	Q6G338				phosphoribosylaminoimidazole-succinocarboxamide synthase	Potential drug target		MNRRHRIYEGKAKILYEGPEPGTYIQFFKDDATAFNAKKHEIIDGKGVLNNRISEHIFSHLGRLGIPTHFIKRINMREQLIKAVEIIPLEVVVRNVAAGSLSKRLGLEEGTPLSQSIIEFYYKNDSLDDPMVSEEHITAFGWAVPQEIEDIMQLSIRINDFLSGLFAGVNIQLIDFKMEFGRLWEDEAMRIVLADEISPDSARLWDIQTQEKMDKDRFRRDMGGLINAYQEVAKRLGIINENEPSRPNGPVLVK		254		5	Purified	-1	 	
Batch03	BaheA.01215.a	Bartonella henselae	YP_033048.1	Q6G5T9				ribonucleotide-diphosphate reductase subunit beta	Potential drug target		MTKITTKNPVVCAVNWNRLHDEKDLEVWNRLTGNFWLPEKVPLSNDIPSWASLTEEERKLTIRVFTGLTLLDTIQNTVGAISLMADAITEHEEAVLTNIAFMEAVHARSYSSIFSTLCSTVEVDDAFRWSEENIHLQKKARLVLERYEGNDPLKKKIASTLLESFLFYSGFYLPMYWASRAKLTNTADLIRLIIRDEAVHGYYIGYKFQLGFAKLDETKKKEVKDFAFNLLFDLYNIECKYTEDLYDALGLTEDVKIFLHYNANKALMNLGFEALFPSEVCRVNPAILAALSPNSDENHDFFSGAGSSYVIGKAVATTDDDWEF		324		5	Purified	-1	 	NR-16258
Batch03	BaheA.01216.a	Bartonella henselae	YP_033127.1	Q6G4Q8				ABC transporter ATP-binding protein	Potential drug target		MGIIKFDKVTQVFGDLYVLRNITVQLTERRIAVIGANGSGKSTFVRLINGLQLPSHGFVSVDGLDTKNDAKAIKHKVGFVFQNPDNQIVLPLVEEDLSFGLKNLKLSKEEVKERVDEILQRYDLQNFRNHAVHLLSGGQKQLVAISGVVAMKPDYIIFDEPTTLLDLRNKRLITQVIEELSQTAIVVSHDLEFIRNFDRVLVFDKGEIVVDDIPLVAIKEYIRRMS		226		3	Expressed	-1	 	NR-16259
Batch03	BaheA.01219.a	Bartonella henselae	YP_034018.1	Q6G5P1				Ferredoxin-NADP reductase	Potential drug target		MNTSASNVQSNISSVASDFPIPENVFALTVQEVYHYTDRLFKFRLNRPESFRFRSGEFVMIGLPNAEKPIYRAYSIASPFWDEQLEFFSIKVPGGPLTEHLQKIKIGDTVLMRKKSTGTLVLDALIPGKRLYLLSTGTGVAPFASLIRDPETYEKFSEVVLIQTTRECDELNYAKDLVVSLQQDPLIGEYAPQLKFYPMTTRESSEHMGRITTVMESGAFFEMTGLPKIHADEDRVMICGSMAMLKDCARMCEVFGLVEGANNAPATYVVERAFVG		276		3	Expressed	-1	 	NR-16260
Batch03	BaheA.01231.a	Bartonella henselae	YP_034080.1	Q6G291				expressed protein	Potential drug target		MIRKTVPNTTFHTRVRDESIGGDNPYRWQEVNSDAYFKGKRVILFSLPGAFTPTCSTFQLPDFEKLYDEFKKVGIDEIYCLSVNDAFVMNAWGKAQGIKNVKLIPDGSGEFTRKMGMLVAKDNVGFGMRSWRYAAVINDGVIEHWFEEQGFSDNCATDPYEVSSPQNVLKTLKG		174		5	Purified	-1	 	NR-16261
Batch03	BaheA.01232.a	Bartonella henselae	YP_033388.1	Q6G426				nucleoside diphosphate kinase	Potential drug target		MAVERTFSMIKPDATRRNLTGAITKMLEDAGLRVIASKRVWMSQREAEKFYAVHKERAFFSELVELMSSGPTIVQVLEGENAIAKNREVMGATNPEDAQEGTIRKVHALSIGENSVHGSDSAETAKTEIAFWFSEVEIVG		140		5	Purified	-1	 	NR-16262
Batch03	BaheA.01242.a	Bartonella henselae	YP_034169.1	Q6G202				Deoxyuridine 5 27-triphosphate nucleotidohydrolase	Potential drug target		MPHTQTDAHQNNQENFSSSLISSRPSQPMTLSIQRLDHGQGLELPHYATAGSAGLDLRAALSEEETVILAPGQRALIPTGLIFHLSPGFEAQIRPRSGLALKHGITCLNTPGTIDSDYRGEVKVLLINCGQEDFAIKRGMRIAQTVIAPVLQVNVCALEPQQNESTKNTVGNRGAGGFGSTGHD		184		3	Expressed	-1	 	NR-16263
Batch03	BaheA.01246.a	Bartonella henselae	YP_033402.1	Q8L1Z5				triosephosphate isomerase	Potential drug target		MSPNIRPFIAGNWKMNGTGESLGELRAIAAGISSDLGRLFEALICVPATLLSRAFDILGGENILLGGQNCHFDDYGPYTGDISAFMLKEAGASHVIIGHSERRTVYQESDAIVRAKVQAAWRAGLVALICVGETLEERKSNKVLDVLTRQLEGSLPDGATAENIIIAYEPVWAVGTGNTATSADVAEVHAFIHHKMHSRFGDEGAKIRLLYGGSVKPSNAFELLSTAHVNGALIGGASLKAIDFLTICDVYRKL		254		17	In PDB	-1	 	NR-16264
Batch03	BaheA.01257.a	Bartonella henselae	YP_033343.1	Q6G461				4'-phosphopantetheinyl transferase	Potential drug target		MIVGLGSDLTDIRRIERMLARYGDRFVQRIFTDIERNRSESLQKKSSSYAKRFAAKEACAKALGTGIACGINWKDMGVINLPSGKPIMKLTNRAQMQLQKLLPSHHDAIIHLSMTDDFPWAQAFIIIEAFPRG		133		3	Expressed	-1	 	"NR-16265, NR-16430"
Batch03	BaheA.01267.a	Bartonella henselae	YP_034017.1	Q8L204				2-keto-3-deoxy-6-phosphogluconate aldolase	Potential drug target		MCQKIEKLLSLLQEQTIIPVLHIDTLQNAVPLARALVKGGLRTIEVTLRTANALDAIKAITQEVPESIVGAGTILSTIHYKQAEHAGAKFIVSPGFSNKLIDYAKNSEIPLLPSALTPSEVMKALDKGYSYLKFFPAEAAGGITFVKALAAPFSEIRFCPTGGIKQKNAAQWLQLSNVFCIGGSWIAPRNLITAKNWHAISALAQTAAQLSSYPTKVCSTI		221		3	Expressed	-1	 	NR-16266
Batch03	BaheA.01272.a	Bartonella henselae	YP_033409.1	Q8L1Z6				"Pyruvate dehydrogenase E1 component, alpha subunit"	Potential drug target		MAERLKKNSASVVHNALSNTTKKAKIANFTKEEEIDAYREMLLIRRFEEKAGQLYGMGLIGGFCHLYIGQEAVVIGTLKAAKEGDQVITSYRDHGHMLAVGMSPRGVMAELTGRQGGFSKGKGGSMHMFSKEKNFYGGHGIVGAQVPIGSGLAFSNQYLGKDNVTLVYFGDGAANQGQVYESFNMASLWKLPVVYIIENNQYAMGTSVARASAETDFSRRGLSFEIPGIVVDGMDVRAVKGAADEAITWTRSGKGPIILDMQTYRYRGHSMSDPAKYRSKEEVQKIKEEQDPIDQVRNRILQQGFASEDDLKSIDKEVRAIVADAVDFAQSDQEPDASELYTDILV		346		3	Expressed	-1	 	NR-16319
Batch03	BaheA.01280.a	Bartonella henselae	YP_034029.1	Q6G2E2				"ABC transporter, ATP-binding protein"	Potential drug target		MENPSLISLKKISRCFNTTTDICALDNLSLNIHAGEILGIIGRSGAGKSTLIRCLNGLERIDAGSIFFEGVNVSNLSETEWAPYRQRIGMIFQHFNLLSSQNILNNIALPLKLTGINKKQRHKRALELIELVGLCGKEYCYPAELSGGQKQRVGIARSLAANPKILLSDEATSALDPETTQSILELLADINKRLNLTIVLITHEMEVVRAIAHRVVVLNQGRIVEEGRVKDIFTSPQDDTTIAMLKLVTPQLPEKFAKNLKPRGQEAIIEINIAGEITQQPFLNLLEDEIGLRARILHGGIDTVQGETIGRLFLGLPAQNQEALKKAVQWLTEKGRYCEVLGYV		344		3	Expressed	-1	 	NR-16267
Batch03	BaheA.01300.a	Bartonella henselae	YP_034048.1	Q6G2C3				bifunctional riboflavin kinase/FMN adenylyltransferase	Potential drug target		MLPLVWKGAVLALGNFDGVHCGHQVVLQKALDLARMRNKPALVLTFEPHPRSFFQHSAPIDRLTEAPEKAEIFKILGFNGVIEQPFDAHFAALSADEFINVILKKAFEVSVVVTGENFQFGRQKSGNSRLLCQKGEEWGFEVVQIPCVSSAPNSQSVIISSSVIRKLLSQGQVEKAARLLGYHYRVRSNIIQGEQLGRLLGFPTANQILPPQASLAYGVYAVRLRRANGVLYDGVASFGCRPTVVKNAAPFLETYLFDFNGDLYGENCTVSFFQFLRKQEKFDGLEPLIAQMHHDKKKAKAILAAVQPLSQLDQLLTFKNRT		322		3	Expressed	-1	 	NR-16268
Batch03	BaheA.01324.a	Bartonella henselae	YP_032996.1	Q6G507				50S ribosomal protein L27	Potential drug target		MAHKKAGGSSRNGRDSESKRLGVKKFGGEAVIAGNIIVRQRGTRWHPGDNVGIGKDHTLFALSKGMVSFQRKANNRSYVSVIPVVETVE		89		-2	Work stopped	-2	Work stopped	NR-16431
Batch03	BaheA.01328.a	Bartonella henselae	YP_033089.1	Q6G4U6				3-deoxy-manno-octulosonate cytidylyltransferase	Potential drug target		MALEPIILIPARIGSTRLPQKALAEIAGKPMIVHVAEQAKKAAFGRIIVATDHNNIAKVVTAYGHECIITCRDHKSGSDRIYEALTHIDPERRYNVILNVQGDLPTITPHEIISALRPLENSLTDIATLGAKIVEENEKTDPNIVKIIGTPLSHNRFRALYFTRATAPYGDGPLYHHIGIYAYRREALEKFVALKPSPLEQREKLEQLRALEHNMRIDVEIVDTIPLGVDTQRDLERVRKILA		243		4	Soluble	-1	 	
Batch03	BaheA.01335.a	Bartonella henselae	YP_033376.1	Q3V7R0				4-hydroxythreonine-4-phosphate dehydrogenase	Potential drug target		MDVLVVSGGDPAGIGPEIALKAWNLRATRQIPPFVLIADPDVIRARAHFLQIDVKVEAVLTDNPVKNFQEALPVIPLKNRQSDQLGLPSHENAAGIIEAIKRGVQLIQSGHACALVTCPIAKKSLYDAGFEFPGHTELLADLAHQASDKYYHPVMMLSGPRLKTVPITVHIPFKKVPSHLTHHLIVQTALITEKDLRTRFKIISPRLAVAGLNPHAGEEGAIGKEDIEIIIPAIETLKNKGLNIVGPLPADTMFHECARKAYDVALCMYHDQALIPVKTLDFDTTVNITLGLPFIRTSPDHGTAFDIAAKGIASPESFISALKLAHQLAENSFTPCQ		337		2	Cloned	-1	 	NR-16269
Batch03	BaheA.01337.a	Bartonella henselae	YP_032939.1	Q6G5F0				Polypeptide deformylase	Potential drug target		MPMRPLVIVPDPILREISKPVEYIDSAVQKLADDMLETMYHAQGVGLAAIQIGIPLRMLVLDVSRNDEQKNPLVIINPEVLWLSDERNIYKEGCLSIPEYFAEVERPKRLCVRYQNREGKQTEIEADDLLATCLQHEIDHLNGRLFIDYLSKIKRDMVIRKFKKRAKEKNTQEAVL		176		4	Soluble	-1	 	"NR-16270, NR-16432"
Batch03	BaheA.01340.a	Bartonella henselae	YP_033412.1	Q6G402				dihydrolipoamide dehydrogenase	Potential drug target		MANLYDVIVIGSGPGGYVTAIRAAQCGFKTAIVEREHLGGICLNWGCIPTKALLRSAEIKHFSEHLKDYGLKLNGSIEADIKDVVARSRAVSARLNAGVGFLMKKNKIDIIWGEAKFTKKAKGSQLVEITVSSSSKPIMQPQNPVPKGTLGEGIYQAKHIIIATGARPRILPGIEPDGKLIWTYFEAMIPHVMPKSLLVMGSGAIGIEFASFYHDMGASVTVVEMMPHIMPAEDIEISTFARKRLEKKGIRILSQAKVTKVEKAVDSITAHIDVKGKRETITADRLISAVGVQGNIENLGLEALGIKTDRGCIVTDEWSWTGVEGIYAIGDVAGPPMLAHKAEEEGVICIERLARLENIHPLDKRKIPGCTYCTPQVASVGLSEAAAKEAGYDIRVGRYSFSANGKAIALGEDQGLVKTIFDKKTGQLLGAHMVGAEVTELIQGFVIAMNLETTEEELMHTVFPHPTLSEMMKESVLDAYGQVLNA		486		5	Purified	-1	 	NR-16271
Batch03	BaheA.01344.a	Bartonella henselae	YP_032974.1	Q6G529				Heme exporter protein A	Potential drug target		MVLSGKDLTAYRNEDVLFQGLSFCLFPQQLMTITGPNGIGKSTLLRIIAGLFKAAEGHVSLKDQEQIYPVATACHYLGPQNAMKPFLSVIDNLQFWSAFYGQPLHSPHEVLADIGLSDLEHVPFNVLSTGQKRRIAIARLLLSYRPVWILDEPISGIDSYAQTLLTNIFQYHLNQGGMIIAATHSPLGIPENHKITLEKFLPPQEKIQ		208		3	Expressed	-1	 	NR-16272
Batch03	BaheA.01351.a	Bartonella henselae	YP_033904.1	Q6G2P7				S-adenosyl-methyltransferase MraW	Potential drug target		MAIDLKKHKSRRIILTKQGKRTERHIPVLLQPVLAGLIPLVGAKVIDGTFGAGGYTRALLNAGAQVIALDRDPHAIREGQSLVDEFFPRLRLVQGNFSQLDCVVEEKVDAVILDIGVSSMQLDEAERGFSFQKDGPLDMRMAQTGFTAADVVNRLKSDELARIFKILGEERYARRIARMIEKRRCVQPFLRTGDLAHAIEVLVGRKSGERIHPATRVFQALRIYVNDEIGELARGLFAAERVLKPGGRLGVVSFHSLEDRMVKRFFSARSGESVRSRYLPEIEMAPATFFPLFKGGITANKEELERNPRSRSARLRIGVRTEAECLFADMKLFGLAKIASFEGGKK		346		2	Cloned	-1	 	NR-16273
Batch03	BaheA.01378.a	Bartonella henselae	YP_032958.1	Q6G545				3-phosphoshikimate 1-carboxyvinyltransferase	Potential drug target		MQKTIPMTAYKSTRLSGIIKIPGDKSISHRSLILGGLASGETHIHGILESDDVFNTAAAMQALGACIIKKDDLWIIRGTGNGCLLAAQKPLDFGNAGTGARLVMGMVGPYHMKTTFIGDASLSKRPMARILDPLQLMGVEIEATHGNYLPLTLYGPKMTNPICYRIPVASAQVKSAILLAGLNTAGTTTVIEPILTRDHTEKMLKAFGAKLEIEKNAEGTRFIHLNGHPHLTGQTIHIPGDPSSAAFPIVAALLIEDSDITIENVLINNSRMGLIETLWEMGAQIELLNQRQTGGEDVANLRVKSSVLKGVTVPKERAPSMIDEYPALAVAAAFAEGKTVMLGIEELRVKESDRLSVLAQGLKINHVDCEEGQDFLIVHGKGSAKGLGGGHVTTHLDHRIAMSFLIFGLVSEKPVTIDDKRMIATSFPEFIPFIQQLGGKIS		442		3	Expressed	-1	 	
Batch03	BaheA.01383.a	Bartonella henselae	YP_033671.1	Q6G3B6				tyrosyl-tRNA synthetase	Potential drug target		MLAFKSDFLNIMSERGFIHQISDEKGLDALFSKEVVSAYIGFDPTASSLHAGSLLQIMMLYWLQKTGHRPIVLMGGGTGLIGDPSFKDEARRLLTQDDIAANIADIKKVFARYLTFGERETDSCIVNNAEWLCTLNYLEFLRDIGKHFSVNRMLSFDSVRLRLEREHSLSFLEFNYMILQAYDFVELYKRYGLRMQMGGSDQWGNIINGIELGHRLGTPQLYALTSPLLTTSSGAKMGKSLNGAVWLNADMLSPYQFWQYWRNTEDADVTRFLKLYTPLPMDEILKLSALQGTEINEAKKILATEITAMLHGRDLANAVAETARKTFEERTLGENLPTFEINANDLKMGTGLLILLVQAGLSKSNSEARRHIQGGGVRVNDHIIEDETHLIREEDINAQGIIKLSFGKKKHVLIKPL		417		2	Cloned	-1	 	NR-16274
Batch03	BaheA.01386.a	Bartonella henselae	YP_034320.1	Q6G1P7				Phosphomethylpyrimidine kinase	Potential drug target		MKLQVSQDTLFIPRILSIAGTDPSGGAGMQADLKVFSAMKTYGMSVVTAVVAQNTQGVRAFQALDASFVADQIDAVFEDIHVDAVKIGMVANAQIARTVAERLAYHKARFIVFDPVMVAKSGDVLLKSDAIEIMRDVLVPMSTLITPNLPEASLLLGCEVKWSLDAMYQYGPQLLTLGCHAVLLKGGHLDVFSRTNEANYDYSSPDLYCDCEDLVMLEAPRFITTHDHGTGCTISAAIAALLPTKPLVDAVKQAKDYLNGALSTSSALQVGKGRGPLHHFYELWKNV		287		3	Expressed	-1	 	NR-16275
Batch03	BaheA.01388.a	Bartonella henselae	YP_033318.1	Q6G486				Methyltransferase (fragment)	Potential drug target		MLNISQQRIFCLKNVSIGGLLVAKSRKGICNIALGDTPEQLLQEFTVRFGDVQQVDDDSTFKKEVTHIVAMIESPKFVRKHDFPLDIIGTVFQQKVWTGLCEVPCGETISYEALAQHIGMPNAFRAVANACARNELALLIPCHRVVRKDGFISGYRWGIWRKKILLQREQKGEI		174		3	Expressed	-1	 	
Batch03	BaheA.01406.a	Bartonella henselae	YP_033558.1	Q6G3M1				acyl carrier protein	Potential drug target		MSSTFDKVADIIAEISEVDRNMITYESHTIDDLGIDSLDFLDIVFAIDKTFGIKIPLEQWTQEVNEGTVATEEYFVLKNLCAKIDELVALKQEN		94		5	Purified	-1	 	NR-16276
Batch03	BaheA.01412.a	Bartonella henselae	YP_034342.1	Q6G1M5				dihydrolipoamide dehydrogenase	Potential drug target		MSYDVVVIGAGPGGYVAAIKAAQLGLKTAIIEKRMTLGGTCLNVGCIPSKALLHASEVFAETQHGFETLGISIAKSKLNLEQMMAHKKAVVTANTSGVSFLMKKNKIDTFFGTAKILNAGQIEVVARDGNKQTIETKNIIIATGSESSGIPGVNVEIDEKVIVSSTGALALEKVPTRMIVVGAGVIGSELGSVWSRLGAKVTIIEYLNKVLGSMDGEVSRQFQKIMEKQGIEYKIGAKVTAITQSGSVAQVTFEAVKGGPSETLEADVVLIATGRFPYTEGLGLEEAGVQLDERGFITIDAHWQTNIPGVYAIGDVVKGPMLAHKAEEEGVAVAEILAGQKGHVNFDVIPSVVYTQPEIASVGKTEEELKAAGIDYNVGKFPFMANGRARAMQKSDGFVKILADKKTDRVLGGHILGFGAGEMIHEIAVLMEFGGSSEDLGRCCHAHPTLSEAVREAALATFAKPLHI		468		1	Selected	-1	 	
Batch03	BaheA.01415.a	Bartonella henselae	YP_033845.1	Q6G2V5				Glutamate /aspartate transport ATP-binding protein	Potential drug target		MSTHMIEIKNVSNWYGEINVLKNCTTTIDKGEVVVICGPSGSGKSTLIKTINALVPFQKGEIWIDGTPVHSKKTNLSKLRSHVGMVFQHFELFPHLSVIENLTIAQIKVLKRSKKEALERALLYLERVGLIEHKNKYPGQLSGGQQQRVAIARALTMDPLVMLFDEPTSALDPEMVGEVLDVMISLAEEGMTMICVTHEMGFAQKVSERVIFMDQGRILEDCSSKEFFSSPQDRTPRAQEFLSKILNH		248		1	Selected	-1	 	
Batch03	BaheA.01417.a	Bartonella henselae	YP_033013.1	Q6G4Z0				Gamma-glutamyl phosphate reductase	Potential drug target		MKDMGRKARRAATVLAVMSSEQKNKALEMIALSLEAHSDEILRANHQDLLNATQNNLTVAMVDRLKLNEVRLCTIIDSVRQVACLPDPVGQVMDEWTRPNGLHISRVRTPLGVIGIIYESRPNVTIDASTLCLKAGNAAILRGGSDSFHSAHALHCALVKGLKKAGFPKDAIQMVATKDRGAVGEMLKGLDGAIDVIVPRGGKNLVARIQVDARVPIFAHLEGLCHIYIDQSADLDMARNIVLNAKLRRTGICSAVETVLIDRQALEKFLPILTALQKKGCEIRATEDIVFLMPDAKLAFEEDWSHEYLDAIVSVKTVESVEGAIAHIKRYSSGHTESIIAEDMEIVEKFFNHLDSAILLHNASTQFADGGEFGFGAEIGIATGKMHARGPIGVEQLTSFQYHIKGNGQVRP		412		1	Selected	-1	 	
Batch03	BaheA.01419.a	Bartonella henselae	YP_033977.1	Q6G2I4				DNA-3-methyladenine glycosylase I	Potential drug target		MIKERSFDTVNIPLAEGLLMGTDGKVRCSWAGTDPLYCAYHDNEWGKPVFEDRRLFEKICLEGFQAGLSWFTILKKISSFRDAFDHFDFEKITRYDEVKVQILMQNKDIVRHQGKIRSVLNNALRAQELITEWGSLSQYFWSFQPPQSERYEAVDFQTFLANPITPASLRLSKDLKKRGWTFVGPTICYAFMQSVGIVNDHLEGCFCR		208		1	Selected	-1	 	
Batch03	BaheA.01433.a	Bartonella henselae	YP_033123.1	Q6G4R2				L-lactate dehydrogenase	Potential drug target		MIISSTLDYRKAAKRRLPPFLFHYIDGGAYAEETMRRNYADLQALALRQRILRGVGEVDLSTKLFDQTLDLPIILAPVGLTGMYARRGEVQAARAAVAKGIPFTLSSVSVCPIAEVQKAVGSAFWFQLYVLKDRGFMRDVLERSWASGVRTLVFTVDMPVPGARYRDAHSGMSGSYAGLRRILQAFIHPHWAWNVGIMGRPHDLGNVSTYLQKKIALDDYIGWLGANFDPSIGWHDLQWIRDFWKGKMILKGILDPEDAREAIQFGADGIVVSNHGGRQLDGVLSTVRALPAIAEAVKSDLTILVDSGVRSGLDVVRMIAQGADAVMIGRAFVYALAAAGEKGVAHLIDLFANEMRVAMTLTGVRAIKEITRESLASPDVFEQ		383		1	Selected	-1	 	
Batch03	BaheA.01438.a	Bartonella henselae	YP_033292.1	Q6G4B2				A/G-specific adenine glycosylase	Potential drug target		MLFSFAFYISLWLTKIMHEISLRLLSWYDQKHRHLPWRITPKEQMQGIRPDPYRVWLSEIMLQQTTVEAVKPYFKKFLQLWPDLSSLAKASQDDIMKAWAGLGYYSRARNLKNCAQQLVEDYGGQFPQSIKVLRSLSGIGDYTAAAIAAIAFNHPVAVVDSNVERVVTRLFAITSVLPKAKAEIKEKTQKITALNRPGDFAQAMMDLGATICIPRKPSCSLCPLQGLCRAEKMQKAEFFPVKAPKKERLSKTGAAFVVLNEKRQIYLEKRQGKKLLGGMTQIPNNIGTKNPNGLQNAPFIANWQFKGQITHVFTHFSLKLDVYYISGIREIKHQNGWWCDIHHLAEQALPTVMKKAIAVAIPHPFKLK		368		1	Selected	-1	 	
Batch03	BaheA.01441.a	Bartonella henselae	YP_032950.1	Q6G5I0				Iron transport protein yfeB	Potential drug target		MIGSGIFAQGVTVTYRNGHTALREVNFESPTGSITALVGVNGSGKSTLFKAIMGFVRPSKGKIRMFDLPVDTALKKNLIAYVPQSEDVDWNFPVLVEDVVLMGRYGHMNFFRYARARDYEAVRVALERVDMLAFAKRQIGELSGGQKKRVFLARALAQQAKAILLDEPFTGVDVTTEDKIIALLQDLRKEGAVILVSTHNLGSVREFCDHTVLIKGTVLASGLTETVFTKENLEKTFGGALHHHIFNLQGKKKDDVFTRGKQSAFLENIERVEHVA		276		1	Selected	-1	 	
Batch03	BaheA.01449.a	Bartonella henselae	YP_033835.1	Q6G2W5				50S ribosomal protein L3	Potential drug target		MRSGVIAQKLGMTRIYNDAGEHVPVTVLRLENCQVVAQRTVEKNGYTAVQLGVGFAKVKNTSQALRGHFAKASVEPKAKIAEFRVSPDNLLDIGTEITAEHFVPGQRVDVTGTTIGKGFAGVMKRHNFGGHRASHGNSITHRAHGSTGQCQDPGKVFKGKKMAGHMGQVRVTTQNIEVVSTDVERGLILVRGAVSGSKGAWILVRDAIKKPLPDNAPKPAGIRQLAKEKTEMVAPVTETSEVEGAE		246		-2	Work stopped	-2	Work stopped	
Batch03	BaheA.01454.a	Bartonella henselae	YP_033955.1	Q6G2K6				Poly(a) polymerase	Potential drug target		MSIRQDFKQVDWLQHSHIQKLLHVLSLDGEEARIVGGAVRNQLLEQPISDVDIATTCLPQQIIVRVEEAGFKAIPTGIAFGTVTVVSQSCSYEVTTLRSDIETDGRHAKVAFGRDWQKDAERRDFTMNALYCDAAGNLYDAVGGLDDIASRTVRFIGIAEKRIREDYLRILRFFRFFAWYGAGRPDVQGLKACVCLKHGLQKLSSERIWGEMKKLLTAPNPIRALLWMRQSGILTLIFPETEKWGIDAIHSLVKTEQDLGWKVDPLLRLESLLPPDPVRLYEMAHRLPLSHKEKTRLKEWAELEIICQNCSDHFLQKLIYFHGRQPVLDQLSLSLAAAHVDVLKGNEALQKVEDYMRLYQFAQKWQIPTFPISGKDLMKKGFSKGVLLGQKLKELETLWIESGFLIDRNSLLEKINL		417		1	Selected	-1	 	
Batch03	BaheA.01461.a	Bartonella henselae	YP_033228.1	Q6G4F7				dihydroorotate dehydrogenase 2	Potential drug target		MSFFRCIGRSALFMLDPEHAHRLAIMGLKSGLNSYQKVVDNRLCVTIAGLKFENFIGLAAGFDKNAEVVNDVFHLGFGFTEIGTVTPRPQVGNPKPRLFRLRKDEAIINRMGFNNDGRQIVYGRLHGYKRLGIVGINIGANKDTVDKIDDYITSIAYFYDVADYFTVNISSPNTPGLRDLQVRDSLHLLMNAISQARNEQKKKHGFFVPIFLKIAPDLSEKELDDVAEEMKLSDFDGLIVSNTTLSRQGLRECTLRNEEGGLSGRPLFERSTIVLAKMRQKLGKKIAIIGVGGIRDAKTALEKVKAGADLVQLYSGMVYEGPDLAITILKEILQFMQKDGVESIKAYRDQRVEYWAKHMLSS		362		1	Selected	-1	 	
Batch03	BaheA.01469.a	Bartonella henselae	YP_033411.1	Q6G403				branched-chain alpha-keto acid dehydrogenase subunit E2	Potential drug target		MPIKITMPALSPTMEEGNLSKWNIKEGDQVSSGDIIAEIETDKATMEVEAVDEGTVAKIVVPAGTQGVKVNSLIVVLAEEGEDLAEVAKVAEDSPSSFAIKESEGEKQRDSKVAQISHISSVQQVMQQGKKGMRFFASPLARRLATQVGLDLSLVSGSGPHGRIIKRDVEKAMKGGVSKASYSSQIEQPVTANTSDKQILQLFKEDEYTFTPHNNMRKTIAKRLVESKQKVPHFYVTLDCELDALLQLRTQLNAAAPIIKMQEGSKPAYKLSVNDMIIKAVALSLMAVPDANVSWLEGGILHHKHCDVGVAVSVENGLITPIVRHAEKKSLSIISNEMKDFVKRARELKLKMEEYQGGTTAVSNMGMYGVKSFSAILNPPHATIFAIGAGEQRAVVKNGALAAATVMSVTLSADHRAVDGALAAELARTFKKMIENPLTMLI		442		1	Selected	-1	 	
Batch03	BaheA.01476.a	Bartonella henselae	YP_034014.1	Q6G5N8				Ornithine decarboxylase	Potential drug target		MATQRIRDFLAKHRSEGPCLIVDLDIIRENYLNFEKALPQSRIFYAIKANPAPEILNLLASLGSSFDAASVAEIEMALKAGATSDRISFGNTIKKERDIAQAYALGISLYAVDCVEEVEKIARAAPGVRVFCRVLTDGKGAEWPLSRKFGCVPAMAVDVLRRAHQLGLQAYGVSFHVGSQQTDLSAWDRALSDAATVFRHLEHEGISLKLVNMGGGFPTRYLKDVPTTQAYGTVVFDSLKKYFGNRIPETIIEPGRGMVGNAGVIRTEVVLISKKADNDNIRWVYLDVGKFNGLTETMDEAIRYPIETPHDDKAMEPCILAGPTCDSADVLYEKTPYLLPLSLTVGDELLIHGTGAYTATYASVAFNGFEPLPSYVI		377		1	Selected	-1	 	
Batch03	BaheA.01494.a	Bartonella henselae	YP_033665.1	Q6G3C2				Nitrogenase cofactor synthesis protein nifS	Potential drug target		MENNVQTLSYNVEEIRRDFPLLHRDVYGKRLAYLDSGASAQKPQSVLNAMHNCYRHSYANVHRGIYFLANAATQSYENARETVRIFLNAQTAKEIVFTKNATEAINTVAYGWAMSKLKEGDEIVLTIMEHHSNIIPWHFLREQKGVKLVFVPVDENGVLHIEDFEKAFSERTRLVTLTHMSNILGTVPPVKEIIKQAHQNGIPVLVDGSQGAIHLTVDVQDLDCDWYVFTGHKLYGPTGIGVLYGKEHRLEEMHPFQGGGEMIEDVTIDKVSYNAPPYRFEAGTPPIVEAIGLAAAIDYMQKKDRKAIHAHEMALLTYAHEKLKTVDSLRIYGHSPHKGAIISFAIEGIHAHDIAMFLDRKGVAIRAGTHCAQPLLQRFGLTSICRASLAMYNTCEDIDQLVEALKETRTFFNG		414		1	Selected	-1	 	
Batch03	BaheA.01498.a	Bartonella henselae	YP_034233.1	Q6G1W4				putative translaldolase	Potential drug target		MKFFVDSANIEEIQELQNLNLVDGVTTNPSLILKSGRNILEVTKEICTLVVHGPVSAEVAATEFEDIMKEAAVLANIADNICIKLPLTFDGLKACKALTAQGLKTNLTLCFSANQALLAAKAGATFISPFVGRLDDYGINGSDLLHEIRTIYNNYSFETQILAASIRTINHVKEAALSGADVATIPPTILKALIKHPLTEKGLQSFLEDWKKTGQNIA		218		1	Selected	-1	 	
Batch03	BaheA.01499.a	Bartonella henselae	YP_033972.1	Q6G2I9				Oligopeptide transport ATP-binding protein	Potential drug target		MDKKLLEIEDLRVSFPTTRGVLEAVRGVSFSVGKEKIGIVGESGSGKSMTGRAILKLSPRAAIVKAKKMRFDDVDLLSASESRMQTIRGKRISMILQDPKYSLNPLVRIGDQIMEAYCIHHRVSKVEAREKTISMLESVHIRDPEHVMRLFPHEISGGMGQRVMIAMMLIPEPDLIIADEPTSALDVTVRCQVLSVLDELVTKSGTGLIFISHDLNMIADFCDRVLVMYAGRVLEELPARDLSCACHPYTKALLASLPRLDNPVDVLAVPERDPNWLHNPTIVNGVEGVTS		291		1	Selected	-1	 	
Batch03	BaheA.01531.a	Bartonella henselae	YP_033834.1	Q6G2W6				50S ribosomal protein L4	Potential drug target		MDLLIKTLDGNEVGKLKVSESVFGLVPREDILQRVVRWQLARRQQGTHQSQGRSDVSRTGAKMFKQKGTGRARHSSARAPQFRGGGKAHGPVVRSHAHTLPKKIRALGLRFALSAKLKADDLIVVDEFNVKDAKTRMLVSCFSKLGFDNALLIGGNEVDLNFSRATSNIPNIDILPIQGINVYDILRRSKLVLSKAAVEVLEERFK		206		-2	Work stopped	-2	Work stopped	
Batch03	BaheA.01536.a	Bartonella henselae	YP_033865.1	Q3V7Q9				pyridoxal phosphate biosynthetic protein PdxJ	Potential drug target		MAVKLSVNLNAVAVLRNRRNLPWPNIKSIGHIALTAGAAGLTVHPRPDERHIRFADLPDIRCLINSAFPTAEFNIEGYPSDRFLDLAEKYADQITLVPDDPAQSTSDHGWDFAHNAEFLAPIIQRLKEKKIRVSLFANPLVDGLDIAKTIGADRVEFYTGPYGGAFKDKTKQDQELKKLILAARKAKELQLGVNAGHDLTITNLPALVNHISWLDEVSIGHGLIADALEYGMYETVQRFIRLLS		244		2	Cloned	-1	 	NR-16397
Batch03	BaheA.01537.a	Bartonella henselae	YP_033965.1	Q6G2J6				Cell cycle transcriptional regulator ctra	Potential drug target		MRVLLIEDDKAMTQSIELMLKSANFNVYITDLGEEGVDLGKLYDYDIILLDLNLPDMSGYDVLRTLRLAKIKTPVLILSGMNAIEDKVRGFGFGADDYMTKPFHKDELIARIHAVVRRSKGHAQSVIVTGDLIVNLDAKTVEVAGHPVHLTGKEYQMLELLSLRKGTTLTKEMFLNHLYGGMDEPELKIIDVFICKLRKKLEAVSSNINYIDTVWGRGYVLRDPVEENVRKTA		233		1	Selected	-1	 	
Batch03	BaheA.01550.a	Bartonella henselae	YP_032896.1	Q6G588				Thioredoxin	Potential drug target		MSCIKVDKSNFESEVLTSSTPVVVDFWAEWCGPCKMIAPILDEISMEMQNQVKIAKVNIDENPELATQYGVRSIPTLLMFKDGNIASNMVGAASKGRVSEWIKEGLR		107		1	Selected	-1	 	
Batch03	BaheA.01556.a	Bartonella henselae	YP_034301.1	Q6G5B7				glutamine amidotransferase	Potential drug target		MFVMQRCPDKKQRKSKPRIAVVIHRQSTYTGRLGKFLQKSGFVLDIYRPILGQKLPNTLEHYAGVVILGGLMSVNDKEAYIGEEIDWISLVLKENKPFLGICLGAQMLARNLGGRVCTRNDGTVEVGWYPLEATPQGKALMKWPEMVYHFHDEGIYDLPKEATLLATGYTYPTQAFRYGKNAWGLQFHAEFTRAMMRRLVVRSAQKLTEKGAQPASAHLKGRLIYDQALSRWFENALQKIFCVSTVCV		248		1	Selected	-1	 	
Batch03	BaheA.01559.a	Bartonella henselae	YP_032876.1	Q6G5A8				Dephospho-CoA kinase	Potential drug target		MKIIGLTGSIAMGKSTVADFFRQAGISVFSADEAVYKLYKSEPTLSLIEYKFPGVFENGKVNRQKLSEILINDNEKLQTLEKIIHPLVQEKEKKFIDTARQQGEKLVVLDIPLLLETKGEKRVDSVVVVSAPLAIQKERAMIRQNMSEKKFAFINGRQMSDEKKRARADFIIDTGKDLENTREQVLFVIKSLLKN		195		1	Selected	-1	 	
Batch03	BaheA.01561.a	Bartonella henselae	YP_033231.1	Q8L205				glucose-6-phosphate 1-dehydrogenase	Potential drug target		MVSKIIPVSPFDCIVFGGNGDLAARKLIPALYHCQCVGQLSEPTRIIGVSRSSLSGEEYQNFVRASLEKYVHPKDLNRIELNRFLARLTYISVDITSNRGWRDLALPLSEDPSDIRVFYLAVGSSLFGDIAMRLGQNGLVTQKTRIIIEKPIGCNVKTAVQLNDTFASVFDEDQIFRIDHYLGKETVQNLMALRFVNTLYEPLWNSNYIDHVQITVAESLGLEGRIEYYESAGALRDMVQNHMLQLLCLVAMEVPFTNSANAVRDEKLKVLHSLMPLDVRNVEQYTVRGQYLSGILDDVCVKSYLDDLGKEVSRSETFVALKIKVDNWRWADTPFYLRTGKRMSTRMSEIVIVFKPIPHNIFETDSNEIFSNRLVIRLQPDEGVKQWLMIKDPGPGGIRFRHIPLDMSFASTFSQRNPDAYERLLMDVIRGDQTLFMRRDEVEAAWRWIDPILEGWEAIKQPVHGYSAGSWGPSASKLLMERDGRIWNNLV		491		2	Cloned	-1	 	
Batch03	BaheA.01572.a	Bartonella henselae	YP_033882.1	Q6G2R9				Chloramphenicol acetyltransferase	Potential drug target		MNTKKDLRFRESQPRINTTARLHGCKLGRYVEINERVVLRDVTVGDFSYFEHNSEAIYSDIGRFCSIASHVCVNALEHPMERLSTHKITYRPNEYFRYMSLDRSFRERRCEKRVTVGHDVWIGHGAVIMPGVAIGHGAIIGTNAVITKDILPYTIVAGVPAKPLRMRFPDNVIQTLLEMAWWNWPLDKIYNALSDMQNLPIEVFIHKWK		209		1	Selected	-1	 	
Batch03	BaheA.01579.a	Bartonella henselae	YP_033946.1	Q6G2L5				hypothetical protein	Potential drug target		MNSVHPILAKNLSALHTHGIKHGFFTRQDNVSKSLNVGQSPNNQPEYIAQNHIFIADYFGVKVQNLVTVNQIHSCEVVVVDQAFIDEPPKADALVTTTPGLVIGILTADCGPVLFSDPQAGVIAATHAGWRGSLKGIIAKTIAAMEEQGAKRHSITAALGPCIGPCHYEVTDEFYNQFIDCNNEFQKYFLKTEKINHFHFNLWAFIMNQLKEAGINAFCVELCTYQDEQRFFSYRRAIHRNEPDYGRQFSAIALNK		256		1	Selected	-1	 	
Batch03	BaheA.01599.a	Bartonella henselae	YP_033566.1	Q6G3L3				serine hydroxymethyltransferase	Potential drug target		MTKQGNDTQKRFFNDNLQTVDVAIFDAIRGEFERQQHEIELIASENIVSRAVLEAQGSVLTNKYAEGYPGKRYYGGCQFVDVIENLAIERAKKLFGADFANVQANSGSQMNQAVFLALLKPGDTFMGLDLNSGGHLTHGSSVNMSGKWFKSISYGVRKEDQLLDMEAVERLAKEHKPKLIIAGGSAYSRLWDWKKFREIADEIGAYLLVDMSHIAGLVAGGVHPSPVPHAHIVTTTTHKSLRGPRGGLILTNDEILAKKINSAIFPGLQGGPLMHVIAAKAVAFEEALQPVFKDYSANVVANAKTLAKTLQSNGFDIVSGGTDNHLLLVDLRSKKVTGKCAELALGRAHITCNKNSIPFDLETPFITSGIRLGSPAATTRGFAENEFIEIAHMISEILDNLGMAKSDEDNSAVEMVVRKKVEDMTNKFPLYSYLHTC		437		5	Purified	-1	 	NR-16552
Batch03	BaheA.01606.a	Bartonella henselae	YP_033301.1	Q6G4A3				Superoxide dismutase	Potential drug target		MAFELAPLPYDYDSLSPYMSRETLEYHHDKHHLAYLTNTNNFVKDLGLENESLENIVKKSFGQNIGLFNNAAQYYNHNHFWHWMKKGGGGQKLPEKLAKAIESDLGGYDKFRADFIATAIAQFGSGWAWIAVKDGKLEIMKTPNGENPLVHNAQPILGVDVWEHSYYIDYRNVRPKYLEAFVDHLINWDYVLKLYEDCGL		200		3	Expressed	-1	 	NR-16553
Batch03	BaheA.01617.a	Bartonella henselae	YP_033434.1	Q6G3Y0				transcription antitermination protein NusG	Potential drug target		MAARWYIVQAYSNFEKKVAEAIDKEAKQKGLDHLFEKIFVPTERVIEVRRGRKVDAERKFFPGYVLVCAELTDEVYHLIKNTPKVTGFLGSDSRPVPISDREAEQILKQVQERVESPKASVLFEVGEQVRVADGPFVSFNGVVQEVEEERSRLKVEVLIFGRPTPVDLEFNQVEKL		176		3	Expressed	-1	 	NR-16554
Batch03	BaheA.01619.a	Bartonella henselae	YP_033798.1	Q6G302				Single-strand binding protein (ssb)	Potential drug target		MAGSLNKVILIGNLGADPEIRRLNSGDQVANLRIATSESWRDRNTNERKERTEWHNIVIFNENLVKVVEQYLKKGSKIYIEGQLQTRKWQDQNGNDRYTTEIVLQKYRGELQMLDGRAAAGGEQMQGANQSSGAYSSVGFGDNSANQRDVFGSNNSQLGESFSHKLDDDVPF		172		7	Crystallized	-1	 	NR-16555
Batch03	BaheA.01629.a	Bartonella henselae	YP_033038.1	Q6G5J0				"Sugar ABC transporter, ATP-binding protein"	Potential drug target		MAIIQLSNIKKQYENGILVIDDLNLTVADKELLVLVGPSGCGKSTLLRIIAGLEQVTSGELYIDNERINNREPADRDIAMVFQNYALYPHMTVRGNLEYGLKNRKTPKDEINKRITHAAKLLQIEPFLDRKPRQLSGGQRQRVAMGRVIVRQPRVFLFDEPLSNLDTQLRAQMCIEIKTLQRSLGTTSLYVTHDQLEAMTLADRIVVMNKGAIEQIGTPMEIYDYPETTFVADFIGSPSMNFLDRKTLEQHLGHSLSYSQETDLLAFRPEVILLGEYPNQGAVFHTQIELIKPVGTGCHVLTHWNNNIFTIEIKERLTHDYGQKLSFTVPHQSFHSFNKSTGKRTREN		348		3	Expressed	-1	 	NR-16556
Batch03	BaheA.01631.a	Bartonella henselae	YP_032900.1	Q6G584				S-adenosyl-L-homocysteine hydrolase	Potential drug target		MTAQDYVVKDIALAAYGRKELDIAETEMPGLMACREEFSSSQPLRGARISGSLHMTIQTAVLIETLKAIGANVRWSSSNIFSTQDHAAAAIAATGTPVFAVKGETLEEYWTYIDAIFQWPDGNPSNLILDDGADATNYILMGSRAETNKDILSHPKTEEEELFFKQIQRRMEATPGFFTRQRAAIKGISEETTTGVHRLHQLQKEGLLPFPAININDSVTKSKFDNKYGCRESLVDGIRRATDVMIAGKTAIVCGYGDVGKGSAASLSGAGARVKVTEIDPICALQAAMDGYEVVNLDDAASSADIIITTTGNKDIVRLDHMRKVKDMCILGNIGHFDNEIQVAALQNLPWTNIKPQVDMITFPDGKRIILLSEGRLLNLGNATGHPSFVMSASFTNQVLAQIELFTRSGHYKNEVTVLPKYLDEKVARLHLDQLGIKLTTLSQEQAAYIGVTPQGPYKPDHYRY		465		7	Crystallized	-1	 	NR-16557
Batch03	BaheA.01633.a	Bartonella henselae	YP_034021.1	Q6G2F0				glycine cleavage system protein H	Potential drug target		MSKTYFTQDHEWLSVEGQVVTVGITDYAQEQLGDLVFIDLPQNGTKLSKGDAAAVVESVKAASDVYAPLDGEVVEINAALAESPELVNQKAETEGWLWKMTVQDETQLERLLDEAAYKELIG		122		17	In PDB	-1	 	NR-16558
Batch03	BaheA.01643.a	Bartonella henselae	YP_033901.1	Q6G2Q0				"UDP-N-acetylmuramoylalanyl-D-glutamate--2,6-diaminopimelate ligase"	Potential drug target		MLFGTIFTECLEDENLSSMEITGISADSRQILPGYIFVALQGHQDDGKHYINDALKRGAQAIVTDCNVVLENLSVPLLRVLDARHSLAVAAARFYGSQPETVVAVTGTSGKTSVVSFLRQIWTKVGLCAASIGTLGVVSPKRNDYGSLTTPDPVFLQRLLSEIANEGVTHAALEASSHGLDQCRLDGVRLTAAAFTNLGRDHMDYHTSVEDYLRAKMRLFDTLLPRDASALIFADDIYSQKVIDTLTQARRHVLTIGRKGQFITINRIEHQRSKQCVECRLENNIYTFNLPLAGDFQVNNALMAAGLAISTGISPDKVFRSLETLQGAPGRLELVGKTENNASVYIDYAHKPEALEQVLLSVRPFTQGRLILVFGCGGDRDQGKRPLMGKIAENKADIVIITDDNPRTEMPAKIRKDILQAAPKAIEIADRGEAITYAVGLLKAGDTLIIAGKGHENGQIIGQKTYPFSDRLKAIEALQERIR		483		4	Soluble	-1	 	
Batch03	BobuA.00177.a	Borrelia burgdorferi 	NP_212398.1	O51279				heat shock protein 70 (dnaK-1)	Potential drug target		MFMKKWIGIDLGTTNTVASYFDVSSKIILNERGERITPSIVSFSDKDVLVGSAAKNQILVNPQKTFYNFKTNIGSNNFYKVDGEFYKAEYISAHLLASVKRNAEKFLDEEIENAVITVPAYFSEIQRRCVVEAANFAGLNCKAILNEPTAAAIAYAFERQIDGIFLIYDLGGGTFDVTLMEKQGDTYTVLSVKGQSRLGGNDFNKIIEKYVLDSFKNKYPDFNLEDIFLLEQLRERIEEGKKNLSVMEEVDITLLFLDGKHLNYNLKRDEFNSMISEYIDKTIQLSMECIADSGVDISSVSKIILSGGSTRIPLIEKVLKESFPSATILDALNQDEVVAIGAGIHAFSLSRNDSVIKFKDVTPYSLGLEIKDNEFFTLIKRNTALPISRSKLFTTTNDYQDEIEIHILQGEYKKASLNYSIGRFSFGNIQKALKGIPKIEVLFTLNESGILSVNAKDLETNSSNFIEIKITSSSDNVAKESLSNTFTSIID		491		3	Expressed	-1	 	
Batch03	BobuA.00194.a	Borrelia burgdorferi 	NP_045689.1	P17739				outer surface protein B (ospB)	Potential drug target		MRLLIGFALALALIGCAQKGAESIGSQKENDLNLEDSSKKSHQNAKQDLPAVTEDSVSLFNGNKIFVSKEKNSSGKYDLRATIDQVELKGTSDKNNGSGTLEGSKPDKSKVKLTVSADLNTVTLEAFDASNQKISSKVTKKQGSITXETLKANKLDSKKLTRSNGTTLEYSQITDADNATKAVETLKNSIKLEGSLVGGKTTVEIKEGTVTLKREIEKDGKVKVFLNDTAGSNKKTGKWEDSTSTLTISADSKKTKDLVFLTDGTITVQQYNTAGTSLEGSASEIKNLSELKNALK		296		3	Expressed	-1	 	
Batch03	BobuA.00198.a	Borrelia burgdorferi 	NP_212287.1	O30563				superoxide dismutase (sodA)	Potential drug target		MSWQKLKQEVFMFKLPELGYDYDAVEPYIDAKTMEIHHSKHHNGFVMNLNSILEKMGKIHLTDVSNILKNIHDFPEEFQTLIRNNAGGYSNHTLYFRTLRPGNKDNLFEKFKDDINAAFGSLDVLKANLKDTAMKIFGSGWAWLVLCPESGLKVISMPNQDSPLMNSYKPILGIDVWEHAYYLKYQNRRIEYVDAFLKALNWEEVSKVYNEVIN		214		2	Cloned	-1	 	
Batch03	BobuA.00220.a	Borrelia burgdorferi 	NP_212331.1	O51215				"protoporphyrinogen oxidase, putative"	Potential drug target		MNINEVINYAKGXNLDTIEALLILELILKTKKELIIANIKKSLTKKEKKLFFDQIDKIEKGIPIHYILQKKEFMGIEFSLNKHVLIPRFDTECLAEEALIQIQQNGFKKILDLCCGSGCIGLSIAYYIRKKVILSDISTKALQIVEKNTKKLKLEKFVEIIHSNLLKCIKGKLDIIITNPPYLNKEELEIKNKIKKEPTKALLGFGKDGLNISRKILNQAKEKLSPNGLIIIESAPWQIKSLKDFAIKKGFSHLKTIYDLEKRARALILGQRDDTSIRNCTFNQDK		286		2	Cloned	-1	 	NR-16013
Batch03	BobuA.00222.a	Borrelia burgdorferi 	NP_212828.1	O51637				signal recognition particle protein (ffh)	Potential drug target		MFLMLESLGSNFRNFINYLSGKSTINDKNIAEAIEIIKNSLVDADVNLRVIRRFLNSIIEESKGVKVLRGIDPKSQFIKIVNDNLVKFLGGKNYELSLHPANKQSYILMLGLQGSGKTTTCAKLSLKLKKENRKVLLVAADTFRAAAVEQLKILGGQVGVPVFSIEGEKDPIKIVKASMKFAESNFFDSVIVDTRGRLEIESLLVEEIKKIKGILRPAETILVVDSMMGQVAVNIAKEFNENVGLTGAIFSKFDSDTRGGAVLSFKSICAVPIKFIGVGEKIEDLDSFYPERIASRILGMGDVVSLVEKVQSVVDKEEAIKLEEKINKASFNFEDYLSQFRRIRQVGGFSNFVSFLPGVSKSMLNSNNLNEESFNKEEAIILSMTKKERINPVILNNPSRKKRIAMGSGTTVFDVNKLIKKFSQATLIMKKMKNKDFQNKIASLLGK		447		2	Cloned	-1	 	NR-16014
Batch03	BobuA.00224.a	Borrelia burgdorferi 	NP_212806.1	O51615				chemotaxis response regulator (cheY-3)	Potential drug target		MIQKTTIAADSSSKPRGINYDTGIPFNVLIVDDSVFTVKQLTQIFTSEGFNIIDTAADGEEAVIKYKNHYPNIDIVTLDITMPKMDGITCLSNIMEFDKNARVIMISALGKEQLVKDCLIKGAKTFIVKPLDRAKVLQRVMSVFVK		146		-2	Work stopped	-2	Work stopped	NR-16015
Batch03	BobuA.00238.a	Borrelia burgdorferi 	NP_212668.1	O51484				exodeoxyribonuclease III (exoA)	Potential drug target		MKLISWNVNGIRAVLKKGFLEFVKEYTPDILCIQETKALREQLPKDLILENYYSYFSNSKIKGYSGVCIYSKVEPISVRLLGEEIFDNEGRGLVACYDDFILVNGYFPNSQVLRRRLGYKLDFLSYVENLADSLVCDGKNVVICGDFNIAHTEIDLISPDSNRDSPGYYIEETTWLDDFLNKGYVDTFRIFNKDPGYYTWWSYRTRARERNMGWRIDYFIVNEFFKRNVEKSLILDKVMGSDHCPVFLELADVVS		255		2	Cloned	-1	 	NR-16016
Batch03	BobuA.00260.a	Borrelia burgdorferi 	NP_212976.1	O51782				"ornithine carbamoyltransferase, catabolic (arcB)"	Potential drug target		MMYNLRNRSFLNLLDFTSKDIKYLLDLSINLKKSKYAGIEVQKLKGKNIVIIFEKDSTRTRCAFEIAAYDQGANITYLGSKGNQMGSKESMIDTARVLGRMYDAIGFRGFSQQTVECLANYSNVPVYNGLTDISHPTQILADLMTIKEHKGSLKGIKIVFCGDGRGNVANSLLKGCAIMGLDFRIFAPKELFPDPDLTLKARSLALESGGKITITDSKEEAVKCADVVYTDVWVSMGESNWEDRINLLKAYQVNKEIMCMAKDDAIFMHCLPAFHDLNTVIGKDIFDKYGLDGIEVTEEIFESKNSVVFDVAENRVHTIKAIMVSTLG		328		2	Cloned	-1	 	NR-16017
Batch03	BobuA.00262.a	Borrelia burgdorferi 	NP_212794.1	O51604				GTP-binding protein Era	Potential drug target		MKSGFAAILGRPSTGKSTLLNSICGHKISIISPIPQTTRNNIKGIFTDDRGQIIFIDTPGFHLSKKKFNIAMMKNIHSSIGEVELILYIIDIQDKPGEEENKMLEIIKNSKIKFLVILNKIDLKNTKIKEITQFLKEKGIEDSNIIKISAEKKINTEELKNKIYENFSEGPLYYPQEYYTDQEINFRISEIIREKAIENLKEELPYSLYVDIDTLENKKGSLFIRANIFVANESQKGIIVGKNGKEIKSIGERARKTIAKIFETKCNLFLQVKLKKNWNKEDKLIKRLIN		290		2	Cloned	-1	 	NR-16018
Batch03	BobuA.00269.a	Borrelia burgdorferi 	NP_212255.1	O51147				ribosome releasing factor (frr)	Potential drug target		MEDYKAFLDEKMNKVLLSLDNEYKTLRTGRISSNIFDRICIQYHDRRTPITQVSSIRIPEARLVVIQPWDKSILNKIEQAILNSDLSMNPSNDGSVIRIKVPNLTSERRQEIVKHAKKIAEEHKISTRNIRQDLNNKVKKQEKESEITEDCLKRILDDIQKSTDMYIKKIDSILESKIQEIMEA		184		2	Cloned	-1	 	NR-16019
Batch03	BobuA.00276.a	Borrelia burgdorferi 	NP_212189.1	Q59182				triosephosphate isomerase	Potential drug target		MRKTFLAGNWKMHYTSAEASIVAKKIATEVKTLKDDVVIMITPPFTALSKVSECIKGSNILLGAQNMSYMESGARTSEISPSMLLEFGVEYVILGHSECRLYLAETDEIINKKILAGLKHPFKYLILCVGETLDERDSGKTLEVVLNQVKKGLNCVSESDIQRIILAYEPVWAIGTGKTATKEEAEEVHKAIRLEITKLYSKSASDNIIIQYGGSVNSNNVKELMNEPNIDGALIGGASLKAESFLSIINNVL		253		5	Purified	-1	 	NR-16020
Batch03	BobuA.00280.a	Borrelia burgdorferi 	NP_212617.1	P94272				50S ribosomal protein L22	Potential drug target		MLVNRRYTAKGKNLPSSPKKVRPIADNIRGESYIKAIAVLCSMPNKGAKLLEKVVKSAASNAMYHNKNLSEDMIFVKTVMVDDGRRRKKIWPRARGRADRLVNRNCHIFVEVDEKKDIKG		120		-2	Work stopped	-2	Work stopped	NR-16021
Batch03	BobuA.00298.a	Borrelia burgdorferi 	NP_045547.1	O50870				hypothetical protein	Potential drug target		MKYHIITTIFVFLFLACRPDFNIDQKDIKYPPTEKSRPKTESSKQKESKPKTEEELKKKQQEEELKKKQQEEELKKKQQEEELKKKQQEEELKKKQQEEELKKKQQEEELKKKQQEEELKKKQQEEELKKKQQEEELKKKQQEEELKKKQQEEELKKKQQEEELKKKQQEEELKKKQQEEELKKKQQEEELKKKQQEEELKKKQQEEELKKKQQEEELKKKQQEEELKKKQQEEELKKKQQEEEKEELRKQQLKNTLSNDLKKQIESAYNFKEKYVKSMEKEPEDHYGMTSFRGLNWGPGTEDISDNTERSIRYRRHTYTVLSPLDPHELKEFANIIQDINKLASVASIFNSFSAIGGALDIVSDHLYFKKDNLDKLDIADLEILKNSFEQILYIKGSVAGKAKKLLLDYKNLKTDINKLKSYSNELVNGIKQQALEAENLEELIVSKYKL		451		1	Selected	-1	 	
Batch03	BobuA.00299.a	Borrelia burgdorferi 	NP_212199.1	O51092				polypeptide deformylase (def)	Potential drug target		MKGGWVFMEMVFYPNDLLRVKTKQIENIDDKIRDYAKKMIELMDISGGVGLAAPQVGLDLALFVVRENKMARPLVFINPSIIETSYEFSSYKEGCLSIPGVYYDLMRPKAVVINFHDENGKSFTIENSDFLARIIQHEMDHLNGVLFIDYYEEKLKNKLLKPYMRERGLKAK		172		2	Cloned	-1	 	NR-16022
Batch03	BobuA.00310.a	Borrelia burgdorferi 	NP_051280.1	O68235				"plasmid partition protein, putative"	Potential drug target		MDNKKPKIITIASIKGGVGKSMLSIIFSYILSEMNNKVLIVDLDPQNSLTSYFLQYIRNIELNNVYYLLKRDQNIAFNEYINSINNNMYIIPAHPILCKFEKGDIPYKELMLEHIFDKNLHYYNFDYVVIDTPPSLSSLLFNALNITHKVIIPIQAERWSVESLPILMNEIKEVEIIRKKNIDVLIIENQFIKNRNTYKDIESILQSEYKDLIKGRVHFYNSIKVFINELKEPNNKEIYYQEIKKILNNMF		251		2	Cloned	-1	 	NR-16023
Batch03	BobuA.00327.a	Borrelia burgdorferi 	NP_045749.1	O50965				FAD-dependent thymidylate synthase	Potential drug target		MNKEYKILDNGFLKLIDFMGDDRRIVKAARISYREESVKRKDAELIDYLIRNGHTSPLEQVVFTFHVKAPIFVARQWMRHRTARINEVSGCYSLAREEFYVPLEEDLKCQTSSNSSEKEFKSLEKLSDKIKHHQKHSYELYQDMINANIPKELSRIVLPLSLYTEWYWQIDLNNLFHFIKLRLALDSPKEIKENSPKEMREYAKALISIVREIVPIAFNSFENHFLRGKRFSHEEIIAIINALDLNKLSMDAEKLNLLKDKLGID		265		2	Cloned	-1	 	NR-16024
Batch03	BobuA.00362.a	Borrelia burgdorferi 	NP_212732.1	O51544				UDP-N-acetylmuramate dehydrogenase (murB)	Potential drug target		MPKSLNNFLKKINIKPQTKNLANYTTYKIGNISKLFLTPKNIKEAENIFKAAIEEKIKLFILGGGSNILVNDEREIDFPIIYTGYLNKIEIHENKIVGECGADFESLCKIALDNSLSGLEFIYGLPGTLGGAVWMNARCFGNEISEILKKITFIDDKGKTICKEFKKEDFKYKISPFQNKNFFILKIELNLKKDNKKIIEEKMNKNKQARINRGHYLFPSGGSTFKNNKAFLKPSGQIIEECKLKGLSIGGATVSKYHGNFIININNATSKDIKSLIEKVKAEVYLKTGLLLEEEVLYIGFK		302		2	Cloned	-1	 	
Batch03	BobuA.00365.a	Borrelia burgdorferi 	NP_212513.1	P94252				protein kinase C1 inhibitor (pkcI)	Potential drug target		MLFFYNRIFLMYDCIFCKIINKELPSYKVYEDDLVLAFLDINPLTVGHTLVIPKEHSESLLNMDDKFNERVLKVCKKISNALKRINSSIYGGINIYSALGAGAGQEVFHTHFHVIPRFKNDGFGFKRGNKLNLEVEKFKELSMQISMNI		149		2	Cloned	-1	 	NR-16025
Batch03	BobuA.00390.a	Borrelia burgdorferi 	NP_212916.1	O51723				hypothetical protein	Potential drug target		MVFGYQILFRKEIVRIAILGGTYNPVHIGHIFLAKEIEYLLNIDRVIFIPTCNPAHKLIDENVSVSNRIDMLKLALENEDKMFIDDCDIINGGITYTVDTISCVKKKYKNDKLFLIIGDDLFQNFDSWKDPQSIVSSVELVVAHRIYKERLKSSFKHIYIDNKIIPISSSEIRNRIVNGLPVSYLLPFGVLKYIKDNNLYVKKVNV		206		2	Cloned	-1	 	NR-16026
Batch03	BobuA.00405.a	Borrelia burgdorferi 	NP_212889.1	O51696				ribonuclease Z	Potential drug target		MGFNINIIGTGGTRPLHNRYLSSVLIEYDGDNFLFDCGEGTQMSLRKQKISWQKIKMICITHLHADHITGLLGIVMLMSQSGETRKEPLIIAGPVGIKNYTQANINMLKIYKNYEIIYKEIIIDKTEKIIYEDKTKKIEYTKLKHSIECVGYLFIEKDKPGKFNTEKAEELNIPKGPIRKALQDGKEILVNGKIIKPSEILGKSKKGLKVAYITDTGYFKELIQQIKNFNLVIIESTFKNELKKEADKKLHLTAGGAANIVKQAKVLQTGLIHFSERYTLRKDLENLLKEAKLEHPDGEIFLTRDGMRLEANKNNFIIK		319		2	Cloned	-1	 	
Batch03	BobuA.00420.a	Borrelia burgdorferi 	NP_212243.1	O51136				acetyl-CoA C-acetyltransferase (fadA)	Potential drug target		MIKKVAIIDGLRTPNFKFGGSFKGLNIIDESSKVVKALLERNKLYKVDEVIIGNVISAGLGQNIARQIALKSDLGDTVPAFSVNKVCGSGLKALELAFNSIALGDNDIVLAGGVEDLTNSPYLLPRKIRFDGLKFGNFGIEDSIQKDALIDSLNFISMGLTAENLSEKYRITREMQDEFAYNSHVKALKARELGYFEDEIYPLTVFDKKTNSSVTISSDEEIRDNLTLNKLASLNPVFKESGTVTAGNSSSLNDGACFLILASEERVKSLGLSPLAYIGGFKSVGLDPLYMGFGAYMAIEGIISKLSLNPSEIDLIEVNEAFAAQALSIEKALFKKYNITSDIINVNGGAIALGHPFAVSGSRILLTLSRSMKMKNKTKGIASVCIGGGQGISSFLYR		398		3	Expressed	-1	 	NR-16027
Batch03	BobuA.00444.a	Borrelia burgdorferi 	NP_212191.1	P46795				glyceraldehyde 3-phosphate dehydrogenase (gap)	Potential drug target		MKLAINGFGRIGRNVFKIAFERGIDIVAINDLTDPKTLAHLLKYDSTFGVYNKKVESRDGAIVVDGREIKIIAERDPKNLPWAKLGIDVVIESTGVFSSATSDKGGYLDHVNHAGAKKVILTVPAKDEIKTIVLGVNDHDINSDLKAVSNASCTTNCLAPLAKVLHESFGIEQGLMTTVHAYTNDQRILDLPHSDLRRARAAALSIIPTSTGAAKAVGLVLPELKGKLNGTSMRVPVPTGSIVDLTVQLKKKDVTKEEINSVLRKASETPELKGILGYTEDPIVSSDIKGNSHSSIVDGLETMVLENGFAKILSWYDNEFGYSTRVVDLAQKLVK		335		17	In PDB	-1	 	NR-16028
Batch03	BobuA.00466.a	Borrelia burgdorferi 	NP_212745.1	O51556				ATP-dependent Clp protease proteolytic component (clpP-1)	Potential drug target		MEFMHNLIPTVIENTGNYERVFDIYSRLLRERIIFLSGEINDPKADTVIAQLLFLESEDSSKDIYLYLNSPGGSITAGLAIYDTMQYIKPDVRTICIGQAASMGAFLLAGGAKGKRESLTYSRIMIHQPWGGISGQASDINIQANEILRLKKLIIDIMSNQIGVDKEKLALDMERDYFMTSSDALKYGLIDSILVRE		197		2	Cloned	-1	 	NR-16029
Batch03	BobuA.00508.a	Borrelia burgdorferi 	NP_212334.1	O51218				D-alanine--D-alanine ligase (ddlA)	Potential drug target		MLIFGGVSFEHEISCKSAYSIYLALLDLNKYNIYPVYIDKCTGVWYLLDSVSDPPKPINTDVLPIVSLLPGFGIFSNNKNLEIDVVFPVVHGRTGEDGAIQGVLKVMDIPCVGAGIIGSAISSNKYFCKLLLKSFDIPLVPFIGFRQHDYFLDKEEIKRNVKEVLGYPVIVKPAVLGSSIGINVAYSENQIESFIKEALKYDLTIVIEKFIEAREIECSIIGNEKMKIFSPGEVVVQDFIFYDYDAKYSVIPGNSIIFNIPAHLETNQLLSIKEYAFLTYKNLELRGMARVDFFVEKKSGTIYLNEINTIPGFTDISMFAKMCSNDGLQFKDLVDNLIDYAFQSYINRKKRIDFEN		356		2	Cloned	-1	 	
Batch03	BobuA.00512.a	Borrelia burgdorferi 	NP_212613.1	P94268				50S ribosomal protein L4	Potential drug target		MERKVFSKDGKEIGTINLDDRVFNIEISHGSIYNAIKNELSNLRVGTSSTKTRSEVRGSSKKPWKQKGTGRARVGTKRNPVWIGGGIALGPKPRDYSYRLPKKVKKLAFKSVLSLRAADENSFKVIENFNVESGKTKDLALIIKNFASFNGKVVILLGNDDQMIKRAGKNIRDLKILSFDKLRVVDLFYAKNLIALESAVNKLNEFYIK		209		-2	Work stopped	-2	Work stopped	
Batch03	BobuA.00515.a	Borrelia burgdorferi 	NP_212510.1	O50163				S-adenosylmethionine synthetase	Potential drug target		MNKIIAANQTLTSEAVSEGHPDKIADQISDAILDEILKEDKNAKVACEVIIAQNLVVIAGEINSPVKKNIDIKEVAKNIIKDIGYTNIDYGLDYKTITVIDAIGNQSRDIINAIEKKGSNALGAGDQGIIFGYACDETKNFLPAPYELANSILKKASNLRKSGAIKWLRPDSKSQVTIEYDKNRNPVKIKNIIVSHQHHPNISQKLIQQTIIEEIIKPTVQDKSMLDENTAYCINPSGNFVIGGPTGDTGLTGRKIIADSYGGFARHGGGAYSGKDATKVDRSAAYMARYIAKNMVAAGISKEFELQLAYAIGIENPISIQITGGINDPKYANKILNFIVNNFDLTPNGIIEKLKLKQPIYLKTCTYGHFGKNEFEWEKLDFVKKIQTALKK		392		4	Soluble	-1	 	NR-16433
Batch03	BobuA.00527.a	Borrelia burgdorferi 	NP_212611.1	P94266				30S ribosomal protein S10	Potential drug target		MIAKDKIRVRLFSFDVKILDQSAESIVKAVQKAKAQIKGPIPLPTKIKKYTVLRSPHVNKKSREQFEMRTHKRLIDILEPTSALMDSLMKLELPAGVEVDIKQ		103		-2	Work stopped	-2	Work stopped	
Batch03	BobuA.00529.a	Borrelia burgdorferi 	NP_212897.1	O51704				response regulatory protein (rrp-2)	Potential drug target		MKMSKILVADDEKNIREGIATYLEDEGYFVFTASDGEEALETIENENLDVIISDLRMPQISGEKLLKIVKEKNLGIPFIILTAHGTVDSAVDAMREGAYDFLTKPLDLERLLLIIKRSLNKKENNDNENANLENILIRKDLKYYEKIMGKSLLMQKIFELVIKIAKSNASILITGESGVGKEIIADAIFDLSNRNDKPFIKVNCAALSESILESELFGHEKGAFTGAISKKKGRFELANKGTIFLDEIAEISPEIQVKLLRVLQNKTFERVGGEATIKVDIRLLAATNKNIEEEIKKEKFREDLFYRLNIININIPPLRERKDDISYLTNILIKDVAKENNREEKTLSNDAMKALYYYDWPGNIRELKNVLESALILSKGKQITKEDLPAKIKNNENLIFKITLPXGISLKEAEKEIIKQTLFHSKNNKSKCAEILKIGRKTLHNKIIEYNID		453		5	Purified	-1	 	
Batch03	BobuA.00535.a	Borrelia burgdorferi 	NP_212636.1	O51455				DNA-directed RNA polymerase subunit alpha	Potential drug target		MMLVEKFLKDFTIPEKIEFLKSQGDGSYGKFTIYPFERGFGITIGNTLRRVLLSSIEGYAITAMRVQSNNKDSSSKVVSSEFDLIPGVSEDTLEIIANIKNIHLKLGEGEQRKTISFSVSGKDTNVLKASHFERDGVEVFNKDLVIATLSHDVNLDLEFQINYGRGYVSSEQNSKYLEEVNVIALDSIFSPIEKVSYSVEDTRVGQRSDYDKLVMEIWTTGVISAKDAIKKAASIVREFLFPLVDFEDNVNTSFEKSKSESSNLLDMSIEKLNLSVRSLNCLAKENVRTLGELISKNAEELSKARNFGKKSLEEIIEKLGSYRLYLGMSKEDALSVLSKNVKISE		345		7	Crystallized	-1	 	
Batch03	BobuA.00548.a	Borrelia burgdorferi 	NP_045688.1	P0C926				outer surface protein A (ospA)	Potential drug target		MKKYLLGIGLILALIACKQNVSSLDEKNSVSVDLPGEMKVLVSKEKNKDGKYDLIATVDKLELKGTSDKNNGSGVLEGVKADKSKVKLTISDDLGQTTLEVFKEDGKTLVSKKVTSKDKSSTEEKFNEKGEVSEKIITRADGTRLEYTGIKSDGSGKAKEVLKGYVLEGTLTAEKTTLVVKEGTVTLSKNISKSGEVSVELNDTDSSAATKKTAAWNSGTSTLTITVNSKKTKDLVFTKENTITVQQYDSNGTKLEGSAVEITKLDEIKNALK		273		2	Cloned	-1	 	
Batch03	BobuA.00558.a	Borrelia burgdorferi 	NP_212649.1	P94284				thioredoxin reductase (trxB)	Potential drug target		MLEFETIDINLTKKKNLSQKEVDFIEDVIIVGSGPAGLTAGIYSVMSNYKAAILEGPEPGGQLTTTTEVYNYPGFKNGISGRNLMLNMREQVVNLGAKTFPETVFSIKRKGNIFYLYTENYIYKSKAVIIAVGSKPKKLETLKNSGLFWNKGISVCAICDGHLFKGKRVAVIGGGNTALSESIYLSKLVDKVYLIVRKNNLRAIAMLRDSVAKLPNIEILYNSEAIEVDGKSSVSSVKIFNKKDNVVYELEVSAVFMAVGYKPNTEFLKGFLDLDEEGFIVTKDVVKTSVDGVFSCGDVSNKLYAQAITAAAEGFIASVELGNFLK		326		10	Diffraction	-1	 	
Batch03	BobuA.00564.a	Borrelia burgdorferi 	NP_212286.1	O30564				glucosamine-6-phosphate deaminase	Potential drug target		MRLIIRPTYEDISKWAANHVAQKINEFSPTKENPFILGLPTGSSPIGMYKNLIELNKNKKISFQNVITFNMDEYIGIEENHPESYHSFMWNNFFSHIDIKKENINILNGNASNLKKECEEYEKKIKSFGGIMLFVGGIGPDGHIAFNEPGSSLTSRTRIKTLTQDTIIANSRFFEGDVNKVPKNALTVGIGTIMDSQEVLIIVNGHNKARALKHAIEKGVNHMWTISALQLHKNAIIVSDKNATYELKVGTVEYFNDIERKNFNNDLK		268		17	In PDB	-1	 	
Batch03	BobuA.00566.a	Borrelia burgdorferi 	NP_212832.1	O51641				tRNA (guanine-N(1)-)-methyltransferase	Potential drug target		MKFTVLSLFPAIIKPFFENSIMKKAINKGIVSFELVDVRDFSKDKHKRCDDLPYGGGAGMVLKAEPISFALEHVESAKKTTIFLSPSGIKYSQELAYSLSKREEIVIICGRYEGIDQRIIDLYVDFEISIGDYVLSSGEIAALVLIDSVYRLLDGVINPNSLLEESFGVKNGLLEYPHYTRPYDFKGIKVPEVLLSGHHANIKNWRLVKAREKTKKNRYDLYLKYLEIIGEDNGFDKKN		239		5	Purified	-1	 	NR-16434
Batch03	BobuA.00567.a	Borrelia burgdorferi 	NP_212943.1	O51749				tRNA-guanine transglycosylase (tgt)	Potential drug target		MFSVIKNDKHFNARVGFLNLPHGRVDIPCFMPVGTLGAMKGLKHAVLEKLECNLMLANTYHLYLRLGIKTVEKYVGLHNFTIWNKNFLTDSGGFRVFSFSDLRKIDLKGVHFKSHIDGSYHYFTSEGIFAMQEIFGSDIIMPLDICSSYGIDYNEANLYTNITTNWASSTFKSSKNRKEGYNGLLFLITQGNFFKDLRKRSINDILELDSPGIAIGGISVGEPREKYLEILEYSFLLIPKEKPRYVMGIGTPHYILNAIYYGIDIFDCFNPARITRHGSLLTDNGIMCIGRKEYKDDTSKVEKNCICTLCKRYSRGYLRHLIKSKELFGIVLASEHNIHYMFRLISKIRAAILNDDFLNFRTSYLKKYEEENFDE		375		3	Expressed	-1	 	NR-16435
Batch03	BobuA.00590.a	Borrelia burgdorferi 	NP_212472.1	O51313				30S ribosomal protein S9	Potential drug target		MKKSNFSNVNLSMGTGRRKSSVARVYIREGSGNIKVNNRDFDSYIQLENLRTMALSPLVLTNTLGKYDLYINVYGGGISGQSGAIRHGISRALFKLDESNKMILRSNGFLTRDSRKVERKKFGQKKARKSFQFSKR		136		-2	Work stopped	-2	Work stopped	NR-16436
Batch03	BobuA.00613.a	Borrelia burgdorferi 	NP_212521.1	O51348				30S ribosomal protein S12	Potential drug target		MPTINQLIRKPRKSQTEKTASPALQNCPQRRGICTRVMTVTPKKPNSALRKVARVRLSNGFEVTAYIPGIGHNLQEHSVVLIRGGRVKDLPGVRYHIVRGAKDTLGVNNRKKGRSKYGTKKPKA		124		-2	Work stopped	-2	Work stopped	
Batch03	BobuA.00616.a	Borrelia burgdorferi 	NP_212475.1	O51316				aspartyl/glutamyl-tRNA amidotransferase subunit B	Potential drug target		MEYKLVIGLEIHVQLGLKTKAFCGCKNEFGGVPNSRVCPICLGLPGSLPSVNVELINSAILAGHATNSKIRNVVKFDRKHYYYPDLPKGYQISQNDKPICEGGSLLIETPSGPKKINIIRIHMEEDSGKSLHLLDSENQSYVDFNRSGAPLLEIVSAPDINSGDEAVAFLSSLREIFRYLDLSECNMENGSFRCDVNVNLIVKENGVEHKTPIAEIKNLNSFKSIKAAIEYEELRQQQEWIQFKKTLNSCGKHTRGFDDRSGVTVIQRNKETVSDYRYFQEPDLPLIEIDDSYIDNIKNLKLIELPFHARIRLKGQYGLSDFDVITLTADKHLLKYFEEAVINSSDPKKVANWILSEVLSVLNDKGISVLEFNLLPSYITELVEFIVAGKISGKMAKRVFSEMMTRGVSASVVISENQLEQVSDKFVIKQIVLEVLDENPKSIELYKKGKDHAIKFMMGQIMKKSSGKINPILANEILLESLSNV		485		5	Purified	-1	 	
Batch03	BobuA.00621.a	Borrelia burgdorferi 	NP_212836.1	O51645				lipopolysaccharide biosynthesis-related protein (kdtB)	Potential drug target		MRVAVFPGSFDPITWGHIDLIKRSLAIFDKVIVLVAKNKSKKYFLSDIERFSLTKDVISSLNFSNVLVDRYSGFIVDYALINSIKFIVRGIRAFNDFDIEFERYLVNNKLNFEIDTIFLPSSAEHLYVRSDFVKELMLKKDVDLSNFVPELVFNRLKSKFIDK		163		5	Purified	-1	 	
Batch03	BobuA.00645.a	Borrelia burgdorferi 	NP_212233.1	O51126				hypothetical protein	Potential drug target		MNYLEFEVIWGVNNIYSILELNSKLIYEGIFKGKVLETGCKEYSPLVPGDIVLGYIYSSRKVYIDKRLSRKNILWRYNKKADLRQTIVSNIDNVLIVSSANFPEMKNFFIDRVLIVAEEQNIVPIIVINKIDKGISQKAQEFSEIYENLGYKVLKTSVKTYEGIKEVKEVLKNSRTSFIGQSGVGKSSLINLIDSRASQSVNEISHKYSRGKHTTVYSISFHSDSGIIVDTPGIKEFGIETLPFENLKYYFKEFENFASFCKYKSCLHVSEPYCSVTSSLDNGISKLRYESYLKILSELKNYKNYAR		307		3	Expressed	-1	 	NR-16437
Batch03	BobuA.00648.a	Borrelia burgdorferi 	NP_212149.1	Q59190				uridine kinase	Potential drug target		MMAKIIGISGGSGSGKTTVVSKISEFIPEFVLISQDNYYKSVGDYEHEFSKVNFDHPDAFDNNLFYEHLKNLKKNSPIDMPLYDFINHKRQLKTVLVVPTPVVIVEGIMIFVEERVRNLIDLKIYIDTPNDIRFIRRLRRDISKRGRTVESVIDQYLNTTRWGYYRFIEPTKEYADLIIPEGGHNDKALYVLSTFLKSLSKEGLDFT		207		2	Cloned	-1	 	
Batch03	BobuA.00658.a	Borrelia burgdorferi 	NP_212838.1	O51647				acyl carrier protein	Potential drug target		MDNDEIFSKVRSIISEQLDKKEDEITTDSRFVEDLNADSLDIYELLYLLEEAFDDKIPENEANEFETVGDVVNFIKKRKG		80		17	In PDB	-1	 	
Batch03	BobuA.00662.a	Borrelia burgdorferi 	NP_212888.1	O51695				"ABC transporter, ATP-binding protein"	Potential drug target		MINVEKVTKMYGPFTALFNVSFKVEEGEVLGILGPNGAGKSTLIKILTSFHYPSKGNVKIFGKDIVEHSKEILQQIGYVPEKLALYPELSVKEYLKFISEIKGVKKLKKEIDRVISIFKLKEVEDKLISQLSKGFRQRVGIAGALINNPKLVILDEPTNGLDPNQIIEFKEFLRELAKESTILFSSHILSEVESICKRIIIVNNGVIVADDTKENIIKNKLKEIEIELIVSKKSENEKKIFNSKNDIFSLIKLEEHEKDLNISLKLSQGKTEEDLFSYIVKNNIILKAMIPKHESLEKIFSKLTKEREK		309		2	Cloned	-1	 	
Batch03	BobuA.00664.a	Borrelia burgdorferi 	NP_212597.1	O51419				nucleoside-diphosphate kinase (ndk)	Potential drug target		MSMLLQKTLCIVKPDGVRRGLIGDVVSRFERVGLKMVAAKMLIVDESLAKKHYLYDDIVFRHSEAVWNSLIKFISNSPVFTFVVEGVESIEVVRKLCGATEPKLAIPGTIRGDFSYHSFKYSNEKGFSIYNVIHASANEADAMREIPIWFKDNEILNYKRDDECEHYYC		169		10	Diffraction	-1	 	
Batch03	BobuA.00667.a	Borrelia burgdorferi 	NP_212263.1	O51155				hypothetical protein	Potential drug target		MIALKAPRVHVFLAEKGVGSRRFCEELIRKKLVRVNNTIAKLGDKVTLGDRIIYKKQIFVFKDFQINNRIYLALNKPRNYLCSNFDVDGRKLAISLVQPLFKERVFSIGRLDFKSSGLLLFTNDGKFANDIIHPRQKVEREYIIESKKDIDENLLISFKSGIKVKKEFFKLKSYEILNKNSARLILDEGKNREIRKVFLSKNIFLKKIHRIRIGNINLDSLKEGQVKIVPLSKINSLKSRLEKLNDNSN		249		1	Selected	-1	 	
Batch03	BobuA.00692.a	Borrelia burgdorferi 	NP_212498.1	O51339				methylglyoxal synthase	Potential drug target		MEKKIALIAHDKKKEDLVNFVKQNYLFLSKFKLIATGTTGSKIQQATDLTIFKYKSGPMGGDQQIGAEVAEGNILAIFFFRDPLTSQPHEPDVSALIRLCDVHKIPLATNVKTAEILIKGLESLIF		126		5	Purified	-1	 	
Batch03	BobuA.00704.a	Borrelia burgdorferi 	NP_212746.1	O51557				ATP-dependent protease ATP-binding subunit	Potential drug target		MARVKGQKVKECSFCGLSVAELGGNVVISNGVAICPECSKICHNLFKEKLCKPLDSKSNGLPTPKQLKDHLDMYVVGQEDAKKVLSVAVYNHYKRILKNNKYDNGIEIEKSNILLVGPTGSGKTLLAKTLAAEMNVPFAIADATTLTEAGYVGEDVENILLKLIHAAHGDVSLAEKGIIYIDEIDKIAKKNENVSITRDVSGEGVQQALLKIIEGTVANVPPRGGRKHPYEDTIEINTQNILFICGGAFVGLENIVKNRINKSSIGFSAIEKKNIREDTSLKYLEMEDLIKFGLIPEFVGRLPVHSYLEKLNKEDLLRILVDPQNSIVKQYYHMFKMDNVELVFEKDALESIVDEAILKNTGARGLRSILEGLLKDVMFEVPSISKAKKVVVTKESVLNADVNPLILVGNAIKKPWAKELYEINLKYDKK		430		2	Cloned	-1	 	
Batch03	BobuA.00710.a	Borrelia burgdorferi 	NP_212862.1	O51670				coenzyme A disulfide reductase	Potential drug target		MMKIIIIGGTSAGTSAAAKANRLNKKLDITIYEKTNIVSFGTCGLPYFVGGFFDNPNTMISRTQEEFEKTGISVKTNHEVIKVDAKNNTIVIKNQKTGTIFNNTYDQLMIATGAKPIIPPINNINLENFHTLKNLEDGQKIKKLMDREEIKNIVIIGGGYIGIEMVEAAKNKRKNVRLIQLDKHILIDSFDEEIVTIMEEELTKKGVNLHTNEFVKSLIGEKKAEGVVTNKNTYQADAVILATGIKPDTEFLENQLKTTKNGAIIVNEYGETSIKNIFSAGDCATIYNIVSKKNEYIPLATTANKLGRIVGENLAGNHTAFKGTLGSASIKILSLEAARTGLTEKDAKKLQIKYKTIFVKDKNHTNYYPGQEDLYIKLIYEENTKIILGAQAIGKNGAVIRIHALSIAIYSKLTTKELGMMDFSYSPPFSRTWDILNIAGNAAK		444		5	Purified	-1	 	
Batch03	BobuA.00738.a	Borrelia burgdorferi 	NP_212905.1	O51712				RNA polymerase sigma factor (rpoS)	Potential drug target		MNIFSNEDLNIYLKSVREHKLITHEEEIKLAGQIQRGNAKAKNKMINANLRLVLKIIKRYAGKGLKIEDLIQEGNLGLIRAAEKYDPNKNTKFSTYASFWIKQSLQRALNTKTRLVKVPYRKENLILQINKYLTEEEKSPKKEEIMKRFNLSPAQYIKIIPYLEKEYSLDKEIEGSENSTLLNLYEDNSFNPEITLEQDSTLKHLNYILETKLNEKERYIIKKRYNLDNSPKKSTLKDISTELGISSETVRQIEKRVLKKLKEEIN		266		4	Soluble	-1	 	
Batch03	BobuA.00741.a	Borrelia burgdorferi 	NP_212685.1	O51501				chemotaxis response regulator (cheY-1)	Potential drug target		MDKRSASLEESKKALIADDSLFMRKNLIKILSQLGFKEFLEAEDGIQAVKEFEKQNNIDLITLDITMMGMDGITALERMYEINKKLLKKVNILMVTAIGKQELIQKALSLGARGYITKPFKKEQIIEQIKLLD		133		5	Purified	-1	 	NR-16086
Batch03	BobuA.00743.a	Borrelia burgdorferi 	NP_212139.1	O51038				tryptophanyl-tRNA synthetase	Potential drug target		MILKRKVMLTGDRPTGALHLGHYVGSVVNRLKFQEEYETYFIIADLHTLTTKPDLKSINTIPSNVREMVLDYLACGINPDKVSIYLQSAIPELFELHLIFSMIVTVARLQRIPSIKDMSIAAGLKEIPYGLLGYPVLMSADILMTKANLVPVGRDNESHIEFARELARRFNHLYKNNFFPIPESVFTDSRPLVGIYGKNKMSKSLDNAIFLNDDENLLEKKIMSMYTDPNRIRADIPGNVEGNPIFIYHSFFNSNHEEVEDLKSRYKKGKVGDVEVKKKLFLALNSFLKPIRDKRSFYEAKKKDYIDEIIFDGTSKARFIANKVVKDVKDLIGLSKTWNGIKYSAEKKLKNEE		353		3	Expressed	-1	 	"NR-16087, NR-16438"
Batch03	BobuA.00755.a	Borrelia burgdorferi 	NP_051409.1	Q9S065				"plasmid partition protein, putative"	Potential drug target		MDTKKPKIITIASIKGGVGKSTSSIIFATLLAQKYKVLLIDLDTQASTTSYFCKKLENQKIDLVNKNIYRVLKDTLDVNNAIVNIKENLDLIPSYITLHKFSNEFIPHQELRLKDSLIFLKQDYDYIVVDTNPSLDFTLSNALITSNCVIVPMTAEKWAIESLDLLEFHIENLKIKIPIFLLVTRFKKNNTHKELLKYVESRERFLGFIHEREDLNKKIAGNNEFNMDKDYINEYKEALSKFFEIY		246		4	Soluble	-1	 	
Batch03	BobuA.00758.a	Borrelia burgdorferi 	NP_212722.1	O51534				pfs protein (pfs-2)	Potential drug target		MNNCLIKFFIFLLVFSNSYVAFSKNVNVLIVTAMDSEFDQINKLMSNKEEIVLKEYGLNKKILKGKLSNRNVMVIICGVGKVNAGVWTSYILSKYNISHVINSGVAGGVVSAKYKDIKVGDVVVSSEVAYHDVDLTKFGYKVGQLTGGLPQKFNANKNLIKNAIEAIKSKVGGSNAYSGLIVSGDQFIDPTYINKIIGNFKDVIAVEMEGAAIGHVSHMFNIPFIVIRSISDIVNKEGNEVEYSKFSKIAAFNSAKVVQEILRKL		265		2	Cloned	-1	 	
Batch03	BobuA.00776.a	Borrelia burgdorferi 	NP_212511.2	O50164				S-ribosylhomocysteinase	Potential drug target		MKKITSFTIDHTKLNPGIYVSRKDTFENVIFTTIDIRIKAPNIEPIIENAAIHTIEHIGATLLRNNEVWTEKIVYFGPMGCRTGFYLIIFGDYESKDLVDLVSWLFSEIVNFSEPIPGASDKECGNYKEHNLDMAKYESSKYLQILNNIKEENLKYP		157		5	Purified	-1	 	"NR-16088, NR-16089"
Batch03	BobuA.00776.b	Borrelia burgdorferi 	AAC66762.1	O50164				conserved hypothetical protein	Potential drug target		MGKIRFCKKNTNSAKKMKKITSFTIDHTKLNPGIYVSRKDTFENVIFTTIDIRIKAPNIEPIIENAAIHTIEHIGATLLRNNEVWTEKIVYFGPMGCRTGFYLIIFGDYESKDLVDLVSWLFSEIVNFSEPIPGASDKECGNYKEHNLDMAKYESSKYLQILNNIKEENLKYP		173		5	Purified	-1	 	
Batch03	BobuA.00801.a	Borrelia burgdorferi 	NP_212704.1	O51517				chemotaxis response regulator (cheY-2)	Potential drug target		MKKRILVIDDNRAIRQSVAYILEQNGFGVSEAKDGLEGVLRFKEAVGQGDKDFDLVITDINMPNLDGIGVIKQIREFGSFVPILVLTTESEQSKVDEGRKAGATGWLVKPFNPEALMKTISKIF		124		1	Selected	-1	 	
Batch03	BobuA.00812.a	Borrelia burgdorferi 	NP_212160.1	O51057				methylenetetrahydrofolate dehydrogenase (folD)	Potential drug target		MGFKGYILSIVFNGKDFANKYYLMLKEFLKQHNLRDKIALKVVLANDEPASNLYVSIKSRVAKEIGLNVEVIKFSANSVQSDILEVIDRENKNLSTDGIIVQLPLLKGMDLNSILNSIVYSKDVDGLSFVNLGKMILGDKKGFIPCTALAVLKILRDEGIKTLGKTVVVVGRSPLVGRPISILLSSKPYDATVIVCHSKSIYLDVYLRQADIVISAVGKPRLIDKSMLCGKPYVIDIGISEIETDNGKILSGDTDFDNIKECVKFITPVKGGIGPVTVLMLMFNTIKAHLINNRMFDVLNRLEKLLEV		308		3	Expressed	-1	 	
Batch03	BobuA.00825.a	Borrelia burgdorferi 	NP_212235.1	O51128				asparaginyl-tRNA synthetase	Potential drug target		MINKMFASIKDILKNPILNSNVTINGWIRTKRSNGKIGFIEINDGSTLKGIQAVINEEENQFSEKDLKKLTTGTSISLTGLLVESPAKGQNYEIKTHSFNVIGETDPETYPLQKKRHSFEFLREIPHLRIRTNTFGAIARVRNKISYKIHEYFQKNGFFYINTPIITSNDGEGAGEMFRVSTLKFNKLNNALSNIDFKDDFFGKEAFLSVTGQLHGEAYAMALSKIYTFGPTFRAENSNTTRHASEFWMIEPEMAFYKLNDNIALAEDLLKYLLSSILNECSQDMDFLENYIEKGLIKKLENVINSNFEVITYTKAIEILENSKKNFEIKPYWGIDLQTDHERYLTEETFKKPVVVIDYPKNFKAFYMKANKDNKTVKGMDILVPKIGEIIGGSEREDDLQKLENRIKELNLNIEHLNWYLDLRRFGSAPHSGFGLGLERLVQYSTGISNIRDSIPFPRTPKNLYF		466		1	Selected	-1	 	
Batch03	BobuA.00838.a	Borrelia burgdorferi 	NP_212915.1	O51722				GTPase ObgE	Potential drug target		MYNFKDSVNITVVSGNGGSGCVSFLREKFNAKGGPDGGNGGSGGSVIFKVRENLSTLSFYKNGHVLCAENGKPGMGFKRSGANGKDLTLFVPPNTEVYNENDGTLLYRLKNLNDEFVVLKGGRGGLGNWNFKTSVRRVPRFAQPGESGNSLSVRLELFLVADIGLVGLPNAGKSSLLNRITSAKSRVANYPFTTKIPHLGMLRRSYDDLIIADIPGIIKGASFGVGLGTKFLKHIAKTKILALVIDISEANFLESYNILLNELKSYSHKLFNKKKIIIANKLDLDGSEKNFDCLIKALGKEKVVGISIYENRGIDELIKEFFILAKTF		328		1	Selected	-1	 	
Batch03	BobuA.00842.a	Borrelia burgdorferi 	NP_212875.1	O51683				co-chaperonin GroES	Potential drug target		MFEMKNIKPLADRVLIKIKEAESKTISGLYIPENAKEKTNIGTVIAVGSNKEEITVKVGDTVLYEKYAGAAVKIENKEHLILKAKEIVAIIEE		93		5	Purified	-1	 	NR-16090
Batch03	BobuA.00843.a	Borrelia burgdorferi 	NP_051472.1	Q9S009				"plasmid partition protein, putative"	Potential drug target		MDRKESNIITIASPKGGVGKTTLTILFSYILKDLSKKVLLIDLDPQNSLSSYFSKYIFNIDKCNSYSLLKKDVYFGQCINKINDFISIIPSHPILENFNSEILNYKDLLLENILNRNITNYNFDYILLDTPPNLGFILKNSLNVTDYIIIPVQVERFSVESLSILMQTINDIKDFRNKSFNISIIENQFLKNRNTFKDVEELLYKEYSFYIKGKIHYYNSVKVLINELLEPSVKETYYEETKNTLENIINLHF		253		1	Selected	-1	 	
Batch03	BobuA.00845.a	Borrelia burgdorferi 	NP_212352.1	O51236				"phosphate ABC transporter, ATP-binding protein (pstB)"	Potential drug target		MIKEKDTPKNEVIIETENLNLFYTDFKALNKINMKILKNSITALIGPSGCGKSTFLRTLNRMNDLVEGIKIEGNVIYEGKNIYSNNFDILELRRKIGMVFQTPNPFLMSIYDNISYGPKIHGTKDKKKLDEIVEQSLKKSALWNEVKDKLHTNALSLSGGQQQRLCIARTLAIEPNVILMDEPTSALDPISTGKIEELIINLKESYTIIIVTHNMQQAGRISDRTAFFLNGCIEEESSTDELFFNPKNTKTEEYISGKFG		260		3	Expressed	-1	 	"NR-16091, NR-16439"
Batch03	BobuA.00853.a	Borrelia burgdorferi 	NP_212773.1	O51584				"spermidine/putrescine ABC transporter, spermidine/putrescine-binding periplasmic protein (potD)"	Potential drug target		MKKIFILIVILTTFACTNKDTITLNVFNWAEYIDKTLLDQFEKENNIKINYEIFHNNEEMMAKFNNTKNYYDIIVPSEYLIQELIDEGKIEKLDYSKLPNVTKNITQNLTNLEHDPGNLYSVPAYWGLMGILYNKTKIDLNDMQGFDILFNKKYKKEITMLDSPKDNIGVALKKLGYSINEHDTDKIKEAGELLKIQNPLLIGYFSDVPAKSLMLNGEASIQLTWSGEAQSAMLKDKNLDFYAPENTNLWIDAFVIPIDAPNKNLAYKFINFLYENEPSYKNFKETRYNSPNKNVIKRIEEEAKNNPEMKLYLEEKFLPKDFSKFEIFKKIPKKIKEEILKIYLNLSS		348		1	Selected	-1	 	
Batch03	BobuA.00863.a	Borrelia burgdorferi 	NP_212898.1	O51705				"sensory transduction histidine kinase, putative"	Potential drug target		MNNFFKKALTKLNKLSNEQKTKFIEQIYKKIEIYDGIFASINEGIIVLDKQNNIIYANKILYQILALTSKSKIEILDDIQIPNLINLIKELVRTEDKIIGLEVPISNGIYIKISFMPYVKEKKLEGNIILIEDIKEKKKKEELFRRVEALASFTRHARNIAHEIKNPLGAIDINLQLLKKEIEKQKMKNGKAENYFKVIKEEINRVDKIVTEFLLTVRPIKINLQEKDIKQVIGSVCELLNPGLENKHIKLLLNLNKISNILIDEKLLKQVIINIVKNAEEALLETKKEIKKIEIFLFEKDNKIHINIKDNGNGIKDGVKEEIFKPQFSTKEKGSGIGLTISYKIIKELGGEIFVESKEGKGTIFTITLPKLNKKNILIEGY		382		5	Purified	-1	 	
Batch03	BobuA.00868.a	Borrelia burgdorferi 	NP_212642.1	O51461				GTP-binding protein EngA	Potential drug target		MLSYKKVLIVGRPNVGKSALFNRILDTKRSITESTYGVTRDLVEEVCKVDSFKFKLIDTGGFTILKDEISKIVVQKVLSSLEKVDLILLVLDINEILLEDYQIIERLRKYSSKVVLVLNKVDTKDKECLAHEFHNLGFKRYFLVSAAHCRGITKLRDFLKVEVGEVGIESGADIKVGIIGKPNSGKSTLINYLSGNEIAIVSDQPGTTRDFIKTKFTRNGKVFEVVDTAGIRRRARVNEIVEYYSVNRALKVIDMVDIVFLLIDVQEKLTSQDKKIAHYVTKKGKGIVIVFSKWDLVDESKGYFEALKSHVKFFFPILNFAPIFRISVHKRIGLDSLFKESFKLKDQLELKTSTPDLNKMLNLWIKDYHLNISHKIKYITQVSTNPVKFILFANKIKNFPNSYYNYLVNNLRKIGYKNIPILVELKEKIRDLK		433		1	Selected	-1	 	
Batch03	BobuA.00876.a	Borrelia burgdorferi 	NP_212776.1	O51587				"spermidine/putrescine ABC transporter, ATP-binding protein (potA)"	Potential drug target		MDNCILEIKNLSHYYDNNGNKTLDNINLKIKKNEFITLLGPSGCGKTTLIKILGGFLSQKNGEIYFFSKEISKTSPNKREINTVFQNYALFPHMNVFDNISFGLRMKKTPKDIIKEKVKTSLSLIGMPKYAYRNINELSGGQKQRVAIARAMVMEPKLLLLDEPLSALDLKMRQEMQKELKKIQRQLGITFIYVTHDQEEALTMSDRIVVMNEGIILQIGTPEEIYNEPKTKFVADFIGESNIFDGTYKKELVVSLLGHEFECLDKGFEAEEAVDLVIRPEDVKLLPKGKGHLSGTITSAIFQGVHYEMTLEIQKTNWIVQSTRLTKVGEEVDIFLEPDDIHVMHKE		347		5	Purified	-1	 	
Batch03	BobuA.00895.a	Borrelia burgdorferi 	NP_212914.1	O51721				50S ribosomal protein L27	Potential drug target		MATSKSGGSSKNGRDSISKRLGVKRSGGQFVKAGEIIVRQRGTKFHKGKNVGLGRDYTIFALSSGKVEFKTLKGRKYVSIV		81		-2	Work stopped	-2	Work stopped	
Batch03	BobuA.00907.a	Borrelia burgdorferi 	NP_212429.1	Q44772				ATP-dependent protease ATP-binding subunit	Potential drug target		MCLRRLKMNKLEEHYIVPKDVVAELDKYIIGQDEAKKLVSIALVNRYIRSRLPKEIKDEVMPKNIIMIGSTGIGKTEIARRLSKLIKAPFIKVEATKYTEVGYVGRDVESMVRDLMSIAVNMVKEEMYSTVRDDALVRTEERIVDSLFKGSSNSENMDPNEIKAEEKVKEKLRKKLRAGELDDTTIEIQISSKMPFSTIEIFTGGNFEEIDMGIGGLLGNIFDRKKKRELKIKKAKEIILAEELEKLVDHENISDIAKSKVENMGIIFIDEIDKIAAKNRSGNDVSREGVQRDILPIIEGSKVNTKYGIVDTSHILFIAAGAFNLAKPSDLIPELQGRFPIKVELKSLSIDDLKKILKQTKNSLIKQYVAMFKVYDLDLKFSEEAIDRIAELTFNMNLESENLGARRLHGVMEIVLADLFFEVPGSKLKKFEINLDYVNKKIQINEQKDLNYYII		455		4	Soluble	-1	 	NR-16092
Batch03	BobuA.00915.a	Borrelia burgdorferi 	NP_051193.1	Q45023				"plasmid partition protein, putative"	Potential drug target		MDTKKPKIITIASIKGGVGKSTSAIILATLLSKDNKVLLIDMDTQASVTSYFYKTLVESEFDLLEKNIYEVLKGNQLINDAIINVDHNFDLLPSYLSLHTFSEEPLPYKEHRLKDSFKYLKFKYNFIILDTNPHLDSTLSNALVVSKHVIVPMTAEKWTIESLQLLEFFTDKLKLKPKVFLFVTKFKKNKTHKDLLEMLQKKEKFLGIISEREDLNRRIAKNDRFDLDKDYIKEYVNVLNNFILKI		246		3	Expressed	-1	 	NR-16093
Batch03	BobuA.00940.a	Borrelia burgdorferi 	NP_212254.1	O51146				hypothetical protein	Potential drug target		MNKGSLPSHVGIIMDGNRRWALGKRLSSLEGYKEGLKRAKEIVKYSLRVGIKCLSFYVFSTENWRRDDCEIENLMFLIANYLRAEFDFYEKNGIKIIVSGDVESLSGEVKSSIKDSISFSKNFNNLILNLAINYGGRNEILRAVKKFVSSDFDLESLNENIFSSFLDNPELPDLDLLIRTGGNIRISNFFLWRIAYSELIFSNVLWPEYYDTRYSKDLECFQFRRRNFGR		230		3	Expressed	-1	 	"NR-16094, NR-16440"
Batch03	BobuA.00952.a	Borrelia burgdorferi 	NP_212606.1	O51428				UDP-N-acetylglucosamine 1-carboxyvinyltransferase	Potential drug target		MRFNFIKFLYIGGWIMHSYIVEGGYKIGGQITASGNKNAALPCILAALLTDEEVILENIPNINDVKVVLDILNDIGADIAREGNTLKIKVLNIVKTEIDSSFTDLIRASILLLGPFVSRFGKIDMALPGGDVIGKRRLDTHFYGLCKLGAKLSTKDRRIVLKANKLVGAEMFLDEASVTATENIIMAAVLAEGNTVIMNAACEPHVQDLCNMLNSMGANILGIGSNVLEIKGVKKLSGTVFRIGADFMQVGSLISLAALTGGELEIKKADPQHFRLIRHVYSRLGINFEYDRENVYVRNKQELKVKLDFGGHIPKIDDGPWPAFPTDLMSIIVVTATQVEGTVLVFEKMFESRMFFVDKLIKMGARIVLCDPHRVVVTGKSSLKGNVLSSPDVRAGMSLLIAAFVAEGRSEIQNVYQIERGYEDVVNKLINLGAKIKKVKSQ		442		4	Soluble	-1	 	NR-16095
Batch03	BobuA.00962.a	Borrelia burgdorferi 	NP_212187.1	O51082				uracil-DNA glycosylase	Potential drug target		MKVKIEESWKEVLNNEFNKEYFKKLVKFIKHEYKTKNGKIFPPPKLIFNAFNSLPFKDIKVVIIGQDPYHGKNQANGLAFSVDSKIKIPPSLQNIFKEIEKSLKIKTIPNGDLKRWAIQGVFLINTILTVEEGKPSSHKAIGWEIFTDEVIKIISKNLKNIVFMLWGNLARSKKGLIDPTKHLILETSHPSPYSANNGFLGSNHFSSALDYLKKHNKNIINFQ		223		5	Purified	-1	 	NR-16096
Batch03	BobuA.00981.a	Borrelia burgdorferi 	NP_046992.1	O50982				"PTS system, cellobiose-specific IIB component (celA)"	Potential drug target		MNILLVCGAGMSTSMLVQRIEKYAKSKNINATIEAIAETRLSEVVDRFDVVLLAPQSRFNKKRLEEITKPKGIPIEIINTIDYGTMNGEKVLQLAINAFNNKSSV		105		12	NMR assigned	-1	 	NR-16097
Batch03	BobuA.00990.a	Borrelia burgdorferi 	NP_212381.1	O51263				hypothetical protein	Potential drug target		MKTLFFATTNENKINEVKNILDIPNLNLIVPQNFNIKETGKTFKENSLLKAKALFEILNNNQNVFGEDSGLCIEALNLEPGIYSKRYDTYKLCKKLSTNEKNQLILDLMKNEKNRKAYFICNISYISKNGQILNFEGIIKGKIALSLNDKKNYGFGYDSIFLTKNNKKLSDLTLEEKNKISHRGIAFLKFKKFLLKSLFNS		201		3	Expressed	-1	 	NR-16130
Batch03	BobuA.00998.a	Borrelia burgdorferi 	NP_212739.1	O51550				serine-type D-Ala-D-Ala carboxypeptidase (dacA)	Potential drug target		MNSIYVIGKLLLTLFLIFFPFCYNLFAVNLAEINKLSEYAKSIVLIDFDTKRILYSKKPNLVFPPASLTKIVTIYTALIEAEKRNIKLKSIVPISDSASYYNAPPNSSLMFLEKGQIVNFEEILKGLSVSSGNDSSIAIAEFVVGNLNSFVNLMNINVLNLGLFNMHFVEPSGYSSENKITALDMAFFVKSYIEKFKFMLNIHSLKYFIYPKSRNLGTALSSKFLNLKQRNANLLIYDYPYSDGIKTGYIKESGLNLVATAKKGERRLIAVVLGVEKGINGFGEKMRSSIAKNLFEYGFNKYSKFPLIVKLKEKVYNGTVDTVALFSKEPFYYILTKDEFDKINISYTVDKLVAPLSGDMPVGRAMIFLENEKIGDVALFSGKVKRLGFWQGLYKSFINLFSREY		405		2	Cloned	-1	 	
Batch03	BobuA.01001.a	Borrelia burgdorferi 	NP_212262.1	O51154				cytidylate kinase (cmk-1)	Potential drug target		MIIAIDGPSASGKSSIARELGVRLNYKFISSGHLYRIITLIAQRSLMNSCDFISEDSLLNLILENDISFNNFAFLLNGENVENQILNDKIDFQVSFYSSYVGIRNIVNKKLREVVKFSDDNYIIEGRDITTVVFPESEFKIYLDASVKVRALRRYKQRNGNETLEELERTLKRRDDVDKKKQYGKLKLSKGVFYLDTSYKGLDDVCNIIIEKFNLKKVRER		221		3	Expressed	-1	 	NR-16131
Batch03	BobuA.01013.a	Borrelia burgdorferi 	NP_212792.1	O51602				phosphoglycerate mutase (gpmA)	Potential drug target		MLGDFMYKLVLVRHGESEWNKENLFTGWTDVKLSDKGIDEAVEAGLLLKQEGYSFDIAFSSLLSRANDTLNIILRELGQSYISVKKTWRLNERHYGALQGLNKSETAAKYGEDKVLIWRRSYDVPPMSLDESDDRHPIKDPRYKHIPKRELPSTECLKDTVARVIPYWTDEIAKEVLEGKKVIVAAHGNSLRALVKYFDNLSEEDVLKLNIPTGIPLVYELDKDLNPIKHYYLGDESKIKKAMESVASQGKLK		253		7	Crystallized	-1	 	NR-16132
Batch03	BobuA.01024.a	Borrelia burgdorferi 	NP_212471.1	O51312				enolase (eno)	Potential drug target		MGFHIYEIKARQIIDSRGNPTVEADVILEDGTYGRAAVPSGASTGINEAVELRDGDKSVYMGKGVLKAIENIKNIIAPELEGMSALNQVAIDRKMLELDGTPTKEKLGANAILAVSMATAKAAAKYLGLRPYQYLGAYKANILPTPMCNIINGGAHSDNSVDFQEFMIMPIGAKTFSEAIRMAAEVFHTLKGILSGKGYATSVGDEGGFAPNLKSNEEACEVIIEAIKKAGYEPGKDIAIALDPATSELYDPKTKKYVLKWSTKEKLTSEQMVEYWAKWVEKYPIISIEDGMAEEDWDGWKKLTDKIGNKIQLVGDDLFVTNTSFLKKGIEMGVANSILIKVNQIGTLTETFEAVEMAKKAGYTAIVSHRSGETEDTTIADLVVALGTGQIKTGSLSRTDRIAKYNQLIRIEEELETTAEYHGKSVFYSIKQK		433		4	Soluble	-1	 	
Batch03	BobuA.01025.a	Borrelia burgdorferi 	NP_212468.1	O31309				"oligopeptide ABC transporter, ATP-binding protein (oppD)"	Potential drug target		MEKENILEIKNLTIEFRLKHTTIHPVSNVNLSVKRGEIRAIVGESGSGKSVTSMAILKLLPELTTVYKSGEILFENQDLLKLSEKELLKIRGNKISMIFQDPMTSLNPFLRISTQLEETIILHQGLGKKEAKEKAIEMLKTVGVVNAEERIKHFPHQFSGGMRQRVMIAMALSCHPSLLIADEPTTALDVTIQEQILLLIKNLSKKFNTSTIFITHDLAVVAEICDTVSVMYQGKIVEEGTVEEIFNNPKHPYTIGLLKSILTLEHDPNKKLYSTKENPMKITKTSTEEF		290		4	Soluble	-1	 	NR-16133
Batch03	BobuA.01031.a	Borrelia burgdorferi 	NP_212770.1	O51581				glucose-6-phosphate 1-dehydrogenase	Potential drug target		MKERSVSNFDIVIFGVTGNLSRKKLIPSLFNLFKNKCISNFRVIGFSRKIFTDKEFRLYIKDSLWQEETDSLIEIFLNFFVYVFGDFNEKESYKNLFKFLDRSRETIYYLSTSPAFYGPIINHLKKYFLSEKLTLSKIVLEKPFGSSLETAKKLNSLLYSAFKEDQIYRIDHYLGKETVQNIFTFRFGNSIFENIWNNRYVDFVQITVAEELGLDGRVEYYDSVGALKDMVQNHILQLLSLVAMESPIKFDSEFIHDEKVKVLKSLRKISKEDIKNYIVKGQYIGSQVQGVFKKGYKDETEFLGNSNTETYLAMKVFINNWRWSGVPFYLRTGKGLARKFSEIYIQFKKPSFTLFNNSSVDFSNALIFRIQPRDGIEIKFNTKKPGYNYEIQTANMEFSYHGAFKRLFDEAYERLLLDAFLGDGTLYATSDEIESSWEFVSDIANKWADIEICNYFYGSEGPKEIDSILEKDHFWRKI		478		1	Selected	-1	 	
Batch03	BobuA.01032.a	Borrelia burgdorferi 	NP_212504.1	O51343				tyrosyl-tRNA synthetase (tyrS)	Potential drug target		MNLALSLLHKRGFLKQCTSLKVLSDLMDREKIVFYAGVDATSSSLHIGHLIPFLAMMHLRQHGHMPIVLIGDSTAKIGDPSGKSEMRKILSSEEIGNNALLIKNQLQRITKFTSECFIHNSNWLDNLNYIEFLRDVGMHFSVNRMLSFETYKRRMDFGLSFIEFNYQLLQSYDYYMLNKIKNCRLQIGGDDQWGNIISGVDLIRKKNGSETFGLTFPLITRSDGKKMGKSEKGAVYLDSNLFSIYDFYQYFRNTSDSDVKTFLYLFTFLEEDEIELISNFKGNSLNKAKEILAFEITKIVHGEAEALKVQEASFAAFRGSGDRSNIPFFKFSFSSLKEEILLVDLMLDSKIVPSKSEGRRLIDSGGVYINGKRVESQSHLLTKKDFNNNEVELRVGKKKFLRIVI		405		7	Crystallized	-1	 	NR-16134
Batch03	BobuA.01042.a	Borrelia burgdorferi 	NP_212662.1	O51478				"aldose reductase, putative"	Potential drug target		MNNLKDKINTYSKLILGSWQFGGGYFKQVEKETAKKILKKAYDHGIRNIDTARAYGNGISEKIIGEIIEKDPTIRENILIASKCYPMEISEYRENFNESLKNLKTDYIDIYYIHWPKADFDLRPIASFLEEMRVKGRIKYVGVSNFEISHMESIKKVCKIDVNQIGYNPLFRNKEKDVIPYCEDNNIATISYSTIAQGLLSKANIKDKNKFNDIRTEKLILFKKEIWPYTLKTINKLEEIAKINNLTILELTYSWLKKTKLSGFIVGFSKENYVESNVNSFKAEINDKVYEEITSILDNFNHQTKNFPNLFNKKI		315		3	Expressed	-1	 	NR-16135
Batch03	BobuA.01121.a	Borrelia burgdorferi 	NP_212755.1	O51566				4-methyl-5(b-hydroxyethyl)-thiazole monophosphate biosynthesis protein (thiJ)	Potential drug target		MVVGIILANGFEDIEAIIPIDILRRGNVNIQIISTNDSNVVISSKGVSFLADDIISNCKENCFDLIILPGGMPGATNLFNSKELDLILKDMNSKGKFIAAICASPVVVLAAKGLLGFNKFTCYPGLEKNVLDGEFVDENVVRSNNFITSKGVGTSFEFAFTLLEMVKGKQIMEDVKKATLLCKS		184		3	Expressed	-1	 	NR-16136
Batch03	BobuA.01122.a	Borrelia burgdorferi 	NP_212724.1	O51536				dimethyladenosine transferase	Potential drug target		MILSLLSMNINYNSITSIKQTLKERKIAPRKLWGQNYLINESIRQKIIESLDIKENEKIWEIGPGLGAMTEILLKKTNLLTAFEIDLKYSEILNEKFGKLKNFKLIKGDFLKKYKNENQNIDKIFSNLPYNIASKVISKLIEENFLKEMVFTVQKELADRITAKINSKNYSSFTVLVQSHFKVIKILDIGENNFYPAPKVKSTTLKLIPKKNNIKNFKEFNKLVRTVFSNRRKKLKNTIINFITNKATLRENFLKEYLDKRPENISVEEFIQISNTLNAYH		281		2	Cloned	-1	 	NR-16320
Batch03	BobuA.01129.a	Borrelia burgdorferi 	NP_212565.1	O51392				hypothetical protein	Potential drug target		MKIISVINQKGGVGKTTSAINISYSMTLLNKKILLIDIDSQGNSTSGTNTSKHIAEKSSYELINKKIKVKPLNHFGLDIIPSSIKLALLEKELINELSRENFLKNALTLYEKDKYDFIIIDCPPTLSILTINALIASNYLLIPIETEFFAFEGINQLIDTITTVKQINKNLEIAGVFINKYDIRNKSKEKYVSSLKKVFKEKLLNTKIRKNITISKSQEAKMPVYEYDKESNAAKDFLELSKEIINKIKE		250		2	Cloned	-1	 	
Batch03	BobuA.01162.a	Borrelia burgdorferi 	NP_212482.1	O51323				pyruvate kinase	Potential drug target		MISKLTKIVATISDLRCEPEHIKDLHDAGVNVIRLNTAHQSHEDTIKVIDNVRKISNKIALMIDTKGPEVRTANIENPIIVKTGDKVIISTSPINEPNNFQTNYDGFVKEVPQGSKVLIDDGELEMTVVAKLPDRLICEIKNDGQIKNKKSINTPGISLKLQSVTEKDKGFIELAAKYNVDFIAHSFVRHSKDVQDVQEILTASGNPDVKIISKIENQEGIDNIEEIAKASYGIMVARGDMGVEIPAEDVPIAQLKITQTCIKYGIPVITATQMLHTMIENPRPTRAEVSDIANAILNGTDAIMLSGETAYGKYPIEAVKMMTSIAKKVEKHRKMTLYKDELFYDKSITRNYIIKCAIDATKLMDIKAIIVDSLKGKTARIMATYRASVPLFITTNSERLARELALSYGVYSNLVDNNFKRTTEFVVTSLKMLKEQGVVNDKDTVIIISGNPNRNIEKGTEFMEINTVEDAIKGRNI		477		7	Crystallized	-1	 	NR-16137
Batch03	BobuA.01180.a	Borrelia burgdorferi 	NP_212965.1	O51771				xylose operon regulatory protein (xylR-2)	Potential drug target		MRINMKHYLAIDIGGTSTKYSLSDSSGVFFDKNEISTGATSDEQVNILVNIINSYKESSDIAGVAICIPGFVDLKGNVLRVNAISGFVNYPLKERLESLTGVSTEIENDANCVALAEKFKGNAIDSNNFIAITLGTGIGAGIFANGKLLRGNSFMSGEVGFMITGGISNNIPFNCKWESIASVSALRKRVAMRLGKPLKEVSGEFVFDLAENGNIHAKNEVDRFFENLSFGIFNLTFILNPEKILIGGGISARPDLIDRIYEKLENLWSLEMAFDNNNNIKNLVALEPTKFNNESGKIGALFHYFTCKNQNNTSF		315		3	Expressed	-1	 	NR-16138
Batch03	BobuA.01182.a	Borrelia burgdorferi 	AAC66366.1	O51020				conserved hypothetical protein	Potential drug target		MDIKKPDIIALTSVKGGVGKSTLSILFSYLLKELGKKILLIDLDPQNSLTSYFTKYIPDAETYNVYSMLKGDFYFKKYLNKINDYMYIIPSHPMLEKFNTETDQETFLEYYLNRNIINCDFDYILLDTSPGSNLLLKSALNTSNYIIIPVQSEIWSIESFNILINIINGITKHREKKYNISIVENQFIKNRNILKEVENLIHKEYKEYIKGKIHFYNSIKVLITKRLEPSSREIYYQEIKETLKNIFSL		249		2	Cloned	-1	 	NR-16139
Batch03	BobuA.01182.b	Borrelia burgdorferi 	AAC65994.1	O50684				conserved hypothetical protein	Potential drug target		MDIKKSDIITMASIKGGVGKSVLSILFSYVLKELGKKVLLIDLDPQNSLTSYFNRYISNIEKYNTYSMLKGDFHFNECIKKIDDYISIIPSHPILGKFNSEAIDYKEVILEHHLNENMQNYNFDYVLLDTPPSLDFLLKNALNVADYIVIPVQVEIWSIESFTILINAVNDITKFRKKIYNISIVENQFIKNRNTIKEVEDLLYKEYREYIKGKIHFSNSIKVLINGRLEPSKKEMYYREIKDTLKNIFSL		251		3	Expressed	-1	 	"NR-16189, NR-16441"
Batch03	BobuA.01195.a	Borrelia burgdorferi 	NP_045693.1	O50913				hypothetical protein	Potential drug target		MDKKETKVITIASIKGGVGKSTTSLIFATLLSIKCKVLLIDIDTQASTTSYFFNKIKDNNIDLINRNIYEVLISNLHIDNALITINKNLDLIPSYLTLHKFNSESIPYKEFKLKEQLKLLSNHYDYIILDTNPSLDFTLTNALVCSNYIIIPITAEKWAVESLDLFTFFMNKLLLTLPMYLINTKFKRNNTHRELLKVLEKNNNFLGTISEREDLNKRIAKNDRFDLTKDYIIEYQNTLTAFLNKSSYVH		250		2	Cloned	-1	 	NR-16140
Batch03	BobuA.01197.a	Borrelia burgdorferi 	NP_212551.1	O51378				adenylate kinase (adk)	Potential drug target		MGLVFLGPPGSGKGTISKIISNEFKYQHISTGDLFRENILNSTALGQEIKKIVERGELVPDLITIKIVEDKIKAIKKNKDFILDGFPRNICQAEALDKFLPNVKIINFLIDEELVIKRLSGRRICKSCNNIFNIYTLTTKKNGICDVCGGDLYQREDDKEECLKTRLKEYKLQTKPLIEFYSKCSRLNNVDASVKIDEIKKKIIKIMLKKN		211		5	Purified	-1	 	NR-16141
Batch03	BobuA.01234.a	Borrelia burgdorferi 	NP_212433.1	P45483				cell division protein FtsZ	Potential drug target		MEEALMKDYNMIDSHTRRFDSTTNPTILKVIGAGGGGSNAVNRMIEYGVRDVEFIVANTDLQALQTSIAPIKIALGAKVTAGLGAGGKPEIGQAAAEEDIDVIRNHLSGADMVFITAGMGGGTGTGAAPVIAQVAKELGILTVGVVTKPFKFEGPKKLRLAEQGINNLRKSVDTLIIIPNQKLLTVVDKRTTIKDAFKRADDVLRMGVQGIAGLIIEHGEVNIDFADVKSIMQGQGDALMGIGYGKGENRAVDAATSAISNPLLEEVRIEGSKGLLVNVTGGDDFSLLELEEIMGIITVSVDDEATVIYGHAINSNLEDEIYVTVVATGFASKKQKEISSTPENNTLSSKEFDTLMSGNQNAPSGSYEQQDSSFAAKSKNVNYFDDDIDVPTFLRNLNKKSSDD		404		2	Cloned	-1	 	
Batch03	BobuA.01235.a	Borrelia burgdorferi 	NP_212328.1	O51212				hypothetical protein	Potential drug target		MMDSLLETEKSIFFDKLIDTHVHFYELKKRSLDVNYIINECFKNGFSYFLDVGLHPSDFNDRKDLLSPYSNVFLTAGIHPLNLSDHFKDDIKQLEKILISENVVAVGEMGLDYFKADNKKFQIKALEEQLYLADKYKRPVILHIRDAYDDVYNIVRSLNFLNRGILHCYSGTYEHAKKFIDLGFKVSFSGNITFKNAQPLRILVGKLNINDLLIETDSPFLAPVPLRGKINSPLFLGYVCLEIARIKNCSVNDVAFAVYNSFKDLLLLH		269		2	Cloned	-1	 	NR-16321
Batch03	BobuA.01237.a	Borrelia burgdorferi 	NP_212265.1	Q59180				recombinase A	Potential drug target		MSKLKEKREKAVVGIERASKEEAIELARVQIEKAFGKGSLIKMGESPVGQGIKSMSSGSIVLDEALGIGGYPRGRIIEIFGPESSGKTTLTLQAIAEVQKEGGIAAFIDAEHALDPVYAKALGVNVAELWLSQPDTGEQALEIAEHLIRSGGVDLIVVDSVAALTPKLEIDGEMGDSQIGLQARLMSKALRKITGILSKSNTCIMFINQIRMRIGVMFGNPETTTGGNALKFYSSLRLEVRKIEQVTRSGSSDDVIGNKIRVKIVKNKVAPPFRKVELIIYFGKGISREAGILDAAIKHNLIQKTGSWYSLGDNKLGQGRESVIEYLSKEVELANNLDKRLRKIIFNNFDQENDNFIEFKEDESE		365		4	Soluble	-1	 	NR-16142
Batch03	BobuA.01238.a	Borrelia burgdorferi 	NP_212360.1	O51244				seryl-tRNA synthetase	Potential drug target		MLDLKFIRDNLDLVKRSIKARGLVLDIDKLIYLDDKRKKLITKIGELNAKRNENSSKMQENLDKVLKISLIETGKILKKQLIDLEEELERVSVDFDLENKKVPNILSPDVPIGSSEEDNFEIKRVGVVPQFDFKPKDHLELGRDLDLLDFDRAREISGSKFYYLKNEAVFLEIALINFSLNKLRDKGFDVFITPDVAREFIVDGIGFNPRGNESNIYKIEDTDKYLVGTSEITLGGYYYNKIIDLTLPIRMAGFSHCFRKEAGAYGQLSKGLYRVHQFSKVEMFCFCKAEESGVIHDEFLSIQEQIFTELEIPYRVLNICSFDLGSPAYKKYDIEAWMPGRDGKGGYGEVTSTSNCTDYQSRRLKIRYKDQDGQNKFAHMVNGTAIATTRVIISILENFQDQKGGVRIPKSLVKYTGFDYIPFKN		425		1	Selected	-1	 	
Batch03	BobuA.01245.a	Borrelia burgdorferi 	NP_051365.1	O07492				"plasmid partition protein, putative"	Potential drug target		MDNKKPKIITIASIKGGVGKSTSAIIFTTLLSQDWKVLLIDMDTQASVTSYFYKKIIEDNFNLLEKNIYEVLKGNVLIDNSVINISNNLDLIPSYISLHKFNKEAITFKEIKLQKQLLNLQSNYDYIIIDTNPSLDYTLTNALVCSDYIIVPITAEKWAVESLELLKFSISDLAIDIPIFLIITRFKKNNTHKALFSSLKDNKNFLGLIYEREDLNKKIAKNDLFNLNRDYMLEYKNILSKFITIIMSR		249		2	Cloned	-1	 	NR-16143
Batch03	BobuA.01258.a	Borrelia burgdorferi 	NP_212469.1	O31310				"oligopeptide ABC transporter, ATP-binding protein (oppF)"	Potential drug target		MSSKKEIILKVENLMQTFTTGEDFLFWKNKQKVNAVNNVSFEVEKNKTLGLVGESGCGKSTTLRSIMQLYTPTSGNIYFNGKNITKLSKKELLKTKKDMQMVFQDPHTSLDPRMTIKEIIAEPLEIYNENKILPKTKQEIEQRVNELTDIVGLHKSMLTRYPHEFSGGQRQRIGIARALALNPKLLLLDEAVSALDVSIRAQILNLLKALQKEFNLSYLFISHDLAVVKYMSDKIAVMYLGVILELAPRETLFSNPIHPYTKMLIASIPEINPEKRKNKNIKLDEQTLANIRKIHLSTQVHPKLEEVEKDHFVSKYLFDEMNR		323		3	Expressed	-1	 	NR-16190
Batch03	BobuA.01275.a	Borrelia burgdorferi 	AAC66090.1	O50781  				"ABC transporter, ATP-binding protein"	Potential drug target		MGNVNLDLKLVNKKYKIGQEIIHANKDISLNLKSRDMVWISGPTGSGKTTLMNLLSGIDSLDTGEIRFNSTLLSSMNEKDRTLFRRYNVGLIFQHFELIPSLTGFDNISLPLRFSRESAKRLKSKAEELIEFFKLSKFVNKKPRYMSGGQRQRIGIARAFVYDPKLIIGDEITSHLDKETAIFVYTSIQKYLKEKNAIGIFVSHDYNLKNLANKLYRIEDGVLSLVGGECV		231		1	Selected	-1	 	
Batch03	BobuA.01293.a	Borrelia burgdorferi 	NP_212218.1	O51111				aminotransferase (nifS)	Potential drug target		MDFKQIKSNVEKVKFLRKDFPILNKKFDNKYIIYFDNAATSQKPKNVIYSNVEYYENYNANVHRSGHKFAIQSSIKIEKTRELVKNFINAESAKNIIFTSGTTDGINTIASSFFYSKYFKKKDEIILTTLEHNSNLLPWVNLANLANLKIKLAKFNEMGIITPEEIEKLITEKTKLISISGINNTLGTINDLESIGKIAKKYNICLFVDAAQMAPHIKIDVKKIGCDFLVFSGHKMLAPTGIGILYISNNMAEKLHSSKLGGNTVEEIFIENEKIKFKASDSPNKFESGTPNIAGIIGLEEAIKYIDNISMDFILEHDKQLIEYGVKKLQELDEVEFILNTNLKRNSIISFTVKNIHSHDIETYLDTMGIATRAGRTCSYVAFFPENLNKDHLLRISFYFYNTQEEIDNFILGLKKVIKELS		422		3	Expressed	-1	 	NR-16191
Batch03	BobuA.01297.a	Borrelia burgdorferi 	NP_212210.1	O51103				"cell division protein, putative"	Potential drug target		MGILEKIKNLFKSKQQENVIENLEDILLESDINNEIVIEIINKLTKEKNENEKTIIGKLKELLSSYINTKKFTLENNKLNILLIVGINGIGKTSSIAKLANKLKNEGKNILISAADTFRAAAIEQMKIYGEQIGVRIISQNQGSDPSAVIFDSISSAKLKNYDALIIDTAGRLQNKENLIKELQKINNVILKQIKNTDINYQKILVIDSTIGKNANSQAEIFNKAIEIDGIIITKLDSSSKAGTILNISKILEKPIYFTTFGEKLEDIKEFDINEYFNKLL		281		2	Cloned	-1	 	
Batch03	BobuA.01301.a	Borrelia burgdorferi 	NP_212678.1	O51494				phosphoribosylpyrophosphate synthetase	Potential drug target		MNLLKKKSIGIIACPGGRVFASKIIEELDRIFINIENEIIESICQDSKALKEEIFKIEKVLSPFLEGLSLSTLKSKEPLEIPVKFVKFANGEFKTEILKTIRNKDIFIVQDVANAYEVEINSSEKIIMTVNDHIMNLMTTIDACMQAKANSVSVIIPSYPYSRQDKKHSRECLTASLIGRFLEELGIRHILTLDIHSKAIENVFRKVYFENLNVSYEIFNSLKDLIDIRDSNLVIVSPDTGAVSRNKFFASSLKSPLALLYKERDYSRVSNDVADSNISVTKLLGDVEGKNVFMSDDMLATGGTLIKAMKLLKSMGAKKIICGISLPFFNGDAIKYFDKAYEEGFFYKIIGTNAVCHNDELINKPWYHEANVAPLFAEAIFAIYNKVGLQKILDRKDDIQKLITKG		406		4	Soluble	-1	 	
Batch03	BobuA.01323.a	Borrelia burgdorferi 	NP_212749.1	O51560				30S ribosomal protein S4	Potential drug target		MMNRKQIAKGKLVRRFGINIFEQPKYDKILKKKPHPPGMHGKARKAKITEYGKQLIEKQKIKFTYGVSERQLTNTFKEAKKHHGVTGDNLLSILERRIDNVVYRAGFAISRAHARQIVSHGIIILNGRRVTIPSIILRANDQIQIKEKDSLKKLIRSNIEKTSSLRNLPTWIEVNADDLNIKVKHAPSRDEIPTLANEQMVVEYYSKRA		209		-2	Work stopped	-2	Work stopped	NR-16192
Batch03	BobuA.01325.a	Borrelia burgdorferi 	NP_212144.1	O51043				"holo-acyl-carrier protein synthase, putative"	Potential drug target		MKSIGCDIIKVERFKNFLENKKKMERFFTHKEIENFKLKGGSIIESLAGKFAAKESLIKALSPLLQYKINYTLKDIEVIKSLKGNAEFCLHNEVEKFAIKMNLKLYLTISHEKEYAIAFVIVEN		124		2	Cloned	-1	 	NR-16193
Batch03	BobuA.01334.a	Borrelia burgdorferi 	NP_212824.1	O51633				neutrophil activating protein (napA)	Potential drug target		MYYNNYIKEIVMEKYLSYIKKDDLDAIQLKLQELLASLHIFYSNLRGIHWNIKDTNFFVIHKKTQKLYEYIEKIIDIVAERSRMLGYDSEFRYSEFMKKSFIKELDIESTSNFLPSMESIVCSLTEILKNIFGMRKLIDTAGDYGTANIMDDIMSDLEKHLWMHKALLENCDCFCHDENESKCCECDAK		189		4	Soluble	-1	 	NR-16194
Batch03	BobuA.01345.a	Borrelia burgdorferi 	NP_212849.1	O51657				rod shape-determining protein (mreB-1)	Potential drug target		MELLWKTFREVVLNLFKSFLIDIGIDLGTCNTLVYIKDYGVVMSEPSVVAIDITKGNKVVAVGRNAKKMLWKTPENIKAVRPLRDGVIADIENTEKMIKYFINQIFSRKKLFFKPRMVIGVPTCITEVERRAVKESAMNAGAREVKVIEESLAAAIGSDIPIFEPTGHMVCDIGGGTTEISVISLGGMVVSRAIRTGGDEFDESIIKYMRNSHNIIIGQQTAEKLKIKIGNVYPDIQNLRVEKIDIKGTDAVTGLPRKQLVDSMEVRESLQEPINVVVDEVKRTLGATPPELATDIVERGIILTGGGALLKGLNRLLSKETGVPVYVADNPLLSVAVGAGLFYDYANRIDISKNIYSFINE		361		2	Cloned	-1	 	
Batch03	BobuA.01348.a	Borrelia burgdorferi 	NP_212506.1	O51345				glutamyl-tRNA synthetase	Potential drug target		MSTRVRYAPSPTGLQHIGGIRTALFNYFFAKSCGGKFLLRIEDTDQSRYSPEAENDLYSSLKWLGISFDEGPVVGGDYAPYVQSQRSAIYKQYAKYLIESGHAYYCYCSPERLERIKKIQNINKMPPGYDRHCRNLSNEEVENALIKKIKPVVRFKIPLEGDTSFDDILLGRITWANKDISPDPVILKSDGLPTYHLANVVDDYLMKITHVLRAQEWVSSGPLHVLLYKAFKWKPPIYCHLPMVMGNDGQKLSKRHGSTALRQFIEDGYLPEAIINYVTLLGWSYDDKREFFSKNDLEQFFSIEKINKSPAIFDYHKLDFFNSYYIREKKDEDLFNLLLPFFQKKGYVSKPSTLEENQKLKLLIPLIKSRIKKLSDALNMTKFFYEDIKSWNLDEFLSRKKTAKEVCSILELIKPILEGFEKRSSEENDKIFYDFAESNGFKLGEILLPIRIAALGSKVSPPLFDSLKLIGKSKVFERIKLAQEFLRINE		490		7	Crystallized	-1	 	
Batch03	BobuA.01352.a	Borrelia burgdorferi 	NP_212752.1	O51563				cytidine deaminase (cdd)	Potential drug target		MEKLKQEDIDKAFYMAEKARNNSYSPYSKFKVGACIKTKTNDFFIGTNVENASFGATCCAERSAILNMIAKIGVQEIDFLLLNTSPECIPCAICLQVMAEFFNQDTKIIITESKSFSENKTPIKIYTLKDLLKSPFDKKELRRVTYSELEKKLI		154		7	Crystallized	-1	 	NR-16195
Batch03	BobuA.01363.a	Borrelia burgdorferi 	NP_212190.1	Q59181				phosphoglycerate kinase	Potential drug target		MSIKTVKDFSSFAGKRALVRCDFNVPLKEGSISDDTRIRAALSTIEYLKERGARIVLVSHLGRPDGKKNPKYSLKPVANRLSELLGQDVKMLSDCIGSEVVNSTLQMKDGDVVLLENVRFYAEEEKNDKNFAKKLSENGDVFVNDAFGAAHRAHASTVGVADYLPSVGGFLMEKEDKFLGGILKNPERPFVSIIGGSKVSSKIAVLESLLSKSNVVVIGGGMAYTFLHSEGYSIGKSLLEDEYIGIASSFLKKAKELGVKVILPLDHIVADDFNKNSIPEYIDSFNIPENKIGMDIGANTLKEIENVVKTAKTIIWNGPLGVFEFDSFSKGTAKVAEMVASCSGLTVVGGGDSVAAVNKFNLSDKITHVSTGGGASLEYLEGRILPGIKVLEN		393		7	Crystallized	-1	 	NR-16196
Batch03	BobuA.01384.a	Borrelia burgdorferi 	NP_212174.1	O51069				chemotaxis protein methyltransferase (cheR-1)	Potential drug target		MNTNQNKFNLNINITKDELSRLIKIVYNNFGINLSEKKKLLIESRLSSLLKVKGFKNFTEYINFLEKSTGNIQLIELIDKISTNHTYFFRESKHFDFLNNKILPKLTEKILNSENSEIRIWSAGCSSGEEPYTIAMMLKEYMEHNRVNFKVKILATDISISVLNEAREGIYPEDRIINLPKYLKIKYLNQLQDDKFQVKEILKKMVYFKKLNLMDEKFPFSKKFDLIFCRNVMIYFDEKTRNNLANKFNSYLKKDSYLLIGHSETIRGNKNLEYIMPATYKKN		283		5	Purified	-1	 	
Batch03	BobuA.01394.a	Borrelia burgdorferi 	NP_212612.1	P94267				50S ribosomal protein L3	Potential drug target		MLGLIGKKVGMTQIFQKNGIVVPVTVIEFQPNYIIGKKTVDRDGYSALIAGSVDLKSSKVSKPIKGQYKSLKDIEPKRYVIELKGLDGYDAGDEIKVDVFKSVKYVDVTGTTKGKGFQGAMKRHNFSGGPSSHGSKFHRHLGGTGQATTPARTFKGTKMAGRMGGNQQTIQNLEVVLIDEEKRALLVKGAVPGAKGSFVVVKKSKK		206		-2	Work stopped	-2	Work stopped	
Batch03	BobuA.01402.a	Borrelia burgdorferi 	NP_212579.1	O51401				fructose-bisphosphate aldolase	Potential drug target		MGVLDKIKPGVVYGKELHFLYEICKKEGFAIPSINCIGTNSINAVLEAAKEINSPIMIQFSNSGSAFISGKGLKMEKPQGVSIVGAISGAMHVHLMAEHYGVPVVLHTDHCAKNLLPWVEGLLEYGEKYYSQHKKPLFSSHMLDLSEEPIKENIEISKKFLERMAKIEMFLEIELGITGGEEDGVDNSDRALHELFSTPEDIYYGYSELLKVSPNFQIAAAFGNVHGVYKPGNVKLTPKVLKDGQDYVISKTGVNMAKPVSYVFHGGSGSTIDEINEALSYGVVKMNIDTDTQWAAWEGVLNYYKKNESRLQGQLGDGKDIDIPNKKFYDPRVWLREAEVSMKDRVKIACKNLNNINRN		359		5	Purified	-1	 	NR-16277
Batch03	BobuA.01405.a	Borrelia burgdorferi 	NP_212911.1	O51718				adenine phosphoribosyltransferase	Potential drug target		MKNKTEYYDQFISKIPNFPKKGVLFYDITSVLLKPEVYSSLINEVYSFYNFKKIDCIAVVESRGYLIGAPLSLKMQLPLVLIRKEGKLPREVFSEEYELEYGFGRIEVHKDDVRTYSNILLIDDILATGGTLKSSAILLERAGGKVKDIFCFIELCAINGRQSLESYEVNSLVRYN		176		2	Cloned	-1	 	NR-16278
Batch03	BobuA.01420.a	Borrelia burgdorferi 	NP_045537.1	O50860				pfs protein (pfs)	Potential drug target		MKIKNIANILIFFLSIVLNSWGNESKINTPNENSQSNILIISATKAEIEEINKIIQNKKYISIEEHRRKKKIAIGKLMDHNIITIATGVGKINTALWTSYIISKYKISHIINAGVASGIYSDKNKFIKIGDVVISTETTSYDFDLHRFGYEIGHVPEHPKKFKANTALIRKTSKIKINNITSYMGLIITGDQFIDHQTFQEIPEEFENAIAIDMESAAMAQVAYGFKIPFIIIRGISDIVNNENNYDDYKKFLKKASSSSAKIVENLIKLM		271		3	Expressed	-1	 	
Batch03	BobuA.01425.a	Borrelia burgdorferi 	NP_212528.1	O51355				transcription antitermination factor (nusG)	Potential drug target		MSRAWYVVQTYSQYEKKIEQDIRLLINEGVFGGVVLDVKAPIEKVEEIRNGKKRIRERKIWPGYILIELDLPEVGWKDIIANIIKVQGVINFVGVSKGQRPIPINDEEVKSVFMLTGEIKANKSIFMLYDFEEGERVRIKGGPFDSFEGLISSIDYERKKLKVAVQIFGRSTPVEVDFQHIEKI		184		1	Selected	-1	 	
Batch03	BobuA.01431.a	Borrelia burgdorferi 	NP_212248.1	O51141				single-stranded DNA-binding protein (ssb)	Potential drug target		MADINSLVLSGRLTRDSELSYTESGMAVLRFSIANNRRMKKNDEWIDYPQYFDCVIFSKRAESLNDYLKKGKQVVVSGSLKYESWQDRNTGDKRSKVNIFVDNLQMFSSGSNTIQMQDSDVNSLTNHKKEDVVKDIDIVDDKFSEDIPF		149		7	Crystallized	-1	 	
Batch03	BobuA.01440.a	Borrelia burgdorferi 	NP_212610.2	P50062				elongation factor Tu	Potential drug target		MAKEVFQRTKPHMNVGTIGHVDHGKTTLTAAISIYCSKLNKDAKALKYEDIDNAPEEKARGITINARHIEYETANRHYAHVDCPGHADYIKNMITGAAQMDAAILLVAADSGAEPQTKEHLLLAQRMGIKKIIVFLNKLDLADPELVELVEVEVLELVEKYGFSADTPIIKGSAFGAMSNPEDPESTKCVKELLESMDNYFDLPERDIDKPFLLAVEDVFSISGRGTVATGRIERGIIKVGQEVEIVGIKETRKTTVTGVEMFQKILEQGQAGDNVGLLLRGVDKKDIERGQVLSAPGTITPHKKFKASIYCLTKEEGGRHKPFFPGYRPQFFFRTTDVTGVVALEGKEMVMPGDNVDIIVELISSIAMDKNVEFAVREGGRTVASGRILEILE		394		5	Purified	-1	 	
Batch03	BobuA.01440.b	Borrelia burgdorferi 	AAC66866.1	P50062				translation elongation factor TU (tuf)	Potential drug target		MKFRRLVMAKEVFQRTKPHMNVGTIGHVDHGKTTLTAAISIYCSKLNKDAKALKYEDIDNAPEEKARGITINARHIEYETANRHYAHVDCPGHADYIKNMITGAAQMDAAILLVAADSGAEPQTKEHLLLAQRMGIKKIIVFLNKLDLADPELVELVEVEVLELVEKYGFSADTPIIKGSAFGAMSNPEDPESTKCVKELLESMDNYFDLPERDIDKPFLLAVEDVFSISGRGTVATGRIERGIIKVGQEVEIVGIKETRKTTVTGVEMFQKILEQGQAGDNVGLLLRGVDKKDIERGQVLSAPGTITPHKKFKASIYCLTKEEGGRHKPFFPGYRPQFFFRTTDVTGVVALEGKEMVMPGDNVDIIVELISSIAMDKNVEFAVREGGRTVASGRILEILE		401		1	Selected	-1	 	
Batch03	BobuA.01453.a	Borrelia burgdorferi 	NP_212280.1	O51171				"glycine betaine, L-proline ABC transporter, ATP-binding protein (proV)"	Potential drug target		MSRVAVKIKDCYKVFSYYVNKKQISRAIKDYEDGKDRMQIYKESSIFIANANINLDVYENEILVIMGMSGCGKSTLVRCLNGIYKIDSGSILVNNMEMNAINRKDLSNLRKDKFAMVFQNFGLFPHMNVLRNVTYGLEVKHIPRKIREERAIEVLNLVGLEDSKYKYINELSGGMKQRVGIARALVVNPDILLMDEAFSALDPLIKGEMQEELLRLVAKLKKTVVFITHDLNEAFKLGHRIAFMRDGKIIQVGKPLEILANPSTDFISDFIKNLPVLNILKIKDILKDDFDLNSGGDNGLNVIIKCQGENFSLYDKALNKRYDNLVSLNLDLNDEIKKIVEYLNKQDYLIIKEKGTVVGYISLNEISYLLSR		372		1	Selected	-1	 	
Batch03	BobuA.01456.a	Borrelia burgdorferi 	NP_212756.1	O51567				acetate kinase (ackA)	Potential drug target		MSNTKGKKMKILIINTGSSSLKFAIYQYENSKKIISGIVEKIKSQKSIIKIVNTDGSTTERFEKGIENHQKAIEKMFKILTNSDLKILKTLSEIKIIGHRVVHGGSSLKNSVILNNSILNKLKQISELAPLHNPNAITAIEAVLKILPHAKQVLCFDTSWHQTIKEHAFLYAIPYSWYKNHNIRKYGFHGLSYSYITKRSSEILNKKIDSLNLIILHLGNGASINAVKNGKSYDTSMGITPLEGLAMGTRSGDIDPSIINLMSTILNKTTKQIEEILNKESGILGISEKSNDMRDIWNKIEEGEYQSKLAVEIMTYRIKKYIGSYIAALDFNVDAIVFTGGIGVTDYGIRALALKGFEKIGIELDLEKNEMAQSKYLESEISTINSKLKILAIPTNEESTILEDIYNLIPKNL		413		5	Purified	-1	 	
Batch03	BobuA.01474.a	Borrelia burgdorferi 	NP_212525.1	O51352				50S ribosomal protein L10	Potential drug target		MFGGNIMSAKINAKKLEMFDLLKQFIDSKQNLFFLDYRGLNVAQLTELRNKIEGEHGSLKVVKNNIMKMVLKEKNINVVDSCLVGPTVVVTALEEANVIAKIFYDFVKSSTLKVKGGFVLGEFYDEAKVQAYSKLPTKKESISLFASVLKAPVSKLARTLKALADVKN		168		-2	Work stopped	-2	Work stopped	NR-16279
Batch03	BobuA.01478.a	Borrelia burgdorferi 	NP_051238.1	O68233				"plasmid partition protein, putative"	Potential drug target		MDNKKPKIITIASIKGGVGKSTSAIILATLLSKNNKVLLIDMDTQASITSYFYEKIEKLGINFTKFNIYEILKENVDIDSTIINVDNNLDLIPSYLTLHNFSEDKIEHKDFLLKTSLGTLYYKYDYIVIDTNPSLDVTLKNALLCSDYVIIPMTAEKWAVESLDLFNFFVRKLNLFLPIFLIITRFKKNRTHKTLFEILKTKDRFLGTISEREDLNRRIAENNNFDLNKDYIKEYENILEIFLKKI		246		17	In PDB	17	Ligand-bound structure submitted to PDB	
Batch03	BobuA.01495.a	Borrelia burgdorferi 	NP_212526.1	O51353				50S ribosomal protein L1	Potential drug target		MSKKGKKYIEAFSKVDKNKFYNIEDAILLLKEIKFAKFDETIDISINLNLKKNHTVRDTIVLPNQFMKPKRILVFAKGDRADEARAFGATYVGDDDLINKIKSGWDEFDVVVATPDMMKDVGRLGPILGKRGLMPNPKTQTVTNNLKDAINSLKKGRTEFRANKNGVISFSFGKSSMDNEKIKENYEEFVKEVVKKRPSDLKGAFIDSIYISSTMGPSIKVNFVWR		226		-2	Work stopped	-2	Work stopped	
Batch03	BobuA.01504.a	Borrelia burgdorferi 	NP_212214.1	O51107				"ABC transporter, ATP-binding protein"	Potential drug target		MEVKKTLKLLMDSKMENILIIKNLCKAYKKNKTKIQVIENLNLTVEKGEFISIQGKSGCGKSTLFNMISGIDKIDSGEIISCGIFLKNANEKTLSLYKNRQIGLVFQNYNLINEFSVIENIILPQIISGQKTKETINKKALDLMKILKIENRANHYPSELSGGESQRVAIARALINEPNIILCDEPTGNLDLSTAKTVENLLINTAKNFKKTLILVSHNPQFANKADSKYEFKDRTLKKL		240		3	Expressed	-1	 	
Batch03	BobuA.01508.a	Borrelia burgdorferi 	NP_212691.1	O51507				phosphocarrier protein HPr (ptsH-2)	Potential drug target		MVKKEAIIKAVNGLHVRPASTFVKKAKEYSSEITIESDGKSVSGKSLFRLQTLELSSGKKLLICAEGEDEEIAASELAELIESFKE		86		4	Soluble	-1	 	
Batch03	BobuA.01538.a	Borrelia burgdorferi 	NP_212221.1	O51114				L-lactate dehydrogenase (ldh)	Potential drug target		MLKSNKVVLIGAGGVGSSFAYALTIDNSLVHELVIIDVNENKAKGEVMDLNHGQMFLKKNINVLFGTYKDCANADIVVITAGLNQKPGETRLDLVDKNSKIFKDIITNVVSSGFDGIFVVASNPVDIMTYVTMKYSKFPIHKVIGTGTILDTSRLRYFLSDHFNVNTQNIHSYIMGEHXDSSFATWDETKIAMKPLSEYLAEGKITELELDEIHKKVVNAAYEVIKLKGATYYAIGLGIKNIVNAIIGDQNVILPISSYINGQYGGLIKDIYIGAPAIVCKEGVKEVLNFKISPKELDKFNSSANQLKSYIDKMEF		316		7	Crystallized	-1	 	
Batch03	BobuA.01545.a	Borrelia burgdorferi 	NP_212440.1	O51286				hypothetical protein	Potential drug target		MNNNAFHFPVLLDAICKLIEDLPVKSDLIYIDSTLGEGVHAKAILEKYDFLSLVGIERDPQILERARQFLSIFEERITYFNDWFDNFFVNYPLNVKANFILVDLGISMFHYKGSKKGFSFLEDEPLDMRLCSSSCKISAAEIVNTYSKYDLEALIYDLSNEHYSRRISKAIVEYRKIKKIETTKELQSIISKVYPFSKVKINPATKTFQALRIYVNDELARLKRSLPFWVENLAKDGILAIITFHSIEDRIVKDFFRSLSCDLYAKISKKPIMPSFDEIKKNKPSRSAKLRVVKKL		296		4	Soluble	-1	 	
Batch03	BobuA.01552.a	Borrelia burgdorferi 	NP_212818.1	O51627				isopentenyl pyrophosphate isomerase	Potential drug target		MMDTEFMGIEPNILENKKRHIEICLNKNDVKGGCNFLKFIKLKHNALSDFNFSEINIKEEIFGYNISMPVFISSMTGGSKEGNDFNKSLVRIANYLKIPIGLGSFKLLFKYPEYIRDFTLKRYAHNIPLFANVGAVQIVEFGISKIAEMIKRLEVDAIIVHLNAGQELMKVDGDRNFKGIRESIAKLSDFLSVPLIVKETGFGISPKDVKELFSLGASYVDLAGSGGTNWILVEGMKSNNLNIASCFSDWGIPSVFTLLSIDDSLKANIFASGGYETGMDIAKGIALGARLIGVAAVVLRAFYDSGEDAVFGLFSDYEHILKMSMFLSGSKSLLEFRNNKYFLSSYLLDELGVFKQFYGT		360		2	Cloned	-1	 	NR-16280
Batch03	BobuA.01596.a	Borrelia burgdorferi 	NP_212735.1	O51547				serine hydroxymethyltransferase (glyA)	Potential drug target		MRDDQIFNLIEKEKLREREHIELIASENFTSLEIRQAVGSILTNKYAEGYPLNRYYGGCSFIDEIETLAISRAKELFGAKYANVQPHSGSQANMAAIMALISPGDRILGMQLSHGGHLTHGSRVNFSGIFFNTYFYGVSRDSELIDYDEVLKIAKDCRPNLIIAGASSYSREIDFKKFREIADDVSAYLLCDIAHIAGLIVAGFHNSSIDVAHLTTSTTHKTLRGPRGGIILSGKDFDKLVNFNGKEKPLFNAVNSTVFPGTQGGPLVHVIAGKAIAFKEALQESFKEYIANVIKNTKVMAEYFKSEGFRIVSGGTDNHLFLVDLSSSDLTGADAEKLLESVNITLNKNAIPFDKKSPSLASGIRIGGAAITSRGLNESDSLNVAKFIVRALKAKSDIELKQIKKEVVRFIRDFDMP		417		2	Cloned	-1	 	
Batch03	BobuA.01610.a	Borrelia burgdorferi 	NP_212695.1	O51509				6-phosphogluconate dehydrogenase	Potential drug target		MDVGIYGLGVMGSNLALNIADNGFNVSVYNRDNEKTEIFVKQNSHKKINGFKDIESFVKSLKTPKKIILMVTSSAIEKVIEQILPFMNKSDIIIDGGNSHYKSTMRLEKELFAKDIYFVGLGISGGERGARFGPALMYGGSKSAYEILEPMLNKIAAKTKNNDICSTYIGENGSGHYVKMIHNGVEYADMQLISEVYFFMKKAFNLDNLKISEVFEKWNEGDLSGYLLEITSKILKYKENNEYLVDKILDIANQKGTGVWTAIDALESGVPVNLIVESVFSRFMSGLKHERIIASDLLKMDTSSFEFELSDWILDLYYALLVSKIVAYAQGFMMLKTASVNYGWDLNLGKISLVWREGCIIRSSFLDKIKLAYDKNPHLINLLFDDYFLDLLKNNHKSLRRIISKASEIGIPLPAFYASLSFLDSYSTNYLPSNLIQAQRDFFGAHSFERLDSKRGEFFHSAWQ		464		1	Selected	-1	 	
Batch03	BobuA.01630.a	Borrelia burgdorferi 	NP_212195.1	O51088				thioredoxin (trxA)	Potential drug target		MAISLTEEDFVVKVFDYKNDKEWSFRGDRPAIIDFYANWCGPCKMLSPIFEKLSKKYENSIDFYKVDTDKEQDISSAIGVQSLPTILFIPVDGKPKVSVGFLQEDAFENIIKDFFGF		117		1	Selected	-1	 	
Batch03	BobuA.01632.a	Borrelia burgdorferi 	NP_212548.1	O51375				chemotaxis protein methyltransferase (cheR-2)	Potential drug target		MLEIEDKLFLKFCDFIYNNSGIRFDEKNKFVLQSRVNDAVRALALENPSQLYNLIISEKLKKEYFLDLVTTNLTRFFRNSLHFQTFEKFVIPNLINIKNIEKKNRIIIWSAGCSTGEEPYSLAFVLKSKLPKEIDFVIIASDLSLKSLMIAKEGYYSSNKCENIPKEYRHYIYSHSNGYKIKNEIKNHIRFDYHNLNFESNFSEIDVVFCRNVLIYFDEKSKIKVLKKFYNNMSKNSYLFIGHSESLFGLNLPFKFLKTPWAIIYEKKDTGCQKEKFKSQNKYKL		285		1	Selected	-1	 	
Batch03	BobuA.01647.a	Borrelia burgdorferi 	NP_212239.1	O51132				methionine aminopeptidase (map)	Potential drug target		MTKLRLKSKDEIKKIKASASLLALTLLEVERNIVPGISTKELDLIAYDFIIKNRAKPAFKGYRGFKGTICASVNEEVIHGIPGKRKLADGDIVSIDCGVILDGFYSDMAKTFKVGNVDSSIDKLLEVTNASLYKGIAEMKVGNRILNISKAIEDYIKPFGFGIVREYTGHGVGFELHEEPSVPNYYAPFFKNIRIQEGMVLAIEPMVNLRGHKVSIKSDGWTVFASDLSYSAHFEHTVAVVDGLPLILSEV		251		1	Selected	-1	 	
Batch03	CoimA.00173.a	Coccidioides immitis		Q1DM0	Q1DM09|Q1DM09_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MAPEPLSAAGQNLIDTATSVINGIPVSDFYSVASAAISDDGRVFSGVNVYHFNGGPCAELVVLGVAAAAGATKLTHIVAIANEGRGILSPCGRCRQVLADLHPGIKAIVIGKEGPKMVAVEELLPSIYAWDKDYDRI		137		5	Purified	-1	 	
Batch03	CoimA.00179.a	Coccidioides immitis		Q1DNB	Q1DNB0|PYRE_COCIM			Orotate phosphoribosyltransferase - Coccidioides immitis	Potential drug target		MSASPDYKTNLLSHLISNKVLSFGSYTLKSGRNSPYFFTTTLLHTAPLLHATASACASVLSSPPFVTTSTPDGTPRPNFDIIFGPAYKGIPLCTAVLNELGVRDTTGAWNNISYSFNRKEAKAHGEGGNIVGAPLKGKKIVIIDDVITAGTALREAVGIIEKEGGTVVGVLVLLDREERVNDNEKKSAVGCAQRDLGENVPVKAVLSLSDIIEKLGNDIGEENLKRLKEYRAQYGAEE		238		3	Expressed	-1	 	
Batch03	CoimA.00190.a	Coccidioides immitis		Q1E2Q	Q1E2Q2|Q1E2Q2_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MLAAIVETSLGDDVFREDRTTLDFEAHVASITGREAGMFVVTGTMANELCLHSLISSRPCGILLDAAAHSVNFEGGGPSILSGGMIQTVRPSNGKYLRVEDLEKHAVIDDDDVHKCPTGIISMENTAGGIILPLHELRRIRDWAKRHDVKTHLDGARLFEAVAAGAGSLREYCALVDVVSVDFSKNLGAPMGAMVLGDASLIRRMRRTRKGIGGGMRQGGVITAAAREALFENFGMGAEIEKPVLRDVHRVAERLGEEWVRRGGRLTKEVETNIVWLDIDALGIDRRTLIDLGKKYGVVLDSPRVVCHHQIDAQAVADLVRLFDHLLGVNKHNGINGNGNLLSQ		344		3	Expressed	-1	 	
Batch03	CoimA.00207.a	Coccidioides immitis		Q1DLI	Q1DLI4|Q1DLI4_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MMATSRVPWILPWCLSLIWIACLVSVANAYTALSDDTLKALPRPGNDFDVHKGALLAPILRPRVPGSPGSRAVLEHFVKFFQTTLPDWKIEFQNSTSKTPATGDKEIPFVNLIASRDPPNTQPGNVGRLTLVAHYDSKLEPEGFIGATDSAAPCAMILHAIRSIDAALTKKWEAMKDDPVHELGLDEYQGIQIFLLDGEEAFVQWTEEDSLYGARSLAEHMENTVYPALSTYKSPLGAIKLFVLLDLLGEQNPNVPSYYKTTHWAYQHMAVLESRLRSLNLFKSSKQAQKDGSKKKPETEKPWLSDALKGDNEVFPPFGIGDDHVPFMKRGVDILHIIPSPFPRVWHRAEDNADHLHLDTVEDWSTIITAFAAEWLDLEGYFDKDARTSKWKGEKRKTEL		400		3	Expressed	-1	 	
Batch03	CoimA.00226.a	Coccidioides immitis		Q1E5D	Q1E5D2|Q1E5D2_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MTALPEPFASIPRKALLLEPSPIHLLPNMTADLGGAVKIYAKRDDLNSGLAYGGNKTRKLEYLVADALATKCDTLISIGGIQSNHTRQVAAAAAHAGLKAKLVQEKWVEWSDPGYESVGNIQLSRLMGADVRIERMAGFGIEHKDSLKNLLKECEDKGEKPYYIPAGASDHPLGGLGFARWAFEVREQEQQMGITFDNIVVCAVTGSTMAGMVAGFKLIEKLYPDEPKKKVIGIDASATPAETRAQVLRIAKNTGEKIGLEPEDITASDIMIDERYHAGTYGVPDKQTWDAIEYGARMEAFITDPVYEGKSLAGLIDMVRKGEISGGNVLYAHLGGQLALNAYSQIGTVA		350		5	Purified	-1	 	
Batch03	CoimA.00345.a	Coccidioides immitis		Q1DVA	Q1DVA8|Q1DVA8_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MPHPSLKSNRALPLLTFARTHSFAIPAICVYNLEGILAIIRAAEHKRSPAMILLFPWAIQYADSLLVRTAASACRAASVPITLHLDHAQDPEIIKRAADLSRSETHEPGFDSIMVDMSHFSKEENLRLTRELVAYCNARGIATEAEPGRIEGGEDGVQDTVDLEGVLTTPEESEEFVATGINWLAPAFGNVHGNYGPRGVQLDYERLQRINEAVGERVGLVLHGADPFTKEIFEKCIERGVAKVNVNRAVNNEYVKVMREKAGSLPITRLHEEVTNAMQAAVEKIMDMIDSTGKAEFMMDEK		302		11	Native diffraction-data	-1	 	NR-15942
Batch03	CoimA.00410.a	Coccidioides immitis		Q1E7Z	Q1E7Z9|Q1E7Z9_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MTTPNFELYGYFRSSCSGRLRIAFHLKSIPYTRHPVNLLKGEQHSDTYKSLNPTNTVPLLVVSNINNTVSPSSASFSIGQSLAALEYLEEALPTNARPLLPPISNPVARAHVRTICNIIACDVQPVTNLKIQKKVKALDGDPTVWSRDLATQGFGAVEKLLELSAGRFCVGDEITLADVCLVPAVWAAERVGMDLARFPITKRVFEEMLKEEAVQKAHWQKQEDTPEDLRA		231		17	In PDB	-1	 	
Batch03	CoimA.00415.a	Coccidioides immitis		Q1E7U	Q1E7U2|Q1E7U2_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MASQPQSSSKPAAGKLWGGRFSGATDPLMVAYNESIYFDRAFYAQDIAGSIAFARANVATGILSQAEFEAIEKGLNQIRGEWENNTFVIQPGVDEDIHTANERRLGEIIGKDIAGKLHTGRSRNDQVATDLRLWLRDELKTIETYLVDLISTITDRAEADIEYLIPGYTHLQRGQPVRWSHWLLSYGTAFLNDLERVREVIKRVNKSPLGCGALSGNAFKIDREAMAKELGFEGLVMNSMAAVGDRDFILEAMQCGSTVMLHISRWSEDLILYSSTEFGFVRLSDAYTTGSSLMPQKKNSDSLELLRGKCGRLFGGMAGLMMTIKGIPSTYNKDLQESVEPMIEHVKTLKDSLQIANRVLLTMTTFPDKMIAALTPDMLATDLAEYLVRKGVPFRETHHIAGRVVALGEKENKPIDQLTLEQLKSVDQRIGDDVLDVFNYERSVEMKSAIGGTSKSAVLQQIKVMRQSLGN		471		7	Crystallized	-1	 	
Batch03	CoimA.00447.a	Coccidioides immitis		Q1EBB	Q1EBB2|Q1EBB2_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MVPRVPQPGIWCPAVTFFDSKTDTLDLASQERYYAYLARSGLTGLVILGTNAEAFLLTREERAQLIATARKAVGPDFPIMAGVGAHSTRQVLEHINDASVAGANYVLVLPPAYFGKATTPPVIKSFFDDVSCQSPLPVVIYNFPGVCNGIDLDSDMITTIARKNPNVVGVKLTCASVGKITRLAATLPPAAFSVFGGQSDFLIGGLSVGSAGCIAAFANVFPKTVSKIYELYKAGKVDQAMELHRKAALAESPCKSGIATTKYAAAIFSAKAAGIEDAEEKLRPRKPYDPPSEAAKQEVRKVMAEVAAIEAGLS		314		7	Crystallized	-1	 	
Batch03	CoimA.00478.a	Coccidioides immitis		Q1E64	Q1E644|Q1E644_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MSQMAPSQSLQAALSSVQEAFVKRNPQSNQAHKEACRYFPGGNTRSVLYTTPFPLSFQSGHGSTLTSVDGDTYTDFLGEYSAGIFGHSNPQIAEALAGVLSRGWNFGGVNSHEAILARKVCERFNLEMVRFTNSGTEANMMALAAALAFSARNHPGRPEPKSIVVFSNAYHGSTLSFPNTLVDEIRRGHDVSHLTPNLPHNFLIAPWNNPAETAELLATRPRGSIAAILVEPLQGAGGCRPASAHFLKTLRALADQKSALLIVDEVMTSRLATRGLAQEWALRPDLITLGKWIGGGMSFGAFGGRRDVLQLFDPRTTKVPLGHAGTFNNNVLSMAAGCAGLDVYSGQRVARLNELGSTLKARLHALLADASLCEPPANRTDNDNDDDDDDAQRYPLETDSNSDTNDVPPTPPPGRMYVSGYGSVLSIRFSGPDATTCHQLFFHHMLEEKIYLAARGYMALSLELSRADIEHFIAAVQRFVTKYAALLLKDG		491		7	Crystallized	-1	 	
Batch03	CoimA.00479.a	Coccidioides immitis		Q1E80	Q1E800|Q1E800_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MASQSWLDIPKDSPFSLANIPFGIISTAVSATPRPAIAIGDYALDLFTFASAGGFSKLPALQSHIDVFAQPVLNDFAALGRPVHRQVREYLQEIFRDNTSHPEILKNNEDLKKTALVPRKDATNHLPMRIGDYTDFYAGLNHAYNVGVLFRGPDNALQPNYKHLPVGYHGRASSVVVSGTSVRRPNGQILANPTADPKVPVFSPCKRLDIELELAAFVATPNKMGDPIPISEAEDHLFGVVLMNDWSARDIQAWEYIPLGPFNAKNFATTITPWIVLMDALEPFRTQGLEPGNRDSLLPYLREKRADTAYDIDLEFELKNKGGQPTVVAKTNAKNLLYSFSQMLAHHSVTGCNMNTGDLLGSGTISGKEPGMYGSLLENTNGGKVAIKLADGTERKFLEDGDEVTLRGFAGQEGGYVGFGDCFSVIEPAHPIN		433		2	Cloned	-1	 	
Batch03	CoimA.00559.a	Coccidioides immitis		Q1EAF	Q1EAF2|Q1EAF2_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MSSLNNEEWDLLISGKKATLQYPIPLLCYPAPEVVSIAQIIDHTQLSLSATGSQIDVLCAEAKEYGFATVCVRPDYVSRAVQYLQGTQVGVTCVIGFHEGTYSTDQKVSEAKRAMQNGASELDMVMNYPWLSEKRYTDVFQDIRAVRLAAKDAILKVILETSQLTADEIIAGCVLSSLAGADYVKTSTGFNGPGASIENVSLMSAVCDSLQSETRVKASGGIRTIEDCVKMVRAGAERLGASAGVKIVNETRLGNRQVDEPMEPTNY		267		7	Crystallized	-1	 	
Batch03	CoimA.00584.a	Coccidioides immitis		Q1DP3	Q1DP31|Q1DP31_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MAATPLPPLRLAIACDDAGVSYKEALKAHLSDNPLVSSITDVGVTSTTDKTAYPHVAIQAAQLIKDGKVDRALMICGTGLGVAISANKVPGIRAVTAHDTFSVERAILSNDAQVLCFGQRVIGIELAKRLAGEWLTYRFDQKSASAQKVQAISDYEKKFVEVN		163		7	Crystallized	-1	 	
Batch03	CoimA.00598.a	Coccidioides immitis		Q1DZ7	Q1DZ72|Q1DZ72_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MAGSVPRGLKQILQKSPSDIVILSSLRTAVTRAKKGGFKDAYPEELLAHVLRATLAANPNLDLALIEDVCIGSVLQELGGAKAGRMAQIHAGFSHTVPFHTINRQCSSGLAAISTIAHSISVGAISVGIGGGMESMTRNYGSRAIPTVLWPELKESELQDARDCIMPMGITSENVASRYGINRHDQDAFSAKSHQKAAAAQKNGLFDKEIVAVTTKTIPTDKPDGPAEEITVTKDDGIRPTVSLEKLATLKPAFSPTGSSTAGNSSQVSDGAAAALLMRRSTATELGLTSSIIGKWVSTQVAGCAPDEMGIGPAVAIPKVLKHTGLEVSDVGIWEINEAFASQALYCVRKLGINEDKVNPKGGAIAIGHPLGATGARQLATLLPELERQGEQVGVVSMCIGTGMGMASVFVRE		413		2	Cloned	-1	 	
Batch03	CoimA.00717.a	Coccidioides immitis		Q1DP3	Q1DP30|Q1DP30_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MASALAGPRFPPLPKTLLIISLKMYFTPSRTIDYIQGLLEPRNDIIRQENRSRLLLALIPDFLTIYPCSEAIKEFESNLAAPQDADTPPPLLLGAQDCFWDSLGPYTGEISPVCLRDMNVSIVELGHAERRAIFGETDQQVARKAAAAADQGLIPLVCIGEVSTLGPIVSEAIGRAVGECEAQIRPVLEALPRDAPVIFAYEPVWAIGKPQPARVDHVGAVVSGIRSVIERIDRHRKGEVRILYGGSAGPGLWGPGGLGKEVDGMFLGRFAHDIEGVRKVVREVEESLR		289		4	Soluble	-1	 	
Batch03	CoimA.00800.a	Coccidioides immitis		Q1DRH	Q1DRH5|Q1DRH5_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MACNSAAWLTAAKATPFEVKPAPLWTPGENEILVRNHAVAINPVDGSLQAFAWWPLEYPTILGQDVAGVVKDVGPNVTRFKRGDRIVGHAVGMATKRNQDNGFQAYTIVQTNMAAELPESISFQDAAVIPLAFSTASCGLFQDAFLKLQPPTEPPQNPTGETLLVWGGSSSVGSNAIQLAIAAGYEVIVTASPKNFNYVKKLGAAQVFDYSNPTIVDELVDAFKGRTVAGAMDCIGAAATKACAEVVQKSSGRKFVSTTKGGFEEPPEGVAVKNVFGTTLKDNNVGKMVYVDFLSKALRAGSFVPAPAPLVVGKGLESVQGGVDIIRKGVSAQKLVVLL		339		2	Cloned	-1	 	
Batch03	CoimA.00860.a	Coccidioides immitis		Q1DM2	Q1DM24|Q1DM24_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MPSPSRASALLANLSSVTSRISAASVPGSSVRLVAVSKLKPASDILALYNPPTSHLHFGENYLQELLEKSKILPPEIRWHFIGGLQSNKCVTLARDVRGLWAVESVDTQKKATLLDKGWGERLKNHSAQQQQQQQGRAEPERLRVFVQVNTSGEESKSGVEPSQAVELCRFIREQCPRLKLEGLMTIGAIARSKATTPETQNEDFDCLRETRDRICQELGLEGEEKLELSMGMSEDFEGAIAMGSNEVRVGSTIFGARPPKGEAKVVP		268		2	Cloned	-1	 	
Batch03	CoimA.00871.a	Coccidioides immitis		Q1E2S	Q1E2S8|Q1E2S8_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MATENKALFYQKVPTEFPVPGEHLTIEKVPFDPEAPAPDGGLTLQALYTSFDPYMRGGMRPAQVKSYRPAYEIGKPLPSISIVKVLKSNNDRFKPGDIAIGFMPIQQYIAAPAETVQALRLLDNPLGLDDLRYFLGALGMPGLTAYSSLMEIGKPKKGETIFISSAAGAVGQVVGQIAKHEGLRVVGSVGSDEKLNYIINDLGFDAGFNYKKEKPRDALKRLIPEGIDIYYENVGGEHLDAAIESMNDFGRIVTCGMISQYNVKPEDRYPIKNLFMVVTKRITMRGFIVSDPGMGDKWAKEHRERVSQWIKDGTFKPMIHETVGIDNAAEGLVGLFQGKNFGKAVLKL		348		10	Diffraction	-1	 	
Batch03	CoimA.00961.a	Coccidioides immitis		Q1E2T	Q1E2T0|Q1E2T0_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MSEKKADLNPQPPAPSDPPPSYETAASSTGGPNTNPIPLPRPPPLSLPVLNQLRSKRVILASASPRRKQIISFLGLRNVEIIPSNTPEDFPKTLTPFEYVLQTATHKAITVYQQEVNNLEKGEPALILAADTIVVDISTGDILEKPRSEAHHISMLKLLRDVMDHKVYTAVAAIVPLESARDPGYALETVVEETKVRFDPDVTDELILAYVRTREGVDKAGGYGMQGLGSILVQRIEGSYDNVIGLPLRATLRLIEKAMAKAEDDDLLGDELSEEE		276		7	Crystallized	-1	 	
Batch03	CoimA.01039.a	Coccidioides immitis		Q1E7Z	Q1E7Z1|Q1E7Z1_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MSYQQELLVAQLAVQRAAILTQKVFYEKTKGTLSKDDFSPVTKGDFGAQALIIQAIRANFPQDEVVGEEDADSLRENDALRNEMWNLVKDIKLTDAESDKVIGGPFKNETEMLDALDGGKSPGGPKGRIWALDPIDGTKGFLRGGQYAVCLGLIEDGDVKVGVIGCPNLPLDDSAPLSAEIGQSGAAGTETGVLFSAVKGQGATSRPLSDGAVREGKAISMRPVTDITKACFCEGVEAGHSAQDDNAEVARRLGINSPSVRLDSQAKYCSIARGAGDIYLRLPVRADYEEKIWDHAAGDLIVREAGGEVTDITGNRLDFTKGRKLSANRGVVAAPKSIFEQVINAVRAVYAAKASI		356		1	Selected	-1	 	
Batch03	CoimA.01079.a	Coccidioides immitis		Q1EA8	Q1EA80|Q1EA80_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MNIRPEESPIEETVHAIPPQKDVFTWRNVVYDISIKGEPRRLLDNVSGWVRPGTLTALMGVSGAGKTTLLDALAQRTTMGVITGDMLVNGKSLDMSFQRKTGYVQQQDLHLETTTVREALRFSAMLRQPKSVSKTEKYAYVEDVIDMLNMRDFSEAVVGNPGEGLNVEQRKLLTIGVELAAKPALLLFLDEPTSGLDSQSSWSIITFLRKLADNGQAVLSTIHQPSAILFQQFDRLLFLAKGGKTVYFGDIGENSRTLLDYFERNGAEPCGSNDNPAEYMLDVVGAGPSGKSEQDWPTIWNESEEARRVQEEIDRINAEKEKDESLQEPTETPREFAMPFTSQVYYVTIRVFQQYWRTPTYIWGKLLLGIMAAVFM		376		2	Cloned	-1	 	NR-15943
Batch03	CoimA.01092.a	Coccidioides immitis		Q1DTZ	Q1DTZ5|Q1DTZ5_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MNPPTPLSASSTTSTASQNSQPPDGEQITQVMEGMHLHGSQKANGAALPQKPPRPRMTNPFSRMFSQTGRAAHREIENMKETASDTSTQSKSSSKSAAVVDGSEKATSPKPTPKQQTDKRPEDKKPGREPVQPMKRFDMLPDGNHVHYLKSAKRQEKLSSMLRDMLGGGKKKDDHVEDQQLSLMSTWVDQLKTERDKLASDKKGGPNNTASLVDKYGKCQEIVGRGAFGIVRISHKVDPKDSKTEQLYAVKEFRRRPQETAKKYQKRLTSEFCISSSLRHPNIIHTLDLMQDSKGDYCEVMEYCAGGDLYTLILAAGKLEVGEADCYFKQLMRGVEYMHEMGVAHRDLKPENLLLTTHGALKITDFGNGECFRMAWEKEAHMTAGLCGSAPYIAPEEYTDKEFDPRAVDVWATGVIYMAMRTGRHLWRVAQKDEDEFYERYLEGRRDEDGYAPIETLHRACRPQFIIQVMSM		472		1	Selected	-1	 	
Batch03	CoimA.01100.a	Coccidioides immitis		Q1DUN	Q1DUN8|Q1DUN8_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MQSDTGPEVYGNWNAPVAITHSSTIYCLRCMINLDIPLNQGCLAAIDIRIPERSILSPTKTAAVVGGNVITSQCITDVVFKALRACAASQACVNNLTFGRDPKIDPETGKTIPGFGYYETIAGGSGAGPTWHGESGVHVHMTNTRITDPEIFEKRYPVLLRQFSLRENSGGKGLHSGGEGVVREIEFLSPLQCSILSERRVYRPYGLEGGEDGQTGLNLWITKDTESGTERVVNIGGKNTVMKKTNDRIVVMTPGGGGWGKAC		263		2	Cloned	-1	 	
Batch03	CoimA.01143.a	Coccidioides immitis		Q1EBG	Q1EBG0|Q1EBG0_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MKFRTLQNAYFLSHLLSPIVSFPVFPSSTSETTQLPLVIWHGLGDDFAREGLKHIAQLAEDTHPGTYIHIIHVGDTPEADRQASFLGNVTVQLETVCKQLESDPILSTAPAVNALGFSQGGQFLRGYVERCNSPPVRNLVTFGSQHNGIAKFQSCAATGDWVCRGAEALLRFGAWSNMVQSRFVPAQYFRDPEELDQYLLHSNFLADINNEREIKNEQYKRNLISLNKFAMYMFKDDNLVVPKQSAHFAEVNSTTGYVKPLQEREIYTEDWLGLKVMDEAGSLEFLTVPGEHMQLSDRVLKEAFEKYFGPVEVDLASHPELVLQVQ		326		1	Selected	-1	 	
Batch03	CoimA.01157.a	Coccidioides immitis		Q1DZD	Q1DZD7|Q1DZD7_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MVSIPKTVALVIGSTRVPRVGSRVASLLLDNLRPKAEKSNIKLATVDIAEFKLPVFDENVIPATVPAKASFAHDHTKAWSSEMEKYDGYIVLSPEYNFGPPGGLKNAIDYLYNEIKGKPVLIVTYGAKGGIFASEMLDKIFSGMGLQVCATRPSLPFQGPDIASAMSEGILADATRQAWDQGRMTEIFKGFTELEQALKANSA		203		2	Cloned	-1	 	
Batch03	CoimA.01173.a	Coccidioides immitis		Q1DQE	Q1DQE6|Q1DQE6_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MDAIREVKYLQELSHPNVIALHAVFSSKDRNLNLVLEYLPLGDLEMLIKDSAIQYGAADVKAWVGMLGRAVWFCHENFILHRDIKPNNLLIASDGEVKLADFGLARSFADPRLNMTHQVITRWYRPLELLYGARQYSGAVDVWSMGMVFAELLLRVPFAAGNTDLDQISKICAAFGTPTEDNWPGVTKLPNFVPVEKNQIVPLQGRDFFLRQFPTVGHLGADLLSSMLKLDPRNRSTAKQILQHAWWSAEPRPTRKENLPRKAGGAKKMGNDLSRRGGVTDEGSFKNAARRLDFGGLLPK		300		3	Expressed	-1	 	
Batch03	CoimA.01194.a	Coccidioides immitis		Q1E0F	Q1E0F2|Q1E0F2_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MSESNAFPGSHAGHGERHAGGGAAPFNRIVEEDENVTSPTTSTFHRTDVSRQRAHIHHVLSPFQSGDGVGTFGEFGAFGPNPFGGRGEQEHGTFRPAAGPSDSGFPNHYALGRRTSVSAESLNPTSSDSDSWTPPYHPKPPEQLDRLKTAVAGNFLFSHLEEDQFKTVLNALVEKPVPAKDIKVITQGDAGDYFYIVEQGHFDVFIHPSGSAQPGHNGMGSKVNEIGPGGSFGELALMYNAPRAATVVSTEPSTVWALDRVTFRRILMDSAFKRRRMYEAFLEEVPLLSSLKPYERSKIADALDTIKHPAGHTIIEEGDPGDAFYLLESGEAAAYKRGIDGAVKHYRRGDYFGELALLDDKPRQASVIAKTDVKVAQLGRDGFKRLLGPVEDIMRRTEYGVPEGQPKLEASE		412		5	Purified	-1	 	
Batch03	CoimA.01230.a	Coccidioides immitis		Q1E02	Q1E029|Q1E029_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MAKNQWRPYTNGSHAPSTPRHLLSIADLTPTEFATLVRNASSYKKTIKSDSMPERLTGALSGKTVAMMFSKRSTRTRVSTEGAVVKMGGHPMFLGKDDIQLGVNESLYDTSVVISSMVSCIVARVGPHSDIANLAKHSSVPVINALCDTFHPLQAIADFLTIHESFASQSATHGTHPSSLGLEGLKIAWVGDANNVLFDLAIAATKMGVNVAVATPRGYEIPSHIVELIQKAREGVQSPGNLTQTTVPEVAVKDADVIVTDTWISMGQETEKIKRLEAFKDFKVTSELAKRGGAKENWKFMHCLPRHPEEVSDEVFYSERSLVFPEAENRLWAAISALEAFVVNKGKIA		349		7	Crystallized	-1	 	NR-15944
Batch03	CoimA.01291.a	Coccidioides immitis		Q1DQB	Q1DQB4|Q1DQB4_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MSSQTENSTASEPVVTLAPAPAPLTVAPELTPPLTSNNTTPRFSEKDVSVIFVLGGPGSGKGTQSANLVREYGFSHLSAGDLLRAEQNREESQYGELIRNYIREGLIVPMEITVALLSNAMADILAEKKAQNQLIPGIPSRFLIDGFPRKMDQAIFFEETVVPSMATLFLSCPEEIMLNRLLKRGETSGRSDDNIDSIRKRFRVFVDQSMPVVDHYTKEGKVMSVSSVGSVDEVYSGIKREIEARGIRPVQEN		253		2	Cloned	-1	 	
Batch03	CoimA.01305.a	Coccidioides immitis		Q1E6B	Q1E6B3|Q1E6B3_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MMPPSSSRQAQKSPSTGHKVNQVILGSLLFKTWYEALYPEELVAKDTDTLYVCGWCFRYTCDRTAYAAHLPACQLRSSPPGSQIYQHDGYSVWEVDGEDYKLFAQNLSLFAKLFLDQKSVCFDVSGFLFYLLVYIDPDNPDAHHILGYFSKEKMSWDANNLACILIFPPYQHNQLGKFLMGISYKLSTWEWERGIGSIGGPERPLSEMGERSYIRFWEERIARYFLRDLPRGNGKPAKSRPKKRKKVTQEQITIEELGKATGMLVEDVITAIKSMGVASEEQLKQRRKRAASENANEVEESVAVIKKSKVLEWAKNRGISLEDPVKDEGFTGKWALKREQEQSEPDND		348		5	Purified	-1	 	NR-15945
Batch03	CoimA.01320.a	Coccidioides immitis		Q9HEU	Q9HEU1|Q9HEU1_COCIM			Macrophage binding protein - Coccidioides immitis	Potential drug target		MAPLPRKALLAITSAHPPFWPDGKRTGLFFSEALHPFNELTAAGFEVDVASETGTFGWDEHSLTQEYLSKEDEKVLHSEHNHFMEKMNKQVFKAGDLAPHDYGLMFVCGGHGALYDFPHAKHLQNIAQDIYKRGGVIGAVCHGPAMLPGIHDENGDSVIKDKTVTGFTTKGEIMIKVIDKMREDHLHTIADMAQTANAEYVPPEDPWDDFCKVDGRIVTGANPQSATNTARDTIKVYEGIVNE		243		17	In PDB	-1	 	NR-15946
Batch03	CoimA.01346.a	Coccidioides immitis		Q1E6D	Q1E6D8|Q1E6D8_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MADKPDWSAALRPAPPGGATIIAQERARSIIPVDQLAGYLLTPDFLERQDRVLKVLLKEPVFKKANQANLSRPDRYKLGLARGKKIRQLKEKLGWDEEDYHMAAYLCDDVLPYHLHTAMFITTVSQQGSDAQRARWVPRIERWEIIGAYAQTELGHGSNVRGIELEARWDPETREFILHSPHLTASKWWNGTMGRTATHAIAVAQLMLPVSGKGAETKYKSYGPHPFIVQIRDSRTHQPPESIIIGDIGPKYGYASMDNGYMLFNNHRCETISFYIRFHFKN		282		3	Expressed	-1	 	
Batch03	CoimA.01436.a	Coccidioides immitis		Q1DVW	Q1DVW2|Q1DVW2_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MYTHPEVAWVGQNEADLKAAGIKYRVGTFPFSANSRAKTNLDSEGQVKFLADEQTDRVLGVHIVGPNAGEMIAEATLAVEYGASCEDIARTCHAHPTLAEAFKEAAMATYSKAIHF		116		2	Cloned	-1	 	
Batch03	CoimA.01459.a	Coccidioides immitis		Q1E9J	Q1E9J2|Q1E9J2_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MSLKPFKIYGTLLGPNPFKVATVLSELSLPYEVVQVAREDIKGEAFTALNPNGRLPALVDPNKDDFTIWESGAIVNYLITEYDTEHKLSFPVGTKEYHLTQQWLHFQMSGQGPYYGQWFWFKNYHSEQLPSAVERYANEVRRVTVVLDKWLENKQFLVGDKYTFADLAFFPWQMLVPSLTGVDIEKEAPNVHRWMENMKNRPAVAKVIEEQKASKWN		217		5	Purified	-1	 	
Batch03	CoimA.01465.a	Coccidioides immitis		Q1E52	Q1E525|Q1E525_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MPLLSPERFVGLGIDPPKGALLYGPPGTGKTLCARAVANRTDATFIRVIGSELVQKYVGEGARMVRELFEMARTKKACIIFFDEIDAIGGARFDDGAGGDNEVQRTMLELITQLDGFDARGNIKVMFATNRPSTLDPALMRPGRIDRKIEFSLPDLEGRANILRIHAKSMSVERDIRWELISRLCPNSTGAELRSVATEAGMFAIRARRKVATEKDFLAAVDKVIKGNLKFNSTATYMQYN		241		2	Cloned	-1	 	
Batch03	CoimA.01544.a	Coccidioides immitis		Q1E8U	Q1E8U5|Q1E8U5_COCIM			Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MDDVKKGILLQLFGGTNKTFEKGGSPRYRGDINVLLCGDPSTSKSQILQYVHKIAPRGIYTSGKGSSAVGLTAYVTRDPESRQLVLESGALVLSDGGVCCIDEFDKMNEATRSVLHEVMEQQTVSIAKAGIITTLNARTSILASANPIGSKYNPNLPVPQNIDLPPTLLSRFDLVYLVLDRIDEQNDRRLAKHLVGMYLEDTPENASTEEILVCL		215		2	Cloned	-1	 	
Batch03	CrpaA.00201.a	Cryptosporidium parvum		Q5CTL	Q5CTL3|Q5CTL3_CRYPV			Glutaredoxin related protein - Cryptosporidium parvum Iowa II	Potential drug target		LKNIDTAMNSIKLLVESFISSGDICVISKSYCPYCIKAINSLKSAGYSPLVMQIDGRVDTKEIQDYCRELTGSGTVPRVFVKGRFIGGCDDTLKLLEDGSLSSFVETI		108		5	Purified	-1	 	NR-16144
Batch03	CrpaA.00284.a	Cryptosporidium parvum		A3FPX	A3FPX0|A3FPX0_CRYPV			"Ankyrin-related protein, putative - Cryptosporidium parvum Iowa II"	Potential drug target		MDNQQSELESTKYSESSSNTKALASLKGSLPEDCYYSADEDFQLENEEAVNTNLIAPSGRFSNSNRSNGLKTLGNSNQVYKQDNIRSQKLPSFGFENRFQDNIKGKGRTSGSIYRLDKTENEKDTCQVCELDTNSSLSVLSNSEDNISEFSILSDTDVFSLPAERQNSLILKASKIGNLQLVRQLIASPKFNANATNEKGFSSLHWASLKGHSQVVEELLNANAEPNTKNVMLCTPLHFSASNGFDEIVNKLLNAGANPNAVSALGDTPIFSAAFMGHENTVKTLLKNGADPRYKNKQGLTPKDAAESQGHSEIVKILEGACMQ		324		3	Expressed	-1	 	NR-16324
Batch03	CrpaA.00285.a	Cryptosporidium parvum		Q5CXS	Q5CXS0|Q5CXS0_CRYPV			"Deoxyuridinetriphosphatase, possible bacterial origin - Cryptosporidium parvum Iowa II"	Potential drug target		MHLSLLPLCPIAEELYKNHKTFHDGDSGLDLFIIEDQVIKAGETAYIKLGFKAAAHSDDGKPVSYLLFARSSISKSPIRLCNSVGLIDAGYRGELLAPVDNIKDFDFQVKKGERYFQLVSFNGEKITFSIVDELDKTTRGEGGFGSTDKLDSVKGLPQKIAKIDTENAENLIENVQ		176		4	Soluble	-1	 	
Batch03	CrpaA.00288.a	Cryptosporidium parvum		A3FQ7	A3FQ75|A3FQ75_CRYPV			"Protein kinase, putative - Cryptosporidium parvum Iowa II"	Potential drug target		MEAVKGERGIVQIKGCFYSLTPGGIIMQNIVMPLMTKSLGVFIRENRALRKQNSSHRISPELVKNLSFQIVNGLAALHSSGYTHRDFKPDNILLMDTDDSERKFPTINICDLGKL		115		-2	Work stopped	-2	Work stopped	NR-16145
Batch03	CrpaA.00346.a	Cryptosporidium parvum		Q5CQB	Q5CQB2|Q5CQB2_CRYPV			Putative uncharacterized protein - Cryptosporidium parvum Iowa II	Potential drug target		MSTEYRVGFASKEDIIEKSTYGECEDRTKSLSFSSDVNSITYDEASSSSEEYPEYSLLRTQSSLAPPIEASAIVDVEEAWKALSKELEESHSKPTIRTLGTVFVTREEVGTKDSIEYRLFYKNEDGYKISPWHDVPLWFSETPLLYNMIIEIPKLTNKKFEINTKEEYTPLYQDRKLERLRTYPGPIPWNYGAFPQTWEDPNKKGDENVDFSHGDNDPLDAVEIGVGPLPRGTIIQVKILGCLALIDDDELDWKVVCIRVCDPHASQLNDITDVEKYFPGTIDRIRRWFGLYKAVENKDVAKVNMYGHFGEPQSAEFAHSVILETHHSYLRLIRGEAMNSSSLWIPKSLSNNGETELCHTVCSTNSTATVSSNDIGGLSVNDD		383		4	Soluble	-1	 	NR-16325
Batch03	CrpaA.00370.a	Cryptosporidium parvum		A3FQK	A3FQK8|A3FQK8_CRYPV			Ribonuclease - Cryptosporidium parvum Iowa II	Potential drug target		MNIFPGINITVKPKADALFPSVSGASILAKVKRDDFLSNWWTQASVESCDFNGNKISNYEQGSGYPGDPKTKDFLRRVFDPVFGFPNIVRFSWSTASEIIEKDGYSVNWGELELNNNQQKINFNRPQQNGKLFSSNFPLNEDMH		144		3	Expressed	-1	 	NR-16146
Batch03	CrpaA.00375.a	Cryptosporidium parvum		Q5CXG	Q5CXG3|Q5CXG3_CRYPV			Diphthine synthase - Cryptosporidium parvum Iowa II	Potential drug target		KFTTMVLYLIGTGLNDERDMTLGGIELMKVADKIYLESYTSILSQRADLMKYTDGKPLIEADRKMVEENCDEIIEEAKDKSIVLLVVGDPFCATTHSDLVLRAHEKDVKVEVRHNASIISAIGCTGLQVYRFGETVSIPFFDGSWQPSSFYDKIKANIERGLHTLCLLDIKVKEQTIENMMRNRPIFEPPRFMTVNQAISQLFILEDKLKQNVISPNSLAIGVARIGSSDQKIVSGTLSELSDTDFGNPLHSLVICHPDLHLIEQRFFEIYRKK		274		3	Expressed	-1	 	NR-16147
Batch03	CrpaA.00383.a	Cryptosporidium parvum		Q5CU2	Q5CU29|Q5CU29_CRYPV			Possible proteasome component - Cryptosporidium parvum Iowa II	Potential drug target		SIMTYNGGAILAMKGKECVAFATDMRLGSNGYRTISTDFDKVIRPSSKTLMGFSGLATDIHTLTNLIKFKTNLYHLREEREIGVKALSHMTASILYSKRFSPYFVEPIVAGLDNNNVPFIAGYDLIGCLSVCSEFAISGTADNQLFGICESYYRPDLEPDELMEIVSQCMLSGIDRDAFSGWGCKVYLLTPEKLVTKTLKSRMD		204		4	Soluble	-1	 	NR-16326
Batch03	CrpaA.00423.a	Cryptosporidium parvum		Q5CXZ	Q5CXZ9|Q5CXZ9_CRYPV			Glycolytic phosphoglycerate mutase - Cryptosporidium parvum Iowa II	Potential drug target		MTYKLTLIRHGESEWNKENRFTGWTDVSLSEQGVSEAIEAGRMLLEKGFKFDVVYTSVLKRAIMTTWTVLKELGNINCPIINHWRLNERHYGALQGLNKSETASKFGEDQVKIWRRSFDVPPPVLEKSDPRWPGNELIYKGICPSCLPTTECLKDTVERVKPYFEDVIAPSIMSGKSVLVSAHGNSLRALLYLLEGMTPEQILEVNIPTACPLVLELDDYLKVTKKYYLISEEELKAKMEAVANQGKAK		249		-2	Work stopped	-2	Work stopped	NR-16148
Batch03	CrpaA.00437.a	Cryptosporidium parvum		A3FQN	A3FQN0|A3FQN0_CRYPV			Putative uncharacterized protein - Cryptosporidium parvum Iowa II	Potential drug target		MSNVNVQLSRKQQLLERGCNEMIEEKTNLTNLNHNVTLSSGLSTTATSSTNLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFSPNYKH		433		-2	Work stopped	-2	Work stopped	NR-16327
Batch03	CrpaA.00439.a	Cryptosporidium parvum		A3FPS	A3FPS3|A3FPS3_CRYPV			"Casein kinase II, alpha subunit, putative - Cryptosporidium parvum Iowa II"	Potential drug target		MSNNSNSANKWPLPRLYSDVNIYKPREYWDYESFQIEYSNPNNYEIIKKVGRGKYSEVFEGINVITNEKVIIKVLRPVKRKKIKREIKILYNLHGGPNIVKLLDIIKDPSSGTISLVFECLDNVDFKSLFPTFNDNDIRFYIYQILKALDFCHSQGIMHRDVKPHNVIIDPKKKELRLIDWGLAEFYHPRQDYNVRVASRYYKGPELLIDFQYYDYSLDIWSLGCVLAGLIFKRDPFFCGVDNNDQLVKIARVLGTDGLFEYLAKYKKQLEPYFDDLLGRHTRKPWSKFINAENQHLVNPVVLDLLDKMLVYDHAERILPREALAHPYFEKIHQEEQKGSS		341		-2	Work stopped	-2	Work stopped	
Batch03	CrpaA.00453.a	Cryptosporidium parvum		A3FPL	A3FPL6|A3FPL6_CRYPV			cAMP-dependent protein kinase regulatory subunit - Cryptosporidium parvum Iowa II	Potential drug target		NFYSASSVDAVHPKKSSGKEDKRKKTSGTSSGSESESDSDDVRDNIEIPKNFLARGPRTSVSAEAYGAWNKMKDFTPPSYPKTKEQEKRIREKLLESFMFTSLDDDELKTVILACVETSVKKDTEIITQGDNGDKLYIIDQGVVECYKKTSTEPRKHLCDLNPGDAFGELALLYNCPRAASVVAKTDCLLWALDRETFNHIVKGSASKRISTYETFLKEVEILKTMDVYELNKLTMVLKSSIFEDGQEIIKQGEQGDTFYLIITGNAVALKDNVEVMSYKRGDYFGELALLRNAPRAATVKARGRCKVAYLDRKAFKRVLGPIEDILKRNTDKYKTVIKKITTKV		345		-2	Work stopped	-2	Work stopped	
Batch03	CrpaA.00457.a	Cryptosporidium parvum		A3FQ9	A3FQ99|A3FQ99_CRYPV			"ARF1/2 like small GTpase, putative - Cryptosporidium parvum Iowa II"	Potential drug target		MGLALSRIWNRLFGKKEMRILMVGLDAAGKTTILYKLKLGEVVTTIPTIGFNVETVEYKNISFTVWDVGGQDKIRPLWRHYYTNTDGIIFVVDSNDRERINDSRDELMRMLGEDELRDATLLVLANKQDLPNAMSVTEVTEKLQLSSLRHRSWFIQSTCATAGDGLYEGLDWLARNLEKAAS		182		5	Purified	-1	 	"NR-16149, NR-16150"
Batch03	CrpaA.00482.a	Cryptosporidium parvum		Q5CXD	Q5CXD0|Q5CXD0_CRYPV			Apyrase; calcium-activated nucleotidase SCAN-1-like protein; signal peptide - Cryptosporidium parvum Iowa II	Potential drug target		MKESSTINYLITLTFIIPFVLSQSTLLNLGAGGAQERRVCTDEMPCNFRLVADLDMNSKPGNGEKNYKSLFQKGSIIQDKRGNYRVDWGEILELKSGYNEYGRGMELSELISYNGMMLAGDDRTGIIFEITDDGKGVAPRYILSEGNGRTAKGMKIEWFAVRDGILWVGSFGKEFVSNGIIEKRDNMWVATIDKRGHVSRFNWSFVYEKIRNSLGAQYPGYCIHEAVIWSHLMRKWIFLPRRVSFDEYDEEKDEKRGSNKMIIMTDDFEILEIIDVGLIIPERGFSSLKFLPGSFDQIIVATKSVEESISDTQKSFLTIFTINGKILMEDLEVPGDYKYEGIEFI		345		4	Soluble	-1	 	
Batch03	CrpaA.00484.a	Cryptosporidium parvum		Q5CQ4	Q5CQ43|Q5CQ43_CRYPV			Proteasome subunit beta type - Cryptosporidium parvum Iowa II	Potential drug target		MTFDFLDSGIEAINHYGIRNENLKNSGFLRLDFFGNDKDEEDFVERIYEETFQYAKIENPCKFVSEYNKGEIRKMMNRGTTTLGFIYQGGVILAVDSRASQGSYIASQEVKKIIQINDFLLGTMAGGAADCSYWERVLSKLCRLYELRNGERISVAGASKMITNIFFHYRAYDLSAGIMIAGFDKDGPHLYYVDNEGSRVKDCKFSVGSGSLYAYGVLDSGYRYDLTDEEAIDLGKRAIVIATNRDGGSGGLVRVYQINKNGVIKHVPGEDVSELHYAYSKKQGTDPTKM		290		2	Cloned	-1	 	
Batch03	CrpaA.00497.a	Cryptosporidium parvum		Q5CSR	Q5CSR7|Q5CSR7_CRYPV			Histidine triad - Cryptosporidium parvum Iowa II	Potential drug target		VDLDFLHITVFGSMVDSEVTIFDRIVSGEIPCRKIYEDDLCISFHDINPVAPVHALLVPKKRSGLTRLSKATETHKEILGHLMTKVPVVAKLLDLDDFRIVINDGESSCQTVFHLHIHILGGRNFTWPPG		130		3	Expressed	-1	 	
Batch03	CrpaA.00503.a	Cryptosporidium parvum		Q5CR9	Q5CR91|Q5CR91_CRYPV			"Possible thioredoxin H-type of possible fungal or plant origin, small protein - Cryptosporidium parvum Iowa II"	Potential drug target		YFFPTIFEFLEYKAYISRQGLVVVDYFATWCGPCNMIAPKLEEFSEQVKDVCFIKVDVDSLPSIADAESVRAMPTFKFFLNGKEVKSVVGANFEIIQQAVLANKP		105		2	Cloned	-1	 	
Batch03	CrpaA.00514.a	Cryptosporidium parvum		A3FQ1	A3FQ12|A3FQ12_CRYPV			"Scully CG7113-PA, putative - Cryptosporidium parvum Iowa II"	Potential drug target		MKIEDSVIVVTGGMSGLGKAVVEELLKENPRKVCLMDAVLKEGELEEEPINKCEKYCVDVTDYNCIKSAAKSIIDKYSKIDAVVHCAGITHCPTPIVQKDDNGKIMENNEDIPEIWGKVVNVNVIGTLNVIHCLSPFLAMNQGNSHGFEKGVFILVSSSTARDGPAQNQGYIASKGAINSLTLPLARELGPLGIRVVTIGPGVFDTPMSKHAMSEKTSSTLLKSIPLGRFGVPNEFAETVVNVGLKSEYISGEIIYLDGAWRPPFITSGSVRRLSIQKSSSNDE		284		2	Cloned	-1	 	NR-16151
Batch03	CrpaA.00531.a	Cryptosporidium parvum		A3FPR	A3FPR1|A3FPR1_CRYPV			Rablib - Cryptosporidium parvum Iowa II	Potential drug target		MGSSPDEYDHLYKIILVGDATVGKTHLLSRYTRDALPKTPQPTIGVEFATRTVPLSIGGTVKAQIWDTAGQERYRAITRAHYRRSVGALLVYDITRKSSFLNASKWLEDIKQNSEPDIVVMLVGNKLDLVEKDPSKREVPFDIAANFAQENNLFFSEASAVTRCNVKHIFEHLLQEVYNQKMKDNSSNLDMNGKFIKD		198		7	Crystallized	-1	 	NR-16152
Batch03	CrpaA.00538.a	Cryptosporidium parvum		Q5CSY	Q5CSY2|Q5CSY2_CRYPV			Peptidyl-prolyl cis-trans isomerase - Cryptosporidium parvum Iowa II	Potential drug target		MRFIFAFISLLLGLIVSVFAEKGVRPSTVTPSVVVELTVSIDKEESKLRIGLFGVEVPKTANNFYSLCVGGMKDKDGKEMSYIGSIFHRVIPGFMAQGGDFTNGNGTGGKSIYGDSFEDENFKFVHESHVVSMANRGPNTNGSQFFITFTPTPHLDGRHVVFGKLVDDESKLTLTKIEQLGSYSGRTSKRIEVTACSHYSGTAPSAKLEL		210		2	Cloned	-1	 	
Batch03	CrpaA.00550.a	Cryptosporidium parvum		A3FQI	A3FQI3|A3FQI3_CRYPV			Putative uncharacterized protein - Cryptosporidium parvum Iowa II	Potential drug target		MPKKVLVALANGFEEIEFVTPVDILRRADLNVTIAVSGDCKRVMGAHGITIMGDKLLDEVLSEDYDLVMCPGGMDCAIKLGSDQNLLKILRETKKKGGIIASICASPVIVFEKNGLLSDVEKAVSYPSMMNELNRPDSSNAAVCVSSNVVTSQGPGTSVLFGLKLVEMLCGVEKSKLIADTIVAA		185		2	Cloned	-1	 	
Batch03	CrpaA.00569.a	Cryptosporidium parvum		A3FQ9	A3FQ96|A3FQ96_CRYPV			"Protein kinase, putative - Cryptosporidium parvum Iowa II"	Potential drug target		MSEHTKMAINEEMNGSEKRMTTTRVIRRNSPYLRAPRMYSISDLALACPLHCPELSISDFDIGRKLGSGQFGSVYLARERRTKYIVGLKVLRKKNLVKSGMEVQVRREIEIQAHLKHENILQLYAWFEDKSRIWLVIEIAPGGELYEKLCTDGPLKEYQAARYMKMMIEAIQCCHRKHVIHRDIKPENILIGVDGQLKLADFGWSSHINNNKSRRRTFCGTYDYLPPEITRKQEYGPEVDIWSLGVLCYELVKGEPPFPSNQGHNVQYYLIQNKQPEYSPHWSPILVGFIHSALQKLPQNRITIADMLKHPFITKYTSGETLTQEISLTENPNKNLNVESYSNNDENVCKNSKINQQS		358		-2	Work stopped	-2	Work stopped	
Batch03	CrpaA.00575.a	Cryptosporidium parvum		Q5CYI	Q5CYI7|Q5CYI7_CRYPV			Putative guanylate kinase - Cryptosporidium parvum Iowa II	Potential drug target		MKDILVICGPSGVGKGTLISHLMQEFPDKFGFSISHTSRSPRGKESNGVEYYFCSNEEFINMISMDGFVEYAEVHKYFYGTSKQAIEDIINQRKICLIDIDIQGVEQIQKSSFGDRAYYIGILPKSQMDLEERLRKRKTDSEQAIQIRLQNSVEEIERINRNPNIYKLVNDDLKTACDEIARLVKSYWEDISY		193		7	Crystallized	-1	 	NR-16153
Batch03	CrpaA.00586.a	Cryptosporidium parvum		Q5CWY	Q5CWY7|Q5CWY7_CRYPV			RAS small GTpases RIC1/ypt1 - Cryptosporidium parvum Iowa II	Potential drug target		MNPEYDYLFKLLLIGDSGVGKSCLLLRFADDTYTDSYISTIGVDFKIRTISLENKTVKLQIWDTAGQERFRTITSSYYRGAHGIIIVYDVTDRDSFDNVKQWIQEIDRYAMENVNKLLVGNKCDLVSKRVVTSDEGRELADSHGIKFIETSAKNAYNVEQAFHTMAGEIKKRVQVNSQNTRGSAQQGPKLAGAQPIRQGGCCS		203		-2	Work stopped	-2	Work stopped	NR-16154
Batch03	CrpaA.00591.a	Cryptosporidium parvum		Q5CXT	Q5CXT1|Q5CXT1_CRYPV			Putative 40S ribosomal protein S20 - Cryptosporidium parvum Iowa II	Potential drug target		NRERSQSKMSAAVMKPTDKQFGQFNGEQQQAPLHKIRITLSSKNLKSIERVCADLIQSAKQKDLKVTGPVRMPVKTLRITTRKSPCGEGSKTWDRYEMRIYKRVIDLYSSSDVVKQITSINIDAGVEVEVTISDI		135		-2	Work stopped	-2	Work stopped	NR-16155
Batch03	CrpaA.00593.a	Cryptosporidium parvum		Q5CW9	Q5CW97|Q5CW97_CRYPV			Choline-phosphate cytidylyltransferase - Cryptosporidium parvum Iowa II	Potential drug target		LKQSCKSKPKVIKGICKKNLCKKNSEILTEDSSENGSFIDDEKSDIFNKNTLADGQENNKECDTNRKIRIYADGVYDLLHLGHMRQLEQAKKMYPNTHLIVGVASDEETHRLKGRTVQTLQERTETLRHVKWVDEIISPCPWVIDEKFVEKHKIDFVAHDDVPYVAKQKKRDEEDSSNTDCNSSEEKPVISYDQDDIYGWLKRCGKFKATQRTKGVSTTDLVVRILQNYEEYIDRSLQRGVTPDELNIGYMKANQIQMKKGIQRWGEKVTNELTKVTLTDRPLGITFDESVDNIRNQIHKSFDAWRGVSKKYLEGFARTFDPMRSLFRENRISEGESPSFK		341		5	Purified	-1	 	NR-16156
Batch03	CrpaA.00610.a	Cryptosporidium parvum		Q5CRH	Q5CRH0|Q5CRH0_CRYPV			Actin depolymerizing factor - Cryptosporidium parvum Iowa II	Potential drug target		KMSSGVKIHQDCIDAFQKQKIRKQHRYLLYKMDSTYENIILFKTSGPEETYEDFLKSIPETECFYATIDLPDPNGQTPKLIFLMFTPENAKVKDRMVFASSKDGFVKKLEGVHGKLLQASERSDLDYKLVADQYF		135		4	Soluble	-1	 	
Batch03	CrpaA.00611.a	Cryptosporidium parvum		Q5CUW	Q5CUW0|Q5CUW0_CRYPV			14-3-3 domain containing protein - Cryptosporidium parvum Iowa II	Potential drug target		ILRTQHTIRDSELNIKNSKMSDSVNARESNVYMAKLAEQAERYDEMAKYMKDVVEARQESEELTVEERNLLSVAYKNAVGSRRSSWRIISSVEQKEHSRNAEDASKMCGKYRSKVEAELTDICNDILTMLDKHLIPTATSPDSKVFYFKMKGDYHRYISEFSTGDSKQSSAEDALKAYKDATVVAKDLEPTHPIRLGLALNFSVFHYEILNEPRAAIDMAKEAFEMAIEQLDKLSEDCYKDSTLIMQLLRDNLTLWTADLGASGEAEGAPEAS		273		-2	Work stopped	-2	Work stopped	NR-16157
Batch03	CrpaA.00619.a	Cryptosporidium parvum		Q5CTT	Q5CTT0|Q5CTT0_CRYPV			"2x Ef hands, calmodulin-like - Cryptosporidium parvum Iowa II"	Potential drug target		IEILKMNESSTHIQSKKIPQNRISDIQTIFHLFDKDKDGSISGSDLFETFKSIGLDIPPQQIDVLLNEIKGRASTGMQQDPAISSSIDCAMFSGFISRQLDSAPLSEQLRETFSLLDINGDGYITPECLAEVCSKLGVSLTDQDARQLMVQSDGQAKADYNKFVKLMQLSKG		172		3	Expressed	-1	 	NR-16158
Batch03	CrpaA.00628.a	Cryptosporidium parvum		Q5CSD	Q5CSD7|Q5CSD7_CRYPV			P-loop nucleotide - Cryptosporidium parvum Iowa II	Potential drug target		FFFGIRMSQNKPFVLFCLGPPGSGKGTQCAKIVDEFSFIHLSAGDCLREAMSRKDETSELIDSYIREGLIVPVEITVGLLKKKMQEYGWNDKYFLIDGFPRNQNNLDGWYKIIPDTDVNVIGCLFLNCDDNIVVERLLHRGETSGRVDDNKETIVKRLRVYHEETTPIIEYFKNSNKCFTVDTTGSIESVWEDLKKLFREKIISS		205		5	Purified	-1	 	NR-16159
Batch03	CrpaA.00637.a	Cryptosporidium parvum		Q5CYJ	Q5CYJ9|Q5CYJ9_CRYPV			Small nuclear ribonucleo protein - Cryptosporidium parvum Iowa II	Potential drug target		TRSLRVFENMADSGTIKQNNKSPSDFLRQVIGSPVIVRLNSGVDYKGLLACLDDRMNIAMEDTEEYVDGVFVENHGDTFIRGNNVLYISSPPK		93		4	Soluble	-1	 	
Batch03	CrpaA.00643.a	Cryptosporidium parvum		Q5CYH	Q5CYH4|Q5CYH4_CRYPV			SAR1-like small GTpase - Cryptosporidium parvum Iowa II	Potential drug target		LPITSRSCLCISDFKECTMFVFSWFRDILSWFGLSNKSAKILFLGLDNAGKTTLLHMLKDDRIATHVPTLHPHSEELVIGKIKFKTFDLGGHETARRIWKDYFATVDAIVFLVDASDRSRFGETREELSNLLETPELQNVPFVILGNKIDIPMAASEDELRHSLGLFEHLTYGRGEKRGDNGIRPVEVFMCSVVRRMGYSEAFRWLSQFLS		211		3	Expressed	-1	 	NR-16160
Batch03	CrpaA.00660.a	Cryptosporidium parvum		Q5CW8	Q5CW84|Q5CW84_CRYPV			"Centrin, caltractin - Cryptosporidium parvum Iowa II"	Potential drug target		TMKRRTSPTRKRGNEWPGLTDDEIEEIRKTFNLFDTDGSGTIDPKEMKAAMQSLGFESQNPTMYQLIADLDREGSSAIDFEEFLDAIASKLGDKDSREGIQKIFAMFDDDKTGSITLKNLKRVAHELGETMTDDELREMIERADSNGDGEISFEDFYSIMTKKTFV		166		2	Cloned	-1	 	
Batch03	CrpaA.00669.a	Cryptosporidium parvum		A3FQC	A3FQC6|A3FQC6_CRYPV			Eukaryotic initiation factor 4A - Cryptosporidium parvum Iowa II	Potential drug target		MTNSEQNPPSEENVQVASTGEIESNYDEIVECFEALNLEGDLLRGIFAYGFEKPSAIQQRGIKPILDGYDTIGQAQSGTGKTATFVIAALQKIDYSLNACQVLLLAPTRELAQQIQKVALALGDYCELRCHACVGGTSVRDDMNKLKSGVHMVVGTPGRVFDMLDKGYLRVDNLKLFILDEADEMLSRGFKVQIHDIFKKLPQDVQVALFSATMPNEILHLTTQFMRDPKRILVKQEELTLEGIRQFYVGVEKDEWKMDTLIDLYETLTIVQAIIYCNTRRRVDQLTKQMRERDFTCSSMHGDMDQKDREVIMRQFRSGSSRVLITTDLLARGIDVQQVSLVINYDLPVSPETYIHRIGRSGRFGKKGVSINFVTDDDIVCLRDIERHYNTQIEEMPMGITDILQ		405		3	Expressed	-1	 	
Batch03	CrpaA.00697.a	Cryptosporidium parvum		Q5CQW	Q5CQW4|Q5CQW4_CRYPV			NifS-like protein; cysteine desulfurase - Cryptosporidium parvum Iowa II	Potential drug target		MIVHRYCRQWAPSVVRGISKLAFFSSMSSIAKKRPAYFDYQATTPVDPRVLDKMMPFFTEKFGNSHSRTHGYGWEAEEAVENARTNIANLIKCLPKEIIFTSGATESNNTIIRGVCDIYGDIENKKNHIITTQIEHKCVLSTLRELELKGFRVTYLKVNNKGLISLEELEKSIIPGETILASIMHVNNEIGVIQPMNLIGEICKKYNVLFHSDVAQGLGKINIDVDKWNADFLSLSAHKVYGPKGIGAFYIRSKPRRRIKPLIFGGGQERGMRSGTMPVPLAVGFGEACKIASSEMNSDSIHVKSLYDKLYKGITTQLPDVELNGCGVNRMFGNLNLSFTGVEGESLMMKLYSLALSSGSACTSASLEPSYVLRAIGVGEDVAHTSIRFGLGRFTKHEDVDKAVKEIVESVTLLRKMSPLWDSITDTKVKDEESLKWT		438		3	Expressed	-1	 	NR-16161
Batch03	CrpaA.00721.a	Cryptosporidium parvum		Q5CPK	Q5CPK7|Q5CPK7_CRYPV			Inosine-5-monophosphate dehydrogenase - Cryptosporidium parvum Iowa II	Potential drug target		SNMGTKNIGKGLTFEDILLVPNYSEVLPREVSLETKLTKNVSLKIPLISSAMDTVTEHLMAVGMARLGGIGIIHKNMDMESQVNEVLKVKNWISNLEKNESTPDQNLDKESTDGKDTKSNNNIDAYSNENLDNKGRLRVGAAIGVNEIERAKLLVEAGVDVIVLDSAHGHSLNIIRTLKEIKSKMNIDVIVGNVVTEEATKELIENGADGIKVGIGPGSICTTRIVAGVGVPQITAIEKCSSVASKFGIPIIADGGIRYSGDIGKALAVGASSVMIGSILAGTEESPGEKELIGDTVYKYYRGMGSVGAMKSGSGDRYFQEKRPENKMVPEGIEGRVKYKGEMEGVVYQLVGGLRSCMGYLGSASIEELWKKSSYVEITTSGLRESHVHDVEIVKEVMNYSK		402		-2	Work stopped	-2	Work stopped	NR-16162
Batch03	CrpaA.00749.a	Cryptosporidium parvum		Q5CU0	Q5CU00|Q5CU00_CRYPV			"Pre3p/proteasome regulatory subunit beta type 6, NTN hydrolase fold - Cryptosporidium parvum Iowa II"	Potential drug target		NIFSHNLFCEPLWRNFELVCLINEFKISKKARTKDQKIMELDFLNGEIETGTTIVALKYKDGLVLAADGRTSTGPIIAFRAARKITQITDKVFMCRSGSAADTQIISRYVRRIVQDHELETGEDTKVKSVASVARLISYQNKEHLLADMIIAGMDPNGEFKVFRIPLGGTLIEGSYAISGSGSGYIYSMLDSKYHSEMDLDECKSFARDLVSHAMFRDSSSGGIIRIIVINKSGVEEFVVPGEDVPNL		248		3	Expressed	-1	 	NR-16163
Batch03	CrpaA.00787.a	Cryptosporidium parvum		A3FQF	A3FQF0|A3FQF0_CRYPV			Putative uncharacterized protein - Cryptosporidium parvum Iowa II	Potential drug target		MRYKGTLVSFDEYMNILLNDCEEWIDNTKKGTLGKVFIRCNNVLYISRAEESKETKTEIQKDEEMAE		67		4	Soluble	-1	 	NR-16164
Batch03	CrpaA.00792.a	Cryptosporidium parvum		A3FQ1	A3FQ10|A3FQ10_CRYPV			Protein kinase NPK2 - Cryptosporidium parvum Iowa II	Potential drug target		MSALRLDSFEFEENEEQRKGSFDGSNSLHTDWSLSSDGVSLLHKSTGVHITHEGTKGLESDYGLGDIYVSFGDFEVNPTPLGHGRSSVVFSAIHKLSGKIVAIKDIYVGDILHQSQLSAEIHSWRLTSYCPLLVQFLGAFIKPNKSVVCLVMEYMEFGTLSDILYKNLNRNLQSNETPEGVNENFLKFISIQMVDGLAYLHQNNRIHRDVKLNNILINQDGAVKISDFGISKLIDQNTTKDHNKNVSTFVGTQIYMSPERLQGKSYSFSSDIWSLGICIYELAVGTHPFKNLSLFDMVYILCEDNTENGEPLPFLEKIIKRCPLPEHLHKNPDFYAFLKGCLELDPLKRLTALQLQGLKWLNFGTCNRYEFLAWLQQIQKIDSN		384		-2	Work stopped	-2	Work stopped	NR-16165
Batch03	CrpaA.00844.a	Cryptosporidium parvum		Q5CYZ	Q5CYZ6|Q5CYZ6_CRYPV			RIO-like kinase domain; N-terminal region conserved - Cryptosporidium parvum Iowa II	Potential drug target		NTKMKLDVSNMRFISKDEWRILTAVEMGMRNHEYVSPQLIESISNLRRTGSYQLLQNLLRNKLVSRESKIYEGYKLSYLGYDFLALRALNKRGIISSVGARIGVGKESDIHIAADENGKLICLKLHRLGRVSFRNVKNTRDYLRNRKTSSWLYLSRLAALKEYSCLKALYENGFNEGEIKVPEPIDWNRHAIVMELIDAVPLNSIRHLDDPYGALERLMKMIIRLADCGLIHGDFNEFNLLIDSKENITLIDFPQIVNTDHINAEMYFNRDVNCIIELFRKRFGIQVMEYPKFEDVIVFTSDNVHSSNKIINIGKIDRDMNRLDYLNTIISQNNGKNNLDGSELHDNSEISHEEDDSTQEEEEEEEEEEEEEEEEEEEEDDDDDDDEYNCRNQDQDNSDNEHQEEEEYDEIIDKQEYDEFKARAINERINNLWLPRKNKTTQFDKDRIRKSFVSQYDKHHSSKGNSGSKKSREYRKTKAMIDNIKNDY		488		-2	Work stopped	-2	Work stopped	
Batch03	CrpaA.00859.a	Cryptosporidium parvum		Q5CWC	Q5CWC6|Q5CWC6_CRYPV			26S proteasome regulatory subunit S10b like AAA+ ATpase - Cryptosporidium parvum Iowa II	Potential drug target		IVELGYSKADAEQTKMSGEDEHKNTLATYAQKVKEHRELEVSLKKKRMEIRELSKVYDKTEDDLKALQSVGQIIGEVLRHLDDEKCIVKASTGPRYVVGCRSKLDKSKLTSGTRVALDATTLTIMRRLPREVDPMVYNMLHEDPGSVSYSQVGGLNEQIREIREVIELPLTNPELFKRVGIKTPKGVLLYGPPGTGKTLLARAMASSMNCNFMKVVASAIVDKYIGESARVIREMFGYAKDHQPCVIFMDEIDAIGGKRFSQGTSADREIQRTLMELLNQLDGFDELGAVKIIMATNRPDVLDPALLRPGRLDRKVEIPLPNETSRVEILKIHSSKLAKQGEIDFDAICKLCDGFNGADMRNVCSEAGMFAIRAERDYIIEEDFLKAVRKLAENKKMEGNLDYEKV		406		2	Cloned	-1	 	
Batch03	CrpaA.00861.a	Cryptosporidium parvum		Q5CS1	Q5CS18|Q5CS18_CRYPV			Putative uncharacterized protein - Cryptosporidium parvum Iowa II	Potential drug target		GENILFKMSENEVIDNYMKIKNQIKELCSGFESFPELLVVSKYQSEENIKLLHEKTDQKIFGENYVQELMEKSRNLPKSIKWHFIGHLQSNKVKTLLSIDNLEVIETVDSIKLAQVLNKECQLQGRSVLKVMIQVKTSNEVNKSGAQISEAINIFEYIISECRNLKFQGLMTMGDSDVNLTSECFNKMVNLRNIINEKISKNGNYDQSIECRLSMGTTRDMEIAIKNHTNEVRIGSAIFGDKKKG		245		2	Cloned	-1	 	
Batch03	CrpaA.00864.a	Cryptosporidium parvum		Q5CWN	Q5CWN8|Q5CWN8_CRYPV			26S proteasome regulatory subunit 7 - Cryptosporidium parvum Iowa II	Potential drug target		MAVKPQIKTEKDGGKEEEDQSRPLDQVDIDIMRKYGMGPYVSKIKQVETEVKDLMSAISKLNSIRESDTGLAPPSQWDLAADRQNMQMEQPLQVARCTKIIDAGTEEAKYMINIKQMAKYVVGLGDKVAPTDIEEGMRVGVDRTKYKIQIPLPPKIDPSVAMMTVEDKPDVTYNDIGGAKEQLERLREVVEMPLLHPERFVQLGIDPPKGVLLYGPPGTGKTLTARAVANRTDACFICVIGSELVQKYVGEGARMVRELFKLARSKKACILFIDEVDAIGGARGDESAHGDHEVQRTMLEIVNQLDGFDARGNIKVLMATNRPDTLDPALLRPGRLDRKVEFGLPDLEGRTQIFRIHAKVMSMERDIRFELLSRLCPNCTGADIRSVCTEAGMFAIRARRKSISEKDLLDAINKVVKGYKKFSATAKYMVYN		432		2	Cloned	-1	 	
Batch03	CrpaA.00877.a	Cryptosporidium parvum		Q5CS6	Q5CS65|Q5CS65_CRYPV			Centrin like protein with 4x EF hands - Cryptosporidium parvum Iowa II	Potential drug target		MLQRKEHVGGISVGGASSGAASRRRRLRNEISDEQKQEIKEAFELFDTEKTGRIDYHELKVAMRALGFEVKKAQVLEIMREYDKSGSGQVEYKDFVEIMTQKILERDPREEILKAFKLFDDDNTGKISLKNLRRVARELGESISDDELQAMIEEFDKDMDGEINEEEFISIMKQTSLY		178		7	Crystallized	-1	 	NR-16166
Batch03	CrpaA.00878.a	Cryptosporidium parvum		A3FPQ	A3FPQ3|A3FPQ3_CRYPV			"Small nuclear ribonucleoprotein, putative - Cryptosporidium parvum Iowa II"	Potential drug target		SLIVKLNGNRQIIGSLRGYDNFMNLVLENTTEVLDSTKKSIGTTVIRGNSVIMWECIDKVKI		62		3	Expressed	-1	 	NR-16167
Batch03	CrpaA.00879.a	Cryptosporidium parvum		Q5CRL	Q5CRL6|Q5CRL6_CRYPV			Actin-like - Cryptosporidium parvum Iowa II	Potential drug target		MATLHYDDVITSQPAIIDNGSGTIKCGFAGEEAPRVIVNSYVGRPKYKRCMAGALEGDIFVGSKCTENRGILSISHPITNGIITDWYDMEALWTYCFSEMKTSSEDHPVLLTEAALNPRKHREKMAEVFFEVYRVPALFISTQAVLSLYSSGRTTGVVLDSGDGVTHAVPIYQGFALSNAITRSEIAGRNITEYLNLQLRIAGTVFHTKSEMEIVKDIKETACFVSSNIQKDENDENQMGNSTFDAVTSSGNRVASGYPYKLPDGQVIYLGKERFRAPELLFQPSLIGYEYPGIHEVLTHTINKCDLEIRRSLASQIVLAGGSTMFPGLGDRLLFELRKALPKDVKIRINASSDRNLLPWIGGSILGSLATFKTIWISKQEFMEEGPNIVHSKTI		395		3	Expressed	-1	 	NR-16168
Batch03	CrpaA.00910.a	Cryptosporidium parvum		A3FQK	A3FQK2|A3FQK2_CRYPV			Mitochondrial processing peptidase beta subunit - Cryptosporidium parvum Iowa II	Potential drug target		MSLILKNSILKLGCSNLLRVLPTRYARFNSTLSFKRNDPDLKISKLSNGMRVATMKFGIDSIPNSLTFGLWVDSGSRNEDPGKNGIAHFLEHLIFKGTYNRSRKEIESQIEDLGAHLNAYTTREQTVYQIRCFNQDLPKCMDLLSDIIKNSKFCKSAIEQEKGVVLREMEEVSKSEEEIIFDDLHKEMYKNHPLGNTILGPKENILGFKREDLINYIRTNYIPEKMMILGVGNIDHNSFKNIAETYFGNDSNNSRNLLGLKGYKNINLSNSQYLNEINSDKNHPVLVHKKNNSDGKTLLAMAYNGTSWNSKDFLKVMFLQSMLGEYGTNNINRVTGYKNQIIERILSGIKDHVEFFETFNTCYKDTGKLYLHSYS		375		2	Cloned	-1	 	
Batch03	CrpaA.00942.a	Cryptosporidium parvum		A3FPZ	A3FPZ6|A3FPZ6_CRYPV			Putative uncharacterized protein - Cryptosporidium parvum Iowa II	Potential drug target		MSTLDTYSRSYDDLLVHQLMLQDVERVEAYKRSFEENKELFKGKIVLDVGCGTGILSMLAAKCGAKAVYAVDGSNISFLAKTIVEDNELSEVVKVIHGVIEEIELPVNQVDIIVSEWMGFYLLHEGMLDSVIFARDKWLNSKHGVIFPEKASLYVSLVEIEDFWYKNIEGINNIQGFDYSSMRRIIHSSYLKSPLILGVEPKNVENFSFARILSLDLLKININDLDIIKSQFTLKVKKDTEFVHGFIVWFDIEFPAHKSNAIILSTSPYDKPTHWKQTIVLFQDCLEAKAGLNLKCLSKLERCVNESKRCYTISIEVQDASIEF		324		10	Diffraction	-1	 	NR-16328
Batch03	CrpaA.00964.a	Cryptosporidium parvum		Q5CYM	Q5CYM1|Q5CYM1_CRYPV			BET3 vesicular transport protein - Cryptosporidium parvum Iowa II	Potential drug target		MSNSSNQYKKRSEYLRMGELAFQKTEKINGEVFSLMYGSLVAQFVKDLDNAELINSKLEKIGYNIGIRLVDEFLAKSGISKCDSFRDTAEVIACVGFKMFLGITAETKDWNPEETSCVLVFNENPLADFVELPPCYSSSLNYSNMVCGVIRGALEQLQMQVVCYFVKDILRGDATNEIYLELKERLQEEFFDDDDEEEDQENEYKE		206		5	Purified	-1	 	NR-16169
Batch03	CrpaA.00969.a	Cryptosporidium parvum		Q5CX4	Q5CX49|Q5CX49_CRYPV			Farnesyltransferase - Cryptosporidium parvum Iowa II	Potential drug target		MQELDSLENTNIETIEYSVDFQNEGVCKFLFKPDHYALFSKLKSLLDNECFDLENLDISTQVIDLNPQHYTAWYFRRKIIRENYVEHENKTEFLREELRFVRGICERAPKCYQSWWHMRVIRELLGFDIEELNFISKQLEFDAKNMYVWNHRTWFIRKYNSVENDLLISELDFISKLISEDCRNNSAWCYRHFIFTNLKKMNALKESDLLEEVDYIVNWLMFAPHNDSIWNYIISFFSKIMVNGNVNKETLIKNLSLENAPKSFIDAIDEIYTNHYDSCHQVVYIKACMEYEKGDTDFALKAFKLLQSVDPIRKFYWKWRADNLKT		326		7	Crystallized	-1	 	
Batch03	CrpaA.00978.a	Cryptosporidium parvum		Q5CVI	Q5CVI7|Q5CVI7_CRYPV			Sub2p like superfamily II helicase involved in snRNP biogenesis - Cryptosporidium parvum Iowa II	Potential drug target		VVRMSVQNTEELVDYEEEETTTRIEEESRADEGSKVGRGNYVAIHASGFRDFFLKPELIRAIGDAGFEHPSEVQHETIPHAITGVDILCQAKSGMGKTAVFVLSILQQLNPDEESKNVECICIGHTRELAFQVKNEFDRFSKYLKNVKPQVVYGGIPIQKDIDMLSNSTPNILIGTPGRIIALIRQKKLVTEGIAHFVLDECDKCLESLDMRKDVQEIFMSTPRKKQVMMFSATMTKEIRDVCRKFMQNPVEIFVDDETKLTLHGLLQYYVKLGESEKNRKLNDLLDQLEFNQVIIFVKSVSRAQALHKLLTECSFPSICIHAALSQQERISRYQQFKNFEKRIMVATDLFGRGIDIERVNIVINYDMPENTDSYLHRVGRAGRFGTKGLAITMVSSQTDSQVLNDVQSRFEVNIAEMPNQIDTSSYINQ		430		1	Selected	-1	 	
Batch03	CrpaA.00986.a	Cryptosporidium parvum		Q5CRP	Q5CRP7|Q5CRP7_CRYPV			AtPH1 like protein with a pleckstrin homology - Cryptosporidium parvum Iowa II	Potential drug target		LPHMFLGSPQISIRQDEIVKQGWLYKQSRFLKDWRRRWFVLTRNYLASFKDQRSLSTPTESLMLSECLTVRSADEDTNKENSFRVDTPNRVFFLIAENPIEKEEWIGQIGRQMIRPTVYQHDY		123		4	Soluble	-1	 	
Batch03	CrpaA.01056.a	Cryptosporidium parvum		A3FQN	A3FQN6|A3FQN6_CRYPV			Thioredoxin peroxidase-like protein - Cryptosporidium parvum Iowa II	Potential drug target		MSTLVRKLAPNFTAEAVMADGSFKKVSLSDYRGKYVVLFFYPLNFTFVCPSEILAFNQAQKDFEKLGVQLLAVSVDSQYSHAAWRRTPLEQGGIGPVNFPLISDSSHSISKNYGVLLEEEGIALRGLFIIDKEGVVRSEVIYDLPLGRSVEETLRVIDALQFTETYGEVCPANWKKGQKGMSATHEGVSSYLKDSF		196		7	Crystallized	-1	 	NR-16170
Batch03	CrpaA.01081.a	Cryptosporidium parvum		A3FQL	A3FQL3|A3FQL3_CRYPV			UDP-glucose 4-epimerase - Cryptosporidium parvum Iowa II	Potential drug target		MSKSEIKILCTGGAGYIGSHTVIALIEEGYSVHILDNFSNSDPEVVNRIEKITKVKVPFFEIDIRDKERMLDLFLKERYNAVIHFAGLKAVGVSVSQPLEYYENNVVGTIRLLEVMKEANCNILVFSSSATVYLPKSTPLLETDPLGASNPYGQTKFMIELMMKDIYNASKNTKFSILRYFNPVGCHPSSLIGEDPEEPNNLLPYIQLVSIGRKEKLFVFGNDWPTRDGTGVRDYIHVTDLANGHVKALEKLLNLSNTDKTLDIYNLGCGSGISVLEMVKNFENASGKQIPYEIINRRPGDLASVIADPSKAEKELGWKAKHSIFDACKSAYDWQFNNPNGYSKK		345		3	Expressed	-1	 	
Batch03	CrpaA.01087.a	Cryptosporidium parvum		Q5CX5	Q5CX58|Q5CX58_CRYPV			Possible CutA1 divalent ion tolerance protein - Cryptosporidium parvum Iowa II	Potential drug target		INSNMTETKIESNIILIYISAPNQDEATSIAKTLVDEELCACVSIIPSVRSIYKFKGQVHDENEVMLLVKTTSQLFTTLKEKVTEIHSYELPEIIATKVVYGNENYINWVNQTVRS		116		5	Purified	-1	 	NR-16171
Batch03	CrpaA.01119.a	Cryptosporidium parvum		Q5CSE	Q5CSE7|Q5CSE7_CRYPV			Triosephosphate isomerase - Cryptosporidium parvum Iowa II	Potential drug target		MSRKYFVGGNFKCNGTKESLKTLIDSFKQVESSNSEVYVFPTSLHISLVKEFFGNDHPGVFKIGSQNISCTGNGAFTGEVSCEMLKDMDVDCSLVGHSERRQYYSETDQIVNNKVKKGLENGLKIVLCIGESLSERETGKTNDVIQKQLTEALKDVSDLSNLVIAYEPIWAIGTGVVATPGQAQEAHAFIREYVTRMYNPQVSSNLRIIYGGSVTPDNCNELIKCADIDGFLVGGASLKPTFAKIIESAQ		250		17	In PDB	-1	 	NR-16172
Batch03	CrpaA.01130.a	Cryptosporidium parvum		Q5CVT	Q5CVT2|Q5CVT2_CRYPV			60S ribosomal protein L10A - Cryptosporidium parvum Iowa II	Potential drug target		LSAMSGKVSSETIRRAISEILEGSKAKPRKFVETVELQIGLKDYDTQRDKRFAGTVRLPNVPRPNARVCVMGDAADCERAQKLGFDVMDIEEMKKINKNKKVVKKLCKKYDLFLASQVLLPQIPRLLGPGLNKAGKFPTVITPSDKIDEKANELKASIKFQLKKVLCLGVAIGNVNMTEEEIRQNLTLAINFLVSLLKKNWHNIKSLTVKSTMGKSVRIYG		221		-2	Work stopped	-2	Work stopped	
Batch03	CrpaA.01145.a	Cryptosporidium parvum		Q5CQD	Q5CQD4|Q5CQD4_CRYPV			26S proteasome regulatory subunit S4 like AAA ATpase - Cryptosporidium parvum Iowa II	Potential drug target		MGNSHGVLGEGGMKNNRKSKNNGKDEKKKLESAPPPMEMKRKRKQKGPPQYARLPAVVPNAKCRLRLLKYERIKDYLMMEQEFITSMESVKPSAETAEEEHNKVDDLRGSPMNIGTLEEIIDENHAIVSSSVGSEYYVNILSFVDKNQLEPGSSVLLHNKVYSVVGIMNDEVDPLVSVMKVDKAPLESYADIGGLEQQIQEIKEAVEIPLTHPELYDDIGIKPPKGVILYGPPGTGKTLLAKAVANETSATFLRVVGSELIQKYLGDGPKLVRELFRVAEENAPSIVFIDEIDAVGTKRHDSQSGGERDIQRTMLELLNQLDGFEARGDVKVIMATNKIESLDPALIRPGRIDRKIELPNPDCKTKRRIFQIHTSKMTLSDDVDLEEFIMAKDDISGADIKAICTEAGLLALRERRMRVTQEDLRKAKEKALYRKKGGIPEGLYL		445		1	Selected	-1	 	
Batch03	CrpaA.01154.a	Cryptosporidium parvum		Q5CYX	Q5CYX1|Q5CYX1_CRYPV			Small nuclear ribonucleoprotein - Cryptosporidium parvum Iowa II	Potential drug target		LLNFLEPLDLIRLSLDEQVFVKCRGNRELKGTLYAYDPHMNMVLGNVEETYYEEESKSDTQNSEKKLKKRRIEMLFLRGDLIILVKPAVKLGKST		95		3	Expressed	-1	 	NR-16173
Batch03	CrpaA.01169.a	Cryptosporidium parvum		Q5CYW	Q5CYW0|Q5CYW0_CRYPV			Serine/threonine protein phosphatase - Cryptosporidium parvum Iowa II	Potential drug target		ERQLFSRMPKGLDVYLDSLKLDREISTLLECKTLSENEVKQLCELAKDILEEEQNVQQIGLPLTVVGDIHGQFFDLKEIFRIGGVPPETNFLFLGDYVDRGYYSVESVTLIVALKVRYRNRVFLIRGNHESRQITQVYGFYDECLRKYGTPNVWRYFTDLFDYLPLSALIDNKIFCPHAGLSPSLPSLDSIKSLDRIQEVPHEGPMCDLLWSDPDERYGWGVSHRGAGYTFGEDVSEMFNHTNNLQLICRAHQLILDGYQWSHNKNVVTVFSAPNYCYRCENQAAILRIDDLGNFTFLQFDHAPEKVLPRQENQLPVPDYFV		322		3	Expressed	-1	 	NR-16329
Batch03	CrpaA.01177.a	Cryptosporidium parvum		A3FQB	A3FQB1|A3FQB1_CRYPV			"Cyclin dependent kinase A, putative - Cryptosporidium parvum Iowa II"	Potential drug target		MNMIQKLIWDSINFTLGDGEKDSSIGDYEYLEIIGEGTYGVVYKCKCKQSGELFAVKTFRSATSEFSTTTLREISILREINHSNIVSVQDVILSSKGVNIVFEFFPYDLKRYLSMFPDKVPPVKFIKHIIFEILKGIFHLHMHRIIHRDLKPQNILISCDRNLPDVKIADFGLSRILSTPFKTLTREVVTLWYRAPELLLGNKNYSSSIDIWSVGCIFIELLIGRPIFSGDSEVSTLFKIFKTLGTPNPKVYSNINSLPNYSPDWPKWDIDENWVDNQICMYSPTKQYLLETDAKNLIKM		300		-2	Work stopped	-2	Work stopped	NR-16174
Batch03	CrpaA.01199.a	Cryptosporidium parvum		A3FQJ	A3FQJ9|A3FQJ9_CRYPV			Superoxide dismutase - Cryptosporidium parvum Iowa II	Potential drug target		MSIRFIFNNNSKKLVNKFCRLFSGMPFELPPLPYDKKALEPVISPETLDYHYGKHHAGYVTKLNSLIKSTEFENETDLMKVIMKSSGPIYNNASQIWNHTFYWSCLRSPSETNKPTSKVSKLIEESFGSFESFKESFTANATGHFGSGWIWVVIDPINNQKLKIVQTHDGDNPEKLGLGKPVLTCDVWEHAYYIDYRNNRGSYVDQFFSIINWDFVESNLS		221		5	Purified	-1	 	NR-16175
Batch03	CrpaA.01218.a	Cryptosporidium parvum		Q5CRU	Q5CRU2|Q5CRU2_CRYPV			Nucleoside diphosphate kinase - Cryptosporidium parvum Iowa II	Potential drug target		WINCYGASHFFGLVTMQKSLLFLTFLYLLCSIFVGSSHSEEVPAPSNSTESSLSSEDLVSDTQEQTSTNETAVETVAETSPQSTNPFAERTLVLFKPEVTHRGLIGEILSQIERKGFKIAAMKFLVATAQQIEAHYSDHAGKPFFESLVSRTTNQPIVAMVLEGLNVISEFRRFMGSTDPKKSEMGTLRAQFGMQTERNLIHASDSVENANLEIFLWFSPDEIYSYQRAIDQFVYFE		237		3	Expressed	-1	 	NR-16176
Batch03	CrpaA.01220.a	Cryptosporidium parvum		A3FPN	A3FPN2|A3FPN2_CRYPV			"Uracil-DNA glycosylase, putative - Cryptosporidium parvum Iowa II"	Potential drug target		MSQTSILSYLNKRSAENICKDSIECGSDLNRDSAVKNRRICVKETEIKSSKEAEEENQEYYPSESELREYFGDEWFEALKDELRKPYFVKCMKKVQERRNYAKVYPPSDKMFSCFKATPLNKISVVILGQDPYHQPGQAMGLSFSVPKGVPVPPSLRNIYKEIGKGNPGHGDLSSWAEQGVFLLNSLLSVEEGKPMSHXDLCKFDSNNYSV		211		2	Cloned	-1	 	
Batch03	CrpaA.01223.a	Cryptosporidium parvum		Q5CUU	Q5CUU2|Q5CUU2_CRYPV			Dual specificity phosphatase - Cryptosporidium parvum Iowa II	Potential drug target		MEALKRLIDKRSERMAVVENISGSTESELILPERVNFYFAALRILHQLKRKTPEPMKGMQIQETISLICSLDQVISLYGALVTSPKSTIEDYEEKVESNMRTIISSINRLGFRDILQKEVQYSNKENLDLHRAQRIIPGIFLGGSTVANDLKKLKDLGITHIVCCLQGACKFPNEFLYLNIPIYDTPFEDISKYFSSSFDFIHNALSQSTVERPNNVYIHCAAGISRAPTICTAFLMRELGISSLQALNLIKLSRPYVAPNPGFLNQLYNYQLFLTSAKVCQKRQQISNSNQTQIQVQGVPYQTNLKRNVGRIK		314		4	Soluble	-1	 	NR-16177
Batch03	CrpaA.01236.a	Cryptosporidium parvum		Q5CSE	Q5CSE9|Q5CSE9_CRYPV			Fructose-bisphosphate aldolase - Cryptosporidium parvum Iowa II	Potential drug target		KISFYLFQKKKMSICQERAKELAENARKIASPGKGILAADESTGTIKKRFDQVGIENTEANRAAYRELLFKTEGLNQYISGVILYEETLFQSTASGEKMTDLLKKQGILPGIKVDMGLTTLPLTDGETSTTGLDGLGARCKKYYDAGARFAKWRAVLTIDQAKGKPSCLSISETAHTLARYAAICQENGLVPIVEPEILSDGSHDIEFCAKVTEKVLAEVVKALHLHRVLLEGSLLKPNMVTPGSDCPKRASSQEVAFYTVRTLKRTIPSAMAGVMFLSGGQSEEEASLNLCEMNKIKDCPLFLSFSYGRALQASVLKAWKGDASNVPAAQKALLERAKANSEAQLGVYKGGVGGSAASEGLFVKSYVY		369		1	Selected	-1	 	
Batch03	CrpaA.01255.a	Cryptosporidium parvum		Q5CPJ	Q5CPJ7|Q5CPJ7_CRYPV			"Disulfide-isomerase, signal peptide plus ER retention motif, putative ER protein - Cryptosporidium parvum Iowa II"	Potential drug target		MIGIRSLVSAAFLGFSCLSKVVLGGDEAHFISEHITSLTSSNFEDFIKSKEHVIVTFFAPWCGHCTALEPEFKATCAEISKLSPPVHCGSVDATENMELAQQYGVSGYPTIKFFSGIDSVQNYSGARSKDAFIKYIKKLTGPAVQVAESEEAIKTIFASSSSAFVGRFTSKDSAEYAVFEKVASGHREHNYAFIAFFQEGEQKLEVLHKDEEPVSLPMPKTVEELEAKISIMNVPLFSAISAENYSLYMSREGYTAWFCGTNEDFAKYASNIRKVAADYREKYAFVFLDTEQFGSHATQHLLIEKFPGLVIQSVNVPSIRYMYGPAKFDSVEPLKEFMKQVSEGKHELSIKSEPIPAEQSGPVTVVVGKTFEEIVFRSDKDVLLEIYAQWCGHCKNLEPIYNQLGEEYKDNDKVVIAKINGPQNDIPYEGFSPRAFPTILFVKAGTRTPIPYDGKRTVEAFKEFISEHSSFPQEKESRDEL		481		3	Expressed	-1	 	
Batch03	CrpaA.01260.a	Cryptosporidium parvum		Q5CUE	Q5CUE6|Q5CUE6_CRYPV			Rab5 like small GTpase - Cryptosporidium parvum Iowa II	Potential drug target		MSQTAIKTPKTLHLKLVLLGDASVGKSCLVVRFSKDEFHEYQEPTIGAAFMTQSVNVDDDYTVKFEIWDTAGQERYRSLAPMYYRGAAAAIVVYDITNVETFQGAKSWISELQNINNNDIVVALVGNKYDLESSRTVDSETARNYAKEKGILSFETSAKTGYNVQELFEEIARKLPNTKKLDSNSMSTENNGKTGGFQLFRSDRRGGGNCFSNGCSSN		218		5	Purified	-1	 	NR-16178
Batch03	CrpaA.01270.a	Cryptosporidium parvum		Q5CQ7	Q5CQ70|Q5CQ70_CRYPV			Calmodulin-like protein - Cryptosporidium parvum Iowa II	Potential drug target		MSESSNIRNGNATVKISALYGEEQFCPIVGDTKEKSMETNTRRIPFGMTELTLEHEAALKGLFDTLNTYGDGKIRLNDLIIALRRAFDNGTVTFSRHEASAAEITGEHIDSELEKLKEDFDMNGDGTLDFDEFRRLARMKILRLSRDDEIQLGFRLLDRNNSGYITTLELKQLLTTKGISPLTSEEADELLFIADVDHDGLISYDEIKRYLEYNRRPLLN		220		5	Purified	-1	 	
Batch03	CrpaA.01271.a	Cryptosporidium parvum		A3FPW	A3FPW5|A3FPW5_CRYPV			Elongation factor 1-alpha - Cryptosporidium parvum Iowa II	Potential drug target		MGKEKTHINLVVIGHVDSGKSTTTGHLIYKLGGIDKRTIEKFEKESSEMGKGSFKYAWVLDKLKAERERGITIDIALWQFETPKYHYTVIDAPGHRDFIKNMITGTSQADVALLVVPADRFEGAFSKEGQTREHALLAFTLGVRQMIVGINKMDTCEYKQSRFDEIFNEVDGYLKKVGYNTEKIPFVAISGFVGDNMVERSDKMPWYKGKTLVEALDTMEPPKRPTDKPLRLPLQDVYKIGGVGTVPVGRVETGIIRPGMNVTFAPAGVTTEVKSVEMHHEQMPEAVPGDNVGFNVKNVSIKDIKRGFVASDAKNDPAKGCEDFTAQVIVLNHPGEIKNGYSPVVDCHTAHISCKFQTITAKMDKRSGKVLEENPKLIKSGDAALVVMQPLKPLCVEAFTDYPPLGRFAVRDMKQTVAVGVIKSVTKKEATSKKK		435		3	Expressed	-1	 	
Batch03	CrpaA.01273.a	Cryptosporidium parvum		A3FQJ	A3FQJ8|A3FQJ8_CRYPV			Actin - Cryptosporidium parvum Iowa II	Potential drug target		MSEEETQALVVDNGSGMVKAGVAGDDAPRCVFPSIVGRPKMPGVMVGMDQKDCYVGDEAQSKRGILTLKYPIEHGIVTNWEDMEKIWHHTFYNELRVAPEEHPVLLTEAPMNPKVNRERMTQIMFETFNVPAMYVNIQAVLSLYASGRTTGIVLDSGDGVSHTVPIYEGYAIPHAIMRLDLAGRDLTDFLMKILHDRGYSFTTTAEREIVRDIKEKLCYIALDYEEEMKKSQESSELEKTYELPDGHVITVGSERFRCPEALFQPGFLGKEAVGIGETTFQSIMKCDLDIRKDLYANIVLSGGTTMYPGIGERMTKELTSLAPSTMKIKVVAPPERKYSVWIGGSILSSLSTFQQMWITKEEYDESGPSIVHRKCF		376		2	Cloned	-1	 	
Batch03	CrpaA.01286.a	Cryptosporidium parvum		A3FQP	A3FQP1|A3FQP1_CRYPV			Thymidylate kinase - Cryptosporidium parvum Iowa II	Potential drug target		MLDGYLGKSIKMAPQVSHLLFTANRWELNNYIKENLENGIDVVCDRYSFSGIAYSSGAINLDFEWCKSREQGLISPDIVVFLEVNLDLSSTRSGFGVEIYENISDQISVRKVYQKFSNYSFWRNINASQSPDVSLNIYSTYYSFNSNIIFDSTYLFQLTKIKYLQN		166		3	Expressed	-1	 	NR-16197
Batch03	CrpaA.01292.a	Cryptosporidium parvum		A3FPM	A3FPM1|A3FPM1_CRYPV			"Cyclin-dependent kinase-related kinase, putative - Cryptosporidium parvum Iowa II"	Potential drug target		MFSISERYEQINAHIGQGTYGKVEKAIDKNSDTIVAIKKVKICELPSDLTESRQKVGQCGIHFTVLREIKIMNEINHPNIMGLRDVFVQGDFINLVMDYMESDLRKVFENRIRFSESHIKCLLKQIILGINELHNWFIIHRDLAPANIFINSKGIAKVGDFGLARSYGQPRREYTPEVVTLWYRCPELLFGSTKYTHAVDMWSIGCIFAELLTGGKALLPGDDEVRQLGRIFELLGTPNEDNWPQAKELPLYCEFSPRSPLNFKDIFPNASEMAIDLIQSFLRLNPLERISASQALEHEYFKSYPLPCDPSELPLNYFKN		320		-2	Work stopped	-2	Work stopped	NR-16198
Batch03	CrpaA.01302.a	Cryptosporidium parvum		Q5CR6	Q5CR64|Q5CR64_CRYPV			Putative nucleoside-diphosphate kinase - Cryptosporidium parvum Iowa II	Potential drug target		SKISIYKQSFSFPRVSTAPVIKNMQVEQTYLMIKPDGIQRQVVGEIISRFEKRGYRIAAMKLTIATPAILEEHYAEHKGKPFLPGLIEKMTGPVLCMVFEGVDVIAQARKMMGSTRPGEAAPGTIRADFCQQAGRNLIHGSDSAESAKREISLWFKPEEIQSYKLALSDYIFE		173		5	Purified	-1	 	NR-16199
Batch03	CrpaA.01341.a	Cryptosporidium parvum		Q5CW5	Q5CW56|Q5CW56_CRYPV			Peptidyl-prolyl cis-trans isomerase - Cryptosporidium parvum Iowa II	Potential drug target		MIKDPELRPQRHKDNPVVFLDICLLDENNKIGRLVIELFQDIVPKTSENFRQFCTGEYKKNLKSVGYKGSTIHRVIKDFVIQGGDFVNGDGTGSTSIYNTSYFNDENFEIKHTKPGLLSMANNGSPNTNGCQFFITCNTCSWLDNKHVVFGQLLGHDSFATLKKIENATVLPPNSKPKIPIIIYECGQL		189		7	Crystallized	-1	 	NR-16200
Batch03	CrpaA.01349.a	Cryptosporidium parvum		Q5CTG	Q5CTG8|Q5CTG8_CRYPV			High mobility group - Cryptosporidium parvum Iowa II	Potential drug target		MSNQINLPGGLPGLSVPQPPGSMPSGVGSSTNSDAIIVDILCEFADFFVDLASNVAARTGKMWKPRILLQQKSKRSIRAPEDPNKPKRPHTAYTLWCEHIRQKVRENDPNRALQMKDLAEMWNSLPEQEKGPWERKAQEFKQKYLAEMAAYRASGPTSVGGGPSPSAQQQMQPFSSTSMTGW		182		4	Soluble	-1	 	
Batch03	CrpaA.01368.a	Cryptosporidium parvum		Q5CU9	Q5CU91|Q5CU91_CRYPV			"Small protein with possible EF hand domains, calmodulin like - Cryptosporidium parvum Iowa II"	Potential drug target		ACILFRVLGQTITDRDLKTALLEGWPGLDIQSDETKDKGFKKIDTSSLAPIEFDAFIKIFRAKYKIPFDEDTIIEAFQVFDPENTGLMPANSFVKLMTTTGEPVPANDVEDLLLLANVDKDGKFDYTQLAKRLVEGPKNVRVL		143		5	Purified	-1	 	NR-16201
Batch03	CrpaA.01373.a	Cryptosporidium parvum		A3FPL	A3FPL8|A3FPL8_CRYPV			GTP-binding nuclear protein ran/tc4 - Cryptosporidium parvum Iowa II	Potential drug target		MAAQAPEFKLALVGDGGVGKTTLVKRHLTGEFEKKYIPTIGVEVHPLKFNTDFGPLIFNVWDTAGQEKFGGLRDGYYIKGQCAIIMFDVTSRITYKNVPNWHRDIVRVCENIPIVLVGNKVDVKDRQVKARQIQYHRKRNLQYYDISARSNYNFEKPFLWLARRLTNQPALQLVGQHAKAPEVNIDPTLVAQAERELSEAANAPIEDDDEDL		212		2	Cloned	-1	 	NR-16202
Batch03	CrpaA.01374.a	Cryptosporidium parvum		Q5CR0	Q5CR09|Q5CR09_CRYPV			Putative farnesyl pyrophosphate synthase - Cryptosporidium parvum Iowa II	Potential drug target		ILFHLLKITFIDSIFFALHDNYLTPQFIFNKMNDLQIEYDYTDFINYYDKFKVIVYNVLKKLPLNDEIRKPVIEYYLNCIDYNVKKGKHIRGKILVLISSLSSAYSNIKRDSIYLLGWVVEAIQALILIADDIMDSGKFRRGAPCWYIVHGQSNAINDIFFLKMLSLSLIFELSSVFGNDIVMKIQKIYNESIFFTVLGQHLDLSYFDLSKADKISERYFSMVEMKTSRYTFYMPVFFGLTLSEIQVSSAQLNLIEAILYKLGEFYQVHNDVSDYLFNDSNADDICRFKLTWPLQKSFEIADEEMKLKISENYGKNSSLVKDCYNLLKINEHYLEYQRNALDYLIKLVKDITDDSLQKVFIHLIHQISELITNSRSNADSNNSL		384		-2	Work stopped	-2	Work stopped	NR-16203
Batch03	CrpaA.01392.a	Cryptosporidium parvum		Q5CR1	Q5CR10|Q5CR10_CRYPV			26S proteasome regulatory subunit 26b like AAA ATpase - Cryptosporidium parvum Iowa II	Potential drug target		MACSLAKSQTIMSGNIDREKYLYGSLKELEKELNFLSIQEDYIKDEQKGLKREFQRAKEEIKRIQSVPLVIGQFLEMIDSRYGIVSSTAGSNYYVRVLSTINREDLKPPASVALHRHSHAIVDILPPEADSSIQMLQMQEKPDVTYSDIGGMDIQKQEVREAVELPLVCPELYQQIGIDPPTGVLLYGPPGTGKTMLAKAVANHTTATFIRVVGSEFVQKYLGEGPRMVRDVFRLARENSPAIVFIDEVDSIATKRFDAQTGADREVQRILLELLNQMDGFDQTTNVKVIMATNRADTLDPALLRPGRLDRKIEFPLPDRRQRRLIFQTITAKMNLSEEVDLEEYVSRPEKISAADIAAISQEAGMQAVRKNRYVILPKDFEKGWKIHVKKSDRDFDFYSV		401		3	Expressed	-1	 	NR-16204
Batch03	CrpaA.01393.a	Cryptosporidium parvum		Q5CV3	Q5CV33|Q5CV33_CRYPV			Glutathione peroxidase - Cryptosporidium parvum Iowa II	Potential drug target		MGNFLASTKITTDLASKSVYSYTLTTLEGNPFPMESLKGKVVMVTNVASKCGYTKSYYKQMVRIYSVFAPLGLEIIGLPSREFMGQEFEDPKEIRKFADSHNVKFPLMEICKVNGPDALEFVQKLKRETPELYDEKSNTLSAIKWNFSRFLIDKNGKVVAFRGTRTEPNELIPKIAELLGVSDYQNLFKNYDKLHPESGYDPKDDVCPLKQKQSEQGS		218		5	Purified	-1	 	NR-16205
Batch03	CrpaA.01398.a	Cryptosporidium parvum		A3FPM	A3FPM5|A3FPM5_CRYPV			Putative uncharacterized protein - Cryptosporidium parvum Iowa II	Potential drug target		MSKKTLPRAISIDCEMVGCGENGHISVLGRIAVVDDKLKLLMDAFVKPSMRVTNFRTKWSGLTWDKLKYGESFESIQKKFLQIVEHYRKESTSGLVFVGHDISNDFQVLKWTPPESEIRDTCTYFPLRKLLIKSLLEKGEITHHQKEGFLRQKPSLRSLSKHVLNLNIQQGSHCPWEDAKSTMMLYLMVRDRWEALVYNRNSITNSPTTIALNNEQNEDLGEAVIPHNKKKKNKKKKDIKKGKHVTINGK		250		2	Cloned	-1	 	
Batch03	CrpaA.01472.a	Cryptosporidium parvum		Q5CWB	Q5CWB3|Q5CWB3_CRYPV			Putative uncharacterized protein - Cryptosporidium parvum Iowa II	Potential drug target		IKKFLLLAMLGLGSKEVDFQTYLDLVSHKVMLKADKEELRTAFNVLDRYGNGKVLVSDLKHILCNIGEKLTVSYIN		76		3	Expressed	-1	 	NR-16206
Batch03	CrpaA.01482.a	Cryptosporidium parvum		Q5CQH	Q5CQH8|Q5CQH8_CRYPV			Nip7 like PUA domain containing protein involved in ribosomal biogenesis - Cryptosporidium parvum Iowa II	Potential drug target		KVKMRPLTEEETKILFEKLSNYLGNNLLSLLEREDESYVFRLHKGNVFYMSETLAKAASIVPKKSLLSMGTCLGKFSKNNKFRLGITSLQYIARLTPNKVWVKPGGEQSYIYGNHVIKRHISRMTDGLSNNVGVVVYSMDELPLGFGVLAKSSADMKNADPETIAVYHQTDVGEYLREEADLL		183		-2	Work stopped	-2	Work stopped	NR-16330
Batch03	CrpaA.01491.a	Cryptosporidium parvum		A3FQK	A3FQK1|A3FQK1_CRYPV			Peptidyl-prolyl cis-trans isomerase - Cryptosporidium parvum Iowa II	Potential drug target		MESGLKAQGEVSPRSDASPNTLIKLPTKKNTHVFFDISIGGTPTGRVVFELFTEIAPLTSENFRALCTGEKGRSQNGVDLHYKGCKFHRIIPEFMCQGGDISSGNGTGGESIYGPTFDDENFVLKHNSAGLLSMANSGPNTNSSQFFITTIPCPWLDGRHVVFGKVS		167		3	Expressed	-1	 	NR-16207
Batch03	CrpaA.01505.a	Cryptosporidium parvum		A3FQ2	A3FQ23|A3FQ23_CRYPV			Casein kinase I - Cryptosporidium parvum Iowa II	Potential drug target		MEVRVGGKYRLGRKIGSGSFGDIYLGTNVTNSEEVAIKLESVKSRHPQLLYESKLYKILAGGIGVPTVHWYGIEGDYNVMILDLLGPSLEDLFTICNRKFSLKTVLMLADQMLNRIEFVHSKNFIHRDIKPDNFLIGRGKKLNVVYIIDFGLAKKYRDPKSQAHIPYREGKNLTGTARYASINTHLGIEQSRRDDLEALGYVLMYFNRGTLPWQGLKATSKKDKYDKIMERKIATPIETLCKHHPFEFITFLNYCRALRFEDRPDYAYLRRLFKDLFFREGYQYDFIFDWSFLQPEKDRRRTGNSVGVGVGVPVGAAVANAGANGPIPTNGMGVGVTQGNIPAGQSTNVVAAGIGTATGAILPHNASLPNQAGPSQCMMPGGPSSPAGIPVAGGATQVTYTQTNANCVAGEGGQNVYHESQQDEQWGGVVK		431		-2	Work stopped	-2	Work stopped	NR-16331
Batch03	CrpaA.01517.a	Cryptosporidium parvum		Q5CYV	Q5CYV1|Q5CYV1_CRYPV			Phosphoglycerate kinase - Cryptosporidium parvum Iowa II	Potential drug target		LKGKRVFIRVDMNVPVKNGQVTDKTRIIASLPTIKYALECGAKSVVLASHLGRPDGQRKMEYSLTVIVPILEELLGKSVIFAKDCVGNETEELCKNPAEGSIILLENLRFHLAEEGKGVNENGEKVKATPEEIEAFRKSLSSLGDIYVNDAFGTAHRAHSSMVGVDLTPKVAGLLLKKELEYFSKALESPTRPFLAIMGGAKVADKIQLIKNLLLKVDRMIIGGGMAFTFKKVMDNMQIGKSLFDEEGAKIVKEIMDTAKERNVQILLPSDFVIADNFSNEANARIIKDSEGIPDGWMGLDIGPESSNSFKELILSSKTIVANGPPGVFEMEKFSKGSRSMVEALVAATESGSITIVGGGDTASLVEKCGSANKVSHVSTGGGASLELLEGKLLPGVTSLSSKS		404		3	Expressed	-1	 	NR-16208
Batch03	CrpaA.01523.a	Cryptosporidium parvum		Q5CVA	Q5CVA9|Q5CVA9_CRYPV			Arginine n-methyltransferase - Cryptosporidium parvum Iowa II	Potential drug target		MIKPTEEELKEFKNSWNPLVQEDISSADYYFNSYAHFGIHEEMLKDSVRTGSYQKAIMSNKHLFQDKIVLDVGSGTGILCMFAAMAGAKHVYGIECSEIVHVARNIIKDNNLSDKITFIQSKAEEAVLPVEKVDIIISEWMGYLLLYESMLDTVLFCRDKWLKEDGLIFPDRAQMYIAGIEDAEYKQEKLGYWNNVYGFNYQYVKPCIMEEPIIDTVGENAVNTSSYCILDIDLYKCKKEDLEFVSPFYLKAARKDFVHAFIVWFDIIFGCGHKPVTFTTSPFGKYTHWKQSVFYFEEDLVCDTNDMISGIFALKKNTKNVRDLDIKIKFNFTKNNSSIERINYYRLR		348		5	Purified	-1	 	NR-16209
Batch03	CrpaA.01526.a	Cryptosporidium parvum		Q5CS1	Q5CS19|Q5CS19_CRYPV			Actin-like protein - Cryptosporidium parvum Iowa II	Potential drug target		MKTIIFEPGRTICKGGNSENLLPTVEVPSVCFLKNFEKEGNENKLSELNNLQETNKNIRNLKSNILSKDELKRIVLVGNEAIKSLESTNGNLIYPLHRNLVMSDWLLCELIWEQVLLELGVKTKIEKFKNKKLSSESGSESENQVLMVILPSTGGILIKEKVNEWLKENYDFNQVTFIPAYLLTLYSYGKETGIVVDIGSFWTNITPVIEGVSDDNYSLSIPIGGRSLEEYMKILLSRRGLKFSGKKDTKFIEETKDDLLVRNILSENCFVSTDEKNTREIISYTTSYLELIRVNSKLNNSKSIFLEEERFQVTENVFFKPYKIGIESPSICEAILKVINKCPLDTRTLLMENIFLTGRSSLFIGLPQRIQVNLTQLFLDSKLRGDTNRLNKYKFYVNDDPMRDVSTFKGANIYLQLI		418		4	Soluble	-1	 	
Batch03	CrpaA.01534.a	Cryptosporidium parvum		Q5CUZ	Q5CUZ6|Q5CUZ6_CRYPV			ARF1/2 like small GTpase - Cryptosporidium parvum Iowa II	Potential drug target		RVYTAEMGLALTKIWRNLFGKKDMRILMVGLDAAGKTTILYKLKLGEVVTTIPTIGFNVETVEYKNISFTVWDVGGQDKIRPLWRHYYSNTDGLIFVIDSNDRERINDARDELARMLGEDELRDAVLLVFANKQDLPNAMSATDITEKLQLSGIRNRNWFIQSTCATSGDGLYEGLDWLSRTLASRSNN		189		5	Purified	-1	 	NR-16210
Batch03	CrpaA.01562.a	Cryptosporidium parvum		Q5CUN	Q5CUN6|Q5CUN6_CRYPV			40S ribosomal protein SAe - Cryptosporidium parvum Iowa II	Potential drug target		LYSNMPPAETRKLDDIAKMIVCKTHIGTKNVEDKMLSYVYKRTHEGIFLINLAKTWEKIQIAARIIATIDNLADVVVVSQRPYGSRPALKFAQHTGAHAMVGRFTPGTLTNQITQKFMEPRLLIVTDPRVDSQAVIESSYANIPVIALCDTDSPLQYVDVAIPCNNKGKESIALMYYLLAREVNFLRGKTDKWDVMVDVFFWRDPEEYENSAIGADMELNDGMGVDIEGAAVDSAAAANEWGGVSGNWGGSAADEWRNAP		260		-2	Work stopped	-2	Work stopped	NR-16211
Batch03	CrpaA.01586.a	Cryptosporidium parvum		A3FPY	A3FPY4|A3FPY4_CRYPV			"ATP-dependent RNA helicase, putative - Cryptosporidium parvum Iowa II"	Potential drug target		MKTERLSNDMKGLNIPPKDPRFKTDDVTKTKGSDFEDYFLKRELLMGIYEKGFERPSPIQEESIPVALAGKDILARAKNGTGKTAAFVIPLLEKINTKKNIIQGLILVPTRELALQTSSIVKQLGKHINVQCMVSTGGTSLRDDILRLNNPVHVLVGTPGRILDLSNKKVCNLSGCFMFIMDEADKLLSPEFQPIIEELIEFLPKERQILLYSATFPVTVKGFKDKYLANAHEINLMDELTLKGVTQYYAFVEEKQKLHCLNTLFSKLQINQAIIFCNSVTRVELLAKKITELGSSCFYIHARMLQSHRNRVFHDFRNGACRCLVSSDLITRGIDIQSVNVVINFDFPKYSETYLHRIGRSGRFGHLGLAINLITYEDRYNLYRIEKELATEISPIPAQIDSALYT		406		7	Crystallized	-1	 	NR-16212
Batch03	CrpaA.01588.a	Cryptosporidium parvum		Q5CXS	Q5CXS1|Q5CXS1_CRYPV			"U1 small nuclear ribonucleoprotein A, rrm domain - Cryptosporidium parvum Iowa II"	Potential drug target		IMLKKLVSGSEEQPANKTLYCKNLNDKINKKDLKILLFELFIQFGLIDKITIRGGSPYRGQAFILFQDLNCAINAKNSINGMNVLGKPIHIEYAKENSILNPGLAEKKSSGYILGPKMPDNK		122		5	Purified	-1	 	NR-16213
Batch03	CrpaA.01590.a	Cryptosporidium parvum		A3FQ2	A3FQ20|A3FQ20_CRYPV			"Centrin, putative - Cryptosporidium parvum Iowa II"	Potential drug target		MKNIMRSRPSSSSSLGVNGISGLGGGSGSNLGGNGIGNSYMGSVSKRTELTEQQKMEIKEAFELFDGDSIGYIDIKEVKVAMRALGFDPKKEELKKILSNVELNNGMVSYNDFYDLVETKILQRDPKEEIIKAFKLFDDDETGKITFKNLKRVAKELGENISDEEIQEMIDEADRDGDGEINQEEFIRIMRKTNLF		196		5	Purified	-1	 	NR-16214
Batch03	CrpaA.01637.a	Cryptosporidium parvum		Q5CVV	Q5CVV8|Q5CVV8_CRYPV			Serine hydroxymethyltransferase - Cryptosporidium parvum Iowa II	Potential drug target		MVFLQEKSLKELDPIMYELINEEYDRQINGLEMIASENFVSKGVLDSLSSTFSMFNNDKNMELNSTSAQELLELTNERALKAYGLDPEVWGANVKPHSGSPANFAVLNAVLKPNDRIMGLSLQHGGHLTHGHYTNLKRVNCSSHYFESLPYVTDLEGVIDYDKLEENAILFRPKMIIAGASGYPRMINFKRFRDICDKVKAYLMVDIAHYSGLVVAGKYPSPKDYADFITTTSHKTLRGPRSAIIFYRKDVESKIRVKIDESVSKEIQSSIHFNQVAALCFQLKQVVSASWVKYASRVLESSQLLCKLLEESGIKILTNGTDSHKILIDTRSLNISGAKAEKALEVCEISTSRSSLPCDGRTMNCSGVRLGTAALASRGMELDDFKFVSRIIVEVLTTARDIQKDGETLAEFVSNIKASPAIENIRQTVRKFASSFEFVSIVDKY		445		-2	Work stopped	-2	Work stopped	NR-16215
Batch03	EhchA.00175.a	Ehrlichia chaffeensis	YP_507247.1	Q2GH36				adenylate kinase	Potential drug target		MENKINMLIFGPPGSGKGTQCHILSKIYSTISVISTGDLLRSEAKLDTDDGRKIRQVIESGDLVSDDIVCKMFAKSISRVKSGFLLDGFPRNLSQAEFLTEILEEYNSRIDIVIQLQLDLETIKNRLYGRIVCKNCGQVSNLNFFDRAIDEIVCKFCKSSQLDYRYDDKVEVIIKRVNQYDREIKKLENYYRDKIVCIDAGKPIEEVTCDIKDKIAHLIIG		221		2	Cloned	-1	 	
Batch03	EhchA.00178.a	Ehrlichia chaffeensis	YP_506987.1	Q2GHU6				"phosphoribosylaminoimidazole carboxylase, catalytic subunit"	Potential drug target		MSTNKNIADVAVIMGSQSDFSTMNNSISILKELNITHEVMIISAHRTPERLYTFAKSAEDNGFKVIIAGAGGAAHLPGLVASLTHIPVIGVPVKSSNLNGIDSLLSIVQMPKGIPVATMSIGSSGGYNAAIMAASILSLENDEIRKNLKIWRKNLSDSVKLIPDIPL		167		5	Purified	-1	 	
Batch03	EhchA.00195.a	Ehrlichia chaffeensis	YP_507129.1	Q2GHF4				30S ribosomal protein S6	Potential drug target		MPLYEFTFIAQQGLTQYELEGLVKGLSSLLTKNGAELLKYEYWGLLDFAYTIDKMNKGHYCMIYIKATPSSMDEFKRKVRLNEDILRFLCLKKDKLPKGDSLMIQASQV		109		-2	Work stopped	-2	Work stopped	
Batch03	EhchA.00203.a	Ehrlichia chaffeensis	YP_507721.1	Q2GFR2				pyridoxamine 5'-phosphate oxidase	Potential drug target		MIKKDPIELFDLWYNEVLAVSLQDKKDPTAMVLATCSKDLKPSARVVLLKKYSDQGFVFFTNMNSRKGKEMAENPSVALVFDWSRISKQVRIEGRIKMLPCNDADEYYASRPRGSQIGAWCSKQSSVLENREDFVELIKEMTIKFHEKPIPRPDYWVGIVVVPMLMEFWQEGLNRIHTRYQYTRDSNNMDKWNVVSLYP		199		5	Purified	-1	 	
Batch03	EhchA.00211.a	Ehrlichia chaffeensis	YP_506848.1	Q2GI85				putative pyrroline-5-carboxylate reductase	Potential drug target		MNILLIGCGNLGSILLNKWSHSDQISKVTVVQPSLSKKDTFNNITKVVFVKSHEEVDKDFIPQIVVIAIKPQLVSDVMPNYRIYSESASFISLCAGIDINFLKTCLSPTATIIRVMPNIAMSLGKSVNLSYIEEELPHEKQKVSTIFNNTGLIYWIQKEDIFDKLSPITGSGPAYFFSLAEELVKNTIAAGINEEDAIKLVSQTFIGSAKLLETRQNTISHLISSITSRGGITQAALQVLNLHLPQTISSCLKAAMERLLYLKGLDKNK		269		10	Diffraction	-1	 	
Batch03	EhchA.00215.a	Ehrlichia chaffeensis	YP_507125.1	Q2GHF8				putative thiol:disulfide oxidoreductase	Potential drug target		MRIIATALLVCFLTFTVILTKVLLNQNTITDTTNRVVLPILFTEDQVFDTNDLIGQPYILNVFASWCTTCQEEHSLWLEIAEKKTIKIYGINYLDTEYKVQEWLKKHGDPYTKIAKDYSGKTGNVLGVTGVPETFIFDKNGKILLHIHGSVSRDTWENQILKIIQ		165		1	Selected	-1	 	
Batch03	EhchA.00219.a	Ehrlichia chaffeensis	YP_506962.1	Q2GHX1				"3,4-dihydroxy-2-butanone 4-phosphate synthase"	Potential drug target		MGIIVSENSSFISPVEHIIEDSKQGKMFILIDDEQRENEGDLVVLAEKVTSGVINFMITHGSGIVCLSITEDLMHKLGLEFIPKRHVNCNSASFATSIDARYGITTGVSAHDRAHTILTVVNKNVTEDDFVTPGHIFPIVSKKGGVLERSGHTEASVEIARIAGLAPVAVVCELMNPDGTMSRMPDIIEFSQRYNIKVTSIDKLIQYVKAN		211		4	Soluble	-1	 	
Batch03	EhchA.00223.a	Ehrlichia chaffeensis	YP_507726.1	Q2GFQ7				argininosuccinate lyase	Potential drug target		MKNPLWGGRFTVSPSDIMKKINESISFDKILYEEDISGSIAHCKMLVNQKIISKYEGQLIIHGLEVIQNQISSGTFEFSTDLEDIHMNIEHHLKKMIGNIAGKLHTARSRNDQVATDFKLWIRKSIVKLETLLHELQQTILNIAEANYDTIMPGFTHLQIAQPVTLGHHLMAYFEMLKRDCSRWQDLHKRMNQCPAGSAALAGTSFPIDRHFIAQELKFDSPTENSIDAVSDRDYVIEFLSNASICIMHLSRLAEEIILWCSYNFKFITLSDNITTGSSIMPQKKNPDAAELIRGKTGRIFASLNQILVVMKGLPLAYSKDMQEDKEPVFDAANNLMLCIEAMNSMLNNITINKSNMLKAAEHDYSTATDLADWLVKNLNLSFRESHETTGQIVKLAEQNHCKLHELTLEQMKTIIPSITEDVFSILSVKNSVDSRTSYGGTAPANVIEAIKRGKLYLSNITTLHSENNM		470		1	Selected	-1	 	
Batch03	EhchA.00242.a	Ehrlichia chaffeensis	YP_507260.1	Q2GH23				putative flavin reductase	Potential drug target		MQIGDWSKTHIKSCFSEFVTGITVVTTVSQNGSMHGITVNSFNSVSLVPPMVLFSIEKSASRFEIFHTCSKFIVNILSDKQKSISQNFAECDVQNWEDFSYSVLDGIPIINGIMSYIYCAKKYVYDGGDHKIIVGEVINCAKLNNDDKPLAYYKGKYMVIGGVL		164		4	Soluble	-1	 	
Batch03	EhchA.00244.a	Ehrlichia chaffeensis	YP_507046.1	Q2GHN7				inorganic polyphosphate/ATP-NAD kinase	Potential drug target		MSKYKNIGYVFTDAFDKTAAIALEKQYGLIDIKKNEDIAIDLLIVIGGDGFMLHSLHNYVVNKCNNVPVYGINYGTIGFLLNQYSEYNLIDRINEAIPTQLTILNMVATDTDKKQYNAIAINEVSLFRSTHQATNLQIKINSKLVMEKLVSDGVLVATPAGSTAYNFSAGGSILPLNSNVFSLTAINSFRPRRWRGAILTNSTIIEIDVINPKVRSVAAVADYTEFRNITNIKIKKDTDTTITLLFDKERNLEERITNEQFSA		263		1	Selected	-1	 	
Batch03	EhchA.00256.a	Ehrlichia chaffeensis	YP_507703.1	Q2GFT0				30S ribosomal protein S4	Potential drug target		MVIQRKYRASRRLGVNLWGRSKDPFNTRNYPPGQHGGMGYKKPSDFGKQFAAHKKFKFYYAINSKQMRNIFLKAYKKRGDTGDNFVGLLESRLSSVLYNSGLVPTIFSARQLISHKHVLVNGKTVNISSYVVKVGDVVTLKEKAKNLPAVVFAVQSQEQKVPDYLEVDTQEKSIRYLRVPKYCEVPYPATMEVNLVIEFYSR		202		-2	Work stopped	-2	Work stopped	
Batch03	EhchA.00271.a	Ehrlichia chaffeensis	YP_506889.1	Q2GI44				"2,3,4,5-tetrahydropyridine-2-carboxylate N-succinyltransferase"	Potential drug target		MENFCNFKDAIEDAWNNLANLSSNTSIKKVVDDVMDLLDQGKIRICEKVGDQWVVNEWAKKAILLCFRVYDMNLAEISSADSMLGNLCWFDKVQLKFGRWSADDFRAAKVRAVPGSMVRKSAYIAPNVVLMPSFVNVGAYVGEGTMIDTWASVGSCAQIGKHCHISGGAGIGGVLEPLSSRPVVIEDNCFIGARSEIVEGVVVGEGSVIAMGVYIGASTRIVDRASGEISYGKIPPYSVVVPGSYGSGDLSLYCAVIVKKVDDKTRSKVSINELLRDDS		279		5	Purified	-1	 	
Batch03	EhchA.00273.a	Ehrlichia chaffeensis	YP_507536.1	Q2GG97				"antioxidant, AhpC/Tsa family"	Potential drug target		MNLITKQAIDFTAKAVMPDDKICEFNLKEYVSGKYAILIFYPRDFTFVCPTEIISLHNRIPQFIEKNTEIIGISTDSEFCHSHWRNISINKGGIDKISFPLIADDSHFISNSYGVLHNNSIALRATFVIDDNFIVRHQSINDLPIGRNVDELLRIIDAIKHHQVHGEVCPAGWMKGDPAMEASQHGIEDYLKSHIDHLEKSIMDE		205		1	Selected	-1	 	
Batch03	EhchA.00281.a	Ehrlichia chaffeensis	YP_507036.1	Q2GHP7				putative oxidoreductase	Potential drug target		MQEQVSNVRARIYKPAKSTMQSGHSKLKAWKLEFEPSCTQYTEPLMNWTGSHDTKQQVCLSFTTRELAIAYAVAHKIDYTVLQDNPRTIVPKSYADNFTKPRDM		104		7	Crystallized	-1	 	NR-16281
Batch03	EhchA.00287.a	Ehrlichia chaffeensis	YP_507291.1	Q2GGZ2				signal recognition particle protein	Potential drug target		MFESLTSSLTNVIQKMQSKHVISSEDFDAAMEEVKVALLEADVSLAVVKDFISNVKEKIVGGTTVKGVLPTQMIIKKIQDCLIEVLGSEKCELDISKPLSVIMMVGLQGVGKTTTTAKLALKLKNKKKEVVMASLDVYRPAAQKQLEILGKQIDVQTLPIIENQAPIDIVKRAMDNAQQANCDVLILDTAGRLHVDQVMMEELRAIKDLTSPSEVILVVDSMIGQDAINVAKSFNDNIGITGIILTRIDGDSRGGAALSMKMSVGSPIKFIANGEKLSDLDDFYPERIAKRILNMGDVVSLVEKATEAVGKHAIDEMQKKAQKGKFDLNDLVQQLKALNKLGGIANILKFMPNFGADVKRQVSGIANDSRVKQYIAIVNSMTKKERENPKILNGARKARIAKGSGVHVNVINMLIKQFNQMSSLMNKFSKVDYSKIKNTDFMNMFNKE		448		1	Selected	-1	 	
Batch03	EhchA.00291.a	Ehrlichia chaffeensis	YP_507556.1	Q2GG77				putative tRNA-dihydrouridine synthase	Potential drug target		MDISQFISDYPVILAPMSGVTDFPFRYLVKSLGAGLLVSEMIASRAMIIQTKQSLQKSQIQINTAVQLAGCDPTIMADAAKLNEDMGAQIIDINFGCPVKKVVNSYAGSALMKDETTAAKILESVVKAVKIPVTLKMRTGWDNNNLNSPKLAKIAEETGIKMITIHGRTRTQMFTGKADWKFIRNIKKCVKIPVIVNGDIKNLNDIKTSLEESQADGIMIGRGAYGKPWFINQALHFIKSGTILPDPSPSEKLKIITNHYDHMIEYYGKDTGVKISKKHIGWYSSSLENSSEFRSQVNCSNDYNFIKDKITDFFSQN		317		2	Cloned	-1	 	
Batch03	EhchA.00314.a	Ehrlichia chaffeensis	YP_507705.1	Q2GFS8				phosphomethylpyrimidine kinase	Potential drug target		MTKHQYKGRVLTIAGSDSGGGAGIQADIKTISALGCYAASCITSVTAQNTTQVYSVYNMPQHIIQQQIEVVLSDINIDTIKIGMLPSSKAIKAVAQSLPDIPIIVDPVMVSASNFRLMDSSAISDFIEYIIPKTTIITPNIPEAEALAQIEIKDQNDMTKASKIIKSLGTKHVLIKGGHINQEIINNILLTEENQIINFSHKRISKKELHGTGCTLSSAIASFIAQKMSIQESVNLAIQYILNTIKIVPQIGKGNNPVFHNYNTISSDL		269		1	Selected	-1	 	
Batch03	EhchA.00325.a	Ehrlichia chaffeensis	YP_507846.1	Q2GFD7				riboflavin biosynthesis protein RibF	Potential drug target		MKIIYGYPNQKGNVNSVLAFGNFDGIHLGHQSIINAIKNISVREKITSVVITFSPHPAEYLRNKQNFLLLDLEQKIELLQSYGIDYLYIIDFNESFAQLSPDAFIKDVLVNSCRIKYIVVGHSCFFGHKCLGNIDLLYSYANIYDYEIVRIDPIFINDKLCSSSLIREYLSEGKVDLASKILGRPYQINGKVIKGLARGRVIGFPTVNVDIKHILVPRVGVYSACIKIDDNNVWLNGIVNIGFRPTFNDLSFPILEMHIFDFDSDIYNQHVAIQLLDFIRPERKFSSIEQLKQQINEDIIQVKKSLKYIGSKDDEVV		317		1	Selected	-1	 	
Batch03	EhchA.00336.a	Ehrlichia chaffeensis	YP_506907.1	Q2GI26				ornithine carbamoyltransferase	Potential drug target		MNKANICSFTDLNLHTKEELRTILDYSSIIKKKPNQYSKHLLNKNIALIFLQPSTRTRISFEVGINQLGGNAIILNEKDTQLTRGESIYDTAKVLSRYVDLIVIRILEHNSLLELDKHSTVPVINSLTQHSHPCQVLADIMTYEEKTGPIENATVSWIGDFNNMLVSWIHAATVLNFKLNISTLEYSKNLDLLLKSAQEKGNNITYDANPHNIISDADIITTDSWISMGYENNIKTEFFKYQVNAKLLEKAKPNYMFLHCLPAHRGEEVTSEIIDGPNSYIFDEAENRLHIQKAIMLWCLNLL		303		5	Purified	-1	 	
Batch03	EhchA.00343.a	Ehrlichia chaffeensis	YP_506886.1	Q2GI47				phosphoglycerate kinase	Potential drug target		MKKIQDFSCSGKTVLLRADLNVPVDNGIVLDDTRIVRLTTTIKYLLSNDAKIVIMSHYGSPKSYDKEFSLKFVVEYLNKIFATNVVFIDGVIGDYVEQTIQSVPAGTILLLENLRFYAEEEKNDLNFAKQLALLADIYVNDAFSCLHRKHASIDAITRVMPSFIGFNFQEEMKYLSCVVSNSEKPVAVIVGGSKISTKVHMLKNLIKKIDFLIVGGAIANNFLLSQGLKIGKSLYEELEKDLVTEIVDLAKRYECKIIVPVDYVVAKNYICGDSTIKDNDTLESDDMILDVGPQTVNMIAATINKCRTVLWNGPCGMFEKEPFSKGTFSVANLLSKLTKVGKLKSIVGGGDSICAIKLSGLSNEDFTYISTGGGALLHFLSIA		383		1	Selected	-1	 	
Batch03	EhchA.00352.a	Ehrlichia chaffeensis	YP_507201.1	Q2GH82				dihydropteroate synthase	Potential drug target		MKFNTKLVGILNYTPDSFSDGGQFFSIDKALQQVKHLINGGADIIDVGGESTRPTYLYTQHGNNTISQTEEWDRLKYILPKIIEIAHNHNVQVSIDTRYAKTAEKAIELNVDYVNDVSTLSDKNMLQVLQNSSVNVVITHSLGIPLIKNNTIPKNLDPINEIIIWAKKYIDKLTNAGIDKNRIIIDPGIGFSKTANQTFYILNNIDRLKVLNQKIYVGHSRKFFLTSYTSNDPTRDNATLAISIFLFQQGIDFIRVHNTHLHSEAFNLLRKMHQTHLNNI		280		1	Selected	-1	 	
Batch03	EhchA.00353.a	Ehrlichia chaffeensis	YP_507327.1	Q2GGV6				maf protein	Potential drug target		MLKFDNLILASSSEQRLSLLEQIGVIPGQVVSPDIDEVVLKKELPKVYSIRIAKEKGTKVRVLYPDKFILSADTVVCCGRRVLPKAETEEQALECIRLISGRRHRVYTTVCLYTPYNKLHCRNVMTIVKFKHLSMQEINSYIMSGQWKGKSGACSIQTSAGKFVLSINGSYSSVIGLPLYETYSILSQYFSI		192		2	Cloned	-1	 	NR-16282
Batch03	EhchA.00363.a	Ehrlichia chaffeensis	YP_507056.1	Q2GHM7				"peptidase, M16 family"	Potential drug target		MSPKITQLSNNFTIITDTMPYVESVSINIWVNVGSRYENINITGISHFLEHMAFKGTKTRTALDIAQIFDDIGGNFNAHTDREHTVYHVKTLKRDIKIAIEVLADIILNSQFPEEEIYKEKGVVLQEIYQTNDSPTSIIFDKYIEAAYPNQIFGKSILGTPESVNSLSKADLHIYMSEYYHAGNMLLSVAGNISHEEVIDLVSQYFSHMKKSQRKIADPSIYRSGEYREIRNLEQVHLVIGFPSVSYKDDLFYTIQILDSILGNGMSSRLFQKIREQLGLVYTISSFNSSYSDNGIFSIYAATDKSNLSQLLSTIASEVKNIITNLQENEITRAKGKLTSEILMSRESTTARAESLGYYYSHYNRYISKEELIKKISTITVTDIQNCINNLLGSNNKITLAAIGQIENLPSYDDIAQMFYI		421		1	Selected	-1	 	
Batch03	EhchA.00364.a	Ehrlichia chaffeensis	YP_507603.1	Q2GG30				pyridoxal phosphate biosynthetic protein PdxJ	Potential drug target		MSDVALGVNIDHVATLRNARNVDYPDIVEVANIAVSNGADFITVHLREDRRHIKDDDVFRLKNSLKVPLNLEIAPTDEMLSIAIKVRPKCVCLVPEKRQELTTEGGLDVKRAFSYLISFIEKLHTYNIDVTLFIEPDVDQIDQAKKLSADNVELHTGKYCNNTTQSELSQVIKAAEYCYQRNIGCHAGHGLNYQSAAIIAKVPYISALNIGHFLICESVLHGIGTSVHKMKKAIASAPN		239		7	Crystallized	-1	 	
Batch03	EhchA.00374.a	Ehrlichia chaffeensis	YP_507265.1	Q2GH18				fatty acid/phospholipid synthesis protein	Potential drug target		MSIISIAVDAMGGDFAPEAVVSGLDFALTNLLDDQNVSFNIYGQGSQVLPILDKYKDLKEHSVFIDTPEVVLANDKPSFALRKRRSSSMWCAIDSIKSGVTSGVVSSGNTGALMAISRFLLGTLPNIDRPAICTALPSRGEEYFVLLDLGANIESSSNALFQFAIMGSAFAKAVLNIASPKVALLNVGQEEVKGTDVIREAFLLLKQAEGRINFCGYIEPIDILGDKVDVVVTDGFCGNIVLKVAESIAYTFKSVFEKSVTSSIISKFAGLLLKSQMKKDFMRFNPKMYNGAMLLGLNGVVVKSHGNADKVAFAHAIKVTVNAVRNDINAKIIHELS		337		2	Cloned	-1	 	NR-16283
Batch03	EhchA.00379.a	Ehrlichia chaffeensis	YP_507357.1	Q2GGS6				enolase	Potential drug target		MFNITISKILARQILDSRGYPTIEVETILSNDIKAKACVPSGASVGKFEAVELRDNDKNFYNGYGVTKAINLINSEVAPQIISMNTLNQEKIDNALIEIDGTDNKSRIGANSTLAISLAIAKAAALALNIPLYQYLGGITAKVLPTPLINVINGGMHADNNLDFQEFMIIPNGANKFEDAIRMSAEVFFQLKQILKHKKLNTNVGDEGGFAPNIRINTEVFEIIIDAVEKSGYKMYEDFSLGLDIAASTFYKDQKYKFADYELNTQELVEYYKKIISQYPIISIEDPIAEEDINGWKLITQELGNKIQIVGDDLFVTNCKLIQNGIDNNMANAVLIKPNQIGTLTETFNAIRLAQKNNYNVIISHRSGETEDTTISHIAVATNCGQIKTGSLSRSERLAKYNELLYIEKLLGISAIYYGSL		421		1	Selected	-1	 	
Batch03	EhchA.00381.a	Ehrlichia chaffeensis	YP_507477.1	Q2GGF6				3-oxoacyl-(acyl-carrier-protein) reductase	Potential drug target		MFNLSQKRFLITGASGGIGKAITKTLSNAGAILCISGTKAPVLQEIAEQYSSAGNIYTLPCDLTNDEQINSLIDNACKAMSGIDGIICNAGITLDKLTLRTSDEDWHKVINTNLTTTFKLNRNACRAMLKNNQGRIINISSIIAFTGNPGQASYSASKAGMIAMSKSIAKEFANRNITVNCIAPGFIETPMTDALSEEQRNNIITHIPMKRIGTPEEVAAAVLFLASDESKYITGQTLHINGGMLMY		247		1	Selected	-1	 	
Batch03	EhchA.00408.a	Ehrlichia chaffeensis	YP_507591.1	Q2GG42				"hydrolase, TatD family"	Potential drug target		MIVDSHCHLNYFDPSEIKDVVLRAEENNVKLMQTVCTTIAEFSDLVKVAESYKQVYLSVGVHPTNSANGESVSVDELVDLAQHSKVIGLGETGLDFYKCSQVGEQEKNFLSHINASRETGLPVIIHSRNADKRMMEILESEMKESPFLGLMHCFASSRELAIKAIELGLYISFSGIVTFKSAKVVQEVAGFIPKDRVLVETDSPFLSPEPYRGQRNEPAKTKFVVEYLANLWNESLEEVSNLTTKNFFKLFKKCSEHFHL		260		5	Purified	-1	 	
Batch03	EhchA.00413.a	Ehrlichia chaffeensis	YP_506843.1	Q2GI90				P-loop hydrolase family protein	Potential drug target		MLQFKYSSVDLVFLEKLARFIALGLKKGDSISLVGDLGVGKTTFVRFLVHALAPCEDVGSPTFSIINEYHSNKFTIYHIDLYRINSLREVYDLGIESICDDGVGIIEWPDLLNDILDFNLKINIKYSTKENLRDVEVFIKDDDKCGIFESFVSSN		155		1	Selected	-1	 	
Batch03	EhchA.00418.a	Ehrlichia chaffeensis	YP_507766.1	Q2GFL7				"succinyl-CoA synthetase, beta subunit"	Potential drug target		MNIHEYQAKHILSKFGVNVPKGVVVHSLGEVDGALSQLNSKVVVVKAQIHAGGRGKAGGVVVSRTLDETKTSIKNMLGSTLITHQTSKDGQKVRKVYLEEGCNIKKEYYISAIVNRKQGQVSIIFSTEGGVDIEEVAATSPEKVIVCNINPVFGFQGFHGRNLCFDSNLSLDQTRKISDIAGKIYKAVLSTDANQIEINPLVETSSGEFIALDAKINFDDNALYRHPDIQELRDYDEEIKEEIEASKHGLSYIKMDGNIGCMVNGAGLAMATMDIIKYYGAEPANFLDVGGGASQKTVTEAFKIILADDKVNGILVNIFGGIMRCDIIANGIIAAIQEIGINVPLVVRLSGTNFELGKKLLDDSNLNIITANDLSEAAYNIVNIVRK		387		3	Expressed	-1	 	NR-16284
Batch03	EhchA.00426.a	Ehrlichia chaffeensis	YP_507585.1	Q2GG48				NADH dehydrogenase subunit B	Potential drug target		MINKNDSVLNNQFWQSYNHQGFMVTQFSDLINYISNWARSNSLWPMTFGLACCAVEMMHTAASRYDLDRYGVMFRASPRQADVMIVAGTLTNKMAPALRKVYDQMTEPRYVISMGSCANGGGYYHYSYSVVRGCDRIVPVDIYVPGCPPTAEALLYGIFCLQQKINRGNTSITRKSTQD		179		3	Expressed	-1	 	NR-16285
Batch03	EhchA.00451.a	Ehrlichia chaffeensis	YP_507395.2	Q2GGN8				seryl-tRNA synthetase	Potential drug target		MHDIDFIKQNPELFDNAMQVRNSEKVAKKIIELDVKKRHLLTQLYSLQKERNQITQEIEKLKKNNLQCNIQIELSKNVTSKINDINNMIKEDSQLVNLLNMLPNIPDERVPIGKDENSNVELRRHGNKTSFDFPIKTHYELGENLNLMDFKQAAKLSGSRFVILKNQLAQLDRALSNFMLDIHTKEFGYSEISHPILVHESAMYGVGQLPKFADDSFKTTENFRLIPTSEVALTNLVSNMNINGCDLPLRFTACSPCFRSEAGSAGRDTRGMMRQHQFNKVELVSIVTEEQSAPELERMTQIAEEILKRLELPYRVMMLCTGDMGFSASITYDIEVWIPSQNQYREISSCSNCKAFQARRMNTKYTTIINNVKVSKFVHTLNGSALAIGRTIIAILENYQNRDGSITIPHILRKYMDNQEVIK		423		1	Selected	-1	 	
Batch03	EhchA.00454.a	Ehrlichia chaffeensis	YP_507308.1	Q2GGX5				"superoxide dismutase, Fe"	Potential drug target		MFTLPELPYQQDDLVPYLSLEILGYHYNKHHQGYVNTLNTLVTGTDFSKCTNEDLPKVIEVTSGDLGSRAIFNNAGQVWNHNFYWESMKKNGGGSPTGKLLDKINEDFGSMDGFNNAFINAGKSHFGSGWVWLVFDVNEQKLKIVCTSNGDTPITQYPKTHPLLTMDVWEHAYYLDYFNVRQNYVETFLQHLVNWDFAAQKFLAI		205		1	Selected	-1	 	
Batch03	EhchA.00470.a	Ehrlichia chaffeensis	YP_507162.1	Q2GHC1				phosphoribosylaminoimidazole synthetase	Potential drug target		MKTYSSAGVNIESGNSLVEKIKPIASSTSIPGVVDSIGSFGALFDISRIKEYNKPVLVSSTDGVGTKLCIAQGVDNHKTIGIDLVAMCVNDVLAQGAEPLFFLDYFATGKVNHDTALEIINSIAVGCKKANVALIGGETAEMPGMYSDNKYDLAGFAVGIIEADNILPKSHNIKVGDKILGLASSGLHSNGFSLIRKIISDNKINYHDVCPWSNQTWANYLLTPTRIYVKSLLSTIPLVNGLAHITGGGFTYNIPRIIPSHLSATIDLSSWKMPEIFHWLNTEVQIQQTELLKTFNCGIGMILVTSQENEDQVLSLLKVTDEVVYKIGEITERNTEDQVIFK		342		1	Selected	-1	 	
Batch03	EhchA.00496.a	Ehrlichia chaffeensis	YP_507554.1	Q2GG79				divalent ion tolerance protein CutA1	Potential drug target		MKNISLLYTTTPTYEDAYRISNILLENKLIACANIFSNITSVYVWEDEIHNNTECAIILKTTNDLVQHATNKIQAIHPYDTPAIITIDPTNANDKFIQWVNDCTAL		106		5	Purified	-1	 	
Batch03	EhchA.00522.a	Ehrlichia chaffeensis	YP_507729.1	Q2GFQ4				dihydroorotate dehydrogenase 2	Potential drug target		MSLQHIFTNPLFCIPPEIAHKLVIFALKNNFIPTKKIEIPRSLNIQVFNKLLRTPIGVAAGFDKNAEVIQPLLSIGFGFVEVGTVTKHPQNGNKKPRVHRLISKEAIINSLGFNNKGINFLIKKVNNIQLNHCIFGINIGFNKKSSDPIQDYFDSVKKVYGLSNYITINISSPNTPGLDEFQKKDLLSELLTAISQVRKLADYAESVPIMLKISPDINDNKKQDIVDLAIKYKISGLIISNTSSQHNKLLNMNTNIHGGLSGKPLFDLSTQVLSEIYQASQGKLLLIGCGGVSTGYHAYEKIKAGASLVQLYTAIVYNGFNIANKISLELADLLAADGFPTVRHAIGHNH		350		1	Selected	-1	 	
Batch03	EhchA.00530.a	Ehrlichia chaffeensis	YP_507111.1	Q2GHH2				phosphoribosylaminoimidazole-succinocarboxamide synthase	Potential drug target		MENKEKIYEGKAKIIFATLNPLEVIQHFKDEITAFNNKKAAIIHEKGILNNYISSFLMKKLIDKGIKTHFISLLNQREQLVKKITIIPIEVVIRNLAAGNFSKRFQIADGTPFKSPIIEFYYKNDELSDPMVSEGHILSFQWLTNQELEKIKILSLKINNILSELFFNVGIKLVDFKLEFGKLHNDEQSDLFLADEISPDTCRLWDISTNKRLDKDRYRLNLGNVIEGYREVAHKLNAIPNL		242		17	In PDB	-1	 	
Batch03	EhchA.00546.a	Ehrlichia chaffeensis	YP_507041.1	Q2GHP2				thioredoxin	Potential drug target		MIEQIGDSEFDNKVTSCNDNILILVDFWAPWCGPCRSLEPQLEKLAQQYTENVKIYKINIEDNQDVATQYGVSAIPTILMFKNGKKLSQVIGADISKIISEINNNIN		107		5	Purified	-1	 	
Batch03	EhchA.00568.a	Ehrlichia chaffeensis	YP_506983.1	Q2GHV0				"2C-methyl-D-erythritol 2,4-cyclodiphosphate synthase"	Potential drug target		MNQHPNKPIFKVGIGYDVHKFDNTCYNDANTFITICGIKINYHKKIIAHSDGDVGLHALTDAILGAVGCGSIGQHFPNTDNTWKNIKSDYFLIEAQKKAQEKGYSISNADITIICEQPKIMPHALEMQEYIANLICIDPSCINVKATTTEKLGFLGRKEGIAAQAIVLCCLQN		173		1	Selected	-1	 	
Batch03	EhchA.00574.a	Ehrlichia chaffeensis	YP_507637.1	Q2GFZ6				"putative cation ABC transporter, ATP-binding protein"	Potential drug target		MFHKLLNKSEILAYDKKYVNNYIINVENLSFFYSKEKVIDDISFQVKFGEIVTILGPNGGGKTTLIRILVGIYRNYIGVIKYAKNFIIGYLPQHFSVNSLIPMTVKYFLNSSYTKSKRKLKLSDVLKDINIEKILDRQMSEISHGELQLVLLARCLMLNPDIIILDEPVSCMDVNAKDSFYKLINKLISIYNLSVIMTSHDLHFVMSNSYRVICINRSIYCEGSPSEIVKNEKFLKMFSSYA		242		1	Selected	-1	 	
Batch03	EhchA.00578.a	Ehrlichia chaffeensis	YP_507676.1	Q2GFV7				acyl carrier protein	Potential drug target		MESNDEKLESVKDTVTKIVIDCLKLKDEQKATLSGSTNLAKDLNLDSLDFVDLVMCLEDHFSIEISDEEAQELETIDKIEEYIRNKLSSKN		91		1	Selected	-1	 	
Batch03	EhchA.00581.a	Ehrlichia chaffeensis	YP_507266.1	Q2GH17				3-oxoacyl-(acyl-carrier-protein) synthase III	Potential drug target		MKRSTILGIGSYLPKKIVTNDELALTVETSDEWIVKRTGIKQRHIAENNEMTSDMAANAARLALTDACVHKDDIGLIIVATTTPDRTFPSCATIVQDKLECKNAFAFDIQAVCSGFVYAISIADNFIKSGQVNTALVIGAEIMSRILDWQDRSTCVLFGDGAGAVVLGNNSEKDSGIISTILHSDGAFCDLLYTTGGTAYNGHAGTICMNGTIVFEHAIEKLSASILEILDQNDLEINDVDWFVLHQANIRIIELVARRLKIPYEKMVVSVNWHGNTSAASIPLALSYAKSSGKLKKHDIAILAAIGGGFTWGTCLVRI		319		1	Selected	-1	 	
Batch03	EhchA.00583.a	Ehrlichia chaffeensis	YP_507541.1	Q2GG92				prolyl-tRNA synthetase	Potential drug target		MRLSDYYVPTLKETSADISVISHKYSIRAGLIKQIASGIYTWLPLGLKVLKNIENIVREEMNKSGSLEILMPLIQPASLWKESGRYDDYGSEMLRITDRNQREMLFGPTHEEVITDILRTTPVSHKDLPLILYQIQWKFRDELRPRYGIMRCREFLMKDAYSFDKDFSGAISSYNLMFKTYIKIFQKLGLTPIAVKADSGPIGGNLSHEFHVLANSGESTLYYDQDIIELMNSESIDVEKIKNTYTAADDMHDPQACPISSDKVKISKGIEIGHIFHLGDKYSKPMNANFCDSNNNKLLQMGCYGIGVSRLVAAIIEVFHDNKGIIWPETVAPFKFSLVNLYTSNDKCKKVAENLHMQLYDDVLYDDTDDSPGIKLARTDLLGMPWQVIIGKSTVEQDLIEVRNRLTKDKVLISTEQFLNKLKK		424		1	Selected	-1	 	
Batch03	EhchA.00585.a	Ehrlichia chaffeensis	YP_507306.1	Q2GGX7				lipoyl synthase	Potential drug target		MRSKPDWLKVKMPTGDTFYQVRNLMKLYKLNTVCEEAACPNIGECWNKRHATVMILGSTCTRACAFCNVVSGIPDKLDPHEPQNLAKAVGLLKLEHVVITSVDRDDLEDGGSGHFVECIEEIRKNDQNVTIEVLTPDFLNKHGAIEKVADAAPDVYNHNIETVPRLYAKIRPKARYFHSLYLLKTVKYKNPKVFTKSGIMVGLGETKEEIYQVMNDLRSADVDFITIGQYLQPTPKHAAVDRYVTPEEFDHYKYVAYSKGFLMVASGPLVRSSYHAGEDFQRLKKNRAAMFMHAKSN		297		1	Selected	-1	 	
Batch03	EhchA.00607.a	Ehrlichia chaffeensis	YP_507156.1	Q2GHC7				glutathione synthetase	Potential drug target		MALIVAFQMDKDVVVDKDMSVKFIQEAQNRGHTVFFYSPNQLAVKDNMPIARACLVTIEGQELRFADVQELLLEDVNIIFVRQNPPFDMRYITSTYILERLKRPLVINNPKSLRDHTEKLLPLSFPEFIPDTIVTEDYIMLQDFYNKHKDIVLKPLYSYGGNDVTRMHSNVDIGVIAKLMTEKYGCPIIAQKFIPNVSNDKRIILLDGKPIGVFKRRISFNGINEEIRTNLRMGSVPEVATLSDRDIAICSAIEQELLGKGMVFVGIDVLDGYLIEINVTSPCGILQINELYGVSLEKKCWDCFEEKFYEKHNSI		315		1	Selected	-1	 	
Batch03	EhchA.00615.a	Ehrlichia chaffeensis	YP_507123.1	Q2GHG0				glutaredoxin-related protein	Potential drug target		MTNDIMDKIKHDIENNDVVLYMKGDADFPQCGFSSVVVSILKKMNVKFKSINVLESLELREAIKEFTNWPTIPQLYVKGEFIGGCDIVKEMYHNGELQELLSKNNLIVAQ		110		2	Cloned	-1	 	NR-16286
Batch03	EhchA.00624.a	Ehrlichia chaffeensis	YP_507013.1	Q2GHS0				putative iron-binding protein	Potential drug target		MRLIACLGIIAVVILAFSFFTKKQQVQDLTQEVRVYSSRKEELLHSLFKQFTKETGINVKYINDEAAQLINRMENEGTATSADVFLTADAVNLILAKKKGLLQPVQSEVLNQAIPSKYRDSEGFWFGLTKRARVIVYNKDLVEKSDLSTYEHLANTKWKDKILVRSSSSPYNQSLIAFMIANNGIENTKIWVKGLVSNMARKPSGGDIDQIYAVAADEGSIAIVNSYYFGRIAASDKKSDQIAVKKLGIFFPNQETTGTMINISGGAVTKNAKNKQNAIRLLEFLTSVKAQKVYAQVNQEYPVVEGVELSEILGTFGSFKESNLPLQELEKHLTEAVKMADECGWR		346		1	Selected	-1	 	
Batch03	EhchA.00631.a	Ehrlichia chaffeensis	YP_507273.1	Q2GH10				putative geranyltranstransferase	Potential drug target		MKHHSSLLVKQLESILPENNQDILLTSMRYSMFAPGKHIRPFLVNASAQIFNVNVDRILPVSAAVEIIHVYSLIHDDLPGIDNENIRRGQASSHKKFNEAIAILTGDALLTLAFEILSTIDESPFIRCCMIKALAKALGYQGMIQGQILDTETIAKDTNDIQAIHVLKTAQFFSVACELGGILGNASNIELNALANYGLNLGHAFQVKDDIADANQDKSKNNILNILNNEDAQNYLNSLIDKSIEHLTILSHKADILHSLAEFIRNL		267		1	Selected	-1	 	
Batch03	EhchA.00636.a	Ehrlichia chaffeensis	YP_507750.1	Q2GFN3				30S ribosomal protein S12	Potential drug target		MPTINQLVRKPRKSRSSLNKAPALQHNPQKRAVCVKVYTTTPKKPNSALRKVARVKIAGYGSEVIAYIPGEGHNLQEHSVILIRGGRVKDLPGVRYHIIRGALDSRGVQNRKKARSKYGVKKS		123		-2	Work stopped	-2	Work stopped	
Batch03	EhchA.00678.a	Ehrlichia chaffeensis	YP_507359.1	Q2GGS4				50S ribosomal protein L27	Potential drug target		MATKKSGGSSGNGRDSRGRRLGVKKFGSEKVIPGNIIIRQRGTKYHPGKNVGIGKDHTIFSKISGFVHFRKGVYNKTFVDVLEASSVS		88		-2	Work stopped	-2	Work stopped	NR-16287
Batch03	EhchA.00686.a	Ehrlichia chaffeensis	YP_507112.1	Q2GHH1				histidyl-tRNA synthetase	Potential drug target		MQRDKLREVRGTKDLLGIELYKFQYIHRLSQSIAHRYGFIAVDTPIIEFTEVFTKTLGDDSDIVMKEMYNFQDKSGENITLRPEFTSAIVRVLINKNLIIPVKLFSSGPVFRYERPQKCRQRQFHQVNFEFFGSDLPLADIEMIALGYHILDELKLLDDITLEINFLGDKETMNSYKLSLIEYLNKYKKDLSEDSQRRLITNPLRILDSKAPEDREILLNVPNISYFYSKSSNDFFAEVLYGLDELCIPYKVNHSIVRGLDYYCNTVFEFTTSKLGAQNAVVAGGRYDGLVKSMGGNDTPAVGFAMGVERVSALIDYKHQEPRSVVLIPIGKDAVSYALKLAYELRCNGISVNWNYKNANLRNALRKVGDDNIVLIFGDEELKNNTIQVKDMKTGEQQEIVRCDLLDTLCNKI		413		5	Purified	-1	 	NR-16288
Batch03	EhchA.00694.a	Ehrlichia chaffeensis	YP_506838.1	Q2GI95				tRNA (guanine-N1)-methyltransferase	Potential drug target		MTFNVNVLTIFPEMFPGTLSHSIIGRALNKGLWNLNVIDIRSFAKDKHKTVDDRPYGGGPGMIMKADVIGSAIDEVLSKNKNTKLIYMSPSGIKLNQDISGQLTHFSNITILCGRFEGIDKRILDFYDFHEISIGDYILSGGEVACMVLIETCVRLIPGVVSNTQSIRDESFTLDYKLEYPQYTRPAKWRGLEVPDVLLSGNHKKINLWKANQSYCITKQRRPELTGTIDGDIYE		235		4	Soluble	-1	 	NR-16289
Batch03	EhchA.00695.a	Ehrlichia chaffeensis	YP_507140.1	Q2GHE3				Holliday junction DNA helicase B	Potential drug target		MKNILQSTECLEDQQNVSMRPNLLDDFIGQSSVVNNLKIFINAAYTRKEPMDHVLLYGPPGLGKTTLAHIIAKELKVNFRSTAGPLLSKAGDLAAILTNLQAKDILFIDEIHRLNRNIEEILYSAMEDFCLDIIVGEGCGARTLRVDLPPFTLVGATTRIGLLSNPLRDRFGIPIHLEFYSTEELTKVIQRAAKVIKTNISNSGAQEISLRSRGTPRIALRLLRRIRDFMEVTEHNKIITDTFADKALLRLGIDKLGLDRQDIQYLKFIYDSNNPTGIDTISSGLSEDTGNIEETIEPYLIKINFIQRTPRGRVITEKAISHLREQEYI		329		1	Selected	-1	 	
Batch03	EhchA.00700.a	Ehrlichia chaffeensis	YP_507184.1	Q2GH99				co-chaperonin GroES	Potential drug target		MNLNMLHDNVLIEALEECNSSSPIQLPDSAKKKPTQGKVVAVGPGVYNHSGNILPMTIKVGDVVFYRQWAGNEIEFHDKKYIVMKESDIIAKEA		94		5	Purified	-1	 	NR-16290
Batch03	EhchA.00725.a	Ehrlichia chaffeensis	YP_507555.1	Q2GG78				4-diphosphocytidyl-2C-methyl-D-erythritol kinase	Potential drug target		MLKFLVKAPAKVNLFLHITGKRSDQHHYLESLFVFVNVYDILEVDVGGSKRGVYFSNLRISKYNNTVYKAIELLLKHSAVCPNVSVSIIKNILVSAGLAGGSADAAAIMRLLGNMWNIDYTLLQDLALKIGSDVPACLESKTLFAKGVGEDILLLPDLLLPKYIILVAPRGKTLSTAKVFNNYQSATYSPSICDKLPVKQDDWMELICNAKNDLLEVALKFVPEIEEILFVLKQLKNSVIARMTGSGATCFALFNELSHAEDAARKLQMTRPDWIIFNAKIL		282		4	Soluble	-1	 	NR-16291
Batch03	EhchA.00730.a	Ehrlichia chaffeensis	YP_507581.1	Q2GG52				riboflavin synthase subunit beta	Potential drug target		MSNDHINILIVVSQFYSDVADLLLNGAVDQLKKYSKPVKYDIVYVPGSFEIPAAIVFAIMSDRHHYDGYIALGCVIKGQTDHYYYVCKGVTTALSEIATHHAVPMGFGVITAGSLEIAMARADINKRNVGGNAAKAALTMIELHNKFLS		149		5	Purified	-1	 	NR-16292
Batch03	EhchA.00731.a	Ehrlichia chaffeensis	YP_507324.1	Q2GGV9				dihydrolipoamide dehydrogenase	Potential drug target		MQNYDMVVIGGGPGGYKCAIRGAQLGLKVACIDKNEILGGTCLRVGCIPSKALLHFSHEYYHLKNNLSEVGITFDNLNFDLEKIMSFKDKNIAELGNGISYLFSSHKIDYLCGVGKIQSVGPNNFIIVISGNNGKQEIISRYVVIATGSDVANFPDIDEERVVSSTAALSFKEPPKRLIVIGAGAIGLEMSSVWSRFGSEVTVVEFSDKIAPSMDGDIGKALLTSLKKQGINFKLSTKVSSIDKKGSNLAVHLESVKDGKSEIIEADKVLVSIGRVPYTNGLIDNNSIECDARGFIKVNNKYETNIPGVFAIGDVIGGAMLAHKAEEEGIAVAELISGHVPHVDYEIIPSVIYTHPAVASIGKTEESLKKVNYSYNVGKSNFSANGRSKVTDNVSGFVKVLASKENDAILGVHIIGAYADTMINEAAVAMAYRASSEDIFRICHSHPDVNEAFKDACEAAFLK		463		1	Selected	-1	 	
Batch03	EhchA.00736.a	Ehrlichia chaffeensis	YP_507819.1	Q2GFG4				ApaG	Potential drug target		MTLQYYSMTKLIEVKVVPSYLEEQSAPHENCYIWLYNIRVKNKSNSTVQLLRRSWKIIDSTGVINEVTGLGVIGKQPVLKPGEFFEYTSGAYLSTPSGMMHGEYQFMDEDAAQVFYVSIPMFSLDSPYVNTKPH		134		1	Selected	-1	 	
Batch03	EhchA.00760.a	Ehrlichia chaffeensis	YP_507940.1	Q2GF43				"chromosome partitioning ATPase, ParA family"	Potential drug target		MSKAFAIVNQKGGVGKTTTSINLSTAFAIVNKKTLLIDLDPQGNSSTGFGITYEQRINTVYEVLVNNLPISSTIIKTEIPNLHLLPSTVDLSAAEIELTQVQQREFILKKSLSEVKNSYDYIFIDCPPSLGLLTVNALIAADSIIIPLQCEFFALEGLSHLMKTIEIVKKHLNPLLSIEGIILTMYDKRNKLSEQVEEDIRKYLKESVYKTVIPRNVRLSEAPSHGKPAIIYDFKCAGSQAYIYLAKEILRKQKKY		256		2	Cloned	-1	 	
Batch03	EhchA.00777.a	Ehrlichia chaffeensis	YP_507847.1	Q2GFD6				glutaredoxin 3	Potential drug target		MIKVKIYTKDFCPYCTKAKALFNKKNIPFEEIDITGNNSLLEQMIQQSNGMKTVPQIFINDQHIGGCDDLYKLYESGKLEL		81		1	Selected	-1	 	
Batch03	EhchA.00798.a	Ehrlichia chaffeensis	YP_507267.1	Q2GH16				cytidine and deoxycytidylate deaminase family protein	Potential drug target		MKLAISKAQEDLLEVPVGAVIVHNNEVISSANNSNIHDIDPTAHAEILAIRNACKILSTHILNQCDIYVTLEPCAMCAQAISFSKIRRLYFGAYNKKYGAIENGARIFQFCHHVPEVYGGILEAENTKLITDFFKKLRKE		140		3	Expressed	-1	 	NR-16293
Batch03	EhchA.00799.a	Ehrlichia chaffeensis	YP_507189.1	Q2GH94				leucyl aminopeptidase	Potential drug target		MIDISFSSLMPGVSLFLKTTAIVVGIFEGSNHLEDYSALAERSEQIMKVVEGYKSFDGKFAEVLPITGLDAGYPIVIVVGLGKPEEFDENKSLRIGGVIYSELNRMKISEASIISSNDSDIMANVAYGAFLRSFKFDKYFVQKKDENATYVRKLEFFSKTNPQKTAVLFDNLKAEGESVFLARSFVSEPPNILYPEIYAQMIYEELSKVDVKVEIFDEDYMKANQMMALLGVGQGSAKKSRLVVMRWNGGKETDSPIAFVGKGVTFDTGGISLKPSRGMWDMKYDMAGSASVVGIMRTLAARKAKVNAVGVVGLVENAVGGNAQRPSDVVTSMSGQTIEVLNTDAEGRLVLADALWYTQKMFSPKLMIDLATLTGAVVVALGNNQYGGIFSNDDAIANQLIVAGNESGEKLWRLPLDDAYDKLIDSSIADVQNISTKGYGADSITAAQFLQRFVNKTPWVHLDIAGMAWDNEGNEICPKGATGFGVRLLNRLILKYYEAN		500		1	Selected	-1	 	
Batch03	EhchA.00809.a	Ehrlichia chaffeensis	YP_507487.1	Q2GGE6				argininosuccinate synthase	Potential drug target		MKKIVLAYSGGLDTSVILKWLQENYNCEVVVFTADLGQNDDMSAIRQKAAASNVKEIFIEDLKEEFVKDFVFPMFRANTVYEGYYLLGTSIARPLIAKRQIEIAHLTGADAVAHGATGKGNDQIRFEFGYYSCDPNIKVIAPWRQWELTSRNSLIEYAKKHGIDVPLDKASEPPYSIDANLLHTSYEGKSLEDPYIEPDYTMLSKSVIPELASDTPEYIEISFKNGDPHAINNVPLSPANLLQQLNIIGGRHGIGIIDIVENRYIGIKSRGVYETPGGTILLHAHRAIESITLDREAAHLKDEIMPRYAKLIYNGYWWTTERKMLQALIDKSQDKVNGVVRLKLYKGSVMVVGRTSENSLYSHNLASFDSSGNYNHTDAEGFIKINSLRLRNS		393		3	Expressed	-1	 	NR-16294
Batch03	EhchA.00820.a	Ehrlichia chaffeensis	YP_507261.1	Q2GH22				dihydrodipicolinate reductase	Potential drug target		MTRVNIGIVGCLGKQGRRLVSEISASPYAQVSGGLVRSGNPHVGQILGEVVGCDCSVKITDSLEHLFETSDIVIEFTNPDMLLECIKMAEQKKKPLLSGTTGPAATEMVFEDYIKSIPFLWTTNVSFGVNILAKLVQEAAKKLFDYDIEIWEMHHRYKKDSPSGTSLILGKAAAKGRNVPFQMAQYVRGTPQEARKDVNTIGYSVSRGGADLSDHRVMFVSDEEMIDFNHRTLNKNLYAKGALKAALWLVKQPPGVYTMSDMMAAVE		267		7	Crystallized	-1	 	NR-16295
Batch03	EhchA.00827.a	Ehrlichia chaffeensis	YP_507571.1	Q2GG62				response regulator PleD	Potential drug target		MTAKVLIVDDLPANIKLLQAKLMSEYYNVLTATNGMDAIKIAEEKHPDIILLDVMMPEMDGYETCKRLKSNPETTYIPIVMVTALDNTSDNRVSGLSYGADDFLTKPINDTALFARIRSLTRFKMVIDELRLRGKTNADMSLLHNNMMDYANKIDDASILIVDEDMIRSEHINNVLQKSFQQTVVSHNIDQALTLSNTQNYDLIIIDLEFSGDGLRLCSQLRNKIETRYTPILVLLDENEDPKLLSKAFDIGIHDYITNPIDSNELIARVNVQVKRKRYQDALRINVDNSMAMAITDPLTGCYNRRYFDMHFHNIVNESLQKDKNLSLMILDIDHFKEVNDTFGHTVGDELLQQFKKRVSDNIRITDLLARFGGEEFVVILPDTTITTAEQIATRILSVIEETPFKTSIGDINKTVSIGVVEVQQSDINNIKQLVDRADKCLYEAKNTGRNKVVTYLS		458		4	Soluble	-1	 	NR-16296
Batch03	EhchA.00831.a	Ehrlichia chaffeensis	YP_506926.1	Q2GI07				branched-chain alpha-keto acid dehydrogenase subunit E2	Potential drug target		MPIEVLMPALSPTMKSGTIRKWYKAEGDVVKSGDVIADIETDKAVMECEYTDEDGIMGKIFFAEGSKNIEVNQLIALIAVDEQDLAKVHSYEKGDNVVKNELVALQDSQPAQDESVVLQMNQQIVNASEVLVNSSNSSERVKVSPLAKKIASNLGVDVNLVKGTGPYGRIIKADILDVINQHGHIANSPEDASFTEISSMRRVIAERLVYSKQTIPHFYVSIDCLVDSLLKLRLEINAENPDTKVTVNDFIIKAVAMSIKKFPEINVSWSDDKIVVFPSIDISVAVSIDNGLITPIIFGADKKSLLEISREVKALASKAKSGKLKPEEFQGGGFTVSNLGMFGIKEFYAIVNPPQSCIMSVGCSEKRAMVVNEQICISNVVTVTLSVDHRVIDGVLAAKFLNCFKSYLEKPFLMLI		416		2	Cloned	-1	 	
Batch03	EhchA.00833.a	Ehrlichia chaffeensis	YP_507159.1	Q2GHC4				putative nitrogen regulation protein NtrX	Potential drug target		MSKERLYISEVLVVDDEVDIRNLIKDILSDDNYVTKLAVDGLSAIKMAYEKEPDVVLLDIWLKGSDIDGLSVLEKLKERYPYLPVIMISGHGNIATAVKSLHMGAYDYIEKPFTEGRLKLVVKRAIESGRLRRENDELKSTFEDYEIVGNSPVIKNLRSMINKAATTSSRILITGSPGVGKEVVARLIHKKSKGYDTPFISMYSSMLPANNYLVNIFGSEESSNILSHRVPPHIGIIEQANHGTLFIDEVTDLRYDTQLRLLRLLQEGKIYRENSKIPVSVDVRIIVSSSKDIENEVRAGKFCEDLYYRLNVLPIRVPSLVEYCTDIPELCRYFMSSICKKIGLCTHILSDEALIAMQSYEWPGNLRQLRNVIEWILIMKSPKEIITAKDLPVDIVSNSPINDVLSAKVISVPLRQAREEFERQYLKTQLSRFGGNVSKTAEFVGMERSALHRKLKVLGLCSISE		465		1	Selected	-1	 	
Batch03	EhchA.00849.a	Ehrlichia chaffeensis	YP_507898.1	Q2GF85				isocitrate dehydrogenase	Potential drug target		MSIPITVAYGDGIGPEIMEAVLLILSEAESGLVVETIEVGHNLYKKEWSSGIAPSSWDSIYRTKVLLKSPTMTPQGRGHKSLNVTLRKRLGLYANIRPCISYHPVIKTRYPNLNVVIVRENEEDTYTGIEHRLTNDTYQCSKVITRSGSERICDYAFHYAKVHNRKRVTCLIKDNIMKMTDGIFHKSFSKIAENYPDIESDHYIVDIGMAKVASNPENFDVIVTTNLYGDIVSDIVAELSGSIGLAGSANIGNNYAMFEAVHGSAPDIAGKNIANPSGLLNAAIQMLMYLKQFDKAQLIYNAFLKTLEDGIHTADIYQSQVSKKKVSTMDFAKAVVENFGQSPSQLPKSMFQDNVDRTGVSYTYEPSYVTRVLVGVDITIGCDGVGLDFKQLINNLQNITHDKLELVLIHNKGLEIWPDESVSVNLSYMDQVCCRFYMKSKDDKIMNEHINQLLFDIEQKKIDVVKMEKLYLYNDQPGFFTM		482		4	Soluble	-1	 	NR-16297
Batch03	EhchA.00865.a	Ehrlichia chaffeensis	YP_507793.1	Q2GFJ0				phosphoribosylamine--glycine ligase	Potential drug target		MNVLVIGSGGREHSMLHHIRKSTLLNKLFIAPGREGMSGLADIIDIDINSTIEVIQVCKKEKIELVVIGPETPLMNGLSDALTEEGILVFGPSKAAARLESSKGFTKELCMRYGIPTAKYGYFVDTNSAYKFIDKHKLPLVVKADGLAQGKGTVICHTHEEAYNAVDAMLVHHKFGEAGCAIIIEEFLEGKEISFFTLVDGSNPVILGVAQDYKTIGDNNKGPNTGGMGSYSKPNIITQEMEHIIIQKIIYPTIKAMFNMNIQFRGLLFAGIIIKKNEPKLLEYNVRFGDPETQSILPRLNSDFLKLLSLTAKGKLGNESVELSKKAALCVVVASRGYPGEYKKNSIINGIENIEKLPNVQLLHAGTRREGNNWVSDSGRVINVVAQGENLASAKHQAYAALDLLDWPDGIYRYDIGSCAL		421		17	In PDB	-1	 	NR-16298
Batch03	EhchA.00874.a	Ehrlichia chaffeensis	YP_507292.1	Q2GGZ1				GTP-binding protein Era	Potential drug target		MDHISKKCSMNAIVGTTNAGKSTLINMLVGQKVAAVTPKVQTTRVRMHAVLNNENVQLIFIDTPGIFSPKTKLEKFIVKHAWMSLKGIENVILLLDVKNYLNKHIEKIISRIKQSNINAILVVNKIDTVPTSSVDKAIEHMYSLHSFSKTFTISALHDIGLSRLVDYLCEISPNGPWLYPEDQISDAPLKFFMAEITREKLFLSLHHELPYSLSVVTEALEEKEDGSLVVKQVIYVTKDSHRTIILGKKGEMIKKISMESRSDLAKILDLKIHLFLFVKVREFWQNHLDECVGYVE		296		1	Selected	-1	 	
Batch03	EhchA.00899.a	Ehrlichia chaffeensis	YP_507143.1	Q2GHE0				guanylate kinase	Potential drug target		MNDSLKSRGIMLVISSPSGGGKTTISHLLINELQNDLVRSISVTTREPRDGEINGKDYFFVTEPEFINLCNTNQMLEYAKVFGNYYGIPRKFVTDNIANGVSVLFSIDWQGAFKLIDIMREHVVSIFILPPSMEELQRRLYNRSGESDVINKRLGEAAFEISHCYRYDYVIVNHDIEQSVYQIKCIFTSEKLKTQRRVSLKQFIDNCIR		209		3	Expressed	-1	 	NR-16299
Batch03	EhchA.00908.a	Ehrlichia chaffeensis	YP_507278.1	Q2GH05				adenylosuccinate synthetase	Potential drug target		MVNIVVVGLQWGDEGKGKVVDWLSTNADAVVRFQGGNNAGHTIVINDKVYKLNLLPSSVLQNNKLSIIGNGVVLDPYALVSEIDNLKSSGINITTQNLAISESCPLVLSVHKQADILFEQLRQDTIGTTNKGIGPCYADKISRRAIRVCDLLDTKDLLYSKVNHLLIYHNLLRKSLNTPPIKAEDIVNELLNIAPKILPFVQPVWKTIYNLTQQNKTIIFEGAQGTFLDIDHGTYPFVTSSNTIASQAWVGCGINPSNKSYILGLVKAYTTRVGNGPFFTEQNNDIGKIMFKTGKELGTVSNRKRRCGWFDAVLARQAIMLSGVSGLVMTKLDVLDQFSEIKICVKYKYGDKTYDYLPASPHIQSNLEPIYEILPGWQTSTFGSVSYKDLPQNAILYIKKIEEILKVPIHLISTGPERNSMIILNNDFLQ		430		3	Expressed	-1	 	NR-16300
Batch03	EhchA.00909.a	Ehrlichia chaffeensis	YP_506892.1	Q2GI41				phosphopantothenoylcysteine decarboxylase	Potential drug target		MKILLVISGSIAAYKSLDLIRKLQENNHTVTSIISKSGERFVTPLSVASLSGNSVYTDADLFHAHKSMHHISLTRSSDIVLVAPATLDIIAKTAHGIADELATTALIASNIPIIMVPAMNPAMWNSKANQRNIHCLKSDNVTIIEPKEGLAICNEYGTGKMAEVQEIVSFIENFHKTDKK		180		1	Selected	-1	 	
Batch03	EhchA.00923.a	Ehrlichia chaffeensis	YP_507901.1	Q2GF82				nucleoside diphosphate kinase	Potential drug target		MLEKTLSILKPDVIKRNITGQVNSYIENSGLKIIIQKMCLLTRCQAEEFYAIHKSQHFFVPLIDFMVSGPIIVQVLQGENAISLYREIMGATDPKKASPGTIRADFAENIDANCVHGSDSLDNAMREIRFFFSDYELLALNG		142		1	Selected	-1	 	
Batch03	EhchA.00925.a	Ehrlichia chaffeensis	YP_506925.2	Q2GI08				fructose-bisphosphate aldolase	Potential drug target		MLANNRIQDILGFYESENPGVKANLMRMLLHGKVAGSGKLLILPVDQGMEHGPTKSFSKNPQSYDPHYHFLLAIEGGFSAYAAPLGMLEAGASTYAGLIPLILKLNSSTLLSPKNSFPDQVVTSSVKDALRLGCSAIGITIYPGSHNFFSMVRETRELIAEAKAAGLAVVIWSYPRGNDISKQGETAVDIVAYAAHIAASLGANIIKVKLPTSNIERDSIPYDITSLKQRIEYIKLSCFSGRRLVVFSGGEAKTDEELLQEIQSIKLGGGDGSIIGRNSFQRPKNDAISMVGKIAKIYHN		300		4	Soluble	-1	 	NR-16476
Batch03	EhchA.00935.a	Ehrlichia chaffeensis	YP_507439.1	Q2GGJ4				cysteine desulfurase	Potential drug target		MEQEKRQINLPVFLDYQSTTKTDDRVLEAMMPYFKQFSNPHSRSHSFGWKAESAVELARERVASLINAEAKEVIFTSGATESNNLAIKGVANFYKNKGNHIITVRTEHKCVLDSCRYLETEGFHVTYLDVQKNGILDLELLKSSITDKTILVSVMMVNNEIGVIQPIEKIGKICHEHGIFFHTDAAQAFGKISIDVKKMNIDLLSISGHKIYAPMGIGALYIRKRQPRVRLTPMINGGGQERGMRSGTVPTPLAVGLGEAARIAQEVMEEENIRIRELRDILYNEIKKHLPYVVLNGDYEQRIAGNLNLSFPYVEGESIIMAINNLAVSSGSACTSASLEPSYVLRALNIEKDLEHSSIRFGIGRFTTREEILYAAELIVSSIKKLREMSPLWEMVQEGVDLNNIKWDAH		410		5	Purified	-1	 	NR-16477
Batch03	EhchA.00948.a	Ehrlichia chaffeensis	YP_507088.1	Q2GHJ5				ribosome recycling factor	Potential drug target		MISEVKQDAKSRMEKSLSVYLSDIDGIRTGRARTSVLNGIVVETYGGRVKLNTISSVSVSDNKTLMIKVWDSNNIGAIKTAIMNSNLGFGISCEATTIRLTVPDMTQDMRKNLVKLLGKISEDCRVSIRNIRRDIMDRLKVMQDSKEISEDDLRVAGVEIQKITDDIMKKVNDAFTSKEKELLHV		185		7	Crystallized	-1	 	NR-16478
Batch03	EhchA.00979.a	Ehrlichia chaffeensis	YP_507617.1	Q2GG16				delta-aminolevulinic acid dehydratase	Potential drug target		MQFPNTRLRRKRSNEWLRNLVRETSLSIHDLILPLFVHDRDGVSEPVKQLPDIKRYSIPELLKVVEHAANLGINAISLFPVVETHLKSENAEEAFNPNNLICRAIKEVKKHIPTIGIIADVALDPYTISGHDGIVINKQIDNDATLEVLYKQALVLAAAGCDIVAPSDMMDGRVKKIRSALDNCNFQDVCILSYSVKYCSSFYKPFREAVGSRSISQTIDKSTYQLDIANINEAILEAQMDIDESADIIMIKPGMPYLDVIKSISSRCQIPVFAYQVSGEYAMIKAASQNHLLDYDSVIYESLLGFKRAGAKSIITYAAIDAANILIKNKM		331		10	Diffraction	-1	 	NR-16479
Batch03	EhchA.00994.a	Ehrlichia chaffeensis	YP_507228.1	Q2GH55				50S ribosomal protein L4	Potential drug target		MEVNIINVNSDRIGTIDLNPLIFSVNYRPDILKMVVDWQLSKRRAGTHKAKTIGDISGTTAKPHRQKHTGRARQGSLRSPQFRGGAVIFGPVVRSHAYSLNKKVRNLGLKVALSLKNSCNKLLILDSIDVNFVKTTQVLQFIKNFEHKSFLIIDKDYNKSVVCSCRNLHNVTLLKQIGTNVLDILRHDCIILTVGAVKYLEERLL		205		-2	Work stopped	-2	Work stopped	NR-16480
Batch03	EhchA.01000.a	Ehrlichia chaffeensis	YP_506915.1	Q2GI18				"ABC transporter, ATP-binding protein"	Potential drug target		MNYISLSDLHIDFHGHQVLKGISLDIAYGESLVIVGESGSGKSVLTKTILGLIAPTSGKVIVSGVDIRHDKSLIKNFGVLFQNCALFDSLTVCENIAFNLHYRFNRDKQLSRKIAASGLNLVGLSSDVLDRYPIELSGGMKKRIALARAIVSEPKIMILDEPTSGLDPIMSDVVNEIIIKCHKEFNLTVITITHDINSAFKIASKIAVLYDGKIVACESVQDIKNIDNQYVRNFICRN		238		4	Soluble	-1	 	NR-16481
Batch03	EhchA.01012.a	Ehrlichia chaffeensis	YP_507609.1	Q2GG24				aspartyl/glutamyl-tRNA amidotransferase subunit B	Potential drug target		MTIIKGNRCDWEVVIGLEVHAQVISNSKLFSGASTKTYDALPNTQVALFDVAMPGMLPVLNEYCVYQAIKTGIALSCKINKYSAFDRKNYFYPDLPSGYQITQFYYPIATEGKIVLEDHDMKEIRIARIHLEQDAGKSIHEFDKTYIDFNRAGVALMEIVSEPDFRSIEEVAEYLKKLRMILRFIETCDGDMEKGSLRCDANVSVKPVGSSELGIRSEIKNLNSIRYVMQAIEYEANRQVNALENGEIVTQNTLLFDVTSGQTRVIRTKEDAHDYRYFPDPDLFPLKIDDQYIDHVRSSLPELPMQKRERYTNDFSLSKYDADILSSDKDVAIYFEKVAEKHDGKLAASWITGELFGRLNRLGITIGESSVTAEDLIQLLDLIVNNTISGKIAKQVFDMMFESGKSPALIVSEHGLKQVSDENALSVIVERVLKNNASKVVEYKQGKEKLFGYFVGQVMKETQGKANPDMVNSIIKQQLEN		481		3	Expressed	-1	 	NR-16482
Batch03	EhchA.01022.a	Ehrlichia chaffeensis	YP_506919.1	Q2GI14				"glutamine synthetase, type I"	Potential drug target		MFLSIEDTLNYIKKNAINFIDLRFTDSNGKWHHITRSAETINAQVLLAGVNFDSSSIPGWQSIEKSDMILLPDVSTAFMDPFSAQSTLVILCNIVDPYKQSQYSKDPRYIAQKAYKYMLSTGIADKCYFGPEVEFFIFDNAQFYAGMYNSYFKIDSAEHDILFQKREFSNNSHRPKVKGGYMPTPPIDSLHDIRSEMLTMFKEVGIIPLIHHHEVAASQCEVGFQHDELLLSADNVQKCKYIVHGVASSYGKTATFMPKPVIKDNGSGMHCHQSLWKDNVNIFVNPDGSISETCLYYIGGIIKYGKAINAFTNPSTNSYKRLVPHFEAPTWLTYSYENRSSAIRIPYVPKNDLNAKRIEARFPDPLANPYLCFSAQLMAGLYGIQNKIHPGPAIDKNLYSLDKEELQQFTSVASSLEEALDSLDNNREFLLVGDVFTNDQIDAYINLKMLEVKDLQLHPHPIEFINYYSS		470		1	Selected	-1	 	
Batch03	EhchA.01029.a	Ehrlichia chaffeensis	YP_507784.1	Q2GFJ9				ATP-dependent protease ATP-binding subunit	Potential drug target		MFVTPNNKLKLNNDTTNNINDEQASSEVLNSENAISTEGYEDDINLDDLYNPQELTPQQITQELDRFIIGQADAKRAVAIALRNRWRRNRVPEPLREEIIPKNILMIGHTGIGKTEIARRLAKLAKAPFIKVEATKFTEIGYVGRDVDSIIRDLVDVAINLEKEKSRKFVETKAKSLAENIILEALVGADASQETKTIFQEKLRNGEFENFEISISIKESKNAIPSIDIPNIPGNQVGIMNINEIVHKMLGNNKQLKTIKVTVKEARELLINEESEKLMDEDKIIKDALLLASNDGIVFLDEIDKIAARTEIRGEVNREGVQRDLLPLLEGTSVTTKYGTITTDHILFIASGAFHLAKPSDLLPELQGRLPIRVELKPLSKDDLVRILTEPESSLLKQYCALMKTENITIDFTDEGVSTIAEIASTVNREVENIGARRLHTILEKLMEDISYTATENSGRTYVIDSEYVKKKLEDIAKQLDLSKFIL		487		1	Selected	-1	 	
Batch03	EhchA.01036.a	Ehrlichia chaffeensis	YP_507232.1	Q2GH51				50S ribosomal protein L22	Potential drug target		MIVAKGMGLKSTPSKLNLVADLIRGKDVSVAMMYLKFCRKKSAGYISKVLKSAVANAQANYNIDLDNLYVKEVLVGKSFSLRRIHARARGKACRVYKHYGNVIIKLFERI		110		-2	Work stopped	-2	Work stopped	NR-16483
Batch03	EhchA.01043.a	Ehrlichia chaffeensis	YP_506977.1	Q2GHV6				pyruvate dehydrogenase subunit beta	Potential drug target		MRTLTVREALCEAIREEMERDHTVLIMGEEVGEYQGAYKVTQGLLEQFGPDRVIDTPITEHGFAGIGVGAAFAGLKPIVEFMTFNFAMQAIDQIINSAAKTSYMSGGQLNCPIVFRGPNGAAARVGAQHSQCYASWYAHIPGLKVVSPYFAADCKGLLKAAIRDLNPVVFLENEIAYGHKHEIPNEVSTSDYITEIGKAAIVKEGTDITITAFSLQVKFALEAAELLAKEGINAEVIDLRTLRPLDTETILRSIKKTNKIISIEEGWPYSGIGSEIAALIMEYAFDDLDAPMIRITGKDVPLPYATNLEKLALPQIEDILEAARALCIRNYR		332		5	Purified	-1	 	NR-16484
Batch03	EhchA.01053.a	Ehrlichia chaffeensis	YP_506992.1	Q2GHU1				tryptophanyl-tRNA synthetase	Potential drug target		MSIPIVLSGIQPSGGIHLGNYLGSIRNWVSLQSSYKCFFFLADLHTLTSNNYNSAELKQNSINTLATYLACGIDPNKSVLFVQSSIHAHAELLWIFSCITSTGQLNRMTQFKEKSRNKVSTACLGLYSYPVLMAADILIYKANIVPVGIDQKQHLELTRDIAMNFNSTYNTQYFQIPEPLIMQESAKIMNLRNGKKKMSKSDSSDYTRINLYDSNDVISKKISKATTDSIVGFNFSTLDSRPEVKNLVSIYATLLNINIEQACTNIENFSTKQFKEQLTELLIDNIAPIRHKVTEFLEDKEHLHNIIVSGNNKAASIANKHILEIKEIIGCWS		333		1	Selected	-1	 	
Batch03	EhchA.01061.a	Ehrlichia chaffeensis	YP_506847.1	Q2GI86				isoprenoid biosynthesis protein with amidotransferase-like domain	Potential drug target		MALNSAVILAGCGHMDGSEIREAVLVMLELDRHNVNFKCFAPNKNQKQVVDHKKKESVGEVRNILVESARIARGSVYDIEQIRVEEFDMLVIPGGYGVAKNFSNLFDEDKENDYILPEFKNAVREFYNAKKPIGAVCISPAVVVALLKDIAKVKVTIGEDSNGLIDKMGGVHVDCPTIKSVKDDVNRIFSCSAYMRNDSLYNVYLGIQDMISSMVNYLKSK		221		17	In PDB	-1	 	NR-16485
Batch03	EhchA.01072.a	Ehrlichia chaffeensis	YP_507223.1	Q2GH60				cytidylate kinase	Potential drug target		MTKHCNNFVITIDGPSASGKGSLAKKLANFLNFQYLDTGKLYRIIATIFGTSAQNHLKIDNKLEDKILSLLLEDNNTIYNNEDIGKTASILARYQHIRLALLPIQRKLIHLAEPGIILDGRDTSSTVFPEADLKIFITAQASIRAQRRFKEMLYHKKEMYKKIHKQILERDIRDTYRKFSPLVKVKDALYINTSYMNKEQVLLYIKEKIKTYL		213		3	Expressed	-1	 	NR-16486
Batch03	EhchA.01074.a	Ehrlichia chaffeensis	YP_506859.1	Q2GI74				nicotinate-nucleotide pyrophosphorylase	Potential drug target		MKISFSEIIHNALKEDLGDKGDITTNSILINEKVNFAINTRENLVVCGIPILEEVFNMNKEHVKYEIHKKDGDITGKNSTLVSGEALAIYLLPIERVILNFIQHASGIASITRQFVDEVSGTKVKIRSTRKTTPGLRMLDKYSVCIGGGESYRDNLCDGVLIKDNHIASCGSITLAIQRLRKNLKNEYIAIECDNISQVEESLSNNVDMILLDNMSISEIKKAVDIVNGKSVLEVSGCVNIRNVRNIALTGVDYISIGCITNSFQNKDIGLDIEYNNNK		279		17	In PDB	-1	 	NR-16487
Batch03	EhchA.01108.a	Ehrlichia chaffeensis	YP_507262.1	Q2GH21				"phosphate ABC transporter, ATP-binding protein"	Potential drug target		MSQRIHASARNLSLWYDTNQILYDINLDVYKREVTAFIGPSGCGKSTFLRCFNRMNDFISNCKIKGSLNVDDIGVYSVNTNVVLLRAKVGMVFQKPNPFPKSIYDNVAYGPKLHGLAKNKKKLDEIVEKSLTSVGLWEELCDRLKDNAFELSGGQQQRLCIARAIAVRPTMLLMDEPCSALDPVATNVIENLIQNLKKNFTIIVVTHSMKQAKKISDRVAVFDSGRIVEYNTTQEIFQNPQSSKTQRYIVDQL		253		3	Expressed	-1	 	NR-16488
Batch03	EhchA.01114.a	Ehrlichia chaffeensis	YP_507804.1	Q2GFH9				30S ribosomal protein S9	Potential drug target		MEKSPDMLSDHQQDDHIKAVKVDARGRAYGTGRRKEAVARVWLTVGKGNVTVNGLDIFNYFKKNTLCRKVYNPFIVTSTSGCYNVVATVSGGGISGQAGAVAHGISKALKDINPSLHPILRSGGFLTRDSRVVERKKYGQHKARKSCQFSKR		152		-2	Work stopped	-2	Work stopped	NR-16489
Batch03	EhchA.01131.a	Ehrlichia chaffeensis	YP_507810.1	Q2GFH3				ribose-phosphate pyrophosphokinase	Potential drug target		MLISSGTSSINLAKCISNITSIKLVNSCISRFSDQELNVEIQENQDDKNKHVIIINSLCSPAHDNLLELLLLTDAINRTLHPRKITMIIPYLCYTRQDRVMYRNLDDNSLMVSALSAKVIINILRTANINNIIFIDLHSNQLSGFFDIATTNLSSHTVFIGDIIEKHNTNNLVVVSPDYGALNRTRTFANVLSKQCKLHNEIQVAVIDKYRAKPGVSEVMNITGNVENKDCIIVDDIVDSAGTLCNAASALKDRGALQVSAYVTHGILSGNAVEKVTNSKLDNLIITDTIHNGFFNTSKIRILSIDKFLSNYILYNLV		318		4	Soluble	-1	 	NR-16490
Batch03	EhchA.01133.a	Ehrlichia chaffeensis	YP_507849.1	Q2GFD4				methionine aminopeptidase	Potential drug target		MGNLGRSITIHSKEDFKYMHNAGRLAAEVLDFITPYVKPGVSSNELNDLCHDFIINAGAIPAPLGYRGYPKSICTSKNFVVCHGIPDDLPLKEGDIVNIDVTVILDGWHGDTSRMYWVGEPSIKAKRLCEAAYRALTVAIEQVIPGQKLNQIGLAIEKEMKKYGYSIVRDYCGHGLGRVFHASPNVVHYYDPDDPVIIREGMFFTIEPMINAGRCDTVLSKKDGWTVTTRDLSLSAQFEHSLGVTENGVEIFTLSPQNMHYPPYVC		266		4	Soluble	-1	 	NR-16491
Batch03	EhchA.01142.a	Ehrlichia chaffeensis	YP_507227.1	Q2GH56				50S ribosomal protein L3	Potential drug target		MAKRIGLFLEKVGHTAIFDNEGKRIPITLLHLRDSFIISKKTKDIHGYDAVVLGVEASINLKKPQSKILEKSKITAKCKIFESRVDNLGDVVEGAKVSITHFVKDQYVDITGYSLGKGFAGVMKRHNFKGLKASHGVSIAHRSQGSTGQCQDPGRVYKGKKMAGQLGNSKVTVQNLKVILVDQERSLLGVRGNNIPGAKGSYVFVKDAVKKSVPKGSFPICAEDLKLDNVV		231		-2	Work stopped	-2	Work stopped	NR-16492
Batch03	EhchA.01144.a	Ehrlichia chaffeensis	YP_507444.1	Q2GGI9				iron-sulfur cluster binding protein	Potential drug target		MPLITFISPDGSRKTYEAYDGETLLSLAHRNNVDLEGACEGSLACSTCHVIIDPSWYDIVEQHNEISDEENDMLDLAFGLTDTSRLGCQIILTKELDGLCVILPTETRNISFVKNS		116		5	Purified	-1	 	NR-16493
Batch03	EhchA.01153.a	Ehrlichia chaffeensis	YP_507895.1	Q2GF88				signal recognition particle-docking protein FtsY	Potential drug target		MTDATNKGFFSNIKKGLFKTSSKLSDGIKKIFSSGKKVDQETLEELKELLITADVGYDNASLLTQKLASTKFNEMDDNTVKQKLAESIENILLQVEKPLSINNKPHVIMVCGTNGNGKTTTIGKLAHRFKNTGKKVLVAACDTFRAAATEQLIVWSQKVNFPVVTGNQGADAASIAYQAMQQALNEQTDVLLIDTAGRLHNHKNLMEELAKIRRIINKHDNNAPHDVILILDATTGQNAVNQVDAFLQFVNISGLIITKLDGTAKGGVVIRIAQKYKLNIHAIGIGESVEQLQDFSAKEFAAGLLDINTI		310		1	Selected	-1	 	
Batch03	EhchA.01175.a	Ehrlichia chaffeensis	YP_507460.1	Q2GGH3				GTP cyclohydrolase I	Potential drug target		MRNGKPSDSEAEEAVNLLIRWIGDDPNREGLVNTAKRVLDVYKRFFSGYQVDIYSMQDLVLLNENYNDMVIFKNTEFTSYCEHHIVPMRGKISIGYVPDKLVFGVGKIVKLINCFTKRLQLQEKLTVEIANALDHCLAPKGIIVAVEAVHDCIVCCEEEDKHNLELQTTCAIGVFQDNMELRREFFSSIG		190		4	Soluble	-1	 	NR-16494
Batch03	EhchA.01179.a	Ehrlichia chaffeensis	YP_506894.1	Q2GI39				"putative NADH-ubiquinone oxidoreductase, homolog"	Potential drug target		MSIKRVVMFGGSGFIGRYLVKYFAENGYVIRIVTRYPEKAKQLKLCGNLGQVEVISGNVANSEEVIEHIRDCNIVINLLGVLYSAKKSTFYDIHAKAAENIAKAAKRCKVKLMIHFSAMGITETQKSDYAKSKLIGENLVKSAFPDAVIIRPNLVFGPEDKFFNKFAQLSMIFPFLPVIGGGRAVFQPIYVDDLAKFVFSIVENSITDKLYNVCGPCTYSFKELLSFILNVTNRKSKLINISFGVTNILAFFCELRIISIFLKLITGTTDPILTRDQVKFIKDMTESHDIYPMNELKEIGVKLSTIENIVPKYLKIYKSF		320		1	Selected	-1	 	
Batch03	EhchA.01190.a	Ehrlichia chaffeensis	YP_507152.1	Q2GHD1				"HAD-superfamily hydrolase, subfamily IA, variant 1"	Potential drug target		MKQPTAVIFDWYNTLIDTSINIDRTTFYQVLDQMGYKNIDLDSIPNSTIPKYLITLLGKRWKEATILYENSLEKSQKSDNFMLNDGAIELLDTLKENNITMAIVSNKNGERLRSEIHHKNLTHYFDSIIGSGDTGTIKPSPEPVLAALTNINIEPSKEVFFIGDSISDIQSAIEAGCLPIKYGSTNIIKDILSFKNFYDIRNFICQLINI		210		17	In PDB	-1	 	NR-16495
Batch03	EhchA.01198.a	Ehrlichia chaffeensis	YP_507032.1	Q2GHQ1				glutamyl-tRNA synthetase	Potential drug target		MITRFAPSPTGYLHVGNVRTALVCWLYARKQNGKFLLRFDDTDTQRSKDEYIREIENDLVWLNINWDSSFRQSSRFDRYEDVFNYLLKEGLIYPCYESKEELEFKRKMKLKLGLPPIYDRSALNLTQAEKDKYSERAPYFRFKIDQNQLISWNDEVRGKVSFNSENISDPIIRRVDGTYTYMLPSIIDDMDFNVTHIIRGEDHISNTAVQIQMLHALKASIPIFSHLSLLYSDDNKISKRVGGSSVKDMQSYGLEPMAINSYFAKIGTSNPVSVHTRMCGLIDSFDITTFSQAPTKFNIDDVLKLNPKVLCSMSFDDVRNRLQSFNITSPSFWNFVCGNIDKFSDIEGWAKICSGDMIPVIGQDDKDFIMLALNMLPQGEVRDNTWNLWISNIKQHTDRRAKNLFTPLRLALTGLSTGPELAKLLPLIGRVEIVRRLSYSEVQ		443		1	Selected	-1	 	
Batch03	EhchA.01201.a	Ehrlichia chaffeensis	YP_506999.1	Q2GHT4				"ABC transporter, ATP-binding protein"	Potential drug target		MSTVFALANIYKSFGRNKEVPVIVNATLQIKKGEIVALIGKSGSGKSTLLHIAGLLDTPSSGSILLNNIECTDKTSDKDKTYLRRHFLGFIYQFHHLLQEFSVLENVMLPQIITGKSKSIAKKNAMEILERVRLQDKLSMPISQLSGGERQRVAIARSLINCPLIVLADEPTGSLDNNTALEVFSLLQEYAKEKNIAILLATHNYSLAQKACRIVKIDSGILRSYSIDESGFNKI		235		2	Cloned	-1	 	
Batch03	EhchA.01203.a	Ehrlichia chaffeensis	YP_507566.1	Q2GG67				cysteinyl-tRNA synthetase	Potential drug target		MIIYNTLTGIKEPFVPFSIDNVRVYVCGPTVYDFAHIGNARSVVIYDVLFRLLKLLYPKVTYVRNITDIDDKIINVAQNTNQSIYDVTAIYIKAFHEDMRMLNCLEPTYEPRATDNIDVIISLIQKLVDSGHAYVYNGSVFFNIESYSSYGQLSGRNISQLIYGSRIDIEVGKKHPGDFVLWKPATEIDNQLMSCWSSPWGLGRPGWHIECSAMSYRYLKENFDIHGGGADLQFPHHENEIAQSCCAFPDSRYAKYWVHNGFLTVNDEKMSKSLGNVLTVRQLLNSGITGELIRYVLLSTHYRKPLDWNSQMVASAQESLNRMYTALSSTNVDLSLDDSVELSSHVIDCLKDDINTPKAISMLHEMVTEINKTADMIEKISLTKTLIKTANFLGILQHSWQDWFKIDDNNQEISQLIDERKKARANNDFKRADDIRQLLLNRGIVLSDNKDGTTHWYKK		459		1	Selected	-1	 	
Batch03	EhchA.01229.a	Ehrlichia chaffeensis	YP_507590.1	Q2GG43				orotidine 5'-phosphate decarboxylase	Potential drug target		MFTNPIICALDTHDINHALLLTKMLYGRVSMVKLGLEFFTAYGLSGVQAIADCGVPIFLDLKLHDIPNTVSKAISVIASLNVAMLTIHVSGGREMMIRAMDSISGSVTKLVGVTVLTSMDDSDLKEIGVNESPVQQVMLLSKLAREVGLYGIVCSAFEAKEVRNRYTEKDLKLIVPGIRFDSDCNDQKRVKSPKDAMLAGANYLVIGRPITMSSDPVQTVEDILLSISKCI		231		10	Diffraction	-1	 	NR-16496
Batch03	EhchA.01233.a	Ehrlichia chaffeensis	YP_507552.1	Q2GG81				O-methyltransferase	Potential drug target		MRNKILSKKSQYIHDLFSITDTDVVATHQLIEDDISLMQLSLMEGQILQLLIKMNNIKSIIEIGTFVGSSAICMVKALPKDGHIYTIEKNTTNAKLAEDNFKKYNLSNNITVINDTGISALNKLTNMSPFDMIFIDANKSGYCDYLDWAELNIKKSGLIVADNTLLFGTVYSNDNVNKKVSKATINKMLSFNKRLSDKNKYLTTLLPTEEGMTIALKLF		219		7	Crystallized	-1	 	NR-16497
Batch03	EhchA.01239.a	Ehrlichia chaffeensis	YP_507194.1	Q2GH89				DNA / pantothenate metabolism flavoprotein family protein	Potential drug target		MVNVLITAGPTQEAIDPIRYISNNASGKQGYAIAEYMNKIGWKVNLVSGPVTIHNHNIQNILHVKNCNEMLQTCIELLPVDIAIFTAAVTDWCPTYSVRKIKKHEITNIKVTNNPDIIHCISTHEKRPKLVIGFSLESENVIENAKIKLKRKQCDWIISNTTTINNEHVMGNDYNKITIITKDHYKEFPIMSKKEIGQLITEEIINFLAKINNTKS		216		5	Purified	-1	 	NR-16498
Batch03	EhchA.01240.a	Ehrlichia chaffeensis	YP_507688.1	Q2GFU5				thiamine-phosphate pyrophosphorylase	Potential drug target		MQKDALIIARASANQSVEDASFLDERYFPIITLNKDYYFDKNFHPMLDPVGFYQIVPDLFWLKYVINLGVKVVQLRIKNEPIEEVEYKIKEGVHIANQNGVKLFVNDYWQFAVKYKAYGVHLGQEDLRSANFNEIYNAGLRLGISTHCYHELAIAKYIRPSYIAFGPIFPTTLKNMNFMPQGTDLLNYWVKNLPYKIVAIGGINLSNVDSVIGTGVDGIAVISAVLNSEYPDKVVHEFIQKCQI		244		3	Expressed	-1	 	NR-16499
Batch03	EhchA.01243.a	Ehrlichia chaffeensis	YP_507639.1	Q2GFZ4				recombination protein RecR	Potential drug target		MDINKLIAMFAKLPSFGPSSSRRIVLHLLRNKEEIMLPLASGIQDLAFQAKECPVCFNIDVKSPCSICSDTKRDHQLLCIVEELGDLWAFEKGKIYQGVYHVLGGTLSAIYGIGPDQLNLDSIVERIKKFNVQEVIIGIGNTMDGQVTTHYITQMVKELGIKVTRLACGIPMGGEIDYLDEGTLSAALSSRYIIS		195		10	Diffraction	-1	 	NR-16500
Batch03	EhchA.01247.a	Ehrlichia chaffeensis	YP_507604.1	Q2GG29				nicotinate (nicotinamide) nucleotide adenylyltransferase	Potential drug target		MRKKLTVGLLGGSFNPPHYGHLYISQEAIKRLGIDRVWWLVVPCNPLKFDGGYSIEDRVSLSQQLVYSDIRVNIVRVKECYSYNVVSRLCKEFSNVKFVWLMGDDNLFSFHYWYRWKDFCKLLPIVVFERGKNVCQALNTPFATYMRNVYFTNCKLLLNCRYGWMFVRLRPCNISSSQIRGYALNKI		187		2	Cloned	-1	 	NR-16501
Batch03	EhchA.01248.a	Ehrlichia chaffeensis	YP_507301.1	Q2GGY2				diaminopimelate decarboxylase	Potential drug target		MIFLANPFFHYKNNILSIENVNVLDIAKNVGTPVYCYSLNAIKNNYRQFQENLPNNSIVCYAVKSNSNLSILSLLNSLGAGADVVSEGEIRRAIAAGISPNKIVFSGVGKTEQEINFALDNRILQFNVESIEELSLINTIACQKNIIAPVSIRINPNINADTNDKITTGLKVNKFGIPEELLDQIFNKDFTWIKIIGISVHIGSQISNLHIFQNTIDKIKKIIKIFKQHNTQIIRVDLGGGLGIPYKSSDTFPTIQEYANLLKKNFENENYQIICEPGRALVGNTGILLTKVLYRKYNQEKSHIILDAGMNDLIRPALYNAEHTIIPAISSTSTQLQPCDIVGPICESDDTFAHNYHIHNLQNGEIVAICTAGAYGSSMSSNYNSRLLIPEVMVNNSSYDIIRSRQTYEDMLKDEIILEF		420		5	Purified	-1	 	NR-16502
Batch03	EhchA.01256.a	Ehrlichia chaffeensis	YP_506873.1	Q2GI60				type IV secretion system protein VirB11	Potential drug target		MTTSYAALDTYLEPLQSIFHEDGVNEVSINQECEVWIENRGNIRCESIPTLNLSHLKALGRLIAQATEQKISEENPLLSATLPNGYRIQIVFPPACEATTVVMSIRKPSAMQLSLDDYEKMGAFNQAVTETQENNTDNQLKELLKQKKIKQFLEHAIINKKNIIISGGTSTGKTTFTNAALRSIPQNERLITVEDAREIVLSNHPNRVHLIASKGGQGRAKVSTQDLIEACLRLRPDRIIVGELRGSEAFSFLRAINTGHPGSISTLHADTPMMALEQLKLMVMQAGLGIPPDQIINYITNIVDIVIQLKRGSEGKRYVSEILFTKSLQKNG		332		3	Expressed	-1	 	NR-16503
Batch03	EhchA.01282.a	Ehrlichia chaffeensis	YP_507318.1	Q2GGW5				carbamoyl phosphate synthase small subunit	Potential drug target		MSQLTSYYNSILVLSDGKHFFGKSIGKKISTVGEVCFTTSMTGYQHTITDPSFAGQIITFTFPHIGNVGINYKDFEDRKILTHGIIVKTISEDSHSSSYSNLELWMIENNLTGISEIDTRALTCHLRQHGSQNGIIYHFDNINSINLAKLQKKASQYNYRDHCSSISFVNNYNSTDDDTLLYNIVVINFGIKLSILDALSKLRCKIHMISGNEDNLSEKVLFIKPQGIVLSNGPGDPSAIPENIIKQIKTIIESKIPILGICLGHQLISLALGAKIIKMLFGHRGSNHPVYNKINNNIEITSQNHGFTVKEDSLPTNVQVTHRSLFDNTIEGIQVNDYPIISVQYHPEGSPGPNDASYIFNHFINLIREND		371		1	Selected	-1	 	
Batch03	EhchA.01287.a	Ehrlichia chaffeensis	YP_507406.1	Q2GGM7				GTPase EngB	Potential drug target		MKLKTIMSKCEFMIGATHIKSLPDFSIPEIAIAGRSNVGKSSLINAITNNKKNAKTSSKPGCTKQINFYLINKDFMVLVDLPGYGYSKADKTTINNYLCLMEYYLLNSRNLLKVILLIDAKVGFKEIDLDFINWLELHQIHYQLVLTKIDKIKKEMLDVNVNYIKNLNLDFIMYPIISTSSQCKQGIEELIYEIAQCIKK		200		5	Purified	-1	 	NR-16504
Batch03	EhchA.01289.a	Ehrlichia chaffeensis	YP_507116.1	Q2GHG7				putative heme exporter protein CcmA	Potential drug target		MLECTDLACIRNNRYLFSQLNFSTQQNLLTLVIGNNGSGKTSLLRLFAGLVPITHGNIKYNGKNIHDSNTYFTSLTYIGHKNFCNDNFTVLENIQLWANLKNTHELIAATICFFKLQPILDIKYKDLSSGWKRRVALSRLLIYNTNIWIIDEPFAHLDINTKELILELIFTRLKQKDSIVIISDHSEVKTYGECQVINLEAFKNQQSNSLQHDLYLY		217		4	Soluble	-1	 	NR-16505
Batch03	EhchA.01310.a	Ehrlichia chaffeensis	YP_507132.1	Q2GHF1				serine hydroxymethyltransferase	Potential drug target		MVGYILDDDLQEVDAEVFNCISGELNRQNSGLQLIASENFVSKAVLQAQGSIFTNKYAEGYPGKRYYCGCHFADIVENLAIERLCRLFGCKFANVQPHSGSQANQGVFAALLKPGDTVIGMSLDCGGHLTHGSAPSISGKWFNAVQYQVDRDTGLIDMDEIEKLAVEHNPSLIIAGSSSYPRVIDFKRFREIADKVGAYLLADIAHYAGLIAAGEFPSPVEYAHVITSTTHKTLRGPRGAVIMTNYEDIHKKIQSSIFPGMQGGPLMHVIAAKAVAFAEALKPEFKDYAKQIIKNSKALGEVFKERGLDLVTGGTDSHMVVLDLRSKSVTGKDAVLALEKLGIICNKNAIPFDPEKPFVTSGLRFGSAAETSRGLQESEFREIGSMVCDVIDSLKASDSVRLSVERDIIKRVKELTSNFI		420		5	Purified	-1	 	NR-16506
Batch03	EhchA.01313.a	Ehrlichia chaffeensis	YP_507539.1	Q2GG94				pantetheine-phosphate adenylyltransferase	Potential drug target		MKIGIYPGTFDPITFGHIDIIKRAYNLVDKLVIGVARSCTKKTIFSAEVRAELIQHEIKLLGMAVNTVIFDGLLVYFAKENNASVIIRGLRAVSDFDYEFQMSWVNYKLTSQIETIFLPASEDTQFISSSFVKEIARLNGDVSVFVPVNVQECLKNFYQKSNVNG		165		4	Soluble	-1	 	NR-16507
Batch03	EhchA.01316.a	Ehrlichia chaffeensis	YP_507767.1	Q2GFL6				"succinyl-CoA synthetase, alpha subunit"	Potential drug target		MSVLVNSNTKVICQGFTGAHGTFHSEQAIAYGTNMVGGVTPGKGGTYHLNLPVFNTVKQAKLEAKANATVIYVPAPYAADAILEAIEAEIELIVCITEGIPTLDMVQVKHALLNSSSTLIGPNCPGIITPEECKIGIMPGYIHKRGHIGIVSRSGTLTYEAVAQTTEVGLGQSTCIGIGGDPIHGMSFTDCIRLFINDPDTHGIIMIGEIGGSEEEEAAEFIKLSGTNKPVVGFIAGKTAPPGKRMGHAGAISSGTSGSAESKIEAMKNAGIIIAETPAVIGKTMLEAMNNKR		293		3	Expressed	-1	 	NR-16508
Batch03	EhchA.01317.a	Ehrlichia chaffeensis	YP_507695.1	Q2GFT8				"ATP-dependent Clp protease, proteolytic subunit ClpP"	Potential drug target		MTLVPMVVEQTSRGERAYDIYSRLLKERIIFITGPIEDQMASLIVAQLIFLESENPEKEICMYINSPGGVVTAGLSIYDTMQYIKPKVSTLCLGQAASMGSLLLAAGEPGMRYALPNSRIMIHQPSGGFQGQATDIEIHAKEILDIKGRLNDIYVKHTGRDLSEVVANMERDNFMRAEKAKDFGIIDKVIEKRLDIGVE		199		4	Soluble	-1	 	NR-16509
Batch03	EhchA.01321.a	Ehrlichia chaffeensis	YP_507586.1	Q2GG47				"NADH dehydrogenase I, C subunit"	Potential drug target		MSDSNNAIDNISTYINTSINVECVIKDNITLELHSDVQNIYNHISFLRTDTKCKFHILVDIFAIDYPTRLARFEVIYSLLSIINNIRVSCKVPLQENESIPSITNIFSAAGWFEREVFDMYGIIFANNPDLRRILTDYGFSGHPMLKDFPLTGYKEVRYDISKKEVAYENVNLQQDFRSFDFLSPWKELKNE		192		3	Expressed	-1	 	NR-16510
Batch03	EhchA.01329.a	Ehrlichia chaffeensis	YP_507226.1	Q2GH57				30S ribosomal protein S10	Potential drug target		MVTQKIYIELKAFDSCLLDRSARSIILTAKRSGARVNGPIFFPRKIMKFIVNRSTHVDKKSREQFEIRTHKRLISLPKANSTIIQALMSLQLPAGVDVKVKVIGGSNG		108		-2	Work stopped	-2	Work stopped	NR-16511
Batch03	EhchA.01330.a	Ehrlichia chaffeensis	YP_507138.1	Q2GHE5				FAD-dependent thymidylate synthase	Potential drug target		MIDYMGSDESIVQAARISYGRGTKSVSQDAALINYLMRHSHTTPFEMCEIKFHIKLPIFVARQWVRHRTANVNEYSARYSVLDHEFYIPEHSQVAMQSEDNAQGRGNNLSDEDAKYVADLLTRDSDMVYETYNKFLEKGVSREIARVNLTLNYYTEWYWKIDLHNLLHFLKLRSEMNAQYEIRVYAETMLDIVKKWVPLTYAAFVEYCLKSQNFSRSALDVVKKLIVGEKVVQEDTNIGKREWRELMAILKPE		253		3	Expressed	-1	 	NR-16512
Batch03	EhchA.01332.a	Ehrlichia chaffeensis	YP_507431.1	Q2GGK2				aspartate carbamoyltransferase catalytic subunit	Potential drug target		MKTLLEVSNLTSDDIESIFNLTIQYFNNTNLNHNILTGKVIVNLFFESSTRTLSSFEIAEKSLGAHSITLNINTSSINKGESIIDTISNIDAMNPDLIIIRSQYSQFIKKISEYLPSCSIINAGDGHHEHPTQALTDYCTIRYIKKDINNLNISICGDILHSRVARSNIRLLSRYGANISLVAPPTLSCNLTGISHIYHNLIEGIRNADVIMLLRLQKERIINCVIPSEQEYSHLYMLNHEKLLHAKKDVIVMHPGPTNKGIEISNNVAEKNSVILLQVKMGVAARKAILHYLLYNKSI		299		3	Expressed	-1	 	NR-16513
Batch03	EhchA.01333.a	Ehrlichia chaffeensis	YP_507405.1	Q2GGM8				acetylglutamate kinase	Potential drug target		MKLHNVLKNNNKEDVVSNIEQFGGNADWFNAARVLSESLPYIQQFSGETFIIKYGGAAMKDRKLAENFAHDIVLLKQLGINPIVVHGGGSKINEFLEKINKKSTFVNGLRVTDAETLEIVEMVLCGLVNKDITQLINKAGGNAIGLCGKDANLIEAKKVCYTYKENQSNNVEKILDMGFVGEPHEVNTDLLFFMEESDFIPVIAPVCSGENDLTYNVNADLVAGALANALAAAKLIILTNVPGVTDVNGNLLSEISVSNAESLIEQGIANAGMIPKLQTCIKVVKEGYGSAHIIDGRIPHVLLLELFTIHGTGTMVLNTDI		321		5	Purified	-1	 	NR-16514
Batch03	EhchA.01342.a	Ehrlichia chaffeensis	YP_507433.1	Q2GGK0				"holo-(acyl-carrier protein) synthase, truncation"	Potential drug target		MILGIGADIVYVPRISNLWKKFGTKFLKRVFSEKEIEDSKKYTNFDAQVRHFAKRFAAKEAYVKAVGTGFGKSIKMPDIYYC		82		1	Selected	-1	 	
Batch03	EhchA.01342.b	Ehrlichia chaffeensis	YP_507542.1	Q2GG91				holo-(acyl-carrier-protein) synthase	Potential drug target		MILGIGTDIVYVPRISNLWKKFGTKFLKRVFSEKEIEDSKKYTNFDAQVRHFAKRFAAKEAYVKAVGTGFGKSIKMPDIIVSNNLHGKPQITINNSNIKYKIELSISDEKDYAIAFVVLYTEL		123		4	Soluble	-1	 	NR-16515
Batch03	EhchA.01354.a	Ehrlichia chaffeensis	YP_506863.1	Q2GI70				uroporphyrinogen decarboxylase	Potential drug target		MLKTITSRAKQKEIPVWFMRQAGRYLPEYRKVAEEAGSFLELCYTPELVKEVTLQPVRRFGLDAAIIFSDILVIPDALGCKVEFTKEKGPELQLISNHSEISVPEEAALDHLKNVFRGIKEVRKSLQRDKPLIGFAGAPWTIASYMIGRDKNFSKIREMCYSQTKNLEKIVEKITKVTTLYLIKQIESGVDIIQIFDSNAGIVPAGEFKKWIIDPTKEIVSSIRKLYPEFPIIGFPKGAGVMYKQFSEETEVSVTSVDYNTPMSWAKSNIPSVLQGNIDPYLVAYDKSKAISQTKELINIMKDKPFIFNLGHGVIPSTPIANIAALVDTIKSVV		334		2	Cloned	-1	 	NR-16516
Batch03	EhchA.01355.a	Ehrlichia chaffeensis	YP_506921.1	Q2GI12				5-aminolevulinate synthase	Potential drug target		MIDYEEIFCSKIKRIKDEGRYREFTGFSRIPGQFPYAIECDVNNVVTLWCSNDYLGMGQNEHMILAIKNYSSSVGAGGTRNISGTTKEIIELEKSLADLHKKPAALTFVCGYIANQTTISTVLSVIPDIVVFSDEKNHSSMIEGIRSTNRAKHIFRHNDLNHLETLLKSVDISVPKIIIFESLYSMDGDIAPIAKICDLADKYNAITYLDEVHAVGMYGSRGGGISEQENISDRVTIIQGTLSKAFGVMGGYITGSKNVVDVVRSFAPGFIFTTALSPLIASSARISVEHLKNSSIEREKQREVVNKVKESFSKAGIDFVKTDTHIIPVIIGDSVACTEISRVLLKEYRIYIQSINYPTVPVGTERLRITPTPYHTDEMIDKLTQALVDVLCRFKIMNKQN		401		5	Purified	-1	 	NR-16517
Batch03	EhchA.01357.a	Ehrlichia chaffeensis	YP_507386.1	Q2GGP7				putative translaldolase	Potential drug target		MKIFLDTIDIDFLKEFSVTGLIDGITTNPLLLSKSNLECYDLIVKICSLITGPVSIEVISTSYKDMIKEGLEISRIAGNVVVKLPLTYDGLIACKVLSCEHNVKVNVTLCFSVSQAILAAKAGAYFISPFVGRIDDIGQPGMQLIKDIRDVYSNYNAFNTEILVASVRNITHVIQSAKIGADIVTIPPSIFKQMFMHPLTNKGLEDFLQNWNASGKKIFS		220		3	Expressed	-1	 	NR-16518
Batch03	EhchA.01362.a	Ehrlichia chaffeensis	YP_507316.1	Q2GGW7				deoxyuridine 5'triphosphate nucleotidohydrolase	Potential drug target		MEHSIIPNMSIKVIKLTKNNLPLPSYSTDNSSGMDLYSAVVTDVILEPGCRVCINTGIAISVPNGYEAQVRPRSGLALKFGITVLNTPGTIDADYRGEIKVILINLGNEAYTIKYGDRIAQMIIAPITRISWDLVEDFDNDKTKRGAQGFGSTGI		155		5	Purified	-1	 	NR-16519
Batch03	EhchA.01376.a	Ehrlichia chaffeensis	YP_507608.1	Q2GG25				enoyl-(acyl-carrier-protein) reductase	Potential drug target		MKGKKGLVIGIANDKSLAWGIAKTLAMHGADIAVTYLSDVFKKRIDPLAESIGVKLVLQCDVSKEETVDNMFAQLSDEWESMDFLVHAVAFSDKNELKGRYIDTSLNNFLTSMHISCYSLTYLAKKVEKMMCNGGSILTLSYYGAQKVMPHYNVMGVCKAALEASVKYLAVDLGSQNIRVNAISAGPVRTLASSGIGDFHYILTWNKYNAPLRRNTTIDDVGGAALYLLSDLGKGTTGEILYVDGGYHAIGMKAIDAPDINYIEAK		266		4	Soluble	-1	 	NR-16520
Batch03	EhchA.01409.a	Ehrlichia chaffeensis	YP_507694.1	Q2GFT9				ATP-dependent protease ATP-binding subunit	Potential drug target		MADNEKNSCSCSFCGKIHSEVRKLIAGPSVFICNECIDLCSGILQEESRSYKKTDTLKLKPKEIKKVLDEYVIGQEHSKKVLSVAVYNHYKRLSNLSVISEVEISKSNVLLIGPTGSGKTLLARTLARVLQVPFAMADATTLTEAGYVGEDVENILLKLLQAANFNVDAAQRGIIYIDEVDKISRKSENTSITRDVSGEGVQQALLKVIEGTVSSVPPQGGRKHPHQEFIQINTDNILFIFGGAFDGLDKIIESRHRGSSMGFEANVQKVSKNKDIFCYTEPEDLVKFGLIPEFVGRIPVITSLGELDESTLCRILVEPKNSLVKQYKKLFEMDNINLQFDDSALSVIAKKAAVRKTGARGLRAILEALLLDLMFESPGSSDVNQVVISKEMVEELMVSSHLFLKH		406		1	Selected	-1	 	
Batch03	EhchA.01413.a	Ehrlichia chaffeensis	YP_507190.1	Q2GH93				phosphoribosylglycinamide formyltransferase	Potential drug target		MTPLKLGILISGRGSNMQALINACAQDDFPAEVSCVISNNPKANGLLIAQKQNIKTFVVQGRPLDFDSIDSILRQHQVDLICLAGFMSIVPEGFINKWFHKIINIHPSLLPSFKGLNAQSQALKAGVKIAGCTVHYVYPEVDGGPIIVQAAVPVFSSDNLTDLSERILKMEHICYPKAVKLIALNQLQLNENLATSAELLHMFYDETI		208		1	Selected	-1	 	
Batch03	EhchA.01432.a	Ehrlichia chaffeensis	YP_507153.1	Q2GHD0				serine hydroxymethyltransferase domain protein	Potential drug target		MHVIVAKAVAFAEALKPEFKDYAKQIIKNSKALGEVFKERELDFVTGGTKCYTNGKHIICFISNTLHL		68		2	Cloned	-1	 	NR-16521
Batch03	EhchA.01439.a	Ehrlichia chaffeensis	YP_507798.1	Q2GFI5				DNA-binding response regulator	Potential drug target		MRILLIEDDIACAKAVEASLSSEGHFCETMTSAQDCYGSIIPKNDDYDVVILDIHFPGKIDGYDILVKLRESGIKVPVLILSCISSVSHKVKGLYYGADDYVTKPFHKSELLARIKAIVRRTRGHPESIVRVGNIAINLDHKCVECNGEIVHLTKKEYGMIELLSSRLGTVLTKEMFLSHLYRELDEPSDDKIIDVFMCKLRKKLKVANNGKNYIETVWGRGYVLKECVDEDESDDRGGYRWDHGGANVDSIYGQEEDKKYVEEA		265		2	Cloned	-1	 	NR-16522
Batch03	EhchA.01444.a	Ehrlichia chaffeensis	YP_507599.1	Q2GG34				dephospho-CoA kinase	Potential drug target		MVIFGLTGGIGSGKSLVASYFKTLFKAVVFDADQVVCQLYNCDNSVIKLVKTYFPDSVDHGVVNKNSLRQHFFAYSNLWVEFQSTLHSIILEKQKNFIMFHNRQSTKYVVLDVPLLIESNFYSCCNFIIHVTTNRLLQMQRVLYRGLSIREFESIIAIQLSENDRKKFANFTIRTGLSKGDVLFQIQKIMFDISHRSKYLSC		202		2	Cloned	-1	 	NR-16523
Batch03	EhchA.01446.a	Ehrlichia chaffeensis	YP_507356.1	Q2GGS7				GTPase ObgE	Potential drug target		MSFIDEAKVYLKAGNGGNGCSSFRREKFIEFGGPDGGNGGNGGNIVFATSNHINTLLYFRYKQHIKAENGNPGSGKKKSGSSGKDIIIKVPIGTQLYDEDGILIADLSSENQKVIVAQGGKGGTGNANYKTSTNRAPRYFTLGEAGEEKYITLKLKIISDIGIIGLPNAGKSSFLASCTDSKTKIADYPFTTLEPHLGVAFIDNRELVLADIPGLIAGAHLGYGIGDKFLKHIERCSTLLHIIDCTLDDIIDSYECIRKELLLYNKELINKPEFIVLNKSDLLEKKEITKKKQLLSQYTKKEIFVSSIKDNRYAILSTLIQYIHKKNANAEPYIYDPFNI		340		2	Cloned	-1	 	NR-16524
Batch03	EhchA.01460.a	Ehrlichia chaffeensis	YP_507319.1	Q2GGW4				GTP-binding protein EngA	Potential drug target		MLKIAIVGLPNVGKSTIFNRLTSQKSAIVSNIPNLTRDRREGDADLCGLKFKIVDTGGVDNTIKLSSLVLDQVKLSIEESDIIFFVVDARIEHDDKNIEFAKYLRKKVKKPIILIANKCESQKRCYSIDYLGYFDFIGPVYISAEHNLGLVDLYEALLPFIKEYDLNTLDLHNIKLSIVGRPNAGKSTFINRLLAENRMIVSPEPGTTRDSIDVEYTYRGQKFTLIDTAGMRKKAKVTESIEVTSVHKTIESINRSDIVILMIDSVYGIEQQDLSIAELAIQKGKAIIIALNKWDMIAKKDRSELLKDICNYNKLNFKVPVIEVSALKNINCNKIIETSIELYKCLTMRISTSVLNKWLKLAVEYHKPPLCNGKVVKIKYITQVKVIPPTFIAVVNGSYSIDLTYRQYLMSSLRKHFSIDGIPIRLNFKKNKNPYDDSYSKS		442		4	Soluble	-1	 	
Batch03	EhchA.01466.a	Ehrlichia chaffeensis	YP_507611.1	Q2GG22				single-strand binding protein	Potential drug target		MSTIGVNKVILIGNLGKDPDIRVMQNGKEMASFSIATSESWVDKASGMRTEKTEWHNVVVFNEGLVKIIKNCIRKGSKIYIEGSLRTRKWTDQNNVDRYTTEVILQGFNSALYMLDAKNNTMDNNGISEDYATESFNKENSLNSSCDDIIIDDEIPF		157		5	Purified	-1	 	
Batch03	EhchA.01468.a	Ehrlichia chaffeensis	YP_507848.1	Q2GFD5				"modification methylase, HemK family"	Potential drug target		MDTVISLFNRAVDFLSTYNIDNPKRDVEIIIKHLINTENLVTILDPHMPINKCDVEVFWKMVKQRSTNIPISHIIGKREFWSTDFIVNSDVLDPRPDSETIISSVFAMYPCKNRRLIIGDFGTGSGCLLSILLLRYRNAVGIAIEKSVKAYRVAYQNFKNHGLYSRIKMRLSSWNTCYDTFDLIVSNPPYIRRSKITTLQPEVKLHEPMVALDGGPIGLEIYSQIFVIIKRCLKQNGVAILEIGEDQHQIHRIVHRYGLKFCTYHNDLSGKLRCIVVKQM		280		1	Selected	-1	 	
Batch03	EhchA.01502.a	Ehrlichia chaffeensis	YP_507893.1	Q2GF90				recombinase A	Potential drug target		MSDSKNLNQERQKALDSAISQIEKAFGRGAIMKLKQGAIEKIDSISTGSIALDTALGIGGFPKGRIVEIFGPESSGKTTLALHVIAESQKKGGNCAFIDAEHALDIMYARKLGVNTGDLIVSQPDTGEQALHIVEYLVCSGAIDVIVVDSVAALTPRAEIEGDMGDQHMGLQARLLSHALRKLTSIVSKANCVLIFINQIRMKIGVVYGNPETTTGGNALKFYSSVRLDIRKVSAIKDKDVIIGNQTKVKVVKNKVAPPFKQVDFDIMYNEGISKVGEIIDMGVKLNIIEKAGSYYSYNSVRLGQGKENAKSYLKANCDTAHEIEQKIRSILASDNEVSCFNAEVNDNLHEVEETVF		357		1	Selected	-1	 	
Batch03	EhchA.01506.a	Ehrlichia chaffeensis	YP_507043.1	Q2GHP0				"pyruvate dehydrogenase complex, E1 component, pyruvate dehydrogenase alpha subunit"	Potential drug target		MTKKYSHNLTNEQLVNCYYSMLLMRRFEEKSGQLYGMGLIGGFCHLYIGQEAIATGIQNAIIDGDSIITSYRDHGFMLSVGTDPKYVMAELMGKSTGCSKGKGGSMHMFNIEKHFFGGHGIVGAQVPIGTGIALANKYKKNNNVVFVCLGDGAVNQGQVYESFNMAALWKLPVIYVIENNEYAMGTSVSRSSYITDLYKKGESFGVPGHQVDGMDLFSVTQAATDAVNYCRANNGPILLEMKTYRYRGHSMSDPAKYRSKQEVEEIKEHKDPITNLKNYLISNNIISDDECNKYDKEIRNIVKESVDFSQNSSEPDAKMLYTDIYKD		327		1	Selected	-1	 	
Batch03	EhchA.01511.a	Ehrlichia chaffeensis	YP_507743.1	Q2GFP0				50S ribosomal protein L1	Potential drug target		MNSLISNEVYDVESGLRKVIESAKANFCESVDVAINLNINSSKSDEQVRGCVVLPKGLGREIKVAVFAKGGYLEMAREAMADIVGDEELIEEVKKKQCKLDVDWCLTTPDFMASVSSIAKILGPKGLMPNPKFNTVTFELAKAIKMIKSGQIKFKSDKTGIVHAKIGNIKFSIEDLLENFNAVISAVKQCKPASIKGLYFKDVFIISTMGKSVKVENLNN		220		-2	Work stopped	-2	Work stopped	
Batch03	EhchA.01518.a	Ehrlichia chaffeensis	YP_507426.1	Q2GGK7				NADH dehydrogenase subunit D	Potential drug target		MSDRVKITPMTLNFGPQHPAAHGVMRLVLEMGGEVIERIDPHIGLLHRGTEKLIEYKTYLQALPYFDRLDYVSPMCQEHAYSLCVEKLLKCEIPIRAKYLRVIFCELTRILNHLLNISSQALDIGAMTPLLWMFEEREKILGFYERASGARFHSAYIRPGGVAADVPDDLIDDIFKFIKTFPKFIDDVDELLTENRIWKQRNVDIGIVSKEQALDWGFSGPMLRACGIPWDLRKSQPYEIYEDLEFEIPIGKKGDCYDRYLVRMAEIRQSIKLLEQCLNRLPNGPIKTDDRKIAPPKRSEMKESMEALIHHFKLYSEGYSVPIGETYMAVEAPKGEFGVYIVSDGTNKPYRCRIRAPGFAHLQAIDMMAKGHMLADLTAIIGSLDIVFGEIDR		393		2	Cloned	-1	 	NR-16525
Batch03	EhchA.01519.a	Ehrlichia chaffeensis	YP_506903.1	Q2GI30				peptide deformylase	Potential drug target		MSVLSIVTVPDKRLSLCSEEVEKVDQSIRKLVDDMFETMHANQGLGLAAVQVGVHKRILVMNVPEEFEDSEDIENVEDKIEGYELYGGPYCIINPKIVDISQEKVKLKEGCLSVPGYFDYIVRPQRIAVQYLDYNGNECIIKAQGWLARCLQHEIDHLNGTVFLKYLSKFKRDFAIEKVKKKERTDLI		188		11	Native diffraction-data	-1	 	NR-16526
Batch03	EhchA.01521.a	Ehrlichia chaffeensis	YP_507415.1	Q2GGL8				glutamyl-tRNA synthetase	Potential drug target		MSHNVITRFAPSPTGHLHLGGARTALFNWLYAKHNNGKFLLRIEDTDKKRSSKELIDSIINAMSWLKIPYDGEIVLQSKNISRHIEIANQLILNNKAYYCYCSEEEINKEKEEFSKKGLYYKHNCIWKNKNFTIDNLTRVIRLRSPTEGVTSFDDKVYGNITVSNTQLDDMVLLRSDNTPTYLLSVVVDDHDMNITHIIRGTDHLTNTARQLLIYNALEWNPPKFAHIPLIHDEDGNKLSKRHQAIGIHEYKNLGILPEAISNYLLRMGWSHEDDEIISMDQAIKWFSIKNIGQSPARLDNKKLEFLNNHYISLTEDEVILNMIIPIIEKKIGYMLNEVKKGYLLKGLYELKKRTKNLVNLANESLFYVEDVPISIDQEASAIIKDYKHVFSILYNNLSRISEKEWNNSILTSTIKNISQNLDIKISNIYHCLRASIVGRMNAPSIIEIMINLQQEECLKRIKYAQNIE		469		5	Purified	-1	 	NR-16527
Batch03	EhchA.01525.a	Ehrlichia chaffeensis	YP_507937.1	Q2GF46				cell division protein FtsZ	Potential drug target		MSLNICLPDQSLLRPRITVFGVGGAGGNAVNNMIQSNLHGVNFVVANTDAQALELSLSEKKIQLGIGLTKGLGAGSLPEVGRGAAEESINEIIEEISDSNMLFITAGMGGGTGTGAAPVIARVAKENKILTIGVVTKPFHFEGAHRMRTAEFGLEELQRYVDTLIVIPNQNLFRIANEKTTFADAFKLADTVLHTGVRGITDLMVMPGLINLDFADIRAIMSEMGKAMMGTGEAEGENRAIAAAEAAISNPLLDNISMKGAKGILINITGGLDMTLFEVDAAANRIREEVDSHANIIFGSTFNKESEGKIRVSVLATGIDNEEVVIQNKSALKDKEAHNDKLSETSSKPFNPLDNEIAYYKPSNPGEDMIHSINHTKKQDHNIENQKSNNKIPESAYKMQFNKNEYWDEESFNIPTFLRKK		421		2	Cloned	-1	 	
Batch03	EhchA.01528.a	Ehrlichia chaffeensis	YP_507250.1	Q2GH33				DNA-directed RNA polymerase subunit alpha	Potential drug target		MSDHWSKLTKPSSIKVVPSGASPNKADLIIEPLESGFALTLGNALRRVMMSSLRGFAVYGVEIENVLHEFTSISGVREDVTDILLNISMMRVKLSGMNSKVLSLKVKGPCEVRSGMIPDTDDCIILNKDLLICTLDQGVDFNIKMYVNAGKGYVPAVKRKSVNKLGDIPINFIATNALYSPIKKASFKVESSRIGQFTDYDRLIMSVETDGSILPDEAVALAARILQDQFQPFINFDETDEPHKKVDAKDTLPYDSNLLRKVDELELSVRSYNCLKNDNITYIGDLVQKTESDMLRTPNFGRKSLNEINELLASMNLHLGMKIANWPPESIESLSKQYSEE		341		5	Purified	-1	 	NR-16528
Batch03	EhchA.01535.a	Ehrlichia chaffeensis	YP_507534.1	Q2GG99				aspartate aminotransferase	Potential drug target		MSLIAERMGCIKPSPTLEIANQAQKLKMSGVDVISLSAGEPDFDTPQHIKQAAIDAINSGKTKYTAVNGIIELKKVIIDRFKQDHDLIYNVNQISVGNGAKQCIYNLFMATINSGDEVIIPSPYWVSYPDVVKISGGNPVIVDCGETFKLTPDILESVITEKTKWLIMNSPNNPTGLVYTYEELKSIAEVLLKYPNIYVMTDDIYSKIIYDDLEFFTIAQVEPRLYDRVFTINGVSKAYAMTGWRIGYIAGDSRVISAISVIQSQSTTNPNSIAQFASIQALAGDQEFLKERNKIFAARRDMMVDMVNNTSLLSVKKPQGAFYVFISCKKLIGKSTRNGLVINSAMDFTKYLLEDYNVAVVPGEAFGAQGFFRISYATSTEHLSKACDRILDACGKLS		398		1	Selected	-1	 	
Batch03	EhchA.01543.a	Ehrlichia chaffeensis	YP_507745.1	Q2GFN8				transcription antitermination protein NusG	Potential drug target		MKYEWYIIQVSSGSEEKVCQTILENSRVLGLEESFREVFIPYEEITRVKHNKKVLVKRKLSPGYVFLYMSLHENSMNFIRSIPRVLNFLNNDFGVPKVISENEMESMRKKMCQSVVDDTSVVNFEIGDEVVINDGLFQDFNGKVEYINDDKKIAGVSVMIFGRLTKIEFKLEHIQKVEG		179		1	Selected	-1	 	
Batch03	EhchA.01551.a	Ehrlichia chaffeensis	YP_507677.1	Q2GFV6				3-oxoacyl-(acyl-carrier-protein) synthase II	Potential drug target		MAKKRVVITGLGLVTSLGSDLKTVWDSLSKGISGIRKIDRFDTSDLDCKVAGQVTTKPESEEYIFDAGDYIPEKDLKKMDTFIHFGIASATQAINDSNLLDYKDLDYSRVGVIVGSGIGGLQFIEKTVICLKERGPKRISPFFIPASLINLTSGHISMKYGFTGLNDAVVTACSTGAQAIGNAARVIQSGEADVIIAGGTESAICRIGIAGFAAMKALSTKFNDTPELASRPWDKQRDGFVMGEGSGVVILEDYEHAKKRGARIYGELLGYGMTSDAYHMSAPHPEGKGGIKSIELALSNAQLNPESINYINAHGTSTPIGDSIEIQAIKNVFKESVYKVPISSTKSSIGHLLGAAGSVEAIFCILAMNTGIAPPTLNLHESSEDPKLNLVPLNAQEHKINYCLSNSFGFGGVNVSLVFGKV		422		1	Selected	-1	 	
Batch03	EhchA.01553.a	Ehrlichia chaffeensis	YP_507205.1	Q2GH78				quinone oxidoreductase	Potential drug target		MVKVIIIDKTGSAEVLKYVNHNIGEPKDDEVLIKHTAIGLNRYDLECRNGMRKNKKLPAVLGVEAVGVIERLGKDVEVFNIGDRVGYCTVSGGAYSEKRLIKQKYLVRIPDDITDQVAAAVLFKGMTAHYLTHLVYAIRPNTFALVHGATGGVGQILCQWASYKGCKVIGVISSDDRANIALRAGCSYVVNNNSKNFVEQIMEITHGSGVNVVYDCIGDLASKVSFESLCMFGIYVSYGQISGPISNVSASMLSSRSLFFTSPLVFHYKRSSFDLAMTAMELFEVIRRNYIKVGINKIYKFGDIVTAHQDLENRKLTGSNIIEL		324		4	Soluble	-1	 	NR-16529
Batch03	EhchA.01563.a	Ehrlichia chaffeensis	YP_507624.1	Q2GG09				dihydrodipicolinate synthase	Potential drug target		MYSLMGVFTALITPFKDDFSIDENAFCHLIEEQISNNIHGLVPCGTTAECPTLSFEEYCKVIELCVKITNKRVPIIAGSSSNSTQEAIKRTLYVQSLNVDAALVVVPYYNRPSDEGIYQHFKAVHDATNLPIIAYNIPNRSAIDASDALLARILSLPRIIGLKDSTGDVSRPLNLKLLLNKEVVLFSGDDSTCLGFYAQSGSGGRTGCISVVSNVIPKIHADMHNAFLANNMKEAMNANLSVFKLAKALFCQSSPAPTKYAMSLIKNISPAVRLPLVELTQENKLKVEKTLKELKLI		297		1	Selected	-1	 	
Batch03	EhchA.01564.a	Ehrlichia chaffeensis	YP_506846.1	Q2GI87				"glyceraldehyde-3-phosphate dehydrogenase, type I"	Potential drug target		MKIGINGLGRIGRCLIRAIYENELLYKHKIELSALNGSTSPETHAHLIQYDSVHGKFPHNVTSEEGYIIINDKKIPLSTEKEPKSIPWEKHNVDIVLECTGKFNKKSLAEQHINSTVKKVLVSAPMQDSDATIVYGVNNEMLKKEHNIISAGSCTTNCIAPILKIMNDTIGINNGFMTTIHSYTNDQNLVDNNHKDVRRARACMMSIIPTTTGATKTIDLIIPELKGKLNGTAVRVPTANVSMVDLVFNSIKSTTANEINDIIKNSSQNSKVINITDKKLVSIDFCHSTYSSIVDADETYVTNNNLCRIAAWYDNEWAFAMRMLDIVLLLSENHI		335		1	Selected	-1	 	
Batch03	EhchA.01570.a	Ehrlichia chaffeensis	YP_507170.1	Q2GHB3				2-amino-4-hydroxy-6-hydroxymethyldihydropteridine-pyrophosphokinase	Potential drug target		MFNDVVMLALGSNCGNMLAYIKSAINMLPLHNKNYSYLYKTPALLPENAADHWDTPYLNMVVSGYTNLSSSAMLERIKSIEKMLGRINHQRWAPRPIDIDIILWGNKVVDSQTLSIPHQQMHCRDFVLVPLCDIYARFIHPVLQIPIYEMLLSLNNINLIKQNSHVLQQ		169		1	Selected	-1	 	
Batch03	EhchA.01571.a	Ehrlichia chaffeensis	YP_507622.1	Q2GG11				HIT family protein	Potential drug target		MQDNTSYDNNNVFAKILRKELPCNVVYEDEFVLAFHDIHPQAPIHILVIPKGEYISFDDFSDSSADIRHFFSIVKKITHQFQLEKTGYRIVTNHGKQGGQIVPHFHVHILGGKQLP		116		1	Selected	-1	 	
Batch03	EhchA.01578.a	Ehrlichia chaffeensis	YP_507186.1	Q2GH97				"oxidoreductase, short-chain dehydrogenase/reductase family"	Potential drug target		MEKQLAGKVAIITGASGSIGSAVAKRFAKEGACLILVAKNINKLNAVYDSIKELGGDAMLAAVDLQDFDTIKNFAMSIGNKFKNIDILILNAAVVGDLSPTQDYEYDTWKRIMDINFIANWHLIKYFDPLLKLSPAGRVIAVTSEVTQSPSRYPYWSTYASSKAALETMLRIYATETKHSKLCVNMVYPSLMDNDIYAQALPIKETAQSVLPENFTDKFIELSSNQCNVTGQIYKIGSEDEC		242		5	Purified	-1	 	NR-16530
Batch03	EhchA.01583.a	Ehrlichia chaffeensis	YP_507196.1	Q2GH87				fumarate hydratase	Potential drug target		MRKERDSLGEIDVPACHYWGAQTQRSIDNFKIGSEKMPKPLIKALGLVKLAAARVNMKNGDISETIGNAICNAASEIIDGKFDDEFPLVIWQTGSGTQSNMNVNEVIANRAIEILGGEKGSKYPVHPNDHVNYSQSSNDTFPTAMHIAAVIETENSLLPNLKNLYDALHSKSIAFQNIVKIGRTHLQDATPLTLGQVFSGYAYQILQGMSRVKSALGHLLELAQGGTAVGTGINSRKQFDVHFASEIKKLTGFNFVASVNKFEALATHDALVEFSGALNVLAVSLMKIANDIRLLSSGPRCGIGEIILPTNEPGSSIMPGKVNPTQCEAVTMVCAQVMGNHTTVTVAGSNGHFELNVFKPVIIYNVLQSIRLLSDVSINFSHKCVQGIKADTNRISFLLSQSLMLVTALNKHIGYDNAAKIAKTAFDEGITLKNAAVKLNLISEEEFDKIVNPENMIYPTG		461		1	Selected	-1	 	
Batch03	EhchA.01584.a	Ehrlichia chaffeensis	YP_507425.1	Q2GGK8				NADH dehydrogenase subunit E	Potential drug target		MSNIQKNSNEHYTETFKFNKDNLKQANDTISKYPHDRKSSAVMDLLHIAQKQCGGFIPLSAMNYIADFLGMRLIHVYEVAKFYSMYNLSPTGKYLIQVCRTTPCWLCGSDDILKSCKELLNICVGETTSDNLFTLKEVECLGACVNAPVMQINDDYYEKLTPDKVKDILMEIQKKEAVVSD		181		1	Selected	-1	 	
Batch03	EhchA.01600.a	Ehrlichia chaffeensis	YP_507060.2	Q2GHM3				riboflavin synthase subunit alpha	Potential drug target		MFKGIIEDIGTIIQVDYTKGQDRRLVIKPTNANFLSETKIGDSIGCSGICLSAVELDNECFSADVSDATLSVTSAAHWKEGTKINLELPLKMTDRLDGHFVQGHVDGVGNIISITNVNSSHNIEFHIPDALLKYMIRKGSIAIDGVSLTINSISNNILSVNIIPHTWKKTTFQYNKVNDNINIEVDMLAKHLERLYEHNIKV		202		7	Crystallized	-1	 	NR-16531
Batch03	EhchA.01603.a	Ehrlichia chaffeensis	YP_507537.1	Q2GG96				thioredoxin-disulfide reductase	Potential drug target		MTQTYNTKVLIIGSGAAGCTAAIYAARANLKPILITGMCPGGQLTITTDVENFPGFAHAVQGPDLMEQMKQQAHNSGAQIISDEIKEIHSDVYPFKCIGIFGDQYIADSIIIATGAQAKWLNIKSEETFKGRGVSACATCDGTFFAGSDIAVIGGGNTAVEEALYLTRYATKVFLIHRRDTLRAEPIMQERLFSNDKIQVIWNSVVEEILGNKESGNVEAIALKSVKTGDITTISVKGVFIAIGHTPNTQILTTKDNGNIVDLDNEGYIITKPGSTVTSHPGIFAAGDVQDKIYRQAVVAAGSGCMAALEAAKFLSEQ		318		5	Purified	-1	 	NR-16532
Batch03	EhchA.01615.a	Ehrlichia chaffeensis	YP_507355.1	Q2GGS8				S-adenosyl-methyltransferase MraW	Potential drug target		MHTPVLLNEMLDILNPQDGKVYVDATFGAGGYTRAILKSANCQVYAIDQDECTNVFYEKLVNDFPGKVHFCVSKFSKIKQILHGAQLKKVDGIVFDIGVSSMQLEDASRGFSFSKDGPLDMRMSTSISNVDASVFVNTAFEEEIANVIYQYGGEKYSRKIAKAIAESRKKKPIKTTGELASIVRSVISRSKNHSIDPATRTFQAIRIWVNKELEELEQGIIDSADLLNPGGKIIVVSFHSLEDRIVKVMFKSLCSGSSVISPIGFQLINKKVIRPSFEEILNNPRSRSAKLRAILKI		297		1	Selected	-1	 	
Batch03	EhchA.01616.a	Ehrlichia chaffeensis	YP_507050.1	Q2GHN3				thymidylate kinase	Potential drug target		MFITFEGIDGSGKTTQSHLLAEYLSEIYGVNNVVLTREPGGTLLNESVRNLLFKAQGLDSLSELLFFIAMRREHFVKIIKPSLMQKKIVICDRFIDSTIAYQGYGQGIDCSLIDQLNDLVIDVYPDITFIIDVDINESLSRSCKNGYEFADMEFYYRVRDGFYDIAKKNPHRCHVITDKSETYDIDDINFVHLEVIKVLQMV		202		17	In PDB	-1	 	NR-16533
Batch03	EhchA.01623.a	Ehrlichia chaffeensis	YP_507800.1	Q2GFI3				inorganic pyrophosphatase	Potential drug target		MNLDNVTGGDNVPKEINVIIEISQNSCPVKYEFDKEKNLFCVDRFLPTSMYYPCNYGFIPHTCAGDGDPVDVLVASRFPVMSGAVIRARPVGVLVMHDESGEDVKILAVPTHKVDQYYNNIKDYSDFPVSFLNSISHFFTFYKKLEEDKFVSVEGWKDVTVAEKLILSALIK		172		17	In PDB	-1	 	NR-16534
Batch03	EhchA.01634.a	Ehrlichia chaffeensis	YP_507225.1	Q2GFN6				elongation factor Tu	Potential drug target		MVEERKPHINVGTIGHVDHGKTTLTAALTTVLAKRLSGEGNKSVKYDEIDKAPEEKARGITISTAHVEYETENRHYAHVDCPGHADYIKNMITGAAQMDAAILVVSATDGAMPQTREHILLAKQVGVKDIVVWMNKCDVVDDEEMLSLVEMEIRELLSKYGYPGDDIDVVRGSAVKALEEETGSGVWSEKIMELMNALEKISLPTREKDKPFLMSIEDVFSIPGRGTVVTGRIERGVIRVGDKIEIVGLRDIQSTVCTGVEMFHKALDAGEAGDNAGILLRGIKKEDVERGQVLSAPGQIHSYKKFKAEVYILKKEEGGRHTPFFSNYQPQFYVRTTDVTGSIKLPEGVEMVMPGDNISIEVSLDKPVAIDKGLRFAIREGGRTVGSGIITEILE		395		1	Selected	-1	 	
Batch03	EncuA.00196.a	Encephalitozoon cuniculi		Q8SR1	Q8SR19|Q8SR19_ENCCU			Serine/threonine protein phosphatase - Encephalitozoon cuniculi	Potential drug target		MTKDHAEPKYLEILRRIKNSILPARDEVLELVGEVRKILEQEPNVLHIDTPVNVVGDVHGHFYDVLNMLDLMEDPSEKPYLFLGDYVDRGYNSVDLVLLLFVYKRLYRDRVHLLRGNHETRMLSSVYGFKEECMRKYDLVVYWRICETFQYLPIAAVVLEKYFCVHGGMVPGMSLDFIMKHDRIGEITELNDVLWSDPDETPGFQKSQRGAGYLFGEDVLKSFLDEHGLSHFVRSHQLVNDGYKAYFDEKLYTVWGAPNYCYSSGNIACVMAIDEDGHDFRLFDRCEEQFKEAPVRHSFFD		301		3	Expressed	-1	 	NR-16451
Batch03	EncuA.00208.a	Encephalitozoon cuniculi		Q8SW2	Q8SW28|Q8SW28_ENCCU			Similarity to 14-3-3 PROTEIN 1 - Encephalitozoon cuniculi	Potential drug target		MASKQYEEALQKANLSDMAERYDDMAKEMRLAVTLAHEDKHILNVMARNLFSVAYKNLVSSRRSSWRMLCSERQKLEGKDPSVVHVINEKIKVVEEELLRFCDEVLDIITTYILSLEEAQKNIEYNIFFLKMKGDYYRYKAEVVTGPEHSEVSKHAAESYKEATEKAKTLPPTNPIKLGLALNYSVFHYEILNDSEKACSIAKGAFDEAIKELDTLSEEHYRDSTLIMQLLRDNLTLWTSREEGNVMGDEGKGDPDEN		258		5	Purified	-1	 	NR-16452
Batch03	EncuA.00234.a	Encephalitozoon cuniculi		Q8SRH	Q8SRH6|Q8SRH6_ENCCU			20S PROTEASOME ALPHA-TYPE SUBUNIT - Encephalitozoon cuniculi	Potential drug target		MLSNKRGIHSASGGIDLRTLREYCLFEDFDVCMPFNPMGVPGGKGNRGSDGAIRGMLPLGDAMGDLFTAGKAGSTKMEDKERFDPYEDNSGTTICLKQGDFIVVAGDTRHSSSMVINSREMSKIFQVGDFLLTGTGFYADTHEVYVKMVYEIRQYEVDDSINIHSAANLLSKILYSKRFFPYYSFCVLSGFEKGKPYVYSYDPIGSFGSVTCVCSGSGRSMIQPLLDSFIDKKNWNNAEETQLSQEDCIRLVVKAFNSAAERDVKTKDNLEVCVMRENQVMRETFPLRRD		290		3	Expressed	-1	 	NR-16453
Batch03	EncuA.00240.a	Encephalitozoon cuniculi		Q8SR6	Q8SR60|Q8SR60_ENCCU			Uracil-DNA glycosylase - Encephalitozoon cuniculi	Potential drug target		MTMDREKKEDLPGVFSVSESKGCHGKRQLSLDDMFSKRKTSAGTGPSKSLEAGWTYEGCAQPCEYCRLEEKIDPRWRMHLKPEFGKDYFRGVKRFLHENRNHLPPIDKIFTFSRFFPLEKTKVVIMGQDPYHNDNQAMGLSFSVPVGIPVPPSLKNIYLEISSDIEGFEVPSHGDLSGWAERGVLLLNDVLTVTKNRPNSHAGIGWREFTSCILQVINEKCTNVVFMLWGRHAQAKGKFINRNKHLVLTCGHPSPLSSSHFFGCKHFSKANKYLMDHGKSPVEWQV		286		7	Crystallized	-1	 	NR-16454
Batch03	EncuA.00253.a	Encephalitozoon cuniculi		Q8SQM	Q8SQM5|IF4A_ENCCU			ATP-dependent RNA helicase eIF4A - Encephalitozoon cuniculi	Potential drug target		MKQVTEQAEDFVDTRSSGTEIREFEDLRSDSSQIRMFDTWEDYGLKEDLLKGIYSIGFETPSFIQKAAIQPIIDGRDIRAQAQSGTGKTGAFAVAALQICDMSQDVTQILVLASTREIAAQNAARFEDLGCFMGARVALLSGGSPIAADKVALEKKPHIVVGTPGRVEHMININELSMDNIKLFVIDEADEMLKAGFQEQVKSIFRRITNKDEVQIAMFSATYDEEELRVSEEILINPVIIDLRYNDQTLKGIRQYFIDLRKEPPFRKGREDYLLPKLVTLYDIFRKQRLGQSIVFINSKEDARIVYDWLIRHEWECELISAELTQAERERTLNRFRGGTGRCLISSGLLSRGIDIQNLSVVFCLDVPSFERKSTYIHRIGRSGRYGRKGIAINIVYEHELKNLKAIERFYNTTIKELPADFSFQ		425		7	Crystallized	-1	 	
Batch03	EncuA.00278.a	Encephalitozoon cuniculi		Q8SR8	Q8SR86|Q8SR86_ENCCU			CDK2-LIKE CELL CYCLE PROTEIN KINASE - Encephalitozoon cuniculi	Potential drug target		MTESFQKLEKIGEGTYGVVYKARERNTNRVVALKKIRLENENEGIPATTIREILLLKNLKHSTIVELSDVIYNNNKMYLVFEYVELDLRRYLDRMSDEGRLVEEGFVRKMSQQLLTAMEYCHSRNIFHRDLKPQNILVDPKENIKLADFGLGRAAGIPLRTYTTEVVTLWYRPPELLLGCKYYDASVDVWSAACIMAEVVLMRPFFPGDSEIDQLFRIFKVLGTPNNSRWSNVENFPNYKVEFPVWDPVDLKTIFRGDPDFVDLISKMLEYDPKMRMTAKNGLSHKYFEGMPLIME		296		3	Expressed	-1	 	
Batch03	EncuA.00286.a	Encephalitozoon cuniculi		Q8SS8	Q8SS82|Q8SS82_ENCCU			26S PROTEASOME REGULATORY SUBUNIT 7 - Encephalitozoon cuniculi	Potential drug target		MNGQKQENIIEEKDVGFILSYGRNYYADGIVEKEAEIRRLFEQISLKLGTREVETGLAPPMCWDLLGDRNRIQSEPNLQVARVCKVLDGYQEPRYMIGIKMIAKFIVGKGKRVDSSLIQEGMRVGVDRNKYQIILPLPRKIDASVTLMQVEERPDVTYHDIGGCKEEIEKIREVVEAPLLNPERFVALGIDPPKGVLLYGPPGTGKTLLARAVANRTNACFIRVIGSELVQKYVGEGARMVREIFAMAKGKKACIIFFDEVDAFGGTRFDDDDDNEVQRTMLELINQLDGFDPRGNIKVLMATNRPDTLDPALLRPGRLDRKVEFGLPDLEGRTSILRIHAKTMSVDKDIRFDLIARLCNNATGAELRSVCTEAGMFAIRERRKIATEKDFLKAVDKVVKGYAKFSSTPRYLTYN		415		1	Selected	-1	 	
Batch03	EncuA.00300.a	Encephalitozoon cuniculi		Q8SVZ	Q8SVZ2|Q8SVZ2_ENCCU			Similarity to RAS-RELATED CELL DIVISION PROTEIN 42 - Encephalitozoon cuniculi	Potential drug target		METIKCVLVGDPSVGKSWLISTYITGRNPEGYIPTLFNNYSKVVNMGDKKYNMTLWDTAGSEEYNKLRNLSFQETDVFLVCYAVNNILSFHNTRRWVEELARYNVPMILCGTKCDIIDGNIVDKELPVQLSKEYGLYGSMECSSVELINVKKVFDIALEAALKPRKSKFRSIWFCCKCG		179		3	Expressed	-1	 	NR-16455
Batch03	EncuA.00307.a	Encephalitozoon cuniculi		Q8SQI	Q8SQI9|PRS6B_ENCCU			26S protease regulatory subunit 6B homolog - Encephalitozoon cuniculi	Potential drug target		MSARLKGGLFVRYKQMERKLRLLEIREGYVRKEIETLKREERHSREELDRVKSVPLIMGQFLEPIDSSTAIVGSTAGSNFVVRILSTVDRELLKPNTTVALHRHSSAIVGVLPPEVDSTIPVMGESEKPSVTYGDVGGLDVQKQEIKETVELPLLQSDLYRQIGIDPPQGVLLYGPPGTGKTMLVKAVANHTKATFIRVNGSEFVQKYLGEGPRMVRDVFRLAREKAPSIVFIDEVDSIATKRFDASTSADREVQRVLIELLNQMDGFDPAANVKVIMATNRADTIDPALLRPGRLDRKIEFPLPDRRQKRLVFNAITSKMSLNDSVDIESLVCRPEKISCADINSICQEAGMLAVRASRYMVTQRDFEEAYSKVVERSGTQPAFYN		387		3	Expressed	-1	 	NR-16456
Batch03	EncuA.00319.a	Encephalitozoon cuniculi		Q8SQL	Q8SQL3|Q8SQL3_ENCCU			RAS-RELATED PROTEIN GTP-BINDING PROTEIN - Encephalitozoon cuniculi	Potential drug target		MAALRIDYRYKIIVLGESDVGKTCLLHKYKEDDFKQSLMTTIGVDTVSKSIVLNGKNIMLNIWDTAGQERFFSITKSYYRNADGILLIFDISDERTFSCVDRWFGRIREETGNVPLFLVGNKRDKVDSAMYHEMEGRFKNKADEMRARYYTTSAKTGENVNNIFEDMAMVLLKKQTLGQKWEAGSLYDPSVGGPNRKTNGRCC		203		4	Soluble	-1	 	NR-16457
Batch03	EncuA.00320.a	Encephalitozoon cuniculi		Q8SS6	Q8SS60|Q8SS60_ENCCU			40S RIBOSOMAL PROTEIN SA or P40 - Encephalitozoon cuniculi	Potential drug target		MPQDNTRISDSIKIPDEFVKLLIVSQSHLGGTSTNKSFARYLYGTRPRDRINIIDINATWEKLIIAARAFCGIKHPSSIAVVSTKTFGRKPVVKFCEAVGATPITGRFIPGSFTNSEVKRVYDPRVLIVSDTYADKQAILESQYCNLPTIAFVNTDNSLVGVDIAIPMNNRSPSAIAAGFFILSRLINYMKTGAELVRDMKEVELFLFRDSVELEQLVEEQLLETTDSILNVGKEGILSGIGTGNADEWNSF		252		-2	Work stopped	-2	Work stopped	NR-15948
Batch03	EncuA.00324.a	Encephalitozoon cuniculi		Q8SS0	Q8SS09|Q8SS09_ENCCU			ADP RIBOSYLATION FACTOR-LIKE GTP BINDING PROTEIN - Encephalitozoon cuniculi	Potential drug target		MLDNIQEYLGVVKAKLTEFYEKVFQNFVKSLFGKPSSILFLGIDNAGKTTLVNKLKSDSTDVYMPTHHPSTSYIEIGNLKAQVIDLGGHTAARLAWRDYFYDCHGIVFIVDVHDVERFQEVREAYETVLSLEKRAPVVVLMNKIDLEGHTPETAEADYQWKSWLSQETGIENQEDPERGQVVKIFYVTITSGSANSITGPLARAFKWLEAMITYNNKKESL		221		1	Selected	-1	 	NR-16458
Batch03	EncuA.00326.a	Encephalitozoon cuniculi		Q8SS2	Q8SS26|Q8SS26_ENCCU			PYRUVATE DEHYDROGENASE E1 COMPONENT BETA SUBUNIT - Encephalitozoon cuniculi	Potential drug target		MVTVREALNQAIDEEMKRDERVFVLGEEVGVSGGSHGVTGGLYKKYGKWRVLDTPISEMGFTGLAVGASYLGLRPIVDFMTWNFALQSIDHIINSCAKTLYMSGGKINCPIVFRGPNGFNPGYAAQHTQDFSSYYGAVPGLKVVAPYTAKDHKGLMKSAVRDENPVVFLENETLYNDTYENIEEGYVQPLDKAVVEIEGSDVTLIGISLSVKTCLEAAEALGALGISCEVINLVSIRPIDIQTILRSAMKTRCVFVVDFSWPSFSIASELSATIHESCFGRLMAPVQRINGKDTPTPYSKEIEKMAFPTSLDVVNSVMGICREKLHKNNKSNL		333		4	Soluble	-1	 	NR-16459
Batch03	EncuA.00329.a	Encephalitozoon cuniculi		Q8SS8	Q8SS85|Q8SS85_ENCCU			THIOREDOXIN PEROXIDASE - Encephalitozoon cuniculi	Potential drug target		MFPKTLTDSKYKAFVDGEIKEISLQDYIGKYVVLAFYPLDFTFVCPTEINRFSDLKGAFLRRNAVVLLISCDSVYTHKAWASIPREQNGVLGTAWPMVWDAKRELCNQFGLYDEENGHPMRSTVILAKDLSVRHISSNYHAIGRSVDEIIRLIDAITFNDENGDICPAEWRSENKDN		177		4	Soluble	-1	 	
Batch03	EncuA.00330.a	Encephalitozoon cuniculi		Q8SSK	Q8SSK6|Q8SSK6_ENCCU			ALDOSE REDUCTASE - Encephalitozoon cuniculi	Potential drug target		MICKTQKLNNGKEIPTVGLGTWGMEDEAVLEGAIRNALSLGYRHIDTAFIYGNEKMIGNILKKLFDEGVVQRKDLFITSKLWNTFHGCPEDGLRRSLNDLQMDYVDLYLIHWPVTFDPAPDGTVESCGKKYNVGKFDAVGVWKKMEALVDLGLAKSIGISNFGKANTEKILGTCRICPAAIQIELHPYLNQKELVEFMKSKGIQVISYSSLGSAPGSSAKVRDDKTIKAIAKKYGCAPSQIILSYITAQGICVIPKSRSKEHLRENIDLKELSREDISAIDALNTGHRYVDPPGFGPEKFK		301		7	Crystallized	-1	 	
Batch03	EncuA.00350.a	Encephalitozoon cuniculi		Q8SS5	Q8SS52|Q8SS52_ENCCU			RAS-RELATED GTP-BINDING PROTEIN RAB11 - Encephalitozoon cuniculi	Potential drug target		MVPLMECFRCGFRYLDLISLRCLLIMPGVAKGENFDYLFKIVLIGDSAVGKTNLLSKLTRNEFHKDSKATIGVEFGTITFKIGEDVVKAQIWDTAGQERYQAIVQAYYRGTSGAAIVYDITNKDSLKKATGLWLKQLRDFSPNEIPIVLIGNKKDLESDREVPTQRGKDEAVTNELSFFETSALTGENVRDAFFELVKIIHKRAKAQKVSIGKKKLRTVEFKRESLREVKPSPKKGCC		238		3	Expressed	-1	 	
Batch03	EncuA.00397.a	Encephalitozoon cuniculi		Q8SR0	Q8SR04|Q8SR04_ENCCU			SMALL NUCLEAR RIBONUCLEOPROTEIN D2 - Encephalitozoon cuniculi	Potential drug target		MFLPNNLDDPNEKETMEMKGPLSLVRRAMVKMKPVLVSLRSNRKVLGRVVAYDRHYNLLMEDAKELGTTRGKNKGRKKRQGCEFSRKLGKVFIRGDTVILVAGEIEVDQVEKDGLEDGKGEDASLPGEVAAGDEI		135		4	Soluble	-1	 	NR-16460
Batch03	EncuA.00411.a	Encephalitozoon cuniculi		Q8SUJ	Q8SUJ2|Q8SUJ2_ENCCU			Putative uncharacterized protein ECU08_1860 - Encephalitozoon cuniculi	Potential drug target		MKIKELKIELTKVRDFSKMSVGLEQYMTPPDIAASMVSVIHSTYGDIEGKSILDLCCGTGMLSFACSYFSPSYILGVDLCPVALEIFRQNSLEFQINADLLRCSIDDLIFINGRFDTAIINPPFGTKIRHADTRAVDKALELCNVVYSLHKTSTREYMVKRYPGAEVLAEIRYELPRKHDFHKKDKRSVGVDFIRIERR		199		3	Expressed	-1	 	NR-16461
Batch03	EncuA.00440.a	Encephalitozoon cuniculi		Q8SSM	Q8SSM8|Q8SSM8_ENCCU			Fructose-bisphosphate aldolase - Encephalitozoon cuniculi	Potential drug target		MMDCDHLLRLGMTAKKILENGKGILAADETPKTLGRRFEKLGITNTEENRRKFREILFSTKGIERYIGGVILNQETFEQTSGSGVPLTELLKKKGIEIGIKLDKGLIDYKEKEKISVGLEDLDLRCKSSAFKDATFAKWRSLFYFYDGIPSEDCINENCSILAKYAIICQKNGLVPIVEPEVFLEGDYSMKRSYEVTRQILSTLMKYLNYELVYIPGVLIKASYVTSGQLSNEKYTPKKVATFTLRALLSTIPCGIPGIVFLSGGHGSEDAIGFLNAINMERGCRTWSLSFSFARALTDGVLETWRGDDSNIEEAQKILLETSFKACRGAEGKLWDQE		338		17	In PDB	17	Ligand-bound structure submitted to PDB	NR-16462
Batch03	EncuA.00445.a	Encephalitozoon cuniculi		Q8SQN	Q8SQN7|Q8SQN7_ENCCU			Proteasome subunit beta type - Encephalitozoon cuniculi	Potential drug target		MITKTGTTIVGMKYKTGVILAADTRSTQGPVVSDKNCVKIHQITDKIMCCGAGTAADASRVARMASRELRLFQNKYLRLPLVSHFRKVCTQHLHKYGGGIGAALIVGGIDSEGCHLYEIHPHGSENSALFVSLGSGSLGAIATLESRYRAMDKDEAIDLACDAVKAGILNDLYSGSNIDVCVIDYSGVEFLRNYRRIGVSENTDTLVYPLDSVRIKREEVFDIVEEY		227		2	Cloned	-1	 	
Batch03	EncuA.00475.a	Encephalitozoon cuniculi		Q8SSI	Q8SSI2|Q8SSI2_ENCCU			DNA REPLICATION FACTOR C - Encephalitozoon cuniculi	Potential drug target		MHQQLTEKYRPGSLLEVVGNREVVSSLQSISSAGRIPNMLFYGPPGTGKTTSIRAIANNLPRTSVLELNASDERGIATVRETIKEFASTYSKTMKLVILDEADMMSRDAQNALRRIIEDFSANTRFCLIANHLRKIISPILSRCTKFRFGPIGDTENRIEEICKRESIKYTPEGIKAVSRISMGDMRKAVNDIQGISASLGQVDESNVRRFNGIAPSSVYEELFRNLGSMGMPELRVELERLRYEYSMDCDALLGNLGELVRESKMRNKMKILKEMSDIEYRKSIGCSEKVQLDAIISIFILNRS		305		3	Expressed	-1	 	
Batch03	EncuA.00488.a	Encephalitozoon cuniculi		Q8SUA	Q8SUA2|Q8SUA2_ENCCU			Putative uncharacterized protein ECU10_1710 - Encephalitozoon cuniculi	Potential drug target		MENIIKEFALEECTTCPEGNLYIGRIRGKKALLIFPKQLVLPDTFSQVLSLPKENTQSNDIYYSFKASVPMNIDFRLIYPATEEHVRKYCSKRIYVEETYEEYLDFIKSASQITSNWMDNLIAQDRSDLNEEIMYEDEEVIMIPDYKWNPQTVDLLHFLVVFKDPGLKTIRDIRDYQILVDAREKARNLLETRFGLDFNHVFMFFHYRPTYFRLHLHVMNIKMAHEGNVSCTRAIPLHDVIHNLRIDINYYKKSMFVMSNEVN		263		5	Purified	-1	 	NR-15949
Batch03	EncuA.00500.a	Encephalitozoon cuniculi		Q8SRN	Q8SRN5|Q8SRN5_ENCCU			SOMA FERRITIN - Encephalitozoon cuniculi	Potential drug target		MDPKTKQASSDEWNVEAGLLLSSQLLLEYNAYYFYSACAAHFSRSDVCLKGLASFFRKKSLDENAQAQKIIGFMNMRELDIEFRAIEAPDIKKYGKTSGVLKACKEFEQTVLSNISTISEIARKAGDGAIVQFLEDFIAEQVRSISELSDLCANCARCGDGGVGLFLFDQSLISQH		176		4	Soluble	-1	 	
Batch03	EncuA.00510.a	Encephalitozoon cuniculi		Q8SR1	Q8SR13|Q8SR13_ENCCU			26S PROTEASOME REGULATORY SUBUNIT 6A - Encephalitozoon cuniculi	Potential drug target		MSLEELEAMDQSNPGEFLERVREKIRMLNSETRILQSRVNTIKHDISTKNASIAENMERIRLNKQLPYLVGNVVEVLDEHSGVVNASTRMSSYLPITGLIPNSELRPGDLVALHKDTNIVFEKLPPDYDMKVGGMVLKSDAKPDETYEDIGGLERQIEELNEAIVLSLTHPERFEKLNIKPPKGVLMYGPPGTGKTLMARACASKTNATFLKLAGPQLVQMYIGDGARLVRDAFALAKERKPTIIFIDEIDAIGAKRSDSDQTGDREVQRTMLELLNQLDGFSSSEEVKIIAATNRVDILDPALLRSGRLDRKIEFPLPNTLGRKRILQIHARKMSVRDDVNFDELARSTEGFNGAQCKAVCVEAGMAALRKEKTEISQNDFMDGIQEVLSRKKSKLLYFT		401		3	Expressed	-1	 	
Batch03	EncuA.00523.a	Encephalitozoon cuniculi		Q8SRB	Q8SRB7|Q8SRB7_ENCCU			KINESIN-LIKE PROTEIN - Encephalitozoon cuniculi	Potential drug target		MLENVRTYLRIKPQAIPEDIVVGGDSVIVDGSSFCFDRVFRGSTQQEVFQEISKSLLVECMQGYNCTLFAYGQTGSGKTYTIQGNAHSIGIVQRSLSLLHRNADLRISLSFVEIYNETMLDLFDPEAILSIREDPLCGVVVDGLTIVDCDSYEKSMEMYSRGTRTRRTSSTSMNKESSRSHSVFTVYLKSSGEVMSRSSRVCFVDLAGSERLREREVEETKMKETANINKSLLYLGKVINKLSNGEEGHIGYRESKLTFLLKDSLGGNCKLTVIGNVSLESRSDSINTMNFLQRSKMIRNLAVVNSDVNGELEEVKSRLKTLDSENQSLKARIALIDSQIQEESRALPSYHYDIKRVKDAVDDIMSTVLDLGETVGRVSGVEFDKNRRLLLSIHECFMSMHRRQEDAESSTKRKRRDAKE		420		3	Expressed	-1	 	NR-16463
Batch03	EncuA.00533.a	Encephalitozoon cuniculi		Q8SQZ	Q8SQZ8|Q8SQZ8_ENCCU			Peptidyl-prolyl cis-trans isomerase - Encephalitozoon cuniculi	Potential drug target		MKGHNTLILLLFGEVLKALAMHGTPYLDVEYNVGGEKRSGRITFELYWDITPKTARNFYEFVKGTEIGGKYYKYENGLFHRIIPGFMMQGGDVVMGNGSGSISIYNAEPFSDENFEIAHDSIGKLSMANRGPHTNGSQFFITFDKQHHLDGKHVVFGNVSGECLSLIRDIQKIDIDRDRPVHPVRIVRSGIVEEGEEKYL		200		3	Expressed	-1	 	NR-15950
Batch03	EncuA.00570.a	Encephalitozoon cuniculi		Q8SSH	Q8SSH9|Q8SSH9_ENCCU			RAS-LIKE GTP-BINDING PROTEIN - Encephalitozoon cuniculi	Potential drug target		MAETATADVSKQLTIIGSATCGKTSILTRHVKRTFGTEISPTVFNSVSNTYKHKDHVIELRLWDTAGQDEYARFRHLALPSADYIMIVYAVDDRSSYAEVKNSLVGQVREKAPQAKYFLVGAKTDLREDSARLEELARNGDSPITTSEGLELSQSIGAMGYFECSAKNNVGIDEIFEKISEYALRAQQKESMSFIGAMCASLWNCLSCRQIN		212		5	Purified	-1	 	NR-16464
Batch03	EncuA.00600.a	Encephalitozoon cuniculi		O9677	O96771|SYW_ENCCU			Tryptophanyl-tRNA synthetase - Encephalitozoon cuniculi	Potential drug target		MAEQRITPWDVEVVSTDEVPVAIDYDKIINQFGCEKFNQALADRLEKLSGKPAHYFFRRGIVFAHRDFNLLLDEIANNRPFYLYTGRGPSSKTMHIGHTIPFLLCKYMQDAFKIRLVIQITDDEKFLWKSMRLEDAMAYGRENIKDIVALGFDPKLTYIFSNVEASHHFEENILKISKTINLNEAIKVFGFDMSSNIGQVGFPAKEIAPCFSSSFRFIGKGAMCLVPAAVDQDPFFRLARDKAKALGEKKPSSIYVSLLPDLKGVNRKMSASDPNSSIYLDDAQDTIRKKIIAYAYSGGRKTLEEHREKGGDIDVDVPFEYLKYFLDDDQELEKYRSGYIKGEITSKEMKEKCVVVIQEFVSRYQESRKRVTDDDLRAFIDINKF		385		7	Crystallized	-1	 	NR-16465
Batch03	EncuA.00605.a	Encephalitozoon cuniculi		Q8SQR	Q8SQR2|Q8SQR2_ENCCU			CASEINE KINASE 1 - Encephalitozoon cuniculi	Potential drug target		MRGEIMDYTICREIGKGGFGKVYEVKKKADQKSYALKIETNAPKAGRNSIINEIQAYSELQGCEKIPRLVDHGSYEGLTFLVLPLLKYSLKDLLERHPRFFTKKSATIVGKKLLNAIEFIHGKGRLHRDIKPENVMFGHNNRIYLVDFGMSAPYLRGDGSHIPEVGGKSVSGTLWYMSINTHRGIEQSRRDDLESLFYLLILLYKSRLPWMEPGASVSKKQEARTKEIKENLSVYDLCDGIHGKEHLIKFFQHISSLEFAEKPNYRYLNSLLDKIFHSNKELQGYKRAPKKEDTGLIRTSLWHKFISILSPFEVKYDG		318		2	Cloned	-1	 	
Batch03	EncuA.00612.a	Encephalitozoon cuniculi		Q8SS5	Q8SS56|Q8SS56_ENCCU			Lysyl-tRNA synthetase - Encephalitozoon cuniculi	Potential drug target		MSMRLHARFCFFVVTSNGESLQVVVDTKEAGREQMAKFLRRGDVVGFTGNPGRTRTLEASVFATDIIVLTPCLRTIPTEHFGLKDPETIYRKRYMDLLINRESRNRFQKRAQIIGYIRSFLDSRGFLEVETPMMNLIPGGAAAKPFITHHNELKLDLYMRVSPELYLKKLVVGGLERVYEIGKQFRNEGIDLTHNPEFTSCEFYMAYADYNDLMEMTEELISGMVENMFGTDTIVYSPKKREERTESVELSFKRPFRVISILEELNARLGLDLSGETLDREETLEKLLSACDKEGLSVEKPRTLSRVLDKLIGHVIEPQCVNPTFVKDHPIAMSPLAKNHRSKAGLTERFELFINCKEICNAYTELNNPFEQRERFLQQTQDLNAGDDEAMMNDEDFCTALEYGLPPTGGWGIGIDRLVMYLTDAANIRDVIFFPTMKPE		440		3	Expressed	-1	 	NR-16466
Batch03	EncuA.00627.a	Encephalitozoon cuniculi		Q8SQV	Q8SQV7|Q8SQV7_ENCCU			Superoxide dismutase - Encephalitozoon cuniculi	Potential drug target		MVRNVVPMEFKLPELDYPYDALEPIIDEETMRTHHSKHHQAYINSLEKTLRSNSIKGKSLYYYVTKGRGIRGVKSSARRDLLNFSGGHYNHSLFWKMMCPPGTSGPMSPRLLEYIERSFGSQEKMVKEFSNAAVSLFGSGWVWLCYRQSEGILVIRKTYNQDAICMKTSSTVPILGLDVWEHAYYLKYKNVRSEYVANWWKVVNWGLVSRLFEEIALENKKLCVMSDGSIKFD		233		4	Soluble	-1	 	NR-16467
Batch03	EncuA.00646.a	Encephalitozoon cuniculi		Q8SRM	Q8SRM7|Q8SRM7_ENCCU			NUCLEOSIDE DIPHOSPHATASE KINASE A - Encephalitozoon cuniculi	Potential drug target		MERTFIMIKPDAIKRRLISRIIQRFEEKGLYLAASKCVIPKREVLETHYSHLSSMPFFSEMVEDMMSGMVLAMVWVGKDAVSIGRKLIGETNPQAASVGTIRGDYGVSTGKNIIHGSDCVENAEKEIKLWIGDDVQPVSFFDKEWIY		147		17	In PDB	-1	 	
Batch03	EncuA.00649.a	Encephalitozoon cuniculi		Q8SQZ	Q8SQZ1|Q8SQZ1_ENCCU			Triosephosphate isomerase - Encephalitozoon cuniculi	Potential drug target		MKGNKLLAGNWKMSSSLQTFEIIKSFRANLFAGNDTFIAVPFPYIHVAKKMFPEYIKVGAQDCSQFKSGPYTGEVSASMVSEMGAEYVIIGHSERRRWFGETSATVVKKIRNARSEGLKIVVCIGEDEKCREDGRHLDVIKDQLLSLGEEIGGEGIDIAYEPVWAIGTGKVPTNDQIREVVSGIKRWGTGMGFVGRVIYGGSVSMLNCQTILDVEEIDGFLIGGTSLKMDFCMISSEMSTKT		242		5	Purified	-1	 	NR-16468
Batch03	EncuA.00671.a	Encephalitozoon cuniculi		Q8SS0	Q8SS02|Q8SS02_ENCCU			DEOXYURIDINE 5'TRIPHOSPHATE NUCLEOTIDOHYDROLASE - Encephalitozoon cuniculi	Potential drug target		MEQEEIKMMILDGARAPRHINGVYKLYASISGRVLPRCGAKIPAGFMMKIPSCYFGKIQRTRIKKLGGVVDSDYRGEVCVLVYNDTDREFVYEKGDEVGEMAVCKIATPEIRDVSSNEASLQ		122		5	Purified	-1	 	NR-16469
Batch03	EncuA.00673.a	Encephalitozoon cuniculi		Q8SRH	Q8SRH0|Q8SRH0_ENCCU			26S PROTEASOME REGULATORY SUBUNIT 4 - Encephalitozoon cuniculi	Potential drug target		MSRDKSERDNLQDTTTINLRRRRRVKEGKAASKPPQVYPLMKCKLRYLKLKKLAHLLSLEDNILSLCEPDKSSEGSNSQKHVVEQLRGSPLSVGTLEEFVDDHHGIITTGVGLEYYVNIMSFVDKDLLEPGCTVLLNYKDNSVVGVLEGEMDPMVNVMKLEKAPSETYADIGGLEEQIQEIKESVELPLTNPELYQEMGIKPPKGVILYGLPGTGKTLLAKAVANQTSATFLRVVGTELIQEYLGEGPKLVRELFRVADMHAPSIIFIDEIDAIGGKRYNTSSGGRREVQRTMLELLNQLDGFDTRNDIKVIMATNKIEALDPALIRPGRIDRKIEFGMPDAATKKKIFDIHTSRMTLDESVNIELLITSKEDLSGADIKAICTEAGMIALRERRKTVTMKDFISAREKVFFSKQKMVSAGLYS		424		2	Cloned	-1	 	
Batch03	EncuA.00675.a	Encephalitozoon cuniculi		Q8SQT	Q8SQT4|Q8SQT4_ENCCU			NIMA-LIKE SER/THR PROTEIN KINASE - Encephalitozoon cuniculi	Potential drug target		MWIVGALDFILDIHAVERFRFIRRLSRGAHGTVYLLETEAPTREKVACKSMLKRYRRYAEKEVEMLSSISHRRVVRLLDFFPTKSGLSIILEYLNYGSLHEMIEYLMENGYRVAGDLVWSVLAQAADGLRYLHSKQIIHRDVKPSNILMNRTLVQKEELLEFKLCDFSLAKNLCGKESVCGIVGTPSYMAPEVVSGERYSTSVDIWSLGISIYELLTLRRPFEGRTRDELFRMIVQGGLPHSICADREMERLVRRCLSRTNRISARAITSDASVRVHLRMLEAKLRRGEEPSYDTLDSTE		300		3	Expressed	-1	 	
Batch03	EncuA.00682.a	Encephalitozoon cuniculi		Q8SRE	Q8SRE1|Q8SRE1_ENCCU			Peptidyl-prolyl cis-trans isomerase - Encephalitozoon cuniculi	Potential drug target		MAKEASGNVYFDVYANEESLGRIVMKLEDDIVPKTAKNFRTLCERPKGEGYKGSTFHRIIPGFMVQGGDYTAHNGTGGRSIYGEKFPDENFELKHTKEGILSMANCGAHTNGSQFFITLGKTQWLDEKHVVFGEVVEGMDVVHKIAKYGSESGQVKKGYRIEIRDCGVLGSN		172		17	In PDB	-1	 	NR-16470
Batch03	EncuA.00687.a	Encephalitozoon cuniculi		Q8SUF	Q8SUF5|Q8SUF5_ENCCU			Putative uncharacterized protein ECU10_0670 - Encephalitozoon cuniculi	Potential drug target		MRDLKPEEEKEVLKKLRFFIGDNVHRILSGEDRLFLHNQRVMILSERMRAATSMISRKNLGMVGTVIGKFTKSGSFRLGVASLNLLSRWAIHKVWIKNSAEMNYVYGNNALKSHVFRISEGIPINSGVFVFNQHDVPLGFGITALSPQGYSAAKGHALAILRQSDTGEYVRNEARV		176		3	Expressed	-1	 	NR-16471
Batch03	EncuA.00696.a	Encephalitozoon cuniculi		Q8SRG	Q8SRG9|Q8SRG9_ENCCU			PHENYLALANYL tRNA SYNTHETASE BETA SUBUNIT - Encephalitozoon cuniculi	Potential drug target		MTAVAQKIIENLKMQDEVRSSDIDAPYSEIHGALISLESRGICNVKMEESYEEVLTPEGEEVERSGSQEYLLLESIGEDGMSIEELERHSLGKMNAFRNKWIRREGNRVFRNVESIEDTVRNMVISMKRGTASAEEVEALRKRKLVSRRKKIVFIATKGPMFFDNTSYVTELTSEMVLDGSYRDLSFKHYNFNAEGNAPQCGSIHPLMKIREDFRRIFIELGFSEMATNQYVESSFWNFDALFQPQNHPSRDAHDTFFLLNPELSTDFPSDYLKEVGETHRGGKYNSLGYMSNWDIKEAQKNILRTHTTSVSARNLYRLAKKEFKPAKLFSIDKVFRNETVDATHLAEFHQVEGLVVGKGLNLTHLMGILREFFNRLGMGDIRFKPAFNPYTEPSMEVFGYHKGMDRWIEVGNSGVFRPEMLRPMGFDSDVSVVAWGLSLERPAMIKYGLKNIRELVGHKVDIEFSRKSEICFFD		475		3	Expressed	-1	 	NR-16472
Batch03	EncuA.00699.a	Encephalitozoon cuniculi		Q8SRB	Q8SRB6|Q8SRB6_ENCCU			EUKARYOTIC TRANSLATION INITIATION FACTOR 4E - Encephalitozoon cuniculi	Potential drug target		MELASQWVFWQNSNDESNAKSWGDDLVAVGEVSTVPEFLYLCDEISNAGIGRLCTMNLFRKGIKPMWEDEANIDGGRIIMDVPVSGKDNVGELWKRTMAFCVSNTVDNICGCVFNEKQSFYKIAIWFGKDYNQDVIKDMWQEALGPGRLSIYSFLHKKSLDSSKGKKKWGGRR		173		1	Selected	-1	 	
Batch03	EncuA.00702.a	Encephalitozoon cuniculi		Q8SUC	Q8SUC7|Q8SUC7_ENCCU			Putative uncharacterized protein ECU10_1270 - Encephalitozoon cuniculi	Potential drug target		MLRLLRILRDFCTCYRKKVVVGGERGTGRTWRDTGTAEPQVTQRHSTKPTLVLDLDNTLVYSTFRMPKLYDFCVEIPRSRNILIYVKARPYAAEFISAAEALYEVVIFTSAKREYAKKVVDRIDTNKNISRILYRESCTFTNGRYVKDLRKVGRSLDRVILIDDNPYSYELQPRNGIHIPPYTGAEDDDSLLKILRFLEGLPKDDLLGGTWQAPFRNSPMTGFGTL		226		1	Selected	-1	 	
Batch03	EncuA.00705.a	Encephalitozoon cuniculi		Q8SV1	Q8SV19|Q8SV19_ENCCU			ADRENODOXIN - Encephalitozoon cuniculi	Potential drug target		MDMFSAPDRIPEQIRIFFKTMKQVVPAKAVCGSTVLDVAHKNGVDLEGACEGNLACSTCHVILEEPLYRKLGEPSDKEYDLIDQAFGATGTSRLGCQLRVDKSFENAVFTVPRATKNMAVDGFKPKPH		128		5	Purified	-1	 	NR-16473
Batch03	EncuA.00726.a	Encephalitozoon cuniculi		Q8SRX	Q8SRX2|Q8SRX2_ENCCU			SORTING NEXIN GRD19 HOMOLOG - Encephalitozoon cuniculi	Potential drug target		MEEKSVLEITIPGSRNVQNKYTEYEVVCVTNSRSFRKCYTKVFRRYSDFHRLHCRLKYLMKVLPEFPRKRWNKMSREVVEERVRMLTVYMRFVCDQLLRSREGVEKIEADIVAFIQGRSSVPET		124		1	Selected	-1	 	NR-16474
Batch03	EncuA.00735.a	Encephalitozoon cuniculi		O6258	O62583|DYR_ENCCU			Dihydrofolate reductase - Encephalitozoon cuniculi	Potential drug target		MLALVVALASHRGIGNANALPWPRPLAADMAWFRTLSQSIPLISPDRIALAPSASNAVVMGRRTWDSIPSRFRPLANRINVVLSRGPARSTENTFFIQTFEALDSLPLPPSSMTFVIGGRDVYSLALESGRPHLIFATEVFESPECDVFFPHIDWASYEKRDITRDVSRLIDRTLASAFYSPETATFTENGTSFKMFLYTKPETR		205		7	Crystallized	-1	 	NR-15951
Batch03	EncuA.00739.a	Encephalitozoon cuniculi		Q8SQM	Q8SQM9|Q8SQM9_ENCCU			Serine/threonine protein phosphatase - Encephalitozoon cuniculi	Potential drug target		MYLVFNPSPMKRLVSKLLNLELLSEAEVQGICNKVSEILMREPNVPNKRAPVIVCGDIHGQFFDLVSLFRIDGIPSGKRYIFLGDYVDRGRNSLECILLLLLLKILYPENVTLIRGNHEQSTINRVYGFYEEIVEKYGNPRIWRMINEVFSLMCIGCLVDGRILCVHGGISPKIMSLNQIRRLDRLQPIGEGSEFADILWGDPYEGRGFQASPRGSGYLYGEDVVIRFLELNGLISIVRSHQLVIEGYKFHFPERNVITVWSAPNYMGKCGNPASILRINETLDVSDKDFCIFKATPQRKEFLEKLEGFNL		311		3	Expressed	-1	 	NR-15952
Batch03	EncuA.00742.a	Encephalitozoon cuniculi		Q8SRG	Q8SRG4|Q8SRG4_ENCCU			GLUCOSAMINE PHOSPHATE N-ACETYLTRANSFERASE - Encephalitozoon cuniculi	Potential drug target		MKKENGLLLTIGAIATLITILVLADGMFNRKISHESDGNIHSIDFHGLTMCDIPVIKRDRYTLRGLSMDDYGKGFIDCLNELTKSGVVTREQFEERYLSLCKEGNYKIVVAYDPSKEEVIGSGTLFIEKKFIRGCASKGHIEDVVVSKERRGEGIGRDVIEMLIDISRNMGCYKTALVCDPKNVEFYMKCGMTEKEREMVVYH		203		2	Cloned	-1	 	
Batch03	EncuA.00782.a	Encephalitozoon cuniculi		Q8SSA	Q8SSA4|Q8SSA4_ENCCU			Ribonuclease - Encephalitozoon cuniculi	Potential drug target		MESKNIFFSSFGQIEEEVVVGIDEAGRGPVVGYMVYGALVVPRGVLEDVGFKDSKVLTPAQRYNFFQMIKKKGFGYAYHCSHPDYITEMMQVRSVSLNEVSIGSVLRILDEVQSKCRRVDTIYVDALGDCRKYKERLEKDYPYRFVVEERADSKFQVVSGASIVAKVQRDMLISEFGEDLGSGYPSDPETIRWLRKNINVVFGFPPGVRYSWATVKKMLGERKSRPLKGALSGFYLDST		239		3	Expressed	-1	 	
Batch03	EncuA.00788.a	Encephalitozoon cuniculi		Q8SS3	Q8SS36|Q8SS36_ENCCU			SIGNAL RECOGNITION PARTICLE 54kDa SUBUNIT - Encephalitozoon cuniculi	Potential drug target		MITELGRSITNTLSNLLSSPATDQHIETAIREICNSLILSNVNPRYVSDLRDELRAKLDPGKMAPGFNKARMVQNAVYERLVDLLDPRTESYKIEKGRTSVVVFVGLQGSGKTTSICKYANFYKKKGYKVGIVCADTFRAGAFDQVRQNALKIKVPFFGSSEADPVKVASAGVERFRKERFELILVDTSGRHTQETELFTEMKDIIREISPSSIVFVMDAGIGQSAEDQAMGFKRAVDVGSIILTKIDGTTKAGGAISSVAATKCPIEFVGTGEGMDDLEAFDARRFVSRMLGMGDVEGLMEKVGSLGIDEKEVVKKLRQGRFTLGDFYDQFQKILSLGPISKLLEMIPGFSGLSLPDEDTFKKLIYVFDSLSRGELDSTGQVFEKEPSRIMRVARGSGTSVQGVVEILTQFKKAHAVMQKISSIPGIEGMMGNPSSMSLAQKAKLKEQARNILPKDLLDRMGSMF		466		1	Selected	-1	 	NR-16475
Batch03	EncuA.00790.a	Encephalitozoon cuniculi		Q8SRE	Q8SRE0|Q8SRE0_ENCCU			CYSTEINYL tRNA SYNTHETASE - Encephalitozoon cuniculi	Potential drug target		MDKTLKLYNSITRTIDIFTPRKGNEVKMYICGPTVYDSSHIGHARTYVMFDVIRRVLSDYLKYNVRFVMNITDIDDKIIARANETGASMEEVTRKYTEEFFEDMKTLNVRSPSFVTFVTSYVDKIVKFIEKLEANGLAYESRGSVYFDLNSYQQRYSYPLFKSKDGINSEGDENKDKRSPCDFVLWKRSKENEPRYESKWGHGRPGWHIECSVMSSDILGEDLDIHAGGVDLAFPHHENEIAQCQAYFMQEPWVKCFLHTGHLNISGLKMSKSLKNFTTIKEALKTISPRQLRVLFLHHQWNKDMNYEKEHLKFAETIEKKIFNFMSVAESMRKNALAFETLENADREVLRELGNVQEAVHAALLDNVDTPAVMKRIVEMINFTNARIKTISPSTVLVVKDYIKEITDVLGLSEEERQESPGEDLIAQLLSNFRESIREMARRKEPYSKFLEKCDWIRESIKDYGYIIEDNSEGSILRKK		480		5	Purified	-1	 	NR-15953
Batch03	EncuA.00835.a	Encephalitozoon cuniculi		Q8SQH	Q8SQH8|ARF_ENCCU			ADP-ribosylation factor - Encephalitozoon cuniculi	Potential drug target		MGNMMSKVNNLLYTKLRGLFSGQSERSITMIGLDGAGKTTLLLYLQTGEVHQTVPTLGFNCENVTLGSMKFQVWDIGGQNSFMRFWHQYINEGCGIIYMVDCADPQRFGKSGEELWRILNILNSPRPLLVLANKIDLIREHERSEVVKSIRNEFNLERYNGPSQVVPISVLQAGSMTSANDENGREIIDAFRWLNKELEKMPRAEAL		207		5	Purified	-1	 	NR-15954
Batch03	EncuA.00839.a	Encephalitozoon cuniculi		Q8SRJ	Q8SRJ8|Q8SRJ8_ENCCU			Glyceraldehyde 3-phosphate dehydrogenase - Encephalitozoon cuniculi	Potential drug target		MKVGINGFGRIGKLVYRILRERGVEVPLVNDPFLTPESMEYLLKYDSVFGRCREECRLEGKKMVYKGKATSLSKFHRPEDIPWSEHGIDAVVEASGAFTTLKDCEGHRDAKVVVITAPSKDAPMFVYGVNHHDYVSQRIISNASCTTNCLAPLAKVIDDNFGIVEGLMTTVHAVTATQKIVDGTGRCYRSGRSGLSNIIPASTGAATSVGKVIPSLASKLNGMAMRVPVPNGSVVDLVCRTRKETTIEGIADAIEKFSKNNEGIIGTTRDSVVSSDFIGDSRSSIFDVTASISMGSNFFKLISWYDNEYGYSHRVCDMLEYAYSRKK		327		7	Crystallized	-1	 	NR-15955
Batch03	EncuA.00881.a	Encephalitozoon cuniculi		Q8SW9	Q8SW92|Q8SW92_ENCCU			Similarity to SER/THR CYCLIN-DEPENDENT PROTEIN KINASE KIN28 - Encephalitozoon cuniculi	Potential drug target		MKTYIRERRLGEGTYAVIYLGYRALPQDKPLVSSGTRIEDVPVAIKKIKPTKYTQGHEISAIREIKSLKRIDSKYVVRLIDTFVYDKCVHIVLEYVETNLENVIRNSDKIIMPGDIKAWILMVLRGVYECHRLFIIHRDIKPNNILITSEGMVKLADFGLTRGIGNRMTPQAVTRWYRAPELLMGSRDYGSPVDMWSVGCVFAELFLRVPLFAGDTDIQQLDMIFRALGTPVEREWPGVSTLPEFLDFQQYPKASLNGLFSAASSDALDLLEKLLTLNPCNRISCDDAIKHPYFKSSPPPTPIGKLPV		308		3	Expressed	-1	 	
Batch03	EncuA.00884.a	Encephalitozoon cuniculi		Q8SVU	Q8SVU9|Q8SVU9_ENCCU			Similarity with M phase inducer phosphatase - Encephalitozoon cuniculi	Potential drug target		MTNSSAFASSDNEQCPAAVDQMYIKPFYEIPWSSSENIEFEDPGHDPFVDNSDAIKMNHLRGSGKQGKCREKAVWTSLQGMRGQSRAGPAPAANRHLIDFWKDFSNGEVFSLPTLGPGKSDSIQRISVDVAKQVVEGMYNIDYLVIDCRFPYEYRGGHIINAVNISSTKKLGLLFRRPRALIFHCEFSSIRAPRLAQHLRNMDRMKNPYPLLTIPEVYVMEGGYRKFYSRYPDLCDPKGYVTMDNLDYRDLYKRDKLRSNK		261		5	Purified	-1	 	NR-15956
Batch03	EncuA.00893.a	Encephalitozoon cuniculi		Q8SSF	Q8SSF2|Q8SSF2_ENCCU			THIOREDOXIN REDUCTASE - Encephalitozoon cuniculi	Potential drug target		MENIVIIGSGPAAYNAALYAMDKEPLLFEGGYIGNNGPGGQLTTTTSVDNYPGFPDGVEGPVLTDLMKDHAVSRGLRVVKETVSDLRKEGECFVVVSEKGERRARAVIVATGASARRLFVPGTGDGEFWQRGVSSCAVCDGFAYTNKITCVIGGGDAAMEEALYLSGIAKKVYIIHRRNEFRARNDMVEKARETVNIEMVTPYVLESALGTSKVERITIRNVETGEMKTIPMDGVFFGIGHDPNTSFLKNTKVEMDLNGYIVVRDEVYTNIPGLFAAGDVCDKKYRQAVTAAASGAISGMKAVEFLCKE		309		5	Purified	-1	 	NR-15957
Batch03	EncuA.00932.a	Encephalitozoon cuniculi		Q8SRV	Q8SRV7|Q8SRV7_ENCCU			TYROSYL tRNA SYNTHETASE - Encephalitozoon cuniculi	Potential drug target		MSVEQKLYLITRNLQEILGEEELKRIVSERELNVYWGTAITGKPHIAYLVPLMKIKDFVDAGCNVKILFADIHGFLDNLKAPIEKVQHRCAYYEKLIKSALKMLCVDLDRIQFVKGSEFQKSERYTMDLYRILSITSKHDAKKAGAEVVRQVENPMVSSLVYPSMQALDEVHLSVDAQFGGVDQRKIFTYARKYLPLLNYEKRIHLMSPMLPGLNSDKMSSSDDLSKIDLMDSKEAIWRKIRKCFCEEGNKDNGLMMIFSHIVFPILQLKGECVRITDRDGREMAFEKYQEFEEEFVRKSIHPGDLKSNAARLIDEIIRPIREEMEKDLDMVREAYN		337		5	Purified	-1	 	NR-15958
Batch03	EncuA.00939.a	Encephalitozoon cuniculi		Q8SR5	Q8SR57|Q8SR57_ENCCU			RIBOSOMAL PROTEIN S6 KINASE - Encephalitozoon cuniculi	Potential drug target		MPSKLPDRNAHRMIRKEDIMCVEKTGFGPFWEEFLVFIEVGERIGGLYGLRVMKKKKIVDYGEQNMMHHEYYVRSRIRHSFLINTICGFQDYEHLFLLSEQSQNYLIKLINSEGRFSAKVSRFYLAEILLAIQHLHSKGLSYGFLSPSNMMIGDDGHIKLKYDFLNRIDCVVGDPERNVEYASIDYKERGEISPVSDYWSMGIILYYMLVGVTPFAAPDTALVVARIKRGRIEFPEFLDENARDLISRLLAVSPRDRLGYAEGDAETIRRHPFFGGMNWEEVLQKKVAPPFLFNTTRKECLSRSANLKVLYTTDYLPDQKDGYGQTFRGYGATYAPDTYRKIWRCGYI		348		-2	Work stopped	-2	Work stopped	
Batch03	EncuA.00954.a	Encephalitozoon cuniculi		Q8SQW	Q8SQW2|Q8SQW2_ENCCU			CELL DIVISION CONTROL PROTEIN 2 HOMOLOG - Encephalitozoon cuniculi	Potential drug target		MEPAEEGEILAHRRFTATKMEYEKIRIIGEGTFGQVILARKGRARYALKKVSKEKEGLSVTTIREVQVLRAMGHPSIVRLIEVVVEPGGDIYMVFPYFPYDLNRFIRSNKMTCSEIKHIFYQIAQGVCYIHSKGIMHRDLKSANILLDQKLNASIADFGMARYTTKTGAYTPGMVTLWYRAPEILLGSSSYTYAVDIWSLGCILTEMYLGHMIFQGSTEMLQLEMVIHACGSINENSYPGVQDLPGFRNFRLPQSPRRIEGIIRKHDASAVELVSKMLCLDPSKRITVEQVVGSKYFEHEARRDASSAGLQGCSYREDRLSLSKRKNVD		329		3	Expressed	-1	 	NR-15959
Batch03	EncuA.00967.a	Encephalitozoon cuniculi		Q8SRF	Q8SRF1|Q8SRF1_ENCCU			Proteasome subunit beta type - Encephalitozoon cuniculi	Potential drug target		MDSSIGIKGRNFAIVAADTKISSSILVVKENHEKFQVIKDRIVMAMTGNQGDAFRTMLYVSESALYEEIQNGIELSPSVLAHMIQNKVHESLRRRQLDISSIVAGRGPEKYDLWSVDKYGAISSVPFCASGYAAYFVYGILDREYSEDITIDAALSIMQKCVNLLKERLMINLEGFMVKIVTDDGILTRTLVPEIKG		197		5	Purified	-1	 	NR-15960
Batch03	EncuA.00972.a	Encephalitozoon cuniculi		Q8SRP	Q8SRP4|Q8SRP4_ENCCU			PROTEIN OF THE ERV1/ALR FAMILY - Encephalitozoon cuniculi	Potential drug target		MKREQSYGRILVVLAAAWVTYRCYGLMVRDREGKVSSELLGGSGKSENPRTEKLSKKEIRERLGRSTWTLLHTMGARYPAFPTYQQKKDTLSFIHLLSSVFPCGECTKHFQKLLSDYPPRVGSNEEFKTWLCEVHNVVNRRLGKTVVDCRTVDEIWDCGCEA		162		2	Cloned	-1	 	NR-15961
Batch03	EncuA.00997.a	Encephalitozoon cuniculi		Q8SVR	Q8SVR6|Q8SVR6_ENCCU			Similarity to E. COLI PERIPLASMIC DIVALENT CATION TOLERANCE PROTEIN CUTA - Encephalitozoon cuniculi	Potential drug target		MKRPFAVSVTYPTRESAEESSCELVRRRLAACCQISEITSIYFWKEAIVKETEYKLIAKTFSSLFAGIQEFVAGSHPYEVPEITGMEMHLASRQYLEWMNSCVDDTGQAPNTRQ		114		7	Crystallized	-1	 	NR-15962
Batch03	EncuA.01002.a	Encephalitozoon cuniculi		Q8SS1	Q8SS11|Q8SS11_ENCCU			GTP-BINDING NUCLEAR PROTEIN - Encephalitozoon cuniculi	Potential drug target		MERRELTYKICLIGDGGVGKTTYINRVLDGRFEKNYNATVGAVNHPVTFLDDQGNVIKFNVWDTAGQEKKAVLKDVYYIGASGAIFFFDVTSRITCQNLARWVKEFQAVVGNEAPIVVCANKIDIKNRQKISKKLVMEVLKGKNYEYFEISAKTAHNFGLPFLHLARIFTGRPDLIFVSNVNLEPTEVNYDYHSPEESKYIDYMEQASKMAPEE		214		5	Purified	-1	 	NR-15963
Batch03	EncuA.01011.a	Encephalitozoon cuniculi		Q8SRF	Q8SRF8|Q8SRF8_ENCCU			CALCINEURIN BETA SUBUNIT - Encephalitozoon cuniculi	Potential drug target		MGSLSSTMLCEEEIEELKNTTVFDEREIEHLYERFQFLDRESRGYLTYNELNNIPEFQSNPFSHLIMKSIEKMTDYEKMTFPHFLEFLGIFSERNSKRNRIRYLFDIFDLNGDGRLCRNVLIRINKMMGQDGRVEEAENLLNIYDEGGKGYLDISDFTRFYESDPLIDKNMIIDFSKNLKERRQVGFMQVLWPSTYKDEP		200		5	Purified	-1	 	NR-15964
Batch03	EncuA.01086.a	Encephalitozoon cuniculi		Q8SS8	Q8SS83|Q8SS83_ENCCU			CYTIDYLATE KINASE - Encephalitozoon cuniculi	Potential drug target		MKTYKIAVDGPAASGKSSTSDLVARKLGFSHLISGNLYRAVTYGLVRRFGEVRPGDEEQKRFVLELSIEVRNNRVFLDGEDVSESLRKEVVDRHVVSVAREKYIREKVFTIQRSVIDLEKRGIVVDGRDIATRIMPNADLKVFLTASPETRARRRYMEGGSESYEELLESIKKRDHNDRTREHDPLVATCDSIVIENDSMTLEETADEIIRLFRRVESFN		220		10	Diffraction	-1	 	NR-15965
Batch03	EncuA.01089.a	Encephalitozoon cuniculi		Q8SSB	Q8SSB5|Q8SSB5_ENCCU			GTP-BINDING ADP RIBOSYLATION FACTOR - Encephalitozoon cuniculi	Potential drug target		MYFSRIVRSIKKERSQLRILVLGLDNAGKTTILHKLLGKPTERVHPTFGYQIHDVVYKAHSLIVLDIGGQSVFVEYWSSYYEDVDGVVFVFDSSDRRSFAEHIGHIRSALVDTPMLILANKSDLNPTFNAESLGSDLCELLKKSDVRLVKCCGVSGDGLEAGFDWILGKSMRRLVSEAEKETAEALQGQVL		191		2	Cloned	-1	 	NR-15966
Batch03	EncuA.01098.a	Encephalitozoon cuniculi		Q8SS8	Q8SS80|Q8SS80_ENCCU			HISTONE DEACETYLASE 1 - Encephalitozoon cuniculi	Potential drug target		MNNKRVVYFYDPEIGCFSYAMGHPMKPLRVKMTHTLLVGYELYKYMDVLRPFQASYENLTNFHAVDYINFLSSVSSENMEEMIKDLHKFNIRDDCPVFPGLYDYCRLTSGGSIYAAQKINSGKYDVAINWAGGLHHAKRGEASGFCYVNDIVLGILELLKYNKRILYIDIDIHHGDGVEEAFYTTDRVMTVSFHKYGDYFPGTGMVTDTGLAKGKGYSVNVPLKDGIDDESYFSIFKPIVSKVIETYQPNAIVLQSGADSLSGDKLGCFNLSHLGHSRCIKFVQSFNIPLILLGGGGYTIGNVSKAWAYGTSVVLDVDIPREIPYNEYFDYYAPTYRIDVPTSNMANQNTREGLEDIIAKVYENLRSLSHAPSVQMVSIPPSFISDESDEDEVSKKKAEAEDSDDYKAFSDSKDED		416		3	Expressed	-1	 	
Batch03	EncuA.01101.a	Encephalitozoon cuniculi		Q8SRV	Q8SRV1|Q8SRV1_ENCCU			ATP-DEPENDENT RNA HELICASE - Encephalitozoon cuniculi	Potential drug target		MIKLIQEYLSFVSSPMRNPLVLRSLKNKILEKTKSRKQMACTVDTPRPWRSPRIVSNGSKEPLTEWPSSFNKGLLPPHPTDVQRFVIPYILAGEGVDVISETGSGKTLSYVLPHIHLLESGDKRLLVIVPTRELVSQVGQVFRKFSEGLLRIVEITGEVSIESQRLQVSRPFDVAISTPGRLRELLELKSIGGFEYVVVDEADRLMQHDIRSDVTFILERMKPEVASFFSATPFEWSGGTRILVGNVSVGRDVEEFFMYVEKKEKMQVLGEILVSCEGWLAKNMGVDRNGLEVKKIIVFCNSIRTCENLHKRFRQLLVLHSRRTMQERKAVIEALEGERAVLIATDLGGRGIDIKDVDLVVNYDLPRAVDGYVHRCGRTGRQRKGMALSMICREDREILPKLKRLVEKRGGTVPGFMNVKEDVILD		426		3	Expressed	-1	 	NR-15967
Batch03	EncuA.01107.a	Encephalitozoon cuniculi		Q8SRC	Q8SRC8|Q8SRC8_ENCCU			RAS-RELATED PROTEIN RAB5 - Encephalitozoon cuniculi	Potential drug target		MSRLKEDMKTYTFKMVVLGYYSVGKSSLVLKYVKGEFNPNEESTIGASFLTKTVFTQERGIKFEIWDTAGQERYNSLIPMYYRGAQVALIVYDITSVESFETAKRWVEELGFEKPREFIKVLVGNKSDLDSDRKVDYQQGKDYADSQGLLFFESSAKTGKNIAEIFSAIAERVPKEETKKKTKGFRLRDDYIKYLCC		197		5	Purified	-1	 	NR-15968
Batch03	EncuA.01116.a	Encephalitozoon cuniculi		Q8SSH	Q8SSH7|Q8SSH7_ENCCU			Glutathione peroxidase - Encephalitozoon cuniculi	Potential drug target		MERGMESEAFYGLSARGWDGSEVSLGSFRGCVIMIANVASSCKFAESNYKSFAGLLDKFYRKGLRILLFPCNQYLGQESRPIEEIRGEVSKKYSDRFVVFDKVDVFGKGAHPVFRHLVNTKNGKGRLGNFIKWNFTKFLVDRKGCVVKRFGPSDIVKEDDENLLRSIEDGENGMQNS		177		5	Purified	-1	 	NR-15969
Batch03	EncuA.01150.a	Encephalitozoon cuniculi		Q8SRU	Q8SRU0|Q8SRU0_ENCCU			CASEIN KINASE II ALPHA CHAIN - Encephalitozoon cuniculi	Potential drug target		MVVVTVARSNADVNEKKDERYWNYECYTITTGSIEKYQIYQRMGRGKYSEVFEGRKDREKIVIKALKPVRKAKICREVLILRNLSHKNIIKLMDVVVDPESQIYSLIFEYIEHEDYAKIFEKLCYKDIVEYSRQILSALSYCHSMGIIHRDIKPQNMVINQARRELKIIDWGLAEFYHPKKEYSVRVASRYYKGPELLVDYPYYDYSLDIWSFGCVLAELVFKKRPFFHGESNSDQLVKIARILGYTHLKKYVRKYKMAPLNPKYEGVGERVLLSSFTPPGKTGLYTNAIDLLEKILIYDHQDRPTADECLRHPLFESR		319		3	Expressed	-1	 	NR-15970
Batch03	EncuA.01167.a	Encephalitozoon cuniculi		Q8SQM	Q8SQM0|Q8SQM0_ENCCU			REPLICATION FACTOR C - Encephalitozoon cuniculi	Potential drug target		MDLLVNKYQPSEIQDIVGNEATMELVSLMIESRDMPHLLFTGPPGTGKTTCAKILARRLLGNKEGLLELNASDERGIDTVRTTIKSFAQRRVKDCEFKIIILDEADSMTTTAQQAMRRVMEIHSSECRFILICNVFTKIFEPIQSRCAILRFDRIEQSVILKRLKEISEGEGIRITAEALDLVVELSDGDMRQSLNILQACINSPGTVDQDYIIKIIGLPSPKRIEKVLQRLLKREVEEALEMFDEIWEEKFDPLDLINSFFRAAKNMESYELLKVIGLANLRISEGVNSRLQFYGMFWDILDMGSKRL		309		3	Expressed	-1	 	NR-15971
Batch03	EncuA.01171.a	Encephalitozoon cuniculi		Q8SR6	Q8SR63|RRP3_ENCCU			ATP-dependent rRNA helicase RRP3 - Encephalitozoon cuniculi	Potential drug target		MEFGDLRIDESLIKTCQEKGITRPTEVQRQVIPAVLGGGDVIAVSQTGSGKTLAFVLPIVSHLLQKNRSFYCLVVAPTRELSSQIAECFNMFQATGLRVCLLVGGANFNVQANQLSKRPHVVVGTPGRIAEHVLKTKSFRTERVRKFVLDEADRFFEQDFVEDLETIIPSLREKRQTLLFTATMSDEISKLSSSILKRPKTIRTAEKYETVPALKEYYLFVAMKWKNSALVELLEMSQGMSVIVFVSMCVTARVMSLALARLGFCSEALHGELSQEKREEAMRSFKESRFNVLVCTDLGSRGLDISHVDLVINFDVPKSGKDYIHRVGRTARAGRSGTAITLVTQYDVEQIQKIEFTLEKKLEEFKMMKKNFGTICARIEEAIQEAQETLKEERKRNRRP		400		7	Crystallized	-1	 	NR-15972
Batch03	EncuA.01251.a	Encephalitozoon cuniculi		Q8SVC	Q8SVC2|Q8SVC2_ENCCU			Similarity to adenylate kinase - Encephalitozoon cuniculi	Potential drug target		MVNSGRLAPDEIVNELVLKKIRSMSKYILDGYPRRIEQAGMLGDDVDLVIFIDVDEDTCISRICGRNEGRDDDDEEVGRKRCMVYNKETAPVLEFYKRHGKLLTINGCASPGTVFEEIRRSIE		123		3	Expressed	-1	 	NR-15973
Batch03	EncuA.01276.a	Encephalitozoon cuniculi		Q8SS4	Q8SS44|Q8SS44_ENCCU			CALCIUM-BINDING PROTEIN OF THE RECOVERIN SUBFAMILY - Encephalitozoon cuniculi	Potential drug target		MGSGASTIPDNVEEDVRQFSHFPPRDIQEWSSSFRSEYPGGCMTLKDLEAMFRSFFPFGSPTNFSRRLFETINISQTETVDFHELLIAYSILVKGSDHEKLRWMFRFYDKDNDGVVSKEEMVEVVQCLADMTSHTLDISIDAEGIVSEIFASVESDRGFLTFEDFKTLSIRSEKLFKMLVPFSD		184		7	Crystallized	-1	 	NR-15974
Batch03	EncuA.01277.a	Encephalitozoon cuniculi		Q8SRZ	Q8SRZ8|Q8SRZ8_ENCCU			Phosphoglycerate kinase - Encephalitozoon cuniculi	Potential drug target		MKTISNAEIEGKRVFLRVDFNVPILDSVVLNDFKITSVLPTIRLLHSRNPRRVIIGSHLGRPKGKYSKELSLRPVYSVLKARLWEELGVELDFCDLWDVGNVQSPWILLENLRFYSAEEDAGDKDAVDQYRNVFVDNMDVAVIDAFGCLHRECGSIQRTGLPSFSGLLVQKELNFTKEIMEERVDLMILGGKKVSDKIKLLESLGQKTGSLFVTGGLAFPFIRYILGKEVGKSIGESVSEEEVKRIHKICEEHKTRIILPSDFTVVCNDSVQTTSNIPPEGSAMDIGPETIEMLRREVSKAKAVFWNGPPGMYEEQSFSRGTEALVSALESLKGEGKKSFCGGGETAGAIRLFGSYDAFTYVSTGGGVLMKLLGGKRLPGLDFLSMQP		388		5	Purified	-1	 	NR-15975
Batch03	EncuA.01299.a	Encephalitozoon cuniculi		Q8STV	Q8STV7|Q8STV7_ENCCU			Putative leucine repeat-rich protein - Encephalitozoon cuniculi	Potential drug target		MSDAVYIVHRQLEKIPTIPEHVRTVDLRRNNISRMTLNKAESVEYLDLSDNRIRTISSLENVPNLKVLDLSYNLITDISIPPMNLEELYLISNDIATIHGLNLPRIKKLDMAVNDICKIENLEKCTTLEELYLGSNQIGAVEGLEEMRSLKILDLQNNKLELVDCSMIPSSVEVLLLGENRSLEVVENIELLKNLKILGLEKTRVSENMEGKSFTIWR		218		7	Crystallized	-1	 	NR-15976
Batch03	EncuA.01303.a	Encephalitozoon cuniculi		Q8SRM	Q8SRM0|Q8SRM0_ENCCU			26S PROTEASOME REGULATORY SUBUNIT 10 - Encephalitozoon cuniculi	Potential drug target		MFQEEKNKLYEEYTQALLSNEKAYKALKAEQEVYRQTHKHYLKSESDVKALQTVGHIIGEVLEKLSDEKFIVKSSQGPRYVVGCMKAIDRAKIATGTRVALDITTLTIMVVLPREVDPMIHLMGEESPREISFESVGGLKDQIRELREVIELPLKNPDIFKRIGVHAPKGVLLYGPPGTGKTLLARIVAATMDVNFLKVVSSALIEKYIGESSRMIREMFAYARRKAPCIIFMDEIDAIGGKRSRESSSSDREVQRTLMELLNQLDGFKELDSVKVIMATNRPDILDPALLRPGRLDRKIEIPLPNEQGRKEILKIHSRLMNSIEEIDYDSLVKLTSGFNGADLRNVCTEAGMIALKDERDYVKHEDFVKSARKIADAKKLETRLDYRKK		390		3	Expressed	-1	 	NR-15977
Batch03	EncuA.01308.a	Encephalitozoon cuniculi		Q8SQX	Q8SQX0|Q8SQX0_ENCCU			DNA REPAIR PROTEIN RAD51 HOMOLOG - Encephalitozoon cuniculi	Potential drug target		MSEEYQYQDTEYHSESISISELKNGGILAVDIAKLIEAGFTTVESLAFAPKRQLLSIKGFSDIKVDKLIKEAAKLVPMGFTTASAYHQRRSELVYLTTGSSEVDKLLSGGFESGSITEIFGEFRTGKTQLCHTVAVTCQLPPEQGGGGGKAMYIDTEGTFRSERLVPIAERFGLDPNEVMDNISYARAYNSDHQSQLLIKASAMMSESKYSVLIIDSATALYRTDFSGRGELGARQLHLAKYLRSLVNLAETFRIAVIITNQVVSNVDGAVGMFTGDIKKPIGGNIMAHASTTRLYLRKGRGETRICKIYDSPCLPESEAVFAITEQGINDPDE		334		4	Soluble	-1	 	NR-15978
Batch03	EncuA.01336.a	Encephalitozoon cuniculi		Q8SW0	Q8SW02|Q8SW02_ENCCU			Similarity to RAS-LIKE GTP-BINDING PROTEIN YPT1 - Encephalitozoon cuniculi	Potential drug target		MDSECKYLFKMILIGNSGVGKTCLMKRYTDETYSFTQSSTIGVDFKIKSLEVAGEKVKLQIWDTAGQERFRAIISNYYRGAHGIIIVFDMGSKESFDNLGDWLSEVRKNTSENVEIIILGNKVDDKEKIVVTDEEIEKFLGENGIEKSSFYMTSAKDNICVNESFEHLTKRLIEKYKKIGFGTAKESFKLNARDSKSACCM		201		5	Purified	-1	 	NR-15979
Batch03	EncuA.01411.a	Encephalitozoon cuniculi		Q8SR8	Q8SR88|Q8SR88_ENCCU			Proteasome subunit beta type - Encephalitozoon cuniculi	Potential drug target		MEETLRRDIRKIDATCVDQETIRSLIKPYHGTTTLAFIFKEGMVIAVDSRATSGSYIASQTVNKVININKNLLGTMAGGAADCLFWENLMGLYAKNYELTNGRRITVAAASMYLSNCVYRYKGYGLSMGTMICGYDSSGPSIYYVDDDGKRVSGSLFSVGSGSTIAYGILSSSYRFDMDKDEALNLGRDAIFHAAHRDAFSGGLINLYYMNEDGWTKVGSYDVNEFDKE		229		3	Expressed	-1	 	NR-15980
Batch03	EncuA.01426.a	Encephalitozoon cuniculi		Q8SR9	Q8SR90|Q8SR90_ENCCU			CELL CYCLE PROTEIN KINASE - Encephalitozoon cuniculi	Potential drug target		MEKYENIKQVGEGAFGQVYKSRRTSDGAVFAIKKMPVDRETGFPFTAIREIKLCKSVINKHIIGLDEIVFEEGFIFVVLEYMPYDLTGLLASGAKLSTDQIRSITSQLIEAVSSMHGMGLVHRDIKPSNILLDCHGMLKLTDFGLTREISGMMTNRVCTLWYRAPELLLGETSYSLKVDAWSVGCIMLEMRLGRPPYRGSDEVSQIKLIFEELGIPQDKYKWSDLLDVDIYSKSRSTEEIIAERYGHLFDEEELKVLSGFLCLTSRKRLSVANSRYFTVISSHKNTYIPLSFEEAHELYTKERKETKKP		309		3	Expressed	-1	 	NR-15981
Batch03	EncuA.01427.a	Encephalitozoon cuniculi		Q8SR6	Q8SR69|Q8SR69_ENCCU			INORGANIC PYROPHOSPHATASE - Encephalitozoon cuniculi	Potential drug target		MPAYSTVRVGKKYSPSFKVYVTQDGKIVSPFHDIPLYMSGNREIVSVVNEIPRFENGKFEINKEEAFNPIKQDIKKGWPRFVKNVFPMKGYLWNYGALPQTWENPHEVDRHTGARGDNDPLDVIEIGRKRKEVGEVYQAKVLGSIALVDEGECDWKVVVIDVNDEKAKEINDIEDVRKVYEGLLEQTIFWFKNYKVPDGKPKNNFALDGKYMDKKFTVGIIKSAYENWCGMINSKSDTNICKENSTLMDKVDSPAIIQEDLSDEEVPECVHQFEFIK		277		7	Crystallized	-1	 	NR-15982
Batch03	EncuA.01443.a	Encephalitozoon cuniculi		Q8SR6	Q8SR62|Q8SR62_ENCCU			BIS 5'-ADENOSYL TRIPHOSPHATASE OF THE HIT FAMILY - Encephalitozoon cuniculi	Potential drug target		MEFGDHVIPFDHVIVKTRHSFIFTNIRPFLPLHILASPISRKQRLYELTAEETSDLFNSVRVAMKGLRELCDGFTINIQDGECAGQTVFHAHVHIVPRVAQDLKDNNDIYKEGALDSADRPAREYNEMKEEAMRLREVIGKAFDAEGIYHQKSLQ		155		5	Purified	-1	 	NR-15983
Batch03	EncuA.01450.a	Encephalitozoon cuniculi		Q8SSG	Q8SSG6|Q8SSG6_ENCCU			DNA REPLICATION FACTOR - Encephalitozoon cuniculi	Potential drug target		MLWTEKYRPKSTDAFEGPEHLKNILRNSSGRGHPNLLLYGPPGTGKTTFAHLLASQKLELNASDERGISVIREKIKVYASTLGKDKTVILDECENLTSDAQHCLRRVIEDSVNTRFIFITNYPSKIIGPLRSRLVSVKFTPTESKILENIGSKEGLGYDKELYHRILKLCGNDLRRAINVLQGVAPLGSFCIEEAVGAVPQKTVDMFWEVDRPRVVEYVREFLREGYSALQLIHQLAGSSKGSDAQSAELHLALSLLEEKSVSGCSDELVLYNLLGRKIEIFG		283		3	Expressed	-1	 	NR-15984
Batch03	EncuA.01451.a	Encephalitozoon cuniculi		Q8SRI	Q8SRI3|Q8SRI3_ENCCU			MRK1-LIKE SER/THR PROTEIN KINASE - Encephalitozoon cuniculi	Potential drug target		MESDGFPSRTNFGLPQMATLSQKKLMESVRLMEREWVKMHKALVRSRCGEVKEVRYRYVEMIGRGSFGVVVKIMDDRHNFFALKRVYQDRRYHNRELGILMEVDHPNIVRLVSYFHTDKTSSGAYLNIITDFVGMNLEEYIKANRGVETEEIRSVYRQILEGLRYLHEKNICHRDMKPSNILIDTNGLVKICDLGSAKVIKSGERNITYICSRFYRAPENLLDYKEYDFKIDIWSVGCVIAEFRHPGPIFKGDTSGSTLNRILEIVRVTSDDLIGLGCLKPDLKQGVGIRKYLEAFFSDPDLLEVLEKSLAFSPCKRSTASELLRKQFFQQAHE		334		3	Expressed	-1	 	NR-15985
Batch03	EncuA.01470.a	Encephalitozoon cuniculi		Q8SRB	Q8SRB4|Q8SRB4_ENCCU			HEAT SHOCK TRANSCRIPTION FACTOR HSF - Encephalitozoon cuniculi	Potential drug target		MMSMRLATGSEFVVKLFQILEEPENYPYISWMPDGRSFVISDQQGFSEFVLEKHFRHKNWSSFVRQLNKYDFYKVRRDGERTGCIEAMWEYRNKHFQRGKHELLSKIRRKKAPSEGCGAGGTNPKQIESGIVYQSHVLDTVRSISKYLQTVVEDINEIKKYIYHERMRIALKTSVLFVREGVPGSEWVYGALKIPNYSLTVVEESADVGSIMRWRYDVVVLYANSPRCITAVSRIRDEDEEVPIVLVVDEGFKSEYANILGIRATEALLMPFDPSELVDAINRHGSQRSPEGVHG		295		4	Soluble	-1	 	NR-15986
Batch03	EncuA.01475.a	Encephalitozoon cuniculi		Q8SR0	Q8SR03|Q8SR03_ENCCU			CHOLINE PHOSPHATE CYTIDYLYLTRANSFERASE - Encephalitozoon cuniculi	Potential drug target		MKKDDASEEYRMMMPSYPDRNAFEYEDMTTDVGMYRVPVNRPVRIYCDGVYDLFHYGHARSLKQAKNLFPNVYLLVGVTDDDITVRLKGNLVMDENERAEGLIHCRYVDEVITSAPWELTLEFLQKHKIDFVAHDDIPYKGEDKDDIYKFVKDMGMFIPIRRTKGISTSGIITSIVKNYDMYVRRNLERGVSAKDLNISFLQMKRIKMSKKMNEMIKNVDIQREIDDIRREIRIAMRYWERVSNEIISGFIENFYHGKSSNRFIDRLVGLVKLKKENA		278		3	Expressed	-1	 	NR-15987
Batch03	EncuA.01477.a	Encephalitozoon cuniculi		Q8SQQ	Q8SQQ1|Q8SQQ1_ENCCU			GTP-BINDING PROTEIN - Encephalitozoon cuniculi	Potential drug target		MAFLHLCLCIKINKGAGIQMRSTYKIVFLGSSNVGKTTLMSQYLHQEVQKSYGPTIGLDFVSTTIVVSGHRVRLQLWDTAGQERFNSIIPNYTRNSFLAIIVFDMKDKGSFESIDHWINTLTKANDSSGRRVRILIVGNKKDLSDEDTRGWYREAGNRKAKKHGGEYVETCAMKHEGIEDLVKAVDRLIEEDLESPMEEESTVRPESIRFTKRRGCC		217		2	Cloned	-1	 	NR-15988
Batch03	EncuA.01479.a	Encephalitozoon cuniculi		Q8SQZ	Q8SQZ4|Q8SQZ4_ENCCU			SER/THR PROTEIN KINASE - Encephalitozoon cuniculi	Potential drug target		MKKKVLTFPSEKIGFSSDNEEFDLVMARGDYLAKNKSQKYMIIDMLGTGTFGQVVRCVGSDGEEVAIKVVKNQPKYYNYEMNEVRILHKLLYNNLNDRFVTIKDVFMYKQHLCIVEELLGRNLYTFLKMTRFKGLDHPTLRTILHQILEGMVQLSLLGIIHCDLKPENILIADYDTFKIKIIDFGSAVTSPQGSHFYVQSRYYRAPEVILGIPYGSSCDIWSLGCIGYELYVGHPLFPGKDNMDQIGRIHGLFGSLPMFMLEHGKNSSTFFEKENGYRFMGPPSNFTLEDMKKMIRSKGNSKEDDNMLIKFLLRALQPSHLIRPDAKSLASHSYLKVRDTSAEADKACNDRSGVQQNIFPANKNMRHMSTTGVILPSKKQKPTDDRRKISVYGISYENNLNRDSE		405		4	Soluble	-1	 	NR-15989
Batch03	EncuA.01483.a	Encephalitozoon cuniculi		Q8SQT	Q8SQT9|Q8SQT9_ENCCU			Diphthine synthase - Encephalitozoon cuniculi	Potential drug target		MGDKSPIPKPPMLYLVGFGLHSYKDITLRGLEAVKGSATVYLESYTSIHGESLDAFEKLIGKKVHLADRAMMEQTDKIVDESCRENVSLLVVGTPLFATTHSDIMIRAKEKGVDVEVIHNASIINVLGCCGLYSYSFGRVVSIPYFTERWKPTSFYDNIVRNHQSNLHTLCLLDIRTDEDRFMSVNEAVDQILEAAAITGSPLINEDTRIFAVCRFGSPSEEIVYGKIGDLKLRSFGDPLHSLIVPAELDRVEAELVGSLFK		262		7	Crystallized	-1	 	NR-15990
Batch03	EncuA.01497.a	Encephalitozoon cuniculi		Q8SRB	Q8SRB2|DBP2_ENCCU			ATP-dependent RNA helicase DBP2 - Encephalitozoon cuniculi	Potential drug target		MMHRGYGGDRRGFRPSFRSDRNSRYAPRTRREPQRYDPMPELAPVEFQKNFYQEAESISRMTPSEVSSFRKTNEMIVKGTNVPHPIQKFEEAGFSSEVVSSLVEKGFSEPTAIQGQGWPMALSGRDMVGIAQTGSGKTLSFILPALVHAKDQQPLRRGDGPIVLVLAPTRELVMQIKKVVDEFCGMFNLRSTAVYGGASSQPQIRALHEGAEVVIATPGRLIDLHDQGHAPLSRVTFLVLDEADRMLDMGFEPQLRKIIPKTNANRQTLMWSATWPREVRGLAESYMNEYIQVVVGNEELKTNSKIKQIVEVCSGREKEDKLIGVLDNFKGDKVIVFCNMKRTCDDLEYVLNRSGYGAAALHGDKSQNIRDKVLDDFRSGRRPILIATEVAGRGLDVNDVKLVINFDFPGSCEDYVHRIGRTARGNTKEGISHTFFTVGDKANARELIRMLREANQTVPSDLEDMVRVSNDRYGSRSTRHGYDYRGRAGRFPYRG		495		3	Expressed	-1	 	
Batch03	EncuA.01512.a	Encephalitozoon cuniculi		Q8SSD	Q8SSD2|Q8SSD2_ENCCU			ATP-DEPENDENT RNA HELICASE INVOLVED IN mRNA EXPORT FROM THE NUCLEUS - Encephalitozoon cuniculi	Potential drug target		MAEKTLIQDDKEVARELFTMIKHDTTAIETGLDGSISGVGTDRGQKLLVAEHFSDMGLSDELLKAIYNQGFEKPSLIQKSAIPHILRGHNVVVQSKSGTGKTIAYTCGVLGNTKIGERTQVMVVTPTRELSTQVTEVISGLAGPLGIKVFSALKNKITDSIGEEVVVGSPGTILKLMELGKLNYKGVKMIVLDEADILLDKDMMGTQTFRILKLISGAQMIFFSATFSEQVKQTIEFYAPDAVKMYEERNGKPDEIKLFYIEAEGENKRRALKSLYEYLSISQMIIFVSTKATVNYLRKKLEDDLHSVSCLHGDLEIEEREKAVGDFRSSKSKILLTTDVFSRGMDIPQVNLIVNYDLPIYRGVASTQTYIHRIGRSGRFGRTGFVVDFVRDEELEAYLSFQKELKFASKKFTIRALEEVAEELG		425		7	Crystallized	-1	 	NR-15991
Batch03	EncuA.01541.a	Encephalitozoon cuniculi		Q8SQN	Q8SQN2|DHYS_ENCCU			Deoxyhypusine synthase - Encephalitozoon cuniculi	Potential drug target		MARAGQISVTQEAWVCTGDGKKSFPQLPMDRPQNVKDLARKVKDNLSFSREVRGMDFEKEWDFMAIMRSFETMGFQGSNLYRAVEEIERMKNSKIFFGCTSNIISSGLRDVIATLVKRRHVHVLVITGGGIEEDIIKAFKPTFCADFRLDGAELRDNGLNRIGNLVIPSENYEHLESWLNNIVNDITEGYTAERPRILTPSSFIRILGERIDDESSILYWAAKNDIPVYSPAVVDGSLGDILSFHPRRKMLKLDIVEDVYRINCETIFCGETAAIILGCGVVKHHILNANLFKNGLEHCVLINNAQEFDGSDAGASLDEAVSWGKVKPGTRGVKVFGDATILFPLLVGATFMRKDKDVPKGE		362		4	Soluble	-1	 	NR-15992
Batch03	EncuA.01565.a	Encephalitozoon cuniculi		Q8SQS	Q8SQS1|Q8SQS1_ENCCU			UDP-N-ACETYLGLUCOSAMINE PYROPHOSPHORYLASE - Encephalitozoon cuniculi	Potential drug target		MGYISMNSTNLIRPYEGTELNDAGRKYKKIGERLLREKKLGVVILSGGQGTRLGSDEPKGLFKIKGKTLFEWHMETIKELISKYNADIAVFIMTSSFTDEAVRKYFQSTDFGLKIQFFKQRNSLCVGTDGKPLEWYDGHAESPYGNGDIFNAIQQVNLEGIEALNVICIDNVLAKILDPVFVGAFYSDDYDILSKSVTKEEKESVGAFLMDERLKIKEYSENDAKGEGIQGNICNHIFKTSFIKKMKNINLPEHKAFKKIPYTISGKLIKPVKPNGFKKETFIFDSFEYTQKNGVMNVPREKEFSPLKNGMDSSVDNPVTCTIAVERHRIKTTIQ		335		5	Purified	-1	 	NR-15993
Batch03	EncuA.01573.a	Encephalitozoon cuniculi		Q8SRL	Q8SRL5|Q8SRL5_ENCCU			SER/THR/TYR PROTEIN KINASE - Encephalitozoon cuniculi	Potential drug target		MVEYWTLDRFEIGRLLGRGKFGQVWLAREREKGFIVALKIIPIKEIQTVETARQIRREIEIHSNLKHPNILRMYGHFHDKDNIYLILEYAGKGEFFKFLSDRGGKFGEKETSLYIRQVMLALTYMKECNVIHRDIKPENLLLGSDNQLKIADFGWAVYNADKRRMTFCGTMEYLAPEMVNNDIHDSGIDLWCLGILTYEFLMGKTPFESKNRNMREAYKKINSLKYTIPETISSNASDFISRLLVLSPGDRMELTEALNHPFIVKHHGRSSD		272		4	Soluble	-1	 	NR-15994
Batch03	EncuA.01574.a	Encephalitozoon cuniculi		Q8SWN	Q8SWN8|ACT_ENCCU			Actin - Encephalitozoon cuniculi	Potential drug target		MSEIVQALVIDIGSGVVKSGFAGDDAPRAVFPSIVGFPKHKGVMVGMGQKDAYVGDEAQTKRGILHIKYPIEHGIVNNWDDMEKIWHHTFYNELRVAPEEHPVLLTEAPLNPKANREKITQIMFETFNVPSFYISIQAVLSLYASGRTTGIVFDSGDGVSHVVPIYEGYSLPYAINRIDLAGRDLTDYLQLILTESGNSFTTTAEREIVRDIKEKLCYVSLNYEEDMRNTEHLASITKTYEMPDGQVISIGNERFRAPELLFQPKLRGLELKGIHQNIYDSIMKCDVDIRKELYGNIVLSGGTTMYPGLAERILNEIKALAPPVIKIGVVAPPERKYSVWIGGSILASLSTFQQMWVSKAEYQEHGPSIVHRKCF		375		3	Expressed	-1	 	NR-15995
Batch03	EncuA.01621.a	Encephalitozoon cuniculi		Q8SS9	Q8SS96|Q8SS96_ENCCU			CASEIN KINASE 1 HOMOLOG - Encephalitozoon cuniculi	Potential drug target		MPRTLPELRNKSFCYPWNHSNRTMTTEIRNIKLVQKIASGAFGDIFIGQNTVTNQTVAVKLEKKAHYGQLKHEYGVYKALGGTRTPRIYEYGKILYENVYVNGLVMELMGKSLEQLFVTCSRRFSLKTVLMLGERMVDNVEYLHHRNYVHRDIKPDNFVFDVQGDRLYLIDYGLAKEFRNPMTFKHREMRTDKSLTGTARYASLRTHQGYEQSRRDDLESVGFCMVYFLKGRLPWQGLKAKTKQEKYDRIRESKESISLYELCMGLPKEIHSFCFYVRNLGYEDMPNYAYLRTLLSDALRQRGLRSDGVFDWMVRTPSDSMGDLEIL		327		2	Cloned	-1	 	
Batch03	EncuA.01628.a	Encephalitozoon cuniculi		Q8SS2	Q8SS22|Q8SS22_ENCCU			THYMIDYLATE KINASE - Encephalitozoon cuniculi	Potential drug target		MSKGKFVVFEGLDRSGKTTIVGSLYESLLPIVPTSKIRFPNRSGPVGKIIDGYLQKKTNLESETIHLLFSADRYEHRLMIEELRRDTIILCDRYSMSGIAYSVAKGLSLDWCIASEALLPKPDLTIFIDVPMDEICRRKGFGTEIHDTVPFLKKVLSAYQALLKKEENTLVVDGTLPVREVVEIVRKRILG		191		10	Diffraction	-1	 	NR-15996
Batch03	EncuA.01641.a	Encephalitozoon cuniculi		Q8SRK	Q8SRK8|KAPC_ENCCU			Probable cAMP-dependent protein kinase catalytic subunit - Encephalitozoon cuniculi	Potential drug target		MLKIQDFEFVKVVGVGAFGKVHLVRLKSSPTSVFAMKMLDFGEILRQRLADQLENEISILKRIYGCPFVAKLYSTDFHGGKVGLIMEYVGGGELFYWLKKCGRFDEQMARFYAAEIISALRFIHGRGILYRDLKPENILITSTGHIKLIDFGFSVYESENIYMISGTPEYMSPEKLRSEDDGRASDYWGLGVMIYEMLCGDPPFYDSSADAIYHKILESNVVFPHYVSPVARCLITGLLDKNRATRLGTKGICEIMGHPFFKGIDWHEVESRRIEPPFIPNPNTVLSSLASSGELKGTDDAETVVLKPYKHIKHLYKVSKGL		322		3	Expressed	-1	 	NR-15997
Batch03	EnhiA.00174.a	Entamoeba histolytica	XP_656214.2	C4LTI9				"serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSFFSESNLDRMIENLLNMNLIPEDALRALCDKAKEILLNEPNVIKIDYPVTVCGDLHGQFPDVKEVFNIGGKLPDTNYLFLGDFVDRGFHSIETASLMVALKVRYPNRVHLLRGNHESRQITQIYGFYDECMKKYGSSDAWQILTNLFDCLPLSALIDQRYFCVHGGLSPSLKKVDQISMLNRVREVPHEGPMCDLLWSDPEEKAGWEQSPRGAGFIFGKDASDQFNQINGTEIIVRAHQMVMEGYQWNHNKTVVTIFSAPNYCYKCNNLAAIMELSDTGEYSFSQFSPAPSQDEFPNTKHVPSFLFE		309		4	Soluble	-1	 	
Batch03	EnhiA.00182.a	Entamoeba histolytica	XP_656942.1	C4LWH8				"GTP-binding protein, Ras family [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTEPITPRRKRRLSDIFRLPKKESREDDSSSKYKYGKKSILFIGDLIADKNELVNTYLNGKYLAGKSQKVDNEVIVKRLDDEGKCKVVIMTCEGEENYPGNRKRLYEGRDIVVLTYAVDNLESFKNIEELWLPEVAFYDEGAYLGLIGTHSESDAVVTQEEVLQFAKNNNIPFVAEVSSKNYSNIDETFFDLILKAVNADFAKKGLPLIK		210		5	Purified	-1	 	
Batch03	EnhiA.00186.a	Entamoeba histolytica	XP_657364.1	C4LSI6				"cysteine proteinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MFGLLFVTLISLSNAISFDKWMAKNNQKFKGIELLRRRAIFNMNSMFVAKFNQQHNFQLSVDGPYAAMTNAEYNTLLKARTVKNVNAPVRKAIKGDIPTAIDWRAEGKVTPIRDQAQCGSCYSFGSLAAIESRLLIGGSQTYNADNLDLSEQQIVDCSNKNNGCNGGSILYVFAYTKRNGVMQEKDYPYTATNGTCQYDADKIIVKNAGQVIVEQRNEVALVEAIAEGPVAVAIDAGQASFQLYKSGVYDEPKCKKVILNHAVCAVGYGSQDGQDYYIVRNSWGTSWGMDGYILMSRNKNNQCGIANDAIYPTGVTEVKK		320		2	Cloned	-1	 	
Batch03	EnhiA.00188.a	Entamoeba histolytica	XP_656865.2	C4LZQ1				protein kinase domain containing protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MNSLLIVLLLTLVNSFQFNYFSLELQLVNKFPMSQCPAKHTVSISKVYADVLANVPEEEWNYEKVNISWGSPQPYQIVSRIGRGKYSSVFKGVITEGLYPCAIKCLKPIKEDRFKREILVLQRLINGPNIIRLYDCVKEDITGIPSLVMEYIENTKFQFFYKKFTLQDIQYYLYELLKALKYAHSKGIMHRDIKPDNICYDLNTKKLRIIDWGLAEFYHPGKEYNVRVASRSYKAPELLLNMQQYDYSLDMWGFGCILGSLIFKKEPIFEGRDFDDQLLQIVQLFGTNELYIYITKYNCNIDSSLLFKLKNYSTSSFSKFINENNKSFCTTEALDLLEKVLVFDHQKRLSADEAMNHPFFKSLRNN		366		2	Cloned	-1	 	
Batch03	EnhiA.00192.a	Entamoeba histolytica	XP_001914233.1	B1N4W7				Ras family protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MDLYHSPKEDILTDSPVFIGKADAIVAVFSFDDYKSFEDTEGWLFFGMSHSDPKVQFIIASKADKKEKVVQRSEGIDLAKRLGVNYFEVSARSGKNIQDFFETLAKILLKQKLVSTQKLSKQPSLPQQFSKSNDEYQRLDSEINSVFDH		149		4	Soluble	-1	 	
Batch03	EnhiA.00193.a	Entamoeba histolytica	XP_651446.1	C4M9T7				Rho family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSDSVKLVVVGDGTVGKTCMLMCYTSNDFPSDYVPTVFDNYVANVTIDKETISLGLWDTAGQEEFDSLRPLSYPGTDIFLLCFAVIYEPSFHNLKDKWQPEVRQHCPNAALMMVGTKIDLRDNAAEVKKITDQGLQVISPEKGQQMADELKCVKYMECSALTRKGLKEVFETAVKYVLENNAAAPPPEKKDRKKCVLL		198		3	Expressed	-1	 	
Batch03	EnhiA.00199.a	Entamoeba histolytica	XP_657024.1	C4LU68				"dual specificity protein phosphatase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MDNDSLKQQRNCLKSTQTKVTAIDGKIHFEKSGEIIGSSQQQTFGFVVDNSPDIVANEIISNLYLGSQDCVTNKMYLHSLGIKHILCVAPLIPSLFPNEFDYKNIELLDLPSFNIKPLMNECIDYIDLCLNQEEAVICHCNAGVSRSATVVIAYLILKKKMSFTEAYNLVKQKRPSIKPNDGFLLYLKMLNQQNLIQKA		199		1	Selected	-1	 	
Batch03	EnhiA.00206.a	Entamoeba histolytica	XP_654544.2	C4M1T0				"phosphopantothenoylcysteine decarboxylase/phosphopantothenate--cysteine ligase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MKTNNKIILGITASIAAYKGIDIANELTKRGYDVHVTLTKNTLHLIQPSTIEVLTHNKCIIDSFDRPNEYDVHHISLAHSASLFLIAPATADIIAKLASGIADDFLTTTFLAATCPKLIAPAMNTTMLHNPITQRNIQILKSFGVTFINSSYGKLACGDVGDGKLASVDSILTFVDQQLHPIQPLLNKKIVITAGPTIEPIDPVRFITNHSTGKMGYAIAQVAQQFGATVTLITGPTTIQKPSGVSIVNVQTAIEMYDAVMKEKDVDIYIMSAAVADYRPMNISNQKIKKDENELTITLVKNPDILKEIGDKRNDHQIIVGFAMETQDLIQNAQEKLKKKHCDMIVANQLNVKGAGFGGETNKVAFITKDVIEETEVLLKSEIARLIIEKVIDRINQ		397		3	Expressed	-1	 	
Batch03	EnhiA.00210.a	Entamoeba histolytica	XP_001914336.1	B1N570				"NMN adenylyltransferase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MEEKDIIIVCCGSYNPIHYIHLLLFELTKNYFKEHGRNVVKGIISPANDLYWKKGLLSSKHRVAMCQEAVKTSDWIIVDDWESKQKEYVRTYNVLKHEREVYGNEYDIYFIGADDLIPNMMNKNCWDQVLLEKIVNEFGIVFFKRTNPNCSEQIKSYPLFARHLNHIFIIDSFQSQHSSTLVRQLVKSRMSIKYLVPDEVIYYITQHQLYLE		212		5	Purified	-1	 	
Batch03	EnhiA.00214.a	Entamoeba histolytica	XP_656764.1	C4LU01				protein kinase domain containing protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSDIPVQKTNEPKLTLKEIIGQRYSKTGKKITDFFGVVYQAKDEKKAIPVSIKLYQQSEEDIDGIQSNCLREIAILKKLNHNNIIKMIDYYYGIEGCYIVFESCDRNLEEYIKTFAGELSLNTVQLISKQLLEAVEYLHSHRILHRDIRPSNIILSLSRTIKLTNFSLSRQVTIPIRKYTQEVANIWYRAPEIILGDQGYGTGVDIWSVGCVVAELINSKPLFSGDCKIGQLFQIFQIFGTPTEESWPGVTQMINWSNRFPKFKGKTLHSVCSRIGDQGIDLLNKMLCCYPNKRIDAKEALNHPFISFYN		310		2	Cloned	-1	 	
Batch03	EnhiA.00216.a	Entamoeba histolytica	XP_653800.1	C4LTI2				"proteasome beta subunit, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MESLIKDLNKQKETKKERVILPCKELSLPKALTEHKHGTTTLSMIIKEGIIVAVDSRATRGAFISSGSVQKYIPITSHIIGTMAGGAADCAYWERELTRQCRLFELRNKPPISVAAASKMLANILYQYRNYNLSVGSMICGYDKTGPHIFYVEDGGVRIPGHLFSVGSGSPYAVSLIDSEYDYNMPKEKAIELARRAIFHATHRDVASGGNVNVIFIDKDGWRLISRNDCYDLYYDHYNIEEYQKHGQMEED		252		4	Soluble	-1	 	
Batch03	EnhiA.00229.a	Entamoeba histolytica	XP_649445.1	C4M982				"inorganic pyrophosphatase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSITSIVPNFGTIRTEPVGTLGKKDYRIYFEQEGKKISPWHKIPAFVSKDVVNMVCEIPRGTNAKMEISTTNKFNPIKQDLNKDGSLRYMKHGNVLNHYGAVPQTWEDLFERDSIVGIPGDNDPIDIIDISQKKVARGEIVQIKPICALALLDGGETDWKVIGINVNDPLAQTITSANDIEKTVDEIREWYRVYKVAEGKKLNKYAYGGKAFNQKSTLDIINETHLQYRKLKTTQKKLSKLALD		244		3	Expressed	-1	 	
Batch03	EnhiA.00230.a	Entamoeba histolytica	XP_652048.1	C4LUS0				"calmodulin, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MQKHNEDLKESFLLFDGDGDGYLTLNEFESLVRVLGVVMETSAIASTYNSNSKVRGMSYELFTSCFSQLKTKSFNKDEIKTAINVLDKDKKGFIPAIELRRILSTIGDNMEQKEITDLFTFMGIDEQGVVKVDDFINQLMTVFK		144		3	Expressed	-1	 	
Batch03	EnhiA.00231.a	Entamoeba histolytica	XP_657171.1	C4LUI9				"threonine dehydratase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSDVEVPALALRDASFSEIHIGEGDEQVLEQIFLSDVYTAKHVISDHIHHTPLDSNASISADIGMDVYFKLENMQKSGSFKVRGVMNKFNSLTLAEKKRGVIAASSGNHGMAVAYCGKQLGVPTTIIVPNFTNPRRAETMKRYGATVILHGVTVAEAEAYAKEMSTEKRLAYIEARDDVSIIAGDGTVGLEILRDLPDVDAIIAPIGSGSLLCGLALAVKTLDPRVKVYGVQNEKGSSAYLSKKHHVLCRTHQNEDNELTDVVNTIGNLTLHMIESYVDDIITVDETQITRAMMLLMERCKVIIEGAGAVALAGLLSKKLPIEKGSKVAVIVSGGNVNMRLLNTVIDLGLINCERSLKLEVTAPDSPINLNELVSIIAEQKAQLYDFQVKKNVGIGMCTIRFSVEVADKNHKQALGDALKAKGYEFVFV		429		5	Purified	-1	 	
Batch03	EnhiA.00232.a	Entamoeba histolytica	XP_655213.1	C4M1X8				"glycerol kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MKYILAIDQGTTSTRVILFDEKCQSIHTEQEEFDSIFPHPGWVEQDPEVIYTSVVNLMKKCLVNTGINKEDIAAIGITNQRETTVMWDKRTGKPIYNAIVWQSKQSGNETSYLMEKGYEEIFQSKTGLVLNPYFSASKIMWIFNNVEGAKALAEEGVLLFGTIDTWIIYNLTGGQSHSTDISNAARTLLFNIYEKKWDDELLAKTNIPKSILPIVKQSSDDFGIVSTIQEFNGIHITGVAGDQQASLFGHGSPIGGCKSTYGTGCFVVKNIGDTIKEIPKGLLATVGWEINGKITYALEGTVMTAGAALKWIRDIGILKDYNEISKIVTSKNGGVYFVPAFQGLGTPYWDDDVRGIIVGLTSGTGKGELVRATLESIALQCAQVIEIMGKINEIKVDGGVSRSDCMLQFQADICNCTVIRLKEKEITAMGAAMLAGLYVHLFKEDELDSMRVIEHVFKPQMSEEERKQIFSVWNKAVESARSFVH		485		4	Soluble	-1	 	
Batch03	EnhiA.00235.a	Entamoeba histolytica	XP_655675.1	C4LWI4				"cysteine proteinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MYRNNLFFLIIVNFSFAINFDQWKIKYNTKYSGSEALRRRAIFLQNSKLIQMINKQNLSFTVTNEGPFSVLTNEEYRMLHHRIDIEKEIKQLKSHRMNLVKKMDNKEVLDSIDWRSEGKVTPVKNQRKCASCYAFGSIATIESLIMQETSIKEIDLSEQQIVDCSQGEYSNWGCTCGNVGNSFNYVRDHGILLERDYPYTGKANNCSIDGKKPVIKIKDYSFVFPQTEENLKIAVYHQPVAVSIDSSQLSFQFYEGGIYDEPNCKWVDHIVTVVGYGTTEEHQDFWVVKNSYGNEWG		297		1	Selected	-1	 	
Batch03	EnhiA.00237.a	Entamoeba histolytica	XP_655257.1	C4M2A7				"cysteine desulfurase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MQSTKSVYLDNNATTMVDPEVLNSMLPYFSEIYGNPNSLHAFGQKARKALSDSLDIIYECIGASDDDTVLITANSTEGNNTVLKTMLARYETMKGRNKIIVSQIEHPSISESEKYLKERGIEVIKMPVNEDGVVDPKDLERLIDDKTALVSCMWVNNETGLIMPVEELCKIAHDHGALFHSDATQAMGKIKVSVKDVPVDYLTFTAHKFHGPKGVGALFIRAGKPITPLLHGGEQMGGLRSGTIDTPSVVGMAVALKKATHDINIENTYVRKLRDKLEAALRTIPDVTIVGKPELRVPNTILVAFKGVEGEAMLWDLNKHGIAASTGSACASESLQANPTFKAMKFGEDLSHTGIRLSLSRFNTEEEIDYTIDIIKKSVDRLRQLSSTYA		390		5	Purified	-1	 	
Batch03	EnhiA.00243.a	Entamoeba histolytica	XP_651433.1	C4M4F3				"proteasome beta subunit, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MDSCIGIVGKDFVLMAVDGNSGRGVITVRNDFNKIYPVQGNRLLTIIGEGNDRQVLADFVQRNIALNYYRNGLKSTTQSIAHWIRRQVSDSLREGGYQCSMLLGGVDEKPELFMIDQFGTLVPETYASHGIGSNFVYALLDKNWHSGMEFEEALELMKKCIKEIQKRVIVSSSHYCIEVCYKDKTELIQGPEVFPPVN		198		5	Purified	-1	 	
Batch03	EnhiA.00245.a	Entamoeba histolytica	XP_001913582.1	B1N316				"40S ribosomal protein S16, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSAVKAAGKTQKKHTEALKSVQVFGKKKTAIAVCLCKEGKGMIRVNGVPLDLINPPVLRIKVFEPLFIVGKENYAKLDLKIRVTGGGQVAQAYAIRQAIAKALIAYNQKFVDETTKNELKAKFLEYDRTLLVADPRRCEAKKFGGPGARAKYQKSYR		157		-2	Work stopped	-2	Work stopped	
Batch03	EnhiA.00245.b	Entamoeba histolytica	XP_656860.1	C4LZP6				"40S ribosomal protein S16, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSSAVKATGKTQKKHTEALKSVQVFGKKKTAIAVCLCKEGKGMIRVNGVPLDLINPPVLRIKVFEPLFIVGKESYAKLDLKIRVTGGGQVAQAYAIRQAIAKALIAYNQKFVDETTKNELKAKFLEYDRTLLVADPRRCEAKKFGGPGARAKYQKSYR		158		-2	Work stopped	-2	Work stopped	
Batch03	EnhiA.00245.c	Entamoeba histolytica	XP_649613.1	C4M2R7				"40S ribosomal protein S16, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSATVKATGKTQKKHTEALKSVQVFGKKKTAIAVCLCKEGKGMIRVNGVPLDLINPPVLRIKVFEPLFIVGKENYAKLDLKIRVTGGGQVAQAYAIRQAIAKALIAYNQKFVDETTKNELKAKFLEYDRTLLVADPRRCEAKKFGGPGARAKYQKSYR		158		-2	Work stopped	-2	Work stopped	
Batch03	EnhiA.00251.a	Entamoeba histolytica	XP_653898.2	C4M1H4				"protein kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MIPLPGAGKKKKKGIFSKLFGKKKEETTVLTVQQGTHMTYDEKAGITGYPPQWEAFIKGSGLIKEEIEEIKTDKEQNAAFEDVLKFHLKTEPQILNQILPSKTSEQNVEEEDDTAEMPDIQDPEEVLPEKESDLTLEDLAEEGLPEDFYENFSKIGEGAAGEVFVAQNKQTGKDMALKKCIITSKNEKSLINEIEIMKNCKHPNIVSFFGSYLEEGYVWVVMEFMDSGCLTEVLTEYENGFKMTEPQMAYVLREVMKGLLYLHQRHKIHRDIKSDNILISSDGSVKIGDFGYAAQLTSQRDKRNSIVGTPYWMAPEVIRNKLYDAKADIWSIGIMIMEMTEGDPPYMELPPLRALFLITTKGIPPLKERDSWSPDLVKLVESCLMKDPNQRPTSEQILESPFIATACKKEEFARVVAETHK		421		4	Soluble	-1	 	
Batch03	EnhiA.00254.a	Entamoeba histolytica	XP_651032.1	C4M7K9				"thioredoxin, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MRAFLALCLIAIASANVVSISTANFNDYVKGEKPVFIKFFAPWCGHCKRLAPIYEEFSNVAATEFPNLIVAEVDCTQNQDICEHVQGYPTVILYKGNENIEFEGPRTVEALKEFIAQKI		119		3	Expressed	-1	 	
Batch03	EnhiA.00255.a	Entamoeba histolytica	XP_657095.1	C4M3C4				"protein kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSHISAKITILEAKNTVSHKGEGIDSYFKLKANFLAVALKTRTAEKSSTPKYNETFTIEVPDSQKKGVSRTIVLIGYKPKRFSDKVLGEVEINLEKNEDVDGWFELKKKKEDKKGKVSVHVIVKFAGQKEAKKEETFEEFPDRSEFDKKYTKENEIGQGAFSVVYKGIRKEDGVSVAVKQVNKTSQSSDQLKLLRREIDVMRKLSNHPNVVKLYDVYEDEKTILMVIEYMSGGELYDQIIQRGSFTEADASDIVYQILSALCYIHSNGIGHRDLKPENLLCATPKGDIVKIADFGLSKDNSDGNTAMTTCCGSPSYVAPEVLEGSSYDHECDIWSLGVITYVLLSGYLPFFGETQDELFQKIMSGDYTFNYSCFKGVSEEAKDFINKCLVVDPQERATAAQLMEHPWVHPENRNLPSMKSAALHPTASMNELSSGFNPKNRQNPGA		446		3	Expressed	-1	 	
Batch03	EnhiA.00259.a	Entamoeba histolytica	XP_652994.1	C4M5Z6				Rab B GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MGDVSSLKILLIGDSGVGKTALLRQYCDQKFSEDVSSTIGVDYRTKRVTFGDKTITLQLWDTAGQERFRNITTSYYRGSQGILIVYDVSNFDSLKQVTYWIGELKKENVDGIIFLVGNKIDVTNSLTKEHEDIIKTIDLPHFTVSAKTGEGVQDLFTQLVKSILEKGLVPEPVGNMEEVSLEKEPTESKGCC		192		5	Purified	-1	 	NR-16332
Batch03	EnhiA.00268.a	Entamoeba histolytica	XP_651041.1	C4M7J5				RIO1 family protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSKEEFRVLTAIEMGMRNHELVPLELIIQISKLNQSLVVRSMKDLHKHKLVWHSTMPYNGYRLTYLGYDYLALRTLTQRGVITGVAQKIGVGKEADIYLATNEKGDDLVLKFHRLGRTSFRAVKKKRDYTKGRVTTNWLYLSRLSAQKEFAFMKALYAKGFPTPIPVDCNRHCVLMSRVKGTLLANVREIEEPIAVFHQGLDLAVKLAECGLIHCDLNEFNLILSDDDKLTMIDFPQMVSVHCSEAEEFFDRDVGCIKTFFWKRFGFGTEEVITLKDIEQTENLDEEVKASGFDFKNEKLLEKARKEFVEDDSVDEEMKDSIDEDVNGNEENSYSDEHEQNEELE		345		2	Cloned	-1	 	
Batch03	EnhiA.00275.a	Entamoeba histolytica	XP_655138.1	C4M2U6				"hypothetical protein, conserved [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSEESYPSVIGKINHLASQREKPVCLIAVSKTKPKEAIQHLYNVYNHRVFGENYIQELHEKATELEEVCPDIEWHFIGRLQSNKLKLLVSTPHLKCVQTVHSIEIAEKLNKACINANKTIDVMVQINSSGEEQKGGVSVEEAISVVKEVMKCSNLHFIGIMTIGMVGDSKKNFTTMKQLADTICSQEHLGSIEISMGMSSDYEQAIELGATMVRVGTALFGARDYSKHQ		229		2	Cloned	-1	 	
Batch03	EnhiA.00292.a	Entamoeba histolytica	XP_651470.1	C4M7X7				hydrolase TatD family protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MAQQFIDIGANLTDDNYFGNYHGKHYHEEDIDVVLQRAERNGLSHIIITSGCLNDFKKAIEIINKYQNLTNIKLVTTIGVHPTRTNELKQEGYLDELLLLCEKNIDKVVAIGEIGLDYERLQFSDKETQLSGYRTLSILHQKYPYLPFFFHCRKSWSDLCQLNKELGYNGCKGVVHCFDGTEEEMNQILNEGWDIGVTGNSLQSIELLNVMKQIPIERLHIETDCPYCGIKKTSAGFKYLKEKDFGVKVEKYQRNKYVQRRNEPSNIIDIAIIMSSIKHISLFEFVNKVYSNSMNMYFPTMN		302		17	In PDB	-1	 	
Batch03	EnhiA.00294.a	Entamoeba histolytica	XP_649078.1	C4M8D7				"26S protease regulatory subunit, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MEIERQSEESAMVKYYKHKIDEMTYEYCTELQNQRRLISKRNQLNDQVRRMKEELQLLSEPSCSVGEVIRAVGKDKVLVKSTQEGKYVVKVEAGIDIRALKPNQRVALKSDTYSICKVLPNQVDPLISLMRVEKVPDSTYDMIGGLDQQIKEIKEVIELPIKHPELFESLGIAQPKGVLLYGPPGTGKTLLARAVAHHTDCTFIRVSGTELVQKYIGEGSRMVRELFVMAREHAPSIIFMDEIDSIGSSRIEGKSGGDSEVQRTMLELVNQLDGFEPTKNIKVLMATNRIDILDPALLRPGRIDRKIEFPNPKEEARLDILKIHSKKMNLVRGIDLKKIAERLDGASGAEIKACCTEAGMFALRERRSHVTQEDFELAAAKVMKKDNNASISLQQLWK		398		3	Expressed	-1	 	
Batch03	EnhiA.00301.a	Entamoeba histolytica	XP_657296.1	C4LTF8				Ras family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MNTVRVTFIGHPATGKTALIKQYLYHKTINEYLPTIQDTYNSLITVDGYKTEVTLVDTSGEEEFHLLRDSELTRTDYLVYVYSVTDLGSFVNAQEDIAECLSIIANNGNKGYPSILIIGNKCDASHRVISPEEGEKLKNKIQKVCPCAFFETSATTNLNLQRVFNTFVTGISTSEHKMNETKEQDKKYKKPVAFKTTLEDLDRPLSHQNRFIAFFSPRRKNEKR		224		4	Soluble	-1	 	
Batch03	EnhiA.00303.a	Entamoeba histolytica	XP_650141.1	C4M4I4				"small nuclear ribonucleo protein G, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MEKPKPELKHYLEKRILVKIHGKRSIIGVLSGYDEYMNLVLDEAYDASNPDTDKHIPIGMIMIRGNSILSVETIDPVHTTK		81		4	Soluble	-1	 	
Batch03	EnhiA.00306.a	Entamoeba histolytica	XP_649582.1	C4M9E9				Ras family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSLKRIVMLGTGAVGKSAITLQYVSHYFASDYNPTIEDSFRTSITIGDDNYPIEILDTAGQEEFDALKDTYIRSGDGFAIVYSITSLNTFLEANEIRERIYRVLDKDPSQHIPICLVGNKSDLESERIVSKEQAEELACLWGISFIETSAKKKSNINELYQIIMKDIIDTKTKEDEEKKRLEEHESITKKSSKKQRDGKKFYKKIGCSVM		210		5	Purified	-1	 	NR-16333
Batch03	EnhiA.00308.a	Entamoeba histolytica	XP_001914003.1	B1N487				"acetyltransferase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MNTTAEQETKYMLEGKIMIPATPDGVAASIALGNKLFDFNHERDFTKRREILQTIVGHLGENSNVFVPFNCTRGNFIDIGDNTVININCYILEGGPVKIGNNVMIGPNVSLIGGTHSTDPKIRNACGGTAYGKPITIKDGAWIGCGAIILPGVTIGENAVVGSGSVVTHDVPDNMIAVGNPAKVRRRVSEHLGWTIENRDVPLD		204		2	Cloned	-1	 	
Batch03	EnhiA.00308.b	Entamoeba histolytica	XP_001914383.1	B1N5B7				"acetyltransferase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MNTTAEQETKYMLEGKIMIPATPDGVAASIALGNKLFDFNHERDFTKRREILQTIVGHLGENSNVFVPFNCTRGNFIDIGDNTVININCYILEGGPVKIGNNVMIGPNVSLIGGTHSTDPKIRNACGGTAYGKPITIKDGAWIGCGAIILPGVTIGENAVVGSGSVVTHDVPDNMIAVGNPAKVRRRVSEHPGWTIENRDVPLD		204		4	Soluble	-1	 	
Batch03	EnhiA.00308.c	Entamoeba histolytica	XP_656108.1	C4M9L8				"acetyltransferase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MNTTAEQETKYMLEGKIMIPATPDGVAASIALGNKLFDFNHERDFIKRREILQRIVGHLGENSNVFAPFNCTRGNFIDIGDNTVININCYILEGGPVKIGNNVMIGPNVSLIGGTHSTDPNIRNACGGTAYGKPITIKDGAWIGCGAIILPGVTIGENAVVGSGSIVTHDVPDNMIAVGNPAKVRRRVSEHPGWTIENRDVPLD		204		2	Cloned	-1	 	
Batch03	EnhiA.00315.a	Entamoeba histolytica	XP_001914006.1	B1N490				pumilio family RNA-binding protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MENDPTIISDIIQKIKDDVVFYSKQKFSSNVVEKCLKCSTENERQPLLDILSQPESLDALVEDQYGNFVIQAFLDALPEKTKEEMAHQIIPLIPSNSQFSYHVEKKLLQSFTK		113		4	Soluble	-1	 	NR-16334
Batch03	EnhiA.00322.a	Entamoeba histolytica	XP_001914640.1	B1N624				"aminoglycoside 3'-phosphotransferase , putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MDADLYGYKWARDNVGQSGATIYRLYGKPDAPELFLKHGKGSVANDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF		253		-2	Work stopped	-2	Work stopped	NR-16335
Batch03	EnhiA.00331.a	Entamoeba histolytica	XP_655418.2	C4M1M4				"hypothetical protein, conserved [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSHTSRQIAMFFNSNFDTKFKDLDFAKPTPTIARRVFNVLMGETMQIKKRERNRMLEGACPISLPKLIYIKELGEVMGKLGYEDFDIINDIGFVEKQRFLKMCESIMEYLEKHKEYGKRKEEIIEEYKEKRKEVEEKEGEYKRKRKEKEELIKRKEGDQPEIERHERIKEEEKKKGEEIKEEIKEIKEEINNIIEKIEQKEKDKRIKEDCIKKEKEYNERSKKIQENIEEIKVQEERIKRLKEEINNTEKEKEKKENQITRYNALKQSCVVWRSNIQIVKEGIEQIKRKEEEIERINKEKKERSEEIKHKEDKYKDLEDKTKKEEKEQAIKEEERNKMKEKVDKEINQFELDTSQLHLIYEDINKKVEITKSNKATIIEIIKDIEKRINNIKTTHFYMVRELHDQLLQLKSILSTLDTLIN		421		2	Cloned	-1	 	
Batch03	EnhiA.00335.a	Entamoeba histolytica	XP_001914456.1	B1N5J0				"alcohol dehydrogenase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MDFYFTLNNGYKIPKLGLGTWMSANGEVGKAVEIAIKNGYRHIDCAKAYGNEKEVGDGIKSAIAKGYVKREELFVTTKLWSTDKHKEDVRPACLESLKKLQLEYLDLYIIHIPLTADKKTGEFTEEIIPIEETWREMEKLVEEGLVKSIGVSNFNIKK		158		5	Purified	-1	 	
Batch03	EnhiA.00335.b	Entamoeba histolytica	XP_653766.1	C4M8C2				"aldose reductase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MDFYFTLNNGYKIPKLGLGTWMSANGEVGKAVEIAIKNGYRHIDCAKAYGNEKEVGDGIKSAIAKGYVKREELFVTTKLWSTDKHKEDVRPACLESLKKLQLEYLDLYIIHIPLTADKKTGEFTEEILPIEETWREMEKLVEEGLVKSIGVSNFNIKKLEELLAIAKIQPAVNQFEFHIYYQRPKLHQFCKKHNIHITGYCPLGNPGISSGVPAPFENEVVKAIAKKHNKKAAQICIKFSIASGHSVIPKSVHEERIKENGEVFDFELDEEDMEKLRGLDKNIKVCDMSFYFKDENKRKEFWDDE		305		5	Purified	-1	 	
Batch03	EnhiA.00335.c	Entamoeba histolytica	XP_648383.1	C4M7W2				"aldose reductase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MDFYFTLNNGYKIPKLGLGTWMSANGEVGKAVEIAIKNGYRHIDCAKAYGNEKEVGDGIKSAIAKGYVKREELFVTTKLWSTDKHKEDVRPACLESLKKLQLEYLDLYIIHIPLTADKKTGEFTEEIIPIEETWREMEKLVEEGLVKSIGVSNFNIKKLEELLAIAKIQPAVNQFEFHIYYQRPKLHQFCKKHNIHITGYCPLGNPGISSGVPAPFENEVVKAIAKKHNKKAAQICIKFSIASGHSVIPKSVHEERIKENGEVFDFELDEEDMEKLRGLDKNIKVCDMSFYFKDENKRKEFWDDE		305		1	Selected	-1	 	
Batch03	EnhiA.00335.d	Entamoeba histolytica	XP_001914269.1	B1N503				"alcohol dehydrogenase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MDFYFTLNNGYKIPKLGLGTWMSANGEVGKAVEIAIKNGYRHIDCAKAYGNEKEVGDGIKSAIAKGYVKREELFVTTKLWSTDKHKEDVRPACLESLKKLQLEYLDLYIIHIPLTADKKTGEFTEEIIPIEETWREMEKLVEEGLVKSIGVSNFNIKKLEELLAIAKIQPAVNQFEFHIYYQRPKLH		187		5	Purified	-1	 	
Batch03	EnhiA.00338.a	Entamoeba histolytica	XP_653242.1	C4M6J2				Ras family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MKKLTSTINIVVFGSGAVGKTALIYRYINSSFITQYNPSIDNLERCTKIINDVICTVNIQDTCGSDRFETLRELYVTSSDGALLVCNGNSPFTLTELPNFYELIREFKSEEEYVVVVVINKIDLDLKIDIEEANQFAESINAPCIQTSAKTNKNVDKAFSILLQRILKKNPPKTPRKCSIL		181		3	Expressed	-1	 	
Batch03	EnhiA.00351.a	Entamoeba histolytica	XP_656580.1	C4LTR6				"Meiotic recombination protein DMC1, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTEVKSKTNEQEENVQEIEEDEVEEVPSFHSIDILQQQGINVGDINKLKSAGCNTIESVVMHTHKELCAIRGFSDSKVDKIMEAVSKIFPTHSFISATTSLERRANVIKITTGSSQFDQLLGGGIETMSVTEMFGEFRTGKTQLCHTLAVTTQLPSHLKGGNGKVAYIDTEGTFRPERIAQIAERFGVDQTAVLDNILIARAYTHEQQFDLLIEVAARMAEDHFRMLIIDSVTSLFRVDFSGRGELSERQQKLGKMMNKLIKISEEFNVAVVITNQVMSDPGGGAMFVVDPKKPIGGHVIAHASTTRLYLRKGKGEQRIVKIYDSPNLPEAEATFAIDTGGIIDAKD		347		4	Soluble	-1	 	
Batch03	EnhiA.00356.a	Entamoeba histolytica	XP_655672.1	C4LWI7				"acetyltransferase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSIFRVEFEEKCSAEGKICCFKLPELAEEAKILNDKMFDFNNERDLTKRQEIIKTIVKSIGENSVIFPPFRCSKGRFITIGNNTVINVNCYIIDGIPITIGNNVMIAANVSILGGTHSTDPIIRNYGTVYRKPVTIEDGAWIGCGAKILPGVRIGKNAVVGAGSVVTHDIPDNMVAVGNPARVKRRVSEHPGWTIENRDVPLD		203		2	Cloned	-1	 	
Batch03	EnhiA.00360.a	Entamoeba histolytica	XP_001914133.1	B1N4L7				"tyrosine kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MKIQISSKEENEKYSIRINPNVITIEGGYACEFELFITIKCTTKIKDKIMIISKTLNKAQEETIKSISIEGETEISTRLDPDEIKEEKKIGEGSFGIVYVGEFRGNKVAIKKMKQVEESEDKKKEFEKEVAMLDKFRDEYIIQFYGAVFIPNKICMVTEFAKYGSIQDIMNKRNITEISKKIRIKFMIDGAKGISYLHSNGILHRDIKPDNFLVVSLDDNIEVNCKLTDFGSARNINMMMTNMTFTKGIGTPKYMAPEVLNHQHYKMQSDIYSFSITMLQIITWQDPFPKSEFKFPWKLAEFISTGNRPVIIQEVEEDIKDVIEKSWQQEPKERIRIDEIVRIIIKENHNQLNVVQL		357		2	Cloned	-1	 	
Batch03	EnhiA.00360.b	Entamoeba histolytica	XP_655228.2	C4M2B9				protein kinase domain containing protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MIISKTLNKAQEETIKSISIEGETEISTRLDPDEIKEEKKIGEGPFGVVYVGEFRRNKVAIKKMKQVEESEDKKKEFEKEVAILDKFRDEYIIQFYGTVFIPNKICMITDFVEYGSIQDIMNKRNITEISKKIRIKFMIDGAKGISYLHSNGILHRDIKPDNFLVVSLDDNIEVNCKLTDFGSARNINMMMTNMTFTKGVGTPKYMAPEVLNHQHYKMQSDISIFIFNNNITIHYLFLLSL		241		3	Expressed	-1	 	
Batch03	EnhiA.00371.a	Entamoeba histolytica	XP_651888.2	C4M905				pumilio family RNA-binding protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MIKTDMNCIRNDRKETSPIGLNNDYSAEGYEPFLQKYFRTETEQSNNNNSTFNHSSNPPSIPSTPTKHFHQILFNEDYLRLSQDQTGSRTVQHKIETSTTERDIIFDSIEKEAVTLSKDVFANYVIQKLFEFGVFWQKSQLIKRLTGSFVELSLHMYGCRVVQKAIEFVDDIDKRIIFNEIEDNIIACIQDQNGNHVIQKCVEKGDLKIIDSIIFAFKGRVLAFSQHPYGCRVIQRILEKIPPEKSYPLLEEILPNTLELSKDQYGNYVIQYIVEKCPSERNKIRKALQGNIALLSMQKYSSNVIEKCFMCANLKGRQEILKEIYGVKKDGAPLLMMMRDQYANYVVQKIIENVSDEDREFMVNNVVLPQINSLRKVPYAKHILVLLQNYGVDV		394		2	Cloned	-1	 	
Batch03	EnhiA.00372.a	Entamoeba histolytica	XP_651849.1	C4M2G2				"GTP-binding protein, Ras family [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MNQTQPNKPKMRIVFVGTFGVGKTSLIQQYCNEEFHENPVSIDKINKEDKRKKNVFDIEMVDSMGIEKDDPNNYFYFQKCHGCALVFDRTSQESFDALQQLYTNIKKYGSQDMSLILIGNKSDGSVVVQNGIAQQFATEHSMRYFALTAKQHSQVVESVEYLVDLIYKNYYKENKSCYIV		180		5	Purified	-1	 	
Batch03	EnhiA.00373.a	Entamoeba histolytica	XP_001914535.1	B1N5R9				"heat shock protein 70, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MQEEIFVGIDLGTTFCCCHFFNTQTNKYECINYLNGNSTIPSTVDFFTQPVSVGIPKPTAICEVKRFIGKKFDDEQVQEDINKNYFPYQIVKAEDGYCLVVVDYPDKEEERVEPEVVSAIVLKAIKIEIQRRLNIKDNISLRAVVTVPAYFDDSQKDRTKKAVLMAGFSLIRLLAEPSAAAYAYGLESTKDQMYLAFDLGGGTLDVTILEKKGEEFKFRATGGDVHLGGLDFDMNFMELVISKMKEVDEKKARRFILKGSDSRSQKKMKKQRRYRLRKEVEKAKIELSANSYCELDLSELVDEDEFIISIDRSEFEECNKKE		322		3	Expressed	-1	 	
Batch03	EnhiA.00376.a	Entamoeba histolytica	XP_654865.1	C4LZJ5				Ras family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MTTNTYKLVMLGGGAVGKSAITVQLVSGHFVQIYDPTIEDSYRTSISVDGEMVSLDILDTAGQEEYSALRDQYMRSGDGYVIVYSITSTTSFLEANGFREQLYRVLDKDVSEHVSIALCGNKCDLENERQVETAEAKKLADEWKVLFFETSAKAKINITETFQALVKDIKVNRVSSEPTASIEPTDTKGKKERKPSKSKCELL		203		1	Selected	-1	 	
Batch03	EnhiA.00376.b	Entamoeba histolytica	XP_654039.1	C4LZD3				Ras family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MTANTYKLVMLGGGAVGKSAITVQLVSGHFVQIYDPTIEDSYRTSISVDGEMVSLDILDTAGQEEYSALRDQYMRSGDGYVIVYSITSTTSFLEANGFREQLYRVLDKDVSEHVSIALCGNKCDLESERQVQTNEAKNLAEQWKVLFFETSAKAKINITETFQALVKDIKANRAATEPSATTAEANDSKGKKDKKEKKEKKCIMF		205		5	Purified	-1	 	
Batch03	EnhiA.00378.a	Entamoeba histolytica	XP_001914358.1	B1N592				"deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial precursor, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MNFYYVNQINTLYKHYLNEHFTSKENNEETLFIKKLHKDAIIPTRGTEQSVGFDLYSIDDNIIYPHDRCLISTGIAVQIPHSCYGRIAPGSSLAIKYGIDIGGGVIDEDYRGEIKVIVFNHSNTIYRCKKGDRVAQLIIEKIKQCKIEEVKEISETIRGEKGFGSTGK		168		3	Expressed	-1	 	
Batch03	EnhiA.00378.b	Entamoeba histolytica	XP_001914572.1	B1N5V6				"deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial precursor, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTEKEREEITNKIYLIEKEYQLEYNKYNTYCISTDYATPNDIARNIFTEWVKRENIENETFHVFLYANEENQKKRIIKRNRGVISEMNFYYVNQINTLYKHYLNEHFTSKENNEETLFIKKLHKDAIIPTRGTEQSVGFDLYSIDDNIIYPHDRCLISTGIAVQIPHFCYGRVAPRSSLAIKYGIDIGGGVIDEDYRGEIKVIVFNHSNTIYRCKKGDRVAQLIIEKIKQCKIEEVKEISETIRGEKGFGSTGK		254		3	Expressed	-1	 	
Batch03	EnhiA.00380.a	Entamoeba histolytica	XP_655567.1	C4M651				"eukaryotic translation initiation factor 4E, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSVKVLEPHQLTMTLNAEPIDGQHKLNTSWTLWYDQPSNESIPYGSNTKEVYCFGTVENFWRMYNNIIKASDLVCMSSYYLFRKGIEPKWEDAQNKNGGRWIHYCSKTMKNEGIEEKWLNTILACIGEDFPSSELVKGCVFNCKKNQIRISLWVGEHDDSKAVKLIGSKFKSILDLDQEKIVFHIHQDSVDGRFFNVISL		200		5	Purified	-1	 	
Batch03	EnhiA.00389.a	Entamoeba histolytica	XP_656355.1	C4LSF1				Rab family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MAAKAHYDHLFKILIIGESGVGKTAIMQRLCEDTYDNVYISTVGVDFKPKILNIRNKTVKMQIWDTAGQERFRNITASYYRNAQGVIIVYDVNDIGTLEKVDSWFNEVKERTGANPPVVFLVGNKSDSPNPTVSKEMVKNVVNNLGGIPDYNCSAKEGTGVNEIFNALAEAMMDKSNQGGNGSTKPNELTNLTDKPKDNGKGCC		204		5	Purified	-1	 	
Batch03	EnhiA.00394.a	Entamoeba histolytica	XP_656895.1	C4LWD3				"thioredoxin, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSNSVHYFLRIKPYTEISSLSEFNSIIKTNSRVVVDFYVTWCGPCKMISPIFIELAQDYPLIKCIKVNVDAAPEIARQCNIRSMPTFRFYRQGGLVKEFTGANPSHLKYEFSHL		114		4	Soluble	-1	 	
Batch03	EnhiA.00395.a	Entamoeba histolytica	XP_657150.1	C4M9G5				"troponin-like protein, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTEADIKHVFDMIDTDHSGYLDIDEFVKACSQLIEGCEKESAVALFHMADENEDGKMDLNEFKNMIEFYLKNSEEEDPYVLLFKRCDVNGDGVLDKKEVFDILQSIDPNITIQDINETFDIYDTDKNGSLDFDEYMKMVEDIKSQ		145		5	Purified	-1	 	
Batch03	EnhiA.00400.a	Entamoeba histolytica	XP_001914339.1	B1N573				"2,3-bisphosphoglycerate-independentphosphoglycerate mutase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MEGLKPNTKLQPRQGPVVVCILDGFGIDKEGPGNCVTLANPPYYNKLLAEAKEQHLHTIIKANGPYVGLPTEADMGNSEVGHNALGAGQIYSQGTKLVEESIESGKFFETENWKNVVGAAVKEGKTVHFIGLLSDGNVHSNTTQLFQMMDGVVKCGGXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXQYNTLFKEFRKNSSINHET		210		1	Selected	-1	 	
Batch03	EnhiA.00401.a	Entamoeba histolytica	XP_647871.1	C4LWT9				"Actin-related protein 3, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSTLPAVVLDNGTGYTKIGYAGNTEPSYLIPSLIAVDSKADLNTATKSTEDFDFYIGQEAENAPKSYTKTFPLKHGQIENWTLMEMYWEQAIFKYLRCDPQDHYFLLTEPPMNPPENREYLAEVFFETFNVPGMYIAVQAVLAIVASWSRKDNNPANARLTGTVIDSGDGVTHIIPVADGYVIGSSIKSIPLAGKDITAFIQQMLVEREEPIPASERMEMARTIKENYSFVSKDMCKEFSIMDSGNDPKSSFKKHQAIDPISKKPYTFDVGYEQFLAPELFFNPEIFSSDFTTPLADLVDDSIQSCPIDCRRDLYKNIILSGGSTMFKGFGHRLQRDVRRFTDFRTQKAVQLSGGKLTPKPMEVNVVSYPYQRYAVWYGGSVMAELPVFVQHCHSKAEYEEKGPSICRYNHVFVAC		416		1	Selected	-1	 	
Batch03	EnhiA.00406.a	Entamoeba histolytica	XP_001913612.1	B1N346				"seryl-tRNA synthetase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MRRELMAKTAQLSDFDETLYHVGTGKDVELDDQKYLIATSEQPLTALHAGEWILPKQLPIRYMGFSTNFRKEAGAHGKDTWGIFRVHQFEKIEQFCMTLPDKSWEMHEEMIKNSRDFFESLKIPYRVVNIVSGALNNAAAKKYDLEGYFPGFNEYRELVSCSNCTDYQSRELEVRLQTDKKDKTKSYVHMLNSTLCATERALCCILENYQCEDGIIVPEVLRPYVGGVEKIPFIAPKPVWAKEEKKSTKKN		251		2	Cloned	-1	 	NR-16336
Batch03	EnhiA.00407.a	Entamoeba histolytica	XP_654690.1	C4LZW2				"ADP-ribosylation factor, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSFLSFLFKKKQMNILICGLDGAGKTSMLLKMQGQDPKTIQTKPTIGYLNPTLKYKTFEWLFWDVSGAAKFRGLWKSYYPNVKCIAFVFDNTDEDRFDESKNALLNMLADSELKGMPFLIYVNKTDKKEFDQTTFNEKLGLTETQKLRCQIFPCSAYTGDGLFEGLDWMCYTLKKMTKN		179		5	Purified	-1	 	
Batch03	EnhiA.00409.a	Entamoeba histolytica	XP_657538.1	C4LSX4				"proteasome beta subunit, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MNMTNDPLPIATSYVNDKTKFLKTGTTICGLVCDKGQTVVLACDSRATVGPIVADKACMKLHKLAPNIYCGGAGTAADLTHATNFIATKLGVHRFTIGQMPRVDTAVTMLKRHLFPYGGHIGAYLVVGGYDYTGAHLWGVYADGSTSQHNYYSLGSGSIAATTMLDDQWNENLTREEGVKLATQAILAGIFNDMGSGGRVNVCVIDKNGVEEKLNIEHPNDRKFKNPDFKGFPKKLEILKKTVIPIEHEEEDFKDQKQMELE		262		7	Crystallized	-1	 	
Batch03	EnhiA.00412.a	Entamoeba histolytica	XP_001914409.1	B1N5E3				D-phosphoglycerate dehydrogenase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MKIVVITEKPFAENAVKGIREILEKAGHEVVMIEKYKKKEDVIERIKDADGVIVRSDKIDEEIIKAGEKVKIIVRAGAGYDNIDIEACNQGKIVVMNTPGQNRNGVAELCIGMMIFGFRKGFKEGKGRELKDKTLGICGCGYVGKRVKEIAEGIGMKIKVYDPFITTENQVKKIEELFEECQVISLHLPLTKETKGKIGYELIKKLPYGGMICNTARKEIIDE		223		4	Soluble	-1	 	
Batch03	EnhiA.00419.a	Entamoeba histolytica	XP_648646.1	C4LZ68				"apyrase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MALIKRLTPNSYQYQPVYKSYHKNSPILRVALVSDLDKASKEGQMWRSVVIVGIIFRQGNSYDFQEQEEFNISLPINENGRGMELSELLSFNGSLYGFDDRTGLVCAIDIEKKKAYPRLILRDGDSFSDKGMKIEWATVYKDSMYVGSIGKEFTTPTGEYLNDNPLYVKQINVDGKVSVLNWKNKFNAIKNAVRIYGEGYMIHEAVAYSVSDNKWYFAPRKCSNERYDDIKDEVRGCPYIISTKDFIHFNIINDPQHDFNKGFSSIKILPHDENKLIYLKSVEVGKRSETYMGMISTTGEVIMKEKLITKMKMEGIEFIPI		321		2	Cloned	-1	 	
Batch03	EnhiA.00425.a	Entamoeba histolytica	XP_651869.1	C4M7D4				elongation factor 1-alpha 1 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MPKEKTHINIVVIGHVDSGKSTTTGHLIYKCGGIDQRTIEKFEKESAEMGKGSFKYAWVLDNLKAERERGITIDISLWKFETSKYYFTIIDAPGHRDFIKNMITGTSQADVAILIVAAGTGEFEAGISKNGQTREHILLSYTLGVKQMIVGVNKMDAIQYKQERYEEIKKEISAFLKKTGYNPDKIPFVPISGFQGDNMIEPSTNMPWYKGPTLIGALDSVTPPERPVDKPLRLPLQDVYKISGIGTVPVGRVETGILKPGTIVQFAPSGVSSECKSIEMHHTALAQAIPGDNVGFNVRNLTVKDIKRGNVASDAKNQPAVGCEDFTAQVIVMNHPGQIRKGYTPVLDCHTSHIACKFEELLSKIDRRTGKSMEGGEPEYIKNGDSALVKIVPTKPLCVEEFAKFPPLGRFAVRDMKQTVAVGVVKAVTPRAANASAAGKKK		442		1	Selected	-1	 	
Batch03	EnhiA.00425.b	Entamoeba histolytica	XP_648717.1	C4MAC9				elongation factor 1-alpha 1 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MPKEKTHINIVVIGHVDSGKSTTTGHLIYKCGGIDQRTIEKFEKESAEMGKGSFKYAWVLDNLKAERERGITIDISLWKFETSKYYFTIIDAPGHRDFIKNMITGTSQADVAILIVAAGTGEFEAGISKNGQTREHILLSYTLGVKQMIVGVNKMDAIQYKQERYEEIKKEISAFLKKTGYNPDKIPFVPISGFQGDNMIEPSTNMPWYKGPTLIGALDSVTPPERPVDKPLRLPLQDVYKISGIGTVPCGRVETGVLRPGTIVQFAPSGVSSECKSVEMHHTALAQAIPGDNVGFNVRNLTVKDIKRGNVASDAKNQPAVGCEDFTAQVIVMNHPGQIRKGYTPVLDCHTSHIACKFEELLSKIDRRTGKSMEGGEPEYIKNGDSALVKIVPTKPLCVEEFAKFPPLGRFAVRDMKQTVAVGVVKAVTPRAANASAAGKKK		442		1	Selected	-1	 	
Batch03	EnhiA.00443.a	Entamoeba histolytica	XP_655208.2	C4M1Y3				Rab family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSDTKETVPTNNEEKLDIEPKKDIKEEVKPEEEHKEEEHKEEKPEEVKPEEVKPEEVKPEEVKPEEEKKNESNEQQKVKVIMVGESSVGKTCCMNRYVSNEFAEQTKATIGVGVGSKEVEVEGKHIKLQIWDTAGQERFATLTGNYFRNAMAAIIMFDVSNKESFENIPNWVEQCCKSDGKHIIFIAGNKIDLENRVVSKEEAEEKAKELKLKYFEVSAKTGDGIEDLFNELIKEIMKTPFCNEQEKEGVELDGQKKQKKGGCC		264		5	Purified	-1	 	
Batch03	EnhiA.00450.a	Entamoeba histolytica	XP_652900.1	C4M341				"dual specificity protein phosphatase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSDIQEVGESNWMISTIEKGTLFLGSVYAAEDEEVIQEYQIKSVLSILGYEVYLPSVIKEKKWIVLEDSSSENISSYFTECFKFIDNALKPVLVHCEMGVSRSATIVIGYLMYKGKTLKEAYEYVQQRRKNISPNNGFMYQLYKYSEELYPHNEETMLFIYNKYGRKDTVDKFNERDKNKVESFVNQFSECEFKWGSYFKTKYNY		205		5	Purified	-1	 	
Batch03	EnhiA.00456.a	Entamoeba histolytica	XP_656494.1	C4LVX0				"peptidyl-prolyl cis-trans isomerase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MARPKVFFDITIGGEKAGRIVMELFNDIVPKTAENFRCLCTGEKGNGLTYKGCGFHRVIKDFMIQGGDFTRHNGTGGKSIYGTKFADEAFTVKHTKPGMLSMANAGPNTNGSQFFITTVPCPWLDGKHVVFGQVVEGYDVVKMIENNPTGAQDKPKKAVVIADCGQL		167		5	Purified	-1	 	
Batch03	EnhiA.00459.a	Entamoeba histolytica	XP_657480.1	C4LT28				"choline/ethanolamine kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTVVQRNPKIINFHNVCGAENDDSFTHRVLFIALDASNNKEFTSGAVFIVKILVPEFANLQNDQFSFQFFTEGITNKLVCITAIPTGKKVVLRTFGNYTEYLVDRRQESVIMNTYGQKVYGGFLNGIVYDFTPGRTMDYNEFRKSEILSKMAECIAGVHQLKPNLKKEPILFKEMRAWLNNVPSHYLDPEKQKTFAAANIKFEDLSKEIDYVEKKLTALNSPIVCCHNDLYLKNFIYNEEDRSIKLIDFEYASYNFQAFDLANHITEWCGVIMDWNKYPTKEEQDFFLRSYLEAYNGKKPSDEEVDHLYDVVNQFQLATNLLWSLWGFVDASLSSIEWDYLDYAFMRLNKYYELKKIL		358		1	Selected	-1	 	
Batch03	EnhiA.00460.a	Entamoeba histolytica	XP_656330.2	C4MBR0				protein kinase domain containing protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MASSAVQSRSSLDGDEPSNEIDIVPKTLESINRGFTPLMTICDPTDKKPAIPIDFKKIALIGRGNIGRVYLVQKKGTKEFYSMKVMEKKIIEERKKEQRVESERNILKSLNHPFLVHLVWDFETPFYYIFVMTYCAGGDFWRLLNKQPGNCFREVVAKFYLAEIICALEYLHMEGVVYRDLKPENILLHESGHIMLSDFDLSKHSDVEDHARIKSSLFGEDEVVVEPSNFRSNSFVGTDEYLAPEIIAKDGHSASVDWWTLGVLMYEFLYGCNPFAASSIQETYSKIQKGEFTFPKMHRYKVSKDAKDLIKELLDVDSEDRLGSKYGASEIKQHDFFSNIKFALIRNMTPPIIPRLNGRRDTSYFYQYKPYDDDVPDDWGYASEQSIELNTMEFHSLQQDEIKTQ		405		4	Soluble	-1	 	NR-16030
Batch03	EnhiA.00464.a	Entamoeba histolytica	XP_655621.1	C4LUQ9				"calmodulin, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSRRRDEEVDQELVGELKDAFDMFDSSKKGYLDKDDVKKLFKTNGIRVTDEDLDAAFKEADADGDKKIECMEFINMMTGKMKTASTEQKLTEAFKVFDPEEKGVIDSKELTEALLNIGERCTTSEVGELKTVAENQEGQIRYELFIQAVFAKK		153		5	Purified	-1	 	NR-16031
Batch03	EnhiA.00467.a	Entamoeba histolytica	XP_001914362.1	B1N596				hypothetical protein EHI_097060 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSSLIQSKHTSVQNTTRKPTNVFHGRVVYSYNPQNESELKLEKGEWITVISTDGEWWEGESKGKIGIFPSHYVERDVKIN		80		2	Cloned	-1	 	
Batch03	EnhiA.00469.a	Entamoeba histolytica	XP_649609.1	C4M2S0				Rab family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MEGETECMYKLVIIGESGVGKSNLLLRFTRNEFEPEKKFTIGVEFATRTIEYEGKTIRAQIWDTAGQEKYRAITDAYYRGAEGAMCVYDVSKKDSFDAIERWMNELKNGCDSDITIMIVGNKADLKQEREVNTSDGTEFAQKHSAFFIETSALDGTNVEKAFSDLLIQIYKKKNATLKNDSVPSDNSKPKTEEKVDISQTQSAQTQGGKKCC		212		5	Purified	-1	 	NR-16032
Batch03	EnhiA.00474.a	Entamoeba histolytica	XP_656920.1	C4LWF7				Rab family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSSNNKDKTIKYKVITVGNYGIGKTTFVKKYCHAEDMKESFDSLVKHITLKDKQYDIVLCDTQDMEDISYITAFYYNDSQGVLLMVDLSNENGLKDIQNWVEPINLYEPKDDIKKPIKILVGTKADLEQKISDETMQAKAKELNMEYFKISSQTGVGVEEVMDKLFTCMTQKFNPSPEKSKSGCCTVM		188		2	Cloned	-1	 	
Batch03	EnhiA.00477.a	Entamoeba histolytica	XP_001913422.1	B1N2K6				"protein kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSITPSQHTLDASLEAKMKIVAQREQQTQYLEERKNRKEILENYLKNSNLSEKDKNELREELNEKESEYMRFMRAKLSPKDFETIKVIGRGGFGEVKLVVRKGSNEVYAMKLMKKKDMIERKQIEHVRAERDILAQTHFTNDWVVKMYYSFQDEEYLYIVMEYLGGGDMMSLLIKEDIFTEEMARFYIAELFLAIDSIHKLSYIHRDIKPDNILIGYDGHIKLTDFGLCTGFHRIDTSITLKSLIEKAQKEQIKVDLGVTTMKQMHDYKHRSRDLVYSVVGTPDYTAPEVFERVGYGKECDYWSIGCILFEMVCGFPPFLSDDAVQTCLKIVNYPESYKFPSRLDLSDEVKDLIHHLICPVNKRYSSIEEIKAHPFFKGFDFSCVEKNTPPYLPKLSSMFDTSNFEDFEEEESFDAKISPQDTKNLAFVGYTYKGFLNVCNPNKKKVSHSGVTLEQIFTSHENTKTN		467		2	Cloned	-1	 	
Batch03	EnhiA.00480.a	Entamoeba histolytica	XP_649344.1	C4M3B6				"dual specificity protein phosphatase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MGNKPSRPSRNEIQKEVQKVSEILPNLFLTSRITAMKPSIYREYGISAVLSLTTNNINYPDGVISKHLHIQDSFFFLLQKSLEESIEFIEEMMKEGRKVLVHCEVGMSRSASAVIAFLMKRNDWCIRDAYLYTKERREIVCPNPGFIIQLYEFQLKLGIKDSKSNRLFVRDLLDRTNSLYREIPTYALWNAFVSSGFSYEKAIKDQPRMAVVNMNA		216		2	Cloned	-1	 	
Batch03	EnhiA.00486.a	Entamoeba histolytica	XP_656803.1	C4M5A0				"40S ribosomal protein SA, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSKNVKTNFPDILKPSAEDIKMMVACRVHIGATNLNFAMEEYVYERGNNNECIFNLMKTWEKLSLAARVIAGISNETPSDVVAVAGREMAHRASLKFMKYTGCTAVAGRFTPGSFTNQIQKKFMEPRLIIVSDPSVDHQALRESGYINVPTIAFCNSDNSLKNVDIAIPCNNRSRLSIGLMWWMLTREILRYQGKLARDEKWDVMVDLFLHRELDAKKDAPVIAGEEKVAKVEDKKAASDATVASTEWDDQKKN		254		-2	Work stopped	-2	Work stopped	
Batch03	EnhiA.00492.a	Entamoeba histolytica	XP_001913761.1	B1N3J5				"sphingosine-1-phosphate lyase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MEQDTPVVAFTTTDLNIYKVSDCMNKEFQWEFNTLQFPAAVHFCVTEKTIGCEKQFMEDLNKALDIIRKDPKNPKYNVWAPVYGMTSSLPDIDTLEDMVSQVIAQYCDVI		110		2	Cloned	-1	 	NR-16033
Batch03	EnhiA.00499.a	Entamoeba histolytica	XP_001913777.1	B1N3L1				"alpha-actinin, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MADSELVAQWEKVQIKTFTKWVNMHLAKKGRKINDVTTDFKNGVELCALLEIIGETTIKCVTNPKMRIQMTENLDKALRFIQSRDVKLTGIGPTDIVDGNVKLTLGLVWTLILRFAISELSAEGLSAKQGLLLWCQKKCEPYPVKVENFSESFKDGKVFCALIHRHRPDLLDWETVGEDDRANLEKAFDVAEKELGIPKLLDVDDIVNMPRPDERSVMTYVAALYKVFSSNDQVEKAGKRAGNFLDFXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXQTFKYSKDNLYITFGISFFTSME		304		1	Selected	-1	 	
Batch03	EnhiA.00505.a	Entamoeba histolytica	XP_654104.1	C4LYN9				"guanylate kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MGKYQVLVLFGPSGAGKSTIMHHLMEKFPGKFSFSISHTTRKPRGKEQNGVDYYFIEEEEMKKMIEEDKFIEHAHVHTAFYGTSKMEIERIANNNQIAILDIDLQGSRQIRGKVAAFFLFIAPPSMEILEQRLRSRGTETEEQVQVRLKNALIEMEGEKEADAVVVNNVFTEGYGKIDEIIEKNLF		186		2	Cloned	-1	 	NR-16034
Batch03	EnhiA.00517.a	Entamoeba histolytica	XP_651792.1	C4M5D3				"ADP ribosylation factor family GTPase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MGSWFSKLFSTQEINIAMVGLDNAGKTTILYQLRLGETVTTIPTIGVNVESIKINNINFSVIDLGGQSKIRPLWRHYYEGTQGIVFVVDSSDKERIEESGDVLRKMCKNELLKDCALLILGNKKDIEGAVNEDELTKLLKLEMIQLKYLVKSVSATNNEGLTEAFIWLSENVCH		174		2	Cloned	-1	 	NR-16035
Batch03	EnhiA.00528.a	Entamoeba histolytica	XP_655748.1	C4LW95				"thioredoxin reductase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSNIHDVVIIGSGPAAHTAAIYLGRSSLKPVMYEGFMAGGVAAGGQLTTTTIIENFPGFPNGIDGNELMMNMRTQSEKYGTTIITETIDHVDFSTQPFKLFTEEGKEVLTKSVIIATGATAKRMHVPGEDKYWQNGVSACAICDGAVPIFRNKVLMVVGGGDAAMEEALHLTKYGSKVIILHRRDAFRASKTMQERVLNHPKIEVIWNSELVELEGDGDLLNGAKIHNLVSGEYKVVPVAGLFYAIGHSPNSKFLGGQVKTADDGYILTEGPKTSVDGVFACGDVCDRVYRQAIVAAGSGCMAALSCEKWLQTH		314		2	Cloned	-1	 	
Batch03	EnhiA.00534.a	Entamoeba histolytica	XP_001914154.1	B1N4N8				"disulphide oxidoreductase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MQERVLNHPKIEVIWNSELVELEGDGDLLNGAKIHNLVSGEYKVVPVAGLFYAIGHSPNSKFLGGQVKTADDGYILTEGPKTSVDGVFACGDVCDRVYRQAIVAAGSGCMAALSCEKWLQTH		122		2	Cloned	-1	 	NR-16036
Batch03	EnhiA.00543.a	Entamoeba histolytica	XP_656897.1	C4LWD5				Rab family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSSHQYDFLFKILIVGDSGVGKTAILQRYCNNTFDERYISTIGVDFKPMILNVGERTIKLQIWDTAGQERFMNITAAYFRNTTAVIIVYDVNNRDSLSKVYSWYGEVNEKTTQQNPVIFLVGNKKDENLNSLIDIEEAKNIASKLGNIKVMECSAKDNIGIKELFGSLVDTILEKIDNNSYLPKESQYVDGLTIGEKKESNCC		203		2	Cloned	-1	 	NR-16037
Batch03	EnhiA.00544.a	Entamoeba histolytica	XP_654105.1	C4LYN8				"vacuolar sorting protein VPS4, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTSLLDKGKEFSKKAMEEDEKGNSKEALEYYKKAIDCLVAHKKTEKNEKVVNIINKRVKEYVERAEYLKRMISGERVKSDDPDKEEDAENKARSNAVGNAVLKEKPNVHWEDVIGLEKAKEALQEAVILPIKFPQLFTDKRKPWTGILLFGPPGTGKSFLAKAVATEADSTFYSVSASSLLSKYLGESEKMVKELFETARKNKPSIIFVDEVDSLCSSRGDGETEASRRVKTEFLVQMNGVGNSMEGVLMLGATNIPWQLDTAIRRRFEKRIYIGLPDASARAKMIKWNLGKLPNQLTDNDFKILGEQTELFSGSDIATLCKDAIYQPVRTLQAATHFKYVTGPSPITGEIQNDLVTPCSPGDKGAMEMNWKQIEGSKLVVPPVTMMDFMKSIKNSRSSISVEDVNRHREWAEQFGQDG		419		5	Purified	-1	 	NR-16038
Batch03	EnhiA.00547.a	Entamoeba histolytica	XP_653642.1	C4LZY2				protein kinase domain containing protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MNGQLIGCGTFGKVYKSQTEDGEIIAVKEFNNQSTNNELKLQTFREIKFLQQLRHEKIIKIKNFIVEQNTLFIIMPFIPNNLEKEIKKKHSSTISFEELISWITPLQYQFFEVLKYLHSLHIVHRDIKPSNFLLTDKQQIQLIDFGNAYHYHSNELVKANCVTPNYRPPEGDLNILVNPQSIDVFSIGCVLFEMISGKLFLQLSNNKTIFDFINSTYSFDANEILMNPSITIPTTLTVSQSLIDSSIPYHTKNTYDFFNKLLNLNSNLRPSIDTCAKLILF		281		3	Expressed	-1	 	NR-16039
Batch03	EnhiA.00562.a	Entamoeba histolytica	XP_651800.1	C4M5Q7				Rho family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MTMRPVKLVIVGDGAVGKTCMLISYTTNAFPNEYIPTVFENYNSSLVVDDVKINLGLWDTAGQEDYDRLRPLSYPSTDVFLVCFSVIAPASYENVEGKWKPEIDQHCPNVPIILVGTKIDIRDDPEQVKRLAEKNIVPIQPPQGDELAKKIGAVKYIECSALTQANLKLVFEEAVRAVLAKAAKEPTGKKEKGGKKGCSLF		201		2	Cloned	-1	 	NR-16040
Batch03	EnhiA.00563.a	Entamoeba histolytica	XP_652927.1	C4M4D9				"casein kinase 1, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTEFMFVVANKYKLEKKLGSGSFGDVYLGTDVELHNEVAIKLELLKCKHPQLKDEFELYQKLIGDKKEEHEGISGIYYYGQEGDFNVLVMDYLGPSLEDLFNYCGRRFSLKTVLMLLNQMLKRLQFVHSKGYIHRDIKPDNFIMGNGEQSHVCYLIDFGLSQRYLNQNNEHISYSEDKSLTGTARYASLNNHLGIEQSRRDDMESLAYSVIYLLRGSLPWQGLHVAKGENRYNKIYSKKVEIPVSQLCENLPSEFGSFLSYCRNLKFDEEPKYDFWRHIFQQVAQNNSIIFDYEYDWIIKRKAEKELV		308		2	Cloned	-1	 	
Batch03	EnhiA.00565.a	Entamoeba histolytica	XP_654999.1	C4LWS6				"cytidylyltransferase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MKGKTKQTKQILHDLKERFGEGPYEVMIAGTFDLIHPGHIHFIQEAAQFGRVIVIIARDSVVKRIKQRETVLDEKMRQSIVEGIKGVSEVVLGCENGNWYEPILKRNPHLFLMGFNQPGDLFRFEKVIHEKGGRTIFRRSNSMEKSYSLQSSSQIRRRVIEIVNNKIQ		168		2	Cloned	-1	 	NR-16041
Batch03	EnhiA.00579.a	Entamoeba histolytica	XP_651357.1	C4LXT9				"endoribonuclease L-PSP, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSKLTVVASPLAPEAVGAYSQAIICNGMVYCSGQIGLDRKTGDFAGKTIEEQSKQVMTNLKYVLEEAGSSMDKVVKTTCLLADIKDFGVFNGIYAEAFGNHKPARACFAAAALPKGALVEVECIATL		127		17	In PDB	1	Target selected for ligand screening 	
Batch03	EnhiA.00582.a	Entamoeba histolytica	XP_654610.2	C4MBB8				"hypothetical protein, conserved [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MEELINKNNQLFKEVVETLPNIQQSIDDTTKNYQYYLGSIKNEVFELEDNETYSEAIKRGEGIFDRIDETERRRKLVIEKSQETINQIEILKNKMSRIIEECNNDEETLSKTRNELIDKIISIEEMVMKNKLFRKPKETDTITAEFNKKKEEWQTYYSDYLERKRRQEEERRKEEEERRQQQEEEERRQQEEEEERRRQEEEEERRQEEEEEERKRQEEEEERKKQEQERKIQEHERKIQEYERKIKEQEEERKKQKEEQERKTQEQERKIQQLENKTQEQEKKIQEQERKIKEQEEERNKQKEEQDRKIQEQKEEQDKKIQEHERKIQEQERKTTEQEKKIQQLEKLRIIKEERKEEERLQIMKGMNTIEEMLQLEEWTNRKVEDIL		388		1	Selected	-1	 	
Batch03	EnhiA.00595.a	Entamoeba histolytica	XP_656888.1	C4M937				"transport protein particle component, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MISKSEKQKTGELVWNDMKKINSELLTMTYGGIVLQLLKENEFDGEKVNNELDEMGYNIGTRIVEEYLAKVEGKMSTKCLSFKEHIESITYVAFKMFLGINAECYEVNEKQWKISIPNNPLSECVELPEKLKNKLWYSNIYCGIIRGSLEMLKYKVECKFIGDILRGNSTTEIEVTLIDLLEQAKYVNYNE		191		2	Cloned	-1	 	NR-16042
Batch03	EnhiA.00597.a	Entamoeba histolytica	XP_653094.1	C4M371				hypothetical protein EHI_086160 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MVTECTEYGSIQDIMNKRNITEISKKIRIKFMIDGAKGISCLHLNGILHRDIKPDNFRVVTLDDNTEAKRKLTDFGSARNINMMIMLIKRKE		92		2	Cloned	-1	 	NR-16043
Batch03	EnhiA.00618.a	Entamoeba histolytica	XP_651915.1	C4M5T9				Rab family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MAGRPALFKAILIGDSGVGKTSLINRYVNNQFSDVYKATIGSDFLIKPVTVNGAQYTLQIWDTAGHERYSCVVTTFYRGSDCCVLCFDVTNRDSFNHLEKWKNEFIDGANATNPASIPIYVVGNKIDCEPNKREVSQEQAREWCKLNGHKYFETSAMNAENVTDLFTTLAEDVVSRREDEEEPEKPAPIIIQKQSEEKKEGGCC		204		5	Purified	-1	 	NR-16044
Batch03	EnhiA.00622.a	Entamoeba histolytica	XP_655529.1	C4LXI5				Rab family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MNDFNDSIVFKIIVIGDANVGKTSLVKRYVDREFYKELKPTIGVDIKNKTININEENICLTFFDTAGQEKFAAVTDSYFKGAKACIIVYDITKAVTFNSVDKWYNKLRNIVSDPIPVLIIGNKSDIEQQRDITTDVGASLARKLGAFFIETSCLNGSNVDKAIKIISNEIINNKVVENLRLTQSTSLRLEKPDVEQQSSKQCC		203		2	Cloned	-1	 	NR-16045
Batch03	EnhiA.00639.a	Entamoeba histolytica	XP_649164.1	C4LXE5				Rab family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MTSNKQIKVTLVGESSVGKSSICNVISKGVFEKTSATIGAEFIKFNRTYKEQQVLVSLFDTSGEERYHSIPQSYYRKSNAVIMVYDISRKETFEQLEYWLNDVKGNCEIDTIICVGNKIDLERAVSKEDALEFARRHSLIYTETSAKTFEGVEDLVNEMIAAVMESNQKDETISSNENLHIEDISSQQTSYGCC		194		2	Cloned	-1	 	NR-16046
Batch03	EnhiA.00650.a	Entamoeba histolytica	XP_647919.1	C4MAL2				Ras family protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSNVNSICLKSLIIGNSCDAKQRMLRFPGNSMNLLKFGLDFKFVTVIIDRVFIKMQVWDIAGQERLRTNIEAFLPHTDIIYFVYDMTDASSFRFIQTTLNQINQRTPCNSMKILVGLGREFESQQEVIQEEIMELSLRYKIKHYEFDLNDDSQVSDLYFKSIYQFISENQYQIENQHSTNKCVIV		185		2	Cloned	-1	 	
Batch03	EnhiA.00653.a	Entamoeba histolytica	XP_001913849.1	B1N3T3				Grainin 2 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MRVFDIDMSGSIGFFEFLALWNFMNLCNETFKHFDADKSGSLDVNELIKALPMLGFNCNKRSVDVLLKMNGSSLGSKKVSKNQFISTAAYLGQCRSIYQKTFNMKREEIDNAEFDKFVNLVLALSG		126		2	Cloned	-1	 	
Batch03	EnhiA.00659.a	Entamoeba histolytica	XP_657390.1	C4LSM9				EF-hand calcium-binding domain containing protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MPEDKPQGKTIEEFFAEIDLDKDGSVNVDEYFNGVKMWRNDITDDDKPSQALLFHLADLNDDGEIDIRQFARLIAILNRGFGKDIKSVFTAVFRLLDIKDQGKIGAPELERLLKKMGLQIESDDIEGFMDQVDQDLDGFISLKEFLAHFVKESKDGQ		157		5	Purified	-1	 	
Batch03	EnhiA.00688.a	Entamoeba histolytica	XP_657052.1	C4LU94				"tryptophanyl-tRNA synthetase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTETVEKQIVTPYNVSGLVDYNKLVKDFNAELLTQEQIARIGAITHKEPHMWLRRGLFFCHRDINAVLDDVEKGNKIYLYTGRGPSSDALHLGHLIPFIFTKYLQDAFDCQLVVQLTDDEKYLWKPVTIADTEKYAIENIKDIIASGLNPKKTFIFTDYTYMERMYPVVTKIQSRVTFNQVKGIFGFQPHHNLGKISFPAIQAAPAFPESFPHLFGKQKIRCLIPCAIDQDPYFRMTRDHAESLGAYKPSLIMSKFFPALQGSMGKMSASDPNSAIYLIDTPQQIADKINNHAYCSVQDIKEFKKNGTNVDDDVPYQYLRFFLNDDQQLEKIKNDYESAQMMPQDVKNILIHQLQELVMNHQIERQKVTDEVIKHFMEIRKPEVQ		385		2	Cloned	-1	 	NR-16047
Batch03	EnhiA.00688.b	Entamoeba histolytica	XP_649189.1	C4M7U9				"tryptophanyl-tRNA synthetase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTETVEKQIVTPYNVSGLVDYNKLVKDFNAELLTQEQIARIGAITHKEPHMWLRRGLFFCHRDINAVLDDVEKGNKIYLYTGRGPSSDALHLGHLIPFIFTKYLQDAFDCQLVVQLTDDEKYLWKPVTIADTEKYAIENIKDIIASGLNPKKTFIFTDYTYMERMYPVVTKIQSRVTFNQVKGIFGFQPHDNLGKISFPAIQAAPAFPESFPHLFGKQKIRCLIPCAIDQDPYFRMTRDHAESLGAYKPSLIMSKFFPALQGSMGKMSASDPNSAIYLIDTPQQIADKINNHAYCSVQDIEEFKKNGTNVDDDVPYQYLRFFLNDDQQLEKIKNDYESAQMMPQDVKNILIHQLQELVMNHQIERQKVTDEVIKHFMEIRKPEVQ		385		2	Cloned	-1	 	NR-16048
Batch03	EnhiA.00689.a	Entamoeba histolytica	XP_649732.1	C4M8M2				"ABC transporter, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MQKSFKDDSNVEKSDIPLFAYKLIKETSPTFQLENLTESNPNIINSNQNKLFGEVIVSAEHLEKEYKIEGRNESVFAVRDISFGSKSEILGIRKGEFVMLRGPSGGGKTTCLNMIGLIDKPSHGKLTMFGTEINEKTKESFMANLRLEKIGFVFQTYNLLSTMSAYENVELPMKILGRLNKKQRHERTIKLLELVGLQDRMNHLPSELSGGEQQRVTIARALSNEPELLLMDEPTGDLDTKNTIEVMNLILELNQKIGTTIIMVTHNPDIECYADRIIYLQDGHIIKQVINSQQTKLDYTAFMRYISLREESQS		314		2	Cloned	-1	 	
Batch03	EnhiA.00691.a	Entamoeba histolytica	XP_001914157.1	B1N4P1				GTP-binding protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MWIWEWFWNLLADLGLAYKTGKMLFLGLDNAGKTTLLHLLKDGKVSQHIPTQQPTMEELVMGNIKFNTYDLGGHTPARKVWKTYCTEVDAVIYIVDCAAPERFGESKKELDSLLNDEMLQNTPFLILGNKIDIPGAVSEAQLREAMGLTHTTGKGNVTCEGIRPIEVFMSSIVNRQGYPEGFKWISQYMQ		190		3	Expressed	-1	 	NR-16049
Batch03	EnhiA.00691.b	Entamoeba histolytica	XP_654099.1	C4M4L8				GTP-binding protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MWIWEWFWNLLADLGLAYKTGKMLFLGLDNAGKTTLLHLLKDGKVSQHIPTQQPTMEELVMGNIKFNTYDLGGHTPARKVWKTYCTEVDAVIYIVDCAAPERFGESKKELDSLLNDEMLQNTPFLILGNKIDIPGAVSEAQLREAMGLTHTTGKGNVTCEGIRPIEVFMSSIVNRQGYPEGFKWISQYMK		190		2	Cloned	-1	 	NR-16050
Batch03	EnhiA.00703.a	Entamoeba histolytica	XP_648064.1	C4MBB2				"protein kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MERQMSAQVETELSSKSVTASIRTKMTIEAQAGLREQERKEREERSKTLENYLSKSTLSDKEKNSLRAELAEKENEYNRCKRAKLKKSDFETIKVIGRGGFGEVRLVVKKNSNSLFAMKMMRKKDMIERGQTGHVKAERDILAQTHFTNDWVVKLYYSFQDNDYLYLMMEYLAGGDMMTLLIRENIFSHEMARFYIAELLLAIDSIHQLNYIHRDIKPDNILFDNNGHIKLTDFGLCTGFHKDHESSYFEIVDKASKLNLSDLKSQKLSKELAHNYKNKKRNLAYSVVGTPDYTAPEVFLQKGYYKECDYWSVGCILFEMLAGYPPFVSDDSVQTCLKIINCNETLQFPDDVEIHDDAKDLIKKLVCLKEKRLADIKLIQQHPFFKGFNWDTIFEQTPPYLPKLKSPFDTSNFDDFELNEDDVEEKPVNINNPKDLAFVGYTYKGFLNVVNTPSKKRHAQGITLSQIFSTHIAN		474		2	Cloned	-1	 	
Batch03	EnhiA.00706.a	Entamoeba histolytica	XP_656536.1	C4M4H9				Rab family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSTNANRNKQASDELPIKIVIIGDLGVGKTSLIHKYCEYSGEVKELNHKSLVFQNRKLKLVLPDTCGAEQMATVTSAVYQNASACVFVYDITKNDSLLSLQNWVGELKRYGPDKGNVPKFLCGNKTDLESQINENDFKDFLTKNPMKDFKISVQNGEGIDAMFNTILPEAIEESIKQLKAKGRPIPPPIKEKKSGKCALL		200		2	Cloned	-1	 	NR-16051
Batch03	EnhiA.00707.a	Entamoeba histolytica	XP_651689.1	C4LVG4				"actophorin, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MAGIQLADEVTSVYNDFKLSHKYRYIVFKMNDGMTEVVVEKTAEKNATYDDFLKDLPEKSARYAVYDLEYDTPEGLRQKIIFYLWTPEGCKIREKMLYSATKATIKQALVGLSAEIQATDAGELNLDEVIAKVKTISK		138		2	Cloned	-1	 	NR-16052
Batch03	EnhiA.00719.a	Entamoeba histolytica	XP_656978.1	C4LSS0				"Arginase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MQFEKVTYIAVPQKYGQKKVGVEEGPKFLEKLGFMNVLEQVAKSVNKKTITEPKTPQELGVTNARNLNEVESVNIELRDTIAKEYDVNNLLINIGGDHSIGLGTIAGVVKAMKPNARVGVVWFDAHPDMNTPENSPSGNIHGMPLACAVGLGPQRLTSIMPHYITPKDIMYVGIRSIDVGEQFEIQDKHIDHFTAEDVKRVGMKEVIEAINKKFVDYDVIHLSFDIDGIDPEFILGTGTPVPKGISLEDSLYFMSEMGKMKKLHSVDIVEYNPKIEEEITGKNVLKCISSLFGIKC		296		5	Purified	-1	 	NR-16053
Batch03	EnhiA.00724.a	Entamoeba histolytica	XP_653630.2	C4LXA3				"beta-amylase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MIFYFLTFIFGCSAVDVNGMLELDIISSTGFKNKALLQSQLMKVKQAGFTGVMGDVWWGLVETSPKNYNFKYYLELVEMIKNVGLKYQPVMSFHKCGGNVGDTCNIPIPKWAIDAVKKLDGFFKDSHGNVNDEYINFALDNVAVEGGRTPIDFYYDFMNAFSTEFKSYISDGVIDEIQIGVGPSGEIRYPSYCAANGWQYPGIGEFQVSDSNSLSLLQHAAEAKSHSEWAHIPTDAGVYNSKPSDTSFFDDNKPNNYASDYGKFFLEFYTQLMLNHTDRVIIAARKAFGTSLPLAAKVSGVHWWYGSSSHAAEATAGYYQVNGYSTYSKINDILGKHGARFTFTCLEMANPTDLKADPKSRPEDLVTEVFGVVTKCDKRGENALDMMGNSNEFWVDEGALSTTINQVASKKLNGFTFLNYMKVCCQVLNFIRNYKIFVSQLNSI		444		1	Selected	-1	 	
Batch03	EnhiA.00732.a	Entamoeba histolytica	XP_652330.1	C4M714				"ADP-ribosylation factor, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MGNWLSKILSVKKETRILMIGLDAAGKTTILYKLKIGDVVTTIPTIGFNLETIDYKNLHFNVWDIGGQNKLRPLWRYYYSGTNAIIFVVDSNDDSERLDEARVVLFNVLNDDYLKGVPLLIFANKHDLPHAKSVSEIVKGLMLSSIKDREWYCQTSCATNGDGLYEGLDWLSSRLE		176		2	Cloned	-1	 	
Batch03	EnhiA.00733.a	Entamoeba histolytica	XP_001913945.1	B1N429				"L-asparaginase 1, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MKQGKQGWEPQPGYLQSLMREMPQFQSETLPYYDIIELNPLLDSSAMTPKDWVRMAVVINENYNDYDGFVVLHGTDTLAYTSSILSFMFENLNKTIVVTGAQTPLCQPYSDATNNLLSALTTAGDIPIPEVVVTFGGHLYRGNRVQKLKANSYEGFDSANYPALAMFGXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXYILFQCFNLQHLLKVFV		218		1	Selected	-1	 	
Batch03	EnhiA.00744.a	Entamoeba histolytica	XP_657385.1	C4LSN4				"casein kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MMDMKIANKYRLVKKLGSGSFGDIYMGVNTFNEEEEVAIKMESTKARCPQLRYEYNLYKILMETGESGTKATGIPAVKWWGMQDDWNLMVMELLGPSLEDLFTYCGRKFSLKTTIMLADQCIKRIQEVHDRFFIHRDIKPDNFVMGMRNMSNTVYVIDFGLSKKYRDNKTMKHIKYAEDKAFVGTVRYASINNHRGREQSRRDDLEALGYMFVYFMKGSLPWQGIKGKKVDKNTQILAKKESTPLSELCEGLPEEFATYLDICKKLGFDQTPDYLQLRMLFWRIAKREGIEFDGQFDWIQYKGDKTPQGNMPEMVDIERHGSGNGDSGSKSGSVE		335		2	Cloned	-1	 	
Batch03	EnhiA.00745.a	Entamoeba histolytica	XP_001914507.1	B1N5P1				"heat shock protein 101, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MEIVKKSFKPEFLNRMDDIIVFSPLSEKELKEIVKLQMGEVIKVIKKRYPGSEVEMTEAAIEGIIKAGYSIAYGARPMRRYIEKTVVTEITKSIIGGVMKEKSKIKIGYEDGKIEVKITDN		121		2	Cloned	-1	 	
Batch03	EnhiA.00761.a	Entamoeba histolytica	XP_651330.1	C4M831				protein kinase domain containing protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MLPFDPSENVINDKYEIINQIGCGAYASVYKARTKTTGKLVAIKQLKNDRDQGFPVTSLREIQLLQEIHHPNIIQLIEVLHANDFIERNTTISLVFEFMPHDLSSFLKCEEIVSKVAIGQLKGYMLQILQAIQFLHSNNIIHRDIKTGNILISDDNHIKLGDFGLARKQDDVGIYTNNMVTLWYRPPELLLGETRYKGEVDMWSVGCVFLEIFKHRPVFHGKTENEQLSKIWEICGTPTDLEWPQFKEMKMFQTLALPTPQKRILKDVFKGYDPIFMDLIDHLLQLNPKSRFTADEALQHKYFTGEPRPLKPEEMTKFEPSLESCYRKMQKEKQINRSDSRERRDDRMNRRRQEDDFRYQRANKRGTSFNNRRRTDYSRRDNWRGRRGSNEKFY		394		4	Soluble	-1	 	
Batch03	EnhiA.00764.a	Entamoeba histolytica	XP_657097.1	C4M3C2				"protein kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSVKTGWGIKEGGSWKTWKRRMFKLSEGKIEYFKDEGMTKKMGDIELSKVTHVLAVDQYKKRKNLIRIITPSRTYHISVNEESDRDSWVEAIRGMIGDNKEKKTQEEKEENKISMEDFDIITLLGKGAFGKVMLVKYKKEGKIYAMKTVEKAQIIDSNEVEHILSEKVVLSQINNPFLVNMHYSFQTPTHLVFILDYCAGGELFSYLQKHPAGLPEVDVKFYAAQIVLALEHMHSTGIIYRDIKPENILFEKDGYLRMTDFGLAKSTKKGTTNTFCGTPEYLAPEVVEGLDYNEYIDWWGLGILIYEMLFTQSPFLAETMEELYENILQREPKYPSTKPITEECMNFINSLLIKEPSKRLTDPDQIKTHPWFNGFNFDDLYKKKLTPPYVPKIQSQTDTSNFDDEITQEEVDLKTGVEVVADNRFFTDFTYVQK		434		2	Cloned	-1	 	NR-16054
Batch03	EnhiA.00766.a	Entamoeba histolytica	XP_657512.1	C4LSZ8				p21-activated kinase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MKSWKRKWVRLTKTDVYVFDSPTKNTPILTIPLQRTVVSLVASMGDSYLKLDSKKLGKQFIFNAPCKDQAERWVTAINNTIDAGLTRPSGMTQVVHVDFDPNLGYIGLPPEWERFLNEGGITTDEYKKNKDVVDDVLNFQIQRQGDKTNLPSVPAPISQPKQSKAVVEPLPEDVEKVQLKDVTIEQDPREFYSDFEKIGEGASGEVFSAKRKADGIVVALKQMEVNNDNEKLIATEISLMKGCKHDNVVTFYEAFYLPAKKLMWMSMEYMDGGCLTDILENHDIIEMTEPQIAYVCRETLRALNFIHGLHCIHRDIKSDNMLLTNDGHVKLADFGYAAQLNQKQKNRNTVVGTPYWMAPELIRGHDYGVKIDIWSLGIMVMEMAEGDPPYMEFPPLRALFLITTKGIPPLKNAEKWSRDMNGFVARCLETIPDNRADSEELLQHPFMKIACENTDFAQLIADVRKLA		467		2	Cloned	-1	 	
Batch03	EnhiA.00769.a	Entamoeba histolytica	XP_653621.1	C4LXB1				14-3-3 protein 2 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MTSREDLVYLSKLAEQSERYEEMVQYMKQVAEMGTELSVEERNLISVAYKNVVGSRRASWRIISSLEQKEQAKGNTQRVELIKTYRAKIEQELSQKCDDVLKIITEFLLKNSTSIESKVFFKKMEGDYYRYYAEFTVDEKRKEVADKSLAAYQEATDTAASLVPTHPIRLGLALNFSVFYYEIMNDADKACQLAKEAFDEAIQKLDEVPEESYKDSTLIMQLLRDNLTLWTSDMGDDE		238		2	Cloned	-1	 	
Batch03	EnhiA.00775.a	Entamoeba histolytica	XP_001914629.1	B1N613				"glycogen phosphorylase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTPMQRMKLVPRVKIFAGKAAIGYDMAKGIIKLINSVADTVNNDPEVGNLLKVVFIPNYSVSLAEVIIPANDINEQISTAGYEASGTSCMKFVMNGGLIVGTWDGANVEIAEEVGEENMFMFGAKAYEVAGIRANPIPISKDLAEVLAAIDNGMFGDASIHKFVIDQFRGGSDYYLVCRDFDGYVKIQEHIDS		193		2	Cloned	-1	 	
Batch03	EnhiA.00785.a	Entamoeba histolytica	XP_650937.1	C4M4R0				"cysteine proteinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MFTVLLLVVVAYATNFNTWVANNNKHFTIVESLRRRAIFNNNARFIAKFNKNNSFQLSVEGPFAAMTEAEYNSMLKPFVIDKQHEEIVYDSRGDVPESVDWRAKGKVPAIRDQASCGSCYSFASVAAIEGRLLVAGSKKFTVDDLDLSEQQLVDCSVSVGNKGCNGGSLLLSFRYVKLNGIMQEKDYPYVAAEETCTYDKKKVAVKITGQKLVRPGSEKALMRAAAEGPVAAAIDASGVKFQLYKSGIYNSKECSSTQLNHGVAVVGYGTQNGTEYWIVRNSWGTIWGDQGYVLMSRNKNNQCGIASGAAYPVGVADA		318		2	Cloned	-1	 	NR-16055
Batch03	EnhiA.00789.a	Entamoeba histolytica	XP_650041.1	C4M5K1				Rab family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MTERITLKIIVLGDSFVGKTSLINQFVNRKYSSEYKSTIGVDLSTKVISIKDQLVSLQIWDPSGTERFRCISESFFRGTDGCVLVCSVTSIESFNSFESWMSDIINHIGYNVPFVAVANKSDLDPIEWQVTSNRLDTWCKKKNIPSFFVSAKDASNVENAFIRLSEDVLINNSTKQSTVEITQINLNQIKQNSQNSPNQKDSCC		204		9	Diffraction-quality Crystals	9	Experimental evidence of bound ligand(s)	NR-16056
Batch03	EnhiA.00791.a	Entamoeba histolytica	XP_656726.1	C4LYR0				"thioredoxin, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MAVLHINALDQLTALLSTEKVIVIDFFATWCGPCRSISPYFEELAGQYNNIKFVKVDVDQAEEICVNYKVRSMPTFVLVKDGIEQKRFSGADRNALKQMVETA		103		2	Cloned	-1	 	
Batch03	EnhiA.00793.a	Entamoeba histolytica	XP_650707.2	C4M079				bacterial transferase hexapeptide family protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSSQQFIPHNGNVPKVAKDAFITPGVFLIGDVEVESKASIWFNAVLRGDMAKIVIGENSNVQDCSVVHTSIGKPTIVGKNVTIGHSVILHSCEVGDGSMIGMGSTILDDVKIGKNVLIGANSLVTSRTVIPDNSLVMGSPAKVVRELREKEFEYLKENIKEYDDIKQGYHLEQPQNQ		177		5	Purified	-1	 	NR-16057
Batch03	EnhiA.00794.a	Entamoeba histolytica	XP_656680.2	C4LXK8				"ADP ribosylation factor, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MNILICGLDGAGKTALVLKMQGTDPKSMEIKPTIGYLNPSFKYKTYEWLFWDVSGAAKFRGLWKSYYPNVKCIAYVFDNTDNDRFDESKTALLNMLADNDLKGMPFIIYVNKIDLKPYEPSFADKLALTELQKSRCQIFPCSAYTGEGLMDGLDWMCYTLKKLMKHDNNKK		171		3	Expressed	-1	 	NR-16058
Batch03	EnhiA.00795.a	Entamoeba histolytica	XP_655965.1	C4LXD6				hexokinase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MQEIIDQFAIDKEKLEIIVQRMSEELTNGLQDKPSTLKMLPSYAPIPTGKEVGTFMGIDVGGTNLRVLLLEIPEPGVRGELKSVECIMPKTSTTVDQFFGFIAQKIKEFVENNNLKEKEIKAGLTFSFAVEQIAIDKGIQQSWSKGWDVKESIGKDIVEIFHNQLAKINVNNIRIVAFINDTVGTFANLAYDDASCGMGLIFGTGTNGCYIEKTSNFAASKLKSVCKEDYMIVNTEWGALDIPELGYNKFDKMIDDVSINKGEHYFEKMISGIYMGWLARLAIRELIEKKVIFERYADAEVFSGSPDDTDCDHSKKYTSRNTGIVEDTTPELILVDEMLKSLGVNDSTLEERKMLKAITEAVVKRAAYLAAAATVCLYRKMVPYMKERTTAGVDGSVFEKSVPFKRFYLEALDLLQPVEKVTCQLSKDGSGLGAVIVAAAVACKQ		445		2	Cloned	-1	 	
Batch03	EnhiA.00795.b	Entamoeba histolytica	XP_653620.1	C4LXB2				hexokinase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MQEIIDQFAIDKEKMEIIVSKLLEEMENGLQDKPSTLQMLPTYAPIPTGKEVGTFMGIDVGGTNLRVLLLEIPEPGVRGELKSVECIMPKTSTTVDQFFGFIAQKIKEFVENNNLKEKEIKAGLTFSFAVEQIAIDKGIQQSWSKGWDVKESIGKDIVEIFHNQLAKINVNNIRIVAFINDTVGTFANLAYDDASCGMGLIFGTGTNGCYIEKTSNFAASKLKSVYKEDYMIVNTEWGGLQFPELGLNRFDDMINDVSVNKDQQRYEKMISGIYMGWLARLAIRELIEKKVIFERYADAEVFSNSPDDTQFNDKKKYSSRHTEIVEDTSPELSRVDTILKSLGVNDSTLEERKILKAITEAVVKRAAYLSAAATVALYRKMVPYMKERTTAGIDGTVYEKSVPFKRFYLEAIRLLQPKENFTCQLSKDGSGLGAVIVAAAVACKH		445		2	Cloned	-1	 	NR-16059
Batch03	EnhiA.00796.a	Entamoeba histolytica	XP_001914397.1	B1N5D1				"actin 2 protein, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MGDEEVQALVVDNGSGMCKAGFAGDDAPRAVFPSIVGRPRHVSVMAGMGQKDAYVGDEAQSKRGILTLKYPIEHGI		76		2	Cloned	-1	 	
Batch03	EnhiA.00803.a	Entamoeba histolytica	XP_654722.2	C4LZW8				"26S protease regulatory subunit, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MEIDGERKSVLKAYLQKLKTYQAKEEALEKIKETLKVSKENMGRNEEMLLSLQTIGMSIGEVLKCLSEEKYIVKVSLGPHYVVGCRSCIDKKKITQGTRVALDVSTNTIMKILPREVHPAVYSMTVESPGKVKYEDIGGLRNQMREIREVIELPMTNPELFERVGVKAPKGVLLYGPPGTGKTLLARALASNLECHFLKVVASGIVDKYLGESARLIREMFAYAREHQPCVIFMDEIDAIAGKRIAEGIHSDREIQRTLMELLAQMDGFNEISKVKIIMATNRPDVLDPALMRPGRLDRKIEISLPNDQGRIEILKIHSKKMNIQEEVDYEAMGKLTEGFNGADLRNVCTEAGMFAIRDDRDYCIEEDFFKAIRKQAEAKKLENQFGDIKI		391		2	Cloned	-1	 	
Batch03	EnhiA.00807.a	Entamoeba histolytica	XP_657523.1	C4LSY9				Ran family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MQQPDGIPTFKLVIVGDGGTGKTTFVKRHLSGEFEKKYIPTIGVDVHPMLFNTNCGPIRFEVWDTAGQEKFGGLKDGYYVQAHCAIIMFDVTSRDTYKNVATWYKDLVRVCENIPIVLVGNKCDVKDRKVKQRQITFHRKKNLQYYDVSAKSNYNFERPFLWIARKLTGNPNLVFVADPRMLKPAEIDPRTIQQESIDINDPSIPMNSFNDDVFGNGPI		219		2	Cloned	-1	 	NR-16060
Batch03	EnhiA.00813.a	Entamoeba histolytica	XP_648924.1	C4MAI1				Ras family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MTEKTYQVVVIGEGSVGKSALCLLFVKGEFNIEYNPTIEDSYSIDVKVGDQTVKMSIIDTAGQEEYISLREQYYIKGDGFVLVYSIDNKNSFHALKNHRDSILGLRTGRKTIMVMAGNKCDLEEQRQIPNEEAKKLAEEWKIPFFETSAQNNINVTELFNSIASELLKSSQEETAATPSTTAPSQTQQESQSNSEDNKKSKKEKKKGKCILF		212		3	Expressed	-1	 	
Batch03	EnhiA.00815.a	Entamoeba histolytica	XP_657292.1	C4LYH1				high mobility group (HMG) box domain containing protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MPKGNTKTSKAKNIKDKKAKKDKKDPNRPKRPPTPYFIYLNEHRASIKEEHPDIRFTEISKVASEQWKALGEEEKKEYQTKADAAKEQYKKDMEKYNNKKQASEEEEEEEGDSE		114		5	Purified	-1	 	
Batch03	EnhiA.00815.b	Entamoeba histolytica	XP_653586.1	C4LTF9				high mobility group (HMG) box domain containing protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MPKGNTKTSKAKNTKDKKAKKDPNRPKRPPTPYFLYLNEHRASIKEEHPDAKVTEIAKIASEQWKALGEEEKKEYQTKADAAKEQYKKDIEKYDGKKQASEEEEEEEGDSE		111		10	Diffraction	-1	 	
Batch03	EnhiA.00823.a	Entamoeba histolytica	XP_655004.1	C4LZ47				"nucleoside diphosphate kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSVERALVLAKPDAVCIRQAPITAVETLLKSINGGKLLCFEHHVVPTELAEQHYEEHKGKGFFPKLLNFICNPNGVIVMVFEGVNAVKTIREVFGPTFVEKAIQVECLRGKFGSCGGINCFHSSDSAESGARETKLWVDYFKIELNEEKAKKAFDEYKAKYDGKYKCDVSKVRDIVKKIRADSEEYVNAMKELSDCDDFLIKQLLASIILN		211		2	Cloned	-1	 	NR-16061
Batch03	EnhiA.00828.a	Entamoeba histolytica	XP_654852.1	C4LZH6				"thioredoxin, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MKAIIIVFVFALVYANKQGLVQLNKSNHELVLKQNKNVIVKFFSPYCPHCVRFSPIYSEFAVKMQNEENLVVAELNCVDFRDLCGFYKIRGYPTVNFYHNGEFVERFGQQRTVDNLVEFSKKNMK		125		2	Cloned	-1	 	NR-16062
Batch03	EnhiA.00830.a	Entamoeba histolytica	XP_650203.1	C4LYP7				"guanine nucleotide regulatory protein, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSGINLNLSAKKFVPRKKKLEQQNATAAQTTTPNGPAISEDEVKQEIAKIETEENEVVKESANIIFIGHVDAGKSTTSGNILFQSGNIEQRIIDKFEKEAKENQRESWWLAYIMDQIEEEKSKGITIDVGRALFETEKRRYTILDAPGHRSFVPNMISAAAQADIAVLIVSARKGEFETGFDKGGQTREHSQLCRTAGVKTVIIAVNKMDEKTVGWEKSRYDEIVNKVKPFLRQCGFSDIYSIPISGFSGLNLTKRLDKGVCSWYDGPCLVELLDSIKLVMGNPNGPIRMPIIDKFKDGKGNSVIMGKVESGTIYKGSKCVVMPNKVDLEVTGITYDENSVPASKARPGDNVRIQMKGDQADSIQTGFVLCSPSDVCHFTNLFQAQLVVLELPRPLLTPGYEAVIHIHTSQEEVVITKITDQFDRSGKLAKKNPPFLRSGSVGNVVIKTAKPICIEPYELFPQLGRFTLRDAGKTIAFGKIIRIHGGK		488		2	Cloned	-1	 	
Batch03	EnhiA.00836.a	Entamoeba histolytica	XP_651955.1	C4M4T4				phosphoribulokinase/uridine kinase family protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MNSTVRYHFYNNPTVLIAVAGGTASGKTTFCQEIANTLKGEKFVVISQDSFYRPLTKEEHDNVAEYNFDSPSSFDWDLIIDTLKKIKAKKNVSLPVYDYVTHSRKPDWVPVETGDVVIFEGLYTFYQMKEYENYFDMFDLKIFIESDNDTRLARRILRDINYRGRTLDSVLFQYKKFVKPAYDKWVYPQRKRADIIVPWGEIEKAQTPGVLSQMPALKMVSQYIEQFFTQGPYKKISSMNNFEISADLECPKGSLSDVDN		260		2	Cloned	-1	 	
Batch03	EnhiA.00850.a	Entamoeba histolytica	XP_001914639.1	B1N623				"peroxiredoxin, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		QIGKEAPEFKAPAYCPCGSIKEIDINEYRGKYVVLLFYPLDWTFVCPTEMIGYSELAGQLKEINCEVIGVSVDSVYCHQAWCEADKSKGGVGKLTFPLVSDIKRCISIKYGMLNVEAGIARRGYVIIDDKGKVRYIQMNDDGIGRSTEETIRIVKAIQFSDEHGAVCPLNWKPGKDTIEPTPDGIKKYLTAH		192		2	Cloned	-1	 	
Batch03	EnhiA.00851.a	Entamoeba histolytica	XP_001914120.1	B1N4K4				"cysteine protease, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		TKIKVSIEGLRTADISDAALTAAIAEAPVGVCIDASQISFQLYKSGVYDEPKCKKIMNHCVAAVGYGSQDGQDYYIVKNSWGSFWGMDGYILMSRNKNNQCGICTGISFPVGVKEI		116		2	Cloned	-1	 	
Batch03	EnhiA.00855.a	Entamoeba histolytica	XP_656419.1	C4LVR9				"glyceraldehyde-3-phosphate dehydrogenase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSIKVGINGFGRIGRLVARVVLERKDFELVAINDPFMDPKYMVYLLKYDTVHRQFEGTVEAGENAIIVNGHKIVVKAERDPAQIGWGALGVDYVVESTGVFTTIPKAEAHIKGGAKKVIISAPSADAPMFVVGVNTEAYKPEMNIISNASCTTNCLAPLAKVINNEFGIVEGLMTTIHATTATQKTVDGPSGKDWRAGRCACANIIPASTGAAKAVGKVIPSLNGKLTGMSFRVGTPDVSCVDLTCRLEKEVTVESIKAAIKKASEGEMKGILGYTEDLVVSSDFVHDNRSSIFDAAATILLNPHFVKLVSWYDNEWGYSNRLVDLIQIISKVH		334		2	Cloned	-1	 	
Batch03	EnhiA.00857.a	Entamoeba histolytica	XP_001914494.1	B1N5M8				"heat shock protein70, hsp70A2, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSKYTGLGIGIDLGTTYSCVGIWQNDRVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQIGMNVKNTVFDAKRMIGRRFSDPTIQNDMKHWSFEVVDDGHDKPLIEVEYKGE		113		2	Cloned	-1	 	
Batch03	EnhiA.00883.a	Entamoeba histolytica	XP_657492.1	C4LT17				"aspartate--ammonia ligase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTTIFPENYFPLLNSFQTEIAIRKIKQEFEKNLTYDLDLLRITAPLFVESGYGLNDDLNGVEVPVHFPVKGMNNSVVEVVHSLAKWKRLQLHELKIPIGEGIVTDMNAIRPMEDLDNIHSIYVDQWDWEKSISKEDRTLDYLKNVVKKIYHTIYKTEEYICNEYSQLKRRLPKEITFLHTEDMEKEYPNLSPKEREHTVAKKYGAVCVIGIGYPLPLSKVTHDGRSPDYDDWSSETKEGYHGLNCDIIVWNDVLQQSLELSSMGIRVDPTALKRQLEMRNATDREKFMFHQMLLKGELPLSIGGGIGQSRLCMFYLQKAHIGEIQASVWNHETKEQLAQHNIFLL		345		1	Selected	-1	 	
Batch03	EnhiA.00885.a	Entamoeba histolytica	XP_651708.1	C4M0U8				"calmodulin, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSEQKKVLTAEEQQEYKEAFQLFDKDNDNKLTAEELGTVMRALGANPTKQKISEIVKDYDKDNSGKFDQETFLTIMLEYGQEVDSTEDIKKAFEIFDKEKNGYISASELKHVLTTLGEKLTEQEVDDLLKEIGVEEGLINVDDFVKLITSK		151		5	Purified	-1	 	NR-16337
Batch03	EnhiA.00889.a	Entamoeba histolytica	XP_648690.1	C4LXT2				Rho family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MEQLNLEKKIVITFTGAPGIGKSQLISVMTSGRFTSQYEPTIQEHYTMKMVEGNNIFNLTIVDTSGSPDYSKLASGAIGNSDCIVVCYCPYIPKSFDRVVEAIKEVRTISDDIPIIIVATKMDLKDDKVTMNKIGKQKIRMVKDLKSELKKGKISGFFETSAISGDSYKEILETAIKYTQKSSIWKKKQ		189		4	Soluble	-1	 	
Batch03	EnhiA.00889.b	Entamoeba histolytica	XP_001914285.1	B1N519				Ras family protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MTSGRFTSQYEPTIQEHYTMKMVEGNNIFNLTIVDTSGSPDYSKLASGAIGNSDCIVVCYCPYIPKSFDRVVEAIKEVRTISDDIPIIIVATKMDLKDDKVTMNKIGKQKIRMVKDLKSELKKGKISGFFETSAISGDSYKEILETAIKYTQKSSIWKKKQ		161		4	Soluble	-1	 	NR-16338
Batch03	EnhiA.00892.a	Entamoeba histolytica	XP_001914288.1	B1N522				"P-glycoprotein 5, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSVLSASQTLSMIATPLNLLFSAKASAYKIFTTIDRIPDIDCQSIGGECPTECNGNIRFDDVQFVYPTRPSHHVLKGIDLEIKKGKTIALVGASGCRKSTTIQLIQRNYEPNGGRVTLDGKDIRELNIKWLRNQIGIVGQEPVLFSGSVIDNIKRGVSEGVEVSNEQIYAAAKMANAHDFISAMAEGYDTIIGDRGAQISGGQKQRIAIARALIRNPKVLLLDEATSALDTQSEKIVQEALDKASKGRTAIIIAHRLSTIQNADQICVIMRGKIVEQGTHQELMDLKGFYYTLAMQQFGTVN		302		3	Expressed	-1	 	NR-16339
Batch03	EnhiA.00903.a	Entamoeba histolytica	XP_655385.1	C4M5V0				"thioredoxin, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MRTFFALLLIALVSANSEGLVSLNPDNFKTYQNSGKTLLVKFFAPWCGHCKRLAPTYEEVAQAFTENEDVIIAEVNCDDYRELCQEHGIRGFPTVLVFNGEESKKFQEQRTVEELKKFVLENVPAKN		127		3	Expressed	-1	 	
Batch03	EnhiA.00905.a	Entamoeba histolytica	XP_653882.1	C4M1G8				"scavenger mRNA decapping enzyme, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTENIIVLNDLKDSKGITLLKDEKSIFCIVKSQIGIDEANELIQLIKKEPNKDIITQTISSIKYNKLIKLNNQQTSYEINVMKPQNIQEINKYKKQQYELFLETPELYQQYTLPYISTIPSSTLQWINDYSNDITKPLLKGDGFFLVPDVKWNMKDMNLFYGICFSKDPSILSIRSLRQCHLPLLKRMRFEVLKYINSITGLKEEEIVIYCHYHPSFWHFHVHFTSINFPTLARNNSIGKAILLDTIIQNIELDDLYYSKASIMISIGTAHQLYDKFNQTK		281		1	Selected	-1	 	
Batch03	EnhiA.00917.a	Entamoeba histolytica	XP_655230.1	C4M846				26s protease regulatory subunit [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MEEDFEKKPKTLDEEEIAILKAYNRGPYANSIKQLEKEVADLATEIHNLVGIQESDTGLAPVSQWDLNADKKLMEEQPLLVSRCIKAMPDEREPRYVISIKEYAKFVVGKSNRVEKDAVQDGTRVGVDRARYEIKMALPPKIDPSVSVMQVEEKPDVTYKDIGGCKEQIERIREVVELPMLHPEAFENLGIDPPKGVLLYGPPGTGKTLLARAVANRTESTFVRVIGSELVQKYVGEGAKMVRDLFDMAKSKKSCIIFFDEIDAIGGTRFQDDTGESEVQRTMLELINQLDGFDKRGNIKVLMATNRPDTLDPALVRPGRLDRKIEFGLPDIEGRTEIFKIHTKPMSVAKDIRYDLLARLCPNATGAEIQSVCTEAGMFAIRARRKVVTERDFLDAVEKVIKGYQKFSATPKYLAYN		417		4	Soluble	-1	 	NR-16340
Batch03	EnhiA.00917.b	Entamoeba histolytica	XP_001914172.1	B1N4Q6				"26S protease regulatory subunit 7, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MEEDFEKKPKALDEEEIAILKAYNRGPYANSIKQLEKEVADLATEIHNLVGIQESDTGLAPVSQWDLNADKKLMEEQPLLVSRCIKAMPDEREPRYVISIKEYAKFVVGKSNRVEKDAVQDGTRVGVDRARYEIKMALPPKIDPSVSVMQVEEKPDVTYKDIGGCKEQIERIREVVELPMLHPEAFENLGIDPPKGVLLYGPPGTGKTLLARAVANRTESTFVRVIGSELVQKYVGEGAKMVRDLFDMAKSKKSCIIFFDEIDAIGGTRFQDDTGESEVQRTMLELINQLDGFDKRGNIKVLMATNRPDTLDPALVRPGRLDRKIEFGLPDIEGRTEIFKIHTKPMSVAKDIRYDLLARLCPNATGAEIQSVCTEAGMFAIRARRKVVTERDFLDAVEKVIKGYQKFSATPKYLAYN		417		2	Cloned	-1	 	
Batch03	EnhiA.00920.a	Entamoeba histolytica	XP_648721.1	C4LY36				"26s proteasome subunit P45 family protein, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSETKHQLRDAYLKMKSLQADLDHLRLIDGYIHEEQQALRLELSRAQEEVKRVQSVPLHIGQFVEMVDKDTAVVTLSSGTTQFVRILSTINRELLKPGTSVAHHKQSNALVDVLPPEADSAIRILSKGETPNVTYADIGGCDIQKQEIREAVELPLTQSELYKQIGIDPPRGCLLYGPPGTGKTMLAKAVAHHTSASFIQIVGSEFAQQYLGEGPRMVRDVFRLARENAPSIVFIDEVDSIATKRHDAQNGADREVQRVLLELLTQMDGFDQTTNVKVIMATNRADSLDPALLRPGRLDRKIEFPLPDRRQKRLIFQVLTSKMNLSKEIDLEDYASRPDKISGAEIASICQEAGMHAVRKNRYIILPADFEKAYKKVVRKQTQAMDFYR		389		1	Selected	-1	 	
Batch03	EnhiA.00927.a	Entamoeba histolytica	XP_656184.1	C4LTL7				Rho family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSAAPTDAKSVKLVVVGDGAVGKTCLLICYTTNEFPKDYVPTVFDNYMAPMTVDGEPINLGLWDTAGQEDYEQLRPLSYPNTDLFLLCFSVISRTSFNNISSKWLPEIKHYEPKCKMMVVGTKTDCRNDEAMIRKLADENQKPITTEEGEKLAKDIKAICYMECSALTRSGLNQVFDEAIHIVLNKNQSSKKSSKKCALL		200		1	Selected	-1	 	
Batch03	EnhiA.00927.b	Entamoeba histolytica	XP_656301.1	C4LX92				Rho family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MAAQTDATSVKLVVVGDGAVGKTCLLICYTTNEFPKDYVPTVFDNYMAPMTVDGKPVNLGLWDTAGQEDYEQLRPLSYPNTDLFLLCFSVISRTSFNNISSKWLPEIKHYEPKCKMMVVGTKTDCRNDEAMIRKLADENQKPITTEEGEKLAKDIKAVCYMECSALTRSGLNQVFDEAIHIVLNKNQPQKSSHKMCTLL		199		1	Selected	-1	 	
Batch03	EnhiA.00928.a	Entamoeba histolytica	XP_652359.1	C4M804				"UMP-CMP kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSLSDKHVLFCLGGPGAGKGTQCQKIINKYPITHLSAGDLLRAEVKREGSQNGQLIQTLIKEGKIVPAAVTVELLLNAIRNDEHKVFIIDGFPRNAENKEAWFLQANKVNIDTALCVFIDVSEETMINRIHKRSVNSGRVDDNDDSLMKRFRTYKSETLPVIESFENENKLLRVSGEGSVDDIFNKIDSSLAKFFADNHILL		202		1	Selected	-1	 	
Batch03	EnhiA.00933.a	Entamoeba histolytica	XP_653614.1	C4LXB8				"deoxyhypusine synthase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTTTIKGYDFDKGINYEELVNSYLTTGIQSSNVGRAINIINKMLTWQPSEEEKKEYVEGDERLKRCTIYLGFTSEMMTSGLRDTFRYLVEHKCVDYIVTTAGAIETDIMKCFGNMNIGDFYMKPEEVQGERHGNMIIPKELIEKTKQWLKEFILDIQECQDTSMPFTPSQLITMMGERLNDTTSVITWAAKNNITIFCPALTDGLFGTCITELNEINPVRLMVDLVQDLRLINSSTIHSVETGVIILGGGVMKHHIMNANLMRNGADFAVYINTAGDFDGSDASARPDEAVSWGKIKIDSENVKVLAEASLVFPLIVSKTFAVTKRFDGKI		331		7	Crystallized	-1	 	
Batch03	EnhiA.00947.a	Entamoeba histolytica	XP_001914200.1	B1N4T4				"alcohol dehydrogenase 3, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MKMAGQDVSVFPKWSIVDPCHSMSLPDNQVRNGIIDSFVHVYEQYIGHYQENPVTDGEAEAVMRTLMKVAPITLKDHYDYQARATFCYAATVALNYSLACGVEQCWGAHMIGHEITAYYGLAHGETLAMTMPGVMRFHKEKNAKKLIQMAQQVFGIPNPKPEDAITATENFFLSIGAKVRLSQWEKGKEFFDQIAQKFDSRPCGVYKDIDSKACLTILNDIY		222		5	Purified	-1	 	
Batch03	EnhiA.00956.a	Entamoeba histolytica	XP_652175.1	C4LWZ2				nuclear LIM interactor-interacting factor 3 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MKIKEEEKILIDIYKVLNMSTLVRRKLIRSNLYTSFNQSPQEVKIIKQKTFLLPQKVDDKLTIVFDLDETLIHTHVTSQNLSDDLITIEFQGKQYFVSVRPGARELLKSLAGKYELILFTASTEGYATQIINNLERDGQIFDYKLYCHNCKEKFGQLFKDVHKLGRDLDRVLIFDDSTIVWTTSENLFVCKRYEGGNEDNEIETIKKVIEEFKRTRSSQSVVRFIL		226		4	Soluble	-1	 	
Batch03	EnhiA.00957.a	Entamoeba histolytica	XP_656294.1	C4LUV5				"uracil-DNA glycosylase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MKRGSNCKKGKTDITDFFQTKKTTQPQTISSNEVWEHPLFKYLTDPGWRQVLEPVFKKYVNNKEILNIAAIYEKENIYPPKELIFNAFNVTPFEQVKVVIIGQDPYIKKGQAHGLCFSVNKGIAIPPSLKTIYKELKRTIPEFQIPKHGYLMEWAKQGVLMLNATLTVKEGKSNSHEKLWKNFTDDIINVLCQKKEGLVYLLWGAFAQKKASGVDSTKNCCLKAPHPSPLAKGGFDNCNHFIQCNDYLKQIGKEPINWVLTP		262		2	Cloned	-1	 	
Batch03	EnhiA.00966.a	Entamoeba histolytica	XP_651609.1	C4MB22				"ribose 5-phosphate isomerase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MEVIIGSDHAGFPLKEIVKKYLIEKGIKVNDMGTYSTERCDYPDFAEKVAREVVKTGKKGILVCGSGIGISIAANKINGVRCALCHDHYTAVMCRRHNDANIIAFGARVIGSDIATDMVDVFLSTPFDGMQHTARVEKIHKLEQNH		146		2	Cloned	-1	 	
Batch03	EnhiA.00968.a	Entamoeba histolytica	XP_649046.1	C4LYJ6				"aldose 1-epimerase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTTIVKREDFCSIVNGKEVDLYTLTNEFLTINLTNYGCRLIDIITQGKNGPVNVLIGFRSLKGIMQCDNCMGAIIGRYANRIYKGDLVIDSHKYQLPINNGINCLHGGDGFDKKVFTVTKITKTEVVLELDDKDGSNNFPGNVHVVITYKLHENNLVMTFEATTDQTTVVNITNHSYLNLNGEGSIVHHQLQIYSDQFLPITDEIVPTGEIRKVENTPFDFREFKEIGKEINNDYEQLKLGSGYDHSFIINENAPHCSWDKSIKQIANIKGDISEVQMSIYSSQPGVQFYTSNFMPEGFKTRSAFCLETQHFPDSPHHPEFPSTYLKRGDVYHHVCVYQFQ		341		2	Cloned	-1	 	
Batch03	EnhiA.00980.a	Entamoeba histolytica	XP_655383.1	C4M5V2				"phosphoserine aminotransferase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MERQNIHNFGAGPAAMAKEVIEATAKAVNNFWEGLSILEISHRSKEWINVMNETKALMKEVMDIPEGYEILFFGGGASLQFLMVAMNLLNKKACYLDTGVWASKAIKEAENIGEVKIIGTSKDKNYTYIPEYQIPSDYDYFHITTNNTIYGTEIRKDIESPIPLVADMSSDILSKPIDISKYSLIYAGAQKNCGAAGVTIVIIKKEILGKVQRKIPIILDYQVHILNNSMYNTPPVISIFTVNQTLKYIKKIGGLKKIQELNEEKARLLYAEIDRNKIFRGTVRKKDRSIMNVCFVMEEQYKQLENEFSEYALQKGIIGIKGHRSVGGFRASIYNAVTIESVQALIKCMHDFEQLHTH		358		7	Crystallized	-1	 	
Batch03	EnhiA.00982.a	Entamoeba histolytica	XP_655976.1	C4M1D6				Rap GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MNSTIKRISVVLLGDHGVGKSSVAIRFATNVFMSEYSIHPKQIQVSRVSVDGTDYDIGVIDTNATMTIQNDDLIMKGDAFVVMYSVTNKNSFLHLPLYLNRIYELRKDHSKTIPIIIVGNKCDEKRREVIYESGQLFSDSISCLFMETSALDYTNINHLFDIIIREWVSFHPVENNTSCVVA		182		5	Purified	-1	 	
Batch03	EnhiA.00987.a	Entamoeba histolytica	XP_001913570.1	B1N304				"protein kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTEVSCRLSPSDIVEERIIGEGSFGVVFLGYFKGNKVAIKKLKKLQVLENMINEFKDEVSMLEKFRNEYIVHFYGAVMIPNKLCFVTEFAEYGSLSDLIEKRMKNNPLDEKLKIKFCLDAAKGIEYLHSNGILHRDIKPDNILAISLEKNVEINGKLTDFGSSRNINMLMTNMTFTKGIGTPVYMAPEILKKDKYKMPADVYSFAVTMLHILMWNAPYQGSLFKYPWSIANFVADGNRLDCPENVSPECFELIEQSWVQNPKERLSINEIVIKLQQLYDIIQIN		284		3	Expressed	-1	 	
Batch03	EnhiA.00992.a	Entamoeba histolytica	XP_650464.1	C4MBI6				"calcineurin B subunit, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MGNTLSGLKQEDVEQMMATTNFTESELRRLFRRFKKLGMKAKEGASEEYDDLAELTSNPVLQRLLEIFNRYENEEVQFSQFVATLSTLSDKGSQEAKLRFAFQVYDVDNDGFISNPELFKVLKMIIGSSFTDEQLQQVVDKTIIEADKDRDGKISYEEFCSIILKNSENIGEKLTINWQ		179		7	Crystallized	-1	 	
Batch03	EnhiA.01003.a	Entamoeba histolytica	XP_653959.1	C4LXM5				mitogen-activated protein kinase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSDKEYMSSCDPDEELDLKIAKKYDIVQKIGKGAYGVVWKAVDKTTHETVALKKIFDAFQNATDAQRTFREIMYLQRMDHENIVQLVNVMKAENNKDIYLAFEYMETDLHAVIRANILEDIQIRYIIYQLLKALKYLHSAGIVHRDIKPSNLLLNSDCLLKVADFGLARSLDKETLQTDYVETRWYRAPEILLGSQRYSFAIDLWSVGCILGEIINGKPLFPGSSTLNQLDKIIEATGQPSAEDLEVIDSPLSMNLLSSLPQRETKGLAEIVPKASDDALELMEELLTFNPEKRATAEKALESTFVADFHDPNDEPSAPGKITIPITDNHKYSINNYRGSLYVEIMRKYPQN		352		7	Crystallized	-1	 	
Batch03	EnhiA.01020.a	Entamoeba histolytica	XP_654076.1	C4M4K4				"DNA repair protein RAD51, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSAKQIQRGSEEELLESEENLKEKEKVNEEEHEEEEEEEEEEENAAVPIRKLIGLAGITEGDCKKLEEAGFFTVQSIAFTPKKQLITIKGISDAKADKLLAESSKIVPLAFTNAAELNNLRKETIRITTGSRELDKLLCGGFETGSITELFGEFRTGKTQLCHQLCVTCQLGIENGGTEGRAIYIDTEGTFRPERLTQIAEKYGLNSEEALNNVAVARAHNTEHQMQLLQMASGLMAKERYGLLIIDSATALYRTDYSGRGELASRQMHLAKFLRALQRIADEFSVAVVLTNQVVAQVDGQASMFGGDTKKPVGGNIIAHASTTRLYLRKGKGEARICKVYDSPCLPESEASFAITTNGIEDVKDD		366		2	Cloned	-1	 	
Batch03	EnhiA.01021.a	Entamoeba histolytica	XP_650536.1	C4M799				Rho family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSVSTSVYYYLNIVVVGEPQCGKTSLLFAYIKNEFLDEFTATSYDEQPTLILYKSRQYLVSFVDSSGFNGEVNKPLRKTLYNNADFFIVCYAIDDPISLQKAENVWIPEIYSFKHDASIILVGTKSDLRDNSINHSPLIDHNNLLTKEDGYNVKRRTRCKLVAETSAKTKEGILEVFNGIYELAIFEQKKEKHCIIL		197		2	Cloned	-1	 	
Batch03	EnhiA.01033.a	Entamoeba histolytica	XP_655507.1	C4LXG4				"purine nucleoside phosphorylase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MAEHCPTPHNGAKYGEIAETVLMAGDPLRVKLLADTYLTDVVQYNSVRGAVGYTGYYKGVKLSVQAHGMGMPSIGIYAYELFNFYGVKRIIRIGSAGAFDESLKLGDIVIGMGACYDSNFERQYDIPGKYSCIADFQLCREAVDAAEKLGYRYKVGNIYSANYFYDDGDHSGAWKKMGVLAVEMEAAALYMIAARARKQALCMLTISDLCYGSGEKMTAEERRTKFTQMMEVALSLAK		238		2	Cloned	-1	 	
Batch03	EnhiA.01040.a	Entamoeba histolytica	XP_001913391.1	B1N2H5				"pyruvate, phosphate dikinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MYGTMVECVRAALTADKIATEASFFSFGTNDLTQGTFSYSREDSENKFIPKYVELKILPANPFEILDRPGVGEVMRIAVTKGRQTRPELLVGICGEHGGEPSSIEWCHMIGLNYVSCSSYRIPVARIAAAQAQIRHPREN		140		3	Expressed	-1	 	
Batch03	EnhiA.01045.a	Entamoeba histolytica	XP_652481.1	C4LVZ4				"pyridoxal kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTNKVLTISSYVCSGFVGNRCGMIILDSFQIQSIFVLTTHLANHTGYPVVGGSGVLLNDFISIMDSLEVNHLDKDIEFLVTGYFPSSDLVYETINRVKRIKDNKKVYFLCDPILGDNGKMYTKSEVQDSMKELIKYADIITPNATELSFLTGLEVNSVSEAIKACHILHEQGIPVILVTSIKEGNDIILLCSFKDTLNNKNFTIKIPRIEGDFTGVGDTLTYILLSWIIKGIPLEHAVNRAISTLQTILRNTVGTAEINIINCIPYLKGTEESFTITYI		279		3	Expressed	-1	 	
Batch03	EnhiA.01051.a	Entamoeba histolytica	XP_657192.1	C4LTQ1				"casein kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MGENKIANKYLLVKKIGSGSFGDVYLAFNKSEPNELVAVKMERQDIARSQLNYEYKLYQYLNQGQSTLGIPSVIYWGLYGSYNVMVMDLLGPSLEDLFNFCGRKFTLKTTLMLIDQCIKRIQFIHSKDFIHRDIKPDNFVMGRNERSNTVYTIDFGLAKKYRDGRTKKHIEYNEDKNLVGTVRYASINNHLGREQSRRDDMESLAYMFIYFMKGNLPWQGIKGTTKKDKYMKILLKKQSSINNELCQGLPPEFEKFLSISRSLKFEEEPDYLSMRKLFWSIAKRENIQFDGEFDWIHYKNQK		302		1	Selected	-1	 	
Batch03	EnhiA.01052.a	Entamoeba histolytica	XP_001914515.1	B1N5P9				"heat shock protein70, mitochondrial, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MLGGEDFDKAICQYIEKEFERKYKRNLQRNKKGISRIKEAAEKVKCELSSSEESVISLPYLDRQDSLEITISRRKIEQLCKGICKRTEYPCLQCMKDAKLRKKDISDVVLVGGMTRMPLIQNTVQEIFGKKPSKNVNPDEAVAIGAAIQASIIEGKKKDIILVDVTPLTLGIETYGGVMTPLINRNTTIPTSVSKEFTTSMDNQQEVDIKVFQGERRVTRKNKKLGEFKLVGIPPAKKGVAKIEVTFDIDVNGIVKVSALDKGTGKKTGIQVKSNGGLNEEEINRLVKEGEEHAAEDKRKEQLLLHRQRLKEMIESAEDIQKELLKKKIETTSELERVINQSKKVITSEDENEIKRLIDQLGEETSNSSAKLYN		374		1	Selected	-1	 	
Batch03	EnhiA.01055.a	Entamoeba histolytica	XP_001914084.1	B1N4G8				Rab family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MKQVKVSLIGDSGVGKTSLLSRFINNTFSPTTESTVGANFYMHEFLIDGKMTQVALWDTASQERYRSLVSMYYRNTNGCLIVFGLDNRDSFYNIKTWYNSLVNTVGMDVAIIIVGNKNDLPQPSVTQQEIKALANELHCSWCLISAKTGDGVSNVFETIASKLHISNDDESDEQLQHELNDSHSQNVCC		189		2	Cloned	-1	 	
Batch03	EnhiA.01060.a	Entamoeba histolytica	XP_657074.1	C4MB39				Rab family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MANKIKIGLLGDMGVGKTCIVQRFCFHKYRDLYESTIGIEMSDQEVVVDNQSYPIQIWDTAGQERFRSVSRVFFNDIKGIFIVFSLDNMESLNHCKDWLDDFYSLVDQSKNIPVVLVGNKLDLITDENNVRVPEDIIKKFVSNNDIPLYIETSSKKDINIDSAFQEMVSIIIKRNLHISEKKNEIVEITQEQENSPRSNQQTTNDCSC		208		7	Crystallized	-1	 	
Batch03	EnhiA.01060.b	Entamoeba histolytica	XP_654758.1	C4M535				Rab family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MANKIKIGLLGDMGVGKTCIVQRFCFHKYNDLYESTIGIEVFNQEVVVDNQSYPIQIWDTAGQERFRSVSRVFFNDIKGIFIVFSLDNMESLNHCKDWLDDFYSLVDQSKNIPVVLVGNKLDLITDENNVRVPEDIIKKFVSNNDIPLYIETSSKKDINIDSAFQEMVSIIIKRNLHISEKKNEIVEITQEQENSPRSNQQTTNDCSC		208		5	Purified	-1	 	
Batch03	EnhiA.01063.a	Entamoeba histolytica	XP_001914455.1	B1N5I9				"rac-like GTP-binding protein RAC2, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSAKINKVIKIGLVGDGAVGKTTFLLSYTSQSFLTEYTPTIFDNFCQIEPVGNDIFNVSLWDTAGQDEYSSYRAGCYNNCNFDVFLLCFSVTQRSSFRNIKNKWIIELRKYAPTVPVIVVGTQVDLREDNNKDHISKKEGEKMAKELKAKRYVECTSKDYETTHNVVLAAIEDYLEKEKEMIAKVKKQYKKEIEEEEKMMKLMKKEMEKQKAIEKENNSITPRDQSKNEEQPTTPSEQK		239		3	Expressed	-1	 	
Batch03	EnhiA.01069.a	Entamoeba histolytica	XP_652693.1	C4M5T0				Rho family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSEKPTSIKLVVVGDGAVGKTCLLISYSIRKFPEDYIPTVFDNYVVSLTAGTRQIQLALWDTAGQEEYDQLRPLSYSSASIFLICFSVTSSVSYDNVITKWHPEVIHFAPKVPIILVGTKLDTRNDPAIVKRLTEQGMTVINTAKGEELKNRIKAVKYIECSAKTSENLKTVFDEAVKTVLMNKPQQRSKCALL		194		2	Cloned	-1	 	
Batch03	EnhiA.01077.a	Entamoeba histolytica	XP_650272.1	C4M7C9				rodhanase-like domain containing protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MIRGFETRTSEPSPLFRSVELTSSEPQTTQVTPQKSDNSINYFGFNYSNPQRISLVRSQSAILTDEIIRPIIPVRNSHPCSTGKVSIKSFSRIGFKTLSPYELNQMINSSKLDELFIIDVRYPYEYNGGHVRSSMNISTETALYKELNKLFEINYSKKIILIAYCEFSKTRAPNLLKELRHTIRNKLIDIFLVEGGYERIFEEFPSLCEGGYVQMNDPQYFDEFIYYSKIHSQSTTRHSAVRKHFLQGKTLSF		253		2	Cloned	-1	 	
Batch03	EnhiA.01084.a	Entamoeba histolytica	XP_001914559.1	B1N5U3				"T-complex protein 1 subunit eta, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSFSTQTPTIVVLKEGTDLSQGKGQIINNINACLAIQDTLKPTLGPFGSDILIVSSNGKTTISNDGATILKLLDIVHPAAKMLVDISRAQDAEVGDGTTSVTILAGELMKESKTFIEDGISSHLITKGLRKASELAVAKVKEVALEIKKERKSNSAIY		158		-2	Work stopped	-2	Work stopped	
Batch03	EnhiA.01088.a	Entamoeba histolytica	XP_651737.2	C4M483				"G protein alpha subunit, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MGCGQSKDNSIDKQIVEMAKSKPITVMLLGSGESGKSTIAKQLKILFGGGFPEQERATHKSSICSNVVTCMRTLIEQSAILNHPMKYQPKSKEFTTEDPVTLPFSPELVGDVEALWADEGIQATYEESAKFQLPDCAKYLFENVKRIAMEDYVPTEEDLIHNRTKTTGIHEYDFVVKDIPFHLIDVGGQRSERKKWVSFFSDVDCAIFVTSLAEYDMKLYEDGNTSRLTESIAVFKDIMTNEFLKGAVKLIFLNKMDLFEEKLTKVPLNTIFPEYTGGDNAVMGAQYIQQLFTGKLQTEEMNISGADGTANIEGAVNEKVYTNPTNATDGSNIKRVFMLAVDVIMKNMAANGKMRPTK		358		2	Cloned	-1	 	
Batch03	EnhiA.01096.a	Entamoeba histolytica	XP_655864.1	C4LUE1				"casein kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MARNAEFIIHDRYKLEKKLGGGSFGDVFQGTDLETGQSVAIKIELKKCKHPQLKAEAQLYAYLAEGETNPPGITKVYYSGEQDDYNIMVMEFLGPSLEDLFQYVGHPFSLKTVLMIVDQCLRCIEHVHKKGYIHRDIKPDNFVMGSGKNVHFVYIIDFGLSKKYIENGKHIAYSEDKSLTGTARYASINNHKGYEQSRRDDLESLAYMFIYFLKGKLPWQGFNRQNNTEKFDKICKKKMEIPLEELCENLPVEFASFLSYARSLRFEEEPKYQFWREVFQNVARENGIEYDGEFDWYLTKQK		302		1	Selected	-1	 	
Batch03	EnhiA.01118.a	Entamoeba histolytica	XP_650372.1	C4MAF9				Grainin 1 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSLFAIQAAADAWVAQHITAAYQADPLIQREWWYPLATSISGTEFKELQDFFVKTDKDKSGSLELDELKKAKFPGGIKLDENACRHLMRIFDVDLSGSIGFYEYLALMKFVKLATAVFTKFDKDKSGNLDEQEIYAALPELGFDLNMKACKILIQLCGKGLLTKKIQISQFISCAAYLGQIRTIYQHGFKQAQGDFNRATFSKFMNLTLMLMDDA		215		2	Cloned	-1	 	
Batch03	EnhiA.01126.a	Entamoeba histolytica	XP_651966.1	C4MA87				"UDP-N-acetylglucosamine pyrophosphorylase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTYQPVDITTNTIPVTKEHYYRGLELISQGKTALITLAGGQGSRLGFEHPKGMFVLPFEIPKSIFQMTSERLLRLQELASEYSHQKNVMIHWFLMTNEETTEEINNYFKEHQYFGLSSEQIHCFPQGMLPVVDFNDKPLYEKKDKICMAPNGNGGLFKALKDNGILEFMNEKGIKYSVAHSVDNILCKDVDPNMIGYMDLLQSEICIKIVKKTIKEEKIGILVKEQERIKVVEYTELTDELNKQLSNGEFIYNCGHIAINAFSTPFLEKAAEYQLPYHIAKKKVPFVNEQGIVIHPSENNGIKKEMFFFDVFPLATKVSIFEIQRFIEFSALKNSLNESFDNVNTVKRDWYRLNIYYLKKAGAIVDDSKSPICEISFRRSFEEEGLKEFKGKTIQLPFILN		401		5	Purified	-1	 	
Batch03	EnhiA.01126.b	Entamoeba histolytica	XP_655359.1	C4M036				"UDP-N-acetylglucosamine pyrophosphorylase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTYQPVDITTNTIPVTKEHYYRGLELISQGKTALITLAGGQGSRLGFEHPKGMFVLPFEIPKSIFQMTSERLLRLQELASEYSHQKNVMIHWFLMTNEETIEEINNYFKEHQYFGLSSEQIHCFPQGMLPVVDFNGKILYEKKDKPYMAPNGHGGLFKALKDNGILEFMNEKGIKYSVAHNVDNILCKDVDPNMIGYMDLLQSEICIKIVKKGFKEEKVGVLVKEQERIKVVEYTELTDELNKQLSNGEFIYNCGHISINGYSTSFLEKAAEYQLPYHIAKKKVPFVNEQGIVIHPSENNGIKKEMFFFDVFPLATKVSIFEIQRFIEFSALKNSLNESFDNVNTVKRDWYRLNIYYLKKAGAIVDDSKSPICEISFRKSFEEEGLKEFKGKTIQLPFILQ		401		7	Crystallized	-1	 	
Batch03	EnhiA.01138.a	Entamoeba histolytica	XP_657099.1	C4M3C0				"26S protease regulatory subunit, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MEGFTEEEMITLNEADVLSLSNEEIKQQIKQMERQEGVIRHEHERIRQELAVINKQNKESKEKIEMFAKLPFLISNVVEILDLPPEESDDGSGLDNKGNVGTKGVVINTSMRSNVFLPVSGLVNVKDLKPGDLVGVNKDTYLILEKLPQQYDGRVKSMEVIERPTETYNDVGGLDKEMKEMIEAIVLPMTQKEKFEKLGIQTPKGVLLYGPPGTGKTLMARACAAQTKSTFLKLAAPQLVSSSIGDGSRIIREMFELAKSKAPAIIFIDEIDAIGTKRTESEHSGDREIQRTMLELLNQLDGFSKTDDVRVIAATNRIDVLDPALLRSGRFDRKIEFPTPNEEARVHILQIHSKKLKCSDDINFEELARSTQDFNGAQLKAVCVEAGMIALRREAIEIRHEDFQQGILEVQSKKKKSLTYFA		422		2	Cloned	-1	 	
Batch03	EnhiA.01139.a	Entamoeba histolytica	XP_654907.1	C4MBD8				"thioredoxin, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSLIHLNSLQEFQQIISTNDCIIDFYAEWCGPCRFISPLFEQYSRQYPNVKFCKVNVDTAHEISMLCGIRCMPTFQFYSSGKKMSEFSGADKNKLNDMVMWAAFQ		105		1	Selected	-1	 	
Batch03	EnhiA.01146.a	Entamoeba histolytica	XP_652718.1	C4M2W8				"dual specificity protein phosphatase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSIEGYTNHDCAAIYPEKLYLGAVAVANDISILRKLNIKNIVNATGYLRGGYDNTIEQYPDAFPNEIHYLHLHINDQENFQITNYFQSCFDFIDHAFSQNEKVLVHCQAGISRSATLVIAYLIYHEKISLKDAYFKVYQVKKNIAPNKGFWKQLEDFEIKYFEYSKSSYPLVEYLTDRLYPMLSEQHSRDLIKEKLIETNCDITMTVALLLYN		213		5	Purified	-1	 	
Batch03	EnhiA.01151.a	Entamoeba histolytica	XP_654362.1	C4LYF6				"heat shock transcription factor, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MRWCDEPNRNGFVVLEPIELSAKYLPRFFKHNNFSSFVRQLNIYGFHKVDHPQGQCFQHPNFCRDKPELLTRIQRQHSKKADAENTELYKMLLDKLRELQKDSLHTQNDLQQLNEMLFTLKSRVDNLDTRMQRVGQFINFFNPNFKPFKREPSFDTKNKDSLMTGMNPWE		170		2	Cloned	-1	 	
Batch03	EnhiA.01159.a	Entamoeba histolytica	XP_654418.1	C4M942				"peptidyl-prolyl cis-trans isomerase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MRFLFLLCVLTVFAENERGPQPPPKVQPKITNKVFLDIRIGYEKVGRIVIGLYGEIVPKTVENFRALCTGEKGIGKYGMPLHYKGTKFHRVIPGFIIQGGDIVSANGLGGESIYGDMFDDENFVLNHTKKGLVSMANYGENTNNSQFFIEMIPTYWLDGRHVVFGEVIEGMDVCEKVMNQGNRSGETTKPVIIEDSGEL		199		1	Selected	-1	 	
Batch03	EnhiA.01170.a	Entamoeba histolytica	XP_654208.1	C4M3N8				"acetyltransferase, GNAT family [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSEVKSMSDAPKVRGAIPREKEKKGEIKFITVANRGTREQLELLTAMKNIVSRHLPNMALDYISRIVYDTVYHESLLLINCKDNKPFGGICFRPFPTQGFVEIVFCAVDSTQQVQGFGSYLMQHLKKEIQSRGIYHILTYADNQAIGYFMKQGFHKHVTLNKERWQGYIKDYVEATLMECVLHKNVEDYTDVPSTIKKQRDALQSLIGQVSKSEVRPGLTCFKQGIPKIKIEEIPGLKETGWKPDVH		247		1	Selected	-1	 	
Batch03	EnhiA.01174.a	Entamoeba histolytica	XP_656259.1	C4LUT1				"aldose reductase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MLQHGFFLNNGKFMPAIGLGTWLAAPGEVGKAVTLALENGYRLIDCARFYKNEKEIGEMGIEPFLKNHPREELFVTSKLWMDQVTRIRESCLESIQDLKCKYLDLYLIHWPIALKVDASNPPKPEDFLDMDITEIWQEMERLVDEGLVKSIGLSNFTIPQIEKIMKMCRIKPVINQVELNVYLQQNKLREVCKSYNIVVEAYRPIGGKPANESDKNCLDDEVVVSLAKKYNKTTAQICLRWLVQNGIIAVPKSTNPNRLLQNYQVFEWSLSNEDMKALEKRNLNKRNVKFENYWNGKTYEEFWGEEQ		307		7	Crystallized	-1	 	
Batch03	EnhiA.01181.a	Entamoeba histolytica	XP_649500.1	C4M9S5				adenylate kinase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MAKVFLIMLGGPGAGKGTQCANIEKHLNSSAHISTGDLLRAEIKNKTEIGLKVEDIIRNGQLVSDEIICNMVNNFIAKNEKEVIVFDGYPRAVSQLEALLKEATAETKICVINLEIPDEILIQRIVSRGKTSGRADDNTEAAAKRLAVYHAQHDEMIKAIKAKNLPYFVVDHLGGPDEVFNEIKGVFANVGLH		193		5	Purified	-1	 	
Batch03	EnhiA.01185.a	Entamoeba histolytica	XP_001914198.1	B1N4T2				"small GTPase RhoQ, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MEFKCVLVGDNCVGKNKLAAICAGIIAPGEIPPTAVQDQKVSISVDGVMNTINIISTEGSEEYARLRPLSYPATDVFIVLFSITDADSYNHVEKLWKPEIKE		102		2	Cloned	-1	 	
Batch03	EnhiA.01185.b	Entamoeba histolytica	XP_001914247.1	B1N4Y1				"RAS-related protein racG, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MEFKCVLVGDNCVGKNKLAAICAGIIAPGEIPPTAVQDQKVSISVDGVMNTINIISTEGSEEYARLRPLSYPGTDVFIVLFSITDPDSYNHVEKLWKPEIKEYCSDVPIILVGSCAEVRKTPEKINSLAEQGITLISQEQGEAMAKRIGAVEYIEWNDSDKEDVVFIFEEAIRACLKKSKENSTGNKKDKDKGCNLS		197		2	Cloned	-1	 	
Batch03	EnhiA.01205.a	Entamoeba histolytica	XP_651785.1	C4M5C6				"deoxyribose-phosphate aldolase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MDKATLAKYIDHTLLKADATEEQIRKLCSEAAEYKFASVCVNPTWVPLCAELLKGTGVKVCTVIGFPLGATPSEVKAYETKVAVEQGAEEVDMVINIGMVKAKKYDDVEKDVKAVVDASGKALTKVIIECCYLTNEEKVEVCKRCVAAGAEYVKTSTGFGTHGATPEDVKLMKDTVGDKALVKAAGGIRTFDDAMKMINNGASRIGASAGIAILNGIH		218		17	In PDB	-1	 	
Batch03	EnhiA.01206.a	Entamoeba histolytica	XP_651016.1	C4M4M6				"deoxyuridine 5'-triphosphate nucleotidohydrolase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MDEVLLVKKLVEDAIVPTRGSKCAAGIDLYSNTNFIIQPHERFLVSTGVSVQIPHQCYGRIAPRSSLALKYGIDVGAGVIDEDYRGEIKVILFNHSNEIFNGRKGDRIAQLIIERISYCRISEVKELNTTDRGTNGFGSTGK		142		17	In PDB	-1	 	
Batch03	EnhiA.01208.a	Entamoeba histolytica	XP_651092.1	C4M7R7				"dual specificity protein phosphatase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSKQSTILQFFKATTQINENKNIEEKKPRQQKKKKVEIKKGMGLERFFRITTDMSPAAIERRERIKQQMAEQLKKLNAAKEEQIRKMKEKREIKKKKRKENERNLEEEEENERRYRNITYNENDFGIEICKNVYLGSAAAGANIEWLEEVGINYIVNCTPDVMCFYNSKENPDFNLNDFPGITEKEYLRIAINDADDEDISKFFNQSFEFIEKAIKLKQKVLVHCLLGRSRSATIVTAFIMKKYKIKLNDVLELFELRNYETNINDGFTSQLLQLQSKLFNEPINMRRTRRITSQNSEHLDIVNNIINELN		311		4	Soluble	-1	 	
Batch03	EnhiA.01214.a	Entamoeba histolytica	XP_657555.1	C4M1V6				"molybdopterin cofactor sulfurase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MLLLFITFCSAISLTELGYWNGVKRIRREFPYLENNVYLDYTASGLHQISQLKDFYYDVSKKLYGNAHSISPSSINTDTVVKQMRKRILKYFNANPKEYDVIFTSGATEALKIVGENFPFTPASVFLYLLQNHNSVLGIREYASHANATWGYFTEEDPEQQWKSVLDKLNKLQTTNVTHHLIAFPGEDNFNGAKFPLDWICKINSLSNNKHKFHVLLDAAALVPSAKLDLTKYHPDFVSISFYKMFGFPTGVGCLIIKKEVAKELKISYFGGGTVVMAAADRDWKVFPDYLPPKYEAGTLNFLGILGLKHAFNHFPNIDIIHKHTYALTRVLFTELNKLTYSNGTKAVEIYGNHNHSTYENQGPIVTFNILNSKYKYNGVFPKHVPLLTVNEFLAKKNIHVRVGCTCNPGSCLNSLNVTSLAAAAVTNPNTPVDTTLEGKQYGAIRVSIGYPTTIGDIRKFIRAIKEFIKMVE		473		3	Expressed	-1	 	
Batch03	EnhiA.01221.a	Entamoeba histolytica	XP_656586.1	C4LTU4				"L-asparaginase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MKIISLIILFGLLLNCNGGKITKKYKWSDVGKWSKKATGSKVLIIYTGGTIGMLKGKNGLEPRKGYMGDVLRGMSEIQSETAVTYDIVELDPLLDSSSMSPSDWTRIGDVINAHYKNYDGFVVLHGTDTMQYTASALSFMFENLSKTIVVTGSQIPISEPYTDAKNNLISSLKVAAHLNVPEVVLVFGGLLLRGNRVTKTSANSLRGFSSVNYPALAKLDLRIELAKPFVLQQPKGPMVYHPVMSKDVAVLTLYPGITGKTVRSIVDSGVKGIVIQAFGEGNAPENKDFVSALQYADQKGIVLVDTTQCGNGNVNMDSYAAGSGLKAAHVVNGRDMTVSAAFTKMANLIGRGLKVSQIKELMEKDLCGEMSIPQKDEL		378		3	Expressed	-1	 	
Batch03	EnhiA.01228.a	Entamoeba histolytica	XP_649756.2	C4M213				"malate dehydrogenase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSTSQTKNVSIDTIKEFMYQVLLKVGSDEENARMVRDTLIAADLRGMDTHGIQRFKTVYIDRIKKGMINPTAKPSIIRETSTTCVLDGNNGFGHVNGTIGMKMAIEKAKKYGMGMVVVRNSTHFGIAGYYSLLAAQEGCIGICGTNARSSVAATFGDEPILGTNPLAIGIPSDEAFPYCFDGATSISPTGRFEKYVRMGKTVDKSWASMKGGKPIEDPKELLENYPKGKAYLHPLGGSDEVSGSHKGYCLSEFVEIMSSCLSIANFLNHIEEEKEKSGKFSLGHFFIAINVECFRDLNEFKKNVGDINRTLRNTDKLPGHDRIYTAGEKEYETEQKRRKFGDDLPLVTINEMKELSSFYNVPLPF		365		17	In PDB	-1	 	
Batch03	EnhiA.01252.a	Entamoeba histolytica	XP_655136.1	C4M3J6				PH-protein kinase domain containing protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MDSVKSGFLVKQGGSWKSWKKRWCVLTPTGMIFYFKDKKDVNSKGCVDVNSASDVLLEDEKKKNCFGIVTPNRTFFMAAESKAERDSWIQAVSRFVRNKNLSAMSGNSLQSSQEGIQSNSNNNLTQNLGDGNTNSHSSEPHKVGVDDFEMLSLIGKGSFGKVMQVKEKATGQIYAMKILNKTHIIDNNEIEHTMAEKNVLSKSKNPFLMQMHYSFQTPDKLYFILDYVNGGELFAHLQREHRFSIERTRFYAAELLIGLKYLHDAGIVYRDLKPENILLTDEGHVCITDFGLCKEGLTEKDQTNTFCGTPEYLAPEILLGNGYGFAVDWWSYGTLIYEMLLGLPPFFDNDVQTMYQKIVSDDVRFPKNTPPAIREFISALLQKDPEDRLTNPDIMMKHPFFKNMDFEMVKAKKIKPPFIPNVTSKEDLAMISEEFLEETQEAIDEEKQYVPRNGGVDFSGFTYVGK		466		5	Purified	-1	 	
Batch03	EnhiA.01253.a	Entamoeba histolytica	XP_650346.1	C4M746				"UDP-glucose 4-epimerase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MAPTALVTGGTGFIGSHTVVELIEIGYDVVIIDNLTNSHETVISHILQITKADPKRITFYKADLLNIDEIDQILNKHTIDFVIHFAALKAVGESVSKPIEYYRNNLNGVLNLLDSMQRHNIWRIIFSSSATVYGEPEVMPVKETTPLQKPSNPYGQTKAMTEQILTDFSKAHKEASVILLRYFNPIGAHKSGLLGENPLGIPTNLMPIITKVLVGKLPQLSVFGNDYNTRDGTCIRDYIHVVDLAQGHVAALKVLLKQQGLNIYNLGTGNGCTVLEVIHAMEKASGKKINYTIVGRRPGDIPAIYAECKKAEEELGWKAKLTLEDMCKDSWRWQTNYPDGI		341		5	Purified	-1	 	
Batch03	EnhiA.01261.a	Entamoeba histolytica	XP_657214.1	C4LTA1				"calmodulin, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSSLTEEQKKKFKATFKHYDKDKDGQITFEELGQILRGMGRNTTDVEIYQMQQIHGSDKIDEATYLALLAQKLQEPDSVEEIQKAFDTFFGPGKTTITSDEFKAMMMEFGERVSEDEADELIKDTGLNKEGCIDVKAFIDHVFESK		146		2	Cloned	-1	 	
Batch03	EnhiA.01261.b	Entamoeba histolytica	XP_652365.1	C4M815				"calmodulin, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSSLTEEQKKKFKATFKHYDKDKDGQITFEELGQILRGMGRNTTDVEIYQMQQIHGSDKIDEATYLALLAQKLQEPDSVEEIQKAFDTFFGPGKTTITSDEFKAMMMEFGERVSEDEADELIKDIGLNKEGCIDVKAFIDHVFESK		146		4	Soluble	-1	 	NR-16063
Batch03	EnhiA.01266.a	Entamoeba histolytica	XP_651808.1	C4M5P9				phosphoglycerate mutase family protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MTKLILIRHGETEWNLLGKIQGCTDIELTPNGIQQANEVAQQIKGNFDIIYSSPLHRALITAQKIAGDKEVHLIEGMKEIPFGTWEGHTFEELNGDINYKKFLSGEDGCPFDSTGMSIASWSKKNAQLLLDLCKQNENKTIVCVSHGAWIKTSILGLLEMEPTMYHKFQLGNTGITTFIFRHGHPVLTSFNSTQHLLTENKSKTG		205		2	Cloned	-1	 	
Batch03	EnhiA.01274.a	Entamoeba histolytica	XP_001914152.1	B1N4N6				"heat shock protein70, hsp70A2, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSKYTGLGIGIDLGTTYSCVGIWQNDRVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQIAMNVKNTVFDAKRMIGRRFSDPTIQNDMKHWSFEVVDDGHDKPLIEVEYKGEVKRFTPEEISSMVLSKMKEKTETFVGKEIKNAVITCPAYFNDSQRQATKDAGTIAGMNVMRIINEPTAAAIAYGLDKKSSGEKKVLIFDLGGGTFDVSVLAIEEGVFEVKATNGDTHLGGEDFDNRLVKYFIGEIERTYKKDISGNARAVRRLRTACERAKRTLSSASVANIEVDQLYEGIDFYTSITRARFEEINIDLFKSTIGPVSRVLEDAKIDKSSIDEVVLIGGSTRIPKVVEILKEFFNGKEPNKSINPDEAVAYGAAVQAAILTGTGGKATEDVLLLDVAPLTLGIETAGGVMTALIARNSTIPAKKSEIFSTYADNQAEVLIQVFEGEASMTKHCNLLGRF		462		2	Cloned	-1	 	
Batch03	EnhiA.01274.b	Entamoeba histolytica	XP_649685.2	C4M8D4				"heat shock protein 70, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MNKYQVKRFTPEEISSMVLSKMKETAETFVGKEIKNAVITCPAYFNDSQRQATKDAGTIAGMNVMRIINEPTAAAIAYGLDKKSSGEKKVLIFDLRGGTFDVSVLAIEEGVFEVKATNGDTHLGGEDFDNRLVKYFIGEFERKYKKDISGNARAVRRLRTACERAKRTLSSASVANIEVDQLYEGIDFYTSITRARFEEINIDLFKSTIGPVSRVLEDAKIDKSSIDEVVLIGGSTRIPKVVEILKEFFNGKEPNKSINPDEAVAYGAAVQAAILTGTGGKATEDVLLLDVALIKFCESFLFFVYSQNILTP		312		4	Soluble	-1	 	
Batch03	EnhiA.01274.c	Entamoeba histolytica	XP_001914577.1	B1N5W1				"heat shock protein 70, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MNKYQVKRFTPEEISSMVLSKMKETAETFVGKEIKNAVITCPAYFNDSQRQATKDAGTIAGMNVMRIINEPTAAAIAYGLDKKSSGEKKVLIFDLRGGTFDVSVLAIEEGVFEVKATNGDTHLGGEDFDNRLVKYFIGEFERKYKKDISGNARAVRRLRTACERAKRTLSSASVANIEVDQLYEGIDFYTSITRARFEEINIDLFKSTIGPVSRVLEDAKIDKSSIDEVVLIGGSTRIPKVVEILKEFFNGKEPNKSINPDEAVAYGAA		269		2	Cloned	-1	 	
Batch03	EnhiA.01283.a	Entamoeba histolytica	XP_656689.1	C4LXK0				"HAD hydrolase, family IA, variant 3 [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MEAVLFDFNGTLIFDTPLHAFCWKEMAKRIRGTPLSEDEFKLLNGRTNKQLIEHILNKEISDEDAKKYAEEKENLYRTMLMKSDIKLCDGAINLFEALKKCNIPFTIATSSDWGNVQVFIQKYHLEEWFDIDKIIFNDFTFKGKPAPDIYLKASKKLGVSISHCIVFEDTISGIHSALSAGATPIGIASEMTVNELLQIKGCNLAIHTFNEITIEEMVDLIKNK		224		5	Purified	-1	 	
Batch03	EnhiA.01290.a	Entamoeba histolytica	XP_656157.1	C4M9M8				"apyrase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MKKLLLFSIFIVGVITLFLFEALVIYDYPTVSNSRLSHLKSVFLKSNDLVYPESMSGYSTYNENSFAFQLIYVTDNDKYNVEDNKFISKIHFGMISKIDNKWSFTENTQKSFQTQTQLNYNGRGNELSEVIQYFNNLYVFDDKTGVIAQLDLDHKNFYPWIIIADGNGNQTSGAKNEWATVVGDKLYVGSHGPNTYDSLGRVDRTNKYYIQKVNKEGSFEYEDWSGVYNNILNALNIEVPGYITNEAVVYSNLKKKWYFAPRKCSNKAYDKQEDEELNNCKYIIELDENLNNPRLIEDKQYDKTHGFSSIKVLPFNEDILVYLKSYEVDNKFKSFIGMINVNGEIVMEEQPLGSEKFEGLEIIPLNI		367		2	Cloned	-1	 	
Batch03	EnhiA.01294.a	Entamoeba histolytica	XP_001914465.1	B1N5J9				"transketolase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSLEERSIQTIRLLACEMINKAKSGHPGVPTGCATIAYTLFTKHMKFDVKDPKWISRDRFVLSNGHGSSLLYVINHLLGYNISMEDLKEFRQLDSKTPGHPEYGWTEGVEVTGGPLGAGMSTAVGLAAAEKHMAATFNTKDKKIIDNYTYVLLGDGCLMEGVTAEAASLAGHMKLNKLICLYDDNHITIDGNTNLAFTEDVRKRFEAYNWNVLKCNGDNVNEIDAALVLAKASDKPTLICCKTTIGLGMPNKQGTSKAHGEPPGPELELMKKAYGVTEEFHVDEDVYAVYHAASERGSLKHTEWKKMYEEYKKEEVELAKEFERRLKRDISSISELFKEEIKADEKGEATRISSGKAFNEIAQKLPEIIGGTADVGGSVKVVLPGVSFHEDPKGRNIHYGIREHAMGNMVNGMSIYGGLIAYGSTFFVFSDYCRPTIRLAALSHYPSIFVFTHDSIG		457		5	Purified	-1	 	
Batch03	EnhiA.01295.a	Entamoeba histolytica	XP_649057.2	C4LVL3				"soluble calcium-activated nucleotidase 1, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MFLNDDRYNSRLKEKEPFTYGDSMAGYRQYSPESKVFQVIFVSDNDKYNLDSTKKQHICKVHFGMLFKEKDEWKFNESVSKGFDVVSNYLYKTRGNEMSEIISFYDKLFVFDDKTGIGHQLDIKNKKFYARVIMADGNGTSDSAFKPEWATIVDDTLYLGSQGLDSLNVDGVIGRSNKYYIQKVKKNGVYETVDFSFVYKTIDNLLGVSSPGYTSMEAVVFSNVNRKWYFAPRKISNIAYNETYDNLYASGKYVVEFDENFQNPRVFTDSQFNKSHGFSSIKLIPYQEDVILYLKTFENEDKLETFIGMMNLEGKSLMKEKSLGANKFEGIEIIPLDI		338		2	Cloned	-1	 	
Batch03	EnhiA.01296.a	Entamoeba histolytica	XP_655618.1	C4LYI2				"hypothetical protein, conserved [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MADSCIFCKIAQKQIPSTIVYEDDEIFAFKDINPIAPIHILVIPKQHIASLNEITEENEAFIGKVLYKVSLIGKKECPEGYRVVNNIGEDAGQTVKHIHFHILGGKKLAWDKL		113		7	Crystallized	-1	 	
Batch03	EnhiA.01307.a	Entamoeba histolytica	XP_650672.1	C4M156				"ADP-ribosylation factor, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MFSLAKEVVSLCKKKPNPSLKIMIVGIDGAGKTYFEEYFGSIIGHTPLQEVYEMTTIGVNTKVVQYGGFELSLWDIGGTDSFRNVWKRYLNESNCIIYCIDSSNEQRLNEAYDAFTELKRSDDKDLPVCFILTKSDQLQQTVELSVKSFITTQSCISSVKYFSIKTAQNEIPQVEDIADWCIQHALF		187		3	Expressed	-1	 	NR-16098
Batch03	EnhiA.01309.a	Entamoeba histolytica	XP_657549.1	C4M1V0				"cell cycle-associated GTPase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSQIKLKIAMVGDAGVGKTSLMVKYVEGNFDEDYIQTLGVNCMEKTISLKGKEVTFSVWDLGGQREYITMLPMVMDGARVILFFFDLTRVMTLNNIKDWYKEARAHNNSASCILVGTKYDLFADLDATEKSRITATALKYAQAMKASCVFCSSSQGINIQNVFKVSLAKVFGLTLNVPQTTEGAVLVVD		189		2	Cloned	-1	 	
Batch03	EnhiA.01311.a	Entamoeba histolytica	XP_650901.1	C4M6Y1				"Riboflavin kinase / FAD synthetase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MQTTIKGNVVKGFQRGRTIGYPTANINPTIELEQGVYYGQVKLMGKVYHAAISVGKNPTFCLKNIVVEVHIFEQFKDEFYGEEIEVKIMKFLRGMKKVNGIDELKKMISNDCNIIENEIIPNTPLINITDF		131		5	Purified	-1	 	NR-16099
Batch03	EnhiA.01312.a	Entamoeba histolytica	XP_657222.1	C4LT93				"UMP-CMP kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSDIKYVYFILGGPGAGKGTQCDKLVEKFPITHLSAGELLRAEMARPDSQDGQLISSLIKEGKIVPSHITVKLLLKAIQEHPHKVFLIDGFPRNEENKNVWEEMADSKIFEVVKCITIDVQRETMKKRIMKRSVDSGRSDDNEVTVLKRFDTFEKETCPIIEHFGKINKLLRVSGEGSVEEVFKTINEEMTKFYTEKKIPF		201		5	Purified	-1	 	NR-16100
Batch03	EnhiA.01314.a	Entamoeba histolytica	XP_001914461.1	B1N5J5				"heat shock protein70, hsp70A2, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		STRIPKVVEILKEFFNGKEPNKSINPDEAVAYGAAVQAAILTGTGGKATEDVLLLDVAPLTLGIETAGGVMTALIPRNSTIPAKKSEIFSTYADNQAEVLIQVFEGEASMTKHCNLLGRFELTGIAPAPRGVPQIEVTFDIDANGILNVTAEDKSSGKKNKITITNDKGRLSKEDIDKMIREAEKYKAEDEENKARIEAKNQIENMCYSMKNSIKEMGDKISEEDKKKAEEIIEKNLKWVDNNQNGSKEEYEKKKEEVEKEIGEIYSKITQGGRGFTGTRNTEKENKGPRIEEVD		295		4	Soluble	-1	 	NR-16101
Batch03	EnhiA.01327.a	Entamoeba histolytica	XP_652995.1	C4M5Z7				Rho family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MQAVKCVIVGDGAVGKTCLLISYTTNAFPNEYIPTVFDNYSATVMVDSKPINLGLWDTAGQEDYDRLRPLSYPQTDVFLICFSVVSPPSFDNVSSKWQPEVSHHCPKTPCLLVGTKLDMREDKEQLKRLEEKKITPITTEQGEAKCKDIGAVKYIECSALTQKNLRLVFDEAVRAVISPAGGAKKDKKNNRGCLLF		196		4	Soluble	-1	 	NR-16102
Batch03	EnhiA.01339.a	Entamoeba histolytica	XP_648827.1	C4LX20				Iron-containing superoxide dismutase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSFQLPQLPYAYNALEPHISKETLEFHHDKHHATYVNKLNGLVKGTEQEHKTLEELIKQKPTQAIYNNAAQAWNHAFYWKCMCGCGVKPSEQLIAKLTAAFGGLEEFKKKFTEKAVGHFGSGWCWLVEHDGKLEIIDTHDAVNPMTNGMKPLLTCDVWEHAYYIDTRNNRAAYLEHWWNVVNWKFVEEQL		190		7	Crystallized	-1	 	NR-16103
Batch03	EnhiA.01358.a	Entamoeba histolytica	XP_652660.1	C4MA80				Rho family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MAIKPIKLVIVGDGAVGKTCMLISYTTNSFPNEYIPTVFENYNATVVVDDNKINLGIWDTAGQEEYDRLRPLSYPSTDIFLICYSIMSKASYENVEGKWVKEIKTHCPDTPFLLIGTKSDIRDDYEQQQIIKNKGIELISLNEGQEMAQKMGAIKFMECSALTQSNLVDVFKEAIRAGVNYKDSLFSKPSKKATNKHKCSLL		202		1	Selected	-1	 	
Batch03	EnhiA.01364.a	Entamoeba histolytica	XP_653064.1	C4LYV3				Rab family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSQICKTVIIGDSGVGKTCIIQRFTKGTFNEEQSATVGASFVDCEFKLPNNESYKLRIWDTCGQESFQSIIPMYFRNASCIILVFDVSNFQSFKGIKSWLSIALSSAPESTPVVVLGSKSDLPSVVPESTINDFVRQRNYLYFPVSSKNNTGIKEAFDKISSLAFEKQSSMTKEQEIRINDEVKQSDKKCC		191		5	Purified	-1	 	NR-16104
Batch03	EnhiA.01367.a	Entamoeba histolytica	XP_651512.1	C4MBH1				short chain dehydrogenase family protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MDFITNIILIGVFLFLLKMYCSGRQNLVEKDLKDKVVVLTGGTHGMGIALVRELLKHHATVVSFSRNESLAQRISNELIKEFPNSQFEHITMDLGDLKSVKEATEICIEKYPEIDYIIDNAGILISPFTKTKQNLEGIIGINYVGHFLFNLKLLNALKIRHGRFIITSSIMAQFANKPITLDCKKNEFNCYQRYSQSKLALMMMAKELSLHGIEAVSIHPGVVISNILHKYPLFIQWGYKILGFFIFKSVEDGIQTALHCIFSDSIINGGYYKDCECSMLYKRAENTIERQEVWDKTYEIIKPFL		305		1	Selected	-1	 	
Batch03	EnhiA.01372.a	Entamoeba histolytica	XP_651987.1	C4M538				"phenylalanyl-tRNA synthetase alpha subunit, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSAKDLILSSLEKEPQIESAYEFAEKNKLAYDNSFIGAIRSLDAAGIIISEMKKVTKQTVSANAEDVLKNGSEEFRLFNLIKKEGTPKAEVEHLPFYRTGFAEAMKLKLIKINGPNLIRIVDTFEDSIQKSLKEVLGGRVATKNEEVIFKRRKFLRQETITDYVLKQGPSFNKRSKPVANLTAEMLLNGSWKDANWKEYNFNALGVYPKGGSRHQLSKVRMNFKNIFLEMGFEEMKTDMYVESSFWNFDSLYQPQQHPARDAQDTFFLSEPATTSSADMNPDYVAKVKKVHTTGDFGSIGWRSDWKVEEAQKTILRTHTTAVSSRTLAKLAADAIAKGEPFKPIKCFSIDRVFRNETVDQTHLAEFHQIEGFIADRNIGLPQLIAVIREFFTKMGLPDVRFKPAYNPYTEPSMEIFAYHPGLGKFVEVGNSGVFRPEMLRTMGVPEDITVIAWGFGLERPTMISYGIKSIRSIFGPKTDLDFIKNSEICTYGI		493		1	Selected	-1	 	
Batch03	EnhiA.01380.a	Entamoeba histolytica	XP_656477.1	C4LVS6				Rab family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MLKLILIGESGVGKTSLIQRYVMNKFEPTYKTTIGCDFLAKTVYVENKEYNLQIWDTAGHEKFSSMVSSFYRGSDGAIIVFDVTNTSSFTAIDTWISEYSRALNGKDVPIIICGNKVDCQPRLVSTESARQWCEGRNYSYIETSAATAQGVNDLFMEVVKVIIENKEDDNGDDLNPVPIALETKSESGCC		190		1	Selected	-1	 	
Batch03	EnhiA.01385.a	Entamoeba histolytica	XP_001913575.1	B1N309				"rab GDP dissociation inhibitor alpha, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MDDTYDTIVLGTGLKECILSGLLSVDGKKVFHLDKNDYYGGASASLNLKQLFDTFANGKPAPESLGRPRDYNIDIIPKFIMSSGEMVNLLLHCNVHNYLQFRAIHGSYVFTKGKVYKIPATVAETVSTPLLGFFEKNRFKNFLTYLQNYDENKPETHKGRNLKTMTMAQLFKDFSLDDATIEFVGHTIALYREDSYLTRPAIETVKKIVLYFESLSRFQKSPYIYPEYGLGELPQAFARMSALYGGTYMLRAKIQEIVFENGRVAGVKFESGEVAKCSNIIADPSYFPDKVKKVGQVIRAICILNHPVANTDNAESCQIIMPQKQVGRKSDIYISVLSGNNQVCPKGKYIAIVGTTVETSNPEKEVEVGLKLLQPIEQQFISITDSFEPINDPKQDGVYITKSYDATSHFETTVEDCLEMYTTITGKKLEMKGPNETSQ		439		1	Selected	-1	 	
Batch03	EnhiA.01385.b	Entamoeba histolytica	XP_655209.2	C4M1Y2				"rab GDP dissociation inhibitor alpha, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MEDTYDTIVLGTGLKECILSGLLSVDGKKVFHLDKNDYYGGASASLNLKQLFDTFANGKPAPESLGRPRDYNIDIIPKFIMSSGEMVNLLLHCNVHNYLQFRAIHGSYVFTKGKVYKIPATVAETVSTPLLGFFEKNRFKNFLTYLQNYDENKPETHKGRNLKTMTMAQLFKDFSLDDATIEFVGHTIALYREDSYLTRPAIETVKKIVLYFESLSRFQKSPYIYPEYGLGELPQAFARMSALYGGTYMLRAKIQEIVFENGRVAGVKFESGEVAKCSNIIADPSYFPDKVKKVGQVIRAICILNHPVANTDNAESCQIIMPQKQVGRKSDIYISVLSGNNQVCPKGKYIAIVGTTVETSNPEKEVEVGLKLLQPIEQQFISITDSFEPINDPKQDGVYITKSYDATSHFETTVEDCLEMYTTITGKKLEMKGPNETSQ		439		1	Selected	-1	 	
Batch03	EnhiA.01387.a	Entamoeba histolytica	XP_001914551.1	B1N5T5				"heat shock protein 101, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MDPNKWTDATVQMFKESQEKAFERKNAYIMPIHMMNAIVEEESNIIIRIVEMMGGDVSKMKKEIQEGMNKIAVQNPPPVEIGLHPTTQQVIRRAIEKQKTMGDTYLAVDVIVMSLMEEKEISTIVGNSGINVLEFNKKIMEMRKGQSVETKEAESQYEALKKYGNDLTAQAESGKMDPIIGRDEEIKRVIRILSRRTKNNP		201		1	Selected	-1	 	
Batch03	EnhiA.01390.a	Entamoeba histolytica	XP_653833.1	C4M285				"26S protease regulatory subunit, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSMTLGKKRLREYGNNNKLPQINPRTQCNLKKLRLERLKDILLIQRDFIENQEQIKPKEELEKDSRQKVEELRGSPLEVSKLHEMIDDHHAIISSGNTMQYCVPVLSIVDRELLEPGVQVLTHNHNKAIVGVLQNDEDPHVSVMKVDKAPLESYADVGGLEKQIQEIKEAVELPLSHPELYEEIGIKPPKGVILYGPPGTGKTLLAKAVANETSATFLRIVGSELIQKYLGDGPKLVRELFQAAKDSAPSIVFIDEIDAVGTKRYDAHSGGEKEIQRTMLELLNQLDGFDTRGEVKVIIATNRIESLDSALIRPGRIDRKIEFPLPDIKTKRKIFEIHTSKMTLEEGVDMEEFVMSKDDLSGADIKAICTEAGLLALRERRMKVNQEDFKKAKEKVMYRKKEGVPDGLYL		410		1	Selected	-1	 	
Batch03	EnhiA.01400.a	Entamoeba histolytica	XP_656675.1	C4LXL3				"protein kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MNEHLYSLIIFNGNEEIGRITIKKEQFVYGRNEVEFLRKYIWISRQHFQIEIKGEKEKKEYVLTVKTNVITFHNNKQIKRDTEIFINSLDVISIPIPKTSIRQNILFISKDFEEKEMCCCFYTKYQIIKFIGSGSFGKVFQIKRKSNNKINAVKIIDITQKKKSEIAQRESEVLEQIHHQNIIKKYETIQSQRFMYIIMEYIEGLTLEQYLQLKQHHTFNENEIKIIIKQVFNAINYLHSNKIIHRDLKLENIMIRGKTNEEYKKLNIVVMDFGLGKILETKEYTLTKCGTSNYTSPQILQSGPYDGFKTDIWCCGVMLFYMSIGMFPFNQEGVNSSLMLRVNIRNGKICHQKEFNMISLELQDLIKNMLIVDEQKRFTIQQCLNHEFVSLKHQKT		396		4	Soluble	-1	 	NR-16105
Batch03	EnhiA.01403.a	Entamoeba histolytica	XP_654466.1	C4M0F3				"casein kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSERPKSFSRYYRDVLEHKEKIFYDYENVTVEWGNQDPYQIVRKIGRGKYSDVFEGVVVEQNVPCTIKVLKPVKAKKFNREILILQDLRDGPNIIQLYDVVMEPSTQTPALVMEYVENVDFKTLYPSLNYMEICYYLKELLKALDYTHSMGIMHRDVKPHNVMIDPKKKILKLIDWGLAEFYHPGTEYNVRVASRYYKGPELLTDLQDYDYSLDMWSFGCMVATMFFVKEPLFKGSNNKDQLVKIVQVLGTDGFQKYVQKYHLEIEDKLMQLLIGFPKVDWDTFKNEKNQHLITPYVYDLLSKLLVYDHQERLSAKEAMNHPLFQCLSK		329		5	Purified	-1	 	NR-16106
Batch03	EnhiA.01404.a	Entamoeba histolytica	XP_001913786.1	B1N2P0				"actin, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MGDEEVQALVVDNGSGMCKAGFAGDDAPRAVFPSIVGRPRHVSVMAGMGQKDAYVGDEAQSKRGILTLKYPIEHGIVNNWDDMEKIWHHTFYNELRVAPEEHPVLLTEAPMNPKANREKMTQIMFETFNTPAMYVGIQAVLSLYASGRTTGIVMDSGDGVSHTVPIYEGFSLPHAILRLDLAGRDLTDYLMKILTERGYAFTTTAEREIVRDIKEKLCYVAEDFNEEMQKAASSSELEKSYELPDGQVITVGNERFRCPEALFQPSFLGMECNGIHETTYNSIMKCDVDIRKDLYGNIVLSGGTSMYPGINTRLEKEMIQLAPPTMKIKVIAPPERKYSVWIGGSILASLSTFQNMWITKEEYDESGPAIVHRKCF		376		1	Selected	-1	 	
Batch03	EnhiA.01404.b	Entamoeba histolytica	XP_001914637.1	B1N621				"actin, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MAGMGQKDAYVGDEAQSKRGILTLKYPIEHGIVNNWDDMEKIWHHTFYNELRVAPEEHPVLLTEAPMNPKANREKMTQIMFETFNTPAMYVGIQAVLSLYASGRTTGIVMDSGDGVSHTVPIYEGFSLPHAILRLDLAGRDLTDYLMKILTERGYAFTTTAEREIVRDIKEKLCYVAEDFNEEMQKAASSSELEKSYELPDGQVITVGNERFRCPEALFQPSFLGMECNGIHETTYNSIMKCDVDIRKDLYGNIVLSGGTSMYPGINTRLEKEMIQLAPPTMKIKVIAPPERKYSVWIGGSILASLSTFQNMWITKEEYDESGPAIVHRKCF		332		1	Selected	-1	 	
Batch03	EnhiA.01408.a	Entamoeba histolytica	XP_654266.1	C4LUB5				"tryptophanyl-tRNA synthetase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSLQTQTPSQLLQSFTTRTTDYNQLINSVGINAITPQQIQRIEKLSGKAPHHYLSRGVFLAEKSLDKFLDDVEAKKPTFIFIQKYPQKEVALEEYITLEFARYLQDAFNIQVIIQILDDIKVLNREATINEASKMSNDLMKYILAFGFNEDKTFIYTDYQYFGKMYRTISLVEKATAYNVVQPFFNFEYSDNIGKLASPSIMTASMFSQSYSHFFSSPARCLVLDSIKNVQFHSIIDQIATTLNFIQPTVLFHKMVPLLSGVTKFDIPSDHNSILLSDNAKQVERKINKLAFSGGRNTTEEHKKLGGQCDIDVSFQLLNIFSSDNAQVKDVEEKYSKGELLSGELKKIVSASMKDFIVAYDAKKKPITTAYLKAYISKTKF		381		-2	Work stopped	-2	Work stopped	
Batch03	EnhiA.01410.a	Entamoeba histolytica	XP_001914304.1	B1N538				"chaperone clpB, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MFLGPSGVGKTELAKALAAELFDSEENIVRIDMSEYMESHSVSRLIGAPPGYVGYEEGGQLTEAIRRRPYSVILFDEIEKAHPQVFNVLLQLLDEGRLTDGRGRTVDFKNTVVIMTSNLGSEIIMKGVETTRQVDEQVKEQVMEIVKKSFKPEFLNRMDDIIVFSPLSEKELKEIVKLQMGEVIKVIKKRYPGSEVEMTEAAIEGIIKAGYSIAYGARPMRRYIEKTVVTEITKSIIGGVMKEKSKIKIGYEDGKIEVKITDN		263		1	Selected	-1	 	
Batch03	EnhiA.01410.b	Entamoeba histolytica	XP_001914563.1	B1N5U7				"chaperone clpB, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MFLGPSGVGKTELAKALAAELFDSEENIVRIDMSEYMESHSVSRLIGAPPGYVGYEEGGQLTEAIRRRPYSVILFDEIEKAHPQVFNVLLQLLDEGRLTDGRGRTVDFKNTVVIMTSNLGSEIIMKGVETTGQVKEQVMEIVKKSFKPEFLNRMDDIIVFSPLSEKELKEIVKLQMGEVIKVIKKRYPGSEVEMTEAAIEGIIKAGYSIAYGARPMRRYIEKTVVTEITKSIIGGVMKEKSKIKIGYEDGKIEVKITDN		259		4	Soluble	-1	 	
Batch03	EnhiA.01416.a	Entamoeba histolytica	XP_650373.1	C4LXD7				"fructose-1,6-bisphosphate aldolase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MAAKTVNYKELGLCNHKEMFEHAIKGGFAVPGFNFNNLEQMQAIIQACTEAKSPVILQVSKGAREYANATLLRNLAKGAVEYSKEIDPEHKGVPISLNLDHGANFQICKECVDNGFSNVMIDGSALPYEENVKLTKQVVEYAHKFGVTVEGELGVLSGVEDDVAAAEHVFTDPKDVEAFVKDTGVDALAISIGTSHGAYKFKPGMHPRIRLDILHEVEKRIPGFPIVLHGSSSVPQEWVAVINQYGGKLESAIGIPEDQIREAVKSAVCKVNIDSDGRLAMTGSIRRYLAEHPKDFDPRQYLGPARQALKELYLHKVSDKVLNSAGKSWY		330		7	Crystallized	-1	 	NR-16107
Batch03	EnhiA.01422.a	Entamoeba histolytica	XP_653574.2	C4LTE8				C2 domain containing protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MKIEVRVIEAKDLRVTDYFAGTSDPYIKLSINGQMHKTNVVYRTCDPKFNQSFTFDIIPGQQITFEVFSFDESGRHDPLGTVQHSLSYFYQGQVSDLWLQLSKKGQIHIQVFSPGGLPNVLSAEQLNSLHLGINQKQMTTQSPLIGYKYFGYTPSFNELM		160		1	Selected	-1	 	
Batch03	EnhiA.01423.a	Entamoeba histolytica	XP_653171.1	C4LZC1				"MTA/SAH nucleosidase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MIIGILAPMKEELQAICDKYPQSTMLEKCGIHYHYIKIKDNEIIIMQCGVGKVNAALAVSTIKHLFNVDIIINLGSAGGMKLGQKPLDIVIGTELVYTDVDITPLGFAYGELLGEPKSWFSDKELVSLATKCSSSDLPTIHYGTIGTSDAFVSAPMVQSIQNKFDNRIVCAEMEGCAVAHSCTKLGIRFIVIRSLSDVPSEDGKSHEKMMDYLSRASHNASILVSRIIEQLIVN		234		7	Crystallized	-1	 	NR-16108
Batch03	EnhiA.01424.a	Entamoeba histolytica	XP_656359.1	C4LSE7				"protein tyrosine phosphatase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MKLLFVCLGNICRSPAAEAVMKKVIQNHHLTEKYICDSAGTCSYHEGQQADSRMRKVGKSRGYQVDSISRPVVSSDFKNFDYIFAMDNDNYYELLDRCPEQYKQKIFKMVDFCTTIKTTEVPDPYYGGEKGFHRVIDILEDACENLIIKLEEGKLIN		157		4	Soluble	-1	 	
Batch03	EnhiA.01424.b	Entamoeba histolytica	XP_653357.1	C4LVM2				"protein tyrosine phosphatase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MKLLFVCLGNICRSPAAEAVMKKVIQNHHLTEKYICDSAGTCSYHEGQQADSRMRKVGKSRGYQVDSISRPVVSSDFKNFDYIFVMDNDNYYELLDRCPEQYKQKIFKMVDFCTTIKTTEVPDPYYGGEKGFHRVIDILEDACENLIIKLEEGKLIN		157		17	In PDB	17	Ligand-bound structure submitted to PDB	NR-16109
Batch03	EnhiA.01428.a	Entamoeba histolytica	XP_652114.1	C4M013				"acetyltransferase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MATPTFDERSLMLNGKLYDSTVPELAHDRESCCEKIIDFNCERNAQKRLEMLKDIVGSLGENSCILPPFRCDYGKYISVGHDTFINYNLTVLDANYVKIGNHVLIGPNVQLISATHPTDPLIRNSLVEYGLPIVIKDGAWIGAGATILPGITIGENSVVGAASVVTHDVPDNTVVAGNPARIIRKVSEHPGWTREQRDVPLN		202		1	Selected	-1	 	
Batch03	EnhiA.01428.b	Entamoeba histolytica	XP_648894.1	C4MAJ4				"acetyltransferase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MATPTFDERSLMLNGKLYDSTVPELAHDRESCCEKIIDFNCERNAQKRLEMLKDIVGSLGENSCILPPFRCDYGKYISVGHDTFVNYNLTVLDANYVKIGNHVLIGPNVQLIAATHPTDPLIRNSLVEYGLPIVIKDGAWIGAGATILPGITIGENSVVGAASVVTHDVPDNTVVAGNPARIIRKVSEHPGWTREQRDVPLN		202		7	Crystallized	-1	 	NR-16110
Batch03	EnhiA.01430.a	Entamoeba histolytica	XP_653593.1	C4LTG6				Rab family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MNIEPHLQQQVDMTFKILIIGESAVGKTAILERYCENEFHDELISTIGVDFKSRIINYQGKTVKLQLWDTAGQERFRNITSSYYRGTHGCLIVYDVTDITSFEKITYWINELNDCSIKPEILVVGNKIDSEDAVVTSEIAEKFCRLSGGLRSMRCSAKTGENVESIFNVLVDSISKNKNIMERLISVPKLLDDASLQPTQKKQSCC		206		7	Crystallized	-1	 	NR-16111
Batch03	EnhiA.01437.a	Entamoeba histolytica	XP_652166.1	C4LWZ7				"diphthine synthase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MLYIIGLGLYDEKDITVRGLEAVKSCDLVFLEHYTAILQCDVAKLEEFYGKKVIIGDRDLVETEADQILEPAKTKNVALLVVGDVYGATTHSDIFVRCQKMGIEVKVIHNASIMNAIGCSGLQLYRFGQTVSVCFWSEHWRPSSYYPKIKINRDNNMHTLVLLDIKVKERSEENIIKGRDIFEPPRYMTINQCIEQLLEVEKEQHLGVYDEDTMVVGMARVACADQKIVYGKMKDLLHYDFGAPMHCLLIPAPQVDDPELDHLEYFKYKPE		271		17	In PDB	-1	 	NR-16112
Batch03	EnhiA.01442.a	Entamoeba histolytica	XP_001914546.1	B1N5T0				"chaperone clpB, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MNQSEKARLLNLESEIHKRVIGQDEAVTAVSDAIIRSRGGLGNEKRPIGSFMFLGPSGVGKTELAKALAAELFDSEENIVRIDMSEYMESHSVSRLIGAPPGYVGYEEGGQLTEAIRRRPYSVILFDEIEKAHPQVFNVLLQLLDEGRLTDGRGRTVDFKNTVVIMTSNLGSEIIMKGVETTGQVDEQVKEQVMEIVKKSFKPEFLNRMDDIIVFSPLSEKELKEIVKLQMGEVIKVIKKRYPGSEVEMTEAAIEGIIKAGYSIAYGARPMRRYIEKTVVTEITKSIIGGVMKEKSKIKIGYEDGKIEVKITDN		314		10	Diffraction	-1	 	NR-16113
Batch03	EnhiA.01445.a	Entamoeba histolytica	XP_652352.1	C4M811				Rab family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSRGNYDHLFKILIIGESGVGKTAIMQRFCENTFEPVYISTVGVDFKPKVIKVGNKTVKMQLWDTAGQDRFRNITASYYRGTQGVLIVYDVTDRASFDKVSSWFTEVRDRTENDPPVIILVGNKTDLMDHAAVKQEAVEQLARQLGGVQTFTCSAKDGSGIDEVFNALTQAIISKVGCAPGKKEDPSVVQLGGKGGSQPAQKSEGGCC		208		1	Selected	-1	 	
Batch03	EnhiA.01462.a	Entamoeba histolytica	XP_655932.1	C4LY16				calcium binding family protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MTTSELIDDYFSILDIDHDKKISRDQVIELLRALGKAPTQQQEEAIMREVKEDLVGVEKIRQLYKKCEMKVPKDLYDDMFGVFTALDKEENGQIHEAELRQILSVLGRPLSNSEVEAIMRSATVSREGYVDYKEFADMLVKEYPPE		146		5	Purified	-1	 	NR-16114
Batch03	EnhiA.01467.a	Entamoeba histolytica	XP_655550.1	C4LXG1				"purine nucleoside phosphorylase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTNTPTPHNNANIADFADTVLVAGDPLRCKFVADTYLTDVVQVNGVRGALGYTGYYKGKKVSIQAHGMGIPSIGIYAYELFNFYGVKRIIRIGSAGAISSKLDIGDIVIATGACHNSNFMQQYKLPGTFCPIADYELVHKAVEAVEKIGAKYAVGNVFSSDCFYDDSSSLKEWDKMGVLAVEMEAAGLYAIAARAGKQALTICSISDCPFKETALSAEERQTKFTQMMEVALSIA		235		1	Selected	-1	 	
Batch03	EnhiA.01480.a	Entamoeba histolytica	XP_657127.1	C4M3D1				"protein kinase 2, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MGNSNHKPEKKNNKGKKEKGKRKNEKIKDETNEKEAIEEPTPNEEKEPCTDTKPNEDNQIVKGKEGEKEEYIELYNEGKKKVTQDDFELLKVIGRGSFGKVMMVKKKDDGRIFAMKILRKDIVKERKQVDHTKAEKNVLMQLHHPFIVKLYYAFQTTDKLYMVMDFVNGGELFYHLKNENCFSEERAKFYAAEIATVLIHIHSLGIIYRDLKPENILLDNTGNIVITDFGLSKQLAAGEETQTFCGTPDYLAPEILKGVGHGPGVDWWSLGILIYEMIVGIPPFYDDDVSLMYQKILKSQPHFPRNISYDAKSVIMGLLEKDPAERLGGEDVIHMAWFDSIDFEKLKRKELTPPWIPPVKSQTETSQIDEEFVQEAAVDTPPSEEQEQNKDNTFEGFTFVQTNAMEEQQ		409		1	Selected	-1	 	
Batch03	EnhiA.01486.a	Entamoeba histolytica	XP_656602.1	C4LTT0				"cysteine proteinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MFNFLLLVVAASAIDFKSWAAKNNKHFTAVEALRRRAIFNMNAKFVAKFNKEHSFELTVEGPFAAMTNQEYNNLLKTHETEAAADSVYDNTIITASSKDWRAEGKVTPVRDQGNCGSCYSFSSLAVLESRLLIAGSKYNQNNLDLSEQQIVDCSAANNGCNGGSLSATYLYVKNKGVTDEASYPYTATKGTCKAFTPKVQTTGLTHVTPTEEALTAALAEGPVAVCIDAGKASFQLYKNGVYDEPKCSKTVNHGVAAVGYGSQDGQDYYIVKNSWGTSWGDKGYILMSRNKNNQCAIASVAYFPTGAHDAN		311		1	Selected	-1	 	
Batch03	EnhiA.01487.a	Entamoeba histolytica	XP_652171.1	C4LWZ5				"synapsin, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSINKVKKLLVIGGRPTINWYKLFKNTSIGNYSIEVEFTMWDEMVLTSYSDSGCIISIMPSKYAIPDTPMNTRRTFQPDFLLIRGACQGVYGQDWKNELLGLMYCGIPSINSLESLYMCLEKPVIYSKLLQIHKQYKEKFPLIPQTYYPSWSSMSFNTGFPLVAKVGTVHAGFGKMKLENQEDFDDLVSLIALQNRYVTTEPYIKWDYDFRIQKIGDHYRAFQRVSSCWKGKGMNQTDNDVPVTDEYKRYIDLASKALGMDICALDGIHDPITNKNYIIELNDSAIGLVQRHVEEDLNYIKELVLSRIKQIYKL		314		1	Selected	-1	 	
Batch03	EnhiA.01488.a	Entamoeba histolytica	XP_655207.1	C4M1Y4				"serine/threonine-protein kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSETPTHNSVIRMSVETSPTKEDKKLTLVRQSPTAITTTPITTTPRKVPCLNLNSTKKTGIFDVHVINDYTSSPRQNKEAPSQTLQIQLSQGQLHHQESLQMLSFKRSESPITRTQLSPRTITTKKESDLYMKRKERQIKRPRTMQLIQTQPLSIDKIVDEGCPAKFLVNIKKVGEGAMGEVYRANERATNKEVAIKKIIVTRKNMNNLIGEITIHKSLNHKNIVSFIGSYLDDGYLWVAMEYMDGGCLTDLLNQYSYGLTLNDSQIAFVMKEIIMGLAYLHGNNMMHRDIKSDNILINKNGDIKLADFGFAVKGKTAKGMVGSPYWMPPEVILDKVYNNKIDIYSAGIVLFELLEGYPPHYELRGEELMKAIVNEGIPEPKNSKSSKEFKRVMKQCTCFNPTLRPDCVELLTDKFITLSCHKNGFKGIVEMVMV		435		1	Selected	-1	 	
Batch03	EnhiA.01489.a	Entamoeba histolytica	XP_656956.2	C4LSU1				"protein kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSFFKKKKDEEELIISDPTDFEQITHVELGDSGLTGFPPEWREKLIKAGLTEAEINTNEDSAKLVAASGISNDNGNRTTFTNGKEEEDDITQYTTAADPDENYENLAKTIYGDEDEYMATRKSDGMEVSLRRMRITKKTKRAVVREVVVLSKCVNDNIVKYVECYLINDMLWLVTELMDAGELTNAIDLHPTLPMKECHIAYVCKRVLQGLVYLHKMGIIHRDIKSDNILLHHKGTVKLSNFGFAAILTSAHPNRNSIVGTPFWMAPELIKSQNYDTKVDIWSLGITCREMADGTPPYMDFPPMKALFQITTKGIPPLEGIWDDKFKNFLNKCLNPDASKRASAEELLQDPFISMECTEEEFIDFLTQVRKISDEEMAQEDDEIPAEE		388		1	Selected	-1	 	
Batch03	EnhiA.01500.a	Entamoeba histolytica	XP_651163.1	C4M8B0				Ras family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MPVKDYKIVVLGSGAVGKSSITVRFVQGIFLVKYDPTIEDSYRKQLDLDGQQYVLEILDTAGTEQFTAMRDLYMKTGQGFVLVYSIIAQSTYNDLDPIHDQIVRVRDTENVPIIVVGNKCDLESQRIVSQDDGKALADKYGAEFLEVSAKAEIRISDIFTTLIKRINAMNQTKPKKKSGGCSLF		184		1	Selected	-1	 	
Batch03	EnhiA.01503.a	Entamoeba histolytica	XP_652361.1	C4M802				"tartrate dehydrogenase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MACEKDVTYQHKIIVIPGDGIGAEVMNEAEKMFQSLNLPIQRDYVDWGIQHYLKTGKVVPIDYIDQVKQYDAILLGSLGDPRTLPDYVTLEPLIQMRQQLDQFLCLRPAKHFPGIPTPLKKCEIDVLVVRENSEGEYSNIGGIFKSGTPEEFAIESAVHSRRGLERVIRYAFEASRKRRNHVTLATKSNAMKFGMVLWDSVFEAIAMEYPDVTAEKYYMDALSAEIVKNPSKFDVIVGSNLFCDIISDLTVTVAGSMGIAPSANINPERTFPSLFEPVHGSALDIAGKGICDPIGTMRASSMMLEFLGYSEESVLIEEAIQSSILQKITTIDIGGTKTTIEVGDFIANYIRSKKSSTSSSMTRSSKQRKQ		370		1	Selected	-1	 	
Batch03	EnhiA.01510.a	Entamoeba histolytica	XP_657249.2	B1N2G7				"protein kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSDVLKRGVMIKEGSKVKNWKKRWFVFHNNGMLDYFTDKKETDQKGSVDMNRASSLRKTEDKKRIMLEILLETKVFRLAFDSETTRDEWTTVFQKFIDEKCSKSDQSSNALKPKLEDFETLKLIGKGTYGKVMLVKKIDTGKIYAMKILDKKAVVETNEVEHTMAEREVLGTIDNPFIVHMHYSFQTENKLYFVMDFINGGELFYHLQNERRFSIARAKFYAAEILLALEHLHLHGIIYRDLKPENVLLNADGHVCITDFGLSKTGMKGEGDMTSTFCGTAAYLAPEILLGEKYDSAVDWWSFGILTYEMMVGIPPFYSEDEREMYQNIVNEAVRYPPNTPSSIKTFIDALLEKNPTRRLTDTTIMKHHPFFQGLDFDRLMKKEVVPPYIPQVHSADDVANIDPYFLGETDAAIAEEKNSNTSGGQEFKFDGFTYISKKD		440		5	Purified	-1	 	NR-16115
Batch03	EnhiA.01514.a	Entamoeba histolytica	XP_655924.1	C4LY57				"thymidine kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MNESISVSTAPVTPQNELEKTYDGSIQLIIGPMFSGKTTELIRLIKRFRYSKKTTVVIKYSKDTRYGSEDEAISHDKESWKAIPTMKLMPVLETALNYEVIGIDEGQFFPDLIEFSEACASYGRLVIIAALDGTFQRKPFGQITDLIPLCESVKKLSAVCVNCGKKAAFSLRTSSEESIEVIGGVDKYCAVCRKCFYKDGATLKTQRSVEFASHISEL		218		5	Purified	-1	 	NR-16116
Batch03	EnhiA.01515.a	Entamoeba histolytica	XP_657233.1	C4LT85				"protein kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MATNPEQSIASDAVCQSQSDLPQIVTVDSFRKVKLIGMGNVGRVYLVQLKGTNHYFAMKILIKKQMEERNKTNRVTTEREILLTTRHPFIVHLYWSFATETCFYFIMDYCSGGDFYHTLKETPHRCLQEETAKFYLAEVLLALEYLHLNGIIYRDLKPENVLLNGNGHIMLSDFDLSKTGPSKGSTMSQALLNVKEQFKKEPSFITNSFVGTAEYLAPEVIVGYGHSGSVDWWTFGIFMYEILYGRTPFFSRNRDQVFSQILDGEVLFPKNWTYPVSSSARDLIKKLLVTDPERRLGTKKGAEEIKSHKFFRSVKFQLIRNIPPPIVPEVHGPEDTHHFNDLKDDGEIEKLEELAKNTQPTLVTPQQPQDKAPAQIILGDTLPK		384		1	Selected	-1	 	
Batch03	EnhiA.01516.a	Entamoeba histolytica	XP_656977.1	C4LSS1				"choline/ethanolamine kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MDDTVSYENLIPSEERDIMKLEHYPHTISYGNYLCNSLKSPSPNYSNQPPSLFVAVDTTNNTMFTKSIIYVVKKLVPEFKDTAADKFTFRHFTEGITNKLVCITDTTNGFAVNVRTYGSYTEYVIDRKQELLITEACSSVILYGTFLNGVVYSYIPGRTLTIGDLIDLNTFRNTAIAIAKHHKINPPLIKSPLLFVTLRKWIINVPTEYVDSKKVPFDVKILKNELIFLENILKNKSDVVLCHNDLLLKNFIKGEDNVSLIDYEYSGYNYRAFDLANHFCEWCGFDCNWDSYPNEETQRRFIGIYLSTYYKKSVEELSSEIEKIIEDVKWFELASHYFWGTWALIQAALSTIDFGYIEYAHKRFDRYFVVKALLLKEHPQVAK		383		3	Expressed	-1	 	NR-16117
Batch03	EnhiA.01520.a	Entamoeba histolytica	XP_652397.1	C4M6K7				"acetyltransferase, GNAT family [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MDFESKIVQLKDIPKLQEITKITFYSTYNDNLLSPEARDAIYKYLYNTEQLKQQINSNYQFVFHYVNLQLFGYTGIEYNSSEDYCYLHDFYLLPSFRGQGLGHKLMDKVKDMAIEHHYKKIHLNCHQQNTARQFYEKQGFHFVKNLNTIFNGFDLLDMEMEFNF		164		5	Purified	-1	 	NR-16118
Batch03	EnhiA.01524.a	Entamoeba histolytica	XP_001913651.1	B1N385				"78 kD aglucose-regulated protein homolog precursor, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MARYDEHHQRVEVIKSKEGKEKIESIVRFTKEGRIIGEEARRSSQGVIIYDTKRLIGKKYDEMIEKEGEKLEYRIRRNAGNGEVEIGVSEEEWYSGEEIGNMIIRKLIEEAKEQYKIAPRKAVIAVPAHFKDEERKATIYAGEIAGLEVIGIINEPTAAAIAYGYDKKYCEGKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXKQANLPTLIQRSNLLDIQDVELKKIKSLHSEKNRLLHILKKQGKSNEIQIINSWFNSNPHASSVQIKSFLDNFTHSFYSLSSFHSSFN		295		1	Selected	-1	 	
Batch03	EnhiA.01527.a	Entamoeba histolytica	XP_654465.1	C4M0F4				14-3-3 protein 3 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MAESREDCVFLSKLAEQSERYDEMVQYMKQVAALNTELSVEERNLLSVAYKNVIGSRRASWRIITSLEQKEQAKGNDKHVEIIKGYRAKIEDELAKYCDDVLKVIKENLLPNASTSESKVFYKKMEGDYYRYYAEFTVDEKRQEVADKSLAAYTEATEISNADLAPTHPIRLGLALNFSVFYYEIMNDADKACQLAKQAFDDSIAKLDEVPESSYKDSTLIMQLLRDNLTLWTSDTADEE		240		5	Purified	-1	 	NR-16119
Batch03	EnhiA.01527.b	Entamoeba histolytica	XP_652946.1	C4M323				14-3-3 protein 1 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MASREDCVYTAKLAEQSERYDEMVQCMKQVAEMEAELSIEERNLLSVAYKNVIGAKRASWRIISSLEQKEQAKGNDKHVEIIKGYRAKIEKELSTCCDDVLKVIQENLLPKASTSESKVFFKKMEGDYYRYFAEFTVDEKRKEVADKSLAAYTEATEISNAELAPTHPIRLGLALNFSVFYFEIMNDADKACQLAKQAFDDAIAKLDEVPENMYKDSTLIMQLLRDNLTLWTSDACDEE		239		5	Purified	-1	 	
Batch03	EnhiA.01529.a	Entamoeba histolytica	XP_657161.1	C4M9G7				Rho family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MTKKESISQINIVVLGDSKAGKTALLITYRDGKFPRDYIPIMFDGVELDKTYREKEYHVVIKDCSGMEDYECLRKSLYMDANFFVICYSIDKPDSLKRVESTWVPEIQHQNSNAPIILVGTKKDLRKKKNRQETIEEEEGYDVARRIKNGFYTEISALNEEGITELFNGVFEMFRAQEKPKKNKKEKCIIC		191		3	Expressed	-1	 	
Batch03	EnhiA.01532.a	Entamoeba histolytica	XP_650341.1	C4M750				"inosine triphosphate pyrophosphatase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MEVRIVTSNPHKAKEINEILKDLGLQIGIVNINLMEIQESPLNIIEYKAKEAIKHSNTPVIVEDVSFNLKCMGELPGPYIKYFVQSIGPAGLYKMAKGFDDYRAQAILSIGLTRKESDEVVKIQAIIEGKVVEPRGSNGFGFDSCFVPEGYDKTYAEMSEVEKNQCSHRGVGYRKLAQWLKEHPNYFK		188		5	Purified	-1	 	NR-16120
Batch03	EnhiA.01533.a	Entamoeba histolytica	XP_656677.1	C4LXL1				"ADP-ribosylation factor, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MGSWLSKLLGKKEMRILMVGLDAAGKTSILYKLKLGEIVTTIPTIGFNVETVEYKNISFTVWDVGGQDKIRPLWRHYYQNTQAIIFVVDSNDRDRIGEAREELMKMLNEDEMRNAILLVFANKHDLPQAMSISEVTEKLGLQTIKNRKWYCQTSCATNGDGLYEGLDWLADNLK		174		5	Purified	-1	 	
Batch03	EnhiA.01542.a	Entamoeba histolytica	XP_651815.1	C4M5R3				"type A flavoprotein, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MQNLAVKVVDNLYWVGVFDFDLRTFDVIVPTPFGTTYNSFLLTTNDGNVLFETVKEPFYQEHLERIENVIGKKGQINYIILNHTEPDHSGSLNHILEKYPNATIIATVAALNNLKFISHLSPEVKTVCSIKLKSLQVGEYHLKFLIQPFLHWPDTMMTVIEELKILLPCDFFAVHYAEPKLFDDQIEGKEHIFEKLYRHYFDAVMSPFKSSVLKGVQLVETQMGFPVEELQVICCSHGLIIRKDIKKIIEKYKEWSQPQMLKNKVIVVYGSAYGYTKIMTNKIVEGIKSTGVEVIVYNIVNTTITEILKDFKDAKGLLLGSPTIVGDATPPFYDLLGHLNPFMHNNRLIQCFGSFGWSGEGVKNLIPRIQQLKVKEVNKPLSIRFRPTKEQEIECFNWGKDFGSKVIDHNH		411		1	Selected	-1	 	
Batch03	EnhiA.01546.a	Entamoeba histolytica	XP_649693.1	C4MA96				Ras family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSEGYQVVIIGEGSVGKSALCLQFVREVFSVEYSPTIEDTYNKTIKVDSHTVTFNLIDTAGQEEYVALREQYYLKGDGFVLVYSIENKSSFMAIGNHKDSISVIRPDGDVALILAGNKCDLEEQRVVSKADGEALAKSYGIDFFETSAAKRINVDELFIALGRKLLQINHKGEDAPNTTSPSTEKKSEKNEKPKKEKGKKKGGCIMV		207		1	Selected	-1	 	
Batch03	EnhiA.01554.a	Entamoeba histolytica	XP_648283.1	C4M525				"peptidyl-prolyl cis-trans isomerase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MQIQLLFVIIAIAMAHGPKVTNRVYFDVIIGDEEKPSRIVMDLFGKTVPKTVENFRALCTGEKGMGKSGKPLHYKGSIFHRVIPGFMIQGGDFTRFDGTGGESIYGAKFEDENFKLRHTKKGILSMANAGKDTNGSQFFITLVPTAWLDGRHVVFGEVSEGLDVVDRIAAVGSQSGKTSKRVTIVDSGELPMQE		194		1	Selected	-1	 	
Batch03	EnhiA.01555.a	Entamoeba histolytica	XP_656676.1	C4LXL2				"ADP-ribosylation factor, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MAAWLSKLFGTIKNRRIIVTGLNGAGKTSIRYKLLLGKFAMNIPTIGFGVESFEYKDICFSLWEVKEKDRTKPLWKEYYTYSDGIIFVIDSTNTKDQLVQAKNLLNQILKLKELEGIPLLIYINKDDLLQDKNVTDIINQLGVNQIKGREWYYQSSCAINGDGLYEGLDWLSSKIN		176		1	Selected	-1	 	
Batch03	EnhiA.01558.a	Entamoeba histolytica	XP_657014.1	C4M8B7				Ras family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MPSVKIVVLGPPCVGKTAVTIRLVNHVFQQQYDPTIEDCFRTTRNLDGIDVCLDILDTAGQDEFVSVKQQYMVVGNGFLILYSIISKQSFVECQSTVEMLLRIRDVTVPWMLIGNKIDLKEEREVTQEDALEYAKQKGAVGFLETSAKSNINIEHAFISLAKQILKVRGKQENQSTKDKKCFIL		184		3	Expressed	-1	 	NR-16121
Batch03	EnhiA.01567.a	Entamoeba histolytica	XP_652162.1	C4LX01				protein kinase domain containing protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MYGVWDDKAFKIESGDQNKYQIIRWIGNGSYGKVFLGAIEERYECVIKIFSSFSGCTLKREVYFLNQLQHPNIVKLYDVIVNEQQNKSIIMEYIHNIPLNQISKKLTIKEIKILFLQLIKAVNYIHSKNIMHRDIKPSNIMFNYNNMTLKLIDFGLADYYIQNTKYSIHVGSINYKAPELLLYIHYYTPAVDIWSCGCVLAEMIIRNYPLFEGECLNDILEEIIKLEGTVVLTDFLRKEHVQISRCQALHLVGRKSRSISEYTDPVFQKKQTPGLIHLLKELLEFNYHKRPSASYLLKHITEFFN		305		1	Selected	-1	 	
Batch03	EnhiA.01569.a	Entamoeba histolytica	XP_650440.1	C4M588				Ras family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSHYTLVMLGGGAVGKSAITVQLVSGVFVQMYNPTIEDSFNTTIDVDGEMVSLNIVDTAGQEEYSSLRDQYMRSGDGFVIVYSIISTTSFLEVSGIRDQLFRVLEKEPDEHICMVLCGNKCDMESDRQVNTSEVKQIAEEWKCPFYETSAKERINILESFQALVRDIKKWNAIPGTESTSSNSSSKPEKKKKGCFIF		197		3	Expressed	-1	 	NR-16122
Batch03	EnhiA.01575.a	Entamoeba histolytica	XP_649119.1	C4LUV6				"L-asparaginase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MIFLYILLLFSIVQATHNPKHVLIVYSGGTIGMKQGKQGWEPQPGYLQSLMREMPQFQSETLPYYDIIELNPLLDSSAMTPKDWVRMAVVINENYNDYDGFVVLHGTDTLAYTSSILSFMFENLNKTIVVTGAQTPLCQPYSDATNNLLSALTTAGDIPIPEVVVTFGGHLYRGNRVQKLKANSYEGFDSANYPALAMFGAEILVDWPHVNPYANEPMRFIPTVTDGVIIIYLHPGITSTFIEAVLNNNVRGVILAAFGAGNGPDKENFLKPMREAIQRGVVIVDVTQCHMGRVDLDDYSAAYGYKSIGVVSGGDMTIEAAFSKLTWLLAQGMTPDEVRNNIKSNLRGELTIL		353		1	Selected	-1	 	
Batch03	EnhiA.01576.a	Entamoeba histolytica	XP_657596.1	C4M5I6				"actin-like protein, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTTLVVDNGTGFVKCGFAGENFPTAIFPSMIGRPLLRSEEKIGGVEIKDVMFGDEAAAVRQNLQITYPLENGIIKSWNDMELLWNYTFNEKLHVETTGKSILLTEPPMNPQQNKKKMGEIMFEKFGFNRVYVAVQAVLVLYAQGIMTGVVVDSGDGVTHIIPVYEGCDLPSVKRLDVAGSDITRRLIELLLIRGYSFNRTADFETVRMLKEKFCYVGYDLAVENRLGTETTVLMQQYTLPDGRVIKLGPERYMAPEILFNPSLIGRESLGIHHCLFDSINQCDLDLRAELYKHVLLSGGTSMLPGLPSRLKKEVLQLYDENAAATLKKGSASVTSRSGNSGTNAKKASIQIVIEDPPRRKHLVFQGGAVLAKVIEDRDEAWVTKAEYDEKGAEVMLKRPSF		401		1	Selected	-1	 	
Batch03	EnhiA.01577.a	Entamoeba histolytica	XP_649638.1	C4M9V7				"DEAD/DEAH box helicase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTDPTMQIPDFVQSETFKMQVEPSNKDTYVGTVSFQEMGLKKEIMQSITDCGFEHPSEVQSQVIPKALLRQDILCQAKSGMGKTAVFVLSILNQGLFLGDHVSAIVICHTRELARQVQNEFDRMKKRLVESIGKDIQTASYIGGNPESNDVDDLKNRKPTIIVGTPGRLASLNNSGALDLSKLDTFVIDECDKILSSKSELDIMSLFMSSSKNKQVMMFSATISEQNKALCRKYLKNPFEVFIDDGEKLFLHGLHLYSKKLQDMEKQDKLGEILDEIDFNQAIIFADRKERCQAIVQRLKKEKYPCGILYGRMEEYLREREFERFRKGESRILVSTDLCGRGIDIEKVNLVVNFDMALDSDQFLHRVGRAGRFGTKGVAISFIDTEEDEKVLKEVQSRFAVQMKELPDDLKEIPSTYYK		419		1	Selected	-1	 	
Batch03	EnhiA.01589.a	Entamoeba histolytica	XP_650292.2	C4M5F8				Ras family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSVSGNPYKLVALGKIDSGKTSILIRFFSGHFFKMYDPGIEDEYRTVMKVDDISIIIDVADPCSGDEFSILRDLYIKQSDGFILIYSITSKESFEEMKGIYEEIYRVKDKDENEVIPIIIVGNKCDLENERQVTKEDGIEYADSVKCPFLECSAKTNENINQIFDIITRNVVEYKYSIEEEIWTIEKPKKEKGCCLF		197		5	Purified	-1	 	NR-16123
Batch03	EnhiA.01589.b	Entamoeba histolytica	XP_001913483.1	B1N2R7				Ras family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSVSDKPYKLVLLGKIDSGKTSVLIRFFSGYFVQMYDPGIEDEYRTVMKVDDISIIIDVADPCSGDEFSILRDLYIKQSDGFILIYSITSKESFEEMKGIYKEIYRVKDKDENEVIPIIIVGNKCDLENERQVTKEDGIEYADSVKCPFLECSAKTNENINQIFDIITRNVVEYKYSIEEEIWTIEKPKKEKGCCLF		197		3	Expressed	-1	 	NR-16124
Batch03	EnhiA.01589.c	Entamoeba histolytica	XP_650287.1	C4M5G1				"Ras-like protein 1, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSVSGNPYKLVALGKINSGKTSILIRFFSGHFFKMYDPGIEDEYRTVMKVDDISIIIDVADPCSGDEFSILRDLYIKQSDGFILIYSITSKESFEEMKGIYEEIYRVKDKDENEVIPIIIVGNKCDLENERQVTKEDGIEYADSVKCPFLECSAKTNENINQIFDIITRNVVEYKYSIEEEIWTIEKPKKEKGCCLF		197		5	Purified	-1	 	NR-16125
Batch03	EnhiA.01592.a	Entamoeba histolytica	XP_649196.1	C4M920				small GTPase Rab7A [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSKKKILLKVIILGDSGVGKTSLMNQFVNHKYSSVYKATIGADFLTKDLVVDNHEVTMQIWDTAGNERFQSLGVAFYRGADCCALCYDVNDPKTFESLNNWREEFLVQASPKNQDQFPFVVLGNKVDTYEGSPDAIKKKAEQWCSEHFNIPFFETSAKNATNVDAAFQSIAQAAIAQKGTDTDIYVMNQVNIDQPAPQAQKSDCPC		206		5	Purified	-1	 	NR-16126
Batch03	EnhiA.01595.a	Entamoeba histolytica	XP_001914087.1	B1N4H1				"actin, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MQCDCDLRKDMYNNIVLCGGSSMFPGMKQRFIKEITVLSPPTIQINVDCNRKRKYGAWIGGKMFASLSSFEERYMKKAEYDEFGASYINSKDKK		94		2	Cloned	-1	 	NR-16127
Batch03	EnhiA.01602.a	Entamoeba histolytica	XP_652253.1	C4LYQ1				Rab family GTPase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MNKPELRINVVIVGASTVGKTSLANQLVNNCFNEHYETTHGMDIFSYKMELDNCVVSLTLRDTCGQEQYRSLAAQYYRETHGALVVYDISNRDSFEYLQDWVNDVSNYCPQGVKIVVVGNKVDLADEDLRVVSTEEGQKFSNEGNFDFFETSAKRNIKVEAAFRDLVTKIVQSENLPKQSQFEVSTSKVSISTESSKENKKCC		203		5	Purified	-1	 	NR-16128
Batch03	EnhiA.01605.a	Entamoeba histolytica	XP_650555.1	C4M1Q5				"thioredoxin, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTIPLNTTNLEELKEKTATGVAVVQFHATWCKDCINVRPLYRKLITQAPTTTYLDIDIDKAPELKKIYNIVHVPTFILYHNGQELKRIVEPGYDELESFMDEASKL		106		7	Crystallized	-1	 	NR-16129
Batch03	EnhiA.01611.a	Entamoeba histolytica	XP_001914238.1	B1N4X2				protein kinase domain containing protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSFLRNIINGIKSSFLTDPSIPKSRYVILNKLHSARFSKVYHCRLRESGKEVCVKIYQVGEKERNNEVLETQILNEISILRRVNHPCILGCLNVYLTSHRAVMEMEYMNGGDLFDYLVKNGIQNEQVVRQVAIRLMSAVKYLHSVSITHRDIKLENMLLEKPNDISSVKLSDFGLSVETEKETLMTEQVGTSYYMAPELYRRLPYGNKIDCWSCGVVLYSLLCGTFPFAGEDQELVSHILRGKVTFPNDIKISDDCKDFIL		261		3	Expressed	-1	 	NR-16216
Batch03	EnhiA.01612.a	Entamoeba histolytica	XP_001914626.1	B1N610				"threonine dehydratase catabolic, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MPEFASTAKVTATRGYGAEVVLHGKVFDESLAYAMQLCKEEGKTFVHPFNDPWVMAGQGTIALEILEQLEKCDVIIGAIGGGGLMSGVAFAAKQIKPEIRIIGVQAAECPSMAVSKAEHKICCVKTAKTMADGIAVKAPGDKTAPVLLKYVDEIVTVDEESIAQAMLLMLERCKIVSEGSGATPVAALLSGKIKGLTEDTNVVCIVSGGNLDVNVINKVIERGLVKAGRKVEFTVEIADVPGAIKDLLAHITEEKATVVG		260		3	Expressed	-1	 	NR-16217
Batch03	EnhiA.01624.a	Entamoeba histolytica	XP_001914429.1	B1N5G3				"cysteine proteinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MIVLIYLLSIVNGIDFNTWVGKYNKHFTAVEMLRRNAIFNMNGKIVGEFNKEGTFKLSLEGPFAAMTNEEYKNILKSKRSEEGKGKVKYLNIEAPETVDWRKEGKVTPIRDQAECGGCYAFGSIAALEGRLLVEQGGDANTLDLSEEEMIQCTREYGNNGCGGGFGSNAYDYIIEHGVSNETEYPFTGMDSECKTNIKPYVTMKGYNRVARNNVRELKSAISQGMVDVAMDASSVKFQLYKSGAYTDKKCKKSFFALNHEVSAVGYGVVDGIECWIIRNSWGTTWGENGYFNIAIEGNTCGIATDPLYPTGAQYL		315		4	Soluble	-1	 	
Batch03	EnhiA.01636.a	Entamoeba histolytica	XP_648010.2	C4LYC9				"ankyrin repeat protein, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MQTNGFDVESVNVFLEEVRYGELDIVKSFIEQDHDILTVKNEYGNSALHYSCGNNNLEMTSFLLSFDEIKRIINDKNESGSTALHWAVRGDIQIVQMMLDAGADKTILNAQNKTAIELASEEHKDDIVALLIGPVADDLVDDENGENVGDDIIVESISSDDNTQNKQETKEEKTD		175		5	Purified	-1	 	
Batch03	EnhiA.01638.a	Entamoeba histolytica	XP_654093.1	C4M4L2				60S ribosome subunit biogenesis protein NIP7 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MRPLTDEETKSFFEKLAKYIGRNIRFLIDNENEEYCFRLQKDRVYYVRLSIAEQATTIGRENLLSLGTCFGKFTKTGKFKLQITALPYLAQYCSCKIWVKPEAETSFLYGNHLVKNGISKITDNMARNIGCVMFNENDIAIGFGTTACSSVEYSRLSATGIVCYNQGDLGEYLREEDTMMVQN		183		1	Selected	-1	 	
Batch03	EnhiA.01638.b	Entamoeba histolytica	XP_001914367.1	B1N5A1				60S ribosome subunit biogenesis protein NIP7 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MRPLTDEETKSFFEKLAKYIGRNIRFLIDNENEEYCFRLQKDRVYYVRLSIAEQATTIGRENLLSLGTCFGKFTKTGKFKLHITALPYLAQYCSCKIWVKPEAETSFLYGNHLVKNGISKITDNMARNIGCVMFNENDIAIGFGTTACSSVEYSRLSATGIVCYNQGDLGEYLREEDTMMVQN		183		1	Selected	-1	 	
Batch03	EnhiA.01646.a	Entamoeba histolytica	XP_648806.1	C4LW68				methionine gamma-lyase [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSQLKDLQTRVLHTPSKWGEPLHAHTFPIFQTSTYLFDDTQMGADLFGGKREGHMYSRMGNPTVEYFEELVNSLEGGVGTAAFGSGMGAIHSATMGLLKAGDHLISGDTLYGCTVELFGNRFKDMGVDVSFVNTASDEAVVKAWKPNTKMVYLESPANPTCKVSDIKGIAKICHEKGAILVVDCTFTTPVFLPALELGADVVLHSITKYINGHGDVVGGVVTTKNPELLQKIKAFRKDTGSLMAPMDAFLCIRGVKTLPMRMKVHMENGLKVAKFLEQHPKIKQVNHPGLESFPGHKIAMEQMKGFGSTFSFEMKSFEAAKKLMEHVKLCGLAVSLGTLDTLIEHPASMTHAAVPEHLLKQQGLTRELVRISVGLENPDDIIADLKQALEQC		392		1	Selected	-1	 	
Batch03	GilaA.00217.a	Giardia lamblia	XP_001708076.1	A8BBV5				Guanylate kinase [Giardia lamblia ATCC 50803]	Potential drug target		MQTRCFRPTQNKIIVLNGPSGSGKSTLFRAITTMDRYKDYFGFSVSHTTRAPRPGERDGIDYYFVSHEQFQSLREQGGFLETVENFGNFYGTSFAAINDVLKRQHCILDIDYRGAMTLNAVLEQERNVKALFVFISPPSVELLEQRLRGRQTESEEQIKKRLDTALRELDFFNANRSFYDVHIINDNLEEAIQTLDLSVRRFLSG		205		2	Cloned	-1	 	
Batch03	GilaA.00218.a	Giardia lamblia	XP_001704644.1	A8BV55				UBC3 [Giardia lamblia ATCC 50803]	Potential drug target		MSRAIERLNEERKHIKRELPPGFFSKPLPKKTGTTVLPNELDLFRWICGVPGKKGTIWEGCTLRVYMFFPEDYPIAPPKVQFDPTLFHPNVYPSGSVCLSILSYEWKPSITIKEILLGLQVLLDEPNLQSPAQHEAFQLRREDLTAYNKRIRAIVEENPSSEFERRVKNIVMSGEFRTCPRPPPKNDDIAID		192		5	Purified	-1	 	
Batch03	GilaA.00228.a	Giardia lamblia	XP_001707157.1	A8BGB2				ABC transporter family protein [Giardia lamblia ATCC 50803]	Potential drug target		MWGLNFFIMAVQRQVFLDEPTTGLDPVTKRAVWRTIEEAKQGKTIILTTHSMEEADSLAQYIAIMAAGQLRCIGTKERLKARFGSGYRVQIIHVTESVGRVDALLVCSAPYIRLEKREHIPNDKTHTRSFYVVPQGHPISYLYKALYREKSSGSGLIKEFGVSFTGLEEVFLTIAHMVEPPPEGV		185		2	Cloned	-1	 	
Batch03	GilaA.00233.a	Giardia lamblia	XP_001708926.1	A8B819				Protein 21.1 [Giardia lamblia ATCC 50803]	Potential drug target		MSRPPNGKNDDKWEIMGEPTEYVYTITTNRAFTALMEAARADALEDVLNYSSTQARMTTPTGQTALMIAAEAGNFNSARVLLPLEKGMQTNDGRTALMHAAAAGSISLTKLLIPHEAKITSERDGHTALMEAAREGHCGVVEILLQHEVGMRQYMGLTALIYAIHEGHSECVAALAEAESHLCSYDGKSPVVHALDTGNKYLFPYLKI		208		3	Expressed	-1	 	
Batch03	GilaA.00282.a	Giardia lamblia	XP_001709089.1	A8B6Y4				Glucosamine-6-phosphate deaminase [Giardia lamblia ATCC 50803]	Potential drug target		MTVCVAQAERGASELESKAMVKKSNDAALLVAHRIAEVVRSKPNCVLGLATGSTPIPVYQELARLHREEGLDFSQVRTFNLDEYAGLPPTHDQSYRFFMEEHLFSKVNIKPENVHFLSGLAIRAEDECIRYENALQTIGPCDVWLLGIGHNGHIAFNEPGSPRDSRTRVVCLTQSTIDANARFFGNDKSKVPTKALSVGIATIMESREILLLATGESKCEAVTKAIVGEPTNAVPASLLQRHPRCCFYVDEAAGAEVAETVTE		263		7	Crystallized	-1	 	
Batch03	GilaA.00290.a	Giardia lamblia	XP_001707871.1	A8BCC2				ARF3 [Giardia lamblia ATCC 50803]	Potential drug target		MGIALGRLIQSLFGSRQARVVMVGLDAAGKTTILHQMAYGMTVETIPTMGFTLQTVKKGKLELDVWDIGGQSEFRNIWVHYYVDKHAAIFVVDAADHSKARMEEARTALEGVLTAPELSGVPILILANKQDIDGAMSGDAVASMLDLQNVKDHEVKVVETVGTTGKGLDDALKWLSTAIERRWKETS		187		7	Crystallized	-1	 	
Batch03	GilaA.00297.a	Giardia lamblia	XP_001709101.1	A8B700				Adenylate kinase [Giardia lamblia ATCC 50803]	Potential drug target		MKVIVFLLGGPGAGKSTQADLLAKHPKVACVGAGDCLRAEMNRAGSEHAAYIKECIANGVIVDGMITAALLHDFCVTSNKEVIIIDGFPRSVNNYNCFLKIFGETPHIMLTLSCSEETLRNRIRQRILSKSTRIDDNEETLMKRIAIYNSETQEIYRELDRKGMRINVEATNNIEETHQRILNKLALYFE		190		7	Crystallized	-1	 	
Batch03	GilaA.00312.a	Giardia lamblia	XP_001707732.1	A8BD71				Hypothetical protein GL50803_14299 [Giardia lamblia ATCC 50803]	Potential drug target		MIYGILSKNLGMPTPTFLVCPDVVKFENVGQIAVVNGMVYLGGSVGIDKSGTLHKGLEEQTRQTFDNIRKCLEYANSGLDYIVSLNIFLSTSLSDSEEARFNELYREVFCVPATRPCRCCVRAQLQEGLLVEVVNVVAAQK		141		17	In PDB	-1	 	
Batch03	GilaA.00333.a	Giardia lamblia	XP_001704058.1	A8BZ95				"Kinase, CMGC CDK [Giardia lamblia ATCC 50803]"	Potential drug target		MSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP		308		17	In PDB	17	Ligand-bound structure submitted to PDB	
Batch03	GilaA.00349.a	Giardia lamblia	XP_001710001.1	A8B2L8				Dmc1b [Giardia lamblia ATCC 50803]	Potential drug target		MPPRKAAEVSESDVTEGTEATDVVDAASAGTEEATEGDLTMADVTQTKHIVSPIDDLTKSGIATMDIKRLKEAGIHTIQSLLMHTKKALGNVKGISEAKVDKILSVATEMCGKTFITGSEALKKRQQVKRLSTGCADFNALLGGGVETMSITEVFGEFRTGKTQLCHTLAVTAQLPVSKGGGGGKTVYIDTEGTFRPEKVAPIAERFGLNPKKALDNIMVARVYTHEQQIECITALPKLMVENQFSLVIVDSLTALFRVDFTGRGELADRQQKLGQHLSGLAKLADEFNLAVFVTNQVMAQVDGAAMFTADPKKPIGGHILAHASTTRLYLRKGRGDTRVAKIYDSPSLAEGEASYSIAAEGIIDAAE		368		2	Cloned	-1	 	
Batch03	GilaA.00357.a	Giardia lamblia	XP_001709330.1	A8B5X9				Glucosamine 6-phosphate N-acetyltransferase [Giardia lamblia ATCC 50803]	Potential drug target		MAKYLGRYSLRSIQERDLSRLTTLLEQLSVVGEVPREKLVSFYKSVSTNPSHDVTVVVDETDTVCACATLIIEPKLLHAGRSVGHIEDVVVDLTLRNQGIGRFLITSLIERARNNDCYKVILDTDPDTAEFYKKCGMKQKGLMMAIYF		148		5	Purified	-1	 	
Batch03	GilaA.00359.a	Giardia lamblia	XP_001710215.1	A8B3G7				26S protease regulatory subunit 6B [Giardia lamblia ATCC 50803]	Potential drug target		MTDTFHALQQAETELQFLQSQIEFAQADYQHLWNLITSLRSQLEQHCVTPLAIGQFVEFADEDYAVVQASTNFGNSLVRISSSVDRLKLKPMSTLALAKNSLALLKVLPSDNEMNSNVISIEAKPTVTYADIGGYDQAKLELREAVEFPLKSPELFAALNIQPPNAVLLHGPPGCAKSLLVKACANSCDCTFISVTSSSCVNKYLGEGPRTIRDIYRLARENAPSIIFFDEIDAIANKRGDSTTEGDKETARILMELLTNLDGFDNDSNLNNGKIVKTIFATNKPEMLDPALLRTGRADRKIFMDYPTKRDKRLIFQTCSKDMKLANDVDFEIFVMRGEKISGAEIASICTEAGMSAIRANRYTVNMADFEKAYSIVVSKRQSANRQIFE		390		2	Cloned	-1	 	
Batch03	GilaA.00361.a	Giardia lamblia	XP_001706755.1	A8BJ73				14-3-3 protein [Giardia lamblia ATCC 50803]	Potential drug target		MAEAFTREDYVFMAQLNENAERYDEMVETMRKISGMEGELSDKERNLLSVAYKNVIGPRRAAWRIVSSIEAKEKGRQKPNAKRIEQIRVYRQKIEKELSDICNDILKLLQEQFVPRSTNADAKVFYYKMQGDYYRYLAEYSSGEDKEKIAGSALNAYNSAFEISQQLPPTHPIRLGLALNFSVFYYEILASPDRACELARKAFDAAITDLDKLTEESYKDSTLIMQLLRDNLNLWVTDSAGDDNAEEK		248		7	Crystallized	-1	 	
Batch03	GilaA.00366.a	Giardia lamblia	XP_001704944.1	A8BT90				Hypothetical protein GL50803_6369 [Giardia lamblia ATCC 50803]	Potential drug target		MDYWIARNSWGEEWGENGYFKIIRGSNECGIESHSQGFYFIASK		44		3	Expressed	-1	 	
Batch03	GilaA.00385.a	Giardia lamblia	XP_001704914.1	A8BTN6				Adenylate kinase [Giardia lamblia ATCC 50803]	Potential drug target		MRIVHFLGVPGAGKSTVIGRFCQEYPLCASLYIGQIVREEIQRQTPLGQEMQLMLAQGNVLSGDAVIPILQQEIAHHEATGTAVLFVDGFPRSDDQARAYLLHFGSPTLTLCLSASDEVIAERLMTRQQSTTLRLDDTKDIIQRRIEKAREHVQPGLDVYIEHNCKVEIIDSSGYLDEVCSSVLKMLHKHKVL		193		7	Crystallized	-1	 	
Batch03	GilaA.00393.a	Giardia lamblia	XP_001706307.1	A8BLJ4				Aldose reductase [Giardia lamblia ATCC 50803]	Potential drug target		MLDRPPCVGFGTYLVEDPEAIRSAVKLGYRHFDCAYRYGNERMIGEVFKEIFNDDSYGVKREDLWIVSKLWPNFHEPEKVAYQISETLRDLQLEYLDVFLMHWPLAIKHLADRDYASSDGKGGTLLGTTPIRKTWEAMEACVDKKQTRFIGVSNMGTAMLVDLLSYCRIKPFTNQFESQPYFPNDRLIEFCNSNGIYVTAYRPLGGRCRVDAKAPLTDPALEELAKKANLTVSELILAWHWTRWGTSGTYSVIPKSSDRERQKQNLESVKLRLTPDQMDAFARLGCVHQRTCFTSFASVPLFD		303		5	Purified	-1	 	
Batch03	GilaA.00402.a	Giardia lamblia	XP_001707994.1	A8BBK1				Hypothetical protein GL50803_12942 [Giardia lamblia ATCC 50803]	Potential drug target		MQYACHQKKIVLKGRKRGVYLVTAEIMAQARDLIQSVRTGVCFLFLMHTSASLSINENADPTVREDMNAIMHNLVPDSSNYRHNYEGDDDMPAHALSTLAGCSLTIPISGGTLALGTWQGVYLLEYRHFGGDREIMVTVQGAAAK		145		2	Cloned	-1	 	
Batch03	GilaA.00417.a	Giardia lamblia	XP_001704003.1	A8BZH8				Calmodulin [Giardia lamblia ATCC 50803]	Potential drug target		MSLEAYSQVLVRKVGDTFDIFDTEKNGTIDVREVGTVLRSLGVYPTEAQLHSMLLEIQQDEPSMYVSKASFMAVVCRVISTNEITGPAPDELARAFAVLDPNNTGFLETEQLRVYLTTSGERLNADEMENFSAFATDTETGLIDWRSYLTAVTDILWQNDD		161		2	Cloned	-1	 	
Batch03	GilaA.00424.a	Giardia lamblia	XP_001706649.1	A8BJT1				"Kinase, NEK [Giardia lamblia ATCC 50803]"	Potential drug target		MANAGGRQAAGGVGQAFGAKPTSAGKEAKDVRQQYIFLNIIGSGSFGKVHKVQSRTNGRIFACKEIDYAKMSEKEKKLLVHEVNTLKELSHENIVSYIDRFVERENAKMFIVMEYCENGDLARYIKRHKTDRRYIAEEKIWSVFVQLLHALNYCHSLHKHDDTGTHKVIHRDIKPGNVFLTRDGSIKLGDFGLCRSLGELSQAKTNVGTPLYMAIEVLQKQSYTEKADIWSLGCVIYELCALQPPFVASNMDSLKAKVKQGARPAIPAHYSSDLSAVIDSMLNSNFNSRPSAAELLNHRKIIEMSERMKNAGMTGAGMQAAANPPPPVQAPVSAAAPRAGEALAALKNEAANIGNPVDVAQKERELKEWEERLQQREQQIRAREEQVERALVSGKSNGGAYKYKM		405		2	Cloned	-1	 	
Batch03	GilaA.00433.a	Giardia lamblia	XP_001704762.1	A8BUD9				"Kinase, NEK [Giardia lamblia ATCC 50803]"	Potential drug target		MKARFVKQTLLGEGSYGRAYLATDNVSNESVVIKEFVGKKMSTNAKRLAMEECALLSKMNNPNIVAYFGHFMQNGNLSIVMEYANKGDLSGLINKANGKRISEEIIKDIFYQLIKAVAYIHKRNILHRDIKAGNIFLTSAPDSNFYRVMLADFGVSKVLSNDDALTETLAGTPYYLSPELCNSEPYGKKSDMWALGIVLYELMMLTTPFRGKNLQAVSARITRGKFPEITGPYSEAIKNVCYSLLRNDPNERPSAVQLLDHKMFKGYTELYIAESVRGNKTYISNPASPAPETGNRNSVSGVTREPSSAEVSPSNGCIKPSDPMDSTPTEPYLIEVSPLKIAKKQYHRILCDQVEKDGDNSDYECMSESALHNLVYRNSVLLQLAGYRKQIVNEIGNDRFQQYLQKIAASDQTQLTRSAIETVVRQILVGEKEKAILTVVDYVTCYTSFMCFERN		455		2	Cloned	-1	 	
Batch03	GilaA.00438.a	Giardia lamblia	XP_001706095.1	A8BMG9				Nucleoside diphosphate kinase [Giardia lamblia ATCC 50803]	Potential drug target		MARERTFLMVKPDGVQRGLVGEIISRFERRGFKLVAMKFFVPSKNLVEEHYKEHAARPFFAGLCKFLSSGPVCAMVWEGANVVSISRTMMGVTKPAESAPGTIRGDFGIDVGRNIIHGSANLDDAAREIALWFKPEEVASWSCSLESHIYE		151		14	Crystal structure	1	Target selected for ligand screening 	
Batch03	GilaA.00442.a	Giardia lamblia	XP_001704653.1	A8BV70				Actin related protein [Giardia lamblia ATCC 50803]	Potential drug target		MTDDNPAIVIDNGSGMCKAGFAGDDAPRAVFPTVVGRPKRETVLVGSTHKEEYIGDEALAKRGVLKLSYPIEHGQIKDWDMMEKVWHHCYFNELRAQPSDHAVLLTEAPKNPKANREKICQIMFETFAVPAFYVQVQAVLALYSSGRTTGIVIDTGDGVTHTVPVYEGYSLPHAVLRSEIAGKELTDFCQINLQENGASFTTSAEFEIVRDIKEKLCFVALDYESVLAASMESANYTKTYELPDGVVITVNQARFKTPELLFRPELNNSDMDGIHQLCYKTIQKCDIDIRSELYSNVVLSGGSSMFAGLPERLEKELLDLIPAGKRVRISSPEDRKYSAWVGGSVLGSLATFESMWVSSQEYQENGASIANRKCM		375		3	Expressed	-1	 	
Batch03	GilaA.00446.a	Giardia lamblia	XP_001704014.1	A8BZJ9				"Kinase, NEK [Giardia lamblia ATCC 50803]"	Potential drug target		MYIKNRILGRGAYGIAWLAKDTETGASVVIKELTLAQLPAAERERALREANLLSQLFHPNIVSYKQSFLENGALNIITEYANKGDLQNFMRSSSEPFDEPFITYVATQILNALIYLHSHNVIHRDVKPANIFLAKTTVESSKERKYPFRVMLGDFGIAKVLGESSLATTLVGTPYYLSPELISKHMYSTKSDIWSLGVTLYELAAQKRPFTGRTIVSVAMQIVEGKYDPLPEKFSKPFCNAIYNMLEKEEKRRSDAAEALAMFGVLASAGQSANGKMSQPGVLTPIVLNTEYTKVLRAELAHRYKQLYQKAQTVIGRELLDKSLRSIIKLVLENPSVECIHAAVAQHFSPDSTGASNITDLVVCITHSWLNTGSFTVK		378		2	Cloned	-1	 	
Batch03	GilaA.00461.a	Giardia lamblia	XP_001706804.1	A8BIB0				Nuclear LIM interactor-interacting factor 1 [Giardia lamblia ATCC 50803]	Potential drug target		MATPLDRPLTRGGAFGGCCGSSGDAQGDDAEISLAKTYNTSQGGGWRPPEDKKPRKQKSVVDLLEAVTVKYKTAQDAPILPPRAGNDNKPTLVLDMDETLIAVKFDLYLPGSDYIVPLRLCHLTETGTGMTELYTIAWVRKRPYLEDFLASVAKDWEVIIMTAGIEDYAKPIIAEFDRNKIVSYSLYRDSCSCDKSDGIIYKDLSILGRDVNRTVIVDNTPTCYKKHPENAIPISTWESSSKDRALRSLIPILQELSRAPNIVKALKRMRLNEF		274		2	Cloned	-1	 	
Batch03	GilaA.00465.a	Giardia lamblia	XP_001708016.1	A8BBM9				Aurora kinase [Giardia lamblia ATCC 50803]	Potential drug target		MPQHLVPHTGTGKRTTIEDFEIGRFLGRGKYGLVYLAREQSSKLVVALKVLYKSYIKSERVEGQVRRELDIHLNVRHINIIRLYTWFQDETRVFLVLEVAPYGELYQRLQQFGKFPLPVVSKIIRDVAQAIQYLHRKNIFHRDLKAENILICKGKETKEHTDAHNSDDSISVHEHELVRMAHYTYKIADFGWSVHHPTHGGRRRTQCGTLDYLPPEVMLGQSYDKACDIWSLGALCYELICGTAPFYHDEIKITRQNIANVEYSFTKDFSPASKDFIQRMLIRSPEARISIEDILRHPFLRQTDHRSKVPK		311		4	Soluble	-1	 	
Batch03	GilaA.00524.a	Giardia lamblia	XP_001708123.1	A8BAP8				"Kinase, NEK [Giardia lamblia ATCC 50803]"	Potential drug target		MILSVMKQVAAALAYLHGLSGVGAKGLVHRDLKPANVLISADGERFVIADFGLCKDALRCGSTIAGTAVYMAPEALLRNEASPASDVWSLGVIIYELTTLRRPDFLGGKEPAEVFIDGWRPDLSGVTDGFIKSVLERIFVLEPERRPTARELHETLATFDIPVGELGGQCVMLKYKCGSLEAALNGANARIALLEEDVKTRSTKIDALEDQGKEHLAMSKALENRLAQFGDRMNTTDPQSSLFLLPGLMRAAHK		254		5	Purified	-1	 	
Batch03	GilaA.00525.a	Giardia lamblia	XP_001709931.1	A8B2A9				"Kinase, CMGC CDK [Giardia lamblia ATCC 50803]"	Potential drug target		MTDPLNRYERIQGLGEGTYGVVFKAKDKETGQIVALKRIRLENADEGIPATAIREIAILKEMKHKNVVDLLSVIHTEAKLTLVFEYLDMDLKKYIDSKQGKLTPKEVKSFMGQLMTGLTYIHNKRVLHRDLKPQNLLVTSSGLLKLADFGLARGSGIPVRSYTHEVVTLWYRCPSVLLGCRKYGGALDIWSCGCIFYECVTGKPLFPAKTEKDELIKIFKTLGTPDKQSWPDVDTLPQWQKDFPVYPGINVAELLPTLDEAGRDLFSKMMALDPSKRPSARDCLKHPYFAK		291		5	Purified	-1	 	
Batch03	GilaA.00526.a	Giardia lamblia	XP_001709079.1	A8B6X3				"Translation initiation factor eIF-4A, putative [Giardia lamblia ATCC 50803]"	Potential drug target		MEDSTNRAEIAQTPDLKSYEKFDDMNLHPDLLFGIFTYGYKIPSAIQSQAIVPIISGKDTIAQAQSGTGKTAAFTIGMLQRIDIGLKSPQAIILSPTRELALQTLKVVDGIGSRLKVQVAQCIGGTQVDDDIAAAQSCHLIVATPGRLLSLLQKKYVTTSNVKMVVLDEADEMLSRGFTEQIVSIMKFMNADIQIVLVSATLPPEILELTRQFMRDPVSILVKEAELTLDGIRQYVVELQDAWKTEVVEDIYKVLSVQQGVIFCNSIGRVKELAEKLKSAGHTLSCIHSELDQAERNKIMGEFRSGQTRILIATNIIARGIDVQNVSLVINYDIPREPETYLHRIGRSGRFGRKGVAINFVTDKDKQSMQAITDKFNVTTENLPEDLSSLF		391		5	Purified	-1	 	
Batch03	GilaA.00536.a	Giardia lamblia	XP_001706785.1	A8BI72				Peptide methionine sulfoxide reductase msrB [Giardia lamblia ATCC 50803]	Potential drug target		MTTSSLIADLPKWRAVPDEQYAALKTNARSPKDAHGARELTPAQRNVLFNHGTEQAFNNEYYACKSSGTYICRACHLALFSSGDKFDSGTGWPSFVSPLDYRVVAYTHDTSHNMERTEVHCANCGAHQGHVFNDGPAPTGLRFCINSASILLRPEDSK		158		5	Purified	-1	 	
Batch03	GilaA.00540.a	Giardia lamblia	XP_001707845.1	A8BC79				Cyclin-dependent kinases regulatory subunit [Giardia lamblia ATCC 50803]	Potential drug target		MSGTAHNGFYYSRKYYDDVYEYRHVIMPEEMVKKYNFDHLLSEQEWRGLGIQMSQGWVHYDYHKPEPNILMFRRPHDGNIPEDAQ		85		7	Crystallized	-1	 	
Batch03	GilaA.00542.a	Giardia lamblia	XP_001706190.1	A8BLV8				"Kinase, CMGC RCK [Giardia lamblia ATCC 50803]"	Potential drug target		MDAYTPVRRVGSGTYGDVLHAVDTKGDFVAIKIMNSHTLCVSDPLQLPEVATLRRLPPHPNIIRLIRVVVTRDHTHLIFEYAGGGTLLNFLRSSGPLKEHMLRNIAFRILQGLYHIHTNSVIHRDLKLENILLTSETGDANGDIVGVKIADFGLSRAQGSRQNTDYVSTRWYRAPELLLHYSGYGPPIDIWAAGCCFAELLTGDPLFPGDTEIQQLQLICAFLKPLKPDACKGAMHALPRFITENMTVSDADIYTLAEAREALRRELGCSHVLADLLAHMLAWNPEDRITAQRALMHQFFAI		302		3	Expressed	-1	 	
Batch03	GilaA.00592.a	Giardia lamblia	XP_001709139.1	A8B747				Ser/Thr phosphatase [Giardia lamblia ATCC 50803]	Potential drug target		MDRWLEKAKKREFFDEEELRRVIWKAIEIFIMEPNVLQVKSTGDKINVCGDVHGQFQDVIKMINEVGGEVSGTNRYLFLGDYVDRGYYSLETITLLLCYKINYPNDIFLIRGNHECRSVTQTYGFYEETTKKYAHAGVWKLFMELFDHLPIAAIVDNSIFCVHGGLSPALPTLDDITLLNRTIEIPSEGPFADLNWSDPCTNLDNWEHSYRGAGYLFGKKAVEQFLSMNDLKMIARAHQLATEGYQEYFDKKLVTVWSAPNYSYRTKNKACIMPVSNGEAKDYLIFDAYKYTEADLPNELLEAIKGLK		308		2	Cloned	-1	 	
Batch03	GilaA.00594.a	Giardia lamblia	XP_001707343.1	A8BFU8				Tem-1-like protein [Giardia lamblia ATCC 50803]	Potential drug target		MSQQLIVKIALLGNAEAGKTSLMVRYVEGEFNHNYIQSLGVNFMERTITLHDNPVLLSIWDLGGESEFKNMLPLVCDGSMVFLYIFDLTSKTSLASIKEWYRQAKALNRSAFPVLVGAKYDRFRELREDKKREIIEHARRYSKAMKNCPLVFTSAELGVNINRLFKLVVCLVFGLNPGIEQIEADDQPIFEYTLIQ		196		2	Cloned	-1	 	
Batch03	GilaA.00596.a	Giardia lamblia	XP_001706202.1	A8BLX8				"Small nuclear ribonucleoprotein Sm D2, putative [Giardia lamblia ATCC 50803]"	Potential drug target		MYLPILPQHSAYSSTEDSSAAQVDESGKVNFQTQKITIVTTMSNKISDSPYAFFDEVLALRKPVLVQLRSGRFITGVLKAYDRHLNLVFSEATETWEENGIEYTEERKNFMLRGDNVIMVVSNS		124		2	Cloned	-1	 	
Batch03	GilaA.00601.a	Giardia lamblia	XP_001708612.1	A8B8G9				UBCE14 [Giardia lamblia ATCC 50803]	Potential drug target		MTTRAQRHLAREFQAYERDPIPGVSIGLKGDSLFLWTLMLQGPPGTLFEGGLFRAELRFPDNYPDQPPKFVFITDIFHPNIYSDGSVCISILHPPGPDPHQYETAAERWLPVHTVSSIILSVISLLSDPNCKSPANVDAAKLYTDDYPMYKKRVLTCVRRSMEE		164		3	Expressed	-1	 	
Batch03	GilaA.00623.a	Giardia lamblia	XP_001703990.1	A8BZN6				RabB [Giardia lamblia ATCC 50803]	Potential drug target		MPPPPISNKPLVVRLKVTTAGMSQVGKSCLIKYYCEGRFVKKYLPTIGVDYGVRALDLEGCTVRINFFDLSGLDEYQDIRKEFYSDTQGLLLIFDMSNRDSFTALEKYYGEFIKSSTGAGAGAGSVSIYVIGTKADLPAAVSVDEATTYASRLKGVFFKVSSCTGDGVAPALNTIFKQLFSKAKA		185		3	Expressed	-1	 	
Batch03	GilaA.00634.a	Giardia lamblia	XP_001706989.1	A8BGT6				Rab GDI [Giardia lamblia ATCC 50803]	Potential drug target		MDTLPKEFDAIVLGTGLKEGIVSALLSVHGRKVLHIDRNDFYGGDCASLKLSQLYSFFGESLSSIPAEFGKDNEWSIDLIPKFILSSGDLFYMLRHVDCLHYLEFGRVAGAFVYNNGVIHRVPATTKQALDSKLMGLFEKKRMANLFEYITSFEENPSATSNLSSQGKTPATATCNEYFDAYKLSDSTKEFIGHAMALELDDEYLNKPALETFRRIDLYTQSLSRFGQSPFIYPLYGLGDLPQAFSRVAAVWGGIYMLNTPVSEILYNDDKKVRGVRFGDHEVSAPIVVGDPSYFPDLVVSKGRVGRAICILKGPIPECDQQSDVEKDGAGNRIVQTAHQVILPASQIQRKSDIYVSTQGYNHRTTPRNCVLGYVSGLVYGSRSDNRDELKAGFDILKRAGISKTFYKEYDLLEPKEEAQRRNIFISKSYDATSHFESTVADAIDMYQRITGETLDLTTIVKRQAPTVEDA		471		7	Crystallized	-1	 	
Batch03	GilaA.00638.a	Giardia lamblia	XP_001708729.1	A8B8Z9				Bet3-like protein [Giardia lamblia ATCC 50803]	Potential drug target		MVGFNAEFFAVTYGAIVTSLLEELHDPGMVTKELDRMGFNIGQRCVDEYLANSSSICTKFHHTATGVLGGLKMFLGCASGTITGCEPECSAYTIFVENNPLEKYVKLPAQLDRLVYSQIVCGAIRGALSLIGYNVTVELIPAHNAMVHPLHLRVELQNEITESFAC		166		7	Crystallized	-1	 	
Batch03	GilaA.00644.a	Giardia lamblia	XP_001704041.1	A8BZG5				Hypothetical protein GL50803_33870 [Giardia lamblia ATCC 50803]	Potential drug target		MASHGRVHRATQEFLDLYSSAKIPTKQELAANPITPEEVLRHRDVNDCWVSHKGIVYNLTPYLRYHPAGIAPIEDYYGYDITAVTAAVHGFVQVEQIIAPLAVGVLNGDPCVPPEKKLKVETGVLRRRY		129		5	Purified	-1	 	
Batch03	GilaA.00661.a	Giardia lamblia	XP_001704515.1	A8BW38				"Kinase, CMGC GSK [Giardia lamblia ATCC 50803]"	Potential drug target		MLPQKLPELFQDSTATCPQSTDGPEITFTTMRTIGSGSFGVVFIAKTSTGELIAIKKVFQDRKYRNRELSIMQELGQHPCIIRLINSYISVATNQTNGDFLNILMDYYQENGYQIYKSYIRAGIKMPMFHIKLYTFQFLRGLAYMHSFNIANRDLKPQNTLVNRESGRAVLCDLGSAKKLNPAEPNIAYICSRYYRAPELIFGSRYYTTVIDIWSFGCVVAEMIIGKPIYAGSSPLDQIIEIIKILGPPSLKELKEMNPTLKEYAFPTIRTTPMSDVLGTKDPVVLDFFARCFKYSPNERITAYEALAHPFYDDLRARDAPISKDLKLFEFSEYERKAMSPELLSKIRPQ		350		3	Expressed	-1	 	
Batch03	GilaA.00708.a	Giardia lamblia	XP_001706570.1	A8BJE5				Proteasome subunit beta type 2 [Giardia lamblia ATCC 50803]	Potential drug target		MDSVFGFKGKDFVCLVADTVFKHSILVLKECADRTVKIHEGQGMIVTGEDGDVLQFTDYIKHSLKLRSLRQGYTPTVKSSANFIRTELARAIREGPYNVYVITGGVDAAGPQLYYMDYLGTMGEDNFCVQGYSMYFLLSVMSEYWKPDMTKQDALDLIKHCIDALGRRFLLQPTKFTASFIYQSLTEKEFINYVPQSIDPTKQQLPNIM		209		5	Purified	-1	 	
Batch03	GilaA.00722.a	Giardia lamblia	XP_001704008.1	A8BZI8				"Kinase, NEK [Giardia lamblia ATCC 50803]"	Potential drug target		MAKFEEHYVSTGPVLAKTALGHVEVVRSLDPACNDGSQGQDYAVKVVNITSIPNRYRSVVRNDFIKLCSLSHKNLVKYYDVYYNDTKNLGHFVMEYYERCCLMDVILFYRMKERVIPEETVWYILSHLAEALLYYHSPQKDNTDMGPLVHRNIKPSKVFLAADGYCKLADSGTFRLLDNVILSSTIFGTLGFCPPEVLKMERYTEESDLWSLGALVYCVCALKPPAYSANPEELLKKLQGFEVDVNELREREYSEELIGTLQSMLNYDPKQRIDLSKLNAIPQIVDKKGPIKSSTWGLNFSSK		303		4	Soluble	-1	 	
Batch03	GilaA.00737.a	Giardia lamblia	XP_001708050.1	A8BBS1				Hypothetical protein GL50803_112696 [Giardia lamblia ATCC 50803]	Potential drug target		MLSMDDLDQFLQECDCALLLMSEKDASEEGAGNPTESPQTDDEGSVDEDGVTTLMEAARRNDVDAVKRYIPYQARMVAKLVKTGRVDISGGTAMMVAAVLGHTRVVKLLMRCEGGMRSSNGWTALMWAALVGRTEVVKLLLDVEGGMQINGGVTALTAAAGFGRLDCVKLLLEREKDVGGESALCMASTRGHPEVASFLENKGIRLVDPCL		211		5	Purified	-1	 	
Batch03	GilaA.00740.a	Giardia lamblia	XP_001705159.1	A8BS62				GTP-binding nuclear protein RAN/TC4 [Giardia lamblia ATCC 50803]	Potential drug target		MSDPISFKVILVGDGATGKTTFVTRHITGEFRKQYISTIGVEIRQLPFYVAGQSCPNGREVLLNVHDTAGQEKFGGLRDGYYVDSDACLLFFDVTNRVTYKNVESWYRDVFRICPTRRDASTGEEKPLAIVLVGNKCDVKDREIRTQTVKFHRSKNIPYVEISAKDNFNYELPILSILRTLLNDPTIQFSQAPALLPADIGMDAATREQINKDLEAVNNVPLPDDD		226		5	Purified	-1	 	
Batch03	GilaA.00747.a	Giardia lamblia	XP_001704140.1	A8BYV1				"Kinase, CK1 Casein kinase [Giardia lamblia ATCC 50803]"	Potential drug target		MTDLRIAGKYQLHYRIGRGAFGELYRGVNLATGEDVAIKLEPIDAKPPQLLYESKLYKILVGGVGIPYIYHYAPEGEYNVLVMDLLGPSLEDLFTACNRHFSLKTVLMLADQMITRVEFLHLKNFLHRDIKPDNFLIGLGRRKTTVYIIDFGLAKRYMVGNTHIPYREHKSLTGTARYCSINTHLGLEQSRRDDLEALAYVFLYFLRGFLPWQGLKANTKRQKYEKILEKKLSSPIESLTRGQPTEFAAYLHYTRALRFDDRPDYAYLRKIFRELFVREGFSYDYVFDWTLLGIDVDKYHENKLRGKELNPNADGKKKGSDSGAENGDDDADDKDDKDDKGEKKKKDKDKDDDDSEDGAKRSERRSRRGSMRGEDHSTKDEKRKKTDSHRNSKRFGGDFHF		401		4	Soluble	-1	 	
Batch03	GilaA.00752.a	Giardia lamblia	XP_001709155.1	A8B770				FKBP-type peptidyl-prolyl cis-trans isomerase [Giardia lamblia ATCC 50803]	Potential drug target		MSLALYKHILRHGDRRTYPQKGSSVLVHYTAAFKNGKVFDSTRFTNKPISFKVGINQTIRAWDIAIPTMSEGEHAILQVPAEFGYGPRGLFEIVPPNTDLIYDIHLVKVLH		111		4	Soluble	-1	 	
Batch03	GilaA.00765.a	Giardia lamblia	XP_001704478.1	A8BWC7				Flavohemoprotein lateral transfer candidate [Giardia lamblia ATCC 50803]	Potential drug target		MTLSEDTLRAVEATAGLIAAQGIEFTRAFYERMLTKNEELKNIFNLAHQRTLRQPKALLDSLVAYALNIRRINELYELKGKGLPVPPEHWAELQGFFSAAERVANKHTSFGIQPAQYQIVGAHLLATIEDRITKDKDILAEWAKAYQFLADLFIKREEEIYAATEGCKGGWRQTRTFRVEEKTRVNEIICKFRLVPAEEGAGVVEHRPGQYLAIFVRSPEHFQHQQIRQYSIISAPNSAYYEIAVHRDEKGTVSRYLHDYVSTGDLLEVAPPYGDFFLRYLEADEQAPADTQASQEFQMLQSGAINFAAEKTMPIVLISGGIGQTPLLSMLRFLAQKEGKETARPIFWIHAAHNSRVRAFKEEVDAIRETALPSLRVVTFLSEVRATDREGEDYDFAGRINLDRISELTKLEADNANPHYFFVGPTGFMTAVEEQLKTKSVPNSRIHFEMFGPFKASH		458		2	Cloned	-1	 	
Batch03	GilaA.00767.a	Giardia lamblia	XP_001709186.1	A8B7B3				Cytidine deaminase [Giardia lamblia ATCC 50803]	Potential drug target		MPITREQRSALIKAAIEGSEHAYIPYSKYKVGAAILTESGEIFKGCNVENAAYPIGVCAERTAVVKAISEGKKDMVACAVVTRDGGSPCGMCRQTLNEFNPKMHMILAKLDGEVITEMPLDELLPLGFGPANLL		134		2	Cloned	-1	 	
Batch03	GilaA.00780.a	Giardia lamblia	XP_001709658.1	A8B4P7				"U6 snRNA-associated Sm-like protein LSm3, putative [Giardia lamblia ATCC 50803]"	Potential drug target		MSGASLTYLQSEGAGRKTGMDVDHSNEEYMEAPLFHGSAGDRVTPEYTEFSNPLYLLKTSLEDRVSVLLQNNSSITGLLASFDEHMNLILINAEETGHSLNRFFPLLVIRGDSIIFVTRRRFTSIT		126		3	Expressed	-1	 	
Batch03	GilaA.00816.a	Giardia lamblia	XP_001708389.1	A8BAF9				Flavohemoprotein B5+B5R [Giardia lamblia ATCC 50803]	Potential drug target		MKGGTIAQRRDAMMRAHILSKVRQRTDAEINSTFYTPEEIASHASMDDAWMSYRGKVYDITHYVRYHPGGLQCMQEYMGKDMTHAADSVHKWVNVATMLRPLAIGTVKTHVDNSNAFSCLPTIAEVAEEENNKDAS		136		7	Crystallized	-1	 	
Batch03	GilaA.00834.a	Giardia lamblia	XP_001707311.1	A8BFP4				Macrophage migration inhibitory factor [Giardia lamblia ATCC 50803]	Potential drug target		MPCAIVTTNADFTKDQADAFCLDMGQVLAKETGKPVSYCMAGVRKADMSFGTSTDLCCFVDFYCIGVISQAKNPSISAAITGCLTQHFKVKPERVYISFNEAKGHNWGFNGSTF		114		5	Purified	-1	 	
Batch03	GilaA.00840.a	Giardia lamblia	XP_001709141.1	Q8I6M8				FKBP-type peptidyl-prolyl cis-trans isomerase [Giardia lamblia ATCC 50803]	Potential drug target		MSAQLEKKVLTPGDGVTKPQAGKKVTVHYDGRFPDGKQFDSSRSRGKPFQFTLGAGEVIKGWDQGVATMTLGEKALFTIPYQLAYGERGYPPVIPPKATLVFEVELLAV		109		8	HSQC	-1	 	
Batch03	GilaA.00872.a	Giardia lamblia	XP_001706760.1	A8BJ82				26S protease regulatory subunit 8 [Giardia lamblia ATCC 50803]	Potential drug target		MQQDKVGEPIQFTLENYYKARLENTRALVFKKRQELETILFRRSELNNQVKHLKEELATLQEPACDIGEVIRPLPDNKCYIKSSVDDKQIVNVSSKVSMSDLKPGLRVALRSSDSEIVMILPKHVDPAISLMKLDKVPDQSYDDIGGLSKQVLELREILELPIKHPEVFKRLGIPMPKGVLLYGAPGCGKSAVARAVAHHCGCTFIRVSGSELLSKYIGEGSRMVRQVFQMALKNAPAIVFIDECDSIGTKRSEDSHGGESEVNRTMTELLSQVDGFEENNSVKLIMATNRIDTLDDALLRPGRIDRKVEFPLPDVAGRIEILRIHSRKMNLVRQIDFKKISQSMEGASGSDCRAVCMEAGMFALRERRNYVTEDDFTLAATKVMSWKDVGVKISEKKMVK		401		3	Expressed	-1	 	
Batch03	GilaA.00873.a	Giardia lamblia	XP_001708351.1	A8BAB3				26S protease regulatory subunit 7 [Giardia lamblia ATCC 50803]	Potential drug target		MPPSQAKLQEYRNVVREHNKIDADLKAIRAKEKEITQTLEDSNELLLSLHAYGEQLATVIQVIDADNILIRLLSGPRYLVNRRSGINPRYIKSGTRVSVSLSTYSIMHILPPQMDESIYSMSDAGTTGVSPEDAVTYADIGGLHDEIKLIKESIELPLRNPDIFKRVGIKPPKSILLYGAPGTGKSLICKCLANSLGISYIKCVGSQLIRKYIGESARLVRDLFAYAKLKKPCLLMIDEVDAIATKRSDDGTHNDREVDRALLQLLTEIDGFTGLDESIKIVFCTNRPEALDPALMRPGRCDVKIEIRLPDPTGRYEILKIHSKGLSLGEDVDFAGIVKSTDGFNGADLRNVITEAGLGALRAERGEIHQEDLLAAVAVIRSNKSIESETHSYTLKGHNSK		401		2	Cloned	-1	 	
Batch03	GilaA.00890.a	Giardia lamblia	XP_001710108.1	A8B326				Cysteine desulfurase [Giardia lamblia ATCC 50803]	Potential drug target		MIYLDNQATTAIDPRVLAKMVPYMTTNFANVHSTHRLGRSLRKVVEKAREQVAGAIGAAPGEIIFTSGATESNNIALKGVCHFYGDDKPHLAISRIEHKCVLESARKLESEGFKLHWIDVDDEGLVKLDQLQDLLKTYYDPEEEESKVAIVSIMAANNEIGTIQDLGAIGKVCEQYETLFHTDAAQALGKIPLDVVRDKIDLMSLSGHKIYGPKGVGALYIKRTDEKRVHLDPVFSGGGQEGGIRSGTLPVFLVVGMGEAAELAQKEMKKDALHYKSLFEIAREKLLSLPSVRLNGPFPEDAILADKTKGAQKSQKKEPFSKKRILNNMNISFFGVEGESLMLGLDDAICMSSGSACTSQSLEPSHVLFALGLDPEFAHTAVRLGTSRFTTEAEFRRACDLIAKQVAHLRDLSPLWEMTQKGIDTKSIEWKHD		433		3	Expressed	-1	 	
Batch03	GilaA.00894.a	Giardia lamblia	XP_001709732.1	A8B4Z0				GA binding protein beta-1 chain [Giardia lamblia ATCC 50803]	Potential drug target		MTLASRRELDNREQHTVSLFLSYISSSNIAEIQRLLSFPLTALSSYQYEVPPIHICAASKNSTVLDFLLRNGFSVGTPDISCNGGTILHRAAIDGSEEIARIALQHGIDVNATDASGNTALHQAIQHGHGDIVQIILKYNPDMRILNDAGLSAYQVAVSKRSDEIAKLLVPLKYDWHAAKQTREDHIRSNLLFSAEDLTSKLKKVKAKKSSKNAKTKSKK		220		5	Purified	-1	 	
Batch03	GilaA.00901.a	Giardia lamblia	XP_001704199.1	A8BYC4				Peroxiredoxin 1 [Giardia lamblia ATCC 50803]	Potential drug target		MPVPIPGTPCPDFEVDVVTPELKFAKRKLSDYKGKYLIVFFYPLDFTFVCPSEIIHFSNLAEQLKKKCNAEIIIGSTDSVYSHYAWCLQGQNEGGIGTCKCDLFADTNHKMARDFGVLVEDAGIALRGMFIVSDKGVVRHVTINDLPVGRSVEEAMRLVQAFQYADKTGGDIPCGWTPEKNDTIIPDPEKKKEYFSKTFKE		201		4	Soluble	-1	 	
Batch03	GilaA.00901.b	Giardia lamblia	XP_001710116.1	A8B338				Peroxiredoxin 1 [Giardia lamblia ATCC 50803]	Potential drug target		MPVPIPGTPCPDFEVDVVTPELKFAKRKLSDYKGKYLIVFFYPLDFTFVCPSEIIHFSNLAEQLKKKCNAEIIIGSTDSVYSHYAWCLQGQNEGGIGTCKCDLFADTNHKMARDFGVLVEDAGIALRGMFIVSDKGVVRHVTINDLPVGRSVEEAMRLVQAFQYADKTGGVIPCGWTPEKNDTIIPDPEKKKEYFSKTFKK		201		5	Purified	-1	 	
Batch03	GilaA.00919.a	Giardia lamblia	XP_001704561.1	A8BVI1				"UBC2, putative [Giardia lamblia ATCC 50803]"	Potential drug target		MSVTSRLMREYQKFSKTDIPGVMALPDQKDERCWNCIILGPAGTAWENGKLCIRMKFPNEYPIKPPSVHFVTSMYHPNVYTDGSLCLDILQSQWSPCFTILSVLLSIQSLLTDPNPSSPANSDAAHKYNCDIDAYNREVRARMERSQSFIKEEPWCRVYEALQNRKVADNTS		172		5	Purified	-1	 	
Batch03	GilaA.00924.a	Giardia lamblia	XP_001706833.1	A8BIF7				"Kinase, AGC PKA [Giardia lamblia ATCC 50803]"	Potential drug target		MEDIQVEAYPELSYKDLRHIKNIGSGSFGRVTLAQHIDTGKYYAVKAMSKRKIIALRQVAHINNECSILRVVRSPFIIRQYGTYQDDKNVYIILDFIQGGELFYHLRRYNKFPLQVVKFFAVEILLALGYLHNLGIAYRDLKLENVLVDNTGHIKLADLGFAKRLVEKNADGDTVSQLTFSIVGTPEYLAPEIIRSTGHDMSADWWAFGVLIYEMLTGSPPFFDDNPDMTCKKILGGKITFASGFDKAAKDLIIRLLNPDKTRRLGASINNGTADIMKHAFFSGVNWSWFEKKVVKAPIVPKLTDPADTANYEDYLDENGNFEEDEIDYENLGSDAAELGLAEIPGTQEEIDALFVGFK		359		3	Expressed	-1	 	
Batch03	GilaA.00949.a	Giardia lamblia	XP_001707024.1	A8BH09				Translation initiation inhibitor [Giardia lamblia ATCC 50803]	Potential drug target		MPEAVATSTPCLGPYSPAVKTGNLVFVSGQLGIKDGELADGVQAQTRLCLENLKGVLEAAGTTMKNVVKCQVYLKNMDDFAKVNEVYAEFFTESKPARICVEVARLPKDALVEIDAIAEQ		120		4	Soluble	-1	 	
Batch03	GilaA.00953.a	Giardia lamblia	XP_001704049.1	A8BZ76				"Kinase, STE STE20 [Giardia lamblia ATCC 50803]"	Potential drug target		MKRRPMALTLDASTASADGGVEDVQKGGSGTQYIKITDSGSLNTLHESLQISAHGITKTSSPEHILNVQESDLEVVKPLGAGAFGTVNLVKVKTTGQLCAMKEIRISDEEQTQKNIYREIKASISLSCNPYMVKTYNIYSHPGSILHILLEFCKYGSSQDMLKKLKTGKLTENALAVFIIDTLRGLAYLHDNCKIIHRDIKSANILIDEHGYCKLADFGVASSVLPNDDEAAMKTFVGSLSYMSPERIQNQPYSYVSDVWSMGLTYVELLTGSYPYDNVNSFWDAMNVIVNGAPPLLKEDAGYSPGLCDLVNAMLEKDPSKRMTAAQLLKLPFCKKYLAKEEDLRKLFVKWVQDNLK		357		2	Cloned	-1	 	
Batch03	GilaA.00958.a	Giardia lamblia	XP_001709853.1	A8B1W6				Proteasome subunit beta type 7 precursor [Giardia lamblia ATCC 50803]	Potential drug target		MSSSAYLIDMSQFCMKLQFLSKVKGPMLQTIDDLTKVAPLSFENCKRNAQLPQDFLAECSKSFKKTGTTIMGLTFKGGVILAADTRSTGGPVVMNKNKKKLVCINEQMYMAGAGTAADTAAVGRMAASSLRLHAYKTGRKPLVQSAVKLISDHLFRYMGYVSAYVIIAGVDYKGAHLCSIDAHGSITAQPFVTDGSGRLAAQSMLEKHWKPDMEENDAVECACKAVEAGVFNDLGSGSGVDLVILRLDGTSELKHCIRESGSYSGSAPTGVYY		273		2	Cloned	-1	 	
Batch03	GilaA.00959.a	Giardia lamblia	XP_001705820.1	A8BNY0				Calmodulin [Giardia lamblia ATCC 50803]	Potential drug target		MEGDMPINLPQETLEEFKEAFNLFDRNGDGNITTAELGTVMRSLGQNPTEADLADMINSIDTDGNGVISFVEFVRLMVTKSRNTDSEEELREAFRVFDRNGDGYVNAAELRHVLTHIGEKLDEDEVDDLLREADIDGEGQIKYADFVKILCRR		153		7	Crystallized	-1	 	
Batch03	GilaA.00985.a	Giardia lamblia	XP_001709021.1	A8B6N4				Protein disulfide isomerase PDI5 [Giardia lamblia ATCC 50803]	Potential drug target		MHLNTSYGAIQKTPRKLKMIAGLLLVASAFGAVLDVTSSFKAELAKGKPMMVKFFAPWCGHCKALAPTYVELGDNAPEGVVIAEVDCTVAREVCQEEGVRGYPTLRFYKNGEFLEAYSGARDLESLKAFVTSKK		134		2	Cloned	-1	 	
Batch03	GilaA.00988.a	Giardia lamblia	XP_001710217.1	A8B3G9				Arsenical pump-driving ATPase [Giardia lamblia ATCC 50803]	Potential drug target		MLPSLHDILDQHTYKWIFFGGKGGVGKTTTSSSFSVLMAETRPNEKFLLLSTDPAHNISDAFDQKFGKAPTQVSGIPNLYAMEVDASNEMKSAVEAVQKETGSAADNDAESKSEGDMFGGLNDLITCASSFIKDGTFPGMDEMWSFINLIKLIDTNEYSTVIFDTAPTGHTLRFLELPETVNKVLEIFTRLKDNMGGMLSMVMQTMGLSQNDIFGLIDKTYPKIDVVKRISAEFRDPSLCTFVGVCIPEFLSLYETERLVQRLAVLDMDCHAIVINFVLDANAATPCSMCRSRARMQNKYIDQINELYDDFNIVLSPLRHDEVRGIANLRDYAETLIKPYRFCWSANPDPSSAK		354		5	Purified	-1	 	
Batch03	GilaA.00995.a	Giardia lamblia	XP_001708232.1	A8BB85				Carbamate kinase [Giardia lamblia ATCC 50803]	Potential drug target		MSAGKTVVIALGGNAMLQAKEKGDYDTQRKNVEIAASEIYKIHKAGYKVVLTSGNGPQVGAIKLQNQAAAGVSPEMPLHVCGAMSQGFIGYMMSQAMDNVFCANNEPANCVTCVTQTLVDPKDQAFTNPTKPVGRFYTEQEAKDLMAANPGKILREDAGRGWRVVVPSPRPLEIVEYGVIKTLIDNNVLVICTNGGGIPCKRENKVISGVDAVIDKDLATSLLAKTLNSDYLMILTDVLNACINYKKPDERKLEEIKLSEILALEKDGHFAAGSMGPKVRAAIEFTQATGKMSIITSLSTAVDALNGKCGTRIIKD		316		-2	Work stopped	-2	Work stopped	
Batch03	GilaA.01010.a	Giardia lamblia	XP_001704800.1	A8BU24				"Kinase, CMGC MAPK [Giardia lamblia ATCC 50803]"	Potential drug target		MPLAVFNIKGTRFCVPDYYKVTKALGAGAYGVVAEAVDTRTNTTVAIKKISNLFVHLVDSKRTLREITILRMLDHENIVKLLDVLVPEDPSNFDDLYVVFDFMQTDMHKIISSKQDLSPDHMQYFVYQLLRGLKYLHSANCVHRDLKPSNLLLNSDCALEICDLGLARLVDDHAAKTKELKDAEKHDTQMTEYVATRWYRAPEIILGWPQYGKPVDIFSVGCIFAELIARKPLFPGRDYIHQLHLILEVLGTPEKELLDRIASDSAKSYVLALKPSAPQDLSQKFPMLDEAGIDLLTRMLTLDPLKRITVNECLSHPYFEGIHDESDEPVYTGQPLELFFEKYELTKPLLEMCFLNEARKFHPDELKDEVAKRAKALGIPESVWM		385		2	Cloned	-1	 	
Batch03	GilaA.01014.a	Giardia lamblia	XP_001706324.1	A8BLM2				Calmodulin [Giardia lamblia ATCC 50803]	Potential drug target		MAAEAFCAFDKDGSGYLTLQELCEALESIGCDVTMDRAESLLSIIDANNDGKVQLCEFEQLMYILQHADLACDESVLFYATDLDRSGSIGTNELHSILTKIGIDCSQRRVEQLMGRICSGEMNYVEFMRLMTTVRQCLRLHSQPNTPNTTHEYA		154		5	Purified	-1	 	
Batch03	GilaA.01017.a	Giardia lamblia	XP_001708575.1	A8B9V6				Deoxynucleoside kinase [Giardia lamblia ATCC 50803]	Potential drug target		MAARNLDATNQKLDPQVGKKDDDMGFPYPKMFISISGLIGAGKTTLAEELAKEMGFPVYYEPVEDNIYLEDFYKDMKTYGFPMQVYLLNKRYQQHQQIIWSGEGAVQDRSIYEDAVFARILVKQGNMSKRDYKTYTDLYNNMSKYLTHPNFLIHLDVTPEESLERIKERSRNCEAGIPLSYLQDLYDEYNIFLAEISKRIPVIRIRWANYRSAKELAMRVYAEMKKHQAIVDVPFDGTMTAPIPQSSSNFY		251		5	Purified	-1	 	
Batch03	GilaA.01027.a	Giardia lamblia	XP_001709231.1	A8B5I7				"Ribonuclease HI, large sub [Giardia lamblia ATCC 50803]"	Potential drug target		MIVGIDEAGRGPVCGPLVYGIAWMPAEVYQTGILEKLGVTDSKALSANTREHIYNRLQDLPKEDFGCNTAIVSADQISRAMLAPHKTSLNLLSFEAARSLLYQLFISHEIEHVYIDLVGPESQYAAYIRELMPSIALTICAKADAKYPITGAASIVAKVIRDRNIKPQWGSGYPSDPKTKKYLDKTCHGIYGFPTHIRHSWETIKRIYDTASKCVKCVFIADTPLENGADMPTLESLGIATDA		243		2	Cloned	-1	 	
Batch03	GilaA.01034.a	Giardia lamblia	XP_001708654.1	A8B8P7				GTP-binding protein Sar1 [Giardia lamblia ATCC 50803]	Potential drug target		MGFGDWFKSALSFLGLYKKKATIVFVGLDNAGKSTLLAMLKNSATTTVAPTQQPTSQELVMGSIRFKTFDLGGHEVARQLWEQYVTNSDGIVFLVDSADPSRFEESRRTLQELLDNHDLATTPILILSNKVDIQTAVSMETMVQSFGIQHLLTGKGGSKLRSDQRPLEVFPCSVINRFGYTDGFKWLSKYL		191		5	Purified	-1	 	
Batch03	GilaA.01037.a	Giardia lamblia	XP_001708893.1	A8B7W4				Rab11 [Giardia lamblia ATCC 50803]	Potential drug target		MTDAYDHLYKLILIGDSAVGKSNILSRFTSNKFNASSAATIGVEFTTKTLTVEVQGKMISTRLQCWDTAGQERYRSITSSYYRGAHGCLLVFDVTKRTSFEHCTEWLTELRNASANSTACKVILVGNKVDLRHLREVTTEEATAFAQQQGLSYIETSASSGHGIDDAFKQLVTELAVVELANTAVAGAQRQLPVGVAPISQVSLNNAAKTKQKKRC		216		5	Purified	-1	 	
Batch03	GilaA.01041.a	Giardia lamblia	XP_001705771.1	A8BPK1				Rac/Rho-like protein [Giardia lamblia ATCC 50803]	Potential drug target		MTSTGNEDTAGARMIHIKAVVVGDGSVGKTCLLFVYANNSFPEDYLPTVFDNYSANVVVDNLTINIGLWDTAGQEDYDKLRPLSYPGAHVFLLCFSVVSSTSFANIRSKWYTEVKEYCPNVPMILVGTKYDLLSDEAYLAKMKEKNQSPVSDERAEEVAKEIKAIKYISCSARCQLRVKDVFDSAIRAALKNMGMMGSGTSKAGKKKDGSGKGKCVIF		218		3	Expressed	-1	 	
Batch03	GilaA.01054.a	Giardia lamblia	XP_001709286.1	A8B5R4				Proteasome subunit beta type 1 [Giardia lamblia ATCC 50803]	Potential drug target		MVLKAPLSRKIFWNGGFVVGWFIAHPVQGPKIKKMPEVSNAPLKDPDFDPYIDNGGTIIAIAGPDFAMIAGDTRLSEGYNILSRNVRKVFPVTDKIVYAASGMHADVQRLLKHMKIESTEYYLKTQKEIAIEQFIRLLSAMMYYRRSFPWYTSSIVAGIDSEGRGAVYSYDVIGSTLRTRYGSAGTGNAMICPILDEAILSKNEAEITREFAFELIQSAFRSCAERDIYTGDSVVAMCISADGIQERTFELRKD		254		3	Expressed	-1	 	
Batch03	GilaA.01082.a	Giardia lamblia	XP_001704143.1	A8BYV7				"Kinase, NEK [Giardia lamblia ATCC 50803]"	Potential drug target		MILSAMKQVAAALAYLHGVNGANNRGLVHCDLRPANIFISADGERFIIAGLGLCKDALWSESTLMGVAVYMAPEVLLRNESSPASDVWSLGVILYELTTLRRLDFLGGKEPAEVFVTGGGRT		122		3	Expressed	-1	 	
Batch03	GilaA.01085.a	Giardia lamblia	XP_001707613.1	A8BE86				Ribosomal protein SA [Giardia lamblia ATCC 50803]	Potential drug target		MSTEKTSQASKEYQLKEADVKKMLVATTHLGVRNIDRRMQFYIFDRQKDGTFVFNLQKVWAKIVFAARILVTIDDPAEIAVVANRPDAQRAILKFCKYTHATAFPGRFIPGNFTNRMNPNYCEPRLLLVNDPVVDRQAILEASYVNIPTISLCNSDANLKFIDVAIPCNNKTPMSIGLIYWLLAREVLRLKGSISRTEEWDVKPDLFVALPEEIPDEEESEDFYDDDEEEDEEFSAGNGNLFDEY		245		-2	Work stopped	-2	Work stopped	
Batch03	GilaA.01093.a	Giardia lamblia	XP_001709116.1	A8B719				Serine-pyruvate aminotransferase [Giardia lamblia ATCC 50803]	Potential drug target		MFKTPLLYLPGPTAVPDSILRARMGPLMDDQALYKEISGAVQRILKTKSSVHILAGEGMLALDSVSCSLIEQGDSVLIISNGVFGDWFLDLVGKYTSSYTIFQCGPTSGVSASALGEFLIAQEQKGVSFKLATLVHCDTPSGVLNDIASLVPVLSRHSILSVVDVVASSFGISIDLDLCGVDVALMGSQKALSCPSGLSMLAISERAWRAMETRRTPIPSYYCNLLLFKNAPATFPYTVSSYDLLGLREALRLLEEEGLDNVYRRHMRIAEAVRYAVQKSGLTLYLVSDYSPTITAFHVPQGTTSDAILQTMLNDYGIRFSSSLGSLDKKVMRIGHMGFNSNVPVVLYVLKCLTRTLRSHGVCLRDDMGESFFERYHSMVEVE		383		3	Expressed	-1	 	
Batch03	GilaA.01102.a	Giardia lamblia	XP_001707172.1	A8BGE2				Endonuclease/Exonuclease/phosphatase [Giardia lamblia ATCC 50803]	Potential drug target		MPPAPVKMKKTSAAKERPPPPPYSTFQIGSDEKTEPVPFTILAINVNGIRSAFSKGLKDFIHKKNPDIVCFSETKLGSSAFAAFMEKEATRDPDTGVYTVMKGYKHVFCCSTAKQGYASTAMFAKESVPVLDLCMQMGDPEFDSEGRFLHVSLPSFELIHVYAPNSGRGSSGKAFTSKNRPANLSTRIKYEKLISKYIGNLVAAGKDVVYCGDLNVAHNEIDLYNPKSNHFSPGFTDEERNAFSKLLDGHGLIDAFRAMHPHRINYSWFSNFGRAREQKHGWRIDYFVVTSKIFKRVTTVDILDDYNSYSDHVPIIMTLTGI		322		5	Purified	-1	 	
Batch03	GilaA.01134.a	Giardia lamblia	XP_001705767.1	A8BPJ6				RabF [Giardia lamblia ATCC 50803]	Potential drug target		MARFAELDESSDEQAPTVRTFKVTVLGDGSVGKSSICSRFAKDFFATSYKQTIGVDFFSQTVCLDDGNKVTFNLYDIGGQSIGSKMLSAYISGTNALIFVYDLTNAESLENVVEWYAMARRSVKSMKDVVVYLVGNKSDLATLRVVRSFRSNEISAAINASAHLLLSALTGDRVGLLFISLAGRLCGVDVTSMILDGKMGHTVEVSKDTEETVSCINKDRFLGNADTVDGASAVARAKDLESRMAKKIQELEGQATGIPHQTLVGVERAKRSGRCAVM		278		4	Soluble	-1	 	
Batch03	GilaA.01141.a	Giardia lamblia	XP_001709091.1	A8B6Y7				Ribokinase [Giardia lamblia ATCC 50803]	Potential drug target		MAAASTAKIVIIGSYNRDLVWYVKDFPIGGQTINGSFASSHGGKGSNQAIACGKVLRDPSRAFFVGAVGKDTFGDEILAHYRELGIPNCIKQVSGAPTGNAGIYVAESGENMIVISEGANGMLKPSLVPDLMAVLVKATLVVMQCEISPDNTLLFVEVIKQAKAQNSSLRFVFNPAPYRADYDFSKILSITDIFCPNELEALEISGTGRLEGICDDSMMKALVEKMSSLSPSLKFVLFTLGSRGSRIVQTKSYESRTVGIYSHGRAIDTSGAGDCFIGSFCVRLMELAEESTRGPSALNDIDTIAEAARFASVAAGISVTRKGTSASVPRRQEVDDALSKFSGK		344		10	Diffraction	-1	 	
Batch03	GilaA.01158.a	Giardia lamblia	XP_001708858.1	A8B7Q4				"Kinase, CMGC GSK [Giardia lamblia ATCC 50803]"	Potential drug target		MSDDETAFPPEFELQLGKALDIPGEKGEEGIQVVPEKVIGKGSFGVVYLVKSLKGNTPLALKLVLQDRRYKNREFQIMRTLVHPCICRLVKGTFIPSISSPDDLILYLLMDYYPETIHSIYRQYSRLRQHVPLLIVRLITYQLARSLAYLHYHNIAHRDCKPTNVLIDPLTYRCVLCDFGSAKQLVPQENNVAYICSRFYRAPELVIGNQNYTCAIDIWSFGCIMAEILLGQPLFPGDSSIDQLVEIVRVLGSPTAEEFLAMNPTLKSVKFKDVKRYPFSKIFRSKAHTDAVDLLTKVLVYDPKKRPTAMEILAHPFYDILRDPDTLLPNGERLPAFLFEFTEEERKAAGPELMAVLTKNREQFNILSSH		370		3	Expressed	-1	 	
Batch03	GilaA.01163.a	Giardia lamblia	XP_001709991.1	A8B2K2				Ribose 5-phosphate isomerase [Giardia lamblia ATCC 50803]	Potential drug target		MKVAFASDHGGRDLRMFLQQRASAHGYEVMDLGTESDASVDYPDFAKIGCEAVTSGRADCCILVCGTGIGISIAANKMKGIRCALCSTEYDAEMARKHNNANALALGGRTTGPEVAASILSRFLSTNFEGGRHAARIAKISAMEE		145		11	Native diffraction-data	1	Target selected for ligand screening 	
Batch03	GilaA.01186.a	Giardia lamblia	XP_001705526.1	A8BQH7				ARL2 [Giardia lamblia ATCC 50803]	Potential drug target		MGFLSVLRAIKASENEARVLVVGLDCSGKTTIVSSLLGKPLTEIAPTLGFKISTWRPQNTSMAVALWDVGGQQTIRTYWRNYFSSTDALIWVVDSTDRRRMDTCRKALSEVLHAERLQGCPVMILCNKQDIPSALSVEEISAAITLDALCSNRKWAVLPCSAMSRQGLDEAFSWLLSELLIDSGNAREDDNLETAIW		197		3	Expressed	-1	 	
Batch03	GilaA.01193.a	Giardia lamblia	XP_001706081.1	A8BME4				"Kinase, NEK [Giardia lamblia ATCC 50803]"	Potential drug target		MYNANPKPSQQGGARESRDSRDVRQQYIFLNIIGSGSFGKVHKVQSRTNGRIFACKEIDYAKMSEKEKKLLVHEVNTLKELSHENIVSYIDRFVERENAKMFIVMEYCENGDLAKYIKRHKTDRRYIAEEKIWSVFVQLLHALNYCHSIHSEDESGVHKVIHRDIKPGNVFLTQDGSIKLGDFGLCRTLGEDSVAQTNVGTPLYMAIEVLQKQSYTEKADIWSLGCVIYELCALQPPFVASNIESLKTKVKQGARPAIPSHYSSDLSAAIDLMLNPNPSARPSATDILQHSRIIEMNERIKAMPAYAAQAPPEIPKSAPPGGGHAQRERELREWEERLNTKEQSLRAREEHVDRTLAALNAGTYKGY		367		5	Purified	-1	 	
Batch03	GilaA.01209.a	Giardia lamblia	XP_001706287.1	A8BLF9				"Kinase, CAMK CAMKL [Giardia lamblia ATCC 50803]"	Potential drug target		MSDEQPVQLGQYEVSELLGSGAFAKVRLATRKDTGKKYAVKIIKKVGLSQRAADRLNLEIAVTKGISHPNVIKMHEVIGTSSKFWLVMDYHANGELLKHMKTKLSDDQAFDYFIQIACALRYCHRFGICHRDLKFENVLVANDGHLVITDFGLGAISYNPDKTFYSQATFCGSTHYIAPEVSSGSRYDGRKSDIWSLGIMLYAMLIGKLPFPSDNYEVLVESMLNRRYDPIPSFVNDQAKNLLEALLEPDPRTRPDWREIFNYPWIASRVALVDEAGHTVDKFPSEITDTGVLCRVMRKKKVHMEIPLHPNKKSYSVLSNIHAALMQTNSAPSTAQPVSDEGFTCPSCGNIVVPPKTADIASYSVKKAIMISDISISDALILAAYGVRKVTKKPVVVYPHEFRASSDVQLMEARVFGTQKLVILIGTNDAEMYTTVSTVLTNLAADKAKLSAITLGRINDVSVVCEDAR		469		5	Purified	-1	 	
Batch03	GilaA.01226.a	Giardia lamblia	XP_001705487.1	A8BQU2				Caltractin [Giardia lamblia ATCC 50803]	Potential drug target		MNRAAIGAGKPSGSISTGKPRRKTRAEVSEEMKHEIREAFDLFDADRSGRIDFHELKVAMRALGFDVKKEEIQRIMNEYDRDQLGEITFQDFEEVMIEKISNRDPTEEILKAFRLFDDDATGRISLKNLRRVAKELSENISDEELLAMIQEFDRDGDGEIDEEDFIAILRSTSAFS		176		1	Selected	-1	 	
Batch03	GilaA.01259.a	Giardia lamblia	XP_001707575.1	A8BE28				Ribosomal protein L10a [Giardia lamblia ATCC 50803]	Potential drug target		MGFAMQRINPEALNKHIAEIIERATNEKPRKFLETVELQVGLKGYDPKKDPRFNLPLVLPHIAKQNLKLCVIADARDADRAKKLGLNYVEIEHLQQFNKDAKQIKKFAKSYDVFLASKSLIRQITVYAGPGFTKAGRTPLPLAPDEDLELKVLECKSTIKVQFKKAVGLNWPIGNVKMPASEIAQNIMTTLNFLATQLKKGWQNIKTVYIKSTMGPSHRIF		221		-2	Work stopped	-2	Work stopped	
Batch03	GilaA.01262.a	Giardia lamblia	XP_001709135.1	A8B742				Rab2b [Giardia lamblia ATCC 50803]	Potential drug target		MSSGGHHYIFKYIIVGDSAVGKSCLLLRFVEQKFIPLHDVTVGVEFCNKTLQVPSKDGSEKTVKVQIWDTAGQEQFRSITRSYYRGAAGALLVYDVTNRSSFEALEGWLKDMLAGVGMEASPNGVSGMVIMLVGNKTDLEHKRKVSKEEGEQFARDHGLLFIETSAKDDLNVSESFNETARTILEKVETGEIDCVSKDSGVKAGALNMSAAATTASSTDSTFGNCSC		227		5	Purified	-1	 	
Batch03	GilaA.01264.a	Giardia lamblia	XP_001706502.1	A8BKC6				Ribosomal protein S16 [Giardia lamblia ATCC 50803]	Potential drug target		MAKGNRRDLLERNDIEVRERDKYTVHTLGKKKNSVAVAFVKAGKGDILVNNVPLALVRPEILRTKVSEPIMILGESLFKGLDMNIKVAGGGHVSQIYAVRQAISRGVLASVKDEAARSELRAKLVSYDRQLVVSDPRRCEAKKFGGRGARARRQKSYR		158		-2	Work stopped	-2	Work stopped	
Batch03	GilaA.01265.a	Giardia lamblia	XP_001709140.1	A8B748				Phosphatase [Giardia lamblia ATCC 50803]	Potential drug target		MPDFASYLERCLNREILPEADVLALLWRAMELLSEEPTVIPISSAPSLNVCGDVHGQFYDVRYMFEFGGKIVDGARYLFLGDYVDRGYYSLETITLLLCLKVNYPARIYLLRGNHECRAVTQTYGFYDEAYRKYGHAGVWKMYMELFDQLPLVAIIDERIFCVHGGISPSLPTIDDIRILNRSSEIPSEGPFADLQWSDPSTALETWEHSYRGAGYLFGPRAVDQFLRINDLKMIARAHQLAIAGYQKYFNGTVVTIWSAPNYSYRTKNSASIMVVKSAEEEFKIFEAVPADQRELPPDSYMSSLTGGWD		310		3	Expressed	-1	 	
Batch03	GilaA.01269.a	Giardia lamblia	XP_001708623.1	A8B8J3				"Kinase, CMGC CDK [Giardia lamblia ATCC 50803]"	Potential drug target		MATHPLPKDYEFISQIGEGTYGTVSKCSLHGQLLAVKRIKMDSSSKGVPATTLREVAILKALNAKQRELVEQGKLESLSQANVVNLLDVVYDLSNIFLVFEYCHVDLDQYLKHNVLSPYQIKKFMYQLLQGLSLVHKNEILHRDIKPNNILLAFRGDAGEQLAANASVTTPNPDADNCVLKITDFGLARSYGINVTSISANVVSLWYRAPELVLASKTYSTAVDMWSMGCIMYFLANKRALFQVRKDADLLQLAFSYFYVDSSSISDLISLPNWNMYVGENQVIDLAALNAPGRKPREVDINIDDVGKDLFYKLLMLNPSKRISCDEALQHPWFDDLKKG		340		5	Purified	-1	 	
Batch03	GilaA.01304.a	Giardia lamblia	XP_001704132.1	A8BYT6				Adenylate kinase [Giardia lamblia ATCC 50803]	Potential drug target		MTTPDDGSTARENTSSGVSCSLTDYIQKHNVYTTLQLAMQSLIKYQPKSPLKYLSSYFGDRKKNLFKLVLLGAPGAGKGTQAKHLVSKYSLKHISPGNLLREEMNRNSPITAQIKDYVSKGQLVPDSIVIKLIENHIATIGDSNWLLDGFPRSESQAAALRASPDLFPTHIVELKVDQEAVVQRLGGRRFDPITGNTYHIIYDPPPPDIADRVVVRTDDREDVIRERFRVYAENKDLVDKVFNHSVVSINCEGQTIDEVSLQLDRVLSMPSTIHPSIIMPERNKK		285		3	Expressed	-1	 	
Batch03	GilaA.01315.a	Giardia lamblia	XP_001707297.1	A8BFM3				Rab2a [Giardia lamblia ATCC 50803]	Potential drug target		MADSSYNYLFKYIVVGDTAVGKSCLLLQFTEQRFQNAHDMTVGVEYGTRTIEVGGKKIKAQIWDTCGQESFRSITRSYYRGSCCALLVYDITRRASFEHVANWLEECRTYGGDKTTILLVGNKTDRESSRMVTYDEGEKFAKENNLFFIETSAKTNSNVEEAFMIIAKAVLDKVNSGEIDITDESCGVKAASTSKNTVNMKTEAPSKESGGCGC		214		7	Crystallized	-1	 	
Batch03	GilaA.01359.a	Giardia lamblia	XP_001707838.1	A8BC67				Peptidyl-prolyl cis-trans isomerase B precursor [Giardia lamblia ATCC 50803]	Potential drug target		MNSPVSDKVFFDITIGGKPLGRITMGLFGSIVPKTAENFKKLCTGEMGFGYKGSTFHRVIPKFMIQGGDFTNHNGTGGKSIYGAKFPDENFEIKHFVGCLSMANAGPNTNGSQFFLTVADTAWLDGKHVVFGRVLDGMDVVKAIETTKTGANDKPVEKVVIADCGVLQ		168		7	Crystallized	-1	 	
Batch03	GilaA.01391.a	Giardia lamblia	XP_001705161.1	A8BS66				"Kinase, CMGC MAPK [Giardia lamblia ATCC 50803]"	Potential drug target		MSDDESIDRHVLRKYEIIHRVGKGAYGVVWKAVNRKTNETVALKKIFQAFQNDTDAQRTFREIMFLQELDHDNIIRLFNVLKAENDKDIYLVFEFLDSDLHQVIKSNILEDIHKRYIIYQCVKALKYLHSAEILHRDLKPSNLLLNSECHMKMADFGLARSIAALSEPSSATNPILTDYVATRWYRSPEILLGCTRYTKGVDMWAIGCILGEMLGGSPMFPGSSTMNQLDKIMEVTGRPTPEDIEATESPFASMMLDSLQPKTGKALSEIYPNAPADALDLLKKLLQFNPNKRLTAEQALEHPYLSKFHDPATEPSAPGPIKISIDDDDKRSVSEYRDLLYSEILRKKKEIRSKSLKEDE		360		2	Cloned	-1	 	
Batch03	GilaA.01396.a	Giardia lamblia	XP_001706143.1	A8BMP7				Hypothetical protein GL50803_7871 [Giardia lamblia ATCC 50803]	Potential drug target		MQGSMPSSSEDVTTLCYRVTGKVQGVFFRKYTKKEADALSLVGYVTNNEDGSVSGVVQGPKEQVDAFVKYLHKGSPKSVVKKVSIHASSRVDADGFEIRR		100		7	Crystallized	-1	 	
Batch03	GilaA.01399.a	Giardia lamblia	XP_001709047.1	A8B6S9				Protein disulfide isomerase PDI3 [Giardia lamblia ATCC 50803]	Potential drug target		MIAGLLLVASAFGAVLDVTSSFKAELAKGKPMMVKFFAPWCGHCKALAPKYVDLSDDAPEGVVIAEVDCTKANELCGSEGIEGYPTVKFYKDSKFVEEYSGPREVVAMKEWIKQRL		116		3	Expressed	-1	 	
Batch03	GilaA.01401.a	Giardia lamblia	XP_001706678.1	A8BIU0				Uracil phosphoribosyltransferase [Giardia lamblia ATCC 50803]	Potential drug target		MGLTIFDHPLIQHKVGLLRSVTTGPKEFRELLREIGLLMMYEATRSLELEDYEIATPLCTTVGKRLRGKKAAVVPILRAGLGMVDGLLEILPAAKVGHMGLYRDHDTLQPVTYFCKMPVDMAERSIYIVDPMLATAGSVIATIDTLVKKYNCPLSSIKVMVIIAAPEGIDNLRKAYPDIEVFCAQKDSHLNEKGYIVPGLGDAGDRIFGTL		211		5	Purified	-1	 	
Batch03	GilaA.01418.a	Giardia lamblia	XP_001706629.1	A8BJP8				Peptidyl-prolyl cis-trans isomerase B precursor [Giardia lamblia ATCC 50803]	Potential drug target		MLLFFVCLLVVLAKKSPEITDHVIFEVRQGSATLGNITLGLFGKVAPKTVTNFVEISKGSHGYSYEGSKFHRVIANFMIQGGDFERGDGRGGYSIYGSEFDDENFQLEHRIGSLSMANRGRNTNGSQFFICTVVTPWLNGKHVVFGHVVDGMTVVKTIENVKKDPQDRPLEDVVISAVYVTKPDPYTLDSW		191		3	Expressed	-1	 	
Batch03	GilaA.01421.a	Giardia lamblia	XP_001705310.1	A8BRN4				Ribosome subunit biogenesis protein NIP7 [Giardia lamblia ATCC 50803]	Potential drug target		MRCRHPLTTIYAWCIYLSKSLHITGDAWKAQTYGFVASSRSSKSRLTIELKMRELKPEEVETVFGKLAKYIGKNVEKLIDRNDGKYVFRVLKDRVYYMSQQLEKMASNIPRKQLIGSGLLIGKFTHHKKFHIKITALPLLAVFAPYRIRITPASELSFLYKNDVMKSHITHMSEGIPDNAGVVIVSADDQPVGFGVTTKSGNEALNSDPASKIVIHQADVGEFLRDQDTMF		231		3	Expressed	-1	 	
Batch03	GilaA.01434.a	Giardia lamblia	XP_001704822.1	A8BU63				CDC8 [Giardia lamblia ATCC 50803]	Potential drug target		MSTHRSTNCQPSNLQGSEYPEGRRKGDNVTRGLFVVIEGLDRAGKDTMIGQVVALLRQAGESVVVQAFPDRTTKSGAVLDRFLQRELDLSDWDCHRLYAENRKELEEVLCNTLLAGTTVICSRYAYSGVAYTAAKGHDMRRCMEADKGLLRPDLVIFLDVDASAVAVRTGFGKERYETQDFQVKVYTAFQTLWELLRNSQNGSQDEEDRTTLLTIRPEDISEAPKQILQAILERKKRVRHTLCRDLFHLELNLC		254		5	Purified	-1	 	
Batch03	GilaA.01452.a	Giardia lamblia	XP_001707007.1	A8BGX6				Aldose reductase [Giardia lamblia ATCC 50803]	Potential drug target		MQYPPRLGFGTWQAPPEAVQTAVETALMTGYRHIDCAYVYQNEEAIGRAFGKIFKDASSGIKREDVWITSKLWNYNHRPELVREQCKKTMSDLQVDYLDLFLVHWPLAFVRNDVGDLFPKDAEGRAMLEKVPLADTWRAMEQLVEEGLVKHIGVSNYTVPLLADLLNYAKIKPLVNQIEIHPWHPNDATVKFCLDNGIGVTAYSPMGGSYADPRDPSGTQKNVILECKTLKAIADAKGTSPHCVALAWHVKKWNTSMYSVIPKSQTPARIEANFKCTEVQLSDDDMDAINNIHLNKRIRFCDPAIFWKVPLFD		313		17	In PDB	-1	 	
Batch03	GilaA.01458.a	Giardia lamblia	XP_001707577.1	A8BE32				Centrin [Giardia lamblia ATCC 50803]	Potential drug target		MARKPNARSTEPDLTEEQKHEIREAFDLFDSDGSGRIDVKELKVAMRALGFEPKREELKRMIAEVDTSGSGMIDLNDFFRIMTAKMAERDSREEILKAFRLFDEDDTGKISFKNLKKVAKELGENLTDEEIQEMIDEADRDGDGEINEEEFLRIMRRTSLY		161		5	Purified	-1	 	
Batch03	GilaA.01471.a	Giardia lamblia	XP_001709849.1	A8B1V5				"Aspartate aminotransferase, cytoplasmic [Giardia lamblia ATCC 50803]"	Potential drug target		MSVFSGFPASPPDAILNLTVLYNADTNPKKVNLGVGAYRDESGKPWILPAVKEAEAIISSDLSKYNKEYPPVAGFPLFLEAAQFLMFGKDSKAAQEGRIASCQSLSGTGSLHIGFEFLHLWMPKAEFYMPSTTWPNHYGIYDKVFNKLKVPYKEYTYLRKDGELEIDFSNTKKDIQSAPEKSIFLFHACAHNPSGIDFTEAQWKELLPIMKEKKHIAFFDSAYQGFATGSFEADAFAVRMFVDAGVEVLVAQSFSKNFGLYGERIGCLHVVHAGVEGSVEKNKALSAAMVSGMTLQIRKTWSMSAIHGAYIVQVIVHDKRLLQMFYDNVKEMSARIHRMRSLLHASLAKRKTPGPGSKGTWDHILTAIGMFTFTGLTPEHVDYLKEKWSIYLVKAGGRMSMCGLTESNCDYVAEAIHDAVTKLPFKK		427		17	In PDB	-1	 	
Batch03	GilaA.01481.a	Giardia lamblia	XP_001706877.1	A8BIP3				RabD [Giardia lamblia ATCC 50803]	Potential drug target		MSTLGERYKLVVLGNARVGKTSLIVRLTTNVFKDACTPTYGVDWFYKDIEVPDGNAKVSLHIWDTGGTEHYSGMQPLYLRGAVVVLLCYDMTNRLSFENLLYWKDLAANVKSAEFYYLVATKSDQAEHRAVKQQDAERLSVLLGCRAYFEVSAADGTNIDNLLGKLAQDLKGRMELSKTSPQVGPPTVDVQALTNESRTKGCYC		204		3	Expressed	-1	 	
Batch03	GilaA.01492.a	Giardia lamblia	XP_001704106.1	A8BYZ8				RabA [Giardia lamblia ATCC 50803]	Potential drug target		MRYKVSVVGSAGCGKTTLVHSLAYNRPPRDTTETVDIHSMRLRVGSETVSIRLWDTMKGEYMGGVSSLAHKSACICLVVFDFVSRPSFVAASQYVQKVLGLEPDLSIIFVATKCDLAELNHKIAVTHEEARAFAALYDSPIFFICGLTGIGTNQVIAEMSTIIARKMASSMPKSVLSLEDLEIAPPSSRCYC		192		3	Expressed	-1	 	
Batch03	GilaA.01493.a	Giardia lamblia	XP_001707349.1	A8BFV8				"Hypothetical protein, enzyme with a TIM-barrel fold [Giardia lamblia ATCC 50803]"	Potential drug target		MSTVAGALRDIRAGLGHAKLIAVSKTKPVEAILEAYAAGQRLFGENYVQELVKKAEAVQGVASDIEWHFIGHLQTNKARDVAFIPNCVVQTVDSDRLARRLSELRPDELGPLRVMIQINISGELTKSGCTVEDAIELAQLISALPRLRLIGLMTIGAPDASEYSFRALVDARNVIEQAVKLEEKLELSMGMSSDYQLAVKMGADYVRVGSAIFGERTYSQQKGQLQNSDE		230		5	Purified	-1	 	
Batch03	GilaA.01496.a	Giardia lamblia	XP_001710089.1	A8B2Z9				Hypothetical protein GL50803_113788 [Giardia lamblia ATCC 50803]	Potential drug target		MSQFVQNAKYPPEFPGLLMDLCREVLREQPSNIYEFAVKHFTQLRDAMAAEKARGS		56		7	Crystallized	-1	 	
Batch03	GilaA.01513.a	Giardia lamblia	XP_001706269.1	A8BLC7				"26S proteasome ATPase subunit S4, putative [Giardia lamblia ATCC 50803]"	Potential drug target		MGNAFSDSWGGMSSQASQQPGNQRGPPQGALRNRPRKTGAIHRMPAQNQVLFRIPTNMAPILPCYLKLLKQQRINALLAVENDFISNFSQSTFYKQVNKEQEQTIAKLRGTTQTIAVVQEIIDEEFLVVKKTEYSSIYTKALSFVDRELLQPNALVHLMEDAHRDIVVGVLSHDEDPNVTMMKVIERPKDTYADIGGQDEAIKELQETIQLPLTNPEYFVDLGIEPPRSCILHGPSGTGKSLLARACANETSACYMKMAGSELIQKYSGEGPRLVRELFKAAKANQPTIIFIDEVDAVGRKRYDADSGGAREIQRTMLELLNQLDGFDRTEGVKVIMATNLIESLDSALIRAGRIDRKIYVGLPDLTARRQIFKIHTRRMMLDKDIVEDEILNCKDDLSGADIKAITLEAGLLALRDRRIRVCMSDFRKARDKVLYKKIQEVGDLYT		447		3	Expressed	-1	 	
Batch03	GilaA.01560.a	Giardia lamblia	XP_001704093.1	A8BYX6				Low molecular weight protein-tyrosine-phosphatase [Giardia lamblia ATCC 50803]	Potential drug target		MKILFVCLGNICRSPMAHGVMQHLVRKAGLSSQVQVDSCGMFGHPEDTSTEYGTQKAIADNLGISFSKKSRHWRKSDYDDFDLILAMDKSNFQDIMREVGRRDQSKVRMFRDYDPEGRGDVPDPYYCGRFELVYSMVERTCRSILNHIESGKPL		154		5	Purified	-1	 	
Batch03	GilaA.01580.a	Giardia lamblia	XP_001709425.1	A8B6A9				DNA repair protein RAD51 [Giardia lamblia ATCC 50803]	Potential drug target		MQSDSQGLYAGAAFSLMRRIRGLRMYVSSVYITNKLVRAMSRSVKKAQEQYVLSTSVSCTQSDTETPVVAGDEAKETWAPIEELHALGIAAADTKRLRESGIFSIQGVLMQTHKDLGQIKGLSEAKVDKILDAARKHSQPGFMSGVVALERRQRIRRISTGCSDLDALLGGGIESMAITEVFGEFRSGKTQLCHTIAVTAQLDGSRVAYLDTEGTFRPEKIGPIAERYKLDPTTTLSRIAYARAYTHEQQIELLAAAAEQMSEKKFALLIIDSLTALFRVDFTGRGELADRQQKLGQHLASLAKLADEFNIAIFVTNQVMAQVDGAAMFTADPKKPIGGHILAHASTTRLYLRKGRGNNRVAKIYDSPSLPEAEATFAVGEQGVCDAEE		389		3	Expressed	-1	 	
Batch03	GilaA.01581.a	Giardia lamblia	XP_001704611.1	A8BVC6				"Riboflavin kinase, FMN adenylyltransferase [Giardia lamblia ATCC 50803]"	Potential drug target		MIFCTKGTVVRGFQRGRVINFKTANLVLSNQDQLEDGVFSGWARVELSGDVLPAVISYGKNPTFANKSKTLEVHILATFPEDFYGATLYTTIQRRLRSPIKFSGIEELNAQIKMDIENAQVDYTEENRKKAELLFEGL		138		5	Purified	-1	 	
Batch03	GilaA.01593.a	Giardia lamblia	XP_001706920.1	A8BHT3				"Kinase, CMGC CK2 [Giardia lamblia ATCC 50803]"	Potential drug target		MPKDKHRSTLSQSEKAFLKIEKNCPMNSQVANIPVDPREHKTALANFPPSFSFYDSIPCLYGSQERYEIGRKLGHGKYSDVFEGYCVDTDSSVVIKILKPVRRKKIYREIKILTNLLAGPNCINLLDVVSVRDSDYPALILEHGGLSLAHSVQMLNDEQIRIVLFQTLRALEWFHIHGIVHRDTKPGNIAYDPTSHRLKLLDYGLAEFYSYGTPLHHRVASRHYKSPEILVNYQLYDYSLDIWSLGTLAAGLIFKRHPFFRGTNNINQLDKIVEVLGSADFFAMINKYNIKLSSSRTYDLQGYERMQFDAFTNHDNHYLVTDQALDFLNKTLVYDPEKRLTVREALLHPYFDCIREKITDMAIEEVNDAKKIMELEEIEQQLKPAKAEKVEDPAGSGSCSQRPPQMHSILGLSPSALPTWKTDLKTQHFPVPMLPSELSKNPSKYSQFDKMWEEYWKTQQMKLVESGMQVYGSQITS		477		1	Selected	-1	 	
Batch03	GilaA.01604.a	Giardia lamblia	XP_001708191.1	A8BB19				"Kinase, NEK [Giardia lamblia ATCC 50803]"	Potential drug target		MILSVMKQIAAALAYLHSVNGANTRGLVHCDLRPASILINADGERFIIADFGLCKDALWSGNILIGIMAYVAPEVLLHNEPSPASDVWSLGVILYELTTLRRLDFLKGKEPAEVFVDGWRPDLSGVTDGFMQNVLERIFVLEPERRPTARELHETLTTFDIPVGELGVSA		170		4	Soluble	-1	 	
Batch03	GilaA.01618.a	Giardia lamblia	XP_001709229.1	A8B5I4				"Kinase, NEK [Giardia lamblia ATCC 50803]"	Potential drug target		MLKLPEYRHGKEVVLSASEFSVTYRAIRLKDLADVAVKVTDTVKLAESGRSDYRHESRVLQNAVHPHILRAVYGYYDEETKKFLLETEYCRGGSLWGLMAWMRKSDMRFSEQEVWELFAQLVSALHYLHKTNEHIGITAHLNLRPDNVLLTQDGILKLCGFGYSATREPNKLFTLRNPGTAYHAPEVVAFTNSQGSSEGYTEAADIWSLGCMIYELCTFRRIENEPVSSFNPLPENLETPGYADDLLILIKACLAPNPRERITAELLMASPPIQAAYARINDILKAGRKWSGLIIEMQRELR		302		7	Crystallized	-1	 	
Batch03	GilaA.01622.a	Giardia lamblia	XP_001708054.1	A8BBS6				ARL1 [Giardia lamblia ATCC 50803]	Potential drug target		MGLFDLIRRHRKGKKEIRVLILGLDNSGKTTILRKLCEEDTSVIMPTQGFNAKTIKGPKGVSLNCWDVGGQKAIRTYWQNYYAGTTCLIWVVDAADVKRMDEVALEVSLALEDCRLAGVPILVFANKQDLATALKPSDLCDKIGLWALRDRVWHIQGCSALTGEGLEEGILWMVSKTDK		179		5	Purified	-1	 	
Batch03	GilaA.01645.a	Giardia lamblia	XP_001707725.1	A8BD58				Serine/Threonine protein phosphatase [Giardia lamblia ATCC 50803]	Potential drug target		MPGIDVDVLLHNIYRHQRLPTHIEIIQLTDLVRDIFFTEANLLSLALPIVVIGDIHGQLFDLFEIFKIAGEVPKSTYLFLGDYVDRGTHSLEVIIYLFLLKIKYPKSIYLLRGNHEDEKICQSYGFQDEIRAKFSHYDINHQKDVWRAMIDTFEALPIAALIQNELFAVHAGLSPSFQIIDQMHTICRFRDFPEGLSCLFSDLLWSDPSAEVQCFERSARGAGCSFGLIPVLKFLHDNQLSHILRSHQLCYEGFVLMFGDLLSTVWSAPDYTQKKNFASVLTVSENLERNYEVFECSSDFDMRATLSTGMSGILRNLF		318		3	Expressed	-1	 	
Batch03	MytuD.00184.a	Mycobacterium tuberculosis	YP_177731.1	P0A5R6				phosphoglyceromutase	Potential drug target		MANTGSLVLLRHGESDWNALNLFTGWVDVGLTDKGQAEAVRSGELIAEHDLLPDVLYTSLLRRAITTAHLALDSADRLWIPVRRSWRLNERHYGALQGLDKAETKARYGEEQFMAWRRSYDTPPPPIERGSQFSQDADPRYADIGGGPLTECLADVVARFLPYFTDVIVGDLRVGKTVLIVAHGNSLRALVKHLDQMSDDEIVGLNIPTGIPLRYDLDSAMRPLVRGGTYLDPEAAAAGAAAVAGQGRG		249		-2	Work stopped	-2	Work stopped	
Batch03	MytuD.00185.a	Mycobacterium tuberculosis	NP_217791.1	P63427				PROBABLE ACYL-CoA DEHYDROGENASE FADE25	Potential drug target		MVGWAGNPSFDLFKLPEEHDEMRSAIRALAEKEIAPHAAEVDEKARFPEEALVALNSSGFNAVHIPEEYGGQGADSVATCIVIEEVARVDASASLIPAVNKLGTMGLILRGSEELKKQVLPALAAEGAMASYALSEREAGSDAASMRTRAKADGDHWILNGAKCWITNGGKSTWYTVMAVTDPDRGANGISAFMVHKDDEGFTVGPKERKLGIKGSPTTELYFENCRIPGDRIIGEPGTGFKTALATLDHTRPTIGAQAVGIAQGALDAAIAYTKDRKQFGESISTFQAVQFMLADMAMKVEAARLMVYSAAARAERGEPDLGFISAASKCFASDVAMEVTTDAVQLFGGAGYTTDFPVERFMRDAKITQIYEGTNQIQRVVMSRALLR		389		10	Diffraction	-1	 	
Batch03	MytuD.00191.a	Mycobacterium tuberculosis	NP_217664.1	P65569				NADH dehydrogenase subunit D	Potential drug target		MTAIADSAGGAGETVLVAGGQDWQQVVDAARSADPGERIVVNMGPQHPSTHGVLRLILEIEGETVVEARCGIGYLHTGIEKNLEYRYWTQGVTFVTRMDYLSPFFNETAYCLGVEKLLGITDEIPERVNVIRVLMMELNRISSHLVALATGGMELGAMTPMFVGFRAREIVLTLFEKITGLRMNSAYIRPGGVAQDLPPNAATEIAEALKQLRQPLREMGELLNENAIWKARTQGVGYLDLTGCMALGITGPILRSTGLPHDLRKSEPYCGYQHYEFDVITDDSCDAYGRYMIRVKEMWESMKIVEQCLDKLRPGPTMISDRKLAWPADLQVGPDGLGNSPKHIAKIMGSSMEALIHHFKLVTEGIRVPAGQVYVAVESPRGELGVHMVSDGGTRPYRVHYRDPSFTNLQSVAAMCEGGMVADLIAAVASIDPVMGGVDR		440		3	Expressed	-1	 	NR-16402
Batch03	MytuD.00200.a	Mycobacterium tuberculosis	NP_216012.1	P63577				arginine/ornithine transport system ATPase	Potential drug target		MMAASHDDDTVDGLATAVRGGDRAALPRAITLVESTRPDHREQAQQLLLRLLPDSGNAHRVGITGVPGVGKSTAIEALGMHLIERGHRVAVLAVDPSSTRTGGSILGDKTRMARLAVHPNAYIRPSPTSGTLGGVTRATRETVVLLEAAGFDVILIETVGVGQSEVAVANMVDTFVLLTLARTGDQLQGIKKGVLELADIVVVNKADGEHHKEARLAARELSAAIRLIYPREALWRPPVLTMSAVEGRGLAELWDTVERHRQVLTGAGEFDARRRDQQVDWTWQLVRDAVLDRVWSNPTVRKVRSELERRVRAGELTPALAAQQILEIANLTDR		334		17	In PDB	17	Ligand-bound structure submitted to PDB	
Batch03	MytuD.00212.a	Mycobacterium tuberculosis	NP_217768.1	O05894				PROBABLE RUBREDOXIN RUBA	Potential drug target		MAAYRCPVCDYVYDEANGDAREGFPAGTGWDQIPDDWCCPDCAVREKVDFEKIGG		55		8	HSQC	-1	 	
Batch03	MytuD.00213.a	Mycobacterium tuberculosis	NP_218291.1	P75019				enoyl-CoA hydratase	Potential drug target		MGETYESVTVETKDQVAQVTLIGPGKGNAMGPAFWSEMPEVFHALDADREVRAIVITGSGKNFSYGLDVPAMGGMFAPLIADGALARPRTDFHTEILRMQKAINAVADCRTPTIAAVQGWCIGGAVDLISAVDIRYASADAKFSVREVKLAIVADMGSLARLPLILSDGHLRELALTGKNIDAARAEKIGLVNDVYDDADQTLAAAHATAAEIAANPPLAVYGIKDVLDQQRTSAVSENLRYVAAWNAAFLPSKDLTEGISATFAKRPPQFTGE		274		5	Purified	-1	 	
Batch03	MytuD.00236.a	Mycobacterium tuberculosis	NP_215979.1	O53154				PROBABLE CONSERVED ATP-BINDING PROTEIN ABC TRANSPORTER	Potential drug target		MTILEIKDLHVSVENPAEADHEIPILRGVDLTVKSGETHALMGPNGSGKSTLSYAIAGHPKYHVTSGTITLDGADVLAMSIDERARAGLFLAMQYPVEVPGVSMSNFLRSAATAIRGEPPKLRHWVKEVKAAMAALDIDPAFAERSVNEGFSGGEKKRHEILQLELLKPKIAILDETDSGLDVDALRVVSEGVNRYAESQHGGILLITHYTRILRYIHPEYVHVFVGGRIVESGGSELADELDQNGYVRFSPASGRYPHQPAPTGA		266		5	Purified	-1	 	
Batch03	MytuD.00247.a	Mycobacterium tuberculosis	NP_217240.1	O33229				PROBABLE ACYL-CoA DEHYDROGENASE FADE20	Potential drug target		MGSATKYQRTLFEPEHELFRESYRAFLDRHVAPYHDEWEKTKIVDRGVWLEAGKQGFLGMAVPEEYGGGGNADFRYNTVITEETCAGRYSGIGFGLHNDIVAPYLLALATEEQKRRWFPNFCTGELITAIAMTEPGTGSDLQGITTRAVKHGDHYVLNGSKTFITNGINSDLVIVVAQTDPEKGAQGFSLLVVERGMAGFERGRQLDKIGLDAQDTAELSFTDVAVPAENLLGQEGMGFIYLMQNLPQERISIAIMAAAGMESVLEQTLQYAKERKAFGRSIGSFQNSRFLLAELATEATVVRIMVDEFIKLHLAGKLTAEQAAMAKWYATEKQVYLNDRCLQLHGGYGYMREYPVARAYLDSRVQTIYGGTTEIMKEIIGRGLGV		386		7	Crystallized	-1	 	
Batch03	MytuD.00250.a	Mycobacterium tuberculosis	NP_218084.1	P96849				POSSIBLE OXIDOREDUCTASE	Potential drug target		MSAQIDPRTFRSVLGQFCTGITVITTVHDDVPVGFACQSFAALSLEPPLVLFCPTKVSRSWQAIEASGRFCVNVLTEKQKDVSARFGSKEPDKFAGIDWRPSELGSPIIEGSLAYIDCTVASVHDGGDHFVVFGAVESLSEVPAVKPRPLLFYRGDYTGIEPEKTTPAHWRDDLEAFLITTTQDTWL		187		5	Purified	-1	 	
Batch03	MytuD.00272.a	Mycobacterium tuberculosis	YP_177822.1	P0A4X4				8-amino-7-oxononanoate synthase	Potential drug target		MKAATQARIDDSPLAWLDAVQRQRHEAGLRRCLRPRPAVATELDLASNDYLGLSRHPAVIDGGVQALRIWGAGATGSRLVTGDTKLHQQFEAELAEFVGAAAGLLFSSGYTANLGAVVGLSGPGSLLVSDARSHASLVDACRLSRARVVVTPHRDVDAVDAALRSRDEQRAVVVTDSVFSADGSLAPVRELLEVCRRHGALLLVDEAHGLGVRGGGRGLLYELGLAGAPDVVMTTTLSKALGSQGGVVLGPTPVRAHLIDAARPFIFDTGLAPAAVGAARAALRVLQAEPWRPQAVLNHAGELARMCGVAAVPDSAMVSVILGEPESAVAAAAACLDAGVKVGCFRPPTVPAGTSRLRLTARASLNAGELELARRVLTDVLAVARR		386		3	Expressed	-1	 	
Batch03	MytuD.00277.a	Mycobacterium tuberculosis	NP_214731.1	P96399				POSSIBLE ESTERASE LIPW	Potential drug target		MSGNEVHPDLRRIAVVTPRQLVGPRTLPVMRALIVVAGLRMSRTPPDIEVLTLESGVGVRLYRPAGSNEPAPALLWIHAGGYVMGTAQQDDRLCLRFSSRLGITVASVDYRLAPENPYPAALGDCYSALTWLASLPAVDPARVAIGGASAGGGLAAALALLARDRGGITPAFQLLVYPMLDDRPSIAPANPHYRLWNGRANRFGWRAYLGDADARVAVPGRRDDLGGLAPAWIGVGTHDLLHDEDLAYAERLTAAGVPCQVEVVEGAFHGFDRVAPNVGVSQRFFTSQCNSLRAALALSNRT		302		3	Expressed	-1	 	
Batch03	MytuD.00289.a	Mycobacterium tuberculosis	NP_214992.1	P63929				deoxyribose-phosphate aldolase	Potential drug target		MLGQPTRAQLAALVDHTLLKPETTRADVAALVAEAAELGVYAVCVSPSMVPVAVQAGGVRVAAVTGFPSGKHVSSVKAHEAAAALASGASEIDMVIDIGAALCGDIDAVRSDIEAVRAAAAGAVLKVIVESAVLLGQSNAHTLVDACRAAEDAGADFVKTSTGCHPAGGATVRAVELMAETVGPRLGVKASGGIRTAADAVAMLNAGATRLGLSGTRAVLDGLS		224		3	Expressed	-1	 	
Batch03	MytuD.00295.a	Mycobacterium tuberculosis	YP_177699.1	Q7DAC8				PROBABLE ZINC-TYPE ALCOHOL DEHYDROGENASE (E SUBUNIT) ADHE	Potential drug target		MPAVQPWLYSNMPAIRGAVLDQIGVPRPYWRSKPISVVELHLDPPDRGEVLVRIEAAGVCHSDLSVVDGTRVRPVPILLGHEAAGIVEQVGDGVDGVAVGQRVVLVFLPRCGQCAACATDGRTPCEPGSAANKAGTLLGGGIRLSRGGRPVYHHLGVSGFATHVVVNRASVVPVPHEVPPTVAALLGCAVLTGGGAVLNVGDPQPGQSVAVVGLGGVGMAAVLTALTYTDVRVVAVDQLPEKLSAAKALGAHEIYTPQQATAGGVKAAVVVEAVGHPAALHTAIGLTAPGGRTITVGLPPPDVRISLSPLDFVTEGRSLIGSYLGSAVPSHDIPRFVSLWQSGRLPVESLVTSTIRLDDINEAMDHLADGIAVRQLISFTGDL		383		3	Expressed	-1	 	
Batch03	MytuD.00304.a	Mycobacterium tuberculosis	NP_215980.1	P63516				PROBABLE CYSTEINE DESULFURASE CSD	Potential drug target		MTASVNSLDLAAIRADFPILKRIMRGGNPLAYLDSGATSQRPLQVLDAEREFLTASNGAVHRGAHQLMEEATDAYEQGRADIALFVGADTDELVFTKNATEALNLVSYVLGDSRFERAVGPGDVIVTTELEHHANLIPWQELARRTGATLRWYGVTDDGRIDLDSLYLDDRVKVVAFTHHSNVTGVLTPVSELVSRAHQSGALTVLDACQSVPHQPVDLHELGVDFAAFSGHKMLGPNGIGVLYGRRELLAQMPPFLTGGSMIETVTMEGATYAPAPQRFEAGTPMTSQVVGLAAAARYLGAIGMAAVEAHERELVAAAIEGLSGIDGVRILGPTSMRDRGSPVAFVVEGVHAHDVGQVLDDGGVAVRVGHHCALPLHRRFGLAATARASFAVYNTADEVDRLVAGVRRSRHFFGRA		417		3	Expressed	-1	 	
Batch03	MytuD.00305.a	Mycobacterium tuberculosis	NP_215988.1	O53163				enoyl-CoA hydratase	Potential drug target		MPHRCAAQVVAGYRSTVSLVLVEHPRPEIAQITLNRPERMNSMAFDVMVPLKEALAQVSYDNSVRVVVLTGAGRGFSPGADHKSAGVVPHVENLTRPTYALRSMELLDDVILMLRRLHQPVIAAVNGPAIGGGLCLALAADIRVASSSAYFRAAGINNGLTASELGLSYLLPRAIGSSRAFEIMLTGRDVSAEEAERIGLVSRQVPDEQLLDACYAIAARMAGFSRPGIELTKRTLWSGLDAASLEAHMQAEGLGQLFVRLLTANFEEAVAARAEQRAPVFTDDT		285		3	Expressed	-1	 	
Batch03	MytuD.00309.a	Mycobacterium tuberculosis	NP_214668.1	P96831				PROBABLE ACYL-CoA DEHYDROGENASE FADE2	Potential drug target		MSAKAIDYRTRLSDFMTEHVFGAEADYDDYRRAAGPADHTAPPIIEELKTKAKDRGLWNLFLSAESGLTNLEYAPLAEMTGWSMEIAPEALNCAAPDTGNMEILHMFGTEQQRAQWLRPLLDGKIRSAFSMTEPAVASSDARNIETTISRDGADYVINGRKWWTSGAADPRCKILIVMGRTNPDAAAHQQQSMVLVPIDTPGVTIVRSTPVFGWQDRHGHCEIDYHNVRVPATNLLGEEGSGFAIAQARLGPGRIHHCMRALGAAERALALMVNRVRNRVAFGRPLAEQGVVQQAIAQSRNEIDQARLLCEKAAWTIDQHGNKEARHLVAMIKAVAPRVACDVIDRAIQVHGAAGVSDDTPLARLYGWHRAMRIFDGPDEVHLRSIARAELSREKSTFAAAVT		403		5	Purified	-1	 	
Batch03	MytuD.00317.a	Mycobacterium tuberculosis	NP_215954.1	P66940				triosephosphate isomerase	Potential drug target		MSRKPLIAGNWKMNLNHYEAIALVQKIAFSLPDKYYDRVDVAVIPPFTDLRSVQTLVDGDKLRLTYGAQDLSPHDSGAYTGDVSGAFLAKLGCSYVVVGHSERRTYHNEDDALVAAKAATALKHGLTPIVCIGEHLDVREAGNHVAHNIEQLRGSLAGLLAEQIGSVVIAYEPVWAIGTGRVASAADAQEVCAAIRKELASLASPRIADTVRVLYGGSVNAKNVGDIVAQDDVDGGLVGGASLDGEHFATLAAIAAGGPLP		261		17	In PDB	-1	 	
Batch03	MytuD.00328.a	Mycobacterium tuberculosis	NP_215155.1	P96932				50S ribosomal protein L1	Potential drug target		MSKTSKAYRAAAAKVDRTNLYTPLQAAKLAKETSSTKQDATVEVAIRLGVDPRKADQMVRGTVNLPHGTGKTARVAVFAVGEKADAAVAAGADVVGSDDLIERIQGGWLEFDAAIATPDQMAKVGRIARVLGPRGLMPNPKTGTVTADVAKAVADIKGGKINFRVDKQANLHFVIGKASFDEKLLAENYGAAIDEVLRLKPSSSKGRYLKKITVSTTTGPGIPVDPSITRNFAGE		235		-2	Work stopped	-2	Work stopped	
Batch03	MytuD.00337.a	Mycobacterium tuberculosis	NP_216779.1	O53537				short chain dehydrogenase	Potential drug target		MAKDLVATVPDLSGKLAIITGANSGLGFGLARRLSAAGADVIMAIRNRAKGEAAVEEIRTAVPDAKLTIKALDLSSLASVAALGEQLMADGRPIDLLINNAGVMTPPERVTTADGFELQFGSNHLGHFALTAHLLPLLRAAQRARVVSLSSLAARRGRIHFDDLQFERSYAPMTAYGQSKLAVLMFARELDRRSRAAGWGIISNAAHPGLTKTNLQIAGPSHGRDKPALMERLYKTSWRFAPFLWQEIEEGILPALYAAATPQADGGAFYGPRGRYEVAGGGVREAKVPAAARNDADSKRLWEVSEQLTGVSYPKSR		317		5	Purified	-1	 	
Batch03	MytuD.00340.a	Mycobacterium tuberculosis	NP_215587.1	O53419				enoyl-CoA hydratase	Potential drug target		MTGESHEVLTNVEGGVGFVTLNRPKAINSLNQTMVDLLATVLMSWEHEDAVHAVVLSGAGERGLCAGGDVVAVYHSARKDGVEARRFWRHEYLLNALIGRFAKPYVALMDGIVMGGGVGVSAHANTRVVTDTSKVAMPEVGIGFIPDVGGVYLLSRAPGALGLHAALTGAPFSGADAIALGFADHFVPHGDLDAFTQKIVTGGVESALAAHAVEPPPSTLAAQRDWIDECYAGDSVADIVAALRKQGGEPAVNASDLIASRSPIALSVTLQAVRRAAKLDTLEDVLIQDYRVSSASLRSHDLVEGIRAQLIDKDRNPNWSPATLDAITAADIEAYFEPVDDDLSF		345		5	Purified	-1	 	
Batch03	MytuD.00358.a	Mycobacterium tuberculosis	NP_215586.1	P64016				enoyl-CoA hydratase	Potential drug target		MTYETILVERDQRVGIITLNRPQALNALNSQVMNEVTSAATELDDDPDIGAIIITGSAKAFAAGADIKEMADLTFADAFTADFFATWGKLAAVRTPTIAAVAGYALGGGCELAMMCDVLIAADTAKFGQPEIKLGVLPGMGGSQRLTRAIGKAKAMDLILTGRTMDAAEAERSGLVSRVVPADDLLTEARATATTISQMSASAARMAKEAVNRAFESSLSEGLLYERRLFHSAFATEDQSEGMAAFIEKRAPQFTHR		257		17	In PDB	-1	 	
Batch03	MytuD.00382.a	Mycobacterium tuberculosis	NP_215620.1	O53452				POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT)	Potential drug target		MVVDSCVAESRYGPVRGADDGRVKVWKGIRYAAPPLGDLRFRTPEPPERWTEVADATTFGPACPQPAIPNMPLDLGASQSEDCWSLNIWAPADTEPGDGKPVMVWLHGGAYILGSGSQPLYNGRRLAASGDVVVVTVNYRLGALGFLDLSSFNTSRRRFDSNIGLRDVLAVLRWVADNIAVFGGDPEKVTLFGESARESSRPCSPPRRPRVCSRRRSPRAHRRHRSTTR		229		3	Expressed	-1	 	NR-16403
Batch03	MytuD.00384.a	Mycobacterium tuberculosis	NP_217051.1	P95018				PROBABLE CYTOPLASMIC PEPTIDASE PEPQ	Potential drug target		MTHSQRRDKLKAQIAASGLDAMLISDLINVRYLSGFSGSNGALLVFADERDAVLATDGRYRTQAASQAPDLEVAIERAVGRYLAGRAGEAGVGKLGFESHVVTVDGLDALAGALEGKNTELVRASGTVESLREVKDAGELALLRLACEAADAALTDLVARGGLRPGRTERQVSRELEALMLDHGADAVSFETIVAAGANSAIPHHRPTDAVLQVGDFVKIDFGALVAGYHSDMTRTFVLGKAADWQLEIYQLVAEAQQAGRQALLPGAELRGVDAAARQLIADAGYGEHFGHGLGHGVGLQIHEAPGIGVTSAGTLLAGSVVTVEPGVYLPGRGGVRIEDTLVVAGGTPKMPETAGQTPELLTRFPKELAIL		372		3	Expressed	-1	 	
Batch03	MytuD.00386.a	Mycobacterium tuberculosis	YP_177745.1	Q7D9G0				enoyl-CoA hydratase	Potential drug target		MSDLVRVERKGRVTTVILNRPASRNAVNGPTAAALCAAFEQFDRDDAASVAVLWGAGGTFCAGADLKAFGTPEANSVHRTGPGPMGPSRMMLSKPVIAAVSGYAVAGGLELALWCDLRVAEEDAVFGVFCRRWGVPLIDGGTVRLPRLIGHSRAMDMILTGRGVPADEALAMGLANRVVPKGQARQAAEELAAQLAALPQQCLRSDRLSALHQWGLPESAALDLEFASIARVAGEALEGARRFAAGAGRHGAPAPRAEQGDTL		263		7	Crystallized	-1	 	
Batch03	MytuD.00391.a	Mycobacterium tuberculosis	NP_217373.1	O33339				short chain dehydrogenase	Potential drug target		MMDLSQRLAGRVAVITGGGSGIGLAAGRRMRAEGATIVVGDVDVEAGGAAADELSGLFVPTDVCDEDAVNGLFDGAAETYGRIDIAFNNAGISPPEDNLIENTELAAWQRVQDVNLKSVYLCCRAALRHMVLAGKGSIVNTASFVAVMGSATSQISYTASKGGVLAMSRELGVQFARQGIRVNALCPGPVNTPLLQELFAKNPERAARRMVHVPLGRFAEPDEIAAAVAFLASDDASFITASTFLVDGGISSAYVTPL		258		2	Cloned	-1	 	
Batch03	MytuD.00392.a	Mycobacterium tuberculosis	NP_217618.1	O05779				PUTATIVE CELL DIVISION ATP-BINDING PROTEIN FTSE (SEPTATION COMPONENT-TRANSPORT ATP-BINDING PROTEIN ABC TRANSPORTER)	Potential drug target		MITLDHVTKQYKSSARPALDDINVKIDKGEFVFLIGPSGSGKSTFMRLLLAAETPTSGDVRVSKFHVNKLRGRHVPKLRQVIGCVFQDFRLLQQKTVYDNVAFALEVIGKRTDAINRVVPEVLETVGLSGKANRLPDELSGGEQQRVAIARAFVNRPLVLLADEPTGNLDPETSRDIMDLLERINRTGTTVLMATHDHHIVDSMRQRVVELSLGRLVRDEQRGVYGMDR		229		5	Purified	-1	 	
Batch03	MytuD.00403.a	Mycobacterium tuberculosis	NP_217213.1	P0A552				deoxyuridine 5'-triphosphate nucleotidohydrolase	Potential drug target		MSTTLAIVRLDPGLPLPSRAHDGDAGVDLYSAEDVELAPGRRALVRTGVAVAVPFGMVGLVHPRSGLATRVGLSIVNSPGTIDAGYRGEIKVALINLDPAAPIVVHRGDRIAQLLVQRVELVELVEVSSFDEAGLASTSRGDGGHGSSGGHASL		154		5	Purified	-1	 	
Batch03	MytuD.00404.a	Mycobacterium tuberculosis	NP_215726.1	O05311				"PROBABLE DNA-3-METHYLADENINE GLYCOSYLASE I TAGA (TAG I) (3-methyladenine-DNA glycosylase I, constitutive) (DNA-3-methyladenine glycosidase I )"	Potential drug target		MSGDGLVRCPWAEVRPGPDAQLYRDYHDNEWGRPLYGRVALFERMSLEAFQSGLSWLIILRKRENFRRAFSGFDIDKIARYTDTDVRRLLADDGIVRNRAKIEATIANARAAADLGSSEDLSELLWSFAPPPRPRPVDGSEIPSVSTESKAMSRELKRRGFRFVGPTTAYALMQATGMVDDHIQACWVPTERPFDQPGCPMAAR		204		2	Cloned	-1	 	
Batch03	MytuD.00414.a	Mycobacterium tuberculosis	NP_215283.1	P71824				short chain dehydrogenase	Potential drug target		MFDSKVAIVTGAAQGIGQAYAQALAREGASVVVADINADGAAAVAKQIVADGGTAIHVPVDVSDEDSAKAMVDRAVGAFGGIDYLVNNAAIYGGMKLDLLLTVPLDYYKKFMSVNHDGVLVCTRAVYKHMAKRGGGAIVNQSSTAAWLYSNFYGLAKVGVNGLTQQLARELGGMKIRINAIAPGPIDTEATRTVTPAELVKNMVQTIPLSRMGTPEDLVGMCLFLLSDSASWITGQIFNVDGGQIIRS		248		4	Soluble	-1	 	
Batch03	MytuD.00416.a	Mycobacterium tuberculosis	NP_216375.1	P95155				PROBABLE MOLYBDENUM-TRANSPORT ATP-BINDING PROTEIN ABC TRANSPORTER MODC	Potential drug target		MSKLQLRAVVADRRLDVEFSVSAGEVLAVLGPNGAGKSTALHVIAGLLRPDAGLVRLGDRVLTDTEAGVNVATHDRRVGLLLQDPLLFPHLSVAKNVAFGPQCRRGMFGSGRARTRASALRWLREVNAEQFADRKPRQLSGGQAQRVAIARALAAEPDVLLLDEPLTGLDVAAAAGIRSVLRSVVARSGCAVVLTTHDLLDVFTLADRVLVLESGTIAEIGPVADVLTAPRSRFGARIAGVNLVNGTIGPDGSLRTQSGAHWYGTPVQDLPTGHEAIAVFPPTAVAVYPEPPHGSPRNIVGLTVAEVDTRGPTVLVRGHDQPGGAPGLAACITVDAATELRVAPGSRVWFSVKAQEVALHPAPHQHASS		369		3	Expressed	-1	 	NR-16404
Batch03	MytuD.00429.a	Mycobacterium tuberculosis	NP_217526.1	P65690				6-phosphofructokinase	Potential drug target		MRIGVLTGGGDCPGLNAVIRAVVRTCHARYGSSVVGFQNGFRGLLENRRVQLHNDDRNDRLLAKGGTMLGTARVHPDKLRAGLPQIMQTLDDNGIDVLIPIGGEGTLTAASWLSEENVPVVGVPKTIDNDIDCTDVTFGHDTALTVATEAIDRLHSTAESHERVMLVEVMGRHAGWIALNAGLASGAHMTLIPEQPFDIEEVCRLVKGRFQRGDSHFICVVAEGAKPAPGTIMLREGGLDEFGHERFTGVAAQLAVEVEKRINKDVRVTVLGHIQRGGTPTAYDRVLATRFGVNAADAAHAGEYGQMVTLRGQDIGRVPLADAVRKLKLVPQSRYDDAAAFFG		343		4	Soluble	-1	 	
Batch03	MytuD.00441.a	Mycobacterium tuberculosis	NP_217012.1	O06160				PROBABLE PYRUVATE DEHYDROGENASE E1 COMPONENT (BETA SUBUNIT) PDHB (PYRUVATE DECARBOXYLASE) (PYRUVATE DEHYDROGENASE) (PYRUVIC DEHYDROGENASE)	Potential drug target		MTQIADRPARPDETLAVAVSDITQSLTMVQAINRALYDAMAADERVLVFGEDVAVEGGVFRVTEGLADTFGADRCFDTPLAESAIIGIAVGLALRGFVPVPEIQFDGFSYPAFDQVVSHLAKYRTRTRGEVDMPVTVRIPSFGGIGAAEHHSDSTESYWVHTAGLKVVVPSTPGDAYWLLRHAIACPDPVMYLEPKRRYHGRGMVDTSRPEPPIGHAMVRRSGTDVTVVTYGNLVSTALSSADTAEQQHDWSLEVIDLRSLAPLDFDTIAASIQRTGRCVVMHEGPRSLGYGAGLAARIQEEMFYQLEAPVLRACGFDTPYPPARLEKLWLPGPDRLLDCVERVLRQP		348		4	Soluble	-1	 	NR-16341
Batch03	MytuD.00448.a	Mycobacterium tuberculosis	NP_216937.1	O86328				nicotinic acid mononucleotide adenyltransferase	Potential drug target		MGGTFDPIHYGHLVAASEVADLFDLDEVVFVPSGQPWQKGRQVSAAEHRYLMTVIATASNPRFSVSRVDIDRGGPTYTKDTLADLHALHPDSELYFTTGADALASIMSWQGWEELFELARFVGVSRPGYELRNEHITSLLGQLAKDALTLVEIPALAISSTDCRQRAEQSRPLWYLMPDGVVQYVSKCRLYCGACDAGARSTTSLAAGNGL		211		3	Expressed	-1	 	NR-16405
Batch03	MytuD.00458.a	Mycobacterium tuberculosis	NP_217121.1	O06209				PROBABLE ACYL-CoA THIOESTERASE II TESB2 (TEII)	Potential drug target		MSIEEILDLEQLEVNIYRGSVFSPESGFLQRTFGGHVAGQSLVSAVRTVDPRYMVHSLHGYFLRPGDAKERTVFLVERIRDGGSFCTRRVNAVQHGETIFSMAASFQTEQEGITHQDVMPAAPPPDGLPGLNSIKVFDDAGFRQFDEWDVCIVPRERLRLLPGKASQQQVWLRHRDPLPDDPVLHICALAYMSDLTLLGSAQVNHLDVRDQLQVASLDHAMWFMRPFRADEWLLYDQSSPSASGGRALTRGEIFTRSGEMVAAVMQEGLTRHRRGHRSVGQ		281		5	Purified	-1	 	
Batch03	MytuD.00463.a	Mycobacterium tuberculosis	NP_216837.1	P71891				PROBABLE ORNITHINE AMINOTRANSFERASE (C-terminus part) ROCD2 (ORNITHINE--OXO-ACID AMINOTRANSFERASE)	Potential drug target		MIADEIQSGLACTGYPFACDHGGVLPDIYLLGKTLGGGAVPLSAMVADREIFGVVHPGEHGSTFGGNPLAAAIGTPVVSMVVWGECQARSAKLGAHLHQRLADLIGDGAVALRGLGWWADVDIERALAIGTDMSMRLADRGVLLKDTYGAALRFAPPLVITAQEIDCAVRRFADALWEAGS		181		3	Expressed	-1	 	
Batch03	MytuD.00471.a	Mycobacterium tuberculosis	NP_217509.1	O53242				"POSSIBLE 2-HYDROXYHEPTA-2,4-DIENE-1,7-DIOATE ISOMERASE (HHDD ISOMERASE)"	Potential drug target		MTAREIAEHPFGTPTFTGRSWPLADVRLLAPILASKVVCVGKNYADHIAEMGGRPPADPVIFLKPNTAIIGPNTPIRLPANASPVHFEGELAIVIGRACKDVPAAQAVDNILGYTIGNDVSARDQQQSDGQWTRAKGHDTFCPVGPWIVTDLAPFDPADLELRTVVNGDVKQHARTSLMIHDIGAIVEWISAIMTLLPGDLILTGTPAGVGPIEDGDTVSITIEGIGTLTNPVVRKGKP		239		2	Cloned	-1	 	
Batch03	MytuD.00472.a	Mycobacterium tuberculosis	NP_216457.1	P95273				PROBABLE SHORT-CHAIN TYPE DEHYDROGENASE/REDUCTASE	Potential drug target		MNHPDLAGKVAIVTGAGAGIGLAVARRLADEGCHVLCADIDGDAADAAATKIGCGAAACRVDVSDEQQIIAMVDACVAAFGGVDKLVANAGVVHLASLIDTTVEDFDRVIAINLRGAWLCTKHAAPRMIERGGGAIVNLSSLAGQVAVGGTGAYGMSKAGIIQLSRITAAELRSSGIRSNTLLPAFVDTPMQQTAMAMFDGALGAGGARSMIARLQGRMAAPEEMAGIVVFLLSDDASMITGTTQIADGGTIAALW		256		17	In PDB	-1	 	
Batch03	MytuD.00489.a	Mycobacterium tuberculosis	NP_215652.1	O06536				POSSIBLE ENOYL-CoA HYDRATASE	Potential drug target		MVITINRPEARNAVNGAVSIVVGDALEEAHDNPDVRAVVITGAGDKSLCAGADLKAIARRENPYHPHHGEWGIAGYRHHFIDKPTSAAVSGTALDDGAEPALASDLVVADEHT		113		5	Purified	-1	 	
Batch03	MytuD.00495.a	Mycobacterium tuberculosis	NP_217832.1	O53367				cytidine deaminase	Potential drug target		MPDVDWNMLRGNATQAAAGAYVPYSRFAVGAAALVDDGRVVTGCNVENVSYGLTLCAECAVVCALHSTGGGRLLALACVDGHGSVLMPCGRCRQVLLEHGGSELLIDHPVRPRRLGDLLPDAFGLDDLPRERR		133		-2	Work stopped	-2	Work stopped	
Batch03	MytuD.00504.a	Mycobacterium tuberculosis	NP_217906.1	Q11198				POSSIBLE DEHYDROGENASE	Potential drug target		MAIDPNSIGAVTEPMLFEWTDRDTLLYAIGVGAGTGDLAFTTENSHGIDQQVLPTYAVICCPAFGAAAKVGTFNPAALLHGSQGIRLHAPLPAAGKLSVVTEVADIQDKGEGKNAIVVLRGRGCDPESGSLVAETLTTLVLRGQGGFGGARGERPAAPEFPDRHPDARIDMPTREDQALIYRLSGDRNPLHSDPWFATQLAGFPKPILHGLCTYGVAGRALVAELGGGVAANITSIAARFTKPVFPGETLSTVIWRTEPGRAVFRTEVAGSDGAEARVVLDDGAVEYVAG		290		17	In PDB	-1	 	
Batch03	MytuD.00519.a	Mycobacterium tuberculosis	NP_216851.1	P95231				PROBABLE SERINE ACETYLTRANSFERASE CYSE (SAT)	Potential drug target		MLTAMRGDIRAARERDPAAPTALEVIFCYPGVHAVWGHRLAHWLWQRGARLLARAAAEFTRILTGVDIHPGAVIGARVFIDHATGVVIGETAEVGDDVTIYHGVTLGGSGMVGGKRHPTVGDRVIIGAGAKVLGPIKIGEDSRIGANAVVVKPVPPSAVVVGVPGQVIGQSQPSPGGPFDWRLPDLVGASLDSLLTRVARLEALGGGPQAAGVIRPPEAGIWHGEDFSI		229		2	Cloned	-1	 	
Batch03	MytuD.00541.a	Mycobacterium tuberculosis	NP_215466.1	P71559				succinyl-CoA synthetase subunit beta	Potential drug target		MDLFEYQAKELFAKHNVPSTPGRVTDTAEGAKAIATEIGRPVMVKAQVKIGGRGKAGGVKYAATPQDAYEHAKNILGLDIKGHIVKKLLVAEASDIAEEYYLSFLLDRANRTYLAMCSVEGGMEIEEVAATKPERLAKVPVNAVKGVDLDFARSIAEQGHLPAEVLDTAAVTIAKLWELFVAEDATLVEVNPLVRTPDHKILALDAKITLDGNADFRQPGHAEFEDRAATDPLELKAKEHDLNYVKLDGQVGIIGNGAGLVMSTLDVVAYAGEKHGGVKPANFLDIGGGASAEVMAAGLDVVLGDQQVKSVFVNVFGGITSCDAVATGIVKALGMLGDEANKPLVVRLDGNNVEEGRRILTEANHPLVTLVATMDEAADKAAELASA		387		3	Expressed	-1	 	NR-16406
Batch03	MytuD.00549.a	Mycobacterium tuberculosis	NP_215384.1	P65384				molybdenum cofactor biosynthesis protein A	Potential drug target		MTLTALGMPALRSRTNGIADPRVVPTTGPLVDTFGRVANDLRVSLTDRCNLRCSYCMPERGLRWLPGEQLLRPDELARLIHIAVTRLGVTSVRFTGGEPLLAHHLDEVVAATARLRPRPEISLTTNGVGLARRAGALAEAGLDRVNVSLDSIDRAHFAAITRRDRLAHVLAGLAAAKAAGLTPVKVNAVLDPTTGREDVVDLLRFCLERGYQLRVIEQMPLDAGHSWRRNIALSADDVLAALRPHFRLRPDPAPRGSAPAELWLVDAGPNTPRGRFGVIASVSHAFCSTCDRTRLTADGQIRSCLFSTEETDLRRLLRGGADDDAIEAAWRAAMWSKPAGHGINAPDFIQPDRPMSAIGG		360		3	Expressed	-1	 	
Batch03	MytuD.00554.a	Mycobacterium tuberculosis	NP_215660.1	O06544				PROBABLE SHORT-CHAIN TYPE DEHYDROGENASE/REDUCTASE	Potential drug target		MKTKDAVAVVTGGASGLGLATTKRLLDAGAQVVVVDLRGDDVVGGLGDRARFAQADVTDEAAVSNALELADSLGPVRVVVNCAGTGNAIRVLSRDGVFPLAAFRKIVDINLVGTFNVLRLGAERIAKTEPIGEERGVIINTASVAAFDGQIGQAAYSASKGGVVGMTLPIARDLASKLIRVVTIAPGLFDTPLLASLPAEAKASLGQQVPHPSRLGNPDEYGALVLHIIENPMLNGEVIRLDGAIRMAPR		250		4	Soluble	-1	 	
Batch03	MytuD.00556.a	Mycobacterium tuberculosis	NP_215467.1	P71558				succinyl-CoA synthetase subunit alpha	Potential drug target		MTHMSIFLSRDNKVIVQGITGSEATVHTARMLRAGTQIVGGVNARKAGTTVTHEDKGGRLIKLPVFGSVAEAMEKTGADVSIIFVPPTFAKDAIIEAIDAEIPLLVVITEGIPVQDTAYAWAYNLEAGHKTRIIGPNCPGIISPGQSLAGITPANITGPGPIGLVSKSGTLTYQMMFELRDLGFSTAIGIGGDPVIGTTHIDAIEAFERDPDTKLIVMIGEIGGDAEERAADFIKTNVSKPVVGYVAGFTAPEGKTMGHAGAIVSGSSGTAAAKQEALEAAGVKVGKTPSATAALAREILLSL		303		3	Expressed	-1	 	
Batch03	MytuD.00560.a	Mycobacterium tuberculosis	NP_215355.1	O53852				PROBABLE PROLINE IMINOPEPTIDASE PIP (PROLYL AMINOPEPTIDASE) (PAP)	Potential drug target		MEGTIAVPGGRVWFQRIGGGPGRPLLVVHGGPGLPHNYLAPLRRLSDEREVIFWDQLGCGNSACPSDVDLWTMNRSVAEMATVAEALALTRFHIFSHSWGGMLAQQYVLDKAPDAVSLTIANSTASIPEFSASLVSLKSCLDVATRSAIDRHEAAGTTHSAEYQAAIRTWNETYLCRTRPWPRELTEAFANMGTEIFETMFGPSDFRIVGNVRDWDVVDRLADIAVPTLLVVGRFDECSPEHMREMQGRIAGSRLEFFESSSHMPFIEEPARFDRVMREFLRLHDI		286		5	Purified	-1	 	
Batch03	MytuD.00572.a	Mycobacterium tuberculosis	NP_215734.1	O86311				PROBABLE TETRONASIN-TRANSPORT ATP-BINDING PROTEIN ABC TRANSPORTER	Potential drug target		MSADNHQVPIEIRGLTKHFGSVRALDGLDLTVREGEVHGFLGPNGAGKSTTLRILLGLVKADGGSVRLLGGDPWTDAVDLHRHIAYVPGDVTLWPSLTGGETIDLLARMRGGIDNARRAELIERFGLDPTKKARTYSKGNRQKVSLISALSSHATLLLLDEPSSGLDPLMENVFQQCIGEARQRGVTVLLSSHILAETEALCEKVTIIRAGKTVESGSLDALRHLSRTSIKAEMIGDPGDLSQIKGVEDISIEGTTVRAQVDSESLRELIQVLGHAGVRSLVSQPPTLEELFLRHYSLGPEVAAEQQVATP		311		3	Expressed	-1	 	
Batch03	MytuD.00577.a	Mycobacterium tuberculosis	NP_216838.1	P71890				PROBABLE ORNITHINE AMINOTRANSFERASE (N-terminus part) ROCD1 (ORNITHINE--OXO-ACID AMINOTRANSFERASE)	Potential drug target		MTNLADATQATMALVERHAAHNYSPLPVVAASAEGAWIADIDGLRYLDWLAAYSAVNLGHRNPASTATAHAQVDTVTLLNRALHADRLGPLGAALAQLCGKDVVLPMNSDAEAVESGLRVARKWGADVNGLPAGRHDIILANNNFHGHTSSVVSFSSDPAAGSGVEPSTPGLRSVPFGDAAAPAQTIDDNTVADLLEPIPGQAGIIVPADDYLPAASSTTC		221		2	Cloned	-1	 	
Batch03	MytuD.00587.a	Mycobacterium tuberculosis	NP_215496.1	O53894				MYCOBACTERIAL PERSISTENCE REGULATOR MRPA (TWO COMPONENT RESPONSE TRANSCRIPTIONAL REGULATORY PROTEIN)	Potential drug target		MSVRILVVDDDRAVRESLRRSLSFNGYSVELAHDGVEALDMIASDRPDALVLDVMMPRLDGLEVCRQLRGTGDDLPILVLTARDSVSERVAGLDAGADDYLPKPFALEELLARMRALLRRTKPEDAAESMAMRFSDLTLDPVTREVNRGQRRISLTRTEFALLEMLIANPRRVLTRSRILEEVWGFDFPTSGNALEVYVGYLRRKTEADGEPRLIHTVRGVGYVLRETPP		230		-2	Work stopped	-2	Work stopped	
Batch03	MytuD.00609.a	Mycobacterium tuberculosis	NP_214587.1	O53618				PROBABLE GLUTAMINE-TRANSPORT ATP-BINDING PROTEIN ABC TRANSPORTER	Potential drug target		MGDLSIQNLVVEYYSGGYALRPINGLNLDVAAGSLVMLLGPSGCGKTTLLSCLGGILRPKSGAIKFDEVDITTLQGAELANYRRNKVGIVFQAFNLVPSLTAVENVMVPLRSAGMSRRASRRRAEELLARVNLAERMNHRPGDLSGGQQQRVAVARAIALDPPLILADEPTAHLDFIQVEEVLRLIRELADGERVVVVATHDSRMLPMADRVVELTPDFAETNRPPETVHLQAGEVLFEQSTMGDLIYVVSEGEFEIVHELADGGEELVKVAGPGDYFGEIGVLFHLPRSATVRARSDATAVGYTVQAFRERLGVGGLRDLIEHRALAND		330		2	Cloned	-1	 	
Batch03	MytuD.00609.b	Mycobacterium tuberculosis	NP_217080.1	P63401				PROBABLE GLUTAMINE-TRANSPORT ATP-BINDING PROTEIN ABC TRANSPORTER GLNQ	Potential drug target		MGGLTISDLVVEYSSGGYAVRPIDGLSLDVAPGSLVILLGPSGCGKTTLLSCLGGILRPKSGSIKFDDVDITTLEGAALAKYRRDKVGIVFQAFNLVSSLTALENVMVPLRAAGVSRAAARKRAEDLLIRVNLGERMKHRPGDMSGGQQQRVAVARAIALDPQLILADEPTAHLDFIQVEEVLRLIRSLAQGDRVVVVATHDSRMLPLADRVLELMPAQVSPNQPPETVHVKAGEVLFEQSTMGDLIYVVSEGEFEIVRELADGGEELVKTAAPGDYFGEIGVLFHLPRSATVRARSDATAVGYTAQAFRERLGVTRVADLIEHRELASE		330		3	Expressed	-1	 	NR-16407
Batch03	MytuD.00620.a	Mycobacterium tuberculosis	NP_215721.1	O05306				hypothetical protein	Potential drug target		MSAKIDITGDWTVAVYCAASPTHAELLELAAEVGAAIAGRGWTLVWGGGHVSAMGAVASAARACGGWTVGVIPKMLVYRELADHDADELIVTDTMWERKQIMEDRSDAFIVLPGGVGTLDELFDAWTDGYLGTHDKPIVMVDPWGHFDGLRAWLNGLLDTGYVSPTAMERLVVVDNVKDALRACAPS		187		7	Crystallized	-1	 	
Batch03	MytuD.00625.a	Mycobacterium tuberculosis	NP_217147.2	P71930				hypothetical protein	Potential drug target		MQVVNVATLPGIVRASYAMPDVHWGYGFPIGGVAATDVDNDGVVSPGGVGFDISCGVRLLVGEGLDREELQPRLPAVMDRLDRAIPRGVGTAGVWRLPDRNTLQEVLTGGARFAVEQGHGVALDLERCEDGGVMTGADAAKISDRALQRGLGQIGSLGSGNHFLEVQAVDRVYDPVAAAPMGLAEGTVCVMIHTGSRGLGHQICTDHVRQMEQAMGRYGIAVPDRQLACVPVHSPDGQAYLAAMAAAANYGRANRQLLTEATRRVFADATGTPLDLLYDVSHNLAKIETHPIDGQLRSVCVHRKGATRSLPPHHHELPAELAAVGQPVLIPGTMGTASYVLAGVTGNPAFFSTAHGAGRVLSRHQAARHTSGEAIRASLAKRGIIVRGTSRRGIAEEKPEAYKDVDEVIEASHQSGLARKVARLVPLGCVKG		432		2	Cloned	-1	 	
Batch03	MytuD.00629.a	Mycobacterium tuberculosis	NP_215709.1	O05295				acyl-CoA synthetase	Potential drug target		MLLASLNPAVVSAADIADAVRIDGDVLSRSDLVGAATSVAERVAGAHRVAVLATPTASTVLAITGCLIAGVPVVPVPADVGVTERRHMLTDSGVQAWLGPLPDDPAGLPHIPVRTHARSWHRYPEPSPGAIAMVVYTSGTTGPPKGVQLSRRAIAADLDALAEAWQWTAEDVLVHGLPLYHVHGLVLGLLGSLRFGNRFVHTGKPTPAGYAQACYEAHGTLFFGVPTVWSRVAADQAAAGALKPARLLVSGSAALPVPVFDKLVQLTGHRPVERYGASESLITLSTRADGERRPGWVGLPLAGVQTRLVDDDGGEVPHDGETVGKLQVRGPTLFDGYLNQPDATAAAFDADSWYRTGDVAVVDGSGMHRIVGRESVDLIKSGGYRVGAGEIETVLLGHPDVAEAAVVGVPDDDLGQRIVAYVVGSANVDADGLINFVAQQLSVHKRPREVRIVDALPRNALGKVLKKQLLSEG		473		3	Expressed	-1	 	
Batch03	MytuD.00640.a	Mycobacterium tuberculosis	NP_214923.1	P63409				acetate kinase	Potential drug target		MSSTVLVINSGSSSLKFQLVEPVAGMSRAAGIVERIGERSSPVADHAQALHRAFKMLAEDGIDLQTCGLVAVGHRVVHGGTEFHQPTLLDDTVIGKLEELSALAPLHNPPAVLGIKVARRLLANVAHVAVFDTAFFHDLPPAAATYAIDRDVADRWHIRRYGFHGTSHQYVSERAAAFLGRPLDGLNQIVLHLGNGASASAIARGRPVETSMGLTPLEGLVMGTRSGDLDPGVISYLWRTARMGVEDIESMLNHRSGMLGLAGERDFRRLRLVIETGDRSAQLAYEVFIHRLRKYLGAYLAVLGHTDVVSFTAGIGENDAAVRRDALAGLQGLGIALDQDRNLGPGHGARRISSDDSPIAVLVVPTNEELAIARDCLRVLGGRRA		385		3	Expressed	-1	 	
Batch03	MytuD.00654.a	Mycobacterium tuberculosis	NP_218063.1	P71855				acetyl-CoA acetyltransferase	Potential drug target		MGYPVIVEATRSPIGKRNGWLSGLHATELLGAVQKAVVDKAGIQSGLHAGDVEQVIGGCVTQFGEQSNNISRVAWLTAGLPEHVGATTVDCQCGSGQQANHLIAGLIAAGAIDVGIACGIEAMSRVGLGANAGPDRSLIRAQSWDIDLPNQFEAAERIAKRRGITREDVDVFGLESQRRAQRAWAEGRFDREISPIQAPVLDEQNQPTGERRLVFRDQGLRETTMAGLGELKPVLEGGIHTAGTSSQISDGAAAVLWMDEAVARAHGLTPRARIVAQALVGAEPYYHLDGPVQSTAKVLEKAGMKIGDIDIVEINEAFASVVLSWARVHEPDMDRVNVNGGAIALGHPVGCTGSRLITTALHELERTDQSLALITMCAGGALSTGTIIERI		391		3	Expressed	-1	 	
Batch03	MytuD.00656.a	Mycobacterium tuberculosis	NP_215169.1	P63357				POSSIBLE RIBONUCLEOTIDE-TRANSPORT ATP-BINDING PROTEIN ABC TRANSPORTER MKL	Potential drug target		MRYSDSYHTTGRWQPRASTEGFPMGVSIEVNGLTKSFGSSRIWEDVTLTIPAGEVSVLLGPSGTGKSVFLKSLIGLLRPERGSIIIDGTDIIECSAKELYEIRTLFGVLFQDGALFGSMNLYDNTAFPLREHTKKKESEIRDIVMEKLALVGLGGDEKKFPGEISGGMRKRAGLARALVLDPQIILCDEPDSGLDPVRTAYLSQLIMDINAQIDATILIVTHNINIARTVPDNMGMLFRKHLVMFGPREVLLTSDEPVVRQFLNGRRIGPIGMSEEKDEATMAEEQALLDAGHHAGGVEEIEGVPPQISATPGMPERKAVARRQARVREMLHTLPKKAQAAILDDLEGTHKYAVHEIGQ		359		3	Expressed	-1	 	NR-16408
Batch03	MytuD.00663.a	Mycobacterium tuberculosis	NP_216228.1	P63803				cytidylate kinase	Potential drug target		MSRLSAAVVAIDGPAGTGKSSVSRRLARELGARFLDTGAMYRIVTLAVLRAGADPSDIAAVETIASTVQMSLGYDPDGDSCYLAGEDVSVEIRGDAVTRAVSAVSSVPAVRTRLVELQRTMAEGPGSIVVEGRDIGTVVFPDAPVKIFLTASAETRARRRNAQNVAAGLADDYDGVLADVRRRDHLDSTRAVSPLQAAGDAVIVDTSDMTEAEVVAHLLELVTRRSEAVR		230		5	Purified	-1	 	
Batch03	MytuD.00665.a	Mycobacterium tuberculosis	NP_216203.1	O33189				PROBABLE CONSERVED ATP-BINDING PROTEIN ABC TRANSPORTER	Potential drug target		MMISSSDELLRDGADPAVIIDQLRVIRGKRLALQDVSVRVACGTITGLLGPSGSGKTTLIRCIVGSQIIASGSVSVLGQPAGSAELRHRVGYMPQDPTIYNDLRVIDNIRYFAELCGVDRQAADEVIEAVDLRDHRTARCANLSGGQRARVSLACALVGRPDLLVLDEPTIGLDPVLRVELWDRFTALARRGTTLLVSSHVMDEADRCGDLLLLRQGQLLAHTTPHRLRKETGCTSLEEAFLSIVRRTTTVPAAG		255		3	Expressed	-1	 	
Batch03	MytuD.00680.a	Mycobacterium tuberculosis	NP_215220.1	P61181				50S ribosomal protein L22	Potential drug target		MTAATKATEYPSAVAKARFVRVSPRKARRVIDLVRGRSVSDALDILRWAPQAASGPVAKVIASAAANAQNNGGLDPATLVVATVYADQGPTAKRIRPRAQGRAFRIRRRTSHITVVVESRPAKDQRSAKSSRARRTEASKAASKVGATAPAKKAAAKAPAKKAPASSGVKKTPAKKAPAKKAPAKASETSAAKGGSD		197		-2	Work stopped	-2	Work stopped	
Batch03	MytuD.00681.a	Mycobacterium tuberculosis	NP_214669.1	P96832				PROBABLE NAD(P) TRANSHYDROGENASE (SUBUNIT ALPHA) PNTAA [FIRST PART; CATALYTIC PART] (PYRIDINE NUCLEOTIDE TRANSHYDROGENASE SUBUNIT ALPHA) (NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE SUBUNIT ALPHA)	Potential drug target		MTDPQTQSTRVGVVAESGPDERRVALVPKAVASLVNRGVAVVVEAGAGERALLPDELYTAVGASIGDAWAADVVVKVAPPTAAEVGRLRGGQTLIGFLAPRNADNSIGALTQAGVQAFALEAIPRISRAQVMDALSSQANVSGYKAVLLAASESTRFFPMLTTAAGTVKPATVLVLGVGVAGLQALATAKRLGARTTGYDVRPEVADQVRSVGAQWLDLGISASGEGGYARELTDDERAQQQKALEEAISGFDVVITTALVPGRPAPTLVTAAAVEAMKPGSVVVDLAGETGGNCELTEPGRTVVKHDVTIAAPLNLPATMPEHASELYSKNITALLDLLIKDGRLAPDFDDEVIAQSCVTRGKDS		366		4	Soluble	-1	 	
Batch03	MytuD.00690.a	Mycobacterium tuberculosis	NP_215974.1	O53149				PROBABLE UNIDENTIFIED ANTIBIOTIC-TRANSPORT ATP-BINDING PROTEIN ABC TRANSPORTER	Potential drug target		MNRAPDTPEVVLRLRGVCKRYGSITAVSNLDLDVHDAEVMALLGPNGAGKTTTVEMCEGFVRPDAGSIEVLGLDPITDNARLRARIGVMLQGGGGYPAARAGEMLDLVASYAANPLDPHWLLDTLGLTEAARTTYRRLSGGQQQRLALACALVGRPQLVFLDEPTAGMDAHARVLVWELIDALRRDGVTVVLTTHHLKEAEELADRLVIIDHGVTVAAGTPAELMRSGAKDQLRFTAPPRLDLSLLASALPEGYQATELTPGEYLVEGPVDPQVLATVTAWCAQIDVLATDMRVEQRSLEDVFLDLTGRKLRQ		313		3	Expressed	-1	 	NR-16409
Batch03	MytuD.00693.a	Mycobacterium tuberculosis	NP_215667.1	P66813				NAD-dependent deacetylase	Potential drug target		MRVAVLSGAGISAESGVPTFRDDKNGLWARFDPYELSSTQGWLRNPERVWGWYLWRHYLVANVEPNDGHRAIAAWQDHAEVSVITQNVDDLHERAGSGAVHHLHGSLFEFRCARCGVPYTDALPEMPEPAIEVEPPVCDCGGLIRPDIVWFGEPLPEEPWRSAVEATGSADVMVVVGTSAIVYPAAGLPDLALARGTAVIEVNPEPTPLSGSATISIRESASQALPGLLERLPALLK		237		5	Purified	-1	 	NR-16410
Batch03	MytuD.00698.a	Mycobacterium tuberculosis	NP_215647.1	O08395				methylcitrate synthase	Potential drug target		MTGPLAAARSVAATKSMTAPTVDERPDIKKGLAGVVVDTTAISKVVPQTNSLTYRGYPVQDLAARCSFEQVAFLLWRGELPTDAELALFSQRERASRRVDRSMLSLLAKLPDNCHPMDVVRTAISYLGAEDPDEDDAAANRAKAMRMMAVLPTIVAIDMRRRRGLPPIAPHSGLGYAQNFLHMCFGEVPETAVVSAFEQSMILYAEHGFNASTFAARVVTSTQSDIYSAVTGAIGALKGRLHGGANEAVMHDMIEIGDPANAREWLRAKLARKEKIMGFGHRVYRHGDSRVPTMKRALERVGTVRDGQRWLDIYQVLAAEMASATGILPNLDFPTGPAYYLMGFDIASFTPIFVMSRITGWTAHIMEQATANALIRPLSAYCGHEQRVLPGTF		393		17	In PDB	-1	 	
Batch03	MytuD.00746.a	Mycobacterium tuberculosis	NP_215754.1	O50454				PROBABLE SUGAR-TRANSPORT ATP-BINDING PROTEIN ABC TRANSPORTER SUGC	Potential drug target		MAEIVLDHVNKSYPDGHTAVRDLNLTIADGEFLILVGPSGCGKTTTLNMIAGLEDISSGELRIAGERVNEKAPKDRDIAMVFQSYALYPHMTVRQNIAFPLTLAKMRKADIAQKVSETAKILDLTNLLDRKPSQLSGGQRQRVAMGRAIVRHPKAFLMDEPLSNLDAKLRVQMRGEIAQLQRRLGTTTVYVTHDQTEAMTLGDRVVVMYGGIAQQIGTPEELYERPANLFVAGFIGSPAMNFFPARLTAIGLTLPFGEVTLAPEVQGVIAAHPKPENVIVGVRPEHIQDAALIDAYQRIRALTFQVKVNLVESLGADKYLYFTTESPAVHSVQLDELAEVEGESALHENQFVARVPAESKVAIGQSVELAFDTARLAVFDADSGANLTIPHRA		393		2	Cloned	-1	 	
Batch03	MytuD.00750.a	Mycobacterium tuberculosis	NP_215448.1	P95302				PHOSPHATE-TRANSPORT ATP-BINDING PROTEIN ABC TRANSPORTER PSTB	Potential drug target		MACERLGGQSGAADVDAAAPAMAAVNLTLGFAGKTVLDQVSMGFPARAVTSLMGPTGSGKTTFLRTLNRMNDKVSGYRYSGDVLLGGRSIFNYRDVLEFRRRVGMLFQRPNPFPMSIMDNVLAGVRAHKLVPRKEFRGVAQARLTEVGLWDAVKDRLSDSPFRLSGGQQQLLCLARTLAVNPEVLLLDEPTSALDPTTTEKIEEFIRSLADRLTVIIVTHNLAQAARISDRAALFFDGRLVEEGPTEQLFSSPKHAETARYVAGLSGDVKDAKRGN		276		2	Cloned	-1	 	
Batch03	MytuD.00751.a	Mycobacterium tuberculosis	NP_214584.1	O53615				PROBABLE SERINE HYDROXYMETHYLTRANSFERASE GLYA2 (SERINE METHYLASE 2) (SHMT 2)	Potential drug target		MNTLNDSLTAFDPDIAALIDGELRRQESGLEMIASENYAPLAVMQAQGSVLTNKYAEGYPGRRYYGGCEFVDGVEQLAIDRVKALFGAEYANVQPHSGATANAATMHALLNPGDTILGLSLAHGGHLTHGMRINFSGKLYHATAYEVSKEDYLVDMDAVAEAARTHRPKMIIAGWSAYPRQLDFARFRAIADEVDAVLMVDMAHFAGLVAAGVHPSPVPHAHVVTSTTHKTLGGPRGGIILCNDPAIAKKINSAVFPGQQGGPLEHVIAAKATAFKMAAQPEFAQRQQRCLDGARILAGRLTQPDVAERGIAVLTGGTDVHLVLVDLRDAELDGQQAEDRLAAVDITVNRNAVPFDPRPPMITSGLRIGTPALAARGFSHNDFRAVADLIAAALTATNDDQLGPLRAQVQRLAARYPLYPELHRT		425		3	Expressed	-1	 	
Batch03	MytuD.00753.a	Mycobacterium tuberculosis	NP_216554.1	O53482				Probable sugar-transport ATP-binding protein ABC transporter	Potential drug target		MASVSFEQATRRYPGTDRPALDRLDLIVGDGEFVVLVGPSGCGKTTSLRMVAGLETLDCGRIRIGERDVTEVDPKDRDVAMVFQNYALYPHMTVAQNMGFALKVAKIGKAEIRERVLAAAKLLDLQSYLDRKPKDLSGGQRQRVAMGRAIVRRPQVFLMDEPLSNLDAKLRGQTRNQIAALQRQLGTTTVYVTHDQVEAMTMGDRVAVLSDGVLQQCASPRELYRNPGNVFVAGFIGSPAMNLFRLSIADSTVSLGDWQILLPRAVVGTAAEVIIGVRPEHLELGGAGIEMDVDMVEELGADAYLYGRIVSGGCEMDQSIVARVDGRGPPERGSRVRLCPTPGHLHFFAVDGRRIPG		357		2	Cloned	-1	 	
Batch03	MytuD.00754.a	Mycobacterium tuberculosis	NP_215778.1	Q11066				HYPOTHETICAL HIT-LIKE PROTEIN	Potential drug target		MPCVFCAIIAGEAPAIRIYEDGGYLAILDIRPFTRGHTLVLPKRHTVDLTDTPPEALADMVAIGQRIARAARATKLADATHIAINDGRAAFQTVFHVHLHVLPPRNGDKLSVAKGMMLRRDPDREATGRILREALAQQDAAAQD		144		3	Expressed	-1	 	
Batch03	MytuD.00762.a	Mycobacterium tuberculosis	NP_218076.1	P96841				short chain dehydrogenase	Potential drug target		MNLSVAPKEIAGHGLLDGKVVVVTAAAGTGIGSATARRALAEGADVVISDHHERRLGETAAELSALGLGRVEHVVCDVTSTAQVDALIDSTTARMGRLDVLVNNAGLGGQTPVADMTDDEWDRVLDVSLTSVFRATRAALRYFRDAPHGGVIVNNASVLGWRAQHSQSHYAAAKAGVMALTRCSAIEAAEYGVRINAVSPSIARHKFLDKTASAELLDRLAAGEAFGRAAEPWEVAATIAFLASDYSSYLTGEVISVSCQHP		262		4	Soluble	-1	 	
Batch03	MytuD.00768.a	Mycobacterium tuberculosis	NP_215324.1	O53823				phosphoribosylaminoimidazole synthetase	Potential drug target		MTDLAKGPGKDPGSRGITYASAGVDIEAGDRAIDLFKPLASKATRPEVRGGLGGFAGLFTLRGDYREPVLAASSDGVGTKLAIAQAMDKHDTVGLDLVAMVVDDLVVCGAEPLFLLDYIAVGRIVPERLSAIVAGIADGCMRAGCALLGGETAEHPGLIEPDHYDISATGVGVVEADNVLGPDRVKPGDVIIAMGSSGLHSNGYSLVRKVLLEIDRMNLAGHVEEFGRTLGEELLEPTRIYAKDCLALAAETRVRTFCHVTGGGLAGNLQRVIPHGLIAEVDRGTWTPAPVFTMIAQRGRVRRTEMEKTFNMGVGMIAVVAPEDTTRALAVLTARHLDCWVLGTVCKGGKQGPRAKLVGQHPRF		364		5	Purified	-1	 	
Batch03	MytuD.00774.a	Mycobacterium tuberculosis	NP_214903.1	P95197				phosphoribosylglycinamide formyltransferase 2	Potential drug target		MIDGWTEEQHEPTVRHERPAAPQDVRRVMLLGSAEPSRELAIALQGLGAEVIAVDGYVGAPAHRIADQSVVVTMTDAEELTAVIRRLQPDFLVTVTAAVSVDALDAVEQADGECTELVPNARAVRCTADREGLRRLAADQLGLPTAPFWFVGSLGELQAVAVHAGFPLLVSPVAGVAGQGSSVVAGPNEVEPAWQRAAGHQVQPQTGGVSPRVCAESVVEIEFLVTMIVVCSQGPNGPLIEFCAPIGHRDADAGELESWQPQKLSTAALDAAKSIAARIVKALGGRGVFGVELMINGDEVYFADVTVCPAGSAWVTVRSQRLSVFELQARAILGLAVDTLMISPGAARVINPDHTAGRAAVGAAPPADALTGALGVPESDVVIFGRGLGVALATAPEVAIARERAREVASRLNVPDSRE		419		5	Purified	-1	 	
Batch03	MytuD.00778.a	Mycobacterium tuberculosis	NP_215499.1	O53897				POSSIBLE PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE MOAB2 (PHS) (4-ALPHA-HYDROXY-TETRAHYDROPTERIN DEHYDRATASE) (PTERIN-4-A-CARBINOLAMINE DEHYDRATASE) (PHENYLALANINE HYDROXYLASE-STIMULATING PROTEIN) (PHS) (PTERIN CARBINOLAMINE DEHYDRATASE) (PCD)	Potential drug target		MKVAAQCSKLGYTVAPMEQRAELVVGRALVVVVDDRTAHGDEDHSGPLVTELLTEAGFVVDGVVAVSADEVEIRNALNTAVIGGVDLVVSVGGTGVTPRDVTPEATRDILDREILGIAEAIRASGLSAGIVDAGLSRGLAGVSGSTLVVNLAGSRYAVRDGMATLNPLAAQIIGQLSSLEI		181		10	Diffraction	-1	 	
Batch03	MytuD.00781.a	Mycobacterium tuberculosis	NP_215590.1	O53422				acetyl-CoA acetyltransferase	Potential drug target		MPEAVIVSTARSPIGRAMKGSLVGMRPDDLAVQMVRAALDKVPALNPHQIDDLMMGCGLPGGESGFNIARVVAVALGYDFLPGTTVNRYCSSSLQTTRMAFHAIKAGEGDAFISAGVETVSRFAKGNSDSWPDTKNPLFDGAQERSAAAAAGADEWHDPRTDQKLPDIYIAMGQTAENVAIMTGISREEQDRWGVRSQNRAEEAIKNGFFEREITPVTLPDGTTVSTDDGPRPGTTYEKVSELKPAFRPNGTVTAGNACPLNDGAAAVVITSDTKAKELGLTPLARIVSTGVSGLSPEIMGLGPIEASKKALERAGMAITDIDLVEINEAFAVQVLGSARELGIDEDKLNISGGAIALGHPFGMTGARITTTLLNNLQTYDKTFGLETMCVGGGQGMAMVIERLA		405		3	Expressed	-1	 	NR-16411
Batch03	MytuD.00783.a	Mycobacterium tuberculosis	YP_177787.1	O53441				serine hydroxymethyltransferase	Potential drug target		MSAPLAEVDPDIAELLAKELGRQRDTLEMIASENFVPRAVLQAQGSVLTNKYAEGLPGRRYYGGCEHVDVVENLARDRAKALFGAEFANVQPHSGAQANAAVLHALMSPGERLLGLDLANGGHLTHGMRLNFSGKLYENGFYGVDPATHLIDMDAVRATALEFRPKVIIAGWSAYPRVLDFAAFRSIADEVGAKLLVDMAHFAGLVAAGLHPSPVPHADVVSTTVHKTLGGGRSGLIVGKQQYAKAINSAVFPGQQGGPLMHVIAGKAVALKIAATPEFADRQRRTLSGARIIADRLMAPDVAKAGVSVVSGGTDVHLVLVDLRDSPLDGQAAEDLLHEVGITVNRNAVPNDPRPPMVTSGLRIGTPALATRGFGDTEFTEVADIIATALATGSSVDVSALKDRATRLARAFPLYDGLEEWSLVGR		426		17	In PDB	-1	 	
Batch03	MytuD.00786.a	Mycobacterium tuberculosis	NP_215857.1	P64307				putative deoxyribonucleotide triphosphate pyrophosphatase	Potential drug target		MALVTKLLVASRNRKKLAELRRVLDGAGLSGLTLLSLGDVSPLPETPETGVTFEDNALAKARDAFSATGLASVADDSGLEVAALGGMPGVLSARWSGRYGDDAANTALLLAQLCDVPDERRGAAFVSACALVSGSGEVVVRGEWPGTIAREPRGDGGFGYDPVFVPYGDDRTAAQLSPAEKDAVSHRGRALALLLPALRSLATG		204		7	Crystallized	-1	 	
Batch03	MytuD.00797.a	Mycobacterium tuberculosis	NP_217204.1	O07190				PROBABLE ANTIBIOTIC-TRANSPORT ATP-BINDING PROTEIN ABC TRANSPORTER	Potential drug target		MTALNRAVASARVGTEVIRVRGLTFRYPKAAEPAVRGMEFTVGRGEIFGLLGPSGAGKSTTQKLLIGLLRDHGGQATVWDKEPAEWGPDYYERIGVSFELPNHYQKLTGYENLRFFASLYAGATADPMQLLAAVGLADDAHTLVGKYSKGMQMRLPFARSLINDPELLFLDEPTSGLDPVNARKIKDIIVDLKARGRTIFLTTHDMATADELCDRVAFVVDGRIVALDSPTELKIARSRRRVRVEYRGDGGGLETAEFGMDGLADDPAFHSVLRNHHVETIHSREASLDDVFVEVTGRQLT		301		3	Expressed	-1	 	
Batch03	MytuD.00814.a	Mycobacterium tuberculosis	NP_216219.1	O33202				Probable catechol-o-methyltransferase	Potential drug target		MLATIDKFAYEKSMLINVGDEKGTLLDAAVRRADPALALELGTYLGYGALRIARAAPEARVYSVELAEANASNARRIWAHAGVDDRVVCVVGTIGDGGRTLDALTEHGFATGTLDFVFLDHDKKAYLPDLQSILDRGWLHPGSIVVADNVRVPGAPKYRAYMRRQQGMSWNTIEHKTHLEYQTLVPDLVLESEYLG		196		4	Soluble	-1	 	
Batch03	MytuD.00829.a	Mycobacterium tuberculosis	NP_217195.1	O53232				enoyl-CoA hydratase	Potential drug target		MPVTYDDFPSLRCEIHDQPGHEGVLELVLDSPGLNSVGPHMHRDLADIWPVIDRDPAVRVVLVRGEGKAFSSGGSFDLIAETIGDYQGRLRIMREARDLVLNLVNFDKPVVSAIRGPAVGAGLVVALLADISVAGRAAKIIDGHTKLGVAAGDHAAICWPLLVGMAKAKYYLLTCEPLSGEEAERIGLVSICVDDDDVLPTATRLAERLAAGAQNAIRWTKRSLNHWYRMFGPAFETSLGLEFIGFGGPDVREGLAAHREKRPARFGADPDPGAGS		276		2	Cloned	-1	 	
Batch03	MytuD.00887.a	Mycobacterium tuberculosis	NP_217317.1	P71650				hypothetical protein	Potential drug target		MMRRGEIWQVDLDPARGSEANNQRPAVVVSNDRANATATRLGRGVITVVPVTSNIAKVYPFQVLLSATTTGLQVDCKAQAEQIRSIATERLLRPIGRVSAAELAQLDEALKLHLDLWS		118		3	Expressed	-1	 	
Batch03	MytuD.00891.a	Mycobacterium tuberculosis	NP_216230.1	O53927				Probable oxidoreductase	Potential drug target		MEEMALAQQVPNLGLARFSVQDKSILITGATGSLGRVAARALADAGARLTLAGGNSAGLAELVNGAGIDDAAVVTCRPDSLADAQQMVEAALGRYGRLDGVLVASGSNHVAPITEMAVEDFDAVMDANVRGAWLVCRAAGRVLLEQGQGGSVVLVSSVRGGLGNAAGYSAYCPSKAGTDLLAKTLAAEWGGHGIRVNALAPTVFRSAVTEWMFTDDPKGRATREAMLARIPLRRFAEPEDFVGALIYLLSDASSFYTGQVMYLDGGYTAC		270		10	Diffraction	-1	 	
Batch03	MytuD.00896.a	Mycobacterium tuberculosis	NP_215411.1	Q10530				type II citrate synthase	Potential drug target		MADTDDTATLRYPGGEIDLQIVHATEGADGIALGPLLAKTGHTTFDVGFANTAAAKSSITYIDGDAGILRYRGYPIDQLAEKSTFIEVCYLLIYGELPDTDQLAQFTGRIQRHTMLHEDLKRFFDGFPRNAHPMPVLSSVVNALSAYYQDALDPMDNGQVELSTIRLLAKLPTIAAYAYKKSVGQPFLYPDNSLTLVENFLRLTFGFPAEPYQADPEVVRALDMLFILHADHEQNCSTSTVRLVGSSRANLFTSISGGINALWGPLHGGANQAVLEMLEGIRDSGDDVSEFVRKVKNREAGVKLMGFGHRVYKNYDPRARIVKEQADKILAKLGGDDSLLGIAKELEEAALTDDYFIERKLYPNVDFYTGLIYRALGFPTRMFTVLFALGRLPGWIAHWREMHDEGDSKIGRPRQIYTGYTERDYVTIDAR		431		10	Diffraction	-1	 	
Batch03	MytuD.00897.a	Mycobacterium tuberculosis	YP_177789.1	P0A586				glucose-6-phosphate 1-dehydrogenase	Potential drug target		MVDGGGGASDLLVIFGITGDLARKMTFRALYRLERHQLLDCPILGVASDDMSVGQLVKWARESIGRTEKIDDAVFDRLAGRLSYLHGDVTDSQLYDSLAELIGSACRPLYYLEMPPALFAPIVENLANVRLLERARVAVEKPFGHDLASALELNARLRAVLGEDQILRVDHFLGKQPVVELEYLRFANQALAELWDRNSISEIHITMAEDFGVEDRGKFYDAVGALRDVVQNHLLQVLALVTMEPPVGSSADDLNDKKAEVFRAMAPLDPDRCVRGQYLGYTEVAGVASDSATETYVALRTEIDNWRWAGVPIFVRAGKELPAKVTEVRLFLRRVPALAFLPNRRPAEPNQIVLRIDPDPGMRLQISAHTDDSWRDIHLDSSFAVDLGEPIRPYERLLYAGLVGDHQLFAREDSIEQTWRIVQPLLDNPGEIHRYDRGSWGPEAAQSLLRGHRGWQSPWLPRGTDA		466		7	Crystallized	-1	 	
Batch03	MytuD.00906.a	Mycobacterium tuberculosis	NP_215595.1	P66875				cystathionine gamma-synthase	Potential drug target		MSEDRTGHQGISGPATRAIHAGYRPDPATGAVNVPIYASSTFAQDGVGGLRGGFEYARTGNPTRAALEASLAAVEEGAFARAFSSGMAATDCALRAMLRPGDHVVIPDDAYGGTFRLIDKVFTRWDVQYTPVRLADLDAVGAAITPRTRLIWVETPTNPLLSIADITAIAELGTDRSAKVLVDNTFASPALQQPLRLGADVVLHSTTKYIGGHSDVVGGALVTNDEELDEEFAFLQNGAGAVPGPFDAYLTMRGLKTLVLRMQRHSENACAVAEFLADHPSVSSVLYPGLPSHPGHEIAARQMRGFGGMVSVRMRAGRRAAQDLCAKTRVFILAESLGGVESLIEHPSAMTHASTAGSQLEVPDDLVRLSVGIEDIADLLGDLEQALG		388		4	Soluble	-1	 	NR-16442
Batch03	MytuD.00922.a	Mycobacterium tuberculosis	NP_215216.1	P60729				50S ribosomal protein L4	Potential drug target		MAAQEQKTLKIDVKTPAGKVDGAIELPAELFDVPANIALMHQVVTAQRAAARQGTHSTKTRGEVSGGGRKPYRQKGTGRARQGSTRAPQFTGGGVVHGPKPRDYSQRTPKKMIAAALRGALSDRARNGRIHAITELVEGQNPSTKSARAFLASLTERKQVLVVIGRSDEAGAKSVRNLPGVHILAPDQLNTYDVLRADDVVFSVEALNAYIAANTTTSEEVSA		223		-2	Work stopped	-2	Work stopped	
Batch03	MytuD.00937.a	Mycobacterium tuberculosis	NP_217422.1	P66968				tRNA (guanine-N(1)-)-methyltransferase	Potential drug target		MRIDIVTIFPACLDPLRQSLPGKAIESGLVDLNVHDLRRWTHDVHHSVDDAPYGGGPGMVMKAPVWGEALDEICSSETLLIVPTPAGVLFTQATAQRWTTESHLVFACGRYEGIDQRVVQDAARRMRVEEVSIGDYVLPGGESAAVVMVEAVLRLLAGVLGNPASHQDDSHSTGLDGLLEGPSYTRPASWRGLDVPEVLLSGDHARIAAWRREVSLQRTRERRPDLSHPD		230		2	Cloned	-1	 	
Batch03	MytuD.00938.a	Mycobacterium tuberculosis	YP_177681.1					hypothetical protein	Potential drug target		MLIRWHIQLGNIVIPKSVNPMRIASNFDAFDFPRSMTEPGLVRIRKPSISQAGEMT		56		2	Cloned	-1	 	
Batch03	MytuD.00950.a	Mycobacterium tuberculosis	NP_214932.1	P96264				PROBABLE LIPOPROTEIN AMINOPEPTIDASE LPQL	Potential drug target		MVNKSRMMPAVLAVAVVVAFLTTGCIRWSTQSRPVVNGPAAAEFAVALRNRVSTDAMMAHLSKLQDIANANDGTRAVGTPGYQASVDYVVNTLRNSGFDVQTPEFSARVFKAEKGVVTLGGNTVEARALEYSLGTPPDGVTGPLVAAPADDSPGCSPSDYDRLPVSGAVVLVDRGVCPFAQKEDAAAQRGAVALIIADNIDEQAMGGTLGANTDVKIPVVSVTKSVGFQLRGQSGPTTVKLTASTQSFKARNVIAQTKTGSSANVVMAGAHLDSVPEGPGINDNGSGVAAVLETAVQLGNSPHVSNAVRFAFWGAEEFGLIGSRNYVESLDIDALKGIALYLNFDMLASPNPGYFTYDGDQSLPLDARGQPVVPEGSAGIERTFVAYLKMAGKTAQDTSFDGRSDYDGFTLAGIPSGGLFSGAEVKKSAEQAELWGGTADEPFDPNYHQKTDTLDHIDRTALGINGAGVAYAVGLYAQDLGGPNGVPVMADRTRHLIAKP		500		3	Expressed	-1	 	
Batch03	MytuD.00951.a	Mycobacterium tuberculosis	NP_215779.1	P63492				amidase	Potential drug target		MDPTDLAFAGAAAQARMLADGALTAPMLLEVYLQRIERLDSHLRAYRVVQFDRARAEAEAAQQRLDAGERLPLLGVPIAIKDDVDIAGEVTTYGSAGHGPAATSDAEVVRRLRAAGAVIIGKTNVPELMIMPFTESLAFGATRNPWCLNRTPGGSSGGSAAAVAAGLAPVALGSDGGGSIRIPCTWCGLFGLKPQRDRISLEPHDGAWQGLSVNGPIARSVMDAALLLDATTTVPGPEGEFVAAAARQPGRLRIALSTRVPTPLPVRCGKQELAAVHQAGALLRDLGHDVVVRDPDYPASTYANYLPRFFRGISDDADAQAHPDRLEARTRAIARLGSFFSDRRMAALRAAEVVLSSRIQSIFDDVDVVVTPGAATGPSRIGAYQRRGAVSTLLLVVQRVPYFQVWNLTGQPAAVVPWDFDGDGLPMSVQLVGRPYDEATLLALAAQIESARPWAHRRPSVS		462		4	Soluble	-1	 	
Batch03	MytuD.01007.a	Mycobacterium tuberculosis	NP_217570.1	P95105				hypothetical protein	Potential drug target		MSDTKSDIKILALVGSLRAASFNRQIAELAAKVAPDGVTVTMFEGLGDLPFYNEDIDTATEVPAPVSALREAASDAHAALVVTPEYNGSIPAVIKNAIDWLSRPFGDGALKDKPLAVIGGSMGRYGGVWAHDETRKSFSIAGTRVVDAIKLSVPFQTLGKSVADDAGLAANVRDAVGNLAAEVG		184		7	Crystallized	-1	 	
Batch03	MytuD.01026.a	Mycobacterium tuberculosis	NP_217105.1	P63504				4-aminobutyrate aminotransferase	Potential drug target		MASLQQSRRLVTEIPGPASQALTHRRAAAVSSGVGVTLPVFVARAGGGIVEDVDGNRLIDLGSGIAVTTIGNSSPRVVDAVRTQVAEFTHTCFMVTPYEGYVAVAEQLNRITPGSGPKRSVLFNSGAEAVENAVKIARSYTGKPAVVAFDHAYHGRTNLTMALTAKSMPYKSGFGPFAPEIYRAPLSYPYRDGLLDKQLATNGELAAARAIGVIDKQVGANNLAALVIEPIQGEGGFIVPAEGFLPALLDWCRKNHVVFIADEVQTGFARTGAMFACEHEGPDGLEPDLICTAKGIADGLPLSAVTGRAEIMNAPHVGGLGGTFGGNPVACAAALATIATIESDGLIERARQIERLVTDRLTTLQAVDDRIGDVRGRGAMIAVELVKSGTTEPDAGLTERLATAAHAAGVIILTCGMFGNIIRLLPPLTIGDELLSEGLDIVCAILADL		449		10	Diffraction	-1	 	
Batch03	MytuD.01046.a	Mycobacterium tuberculosis	NP_216342.1	Q50607				glycine cleavage system protein H	Potential drug target		MSDIPSDLHYTAEHEWIRRSGDDTVRVGITDYAQSALGDVVFVQLPVIGTAVTAGETFGEVESTKSVSDLYAPISGKVSEVNSDLDGTPQLVNSDPYGAGWLLDIQVDSSDVAALESALTTLLDAEAYRGTLTE		134		17	In PDB	-1	 	
Batch03	MytuD.01048.a	Mycobacterium tuberculosis	NP_215266.1	O53815				PROBABLE ACYL-CoA DEHYDROGENASE FADE9	Potential drug target		MFVLNDDERVIVETAAAFAGKRLAPHALEWDAAKHFPVDVLREAAELGMAAIYCRDDVGGSGLRRLDGVRIFEQLAIADPVTAAFLSIHNMCAWMIDSFGTDEQRKDWIPRLATMGVIASYCLTEPGAGSDAGALSTRAVRHGSGKGGDYVLDGVKQFISGAAASDVYVVMARTGAEGPRGVSAFIVEKGTPGLSFGAPEAKMGWHAQPTAQVVLDGVRVPAEAMLGGADGEGAGFGIAMSGLNGGRLNIAACSLGGAQAAFDKAGAYVRDRQAFGGSLLDEPTVRFTLADMATGLQTSRMLLWRAASALDDDDADKVELCAMAKRYVTDTCFEVADQALQLHGGYGYLREYGLEKIVRDLRVHRILEGTNEIMRLVIGRAEAARFRATV		390		7	Crystallized	-1	 	
Batch03	MytuD.01058.a	Mycobacterium tuberculosis	NP_215873.1	P64829				hypothetical protein	Potential drug target		MDRCCQRATAFACALRPTKLIDYEEMFRGAMQARAMVANPDQWADSDRDQVNTRHYLSTSMRVALDRGEFFLVYQPIIRLADNRIIGAEALLRWEHPTLGTLLPGRFIDRAENNGLMVPLTAFVLEQACRHVRSWRDHSTDPQPFVSVNVSASTICDPGFLVLVEGVLGETGLPAHALQLELAEDARLSRDEKAVTRLQELSALGVGIAIDDFGIGFSSLAYLPRLPVDVVKLGGKFIECLDGDIQARLANEQITRAMIDLGDKLGITVTAKLVETPSQAARLRAFGCKAAQGWHFAKALPVDFFRE		307		3	Expressed	-1	 	NR-16412
Batch03	MytuD.01068.a	Mycobacterium tuberculosis	NP_215294.1	P0A5T4				phosphoribosylaminoimidazole-succinocarboxamide synthase	Potential drug target		MRPALSDYQHVASGKVREIYRVDDEHLLLVASDRISAYDYVLDSTIPDKGRVLTAMSAFFFGLVDAPNHLAGPPDDPRIPDEVLGRALVVRRLEMLPVECVARGYLTGSGLLDYQATGKVCGIALPPGLVEASRFATPLFTPATKAALGDHDENISFDRVVEMVGALRANQLRDRTLQTYVQAADHALTRGIIIADTKFEFGIDRHGNLLLADEIFTPDSSRYWPADDYRAGVVQTSFDKQFVRSWLTGSESGWDRGSDRPPPPLPEHIVEATRARYINAYERISELKFDDWIGPGA		297		5	Purified	-1	 	
Batch03	MytuD.01073.a	Mycobacterium tuberculosis	NP_217663.1	P65571				NADH dehydrogenase subunit C	Potential drug target		MSPPNQDAQEGRPDSPTAEVVDVRRGMFGVSGTGDTSGYGRLVRQVVLPGSSPRPYGGYFDDIVDRLAEALRHERVEFEDAVEKVVVYRDELTLHVRRDLLPRVAQRLRDEPELRFELCLGVSGVHYPHETGRELHAVYPLQSITHNRRLRLEVSAPDSDPHIPSLFAIYPTNDWHERETYDFFGIIFDGHPALTRIEMPDDWQGHPQRKDYPLGGIPVEYKGAQIPPPDERRGYN		236		5	Purified	-1	 	
Batch03	MytuD.01083.a	Mycobacterium tuberculosis	NP_215330.1	O05793				PROBABLE THIOSULFATE SULFURTRANSFERASE CYSA2 (RHODANESE-LIKE PROTEIN) (THIOSULFATE CYANIDE TRANSSULFURASE) (THIOSULFATE THIOTRANSFERASE)	Potential drug target		MARCDVLVSADWAESNLHAPKVVFVEVDEDTSAYDRDHIAGAIKLDWRTDLQDPVKRDFVDAQQFSKLLSERGIANEDTVILYGGNNNWFAAYAYWYFKLYGHEKVKLLDGGRKKWELDGRPLSSDPVSRPVTSYTASPPDNTIRAFRDEVLAAINVKNLIDVRSPDEFSGKILAPAHLPQEQSQRPGHIPGAINVPWSRAANEDGTFKSDEELAKLYADAGLDNSKETIAYCRIGERSSHTWFVLRELLGHQNVKNYDGSWTEYGSLVGAPIELGS		277		17	In PDB	-1	 	
Batch03	MytuD.01097.a	Mycobacterium tuberculosis	NP_215761.1	O50460				PROBABLE SHORT-CHAIN TYPE DEHYDROGENASE/REDUCTASE	Potential drug target		MEGFAGKVAVVTGAGSGIGQALAIELARSGAKVAISDVDTDGLADTEHRLKAISTPVKTDRLDVTEREAFLAYADAVNEHFGTVNQIYNNAGIAFTGDIEVSQFKDIERVMDVDFWGVVNGTKAFLPHLIASGDGHVINISSVFGLFSAPGQAAYNSAKFAVRGFTEALRQEMALAGHPVKVTTVHPGGVKTAIARNATAAEGLDQAELAETFDKRVAHLSPQRAAQIILTGVAKNKARVLVGVDAKVLDLVVRLTGSGYQRIFPIITGRLIPRPR		276		5	Purified	-1	 	
Batch03	MytuD.01105.a	Mycobacterium tuberculosis	NP_215215.1	P60442				50S ribosomal protein L3	Potential drug target		MARKGILGTKLGMTQVFDESNRVVPVTVVKAGPNVVTRIRTPERDGYSAVQLAYGEISPRKVNKPLTGQYTAAGVNPRRYLAELRLDDSDAATEYQVGQELTAEIFADGSYVDVTGTSKGKGFAGTMKRHGFRGQGASHGAQAVHRRPGSIGGCATPARVFKGTRMAGRMGNDRVTVLNLLVHKVDAENGVLLIKGAVPGRTGGLVMVRSAIKRGEK		217		-2	Work stopped	-2	Work stopped	
Batch03	MytuD.01113.a	Mycobacterium tuberculosis	NP_215852.1	P63873				PROBABLE CYSTEINE SYNTHASE B CYSM (CSASE B) (O-acetylserine sulfhydrylase B) (O-acetylserine (Thiol)-lyase B)	Potential drug target		MTRYDSLLQALGNTPLVGLQRLSPRWDDGRDGPHVRLWAKLEDRNPTGSIKDRPAVRMIEQAEADGLLRPGATILEPTSGNTGISLAMAARLKGYRLICVMPENTSVERRQLLELYGAQIIFSAAEGGSNTAVATAKELAATNPSWVMLYQYGNPANTDSHYCGTGPELLADLPEITHFVAGLGTTGTLMGTGRFLREHVANVKIVAAEPRYGEGVYALRNMDEGFVPELYDPEILTARYSVGAVDAVRRTRELVHTEGIFAGISTGAVLHAALGVGAGALAAGERADIALVVADAGWKYLSTGAYAGSLDDAETALEGQLWA		323		5	Purified	-1	 	
Batch03	MytuD.01117.a	Mycobacterium tuberculosis	NP_218060.1	P71858				PROBABLE ACYL-CoA DEHYDROGENASE FADE29	Potential drug target		MFIDLTPEQRQLQAEIRQYFSNLISPDERTEMEKDRHGPAYRAVIRRMGRDGRLGVGWPKEFGGLGFGPIEQQIFVNEAHRADVPLPAVTLQTVGPTLQAHGSELQKKKFLPAILAGEAHFAIGYTEPEAGTDLASLRTTAVRDGDHYIVNGQKVFTTGAHDADYIWLACRTDPNAAKHKGISILIVDTKDPGYSWTPIILADGAHHTNATYYNDVRVPVDMLVGKENDGWRLITTQLNNERVMLGPAGRFASIYDRVHAWASVPGGNGVTPIDHDDVKRALGEIRAIWRINELLNWQVASAGEDINMADAAATKVFGTERVQRAGRLAEEIVGKYGNPAEPDTAELLRWLDAQTKRNLVITFGGGVNEVMREMIAASGLKVPRVPR		387		5	Purified	-1	 	
Batch03	MytuD.01124.a	Mycobacterium tuberculosis	NP_217452.1	P96205				PROBABLE DAUNORUBICIN-DIM-TRANSPORT ATP-BINDING PROTEIN ABC TRANSPORTER DRRA	Potential drug target		MRNDDMAVVVNGVRKTYGKGKIVALDDVSFKVRRGEVIGLLGPNGAGKTTMVDILSTLTRPDAGSAIIAGYDVVSEPAGVRRSIMVTGQQVAVDDALSGEQNLVLFGRLWGLSKSAARKRAAELLEQFSLVHAGKRRVGTYSGGMRRRIDIACGLVVQPQVAFLDEPTTGLDPRSRQAIWDLVASFKKLGIATLLTTQYLEEADALSDRIILIDHGIIIAEGTANELKHRAGDTFCEIVPRDLKDLDAIVAALGSLLPEHHRAMLTPDSDRITMPAPDGIRMLVEAARRIDEARIELADIALRRPSLDHVFLAMTTDPTESLTHLVSGSAR		331		4	Soluble	-1	 	
Batch03	MytuD.01125.a	Mycobacterium tuberculosis	NP_217120.1	O06210				hypothetical protein	Potential drug target		MSVPRVGVLALQGDTREHLAALRECGAEPMTVRRRDELDAVDALVIPGGESTTMSHLLLDLDLLGPLRARLADGLPAYGSCAGMILLASEILDAGAAGRQALPLRAMNMTVRRNAFGSQVDSFEGDIEFAGLDDPVRAVFIRAPWVERVGDGVQVLARAAGHIVAVRQGAVLATAFHPEMTGDRRIHQLFVDIVTSAA		198		3	Expressed	-1	 	
Batch03	MytuD.01147.a	Mycobacterium tuberculosis	YP_177782.1	Q7D8W0				Probable cystathionine beta-synthase CBS (Serine sulfhydrase) (Beta-thionase) (Hemoprotein H-450)	Potential drug target		MRIAQHISELIGGTPLVRLNSVVPDGAGTVAAKVEYLNPGGSSKDRIAVKMIEAAEASGQLKPGGTIVEPTSGNTGVGLALVAQRRGYKCVFVCPDKVSEDKRNVLIAYGAEVVVCPTAVPPHDPASYYSVSDRLVRDIDGAWKPDQYANPEGPASHYVTTGPEIWADTEGKVTHFVAGIGTGGTITGAGRYLKEVSGGRVRIVGADPEGSVYSGGAGRPYLVEGVGEDFWPAAYDPSVPDEIIAVSDSDSFDMTRRLAREEAMLVGGSCGMAVVAALKVAEEAGPDALIVVLLPDGGRGYMSKIFNDAWMSSYGFLRSRLDGSTEQSTVGDVLRRKSGALPALVHTHPSETVRDAIGILREYGVSQMPVVGAEPPVMAGEVAGSVSERELLSAVFEGRAKLADAVSAHMSPPLRMIGAGELVSAAGKALRDWDALMVVEEGKPVGVITRYDLLGFLSEGAGRR		464		2	Cloned	-1	 	
Batch03	MytuD.01152.a	Mycobacterium tuberculosis	NP_217194.1	O53231				uroporphyrinogen decarboxylase	Potential drug target		MSTRRDLPQSPYLAAVTGRKPSRVPVWFMRQAGRSLPEYRALRERYSMLAACFEPDVACEITLQPIRRYDVDAAILFSDIVVPLRAAGVDLDIVADVGPVIADPVRTAADVAAMKPLDPQAIQPVLVAASLLVAELGDVPLIGFAGAPFTLASYLVEGGPSRHHAHVKAMMLAEPASWHALMAKLTDLTIAFLVGQIDAGVDAIQVFDSWAGALSPIDYRQYVLPHSARVFAALGEHGVPMTHFGVGTAELLGAMSEAVTAGERPGRGAVVGVDWRTPLTDAAARVVPGTALQGNLDPAVVLAGWPAVERAARAVVDDGRRAVDAGAAGHIFNLGHGVLPESDPAVLADLVSLVHSL		357		3	Expressed	-1	 	
Batch03	MytuD.01155.a	Mycobacterium tuberculosis	NP_217558.1	O53289				phosphoserine phosphatase	Potential drug target		MPAKVSVLITVTGMDQPGVTSALFEVLAQHGVELLNVEQVVIRGRLTLGVLVSCPLDVADGTALRDDVAAAIHGVGLDVAIERSDDLPIIRQPSTHTIFVLGRPITAGAFSAVARGVAALGVNIDFIRGISDYPVTGLELRVSVPPGCVGPLQIALTKVAAEEHVDVAVEDYGLAWRTKRLIVFDVDSTLVQGEVIEMLAARAGAQGQVAAITEAAMRGELDFAESLQRRVATLAGLPATVIDDVAEQLELMPGARTTIRTLRRLGFRCGVVSGGFRRIIEPLARELMLDFVASNELEIVDGILTGRVVGPIVDRPGKAKALRDFASQYGVPMEQTVAVGDGANDIDMLGAAGLGIAFNAKPALREVADASLSHPYLDTVLFLLGVTRGEIEAADAGDCGVRRVEIPAD		409		7	Crystallized	-1	 	
Batch03	MytuD.01156.a	Mycobacterium tuberculosis	NP_217857.1	O53390				O-acetylhomoserine aminocarboxypropyltransferase	Potential drug target		MSADSNSTDADPTAHWSFETKQIHAGQHPDPTTNARALPIYATTSYTFDDTAHAAALFGLEIPGNIYTRIGNPTTDVVEQRIAALEGGVAALFLSSGQAAETFAILNLAGAGDHIVSSPRLYGGTYNLFHYSLAKLGIEVSFVDDPDDLDTWQAAVRPNTKAFFAETISNPQIDLLDTPAVSEVAHRNGVPLIVDNTIATPYLIQPLAQGADIVVHSATKYLGGHGAAIAGVIVDGGNFDWTQGRFPGFTTPDPSYHGVVFAELGPPAFALKARVQLLRDYGSAASPFNAFLVAQGLETLSLRIERHVANAQRVAEFLAARDDVLSVNYAGLPSSPWHERAKRLAPKGTGAVLSFELAGGIEAGKAFVNALKLHSHVANIGDVRSLVIHPASTTHAQLSPAEQLATGVSPGLVRLAVGIEGIDDILADLELGFAAARRFSADPQSVAAF		449		5	Purified	-1	 	
Batch03	MytuD.01188.a	Mycobacterium tuberculosis	NP_217923.1	P65075				PROBABLE DIOXYGENASE	Potential drug target		MTDLITVKKLGSRIGAQIDGVRLGGDLDPAAVNEIRAALLAHKVVFFRGQHQLDDAEQLAFAGLLGTPIGHPAAIALADDAPIITPINSEFGKANRWHTDVTFAANYPAASVLRAVSLPSYGGSTLWANTAAAYAELPEPLKCLTENLWALHTNRYDYVTTKPLTAAQRAFRQVFEKPDFRTEHPVVRVHPETGERTLLAGDFVRSFVGLDSHESRVLFEVLQRRITMPENTIRWNWAPGDVAIWDNRATQHRAIDDYDDQHRLMHRVTLMGDVPVDVYGQASRVISGAPMEIAG		295		3	Expressed	-1	 	
Batch03	MytuD.01189.a	Mycobacterium tuberculosis	NP_217657.1	P95185				PROBABLE NADPH QUINONE OXIDOREDUCTASE FADB4 (NADPH:QUINONE REDUCTASE) (ZETA-CRYSTALLIN)	Potential drug target		MRAVRVTRLEGPDAVEVAEVEEPTSAGVVIEVHAAGVAFPDALLTRGRYQYRPEPPFVLGAEIAGVVRSAPDNSQVRSGDRVVGLTMLTGGMAEVAVLSPERVFKLPDNMTFEAGAGVLFNDLTVYFALAVRGRLQAGETVLVHGAAGGIGTSTLRLAPALGASRTVAVVSTQEKAELATVAGATDVVLAEGFKDAVQELTNGRGVDIVVDPVGGDRFTDSLRSLAAGGRLLVIGFTGGEIPTVKVNRLLLNNIDVVGVGWGAWSLTHPDALAQQWSQLERLLRSGKLPPPEPVVYPLDQAAAAIASLENRTAKGKVVLRVRD		323		3	Expressed	-1	 	
Batch03	MytuD.01204.a	Mycobacterium tuberculosis	NP_215460.1	P71564				short chain dehydrogenase	Potential drug target		MLTGVTRQKILITGASSGLGAGMARSFAAQGRDLALCARRTDRLTELKAELSQRYPDIKIAVAELDVNDHERVPKVFAELSDEIGGIDRVIVNAGIGKGARLGSGKLWANKATIETNLVAALVQIETALDMFNQRGSGHLVLISSVLGVKGVPGVKAAYAASKAGVRSLGESLRAEYAQRPIRVTVLEPGYIESEMTAKSASTMLMVDNATGVKALVAAIEREPGRAAVPWWPWAPLVRLMWVLPPRLTRRFA		253		4	Soluble	-1	 	
Batch03	MytuD.01212.a	Mycobacterium tuberculosis	NP_215756.1	P0A5J6				malate dehydrogenase	Potential drug target		MSASPLKVAVTGAAGQIGYSLLFRLASGSLLGPDRPIELRLLEIEPALQALEGVVMELDDCAFPLLSGVEIGSDPQKIFDGVSLALLVGARPRGAGMERSDLLEANGAIFTAQGKALNAVAADDVRVGVTGNPANTNALIAMTNAPDIPRERFSALTRLDHNRAISQLAAKTGAAVTDIKKMTIWGNHSATQYPDLFHAEVAGKNAAEVVNDQAWIEDEFIPTVAKRGAAIIDARGASSAASAASATIDAARDWLLGTPADDWVSMAVVSDGSYGVPEGLISSFPVTTKGGNWTIVSGLEIDEFSRGRIDKSTAELADERSAVTELGLI		329		5	Purified	-1	 	
Batch03	MytuD.01241.a	Mycobacterium tuberculosis	NP_217800.1	P96888				PROBABLE THIOSULFATE SULFURTRANSFERASE SSEA (RHODANESE) (THIOSULFATE CYANIDE TRANSSULFURASE) (THIOSULFATE THIOTRANSFERASE)	Potential drug target		MPLPADPSPTLSAYAHPERLVTADWLSAHMGAPGLAIVESDEDVLLYDVGHIPGAVKIDWHTDLNDPRVRDYINGEQFAELMDRKGIARDDTVVIYGDKSNWWAAYALWVFTLFGHADVRLLNGGRDLWLAERRETTLDVPTKTCTGYPVVQRNDAPIRAFRDDVLAILGAQPLIDVRSPEEYTGKRTHMPDYPEEGALRAGHIPTAVHIPWGKAADESGRFRSREELERLYDFINPDDQTVVYCRIGERSSHTWFVLTHLLGKADVRNYDGSWTEWGNAVRVPIVAGEEPGVVPVV		297		17	In PDB	-1	 	
Batch03	MytuD.01244.a	Mycobacterium tuberculosis	NP_215961.1	P63338				6-phosphogluconolactonase	Potential drug target		MSSSIEIFPDSDILVAAAGKRLVGAIGAAVAARGQALIVLTGGGNGIALLRYLSAQAQQIEWSKVHLFWGDERYVPEDDDERNLKQARRALLNHVDIPSNQVHPMAASDGDFGGDLDAAALAYEQVLAASAAPGDPAPNFDVHLLGMGPEGHINSLFPHSPAVLESTRMVVAVDDSPKPPPRRITLTLPAIQRSREVWLLVSGPGKADAVAAAIGGADPVSVPAAGAVGRQNTLWLLDRDAAAKLPS		247		17	In PDB	-1	 	
Batch03	MytuD.01249.a	Mycobacterium tuberculosis	NP_214953.1	O53726				short chain dehydrogenase	Potential drug target		MTANDNKTRKWSAADVPDQSGRVVVVTGANTGIGYHTAAVFADRGAHVVLAVRNLEKGNAARARIMAARPGAHVTLQQLDLCSLDSVRAAADALRTAYPRIDVLINNAGVMWTPKQVTKDGFELQFGTNHLGHFALTGLVLDHMLPVPGSRVVTVSSQGHRIHAAIHFDDLQWERRYNRVAAYGQAKLANLLFTYELQRRLGEAGKSTIAVAAHPGGSNTELTRNLPRLIRPVATVLGPLLFQSPEMGALPTLRAATDPTTQGGQYYGPDGFGEQRGHPKVVQSSAQSHDKDLQRRLWTVSEELTGVSFGV		311		5	Purified	-1	 	
Batch03	MytuD.01254.a	Mycobacterium tuberculosis	NP_215907.1	P67733				bifunctional phosphopantothenoylcysteine decarboxylase/phosphopantothenate synthase	Potential drug target		MVDHKRIPKQVIVGVSGGIAAYKACTVVRQLTEASHRVRVIPTESALRFVGAATFEALSGEPVCTDVFADVPAVPHVHLGQQADLVVVAPATADLLARAAAGRADDLLTATLLTARCPVLFAPAMHTEMWLHPATVDNVATLRRRGAVVLEPATGRLTGADSGAGRLPEAEEITTLAQLLLERHDALPYDLAGRKLLVTAGGTREPIDPVRFIGNRSSGKQGYAVARVAAQRGADVTLIAGHTAGLVDPAGVEVVHVSSAQQLADAVSKHAPTADVLVMAAAVADFRPAQVATAKIKKGVEGPPTIELLRNDDVLAGVVRARAHGQLPNMRAIVGFAAETGDANGDVLFHARAKLRRKGCDLLVVNAVGEGRAFEVDSNDGWLLASDGTESALQHGSKTLMASRIVDAIVTFLAGCSS		418		4	Soluble	-1	 	
Batch03	MytuD.01263.a	Mycobacterium tuberculosis	NP_217016.1	O06164				POSSIBLE ACYL-CoA DEHYDROGENASE FADE19 (MMGC)	Potential drug target		MTTTTTTISGGILPKEYQDLRDTVADFARTVVAPVSAKHDAEHSFPYEIVAKMGEMGLFGLPFPEEYGGMGGDYFALSLVLEELGKVDQSVAITLEAAVGLGAMPIYRFGTEEQKQKWLPDLTSGRALAGFGLTEPGAGSDAGSTRTTARLEGDEWIINGSKQFITNSGTDITSLVTVTAVTGTTGTAADAKKEISTIIVPSGTPGFTVEPVYNKVGWNASDTHPLTFADARVPRENLLGARGSGYANFLSILDEGRIAIAALATGAAQGCVDESVKYANQRQSFGQPIGAYQAIGFKIARMEARAHVARTAYYDAAAKMLAGKPFKKEAAIAKMISSEAAMDNSRDATQIHGGYGFMNEYPVARHYRDSKVLEIGEGTTEVQLMLIARSLGLQ		394		5	Purified	-1	 	
Batch03	MytuD.01279.a	Mycobacterium tuberculosis	NP_217959.1	P66639				30S ribosomal protein S9	Potential drug target		MTETTPAPQTPAAPAGPAQSFVLERPIQTVGRRKEAVVRVRLVPGTGKFDLNGRSLEDYFPNKVHQQLIKAPLVTVDRVESFDIFAHLGGGGPSGQAGALRLGIARALILVSPEDRPALKKAGFLTRDPRATERKKYGLKKARKAPQYSKR		151		-2	Work stopped	-2	Work stopped	
Batch03	MytuD.01285.a	Mycobacterium tuberculosis	NP_215049.1	O06401				5'-methylthioadenosine phosphorylase	Potential drug target		MHNNGRMLGVIGGSGFYTFFGSDTRTVNSDTPYGQPSAPITIGTIGVHDVAFLPRHGAHHQYSAHAVPYRANMWALRALGVRRVFGPCAVGSLDPELEPGAVVVPDQLVDRTSGRADTYFDFGGVHAAFADPYCPTLRAAVTGLPGVVDGGTMVVIQGPRFSTRAESQWFAAAGCNLVNMTGYPEAVLARELELCYAAIALVTDVDAGVAAGDGVKAADVFAAFGENIELLKRLVRAAIDRVADERTCTHCQHHAGVPLPFELP		264		3	Expressed	-1	 	
Batch03	MytuD.01319.a	Mycobacterium tuberculosis	NP_218030.1	O53558				PROBABLE FATTY-ACID-CoA LIGASE FADD18 (FRAGMENT) (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE)	Potential drug target		MAASLSENLSCHSSNMCRLSGNAATNLERPGEEPPGDRCTRRQAVRPARTLAKKGNIPVGYYKDEKKTAETFRTINGVRYAIPGDYAQVEEDGTVTMLGRGSVSINSGGEKVYPEEVEAALKGHPDVFDALVVGVPDPRYGQQVAAVVQARPGCRPSLAELDSFVRSEIAGYKVPRSLWFVDEVKRSPAGKPDYRWAKEQTEARPADDVHAGHVTSGS		218		5	Purified	-1	 	
Batch03	MytuD.01322.a	Mycobacterium tuberculosis	NP_217020.1	P63648				PROBABLE SUCCINYL-COA:3-KETOACID-COENZYME A TRANSFERASE (ALPHA SUBUNIT) SCOA (3-OXO ACID:CoA TRANSFERASE) (OXCT A) (SUCCINYL-COA:3-OXOACID-COENZYME A TRANSFERASE)	Potential drug target		MDKVVATAAEAVADIANGSSLAVGGFGLCGIPEALIAALVDSGVTDLETVSNNCGIDGVGLGLLLQHKRIRRTVSSYVGENKEFARQFLAGELEVELTPQGTLAERLRAGGMGIPAFYTPAGVGTQVADGGLPWRYDASGGVAVVSPAKETREFDGVTYVLERGIRTDFALVHAWQGDRHGNLMYRHAAANFNPECASAGRITIAEVEHLVEPGEIDPATVHTPGVFVHRVVHVPNPAKKIERETVRQ		248		4	Soluble	-1	 	
Batch03	MytuD.01326.a	Mycobacterium tuberculosis	NP_217266.1	O33292				3-ketoacyl-(acyl-carrier-protein) reductase	Potential drug target		MIDRPLEGKVAFITGAARGLGRAHAVRLAADGANIIAVDICEQIASVPYPLSTADDLAATVELVEDAGGGIVARQGDVRDRASLSVALQAGLDEFGRLDIVVANAGIAMMQAGDDGWRDVIDVNLTGVFHTVQVAIPTLIEQGTGGSIVLISSAAGLVGIGSSDPGSLGYAAAKHGVVGLMRAYANHLAPQNIRVNSVHPCGVDTPMINNEFFQQWLTTADMDAPHNLGNALPVELVQPTDIANAVAWLASEEARYVTGVTLPVDAGFVNKR		272		5	Purified	-1	 	
Batch03	MytuD.01331.a	Mycobacterium tuberculosis	NP_215953.1	P65700				phosphoglycerate kinase	Potential drug target		MSVANLKDLLAEGVSGRGVLVRSDLNVPLDEDGTITDAGRIIASAPTLKALLDADAKVVVAAHLGRPKDGPDPTLSLAPVAVALGEQLGRHVQLAGDVVGADALARAEGLTGGDILLLENIRFDKRETSKNDDDRRALAKQLVELVGTGGVFVSDGFGVVHRKQASVYDIATLLPHYAGTLVADEMRVLEQLTSSTQRPYAVVLGGSKVSDKLGVIESLATKADSIVIGGGMCFTFLAAQGFSVGTSLLEDDMIEVCRGLLETYHDVLRLPVDLVVTEKFAADSPPQTVDVGAVPNGLMGLDIGPGSIKRFSTLLSNAGTIFWNGPMGVFEFPAYAAGTRGVAEAIVAATGKGAFSVVGGGDSAAAVRAMNIPEGAFSHISTGGGASLEYLEGKTLPGIEVLSREQPTGGVL		412		4	Soluble	-1	 	
Batch03	MytuD.01347.a	Mycobacterium tuberculosis	NP_215501.1	O53899				PROBABLE ADHESION COMPONENT TRANSPORT ATP-BINDING PROTEIN ABC TRANSPORTER	Potential drug target		MNRQPIVQLSNLSWTFREGETRRQVLDHITFDFEPGEFVALLGQSGSGKSTLLNLISGIEKPTTGDVTINGFAITQKTERDRTLFRRDQIGIVFQFFNLIPTLTVLENITLPQELAGVSQRKAAVVARDLLEKVGMADRERTFPDKLSGGEQQRVAISRALAHNPMLVLADEPTGNLDSDTGDKVLDVLLDLTRQAGKTLIMATHSPSMTQHADRVVNLQGGRLIPAVNRENQTDQPASTILLPTSYE		248		3	Expressed	-1	 	NR-16443
Batch03	MytuD.01353.a	Mycobacterium tuberculosis	NP_214905.1	P95199				O-succinylhomoserine sulfhydrylase	Potential drug target		MTDESSVRTPKALPDGVSQATVGVRGGMLRSGFEETAEAMYLTSGYVYGSAAVAEKSFAGELDHYVYSRYGNPTVSVFEERLRLIEGAPAAFATASGMAAVFTSLGALLGAGDRLVAARSLFGSCFVVCSEILPRWGVQTVFVDGDDLSQWERALSVPTQAVFFETPSNPMQSLVDIAAVTELAHAAGAKVVLDNVFATPLLQQGFPLGVDVVVYSGTKHIDGQGRVLGGAILGDREYIDGPVQKLMRHTGPAMSAFNAWVLLKGLETLAIRVQHSNASAQRIAEFLNGHPSVRWVRYPYLPSHPQYDLAKRQMSGGGTVVTFALDCPEDVAKQRAFEVLDKMRLIDISNNLGDAKSLVTHPATTTHRAMGPEGRAAIGLGDGVVRISVGLEDTDDLIADIDRALS		406		17	In PDB	-1	 	NR-16444
Batch03	MytuD.01356.a	Mycobacterium tuberculosis	NP_214836.1	O07248				PROBABLE UDP-GLUCOSE 6-DEHYDROGENASE UDGA (UDP-GLC DEHYDROGENASE) (UDP-GLCDH) (UDPGDH)	Potential drug target		MRCSVFGTGYLGATHAVGMAQLGHEVVGVDIDPGKVAKLAGGDIPFYEPGLRKLLTDNLAAGRLRFTTDYDMAADFADVHFLGVGTPQKIGEYGADLRHVHAVIDALVPRLVRASILVGKSTVPVGTAAELGHRAGALAPRGVDVEIAWNPEFLREGFAVHDTLNPDRIVLGVQDDSTRAEVAVRELYAPLLAAGVPFLVTDLQTAELVKVSANAFLATKISFINAISEVCEAAGADVSQLADALGYDPRIGRQCLNAGLGFGGGCLPKDIRAFMARAGELGADQALTFLREVDSINMRRRTKMVELATTACGGSLLGANIAVLGAAFKPESDDVRDSPALNVAGQLQLNGATVHVYDPKALDNAHRLFPTLNYAVSVAEACERADAVLVLTEWREFIDLEPADLANRVRARVIVDGRNCLDVTRWRRAGWRVFRLGVPRLGH		443		3	Expressed	-1	 	NR-16445
Batch03	MytuD.01365.a	Mycobacterium tuberculosis	NP_216444.1	P95286				short chain dehydrogenase	Potential drug target		MSVLDLFDLHGKRALITGASTGIGKRVALAYVEAGAQVAIAARHLDALEKLADEIGTSGGKVVPVCCDVSQHQQVTSMLDQVTAELGGIDIAVCNAGIITVTPMLDMPLEEFQRLQNTNVTGVFLTAQAAAKAMVKQGQGGVIINTASMSGHIINVPQQVSHYCASKAAVIHLTKAMAVELAPHKIRVNSVSPGYILTELVEPYTEYQPLWEPKIPLGRLGRPEELAGLYLYLASEASSYMTGSDIVIDGGYTCP		255		4	Soluble	-1	 	
Batch03	MytuD.01370.a	Mycobacterium tuberculosis	NP_217774.1	O86374				phosphomannomutase/phosphoglucomutase	Potential drug target		MSWPAAAVDRVIKAYDVRGLVGEEIDESLVTDLGAAFARLMRTEDARPVVIGHDMRDSSPSLADAFAAGVTGQGLDVVRVGLASTDQLYFASGLLDCPGAMFTASHNPAAYNGIKMCRAAAKPVGADTGLTAIRDDLIAGVARYDGTPGTIADQDVLVDYGAFLRSLVDTSGLRPLRVAVDAGNGMAGHTAPAVLGVIDSITLLPSYFELDGSFPNHEANPLDPANLVDLQAYVRDTGADIGLAFDGDADRCFVVDERGQPVSPSTVTALVAARELNREIGATIIHNVITSRAVPELVAERGGTPLRSRVGHSYIKALMAETGAIFGGEHSAHYYFRDFWGADSGMLAALHVLAALGEQSRPLSELTADYQRYESSGEINFTVVDSSACVEAVLKSFGNRIVSIDHLDGVTVDLGDDSWFNLRSSNTEPLLRLNVEGRSVGDVDAVVRQVSAEIAAQSAHAKAGP		465		3	Expressed	-1	 	
Batch03	MytuD.01379.a	Mycobacterium tuberculosis	NP_215284.1	P71825				PROBABLE DEHYDROGENASE/REDUCTASE	Potential drug target		MTAHPETPRLGYIGLGNQGAPMAKRLLDWPGGLTVFDVRVEAMAPFVEGGATAAASVSDVAEADIISITVFDDAQVSSVITADNGLATHAKPGTIVAIHSTIADTTAVDLAEKLKPQGIHIVDAPVSGGAAAAAKGELAVMVGADDEAFQRIKEPFSRWASLLIHAGEPGAGTRMKLARNMLTFVSYAAAAEAQRLAEACGLDLVALGKVVRHSDSFTGGAGAIMFRNTTAPMEPADPLRPLLEHTRGLGEKDLSLALALGEVVSVDLPLAQLALQRLAAGLGVPHPDTEPAKET		295		4	Soluble	-1	 	
Batch03	MytuD.01381.a	Mycobacterium tuberculosis	NP_215420.1	P64014				enoyl-CoA hydratase	Potential drug target		MIGITQAEAVLTIELQRPERRNALNSQLVEELTQAIRKAGDGSARAIVLTGQGTAFCAGADLSGDAFAADYPDRLIELHKAMDASPMPVVGAINGPAIGAGLQLAMQCDLRVVAPDAFFQFPTSKYGLALDNWSIRRLSSLVGHGRARAMLLSAEKLTAEIALHTGMANRIGTLADAQAWAAEIARLAPLAIQHAKRVLNDDGAIEEAWPAHKELFDKAWGSQDVIEAQVARMEKRPPKFQGA		243		17	In PDB	-1	 	
Batch03	MytuD.01395.a	Mycobacterium tuberculosis	NP_216807.1	Q59570				Probable thiosulfate sulfurtransferase SseB	Potential drug target		MQARGQVLITAAELAGMIQAGDPVSILDVRWRLDEPDGHAAYLQGHLPGAVFVSLEDELSDHTIAGRGRHPLPSGASLQATVRRCGIRHDVPVVVYDDWNRAGSARAWWVLTAAGIANVRILDGGLPAWRSAGGSIETGQVSPQLGNVTVLHDDLYAGQRLTLTAQQAGAGGVTLLDARVPERFRGDVEPVDAVAGHIPGAINVPSGSVLADDGTFLGNGALNALLSDHGIDHGGRVGVYCGSGVSAAVIVAALAVIGQDAELFPGSWSEWSSDPTRPVGRGTA		284		5	Purified	-1	 	
Batch03	MytuD.01407.a	Mycobacterium tuberculosis	NP_216605.1	P65810				Probable dipeptidase PepE	Potential drug target		MGSRRFDAEVYARRLALAAAATADAGLAGLVITPGYDLCYLIGSRAETFERLTALVLPAAGAPAVVLPRLELAALKQSAAAELGLRVCDWVDGDDPYGLVSAVLGGAPVATAVTDSMPALHMLPLADALGVLPVLATDVLRRLRMVKEETEIDALRKAGAAIDRVHARVPEFLVPGRTEADVAADIAEAIVAEGHSEVAFVIVGSGPHGADPHHGYSDRELREGDIVVVDIGGTYGPGYHSDSTRTYSIGEPDSDVAQSYSMLQRAQRAAFEAIRPGVTAEQVDAAARDVLAEAGLAEYFVHRTGHGIGLCVHEEPYIVAGNDLVLVPGMAFSIEPGIYFPGRWGARIEDIVIVTEDGAVSVNNCPHELIVVPVS		375		5	Purified	-1	 	
Batch03	MytuD.01414.a	Mycobacterium tuberculosis	YP_177879.1	P0A4W2				PROBABLE SULFATE-TRANSPORT ATP-BINDING PROTEIN ABC TRANSPORTER CYSA1	Potential drug target		MTYAIVVADATKRYGDFVALDHVDFVVPTGSLTALLGPSGSGKSTLLRTIAGLDQPDTGTITINGRDVTRVPPQRRGIGFVFQHYAAFKHLTVRDNVAFGLKIRKRPKAEIKAKVDNLLQVVGLSGFQSRYPNQLSGGQRQRMALARALAVDPEVLLLDEPFGALDAKVREELRAWLRRLHDEVHVTTVLVTHDQAEALDVADRIAVLHKGRIEQVGSPTDVYDAPANAFVMSFLGAVSTLNGSLVRPHDIRVGRTPNMAVAAADGTAGSTGVLRAVVDRVVVLGFEVRVELTSAATGGAFTAQITRGDAEALALREGDTVYVRATRVPPIAGGVSGVDDAGVERVKVTST		351		5	Purified	-1	 	NR-16342
Batch03	MytuD.01455.a	Mycobacterium tuberculosis	NP_215899.1	P71811				carbamoyl phosphate synthase small subunit	Potential drug target		MSKAVLVLEDGRVFTGRPFGATGQALGEAVFSTGMSGYQETLTDPSYHRQIVVATAPQIGNTGWNGEDSESRGERIWVAGYAVRDPSPRASNWRATGTLEDELIRQRIVGIAGIDTRAVVRHLRSRGSMKAGVFSDGALAEPADLIARVRAQQSMLGADLAGEVSTAEPYVVEPDGPPGVSRFTVAALDLGIKTNTPRNFARRGIRCHVLPASTTFEQIAELNPHGVFLSNGPGDPATADHVVALTREVLGAGIPLFGICFGNQILGRALGLSTYKMVFGHRGINIPVVDHATGRVAVTAQNHGFALQGEAGQSFATPFGPAVVSHTCANDGVVEGVKLVDGRAFSVQYHPEAAAGPHDAEYLFDQFVELMAGEGR		376		3	Expressed	-1	 	
Batch03	MytuD.01464.a	Mycobacterium tuberculosis	NP_214744.1	P96413				PROBABLE PHOSPHOTRIESTERASE PHP (PARATHION HYDROLASE) (PTE) (ARYLDIALKYLPHOSPHATASE) (PARAOXONASE) (A-ESTERASE) (ARYLTRIPHOSPHATASE) (PARAOXON HYDROLASE)	Potential drug target		MPELNTARGPIDTADLGVTLMHEHVFIMTTEIAQNYPEAWGDEDKRVAGAIARLGELKARGVDTIVDLTVIGLGRYIPRIARVAAATELNIVVATGLYTYNDVPFYFHYLGPGAQLDGPEIMTDMFVRDIEHGIADTGIKAGILKCATDEPGLTPGVERVLRAVAQAHKRTGAPISTHTHAGLRRGLDQQRIFAEEGVDLSRVVIGHCGDSTDVGYLEELIAAGSYLGMDRFGVDVISPFQDRVNIVARMCERGHADKMVLSHDACCYFDALPEELVPVAMPNWHYLHIHNDVIPALKQHGVTDEQLHTMLVDNPRRIFERQGGYQ		326		4	Soluble	-1	 	
Batch03	MytuD.01484.a	Mycobacterium tuberculosis	NP_215214.1	P0A5X0				30S ribosomal protein S10	Potential drug target		MAGQKIRIRLKAYDHEAIDASARKIVETVVRTGASVVGPVPLPTEKNVYCVIRSPHKYKDSREHFEMRTHKRLIDIIDPTPKTVDALMRIDLPASVDVNIQ		101		-2	Work stopped	-2	Work stopped	
Batch03	MytuD.01507.a	Mycobacterium tuberculosis	NP_215614.1	O53446				fumarate hydratase	Potential drug target		MAVDADSANYRIEHDTMGEVRVPAKALWRAQTQRAVENFPISGRGLERTQIRALGLLKGACAQVNSDLGLLAPEKADAIIAAAAEIADGQHDDQFPIDVFQTGSGTSSNMNTNEVIASIAAKGGVTLHPNDDVNMSQSSNDTFPTATHIAATEAAVAHLIPALQQLHDALAAKALDWHTVVKSGRTHLMDAVPVTLGQEFSGYARQIEAGIERVRACLPRLGELAIGGTAVGTGLNAPDDFGVRVVAVLVAQTGLSELRTAANSFEAQAARDGLVEASGALRTIAVSLTKIANDIRWMGSGPLTGLAEIQLPDLQPGSSIMPGKVNPVLPEAVTQVAAQVIGNDAAIAWGGANGAFELNVYIPMMARNILESFKLLTNVSRLFAQRCIAGLTANVEHLRRLAESSPSIVTPLNSAIGYEEAAAVAKQALKERKTIRQTVIDRGLIGDRLSIEDLDRRLDVLAMAKAEQLDSDRL		474		7	Crystallized	-1	 	
Batch03	MytuD.01530.a	Mycobacterium tuberculosis	NP_218033.1	O53561				enoyl-CoA hydratase	Potential drug target		MESGPDALVERRGHTLIVTMNRPAARNALSTEMMRIMVQAWDRVDNDPDIRCCILTGAGGYFCAGMDLKAATQKPPGDSFKDGSYGPSRIDALLKGRRLTKPLIAAVEGPAIAGGTEILQGTDIRVAGESAKFGISEAKWSLYPMGGSAVRLVRQIPYTLACDLLLTGRHITAAEAKEMGLIGHVVPDGQALTKALELADAISANGPLAVQAILRSIRETECMPENEAFKIDTQIGIKVFLSDDAKEGPRAFAEKRAPNFQNR		263		5	Purified	-1	 	
Batch03	MytuD.01548.a	Mycobacterium tuberculosis	YP_177748.1	Q7D9D5				methionine aminopeptidase	Potential drug target		MRPLARLRGRRVVPQRSAGELDAMAAAGAVVAAALRAIRAAAAPGTSSLSLDEIAESVIRESGATPSFLGYHGYPASICASINDRVVHGIPSTAEVLAPGDLVSIDCGAVLDGWHGDAAITFGVGALSDADEALSEATRESLQAGIAAMVVGNRLTDVAHAIETGTRAAELRYGRSFGIVAGYGGHGIGRQMHMDPFLPNEGAPGRGPLLAAGSVLAIEPMLTLGTTKTVVLDDKWTVTTADGSRAAHWEHTVAVTDDGPRILTLG		266		3	Expressed	-1	 	
Batch03	MytuD.01549.a	Mycobacterium tuberculosis	NP_215643.1	O06579				pyruvate phosphate dikinase	Potential drug target		MTRITRANGCPDGTLENAVVALDGGANYPREILGNKGHGIDMMRRHHLPVPPAFCITTEVGVRYLAAPGSTIAAIWDDVLDRMSWLETETSCTFGRGPNPLLVSVRSGATQSMPGMMDTILDVGMTDAVERVLARPGAADFAHDTRRRFTSMYRRIVGSAGPITDDPYAQLRASIEAVFASWNSPRAVAYRDHHGLDDQGGTAVVVQAMVFGNLTANSGAGVLSSRNPITGANEPFGEWLPGGQGDDVVSGLVAVAPITALRDQQPAVYDQLMAAARSLERMAGDVQEIEFTVEDSQLWLLQTRGAERSAQAAVRLALQLHHEGLIDDTETLRRVTPTHIETLLRPSLQTETRLAAPLLAKGLPACPGVVSGTAYTEVDEALDAADRGEPVILVRDHTRPEDVMGMLAAQGIVTEVGGAASHAAVVSRELGRVAVVGCGPGVAAALAGKEITVDGYEGEVRQGVLALSAWSESDTPELRELADIAQRISS		490		4	Soluble	-1	 	
Batch03	MytuD.01557.a	Mycobacterium tuberculosis	YP_177640.1	Q8VK64				POSSIBLE ACETYL-CoA ACETYLTRANSFERASE (ACETOACETYL-CoA THIOLASE)	Potential drug target		MQLGNQNTMRFAGRPQRFRQSAYPLFNPNSAIALGHPFGGSGARLMTTVLHHMPDKGIRYGLQTMCEGRGQANATIVELL		80		2	Cloned	-1	 	
Batch03	MytuD.01566.a	Mycobacterium tuberculosis	NP_217347.1	P71621				enoyl-CoA hydratase	Potential drug target		MTDDILLIDTDERVRTLTLNRPQSRNALSAALRDRFFAALADAEADDDIDVVILTGADPVFCAGLDLKELAGQTALPDISPRWPAMTKPVIGAINGAAVTGGLELALYCDILIASEHARFADTHARVGLLPTWGLSVRLPQKVGIGLARRMSLTGDYLSATDALRAGLVTEVVAHDQLLPTARRVAASIVGNNQNAVRALLASYHRIDESQTAAGLWLEACAAKQFRTSGDTIAANREAVLQRGRAQVR		249		5	Purified	-1	 	
Batch03	MytuD.01568.a	Mycobacterium tuberculosis	NP_217348.1	P71620				PROBABLE Sn-GLYCEROL-3-PHOSPHATE TRANSPORT ATP-BINDING PROTEIN ABC TRANSPORTER UGPC	Potential drug target		MANVQYSAVTQRYPGADAPTVDNLDLDIADGEFLVLVGPSGCGKSTTLRVLAGLEPIESGRISIGDVDVTHLPPRARDVAMVFQNYALYPNMTVAANMGFALRNAGMSRADTRRRVLEVADMLELTDLLDRKPAKLSGGQRQRVAMGRAIVRRPRVFCMDEPLSNLDAKLRVSTRSQISGLQRRLGTTTVYVTHDQVEAMTMGDRVAVLKDGVLQQVDTPRALYDDPVNTFVATFIGAPAMNLIDAAVAHGVVRAPDLAIPVPDPAAERVLVGVRPESWDVASIGTPGSLTVHVELVEELGFESFVYATPVDQRGWSSRAPRIVFRTDRRTAVRVGESLAIVPHSQEVRLFNSRTETRLR		360		3	Expressed	-1	 	
Batch03	MytuD.01582.a	Mycobacterium tuberculosis	NP_218019.1	O53547				3-ketoacyl-(acyl-carrier-protein) reductase	Potential drug target		MKLTESNRSPRTTNTTDLSGKVAVVTGAAAGLGRAEALGLARLGATVVVNDVASALDASDVVDEIGAAAADAGAKAVAVAGDISQRATADELLASAVGLGGLDIVVNNAGITRDRMLFNMSDEEWDAVIAVHLRGHFLLTRNAAAYWRDKAKDAEGGSVFGRLVNTSSEAGLVGPVGQANYAAAKAGITALTLSAARALGRYGVCANVICPRARTAMTADVFGAAPDVEAGQIDPLSPQHVVSLVQFLASPAAAEVNGQVFIVYGPQVTLVSPPHMERRFSADGTSWDPTELTATLRDYFAGRDPEQSFSATDLMRQ		317		2	Cloned	-1	 	NR-16218
Batch03	MytuD.01585.a	Mycobacterium tuberculosis	NP_217665.1	P65573				NADH dehydrogenase subunit E	Potential drug target		MTQPPGQPVFIRLGPPPDEPNQFVVEGAPRSYPPDVLARLEVDAKEIIGRYPDRRSALLPLLHLVQGEDSYLTPAGLRFCADQLGLTGAEVSAVASFYTMYRRRPTGEYLVGVCTNTLCAVMGGDAIFDRLKEHLGVGHDETTSDGVVTLQHIECNAACDYAPVVMVNWEFFDNQTPESARELVDSLRSDTPKAPTRGAPLCGFRQTSRILAGLPDQRPDEGQGGPGAPTLAGLQVARKNDMQAPPTPGADE		252		4	Soluble	-1	 	NR-16219
Batch03	MytuD.01608.a	Mycobacterium tuberculosis	YP_177921.1	Q50549				ribonucleotide-diphosphate reductase subunit beta	Potential drug target		MTGNAKLIDRVSAINWNRLQDEKDAEVWDRLTGNFWLPEKVPVSNDIPSWGTLTAGEKQLTMRVFTGLTMLDTIQGTVGAVSLIPDALTPHEEAVLTNIAFMESVHAKSYSQIFSTLCSTAEIDDAFRWSEENRNLQRKAEIVLQYYRGDEPLKRKVASTLLESFLFYSGFYLPMYWSSRAKLTNTADMIRLIIRDEAVHGYYIGYKFQRGLALVDDVTRAELKDYTYELLFELYDNEVEYTQDLYDEVGLTEDVKKFLRYNANKALMNLGYEALFPRDETDVNPAILSALSPNADENHDFFSGSGSSYVIGKAVVTEDDDWDF		324		-2	Work stopped	-2	Work stopped	
Batch03	MytuD.01609.a	Mycobacterium tuberculosis	NP_218275.1	O69724				POSSIBLE OSMOPROTECTANT (GLYCINE BETAINE/CARNITINE/CHOLINE/L-PROLINE) TRANSPORT ATP-BINDING PROTEIN ABC TRANSPORTER PROV	Potential drug target		MICFDDVSKVYAHGATAVDRLTLEVPNGMLTVFVGPSGCGKTTALRMINRMVDPTSGTITVDGTDVSTVNAVKLRLGIGYVIQNAGLMPHQRVIDNVATVPVLKGQPRRAARKAGYEVLERVGLDPKVATRYPAQLSGGEQQRVGVARALAADPPILLMDEPFSAVDPVVRHELQNEILRLQAELHKTIVFVTHDIDEALKLADLVAVFAPGGALAQYDETARLLSSPANDFVSKFIGLGRGYRWLQLFDAAGLPVRDIEQVSVNGLSDARDRQVRDGWVLVVDGAGAPLGWIDADGRRRHRGGAALSDAMTVGGSVFRPNGNLSQALDAALSSPSGVGVAVDGGGKVIGGILAADVLAEFQKGKKAGGGAKPCTT		376		3	Expressed	-1	 	NR-16343
Batch03	MytuD.01613.a	Mycobacterium tuberculosis	NP_216450.1	P95280				PROBABLE ACYL-CoA DEHYDROGENASE FADE17	Potential drug target		MDVSYPPEAEAFRDRIREFVAEHLPPGWPGPGALPPHEREEFARHWRRALAGAGLVAVSWPTEYGGGGLSPMEQVVLAEEFARAGAPERAENDLLGIDLLGNTLIALGSEAQKRHFLPRILSGEHRWCQGFSEPEAGSDLASVRTRGVLDGDEWVINGHKIWTSAGTTANWIFLLARTDPSAAKHRGLSFLLVPMDQPGVVVRPIVNAAGHSSFSEVFLTDARTSAGNVVGRVGDGWSTAMTLLGFERGSHIATAAIDFERDLQRLCELARDRGLHTDPRVRDGLAWCYARVQIMRYRGYRDLTLALTGRPPGAEAAITKVIWSEYFRRYTDLAVEILGLEALGPRGPGNGGARLVPEAGTPNSPACWMDELLYARAATIYAGSSQIQRNVIGERLLGLPKEPRPEVLC		409		2	Cloned	-1	 	NR-16344
Batch03	MytuD.01625.a	Mycobacterium tuberculosis	NP_215908.1	P77899				S-adenosylmethionine synthetase	Potential drug target		MSEKGRLFTSESVTEGHPDKICDAISDSVLDALLAADPRSRVAVETLVTTGQVHVVGEVTTSAKEAFADITNTVRARILEIGYDSSDKGFDGATCGVNIGIGAQSPDIAQGVDTAHEARVEGAADPLDSQGAGDQGLMFGYAINATPELMPLPIALAHRLSRRLTEVRKNGVLPYLRPDGKTQVTIAYEDNVPVRLDTVVISTQHAADIDLEKTLDPDIREKVLNTVLDDLAHETLDASTVRVLVNPTGKFVLGGPMGDAGLTGRKIIVDTYGGWARHGGGAFSGKDPSKVDRSAAYAMRWVAKNVVAAGLAERVEVQVAYAIGKAAPVGLFVETFGTETEDPVKIEKAIGEVFDLRPGAIIRDLNLLRPIYAPTAAYGHFGRTDVELPWEQLDKVDDLKRAI		403		4	Soluble	-1	 	
Batch03	MytuD.01626.a	Mycobacterium tuberculosis	NP_215573.1	O53405				hypothetical protein	Potential drug target		MSVMNGREVARESRDAQVFEFGTAPGSAVVKIPVQGGPIGGIAISRDGSLLVVTNNGTDTVSVVGTDTCRVTQTVTSVNEPFAIAMGNAEANRAYVSTVSSAYDAIAVIDVATNTVLGTHPLALSVSDLTLSPDDKYLYVSRNGTRGADVAVLDTTTGALIDVVDVSQAPGTTTQCVRMSPDGSVLYVGANGPSGGLLVVITTRAQSDGGRIGSRSRSRQKSSKPRGNQAAAGLRVVATIDIGSSVRDVALSPDGAIAYVASCGSDFGAVVDVIDTRTHQITSSRAISEIGGLVTRVSVSGDADRAYLVSEDRVTVLCTRTHDVIGTIRTGQPSCVVESPDGKYLYIADYSGTITRTAVASTIVSGTEQLALQRRGSMQWFSPELQQYAPALA		393		2	Cloned	-1	 	NR-16220
Batch03	MytuD.01635.a	Mycobacterium tuberculosis	NP_217767.1	O05893				PROBABLE RUBREDOXIN RUBB	Potential drug target		MNDYKLFRCIQCGFEYDEALGWPEDGIAAGTRWDDIPDDWSCPDCGAAKSDFEMVEVARS		60		17	In PDB	-1	 	
Batch03	MytuD.01640.a	Mycobacterium tuberculosis	NP_214914.1	P95208				ACYL-CoA DEHYDROGENASE FADE7	Potential drug target		MSTPTPPALDRDDPLGLDASLSSDEIAVRDTVRRFCAEHVTPHVAAWFEDGDLPVARDLAKQFGELGLLGMQLHGHGCGGASAVHYGLACRELEAADSGIRSLVSVQGSLAMFAIASFGSDEQKRQWLPGMATGDLLGCFGLTEPDVGSDPAAMKTRARRDGPDWVITGGKMWITNGSVADVAIVWAATDDGIRGFIVPTDTPGFTANTIGHKLSLRASITSELVLDNVRLPADAMLPGATGLRAPLACLSEARYGIVWGAMGAARSAWQCALDYARQRTQFGRPIAGFQLTQAKLVDMAVELHKGQLLSLHLGRLKDRVGLRPDQVSFGKLNNTREALKICRTARTILGGNGISLEYPVIRHMVNLESVLTYEGTPEMHQLVLGQAFTGLAAFR		395		7	Crystallized	-1	 	
Batch03	TogoA.00246.a	Toxoplasma gondii		B6K9T5  			XI|583.m05750	"coding) leucine rich repeat protein, putative"	Potential drug target		MWPQVLYLIDNNLSDVTTIGYLPSLRGLYLQSNELTCTKGLEQLPCLTELNLDDNKISRLEGLDSSTSLSRLSLTAQRTTTPLFLCPNVLTVLSRSLQYLNISKNRVEDLAPFGTLQFLEVLQASENLVREIGSIEAMLVGCRMLSTVDLRRNPVTKVRHYWERLLLGASTTLKEADGRQVTNASRFFVQELQKRRCAIMRQKTLDANDNLENSSNSQFPSRSDLATNSL*		231		2	Cloned	-1	 	NR-16221
Batch03	TogoA.00248.a	Toxoplasma gondii		B6KW64			TGG_994777|207.m00015	"coding) elongation factor Tu, putative"	Potential drug target		MAKEIFKKQKPHINIGTIGHVDHGKTTLTAAITYVLAKNNQAKLKTYKEIDCAPEEIARGITIKTSHIEYETAVRHYAHIDCPGHADYIKNMITGAAQMDGAILVVSAVDGPMPQTKEHLLLAKQIGISNIIVFLNKIDLIDDNEILELVELETRELLDKYNFSSDTPIITGSALKALDNNLTSNIWVDKIYELLTALDSYIPLPKRDLDKPFLLAIEDIFSITGRGTVVTGKIERGSIKLGDTVTMLGFNISKNVVVIGLEMFQKTLEIGEAGDNVGILLRGIQKTEVKRGMILSKPLTMTLHSIFQADVYILTVAEGGREKPIFEGYCPQFYLYTINITGSIKFSSETKETGTKMILPGDRVKLNVTLIYSIAIEKGMRFAIREGGRTIGAGIITDIIK*		402		3	Expressed	-1	 	
Batch03	TogoA.00267.a	Toxoplasma gondii					TGG_995125|438.m00002	coding) S-adenosylmethionine synthetase family protein	Potential drug target		MSLRKNLITSESVAAGHPDKVADQISDAVLDEYLLTDPFSRTAIETLVTKDNVIIAGEVFGPNVANSTIENVVRNTIKDIGYEHDGFHWGEVGVNMLLHEQSNDIAIGVDQGAGDQGIMYGYATIETKSLMPAPIFYAHSILKNVMSVVKEAKLGPDAKSQITLAYESNLPVRAESIIVSIQHPEDLDQLKVKEIIYPYVVSSLPKGWMCAEENFFVNPTGRFVIGGPVSDCGLTGRKIMVDTYGGYIPHGGGAFSGKDATKVDRSAAYMARYLAKNIVFANLAERCLVQLSYAIGVSKPTSFYIDTFGTNKVDEERIKKLIESNIDLSTRGIIKHLSLSRPIYKRTACYGHFGKESEEDDGFSWENLNLSLDLSREFSVQSNRKVSLDC*		391		1	Selected	-1	 	
Batch03	TogoA.00388.a	Toxoplasma gondii					TGG_995103|394.m00001	"coding) transketolase, pyridine binding domain containing protein"	Potential drug target		MIDQFIASAETKWLRSSGLVLLLPHGYEGQGPEHSSARIERFLQLCAEDNMQVVNCSTPANYFHVLRRQIHRDFRKPLIVFTPKSLLRHKRAVSNLSDFKGGFLTIIPEYRKNLVLDDKMRKVIICGGKVYYDIIEACEVQKINDIAVVRLEQFYPFPADKLSIELEKYENAEIIWCQEEPKNMGGWFFVNPLIEEVLLGLNIQAKRLKCITRPAAFLRLTHLIFSKES*		230		1	Selected	-1	 	
Batch03	TogoA.00432.a	Toxoplasma gondii		B6KSA1  			XII|38.m01897	"coding) ras-related protein RAB5C, putative"	Potential drug target		MSFSQAYSSGASLPPYGQSSGSGLGQSYAAGSSEAARPPSYKTVLLGDASVGKSSLVVRFVKNTFSDTMETTIGAAFFTQALQVDGRTVKFEIWDTAGQERFSSLAPMYYRGAAAAIVVYDQSNMASFDRAQVWVQQLQLSGNSNIVIALAANKMDLPHKQVDLHLGRQYAEENGLLFIETSAKTGQNVQQLFSMIARRLPEKPVGAQGLGGGVHTIKLTDEPAVQRQAGGLASKFACCGGNS*		244		5	Purified	-1	 	NR-16222
Batch03	TogoA.00449.a	Toxoplasma gondii					TGG_994778|208.m00001	coding) ATP-NAD kinase family protein	Potential drug target		MHKYKNIGYVASESPKSQEVSKLLQKLNFINITEENKSEVDLLVVVGGDGLMLHTLHNYVVGNKDIHVYGVNTGSVGFLMNKYFSSSEDLIDNIEHATSAQLTLLKMEAIDLSGKKYHHVAVNEVYVFRKANQIVEMNVAINSKLKMEKFRGDGIILSTPTGSTAYNFSAGGPILPLNSNLFALTSINSYYPRHWNGALISNDTIVQIDINNAQNRPALVVSDYKELHNISQIKMQKDHENTVTLLFDKDYSLDERIFDRQFLY*		265		2	Cloned	-1	 	
Batch03	TogoA.00491.a	Toxoplasma gondii		B6KBC4  			VIIb|55.m04800	"coding) acylphosphatase, putative"	Potential drug target		METGGGDCVSRGAGQDLVAVVFEVHGRVQGVFFRVHTQEHAQHLGLTGWVQNMPGGTVKGEAEGPSAQVEKMLHWLRHVGSPQSRIDQLDILEKKSIAQRNYSSFEIIRKKRA*		114		4	Soluble	-1	 	
Batch03	TogoA.00521.a	Toxoplasma gondii					TGG_994901|151.m00002	"coding) ATP-dependent Clp protease, ATP-binding subunit ClpX protein, putative"	Potential drug target		MDNNNDDLHYCSFCNKAQNEVDKLITNSSDGLKVFICNECIELSHKAISQKKGGSFNSDYMSDVKLLLKKPEDIKIFLSKHVVGQEHAQHVLSVAMYNHCQSMAQFNAISDVEIEKSNVMLIGPTGSGKTLLAKTLAKVSDVPFAMADATTLTEAGYVGDDVESVLSRLLQAANYDVAKAQRGIVFIDEIDKITRKSESTSITRDVSGEGVQQALLKIMEGTVAYVPPQGGRKHPQQEFIQVDTNNILFICGGAFEGLNKIIEARKKGTSVGFGADISQSKEQKKKNTLHDVQPEDLIKFGLIPEFVGRVPITAVLDELDHEDLVHVLIEPRNALIKQYKALLAFSKVNLEFSDEAISAIAEKAMSYKTGARMLRAILESLLLDVMYTAGNGGFEGSTIVITKEMVELGKAVINHNNKGNVITVND*		427		1	Selected	-1	 	
Batch03	TogoA.00635.a	Toxoplasma gondii					TGG_994974|334.m00001	coding) hypothetical protein	Potential drug target		MYRIVSSNILKYKNCEPKIDESAFIAGDSHIVGKVEIGREASIWFNCVIRGDIGSIKIGDGTNIQDGTVIHVDRNPGGDTIIGDMVTVGHFCMLHACTVHDKALIGMGSIVMDHAIVESEAMVAAGSLVTHRKVIKSGEMWAGRPAKFFKKISDEEVKYITQSAQNYIMLMKKYKN*		177		1	Selected	-1	 	
Batch03	TogoA.00821.a	Toxoplasma gondii		B6KN66			V|76.m01670	"coding) peroxiredoxin family protein/glutaredoxin, putative"	Potential drug target		MNKRVYRFFSHSAGFKQTKFLLMTKTMAKALCCTATMATVALLATVLLGNLPAGSFSFVIGTKAVGSVPLGSAASSGGMCSSVSGGPASVFSSSALKAASALGSRSLAFAKTKTLSEGDPAPECVWKVRAAAPEGGMTWAELESTTMFKNKRVVIFSLPGAFTPTCSSRHLPDFDKEYDAIRALGIDEVYCLSVNDTFVMNAWASSLNVKHVKMIPDGNGCFTSKMGMLVDKTNLGFGPRSWRYAMVVRNGTIEKLLVEPEKRDDAEDDPFVASDVASVLKYLRDSADVKGA*		293		3	Expressed	-1	 	
Batch03	TogoA.00913.a	Toxoplasma gondii		B6KU33			XII|37.m00001	coding) peroxiredoxin	Potential drug target		MPAPMVSQPAPAFEAEAVMADGSFGKISLSQFKGKKYVVLFFYPFDFTFVCPSEILAFHRLHGEFEKRGCQLLGVSVDSKFVHNAWRNVELKDGGIGKISFPLLADVSHKMAEDYGVLHPEGMAFRGLFLIDKEGVLQHCVINNLPLGRSADEALRMLDALQHVEQYGEVCPANWKKGDKAMKPTAEGVKEYLGSK*		197		4	Soluble	-1	 	NR-16346
Batch03	TogoA.00930.a	Toxoplasma gondii		B6K942			XI|583.m05561	coding) ribosomal protein L22p-related	Potential drug target		MQTVQPHASALRLARAEARFQRLSPIKTRRVLAEIKGMSLGRALAHLATSPRRPAFQVFKTIQSALANAIHAYGAQTLQPRIQSITAQNGPVMKRPFFRARGRMDIRRRPTTHIRVVLQV*		121		-2	Work stopped	-2	Work stopped	
Batch03	TogoA.00931.a	Toxoplasma gondii		B6KUW0			IV|162.m00307	"coding) serine/threonine protein phosphatase, putative"	Potential drug target		MPTVPVAPQQETFVVLASLSLLPFSEENNVQPVPAPCIVCGDIHGQFFDLLKLFEVGGNVGEQNYIFLGDYVDRGYNSVETFEYLMLLKLKYPRHITLLRGNHESRQITTVYGFYDECVRKYGNANPWKFCTEVFDYLALAAVIDDSVFCVHGGLSPDLKLLDQLRLIYRVQEIPHEGTFGDIVWSDPDDVEEWAENPRGAGWLFGDKVVKRFNHLNGLELIARAHQLAMEGFRYIFPDSSVVTVWSAPNYCYRCGNVAAVMKLDSALRRRMLIFKQTDEHQVATRARAIAPYFL*		296		1	Selected	-1	 	
Batch03	TogoA.01023.a	Toxoplasma gondii					TGG_994901|151.m00001	"coding) ATP-dependent Clp protease, proteolytic subunit ClpP protein, putative"	Potential drug target		MTLIPIVIEQTSRGERAYDIYSRLVKERIIFVTGPVEDNMASVIVAQLLFLESENPDKDIYMYINSPGGVVTAGLSIYDTMQYIKPDVSTLCIGQAASMGSLLLAAGTEGKRYSLPHSRIMIHQPSGGYQGQATDIEIHANEILRVKRKLNQIYEKHTGNSLKKIEGMMERDKFMDPEEARRIGLIDRVIAERKDIKVENIKVEQKVG*		209		1	Selected	-1	 	
Batch03	TogoA.01038.a	Toxoplasma gondii		B6KW48			TGG_994758|148.m00014	coding) DNA dependent RNA polymerase beta subunit	Potential drug target		MHKYKLNNYNSFSKGILNLREICLNQLGKLCLIDTTEGINCGLVVSFAKHIRIYKKGIIQVYFSSIFKNKTKEFLNFKTSLDQELYLIQFNNINLRKNKIFNENVRLVYNKNNFRIKFFSNKKSILLKFTDLFSFTENLIPFIKYNDPARCLMGAKMQSQSVPLLNKKKSFVITGYEKEIITKSDTTIKALQEGIVLNASSLKIHIKDLFNREIVYYLSKYKKSNQNTIIHQKPLV*		237		1	Selected	-1	 	
Batch03	TogoA.01369.a	Toxoplasma gondii		B6KJE0			VIII|44.m02604	"coding) cyclophilin, putative"	Potential drug target		MANPRVFFDIAIGGRPAGRVEFELFKSIVPRTVENFRALCTGEKGVGVSGKPLCYKNSTFHRIIPSFMCQGGDFTRFNGTGGESIYGRTFADENFKLKHTEPFLLSMANAGPNTNGSQFFITTVPCPWLDGKHTVFGKVTSGQNVIKMMESQGTQSGSVKQTVVITDCGETK*		173		2	Cloned	-1	 	
Batch03	TogoA.01371.a	Toxoplasma gondii		B6KDX2			X|42.m00020	"coding) proteasome component PRE3 precursor, putative / proteasome subunit beta type 6 precursor, putative"	Potential drug target		MASSSCVAFSYDDLGLPVVAASSPAGLPVPSLSASGRGPTAVSTGTTIVAVSFKGGVVLGADTRTSAGSYVVNRAARKISRVHERICVCRSGSAADTQAVTQIVKLYIQQYAQELPKGEEPRVEAAANVFQSLCYQHKDALTAGLIVAGFDKVKGGQIYALPLGGALVPMQYTAGGSGSAFISAYMDANFKQNMTQEEAVNLVKNSVAYAISRDGSSGGMVRVVVITEDAMLEECVEGNKLPVAP*		246		5	Purified	-1	 	NR-16223
Batch03	TogoA.01591.a	Toxoplasma gondii		B6KR26  			IX|541.m01151	"coding) calmodulin, putative"	Potential drug target		MSSVEQKAREAFKLFDRNGDGELTHQEAVLAVRSCGIPLRIQELDLPEQVTYPQFRQWMMNRVARSDPLEDLIKLFAPFDRKNDGTISTEELAQVMKTLCSSMTEEDIDHLIKQADPNNSGNIKYAEFVHQCF*		134		-2	Work stopped	-2	Work stopped	NR-16224
Batch03	TogoA.01607.a	Toxoplasma gondii					TGG_995003|363.m00005	"coding) bifunctional putA protein, putative"	Potential drug target		MKELIYILIVEAGKVLSDAITEVREAVDFLRYYAIIARNELSNWKKLQGPTGEDNFIFFEGRGVFLCISPWNFPLAIFIGQVSAALAAGNAVLAKPAEQTPIIAYEAVKILHEAGIPKDVLHLIPGDGQYLGKALVPDNRISGVAFTGSTQTAQMINRMLASRNGPIVPFIAETGGLNAMIVDSSALLEQVTVDVLLSAFRSAGQRCSALKVLFIQEDIAEKQIKMICDAAQELKVGDPIQLSTDIGPIIDKASIDMLTKYTEKMSGDRDSSLLSKVPMDTNSHNGHFFSPYIYEIQKISQLKQEVFGPILHIIRFNKSQLNGVISDINNTGYGLTFSLQSRIQNQIDSISRKISVGNVYINRDQVGATVGVQPFGGRGLSGTGPKAGGPNYLQRFSTEKVVSVNTAAFGGNTKLMCLD*		420		1	Selected	-1	 	
Batch04	BaanA.00003.ra	Bacillus anthracis				AE016879.1		PreQ1 riboswitch 	Targets of other biological interest	AGAGGUUCGCGAACUCCCUCUAUAAAAAACUAU	AGAGGUUCGCGAACUCCCUCUAUAAAAAACUAU	33	33		7	Crystallized	-1	 	
Batch04	BaanA.00003.rb	Bacillus anthracis				AE016879.1		PreQ1 riboswitch 	Targets of other biological interest	CGUGGUUCGAAACCAUCCCACGUAAAAAAACUAA	CGUGGUUCGAAACCAUCCCACGUAAAAAAACUAA	34	34		2	Cloned	-1	 	
Batch04	BrmeA.00002.ra	Brucella melitensis				AE009597.1		SAM-II or SAM-alpha riboswitch (responds to S-adenosyl methionine)	Targets of other biological interest	CGUGGUGAUUUGGCCGGCCGGCUUGCAGCCACGUUAAAGAAUUCGCUAAAUAAGGCCG	CGUGGUGAUUUGGCCGGCCGGCUUGCAGCCACGUUAAAGAAUUCGCUAAAUAAGGCCG	58	58		2	Cloned	-1	 	
Batch04	ClpeA.00003.ra	Clostridium perfringens 				BA000016.3		PreQ1 riboswitch 	Targets of other biological interest	AGAGGUUCGUAACCAUCCCUCUAUAAAAAACUAA   	AGAGGUUCGUAACCAUCCCUCUAUAAAAAACUAA   	24	24		2	Cloned	-1	 	
Batch04	ClpeA.00003.rb	Clostridium perfringens 				BA000016.3		PreQ1 riboswitch 	Targets of other biological interest	GACAGUUCGAAAGCCUCCUGUCUUUAAAUAAAACUAC   	GACAGUUCGAAAGCCUCCUGUCUUUAAAUAAAACUAC   	37	37		10	Diffraction	-1	 	
Batch04	LimoA.00003.rb	Listeria monocytogenes				AL591977.1		PreQ1 riboswitch 	Targets of other biological interest	CGUGGUUCAUUCAUACCAUCCCACGUAAAAAAACUAG	CGUGGUUCAUUCAUACCAUCCCACGUAAAAAAACUAG	37	37		2	Cloned	-1	 	
Batch04	MytuD.00001.ra	Mycobacterium tuberculosis				BX842573.1		Thi-box riboswitch (responds to TPP)	Targets of other biological interest	ACGCGGGAGCGCACGCCGAGUGCGCUGAGAGGACGGCUCGGGGCCGUCGACCGUACGAACCUGACCGGGUAAUGCCGGCGUAGGGAGU	ACGCGGGAGCGCACGCCGAGUGCGCUGAGAGGACGGCUCGGGGCCGUCGACCGUACGAACCUGACCGGGUAAUGCCGGCGUAGGGAGU	88	88		2	Cloned	-1	 	
Batch04	StauA.00003.ra	Staphylococcus aureus 				BX571856.1		PreQ1 riboswitch 	Targets of other biological interest	AGAGGUUCCUAGCUGAAACCCUCUAUAAAAAACUAGA   	AGAGGUUCCUAGCUGAAACCCUCUAUAAAAAACUAGA   	37	37		10	Diffraction	-1	 	
Batch05	AnphA.10100.a	Anaplasma phagocytophilum	YP_505690.1	Q2GIW1				protease DO family protein	Potential drug target		MRRFLSFFFFCALVWGHCAFASEVASSALRVSENNGPSTRGFSDLASKLLPSVVNISTEQTVEGDDLAGDGGGGSIFGFPGIPRGFFEGFFNSIEPLFVEPPKPRKVISLGSGFIIDESGLIVTNYHVIANSQEIQVKFSDGTTAKAKVLGQDPKTDLAVLKVDVAKELVSVKLGNSDDALVGEWVLAIGNPFGLGGSVSVGIISGRARDINIGTASEFLQTDAAINRGHSGGPLFNADGEVIGINTAIISPQGGGNVGVAFAIPSNNAARVISILSKGEKVEHGWLGVIVQHVTEGMVEPLGLDSAHGALVSNVVKGSPAEKGGLRVGDVILEYNGKRVEDMSQLTNLIAKTAVNEKVRLLVLRGGKQVTLKITIGKLEEGADGASGKNGSLETGTESLGITVGDMPEGDGKKRDGVVVLRVDNRGAAFAEGIRRGDVIVGIDAVLVRNVADFTSELEKILQSTKKDSVLLLVQRGDSPPIYVAVKLKR		490		7	Crystallized	-1	 	NR-16547
Batch05	AnphA.10201.a	Anaplasma phagocytophilum	YP_505630.1	Q2GJ21				methionyl-tRNA synthetase	Potential drug target		MSSKHFCVTTPIYYVNDVPHIGHFYTTLISDVLARFKRLDGDNVKFTTGTDEHGQKIEETARKRGTPVLQFVDEVSESFRELVHKSGFCADDFIRTTESRHKDAVVALWDRLYSRGQIYKGSYAGFYSVRDETFYQERDLIDGKAPTGAEVTWLEEPGYFFKLSEWQEALLQLYQDNPRFVVPEGKLSEVISFVKSGLRDLSVSRSKAHLSWGIGVPGDPEHLIYVWVDALSNYLALVGFPNEDAEDYNNFWCGENSHVVHVVGKDILKFHAVYWPALLMAAGLPLPKQVVAHGWWLNEGQKISKSLGNVICPLTIINEYGLDNVRYFLLSETPIGNDASFSAKRLKERVNCDLANNIGNLVQRTVTLVHKWCEGKVPSVDMKLMCGDEALPDYQGILEQYRVYVEERRFFEALKFIIGVSSTANEYIAVKAPWKLFKEDTALAEAVLFKLLEYIKCIGLLLQPFLPVTSEKLLEQIAVPVEKRKFEHIAELCTGRVLPKAVPIFSKFDMDDV		513		5	Purified	-1	 	NR-16548
Batch05	AnphA.10365.a	Anaplasma phagocytophilum	YP_504765.1	Q2GLI6				BolA family protein	Potential drug target		MAVDLLKLRELLCNSFPDGIVDVTSLADDNDHYSVRIVSKRFAGKSKLEQHRMVYDALSGVVVHALQIQTSVGSKQDG		78		5	Purified	-1	 	NR-16549
Batch05	AnphA.11339.a	Anaplasma phagocytophilum	YP_505618.1	Q2GJ33				metallo-beta-lactamase family protein	Potential drug target		MKITILGCGSSVGVPSVGCECGVCASEHPHNKRTRTSALIEKGSTRLLIDASPDLRIQALRQNFYTMDAVLFTHCHADHTTGISELQAFTPKVGYHIPVYSDFGTLALITASNAYLFIPSTPGAPWKKCHYLTVNPVRHNVEFNIGEFSIMAIKQSHGEVNSNGFIFDNSVAYCTDVKSFPEASWERLRNKHMIIFGCLRYQAVGAHAHVDLCIEWIRELKPHIAVFTHMSHDIDYEQLLDYLHSKLPGQKVVVAHDGLELEL		263		3	Expressed	-1	 	NR-16550
Batch05	AnphA.11920.a	Anaplasma phagocytophilum	YP_504881.1	Q2GL70				hypothetical protein	Potential drug target		MQQVVDVVLRGSTYKIACREGESARLLELAGRLSRRINAAVPGSEKSKASDTLLLLLVGLQLEDKIEDLESQVLSMSEELSVYKARCEHESEVRNSLKELLRYSITKTNELADSVSILNNKE		122		5	Purified	-1	 	NR-16551
Batch05	BaboA.10050.a	Babesia bovis	XP_001610506.1	A7AQW9				"deoxyuridine 5'-triphosphate nucleotidohydrolase, putative [Babesia bovis T2Bo]"	Potential drug target		MMHIKILPRSPEVAERYKTHKSYYPGDCGLDLFCPDTITLAPKKTTDVVLGVKIAAYRVHDKSEIGSSSMRNVGWILAPRSSISKTPLRLANSIGIIDAAYRGDIKVAFDNISDEPYTIQSGDRLVQVISYDGEEISYELVNELDQTERGEKGFGSTGR		159		0	Target Approved	-1	 	
Batch05	BaboA.10272.a	Babesia bovis	XP_001608748.1	A7AXA7				hexokinase [Babesia bovis T2Bo]	Potential drug target		MIGEISVIRQAAEAVEVPYKVTQVLDCDEAVRLDQIIGQLDIPIRYLKDVAQAFYAELVNGLMAHRRHRNLWLPNECSFKMLDSYITHLPTGNEKGCYYAIDFGGSNLRAVRINVTGTGTMERMQSTFSLRHATALRPKGLLDRTATATELFDHFAKNIGNLMEEAGDVSDPGHIYPVGFTFSFPCTMLSRRNAILLDWTKGFETGRDTTEQVEGRDIGMLMDEAFKRNHVNARVSIILNDTVGTLMSVAYQKPPGYPECRMGLILGTGFNICYVEHDYLHYGYIGKVVNIECGNFDKLLPTTPVDFEIDWYTSNSGRGMMEKLIAGAYLGDIIRRNMLLYLREKAPAKMWNIGTFTSIDAAEILNDQSETFEKAKEIVKENWDAVLEHHHLAGLRRICEAAFSRSAGLAAAAITATARKTRSYVTNKTTCAVDGSLYVKNQWYRDRLAYYLEKVSRSDLIGSVVMYACDDGSGKGAAIAAAMMAED		487		3	Expressed	-1	 	NR-16616
Batch05	BaboA.10317.a	Babesia bovis	XP_001611492.1	A7AMZ0				protein kinase domain containing protein [Babesia bovis]	Potential drug target		MDSINAPNSRISRGYAQTNRMAASNTQSAMASTTDTQSAQATAADTYSTDLNISNSSHIANIDLINEGGMIAYNETTGTTTLRPPERQVVSQAQSRHLHASHRNNQVGADGTISEGIYNMDAMHCGSHPAQHVPGADTLPEAESKYQVQRMIGNGSFGVVHEAIHVESGNKVAIKKVLQDPRYKNRELSIMLELSHPNIVYMFDHFYTEVVREQETQIYLNIVMEFVPGTVHRMMRSYFKRYNQMPIALIKVYAFQLCKALGYLHAVGVCHRDLKPHNLLVDLETNVLKLCDFGSAKKLRAGEMSVAYICSRFYRAPELMLGATEYTTAIDIWSIGCVIGELLMGKPMFAGDTSIDQLVKIIQVLGTPTIEQMYAMHPNYQNVTFPNIRAADLTRLFPTNTPPVAIDFVSQFLRYDPKERLRPLEALGHDFFNDILHNPNSNIFVPKNLLEFTQQELSAMSENTKRKLGIVHQ		473		0	Target Approved	-1	 	
Batch05	BaboA.10365.a	Babesia bovis	XP_001609842.1	A7ATL3				BolA-like protein [Babesia bovis]	Potential drug target		MVSKSIVEERLRSMLSPQFLKVTDNSGGCGAAFNAYIVSQQFEGKGLLDRQRLVNSAIAAEMPQIHAFTMKCLTPGEWEAKNRPEE		86		5	Purified	-1	 	NR-16617
Batch05	BaboA.10384.a	Babesia bovis	XP_001610986.1	A7AS99				"cell division control protein 2 , putative [Babesia bovis T2Bo]"	Potential drug target		MKGYHKLEKIGEGTYGVVYKAQNDHGEIFALKKIRVEEEDEGIPSTAIREISLLKELHHPNIVCLRDVIHSEKCLTLVFEYLDQDLKKLLDVCDGGLETSTAKSFLYQLLKGVAYCHEHRILHRDLKPQNLLINRKGILKLADFGLARAFAIPVRSYTHEVVTLWYRAPDVLMGSKKYSTEVDIWSVGCIFAEMINGVPLFPGVSEQDQLKRIFKVLGSPNVGTWPGVVDLPAYNPDMDQFEKQPWNVIVPKLGGAGVDLISKMLQLDPFQRISARDALCHEYFNDVSENGVTDV		295		0	Target Approved	-1	 	
Batch05	BaheA.10100.a	Bartonella henselae	YP_033313.1	P54925				Serine protease	Potential drug target		MVKKTFFTTLAAVSFSAALETALFFSGCGSSLWTTKAHANSVFSSLMQQQGFADIVSQVKPAVVSVQVKSNKKKKEWFFSDFFSTPGFDQLPDQHPLKKFFQDFYNRDKPSNKSLQRSHRLRPIAFGSGFFISSDGYIVTNNHVISDGTSYAVVLDDGTELNAKLIGTDPRTDLAVLKVNEKRKFSYVDFGDDSKLRVGDWVVAIGNPFGLGGTVTAGIVSARGRDIGTGVYDDFIQIDAAVNRGNSGGPTFDLNGKVVGVNTAIFSPSGGNVGIAFAIPAATAKQVVQQLIEKGLVQRGWLGVQIQPVTKEISDSIGLKEAKGALITDPLKGPAAKAGIKAGDVIISVNGEKINDVRDLAKRIANMSPGETVTLGVWKSGKEENIKVKLDSMPEDENMKDGSKYSNEHGNSDETLEDYGLIVAPSDDGVGLVVTDVDPDSDAADKGIRPGDVIVTVNNKSVKKVSDITDTIKNAQKLGRKAILLQVRTNDQNRFVALPIFKK		503		4	Soluble	-1	 	
Batch05	BaheA.10100.b	Bartonella henselae	YP_033809.1	Q6G2Z1				Serine protease	Potential drug target		MRYSFVGWFFWAIMAQISFHCAYAEIPQTQKEITLSFAPLVKKTIPSVVNIYAARQIRARSPFEGDPFFEQFFSRFQNNLPVRKQSSLGSGVIVDKRGLVVTNYHVIKDANEIKVALSDGREFESKVMLKDEATDIAVLEIDAKEAQFPVLPLGDSDAVKVGDLVLAIGNPFGVGQTVTSGIVSAQARTRVGISDFDFFIQTDAAINPGNSGGALIDMKGQLIGINTAIYSRSGGSVGIGFAIPANLVKVMLDTVRRGGKYFVPPYIGASFQNVTPDIAGGLGLERPYGALVIEVIKDSPAKKAGLRVGDVILSVQGIRVDSPDSLGYRLMTAGIGDSLVLEYLRSGKTFQTKITISSIPDAFSKSEKIIDEGPLSGAEVLDLTPQNSRRFHLSTSAKGVVISNLDEMSNAAGIFRTGDILRVINGHKIQTVSQLKKILMQDRPRVWQLEYERDGMYIRQFIR		463		3	Expressed	-1	 	
Batch05	BaheA.10100.c	Bartonella henselae	YP_033869.1	Q6G2T2				Serine protease	Potential drug target		MGRNVIGKNTSMKCFLIRAFVCVLLFLLGSMNSSWAVETKNRSLSVPDLAAQLLETVVNISTAQTVDGTEQDEHTSVPVIPEDSLLQEYFTDFFSPKDGQKESQFQKVRSLGSGFVIDAQKGLIVTNYHVIVDADDIEVNFTDGTKLKAKLLGKDSKTDLALLQVDAGSKKLKAVRFGDSEKARIGDWVMAIGNPYGFGGSVTVGIISARNRDLNAGPYDNFIQTDAAINRGNSGGPLFDRNGEVIGINTAIVSPSGGSIGIGFAIPSDMALSVINQLRDFGEIRRGWLAIRIQPVTEDIAKSLKLESPVGALVAGKMEQTDVDNSQLQIGDIILSFGNAKIKHARDLPRLVAESLEGKVVDITVLRNGQEKTVKVKLGRLIETDTNENMVEESDNERSGPISKSGTMQFMGMTLSELTADLRQHYSITDKLQGLVVISVAKNSAADKKRIRTGEVIVDINQSTVTTIGEAKKRIHKLREAGRKNALFIIARPDGELRFVTIPMD		505		5	Purified	-1	 	NR-16559
Batch05	BaheA.10201.a	Bartonella henselae	YP_033653.1	Q6G3D4				methionyl-tRNA synthetase	Potential drug target		MPDTYYITTPIFYPNGAPHIGHAYSAIASDVLARFQRLDGKNVFFLSGTDEHGLKMQQTAVALGITPKQLTDRNSAVFQKMLAALNCSNNDFIRTTEKRHYQACQEIWKKMKANGDIYLSRYTGWYSVRQEAYYEEKDTEVGEDNIRREKELGSPVEWNEEESYFFKLSRYEKALLEHYEKHPDFIAPPERRNEVISFIKSGLKDISISRASFNWGICVPNDSKHVMYVWVDALTNYLSAIGFFDENSKKRAFWPASVHIIGKDIIRFHAIYWPAFLMSAGIALPKRIFAHGFLLNNGVKMSKSIGNVVDPFEMIDHYGLDQVRYFLLREVPFGQDGSYSHDSFVNRINADLANDLGNLAQRSLSMIAKNCDAKVPLPAAFLVQDEQLLEKSLQTLDTMRKAMSSQEIHLALSAIFSVVADANRYFANEQPWSLRKNNPERFSTVLYITLEILRRIGIMLLPFMPQSAAKLLDSLKISQEDRLLQHISNSKIQEGLDLPPPEPIFPRYILKKDDIHHVD		519		5	Purified	-1	 	NR-16560
Batch05	BaheA.10252.a	Bartonella henselae	YP_033578.1	Q6G3K1				threonyl-tRNA synthetase	Potential drug target		MSCSVSLSFPDGSKRDYHSEMTGLELAESISKSLAKKALAYSLNGIIRDLSDPIKQSGQIEIITREDTRALELIRHDCAHVLAEAVQELFPGTQVTIGPVIENGFYYDFARQQPFTLDDLTIIEKKMREIIQRNKPFRKEVWSRKKAREIFSEKGELYKVELIDSIPDNQDLKVYYQGDWFDLCRGPHMQSTGQIGNAFKLMKVAGAYWRGDANNPMLTRIYGTAFANENDLKAYLHMLEEAEKRDHRRLGREMNLFHFQEEGPGMIFWHKKGWKMFQNLINYMRRRLDDHQYAEVNAPQVLDRSLWEISGHWEWYKENMFKAIPAAEDWDNENVYALKPMNCPGHVQIFKHGLKSYRDLPTRIAEFGVVHRYEPSGSLHGLMRVRCFTQDDAHIFCTDEQLADECLNINDLILSTYADFGFKEISLKLSTRPEKRVGSDALWDHAENIMESVLKTIETKSAGQIKTSILPGEGAFYGPKFEYTLKDAIGREWQCGTTQLDFNLPERFNAFYIDKDSEKRQPVMIHRAIFGSMERFLGILIENFSGHMPLWFAPEQIVVATITSEANEYAKKLTAKLKSVGLSTTLDLRNEKINYKIREHSLQKVPVILVCGKRESETNSVNMRRLGSTEQIFLSVEEVIEQLKNEATPPDLRRVINA		658		4	Soluble	-1	 	
Batch05	BaheA.10365.a	Bartonella henselae	YP_033766.1	Q6G334				hypothetical protein	Potential drug target		MAMSANEIKTLIREGIPDATIIIRDLAGDGEHYAAEVISESFRGKSRVQQHKMVYDALKGNMGNGLHALMLQTNIPK		77		10	Diffraction	-1	 	NR-16561
Batch05	BaheA.10520.a	Bartonella henselae	YP_033938.1	Q6G2M3				hypothetical protein	Potential drug target		MVSFRTHIIPVTSFQQNCTLLFDNERKVGVLVDPGGDWLQIQDVIRKNGVIVEAIWITHGHFDHVGAAMQAKEALNVKIIGSHRDDKPVMDAVRESAESYGITDARICVPDQWLEDGDSVHFAGHVFRVYHTPGHSPGHVIYFNEKERFALLGDVLFRGSIGRTDFPFCSHKDLMKSLREKVLPLGDDVRFICGHGPGSYLGYERQWNPFLQGFHE		216		5	Purified	-1	 	NR-16562
Batch05	BaheA.10647.a	Bartonella henselae	YP_033902.1	Q6G2P9				Penicillin-binding protein	Potential drug target		MKSYFLFSQKRKRLKKQFNIDNFPVRRSYSSRRRLFFSSFCFLILYGVMGACLISYGFEGGQIEEAKGPRVLQLTARPDILDRNGRLLATDIKTYSLFAEPRRIIDVDETIELLSTVLPDLNWQETYKRLKKKSSFSWIQRGLTPLQKAQIMALGIPGIGFRTEIRRFYPSGPVLSHILGMVNVDNQGIAGMEKYIDDAGLSDLRAAGLATEDSLKPVQLSIDVRVQTIVHDELMKAMKRYKAIAAGAVILNIHTSEVLALASLPDFDPGNPVDALKSDRLNRMTAGTFEMGSIIKSFTTAMALDSDIFHLNSIIDASKPLQASRGFTIHDFHGKNRPLTLWEVFIYSSNIGSAKEAMAIGIDGHRAFLKRLGLLDRMTTELPEVAHPLVPNHWKDIHSMTISFGHGMATTPLQTAVAAAALMNGGWLIAPTFLKRTRDQALQHAKQVLQAKTSQNMRYLYKLNSDIGSGRNAKVEGYRVGGKTGTAEKVENGKYSKTKNFNSFLAAFPIEDPDYVVLTIIDEPQPEDGKYSATAAMNAGPILANIIRRSANFLGIKPDFQKEYEPILTTENSLSFVKKR		580		4	Soluble	-1	 	NR-16563
Batch05	BaheA.11920.a	Bartonella henselae	YP_034209.1	Q6G1Y8				hypothetical protein	Potential drug target		METVSVTIDGKVYRMACDKGQERHLIELAARLDQYITHLKKNFGEMGDHRLSVMAGIMILDEMEEIKRENKKLQEDYEALLRLHNEKNHTMGRIMRDTTKRIEKLTSQLLKDEQNSLISQEQEDL		125		4	Soluble	-1	 	
Batch05	BobuA.11416.a	Borrelia burgdorferi 	NP_212495.1	O51336				ATP-binding protein (ylxH-2)	Potential drug target		MIIIPVASGKGGVGKSLFSTNIAICLANEGKSVLLVDLDLGASNLHSMLNIIPKKSIGTFLKTRINFSDIIIQSGIKNLNFIAGDSDIPELANIAASQKKIIIKNLKSLKYDYLVIDLGAGTAFNIIDFFLMSKRGVIVTTPTVTATMNAYLFLKNIIFRLLSSVFKRGTKGNEILRTIKQNSIDLQRVYIPNLLLKLESEDPENYSKFNKLFRTISPFMIFNMLKAPKDIEKTEKIIKSAKNYLSINLQSIGAIYKDEIVDQALNSKIPITIYKPTSSTSKSIKKIAKKLIEIEDLTNDAELLNEEDLNESYDFVLREAQEEYIEKIEYLESLIKNKTIESSEIIDIIKSQKREIETLRKQNMLFKKKLVEKLEKAKEV		380		2	Cloned	-1	 	NR-16618
Batch05	BobuA.11726.a	Borrelia burgdorferi 	NP_212800.1	O51610				hypothetical protein	Potential drug target		MPLSFGKMILLIDLILFSYLSLYSKTPDYLNVLDFFDTNVFRFDFNIENDVFTIENDKGYLKFRVGFEYALTSSGYYMFVDPIIDIRGEILISQKVLKQIENYFSSLKDYNKPRITSIIIDPGHGGHDTGAVVTLKINGYDVVLQEKDFALTYSIYLSKILSNYFVNKNILLTRINDVYLTLKERSEFANAIKPNFPNNVIFLSIHANDAPNGEARGVEFWYLPKDSKREVIKDFKGYDIKGNRYLSELNDILDIKYKYESKRLAEILYKVFKNELSETNIRPIRKEQWFVIKNSSMPAVLIEMGFLSNILDAKLILDYNYMSKFNILILKALMEFINFYEK		342		3	Expressed	-1	 	NR-16619
Batch05	BrabA.10014.a	Brucella melitensis	YP_413580.1	Q2YNU7				ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase:Sugar transporter superfamily	Potential drug target		MTEKLVGPIIELEDVHLTLGHAASSVHVLKGVSLHIAPGQSVGIVGPSGSGKSTLLMVLAGLEHVDNGIVKIAGETISQMSEDQAAAFRGANIGIVFQSFHLIPNMTALENVAVPLELAGRRDAFDVAERELRAVGLGERLTHYPSELSGGEQQRVAIARALAPSPKILIADEPTGNLDTATGRQIADLLFAKQRENGLTMVLVTHDPSLAARCDREIPVRSGRIAEPVQGAGIPETQAVRA		242		5	Purified	-1	 	NR-16620
Batch05	BrabA.10014.b	Brucella melitensis	YP_413603.1	Q2YNV8				ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase	Potential drug target		MEVRVAGVRKEFARFPALHNVSLTIQSGELIALLGPSGSGKTTLLRLIAGLETPTEGMIFFGDEDASQKSVQERNVGFVFQHYALFRHMTVADNIGFGLKVRPGGTRPSTAEIRRRALELLDLVQLSGLEKRYPAQLSGGQRQRVALARAMAIEPRVLLLDEPFGALDAQVRKELRRWLREIHDKTGHTTVFVTHDQDEALELADRVVVMSQGRIEQVGTPDEVYDKPNSPFVYGFIGESSTLPVRVENGEVWLADRNIGLGAENMPDGDAQLYFRPHDVELLDGCGGCIAGTVIASRRSGGKRRVELEVGGARERIEIEIPAEHPAAEKSRIAFRPRYWTLFRAGDSELPAPKAAATT		359		2	Cloned	-1	 	NR-16621
Batch05	BrabA.10014.c	Brucella melitensis	YP_413705.1	Q2YP78				ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase	Potential drug target		MIEFDRITKNYNGRAAVDEVSFTIEPHSIAAIVGTSGSGKTTLLRMVNRLEEPTSGEIRIDGQSILDEPGHELRRRIGYVIQQHGLFPHRTVGENIATVPALLGWPKQRIEARVDELLELFQLEPGAYRDRYPHELSGGQQQRVGVARALAAGPNILLMDEPFGALDPVIRAKAQEDLKAIQRRFGTTILLVTHDMEEAISLGDRIAVMDEGKLLQFGPPAEILARPATEFVERLVGTGERPFRLLSLTDLKTVLQPGDASGEPLPVTASQRDALAELLWSGRRALPVLDEDGRSLGRVTLEKLLHQAERPA		312		7	Crystallized	-1	 	NR-16622
Batch05	BrabA.10014.d	Brucella melitensis	YP_414202.1	Q2YN82				ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase	Potential drug target		MQVSKTEVAIEITNMHKWYGEFHVLRDINLKVMRGERIVVAGPSGSGKSTMIRCINRLEEHQKGKIVVDGIELTNDLKKIDEVRREVGMVFQHFNLFPHLTILENCTLAPIWVRKMPKKQAEEIAMHYLERVKIPEQANKYPGQLSGGQQQRVAIARALCMNPKVMLFDEPTSALDPEMVKEVLDTMVSLAAEGMTMICVTHEMGFARQVANRVIFMDQGQIVEQNSPDEFFDNPQHERTRLFLSQILH		249		3	Expressed	-1	 	NR-16623
Batch05	BrabA.10014.e	Brucella melitensis	YP_414275.1	Q2YNH6				ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase	Potential drug target		MAAEIILRLERIGRAYKEADRELIILNDADFTLRRGEMVALVAPSGAGKSTLLHTAGLLERPDSGDVVLDGRSCSKLSDDERTAVRRNDVGFVYQFHHLLPEFSALENVMLPQMIRGLSRKAAAERAQQLLEYMKIGKRASHRPAELSGGEQQRVAIARAVANAPLVLLADEPTGNLDPTTSSYVFGALEALVRQSGLAALIATHNHELARRMDRRVTLKDGRVVDL		227		3	Expressed	-1	 	NR-16624
Batch05	BrabA.10014.f	Brucella melitensis	YP_414987.1	Q2YQA2				ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase:Spermidine/putrescine ABC transporter ATP-binding subunit	Potential drug target		MESFGSFRRKFAPWNDPAAKPFISFENVTKIFGDFTAVDNLSLNVFNREFFALLGASGCGKTTLMRMLAGFEEPTSGRITLDGQDMRGIPPYKRPVNMMFQSYALFPHMTVEKNIAFGLKQDGMAKSEIDARVAEMLKLVKLEQYGKRKPHQLSGGQRQRVALARSVAKRPKVLLLDEPLGALDKKLREETQFELMDLQVKLGMTFMVVTHDQEEAMTMADRIAVMDKGRIMQVATPAEVYEAPRSKFVADFIGNVNIIEGEVVKAANGEAEIATEKFGFHIHTETREQLNPGQKVWYAVRPEKTRISREKPDEAAVNAVEGELWDIAYFGDMTVFHVRLDNGRTVKAASLNAVRKTENPLTYDERVWVSFDIDAGLVLTA		381		10	Diffraction	-1	 	NR-16625
Batch05	BrabA.10014.g	Brucella melitensis	YP_415291.1	Q2YLW3				ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase	Potential drug target		MTSPLLRISNLAKSFGNVTALRDISFDVSAGEVVCIIGPSGCGKSTLLRCINHLTAPDGGFVEVGGEYIGRERKPDGTVRMQSHHEIDLMRPKMGFVFQQFNLWPHLSVLENIVKGPIKVQKRPRAEAEAQALALLQRFGLRDKAHMFPAGLSGGQKQRVAIARALAMGPELMLFDEPTSALDPEIVKEVLLFLRELADSGVTMVIVTHEIGFARHVADRIVFLDKGVVAETGPSEDVLSNPANPRLREFLSQISSNHFHAGGAFSPAATH		271		3	Expressed	-1	 	NR-16626
Batch05	BrabA.10014.h	Brucella melitensis	YP_415294.1	Q2YLW0				ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase	Potential drug target		MHLSAKKTSSAVAMRAVSKWYGQFQVLKDIDFDVARGERVVICGPSGSGKSTLIRCINRLEPYQDGQIIVDGIALTDEAKSVDEVRREVGMVFQHFNLFPHLTILENCTLAPMSVRGMSRKAATEIAMNYLSRVMIADHSHKYPSQISGGQQQRAAIARALCMNPKIMLFDEPTSALDPEMVSEVLDTMVSLAEEGMTMICVTHEMGFARRVADRVIFMDQGNIIESAEPSIFFDAPKHERTRLFLSQILH		251		3	Expressed	-1	 	NR-16627
Batch05	BrabA.10014.i	Brucella melitensis	YP_418487.1	Q2YIV5				ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase	Potential drug target		MTIEKPPATSAPIVEMKDVRRMFGETAAINGVSLSVARGEILGIIGRSGAGKSTLIRCVNGLEKPDTGSIHIEGREITSLDEDALRPVRRRIGMVFQHFNLLSAKTAAQNIALPLKIAGMPKAERIKRVAELLELVGLSDKASHYPAQLSGGQKQRVGIARALAAEPAVLLSDEATSALDPETTQSILALLKDINAKLGLTILLITHEMDVIRRIADRVIVLDHGLIAEEGPVWKVFANPQSPVTQSMLQVLTPELPAIWRNRLEKKGDQAILRVKLSGMAAKGAFFNDVAAATSLAPQLIHGGMDTIQGEPVGTLFIGLPAEDKTKLKAAIGYLNTHADATEVLGYVSGNA		352		4	Soluble	-1	 	NR-16628
Batch05	BrabA.10014.j	Brucella melitensis	YP_418690.1	Q2YKZ4				ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase:Glycine betaine/L-proline transport ATP-binding subunit	Potential drug target		MACFKVFGDNPMRAMRELGAGKSKAQIHSDLGATIGVDNATFDIREGEVFVIMGLSGSGKSTLLRLLNRLIEPTAGSIEVEGRDIVKMSKRELIDLRRRDMSMVFQSFALLPNRSVLNNAAFGLEVAGMGEVQRHQKALKALAAVGLEPYAHSMPDQLSGGMKQRVGLARALASEPTVLLMDEAFSALDPLIRTEMQDELKRLQAQHSRTIVFVSHDLDEAMRIGDRICIMQHGKVVQVGTPNEIISAPANDYVRSFFRNVDVSRVFKAADVARDDELIVFEAEQLATALERFDASGKAYGVLVDADRTYRGLVSRDALAAGQRLNDFAAIEADAPLSGLLVHVAKSPWPVPVTDRQNRYVGAISRSVLLETLGRAG		377		3	Expressed	-1	 	NR-16629
Batch05	BrabA.10014.k	Brucella melitensis	YP_418726.1	Q2YKV8				Uridine kinase:Disease resistance protein:ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase	Potential drug target		MDARNLQDERPGEEKCRQHSGTALSLSGICRQFGTMQALNHVSLDVEPGEIICLVGHSGCGKTSLLRIIAGIDAPDSGTLTMGGKTLVSNGIFVEPEKRNVGVVFQDYALFPHLTVRENVRFGLSRMRRSEANARAGELLDLVGLGHMADRYPHMLSGGEQQRVALIRALAPKPHVLLMDEPFSNLDRGLRARVRRETVSLLRVLGTTAIIVTHEAEEALSTGDRVVLMRSGQIVQSGSPRDLHDCPVNRYAADFFCDFNAIPAEVHGDTLVTPFGTIKKEAGFPSGSRVVVYLRPCDIAVLGADDGNLSLHGRIEARTYLGESEELVVKAGDMPLRLHVRGEAPIPSGLADVSLCPHWEKALVFPD		367		4	Soluble	-1	 	NR-16630
Batch05	BrabA.10014.l	Brucella melitensis	YP_418737.1	Q2YKU7				ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase	Potential drug target		MSFLKITDLYKSYGSVSVLKDINIEIDEGGFLVLVGPSGCGKSTLLNTIAGLEPITSGDIAINGKSVSNLHPSQRDIAMVFQSYALYPNMTVAGNIAFGMEIRKVPKPERDKAIQQVADMLQIGHLLDRKPSQLSGGQRRRVAMGRALVRNPQVFLFDEPLSNLDAKLRVDMRTEIKRLHSRMKTTIVYVTHDQIEAMTLATKIAVLKDGVLQQFGTPAEIYNNPANMFVADFMGSPAMNLLPVKVEKSGSDYAITLDQGEGEVLKLPLKAVPQGLAQYVGKEVVFGIRPEALTDPDGADRNAASIVEGDCLIDVVEPAGSDTFAVTRLGGKHVVARLRADARIRAGQSARLAFNLDKSVFFDSASQTRIL		371		3	Expressed	-1	 	NR-16631
Batch05	BrabA.10014.m	Brucella melitensis	YP_418766.1	Q2YKR8				Disease resistance protein:ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase	Potential drug target		MSKIVLDNVRKSYGGNIEVIKGVSLEIADGEFVVLVGPSGCGKSTLLRMIAGLESITSGTISIGERVVNNVEPAERDIAMVFQNYALYPHMTVRENLAYGLKNRKTPKEEIERRIAKAAKALEIEQFLERKPRQLSGGQRQRVAMGRAIVREPAAFLFDEPLSNLDAKLRVQMRVEIKRLQRSLGTTSVYVTHDQMEAMTMADRLVVLNAGHIEQVGTPIELYEKPASTFVATFIGSPSMNLLQSPESAPWQPGRAITLPSGGYTFGVRPEDIRILEEGDQDADGFNAQVRIEAVELVGAESYIHAALSDGKPLIFRVAGRSTHNIDEMVRVGASATDVHIFGADGRRVSD		351		7	Crystallized	-1	 	NR-16632
Batch05	BrabA.10014.n	Brucella melitensis	YP_418891.1	Q2YKE3				ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase	Potential drug target		MGSLQLKSVHKRYGAQEVLKDINLEVNDGEFIIFVGPSGCGKSTLLRSIAGLEDVSAGQVLINGEDVTVTPPSRRGIAMVFQSYALYPHLTVKANMGLGLKQAGAPKDEIEGRVAKASAMLALEPYLARRPAELSGGQRQRVAIGRALVRNPELFLFDEPLSNLDAALRVQTRLEIAKLHRELKATMIYVTHDQVEAMTLADRIVVLNAGRIEQIGSPMELYNRPDNLFVAGFIGSPQMNFIEAARIGATGARTIGIRPEHLSVSRESGTWKGKVIHAEHLGADTILYVETETAGLVTARLFGEQHYNEDDVIFLTPEEGKTHRFDEAGKAIR		333		7	Crystallized	-1	 	NR-16633
Batch05	BrabA.10014.o	Brucella melitensis	YP_418981.1	Q2YK53				ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase	Potential drug target		MLTLEHVDAGYGRTTILQDVSLEVKEGEIVTIVGANGAGKTTTLRTIVGQIQPRAGKITFLGEDITHLPAHEVVDRGIILIPEGRQLFPDMTVRENLQMGTYRRAARAAQESRMEEVLELFPRVRERLDQTASSLSGGEQQMVAIARGMMANPRILMFDEPSLGLAPIVVSQVFDVVRKIAATGTTVLIVEQNVFTTLKVANRGYVLENGRVVLADSSEALLNNDHVRRAYLGI		234		4	Soluble	-1	 	NR-16634
Batch05	BrabA.10014.p	Brucella melitensis	YP_419070.1	Q2YJW4				ATP/GTP-binding site motif A (P-loop):ABC transporter:AAA ATPase	Potential drug target		MATFGTGSETVVLDKVTKSYGGFNAISDASFRLMAGENIALVGHNGAGKTTMIKLMLGLIRPTKGAVRVLGEDPAAGAFAARLRLGYLPEHVSFNMALTGAETLGFYARLKQVPFGQADALLERVGLAHAADRRVGTYSKGMRQRLGLAQALLGQPAVLLLDEPTTGLDPALRQSFYEILESLRQEGTTILMSSHALTELETKVGRVIIANKGKVIADGSIDALRRISRLPMRTRVEVNDVSCLPVETGNLLLRWHRLGPDLYETEAPAEGKMELVRRIVAMNDKLNELDIIPPTLDELYAHFLNMGDMAVQEAAE		316		3	Expressed	-1	 	NR-16635
Batch05	BrabA.10050.a	Brucella melitensis	YP_415037.1	Q2YRG4				deoxyuridine 5'-triphosphate nucleotidohydrolase	Potential drug target		MTAASSSAPTLGIIRLEHAKGLDLPAYETAGSAGMDLRAAVAEDRQIVLLPGRRTLVPTGLILEIPQGYEVQIRPRSGLAFKNGITCLNTPGTIDSDYRGEVKVLLINLGDDDFRIERGMRIAQAVFAPVIQPKIEERAKISETARGAGGFGSTGTA		157		17	In PDB	-1	 	
Batch05	BrabA.10100.a	Brucella melitensis	YP_414077.1	Q2YMX6				"Serine protease, V8 family:Serine protease, trypsin family:PDZ/DHR/GLGF domain:HtrA/DegQ protease"	Potential drug target		MSRARISNYRKGVAAVALSAALAGAFVVTGPLGALNEARAEAVHVTPPPQAGFADLVEKVRPAVVSVRVKKDVQETSNRGPQFFGPPGFDQLPDGHPLKRFFRDFGMEPRGDSRSDNRRGKANKPRPGHERPVAQGSGFVISEDGYVVTNNHVVSDGDAYTVVLDDGTELDAKLIGADPRTDLAVLKINAPKRKFVYVAFGDDNKVRVGDWVVAVGNPFGLGGTVTSGIVSARGRDIGAGPYDDFIQIDAAVNKGNSGGPAFDLSGEVIGINTAIFSPSGGSVGIAFAIPSSTAKQVVDQLIKKGSVERGWIGVQIQPVTKDIAASLGLAEEKGAIVASPQDDGPAAKAGIKAGDVITAVNGETVQDPRDLARKVANIAPGEKAALTVWRKNKAEEINVTIAAMPNDKGKSGSQSNDNDGGQGETLDSYGLTVVPSEDGKGVVVTDVDPDSDAADRGIRSGDVIVSVNNQTVKTAGDINKAITAAEKSGRKAVLLQLQSNDQSRFVALPINQE		513		5	Purified	-1	 	
Batch05	BrabA.10100.b	Brucella melitensis	YP_414615.1	Q2YRU2				"Serine protease, V8 family:Serine protease, trypsin family:PDZ/DHR/GLGF domain:HtrA/DegQ protease"	Potential drug target		MNWRCLGFAGVVLAFFSLAAGPVAAQDSPATAVRQIPLSRGDMQLSFAPLVKETAPAVVNVYAARQVQARSPFEGDPFFEQFFGSQFGASKPRIQQSLGSGVIVDRSGIIVTNNHVIKDADEIKVALSDGREFESRILLRDETTDLAVLKIEAKQQFPVLALGNSDEVEVGDLVLAIGNPFGVGQTVTSGIVSAQSRTQVGISDFDFFIQTDAAINPGNSGGALIDMRGRLIGINTAIYSRSGGSVGIGFAIPSNMVRAVVDAALQGSTRFERPYIGATFQGITPDLAESLGMEKPYGALITAVVKDGPAETAGLKVGDVVLSVQGVRVDNQDVLGYRLSTAGIGKTISVEVMRNGKNLSLPVKLTKAPKVKQAEPKVIEGDNPFDGAAVGDLTASTAAKLRLKRGQQGVAVFDVYSGSPAARLGLRSGDIIRSINGNQIRTVDDMTAVLEAGRGLAWRLEIERNGALLRQFVR		474		2	Cloned	-1	 	
Batch05	BrabA.10100.c	Brucella melitensis	YP_414785.1	Q2YS27				"Serine protease, V8 family:Serine protease, trypsin family:PDZ/DHR/GLGF domain:HtrA/DegQ protease:Glucose/ribitol dehydrogenase"	Potential drug target		MAIAPKAGFARTLFATVALGAMSVAGTVSMGTPPALAAQGPASVADLAEGLLDAVVNISTSQTVKDDGEGDGPVPMPQVPEGSPFQEFFKDFFNDKDGAQGDDSRKVQSLGSGFIIDAEKGYIVTNNHVIADADEIEVNFNDGSKLKAELVGKDTKTDLAILKVDPSKHKLKAVHFGNSEKARIGDWVLAIGNPFGLGGTVTAGIISARKRDINSGPYDDFIQTDAAINRGNSGGPLFDMDGKVIGINTAIISPSGGSIGIGFAIPAEMAAGVIDQLKEFGEVRRGWLGVRLQPVTEDIAQSLGLKETKGALIAGLIENSGVDNKAIEAGDVVIRFDGKPVDTARDLPRLVAESPVGKEVEIVVIRQGAEKTLKVKLGCLVEDDKSTEPAVEDQVPAPDDGEQPGARQETPDKSDKPKKEHKSDAAPSVLGMKLSKLDDDIRGEFGIAEDVEGVAILYVAPGTAAGEKRIETGDVIVDIGQVTVKTPEDVKKRIDALRREGRKNALLMLASRSGELRFVTIRID		524		4	Soluble	-1	 	
Batch05	BrabA.10154.a	Brucella melitensis	YP_413916.1	Q2YMF6				Histone deacetylase family	Potential drug target		MHFPGRRRFTYFLRKMLYSGCMTTRLYWHPIYLEHLTPPGHPERPDRIRALMSELEGPDFYRLDRVEAPHAGEAAILLAHPEEHLEAVRSKIPEPVEDGEASQPIVKLDGDTYVSPKSMDAALTAIGAAMAAVDDVMSGAADNVFVASRPPGHHAERSRAMGFCVFNNIAIAARHAQRHHGLERIAIVDGDVHHGNGTQDIFKDDPGVMFCSTHQFPLYPGSGDKHETGVGNIVNAPLSPNTGSREFREAFNSRILPALDNFRPDLILISAGFDAHFRDPLAEINLDESDFDWATGKLMERAERFCDHRLVSVLEGGYDLEGLSQSASVHITRLLKG		337		2	Cloned	-1	 	NR-16636
Batch05	BrabA.10201.a	Brucella melitensis	YP_414420.1	Q2YQ76				methionyl-tRNA synthetase	Potential drug target		MSREKYYITTAIAYPNGKPHIGHAYELIATDAMARFQRLNGMDVYFLTGTDEHGIKMLQSARKEGITPRDLADRNTSAFRRMAEVLNSSNDDYIRTSEERHYKASQAIWQAMVANGDIYKGGYAGWYSVRDEAYYGEEETEVRADGVRYGPQGTPVEWVEEESYFFRLSAYQDKLLDLYENNPGFIMPAERRNEIVSFVKSGLKDLSISRTTFDWGIPVPGDEKHVMYVWVDALTNYITALGYPDTTDERWAYWPANAHIIGKDISRFHAVYWPAFLMSAQLPLPKRVFAHGFLFNRGEKMSKSVGNVIDPFELVERYGLDQLRYFLMREVPFGQDGSYSHEAIVNRTNADLANDLGNLAQRSLSMIAKNCEGKVPQPGAFSEADKAILDQADAALETARKAMDDQALHLALGAIFAVVAEANRYFAGQEPWALRKTDPARMGTVLYVTAEVLRRVGIMVQPFIPQSAEKLLDILAVPADKRQFADVLASPLAGGTDLPAPQPVFPRYVEADEQN		515		10	Diffraction	-1	 	NR-16637
Batch05	BrabA.10322.a	Brucella melitensis	YP_415237.1	Q2YLQ7				ATP/GTP-binding site motif A (P-loop):Cell divisionFtsK/SpoIIIE protein:AAA ATPase	Potential drug target		MEQTAPSPKPGPRAQREAQPSFLKDNGIFEMPSLHFLAEPKLVQRDPALSKDALEQNARLLEGVLEDFGVRGEIINVKPGPVVTLYELEPAPGIKSSRVIGLADDIARSMSAIAARVAVIPGRNAIGIELPNPKREMVYLREMLASRDFEQSKAKLALALGKTINGEPVIADIAKMPHVLVAGTTGSGKSVAINTMILSLLYRMTPQEFRLIMIDPKMLELSVYDGIPHLLTPVVTDPKKAVVALKWTVREMEDRYRKMSKVGVRNIDGFNQRVGLAQKKGEPIARTVQTGFDRNTGEAIYETEELDLEPMPYIVVIIDEMADLMMVAGKDIEGAVQRLAQMARAAGIHVIMATQRPSVDVITGTIKANFPTRISFQVTSKIDSRTILGEQGAEQLLGQGDMLFMAGGGRIQRVHGPFVGDDEVERIVQHLKLQGVPEYLDAITEDEDDDEGGSGPAGTGNLEDSDDPYDQAVAVVLRDKKASTSYIQRRLGIGYNRAASIIERMEDEGIVGPANHAGKREILVPTGDDDF		531		5	Purified	-1	 	NR-16638
Batch05	BrabA.10478.a	Brucella melitensis	YP_418758.2	Q2YKS6				aminotransferase	Potential drug target		MQGTREMTDTRAMWTYYKGEWREGDVRILGAASQATWLGSLVFDGARLFEGVTPDLDRHSARANDSARALGLEPTLSANDIEALAREGLKKFAPDTDVYIRPMYWAEEGDASTVAPLASSTDFALCLEAIPMVEPKGFTITTTSFRRPYLEVMPVNAKAACLYPNNARMLREAKAKGFHNALVTDVLGNVAETATSNVFMVRGGEVFTPVPNGTFLNGITRQRVIKLLREAGVSVHETTLKIEDFREADEIFSTGNMSKVVPIIGFDERKLDYGLVTKRARALYWEWAHA		290		10	Diffraction	-1	 	NR-16639
Batch05	BrabA.10520.a	Brucella melitensis	YP_414900.1	Q2YRL8				Beta-lactamase-like	Potential drug target		MGQLQAIIVPVTPFQQNCTILFDGETKKGVVIDPGGDLARIREAIESQGIDVEAIWITHGHIDHAAAALDLKEALGVDIIGPHRDDKFLLDNLVAAGLKYGITEGVRNVTPDQWLEEGDKVCVAGHVFDVFYCPGHAPGHVVFFNPEARFAIVGDVLFNGSVGRTDLPGGDHATLIRSIKEKLLPLGDDIGFICGHGPGGRFGEERRSNPFLTDTGYA		218		5	Purified	-1	 	NR-16640
Batch05	BrabA.10537.a	Brucella melitensis	YP_414817.1	Q2YLZ0				Heat shock protein Hsp70:Cell division protein FtsA	Potential drug target		MSILGGHGASQHGTAGRKVRLLTVLDVGSSKVSCVIARLRPHEGGALLPGRTHRMEVLGIGHQRSRGVKSGVIIDLDAAEQSIRLAVDAAERMAGLTVDSLIVNISAGRLKSETFTASVNLGGHEVEQTDIRRVLAAGAKQALAAERHLVHSLPVGYTLDGERGIREPLGMLGDSLGVDMHVLTADAAPLRNLELCINRCHLSVEAIVATPYASGLAALVGDEAEMGAACIDMGGGTTTISVFSEGKFIHADAVAIGGNHVTMDVARGFSTRMEDAERLKVMYGSALPSAADDRDLISVPPIGDDERDVPNQYPRSVLTRIIRARVEETLELVRDRLNQSGLGHIVGKRVVLTGGASQIPGMPEAARRILARNVRIGRPLGIAGLPEAAKGAAFAATVGLLIYPQVAGIEERSVKAASSGLMTGTGGRIQRVGQWLRESF		440		7	Crystallized	-1	 	NR-16641
Batch05	BrabA.10825.a	Brucella melitensis	YP_414818.1	Q2YLY9				"Actin-binding, actinin-type:Cell division protein FtsQ"	Potential drug target		MNAAFVLPRFLRKPFRFAVRLFQGNVNIPRHAGTVGMLGFLGATGLYGMVIGGHSQDVVKATASTMGFAIEDIKVVGNNETSDIDILGQLNLDGETSLVGLSAEEARQSIDKLPWVESAEVRKVYPGTILVSLQERKAFAIWQNDKELSLIDAAGDTIVPFRPGRYNSLPLVVGEGAEKKVKGFVDQIVAYPGLAGKVRAYIRVGDRRWDLLLDNGVRIMLPESAPLKALAQVEKLDREKHLLSRDISAVDLRLEDRVTVQLTASGMEQRQKLLADRKKELSRMGNRV		288		3	Expressed	-1	 	
Batch05	BrabA.11339.a	Brucella melitensis	YP_414422.1	Q2YQ74				Beta-lactamase-like	Potential drug target		MTSPRNCLRFTLLGCGSSPGVPRINGDWGKCDPKNPKNRRRRASLLVERYDAEGNNTVVVIDTGPDFRMQMIDSGVHMLDAAVYTHPHADHIHGIDDLRTYVVDNGRLMDVYANRLTRNRLYDTFGYCFETPVGSSYPPILSMHDIAPETPFSIEGAGGAIRFEPFSQVHGDIESLGFRIGSVVYCTDVSAFPEQSLQYIKDADVLIIGALQYRPHPSHFSLGEALEWIEKLSPKRAILTHMHVPLDYETVMRETPHHVEPGYDGLRFEVAV		272		17	In PDB	-1	 	NR-16642
Batch05	BrabA.11416.a	Brucella melitensis	YP_419035.1	Q2YJZ9				"ATPase, ParA type:ATP/GTP-binding site motif A (P-loop)"	Potential drug target		MGKVIVVTSGKGGVGKTTSTAALGAALAQRNEKVVVVDFDVGLRNLDLVIGTERRVVYDFVNVIQGDAKLTQALIRDKRLETLYLLPASQTRDKDTLTEEGVDLVIDQLKKSFDWVICDSPAGIERGATLAMRHADVAVVVTNPEVSSVRDSDRIIGLLDSKTLKAERGEKMDKHLLLTRYDPSRAERGDMLKVEDVLEILSIPLLGIIPESQDVLRASNVGSPVTLADQRSAPAMAYLDAARRLAGEDVPMNVPSEKRGLLGKLFGRRAA		271		1	Selected	-1	 	
Batch05	BrabA.11726.a	Brucella melitensis	YP_414356.1	Q2YNN6				Cell wall hydrolase/autolysin	Potential drug target		MDLQSHYKVGASFQAIRVLFVLLALFCLSLANVPSTFAADSPAPPLSALTFRMAGDDLRTRVVVMFDREPKLSTRLFGNPHRLVIDLPETRFGFDEKSLEARGLVSHVRYGLAGKGCSRLILTLRGPFDVENLRVLKNENASGYRLVADIVATSDRKFAEKLKEQKGKTGSTERARQQVAGSALPGNGKPRPFTVMIDPGHGGIDSGAESLSGIKEKNLTLAFGKELRDRLSHERNIKVLMTREDDTFLRLAERVRLARQHEADLFISIHADTINQHDIRGATVYTISDKASDAVARAMAERENKSDSLAGALPEEQPEVTDILLDLTRRETHTFSLRFAEKVIGELQGQVNLINNPHRFAGFQVLRAPDVPSVLIEIGYLSNPEDEKLISNPEWRKKLVDRIALAVKAFAARKRPSNLSGG		422		5	Purified	-1	 	NR-16643
Batch05	BrabA.11920.a	Brucella melitensis	YP_415087.1	Q2YRE4				Protein of unknown function DUF710	Potential drug target		MATVTVTIDGKAYRMACDEGQEEHLTGLADRFDQYVAHLKNSFGEIGDLRLTVMAGIMVMDELAEMQKRITGLENEAETLRRSRDEALSRADSNDAALTGMLSDVASRIEQVASRIAPRNG		121		3	Expressed	-1	 	
Batch05	BrabA.12245.a	Brucella melitensis	YP_413779.1	Q2YPF8				allantoate amidohydrolase	Potential drug target		MVLTSNLRVNGDRLWDSLMEMAKIGPGLRGGNNRQTLTDEDGEGRRLFQNWCEKAGLSMGVDTMGNMFFTRPGEDSDADPVYMGSHLDTQPTGGKFDGVLGVLGGLEVMRTLNDMNIRTKRPIVVVNWTNEEGTRFAPAMLASGVFAGVLDQNWAYERTDAKGKTFGEELVRIGWKGDEPVGSRKIHAMFELHIEQGPILEAEHKDIGVVTHGQGLWWLQVTLTGKEAHTGSTPMRMRKNASLGLGKLLQLVNEIAMAHQPDAVGGVGHIDVSPNSRNVLPGQIVFTVDFRSPNQATLDGMKARFEKEAPKIAEELGIGIEIEVAGHFDPVTFDTGCVEAIRNAAERLGYSHRNIVSGAGHDACWVNRVAPTAMVMCPCVDGLSHNEDEDISKEWASAGTDVLLHAVLETAEIVS		415		5	Purified	-1	 	NR-16644
Batch05	BrabA.12797.a	Brucella melitensis	YP_419271.1	Q2YJB3				ROK family	Potential drug target		MSIHLGMVLKILRDEGPQSRAELARRCGLSATTLTHLTAQLLKDGCIAETDAPVLPSGSPMPGRPPVSVRLVPSAHYVAGVHIGAEAVQVAICDLTAQLVTSAAFDHAANDNPLKLTHQTADVLRNLVQAKGISLGSLVGIGMGVPGPVDQVRRRNLLSINTGWRDVAFADAIEAELNIPTVVEHNVTAMALAEAHYGIGQGCPAVLYVYLGTGLGAGLVVDGMPFRPGGHGAVELGHIQIDPQGALCACGNRGCLETFVSERVLRERGAGSAEPLLVALARNPALHDEVAGHFTTALANAVNLLTPDLIVLGGHFAEAPEAFYARLRCDLPPRVLPHMRDVLRIERGGFGNNAGAVGAAAVALDHLFYSGVSR		374		7	Crystallized	-1	 	NR-16645
Batch05	BrabA.12891.a	Brucella melitensis	YP_419036.1	Q2YJZ8				septum formation inhibitor	Potential drug target		MPLTKMNQVLTETRPIRLKGRSFLAMVLSPELPLDGWLERLDDLARRSSGFFLGRPVVLDMENLAIERAQLVYLLQALNDRGVWIMGVEGARPSLLGPGMPPAMRGGQPAADFEAPAGEPQANPGAPEPQISQAVRAPGHAVHAMPSMVITEPVRSGQSVYFPEGDVTIVGSVASGAEVVAGGSIHIYGTLRGRALAGTAGNTSARIFCRKLEAELVAIDGLYKTAEDLEPRFRGQAVQLWLDGDYMMIDTLS		253		5	Purified	-1	 	NR-16646
Batch05	BrabA.13473.a	Brucella melitensis	YP_414337.1	Q2YNL8				hypothetical protein	Potential drug target		MNQNETHCLALLREADRDRYLSVLYAPQEKRGALAALYAFNAEIARIRDLVHEPLPGKVRLQWWRDLINGEARGSAEAHPVAAALIETIEKYELPRIAFDNYCEARVFDLYDDPMPSRNDLEGYCGETASALIQLAGFILDRDAAQAHAETAGHAGVAQAVAGLLRLLPIHRRRGQVYVPADMLKAIGVTRDMLLSSEDKSATERAVTIMLALAREHLAIFDKAKAGLPQTLHPAFLPMALVPAYLNAVERLGAQAAQKVADISAIRKQWLMFRANF		277		4	Soluble	-1	 	NR-16647
Batch05	BupsA.10014.a	Burkholderia pseudomallei	YP_333412.1	Q3JSP1				"sulfate ABC transporter, ATP-binding protein"	Potential drug target		MGITVRNLHKRFGEFAALDDVSLDFPAGELVALLGPSGCGKTTLLRVIAGLEHADSGQVVLQGLDVASVGARERQVGFVFQHYALFRHMTVFENVAFGLRVKPRRERPSEAAIRAKVHELLSLVQLDWLAQRYPSELSGGQRQRIALARALAVEPKVLLLDEPFGALDAKVRKELRGWLRRLHDDLHISTIFVTHDQEEALEVADRIVVLNHGRVEQVGSPQAVYDHPRSAFVYEFLGAANRLDGTVSGNGFVAHGAAQAIAVDADFAGPARAYVRPHDLELAAPHARAQGIAADVRRVVPLGGSVRVELAARSGEVLEAELDRNAWRALALDVGDALTAVPRAVRVFPAR		351		3	Expressed	-1	 	
Batch05	BupsA.10014.b	Burkholderia pseudomallei	YP_333527.1	Q3JSC6				"ABC transporter, ATP-binding protein"	Potential drug target		MIEIERVSRLFGDLAAVDDVSLAVARGTVTALVGASGSGKSTLLRMINRLIAPTSGTIRVDGVDTASVPAETLRRGIGYVIQGHGLFPHWTVARNVATVPRLLGWRAARVDARVRELLELFELDYDTYARKLPHQLSGGQQQRVGVARALAAEPAILLMDEPFGALDPIIRGKAQDDLVALQRRLGITVVIVTHDIDEALRLGDQIAVMDAGRILQAGSPAEILGRPQPGVVERLVAGLDRPLRLLALTRVDALAEPGAAPGEPISGALTLRDAISELLWRGARALPVSSADGAAARRITLDAIVAQAKRPA		312		2	Cloned	-1	 	
Batch05	BupsA.10014.c	Burkholderia pseudomallei	YP_333651.1	Q3JS02				"putative copper-related ABC transport system, ATP-binding protein"	Potential drug target		MPAARAARRRTRIGATRPNPTTRPDNDDADPPRPRDARRGRAADARRVRGDACRPPGRAHRRGARRRAAGRHGARPARPLRGEPENRQAAHAARRRPPDDRRAPRGRRDPRRRAGRDDQRLFDRRQRREPHRAKRGRLRGARLRSHANRALRARLQPVRPLDRALGRRARHRQRDRRQARFAVAQARQRHPALQHDGRAHRRQHDQLHARRHLCRRVASRALRAQHDPRRALRHALHELVLQRLGRQRRLSQPRRPRDHGGARPDRARQPGMGQHRSRHHAAHDPGFADREQRRRRQPARPVHLRRRIQHDPRQPRRRQQDRRASVGRLDPQRRDGQRFRGQPRADPLRRGERRRVARQLLEQLPRLGPARPRRRRRAVQGERSRRPADLARAVGQGADEQSGRAGAARRRAAVSAARGAERRRRRAAHARRARRLAAMGGQAMIELTGVVKTFGPVRAVDGIDLAIAPGELFGLIGRNGAGKSTLFQLMLGLLAADAGNVRIDGVSARDPRFRAVRRTLGYLPENVVLYDNLTGLETLRFFARLKGVDAAACAPLLDEVGLDHAAARKVRGYSKGMKQRLGFAQALLGAPRLLFLDEPTNGLDPAGIRAFYRILHERRRAGTTIVITSHILAEIQQRVDRLAIVRAGRLQAVGSVDALRGETNLPLTIELVVPDDDTREIEAALRRAPFGEPTMRDRRIAFACPRDAKMAALAALAPLGARIVDLRIHEPSLEDMFLGYAGCEANA		747		2	Cloned	-1	 	
Batch05	BupsA.10014.d	Burkholderia pseudomallei	YP_333704.1	Q3JRU9				"putrescine ABC transporter, ATP-binding protein"	Potential drug target		MNSQSGAAVAGAPSYRPQTGADGRAENFVQIIDVVKKFGETVAVRNVELSVRKGELFALLGSSGCGKSTLLRMLAGLETITSGKILIDGEDLAQMPPYKRPVNMMFQSYALFPHMTVEANVAFGLKQEGVPKAELKERVRDALELVQMARYASRKPHQLSGGQQQRVALARSLVKRPKLLLLDEPMSALDKQIRQRTQIELVNILDKVGVTCIMVTHDQEEAMTMAGRLAVMSEGQIVQIGTPHEVYEYPNCRFSAEFIGSTNLFEGVTVEDEPDHVFIESPDLPCRLYVNHGITGPLGMPVTVSVRPERIALTRKPADGAYNWGRGVVTNVAYMGGYSLYHVKLDSGKTVIANVSSLAIADLDSPGWGDEIYVRWSAAAGVVLTS		386		5	Purified	-1	 	NR-16564
Batch05	BupsA.10014.e	Burkholderia pseudomallei	YP_333862.1	Q3JRE1				"ABC transporter, ATP-binding protein"	Potential drug target		MLKITDPIIEVRNVCKRVADAAGELTILAGIDLTVRAGESVAIVGASGSGKSTLLGLLAGLDSATEGTVRLFGQNLGRLDEDARAALRNGAVGFVFQSFQLMPHLSALENVMLPLELQGGVGAREAAQRARALLEEVGLGARTGHYPKLLSGGEQQRVALARAFVTRPALLFADEPTGSLDAATGEAVIDLMFELNRAHGATLVLVTHDTELARRCGATIVLEAGRLRGADRARQEAG		238		3	Expressed	-1	 	NR-16565
Batch05	BupsA.10014.f	Burkholderia pseudomallei	YP_334359.1	Q3JPZ4				"D-methionine ABC transporter, ATP-binding protein"	Potential drug target		MIEIRNLSQRFEGPRGWIEALHNVNLTIPQGEVFGIIGRSGAGKSTLVRTINLLTRPSEGSVFVGGRDLTQLSAAELRGARRDIGMIFQHFNLLSSRTVFDNVALPLELAGVKRAQIEATVLPLLDLVGLAAQKDRYPAQISGGQKQRVGIARALASKPKVLLSDEATSALDPETTRAILDLLRRINRELGLTIVLITHQMEVIKDVCDRVAVLDAGRVVEEGNVIDVFMRPHHEVTRALIGDVIAQELPPAMKARVAERLKTGSGHLLRLAFTGSGVDQPILSETIRRYELDFNILHGQIDEIQGRAFGSLAVLATGEPGKVGQAFAYLREQGVVVEELSYVE		344		3	Expressed	-1	 	NR-16566
Batch05	BupsA.10014.g	Burkholderia pseudomallei	YP_334455.1	Q3JPP8				"ABC transporter, ATP-binding component"	Potential drug target		MRQRIHSMASLSIRDVYKTYPNGVPVLKGVDIDIEDGQFLILVGGSGCGKSTLLNMIAGLETVTKGEIRIGDKVVNDLSPKDRDIAMVFQSYALYPSMTVRENISFGLNIRKVPKNQQKQIVDRVAAMLQIEHLLERKPGQLSGGQRQRVAMGRALARDPALFLFDEPLSNLDAKLRIEMRAEIKLLHQRLGTTIVYVTHDQIEAMTLGDRIAVMKDGVVQQFGAPQDIYDSPSNLFVAGFIGAPPMNFINGKLVEQGSGVGIELDTGAMRGVLNLPFDAKRMNGHVGRDVILGLRPERITDARSAHNGEGARLQPVDVTVDVTEPTGPDTHVFAQVNGKRIVSRVHPAANPQPQQKLSLLFDVSKAVLFDPSTEARIA		379		3	Expressed	-1	 	NR-16567
Batch05	BupsA.10014.h	Burkholderia pseudomallei	YP_335086.1	Q3JMW7				glycerol-3-phosphate transporter ATP-binding subunit	Potential drug target		MAALSLKGVRKSYGGAQYVLHGIDVDIADGEFVVLVGPSGCGKSTLLRMIAGLETVTEGEIAIGGRVVNALEPKDRDIAMVFQNYALYPHMTVAQNMGYGLKIRGVERALIDARVQAAAQILELGPLLARRPRELSGGQRQRVAMGRAIVREPSVFLFDEPLSNLDAKLRVQMRLEIQRLHARLATTSVYVTHDQIEAMTLAQRVIVMNRGYAEQIGAPVDVYEKPATTFVASFIGSPAMNLLHGRLSEDGAAFDVADGPRLPVAGSAGAGRGIAPGREWILGVRPEHMTPQPGEAFATLAVDSCELLGADNLAHGRWGAHDVAVRLPHAMRPTRGETLPVALPARHLHFFDPATGKRAG		360		3	Expressed	-1	 	
Batch05	BupsA.10014.i	Burkholderia pseudomallei	YP_335609.1	Q3JLE4				glycine betaine/L-proline transport ATP binding subunit	Potential drug target		MDAPKVVVEGLCKVFGSNPRQALDMLAAGATKDEVFARTGQVVGVHNVSFDVREGEIFVLMGLSGSGKSTLIRLVNRLVEPSAGKVMIDGRDVAAVRRAELTALRRTDMSMVFQSFALMPQRTVLSNAAFGLEVAGMGRKDRERRAMDVLEQVGLAQFAHKLPAELSGGMQQRVGLARALAVNPSLMIMDEAFSALDPLKRKEMQNVLLQLQKEQRRTIMFVSHDLEEALRIGSRIAIMEGGRLVQVGTPQEIIANPADDYVRAFFEGIDTSRYLTAGDLMLTGAVPTLSKLDAKHVAASLNGSAEYAFVLDEARKIRGFVTRDALNGATPNVRQVESIPRDASLDHVVERCVAHPHALPVVDDDGCYCGSVDRAVLLKAITRSRGSHV		389		3	Expressed	-1	 	NR-16568
Batch05	BupsA.10014.j	Burkholderia pseudomallei	YP_335975.1	Q3JKC8				"spermidine/putrescine ABC transporter, ATP-binding protein"	Potential drug target		MKTDDVIVSFRGVRKTYDGETLVVKALDLDIRRGEFLTLLGPSGSGKTTCLMMLAGFEFPTGGEIRLDGELLNNVPPHKRNIGMVFQNYALFPHLSVEQNVDYPLNVRRMPAAERAARVAVALAMVQMERFAKRYPAQLSGGQQQRIALARALVFEPKLVLMDEPLGALDKQLREHMQYELKALHEKLGLTFVYVTHDQGEALTMSDRVAVFDKGIVQQLDTVDRLYESPCNEFVANFIGDSNRLRGTVASVHGEFCEFRLEDGTRLVGLNAGNAQAGASGVACIRPERMSVAPGSGRAANGAANALAGEARSLIYFGDHVRMRCALPGQDECFVKVPLGTGALDAFAPGVPISLEFQPEHLRVFA		366		3	Expressed	-1	 	NR-16569
Batch05	BupsA.10014.k	Burkholderia pseudomallei	YP_336342.1	Q3JJB1				Maltose/maltodextrin import ATP-binding protein malK	Potential drug target		MASVVLKGVSKAYGGSPPIVRDIDLDITEGEFCVFLGASGCGKSTLLRMIAGLEDVTDGDIYIGSQRMNLIPPARRGVAMVFQSYALFPHMTVYENLSFGLTLSGIAKATVREKVLNVAHALQIEHLLDRTPRALSGGQRQRVAIGRAIVREPGVFLFDEPLSNLDAALRVQTRHEIARIHREIGHASTIYVTHDQVEAMTLADRVVLLNSGETARKVGSLAQSGSPLELYYHPRNRFVAEFIGSPKMNFINAELMDAGEHLAKVRLASGDVLSARVDARVLDPGASLTLGVRPEDLALGTQTQHFVREVMWQERLGEATYVYLNGGDAGSHWIAKLPGTTNVSAGQRLPLSVPPDKLYAFDARGNALRRCLDQRTSITTVPMTECAFVDQDDSSMVARMHADGHYITSKRHFR		414		3	Expressed	-1	 	NR-16570
Batch05	BupsA.10014.l	Burkholderia pseudomallei	YP_336630.1	Q3JIH3				ABC-transporter ATP binding protein	Potential drug target		MAIVRVENVSKTYLLDSVKVTGLAGVSVDIEANRFTVLSGPSGSGKTTLLNMIGCIDRPDAGRVIVAGQDTAALCDDALSDFRAREVGHVFQSFNLLPVLSAYENVEYPLLMARTPARERARRVAYLLDAVGLAGKGAHRPSQLSGGQRQRVAIARALAAGPSLVLADEPTANLDSVTGRAIIALMREMQRESGVSFIVSSHDPQVLEAADDVVQIRDGRIVERRRIAQEAQG		233		3	Expressed	-1	 	NR-16571
Batch05	BupsA.10014.m	Burkholderia pseudomallei	YP_336642.1	Q3JIG1				glutamine ABC transporter ATP-binding protein	Potential drug target		MVEFRNVSKSFGHVPVLKDIDLRIDAGEVVVVVGPSGSGKSTMLRCINALEKITGGDLLVDGQSVKGKAAVIHGIRLEAGMVFQQFNLFPQMTALENVMFGPIQVRGASRAQARDQAMALLAKVGLEARANHYPSELSGGQQQRVAIARALAIRPKLMLFDEPTSALDPELRHEVLKVMRDLANEGMTMIVVTHEIGFAKQVGTRLLFMDQGGIAEDGDPKTLIDHPPTPRLKDFLKHVS		240		2	Cloned	-1	 	NR-16572
Batch05	BupsA.10014.n	Burkholderia pseudomallei	YP_337024.1	Q3JHC9				"ABC transporter, ATP-binding protein"	Potential drug target		MPHKAAAAPATRDAAAPAAVPGAAVSFELVGKVFDGPRGPAAALREVTLDIARGGVFGVIGRSGAGKSTLLRLVNGLERPTSGAVRVNGVDVGTLDERGLVALRRRIGMVFQHFNLLSAKTVAQNIGLPLKIAGVPKAERARKVDALLDLVGLAAKRDAYPASLSGGQKQRVGIARALVHDPALLLCDEATSALDPETTQSILALLADINRRLGLTIMLITHEMEVIRAVCDTVAVVEQGEVVETGPVWRVFGDPRHGATRALLRTLAHDLPADLAARLRPLDGAAPLPCGAQLLLDVRYTGASGGEPDLGALTAALARNVGDAVHFVHGGLDRIQGRVQGRLVIAASLAARGAASPDRIAAALAAARRHANRVEVLGYV		380		3	Expressed	-1	 	NR-16573
Batch05	BupsA.10014.o	Burkholderia pseudomallei	YP_337170.1	Q3JGY3				"putrescine ABC transport system, ATP-binding protein"	Potential drug target		MKSTPSIDTAQLARPPVGTPAGTNEFVRIENVVKKFADSTAVDNVSLSIAKNELFALLGSSGCGKSTLLRMLAGLETATSGRIFVDGEDLATLPPYRRPVNMMFQSYALFPHMSVESNVAFGLKQEGTPKHEIRERVADALNLVQMSRYARRKPHQLSGGQQQRVALARSLVKRPKLLLLDEPMSALDKKIRQKTQLELVNIIEKVDVTCVMVTHDQEEAMTMASRLAVMSEGRIVQIGTPSQVYEFPNSRFSAEFIGSTNLFEGVVVEDEPDHIFVESEDLEARMYVSHGVTGPLGMPVGISVRPERVRVSRERPSAPHNWARGVVTDVAYMGSYSLYHVRLPSGKTVVSNLSSSHLMQDGAPAYNDDVFVSWSPASGVVLTQ		384		3	Expressed	-1	 	NR-16574
Batch05	BupsA.10100.a	Burkholderia pseudomallei	YP_332425.1	Q3JVH8				serine protease	Potential drug target		MTTRILARGAVAVAVAAALSAGYVAGTRRAEPQIITPAVAALMPAEAAAKTGIPDFSGLVETYGPAVVNISAKHVVQRAAQRRAAPQLPIDPDDPFYQFFRHFYGQIPGMGGGRQPQPDDQPSTSLGSGFIISADGYILTNAHVIDGANVVTVKLTDKREYKAKVVGADKQSDVAVLKIDASGLPIVKIGDPAQSKVGQWVVAIGSPYGFDNTVTSGIISAKSRALPDENYTPFIQTDVPVNPGNSGGPLFNLNGEVIGINSMIYSQTGGFQGLSFAIPINEAMKVKDELVKTGHVSRGRLGVAVQGLNQTLASSFGLQKPDGALVSSVDPKGPAAKAGLQPGDVILAVDGVPVQDSSTLPAQIAGMKPGTKADLQIWRDKSRKTVSVTLASLADDQAKAGADEPVEQGRLGVAVRPLSPRERNGSSLTHGLVVQQSAGPAASAGIQPGDVILAVNGRPVTSAEQLRDAVKRAGNSLALLIQRDDAQIFVPVDLG		495		7	Crystallized	-1	 	NR-16575
Batch05	BupsA.10100.b	Burkholderia pseudomallei	YP_333220.1	Q3JT83				subfamily S1C non-peptidase homologue	Potential drug target		MSRQTLGRALIHVAALGAVLAGFACLQPTPLAAGTLQSPAKAKRIAQIGAAGPVDFPTLVERYGPAVVSVSVPAQDPQMSASGLEALDPDDPFFAYFKSAATQPALSPENGPRAMAGAGSGFIVGADGIILTTAYVVGQASEATVRLIDRREFKARVLAVDDSSDVAVLQIDATKLPTVRLGDSSRVRTGEPVLTIGTPDGSANTVTTGIVSATARMLPDGGRFPFFQTDVTGNLDNSGGPVFNRAGEVIGIDVQIYGSGERNPGVTFAIPIDMAMKVRAQVLQAQRQARQQAQPPMQQAQQAQQAPPAAAQNALGVDAQDVGPGLAAAFGLPRPAGALVNAVEPGSPAAAVGLKPGDVIVQIGDRPLGRSAELAGDLAALPPGASAPITLIRNRMPMTVMLGSGAAASAPTGATASPGNAAAGRSETGGADRLGLTMHPLTDDERRSTGLPVGMVVDAVRGPAANAGIRPGDVVLELDDTLIETPDMVPALEAKAGKVVAVLIQRGSERRFVSVKAR		518		4	Soluble	-1	 	
Batch05	BupsA.10100.c	Burkholderia pseudomallei	YP_334279.1	Q3JQ74				subfamily S1C unassigned peptidase	Potential drug target		MTPLAAQSATAAPNVTTTPAATGAAPAARAGLPDFADLVERVGPAVVNIRTTANVPADTRGALPPGLDNGDMSEFFRRFFGIPLPQGPGGQKNAPSTPDAPDTEQNRGVGSGFILSPDGYVMTNAHVVDDADTIYVTLTDKREFKAKLIGVDERTDVAIVKINASSLPTVAIGDSNRVRVGEWVVAIGSPFGLDNTVTAGIVSAKGRNTGDYLPFIQTDVAVNPGNSGGPLINMQGEVIGINSQIYSRTGGFMGISFAIPIDEAMRVAEQLKASGKVTRGRIAVAIGEVTKEVADSIGLPKAEGALVSSVEPGGPADKAGLQPGDIILKFNGRPVEAASDLPRMVGDTKPGAKATVTVWRKGQSRDLPITIAEFPADKAAKADSRQAPQQKPRSSALGLTVSDLSPEQLKTLKLRNGVQIDAVDGPASRAGLQRGDIVLRVGDVDITSAKQFVDVTSKLDPQRAVAVLVRRGENTQFIPIRPRQK		485		1	Selected	-1	 	
Batch05	BupsA.10100.d	Burkholderia pseudomallei	YP_335042.1	Q3JN11				DegQ protease	Potential drug target		MLLALMFIVATLKPQWLQRQGQLGKQLAAPIVALREVAPGVGGAPAQSSYADAAQKAMPAVVNVFSSKDGSLPPDPRAKDPLFRYFFGDRNARRQQEEPAANLGSGVIVSSEGYILTNQHVVDGADQIEVALADGRTATAKVIGSDPETDLAVLKINMTNLPTITLGRSDQSRVGDVVLAIGNPFGVGQTVTMGIISALGRNHLGINTFENFIQTDAPINPGNSGGALVDVNGNLLGINTAIYSRSGGSLGIGFAIPVSTARNVLESIITTGTVTRGWIGVEPQDVTPEIAESFSLAQKSGAIVAGVLQGGPADKAGIKPGDILMSIDGEDITDTTKLLNVVAQIKPGTPAKVHVVRKGKELDVTVVIGKRPPPPKQALDDQNSDEEE		388		2	Cloned	-1	 	
Batch05	BupsA.10154.a	Burkholderia pseudomallei	YP_331748.1	Q3JXF5				histone deacetylase family protein	Potential drug target		MYVVPHGTLNLGEHFDSPLRLAYTKQLLDAVGMTERLTRVAFARATDEQLLRVHRPEYLRQLAEACAVAGEQVVRLGDDAAGSASTEDVARLAAGAACAAVDAVMTGPLRQAYALIRPSGHHAGADFAMGYCYYNNVAIAARHAQAAHGVERVAIVDWDVHHGNGTQQAFYDDPSVLFVSLHEAANFPVDGGEARETGGGAGAGYNANVPLPSGTGDAGYRHAFDELVLPLVEAFAPQLILVSAGQDANAFDPLGRMRVQRDGFRHMARALRQAAGGACGGRIVMLQEGGYSLPYLPIATLGVLEGLVGWNAPFDDPHQFVQYPLGEGERAAVKAARAALAPYWPTLHRS		350		3	Expressed	-1	 	NR-16576
Batch05	BupsA.10154.b	Burkholderia pseudomallei	YP_332719.1	Q3JUN4				acetylpolyamine aminohydrolase	Potential drug target		MLTYFHPDQSLHHPRTYFSRGRMRMPQEVPERAARLVAAAFAMGFPVREPDDFGIAPIAAVHDTHYLRFLETVHREWKAMPEDWGDEAMSNIFVREPNALRGVLAQAARHLADGSCPVGEHTWRAAYWSAQSALAAAAAVRDGAPAAYALCRPPGHHARVDAAGGFCYLNNAAIAAQALRARHARVAVLDTDMHHGQGIQEIFYARRDVLYVSIHGDPTNFYPAVAGFDDERGAGEGLGYNVNLPMPHGSSEAAFFERVDDALRELRRFAPDALVLSLGFDVYRDDPQSQVAVTTDGFGRLGHLIGALRLPTVIVQEGGYHIESLEANARSFFGGFGALRG		341		17	In PDB	-1	 	NR-16577
Batch05	BupsA.10154.c	Burkholderia pseudomallei	YP_333884.1	Q3JRB9				histone deacetylase family protein	Potential drug target		MQPPSSAGYAESPDSKRRLLSLVHASGLAAKLDMSSAPAATDDDLRRIHPAHYLDAFKRASDAGGGDLGELAPFGRGSYEIAALSAGLALAAVDAVLAERTANAFSLSRPPGHHCLRDKPMGFCLLANIPIAIEAARAKHRVERVAVIDWDVHHGNGTQSIYYDDPNTLTISLHQDRCFPPGYSGADERGAGAGAGSNVNVPLLAGAGDDAYRYAFERIVLPALDAFRPELVIVASGLDANAVDPLARMQLHSDSYRYMTHALKQAAQRHCGGRLVIVHEGGYSEAYVPFCGHAIVEALAGMRTDVADPMLELAIAQQPGERFNAFQRQLIDEMATSFGY		340		3	Expressed	-1	 	NR-16578
Batch05	BupsA.10154.d	Burkholderia pseudomallei	YP_334361.1	Q3JPZ2				histone deacetylase family protein	Potential drug target		MPTAFYTHPDCLLHEMGEWHPESPARLSAIQDQLIASRIDDLIVHETAPFASETALARVHTQAHIDYIRSRIPKEGYVEIDPDTSLNRYTWRAALRAAGAAVEATDAVLEGRYDNAFCSVRPPGHHAEPARAMGFCFFNNVAIAARHALEIHGLERVAIIDFDVHHGNGTEAAFANDERVLMCSFFQHPLYPFSGVDHQAPNMVNLPMAARTNGMAVREAVDLMWLPRLDAFRPQMLFVSAGFDAHREDDIGGMGLVEADYEWLTQQICEVARRHAQGRIVSCLEGGYNLSALGRSVVAHLRVLAGV		307		7	Crystallized	-1	 	NR-16579
Batch05	BupsA.10154.e	Burkholderia pseudomallei	YP_335409.1	Q3JLZ4				acetylpolyamine aminohydrolase	Potential drug target		MLTYFHPDQLKHSPLTYLSRGKMRAPHEVPERAVRLLGAVTSLGFDVRAPEDFGAAPLAAVHSEPYLRFLADAHREWRRIPEDWGPEVMSNIYVREPNPLRGVLAQAGYYLADGSCPIGEHTYRAAYWSAQSALAGAAALGRGARDAYALCRPPGHHACRDAAGGFCYLNNAAIAAQALRARHARVAILDTDMHHGQGIQTLFYDRDDVLYVSIHGDPTNFYPAVTGYETERGAGRGEGFNVNLPMPHGSPEAVFFAQLERARSRVERFAPDVLVFALGFDVYREDPQSKVAVTTEGFGRLGALVGGLRVPTLIVQEGGYHLETLERNAAALFRGYEAAR		340		3	Expressed	-1	 	NR-16580
Batch05	BupsA.10201.a	Burkholderia pseudomallei	YP_332622.1	Q3JUY1				methionyl-tRNA synthetase	Potential drug target		MSASDLTSVQAGAPQGRRQILVTSALPYANGQIHIGHLVEYIQTDIWVRTMRMHGHEIYYIGADDTHGTPVMLRAEQEGVSPKQLIERVWREHKRDFDSFGVSFDNFYTTDSDENRVLSETIYLALKEAGFIAEREIEQAYDPVRQMFLPDRFIKGECPKCHAKDQYGDSCEVCGTTYQPTDLIHPYSVVSGAAPVRKTSTHYFFRLSDPRCEAFLREWVSGLAQPEATNKMREWLGEAGEAKLADWDISRDAPYFGFEIPGAPGKYFYVWLDAPVGYYASFKNLCERRGLDFDAWIRKDSTTEQYHFIGKDILYFHTLFWPAMLEFSGHRTPTNVFAHGFLTVDGAKMSKSRGTFITAQSYIDTGLNPEWLRYYFAAKLNATMEDIDLNLEDFQARVNSDLVGKYVNIASRAAGFLLKRFDGRVQASAMNHPLLATLRGAIPQIAAHYEAREYGRALRQTMELADAVNGYVDSAKPWELAKDPANAVALHETCSVSLEAFRLLSLALKPVLPRVAQGVEAFLGIAPLTWADAGTPLSPEQPVRAYQHLMTRVDPKQIDALLAANRGSLQGTAAAAEAGAANGNGAGSKNGKGAKAAAQPAASAANADDGASPIISIDDFAKIDLRIAKIVACQAVEGSDKLLQLTLDVGEERTRNVFSGIKSAYRPEQLVGKLTVMVANLAPRKMKFGLSEGMVLAASAADEKAEPGLYILEPHSGAKPGMRVK		725		5	Purified	-1	 	NR-16581
Batch05	BupsA.10365.a	Burkholderia pseudomallei	YP_335060.1	Q3JMZ3				BolA-like protein	Potential drug target		MLPTPELVKQYIEAGLACTHLEVEGDGQHFFATIVSSAFEGKRPIQRHQLVYAALGDRMKQEIHALSMKTLTPAEWQNA		79		4	Soluble	-1	 	NR-16582
Batch05	BupsA.10478.a	Burkholderia pseudomallei	YP_332404.1	Q3JVJ9				branched-chain amino acid aminotransferase	Potential drug target		MSMADRDGKIWMDGKLIEWRDAKIHVLTHTLHYGMGVFEGVRAYKTADGGTAIFRLKEHTKRLLNSAKIFQMDVPFDQETLEAAQRDVVRENKLESCYLRPIIWIGSEKLGVSAKGNTIHVAIAAWPWGAYLGEEGLAKGIRVKTSSFTRHHVNVSMVRAKASGWYVNSILANQEATADGYDEALLLDVDGYVSEGSGENFFLVNRGKLYTPDLASCLDGITRDTVITLAKEAGIEVIEKRITRDEVYTADEAFFTGTAAEVTPIRELDNRTIGGGARGPITEKLQSAFFDVVNGKSAKHADWLTKI		307		14	Crystal structure	-1	 	NR-16583
Batch05	BupsA.10478.b	Burkholderia pseudomallei	YP_336051.1	Q3JK52				branched-chain amino acid aminotransferase	Potential drug target		MRSATTMKSSYVWKNGELVPWEHAQVHVMSHALHYGTSVFEGVRAYEIGEKAAILCGREHFERLLFSCKVARIASPMSVGQWMEATVETLRANGQRSAYIRPLVYRGAGESLGLDARQCPAEALLITTPWGAYLGDEALQQGVDVQVSSWRRNGAGAASTLAKIGGQYVNGQAIVMEAHENGMSEGIALDTNGFVSEGSGENVFLVYKNEIFTPSIGSSILSGITRHCVIRIARDLGYTVTETSIPREMLYLADEIFFTGTAVEICPVRSVDRMPVGSGKRGAVTKAIQDQYFGIVRGTHADKWNWLTPVAVPSRDGARA		320		5	Purified	-1	 	NR-16584
Batch05	BupsA.10520.a	Burkholderia pseudomallei	YP_331461.1	Q3JY92				metallo-beta-lactamase superfamily protein	Potential drug target		MKVTLIPVTPFQQNCSLLVCEKTGRAAVVDPGGDLELIEQEVARQHVQVEKVLLTHGHVDHCAGAKRLAAHYGVPIEGPHEDERFWIEKLPMQSERFGFPAAEAFEPDRWLADGDTLAFGEETLEVYHCPGHTPGHVVFFSRAHRLAIVGDVLFAGSIGRTDFPRGNHADLIRSIREKLWPLGDDVTFVPGHGPVSTFGDERRTNPFVADEVAG		214		5	Purified	-1	 	NR-16585
Batch05	BupsA.10537.a	Burkholderia pseudomallei	YP_334910.1	Q3JNE3				cell division protein FtsA	Potential drug target		MSKDYKDLLVALDIGTSKVVAVVAELKGEGHYEVIGLGQSESKGLKKGVVVNIEATVQSIQRALEEAELMADCKITNVFTGIAGSHIRSFNSSGMVAIKEKEVTQTDVARVIETAKAINIPTDQQVLHILTQEFIIDGQEDVREPIGMSGIRLEVKVHIVTGAVSAAQNIVKCVRRCGLEVNDLILQPLASSLAVLTEDEKDLGVVLVDIGGGTTDIAIFAEGAIRHTAVIPIAGDQITSDIAMALRTPTPDAEDIKVGYGIAKQALADPDEMVEVPGLGERGPRTLSRQALAAVIEPRVEELFSLVQQVVRESGYEELLSSGVVLTGGAAMMPGMVELGEDIFLKPVRIGAPEYAGGLSDVVRNPRYSTAMGLLVEGSAQRMRGRKVAVQSGSAGQIFSRMKEWFLSNF		410		4	Soluble	-1	 	NR-16586
Batch05	BupsA.10611.a	Burkholderia pseudomallei	YP_332437.1	Q3JVG6				glutathione-dependent formaldehyde dehydrogenase	Potential drug target		MKTKAAIAWKAGEPLTIEEVDLEGPRAGEVLIEVKATGICHTDYYTLSGADPEGIFPAILGHEGAGVVVDVGPGVGTLKKGDHVIPLYTPECRECKFCLSRKTNLCQKIRATQGRGLMPDATSRFSVGGKPIFHYMGTSTFSNYIVVPEIAVAKVREDAPFDKICYIGCGVTTGVGAVVYSAKVEAGANVVVFGLGGIGLNVIQGARMVGADKIIGVDLNPKRVELARKFGMTHFINPNEVENVVDHIVQLTDGGADYSFECIGNVKVMRQALECTHKGWGQSFIIGVAAAGEEISTRPFQLVTGREWKGSAFGGARGRTDVPKIVDWYMEGKINIDDLITHTLPLEKINEGFELMKKGESIRSVVLY		368		4	Soluble	-1	 	NR-16587
Batch05	BupsA.10647.a	Burkholderia pseudomallei	YP_335372.1	Q3JM31				penicillin-binding protein	Potential drug target		MRLNKKPKSSDPYVAVAKNPMLSSSLPMWRSKFVVILVFLAFGALIARAFWVQVANQDFYVGQGQKRYQRTIELGAMRGSIVDRNGALLAVSLTTYEIWANPKQVDEAAHAPLAKLLDMPLAEVRRRLTGDRSFVLLKRQVDPETAARIEKLDIDGVTQIADSKRFYPEGESAAHVVGFTNVEDRGQEGVELAANGRLSGTAGQRQVIRDRLGRIVSDTGPLVPAQHGATIELTIDRRIQQLAYAQLKSTIIANNAQAGSVVVLDAQNGEILALANYPTFDPNDRARLTGQQLRNRAVIDTFEPGSTIKPVVVALSIDAGKVRPQTIIDTSPGAYKIGPNVIHDTSNHGAITVAQALQMSSNIALAKLALNLPAETIWNKYQEYGIGRAPELTFPGVASGRLRPYKRWRPIEQATMAYGYGLSTSLLQIAQVYTAYAGDGTIHPVSLLKASADPQSADAHRGHRVTTPATAAAIRSMLEMAVGQGGTGRAARVDGYRVGGKTGTARKQVGASYVKGKYRALFAGMAPMSNPRLIIAVMIDEPAARSYYGGTVAGPVFSSVMSGSLQLLGVPPDAPIAADKPAGAGAKPQAKAKT		594		4	Soluble	-1	 	NR-16588
Batch05	BupsA.10825.a	Burkholderia pseudomallei	YP_334911.1	Q3JNE2				cell division protein FtsQ	Potential drug target		MWNNVRQLNLAASALYALLLLVLAAAGCYWLIQRPAFALREIRIDGDTEHINAPTVRAGVVGRLKGNFFTVDLDLARVAFEQMPWVRHASVRRVWPNALAVTLEEYKPLGTWGNDQLVSVDGELFTANQGELDAELPSFDGPEGSAKEVVARYRDFAKWFAPIHATPEEVTLSPRYAWTVKLSNGMQVELGRERNSDTLPDRIQRLVAAWPSVTQRWGGDIEYADLRYPNGFAIRAAGMRFLTDTDKGKK		250		3	Expressed	-1	 	NR-16589
Batch05	BupsA.11416.a	Burkholderia pseudomallei	YP_334440.1	Q3JPR3				septum site-determining protein MinD	Potential drug target		MAKIIVVTSGKGGVGKTTTSASFASGLALRGHKTAVIDFDVGLRNLDLIMGCERRVVYDLVNVIQGEANLNQALIKDKKCENLYILPASQTRDKDALTREGVEKVINDLIAMDFEFIVCDSPAGIESGALHAMYFADEALIVTNPEVSSVRDSDRILGILSSKTKRATEGKEPIKEHLLITRYNPKRVTEGEMLSLDDISEILRIKLIGVVPESEAVLHASNQGLPAVHLDGTDVAEAYKDIVARFLGEDKPLRFTDYQKPGLLQRLFGSK		271		2	Cloned	-1	 	
Batch05	BupsA.11726.a	Burkholderia pseudomallei	YP_332476.1	Q3JVC7				"N-acetylmuramoyl-L-alanine amidase, AMIC precursor protein"	Potential drug target		MLIKPFRSIESAATATHNWRRRQILRAGASTLVLGLALPRLAHASSVLGVRVWPARDYTRVTIESDQPLQNTQQLLQGPDRLVVDLNGLELDQALRDLVSKIAPNDPQIQSVRVGQYQPHVVRMVFDLKGSVKPQVFTLPPVGTYKYRLVFDLYPAVAPDPLSDLIAQTERKEQQLNDTLRAQQAQPPTAALNGPTAAPPAATDNSDAFFQRFAQNNPPAAHSARPAPANPPVAQASPPAAPPRPAVKPPPVIARRNDDDSGDTDTYAFTAPKSGRGTVRLLTVAIDPGHGGEDPGAIGGGGTYEKHIALDIAKKLRAKIDAAPNMRAMMTRDADFFVPLNVRVQKARRVGADLFVSIHADAFTTPSARGSSVFALSDHGASSAAARWLANKENSSDLIGGINIKTQDVAVNRALFDMSTTAQIRDSLRYGNYVLREVGGINKLHKGSVEQAGFAVLKAPDIPSILVETAFISNPDEERRLNDDAYRDQMADAIFRGIKRYFSANPPLAKSRMT		514		5	Purified	-1	 	NR-16590
Batch05	BupsA.12245.a	Burkholderia pseudomallei	YP_332718.1	Q3JUN5				allantoate amidohydrolase	Potential drug target		MMASALGGRTLAIDGERLWRSLMEMARIGGTAHGGVRRLAATDDDRRGRDRFAQWCREAGLALSVDEIGNLFARRAGAEAGAPPVLIGSHLDTQPEGGRFDGTYGVLAALEVVRSLNDAGIVTRKPIEIVSWTNEEGARFAPAMLGSAVAAGVMPLAQALAVRDAAGVTLGDALERIGYRGARRAVRPAIDAYFEAHIEQGPVLEANGVEIGVVTGGQAIRWLDVTIAGQPAHAGTTPVAHRRDALFGFAQIADAIERMLAEFAPHGLATIGCVEIPNASRNTIAGAVAFTLDLRHPDDATLDAMARAATDACARIAARRGLRADVSTHWASPSTRFDAACIASVEAAAARFGYRHERIVSGAGHDAIHLAKHGPGAMVFIPCVGGLSHNEAEAVLPADATRGANVLLGAVLDRAGRAAR		420		1	Selected	-1	 	
Batch05	BupsA.12245.b	Burkholderia pseudomallei	YP_335411.1	Q3JLZ2				allantoate amidohydrolase	Potential drug target		MWEIDGRRLWNSLTELARIGGTARGGVRRLALTEADRRGRERFAQWCRDAGMAVRVDAIGNLFARRAGADDTQPAVLVGSHLDTQPEGGRFDGAYGVLAGLELVRTLNDRGIVTGKPIEIVSWTNEEGVRFTPAMLGSAVFTGALPLDAALAARDADGIALAEALEACGYRDALRSAWMRGAHGARGLEPALAPLHERVDAYFEAHIEQGPVLERHGATIGVVTGGQAIRWLDATVTGAAAHAGTTPMPYRKDALFASAELALAIEALVARHAPDALATIGQSAIDNASRNTIAERVTFSIDLRHPDDARLDAIERELRRVCAQIAGRRGVAVDISQHWSSPATPFDPACIALVEAAARGGGYAHERIVSGAGHDAVHLARCVPSAMVFIPCVGGLSHNAAERALPEHVEAGANVLLGAVLARAGVRERAARSARSPRPAPAMQAAHSGTDAGTFAQPH		459		4	Soluble	-1	 	NR-16591
Batch05	BupsA.12707.a	Burkholderia pseudomallei	YP_336648.1	Q3JIF5				squalene/phytoene synthase	Potential drug target		MDDNETDAAAVTSGSSFYLAMRILPAEQRDAMFQVYAFCRAVDDIADEGGARAERAAQLDRWRADIDDCYAGKPRASLVPLAREIGKFGLHRDDFHAMIDGMAMDAAEDICAPDEATLDLYCDRVASSAGRLSVRIFGMPDEPGRVLSHHLGRALQLTNILRDIDDDAAINRCYLPRELLAREGIAIADPQTIARDPLLPRVCATLVERALHHFAQADAVMDASPRAQVRAPRIMSGAYRLILEAAVARGFAPPRAPLRKPRARMLLLAARYALF		275		5	Purified	-1	 	NR-16592
Batch05	BupsA.12746.a	Burkholderia pseudomallei	YP_334604.1	Q3JP99				metallo-beta-lactamase family protein	Potential drug target		MAGDKKFASQADLAEKKVTFERLSEHAYAYTAEGDPNTGIIVGDDAVLVADTQATPVMAEDVIRRIREVTDKPIKYVLLTHYHAVRVLGASAYGADHVIASQDTYDLIVERGAADMKSEIERFPRLFRSVESVPGLTWPTLTFKGEMTLWLGKLEVKIMQLGRGHTKGDTVVWLPQEKVLLSGDLVEYGATPYAGDAYFQDWPATLDAIAALEPEKLVPGRGAALKTPREVADGLAGTRAFVSELYAKVKAGAAAGRDLNAIYKETYAALKPTFGDWVIFDHCMPFDVTRAFDEATQYPDPRIWTAERDKDMWHTLEG		318		5	Purified	-1	 	NR-16593
Batch05	BupsA.12797.a	Burkholderia pseudomallei	YP_336813.1	Q3JHZ0				putative ROK family transcriptional regulator	Potential drug target		MRSPHLGQGSNSANVRRYNERLLLKTLRRAGSASKADLARLANLTGTAVGSIIASLAEAKLIEFAGRRAEGQRGQPASLIRLDPRGAFGIGVRLDRMRIETALVNFAGDVIGRRSHDTLLPQPAAVLEIVREDVAAMQQLLCAHERARLTGVGVAQPYNLGSWLREIDLPADAFGAWAEVDFARELDRAIELPVFSENDGNAAAIAELFYGCGRQRDDFVYLFLGPAIGGGIAVDGDCLRGVTGNAGDFAMMPVPPSRLPSVPKPSGAWDLLITRASLNGLARHLRHRGETLESRADLEACIARGGQAVDEWIDDCVDALAPALRAVLAVLESPVVVLDADTDAGLIDTLIARLHTALAALAPEARGTPVLVRGTFGPDAGAIGAATLPMFFNFSPRAGILRGAGVDSQEARYAAF		416		5	Purified	-1	 	NR-16594
Batch05	BupsA.12800.a	Burkholderia pseudomallei	YP_331619.1	Q3JXT4				"transcriptional regulator, LysR family"	Potential drug target		MDLTLLRAFVAVAREGNLTRAAAQLHLTQPAVSLQIKNLQDLLGIALFVRTSRGLVLTRDGQALLPHAERALDAAADVKRAAAALRHEVRGRLRIGTILDPEFLRLGGFLKRLVEAHPQIETALRHGMSGWVLDEVRARELDVGYYIGRPEEDDPRDAERFHTVTLTQFRYRVLAPAGWKERVQRARTWRELAALPWIWTPAASAHQRLLSRRFADAGAQPVKVAEVDQETSMLDLVKSGVGLTLARDSIALREAHAHALTIVEHVAVPAELTFVTLADRRDEPAIAAALRLIDEQWAI		299		3	Expressed	-1	 	NR-16595
Batch05	BupsA.12800.b	Burkholderia pseudomallei	YP_333218.1	Q3JT85				MarR	Potential drug target		MDLAALAIFRAVVRENGVTRAAAKLNRVQSNVTTRIKQLEEQLGAPLFVRDGRRLVLTPAGETLLPYAERLLALADEARHAVTENRPHGRLRLGAMESTAASRLPALLARYHQAWPDVTLELVTGTTGKLIGLVRDFELDAALVATPAGSEALGEPFETASAFTEELVLLTPRGHPRVRTPRDVRLPTLVAFERGCAYRGCVERWYAAEGLKPERVLELGSYHAIVACVAAGAGVAVAPRSVLAVQREPDSLGVHPIDGMPPIDTMLVWRQGHFSAALAALRDALRDAAAAANATDVAAHEAAKVAPRRTRRGAARETLPA		321		4	Soluble	-1	 	NR-16596
Batch05	BupsA.12891.a	Burkholderia pseudomallei	YP_334442.1	Q3JPR1				septum formation inhibitor	Potential drug target		MSLKKSPFFELRSGSVDTLLFIVKTADLDALRAELVKRFEATPEFFADDVVAIDVRRLADHERVPLDDIRGMLNDVRMRAIGVVAQPEQHAWAASAGLPLLEARDRRAPSSKAADEAPVQQAEPAAPAAGQAALFEQAGPTLADAGAPPESPAPAVAAQSATLVVDRPLRSGQQIYAKGDLVVLGPVSYGAEVIAEGNIHIYAPLRGRALAGVHGNHDARIFCTCLEPELISIAGIYRTTENPLPADVLGKSVQIRLEQEKLMIEPLRLT		270		1	Selected	-1	 	
Batch05	BupsA.13472.a	Burkholderia pseudomallei	YP_333472.1	Q3JSI1				mbtH-like protein	Potential drug target		MTQAQQPASAPADADADDVVYAVVVNDEEQYSIWPTFRAVPAGWREAGVRGPKAECLAHIEAVWTDMRPASLRRHLDAARAS		82		1	Selected	-1	 	NR-16597
Batch05	BupsA.13472.b	Burkholderia pseudomallei	YP_333542.1	Q3JSB1				mbtH-like protein	Potential drug target		MDDELYFVVRNNEGQYSVWMDGRSLPAGWETVGEPATKQQCLQRIEQLWTDMVPASVREHLNQHSGPGIDYAVR		74		5	Purified	-1	 	NR-16598
Batch05	BupsA.15806.a	Burkholderia pseudomallei	YP_332596.1	Q3JV07				hypothetical protein	Potential drug target		MSTKQIEVSILGQTYRLACSAETEAALLEAVARVDAEMSKIRANSSVRGTDRIAVMAALSLASELLRLQQSVRHGEAFPAEEIRRTMRQMNEQLGAVLAQHEVQ		104		5	Purified	-1	 	NR-16599
Batch05	BupsA.15997.a	Burkholderia pseudomallei	YP_331996.1	Q3JWQ7				metallo-beta-lactamase family protein	Potential drug target		MRWLRMPLPFALDHINLWLLRDEIDGQAGWTIVDCGIASEQIKAHWERIFDAHLDGLPVLRVIVTHCHPDHFGLANWLCDGGARARWNVRLWMTLGEYLFGCVMAAGNGSNAGGPAAADHFARHGLADPAALDKLRNRRGYYADLVPAVPPRYRRLREGDALAIGAREWRVVTGYGHSPEHCALHCAADGMLISGDMVLPRISTNVSVFDLEPEANPLALYLESLGRYEAMAEGTLVLPSHGLPFRGVRARVAQLRAHHDARLAEVRAACRERPMSAADIVPIMFKRGGLDIHQMTFALGEAIAHLNLLWLAGELARDTGADGVLRFRHAD		331		1	Selected	-1	 	NR-16600
Batch05	BupsA.15998.a	Burkholderia pseudomallei	YP_332766.1	Q3JUI7				"DNA polymerase III, alpha subunit, form 1"	Potential drug target		MDDTDKVKILFDDCLVNGLAVLPPDINRSNYRFEPVAEADGKRSRTIRYGLGAIKGSGQNAIEEILRAREEKPFADLFDFCERIDRRVVNRRTIEAMIRAGAFDSLHENRAQLLASVPLAMEAAEQAAANALQAGLFDIGGVPAHQHALVDEPAWDDKRRLQEEKGALGFYLSGHLFDAYRDEVRRFVRQKLGELKEGRDKVVAGVIASLRTQMTQRGKMVIALLDDGTGQCEVTVFNEQFDANRALFKEDELLIVQGQARNDAFTGGIRFTAESVMDLERARSRYAQAVRMTMNGNADAAALRRVLEAHVAKPDETPPAAAPAPRGGRDGGRRAQAAIPNGLAVRIAYSNARAQGEMRLGDAWRVKPSDALLADLRAAFGGSVVEIVY		389		3	Expressed	-1	 	NR-16601
Batch05	BupsA.15999.a	Burkholderia pseudomallei	YP_333699.1	Q3JRV4				metallo-beta-lactamase family protein	Potential drug target		MTVEGFFDPATCTISYLLFDSGSGECALIDSVLDYDPKSGRTRTASADQLIARVAALGARVRWLLETHVHADHLSAAPYLKTRVGGEIAIGRHVTRVQDVFGKLFNAGPAFAHDGSQFDRLLDDGDTLALGALSIRAMHTPGHTPACMTYVVTEAHAAHDARDAAAFVGDTLFMPDYGTARCDFPGGDARSLYRSIRKVLSLPPATRLYMCHDYQPNGRAIQYASTVADELRENVHIREGVTEDDFVAMRTARDATLDMPVLMLPSVQVNMRAGRLPEPEDNGVRYLKIPLDAI		294		5	Purified	-1	 	NR-16602
Batch05	BupsA.16000.a	Burkholderia pseudomallei	YP_333894.1	Q3JRA9				"phytoene synthase, putative"	Potential drug target		MSPQHGAMPGRPAPALPAPSRSRLTRSVPVNFDEYCQQKAAPPGSSFYYALRQAPLARQPLVAALFALRRELEQTVKEVSDPTVGHTKLAWWQKELAALASGHPSHPVSQALAAHHPDIARETDALRTLVAGYGMDLEQARYLDFANLRRYADQTGGMFAALVASASAGRPTANGARWAQPLGQALTLAQFVQDLGQDARQGRIYVPIDELQRYGVTAADLLNRRYSPAYTELMRFQTSRARDALNASLSGIPADERRAQRTLRALGALALAVLDEIERDGFQVLHQRIALTPIRKLWIAWRAARRR		307		3	Expressed	-1	 	
Batch05	BupsA.16001.a	Burkholderia pseudomallei	YP_334082.1	Q3JQS1				metallo-beta-lactamase family protein	Potential drug target		MRFASLGSGSEGNALVVEASNGATTTRVLLDCGFSAKELERRLARIDLRVDDLDAILVTHEHGDHVGCALTLARRASLPLYTSWGTARAVGADEADVDLHVLWSDETAAVGDLCVLPYTVPHDAREPLQFVFSDGATRLGVLTDVGMSTPHIGAVLSGCDGLVLEANHDVAMLAASRYPASLKARIGGSHGHLSNDAAAAILAELDRSRLRHLVAAHLSQQNNAPALAQAALAAALGGQADDVLVASQDDGFGWLSLS		258		3	Expressed	-1	 	NR-16603
Batch05	BupsA.16002.a	Burkholderia pseudomallei	YP_334562.1	Q3JPE1				metallo-beta-lactamase family protein	Potential drug target		MFGAGPAHATGAGAPLQIDVYNPGEKSLFPVSSEIVTGKTGTILIDAQFQRNDAEALVNKIKATGKPLKLVYVSHSDPDYYFGLDTIKAAFPDAKIVATPQTVAAIKANKDDKLAYWGPILKDNAPRTLVVPQPLHGDRLTLDGHELRIVGLDGPSPDRTFVSIPSARAVVGGIPVAANIHVWIADTQTPESRRNWIKTLDRIAALHPSRVVPGHYLANPDGSEPYTLASVKFTRDYLVAFDAEAAKARNSGELITAMKARYPNLADASSLEMSAKVIKGEMQWPVVGTASAFPAAGKKALVQFGDIGFRLDFKDDHTMTFVGTAGQYQGATDTVEYKATQIRPQVFMVYWHEPKSGDNVVHVEDFENGIVYTNIAHRNGEFQHLKGTIRIEDAK		395		4	Soluble	-1	 	NR-16604
Batch05	BupsA.16003.a	Burkholderia pseudomallei	YP_336380.1	Q3JJ73				metallo-beta-lactamase family protein	Potential drug target		MILRQFLHCDPVGISYLLGCGGKSTGVVVDAVAEPGTYLQAAADAGMKIDYVIDTHVHADHLSTGPALADAAGAAYVLSAKADVVLPFKGVEDGDEIRVGNVVIKVLETPGHTPEHISLLVTDRTRAEEPWLALTGHTLMIGDLGRTELAESAEAGARNLFRSVRTLKSLPDYLPLLPGAFAGSACGRGLSATPLSTIGFEKRHNAAFGIDDEAAFVRFMLSDMPPAPPEAARLRAANSGRNPDEI		246		3	Expressed	-1	 	NR-16605
Batch05	BupsA.16004.a	Burkholderia pseudomallei	YP_337189.1	Q3JGW4				putative metallo-beta lactamase-related protein	Potential drug target		MQHGTPGRIDSRLAIVGTADVPLYVIVNDEAATLVEGGLSGMTELVWRQLHELLSDYGGIRHLRYWLITHSHYDHCSLLGTLAPRMPWLHIVGSAATADALQSPSACRTIRALDAQACAAWEPVAAAAELSDIPLYPLNPGRSLDIGEGMRMRALALPGHSACLLGYHCPQLDLLFVSDALGEYHAPTQWLPLVFQDLAAYRLSLDAIERQHASRIALGHHGIVGGGIARHAVRHARDGLAARDDEARAARGDANATRALARQWTERYAARSANVVPRALHLKSMERMIDLFQRAA		296		1	Selected	-1	 	NR-16606
Batch05	BupsA.17031.a	Burkholderia pseudomallei	YP_334922.1	Q3JND1				cell division protein FtsL	Potential drug target		MSRLNIFLLIIVMGCALSVVNSTNQQRQIFIQLQRAQSQEHQLQQDYAQLQYQQSALSKTSRIEQLATSSLKMQPITTGRTQYLTLSPGAAKAVDVPLPASAAPTGGAR		109		2	Cloned	-1	 	NR-16607
Batch05	BupsA.17053.a	Burkholderia pseudomallei	YP_334096.1	Q3JQQ7				cell divison protein FtsB	Potential drug target		MRLVTVVLIALLIVIQYPLWWGHGGWLRVHELRQQLNDQLQKNADAKLRNERIAGEVQDLQGGTSAIEERARYEMGMVKDGEVFVQFVSPNSPAPAAQGNASSATSTRGDVSGAPMRVVPNPVSRAKPERRHGGDKAHKPAHG		143		4	Soluble	-1	 	NR-16608
Batch05	CoimA.10050.a	Coccidioides immitis	Q1DY21_COCIM	Q1DY2				Putative uncharacterized protein  - Coccidioides immitis	Potential drug target		MTNIDSTTDSSSPTVTSLSQNTLPPLLVKKLLPQAQAPKRGSAFAAGYDLYAAKQTVIPAKGKGLVDTGLAIAVPDGTYGRIAPRSGLAAKNFIDTGAGVIDADYRGEVKVLLFNFSDVDFTVNEGDRIAQLVLERIYTPEIQVVEHLEESVRGAGGFGSTG		162		2	Cloned	-1	 	
Batch05	CoimA.10154.a	Coccidioides immitis	Q1DYT5_COCIM	Q1DYT				Putative uncharacterized protein  - Coccidioides immitis	Potential drug target		MAGLGPIDLSMTNGAAEKKRVAYFYDSDVGNYAYVAGHPMKPHRIRMTHSLVMNYSLYKKMEIYRAKPATRLEMTQFHTDEYIDFLSKVTPDNMESFQKEQQRYNVGDDCPVFDGLFEFCGISAGGSMEGAARLNRGKCDIAVNWAGGLHHAKKSEASGFCYVNDIVLGILELLRFKQRVLYVDIDVHHGDGVEEAFYTTDRVMTVSFHKYGEYFPGTGELRDIGVGAGRYYAVNVPLRDGINDISYKGIFEPVIKNVMEWYRPEAVVLQCGGDSLSGDRLGCFNLSMRGHANCVKYVKSFGLPTMILGGGGYTMRNVARTWAFETGLLVGEQLPTELPYNDYYEYFSPDYELDVRPSNMDNNNSREYIDRIRKQVIENLKRSAHAPSVQMTDVPRDALVDGMDDEADAILDDLDEDENKDTRFTKRRFDQYIEKEGELSESEDEEMAAENGVRRQPNGTKRRNQVNYRNLEPESGMNSGIATPRDASSVADEEVSDTKMDDVGDIDIPDKRSPTPTAEPSTRPESRIETEEPSVPEQQTAPTTENEDKIPVASPPVSPQGSAQPNGDEDTNMEDAIVEPEPSEPPTAPSEPLVATPPKSPQPEASAQSATSPHPAEPEEGPANAE		626		2	Cloned	-1	 	
Batch05	CoimA.10201.a	Coccidioides immitis	Q1DVD4_COCIM	Q1DVD				Putative uncharacterized protein  - Coccidioides immitis	Potential drug target		MLDFGLRVLPLISRLPKSPRRPWQRAPCRCTIPLLTRRGVASASSNQRKPYYVTTPIFYVNASPHVGHLYTLVLADILKRWQVLLGNNDAQLLTGTDEHGIKIQQAAASHGLEPIKLCDQNCQTFKDLAQKANVQHDHFIRTTDPEHRDAVQYFWEMLDHRGYIYTAKHEGWYSVSDETFYPSNAVHATLDPATGRKIMSTIETGKEVEWSSETNYHFRLSAFKDRLLDFYRENPTFIRPKRYMDNIVQSVSSGLTDLSISRPVQRLTWGIRVPGDDTQTIYVWLDALINYLTYAGYPFTPGKENQSIWPANVHVVFARSSQKADACPGADLDARFHCVYWPAFLMALDLPLPRQVLSHAHWTIGREKMSKSTGNVVNPMYALARFGVDPLRFYLAHDGGLSDDADYENAFVTERYKKTLQWGVGNLTSRLVRSKKWNVRRSIEWGVEGRFPPPSEADRKHQQLLEGIRNVTRSWMDDLNPRKAVESVVGIIHESENTEPTELSRVIYNTAESLRIAGILLQPFMPEKSARLLDMLGVAGDPEKRSFEAAIFGADEHYGVPLVELKKGTEATLFPPLVTEN		581		2	Cloned	-1	 	
Batch05	CoimA.10272.a	Coccidioides immitis	Q1DV34_COCIM	Q1DV3				Putative uncharacterized protein  - Coccidioides immitis	Potential drug target		MLPQSDQPVIAEAKRIAAEFEYSSADVNRGVKKFLSEMEIGLTGEGSTLSQIPSYITCVPDGSEKGVYLAVDLGGTNIRVCSIHLNGDSTFDMTQEKAVIPRELMVSDSAAELFGFIAEQIECFLQKHHEERYASHTEKRRLGNIAFHDEDIFDLGFTFSFPVIQTAINKGNLYRWTKGFDIPEAVGQDVCKLLQDAVDQRNLPVRVSALINDTVGTLMARSYCSSGHSKALIGAIFGTGTNGAYVERLDRVKKLNNRGGDLVDASASEMVVNTEWGSFDNPLEVLPNTRHDQELDGISVNPGVQMFEKRVSGMFLGEILRCTILHMNKSPALNLCGGSSAIPKDSILYQHWGIDTKFLSTVEGDSTDDLREVKEELRSDLGIENASTTDCKAIKVLTHAIGKRAARLSAVPLAAIIISSGRLGTEDVIDIGVDGSLIEFYPGYEKYIREAWREIPEIGEKGEKKIQIGIAKDGSGVGAALSALVARQAEKRKQG		495		2	Cloned	-1	 	
Batch05	CoimA.10317.a	Coccidioides immitis	Q1E4A0_COCIM	Q1E4A				Putative uncharacterized protein  - Coccidioides immitis	Potential drug target		MSQNRPSMFSSLRMGEVIREKVQDGVTGETREMQYTQCKIVGNGSFGVVFQTKLSPGGEDAAIKRVLQDKRFKNRELQIMRIVRHPNIVELKAFYYSNGDRKDEVYLNLVLEFVPETVYRASRYFNKMKTTMPMLEVKLYTYQLFRALAYIHSQGICHRDIKPQNLLLDPSTGVLKLCDFGSAKILVENEPNVSYICSRYYRAPELIFGATNYTTQIDVWSTGCVMAELMLGQPLFPGESGIDQLVEIIKVLGTPTREQIKTMNPNYMEHKFPQIKPHPFNKVFRKASPEAIDLITALLEYTPTQRLSAIEAMCHPFFDELRDPNTRLPDSRHPSASARELPKLFNFTHHELSISPSLNHKLVPPHAKSELFSRGIDIDNFIPLKKEEMMARLD		394		2	Cloned	-1	 	
Batch05	CoimA.10384.a	Coccidioides immitis	Q1DK98_COCIM	Q1DK9				Putative uncharacterized protein  - Coccidioides immitis	Potential drug target		MSLPTSRNRTSFQQLEKLGEGTYATEAKSGASANVYKGRNCQTNEIVALKEIHLDEEEGTPSTAIREISLMKELDHENILSLRDVLNTDNKLILVFEYMDNDLKRYMDAQNGPLDPNTIKSFFYQLMRGIAFCHENRILHRDLKPQNLLINRNGRLKLADFGLARAFGIPINTFSNEVVTLWYRPPDVLLGSRSYNTSIDIWSAACIMAEMYNGRPLFSGTTNEDQLLKIFRVMGTPTELTWPGVSQLPEYKSTFPVYAPQSLRRLVPRIDPIGADLLERMLQLRPDFRLSASDALQHPWFHSLPEFTASHQNTLKLNYPN		321		2	Cloned	-1	 	
Batch05	CoimA.10384.b	Coccidioides immitis	Q1DY95_COCIM	Q1DY9				Putative uncharacterized protein  - Coccidioides immitis	Potential drug target		MDKRQQPSSFQQLEKLGEGTYATVFKGRNRQTGEMVALKEIHLDSEEGTPSTAIREISLMKELKHENIVSLYDVIHTESKLMLVFEYMDRDLKKYMDQRGDRGQLDYLTIVSFMQQLLRGIAFCHENRVLHRDLKPQNLLINNKGKLKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYNTSIDIWSAGCIMAEMYTGRPLFPGTTNEDQLQKIFRLMGTPSERSWPGISQFPEYKPNLHVYATQDLRLILPQIDQLGLDLLSRMLQLRPEMRISAAEALRHPWFHELNQMQAQEAHHQAAIHQQQQHVTAGYGAQGIVSQGY		330		2	Cloned	-1	 	NR-15947
Batch05	CoimA.10384.c	Coccidioides immitis	Q1E8F2_COCIM	Q1E8F				Cell division control protein 2  - Coccidioides immitis	Potential drug target		MENYQKIEKIGEGTYGVVYKARDLSNQGRIVALKKIRLEAEDEGVPSTAIREISLLKEMHDPNIVRLLNIVHADGHKLYLVFEFLDLDLKKYMEALPVSEGGRGKALPDGSLNMSRLGLGEAMVKKFMAQLVEGVRYCHSHRVLHRDLKPQNLLIDRDGNLKLADFGLARAFGVPLRTYTHEVVTLWYRAPEILLGGRHYSTGVDMWSVGAIFAEMCTRKPLFPGDSEIDEIFKIFRIRGTPDERSWPGVTSFPDFKSSFPKWRREDIRKIVTGLEESGLLLLDAMLEYDPARRISAKQACVHPYFRSCSSTYSGRSKTNYQ		322		2	Cloned	-1	 	
Batch05	CoimA.10415.a	Coccidioides immitis	Q1EB20_COCIM	Q1EB2				Putative uncharacterized protein  - Coccidioides immitis	Potential drug target		MTAVAKRRLQALSQQLVEGIPDAGTFENIPRIREVAPDSVGPRCKGKVVIVTGTNSPIGIGRASAHQFARNGAKAVFICDFSSTYLDVHKRELESLYPNVDIHARQFDAGNEEQVKAVVDEAMQRYGRLDIMFANAGIVGQPKIFTEITGDDFMKTMETNAKGPFLATKYAALAMQTTSASKPYPSGSIILTASVAGLRSNAGSTDYSASKAAVVSLAQTCAFQLAGTGIRVNALCPGVVETGMTKGMYDMARARGTEKKIGQLNPLRRGAVADEIARAALFLGSDESSYVNGQAWAVCGGLSAGHPFVPGKLA		314		2	Cloned	-1	 	
Batch05	CoimA.10478.a	Coccidioides immitis	Q1DIF0_COCIM	Q1DIF				Putative uncharacterized protein  - Coccidioides immitis	Potential drug target		MASSASFPPPPVSSIDWNNIGFKVWEVNGHVESRFSHSSSPQWSPPQFVASPYLPIHGMAPGLNYGQQAYEGMKAFRHAPTESHPNGRITIFRPHRNAERMQHSARFISIPPVPESHFLECVKLAVSANAGFVPPHSTGAAMYIRPLIFGSSAQLGLSPPDEYTFVVFVMPTGVYHGVHAVNALILEDFDRSAPDGTGSAKVGGNYAPVLRHSEKARADGYGITLHLDSKTRSEIDEFSTSAFIGVLKDASGHVTLVIPDSKNAIDSVTASSIMAIGSNMFGYKVEKRRVPYDELKEFSEVMAAGTAAALVPIKSITMKSRNDVFNYEAGEGDSGGEVYKKLIHALKGIQRGEIHDKMGWLVDIEPVPAGWVEASRGKEADVSIANLP		388		2	Cloned	-1	 	
Batch05	CoimA.10478.b	Coccidioides immitis	Q1DZR0_COCIM	Q1DZR				Putative uncharacterized protein  - Coccidioides immitis	Potential drug target		MKNILRLSRAGARSLSGSPSHSPFLRYAVNAAWQRGYSAWQSPSRSDGLPGIDASKLSVTKTTSPKNLLPPKELVFGSTFTDHMLRVNWNTKDGWLAPEIVPYQNLSLDPATCVFHYAFECFEGMKAYKGKDGSIRLFRPDKNMARLNKSSKRIALPTFDGETMIKLIGELVKLDSRFIPQERGYSLYLRPTMIGTQSTLGVSPPGSAMLFVIASPVGPYYPTGFKAVSLEATDYAVRAWPGGVGDKKLGANYAPCIVPQLEASTRGFQQNLWLFGEEQYLTEVGTMNLFIAMKNKETGQNELITPPLDGTILEGVTRDSVLTLARERLTPKGWKVSERKLTMPELAEAADEGRLIEVFGAGTAAIVSPVRNISWKGRLVDCGLKKDEEAGKIALEMKNWIEGIQYGEEKHPWR		414		2	Cloned	-1	 	
Batch05	CoimA.10532.a	Coccidioides immitis	Q1E0B6_COCIM	Q1E0B				Acyl carrier protein  - Coccidioides immitis	Potential drug target		MFRSALIRSLRTVSIPRAVRNSSTVRQLPRASAIVRQSQFAPCIPYQAIRSYSAPAGLNQSEVEGRIIDLLKNFDKITPTSHFTNDLGLDSLDTVEVVMAIEEEFSIEIPDKEADAIHSIDQAVQYILSQPDAH		134		2	Cloned	-1	 	
Batch05	CoimA.10678.a	Coccidioides immitis	Q1DZL1_COCIM	Q1DZL				Uracil -DNA glycosylase  - Coccidioides immitis	Potential drug target		MSLSNSLKRNASHLSTVSVNTKKSKSNGTITSFFGAPTSKSTNDPVSGNTTSGPVTSKFCKEKWVASLTSEQRELLKLEIDTLEESWLAQLKEELLTKDFLNLKRFLRKEVASGAEVFPPLNDVYSWSRHTPLHKVKAVIIGQDPYHGYGQAHGLCFSVRPPTPAPPSLKNIYIALKKDYSSFQPPPNGGGLLTPWADRGVLMLNTCLTVRARSPNSHSRQGWERFTQKAIDVVARVRTRGVVFLAWGRPAANRVANVNREKHCVLQSVHPSPLSAHNGFFNCGHFKKANQWLEKRYGPEGGIDWSLTQSTAANKESNDNKQCAGATPETDLCPPRTKETQEA		343		3	Expressed	-1	 	
Batch05	CoimA.11073.a	Coccidioides immitis	Q1DZY7_COCIM	Q1DZY				Methionine aminopeptidase  - Coccidioides immitis	Potential drug target		MKMAVQALPEINKLSVSEEGAANAAAKGQAAQGTAGNDDAENDESDEDKEDEQEVADGAAAAGGKKKKKKPKKKKKKGTAKVQSNPPRVPLSTLFPNNNYPEGEIVEYKDDNAYRTTNEEKRYLDRMNNDFLTDYRKSAEIHRQVRQYAQKELLKPGRSLTEIAEGIEDSVRALTGHMGLEEGDSLVAGMGFPTGLNINHCAAHYSPNAGNKMVLQYGDVMKVDFGVHVNGRIVDSAFTVAFDPVYDNLLNAVKDATNTGIREAGIDVRMSDIGAAIQETMESYEVEINGTTYPVKAIRNLNGHTIGHYLIHGGSTGKSVPIVKGGDQTKMEEGETYAIETFGSTGKGFVRDDMEVSHYAKVPDAPNVPLRLSSAKNLLNVITKNFGTLPFCRRYLDRLGQEKYLLGLNNLVSSGLVDAYPPLVDVKGSYTAQFEHTILLRPNVKEVITRGDDY		454		2	Cloned	-1	 	
Batch05	CoimA.12541.a	Coccidioides immitis	Q1DZ62|Q1DZ62_COCIM	Q1DZ6				Putative uncharacterized protein - Coccidioides immitis	Potential drug target		MLPSFNHSLPSGKEKGTYLALDVGGSTFRVALVKLAGKDEGVKILKMATSHIDEDVKALAGKAFFDWMARKIGEMLPPSAEEYSQDSAPLPMGLSWSFPIEQTSIRSGKVISMGKGFHCSDGTVGDDLRELIMEACRKRNLNVTLEAIVNDGSATLLSRAYTDPTTRMSLILGTGTNMAVHFPVHAIGIDKYGERSPEWFAKADHVITNTEISMFGGRVLQMTRWDDDLNRNHIKPDYQPLEYMCTGRYLGEIVRLIAAEAVQTAGLFGGQMPASMQPRYSLDTAILAYIEEDTSPSFQSSLAFLQKQHQFRVPPTPADLAFLKRVTHCVSQRAAAYLATAIHGLWCLRNESETPIFPATPESTNDEEILKIPAKECTKDPIPLQVNIACDGSVINKYPNFRARCQVYLNQLTFDSKTSETSHMILDSAIASKKASSRVEQLRSITLDLAPEGGIIGAAVAVAVAVPDDE		470		3	Expressed	-1	 	NR-16648
Batch05	CoimA.12541.b	Coccidioides immitis	Q1E8G2_COCIM	Q1E8G				Putative uncharacterized protein  - Coccidioides immitis	Potential drug target		MADLEGQRESDAPSIKSFLAPLVLDDAKVYDISYRLSEVFRDLARTGDGHFFPTPVTHLPSGKETGFYLAVDVGVTNLRVAFIELLGDSSDSPGNGSSSMPTAESYIAHNAIPKVWQRRVRRTLEKAWRIEEHLKEDPTEELFSWIGSCIADVVADELTSHSSEFPAELETGLSFSLPMKQKSLSEATLMPVGKAFFISEDLDLRQALLAGYERHTRRTDLIEPTAKRQKIYELPKLKIVAITNDTVATLVSLAYSVKSLPNTRVAMGIIVGAGCNATVPMKLSDLHESKVRQIRSYNPDATEAIINTEWTLRGTETPLQELGVVTKWDVELDSKTHRPGFQPFEYMTGARYIGELVRIIVFDYFTNVAGISKQDLPQTLTEPYSLTTALVSDVIATSRSDITLASDLARSLPPPTSSSWSWTPESAVVMRATVSAVQTRSAALIAAASVGLLACNHEIKLSEKPGSTSGSPTSTQPTGQNPQDQPEAICPGSGWHSGPEELVVAYTGGIIQHYPNFKEMCQVYIDRLIMRGGPQEEGKSVFLREASDGSIIGAGVLAGMVSRK		564		3	Expressed	-1	 	
Batch05	CoimA.12541.c	Coccidioides immitis	Q1EAX8_COCIM	Q1EAX				Putative uncharacterized protein  - Coccidioides immitis	Potential drug target		MLLTSIAEDDDHNMAVESCDEDDAPQEKGTLEDGPEGRLPEDRAIDNFLQPLVIEDAKLYQLACCFSKVYEKLAKNSDQQFLPTPVTRLPTGQETGRYLAIDVGGSNLRVAFIELLGEAADQIDGGSDEEKSRETLRKAQRNRVRRSLEKAWPIEERLKTDKAEDLFLWIGDCMAEVVADSLTAELADGAQIPEELEMGITFSFPMMQESLSEAILMPMGKGFKWVDSTDLNLGKILLAGYERHTRRPYGSNEPSVKRRKLFALPKLKIAAITNDTVATLASLAYLVKSLPNSRVAMGIIVGTGCNATIPMKLSDLHESKAIQVSSHDANASETIVNTEWTINGAAPPLRELNVTTVWDSILDSQCARPGFQPFEYMTGGRYIGELVRIIFYDYLTSIVGLPKKDLPAILVQGYALSTTYLSSVVANTPSDSALAAKLGATLPPPESSSWNWDIATARAFRKVARAVQTRSAALIASAVVGLLACNKEIKLRHDGATNPRRASNIIVPEFNASTDTLTDVYRPKISNTTNDINNSEISAAVEVEGWQSGPEELVVAYTGGIIQHYPHFKEACQSFIDRLVIWDGPQESGKSVFLREASDGGIIGAGVLAGMVSSS		615		4	Soluble	-1	 	NR-16649
Batch05	CrpaA.10201.a	Cryptosporidium parvum	Q5CVN0|Q5CVN0_CRYPV	Q5CVN				Methionyl-tRNA synthetase of possible bacterial origin - Cryptosporidium parvum Iowa II	Potential drug target		KRSFRVYSDYCRNNLTYNKMTKINTTYRNSSGKYYYFTTAINYTNGTPHMGHAYEIVTSDILVRIARLFGFNTRFQTGTDEHGQKIAATAEKKGISPKELCDENVKQFKNMNEKLQISTDRFIRTTDADHYESCKELWRRCEAKGDIYLGKYNGWYNVREESFMTELEAKMLNYTDPISGLPLTKMEEPSYFFRITNYLESIKNHIIDNPEFIQPESSRESILARLEALGSDSEDLSISRASFSWGVPVPNDQEHVMYVWFDALTNYITGLKWADFDNDLEENSLFNKYWENTVHIVGKDITWFHSVIWPAMLLSVGLSLPKTIFAHGFVTAPDGKKMSKSLGNVVDPFEQIDKIGSDPFRYYLAREGRFGNDIKYQPSSVIDYNNGELADTYGNLISRITNLTHKFCQGVAPSLSQSLLLDKPVDIDTVFEEYYLAWNCFRIDECIQIAMDLSRNINKFLTDHAPWNKDNGKSDEERIEIIRIVLEGSYYISILLSPFITLACKEVFNRLGTPEKIIPEVDINYNNIKPGTPILIGEPLFKRIVNKEEKTFEELKAEKREREKQRRSGNKKLSETKDKGK		581		-2	Work stopped	-2	Work stopped	NR-16650
Batch05	CrpaA.10365.a	Cryptosporidium parvum	Q5CU99|Q5CU99_CRYPV	Q5CU9				Putative uncharacterized protein - Cryptosporidium parvum Iowa II	Potential drug target		FKLSQMSIQETINERISKSLNPTLLDVVDVSNCNCGYMFKVIVVSDCFVGKRILERQRLVNEAIGEVYNEIHSVTMKCYTSEEYSKSQNSA		91		4	Soluble	-1	 	NR-16651
Batch05	CrpaA.11073.a	Cryptosporidium parvum	Q5CTL9|Q5CTL9_CRYPV	Q5CTL				Methionine aminopeptidase - Cryptosporidium parvum Iowa II	Potential drug target		MSENEYNEKDNQNNGKELGTKTEQKTQLLLEESGVLNLDKPLNEIESIDNKQNNKKKKKKKKKKGKENLYEDKDDTYDPDLPTYSIPIQDNTHLRKVCNWPAIEFSKQTSPPTVPINKIYSRHEFPEGEIIEYNGPNSYRISSEELKDKEKLHILDYASLRRAAEVHRQVRKYMQSIIRPEMKLIDMCNILESKVKELVAAEGLKCGWGFPTGCSLNHCAAHYTPNPHDFTKLTQDDICKLDFGVQVNGMIIDCAFTVAFNDVFDPLIQSTLDATNTGLKVAGIDVMFSEIGSAIEEVIKSYEFEYKSKVYNIKPIKNLNGHSILPYHIHGGKSVPIIATNDDTRMEENEIYAIETFATTGRGYVTEGLDCSHYMKYYDNPFLNENSTRLNSAKILLGGINTHFGTLAFCRRWLDQLGFNKHALALKSLVDSEIIRPYPPLNDIPGSFSSQMEHTILLRPSCKEVVSRGDDF		472		2	Cloned	-1	 	NR-16652
Batch05	EhchA.10100.a	Ehrlichia chaffeensis	YP_507837.1	Q2GFE6				"serine protease, DO/DeqQ family"	Potential drug target		MKRFLLLILVLILANVPIGSFADQKAEQYDPRSGFSKLIKESTPAVVNISIVHDLIQEQFPLITLEELLRNILEGKPVKKDIPQEVLSAGSGFVVDESGIIVTNYHVVHNAKEVYVTFSDNKSIPAKILGVDPQTDLAVLKVEVNEKLPYLEFGDSDKTMVGDWVVAIGNPFGLGGSASIGIISARARDLNIGTATEFLQTDAAINKGNSGGPLFNIDGKVIGINTAILSTQKGGGNIGVGFAIPSNNAVSIIKVLSQGKKVEHGWLGVVMQPITEELVEPLQLKEVGGALITNVVKGSPASKANLLPGDIILEFNGTKINSISQLHQLVLRSEADNEVKLLVSRNGSIISILVKIGKFENPDISENGMPKDAIQSPELGLTVGSVQRNNIYNNIEEEEAKGVVILDIDSTSNASTRNIRKGDIILQINQSPVNNLEDFKNVMKKVRKNKSVALLISRDNISAFVTVKLKQ		471		7	Crystallized	-1	 	NR-16535
Batch05	EhchA.10201.a	Ehrlichia chaffeensis	YP_507787.1	Q2GFJ6				methionyl-tRNA synthetase	Potential drug target		MNNIYITTPIYYVNDVPHIGHVYTTLISDIIARFMRLDGHSVKFITGTDEHGQKIEKAAQERNMSLLDFTDNTSAVFRQLADVMNYSYDDFIRTTETRHKKTVVALWQRLCDNGAIYLGSYSGWYSVRDETFYQEKELVDGKAPTGADVEWIEEPSYFFRLSNFQERLLAFYEENPDFVIPKYRYNEVISFVKSGLKDLSVSRQNVLWGIKVPNDDKHVIYVWVDALANYLTVLGFPDENHKDYQAYWASDSSSVLQVVGKDILRFHAVYWPAILMAAELPLPKKILAHGWWTNEGQKISKSLGNVIKPFDLVEEFGVDQLRYFLIKEMPIGNDGDFKRNSLINCINYDLANNIGNLVQRTVSLLYKECGGIVPTVSGNLLQGEEVLPDYQEILEKVRDCVMRCNLNEMIHIIEQLSSAANEYIASRAPWRLSKSDPKIMEAVLYKLLEYIKCIGLLLQPVMPKLSSKILDQIGLPECNRDFSRFSIPINMNTVLPKPEPIFAKIL		506		2	Cloned	-1	 	
Batch05	EhchA.10365.a	Ehrlichia chaffeensis	YP_507124.1	Q2GHF9				BolA family protein	Potential drug target		MTVTQSQLELLIRNAFPEAEITVTSLVGDNNHYSIKVISSQFQGKSKLEQHRMIYKVLDGLNIHAIQIQTGCK		73		17	In PDB	-1	 	NR-16536
Batch05	EhchA.11920.a	Ehrlichia chaffeensis	YP_507218.1	Q2GH65				hypothetical protein	Potential drug target		MNNSNPQVIEITVRNNTYRVACNKTEEPHLRNLVDKFNALVNSISSAEKGKGSDALIFLLAGLTLEDEKHELKTQLKKTKDEMLTYKKYFDDYLKIKNEVSNILSHTLLRIEKLIHNLEKS		121		10	Diffraction	-1	 	NR-16537
Batch05	EncuA.10272.a	Encephalitozoon cuniculi	Q8SU17|Q8SU17_ENCCU	Q8SU1				HEXOKINASE - Encephalitozoon cuniculi	Potential drug target		MFTMHLAKVFAAFIAGTLGMWPALAVSTEEAVKASLFPMEDFEIMEIRKAFIERITRVREDASSGDFLDSHIDLSKARMPYQESRSVLVIDVGGTSLKISEVVIDLGSDEKGNSPSFHDIVECSPSFYRYPDTSGVSGQDRISWNEWVADQVVEFYGRNPPRSKVNASLTFSYPLIQTSVNNAQIKKTTKNFCFREDEATFTTDIVEALNSSLRSRKINVCVNCVLNDSTATYMAGVLRGYKNIIGIVLGTGTNSSFCVKKGRSNEVVLYNSEWGSTRVPRSMLTEADLAVVVDLEMRKISHNIIDVLAGGCKLGDIVLHKLRNTYPEIYEEYAEREEVLHSMIHSAITGSGNGALAKSPKLRNALMPIVRDFRARGMKILASLIGAVVESTMDNANTITLVLNGTTFSNAGLRDALGMEVKRMHPDIEINLVFLSNASLEGSALVSLMYSEYPKVECDLAPLAAPVLSFADQTP		475		5	Purified	-1	 	
Batch05	EnhiA.10014.a	Entamoeba histolytica	XP_651285.2	C4M6F5				"ATP-binding cassette, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSDIKIDDYFGNIRLTEKDVLIDDQNYIISIRNVHKTYLLGIEGVAALRGVSLSVKKGEFVCIYGTSGGGKTTMLNLIGTIDKPSKGDIILCDKRITEETKDRLLSFLRLQKIGFVFQTFNLIASMTAIENVELPMILLGKLSAKERKERAIKLLKKVGMEKRMNHKPSQMSGGEQQRVTIARALANEPELLLLDEPTGDLDSYNTGIVMELLLQLHKEGMTLLMVTHDVSLKNLSDRIIWMRDGKVGKIEEVTKEKRIEALKVISNKIQLKRIVIEKDINIITEIRTPEDYAPIKFQNEFLQLK		305		0	Target Approved	-1	 	
Batch05	EnhiA.10050.a	Entamoeba histolytica	XP_001914595.1	B1N499				hypothetical protein EHI_126430 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MLISDVGNGIERNYTLQKFILQCYEEQLKNNKNKKVIIIERHPREAIEVFCEIDKTMTEKEREEITNKIYLIEKEYQLEYNKYNTYCISTDYATPNIIARNIFTEWIKRENIENETFHVFLYANEENQKKRIIKRNRGVISEMNFYYVNQINTLYKHYLNEHFTSKENNEETLFIKKLHKDAIIPTRGSDQSAGFDLYSIDDNIIYPHDRCLISTGIAVQIPHFCYGRVAPRSSLAIKYGIDIGGGVIDEDYRGEIKVIVFNHSNTIYKCKKGDRVALLIIEKIKQCKIEEVKEISETIRGEKGFGSTGK		310		4	Soluble	-1	 	NR-16609
Batch05	EnhiA.10050.b	Entamoeba histolytica	XP_001914491.1	B1N4J4				deoxyuridine 5'-triphosphate nucleotidohydrolase domain containing protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MNKYSGAIVISGSIGVGKTTTIQALIEYFNKENVGIIEEYIDYSPRIGKMLISDVGNGIERNYTLQKFILQCYEEQLKNNKNKKVIIIERHPREAIEVFCEIDKTMTEKEREEITNKIYLIEKEYQLEYNKYNTYCISTDYATPNIIARNIFTEWIKRENIENETFHVFLYANEENQKKRIIKRNRGVISEMNFYYVNQINTLYKHYLNEHFTSKENNEETLFIKKLHKDAIIPTRGTEQSVGFDLYSIDDNIIYPHDRCLISTGIAVQIPHFCYGRVAPRSSLAIKYGIDIGGGVIDEDYRGEIKVIVFNHSNTIYKCKKGDRVALLIIEKIKQCKIEEVKEISETIRGEKGFGSTGK		359		2	Cloned	-1	 	
Batch05	EnhiA.10050.c	Entamoeba histolytica	XP_001914488.1	B1N4M6				hypothetical protein EHI_144170 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MLISDVGNGIERNYTLQKFILQCYEEQLKNNKNKKVIIIERHPREAIEVFCEIDKTMTEKEREEITNKIYLIEKEYQLEYNKYNTYCISTDYATPNVIARNIFTEWVKRENIENETFHVFLYANEENQKKRIIKRNRGVISEMNFYYVNQINTLYKHYLNEHFTSKENNEETLFIKKLHKDAIIPTRGSDQSAGFVLYSIDDNIIYPHDRCLISTGIAVQIPHSCYGRIAPRSSLAIKYGIDIGGGVIDEDYRGEIKVIVFNHSNTIYKCKKGDRVALLIIEKIKQCKIEEVKEISETIRGEKGFGSTGK		310		2	Cloned	-1	 	
Batch05	EnhiA.10050.d	Entamoeba histolytica	XP_001914261.1	B1N4Z5				deoxyuridine 5'-triphosphate nucleotidohydrolase domain containing protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MNKRSGIIVISGSIGVGKTTTIQALIEYFNKENVGIIEEYIDYSPRIGKMLISDVGNGIERNYTLQKFILQCYEEQLKNNKNKKVIIIERHPREAIEVFCEIDKTMTEKEREEITNKIYLIEKEYQLEYNKYNTYCISTDYATPNIIARNIFTEWIKRENIENETFHVFLYANEENQKKRIIKRNRGVISEMNFYYVNQINTLYKHYLNEHFTSKENNEETLFIKKLHKDAIIPTRGTEQSVGFDLYSIDDNIIYPHDRCLISTGIAVQIPHFCYGRVAPRSSLAIKYGIDIGGGVIDEDYRGEIKVIVFNHSNTIYKCKKGDRVAQLIIEKIKQCKIEEVKEISETIRGEKGFGSTGK		359		4	Soluble	-1	 	NR-16610
Batch05	EnhiA.10050.e	Entamoeba histolytica	XP_649232.2	B1N529				hypothetical protein EHI_072530 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MNVNNSECINKYKTFAYNKKHVFISGSISTGKTMLCNLLFEYLDYYTPAAYIKEYIDYNTDGEFKLKLLHDGLISNFEFQNYILDCYETQLNSSIYEDADIVIWDRHPIESLEVFCATNNSISNEQRLKLRLRIEQLSRRYQIPQLTNKNVGVINVDTSRISTEVIEEALVNTFIHPLLLGLSNGSIYVFLFCSDTNTQFKRLTKRNRTPEIESYKSKEDLYILNNQYALFYTELVQQKLNQIN		244		3	Expressed	-1	 	NR-16611
Batch05	EnhiA.10050.f	Entamoeba histolytica	XP_001914142.1	B1N5M2				hypothetical protein EHI_180800 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MKYQQFIMITGGVGVGKSTLIHGLKKSLPKKERIFIKECIDFKPNIGKKMLEETLKGKGSIYQFQLFIIDCYREQLEKAKDMKYVIMERSPADSINIFATESYLQGKISEEEFNDLKIKTEELYQSYNIPKYHECIFTKIDSCKYSIDGVFQIVKQQTLQCWKRSESALFLLFCSDPLMQKENIEKRGRPEEKDYDINYMIRINNEYEKLFANFA		215		3	Expressed	-1	 	NR-16654
Batch05	EnhiA.10050.g	Entamoeba histolytica	XP_001914110.1	B1N5M5				deoxyuridine 5'-triphosphate nucleotidohydrolase domain containing protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MNKNNRAIIISGSIGVGKTTTIQALIEYFNKENVGIIEEYIDYSPRIGKMLISDVGNGIERNYTLQKFILQCYEEQLKNNKNKKVIIIERHPREAIEVFCEIDKIMTEKEREEITNKIYLIEKEYQLEYNKFNTYCISTDYATPNVIARNIFTEWVKRENIENETFHVFLYANEENQKKRIIKRNRGVISEMNFYYVNQINTLYKHYLNEHFTSKENNEETLFIKKLHKDAIIPTRGTEQSVGFDLYSIDDNIIYPHDRCLISTGIAVQIPHFCYGRVAPRSSLAIKYGIDIGGGVIDEDYRGEIKVIVFNHSNTIYRCKKGDRVAQLIIEKIKQCKIEEVKEISETIRGEKGFGSTGK		359		3	Expressed	-1	 	NR-16655
Batch05	EnhiA.10050.h	Entamoeba histolytica	XP_648882.2	B1N5S7				deoxyuridine 5'-triphosphate nucleotidohydrolase domain containing protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MNKYSGAIVISGSIGVGKTTTIQALIEYFNKENVGIIEEYIDYSPRIGKMLISDVGNGIERNYTLQKFILQCYEEQLKNNKNKKVIIIERHPREAIEVFCEIDKTMTEKEREEITNKIYLIEKEYQLEYNKYNTYCISTDYATPNIIARNIFTEWIKRENIENETFHVFLYANEENQKKRIIKRNRGVISEMNFYYVNQINTLYKHYLNEHFTSKENNEETLFIKKLHKDAIIPTRGTEQSVGFDLYSIDDNIIYPHDRCLISTGIAVQIPHFCYGRVAPGSSLAIKYGIDIGGGVIDEDYRGEIKVIVFNHSNTIYRCKKGDRVAQLIIEKIKQCKIEEVKEISETIRGEKGFGSTGK		359		3	Expressed	-1	 	NR-16656
Batch05	EnhiA.10050.i	Entamoeba histolytica	XP_001914015.1	B1N5V5				hypothetical protein EHI_062990 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MVHHIFISGSVGVGKSTIMEKLVSLLSNEFRVYQMKEYIDIDINGRSRLKEAQEGIISKYTFHKYIIYWYKQQAKSSDFTSADIVLWERHPIEAHDIFCSGTEGISEMEKEDLNNEIINFCKEYSIPLAHKGYCEVKMLDTANQAVNTLVETIYTDVISKIKMDEHQFNFTFFLYCSDIEVQYKRITVRGRNSEIQFYMNRENLYCINKIYFDYFIEVMN		220		4	Soluble	-1	 	NR-16657
Batch05	EnhiA.10050.j	Entamoeba histolytica	XP_654675.1	B1N5X9				hypothetical protein EHI_009620 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MKYQQFIIATGGVGVGKSTLIRRLKRSLPKGESIFVKEYVDYKPVEAKKQLEDTLKGNGSVYEFQLSIIDCYRQQMEQAQNKKYVIMERSPADSINIFAAASYRNGKISEFEFEDLKARVEKLYDLYNIPRFDDCHFTRVDSCKYSIQGVFELVKGQVSIALKRKQSCIFFLYCSDPLQQKRNIETRGRPEEKDYDINYMISVNDEYQILFAKY		214		3	Expressed	-1	 	NR-16658
Batch05	EnhiA.10050.k	Entamoeba histolytica	XP_650037.1	C4MBG7				hypothetical protein EHI_001780 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MKYQQFIVITGGVGVGKSTLIHNLKRSLPKKERIFIKEYIDFKPSTGKKMLEETLKGKGSMYELQLFIIDCFKEQLERAKQMKYVIMERSPIDSIFIFSNEAYFQGRMTTEEYNDLKVRVDDLYTTYGIPRFNEMIINRIDSCKYTINGIFEYVKYQSQEYWKQSKSALFLLYCSDPLKQKENIEKRGRPEEKDYDINYMIRINNEYSKLFAEYI		215		3	Expressed	-1	 	NR-16659
Batch05	EnhiA.10050.l	Entamoeba histolytica	XP_649147.1	C4M972				hypothetical protein EHI_091670 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MIKCLMDNNNNNTNYENSINNDQVLHYKFGKQHFFIGGSIGTGKTTLVNLILEYMDFYSHTVIIKEFINYDKGGEIKLHHLHNQLISNYEFQQYVLDCYEKQLNSELYEEADFVLWVRHPIESLEIFCKNNDSLSVKERNQLDLRMKQMCRRYGIPNIRDKSVAVLNVDTSRLSIEIIQEAIINTYIHPAMLGIMEGDLYVFLFCGDTDTQFKRIKKRGRTVELEQYKKKEDLFSLNNVYYTFYSNIIEEKLKQSN		256		3	Expressed	-1	 	NR-16660
Batch05	EnhiA.10050.m	Entamoeba histolytica	XP_648024.1	C4MAB4				hypothetical protein EHI_034810 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSVLNKPTNYISILATKKKSYFHFRGIGVGKSTLLGNLKSILNDSVRFKIIHEYIDIDYEGEKQLQRLKDGEITNFQFQVYVLHCFETQLDTISYQDAKYVIWERHPIEALKIFCANDNALTQEQRRKLLEIETELCATYGIPKIFDVKSIILKIDTFNYGNKFIAKGFVNQFIQPTIFTDAINHYFIYLYCSNEQEQLRRIITRGRKAELKIYHNIYDLHPVNHAYEDYYDKCIRRKRLLNQGLNI		247		2	Cloned	-1	 	
Batch05	EnhiA.10050.n	Entamoeba histolytica	XP_001914571.1	C4MAA2				hypothetical protein EHI_106800 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MKYQQFIVITGGVGVGKSTLIHNLKRSLPKKERIFIKEYIDFKPSTGKKMLEETLKGKGSMYELQLFIIDCFKEQLERAKQMKYVIMERKLMTFILHMVFQDLMK		105		0	Target Approved	-1	 	
Batch05	EnhiA.10050.o	Entamoeba histolytica	XP_001914544.1	C4M5I9				hypothetical protein EHI_072960 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MNKYSGAIVISGSIGVGKTTTIQALIEYFNKENVGIIEEYIDYSPRIGKMLISDVGNGIERNYTLQKFILQCYEEQLKNNKNKKVIIIERHPREAIEVFCEIDKTMTEKEREEITNKIYLIEKEYQLEYNKYNTYCISTDYATPNVIARNIFTEWVKRENIENETFHVFLYANEENQKKRIIKRNRGVISEMNFYY		196		0	Target Approved	-1	 	
Batch05	EnhiA.10050.p	Entamoeba histolytica	XP_001914295.1	C4LZ36				hypothetical protein EHI_018140 [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MNKNNRAIIISGSIGVGKTTTIQALIEYFNKENVGIIEEYIDYSPRIGKMLISDVGNGIERNYTLQKFILQCYEEQLKNNKNKKVIIIERHPREAIEVFCEIDKTMTEKEREEITNKIYLIEKEYQLEYNKYNTYCISTDYATPNVIARNIFTEWVKRENIENETFHRSYFRNEFLLC		178		0	Target Approved	-1	 	
Batch05	EnhiA.10252.a	Entamoeba histolytica	XP_653365.1	C4LVL5				"threonyl-tRNA synthetase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MAEQQEPIIDCSAALEGRLNYFNELEKKYKEEELKKSKEITIKYKDMTFQGKSFVTSPQEFIKDLVEKGEITKENPVFVAKVNGKLWDLTRPFEEDSTVEYLGFDNQEAHDVFWHSSAHLLGEAMETQYKCYLHTGPATAIDFFYDCKMNGAISAADFKKLQSLIEGYVREHQVFTRIEITKEEALKMFAYNPYKVKIIEKLPEGSTITAYKNGSFVDLCRGPHLANAASIKAIKILSSGSVHLDGTATGDLLQRIHAVSFPTKDLLKEYIKRAEEADKRDHRLIGRQQDLFFFHVLSPGSCFWLPHGTRIYNKLVELMRSEYRVLGYQEVITPNIFLSTLWETSGHWQHYKDDMFSFECEKQTFALKPMNCPGHCVMFASKKRSYRELPLRYAEFGVLHRNELTGALHGLTRVRRFVQDDSHIFCTMDQIESEVTGVLNLMKKIYKIFGFKTEIALSTRNEKKFMGEIETWNKAEAMLTQVLNDSHLPFVINAGDGAFYGPKIDIRIEDALGRKHQVATVQLDFQLPLRFKLDYMSEDPNQPLKTPVMVHRAVLGSIERFTAILTEHLAGKWPFWLSPRQVMVCTVSEKYNEYGAKVTKELNDAGFYADLDDSDNKLPKKIRNAQVAQYNFILVIGEEELVSNSVNVRTRENKVEGKVEFKEFIKHLKQLEADKQ		676		1	Selected	-1	 	
Batch05	EnhiA.10317.a	Entamoeba histolytica	XP_649579.1	C4M9B3				protein kinase domain containing protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MTMHSNHKNNPLAIFGEQKGLTLVSEKNEYKVDDIVGFGTFGIVVVAKDSKGEIVALKRVVQDHHYKNRELPIMELLHHVNVLELKDSFFSKIPNNKDDYILNIVMDYMPYNLYQVISEKKLENIQIKSFSFQLIRSLTYIHSLGICHRDIKPQNVLIDLDNNTLKLCDFGSAKQLDPKGSSISYICSRYYRAPELIFDCTHYSTAVDIWAFGCVVAEMVMRKPLFRGDNSTDQLKKIMKVLGNPSAEQIYAMNRNTSVFRTPQVTGIGIDSVLSVYSYPQGLIELLNSVLKYNPYQRPTGIQLMGHPFHAEARVGITFTESELKEAQSKKVLLN		335		0	Target Approved	-1	 	
Batch05	EnhiA.10317.b	Entamoeba histolytica	XP_657520.1	C4M9F2				"protein kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MEKNVVKKENKTSLLSIFGEQEGIILESEIKRYRVLKIVGRGTFGIVVGVIDEEQHIFAIKRILEDPRQKNRELGIMKELKHPNVIELLDHFYTILPNYKEPCLNLVTECYPESLHQMLHDYAAEQLPIPLRHARLFTYQLCRGLSYIHSKGICHRDLKPQNILVNRQNLELKICDFGAAKVLEANQPNTAYICTRYYRAPELIFGCVDYTTSIDIWSVGCIIAELLTGQILFRGMTTSDQLVKIFSIIGSPSVEQVLAMNPNSPYTKIPRVNGKGMNEVLMYTDSPDNAYELLESILQFDPSKRPSAMEVMLHDFCKDMFRELMKRDGIGEWTNYTVDEWSLADQRNLVGRLKEFCMLEKRRKERYSKK		370		0	Target Approved	-1	 	
Batch05	EnhiA.10317.c	Entamoeba histolytica	XP_651793.1	C4M5D4				protein kinase domain containing protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MDKQSKRGHSKVNPLVIFGNQEGLVLENEDTKYRISKIVGSGAFGIVAFAVDLNTNEVVAIKRVIQDRRYKNRELQMMEMLKHQNVLELKNYFYSKVSCTEDLCLNVVMDYFPQNLHQLMHDYRRRLPIGYTRLFSYELARALGYIHSFGMCHRDIKPQNIMVNRDTGDLKLCDFGSAKLLTPDESNISYICSRYYRAPELIFGATRYSTAVDVWSFGCVVAEMIVGQPFFQGESASDQITRIMKILGSPTVDEVKAMNNESPYTRVPHVGGVGIEAALRFMNPPFTAVLMLIKVMQYTPEKRPTAVQLITDNFHKDLFTEGLLLPNGNPLPILTNYDENEWKRGEEKGVKAKMENFVEMEKKRINSQQAVAPVPKPSEENA		382		0	Target Approved	-1	 	
Batch05	EnhiA.10317.d	Entamoeba histolytica	XP_648915.1	C4LSZ2				protein kinase domain containing protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MSKRLLKRVSQTEVFQNYGIQEGIILDNETNKYRISKVIGYGAFGIVFLATNIKTGEVNAIKRVSQGKRFKNKELRIQEILHHQNVIKLKDSFLSKLSNSSSFCLNLVMDYLPQNLYQFMRSLKKKVPTIYIRLFSYELIRGLAYLHSLNIIHQDIKPENILVNKNTGDLKICDFGSAKNILDSSEPNVSYICSRHYRAPELVFRTSKYNSSIDIWSYGCILAEMFLGKPLFPGSSTSDQVVKIIKIIGTPTEEEMKAMNNEIPPPILPKVDGIGIENTLSSFKPPVQAITILTHTLQYSPEKRLSASKLLTSEFHKELFNEGVLLPNGNPIPILTQYDEDEWKRGKENETIDKMKEFVEGEKKRILSQNSIRKDKETKDIISDAK		386		0	Target Approved	-1	 	
Batch05	EnhiA.10384.a	Entamoeba histolytica	XP_656968.1	C4M6K6				"cell division protein kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MSKEINERYKRLENLGEGTYGVVSKAWDKKLSRYVAIKKIKMDVTTEGISCSSLREISALSDLKHENIVNLLEIYNNGRSLYLVFEFCDSDLQKFIKNYEGDIPLTTIKTILQQLIKALSYCHSHRTYHRDIKPGNVFMNNDGTIKLGDFGLSRVFRSESKHFTPEVISLWYRAPEILLKMPSYTSAVDMWSVGTIFGELILKRPLFCGQSEQEQIVQIFDLLGVPNERNWPGVNKYCHFTPDPDAPPPIDFNSHFSRIGKEGTSLLRSLLMYNPDDRMSAEKALEHPFFNC		292		0	Target Approved	-1	 	
Batch05	EnhiA.10384.b	Entamoeba histolytica	XP_656401.1	C4LSA6				"cell division protein kinase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MIEIHRNDRKNGFLPHSNESLVNNRYRKDTKLGEGTYGEVCKAVDILSNTFVALKKVKADQEEEGIPSTALREIAILRDISHPNIVKLLDVYNSEKHLYLIFEYCNTDLHKFLKNNPQDLSIDFIRHASYQMLDALAFMHSHRILHRDIKPSNVLLSGDVVKLADFGLARSISIPIKRYTVEVVTMWYRPPELIQKYNVYGSGIDIWGMGAVIAEMILHEPIFRGDSDIDQLHKIFDILGTPKPSDYPDLDYFTDKKVFDYFPKNRVEILTKLKTIGGDGYNLLMKMFEYNPGKRISAREAMKDPFFIKH		310		0	Target Approved	-1	 	
Batch05	EnhiA.10384.c	Entamoeba histolytica	XP_652398.1	C4LST0				"cell division protein kinase 2, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTRYEKKQQLGEGTYGVVCKAWDTVCNRYVALKKIKQEREDDGIPVTSVREIAVLLELKHPNVVDLYDIYLEDKFLYLVFEFCDEDLYQFMSRSSKIPINETRSIVYQILQGLAFCHYHQILHRDMKPQNILINKNGTIKLGDFGLARLTTINDRKYTSEVVTLWYRAPEILLGATQYGGAIDIWSTAAIFGELINKEELFKGRCKIDQLFKIFSQLGTPTEDIWNGVTKLPFYLSTFPKWKAKDLHTIFHTDERAVDLLQKMFIYTPEKRISAADALKHPFFDPLNKPNN		291		0	Target Approved	-1	 	
Batch05	EnhiA.10478.a	Entamoeba histolytica	XP_656980.1	C4LSR8				"branched-chain amino acid aminotransferase, putative [Entamoeba histolytica HM-1:IMSS]"	Potential drug target		MTNTGKTSMATPECIIGESVIFNYKLVSSYSKEIGLCFQVTDEPHVYEVVRIINSKVLFFEDHLSRLLYSIEQLPKTSQNNISSELLYDSTYKLIKALHLINGNIRIVVSPTLMLIHEKEHHYPDIETIKKGVILGEVDIMRDNPNVKSMREDYINNVKKAHEQVFFGSKVFEVVLVNQNHQYTEGSRSNIFFINSNELRTAPDSMVLKGITRKYVIQAAESIGLVINQTCITQQELPHYKAFLSGTSLNILPIYSIGNIQLDSANDQTIQKLLKAYLSIVQDYLSRH		288		5	Purified	-1	 	NR-16661
Batch05	EnhiA.10520.a	Entamoeba histolytica	XP_655318.1	C4LU47				metallo-beta-lactamase family protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MKSSFYYSLHPTGMFLANCIVLGDTSTHEFILIDCGGDISSALNDADKHGLKKCTEIVCTHGHIDHIAGLEQAVLKTNAQISLHSQDIQLYNIAPLQAMLFGLQLKPLPTVKRILEDQDRIYVGQYEGVVLHTPGHSPGSICIYFEEPKILITGDTIYNGNVGNSVLPGGDTAKLKLSVLSVLNNTNPETIILPGHGITSTVSKEKQNSTIYYM		214		1	Selected	-1	 	
Batch05	EnhiA.10520.b	Entamoeba histolytica	XP_654172.1	C4LTP6				metallo-beta-lactamase family protein [Entamoeba histolytica HM-1:IMSS]	Potential drug target		MAKLNSLIYSCLPTGIIQANCCILGNPETGNYIVTDVGGDADRVISRAKSIGLKKCVGVYFTHGHFDHVSGAKKIKELTGAPLCLHEKDIELYKNLPMQCDYFGVPEVNNLPPIDVILKGGDEINLDGHKGVVLHTPGHSPGSCSFYFKDEEIVINGDTLFAGSYGRTDLWGGSFAQLKASIKNVLFSLPLNTIVVTGHGSNTTIREAKKSNMICFA		217		2	Cloned	-1	 	
Batch05	GilaA.10478.a	Giardia lamblia	XP_001706262.1	A8BLB2				Branched-chain amino acid aminotransferase lateral transfer candidate [Giardia lamblia ATCC 50803]	Potential drug target		MAVDPSTIDWSALKFSWLQTRSHVRSVWRNGEWSPLELVNEPTFNISIAASALHYGQAVFEGLKVFRTVDGRVAAFRPVENARRLISSCDGLCMESPSEQLFLNALAMVVRDNVDYIPPYGTGGSLYVRPLVIGTGAQLGVAPSSEYMFLMMVAPVGPYYRGGLKSVNAIVMDEFDRAAPYGVGSKKCAGNYAASLKAQSVALKKSFPIQLYLDAATHTFVEEFSTSNFFGIKDIQRDGAGKIVSCTYVTPKSPSILPSITNKTLRELISQYFGWKVDVREVPFTEVKTFQECGATGTAVVVTPIASITRGSTVIDFLQSDDQVGEVTKLLYETVQGIQYGVIPDRFNWNHYIDV		355		7	Crystallized	-1	 	NR-16612
Batch05	GilaA.10520.a	Giardia lamblia	XP_001709175.1	A8BBU3				Hydroxyacylglutathione hydrolase [Giardia lamblia ATCC 50803]	Potential drug target		MSLTVATFPTGPLQANCYVAFDPKSCNALIVDPGASCPDVLDYVKKQKLKVLFILLTHTHFDHVFGTGYVVNELKKEGDRFGSPKIYSHADDVTHWKANRMFAPLFGESVPADFPAEPDETFSEESTFDLGNDNIFRIMHTPGHTPGSSLLYCNKAKVVFTGDTIFANSVGRTDFPGGSSKQLKASVKRIYKELSDDFRIYPGHNHDVTLGESKNDVLEALSWT		224		5	Purified	-1	 	NR-16613
Batch05	GilaA.10520.b	Giardia lamblia	XP_001708067.1	A8B798				Hydroxyacylglutathione hydrolase [Giardia lamblia ATCC 50803]	Potential drug target		MTELRIVSEPVGPLQSNCIVLYNERTRSAILIDPGWEAPVIDKTIQHLKLTVKAILLTHVHFDNALYAGEFKKKYIQRYPPLKIMCHQADLFLWDNLLSTAKECGAEVPKHFPCRPDETFGSDDSWDIDGITLEVIHTPGHTPGSVCLLSDADKVVCTGDTLFANGYGRLDFPEAHRISHKDSIRRLKSRCPGYLIYPGHGPLASISESIPDQQLHY		217		5	Purified	-1	 	NR-16614
Batch05	GilaA.17029.a	Giardia lamblia	XP_001708073.1	A8BBV2				Metallo-beta-lactamase superfamily protein [Giardia lamblia ATCC 50803]	Potential drug target		MPEDVCTVIPNHVYVVDTKFLRDKMCGVTIIRDGEEAILVEAGSTISVPHTLNALKELGIDCNNVKYMFITHAHLDHSGGTGLILQSLPNCTVVAHPAAAPHIIDPHDKLVPAAIQVYGEQVFNQDYPGIVGMPADRMISAEDGSVYGAASSLLKLRVIHAHGHAFHHAVFYSEALKILFAGDGLGFSFSEINFCPLLCTTPTQFDATAWRKTVDIVSKLDVDYLIATHFDCAEKNSLQRRWDCILRQLDDYEALIAASKGRDEVKSKYMGIIQKYLDEYGVKLSSERVYALIYGDINVDGLWYRVQRNLAKA		313		5	Purified	-1	 	NR-16615
Batch05	MytuD.10050.a	Mycobacterium tuberculosis	NP_217213.1	P0A552				deoxyuridine 5'-triphosphate nucleotidohydrolase	Potential drug target		MSTTLAIVRLDPGLPLPSRAHDGDAGVDLYSAEDVELAPGRRALVRTGVAVAVPFGMVGLVHPRSGLATRVGLSIVNSPGTIDAGYRGEIKVALINLDPAAPIVVHRGDRIAQLLVQRVELVELVEVSSFDEAGLASTSRGDGGHGSSGGHASL		154		-2	Work stopped	-2	Work stopped	NR-16001
Batch05	MytuD.10520.a	Mycobacterium tuberculosis	NP_216776.1	O53534				hypothetical protein	Potential drug target		MAAIERVITHGTFELDGGSWEVDNNIWLVGDDSEVVVFDAAHHAAPIIDAVGGRKVVAVICTHGHNDHVTVAPELGTALDAPVLMHPGDAVLWRMTHPDKSFRAVSDGDAVRVGGTELRALHTPGHSPGSVCWYAPELGPGTGTVFSGDTLFAGGPGATGRSYSDFPTILRSISGRLGALPGDTVVHTGHGDSTTIGDEIVHYEEWVARGH		211		3	Expressed	-1	 	NR-16002
Batch05	MytuD.10520.b	Mycobacterium tuberculosis	NP_217097.1	P64261				POSIBLE GLYOXALASE II (HYDROXYACYLGLUTATHIONE HYDROLASE) (GLX II)	Potential drug target		MLITGFPAGLLACNCYVLAERPGTDAVIVDPGQGAMGTLRRILDKNRLTPAAVLLTHGHIDHIWSAQKVSDTFGCPTYVHPADRFMLTDPIYGLGPRIAQLVAGAFFREPKQVVELDRDGDKIDLGGISVNIDHTPGHTRGSVVFRVLQATNNDKDIVFTGDTLFERAIGRTDLAGGSGRDLLRSIVDKLLVLDDSTVVLPGHGNSTTIGAERRFNPFLEGLSR		224		3	Expressed	-1	 	NR-16003
Batch05	MytuD.10611.a	Mycobacterium tuberculosis	YP_177754.1	O53533				POSSIBLE ZINC-CONTAINING ALCOHOL DEHYDROGENASE NAD DEPENDENT ADHB	Potential drug target		MKTKGALIWEFNQPWSVEEIEIGDPRKDEVKIQMEAAGMCRSDHHLVTGDIPMAGFPVLGGHEGAGIVTEVGPGVDDFAPGDHVVLAFIPSCGKCPSCQAGMRNLCDLGAGLLAGESVTDGSFRIQARGQNVYPMTLLGTFSPYMVVHRSSVVKIDPSVPFEVACLVGCGVTTGYGSAVRTADVRPGDDVAIVGLGGVGMAALQGAVSAGARYVFAVEPVEWKRDQALKFGATHVYPDINAALMGIAEVTYGLMAQKVIITVGKLDGADVDSYLTITAKGGTCVLTAIGSLVDTQVTLNLAMLTLLQKNIQGTIFGGGNPHYDIPKLLSMYKAGKLNLDDMVTTAYKLEQINDGYQDMLNGKNIRGVIRYTDDDR		375		2	Cloned	-1	 	NR-16004
Batch05	MytuD.10611.b	Mycobacterium tuberculosis	NP_216775.1	P71818				Probable zinc-dependent alcohol dehydrogenase AdhE2	Potential drug target		MSQTVRGVIARQKGEPVELVNIVVPDPGPGEAVVDVTACGVCHTDLTYREGGINDEYPFLLGHEAAGIIEAVGPGVTAVEPGDFVILNWRAVCGQCRACKRGRPRYCFDTFNAEQKMTLTDGTELTAALGIGAFADKTLVHSGQCTKVDPAADPAVAGLLGCGVMAGLGAAINTGGVTRDDTVAVIGCGGVGDAAIAGAALVGAKRIIAVDTDDTKLDWARTFGATHTVNAREVDVVQAIGGLTDGFGADVVIDAVGRPETYQQAFYARDLAGTVVLVGVPTPDMRLDMPLVDFFSHGGALKSSWYGDCLPESDFPTLIDLYLQGRLPLQRFVSERIGLEDVEEAFHKMHGGKVLRSVVML		361		3	Expressed	-1	 	NR-16005
Batch05	MytuD.12746.a	Mycobacterium tuberculosis	NP_216429.1	O07720				hypothetical protein	Potential drug target		MHFDWERLTDSVHRCRLPFCDVTVGLVRGRTGILLVDTGTTLGEATAIAADVKQIAGCQVTHVVLTHKHFDHVLGSSVFDQAEVFCAPEVVEYLRSATDRLREDALSYGADTAEVDRAIAALKPPQHGIYDAAVDLGDRTVTITHPGSGHTTADLVVVAPATGHADGPTVVFTGDLVEESADPDIDADSDLAAWPATLDRVLAIGGPDASYVPGHGKVVDAQFVRRQRAWLRTRASRQPRETPATLPCKR		250		3	Expressed	-1	 	NR-16006
Batch05	MytuD.12797.a	Mycobacterium tuberculosis	NP_214999.1	P64705				POSSIBLE TRANSCRIPTIONAL REGULATORY PROTEIN	Potential drug target		MYSTNRTSQSLSRKPGRKHQLRSHRYVMPPSLHLSDSAAASVFRAVRLRGPVGRDVIAGSTSLSIATVNRQVIALLEAGLLRERADLAVSGAIGRPRVPVEVNHEPFVTLGIHIGARTTSIVATDLFGRTLDTVETPTPRNAAGAALTSLADSADRYLQRWRRRRALWVGVTLGGAVDSATGHVDHPRLGWRQAPVGPVLADALGLPVSVASHVDAMAGAELMLGMRRFAPSSSTSLYVYARETVGYALMIGGRVHCPASGPGTIAPLPVHSEMLGGTGQLESTVSDEAVLAAARRLRIIPGIASRTRTGGSATAITDLLRVARAGNQQAKELLAERARVLGGAVALLRDLLNPDEVVVGGQAFTEYPEAMEQVEAAFTAGSVLAPRDIRVTVFGNRVQEAGAGIVSLSGLYADPLGALRRSGALDARLQDTAPEALA		438		2	Cloned	-1	 	
Batch05	MytuD.16715.a	Mycobacterium tuberculosis	NP_214920.1	O86336				BETA LACTAMASE LIKE PROTEIN	Potential drug target		MVATRGTRLAALALAPRLAGMAELVQITDKVHLARGHAVNWVLVTDDTGVLLIDAGYPGDRAEVLASLNKLGYTPGDVRAIVLTHAHIDHLGSAIWFAREHSTPVYCHAEEVGHAKREYRENASVFDVALRSWRPRVAVWGIHLLRRGGLTGDGIPTAQPLTAEAAAGLPGQPMAIFTPGHTSGHCSYVVDGVLASGDALITGHPMLRHRGPQLLPAVFSHSQQNSIRSLAALALLETNILAPGHGELWHGPIRKATDEALERAQKSNHVFR		272		2	Cloned	-1	 	NR-16007
Batch05	RiprA.10014.a	Rickettsia prowazekii	NP_221060.1	Q9ZCM4				GLUTAMINE TRANSPORT ATP-BINDING PROTEIN GLNQ (glnQ1)	Potential drug target		MNNIVLILKMISKHYKQGNTIVRVLDGLNLTANEGELIAIIGSSGSGKSTLLHIAGLLDKPTNGQVIIPNIKYKKYHLIRLYYLGFIYQQHHLLKDFTALENVIIPRLIRGLDQKEAIKDATKILDDLGLEKKLYNMPGELSGGEQQRVAIARSLINKPRIILADEPTGNLDPNTTNEVFNLFLKVARKQNTTVIMVTHNHELAHKMDKLYNLKHGLLNIA		221		1	Selected	-1	 	
Batch05	RiprA.10014.b	Rickettsia prowazekii	NP_221216.1	Q9ZC98				GLUTAMINE TRANSPORT ATP-BINDING PROTEIN GLNQ (glnQ2)	Potential drug target		MIILEKVSKHYGKNYAIKNIDLNFTTKETTVIIGPSGSGKTTLLRILNNLEEPSSGTFLVDQQKLMQKDRRKLCLKVGMVFQNFNLFPHFTVGENLMYTPVNVLKLPKEQAISMAIELLTKFKLIQKFYAYPTSLSGGQKQRIAIARALMMKPEILLFDEPTSALDPENIKDVIENINLLKTQMSMVVVTHHLKFAKLIADRIIFMDQGQILANQPANEFFKKPASHRARLFLENIGDLM		240		1	Selected	-1	 	
Batch05	RiprA.10050.a	Rickettsia prowazekii	NP_220780.1	Q9ZDD2				deoxyuridine 5'-triphosphate nucleotidohydrolase	Potential drug target		MTIIEVKIKKLENFLGNLPEYATEHSAGMDLVAANEQSITIKVGSIQLIPTGIAIALPESFEAQIRPRSGLAVKHGITVANSPGTIDADYRGEIKVLLINLGNKDFIIEKGMRIAQMIIAKYERVLWAETSILTETMRGRGGFGSTGL		148		7	Crystallized	-1	 	NR-16663
Batch05	RiprA.10100.a	Rickettsia prowazekii	NP_220516.1	O05942				PROBABLE PERIPLASMIC SERINE PROTEASE DO-LIKE PRECURSOR (htrA)	Potential drug target		MVNLKIFLIVIVLMFNNIILAKENSNALKVVDQEENEFTAINSAPLKISEAARYSFADIVEPLIPAVVNISTIEYVNDKSENSEKDLLQENKHLGFMSDVLEKLNIPLNLEEIAKTPKSIPLGSGFIIAPNGLIVTNYHVIANVEKINIKLADNTEFLAKLIGSDSKTDLALLKIDSEEPLPFVEFGDSNDARVGDWVIAIGNPFGNLGGTVTSGIISSKGRDIDVDTDNIVDNFIQTDAAINNGNSGGPMFNLDQKVIGVNTAIFSPLGTNIGIGFAIPSNTAKPIIERLKKDGKVSRGRLGVTIQDLTEEISEVLGFKGTNGVLVSKVQENGPGYKAGIKKGDIIIKFGDRLVKNTKKLRVIIADTPINQEVKLKILRDAQELELPIKVTADNEEVINDSTEETNKAVIINKKENNLSITKNNITFSNLTEELRKKYDIPQDKTGIVIINIDEEESVFKLGDLITNINHDSIDDIRKLEVLYENAKKLEKQNILLLIERGDTSVFIPLSVS		513		7	Crystallized	-1	 	NR-16664
Batch05	RiprA.10100.b	Rickettsia prowazekii	NP_220575.1	Q9ZDX8				PROTEASE DO (htrA)	Potential drug target		MILQEVKMKKLPILLKLVFIINLVFTNNIVLASSDKNTAIFEKAKKAIVTIETRIAVSAYDDTSSWTGTGFINDKNNGYIITNTHVVGGASIGTYFVTFYNGEQAEAKLIYYDIWQDYAILKVESKDIPVSAIQIAFTSELPKLNQKVFVVGNTEAKGFSFHTGYLSDLYHIEGLMPQCTYVINLNTTGGASGSPVLNDKIEAIGVLYGGGKTHSLALHGDYVARTLKSLKNNKQPSRKHIGIISELYSLNKAVRHHNFPKDEMYKYINKFPDSRNRVISVKAVLSGSPAQKSLKAGDIIWAVNDQETWRQFSII		315		5	Purified	-1	 	NR-16665
Batch05	RiprA.10201.a	Rickettsia prowazekii	NP_221044.1	Q9ZCP0				methionyl-tRNA synthetase	Potential drug target		MKNTYYITTPIYYVNDVAHIGHAYTSVASDVIARFMRFCGKDVMFLTGTDEHGQKVEKAAINQNIDPQTFTDKTSQNFRDLMVAMNISNDDFIRTTENRHKKAVAVFWKKLLDNGAIYEGFYEGWYSVRDEAFYDESEINEDKLAPTGAPVEWVKEPSYFFNLAKWQDKLLEFYELNPDFVRPISRRNEVISFIKSGLKDLSISRTTFHWGIKVPNNRKHVIYVWLDALVNYISALGYPDKQSNYAKFWPANLQIVGKDILRFHAVYWPAFLMAAEIPLPKAIMVHGWWTNEGQKISKSLGNTIDPITLIDEFGVDQVRYFLMREVIFGADANFARNNLITRINSELSNKIGNLLHRIVSFVYKNNDAKVPLIKSGVIDKIYELPILKTAIKFAQENILLMDKTEINKILENIINLAEDANIYITNEAPWNLKTTDPDKMLEVLYSLLEVLRYIAIMLQPFVPNSANKMLDQLGVSKEERLFKHLVRDHALKAGSNILEPSIIFPKFN		508		2	Cloned	-1	 	NR-16666
Batch05	RiprA.10365.a	Rickettsia prowazekii	NP_221162.1	Q9ZCE4				hypothetical protein	Potential drug target		MAISAEELEKILKKSFPSSVIKITDLVGDQDHYALEISDAQFNGLSLINQHKLVKNALSEILNKKLHSISIKTISIP		77		5	Purified	-1	 	NR-16667
Batch05	RiprA.10478.a	Rickettsia prowazekii	NP_220809.1	O05970				branched-chain amino acid aminotransferase	Potential drug target		MTMIKLDQIYGYIWINGDLIPYQFARIHVLTHSLHYSGSVFEGERAYNGKVFKLKEHTERLIQSAESLGLKVPYSVDEIIKAHELLIIQNNIKDAYIRPLIWCGDESLNITNPDLSTNFLIASISSMPRSCEQSVHLHVSRWRKAMPNSTPVQSKSAAQYNMAITSKKEAKALGYDDALLLDYEGFIAECTTTNIFFVKDKTLYTPIADRFLNGITRKTIIEIAKSLCLEVKEERLKLAQIEHFTGCFVTGTAIEVQNISSIDLGNKKILFEDNKIADLLKREYWRIVRG		290		2	Cloned	-1	 	
Batch05	RiprA.10532.a	Rickettsia prowazekii	NP_221115.2	Q9ZCH9				acyl carrier protein	Potential drug target		MSTTDKIEQKVIEMVAEKLNKDKAIITTDSRFIEDLKADSLDTVELMMAIEVEYGIDIPDDEATKIKTVSDVIKYIKERQS		81		5	Purified	-1	 	NR-16668
Batch05	RiprA.10537.a	Rickettsia prowazekii	NP_220636.1	Q9ZDS4				CELL DIVISION PROTEIN FTSA (ftsA)	Potential drug target		MKEKISNFVTFDFGSSKIAVIAAYISKKGEIKVASQNLHHSKGIKSGVILDLKNAETSILTAIYALEKDCGKNINKIILSLSGAETKSYYINYTIKINGQTVTQQDIKKLLQKALVEFKFKNQEIIHYFPLEFTLDNNSVENPIGMYGRALSCELHIISARSNLLSNIVQCFAKCHVEVTNITLAIYASAISCLTNDEKNLGVLIIDIGDQTTSCGIFFADKLIYTWHLNIGSFHISLDIAKVFGIDLVTAEKLKILYGNAIIPLFEKDSIINMDDFHVDIPHNLNISLTIYRLAEVISARAEEILSMVKAEYDKATKGQFEVFRVVITGGGSQLRGLKELSNKIFAKQSRIGKPEIIAGFTEDYNPAMYSAAIGMLKIHALKQQKALSHIRLDENINFFKKAFDWFKENI		411		2	Cloned	-1	 	NR-16669
Batch05	RiprA.11339.a	Rickettsia prowazekii	NP_221217.1	Q9ZC97				hypothetical protein	Potential drug target		MLQVTVLGCGASIGVPVIGCECSTCTSPSKYNKRTRSAIYINDENSQILVDFGFDIRNQLLREKINKLDCAILTHGHSDHVNGIDDLRVFTFMQDKPFEIYTDYNSVAQLHAKFDYLFNLCKLLATKSINFFDKIKINTIEVQFFRQHHGPIDSLGLRIGDFVYSPDVIGFPPESEKFLKDIKIWILDCMDYRSNPNHAGLDKVLAWREKYNPEEILLTNMRHTIDYHEIKKVLPNNVKPLYDGYKFMV		249		2	Cloned	-1	 	NR-16670
Batch05	RiprA.16438.a	Rickettsia prowazekii	NP_221108.1	Q9ZCI4				hypothetical protein	Potential drug target		MPIVTVTLNNKSFQLYCNNGDEEKVLSLADKLNDKIAEIKLSSPTASFDLLLVMASLNAQAEIAILTEKLYKNGFQNNNHEEEKFAETLTTIASYLENLARKMEK		105		5	Purified	-1	 	NR-16671
Batch05	TogoA.10050.a	Toxoplasma gondii	VIII|44.m02770	B6KK00 				"coding) deoxyuridine 5'-triphosphate nucleotidohydrolase, putative"	Potential drug target		MLLRVQALTPEVRAMYAAHGHYHEGDSGVDLFVVQDQEIQPGETAFVKLGIKAAAFTPAEGGEQEKNVSWLIMPRSSISKTPLRLANSVGLIDAGYRGEIMAAVDNIKTVPHTLKKGDRIVQAVAFSGEGITLELVDELNKTARGEGGFGSTTCPAGEPEMKKAKNDVAN*		171		0	Target Approved	-1	 	
Batch05	TogoA.10317.a	Toxoplasma gondii	IX|57.m00024	B6KLR2   				coding) protein kinase 3	Potential drug target		MPDPQYDPAAAQKSSNARGGGSQRTTAVKGERQSRVHTGNPHPTLTYDIGRVLGNGSFGVVTEARCVDTGEVVAIKKVLQDPRYKNRELDIMKELKHPNVVKLIDYFYTEMGERDSNDHNRFLNVVMEHIPETVYRVMKSFLRANQQVPFILIKLYTYQMCRALGYLHALGICHRDIKPQNLLVDSRTHVLKLCDFGSAKRLVPGEQSVSYICSRFYRAPELMLGASEYTTAIDVWSIGCVLGELLLGRPLFAGETSVDQLVKIIQILGTPSRRQMSTMNPNYTEFRFPDVKPREWKSIFASHIASTETNDPSWDQALDLLTKFLRYEPGERLLPLEALAHDFFDELRLPSTRLPSGGPLPELFTFSQLELQNMSPAAQVKCIPKHIASANNRG*		395		-2	Work stopped	-2	Work stopped	
Batch05	TogoA.10365.a	Toxoplasma gondii	VIII|44.m02575	B6KJA5  				coding) bolA-like protein-related	Potential drug target		MATSTSGGAQQTVVEEKLKKALSPAFLKLEDKSCGCGAAYDCVIVSDAFDGKKLLQRHRMVNEALKDELPSIHAFSMQCHTPDEWRSKPAQ*		92		5	Purified	-1	 	NR-16672
Batch05	TogoA.10384.a	Toxoplasma gondii	XII|38.m00005	B6KRY7   				"coding) cell division control 2-like protein kinase, putative"	Potential drug target		MEKYQKLEKIGEGTYGVVYKAQDHSGEISALKKIRLEAEDEGIPSTAIREISLLKELHHPNIVRLRDVIHTDRRLTLVFEYLDQDLKKLLDVCDGGLEPSTTKSFLFQLLCGIAYCHEHRVLHRDLKPQNLLINREGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKTYSTPVDIWSVGCIFAEMVNGRPLFPGTGNEDQLMKIFKVLGTPQVSEHPQLAELPHWNRDFPQFPPLPWDQVVPKLDPLGTDLLSRMLRFDSNQRISARQAMQHPYFSDLADNIKRLATFRGE*		301		-2	Work stopped	-2	Work stopped	
Batch05	TogoA.10415.a	Toxoplasma gondii	XII|50.m00011	B6KHV9  				coding) enoyl-acyl carrier reductase	Potential drug target		MVGFKLLTLGAFVAGELTLVGPAGTMAFTVPNATGAKPLVTSVSVRPSWSSARQNAFSSSSSRSQSSVRPHSAFVTNRLETAGETGTQHRAADSAAGVGAAQSAFPIDLRGQTAFVAGVADSHGYGWAIAKHLASAGARVALGTWPPVLGLFQKSLQSGRLDEDRKLPDGSLIEFAGVYPLDAAFDKPEDVPQDIKDNKRYAGVDGYTIKEVAVKVKQDLGNIDILVHSLANGPEVTKPLLETSRKGYLAASSNSAYSFVSLLQHFGPIMNEGGSAVTLSYLAAERVVPGYGGGMSSAKAALESDTRTLAWEAGQKYGVRVNAISAGPLKSRAASAIGKSGEKSFIDYAIDYSYNNAPLRRDLHSDDVGGAALFLLSPLARAVSGVTLYVDNGLHAMGQAVDSRSMPPLQRATQEIN*		418		-2	Work stopped	-2	Work stopped	
Batch05	TogoA.10532.a	Toxoplasma gondii	VIIb|55.m00019	B6KAJ5				coding) acyl carrier protein	Potential drug target		MEMHPRNAGRKTLLALALFMATSIASSYGFVSPGLIRFNYRYGTCPNMSSGVCATPSTASLGTLGQPAGTVARRPGPFRSVSANVIGSPSSALFAADEASSDDRPLLERVKDVVADQLGVDRARINPESNFIKDLDADSLDSVELVMAFEEKFGVSIPDEEASKIATVQDALSYIEKAKSATA*		184		-2	Work stopped	-2	Work stopped	
Batch05	TogoA.10678.a	Toxoplasma gondii	IX|547.m00089	B6KW10				"coding) uracil-DNA glycosylase, putative"	Potential drug target		MSSTQKKKSIRTLTLSSFFSVKKNTSGEEPVSIAKTVAAASACQLAAGSCSGDRQLEQVSDTVKEEHKGEGAGSVDSVSLVKVPTEARLVDPEGEMKATSEAAALWRQTLGDCWFDALKEELRLPYFRDCMQFIRQERQKYRVYPPSRLVFNAFKQTPLNAVKVVVVGQDPYHQPGQAMGLAFSVPRGIPLPPSLQNIFKEIARNYPGSKLVDQHTNRISSFVHGDLTSWASQGVFLLNSLLTVRESTPMSHRDAGWERFTTKVINVINTQCEGVVFLLWGKPAQKKSAGVSRCRHRILEAGHPSPLSVRFFQGCQHFLKCNELLRSMGKAEIYFASSSC*		341		0	Target Approved	-1	 	
Batch06	MyabA.00010.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MK06				Probable 3-oxoacyl-[acyl-carrier protein] reductase	Potential drug target		MSPKLTDDLYALLVNSGPGNLLAGRLGIPQPEKLRRYKKGQPALAGPVLIGGEGRLAEPLRAALADDYEVVSNNLGGRWADKFGALVFDATGITTPVELKALHEFFTPLLRNVGKSGRLLVIGTTPDKAATTDERIAQRALEGFTRSLAKEFSNGATVQLVYLHPDAKTGATGLESTVRFILSAKSTYVDGQVFYVGADDSTAPADWDKPLAGKVAIVTGAARGIGETIAEVFARDGAAVVAIDMPSEELNELASRVGGTALALDVTSEDAVDTITAHLKEHHGGKADILVNNAGITRDKLLKNMDDARWDSVIAVNLLAPQRLTEGLIGNGTIGEGGRVIGLASIAGIAGNRGQTNYGATKAGMIGITQALAPSLAEKGITINAVAPGFIETKMTAAIPLANREVGRRINSLNQGGEPVDVAETIAYFASPASNAVTGNVVRVCGQSWLGA		452		-2	Work stopped	-2	Work stopped	
Batch06	MyabA.00113.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MPF0				Putative polyketide synthase MbtC	Potential drug target		MTAVHVDPVVISGMAIEAPGGIDTPAAFWNALADGRELISAFPRDRGWPVDELLSLSNLDGWGRISDAGGFITDASAFDPTFYGITQREAVAMDPQQRVAMRVAWKALENTGLNPGAVDGSEAGCFIGISPNEYGPPVGEVNAHSGMRVVGRGQLGAAGRISHGLGLIGPSVCVDSACASSLAALHLAASAVRADECEWAIAGGVCVMGSPGGFYEFSRMHALDPDGHCRSYSDEANGTLWGEAVGMVVLERESRARALGHRVYGRIMAVRTNHNGGGKPILVPRGRAQAKLVAATIAASGVDPADVGMLEGHGTGTRAGDPLEILALQSTYGAGGSNALLGSAKSNAGHAQSAAGMVGLIKLLLSGQHGHIPPTLFADNPTTKIDWSMTGIRLATKLHPWEPKDGIRYGSVSSFGAGGANAHAIIAMPAMDAQGEDGDDF		441		0	Target Approved	-1	 	
Batch06	MyabA.00145.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MCH3				Aspartyl-tRNA synthetase	Potential drug target		MLRTHDAGSLRESNAGQRVTLAGWVARRRDHGGVIFIDLRDASGVAQVVFREDAVLEQAHRLRAEFCVEVSGVVEVRPEGNANDEIATGQIEVNAAELKVLNESAPLPFQLDETAGEEARLRYRYLDLRREGPGNAIRLRSKANAAARSVLSGHEFVEVETPTLTRSTPEGARDFLVPARLQPGSFYALPQSPQLFKQLLMVAGMERYYQIARCYRDEDFRADRQPEFTQLDIEMSFVDQDDVIALAEEILVALWDLVGYRVPTPIDRITYAEAMRRYGSDKPDLRFGLELVECTDYFSETSFRVFQAPYVGAVVMPGGADQPRRTLDGWQEFAKQRGHKGLAYVLVGEDGTLGGPVAKNLSDAERDGLAAHVGANPGDCIFFSAGAAKSSRALLGSVRGEVAQRLGLIDPDAWAFTWVVDAPLFEPADDATAAGDVAVGSGAWTAVHHAFTSPKPESENTFDTDPGSALAYAYDIVCNGHEIGGGSIRIHRRDIQERVFQVMGISNEDAQEKFGFLLDAFAFGAPPHGGIAFGWDRVTALLAGTSSIREVIAFPKSGGGVDPLTDAPAPITAAQRKESGIDAKPEKAEKAGKPADA		597		0	Target Approved	-1	 	
Batch06	MyabA.00148.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MB26				Tyrosine recombinase XerD	Potential drug target		MTAAVGLLDGEIQSYLDHLDVERGVAANTLSSYRRDLRRYQQHLADRKIDRLAEVCETDVSDFVVTLRRGDPANGVPELSASSAARALIAVRGLHRFAAIEGLAPTDVARAVKPPTPNRRLPKSLTVEQVEALLNAAGGGGSDGPLDLRNRALLELLYSTGARISEAVGLDVDDVDVQARSVLLWGKGGKQRLVPVGRPAVEALQAYLVRGRPDLARRGRGGVPALFLNSRGGRLSRQSAWQVLADAAERAKISAAVSPHTLRHSFATHLLEGGADVRVVQELLGHASVTTTQIYTLVTVSALREVWAGAHPRAR		315		0	Target Approved	-1	 	
Batch06	MyabA.00148.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MDF9				Tyrosine recombinase XerC	Potential drug target		MTPQLAAILDEFAEHLALERGRSVHTQRAYRGDLTLLFDHLSASNPEATLADLSLPVLRSWLGAQARQGAARSTVARRTSAVKIFTAWATRRGLLPTDPAIRLQQPKSRRTLPAVLRQDQAAAAMEAAHSGAEQDDPMALRDRLIVEMLYATGIRVSELCGLDIDDIDRPRKVLRVLGKGDKERTVPFGDPAADALSAWLDRGRPHLAVPASGAALLLGARGRRVDPRQVRTVVHQTMSAVPGAPDIGPHGLRHSAATHLLEGGADLRVVQELLGHSTLATTQLYTHVTVARLRAVHDQAHPRA		304		0	Target Approved	-1	 	
Batch06	MyabA.00151.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MF45				Phosphopantetheine attachment site domain protein	Potential drug target		MTAPALDDWLAGKIAGYLSITADQVDRDRSLADYGLDSVYALTLCGEIEDEFGLTVEPTLAWDYPTVDAMSGHLDSLLRAKA		82		0	Target Approved	-1	 	
Batch06	MyabA.00155.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MEY1				Probable DNA helicase II homolog UvrD2	Potential drug target		MARSLLDGLDDEQRAAVTAPRGPVCVLAGAGTGKTRTITHRIAYLVASGHVAAGQILAVTFTQRAAGEMRGRLRDLGVGSAQAVTFHAAGLRQLRYFWPQLVGDTRWELIDSKFTLVAQAANRAKVSTTTDTVRDLAGEIEWAKASLISPETYPAAAAKFGRDAPVPAEQVAKVYAGYEKLKARPDGSTLLDFDDLLLHTAAAIENSAAVAEEFRDRYRCFVVDEYQDVTPLQQRVLDAWLGPRDDVTVVGDANQTIYSFTGATPQYLLGFSRRFPDATVVRLERDYRSTPQVVSLANRLISAAQGRVAGSKLQLIGQRPQGPAPRFSEHDDEAAEAKSVAKSIAALIESGTPASEVAVLYRINAQSEVYEEALTEAGIPFQVRGGEGFFTRQEVRQALVALQRAAGREDAGMPVPEQVREILEPLGLSQEEPHGTQARERWESLRALVELADEECARQPELDLPGLVRELRVRAEARHPPTVQGVTLASLHAAKGLEWDAVFLVGLADGTLPISHALSRAGDIEPVEEERRLLYVGITRARVHLNLSWALSRAAGGRKSRKHSRFLNGIAPTAQLPASATPRRRGGGARCRVCNAALSTPAAVLLRRCESCPSDIDEELLVALKDWRLKTAKEMKVPAFVVFTDNTLIAIAELLPGDDAALVAIPGIGARKLEQYGPDVLRLVRARSS		689		0	Target Approved	-1	 	
Batch06	MyabA.00163.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MAZ4				Phenylalanyl-tRNA synthetase alpha chain PheS	Potential drug target		MADHTQHPSAESSAELLTTAVDAARAAFDTADNLDGLAQAKIDHLGEKSPLAQARQALGSLPKDQRAEAGKLVNAARTQAQQAYDDRLETLRAERDAAVLVAERIDVTLPSTRQPLGARHPITILSENIADTFIAMGWEVADGPEVETEHFNFDALNFLPDHPARSTQDTFYIAPEDSRQVLRTHTSPVQVRTLLARELPVYVISLGRAFRTDEIDATHLPAFHQVEGLAVDRGLTLANLKGTLDAFARAMFGAQAHTRMRPHYFPFTEPSAEVDVWFENKKGGAGWVEWGGCGMVNPNVLRASGIDPGEYSGFAFGMGLERTLQFRNGLPDMRDMIEGDVRFSLPFGVSA		351		0	Target Approved	-1	 	
Batch06	MyabA.00168.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MGY3				2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase	Potential drug target		MRLGANTPKAFVSVGGRTMLQRCVDGLLASGAVDEVVVVVGADQLERAAALVGSGATVVQGGAERTDSVRAGLAAVDAADWILVHDAARPLTPPDMIARIVAELRTGRGAVIPAVAVADTIKSIDVHGDVIGTPDRAGLRAVQTPQGFAADVLRRAYAAAGDIATDDAALVEQIGERVHVVEGDRLAFKITTTLDMTLAEAILGATEGVQ		210		0	Target Approved	-1	 	
Batch06	MyabA.00184.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MHP2				"2,3-bisphosphoglycerate-dependent phosphoglycerate mutase"	Potential drug target		MSGETSSKTNGATLILLRHGESQWNAKNLFTGWVDVDLTEKGRSEAQRGGELLAQQGLLPDILFTSLLRRAINTAHLALDTADRLWIPVVRDWRLNERHYGALQGLDKAETKAKYGEEQFMAWRRSYDTPPPPIERGSHYSQDQDPRYADIDGGPLTECLADVVARFVPYYEEAIVPELRAGKTVLVAAHGNSLRALVKYLDGISDEEIVGLNIPTGIPLRYDLDENLKPVTPGGVYLDPEAAAAGAAAVANQGAK		256		-2	Work stopped	-2	Work stopped	
Batch06	MyabA.00185.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MD79				Putative acyl-CoA dehydrogenase	Potential drug target		MSASEDHQTRMSASEDNQTRMSASEDNQAQINEFEFTEEHGDLRSLVRSWCERVWTPKHVRQIAEAGSVDLDAWRALGSELGVVGLSLPEQHGGGGLGVIELSIVAEELGRALACLPWISSAALGATALVSSGDDSALAEWVPALAAGEKTITLAGGRTRLADAITVSAESDTDGWKLTGDTEHVPDGATADVILVLADTDSGPSLFAVDGDAPGVDRHSLATLDMTRRQANIHFNSAPARLIGAQGRGAEAVATALDVAATVLAAEQAGIAAHMLDVTTEYAKSRIQFGRIIGSFQAVKHRLADMAAATGNVRGAAYHAAWSHDHPSLDDPALATSIAQQVASAGAVEVTAKAIQSHGGIGFTWEHPAHLYYKRAVSNSALFGGRAVHAERIAKEVIDA		400		0	Target Approved	-1	 	
Batch06	MyabA.00185.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MF86				Probable acyl-CoA dehydrogenase FadE	Potential drug target		MAGNPSFDLFKLGEEHDELRAAIRGLAEKEIAPHAKDVDEKARFPQEALDALVASGFNAVHVPEEYDGQGADSVAACIVIEEVARVCASSSLIPAVNKLGTMGLILNGSDELKKQVLPAIASGEAMASYALSEREAGSDAASMRTRAKADGDDWIINGSKCWITNGGKSSWYTVMAVTDPEKKANGISAFMVHKDDEGFTVGPLEHKLGIKGSPTAELYFENCRIPGDRIIGEPGTGFKTALQTLDHTRPTIGAQALGIAQGALDQAIAYTKDRKQFGKSISDFQGVQFMLADMAMKVEAARLMVYTAAARAERGEKNLGFISSASKCFASDVAMEVTTDAVQLFGGAGYTTDFPVERMMRDAKITQIYEGTNQIQRVVMSRALLTS		387		0	Target Approved	-1	 	
Batch06	MyabA.00185.c	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MK00				Probable acyl-CoA dehydrogenase FadE	Potential drug target		MTHMGHYKSNVRDLEFNLFELFKIQQVFGGEEFPELDEDTARTFLAEMRTLAEGPLADSFAEGDRNPPVFDPETHSVAIPEAFKKSVKAITEAGWDRVGLQEELGGTPVPRSLSWAIQEMILGANPAVWMYSGGAGFAQIFYNIATDEQKKWAEFVAERGWGATMVLTEPDAGSDVGAGRTKAVKQDDGSWHIDGVKRFITSADSDDMFENIMHLVLARPEGAGPGTKGLSLFFVPKFIPNFETGEPGERNGVFVTNVEHKMGLKVSATCELSFGQHGVPAKGWLVGEVHNGIAQMFDVIEQARMMVGTKAIATLSTGYLNALEYAKTRVQGADMTQLTDKTAPRVTITHHPDVRRSLMTQKVYAEGLRALYLYATTFQDAVAAKTINGVEAEDAVKLNDLLLPVIKGVGSERAYEKLTESLQTFGGSGFLQDYPIEQYIRDAKIDSLYEGTTAIQAQDFFFRKIVKDQGKSLAFISGQIEEFVKSETGNGRLKAERALLATALEDVQGMAASMTGNLMAAQQEITQVYRVGTASVRFLMSVGDLLIGWLLQRQAAVAIEALDAGATGADKSFYEGKIAAASFFAKNMLPLLTSTRAVLENVDNDIMELDEAAF		614		0	Target Approved	-1	 	
Batch06	MyabA.00200.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MC18				Putative kinase ArgK	Potential drug target		MSAPDNLAALIRSGDRSGLARAITLVESTRQDHRSQAQQLLLELSPEGGNALRVGITGVPGVGKSTTIEALGMYLIEQGHRVAVLAVDPSSTRTGGSILGDKTRMGRLSVHPDAYIRPSPTSGTLGGVAKATRETVVLLEAAGFDVILIETVGVGQSEVAVANMVDTFVFLTLARTGDQLQGIKKGVLELADIVVVNKADGEHAIEAKKAARELSGALRLIYPHDTLWRPPVLTMSALENNGVSEMWDTVLQHRAVLTEAGEFEAKRRRQQVDWMWAMVRDAVLDRVLNAPDVKASRADIEQQVREGTLTPALAAEQLLNLSS		323		-2	Work stopped	-2	Work stopped	
Batch06	MyabA.00213.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MDV7				Putative enoyl-CoA hydratase/isomerase	Potential drug target		MADSLHASGSSVSDSLRASGSSVSDSLHASGSSADGWKAFTVETTGHIAQVTLIGPGKGNAMGPDFWRELPLIFTELDADPEVRAVVLAAAGRHFSYGLDLPAMAGTFMPLMAEKALAKPRTDFLDEIRRLQASVTAVADCRKPVIAAIQGWCIGGGVDLIAAADIRYASSEAKFSVREAKVAIVADIGSLHRLPPIIGDGHLRELAFTGKDIDAARAEKIGLVNDVFDTPEATLAAAHATAAEIAANPPLVVQGVKDVLGRERENVVADGLKYVSTWNAAFLPSEDLQEAIGAVFEKREPDFKGR		306		0	Target Approved	-1	 	
Batch06	MyabA.00236.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MC55				"Probable conserved ABC transporter, ATP-binding protein"	Potential drug target		MTTLEIKDLHVSISPKEGESIEILKGVNLTVNSGETHAVMGPNGSGKSTLSYAIAGHPKYEVTSGSITLDGQDVLELSVDERARAGLFLAMQYPVEVPGVSMSNFLRTAATAVRGEAPKLRHWVKEVKEAMGELEIDSTFAERSVNEGFSGGEKKRHEILQLGLLKPKIAVLDETDSGLDVDALRIVSEGVNRYAEREHGGILLITHYTRILRYIQPQFVHVFVGGRIVESGGPELADELEENGYVRFTQAVGA		254		0	Target Approved	-1	 	
Batch06	MyabA.00247.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MCZ7				Probable acyl-CoA dehydrogenase	Potential drug target		MAGAVKFKRTIFEPEHELFRESFKTFLDRHAEPYKEEWEKNKIVDRALWVEAGKQGFLGTDMPEEFGGGGLIDFRYNTIITEEVTKGRHTGVGFSLHNDVAGPYFRDLANDEQKARWFPGFCSGELISAIAMTEPGTGSDLQGIKTRAVKDGDHYILNGAKTFITNGINADLVIVVAQTDPEKGALGFSLIVVERGMEGFERGRKLDKVGLDAQDTAELSFTDVRVPAANLLGEEGQGFIYLMKNLPQERMSIAVMAAAAMESVLEETIAYTTERKAFGKPIKSFQNSRFLLAELATDATVIRVMVDEFISLLNKEELSVEQAAMAKWYSTEKQVHLIDRCLQLHGGYGFMREYPVARAYMDSRIQTIYGGTTEIMKEIIGRSL		384		0	Target Approved	-1	 	
Batch06	MyabA.00247.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MEA1				Probable acyl-CoA dehydrogenase (FadE)	Potential drug target		MQRTIYTEDHEAFRESVKAFVQRHVDPRAETFIEQRYIDRELWEEAGKQGYLGLDVPEEFGGSSAGDYRYNAVLQEELARSSAALASSMSIHFDIVAPYLVELTTDEQKQRWLPKFCSGEMITAIGMTEPSGGSDLAALKTTAVKDGDDWVINGSKTFITNGARADLVVVAARTAPELKAKGITLFAVEEGMPGFERGRKLDKVGQPEADTAELFFTDVRVPAENVIGEVNQGFISMMQRLPQERMGCAVANIAHAVAVLEETVEYAKERKAFGQQIGSLQYNKFLIAELVTKLEAAQVYVDQAVLAHSKGELTAIDAAKAKWWSSQVQNEVIDACVQLHGGYGYMKEYRVARAWMDARVTKIWAGSNEIMKELIGRDLGF		381		0	Target Approved	-1	 	
Batch06	MyabA.00247.c	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MJK7				Probable acyl-CoA dehydrogenase FadE	Potential drug target		MTAVNSWNTPERKALRETVRDFAEREILPNVNEWEREGLLPRELHRKAGDLGLLGPGSPEAVGGGGGDAIDPVIVCEELHYAGVPGGVFASLFTCGISTPHMIASGDQRLIDNYVKPTLAGELIGSLAITEPGGGSDVGHLTTSAKRDGDHYIVNGAKTFITSGVRADYVVTAVRTGGPGAAGVSLLLIDKDTPGFEVARKLDKMGWRSSDTAELSFTDVRVPAENLVGSENTGFAQIAGAFVSERIGLAAQAYASAQRCLDLTVEWCRNRETFGRPLISRQSVQNTLAEMARRIDVARVYTHALVDRAIAGESNLIAEVCFAKNTAVEAGEWVANQGVQLFGGMGYMAESEIERQYRDMRIIGIGGGTTEILTSLAAKLLGFQS		385		0	Target Approved	-1	 	
Batch06	MyabA.00247.d	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MNN3				Probable acyl-CoA dehydrogenase FadE	Potential drug target		MTFSSEHDDFRRTIRRYIEEKINPRVDEWEREQMMPLHEVIADMAKLGFVGLEYDPEYGGQGADHLFTLVLAEELGRVDHGSFPMAFGVHVAMATPSLHKHGSDELKREFLAPALRGEQIAAIAVTEPDAGSDVAGIKTHARRDGDDWVINGSKMFITNSVQADWLCVLARTSDEGGYAGMSQIIVPTKAPGYEVRKLDKLGMHASDTGLITFDDVRVPVSNTIGEIGRGFQQQMSQFVMERMFGAYGIPASVNRALQRTKEYALARHVFGKPLTKNQHLAYQYAGLAARADMLEVYNRDIAERYMAGENVTRKVTIAKLTAGPLVREAGDWCLQVHGGMGYMTETWTSRFFRDQRLLSIGGGADEVMMRVLSQIDGFS		379		0	Target Approved	-1	 	
Batch06	MyabA.00247.e	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MNP5				Probable acyl-CoA dehydrogenase FadE	Potential drug target		MSELFPAYRASWETDAHRDLRKHAAEFLRKESTPNQERWSAQHQVDREFWNKMGDAGLLGLDLPEEYGGAGGDFGFSAVVGEELALAQDTSTGWAVHSPIVAHYINTYGNEEQRARWMPGIISGDLVLAIAMTEPGTGSDLQAVRTTAIPDGDHYVINGSKTFISNGTHCDLLVIVAKTDPSQGAAGVSLIVAETKDLPGFERGRVLEKVGQHGQDTRELFFTDMRVPIANRLGDKDGLGFYQLMEQLARERLIIAAVCSGMAEGALIEAIKYTKEREAFGKPLIKFQNTKFQLAELKAEVLSIKTTVDYCVQDYINGNNDPATASMAKLIAADKAVSVVDRCVQFFGGYGYMMEYPIARAYAAARVNKIYGGTSEIMKEIISRSL		386		0	Target Approved	-1	 	
Batch06	MyabA.00247.f	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MPB1				Probable acyl CoA dehydrogenase	Potential drug target		MSSPISPWMNAELLELRDLAAKFFSAELAPHANRFADQHHVDRELWNRAGELGLLCMSIPEEYGGGGGTFAHEAVVLEEQARIGDSSWGAGLHSGIVAHYILQYATEELRAQWLPKMASGEMIGAIAMTEPGTGSDLQSVKTKALLDGDEYVITGSKTFITNGQQADLIIVVAKTDPSQGAAGISLIVVEADRAGFRRGKVLDKIGQRGQDTSELFFDEVRVPRSHLLGQAEGQGFIQLMTQLPQERLIVAVGAVAAMELALEQTLKYTREREAFGRPVFGFQNTKFTLAEAATETRIARVFLDYCIDLHLAGQLDVQTVAMAKWWTTERAMKVLDDCMQLHGGYGYMTEYPISRLWVDQRVQKIYAGTNEVMKEIISRSL		381		0	Target Approved	-1	 	
Batch06	MyabA.00247.g	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MPB5				Probable acyl CoA dehydrogenase	Potential drug target		MTDAGTTTASEDGAARFVVAPEAWTTPERRALSQMARSFVEREIAPKLAEWEHVGEIPRDLHLNAAEVGLLGIGFPEEVGGSGGNAIDSALVTEAILAAGGSTGVCAALFTHGIALPHIAANGSDALIERYVRPTLAGKMIGSLGVTEPGAGSDVANLRTRAVREGDTYVVNGAKTFITSGVRADFVTTAVRTGGPGYGGVSLLVIDKNSPGFEVSRRLDKMGWRCSDTAELSFVDVRVPADNLVGAENSGFLQIMQQFQAERLGIAVQAYATAGRALDLAKSWARERETFGRPLTGRQIIRHKLAEMARQVDVACTYTRAVMQRWLAGEDVVAEVSMAKNTAVYACDYVVNEAVQIFGGMGYMRESEIERHYRDCRILGIGGGTNEIMNEVIAKRIGL		399		0	Target Approved	-1	 	
Batch06	MyabA.00249.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MD47				Thymidylate synthase	Potential drug target		MSLPTPYEDLLRLVLEEGTPKADRTGTGTRSVFGHQLRYRLEDGFPLITTKKVHLKSVIYELLWFLRGESNVRWLQERGVTIWDEWASEAGELGPVYGVQWRAWPTPSGEHIDQISAALDLLRTNPDSRRNIVSAWNVGEIPQMALPPCHAFFQFYVADGKLSCQLYQRSADLFLGVPFNIASYALLTHMMAAQAGLGVGDFVWTGGDCHIYDNHVEQVTEQLSRDPYPYPTLVLAQRDSIFDYRYEDITVENYQHHAAIKAPVAV		266		0	Target Approved	-1	 	
Batch06	MyabA.00250.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MBG7				Putative oxidoreductase	Potential drug target		MPENCAQAQFASLMCQLDQPVYVVTVRGADGPAGCLVGFAGQVSIDPPLFLAGLSEKNHTWRASQQASHLAVHIIPRAEDELVHLFGELTGDSVDKFARCTWRDGPHGVPILEQSAAWFVGEILARITLGDHIGHVLLPVAVSRSRELGQYVSLSDVHGLTPGHEA		166		0	Target Approved	-1	 	
Batch06	MyabA.00250.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MAU2				Putative flavin-dependent reductase	Potential drug target		MPTSLDEYRRLRDTRVGVDRTRTLSFYRTLSSTVSIVSAMSEELGPLGLTVSAVSAVSAEPPLLSVCLAHESQTLRAAAESGRFAVHVLQAHQRGLATEFATSNTPRFRAHGFAHTYGAPVLTEAETWTVCEVVDTCGYGDRTLLIGHVIHTHEGTKGAPLVWHDSSFLPVTEHQERD		178		0	Target Approved	-1	 	
Batch06	MyabA.00250.c	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MH00				Possible oxidoreductase	Potential drug target		MSTPEIDPRTFRNVLGQFCTGITIITTTHEDVPVGFACQSFAALSLEPPLVLFCPTKQSRSWAAIAASGKFCVNVLAEDQREVSARFGSREPDKFAGINWRPSGLGSPIINGSLAHIDCEVANVHDGGDHWVVFGSVKELSERAVIPSAESAARPLLFYRGQYTGIEPDKNTPADWRNDLEAFLTATTEDTWL		193		0	Target Approved	-1	 	
Batch06	MyabA.00250.d	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MJZ3				Putative oxidoreductase	Potential drug target		MTSDTTLDAATLREAFGHFPTGVVAIAAEIDGTRTGLAASTFVPVSLDPPLVAFCVQNSSTTWPNLRGAPRLGISVLGESHDEAARTLAAKTGDRFAGLDTSTTETGAVFIGGTTAWIETSVESEVPAGDHAIVILNIHGLTVHSSVAPIVFHRSKFRKLLG		162		0	Target Approved	-1	 	
Batch06	MyabA.00272.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MBZ6				8-amino-7-oxononanoate synthase (BioF)	Potential drug target		MPVVEASSPLAWLGEVERQREAAGLRRRLRTRSAAEPEIDLASNDYLGLSRHPQVIEAGVEALRIWGAGSTGSRLVTGNTELHEELEQELATFMGTESALVFSSGYTANLGAVVALSGPGTLIVSDARTHASLIDACRLSRARVVVTPYRDTQAVAAALAQRPEERALVLTDAVFSADGALAPLAELYGVCRRHGAVLLVDEAHGLGVRGSGGRGLVAEMNLAGRDDLVVTVTLSKALGSQGGAVLGSAAVRAHLIDAARPFIFDTGLAPAAVGSALAALRLMIDEPARIRAVLAHAAALGQWCGVPDKPESAVVPVVLGDPTVAFNAARSCLEQGVRVGCFRPPSVPEGQSLLRLTARASLTEADMERVHEVLAGVLTLARR		383		0	Target Approved	-1	 	
Batch06	MyabA.00277.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MI98				Possible esterase LipW	Potential drug target		MSSPDIHPDLRLAARAFPRQVGLPRTLSILRASIYLTDLLPRHGVRRIAVNDNVTVRAHVPKNLEEPSAALLWIHGGGYVMGTARQDDFFCRKVMHETGIPVVSVDYRLAPEHPYPIPLEDCYAALRWLSVQGWIDPTRIAVGGASAGGGLAAALALLARDRGEVAPAAQLLIYPMLDDRSSERTDIDGTNLRLWSGDSNRFGWDSYLGDADRDIAVPGRRTDVAGLAPAWIGIGTADLFHDEDLAYAERLRTAGVPCELEVVPGAFHGFDKLVPWAGVSRDFVAKACRSLLGALS		296		0	Target Approved	-1	 	
Batch06	MyabA.00289.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MHS0				Deoxyribose-phosphate aldolase (DeoC)	Potential drug target		MAALIDHTLLKPEATPEDVRALVAEAVDLGVLAVCVSPSMLPVLLPEGVERLLVAGVVGFPSGKHLSSVKAHEAALAVAAGAHEIDMVIDVGAAVGGDFGAVQGDIEAVRRAVPAATLKVIIESAALLERSGPEAVRAACRASEAAGADFVKTSTGFHPAGGATVEAVRIMAETVGDRLQVKASGGIRTARDAAAMLEAGATRLGLSGSRIVLDGFAD		218		0	Target Approved	-1	 	
Batch06	MyabA.00295.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MJB9				"Probable alcohol dehydrogenase, zinc-containing"	Potential drug target		MRIRSAVLHAAPIERPYRDTHPLKVIELELDPPGPGEVLVRIEAAGLCHSDLSVVDGNRIRPVPMALGHEAAGVIAAVGPGVRDVSPGDHVVLVYVPSCGACRYCSSGRPALCPDAAAANGRGDLIRGGTRLHDLDGTEVRHHLGVSGFADHAVVDRNSVVVIDENVPLDTAALFGCAMLTGFGAVTHTASVRPGDSVAVLGLGGVGLAVVMSAAAAGAGEVLAIDPVPAKRELALELGATSACAPDEAPGGHDWVFEVVGSAAVLEQAYALTGRGGGTVSVGLPHPDARISLPALNIVAEGRSILGSYMGSAQPQQDIPAMLALWRAGRLPVEKLKSDDLPLSDINIALDALAEGQAVRQILRPGVSA		369		0	Target Approved	-1	 	
Batch06	MyabA.00304.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MC54				Cysteine desulfurase	Potential drug target		MTATVPLDITAIRNDFPILSRTVRGGKPLAYLDSGATSQRPVQVLDAERRFLTERNAAVHRGAHQLAEEATDAYEGARNAIARFVGVDDGEIVFTKNATESLNLVAYTLGDNRFDRAVGPGDEIVVTELEHHANLVPWQELCRRTGATLRWFGVTDDGRIDVDSLELTEAVKVVAFTHQSNVTGAVAPVAELVRRAKAVGALVVLDACQSVPHMSVNFRELGVDYAAFSGHKMLGPSGVGVLYGRRALLEAMPPFITGGSMIETVTMEVSTYAPPPQRFEAGVPMTSQVVGLGAAVDYLNAVGMEAVAAHEHQLVSAALAGLAGIEGVRIIGPTDNLDRGGAVSFVVDGIHAHDLGQVLDDEGVAVRVGHHCAWPLHRRFGIAASARASFAVYNTLDEVDRLTAGVRRAQEFFS		414		0	Target Approved	-1	 	
Batch06	MyabA.00305.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MC45				Probable enoyl-CoA hydratase/isomerase	Potential drug target		MSFVLVDRPRPEIALVTLNRPERMNAMAFDVMLPFKQMLVDISHDNDVRAVVITGAGKGFCSGADQKSAGPIPHIGGLTQPTIALRSMELLDEVILTLRRMHQPVIAAINGAAIGGGLCLALACDVRVASQDAYFRAAGINNGLTASELGLSYLLPRAIGTSRASDIMLTGRDVDADEAERIGLVSRKVASESLLEECYAIGERIAGFSRPGIELTKRTIWSGLDAASLESHMHQEGLGQLYVRLLTDNFEEATAARKEKRPAEFRDKR		269		0	Target Approved	-1	 	
Batch06	MyabA.00305.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MIA6				Putative enoyl-CoA hydratase/isomerase	Potential drug target		MIRVEPREHGILVVTIDRPERRNALDPQTVAELHAVIESIDGDPKVRVVVLTAVGASFCAGADLKSLPSDFTSAGVTSTAALLAATDSELVRTLAAQELMASLFERIHRMRQPVIAAVNGHAIGGGFALALACDIRFASPAASFGAVFIRHGVSNCDMGTSYHLPRLVGAARAAELMLTGRVFDAQEAYRMGLVFDVVPAEELLDAALSKAREIAVHSPLAVWMTKETMWQTVDAPSLRHALDLENRTQVMCTATGELRRSFDAFREGRG		270		0	Target Approved	-1	 	
Batch06	MyabA.00305.c	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MJ43				Putative enoyl-CoA hydratase/isomerase	Potential drug target		MTQTAPAAVAYSVNHAGVAAIVLDRPEASNALDRTMKTELLQALLAAGGDPAVRAVVMSAAGKNFCVGQDLAEHVEALRDDPAHAMDTVREHYNPVLEALDAIKVPVVVAINGACVGAGLGLALGADIRIAGQRAKFGTAFTGIGLAADSALSASLPRLIGASRATAMFLLGDTIDAPTAHTWGLVHEVVDEGSPADVANSVAGRLAGGPTAAFSEVKELLRRNAVAPLGDVLEREASAQQRLGASRDHSAAVEAFLAKDKPVFVGR		267		0	Target Approved	-1	 	
Batch06	MyabA.00305.d	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MKZ4				Probable enoyl-CoA hydratase/isomerase	Potential drug target		MSLDESVGAPDVAVDGGIMRVTFTRPDRMNALNGPATSGLIEALESIPGRDDVRVVVISGGAPGSAFSAGADVTELAAGSADLTPLQAAELTMDNAERLVRAVLNCPVPTIAEVTGVAAGIGASVGLACDLIYAADTAFFLLAFANIGLMPDGGSSALVSASIGRVKANAMALLAQPLSATDAFAAGLVNEALPGDQLRERVDKTARRLAHGSRRAMQLTKEAMNAVSLKLFDEAIARERDGQIELLISPDAHEGFAAFLEGRRPNFS		268		0	Target Approved	-1	 	
Batch06	MyabA.00309.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MFF5				Putative acyl-CoA dehydrogenase	Potential drug target		MDFAPSARAAELIAAVREFIDAEVMPVERAVLAHHDELLGARAGTTAELWHVPPELDSLKAKARAAGLWNLFLPDPELGGGLSNSEYAPLAEQMGRSLFAPTVFNCNAPDSGNMEVLHRYGSQEQKEVWLEPLLEGDIRSAFCMTEPDVASSDATNMAATAVVEGDEVVINGRKWWSTGVGHPDCKVIIFMGLTDPNAHRYARHSMVLVPMDTPGITVERMLPTMGFYDEPGGHGVVSFDNVRLPADAFIAGPGKGFEIAQGRLGPGRVHHAMRLIGLAEVALEHACRRGLDRTAFGKPLVNLGGNRERIADARIAINQTRLLVLHAAWLLDTVGIMGALSAVSEIKVAAPNMAQQVIDMAIQIHGGGGLSNDFPLAAAWVNARALRLADGPDEVHRGVVARIELAKYAND		411		0	Target Approved	-1	 	
Batch06	MyabA.00309.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MFM7				Putative acyl-CoA dehydrogenase	Potential drug target		MIDFSIPEELAAKAQRVREFVTETVIPYERDPRLTAHGPTEELRDELVGKARAAGLLTVQAPESYGGWGLSHIGQAVIFEAAGWSTLGPIAMNCAAPDEGNMFLLGKITNEEQSEKFLRPVIEGYQRSAFAMTEPDGAGSDPSQLKTSATFDGQNFVINGRKWLITGARGAKTWIIMANLEANDHLPEGPTLFLCDGETEGIVIERIMNTMDRNYAEGHAVVRFDNLTLPREALLGETGQAFRYAQLRLAPARLTHCMRWLGAASRAQDIAVDYARTRTSFGKTIGEHQGVSFMLADNEIALHQCRLTIWHACWMMDNGAKGRHESSMAKSFVSEELFKVTDRCVQVLGGIGISDETPVEMIFRDMRAFRLYDGPTEVHKYAIGRQVLRTPRA		393		0	Target Approved	-1	 	
Batch06	MyabA.00309.c	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MMJ4				Probable acyl-CoA dehydrogenase FadE	Potential drug target		MTAMAWDFETDPEYQELLDWADEFVRTEVEPLDYVFPNPYDKSDTVAMDYVRPLKEEVKRRGLWACHLGPELGGPGYGQLKLALLNEILGRSVWAPSIFGCQAPDTGNAEILAHYGTEAQKAKYLQPLMDGDIGSCYVMTEPQGGSDPTLFKTTAVRDGDEWILNGEKWFNSEARHAAFWIVMAVTNTEVSPYQGMSMFIVDPNAPGVEIVRNITVHGFSEDEAYTRFTNARIPAENMLGAEGGAFAIAQTRLGGGRVHHAMRTVAQVRKAFDMMCERVVSREARGGTIAKLQMTQERIADSWIEMESFRLLVLRTAWLIDKHQDYLKVRKDISAIKAAMPKVMHDVAQRALHLHGSLGVSEEMPLAKMFLYSEVMGLVDGPTEVHKVTIAKEVLKDYTPYEGLFPPSHIPALTEKARAHVAARLEHRVGNL		432		0	Target Approved	-1	 	
Batch06	MyabA.00317.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MC85				Triosephosphate isomerase	Potential drug target		MSRKPLIAGNWKMNLNHFEAIALVQKIAFSLPDKYFDKVDVTVIPPFTDIRSVQTLVDGDKLRLTYGAQDLSVYDSGAYTGEVSGAFLAKLGVTYVVVGHSERRQYHGEDDALVAAKAAAALKHGLTPIVCIGEALDIREAGDHVQYNVNSLRGSLAGLSAEQVGKVVIAYEPVWAIGTGRVASAADAQEVCAAIRAELAQIANADVAGSVRVLYGGSANAKNVGEIVAQEDVDGALVGGASLDGEQFAQMSAIAAGGPLL		261		-2	Work stopped	-2	Work stopped	
Batch06	MyabA.00328.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MH85				50S ribosomal protein L1	Potential drug target		MSKNSKAYREAAEKVDREKLYTPLEATKLAKETSSKKYDATVEVAMRLGVDPRKADQMVRGTVNLPHGTGKTARVIVFAVGDKAEAAAAAGADVVGSDDLIERIQGGWVDFDAAIATPDQMAKVGRIARVLGPRGLMPNPKTGTVTPDVAKAVTDIKGGKINFRVDKHSNLHLIIGKASFDAEKLTENYGAVLDEILRAKPSSAKGRYLKKVVVSTTTGPGIQVDPGVTRNFLEA		235		-2	Work stopped	-2	Work stopped	
Batch06	MyabA.00337.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MD27				Putative short-chain dehydrogenase/reductase	Potential drug target		MPRTPYDVDIPDLSGQRAVVTGASDGIGLEIAMKLAGAGADVFMPVRNLRKGQAAVSRIRALHPRAHLTLAELDLSSLVSIADLGEKLCAEGTPIHLLINNAGVMTPPERQTTADGFELQFGTNHLGHFALTGHLLPLLRAGRARVTSHTSIAARSGEINWDDLNWERGYDGMRAYRQSKIACGLFGLELSRLSNTAGWGITSNIAHPGVAPTSLLAARPEVGRTKDTTEVRMIRWLSARGLIVGTVASATLPALMAAVAPEATDGGFYGPRWPGSAGGPPGPQKLWKPLHSIRNASRLWQASQELTGVTFT		312		0	Target Approved	-1	 	
Batch06	MyabA.00340.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MKI3				Probable enoyl-CoA hydratase	Potential drug target		MTDQIETRVEKGVGLLTLNRPKAINSLTYDMIAAMNAVLAEWEADDAVRVVVLSGAGERGLCAGGDVVAVHDSAKIDGVAARRFFRDEYVLNAQIARFPKPYVALMDGIVMGGGVGVGGHANIRIVTDTSKVAMPEVGIGFIPDVGGTYLLSRAPGQLGLHAALTGAPFSGADAIALGFADHYVPHDRLEKFTKAIIDSDIATALAVHGTNAPSSDLLAQRNWIDECYGGESVADIVAALQARGDERARAAADQILTRSPIALSVTLAAVRRARELPSLEAVLTQEYRVSSQSVRSHDLVEGIRAQLVDKDRNPQWVPKTLAEVTKADVEEFFQPVSDDLEWP		343		0	Target Approved	-1	 	
Batch06	MyabA.00358.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MFL5				Probable enoyl-CoA hydratase	Potential drug target		MNAGIPELTGLRCALDDRVLTVLFDHGQLNLLDGPLMSSLSRLARWLSGSDDVTVVLFGSANPDFFIAHLNVEILQSATARTAESVASFQRLVGRFRALRQATIALVEGRVAGGGSEFLLNLDMRFAVRGKALFNQVETGLGIVPAGSGPQHLVQGMGRARALEVILGHEDFGADLAERYGWVNRALNPDEGWRFVNRLARRIAANPLDLIAGVKNTVDALASDLEPGLAAERAAIVAAFADEHSARRIAHFLQRGGQTVEGERRLGDLVSEP		273		-2	Work stopped	-2	Work stopped	
Batch06	MyabA.00358.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MDY9				Probable enoyl-CoA hydratase/isomerase	Potential drug target		MIEPEFVSVRTAPEHPGIGTIALSRPPTNTFTRQMYRELAQAAAEVNARADIRVVIVYGGHEIFCAGDDLAELSELSADEMARSAGDRQAALTAVAELAKPTIAAITGYALGSGLELALTADWRIAGDNVKVGSPEILVGMIPGGGGTVRLARVVGLSRAKEMVFSGRFVGADEARGAGLIDQVVAPDDVYTEAASWARRFVDGPPLALAAAKEAIDHGFDGPLAAGLDKERELFCQVFATQDRADGVTAQLEIGPGTARFRGA		264		0	Target Approved	-1	 	
Batch06	MyabA.00358.c	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MEE0				Probable enoyl-CoA hydratase/isomerase	Potential drug target		MTELHEEIRDGVAVLTLHGPSTRNSFTVELGRQLGAAYQRLDDDPAVRVIVLTGAPPAFCSGAQISAAAETFAAPRNPDFSASPVQPAAFELRTPVIAAVNGHAIGIGMTLALHADIRILAEEGRYAIPQVRFGVAPDALAHWTLPRLVGTAVAAELLLTGASFSAQRAVETGLANRCLPAGKVLGAALRMAHDIATNVAPESAALTKRLLWDAQMTGMSAAEVAARETADHLRLMGSQDAAEGPRAFIDGRPPRWAGQR		260		0	Target Approved	-1	 	
Batch06	MyabA.00358.d	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MJ41				Putative enoyl-CoA hydratase/isomerase	Potential drug target		MTEYQTLCVTTEDDRVIVELHRPEQRNAINAAMVADLHAVCATIEAQPRVLIVTGAGRDFAAGADIAELRVRGRNEALAGINRTVFDRIAALPLPTIAAVEGNALGGGAELAYACDIRIAGAGARFGNPEPGLGILAAAGASYRLADLVGKSVAKQVILGGRVLDAEAALACGLVAEVVAEHSALGAASALTERITRQSPLALRLSKAVLDADSAHPLIDDLAQAVLFESPDKTDRMTRFLERQTR		246		0	Target Approved	-1	 	
Batch06	MyabA.00358.e	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MKI1				Probable enoyl-CoA hydratase	Potential drug target		MTSHNFETILTERIDRVAVITLNRPKALNALNSQVMNEVTTAAAEFDADHGIGAIIITGSEKAFAAGADIKEMSEQSFSDMFGSDFFSAWGKLGAVRTPTIAAVSGYALGGGCELAMMCDVIIAAENATFGQPEIKLGVLPGMGGSQRLTRAIGKAKAMDMILTGRNMDAAEAERSGLVSRVVATESLLDEAKAVAKTISEMSLSASMMAKEAVNRAFESSLAEGLLFERRIFHSAFGTADQSEGMAAFVEKRPANFIHR		260		-2	Work stopped	-2	Work stopped	
Batch06	MyabA.00384.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MCE6				Putative cytoplasmic peptidase PepQ	Potential drug target		MLRAEDLDALLVTDLINIRYLTGFTGSAAALWVAAGDGPEEKATVLCTDGRYRTQAAAQVPDLRALIDRRYGAALVAHAPAGRAGFESHVVTVDGFDKLAEAATDVELVRAPNRIEKLREVKDDSEVLLLERACAAADTALAALIETGGIRPGRTEREVARDLENLMAEHGADGPSFETIVAAGPNSAIPHHRPTGAMLAAGDFVKIDFGALVAGYHSDMTRTLVLGSAAPWQQEIHELVLTAQAAGRAALAPGASLKNVDAAARDVITAAGYGENFGHGLGHGVGLQIHEAPGIGSTATGTLLAGSAVTVEPGVYLPDRGGVRIEDTLVVRPDGPELLTRFPKELIVID		350		0	Target Approved	-1	 	
Batch06	MyabA.00386.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MGI6				Probable enoyl-coa hydratase/isomerase	Potential drug target		MSEEMQPAVRVEKAGPVTTVILNRPHARNAVDGPTAAALLAAFTEFDADPEASVAVLWGDNGTFCAGADLKAMGTDRGNELHPHGPGPMGPSRLRLSKPVIAAISGHAVAGGIELALWCDLRVVEEDAVLGVFCRRWGVPLIDGGTIRLPRLIGHSRAMDLILTGRPVHANEALDIGLVNRVVARGQAREAAETLAAEIAAFPQQCVRADRDSAIAQWGMAEEAALDNEFGSIERVATEALEGAGRFAAGEGRHGAGV		258		0	Target Approved	-1	 	
Batch06	MyabA.00386.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MGI8				Possible enoyl-CoA hydratase/isomerase	Potential drug target		MVDTLKTMTYEVTDRVARITFNRPEQGNAIIADTPLELAALVERADLDPQVHVILVSGRGDGFCGGFDLSAYAEANDEGSVRYSGTALDGQVQLRNHLPNINWDPMLDYQMMSRFTRGFSSLLHANKPTVVKVHGYCVAGGTDIALHADQLIVAADAKIGYPPTRVWGVPATGLWAHKLGDQRAKRLLLTGDCLSGRQAYDWGLAVEAPEPDELDERTERLVERIAAMPLNQLMMIKLACNSVLINQGIANSAMIGTVFDGISRHTPEAHAFTADAIANGYRQAVRHRDEPFGDYGRKPTEL		302		0	Target Approved	-1	 	
Batch06	MyabA.00392.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MEU5				Putative cell division ATP-binding protein FtsE	Potential drug target		MISLDKVTKLYKSSARPALDNVSLEIDKGEFVFLIGPSGSGKSTFMRLLLAEELPTKGDVQVSKFHVNKLRGREIPHLRQTIGCVFQDFRLLQQKTVYENVAFALEVIGKQTDIINRVVPEVLEMVNLTGKASRLPSELSGGEQQRVGIARAFVNRPLVLLADEPTGNLDPETSEDIMALLERINRTGTTVLMATHDHHIVDSMRQRVIELELGKLIRDEQRGVYGVDR		229		0	Target Approved	-1	 	
Batch06	MyabA.00404.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MLL0				Probable DNA-3-methyladenine glycosylase I TagA	Potential drug target		MPSKEPTRCAWAVDSAGSTLYTEYHDTEWGRPLYGRDALFERLCLEAFQSGLAWITILRKREGFRRAFDGFRPEKVARYTDQDIARLMADAEIVRNRAKIESAISNARAVLDLDTDLSDLLWSFAPKRRARPQLLSEVPAVTEESTAMAKELKRRGFRFVGPTTAYALMQATGMVDDHVRSCWVPRAETAPI		192		0	Target Approved	-1	 	
Batch06	MyabA.00414.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MKL5				Probable short-chain dehydrogenase/reductase	Potential drug target		MGEFDNKVAIVTGAAQGIGEAYAHALAREGAAVVVADINAEMGEGVAKQIVADGGRAIFAGVDVSDPDSAIAMADKAVSEFGGIDYLVNNAAIYGGMKLDLLLSVPWDYYKKFMSVNQDGALVCTRAVYKHIAQRGGGAIVNQSSTAAWLYSGFYGLAKVGINGLTQQLSRELGGQKIRINAIAPGPTDTEATRGTVPEQFRSELVKNIPLSRMGTVDDMVGMCLFLLSDKASWITGQVFNVDGGQIIRS		250		0	Target Approved	-1	 	
Batch06	MyabA.00416.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MDZ1				"Putative ABC transporter, ATP-binding protein"	Potential drug target		MSEMTRYRAPADRSRGGIRHDDPVAEIDPDLLLDFRDVLLRRNRKVLVGPVTWSVELDERWVVLGPNGAGKTSLLRIAAAMEHPTSGYAAILGERLGRVDVAELKSRIGLSSAALAQRIPDNEVVRDLVVSAGYAVLGRWREEYEEIDTARAVDMLETLGAEHLSDRTYGTLSEGERKRVLIARALMTDPELLLLDEPAAGLDLGGREELVARLGELAADPDAPAMVLVTHHVEEIPPGFSHALLLSEGGIVAQGLLADVMTSENLSRAFGQSIVVEMIDGRYFARRARARAAHRAQ		297		0	Target Approved	-1	 	
Batch06	MyabA.00416.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MB95				"Molybdenum ABC transporter ModC, ATP-binding protein"	Potential drug target		MSELRFDAGHLARGVRARFTVAAGETLAIVGANGAGKSTVLALVGGLLRPDTGEIRLGDHLLTNCATGVFVPTHRRRTALLLQQASLFPHLTVARNVEFGIRGGDVAGVRDRWLEAVGARDLAERRPGELSGGQAQRVAIARALATEPDLVLLDEPLAGLDAESAPAIRALLSQVLGRDGQSALIVTHDVMDAVAVADRVLVLDSGRVAELGDTATVLARPTSEFGARFAGVNLVDGIAGADGALHSGDLAIHGVWAGPGERVPRGQHAVAVFTPRDVAVYLSPPGGSPRNVIAVSITTLTAHGGSVVVTASRGATIFTAHITAAAAAELRLAPDTPAYFAVKAHEVVIQAAQ		353		0	Target Approved	-1	 	
Batch06	MyabA.00429.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MDU2				6-phosphofructokinase PfkA	Potential drug target		MRIGVLTGGGDCPGLNAVIRAVVRTCANRYNSQVVGFQDGWRGLLENRRIHLHNDDRNDRLLTKGGTVLGTARTNPDRLRAGLDQIKQTLDDNGIDVLIPIGGEGTLTAASWLADENVPVVGVPKTIDNDIDCTDVTFGFDTALTIATEAIDRLHSTAESHQRVMLVEVMGRHAGWIALHAGLASGAHMTLIPEVPFDVDEVCRLIKGRFQRGDSHFICVVAEGAKPAEGSMELRDGGIDEFGHQRFTGVAQQLGVEIEKRINKEVRTTVLGHVQRGGTPTPFDRVLATRFGVNAADAAHAGEFGVMVSLRGQDIGRVPLAEATRQLKLVPKNRYEDAAAFFG		343		0	Target Approved	-1	 	
Batch06	MyabA.00441.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MJ34				"Putative pyruvate dehydrogenase E1 component, beta subunit"	Potential drug target		MTVTTMAQALNAALRDALHDDDSVVVFGEDVGTLGGVFRVTDGLTETFGANRCFDTPLAESGIIGFAVGMAMGGFRPVVEMQFDAFAYPAFEQVVSHVAKLRNRTRGVLSVPMVIRVPYAGGIGGVEHHCDSSEAYYAHTPGLKVVTPATVADAYGLLREAIDDPDPVVFLEPKRLYFSRADVELGRGAKIGEAQVLRAGTDVTLIAYGPSVEPALQAAAAAADEGRDIEVVDLRSIAPFDDQSVTASVRKTGRCVIVQEAQGFGGVGAEIAARIQERCFHHLAAPVLRVSGYDIPYPAPRLERWYLPSTDRILDAVDRLQWDDHPDSRWVVSA		334		0	Target Approved	-1	 	
Batch06	MyabA.00441.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MMK0				Pyruvate dehydrogenase E1 component beta subunit	Potential drug target		MTRMTMSGALDAGLRSALEDDDKVIVMGEDVGKLGGVFRVTDGLQKDFGDHRVIDTPLAESGIIGTAVGLAMRGYRPVCEIQFDGFVYPAFDQIVSQVAKLHYRTKGAVGMPLTIRIPFGGGIGAVEHHSESPEAYFAHTAGLRVVSCSSPQDAYDMIRQAVACDDPVVFFEPKRRYWEKGEVDTALVPVPLGAARVVRSGTAATIAAYGPMVAVANAAAELAATEGISVEVVDLRSLSPVDFDTLEASVRKTGRLIVVHEAPVFMGLGAEIAARITERCFYHLEAPVLRVGGFALPYPANKVEHHYLPDAERVMDAVDRAIAA		324		0	Target Approved	-1	 	
Batch06	MyabA.00448.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MMZ4				Probable nicotinate-nucleotide adenylyltransferase	Potential drug target		MQSERRRLGVMGGTFDPIHNGHLVAASEVADRFALDEVIFVPTGQPWQKQGRKVSPAEHRYLMTVIATASNPRFTVSRADIDRGGATYTVDTLTDLRTAHPDADLYFITGADALASILSWENWEQLFTLAKFIGVSRPGYELSSDHIAHAELPPDGLSLVEVPALAISSTDCRIRAGQARPIWYLVPDGVVQYVAKHRLYSGNKGNQGGLA		211		0	Target Approved	-1	 	
Batch06	MyabA.00458.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MCJ9				Probable acyl-CoA thioesterase II (TesB2)	Potential drug target		MADIEEILTLEQLEKDIFRGNVTPSNLRRTFGGQVAGQSLVSAVRTVEPEYLVHSLHGYFLRPGNPNEPTVFLVDRVRDGRSFVTRRVTAIQDGQAIFSMSASFQTLDTGIEHQDLMPPVPDPEDLPDAQEQDSFNRDLFRQFAEWDIRIVPDELMDRNPRLAAQQRVWFRCRKHLPDDPVLHICALAYMSDLTLLSSSKVPHRDTVLQTASLDHALWFLRPFRADEWMLYDETSPSAGFGRALTQGRIFNRDGTMVAAVVQEGLTRIERNPEQASVARGNMA		283		0	Target Approved	-1	 	
Batch06	MyabA.00471.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MDQ6				Putative uncharacterized protein	Potential drug target		MRLGRIASPDGVAFVSIEGEDGREESAIAREIAEHPFGTPTFTGRQWPLADVRLLAPILASKVVAMGKNYAAHAAEMGGDPPESPVIFIKPNTSIIGPGLPIQLPPSATEVHHEGELAIVIGRPCKDVPAARAAENILGYTIGNDVSARDHQRADGQWTRAKGHDTFCPLGPWIVTDLDPADLEIRTEVNGQVRQRSRTSLLLHDVGAIVEWVSAVMTLLPGDVILTGTPEGVGPIVDGDTVSVTIEGIGTLSNPVVRKAK		261		0	Target Approved	-1	 	
Batch06	MyabA.00471.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MJ53				"Probable 2-hydroxyhepta-2,4-diene-1, 7-dioateisomerase"	Potential drug target		MNLRIVSFAGADQWQPGVLIDDDTVAPLAPMLARHDIQVSSARELIALLPQISPLISDELAGGSFEPVPLDSVALGAPIPEPGQVIALGFNYPTHSDTDSPLPKMADPVVFMKSPTSISGPRDAVIAPRTSHALDYEIEIAVVIGKPGYRIERSQAIKHVAGYMLANDITARDVALPFGFGGSPLQAQVVRGKGYPTFCPTGPWLFTTGSDTTFETFDFELRINGELRQSGSTVDMTLGFAEVVETVSATIALRAGDIILTGTPGGCGFQFDPPRYLRPGDVIEAHSAKLGKMRLPVHDEKPIESASR		308		0	Target Approved	-1	 	
Batch06	MyabA.00471.c	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MJS0				Hypothetical fumarylacetoacetate (FAA) hydrolase family	Potential drug target		MRLYTTDRGIARQGADGHFSLLDLPFDDIGALLRYSDTDTAARALASRVVDSDHVSLAPVILRPGKILAVGLNYLSHAEEALEKFASIGRRDVQLPAEPNIQIVAGSAVQADGRPLMLPVATPHHVDYEGELAVVIGRAGFAIRTDQAWGHVAGLSIINDVSARDIQQRAYTGDPAASIGIAKSFDTFKPLGPCLVTADEFTEKVDLRLQTRVNGDLRQDDRTGNLIHSIPELIAYISRYHTLEPGDVIATGSPRGAGQFTDRYLRPGDVVEISIEHLGTLTNSVQARQSTGTGQSPLR		299		0	Target Approved	-1	 	
Batch06	MyabA.00471.d	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MJS5				Hypothetical fumarylacetoacetate hydrolase family	Potential drug target		MRLYTTDRGIGREDRHGILALLDLPHRDLGELLSDTGLDPARDATVTDEVALTDVAVLAPVIRPGKILIIGLNYPSHAKEALAAFAAMGRDDIVMPTEPNMQLIAGSATTGTDHTIKLPAIAPDEVDYEGELAVVIGRSTHAVSVEEAWKHVAGLTIANDVGARDIQRRAMTGDAAASIGVAKSFDTFKPLGPCLVTADEFSDGVDLTLQTYVNGELRQDDRTGSFIYPIPELIAHLSRYQTLQPGDVICTGTPCGAGAFTGRFLRSGDTVEVAIERIGLLRNRVSAA		288		0	Target Approved	-1	 	
Batch06	MyabA.00495.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MG01				Probable cytidine deaminase Cdd	Potential drug target		MKIEWNELRDKAYAVTKHAYAPYSKYPVGAAALVDDGRVISGCNVENVSYGLGLCAECSVVCALFSSGGGRLMALSCVDSRGEPLMPCGRCRQLLLEHGGPDLLIDHADGPRRLAQLLPDAFGPDDLDRGRI		132		-2	Work stopped	-2	Work stopped	
Batch06	MyabA.00504.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MH35				Probable dehydrogenase/dehydratase (MaoC family)	Potential drug target		MPINVDIALGAATEPAEFSWTASDVQLYHLAIGAGADPVSETELRYLQDKTPQVLPTFATVASGFHAVEPPKVSFPGIEIDLAKILHGTEQVTAHRPLPPSGTARSEGKVVEIWDKGKAAVIVTETTTSDDQGPLWTIRRSIFARGEGGFGGERGPSSHGGVPERDADLEVSTHILPQQALLYRLCGDRNPLHSDPAFAAAAGFPRPILHGLCSYGVVCKAAVDAALDGDVSRVTSYAAKFAGVVFPGETLKTRIWKEDGKLLISAVVADREDAPALADVELTHS		285		0	Target Approved	-1	 	
Batch06	MyabA.00541.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MJJ0				Succinyl-CoA ligase [ADP-forming] subunit beta	Potential drug target		MDLFEYQAKELFAKHNVPTTPGRVTTTAEDAKAIAEEIGKPVMIKAQVKVGGRGKAGGVKYAATPDDALTHAQNILGLDIKGHIVKKILVAEASDIAEEYYISFLLDRANRTYLAMCSVEGGVEIEVTAEENPDALAKVPVDAVKGVDLALAREIAEKGKLPAEVLDSAAVTIQKLWEVFVGEDATLVEVNPLVRTPDNQILALDGKVTLDGNADFRQPGHAEFEDKDATDPLELKAKEHDLNYVKLDGQVGIIGNGAGLVMSTLDVVAYAGENHNGVKPANFLDIGGGASAEVMAAGLDVILGDSQVKSVFVNVFGGITACDAVANGIVGALKTLGNTASKPLVVRLDGNKVEEGRAILAEFNHPLVIQAETMDAGADKAAALAAASN		389		0	Target Approved	-1	 	
Batch06	MyabA.00549.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MJ09				Putative molybdenum cofactor biosynthesis protein A2	Potential drug target		MTPLIDSFGRIATDLRVSLTDRCNLRCTYCMPAEGLDWLRSETLLTTDEYIRLIGIAVTRLGIDSVRFTGGEPLIFKDLEKLVAAVAGMSPRPDIAVTTNGVGLDRKAVALREAGLDRINVSLDTLDAHRFAAITRRDRLSDVLLGLKAAGSAGLSPIKINAVLTPEQYKEDAVALLHFSLEHGYELRIIEQMPLDAGHSWSRARMVTADEIHAALSREFSLSEDPAPRGSAPAQRWLVNGGPATVGIIASVSRPFCGDCDRTRLTADGQVRNCLFATTETDLRGLLRSGASDAEVASAWQAAMWGKKPGHGINDPSFLQPDRPMSAIGG		330		0	Target Approved	-1	 	
Batch06	MyabA.00556.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MJJ1				Succinyl-CoA ligase [ADP-forming] subunit alpha	Potential drug target		MSIFLNKDSKVIVQGITGGEGTKHTALMLKAGTQVVGGVNARKAGTTVSHVDKSGQSVDLPVFGSVAEAIKETGADVSIAFVPPAFSKDAIIEAIDAEIPLLVVITEGIPVQDSAYAWAYNVEKGNKTRIIGPNCPGIITPGEALVGITPNNITGTGPVGLVSKSGTLTYQMMYELRDFGFSTAIGIGGDPVIGTTHIDAIEAFEKDPETKIIVMIGEIGGDAEERAADYIKANVSKPVVGYVAGFTAPEGKTMGHAGAIVSGSSGTAQAKKEALEAAGVKVGKTPSETAKLAREILQSL		300		0	Target Approved	-1	 	
Batch06	MyabA.00572.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MLL8				"Putative ABC transporter, ATP-binding protein"	Potential drug target		MTYPNLAVEIRGLTKLFGKTKALDGLDLSVAHGEVAGFLGPNGAGKSTTIRVLLGLLRADAGTVQLLGGDPWVNAVDLHRLIAYVPGDVTLWPNLTGGQAIDFLTRMLGTEHISIRRRNELIERFELDPTKKARTYSKGNRQKVALIAAFCSDADLFILDEPTSGLDPLMETVFQECVAEVSTRGCAVLLSSHILAEVEKLCHRVTIVRAGRTVLSGSLAELRHFMRTSVTVRTLANPSGLKSIPQLRDVTIGGNRASFTVDRSDLDRTMEQLAGLGIVDLSVAPASLEELFMREYQGASR		301		0	Target Approved	-1	 	
Batch06	MyabA.00587.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MJL0				Mycobacterial persistence regulator MrpA (Two component response transcriptional regulatory protein)	Potential drug target		MPVRILVVDDDRAVRESLRRSLSFNGYSVDLAEDGVDALNVIANDRPDALVLDVMMPKLDGLEVCRRLRSTGDDLPILVLTARDSVSERVAGLDAGADDYLPKPFALEELLARMRALLRRTTIDESADAATLSFGDLTLDPVTREVHRGTRSISLTRTEFALLEMLMANPRRVLTRSRILEEVWGFDFPTSGNALEVYVGYLRRKTEAEGELRLIHTVRGVGYVLRETPP		230		0	Target Approved	-1	 	
Batch06	MyabA.00587.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MNA4				Putative two-component system response regulator	Potential drug target		MPSQRRILVVDDEPTICASISARLRAEGYAVDTEDNGLDAVRHCRENPPDLMVLDVMLPGLDGLEVCRQVQAHAPIPVLMLTARGTETDMLVGLGVGADDYLPKPFSMRVLVARVAALLRRTHRIAPPSTDVRIGQVRIDVSERRVYHRDDEVHLTRTEFDLLAYLADNPRVAISRDRLLDQVWGWSAGLPSGRRTVDSHIKALRRKLGQELIRTVHGIGYALEAPR		227		0	Target Approved	-1	 	
Batch06	MyabA.00587.c	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MDK7				Probable transcriptional regulatory protein KdpE	Potential drug target		MTRVLVVDDEPQILRAMRINLSARGYEVVTASSGAGALRAAAETQPEVVILDLGLPDMDGTEVLAGLRGWTDVPVIVLSARTDSADKVEALDAGADDYVTKPFGMDEFLARLRAAVRRGTPDSAEPVVHTETFDVDLSSHKVIRDGREVHLTPTEWSMLAVLVRNRGKLVGQKELLHEVWGPAYSSETHYLRVYLAQLRRKLEIDPAHPKHLLTEAGMGYRFQE		224		0	Target Approved	-1	 	
Batch06	MyabA.00587.d	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MBP1				Putative two component transcriptional regulatory protein	Potential drug target		MSDAASVSSEKARSSLRRPDGSPVRVLVVDDERSLAELISMALRYEGWEIHVAGDGMSAVKLARQVHPDIVVLDVMLPDVSGLEVLRQLRDLYPGLPLLLLTAKDSLEDRIAGLTAGGDDYVTKPFSLEEVVLRLRALLRRTGIAGDSGDARLIVGDLVLDEDSHEVTRDGELINLTATEFELLRFMMRNNKRVLSKHQILDRVWSYDFGGRSNVVELYISYLRKKIDTGREPMIHTLRGAGYVLKPAH		249		0	Target Approved	-1	 	
Batch06	MyabA.00587.e	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MHU9				Putative DNA-binding response regulator PhoP	Potential drug target		MVSITTETHQGTFSANGTTPAKVLVVDDESNIVELLSVSLKFQGFDVYTADSGAAALDLARTVRPDAVILDVMMPGMDGFGVLRRLRADGIDAPTLFLTARDGLQDKIAGLTLGADDYVTKPFSLEEVVARLRVILRRSGMGSEPARKSRLSFADIELDEDTHEVWKAGEPVALSPTEFTLLRYFMINAGTVLSKPKILDHVWRYDFGGDVNVVESYVSYLRRKIDNGEKRLLHTLRGVGYVLREPR		247		0	Target Approved	-1	 	
Batch06	MyabA.00587.f	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MNV8				Putative transcriptional regulatory protein PrrA	Potential drug target		MTQETTARHKVLMVDDDPDVRNSVARGLRHSGFDVRVAVDGRDALTQLAADEPDALVLDVQMPELDGVAVVTALRALGNDIPICVLSARDTVNDRIAGLEAGADDYLTKPFDLGELVARLRALLRRRGAGSGGLADSAITVGQITVDVSRRLVFVNGERVELSKREFDLLVVLAENTGVVLSRTRLLELVWGYDFDVETNVADVFVSYLRRKLEAGGAARVIHTVRGVGYVMREEP		236		0	Target Approved	-1	 	
Batch06	MyabA.00620.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MLK2				Putative uncharacterized protein	Potential drug target		MNQPLSVCVYCASGPRHPELLDLATRLGTAIAERGWTLVSGGGNVSAMGAVAHAARAAGGRTIGVIPKTLVHREVADTDADELVVTTTMRERKQIMEDRSDAFITLPGGIGTLEEVFETWTAGYLGLHDKPVVLLDPDGHYTGLLRWLDELQDKGYVAAPARDRLLVHTDIAAALDACKPTD		182		0	Target Approved	-1	 	
Batch06	MyabA.00629.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MHE5				Possible O-succinylbenzoic acid--CoA ligase MenE	Potential drug target		MTRLLRALPVPSGQTVLGLLPRLAELLDGRGDAVLPVPADDADHAHFLASELSADEPIADDVAVVISTSGTTGKPKGAMLTGQALTASGTATATRLGGPGQWLLALPPHHIAGMQVLLRSIQAGSDPVVLDVSTGFSVPDFVRAVAEMTGSRRYISLVATQLVKALGDAEASEALASFDAVLLGGGPLPATVAIRAAQARVPVVRTYGMSETCGGCVYDGVALDGVEVRIGPEGRISLGGATVATGYRNIPEHKAFAEHGWFHTDDFGELDEGRLRVLGRLDEAISTGGLTVVPQVVEAALGAHPLVADCAVFGVPDDRLGQRVAAAVVPSAAGAPTLEDLREHVTAALDGTAAPRELHLLDELPRRGIGKLDRRALVKRFS		382		0	Target Approved	-1	 	
Batch06	MyabA.00629.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MLJ3				Probable fatty-acid-CoA ligase FadD	Potential drug target		MLLTSLHPKSPDLADAVRIGEDSWGRGDLVGAATAAAERIGGASGPIAVLARPSIDTVLAVVAGLIAGVPIVPVPADVGIAERRHILADSAAVAWLGESPDESEGLPHVPVRRHARSWHQYSEPNPESTALIVYTSGTTGAPKGVRLSRRALAASLDGLADAWEWTADDVLVHGLPLFHVHGLVLGLLGSLRVGNRFVHTVKPTPEAYAAARGSLYFGVPTVWLRVAGDESCARALSTARLLVSGSAPLPVPVFDELCRLTGHAPIERYGATETVITLSTRADGERRAGWVGHPLTGVRTRLLAENGSPAAHDGETVGQLQIQGPTLFSGYHNLPEKTAEVLTEDGWYRTGDVAVIDAGGMHRIVGRESVDLIKSGGYRIGAGEIETVLLGHPGIVEVAVVGVPDDDLGQRIVAYVVGDVAEDDVIGFVAQQLSVHKRPREVRRVDALPRNAMGKVLKKELIT		463		0	Target Approved	-1	 	
Batch06	MyabA.00640.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MIS7				Acetate kinase (AckA)	Potential drug target		MSAGGSVLVLNCGSSSVKYQLIEPESGRVIAHGLVERIGEEEIGNHEEALRLVFDSIDTGDVVVVGHRVVHGGQKFHEPTVLDDAVVAQIAELSSLAPLHNPAGVQGIEVARRLLPDVPQVAVFDTAFFFGLPPAAAIYALDRAVAERYGIRRYGFHGTSHQYVSQQAAAFLGRGYADINQIVLHLGNGASASAILRGRAVETSMGLTPLEGLVMGTRTGDIDAGIVFHLARHGMSIDEIDTVFNRRSGMLGLCGANDFREVHRLIDAGDAAAQLAYNVYVHRLRKYIGAYIATLGGADVISFTAGAGENDALLRADALAGLEVFGIEIDAARNQVRSGEARRISTDSSRVTVLVVPTNEELAIARAAVEAI		372		0	Target Approved	-1	 	
Batch06	MyabA.00654.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MES5				Putative acyl-CoA thiolase	Potential drug target		MRDAVIIDAVRTPVGKGKPGGSLSGVHPVDLHAHAIRELVERAGIDPALIDDVISGAVGQVGEQSSNTARWAALAAGLPETVPAVTVDRQCGSSQQAIHFAAQGVIAGAYDVVIASGIESMSRVPMGSQSLGKDFFGSEVARRYPEGLVPQGISAELIAAKWNLSREQLDTFAAESHRRAAQAWSEGRFARDVVPIKAPDVNGDLVEVSTDESVRPSTTVEVLAGLKPAFRNELWQQRFPGLDWKVTAGNSSPINDGASAVLITSSETAHRLGLTPRARVHSVAVVGDDPLYMLTGIIPATAKVLDRAGLSLADIDAFEVNEAFASVVLAWQAETGADLSKVNVNGGATAIGHPLGASGGRLMTTLVSVLEQGGGRYGLQTMCEAGGLANATILERL		397		0	Target Approved	-1	 	
Batch06	MyabA.00654.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MH14				Probable acetyl-CoA acetyltransferase FadA	Potential drug target		MSEAYIIDAVRTAVGKRNGALSKVHPLDLGAATFKGLFDRVDVDPDAIDDVYMGVLDAIGGQAGNAGRLAWLAGGYPEEVPGATVDRQCGSSQQAISFAAQAVMSGTADLIVAGGFQNMSQIPISAAMLVGKEYGFTSPTAESEGWLHRYGDQEISQFRGAEMIAEKWDISREEMERFALSSHEKAFAAIRNGHFDNEIIPVGDFRVDEGPRESTLEKLASLNPLVEGGRLTAALASQISDGGSATLVASERAVKAHGLTPRARVHHISARGDDPVFMLTGPIPATRYALEKTGLTMDDIDVVEINEAFAPVVLAWAKELDVDLKKVNPNGGAMALGHPLGATGAKLFATMLNELERTGGRYGLQTMCEGGGTANVTIIERL		382		0	Target Approved	-1	 	
Batch06	MyabA.00654.c	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MH26				Probable acetyl-CoA acetyltransferase FadA	Potential drug target		MGNPVIVEATRSAIGKRGGWLAGLHPAELLGSIQRSVIARAGLDPNEVEQVIGGCVTQFGEQGGHITRQAWLHAGLPEATGATTIDCQCGSAQQANHLIAGLIYSGAIDTGIACGIESMSRVPLGANVGGTGIPRPDSWDIDMPNQFEAAERIAKRRGITRADVDGLGVRSQALAAQAWAEGRFDREITPLDAPQVDKEGNPTGETKTVNRDQGLRETTLESLGNLKPVIAEGIHTAGTSSQISDGAAAVLLMDSDKAKALGLRPRARIVSQALVGAEPYYHLDGPVQSTQRVLDRAGMKIGDIDVVEINEAFASVVLSWAAVHKPDFDRVNVNGGAIALGHPVGSTGSRLITTALHELERTDKSTALITMCAGGALSTGTIIERV		386		0	Target Approved	-1	 	
Batch06	MyabA.00654.d	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MIC2				Probable acyl-coa thiolase FadA	Potential drug target		MTEAFIYEAVRTPRGKQRGGALNEIKPLNLVVGLIEEIRHRHPDLDENLISDVVLGVVSPVGDQGGDIARTAVLAAGLPDTTGGVQLNRFCASGLEAINIGAQKVRSGWDDLVLAGGVESMSRVPMGSDGGAWASDPATNYDVSFVPQGIGADLIATIEGFTRDDVDAYAARSQERAAAAWSGGYFAKSVVPVKDQNGLLVLDHDEHMRPGTTAADLGKLKPAFEGLAALGGFDDVARIKYHYVEKINHVHTGGNSSGIVDGAALVLIGSEEAGKSQGLTPRARIVATATSGSEPLIMLTGPTPATKKVLDRAGLTVDDIDLFELNEAFASVVLKFQKDLNIPDEKLNVNGGAIAMGHPLGATGAMITGTMVDELERRGLKRALITLCVGGGMGVATIIERV		402		0	Target Approved	-1	 	
Batch06	MyabA.00656.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MH64				"Possible ribonucleotide ABC transporter, ATP-binding"	Potential drug target		MLRKERLVGAEVSVEGLTKSFGSQRIWENVTLSLPPGEVSVLLGPSGTGKSVFLKSLIGLLRPEQGAIYIDGTNIMECSSKELYEIRKLFGVMFQDGALFGSMNLYDNTAFPLREHTKKKESEIRDIVMQKLDVVGLTGHETKFPGEISGGMRKRAGLARSLVLDPQIILCDEPDSGLDPVRTAYLSQLLIDINAQIDATILIVTHNINIARTVPDNMGMLYRRNLVMFGPREVLLTSDEPVIKQFLNGRRIGPIGMSEEKDEATMAEEQAHLDAGHHDGGVEEIEGVPPQIQATPGMPERKAVGRRQARVREIMHQLPPNAQAAIQDSFAGTHQYRVHDFGDEPTGVTTATLAPPQAEQPTQSIDTSDDDTPTGQIPPVRG		382		0	Target Approved	-1	 	
Batch06	MyabA.00663.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MB31				Probable cytidylate kinase (Cmk)	Potential drug target		MVAVDGPSGTGKSSVAKELARQLGASYLDTGAMYRIVTLWVLRAGVDLTDPAAIAAATDQVPMSVSSDPDAQTALLAGEDVSVPIRGNEVTGAVSAVSAVPAVRERLVRQQRELAESSGAVVVEGRDIGTVVLPDADVKIYLTASAQARAQRRNAQNVSGGGDDEYEKVLADVQRRDHLDSTRAVSPLRPAEDALEVDTSDMTQEQVVAHLLDLVRTRAGASR		223		0	Target Approved	-1	 	
Batch06	MyabA.00680.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MGE5				50S ribosomal protein L22	Potential drug target		MTTTTEFPSATAKARFVRVSPTKARRVIDLVRGKSVNDAIDILRWAPQAASEPVAKVIASAAANAQNNDGLDPSTLVVSEIFADEGPTAKRIRPRAQGRAFRIRKRTSHITVVVESRPKQEKGGKAGASKASSRAARAQGSKAAAAKKTESKGGTS		156		-2	Work stopped	-2	Work stopped	
Batch06	MyabA.00681.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1ML03				"Probable NAD(P) transhydrogenase, alpha1 subunit PntAA"	Potential drug target		MTDQPVTIGVVRESGEDERRVALVPKAIAGLIGKGVNIVIESGAGERALLPDELYTEAGATVGDAWSADVVVKVAPPTAAEVARLRQGQTLIGFLAPRNAENSIGALRSAGVQAFAVEAIPRISRAQVMDALSSQANVAGYKSVLVAASESTRFFPMLTTAAGTVKPALVLVLGVGVAGLQALATAKRLGARTTGYDVRPEVADQVRSVGAQWLDLGIDAAGEGGYARELTDEERQKQQQALEDAIKGFDVVITTALVPGRPAPRLVTAAAVQGMKPGSVVVDLAGETGGNCELTEPGQTVVKHGVTIASPLNLPATMPEHASELYAKNITSVLELLIKDGALAPDFDDEIVAGSCVTREVS		362		0	Target Approved	-1	 	
Batch06	MyabA.00690.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MC60				Probable ATP-binding protein ABC transporter	Potential drug target		MDSLDLEVHAAQVFALLGPNGAGKTTTVELCEGFLHPDEGTVEVLGMDPVAKNSAVRSRIGVMLQGGGAYPTARASEMLGLVASYSANPLDPQWLLDTLGLTDAARTPYRRLSGGQQQRLALACALVGRPELVFLDEPTAGMDAHARLVVWELIDCLRRDGVSVVLTTHHMKEAEELADQLMIIDHGSVVAAGTPSELMQSGAENQLRFAAPPRLDLTLLTSALPEGYKATEVTPGEYRVEGVVDPQVLATVTAWCARMDVLTTDLRVEKRSLEDVFLDLTGRELR		286		0	Target Approved	-1	 	
Batch06	MyabA.00690.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MIR7				"Putative ABC transporter, ATP-binding protein"	Potential drug target		MIELRSLTKVYGQTPAVDDLSVTIESGVVTGFLGPNGAGKSTTLRMIVGLARPTSGTATIGGKQYHEIDHPLREVGALLDPKQFHPNRSARNHLRWIAAANDISAQRVDEVLEMVGLTEVANRHAGTFSLGMSQRLGIAVALLGDPKVLLFDEPVNGLDPEGIHWIRTLMQSLAAQGRTVLVSSHLLSEMANTADQLVVIGRGRLIAATSMHEFVSRAGADVVRVRSPQIDILRSAAEESGFSVVGGERTGEPGVLEISGALIEQVGELAARRGVTLYELSPQRVSLEDAYLSLTDDAVQYRSQVNDPLAARATGAVADAEGTH		324		0	Target Approved	-1	 	
Batch06	MyabA.00693.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MER1				NAD-dependent deacetylase (Regulatory protein Sir2 homolog)	Potential drug target		MTEVPDELIAAASKARSVTVLTGAGMSAESGLPTFRDAQTGLWSKYDPMTLATPESWQEDPGLVWAWYQNRRIQLLAVQPNDGHRALAQWGSHRDIRIVTQNVDDLHERAGSSNVTHVHGSLLKSHCDTCRSDFEATVSAPEAERVAPPECGCGGKVRPSIVWFGEMLPEVEFGHAVAHSQNCDLMLLIGTSGIVYPAAGLPQLALSRGATVVEINPQETDLSDRADLVWRSTAATALPALLQALAPF		248		0	Target Approved	-1	 	
Batch06	MyabA.00698.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1ML43				Probable citrate synthase	Potential drug target		MTIATPTIHKGLAGVVVDTTAISKVVPETNSLTYRGYPVQDLAVQCSFEQVAYLLWHGELPNDGELALFNQRERAQRRLDRSLMALLAKLPETCHPMDVVRTAISYLGAEDPSEDDSTPDANYAKSLRMFAVLPTIVASDMRRRRGLDPIQPHSHLGYSANFLRMCFGEIPDPVIVKAFEQSMILYAEHSFNASTFAARVVTSTQSDIYSAVTAAIGALKGSLHGGANEAVMHDMIEIGDASKASEWLQSKRSRKEKIMGFGHRVYKNGDSRVPTMRAALEDVARVRDGGQWLEIYKVLESEMDAATGIKPNLDFPTGPAYYLMGFDIPCFTPIFVMSRITGWTAHIMEQAAANALIRPLSEYSGKPQRTLAC		373		-2	Work stopped	-2	Work stopped	
Batch06	MyabA.00725.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MKD5				Probable 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase	Potential drug target		MSETVSDWVPTGAVTVRAPGKVNLYLAVGDLRDDGYHELTTVFHAVSLADDVTVRDADVLSIDVVGQGEGTVPTDERNLAWQAAELFADHVGRAPDVSIFINKDIPVAGGMAGGSADAAAVLVAMNELWHAGVPRRDLHHLAAQLGSDVPFALHGGTALGTGRGEQLATVLARNVFHWVFAFADGGLATPQVFKEIDRLRENGDPPRLAEADELLGALAAGDARRLAPLLGNELQAAAVSLNPELRRTLRAGESAGALAGIVSGSGPTCAFLCTSADDAVQVSAELAGAGVCRTVRVASGPVHGAQVIQGRSDG		314		0	Target Approved	-1	 	
Batch06	MyabA.00746.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MLN4				"Probable sugar ABC transporter, ATP-binding protein SugC"	Potential drug target		MAEIVLNQVSKTYTDGSAAVRDVSLNIADGEFIILVGPSGCGKSTTLNMIAGLEDISSGELTIAGERVNEKAPKDRDIAMVFQSYALYPHMTVRQNIAFPLTLAKMSKDDINAKVAEAAKILDLTDYLDRKPANLSGGQRQRVAMGRAIVRSPKAFLMDEPLSNLDAKLRVQMRTEIARLQKRLGTTTVYVTHDQTEAMTLGDRVVVLRAGKVQQVGAPQELYDTPANLFVAGFIGSPSMNFFPATLTDVGVQLPFGEVTLDAGLYAGITARKPSGDVIVGIRPEQFEDAALVDTYKRITGLTLTVNADVVESLGSDKYVHFTTEGGAAHSDELTELAQESEVAENEFVARLSAASKVAEGQPIELIIDTGKLVIFDAESGENLSLAATAE		391		0	Target Approved	-1	 	
Batch06	MyabA.00750.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MI23				Probable phosphate import ABC transporter ATP-binding protein PstB	Potential drug target		MAKRLDLKDVNIFYGKFHAVQDVALSVPPRNVTAFIGPSGCGKSTVLRTLNRMHEVTPGARVEGSVLLDGADIYGSAVDPVSVRKTIGMVFQRPNPFPTMSIRDNVVAGLRLQGVRNKKTLDEVAERSLQGANLWNEVKDRLDRPGGGLSGGQQQRLCIARAIAVQPDVLLMDEPCSALDPISTLAIEDLISELKQEFTIVIVTHNMQQAARVSDQTAFFNLEAAGKPGMLVEIDDTEKIFSNPTQKATEDYISGRFG		258		0	Target Approved	-1	 	
Batch06	MyabA.00750.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MMD2				"Phosphate ABC transporter, ATP-binding protein"	Potential drug target		MAKRFDLKDVNIFYGDFHAVADVGLSVPPRSVTAFIGPSGCGKSTVLRSLNRMHEVTAGARVQGSVLLDGEDIYGDGVDAVGVRRTIGMVFQRPNPFPTMSIRDNVVAGLRLQGVRNSGALDEVAERSLQGANLWNEVKDRLDKPGGSLSGGQQQRLCIARAIAVQPDVLLMDEPCSALDPISTLAIEDLIAELKQEFTIVIVTHNMQQAARVSDQTAFFNLEATGKPGRLIEIDDTEKMFSNPGQKATEDYISGRFG		258		0	Target Approved	-1	 	
Batch06	MyabA.00754.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MBW9				Hypothetical histidine triad (HIT) protein	Potential drug target		MADDCLFCGIISGVVPSVRVSEDAETYAFMDINPGSDGHLLVVPKRHSTDLLEIPPDDLSAVALAAQRIAKAAVAELGADGVNLLNCCGAHAWQTEFHFHLHVIPRYTDKSRDGLRLPWIPGVRGDTRTIAALGNRLCAALDVKEM		146		0	Target Approved	-1	 	
Batch06	MyabA.00754.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MLR9				Hypothetical histidine triad (HIT) protein	Potential drug target		MSCVFCAIVAGESPSFRVYEDETTLAFLDIRPITRGHTLVIPKAHAQDLTDLKPDDAAAIMTVGQRIANAMRGSELQSDGTNLALNDGRVAFQTVMHAHLHVVPRRGGDKLAFAKGFMVRRDPDLEATAQIIRAAVQAN		139		0	Target Approved	-1	 	
Batch06	MyabA.00762.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MH12				Short-chain dehydrogenase/reductase	Potential drug target		MNLAEAPTEIEGHGLLKGKAVVVTAAAGTGIGSSTARRALVEGADVVVSDYHERRLTETRDELAALGLGKVAAVVCDVTSTEAVDALITESVAALGRIDVLVNNAGLGGETPVADMTDDQWDRVLDVTLTSTFRATRAALRYFREAGHGGVIVNNASVLGWRAQYGQSHYAAAKAGVMALTRCSAIEAVEHGVRVNAVAPSIARHKFLDKVTSSDLLDKLSSDEAFGRAAEPWEVAATIAFLASDYSSYLTGEVISVSSQRA		262		0	Target Approved	-1	 	
Batch06	MyabA.00768.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MI02				Phosphoribosylformylglycinamidine cyclo-ligase	Potential drug target		MPDMSERADKPSNSYAAAGVDIEAGDRAVELFKKSVAKTHRPEVLGGIGGFAGLFALKGGYREPVLAASTDGVGTKIAVAQAMDKRDTVGLDLVAMVVDDLVVCGAEPLFLQDYIAVGKVVPERVSELVAGIAEGCAIAGCALLGGETAEHPGLMAPDDFDLSATGVGIVEADRVLGPDRVRPGDVVIAMGSSGLHSNGYSLARHVLLEIDRMDLFGQVEEFGRTLGEELLEPTRIYAKDCLALAAETEVRTFCHVTGGGLAGNLARVIPDGLVAELDRGSWTPGPIFAMIAQRGRIERAEMEKTFNMGVGMVAVVAPEDVDRALAVLTARHIDCWTLGTIKKSGKDSGSESALLVGQHPRF		362		0	Target Approved	-1	 	
Batch06	MyabA.00778.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MK77				Putative molybdopterin biosynthesis protein	Potential drug target		MTSMSPRTVTVASMAELEAGPVGRSLVVIVNDRTAHGDQDTSGPLVTELLAEAGFVVDGVVVVENDLSEIQNAVNTAVIGGVDLVVTVGGTGVTPRDVAPEATQPLLDRELLGIAEAIRSSGLAAGVTEAGLSRGVAGISGSTLVVNIAGSRAAVRDGMATLTPMAIQIIEQLSSLEI		178		0	Target Approved	-1	 	
Batch06	MyabA.00781.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MJD6				Putative acetyl-CoA C-acyltransferase (Thiolase)	Potential drug target		MTGSAKRRAVIVAGARTPFVRAFGEFTRMDTIALADEAVRGLLDNTKVSSSEIEAIVWGGVILPAGAPNVAREIALDLKLGHGVEGHTVTRACASGLQAITTAAAAIERGEYDVMIAGGSDSTSNAGVNLPQKLIHAAAPLALGKPKPKDYLDAAWSLAPFTGLLPRRPKIEERTTGEVMGESADKMAKIHGITRQAQDEFAVRSHRRAAAAIASGRFDREVVPVAGVTRDGLVRENTSVEKLATLKPVFNRDGTVTAGNASPLTDGAAAVLLMSEEKARALGLRPLAAFRSWSYVSVDPADEVLIGPAISMPRALEKAGLDLDDVDYIDIHEAFAAQTLSVLEALGSKKWATDRLGRSEAVGTPDIDKVNVHGGSVSIGHPFGATGARMVTTMANELALSGKGTALLGICAAGGHGASAVLERVD		426		0	Target Approved	-1	 	
Batch06	MyabA.00781.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MKI8				Probable acyl-CoA thiolase	Potential drug target		MPEAVIVSTARSPIGRAGKGSLVSMRPDDLAAQMVRAALDKVPALDPKDVDDLMLGCGQPGGEAGFNIGRAVAVQLGYDFLPGTTVNRYCSSSLQTTRMAFHAIKAGEGHAFISAGVETVSRFPKGTSDGWPDSHNPLYADAEARTATAAQGATEWHDPRNDGLTPDVYIAMGQTAENVALHTGISREDQDHWGVRSQNRAEKAIADGFFEREITPVTLADGTVVAKDDGPRAGTTYEAISQLKPVFRPNGTITAGNACPLNDGAAALVVMSDVRAKELGLTPLARIVSTGVSGLSPEIMGLGPIEAVKRALANAGKSIGDIDLFEINEAFAVQVLGSARALGIDEDKLNVSGGAIALGHPFGMTGARITATLLNNLTTYDKTFGVETMCVGGGQGMAMVIERLA		405		0	Target Approved	-1	 	
Batch06	MyabA.00786.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MLZ4				Nucleoside-triphosphatase	Potential drug target		MKILVASRNPKKLAELSRVLESSGVSGVELVSLTDVPEYEEVPETGASFEDNALIKAREGVKHTGLACVADDSGLAVDALNWMPGVLSARWSGRHGDDAANTALLLAQLSDIPDERRGAAFVSACALVTPEGEEVVVEGRWKGSIARIPAGQNGFGYDPIFVPRGGLRTAAELTPEEKDAVSHRGRALAALLPMLRNLVNLGRTAP		206		0	Target Approved	-1	 	
Batch06	MyabA.00797.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MNP0				Probable ABC transporter antibiotic-transport ATP-binding protein	Potential drug target		MTEVIQVRELTFTYPKTPEPAVRGMDFTVGEGEIFGFLGPSGAGKSTTQKLLIGLLRGHGGRATVWGREPGAWGRNYYQRIGVSFELPNHYQKLTALENLRFFASLYAGPTRDPMELLDAVGLADDANTRVGAFSKGMQMRLTFVRALINDPELLFLDEPTSGLDPVNARKVKDMVLELKARGRTIFITTHAMSAADELCDRVAFVVDGRIVAMNSPAELKLEYGRRSVRVEYRGAAGELAGQDFPLDGLADNDAFHAVLRGHHVETIHSEEASLDDVFVAVTGRRLA		288		0	Target Approved	-1	 	
Batch06	MyabA.00814.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MLH9				Probable catechol-o-methyltransferase	Potential drug target		MSLTRTLKQKLPFLRYSFLRAVFGGLNVMRTGQMGDGREEATAEHVVATAPAGDIDAAIEAIDNFAYDQSILMNVGDEKGQLLDAAVKRANPKIALELGAYCGYSGLRIARAAPGAKFFSIEKSGANASVARRVWAHAGLADRATCLTGTADDGVTLDTLAKDYGFTEGCLDFVFIDHWKDIYLDDLQRLLERGWLHPGTIVVADNVRFPGAPKYRAYMKDQQGKLWQTIEHETHVEYQTLVKDLVLESEYLG		253		0	Target Approved	-1	 	
Batch06	MyabA.00891.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MK52				Probable oxidoreductase	Potential drug target		MFDDPRALFDIAGKSAIVIGATGSLGQIASRALAGAGANVAICGSREDALSDLRDELAAAPGCIVPIARRPDSESASDAIVKETIEAFGGVDILVVASGVNEVAPAVDMQPARFEAVLDANVTSTWLAVRSAGRAMIERGRGGKIILTSSARGKLGHPAGYTAYCASKAAVDGLVRSFGCEWGRYGITVNGLAPTVFRSPLTSWMFTDEPAAQATRENFLSRIPLGRLGEPEDLAGPILFLSAPASDFLTGHVVYPDGGYTAG		263		0	Target Approved	-1	 	
Batch06	MyabA.00896.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MJ68				Putative citrate synthase CitA	Potential drug target		MTVAAPLPADFAPGLEGVTAFATEIAEPDKDGGSLRYRGVDIEDLVAQRVTFGDVWALLVDGKFGQGLPPAEPFPIPVHTGDVRVDVQAGLAMLAPIWGFEPLLDTEDSVARSQLARASVMALSYVAQSARGNSLPAVPQHIVDECSTVTSRFMTRWQGDPDPKHVEAIDAYWVSAAEHGMNASTFTARVIASTGADVAASLSGAVGAMSGPLHGGAPARVLPMIEQAEKTGDARGVIRGILDRREKLMGFGHRVYRAEDPRARVLRSTAKRLGAARYEVAAALEQAALAELRERRPDRVIETNVEFWAAVILDFAQVPTRMMPAMFTCARTAGWSAHIMEQKRLGKLVRPAALYVGPGPRPIESVEGFGLLHSRVGA		378		0	Target Approved	-1	 	
Batch06	MyabA.00896.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MJ80				Citrate synthase	Potential drug target		MADNNDFATLQYPGGETKLDIVRATEGADGFALGKLLADTGYTTFDAGFVNTASTKSAITYIDGDAGILRYRGYPIEQLADKSTFIEVSYLLIYGELPTPQQLEDFTTKIQRHTLLHEDLKRFFDGFPRNAHPMPVLSSAANALSAYYQDSLDPHDDAQVELSTIRLLAKLPTIAAYAYKKSVGQPFLYPDNTLTLVENFLRMTFGLPAEPYEVDPEIVRALDMLLILHADHEQNCSTSTVRLVGSSDANLFTSVSGGINALWGPLHGGANQAVLEMLERIRSEGGDTHDFVRRVKNREDGVKLMGFGHRVYKNYDPRARICKEQADKILGKLGGDDQLLEIAKALEEAALTDDYFVERKLYPNVDFYTGLIYRAIGFPTRMFTVLFALGRLPGWIAHWREMHSEPGKIGRPRQIYTGYGERQYP		425		0	Target Approved	-1	 	
Batch06	MyabA.00906.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MDP4				Putative cystathionine/methionine gamma-synthase/ lyase	Potential drug target		MPEPGISTRAVVAATAEPVAGQPFLAGPVFASAYHLPVPEDDSLDTYGRASNPSWRQWESGLAALEQADAALVFGSGMGAIASTLRALVRPGQTLLVPEDGYYQTRRYASENLAALGINVITATSDQIVAAAAQADVVVAETPSNPRLDVVDLALLARETHARGGVLVVDNTTATPMGQRPLGLGADLVVASATKALSGHSDLIAGYVAGSRAELVAAVAQERSRAGAILGPFEAWLGARSLATAGLRFERQCQNALAVATMLREHPAVTSVRYPGLPSDPSYSVASAQMSRFGSLVSIELSSAEAVHALTRRSELLASSTSFGGVHTSVDRRARWGDAVPDGFARISLGIEDTDDLLADIEAALAAGTV		370		0	Target Approved	-1	 	
Batch06	MyabA.00906.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MKJ3				Probable cystathionine gamma-synthase (CGS)	Potential drug target		MSEQRSAADASRWQGFSTRAIHGGFHADPQTGAVNVPIYASSTFAQDGVGQLRGGFEYARTGNPTRAVLEASLAALEDAHFGRAFSSGMAATDCVLRALLRPGDHLIIPNDAYGGTFRLIDKVFSQWGIRHTPVPVADVDAIRAAITPTTKLIWLETPTNPLLSIADIAAVAQVAAEHSVKLLVDNTFASPALQQPLNLGADIALHSTTKYIGGHSDVVGGALLTNDEELDTAFAFLQNGAGAVPGPFDGYLTYRGIKTLALRMQRHSENAQAVAEYLAGHSAVAQTIYPGLESHPGHAVAARQMRGFGGMVSVRLAGGRQAALDLCSRTELFILAESLGGVESLIEHPGAMTHASTAGSLLEVPDDLVRLSVGIEEVGDLIGDLEQALR		390		0	Target Approved	-1	 	
Batch06	MyabA.00922.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MGE9				50S ribosomal protein L4	Potential drug target		MKIAVKAPGGKTDGSIELPAELFDAPANIALLHQVVTAQLAAGRQGTHSTKTRGLVSGGGKKPYRQKGTGRARQGSTRAPQFTGGGIVHGPQPRDYSQRTPKKMIAAALRGALSDRARNGRIHAVTELVAGQEPSTKSAKSFLGEITDRKQLLVVLGRDDLASVKSVRNLPNVHVLAYDQLNTYDVLKADDVVFSVEALNGFINAKKKEEVSA		213		-2	Work stopped	-2	Work stopped	
Batch06	MyabA.00937.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MDI3				tRNA (guanine-N(1)-)-methyltransferase	Potential drug target		MKIDVVTIFPEYLQPVRQSLPGKAIDAGLVDVAVHDLRRWTHDVHKSVDDSPYGGGPGMVMKPTVWGDALDEICTSETLLVVPTPAGYPFTQETAWQWSTEDHLVIACGRYEGIDQRVADDAATRMRVREVSIGDYVLNGGEAAALVIIEAVLRLVPGVLGNALSAQEDSHSEGMASLLEGPSYTRPPSWRGMDVPPVLLSGDHAKIAAWRAEQSRQRTIERRPDLLGFDSPTGEHGGDGLS		242		0	Target Approved	-1	 	
Batch06	MyabA.00950.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MIR4				Probable lipoprotein aminopeptidase LpqL	Potential drug target		MALFSARGLARGCSLLAIAAVASCCAHPSTPGAAAPTAPNPNLAADLARSVTVDAMMVHLQQLQQVADANGGNRAEGTSGYDASADYVAKVLKDRGFEVQTPELSRLKVLSEGKPLVDIGGRPYALDQASYFAQTPKGGLKANIIRPSGKASGCAAADYGTLKVDGQIAVVDGTGCSVVDKHNVAKQKGASAVLVAMQAGAGEGLFTPNYYEQLSIPVGIIDSGVDTLLRRNSSPVNLVLDMNVAKVRSHSVIAQTTTGDHANVVLTGAHLDSVSKGPGINDNGTGVAAVLETALQLGPKPVVNNAVRFAFWTAEEDGLAGSLEYAKSRSPEELNDIALYLNFDMLGSPNAGYFVLDGDQSAAKPDPNRPPLDVPEGSAGIERTFAGYLNLAGKRPAAEEFSGRSDYGPFMAAGIPVGGISSGALERMSGPEAKTWEGHAGQPFDPNYHGPKDTLANVGKTALGINGPAVAFAVGTYALSTTGPNGVPERKLRRHSPLER		500		0	Target Approved	-1	 	
Batch06	MyabA.00950.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MIR5				Probable lipoprotein aminopeptidase LpqL	Potential drug target		MATNRVLYAVAVSAACALATVTACDRDAAEAPPRSAPQAGSEEAVGFAHSLHEKVTVDNVVKHLSALQEIADKNNNTRAAGTAGFDQSVDYVVKALKDKGFDVQTPEFSFKYFQAKSLDLTVGPKKVDAGVLSYSPGGRVEGRLVPARAEESPGCTVEDYDGLDVKGAVVLVDRGSCPFADKERVAAERGAVAVIIADNVDENKTSGTLGEDSNPKIPVVSVTKSVGADLRAHPDKVVLNVDAETKDVKARNVIAQTKTGATTDVVMAGAHLDSVPEGPGINDNGTGTAAVLETALQLGPSPDVKNAVRFAFWGAEEEGLIGSTDYVKSLDVAALKNIALYLNYDMLGSPNAAYLTYDGDQSNEPDPNEIPVRIPEGSAGIERTEVAYLAEQGKKAHDTGYDGRSDYDAFSRAGIPTGGIFSGAEDKMSDEEAKQWGGKAGQPFDPNYHQAGDTLANVNKDALKINAGGVAYTVGLYAQSIDGRNGVPVHEDRTRHQLKG		500		0	Target Approved	-1	 	
Batch06	MyabA.00951.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MAJ1				Putative amidase	Potential drug target		MDFSDYSQHDATGLAELVATKQVTPAELLAAARARAADVNNKIGAIVRTLPEADQQVQGDLTGPFAGVPFLIKDLGQDYKGHPTSGGCRALSTLPAPEHSTIVRRWLDAGLVIFGKTNTPEFGSKGITEPELFGASRNPWDLGRTPGGSSGGSAAAVAAGIVPVAGASDGGGSIRIPAGCCGLVGLKPGRGITPMGPTAGEPMHGAAVNGTVSRTVRDTASMLDIIAGPEPTSPYLSAMPQDSYASQVGRDPGRLRIGVRVPTVITPNPDPAAVAAVETAIRLLTHLGHEVEEVSAPYDDGQLARDFLLTWFVHAAYEVDYTKRLTGAGDEGFERDTLLIAALGRTTSGPEYVAAVERRHDYVRELATFFGDYDLLLTPTLAKAPPRIGEFNLPAPLAAVSDLLLRTKTARVLKYANIVDSMINDNLGWVPYTQLANLTGRPAISLPLYQTPKGLPLGVQFVAPLGGESLLIRLAAQLEATEPWAHRRPTL		491		0	Target Approved	-1	 	
Batch06	MyabA.00951.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MHZ8				Putative amidase AmiC	Potential drug target		MTRIHAFTEDALGDLDATGVAERIASGEVTAAECAEAAIVRLERVNPTLNAVEFKDFPRARERAEQADAASSTSGTFRGVPTATKCNIHVAGMPLTEGSAAITPAPQTDDGPFARQFLSTGVIPIASTTMPEYGWSATTERAGGSATRNPWHTDFSAGGSSGGSAALVAAGVVPIAHGNDGGGSIRIPAAACGLVGLKPSRGRLLGDPSSSSAPVKIVAEGVLVRSVRDCARFFESAELHYRNPKLTPIGHVDRPVQRRLRIGLCMDSPFTPATDNPTRQAVNSAAELLESLGHTVEPYTPAVLPSFKIDFEDYWAFLAFAVAKGGPRLFEGFDPAKLDRLTLGLSRRFVRRSYRTPLFLARLAAAARVYERGFTTGIDAVLTPVLTHTTPRIGYLTPDQDPDVLLDKLSSYVGFTPVHNASGAPAISLPLGQDPDGLPIGVMFSGRRGSERTLLELAMEIEEAQPFSILG		471		0	Target Approved	-1	 	
Batch06	MyabA.00951.c	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1ML67				Amidase family protein	Potential drug target		MEVADAVLRRIEKVNPLLNAFVFHNPEQVLRDARRLTEDLTKRTTLPPLYGIPYSVKEVCAVAATPVTSGVVAFKDMVADRDEPVSARLRASGGLFLGKTNIAEGGYKASSDNHLYGSTRNPWHPGMTAGGSSSGAGAAVAAGMGQLAQGTDGGGSIRIPAALNGVVGFKPSLGRIPQTRLAGRFHTFAFHGPITRTVADAALMLTTMAGFDDEDPLSLPSDGVDYLAALDQPIESGRMAWSPDLGISKCDSEIQGICEEALIAFVEMGWTVEEDRPDWTDPAKTMWEGVWGPVYAGKLDAANWDDQAGHVDQELVQVIRDGARLTTVQVQRADAARGKMVDTLREFLRRFDFLVTPVTTAQAFGHDEFCPAVLAGAPLLERLMGWVLTYPFNMTTNPAISIPVGFTRNGVPVGLQIVGRLRADADVLRLAAAFEAVRPWAQRRPSDAVLNGENP		455		0	Target Approved	-1	 	
Batch06	MyabA.00951.d	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MN47				Putative amidase AmiA2	Potential drug target		MSGFPTLTSQAAALSDGSESSVSLTLTALNAIKSSQSTLNAFRVVCTKTALAEATEADKRLARGERLPLLGVPIAIKDDTDLAGTPTAFGTAGAVGSESEDAELVRRLRAAGAVIVGKTNTCELGQWGFTSGPGFGHTRNPWSRGHTPGGSSGGSAAAVAAGLVAGAIGSDGAGSVRIPAAWTHLIGIKPQRGRISTWPFAEAFNGITVHGPLARTVADAALLLDAASGNVPGDLHKPPHVRVLDAVHEDPGQLRVALSLKVPFSGFPAQLHPTIEAATRYVAHQLRSLGHMVSEGDPDYGVGLGLNFLPRATAGLLPWRDRLDAGAHWDPRTVTNMRTGRRLAGWALRRARAAEPRLQARVGKIFGSFNVVLAPTTAQPPTGIYDFDDVGSLATDRGQVGACPMTWPWNVLGWPSINVPAGFTADGLPIGVQLMGPANSEPLLISLAAQLESINNWASEIPDPWW		466		0	Target Approved	-1	 	
Batch06	MyabA.01007.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1ME24				Probable NADPH-dependent FMN reductase	Potential drug target		MAEKVAEKNVLAIVGSLRKASVNRQLAEAAAEHAPAGVSVTIYEGLADLPHYNEDIDGEGAPAAAEALRAAVADADAVLLVSPENNGTISSSLKNAIDWLSRPFGSSVFKGKPTVVIGTSAGRYGGIWAIDETRKAAGIATANVLEDVKLAVPSSAFDGKHPREHAETVAELTKALDALTTA		182		0	Target Approved	-1	 	
Batch06	MyabA.01026.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MI93				Probable 4-aminobutyrate aminotransferase (GabT)	Potential drug target		MTSVYSLQGGPAVAQVRRMATEVPGPRSRELAERRAAALPAGLVSGAGVYAAAAGGGVLVDVDGNSFLDLGSGIAVTTVGNSAPAVVARVAAQAQRFTHTCFLATPYEQYLEVAETLNRITPGDHEKRTALFNTGAEAVENAVKYARVATARPAVVVFDHAFHGRSLMTMTMTAKQAPYRRGFGPFAPEVYRAPMAHPYRWPSGAENCASDAFRQFASLVDNQIGAEAVACVVVEPIQGEGGFIVPAPGFLAMVADFCRARGILLVADEVQTGIARTGAWFASEHEQLVPDLVTTAKGLAGGLPLAAVTGRADVMDAAHPGGIGGTFSGNPLSCAAALGVFEEIETHDLLRRAADMGEMLLREMRGISAETGLIGDIRGRGAMIAAELVVPGTDSPNREAVIQILKYCQDNGVLVLSAGTYGNVLRFLPPLSMPDELLQEALAVLRDAFRNL		452		0	Target Approved	-1	 	
Batch06	MyabA.01026.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MIQ9				4-aminobutyrate aminotransferase (GabT)	Potential drug target		MTDITYRLAQKRTIVTPLPGPRSGALAERRRAAVSAGVGSTAPVYAVDADGGVIVDADGNSFIDLGAGIAVTTVGASHPAVAAAIADQATHFTHTCFMVTPYEGYVQVAELLNALTPGDHDKRTALFNSGAEAVENAIKVARLATGRPAVVAFDNAYHGRTNLTMALTAKSMPYKSQFGPFAPEVYRMPASYPLRDEPGLTGEEAARRAISRIETQIGAQSLAAIIIEPIQGEGGFIVPAPGFLATLTAWASENGVVFIADEVQTGFARTGAWFASEHEGIVPDIVTMAKGIAGGMPLSAVTGRAELMDAVYAGGLGGTYGGNPVTCAAAVAALGVMRELDLPARARAIEASVTSRLSALAEEVDIIGEVRGRGAMLAIEIVKPGTLEPDAALTKSIAAEALSQGVLILTCGTFGNVIRLLPPLVIGDDLLDEGITALSDIIRAKASHQ		449		0	Target Approved	-1	 	
Batch06	MyabA.01046.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MB62				Glycine cleavage system H protein	Potential drug target		MTEIPADLHYTEEHEWVRRTGDTTVRIGITDYAQSQLGDVVFVQLPDVGSELTAGSTFGEVESTKSVSDLFAPITAKVIAANGDLDSDPQLVNSDPYGEGWLVDLEAASAADLDAALNDLLDASGYGDATD		131		0	Target Approved	-1	 	
Batch06	MyabA.01068.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MHW4				Phosphoribosylaminoimidazole-succinocarboxamide synthase	Potential drug target		MRPSLSDYQHVASGKVRELYRVDDEHLLFVATDRISAFDFVLDTPIPDKGRILTAMSVFFFGLLTVPNHLAGPPDDPRIPEEVLGRALLVRRLDMLPVECVARGYLTGSGLLDYQRTGAVCGHVLPQGLGEASRLDPPLFTPATKADIGEHDMNVDFAAVVGLVGAVRANQLRDETIKIYTRAAAHALHKGIILADTKFEFGVDIEGNLVLADEVFTPDSSRYWDAAHYQPGVVQDSFDKQFVRNWLTGPESGWDRASDTPPPPLPDEVAVATRERYIEAYERISGLSFSDWIGPSA		297		0	Target Approved	-1	 	
Batch06	MyabA.01073.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MPG6				NADH-quinone oxidoreductase subunit C	Potential drug target		MTGGEQKPNEIIGVRRGLFGVRGSGDTSGYGGLVQPISLPVSSNRPYGGYFDQVVDRLESVLAEQENVTYADAVEGVVVYRDQLTIHVKAEHLVQVAQSLRDDPQLRFELSLGVSGVHYPDDSARELHAVYPLMSITWNRRIMLEVAVPESDPHIPSLNAVYPTTDWHERETYDFFGIIFDDHPALTRIQMPDDWDGHPQRKDYPLGGVPVEYHGATIAPPDQRRSYN		228		0	Target Approved	-1	 	
Batch06	MyabA.01083.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MI14				Probable thiosulfate sulfurtransferase (CysA)	Potential drug target		MARSDVLVSAQWAQDNLSAPNTVFVEVDEDTSAYDVGHIEGAVKLDWKTDLQDAVKRDFVDQQQFSKLLSDKGISNDDTVVLYGGNNNWFAAYAYWYFKLYGHRDVKLLDGGRKKWELDGRPLSTDTVSRPATSYQAAAPDNTIRAFRDEVIAAIGTKNLVDVRSPDEFSGKILAPAHLPQEQSQRPGHVPGAINVPWSKAAAEDGTFKSDEELAKLYADAGLDGQKETIAYCRIGERSSHTWFVLQEILGHQNVKNYDGSWTEYGSLVGAPIELGS		277		-2	Work stopped	-2	Work stopped	
Batch06	MyabA.01097.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MD59				Putative short chain dehydrogenase/reductase	Potential drug target		MDINGSVAIVTGAGSGIGQALAWGLVDAGATVVASDIDADAVGRTAAARDGIVGQRADASAVSDIEDLIALAEKEFGPVDLYAANAGIAGGLGLGIGEAAWDLTIDVNLRAHIRAATLLVPGWVERGRGYFLSVASAAGLLTQIGSPAYSVTKHAAVGFAEWLSITYGGQGVGVSCLCPMGVKTALLDGLTESDDPDVRVAGTSITAAGDVLEPAVVAAMALDAIRDEKFLVLPHPQVLDMYRQKGADYDRWIAGMRRYQAILEDQIIR		269		0	Target Approved	-1	 	
Batch06	MyabA.01097.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MEC6				Probable oxidoreductase EphD	Potential drug target		MTSGSAQRNSLVVVTGAGSGIGRETSLAFARQGARVVVADINHDTANETVGLIEKLGGSAYPYALDVSDEAAVTAFADDVCAKHGVPDVLINNAGVGHGGRFFETSSTDFQRVLNINLGGVVHGCRAFGPRMAERKSGHIVNISSAAAYTPIPEMGAYATSKAAVFMFSDVLRGELARDKVKVSTICPGIVNTNIIRTTQFSGLSPEDEAKRQQQGAGLYAKRGYGPEKVAKEIVNAVAKGKSVVPVTPEAHVQYHFSRLAPALNRFFWGLSDKISR		277		0	Target Approved	-1	 	
Batch06	MyabA.01097.c	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MLP0				Putative oxidoreductase EphD	Potential drug target		MNLRDQVVFITGAGSGIGRATALAFARGGAKVIATDRNLASAEQTAELVHVSRGVCEPVLLDVADPLAWESALARVEEHHGIPRVLVNNAGYTTAGRFLDHSADDWADLVAVNVRGAVTGSRLCARRMVDAGIRGQIINVASGAAYTPLTVSSPYCTTKAAVMMFSEAFRLELRPHGIGVTAICPGAINTGFYTAARHLGSDAAVNTQRRDLSAGAIARFGSGPDAVAKAIVRSVRANRAIQPVTTEAYLGYALWRLSPTVMKVIARLSGEGTLRYVENTSLVRTAMGWLKERTK		295		0	Target Approved	-1	 	
Batch06	MyabA.01097.d	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1ME27				Putative short-chain dehydrogenase/reductase	Potential drug target		MAYEFTGKRCFVTGAASGIGRATALRLGREGAELFLTDRAADGLESVVEEIKAAGGKVSAYRALDISDHEAVAAFASDILATHPSMDVLLNIAGISVWGSVDRLSHQQWRSVVDINLMGPIHVIESFVPAMIKARKGGQIVNVSSAAGIVALPWHAAYSASKYGLRGVSEVLRFDLARYKIGVTVVVPGAVNTPLVRTVDIAGVDRENENVARWIGRFVGHAVSPEKVADRILYGIRHNRYLVYTSVDIRALYLFKRTLWWPYSVAMRVANYAFTNALRPGFQKTGSASSPRDS		294		0	Target Approved	-1	 	
Batch06	MyabA.01097.e	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MHB2				Putative short chain dehydrogenase/reductase	Potential drug target		MKNFDNKVAVITGAGSGIGRSLALALAQRGARLALSDIDTAGVADTAGRCEKAGATAIPFELDVADRAAVYAHAADVKNEFGQVNLVFNNAGVALSADVKDMEWDDFDWLMNINFWGVAHGTKAFLPHLIESGDGHIVNVSSVFGLMGIPSQSAYNAAKFAVRGFTESLRQEIRAAKFPVGVTCVHPGGIKTNIASSARGIPDGVDRETVRKGFQLMAITRPDSAARIILRGVEKNRPRVLIGPDARVFDAIPRIIGPRYEDLMAPFYGMGRYGIGKKIAGRFGIEL		287		0	Target Approved	-1	 	
Batch06	MyabA.01097.f	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MK40				Putative short-chain dehydrogenase/reductase	Potential drug target		MVSLLGFGRGERRTRKVDAVVTGAASGIGRAFAVELARRGGRVVCADVDLPGAKETAALIGERAIEAACDVSVFDEVEALADTAEEWFGKPSDLVINNAGIGAGGQVVGAAPLADWQKTLGVNLWGVIHGSHVFAPRLRALGRGGIINVASAASFAAAPRMGAYNVSKAGVLALSETLAAELSGTGVAVTVLCPTFVKTSIVDSGIIEESAARLAATAMKWTGVSADSVARGCLDAHDRGQLYVLPQFDARFMWQAKRLAPDTYTKALGIAERFSRQRGN		280		0	Target Approved	-1	 	
Batch06	MyabA.01097.g	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MLP1				Putative oxidoreductase EphD	Potential drug target		MAQGEDQVKRSDIKLVVVTGAGSGIGRAAAERFAQLGARVIVSDINEVAAEATVAAIRDAGGDSCARRLDVTDVNEFEDFARWVQSEHGVCDVVVNNAGIGILGEVIDTTESDWDRIVGINLLGMVHGARLFAQQMVDANKPGHIVNVASAAAFLPMPNLASYSATKYAVKMFTDCIRGELAPNHIGASVICPGPIMTNIFSSATHTGADEQEQVQRSALTGAAFEKIRSWHLIPGPQNVARAIESAVVYNRKTVLVRPEAYLVYLLRRLSPTLLYAFSNLIFGSRTITFAYRLGKNPTVARLLGR		306		0	Target Approved	-1	 	
Batch06	MyabA.01097.h	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MLP7				Probable short-chain dehydrogenase/reductase	Potential drug target		MEGFSGKVAVVTGAGSGIGRALAVELARSGAKIAISDIDNEGLAETERQVKALGAEVRADRLNVAEREAFLLYADAIKDHFGKVNQIYNNAGIAYQGEVEESQFKDIERIIDVDFWGVVNGTKAFLPHLIASGDGHVVNVSSLFGVLSMPGQSAYNSAKFAVRGFTESLRQEMIIGKKPVAVTCVHPGGIKTAIARNSTTAEGYDQQAMAAMFDKYLANTSPEAAARIILTAVRKKKPRVLVGPDAKILDVIVRLTGARYQDIFSVVTRFILPRPGKK		278		0	Target Approved	-1	 	
Batch06	MyabA.01097.i	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MLP8				Probable short-chain dehydrogenase/reductase	Potential drug target		MEGFSGKVAVVTGAGSGIGRALAVELARSGAKIAISDIDNEGLAETERQIKSLGGDVRSDRLNVAEREAFLLYADAIKEHFGTVNQIYNNAGIDFHGELEASEFKDIERIIDVDFWGVVNGTKAFLPHLIASGDGHVVNVSSIFGVMACPGQSSYNAAKFAVRGFTESLRQEMIIGKKPVAVTCVHPGGIKTNVARNATVAEGYDHAEFTKLFDMLARTRPQAAARIILTAVRKKKPRVLVGPDAKAIDILVRLTGARYQDLFVLGERFLMPKRSH		276		0	Target Approved	-1	 	
Batch06	MyabA.01097.j	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MMK5				Putative short-chain dehydrogenase/reductase	Potential drug target		MPHALITGAAGGLGAAIARALAATHSLLLGGRPSLRLDTLADELDATPWPVDLSDQDAILAAVAGIDALDVLVHNAGVSYPATIADSTLADWRKTLDVNVLAPVALTQALLPALRAAQGDVVFINSGAGINAHPGIGSYSVSKFALRGFADVLRAEEPALRVTSVHPGRISTPMQQELTEHEGREYNPDDYMRPESVAQLVADAVNLPRDARVHQIVVRQN		221		0	Target Approved	-1	 	
Batch06	MyabA.01097.k	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MPA1				Probable short-chain dehydrogenase/reductase	Potential drug target		MRLLPFGGAPGRTHRADAVVTGAGSGIGRAFAVELARRGGRVVCADRDPVTAKESAELVRQAGGEGFDIACDVTDLEQIRNLADVSEDWFGKAASLVINNAGIGAGGNRIGATSIEDWKAAISVNLWGVIYGCETFVPRLRSSGHGGVINVASAASFGSAPRMAAYNVSKAGVLALSETLAAELSGTDVKVTVLCPTFVKTNIVKNPQIDEAAARLAANLMKWTGISPQHVARTTLNAHDRGQIYVVPQLDAKVLWQLKRALPGPFTRTLGLVERMASWNDSAE		284		0	Target Approved	-1	 	
Batch06	MyabA.01113.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MLY9				Cysteine synthase	Potential drug target		MTRYDSLLQALGNTPLVGLQRLSPRWDSGGDGSPHVRLWAKLEDRNPTGSIKDRPALRMIEQAEQDGLLERGATILEPTSGNTGISMAMAAQLKGYKMICVMPENTSIERRQLLELYGAQIIFSPAEGGSNTAVATAKELAAQNPSWVMLYQYGNPANADAHYRGTGPEILADLPEITHFVAGLGTTGTLMGTGRYLRENVPGVQIVAAEPRYGEGVYALRNIDEGFVPELYDPEVLTTRFSVGSFDAVRRTRELVQVEGIFAGISTGAILHAALGMAAKAVKAGERADIAFVVADAGWKYLSTGAYAGTVDDAEDALEGQLWA		324		0	Target Approved	-1	 	
Batch06	MyabA.01117.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MH29				Putative acyl-CoA dehydrogenase	Potential drug target		MLIDLTPEQAKLQNDLRHYFSNLVTAEETREMMIDRHGSSYEAVVRRMGQDGWLGVGWPKEYGGHGFGPLEQQIFMNEVMRADVPMPLVTLQTVGPTLQKYGTEEQKKKFLPGILAGEIHFAIGYTEPEAGTDLASLRTTAVRDGDHYVVNGQKIFTTGAHQAQYIWLACRTDPSAPKHKGISILIVDTKDPGYSWTPIITNDGAHHTNATYYTDVRVPVEMLVGEENAGWKLITTQLNHERVSLGPSGRIAGMYDRVYEWASKPGPDGVAPLSHEDVRRVLGEMKAVWRLNELLNWQVASSGDDISMADAAATKILATEWIQKLGRLSEGVVGRYGDPADANTAETLEWLDAQTKRHLVITFGGGVNEVMREMVSTAGLGTPRVPR		387		0	Target Approved	-1	 	
Batch06	MyabA.01117.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MIL0				Probable acyl-CoA dehydrogenase FadE	Potential drug target		MHIAYTPEQEELRRELRAYFDKLLTPERREALASNQGEYGSGNVYRETVEQMGADGWLALGWPKEFGGQDRSVMDQLIFTDEAAIAGAPVPFLTINSVAPTIMHFGTDEQKKFFLPKIAAGKLHFSIGYSEPGAGTDLASLRTSAVRDGDDYIVNGQKMWTSLIEYADYIWLAVRTNTEVKKHRGISMLIVPTTAEGFSYTKVHTMAGPGTSATYYQDVRVPVTSRVGEENAGWKLVTNQLNHERVALVSSAPIITALREVREWAQNTKGPGGRIIDAEWVQLNLARVHAKAEYLKLINWELASTTDAAPSPADASATKVFGTELATEAYRLLMEVLGTAATLRQDSPGAQLRGRVERMHRACLILTFGGGTNEVQRDIIAMTALGQPAASR		392		0	Target Approved	-1	 	
Batch06	MyabA.01125.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MCJ8				Glutamine amidotransferase subunit pdxT	Potential drug target		MSPLVGVLALQGDVREHVAALKDSGAEALGVRRPEELGKVDGLVIPGGESTTMSNLLRVFELLDPLTERLRAGLPVYGSCAGMILLASEILDTRPDAVALGAIDMTVRRNAFGRQVDSFEGDLDFTGVDGAMHAVFIRAPWVERVGDDVEVLASAQGHPVAVRQGSALATAFHPEVTGDRRVHQLFVDMVRAG		193		0	Target Approved	-1	 	
Batch06	MyabA.01147.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MKJ1				Probable cystathionine beta-synthase	Potential drug target		MRIAQHVSDLIGNTPLVRLNSVVPEGCATVAAKIEYLNPGGSSKDRIAVKMIEAAEEAGLLKPGGTIVEPTSGNTGVGLALVAQRKGYHCVFVCPDKVSEDKRNVLRAYGAEVVVCPTAVPPEHPDSYYNVSDRLVREIEGAWKPDQYSNPNGPASHYETTGPEIWADTDGKITHFVAGVGTGGTITGAGRYLKEVSGGRAIGEVKIVGADPEGSVYSGGTGRPYLVEGVGEDFWPSAYDPSVVDEVIAVSDADSFEMTRRLAREEGLLVGGSCGMAVVAAIRLAEKVGPDGLVVVLLPDGGRGYLSKVFNDAWMSSYGFLRSRLDGSVSEPTVGDVLRGKSGALPDLVHTHPSETVRDAIEILREYGVSQMPVVGAEPPVMAGEVAGSVSERELLSAVFEGRAQLADAVAQHMSPPLPLVGSGEPLSTAGSMLRDTDAVMVVDEGKPVGVITRHDLLGFVSSGRGVRH		469		0	Target Approved	-1	 	
Batch06	MyabA.01152.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MCU3				Uroporphyrinogen decarboxylase	Potential drug target		MDGSAPGRHAPAGAPCEAVMAAWAVMTGLNEDSATAAQTTSKTRRDLPLSPYLVAAAGGVPSHPPVWFMRQAGRSLPEYRAVRADHAMLDACFNPELVCEITLQPIRRHRVDAAILFSDIVVPLKAAGIDLDIVPDVGPVIANPVRTTADVAALPRLEPGQVEAVSAAVRLLVGELGATPLIGFAGAPFTLASYLVEGGPSRHHQRTKALLLGDPQTWHALMTALTDITIAFLRAQLDAGVDALQLFDSWAGALSLADYRAAVLPHSTRIFQEFAGVGVPMTHFGVGTAELLGAMGEAGATVVGVDWRTPLNVAASRVGSGKALQGNLDPAVLLAGWPVVESEVRRIVAEGRQAVADGAAGHIFNLGHGVLPDTDPAVLTDAAALVHSL		389		0	Target Approved	-1	 	
Batch06	MyabA.01155.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MBB5				Putative uncharacterized protein	Potential drug target		MTANSTPHPVADIALSPVGSEVGAFFDLDGTLVAGFTPTAHARDRMRRRQASVGEVLGVLEATFRYKLGRMEFERLVVRAAGYLRGDSLAELEAVGERIFHQHNAAMIYPQMRERVSAHQNQGHTVVLSSSALTIHAEPVARHLGITHVLCNHFDVDNRGLLTGDIRKPIVWGRNKASVVRSFCETNGVDLQRSYFYADGEEDIDLMALVGEPRPVNPRGRLAVMAAEQGWPVLRLEDPRPRGMRPSLRRLAGLARP		257		0	Target Approved	-1	 	
Batch06	MyabA.01155.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MDZ5				Probable phosphoserine phosphatase (SerB2)	Potential drug target		MNNRVTVLVTVTGADKPGVTSVLMGVLSRHGVDLLNVEQVVIRGKLTLGVLVKAQGRSDAVEALQDELEEAMHTLGFDVDVEFGGDSSVIKDPSTHTIVVLGRPVTARAFGAVARELAALGINIDLIRGIADYPVTGLELRVTVPQNRLTDVDLHTAMAQVATDEPVDIAVEHSSLDRRAKRLIVFDVDSTLIQGEVIEMLADRAGAREQVAAITEAAMRGELDFAQSLHQRVATLAGLPESVLEDVADELVLTPGARTTIRTLRRLGYSCGVVSGGFRQVIDPLAHELALDFVAANVLEIVDGKLTGRVIGEVVDRPGKAKALRQFAYEAGVPLAQTVAVGDGANDIDMLSAAGLGVAFNAKPALRKVADASVSQPYLDVVLFILGITRAEIEAADAVDGGVRRVDIPDD		411		0	Target Approved	-1	 	
Batch06	MyabA.01156.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MG16				Probable o-acetylhomoserine sulfhydrylase MetC (Homocysteine synthase)	Potential drug target		MTDIDPTTADSRSDKPRSAQWAFETKQIHAGQSADAATNARALPIYQTTSYVFNDTAHAAALFGLSEEGNIYTRIGNPTQDVVEQRIAALEGGVAALLLASGQAAATLAIVNIAQAGDNIVSSPRLYGGTYNLLHYTLPRLGISTTFVEDPDDLESWRNAITPDTKALFAESISNPQNDILDIAGLSEIAHAAGIPLIVDNTVATPYLIQPLAHGADVVVHSATKYLGGHGNAIGGVIIDGGTFDWTQGRHPGFTTPDPSYHGVVFADLGAPAYALKARVQLLRDLGPAISPFNAFLIAQGLETLSLRVERHVANAQRVAEFLVAQPEVTRVNYAGLPTSPWYERAKALAPKGAGAVLAFELDGGVEAATTFIDSLTLHSQVANIGDVRSLVIHPATTTHGQLSPAEQVASGVTPGLVRLAVGIEGIDDILADLESGFTAVRRLKQPAAVASS		453		0	Target Approved	-1	 	
Batch06	MyabA.01188.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MEC2				Putative taurine dioxygenase	Potential drug target		MSSDLRVVKLGENIGARIDGVRLGEVDTATASAINEAMLEHKVVFFRGQHHVDDEVQFAFAKSMGIPTTPHPTLTSSDVKVLPIDSEEGGRANQWHTDVTFVDRIPKASILRAVELPPYGGTTTWTSTVAAYRQLPKPLQDLADNLWAMHNNQFDYTQVDPAKVAELLAKAGSGSKYVREFGATHFETHHPVVRVHPETGEKALLLGNFVKRILDVSASESQALFRMFQDRVTWLENTIRWSWELGDVAMWDNRATQHYAISDYGDQPRRMHRVTLAGDVPVGVNGESSRVIAGDASDYSVIDNPKRLVA		310		0	Target Approved	-1	 	
Batch06	MyabA.01188.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MIR1				Putative dioxygenase	Potential drug target		MTDDQTRRIYRDAGITVEKLGEHIGARVNGIELRGDLSADRVEAIRLALAINKVLVFTEQHHLDDAGQYAFARLLGEPTLPHPTVRSHGTELLNLEGAANGWHTDVTFVDRIPKASVLRPVTLPSYGGATTWASTVAAYEQLPKPLRSLVDDLWATHTNLYDYASSGASGGVSAERRAAYYTEFTSSRYETVHPVVRVHPETGERSLLLGQFVKSFQDLPSAEFASLFQLLQARITKLENTFRWNWRLGDVAIWDNRATQHYGIADFGEQQRELHRVTLAGDVPVDVHGRRSQILLGDASHYSGIETPQRLELFAA		316		0	Target Approved	-1	 	
Batch06	MyabA.01189.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1ML27				Probable oxidoreductase	Potential drug target		MKAIQAQSLSGPEGLVYTDVETPGAGPNVVVVDVKAAGVCFPDYLMTKGEYQLKMEPPFVPGIETAGVVRSAPEGSGIKPGDRVMAFNFIGGYAERVAVAPSNILPTPPQLDDAEAVALIANYHTMYFAYARRGQLRAGETVLVLGAAGGIGTAAIQIAKGMGAKVIAVVNRTAATEFVKSVGADIVLPLEEGWAKAVREATGGAGVDMVVDPIGGPAFDDAVRTLASEGRLLVVGFAAGGIPTIKVNRLLLRNASLIGVAWGEFLRTHADYLYETQAGLEKLVAEGMRPPVSARIPLSEGRQALQDFADGKVYGKMVLVP		321		0	Target Approved	-1	 	
Batch06	MyabA.01204.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MJH3				Putative short-chain dehydrogenase/reductase	Potential drug target		MTRQKILITGASSGLGAEMARQFAAKGRDLALCARRTEALEELKAELLGANPGIKVAVRALDVTNHESVPVVFGELRDELGGLDRVVVNAGIAKGWHLGGGKSWANIQTIETNLIGALVQIEAALALFKEQGYGHLVLISSVTAAKGLPGTKAAYAASKAGLSSLGESLRSEYARGPIKVSTIEPGYIQTDLSAKSPTTPMMVDTLTGVTAMVNAIEKEPGRAAVPRWPWEPVMAVMRLLPPRLAGRLA		249		0	Target Approved	-1	 	
Batch06	MyabA.01241.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MFA9				Putative thiosulfate sulfurtransferase	Potential drug target		MTLPADPSPEFAAYAHPERLVSADWLSGHLGTPGLSIVESDEDVLLYDIGHVPGAVKIDWHVDLNDSTVRDYIDGAQFAELMNRKGIRREDTVVIYGDKSNWWAAYALWVFTLFGHPDVRLLDGGRDLWISEGRDTTLDVPSKHTEGYPVVERNDAPIRAYADDVLAHLGHGPLIDVRSPAEYTGERTHMPDYPEEGALRGGHIPTAVSIPWAKAAAEDSRFRRRGELDEIYGDVIAADGDIVAYCRIGERSSHTWFVLTHLLGVEGVRNYDGSWTEWGNRVRTPIVKGDKPGAVPTQ		298		-2	Work stopped	-2	Work stopped	
Batch06	MyabA.01244.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MC71				Probable 6-phosphogluconolactonase	Potential drug target		MSETIIEKYADTDALVTAAGDRLASAITGALAERGKAMIVLTGGGTGIALLKHLRDVASGLDWTNVHVFWGDDRYVPKTDPERNAWQAWEALLEHVNFPLRNMHAMPNSESEYGTDLDAAALAYEQLLAANAEPGQDCPAFDVHLLGMGGEGHINSLFPHTDAVKETQRLVVAVPDSPKPPPQRITLTLPAIQRSREVWLVVSGEAKADAVAAAVGGADPVDVPAAGAKGIERTVWLLDEAAASQLG		247		0	Target Approved	-1	 	
Batch06	MyabA.01249.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MAY5				Putative short-chain dehydrogenase/reductase	Potential drug target		MPAPLQIRHFRESDVPDQTGKTHVITGANNGLGLVAAEALARAGARVVLACRNQQTGRAALDKVRALGPNADHALVELDLTSLASVRSAADAIRTQAPTIDVLLNNAGVMAIPLQRTAEGFEMQIGVNHLGHFVLTDALLPSLLAADAPRVISLGSVAHAQGRNNLKVDDLNFTQRRYNRMTAYRASKLACMLFGSELARKAAAAGSSLVSVNVHPGVAATNLFDSMIPKLPGLHKAFYFGMGLVLQDERQGAESELYAASMPDVQPDDYLGPTQLTGARGPVARAPRSKEARDPKLAAQLWQKSVELTGADYSRLSG		318		0	Target Approved	-1	 	
Batch06	MyabA.01249.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MH57				Putative short-chain dehydrogenase/reductase	Potential drug target		MTVHWTTADIPDQTGRVAVVTGANTGLGLETARALAAAGAQVVLAVRDPDKGAAAADDITKGAAGSNLALQRLDLSSLSDIRSAARQLGADYPRIDLLINNAGVMYPPKSLTADGFELQFGTNHLGHFALTGLLLENLTAVPDSRVVIVSSNGHKFRAAIHFDDLQWERGYSRVGAYAQSKLANLLFTYELQRRLQAAGAETVALAAHPGASGTELMRHITFGPEALTAAALKIAQSPAMGALPSLRAATDPAAQGGQYYGPSGFGEFRGYPKVVRSSKQSHDKVLQQRLWSVSEELTGVRFPV		304		0	Target Approved	-1	 	
Batch06	MyabA.01249.c	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MHS2				Putative short-chain dehydrogenase/reductase	Potential drug target		MSRSTTKWSTTDIPDQTGRIAIVTGANTGLGLETAKALAAHGAHVVLAVRNAEKGKAAAEAITAAHSNADVTLQSLDLSSLESVRRASDELKGRYDKIDLLINNAGVMWTEKSSTADGFELQFGTNHLGHYALTGLLLERLLPVEGSRVVTVSSIGHRIRADIHFDDLQWERDYDRVAAYGQSKLANLLFTYELQRRLAGTNTVALAAHPGGSNTELARNSPLWVRAVFDVVAPVLVQGADMGALPTLRAATDPAALGGQYYGPDGFMEQRGNPKVVASSEQSYNLDLQRRLWSVSEELTDVVFPVK		307		0	Target Approved	-1	 	
Batch06	MyabA.01249.d	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MKE0				Probable short-chain dehydrogenase/reductase	Potential drug target		MSKSTATWSAAKLPSFEGRTVIITGANSGLGLETARELARVGAHVIMAVRNTEKGNAAQASIKGSTEVRQVDVADLASVRAFADTVEGADILVNNAGIMMVPPAKTVDGFESQIGTNHLGAFALTNLLLPKLTDRVIAVSSVAHRAGKIDLTDLNYERRRYTRAGAYGASKLANLLFTKELQRRLSAAGSPVRALTVHPGVAATELQSHSGNPIFELALKTGNLFAQNAAHGALPTLYAASQDLPGDTYIGPDGPFEAKGYPTRVGRSGRAQDTETAKGLWRLSEQLTGVSFPL		294		0	Target Approved	-1	 	
Batch06	MyabA.01254.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MCC9				Putative pantothenate metabolism flavoprotein	Potential drug target		MSRIIVGVGGGIAAYKACTVVRQLAEAGHSVRVVPTESALQFVGAATFEALSGEPARTGVFDDVPEVPHVRLGQDADLVVVAPATADLLSRAATGRADDLLTATLLTATCPVLFAPAMHTEMWLHPATQQNVATLRSRGAVVLEPASGRLTGADTGPGRLPEAEEITTLAQLLLARPDALPHDLAGVRVLVTAGGTREPLDPVRFIGNRSSGKQGYAIARVAAQRGAEVTLIAGHTVGLPDPAGVEVVHISSAAQLQDAVTKHAPAAEALIMAAAVADFRPAHVATSKIKKSHGAAGENDAPIELLRNADVLAGVVRARADGQLPKMRAIVGFAAETGDANGDVLFHARAKLKRKGCDLLVVNAVGEGRAFEVDSNDGWLLSAQSGGDITEVVLEHGTKVLMASRIVDAVAGLCQ		415		0	Target Approved	-1	 	
Batch06	MyabA.01263.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MKW2				Putative acyl-CoA dehydrogenase FadE	Potential drug target		MTFSTAELPDEYESLRKTVEEFAHSVVAPAAAHHDATKTFPYAVVAQMGEMGLFGLPFPEEYGGMGGDYFALCLTLEELARADQSVAITLEAAVSLGAMPVYRYGSEEQKQRWLPELASGKSLAAFGLTEPGGGTDIPGSIRTRAVEDNGSWVINGAKAFITNSGTDITAVVGVAAVTGRSADGSPEISVIHVPSGTPGFTVEPGYDKVGWHASDTHPLSFDDVRVPYENLLGERGRGYAGFLRILDEGRIAIAAVATGAAQGCVDESLRYARSRPAFGSAIIDYQSVSFKIARMQARAHTARLAYYHAAALLLAGKPFKTEASIAKLIASEAAMDNARDATQIFGGAGFMNESPVARQYRDSKILEIGEGTSEVQLMLIARALTG		386		0	Target Approved	-1	 	
Batch06	MyabA.01279.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MG80				30S ribosomal protein S9	Potential drug target		MTDIEEQTPAEDAANTDNGDQEVAEVVVEESADDTVAAAAPRGPVVIDKPIQTVGRRKEAVVRVRLVPGTGKFHLDGRSLEEYFPNKVHQQLIKAPLVSVNRVDSVDIYAHLTGGGPSGQAGALRLAIARALIIVEPEDRPVLKKAGFLTRDPRAIERKKYGLKKARKAPQYSKR		175		-2	Work stopped	-2	Work stopped	
Batch06	MyabA.01285.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MHE9				Probable 5'-methylthioadenosine phosphorylase	Potential drug target		MLAVIGGSGFYSFFDKPVRTVTPATPYGEPSAPITIGLVGGREVAFLPRHGSRHEFSPHTVPYRANMWALRAVGVRRVFAPCAVGSLTADLGPGAIVVPDQLVDRTSGRAQTYFDSAGIHVEFADPYCPGLRAVSLQPGTIDGGTMVVVQGPRFSTRAESRWYASQGFTLVNMTGYPEAVLARELEICYAAIALVTDLDAGVEHGQGVRAVDVFAEFERNIGGFKELVRSAVTATESVDTCGHCRAHDGVTLPIELP		257		0	Target Approved	-1	 	
Batch06	MyabA.01322.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MH19				Putative CoA-transferase alpha subunit	Potential drug target		MGDKRTTLDEVVAELRSGMTIGLGGWGSRRKPMAFVRAILRSDITDLTVVTYGGPDLGLLCSAGKVKKAYYGFVSLDSPPFYDPWFAKARTTGAIESREMDEGMVKCGLEAAAARLPFLPIRAGLGSDVMNFWGDELKTVTSPYADSSGQAETLVAMPALNLDAAFVHLNLGDATGNAAYTGVDPYFDDLYCLAAERRYLSVERVVSTEELVKAVPLQSLLLNRMMVDKVVEAPGGAHFTIGAADYGRDEKFQRHYAEAAGDPETWQKFVDTYLSGSEEDYQAAVKRFKEAQA		293		0	Target Approved	-1	 	
Batch06	MyabA.01326.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MED6				Putative short chain dehydrogenase/reductase	Potential drug target		MTSQHDKPLAGRVAYITGAGRGQGRAHAIRLAADGADIVAIDTCDKPSPYNDYPATTSHEFDETISAVRDLGRDIITERVDVRDLAGHQKVIQEAITRFGRLDIVVANAGIASWARLWEIEADQWRDVIDVNLTGVWNTIKAAVPAMIEAGNGGSIITVSSSAGIKAMPGCGHYVAAKFGVVGLTNSLAIELGEYGIRVNSIHPYGTNTPLAGDQSVLRMFEMYPGYLQSFSQTLVDNDRLIEPAEIAEVVAWLAGDASGVMTGAQIPVDKGYLKR		276		0	Target Approved	-1	 	
Batch06	MyabA.01326.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MD38				Short-chain dehydrogenase/reductase	Potential drug target		MGKLDGKVAFITGAARGQGRAHAIKLASEGASIIAVDICAQIPSVEYPMATTEDLDLTVKEVDALGRAISAHETDVRDREALQAAFDAGVHDLGPVDIVVANAGIATLTPECGDDGWRDVLDVNLTGVYHTIEVARPSMVQRGAGGSIVLTSSVAGLTGMVMDNPGGLAYTAAKHGLVGLMRSYANMLAPHNIRVNTIHPSGVATPMLINPVTEKLFADGSPEGMSDTGNALPVVLMEPEDMANTVAWLVSEDARYITGVALPVDAGFTNRR		272		0	Target Approved	-1	 	
Batch06	MyabA.01326.c	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MEA8				Putative short chain dehydrogenase/reductase	Potential drug target		MTGRLTGKVALVTGAARGIGRAQAVRFAQEGADIIALDICAPVHTTITPPATRADLDKTSELVESAGRRVIPGVVDVRNLRDVQTFTQDAVTEFGGLDIVCATAGITSRRMLLDMPESDWQTMLDVNLTGVWHTTRAATPHLIARGGGAMVLVSSIAGLRGLVGVSHYVAAKHGVVGLMRSLAIELAPHKIRVNTVHPTNVDTPMIQNEFVRTLFRPDLEQPTREDFAAAAKTMNLLDLPWVEPLDIANASLFLASDEARYITSVSLPVDAGSTQR		276		0	Target Approved	-1	 	
Batch06	MyabA.01326.d	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MEA9				Putative short chain dehydrogenase/reductase	Potential drug target		MTRLGGRVAVVTGAGKGMGRTHCERLAEEGSDVIAIDLPGSDDLAQTAAAVEEHGRRCVWAFADVRDAAALTEAIDTGVRMLGRLDIVVANAGVYDGLAPSCELTEDSWRRALDVNLTGAWHTVKAGAAHLLDGGSVIIISSTNGLKGTANTAHYTASKHAVVGLARTAANELGPQGIRVNTVHPGAVSTGMILNPAVIARLRPDLEHPTVEDAAEALAARTLLPVPWVEAVDISNAVVFLASDEARYITGTQLVVDAGLTQKA		264		0	Target Approved	-1	 	
Batch06	MyabA.01326.e	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MGH3				Putative short-chain dehydrogenase/reductase	Potential drug target		MADQPLAGKVAFVTGAARGQGRQHAVRLAQAGADVVAIDACAPVSEYAGYEAATPEDLKETVRLVEAAGRKIIAEQADVRNGAALQSVVEEAVAQFGHIDILIANAGVLSWGRLWEMSDQQWEDIIDTNLTGTWKTVKAVVPTMIEAGNGGSIVIVSSVSGLKGTPGNGAYVASKFGLTGLTKSLTIELAEYGIRVNSIHPYGVTTPMITGDAMMKILAEHPNYLPSIAPMPLSPTKMLEPDEISDVVLWLASDASGTLAGAQVPVDKGHLTY		273		0	Target Approved	-1	 	
Batch06	MyabA.01326.f	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MLR7				Putative short-chain dehydrogenase/reductase	Potential drug target		MADFEGKTALITGGARGMGRSHAVALAEAGADIAICDRCENSDVVGYPLATADDLAETVALVEKTGRRCISAKVDVKDRAALESFVAEAEDTLGGIDIAITNAGISTIALLPEVESAQWDEVIGTNLTGTFNTIAAVAPGMIKRNYGRIVTVSSMLGHSANFAQASYVSSKWGVIGLTKCAAHDLVGYGITVNAVAPGNIETPMTHNDFVFGTMRPDLEKPTLKDVESVFASLHLQYAPFLKPEEVTRAVLFLVDEASSHITGTVLPIDAGATARMI		277		0	Target Approved	-1	 	
Batch06	MyabA.01331.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MC86				Phosphoglycerate kinase	Potential drug target		MAIKSLNDLLAEGVSGKGVLVRSDLNVPLEYLDGNIAHISDPGRIVASVPTIRALAGAGAKVIVTAHLGRPDGKPDPKLSLAPVGAALGELLGQHVQVAGDVVGTDALARAEGLTDGDVLLLENIRFDPRETSKDDAQRLALARELAELVGGPTGTGGAFVSDGFGVVHRKQASVYDVATLLPHYAGGLVAAEVEVLRVLTASTERPYAVVLGGSKVSDKLAVIESLATKADSLVIGGGMCFTFLAAQGLPVGKSLVQLEMVDTCKRLLDTYADVIHLPMDIVAADEFAADSPSEIVAADAIPDSKMGLDIGPESVKRFAAVLSNAKTIFWNGPMGVFEFPAFAAGTRGVAEAIIAATEKGAFSVVGGGDSAAAVRALDLPDDGFSHISTGGGASLEYLEGKVLPGIDVLED		412		0	Target Approved	-1	 	
Batch06	MyabA.01353.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MIU4				Probable O-succinylhomoserine sulfhydrylase MetZ	Potential drug target		MTQTPSGGSSVRIPKALPDGVSQATIGVRGGLLRSEFEETAEAMYLTSGYVYESAAAAERAFTGEVDRYVYSRYGNPTISMFEERLRLIEGAEAAFATATGMSAVFTALGALLGAGDRLVAARSLFGSCFVVCNEILPRWGVETVFVDGEDISQWEEALSVPTQAVFFETPSNPMQSLVDIEAVCTLAHASGAKVVLDNVFATPLLQQGIPLGADVVVYSGTKHIDGQGRVLGGAILGETEYIEGPVKTLMRHTGPALSPFNAWTLVKGLETLDLRVRHANDSAYKIAQFLEQHPAVRWVRYPFLGTHPQYELAKRQMRGGGTVVTFELDADGDAGKQRAFQVLDGTSLIDISNNLGDSKSLITHPATTTHRAMGPEGRAAIGLSDGVVRLSVGLESTDDLIADLERALG		410		0	Target Approved	-1	 	
Batch06	MyabA.01356.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MIZ7				Probable UDP-glucose 6-dehydrogenase (UdgA)	Potential drug target		MRCTVFGTGYLGATHAACMAELGHEVLGVDIDPGKVAKLSSGDIPFYEPGLRKILQSNIASGRLRFTTSYAEAAEFADVHFLGVGTPQKKGEYGADLRHVHSVIDTLVPLLSRSAVIIGKSTVPVGTARELGQRAAGFAAAGVDVEVAWNPEFLREGYAVKDTLHPDRIVLGVQRDSDRAEKLVRELYGPILDEEVPFLVTDLETAELVKVSANAFLATKISFINAISEVCEAVGADVTTLADALGYDPRIGRRFLNAGLGFGGGCLPKDIRAFMARAGELGASHALTFLREVDSINMRRRTRMVELATKACGGSLLGANVAVLGAAFKPESDDVRDSPALNVAGLLQLNGAAVNVYDPKALENSRRLFPTLNYATSVLEAADRADAVLLLTEWQEFVDFDPDALAKVVRTKVIVDGRNCLDAAKWVNAGWRVFCLGKRVEELAHT		446		0	Target Approved	-1	 	
Batch06	MyabA.01365.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MJ88				Putative uncharacterized protein	Potential drug target		MVVESAEPAERKVMFDLSARSVLVTGGTKGIGRGIATVFARAGANVAVAARSPRELSSVTAELGELGAGNVIGVRLDVSDPGSCADAARTVVDAFGALDVVCANAGIFPEARLDTMTPEQLSEVLDVNVKGTVYTVQACLAPLTASGRGRVILTSSITGPVTGYPGWSHYGASKAAQLGFMRTAAIELAPRGVTVNAILPGNILTEGLVDMGEEYISGMARSIPMGMLGSPVDIGHLAAFLATDEAGYITGQAIVVDGGQVLPESPDAVNP		271		0	Target Approved	-1	 	
Batch06	MyabA.01365.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MM73				Possible oxidoreductase	Potential drug target		MSIRRTVQEFVQRRTLLPDRIDSLIAGPGRDVRGLTVVVTGASAGIGRESVLQLRDQGARVIGVARRADELKALAAETGCEWHTCDLSHQDQIARLLEELTEQGVDVLVNNAGHSIRRRIVDASDRLHDYQRTMALNYFAAVQLSLGLLPGMIERGRGQFVNVCTWALHANTFPRFSAYAASKSALAIFGRSLNAERPHPGVHATNVHFPLVRTEMITPTEEYNDAAALSAQEAGRWIMRAVTHQPVEISPAVLRAVLPTIDLLSPTASDSTIASLT		277		0	Target Approved	-1	 	
Batch06	MyabA.01365.c	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MIN0				Probable Short-chain dehydrogenase/reductase	Potential drug target		MSLLNFDGKVVVVSGIGPGLGAALAIKFAEAGADVVLAARTQSRLDEVARQIAATGRRALAVATDITDEASAANLVERATEEFGGIDVLVNNAFSIPSMKSLEKTDYQHIRDSVELTVVGTLRLTQRVAAALAQSKGAVVNINSMVIRHSQVRYGSYKIAKAALLAMSQSLATELGPQGVRVNSVVPGYMWGENLKGYFEHQAKKYGGTVEQIYEYTAANSDLKRLPTTDEVANAVLFLASDLASGITGQALDVNCGEFHA		261		0	Target Approved	-1	 	
Batch06	MyabA.01370.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MF72				Probable phosphomannomutase	Potential drug target		MARSADAVHAVIKAYDVRGLLGEQIDESFVFDVGSSFARLIKAERDDSADSSRAPRVVVGRDMRDSSPSLAQAFTDGVTAQGVDVVQIGLASTDQLYFASGLLDCPGAMFTASHNPAAYNGIKLCRAGAKPVGKDTGLSVISGELIDGVPGYDGPVGTVTERDVLAEYGDFLRSLVQLSGARPLRVAVDAGNGMAGHTTPAVLGAIPSITLAPLYFELDGNFPNHEANPLDAENLRDLQAFVAAESADIGLAFDGDADRCFVVDERGRAVSPSAVTALVARRELEREIGGTIIHNLITSRAVPELVVEHGGTPVRSRVGHSFIKALMAETGAIFGGEHSAHYYFRDFWGADSGMLAALHVLAALSEQERPLSDLMSDYERYAASGEINFRVSNAGACIDEVLKSFGTQIVSIDHLDGVTVDIGAGTWFNLRTSNTEPLLRLNVEARTDEDVAAVVARISDLVDRTEAAT		469		0	Target Approved	-1	 	
Batch06	MyabA.01379.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MKL6				Probable dehydrogenase/reductase	Potential drug target		MTQQAMKLGYIGLGNMGAPMARRLVDWPGGLTVFDLRAEAVAPLVEEGAVGASDVADIADADLISVTVLDDAQVRQVVGQVAPKAKPGTIIAIHSTISDTTAVELAQAWRPRDIHVIDAPVSGGAPGAHKGELATMVGADGETFARVKEAFSKWASLVIHAGAPGAGTRMKLARNLLHFVAFTAAGEAQRLAESCGLDITDLGKVVRHTDAITGGPGAIMLRDTTEPVTPDSFWLPIFTHVRGLGEKDLSLALALGEEQSVDLPLATLAREQLAASLGVPHEEGASNG		288		0	Target Approved	-1	 	
Batch06	MyabA.01381.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MJ95				Probable enoyl-CoA hydratase/isomerase	Potential drug target		MIGVTSDGPVTTIELQRPERRNAVTYELALAFAEEVKKAAETARAIVVTGQGTSFCAGADLSSGAPDPDKFADAWQHSIKSVDAADIPVIAAVNGPAIGAGVMLAMVADLRVVSETARFQFPVAKYGIALDNWSIRRLTSLVGYGRARAMLLAAEPLDAQTALQTGMANRIGELADAQAWAAELAGFAPLALKHAKRVLNDDGAFEDQWPEHKELFDKAWGSQDIIEAQVARIQKRPPNFQGA		243		0	Target Approved	-1	 	
Batch06	MyabA.01395.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MEA7				Putative thiosulfate sulfurtransferase (SseB)	Potential drug target		MDVLISPSELADRLTDFRLLDVRWTVMAPDGRAAYLAGHLPGAVFVDLDVDLADHSVTGRGRHPLPTPQALAASARRWGLNDGDAVVVYDDWNGQAAARAWWLLRAAGVSNVRILDGGWAAWQRSGGPVATEEVVPVVGDITITSLHGLAAVDADAVAAQAQSPDNLVFDARAAARYRGDEEPLDPRAGHIPGAVSAPTAENLTADGTFKPVAELRERFDKLGAGAAPVTVYCGSGVTATHQIAALAIAGYDAALYPGSWSEWSSDPQRPVATGPNPA		278		0	Target Approved	-1	 	
Batch06	MyabA.01407.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MAK2				Probable dipeptidase PepE	Potential drug target		MAPQRFESDVYADRLRRAAQEAEKVGVTGLVVTPGYDLRYLTGSRAQTFERLTALVVPATGQPTVVAPRMELAALRDSAIGDLNIPISDWVDGENPYELVRAALGTAGTVAVTESMPALHLLPLAQLVGTVPVLATGVLRRLRMVKDASEIDALRKAGAAIDRVHALVPELLIPGRTEAQVAADIAEAIVAEGHSEVAFIIVGSGPHGADPHHECSDRELRTGDIVVVDIGGSYEPGYNSDSTRTYSIGEPDPDVAQRISVLERAQQAAVHAARPGVTAESVDAAARRVLTEAGMGEAFVHRTGHGIGLSVHEEPYIVEGNELVLEPGMAFSIEPGVYFPGQWGARIEDIVVITENGCESVNSRPHGLTVVPTR		374		0	Target Approved	-1	 	
Batch06	MyabA.01414.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MBC1				"Putative sulfate ABC transporter, ATP-binding protein"	Potential drug target		MATGEFLAILGPSGSGKSTLLRVLAGLEELSAGAVVWASDEGRPRTGVVFQDALLMPWLTVAENIAFAKRFGAHRSGFDDAYVDNLVRHFGLQQLSVRYPDQLSGGQAQRVAILRAAATRPGLLLLDEPFSALDPVTRADLQAWLQNLADELAVTVVLVTHDVDEALNLAHRVILLGDDGRIRQEWVLGDEGAGDRAQIRGQILAQYQPIEAAAQ		215		0	Target Approved	-1	 	
Batch06	MyabA.01414.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MN28				"Probable sulfate ABC transporter, ATP-binding protein SysA"	Potential drug target		MTAENTITVRGANKHYGDFAALDNIDFDVPSGSLTALLGPSGSGKSTLLRSIAGLDNPDSGTITINGRDVTGVPPQRRDIGFVFQHYAAFKHLTVWENVAFGLKIRKKPKAEIKKKVDDLLEVVGLSGFHTRYPAQLSGGQRQRMALARALAVDPQVLLLDEPFGALDAKVREDLRAWLRRLHDEVHVTTVLVTHDQAEALDVADRIAVLNKGRIEQVGSPEDLYDRPANSFVMSFLGPVAKLNGILVRPHDIRVGRNADLARAAAEGTGETTGVTKATVDRVVYLGFEVRVELTSAATGEQFTAQITRGDAEALGLREGDPVYVRVTRVPDVGELAEVAS		341		0	Target Approved	-1	 	
Batch06	MyabA.01455.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MCD6				"Carbamoyl-phosphate synthase, small chain (CarA)"	Potential drug target		MTDEPRARRGFGRDKAVLVLEDGRVFTGKPFGAVGETLGEAVFCTAMSGYQETLTDPSYHRQIVVATAPQIGNTGWNDEDDESRGGKIWVAGYAVRDPSNRVSNWRASGTLDDALKAQHVVGIAGIDTRAVVRHLRTRGSMKAGIFSGTVADAPTDFLLSRVNGQPAMLGADLAGEVSTASTYTVEPDGAHRFTVAALDLGIKTNTPRNFARRGIRVQVVPASISPDELLALAPDGVFLSNGPGDPATADHVVSVTRAVLDRKIPLFGICFGNQLLGRALGRSTYKMTFGHRGINIPVIDHSTGRVAITAQNHGFALEGEAGEQFDTPFGRAEVSHTCANDGTVEGIRLLDGSAFSVQYHPEAAAGPHDAEYLFDQFASALETNSENRGNR		391		0	Target Approved	-1	 	
Batch06	MyabA.01507.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MKP6				Probable fumarate hydratase Fum	Potential drug target		MSEQQYRIEHDTMGEVRVPAEALWRAQTQRAVENFPISGRGLERTQIRALGLLKGACAQVNKDLGLLAAEKADAIIAAAQEIADGKHDDQFPIDVFQTGSGTSSNMNANEVIASIAAQATPPVVVHPNDDVNMSQSSNDTFPTATHLAATEAAVRDLIPALEYLQQALATKAKAWKTVVKSGRTHLMDAVPVTLGQEFGGYARQIEAGIERVKATLPRLGELPIGGTAVGTGLNAPDGFGAKVVEVLKQSTGLSELKTASDSFEAQAARDGLVEGSGALKTIAASLTKIANDIRWMGSGPLTGLGEIQLPDLQPGSSIMPGKVNPVLPEAVTQVAAQVIGNDAAITVGGLSGAFELNVYIPVMARNLLESFTLLANVSRLFVDKCVDGLVANEDHLRTLAESSPSIVTPLNSAIGYEEAAAVAKEALKERKTIRQTVIDRGLIGDKLSIEELDKRLDVLAMAKVKD		466		0	Target Approved	-1	 	
Batch06	MyabA.01530.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MIL6				Possible enoyl-CoA hydratase	Potential drug target		MTEADALRASGSSHTVTEQDAPHALVELRDHVLIVTMNRPHARNALSGEMLEIMTQAWDRVDNDPEVRVCILTGAGGYFCAGADLKAMNKRAPGDQFSDGSYDPSVIPGLLKGRRLTKPLIAAVEGPAIAGGTEILQATDIRVAGESAKFGVSEVKWSLYPMGGSAVRLPRQIPYTVACDILLTGRHIKAPEAKDIGLIGHVVPDGQALEKALELANMIAGNGPLAVQAVLKTIRDSEGMHENEAFKADTKVGIGVFTSNDAKEGPRAFAEKRAPNFTGS		280		0	Target Approved	-1	 	
Batch06	MyabA.01530.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MM02				Probable enoyl-CoA hydratase/isomerase	Potential drug target		MSDYETLRIRRDGYVLVIGLNRPAKRNAFDKTMLEELALALGEYETDTDLRAAVLYGEGPLFTAGLDLASVAAEIQGGASLTPEGGINPWQVDGRQLSKPLLVAVHGKVLTLGIELALAADIVIADETATFAQLEVNRGIYPFGGATIRFPRTAGWGNAMRWMLTADTFDAVEAHRIGIVQEIVPVGEHVDTAIAIAQTIARQAPLGVQATLRNARLAVREGDAAAEEQLVPTVRELFTSEDATLGVQAFLSRTTAEFVGR		261		0	Target Approved	-1	 	
Batch06	MyabA.01530.c	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MIA8				Putative enoyl-CoA hydratase/isomerase	Potential drug target		MSAARELLVERDGPVVILTMNRPHRRNALSTNMVSQFAAAWDEIDHDDGIRAAILTGAGSAYCVGGDLSDGWMVRDGSAPPLDPATIGKGLLLSHTLTKPLIAAVNGACLGGGCEMLQQTDIRVSDEHATFGLPEVQRGLVPGAGSMVRLKRQIPYTKAMEMILTGEPLTAFEAYHFGLVGHVVPAGTALDKARSLADRIVRNGPLAVRNAKEAIVRSGWLAEEDARAIEARLTRPVITSADAREGLAAFKEKREARFTGR		261		0	Target Approved	-1	 	
Batch06	MyabA.01530.d	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MJK3				Probable enoyl-CoA hydratase/isomerase	Potential drug target		MSDTLVQYEVEGRAARLTLDSPHNRNALSSGLVRQLREGLQRAAADQTVRAVVLTHTGNTFCAGADLSEASEGSPQDIAKDRAGQLTALLRDILELPLPVIIAVNGHVRAGGFGLVGAADIAVAGPDSTFALTEARIGVAPSIISLTLLPRLTSRAAGRYFVTGEKFDARVAAEIGLVTQSVDSAEAVEAAVTSLVDDIALGSPQGLAESKRLTTAPILADFDARAVELTETSARLFVSPEAQEGMLAFLQKRPPAWQV		259		0	Target Approved	-1	 	
Batch06	MyabA.01530.e	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MJZ4				Enoyl-CoA hydratase/isomerase family	Potential drug target		MTSHVTLRVDGQVARVTLSRPEKLNGLTIDMLNGLTAAARHIASDNSIRVVVLSGEGDTFSTGLDFAAAGKDPARVVANFIPLPWLGTNGFQEACWAWRRLRIPVIALIHGRCYGGGLQLALAADFRFTTPDAEFSILEAKWGLIPDMSGSVTLSQLIGIDTAKRLTMTGEMFDGFYAKEIGLVTQVSADPEADAQELIDQILSRSPDSVAATKTLFDKAWSMVPRRAFGLERRLQLRLMRGANFAIARKAGIDKTEPQFKARSI		265		0	Target Approved	-1	 	
Batch06	MyabA.01530.f	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1ML12				Probable enoyl-CoA hydratase/isomerase	Potential drug target		MADEVLIEQRDRVLLITINRPDARNAVNRAVSQGLAAAADQLDSSADLSVAIITGAGGNFCAGMDLKAFVSGEAVLSERGLGFTNVPPRKPIIAAVEGFALAGGTELVLSCDLVVAGRSAKFGIPEVKRGLVAGAGGLLRLPNRIPYQVAMELALTGESFTAEDAAKYGFINRLVDDGQALDTALELAAKITANGPLAVAATKRIIIESASWAPEEAFAKQGEILMPIFVSEDAKEGAKAFAEKRAPVWQGK		252		0	Target Approved	-1	 	
Batch06	MyabA.01548.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MED0				Methionine aminopeptidase	Potential drug target		MIELKSPAEIGRMRVTGEFVASVLAELSSLAAPGVNLLDLEQRAREMVSDRGAVSCYWDYSPSFGRGPFRNVICLSVNDAVLHGLPHDYVLADGDLLSMDFAVSIDGWVADSAVSVIVGTPEPEDVRLIDTTRAALDAAIGAALPGNRLGDISAAVAAVAEGAGYRINTDFGGHGLGRTMHEDPHVPNKGTAGRGMKLEPGLTLALEPWFGRGTDRLTVDADGWTLRMADGSRGAHSEHTIAITEDGPQVLTVQG		255		0	Target Approved	-1	 	
Batch06	MyabA.01548.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MGB2				Methionine aminopeptidase	Potential drug target		MGLFGRKKTVEQRTPGELDAMAAAGSIVGAALVAVRDAAKAGVSTLELDQVAESVIREAGAVPSFLGYHGFPASICSSVNDQVVHGIPSATAVLADGDLVSIDCGAILDGWHGDSAWTFAVGTVIPSDEALSEATRLSMEAGIAAMIPGNRLTDVSHAIELGTRAAEKQFDRAFGIVDGYGGHGIGRSMHLDPFLPNEGAPGKGPLLAVGSVLAIEPMLTLGTTQTRVLADDWTVVTTDGSRAAHWEHTVAVTEAGPRILTMRP		264		0	Target Approved	-1	 	
Batch06	MyabA.01566.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MD80				Probable enoyl-CoA hydratase	Potential drug target		MTEPILLTHTEDRICTITLNRPQARNALSTALGEEIVKAVTAADADENVDVMILTAADPVFCAGVDLKELGSGDRAESLDPWWPELSKPVIGAINGAAVTGGLELALACDILIASEKARFADTHARVGILPTWGLTTLLPLSVGRGLARRMSLTGDYLSAEDALRAGLVTEVVAHNELLPAAKRLAATIAGNNQPAVRELLASYRRIESELVGNGLQVALDDAHRWIDQNSIAEGVEARRTAIMERGRSQNA		252		0	Target Approved	-1	 	
Batch06	MyabA.01582.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MFS9				Probable short-chain dehydrogenase/reductase	Potential drug target		MGQLDGRVAVITGAGRGIGREHALLFAKEGASVVVNDLGGANDGSGSDAGPAQEVVDEITAAGGKAVANTDNISTWAGASNLVNQAVETFGQLDAVVNNAGILRDGFIAGLEEEQWDAVIQVHLKGHFAVLRHAAEYWKGQAKAGADIKATVVNTASDSGVTLPNPGQGNYGAAKAGIAALSCVAAAELERYGVKVNAIAPVARTRLTLATPGMGAIFAAPVEEGAFDMFSPANISPLVAYLSTEKNPWTGQVFKVTGGSIQRLKGWSVTDTAETDGPWSIDLVRDSIEPWK		292		0	Target Approved	-1	 	
Batch06	MyabA.01582.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MH22				Probable short-chain dehydrogenase/reductase	Potential drug target		MPGLLDGRVVIITGAGRGIGRAHALAFAAEGARVVVNDIGVGLDGSAGISPAQEVVEEITAAGGEAVTNGDDVADWSGAKNLIDTAVNSFGRLDVLVNNAGFLRDRMLANMSEEEWDAVIRVHLKGHFAPLRHAAAYWRDEFKAGNAVDARIINTSSAAGLQGSVGQGNYAAAKAGIATLTLQAAAEMGRYGITVNAIAPAARTRMTEAVFAETMAKPEDGAFDAMAPENVSPLVVWLGSPESREVTGKVFEVEAGIIRVAEGWAHGPQVDKGARWDPSELGPVVTDLLDKARTPVPVYGSQG		303		0	Target Approved	-1	 	
Batch06	MyabA.01582.c	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MIK8				Putative short chain dehydrogenase/reductase	Potential drug target		MSAIADADLSGRVAIVTGAAAGLGRAEAIGLARSGATVVVNDIAPALDKSDVLDEIAAAGSKGVTVAGDIGERATADELISTAESLGGLHVVVNNAGITRDRMLFNMSDEEFDAVIHVHLRGHFLLTRNAATYWRGASKAAGAPTYGRLINTSSEAGLLGPEGQANYGAAKAGITALTLSAARALGRYGVRANAIAPRARTAMTADVFGDAPEDSIDPLSPEHVVTLVRYLAAPAAEAVNGQLFIVYGPTVTLLAAPTVEAKFTADSDAWDPSALNSTLADFFAGHDPKRTFSATALMVED		301		0	Target Approved	-1	 	
Batch06	MyabA.01585.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MPG8				"NADH-quinone oxidoreductase, E subunit NuoE"	Potential drug target		MTEVFVELGSRPSEDEGRFAGRKHYPAEVVSRLAIDAKEILDRYPSRRSALLPLLHLVQSEDGYVTTAGIEFCARQVELTSAEVTAVASFYSMYRREPTGDYLVGVCTNTLCAVLGGDAILARLAGELGVRPGGTTEDGKVTLEHIECNAGCDYAPVLMVNWEFFDNQTPDGAAALVQGLRRGHVPAPRRGAPPCTFKETARILAGFADERPEAVAAAQPGDSTLAGLRLAQDVQRNVQYKADGMRP		247		0	Target Approved	-1	 	
Batch06	MyabA.01609.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MFG2				"Probable amino acid ABC transporter, ATP-binding"	Potential drug target		MITFENVTKQYPDGTTAVDDLNMHVDKGSFTVFVGPSGCGKTTSMRMINRMTDLTSGLLTVDGADVRTVDPVKLRLGIGYVIQNAGLMPHQRVIDNVATVPVLRGESRRAARKTALEVLERVGLDPKLATRYPAQLSGGQQQRVGVARALAADPPILLMDEPFSAVDPNVRDDLQAEMQRLQAELNKTIVFVTHDIDEAVKLGDKVAVFGPGGVLQQYDEPERVLSNPASDFVAGFIGRDRGYRGLQFREAGEVPLYEIRQVREPQITDLIIAPGDWVLVCNADGTPFGWMDDAGADVYRSGKSLYDSVIAGGSLFGPDGTLRQALDAALSSPCGLGVAIDADGRVRGGVRGDDVLTALDRQRRNGQR		368		0	Target Approved	-1	 	
Batch06	MyabA.01609.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MKM2				"Putative ABC transporter, ATP-binding protein"	Potential drug target		MSDVTENATITGGARILLDGVTKLYDGKSTPAVDNVTMEIPAGETVMFVGPSGCGKTTTMKMINRLIEPTSGRIFIGDEDVTDKNPDELRRHIGYVIQGAGLFPHFTVGDNIAIVPKLLNWDKQRIDERVDELLDLVNLDPAQYRNRYPRELSGGQQQRVGVARALAADPPVLLMDEPFGAVDPITRQRLQDELLRLQEELSKTIVFVTHDFDEAVKLGDRIAILREGSQIVQYDTPEVILANPANDFVRGFVGHGAALKQLTMTRVRDVELHEAAVAHVGDDPAQAIEAAESIDREHVIVLDSHERPLRWSSLDELRAPNALQRVSQDEDLEKVSLASTLTDALEDMLTSSHGVVVVTGRRNTYQGVIRVETIMDAMAEMRAAAQ		386		0	Target Approved	-1	 	
Batch06	MyabA.01613.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MBF5				Probable acyl-CoA dehydrogenase	Potential drug target		MDLAFSAEEEQFRTEVREFLDANLTAELRAAGRLQTSVYSDHEASMRWQAILHRKGWAAPAWPVKYGGQPWSLAQHYIFSVESMVAGAPSLSPMGIRMVAHAIIKFGSPEQKEFFLPRILTGEVFFCQGYSEPESGSDLASLQMSAVADGDDFVLNGSKIWTTHAREANWMFALVRTTKGPKKQLGITFILIDFTSPGIDVKPLVMSSGEEVQNVVFFDNVRVPRANVLGEVDQGWTVAKYLLEFERGGGAVAPMLQVGLDQLSVDARSVPAENGTLADDPVFCAKLADLAIRVDVLEVLEHRVLAVVAGGGNPGAASSMLKILGTELSQALTTLTLEAAGPRGRAYQPHVTKPGGPVVEYTPPADGYHSGELWQAVAPLHYFNDRAGSIYAGSNEIQRNILAKAQLGL		409		0	Target Approved	-1	 	
Batch06	MyabA.01613.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MD78				Putative acyl-CoA dehydrogenase	Potential drug target		MPVTSSEPSSAGSNALHTSGSSQRDRVAAAAHEVLAKHPPATTPVTDLLGAVYDAGLAWVHFPVGLGGLDAPPALQAVSDTILRAAGVPDPLFVNVIGYGMAAPTVLAHGQPELIRRILRPLFTGEELWCQLFSEPGAGSDLAGLATRAVRDGDEWVINGQKVWTSGAHQARWALLVARSNPDVAKHRGLTYFVVDMTDPGVEVRPLRQMTGDAEFNEVYLTDVRIPDAHRLGNEGDGWRVSMTTLMNERSALGGAFDHGRGGGSIGNALNLWKQRPDLHTPELRAKLTNLFVRSEGNRYGTQMRIAAQGDAPMGPEGSIGKLMGAELNQQIYDFCVELLGIEATLYASYDMRRVVEDDRRADTMWAFLRSKANTIEGGTSDVMRNIIGERVLGLPGDIRVDTDKAWKDVPRG		413		0	Target Approved	-1	 	
Batch06	MyabA.01613.c	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MH09				Probable acyl-CoA dehydrogenase FadE	Potential drug target		MDLLLDDETEAFRAEVREFLVSNVPNPPLPSYDSPEGAAAHRQWERTLYDAGFSAVSWPKEYGGRDVTPLQWVIFEEEYFKAGAPARISQNGMFLLGPTLFAHGSKDQLDRVLPKMANGEEIWAQAWSEPESGSDLASLRSPARKVDGGWRLSGQKIWSSRAPFADRAFGLFRSDPDAQRHQGLTYFMFDLKAEGITVRPIPQLDGDPGFAEIFLDDVFVPDEDVIGAVHDGWRVAMSTSSNERGMSLRSPGRFLATADRLVELWKSVPENEFASERVADAWIAAQAYRLHTFGTVTRLAGGGELGAESSITKVFWSELDVALHETAIDLRGAEGELTNAWTDGYLFSLGGPIYAGTNEIQRNIIAERILGLPRESSASARTGGAK		386		0	Target Approved	-1	 	
Batch06	MyabA.01613.d	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MH11				Probable acyl-CoA dehydrogenase FadE	Potential drug target		MVESQVSPAPAGEPMSEMSDDQVRTEIREWLAENLVGEFAELKGLGGPGSEHEAFEERLAWNRHLAAAGWTCLGWPVEHGGRGATVSQRVIFYEEYARAEAPHKVNHLGEELLGPTLIAYGTPEQQQRFLPAIRDVTELWCQGYSEPGAGSDLANVSTSAVLDGGDWVINGQKVWTSLALQSQWCFVVARTEPGSSRHKGLSYLLVPLDQPGVEIRPIIQLTGTSEFNEVFFDNARTSADLVVGEPGDGWRVAMGTLTFERGVSTLGNQITYARELSRLAELAKSNGAADDPAIRERLAQAYVGMRTMRAYALATMDEERPGQDNVSKLLWANWHRDLGELAMEIIGTSTLLTNAGEMDEWQRLFLFSRADTIYGGSNEIQRNIISERVLGLPREAR		397		0	Target Approved	-1	 	
Batch06	MyabA.01625.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MCC8				S-adenosylmethionine synthetase	Potential drug target		MTEGHPDKICDAISDSILDAMLAQDPKSRVAVETLVTTGQVHVAGEVTTSAYVDIPHIVRERVLEIGYDSSSKGFDGNSCGVNVAIGAQSPDIAQGVDTAHEARVEGAADPLDAQGAGDQGLMFGYAINDTPELMPLPIALAHRLSRRLTEVRKDGLLPYLRPDGKTQVTIEYDGNKAVRLDTVVLSTQHAADIDLENLLTPDIREKVVQVVLDELNQDGLDISDYRLLVNPTGKFVLGGPMGDAGLTGRKIIVDTYGGWARHGGGAFSGKDPSKVDRSAAYAMRWVAKNVVAAGLADRAEVQVAYAIGKAAPVGLFVDTFGTATVDQAKIEKAINEVFDLRPGAIIRDLDLLRPIYAQTAAYGHFGRTDVELPWEQTDRVDALKAAI		388		0	Target Approved	-1	 	
Batch06	MyabA.01635.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MF66				Rubredoxin	Potential drug target		MSDETCVDSEYKLYECMQCGFQYDEALGWPEDGIEPGTRWDDIPEDWSCPDCGAAKADFVMVEIARP		67		0	Target Approved	-1	 	
Batch06	MyabA.01640.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MI94				Probable acyl-CoA dehydrogenase	Potential drug target		MSTAVTPSPEMCSTPLELFDTDRRLDQDERDIAATVRKFVDTKLRPNIAEWFESATLPRDLARQFGELGVLGMHLDGYGCAGTNAVSYGLACLELEAGDSGLRSFVSVQGSLSMYSIHRYGSEEQKQEWLPQLASGHAIGCFGLTEPDFGSNPGGMRTRARRDGKDWILDGTKMWITNGNLADVATVWAQTDDGVRGFVVPTATKGFAANVIHKKLSLRASVTSELVLDGVRLPDSAELPGARGLSAPLSCLNEARFGIVFGALGAARDSLQAALDYTRTREVFGRPLSSYQLSQEKLANMTVQLGMGMLLALHLGRIKDSVGLRPEQVSLGKLNNVREALNIARECRTLLGASGITLEYSPLRHANNLESVLTYEGTSEMHLLSIGRALTGQAAFR		397		0	Target Approved	-1	 	
Batch06	MyabA.01640.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1ML33				Putative acyl-CoA dehydrogenase FadE	Potential drug target		MATDAAPTNPDELFGIDALLSDEERAIRDSVRALVQARVVPNVQRWYEHGDLPVRKLALELGKIGVLGMHLHGYGCSGTSSLAYGLACMELEAGDSGIRSLVSVQGSLAMYAIYAYGSDAQKQKWLPRMATGEELGCFGLTEPDFGSNPGGMRTHARRDGSDWVLNGTKMWITNGSIADVAVIWAQTDEGVRGFLVSTDSAGFDAQTIHSKMSLRASVTAELNLVDVWVPEKNRLPLAVGLKAPLSCLNEARFGIIFGSMGAARECLRTALEYAQTREQFDRPIAGFQLTQEKLANMALEYGKGVLLALHLGRRKDADTLATPQVSLGKLNNVREAIEIARTARTILGANGISGEYPVMRHANNLESVLTYEGTSEMHTLVIGQALTGIAAFR		393		0	Target Approved	-1	 	
Batch06	MyabA.01649.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MAR0				Putative MbtH family protein	Potential drug target		MKGKLLSTNPFDDENGTFYVLVNDEEQYSLWPNAIEIPERWRVVFGAASRADCVEYVEANWLDMRPKSLRDVMAG		75		0	Target Approved	-1	 	
Batch06	MyabA.01649.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MLB5				MbtH-like protein	Potential drug target		MVSGELLSINPFDDDNGSFFVLVNDEEQHSLWPAFVDVPAGWRVVFGAADRAACLDNIEQQWPDIRPKSLRERVAQGRTVEQ		82		0	Target Approved	-1	 	
Batch06	MyabA.01649.c	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MIF2				MbtH-like protein	Potential drug target		MSINPFDDDKGSFFVLVNDEEQHSLWPAFADVPDGWRVVFGEADRAACLEYIEQNWTDIRPKSLRERLAQGGGLGR		76		-2	Work stopped	-2	Work stopped	
Batch06	MyabA.01655.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MD42				Thymidylate synthase thyX	Potential drug target		MAEIVPLRVQLIAKTDFIAPPDIDWSTDADGGPALVEFAGRACYQSWSKPNPRTATNESYLRHVIEVGHLSVLEHASATFYITGISRSCTHELIRHRHFSYSQLSQRFVPEDDSNVVLPPAVEDDPELVALVRKATDASRAAYVELLEKLESTLADVPNAVLRRKQARQAARSVLPNATETRIVVTGNYRAWRHFIAMRASEHADVEIRRLAIACLRQLADLAPSIFGDFDIATLADGTEVAISPLVYEG		250		-2	Work stopped	-2	Work stopped	
Batch06	MyabA.01657.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MD25				Possible transcriptional regulatory protein	Potential drug target		MALLLREAIGDTLRSARSGQGKTLREVSDSARVSLGYLSEVERGRKEASSELLAAICGALDVPLSQVLSEVSERLARREAPVAASEAALASTAGSLSGIDVATKVVIPQVRAMAAA		116		0	Target Approved	-1	 	
Batch06	MyabA.10050.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MCW0				Probable deoxyuridine 5-triphosphate nucleotidohydrolase	Potential drug target		MAIVRLDRELPLPSRAHADDAGVDLYSAEDVVIEPGRRTLVGTGIAVAIPSGMVGLVHPRSGLAARVGLSIVNSPGTIDAGYRGEVKVNLINLDSEVPIVIARGDRIAQLLVQQVELPELVEVDSFDEAGLAVTTRGAGGYGSSGGHASL		150		0	Target Approved	-1	 	
Batch06	MyabA.10520.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MCI1				Putative uncharacterized protein	Potential drug target		MLITGFPAGMFATNCYIVAPHEGGPAVIVDPGQDAIGGVKEILAERDLTPEAVLLTHGHLDHTWTAQPLADEYGIPVYIHPDDRVMLADPLAGIGPGLGQFIQGQVFAEPKELVEIGDGDKLELAGITLTVDHTPGHTRGSVVFGIEVDSENGPVDVLFSGDTLFQMSIGRTDLPGGNHQQLLDSIAAKLLTRDDSSVVLPGHGNATSIGDERRANPFLEGIQ		223		0	Target Approved	-1	 	
Batch06	MyabA.10520.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MAX4				Beta-lactamase-like	Potential drug target		MTSITIDDDYSGHVEPGSGVARRSVDGATIIKASVGPMDNNAYIVTCTKTGKSLLIDAANDAERLATLVDESAPNIELIVTTHQHFDHWQALEAIVGKTQSPSAAHDLDAGPLPVRPNTLLAGGDSLDIGDLHFDVIHLRGHTPGSVALAFTAAGVTHLFTGDSLFPGGPGRTTNPEEFTSLMDDLEGLVFGRYPDDTVVYPGHGDDTTLGSERPHLAEWRKRGW		225		0	Target Approved	-1	 	
Batch06	MyabA.10520.c	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MM38				Putative uncharacterized protein	Potential drug target		MSGIERVITRGTFELDGGSWEVDNNIWIVGEGDDVVVFDAAHSAQPIIDAVGGRNVVAVVCTHGHNDHITVAPELSQALDAPVLLHPADDVLWRMTHPDKDFRAVEDDMVLPVGGLELHALHTPGHSPGSVCWYAPELRAVFSGDTLFQGGPGATGRSFSDFPTILRSISGRLGPLPEDTVVYTGHGDTTTIGDEIVHYDDWVARGH		207		0	Target Approved	-1	 	
Batch06	MyabA.10611.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MKY4				Alcohol dehydrogenase B (AdhB)	Potential drug target		MYLEGLAESMKTKGALIRELNKPIVVEEITFGDPAEGEVQVQLHAAGMCHSDYHVLTGATPMELPVLPGHEGAGVVTKVGKGVTSVQEGDHVIFAFIPACGKCPPCMRGYRSLCDRGAILLGGKAIADGTNRIHAGNTPVSAMNLLGTFSPYAVVHEDSVVKIDDDVPFESAALLGCAVPTGFGSSTNIAEVKPGEDVIIVGIGGIGMSALQGAVVSGARRVIAIDPVPWKREQALKFGATHAFPTMAEALLPVMDLTWGIMAQKTIITVGEMRGEMIEEAMLLTAKTGTCVVTGMGAMVDVDVKFNLFLFTMLQKTLKGNIFGGGTTHTETPRLVGLYKQGLLKIDEMITSTYSLEQINEGYQDMLDGKNIRGVIKYTEADW		383		0	Target Approved	-1	 	
Batch06	MyabA.10611.b	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MNQ1				Probable zinc-dependent alcohol dehydrogenase AdhE2	Potential drug target		MELVDIVIPDPGPGEVVVKVQACGVCHTDLTYREGGINDEFPFLLGHEAAGIVETVGEGVTTVEPGDFVILNWRAVCGVCRACKRGRPQYCFDTFNAAQKMTLTDGTELTPALGIGAFIEKTLVHAGQCTKVDPTADPAVVGLLGCGVMAGLGAAVNTGNVGRDDTVAVIGCGGVGDAAIAGARLAGARKIIAIDTDDTKLAWAKDFGATDTINARKVDDVVTAIQELTDEFGADVVIDAVGRPETWKQAFYARDLAGTVVLVGVPTPDMTLEMPLIDFFSRGGSLKSSWYGDCLPERDFPTLVSLYQQGRLPLDRFVSERIGIESIEAAFEKMHHGEVLRSVVVL		346		0	Target Approved	-1	 	
Batch06	MyabA.10611.c	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MPB4				Probable zinc-type alcohol dehydrogenase AdhD	Potential drug target		MKTRAAVLWGLEQKWEVEEVDLDPPGPGEVLVRLAATGLCHSDEHLVTGDLPIPLPVVGGHEGAGTVVECGEGVEDLSEGDSVILTFLPSCGRCSYCARGMGNLCELGAALMMGPQIDGTYRFHARGEDVGQMCLLGTFSEYTVVPQASVVKIDGGIPLDRAALIGCGVTTGYGSAVRTGEVRAGDTVVVVGAGGIGMNAIQGARIAGALAIVAVDPVNFKREQASGFGATHTAASMDEAWSLVSDMTRGKLADVCILTTDVAEGSYTAEALALVGKRGRVVVTAIGHPDESSISGSLLEMTLYEKQIRGALYGSSNAPHDIPRLVELYSAGLLKLDELVTREYSLDQINEGYQDMRSGRNIRGLVRF		368		0	Target Approved	-1	 	
Batch06	MyabA.12797.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MHQ2				Putative uncharacterized protein	Potential drug target		MTAPVRRPVSRHQIHPPALYIGDSAASSVFRAARVRGPVARDAIAQVTGLSIATVNRQVTALLDAGLLRERADLAVSGAIGRPRVPVELNHEPFLTLGIHIGARATSIVATDLFGRTLDVVETPTPNGPQGAALASLAGSAQRYLARWHRRRPLWVGVATGGVVDGPAGTVDHPRLGWTEAPVGRVFADTLGLPVSVASHVDAMAGAELLLGLRRFAARSLTSLYVYARETVGFALAIDGRVHSPSSGPGTIAALPVDSELLGGSGKLETTVSDEAVLAAARKLRIVPAGDGVSVSAVYKAARGGNESARELLSERGRVLGQSVALLRDILNPDEVIVGGQAFTEYPEVMNDVETAFLDRSTLSKRDIRVTAFGNRVQEAGAGVVSLGGLFADPLGAMRRASARRGEASALA		412		0	Target Approved	-1	 	
Batch06	MyabA.16715.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MIT3				Beta-lactamase-like protein	Potential drug target		MVEITQVSDAVHVVNGEAVNWVIASDDSGVTLFDSGYPGDRDDVLKSIAALGHKPQDVRAVVLTHGHIDHMGTAIWWAAEHGVPVYAHNAELGNVRRDYVDQAEPLKVVLNLWRPGWLPWVIHAMRLGAGVRDGIPTAAPLGPELADLPGAPAPIPTPGHSGGHCSFLVAGHVLVVGDAIITGHPVAKRSGPQLLPTPFTKDMEQARRSAEALADVDADVLAPGHGPAWIGSLRDAVQIALNT		243		0	Target Approved	-1	 	
Batch06	MyabA.17102.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1MFV6				Putative uncharacterized protein	Potential drug target		MSTSLNTVIKRAAAYSAGSAALGIGYASIIERNAFTVREATMDVLDPGASPLRVLHISDIHMRPGQRLKQAWLRELAQWQPDLVINTGDNLAHPKAVSSVVQSLGDLLSIPGLFVFGSNDYFGPRLKNPAKYLYKSHERKHGEPLPWQDLRAAFTERGWHDMTHTRREIEVGGVRIAAAGVDDPHLHRDRYDTIAGMPNPLATLRLGLTHSPEPRVLDRFAEDGYQLVMAGHTHGGQLCLPLYGAIVTNCELDRSRVKGPSQWGSHMQLHVSAGIGTSPFAPMRFFCRPEATLLTLVPARTSGHGADAESGDRSPSATVQ		320		0	Target Approved	-1	 	
Batch06	MyabA.17112.a	Mycobacterium abscessus ATCC 19977 / DSM 44196		B1ME10				Putative uncharacterized protein	Potential drug target		MTSTSIIGSILSWLSAGYPEGVPPTDRFPLLALLRRTLTEEQVQEVVAKLTDPESSAQIDGVVSKDEIEKFIADVTKDEPTAQDISRVASRLAAGGWPLAGVDSTALNA		109		0	Target Approved	-1	 	
Batch06	MyavA.00010.a	Mycobacterium avium 104		A0QM99				"Oxidoreductase, short chain dehydrogenase/reductase family protein"	Potential drug target		MAPKVSSDLFSQIVNSGPGSFLAKQLGVPQPETLRRYRPGDPPLAGSLLIGGEGRVVEPLRAALAKDYDLVGNNLGGRWADRFGGLVFDATGITTPEGLKGLYEFFTPLLRNLGHCARVVVVGTTPDAAAGTHERIAQRALEGFTRSLGKELRNGSTVALVYLSPAAKPAATGLESTMRFILSAKSAYVDGQVFYVGEADSTPPADWERPLDGKVAIVTGAARGIGATIAEVFARDGARVVAIDVESAAETLAETASRVGGTALWLDVTAPDAVDKITEHLREHHGGHADILVNNAGITRDKLLANMDDARWDAVLAVNLLAPLRLTEGLVGNGSIGEGGRIVGLSSMAGIAGNRGQTNYATTKAGMIGLTQALAPELYDKGITINAVAPGFIETQMTAAIPLATREVGRRMNSLLQGGQPVDVAETIAYFASPASNAVTGNVIRVCGQAMLGA		454		-2	Work stopped	-2	Work stopped	
Batch06	MyavA.00113.a	Mycobacterium avium 104		A0QE92				"Erythronolide synthase, modules 1 and 2"	Potential drug target		MTPMSENGFDAAGIDPVVIVGMGVEAPGGIETAEDYWELLAHGREALGPFPTDRGWAVSELLAGSRRSGFKQIHDRGGFLSGAATFDPEFFGISPREAVVMDPQQRVALRVAWRALENSGINPDDLAGEDVGCFVGASATGYGPEMARFSEHSGHLLAGTALSVISGRIAYTLGLTGPALTVDSSCASALVAFHVAVRALQNGDCDLALAGGVNVLGSPGFFVEFSKQHALSDDGHCRPYSAQASGTVWAEGAAMFVLQRKSAALQAGRRVVAEVRATAINQDGRSAGLSAPSGDAQVRLFRRALGESGVKPAEVGMIEGHGTGTRLGDRTELRSLAQTYGDTEPGAGALLGSVKSNLGHSLAAAGALGLAKVLVSAEHGAVPPTLHATEASGEIDWEHQGLRLAQTLTPWPAIDGQRTAAASAFGIAGTNAHLIVSMPEVA		442		1	Selected	-1	 	
Batch06	MyavA.00145.a	Mycobacterium avium 104		A0QI91				Aspartyl-tRNA synthetase	Potential drug target		MLRSHAAGSLRSSDAGQQVTLAGWVARRRDHGGVIFIDLRDASGITQVVFRDPDVLKQAHRLRAEFCVAVAGLVEIRPEGNANPEIATGDIEVNASSLTVLGESAPLPFQLDEPAGEELRLKYRYLDLRRDAPAAAIRLRSKVNAAAREVLDRHDFVEIETPTITRSTPEGARDFLVPARLHPGSFYALPQSPQLFKQLLMVAGMERYYQIARCYRDEDFRADRQPEFTQLDMEMSFVDAEDVIAISEEILAALWALIGYEIPRPIPRISYADAMARYGSDKPDLRFGLELVECSEFFKDTTFRVFQAPYVGAVVMPGGASQPRRTLDGWQEWAKQRGAKGLAYVLVGEDGELGGPVAKNLSEAERAGLAGHVGAAPGDCIFFAAGPAKPSRALLGAARSEIAHRLGLIDPQAWAFVWVVDPPLFEPADDATAAGDVAVGSGAWTAVHHAFTAPKPGYEDAIETDTGNVLADAYDIVCNGNEIGGGSIRIHRRDIQERVFAVMGLDNAEAREKFGFLLEAFTFGAPPHGGIAFGWDRINALLSRVDSIREVIAFPKTGGGVDPLTDAPAPITEQQRKESGIDVKPEPSKPH		591		1	Selected	-1	 	
Batch06	MyavA.00148.a	Mycobacterium avium 104		A0QH66				Tyrosine recombinase XerD	Potential drug target		MTTVALETQLQGYLDHLTIERGVAANTLSSYRRDLRRYTKHLSDRGISDLAKVGEDDVSDFLVALRRGDPDTGAAALSAVSAARALIAVRGLHRFLAAEGLAELDVARAVRPPTPGRRLPKSLTIDQVLALLEAAGGESPADGPLTLRNRALLELLYSTGARISEAVGLDVDDVDTQARSVLLRGKGGKQRLVPIGRPAVAALDAYLVRGRSELARRGRGTPAIFLNVRGGRLSRQSAWQVLQDAAERAGITSGVSPHMLRHSFATHLLEGGADVRVVQELLGHASVTTTQIYTMVTVHALREVWAEAHPRAR		313		1	Selected	-1	 	
Batch06	MyavA.00148.b	Mycobacterium avium 104		A0QJ30				Tyrosine recombinase XerC	Potential drug target		MPDSEPILEEFDEYLALQCGRSAHTRRAYLGDLRSLLAFAGERGTGLDGLSLPLLRSWLSAAAAGGVARTTLARRTSAVKAFTAWAVRRGLLTADPAARLQVPKTHRTLPAVLRQDQALGAMAAAKNGAAQGDPIALRDRLIVEMLYATGIRVSELCGLDIDDVDTGRRLVRVLGKGNKQRSVPFGAPAGEALHAWLADGRPALANAESGPALLLGARGRRLDVRQARTVVHQTIAAVSGAPDMGPHGLRHSAATHLLEGGADLRVVQELLGHSSLATTQLYTHVAVSRLRAVHDQAHPRA		301		1	Selected	-1	 	
Batch06	MyavA.00155.a	Mycobacterium avium 104		A0QK53				ATP-dependent DNA helicase	Potential drug target		MVPGDEAFRAAGCAGAGRLAGARCTAFVTDLSVWEAKMDAMPTLADPLTAGLDDEQREAVLAPRGPVCVLAGAGTGKTRTITHRIAQLVAGGHVAANQVLAVTFTQRAAGEMRSRLRALAAAAGTDAAVGSVSALTFHAAAHRQLRYFWPRVVGDTGWQLLDSKFAVVARAASRTRINASTDDVRDLAGEIEWAKASLIGPEEYPAAVAAAGRDIPLDAARVAGVYAAYEALKARGDHVTLLDFDDLLLHTAAAIENDPAVAEEFRDRYRCFVVDEYQDVTPLQQRVLAAWLGDRDDLTVVGDANQTIYSFTGASPRFLLDFSRRFPDATVVRLERDYRSTPQVVSLANQVIAAARGRVAGSKLHLVGQRPPGPVPTFHEHPDEPAEAAAVAKSIARLIESGTPASEIAVLYRVNAQSEIYEEALTEAGIPYQVRGGEGFFNRQEIKQALLALQRAAEREGEDARAEPLPAVVRAVLEPLGLTADEPVGTRARERWEALRALAELVDDEVARRPQLDFAGLLTELRMRADARHPPVVQGVALASLHAAKGLEWDAVFLVGLADGTLPISHALAHGADSEAVEEERRLLYVGITRARTHLALSWALARSPGGRQSRKPSRFLNGIAPQTRAEAAPTRSRRNRSAATRCRICNNNLTTPAAVMLRRCETCAADIDEDLLVRLKAWRLDVAKEQKVPAYVVFTDNTLIAIAELRPGDEQALIAIPGIGARKLEQYGPDVLELVRGR		743		1	Selected	-1	 	
Batch06	MyavA.00163.a	Mycobacterium avium 104		A0QHB6				Phenylalanyl-tRNA synthetase alpha chain	Potential drug target		MDLSETALAEAVGAARQAFARAGDLDALARLKTEHLGDRAPLALARQALGGVPKDQRADAGKRVNAARAQAQQAYDERLAELRAERDAAVLVAERIDVTLPSTRQPVGARHPITILAEHIADTFIAMGWELAEGPEVEAEQFNFDALNFPADHPARSEQDTFYIAPEGSRQLLRTHTSPVQVRTLLARELPVYVISIGRTFRTDELDATHTPVFHQVEGLAVDRGLSMAHLRGTLDAFARAEFGPQARTRIRPHFFPFTEPSAEVDVWFVGKKGGAGWVEWGGCGMVHPNVLRAAGIDPDVYSGFAFGMGLERTLQFRNGIPDMRDMVEGDMRFSLPFGVGA		342		1	Selected	-1	 	
Batch06	MyavA.00168.a	Mycobacterium avium 104		A0QAB3				2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase	Potential drug target		MAPETGSSGAVAAVVPAAGSGERLAAGIPKAFCEIDGASMLARAVAGLLDSKVVDHVVVAVPADRVDEAKRLLAAQATVVAGGADRTASVRLALAAVPGNPAFVLVHDAARALTPPALIARVVQALRDGHRAVVPALPLHDTVKAVDANGVVLGTPERDGLRAVQTPQGFATDLLLRAYAAGAGTAGFTDDASLVEHVGGQVQVVDGDPLAFKITTQLDLLLAETIVRR		229		1	Selected	-1	 	
Batch06	MyavA.00185.a	Mycobacterium avium 104		A0QD64				"Acyl-CoA dehydrogenase, C-domain protein"	Potential drug target		MSTVDSPEKILFTSTTQAFLEKEAPLRRVRELHAAGTAFDPGWWRRAAELGWTGLLVPEELGGGSVSESGLADLATVAEQLGKTVAPGPLYPVSIVLSALAECSGAETHRDVIEALISGETVASWAVYEPGQGWAPLNPSVTATETDSGYRIDGVKDRVEAGAQSALLLVVARCGADGQIRQFLVPTDAPGVRIEPQQSVDLVKQYARVHFDGVVVPRSAAVGTAAETATLIERQSQLAQVLQCAEVVGVVQTVFDFTTQWALDRHTFGRPLASYQALKHKFADMKLWLEACRATTWAAVAEVAARSPQAGLSASIAKSYVGEMAGQIVQACVQMHGGIGVTWEHDLHLYLRRVTLYRGMFGTPEEHNLRVYQFEKAGGAAK		382		1	Selected	-1	 	
Batch06	MyavA.00185.b	Mycobacterium avium 104		A0QKE6				Acyl-CoA dehydrogenase	Potential drug target		MAGWAGNPDFDLFQLPEEHQELRAAIRALAEKEIAPHAADVDENSRFPQEALEALNAAGFNAVHVPEEYGGQGADSVAACIVIEEVARVDTSASLIPAVNKLGTMGLILRGSDELKKQVLPSIADGSAMASYALSEREAGSDAASMRTRARADGDDWILNGAKCWITNGGKSSWYTVMAVTDPDKGANGISSFMVHKDDEGFTVGPKEKKLGIKGSPTTELYFENCRIPGDRIIGEPGTGFKTALATLDHTRPTIGAQAVGIAQGALDAAIAYTKERKQFGRPVSDNQGVQFMLADMAMKVESARLMVYHAAARAERGESHLGFISAASKCLASDVAMEVTTDAVQLFGGYGYTQDFPVERMMRDAKITQIYEGTNQIQRVVMSRALLR		389		1	Selected	-1	 	
Batch06	MyavA.00191.a	Mycobacterium avium 104		A0QJV0				NADH-quinone oxidoreductase subunit D	Potential drug target		MSTTTESTHDGAGETLVVAGGQDWDKVVEAARSADPGERIVVNMGPQHPSTHGVLRLILEIEGETVTEARCGIGYLHTGIEKNLEYRYWTQGVTFVTRMDYLSPFFNETAYCLGVEKLLGITDQIPERVNVIRVMMMELNRISSHLVALATGGMELGAMTPMFVGFRGREIVLTLFESITGLRMNSAYIRPGGVAQDLPPNAKTEIAQALDQLRQPLREMGDLLNENAIWKARTQDIGYLDLTGCMALGITGPILRATGLPHDLRKSEPYCGYENYEFDVITADTCDAYGRYMIRVKEMWESIKIVEQCLDKLQPGPIMVENGKIAWPADLKVGPDGLGNSPEHIAKIMGGSMEALIHHFKLVTEGIRVPPGQVYTAVESPRGELGVHMVSDGGTRPYRVHYRDPSFTNLQSVAAMCEGGMVADLITAVASIDPVMGGVDR		441		1	Selected	-1	 	
Batch06	MyavA.00200.a	Mycobacterium avium 104		A0QHS0				LAO/AO transport system ATPase	Potential drug target		MSGRTVTELAEAIRSGDRAALPRAITLLESTRADHQEQAQQLLLELTPDAGDAHRVGITGIPGVGKSTSIEALGMHLIGLGHKVAVLAVDPSSTRTGGSILGDKTRMARLANHPDAYIRPSPTSGTLGGVAKATRETVVLLEAAGFDVILIETVGVGQSEVTVANMVDTFVLLTLARGGDQLQGIKKGVLELADIVVVNKADGEHLAEARSAARELSGAIRLIHPRETLWRPPVLTMSAAQGTGLPELWETIERHRQVLSKAGEFEARRRSQLVDWTWQMVRDTVLDRLLSNPAVRTMRADVERRVKAGELTPALAAQEILAAASR		326		-2	Work stopped	-2	Work stopped	
Batch06	MyavA.00212.a	Mycobacterium avium 104		A0QKB8				Rubredoxin	Potential drug target		MTRYRCPGCDYIYDEAKGAPREGFPAGTPFADIPDDWCCPDCAVREKVDFENLIGQE		57		1	Selected	-1	 	
Batch06	MyavA.00213.a	Mycobacterium avium 104		A0Q9F0				Enoyl-CoA hydratase	Potential drug target		MAQAYESVTVEKKGHVAQVTLIGPGKGNAMGPAFWSELPELFETLDADPEVRAIVLTGSGKNFSYGLDVPAMGGSFTPLLSGDALAGPRAVFHREVKRMQGAITAVADCRTPTIASVHGWCIGGGVDLISAVDIRYASADAKFSVREVKLAIVADVGSLARLPYILNDGHLRELALTGKDIDAARAEKIGLVNDVYADADACLAAAHATAAEIAANPPLTVHGIKDVLDQQRASAVAESLRYVAAWNAAFLPSKDLTEGIAATFEKRPAQFTGE		274		5	Purified	-1	 	
Batch06	MyavA.00247.a	Mycobacterium avium 104		A0QIQ6				Long-chain specific acyl-CoA dehydrogenase	Potential drug target		MSSAIKYQRTLFESEHELFRESYRAFLDRHVAPYHDEWEKAKIVDRGVWLEAGKQGFLGMAVPEEYGGGGNPDFRYNTIITEETTRGRYSGIGFGLHNDIVAPYLLALATEEQKQRWLPKFCTGELITAIAMTEPGTGSDLQGIKTRAVKQGDHYVLNGSKTFITNGINSDLVIVVAQTDPDKGAQGFSLLVVERGMEGFERGRHLDKIGLDAQDTAELSFTDVHVPAENLLGQEGMGFIYLMQNLPQERISIAVMAAAAMEQVLEQTLEYTKERKAFGKSIGSFQNSRFVLAELATEATVVRMMVDEFVRLHLDHKLTAEQAAMAKWYSTEKQVHLIDRCLQLHGGYGYMREYPVARAYLDARVQTIYGGTTEIMKEIIGRSLGV		386		1	Selected	-1	 	
Batch06	MyavA.00247.b	Mycobacterium avium 104		A0QBQ6				Putative acyl-CoA dehydrogenase	Potential drug target		MNLWTTPEREQLRKTVRSFAEREILPHVDEWERSGELPRELHRSAGAAGLLGAGFPESVGGGGGDGADAVIICEEMHQAGAPGGVFASLFTCGIAVPHMIASGDQRLIEEFVRPTLAGEKIGSLAITEPGGGSDVGHLRTSAVRDGDHYIVNGAKTYITSGVRADYVVTAVRTGGPGAAGVSLLVVEKGTPGFEVTRKLDKMGWRSSDTAELSYTDVRVPVSNLVGAENTGFAQIAQAFVSERIGLAAQAYSSAQRCLDLTVQWCRDRETFGRPLISRQSVQNTLAEMARRIDVARVYSRNVVERQLAGETNLIPQVCFAKNTAVEAGEWVANQAVQLFGGMGYMAESEVERQYRDMRILGIGGGTTEILTALSAKLLGFQS		382		1	Selected	-1	 	
Batch06	MyavA.00247.c	Mycobacterium avium 104		A0QDQ7				Long-chain specific acyl-CoA dehydrogenase	Potential drug target		MRRNIFDEVHEDFRATARAFFERECVPNIEKWERDGKVSREAWLAAGEHGLIGWEFDEKYGGLGVKDFRFNQIISEEMFMTGSVGIGLGVQNDILMPYLNNLTTEEQKERWLPKFTSGEYIGSIAMSEPAAGSDLAGIKTTARDEGDHWVVNGQKTFISNGLLSKLVLTAVKTDPSARHKGISLLMIEDGMDGFTRGRKLDKIGQYSADTAELFFEDVRVPKENLVGELNRGFYHLVSNLPSERVGVACYALPAARRALELTKAYALERTAFGQPIGKFQVNRHFLAEMQTKLDAAQAYLDQCVLSVNDGTLSDADAAGLKWWTSEIQWEIIDRCLQLHGGYGYINEYEVARLWRDARVQRLYAGTTEIMKDLVGRAMGY		380		1	Selected	-1	 	
Batch06	MyavA.00247.d	Mycobacterium avium 104		A0QDW5				Putative acyl-CoA dehydrogenase	Potential drug target		MKRLVLESEHEAFRETVRQFIDQELVPNAEKWETNRLVDRSAWVAAGKYGLIGFNMPEQYGGSGVDDFRFNAVIDEEIARYGGPAPALSLQNDVVGPYFSSLSNDEQKERWLPGITTGELIVAVAMTEPGAGSDLAGIRTSAVRDGDDWIINGAKTFISSGINCDLVVVVCRTDPDAGHKGFTLFVVEAGMDGFTRGRKLDKMGLHYQDTAELNFDNVRVPSANLLGKEGRGFYHLMHNLPSERLSIAISAIAGARETWRQTLQYAKDRKAFGQPIGSFQHNRFMLAEMDTELEIGEQYIDRCLQAVVDGELTAVEAAKAKWWCTETAKKVIDGCVQLHGGYGYMTEYRVARDYMDNRIMTIFGGTTEIMKDIIGRDLGL		380		1	Selected	-1	 	
Batch06	MyavA.00247.e	Mycobacterium avium 104		A0QFR5				Long-chain specific acyl-CoA dehydrogenase	Potential drug target		MRRNIFEEIHDEFRATARSFFERECVPNVEKWERDGKVSREAWLAAGEHGLIGWEFDEKYGGLGVKDFRFNQIVSEEMFLTGSVGIGLGVQNDILVPYLNDLTTEEQKERWLPKFVSGEYIGSIAMSEPAAGSDLAGIKTTARDEGDHWVVNGQKTFISNGLLSKLVLTAVKTDPSARHKGISLLMIEDGMEGFTRGRKLDKIGQYSADTAELFFEDVKVPKENLVGELNRGFYHLVSNLPSERVGVACYALPAARRALDLTKTYASERTAFGQPIGKFQVNRHFLAEMQTKLDAAQTYLDQCVLSVNDGTLSDQDAAGLKWWTSEVQWEIIDRCLQLHGGYGYINEYEVARLWRDSRVQRLYAGTTEIMKDLMGRAMGY		380		2	Cloned	-1	 	
Batch06	MyavA.00247.f	Mycobacterium avium 104		A0QFV3				Acyl-CoA dehydrogenase	Potential drug target		MKRLVLEPEHEAFRETVRQFIERELVPNAERWEADRIVDRSAFVAAGKYGLIGFNMPEQYGGGGVDDFRFNAVIDEEIARYGGPSPSLSLQNDVVGPYFSSLANDEQKERWLPGIVSGELIVAVAMTEPGAGSDLAGIRTSAVRDGDDWIINGAKTFISSGINCDLVVVVCRTDPEAGHKGFTLLVVEAGMEGFSRGRKLEKMGLHYQDTAELAFENVRVPSANLLGKEGRGFYHLMHNLPSERLSIAISAIAGARETWRQTLQYAKDRKAFGQSIGSFQHNRFLLAEMDTELEIGEQYIDRCLRAVVDGELTAVEASKAKWWCTETAKKVIDGCVQLHGGYGYMTEYRVARDYMDNRIMTIFGGTTEIMKDIIGRDLGL		380		1	Selected	-1	 	
Batch06	MyavA.00247.g	Mycobacterium avium 104		A0QG56				Putative acyl-CoA dehydrogenase	Potential drug target		MSELFPDYRPSWETDQHRELRKHAAEFFRKEATPNQERWAAQHAVDREFWNKAGDAGLLGLDLPEEYGGAGGDFAMNVVVQEELAYAYDQGFGFAVHSPIVAHYIWAYGSDEQRRRWLPKIISGEAVLAIAMTEPGTGSDLQSVKTTARRDGDFYVINGSKTFISNGTHCDLLVIVAKTDPSKGAAGVSLIVAETDENLAGFERGRVLAKMGQHAQDTRELFFSDMRVPVANLLGAQEGLGFYQLMEQLARERLIIATICAALAEVAVLEAIKYSREREAFGRPIGKFQHTKFVLAECKTEALAIKTMVDYAVGQYLDGKNDPATASMAKLFAAEKSDQIVDKCLQIFGGYGYMTEYPIANMYTASRVNRKYGRTSEIMKEIISRSL		387		4	Soluble	-1	 	
Batch06	MyavA.00247.h	Mycobacterium avium 104		A0QGM3				Putative acyl-CoA dehydrogenase	Potential drug target		MTTLSAATTADIDHYRTVLAGAFDDQVLEWTREAEARQRFPRELIEHLGARGVFSEKWCGGMLPDVGKLVELARALGRLSSAGIGVGVSLHDSAIAVLRRFGKSDYLRDICERAIAGQAVLCIGASEESGGSDLQIVRTEMSSRDGGFDVRGVKKFVSLSPIADHIMVVARSIDHDSASKHGNVALIAVPTSQVSVQRPYAKVGAGPLDTAAVHIDTWVPADALVARAGTGLAAISWGLAHERMSIAGQIAASCQRAIGITLARMMTRRQFGRTLFEHQALRLRMADLQARVDLLQHGLNGIAAQGRLDLRAAAGVKVTAARLGEEVMSECMHIFGGAGYLVEETPLGRWWRDMKLARVGGGTDEVLWELVAAGMAADHGGYRSVVGASSA		391		5	Purified	-1	 	
Batch06	MyavA.00247.i	Mycobacterium avium 104		A0QLV7				Long-chain specific acyl-CoA dehydrogenase	Potential drug target		MAAHLQYTSEHHQFRELVRDFVQRTVVPNHEKWERDGQWDRSLFVEAGKLGLLGFSVPERLGGPGVDDFRYNAIVVDELQRAGAAAEAIAFSLQNDIVLPYLVELTTPEQQRRWLPGVVTGETVLGIAMTEPGTGSDLAGIRTTAVRDGDHYLVNGAKTFISNGQVGDLFVVAVRTAPDRHKGLSLLVVDADTPGFGRGRNLEKIGLHAQDTSELSFTDMRVPAENLLEAEGRGFYQLMKNLPQERLSLAVGAVAAAEAVFAETLDYVKQRHAFGAPIAAFQNSQFVLAELATEIDVARTYLDDCLAAHLTGELTAARAARLKWWTTDLQVRTADRCLQLHGGYGYMREYGVARAFVDARIQTIYGGTNEIMKTIIAKDLGL		382		1	Selected	-1	 	
Batch06	MyavA.00247.j	Mycobacterium avium 104		A0QMQ0				Acyl-CoA dehydrogenase	Potential drug target		MRRSLYGEDHEAYRETVREFLAREVVPFQHDWDRDRWIDRAVFPRAAKAGIYALQVGEEYGGAGESDYRYRMVVCEEVSRVTALSFGLTISLQDDLVLHYLLDLTNDEQKQRWLPGFAAGELIGALAMTEPGAGSDLRGMRTTAHRDGDQWILNGQKTFISSGIMADVVVVAARTDPNGGSGAFSLFVVERDTPGFERGRKLDKIGLPAQDTAELYFRDAQVPGANLLGTVGEGLRYLMSHLPRERLGVTAKSLATTRAIFDTTVEYCQQRMAFGGPLTDKQHIRFELAEMATEIDVAEAYVDKSVLAYNAGELTAVDAAKGKWYLSELQKRVIDRCLQLHGGYGYMTEYPVARAYLDTRIQTIYGGTTEIMKEIIGRDIAKS		383		1	Selected	-1	 	
Batch06	MyavA.00249.a	Mycobacterium avium 104		A0QIU1				Thymidylate synthase	Potential drug target		MPIPTPYEDLLRLVLDRGTAKSDRTGTGTRSLFGQQLRYDLSAGFPLITTKKVHLKSVVYELLWFLRGDSNVDWLHRHGVTIWDEWASDTGDLGPIYGVQWRSWPTPSGEHIDQISAALDLLRTDPDSRRIIVSAWNVGEIPRMALPPCHAFFQFYVADGRLSCQLYQRSADLFLGVPFNIASYALLTHMMAAQAGLSVGEFVWTGGDCHIYDNHVEQVRLQLSREPRPYPELVLAHRDSIFDYTYDDVVVHNYDPHPAIKAPVAV		266		4	Soluble	-1	 	
Batch06	MyavA.00250.a	Mycobacterium avium 104		A0QM95				NADH-fmn oxidoreductase	Potential drug target		MNSNNKLTASSLREAFGHFPSGVVAIAAEVNGTLEGLAASTFVPVSLDPPLVSFCVQNTSTTWPKLKDRPMLGISVLGEEHDEAARTLAAKTGDRFAGLETVSRPTGAVFIKGTALWLESAVEQLIPAGDHTIVVLRVNEVTVDANVAPIVFHRSGFRRLGA		162		7	Crystallized	-1	 	
Batch06	MyavA.00250.b	Mycobacterium avium 104		A0QAD6				Putative flavin reductase	Potential drug target		MAAPIDPRTFRQVLGQFCTGITIITTVHDEVPVGFACQSFAALSLDPPLVLFCPTKVSRSWKAIEATGRFCVNVLTEKQKHVSARFGSKEPDKFAGIDWHPSELGSPIIDGALAHIDCTVASVHEGGDHFVVFGAVQSLSEAPKIKPRPLLFYRGEYTGIEPDKTTPAQWRDDLEAFLTTTTQDTWL		187		5	Purified	-1	 	
Batch06	MyavA.00272.a	Mycobacterium avium 104		A0QHJ9				Putative 8-amino-7-oxononanoate synthase/2-amino-3-ketobutyrate coenzyme A ligase	Potential drug target		MKAPIEVSPLAWLDAVEQQRRAAGLRRSLRPRPPVATELDLASNDYLGLSQHPDVIDGGVAALRLWGAGATGSRLVTGDTELHQQFESELADYVGAASGLLFSSGYAANLGAVVGLSGRGALVVSDAYSHASLVDACRLSRARVVVTPHRDVDAVLAALADRDEERAVVITESVFSTDGALAPLRELHEVCRRHRALLIVDEAHGLGVRGGGRGLVFEAGLAGAPDVVMTTTLSKALGSQGGAVLGPAAVRAHLIDAARTFIFDTGLAPAAVGAARAALGVLRAEPWRVGAVLRHAGVLAEVCRVREVPQSAVVSVILGDPDVAVAAATACLDAGVRVGCFRPPTVPAGTSRLRLTARASLDDAELEVARRVLTDVLAGLG		381		4	Soluble	-1	 	
Batch06	MyavA.00277.a	Mycobacterium avium 104		A0QFL7				Alpha/beta hydrolase fold domain protein	Potential drug target		MADRLPDDAFTAPQVVDPGLRKVARFLPRGYALHRGLKLQRAIMNLMGNAGRLRTVPVVAVNEHVTVRLHRPPNLAEHAPALLWTHGGGTVMGHAAQDDKYLRKLSHRTGVAIAAVEHRLAPEHPYPAPVEDCYAALLWLARQPWVDPERVAVGGASAGGLFAATLAQRAHDRNDVKIAFQMLVYPMLDD